<SEC-DOCUMENT>0001093557-21-000024.txt : 20210211
<SEC-HEADER>0001093557-21-000024.hdr.sgml : 20210211
<ACCEPTANCE-DATETIME>20210211171805
ACCESSION NUMBER:		0001093557-21-000024
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		99
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210211
DATE AS OF CHANGE:		20210211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DEXCOM INC
		CENTRAL INDEX KEY:			0001093557
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330857544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51222
		FILM NUMBER:		21620976

	BUSINESS ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582000200

	MAIL ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>dxcm-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:50830476-969b-49ba-9748-d2c55f5055b8,g:ea51fe61-a1e0-4e98-8988-a47cbbc74de5,d:889b093251984bfb881a094ef59c54bd--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:dxcm="http://www.dexcom.com/20201231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dxcm-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl8zLTEtMS0xLTA_20e7cdfd-1d69-430f-a409-697916b46f5b">false</ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl80LTEtMS0xLTA_e9a9a873-59e6-478e-a2d7-1380ee612351">2020</ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl81LTEtMS0xLTA_2eefece5-d704-4bd9-8373-8363eb1c115b">FY</ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl82LTEtMS0xLTA_93691ceb-370f-4a0f-a9db-0e510827285a">0001093557</ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl83LTEtMS0xLTA_a5970f47-52e7-4ce2-a766-087955421373">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE0LTAtMS0xLTc4NjY_fb45f1c2-c2da-492b-84ee-10fe91b82ae4">us-gaap:AccountingStandardsUpdate201602Member</ix:nonNumeric><ix:nonNumeric contextRef="ia434b2a9257449fd8249cceb27254ff0_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE3MDQyNDMwMjk0NDM5_2fca5438-1d1d-4e75-bbcb-835f55e20811">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="i25599498524d40f9acb652bfbaa12e50_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE0MDk5_34699fb7-9374-4f8a-8afb-b91db71681d7">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="ibbb84a4a26f3410fb9ecbca78f99e413_D20200101-20201231" name="dxcm:AmortizationPeriodForIncentiveCompensationCosts" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI0MTYy_26f15051-f810-463e-bb6f-d6109b4adecc">P1Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i77366a73d9404bcfb0249f49a6494d32_D20170601-20170630" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzYvZnJhZzo1NzdiZDcyM2JmZDk0Y2JjYmM5YTViYTc5NzJkYWI4Yi90YWJsZTo1NzcwNjYyNTU3Nzg0ZWQyYWEzYzVhYTQwNTMwZWExNS90YWJsZXJhbmdlOjU3NzA2NjI1NTc3ODRlZDJhYTNjNWFhNDA1MzBlYTE1XzMtMS0xLTEtMA_c0c182de-8828-4746-91be-84d2f630acd2">0.0000100918</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzYvZnJhZzo1NzdiZDcyM2JmZDk0Y2JjYmM5YTViYTc5NzJkYWI4Yi90YWJsZTo1NzcwNjYyNTU3Nzg0ZWQyYWEzYzVhYTQwNTMwZWExNS90YWJsZXJhbmdlOjU3NzA2NjI1NTc3ODRlZDJhYTNjNWFhNDA1MzBlYTE1XzMtMi0xLTEtMA_9b4e6a53-a2be-4b47-b45a-71f3c9ae8818">0.0000060869</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i87bd51729d3940a5b519f98ea0248948_D20181101-20181130" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzYvZnJhZzo1NzdiZDcyM2JmZDk0Y2JjYmM5YTViYTc5NzJkYWI4Yi90YWJsZTo1NzcwNjYyNTU3Nzg0ZWQyYWEzYzVhYTQwNTMwZWExNS90YWJsZXJhbmdlOjU3NzA2NjI1NTc3ODRlZDJhYTNjNWFhNDA1MzBlYTE1XzMtMy0xLTEtODEyMg_8ace8083-93ac-4d97-b952-333b060a3cfd">0.0000016655</ix:nonFraction><ix:nonNumeric contextRef="if0763f994d3d4e1caba905e8a1c1bf92_I20201231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzI4Mg_e822fe76-398d-4dc9-abc3-bdd5759fa7f2">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i8fe8680967ea40c7b595ca27e03b1bbb_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM3NDA_edbeb2b1-17ac-466a-946c-e20c5a225c47">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dxcm-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="id874e873187245ef8983f0949a6da29c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ib306ec0bfb0d4471a50748795fd3e82b_I20210204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1697460f2cd94010a9df70dc435b1690_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09e2f6d29705425da4375d800e0c8257_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62ab2abda0de42659a37b9c9f8196c4a_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7f9f30a2abc40808a41b3885af720d9_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a3a2bd79c1246d89a94242e2cd12c96_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d1e7482b0864e9f85af3dff1a4430f1_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9fd427acdbc486a9e8edee4ccc7110c_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic82615128e2c4fc99ac6cee2560ef199_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i334065d7da4c4bbd8735b1a9237ca649_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd8fb94803f34b96a82fb0ebc3e1cba8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddc2ad90e3a745f583d12c18ce94e654_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2c0cbd5c0f241d4985442b984220cf7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4859a89543554757a0237d357c2029c8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f94c40295974007abccd11273ce6988_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3afb9980ee644d22897fe66e8e9f3621_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc3e8df174cb41c9a8ef16f4487803b8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd074ca304794ce49a646d4278e77cdd_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb937d881cb42d6a0f935a924001c2f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f5c2cc37a5477db6d781d12fe77f0f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice5479f1e1694af1aafc253e8cf22247_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06733029c370448ba5d57587ce16bda1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cc1828a50774882930e3febccea7246_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3962ec3ca47246e5afc8c09df3185349_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib08750c5e7ec4f89a130804838db3915_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50619200f7264c2d9ac57a9f7ac26a68_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ff836d4cc04bac915b60eb3b0276b8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53e29bb6e76c4d0abc2e92543b07c60d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie43b7f8664fd4e7fa1c96e2b2325534a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i999d507de85644e59daac2a6a6a98654_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c875e94a27c489ca8dbc61fe476e69f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8815ef6d44b14de195293c0935f6df41_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf189edb39e14e54937ee10b5be44dd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2202fad57c63453e9b1b404a15b6e82d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3351b0dd70c24b04bc98a96abb444375_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0eec6c3ccfc41bebe1fab61a4e0fc10_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341885eacad94bbc9b111e97938ab5d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic9cff1bc2dac48ea90553b980fd2c925_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96dbf53aa4aa48419562b1d395e1f854_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaed968ca04841ac838a9395b4ddde38_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadc9086aefb444be9c59339767825b54_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1042cfd24eb042868d75c1ab948d9274_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e33652311eb4e57bd6bfd8727b45672_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9910d7cdf82d4d41af4edfbba713867d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib53ea3ab72fb4434808baeb3dbdd3757_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6bcd786fb0b4ea9b8f9951d9cf922c9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51c0e602241341029dd0c585c07f2640_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e8e542173bc421a8ea7fcba19440c37_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idddb7ec6794e442290c8762383c2f014_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3da214a5bd4cd99d307ec8fba40242_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a50a7ab68a24d07a8592dacb3cb2ed5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia434b2a9257449fd8249cceb27254ff0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i937ac9769efb417fa531b7ef2eaf0b5b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5136399a37e14cb998f33ad3100276b8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie05ee9ac1ff14752904b83c729c90efe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25599498524d40f9acb652bfbaa12e50_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbb84a4a26f3410fb9ecbca78f99e413_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i623dc723c3654d6f84c0203133743a3c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i487acee9456946cdb9c4c15b15b58728_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1e6715852d34c6d9cf08a930ee3485b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i954b8f3c51d640ac8ab5dd40a78b5387_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib32ce2a545784b15ac52d142f35bd1ca_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9471ca1928864644924a2ba32d88cc1f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic931fab80e0d492e975aaa6194f8e114_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4966c3d9c394b12bda5b16597859370_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa97d31ed824316b5f9b802f7fbd276_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf74b07e99d94f2c93e41b91727019c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife10a97075fb4eaebce519044eed7ce7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcf57f15378a4158b986a2e96c250eea_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i615df7321c9348c998d7e063f8bd67aa_I20181120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcc7e8952bad4da2bbf8948b84f5ae8d_D20181120-20181120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-20</xbrli:startDate><xbrli:endDate>2018-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcad237c07544045a0efa52e0443d72f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31d2218e16f24d919d743df0127d21f8_I20181228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4b6d430ae4d4e93bade0e1a590f3f1e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4df6a91f5c464feda5d61246887477e0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceaf0df0d90548128c251bbadb05470c_I20181120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib24f50ea0be64889a78368325e28c1b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8927c59d45b409899e39263bc914622_D20181120-20181120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-20</xbrli:startDate><xbrli:endDate>2018-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6ebe15ea5354284a29045fe47fb46b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09bae00ae8514ff08a6985ab2ac96d46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e343c46b6194f4380e1fe7c51520054_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a5cda91bc024f7090c90466831fa67a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb5aff7c546d45ba9ec38abb08822d8d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id92b9c26d62a4ca287002134a8a256e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib910a32cb01f4e5390ee06e908c61c31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8535192ed8644f5582f70c23c1378c5b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8276529a58434a7b813dcb46b73073f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf3265a756884edc835fa906c7740171_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6072b512879424581f8888ccf4b1714_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ce4bc5e66a842608d994966881082ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf7749c1aed641479a3729499651b209_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cac588c14d54e36b24ced9f8983c608_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33c17b8f03144e119934ea6043ba9473_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica5b87038a814ec1a6c4020d34fb75fb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a704f3be5c848d5b0eb7eca70324e2b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0905eace1d084bdbae0f064671806ef4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd1de93377374c41ad096882be863dc4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88a4128e1836441785ef95ceb6d9f5ef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i370e2a274e894e17830c5dd4de2f0b14_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieebd5d2f1c504a48ad99159aa9507fc7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0632744de077450ba1f1cc509a18cf6e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i314750f344f946b9bb09c3930fd9d8f7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd57f0d5e88a4997a01dff3a6ac5d84f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61493ab0d7cc4e5d840ceb144efade0b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i667ef1514f464c018ac2d87ad6fd7fb4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8f2e89c0f47427ca284b54295ee9475_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i824914321cdf4eb3bab58c165184aebe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea63bf6b583842f8afb95e80d99e8bb1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094a2a8c50c44667a8ed8cffec42dee4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b91b53fe18c4c4ea50245a93565fd7d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6352fa03b74e459290adcf2b8f29d7e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57670ce42c9048fd998b9d1f66f24047_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a7900a1db994a859636735a0f0324a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i833d598aaf8f47baa412832261515cfc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fb0b180cb694f118960ccc9da9e7d85_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f7515fed1ce4589adbabde6cf4f20cd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9decf99cba94ae588c9c036d46e7a88_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaad228cd33024cad88643caf07e6164a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057d34c5ad2a4be99a734d6e91c1a7fe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300b1ce4d8494fc99011c04df98671bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b55a585c4b242df8b97a38b585d21d1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib254b46104664cc0bea561395f6e1d0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45ff6f9c8a1c4dc49b7be4fa6bfb4e0a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id65cdf0bbb534ff8b54804c8c04e4d6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifba7e8356ca14d2ba58dddba2df2d708_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icab58e138022469894bc21a0ced86296_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d744ae1b6b4be5bcb2a6eeb386c04b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa80ff42b6994adb90d475cddbd0d364_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd00f21e56f5451794ad6ac6c3bfa468_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cbe832d48b7469fadfd20a7d4174a82_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01240eeff3424399ac46617dff38a60e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42d67ad56d484dbfa64dbb92ac7c6053_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9b70c30dde844758d39245d643825b8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87fbc88d23bd4515b69081936e2c024c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1297bc3abcfa4f7382b94f81ed19c05b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f56e49768249e5b7989f94f1d74990_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb9d3f521d5d48a9a1710727f9c1ed43_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6a74eecb57e41acb0aa286caff969ec_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic50af612698747bfbe32dc206df1497b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a9055ea7e814dc08a48a9cc25b0a3e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11ec3fd242a40cfb175758ef847aa82_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d4ba8ee71d445d38e472a82695ac35e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa27edbf751044d38c98cc6490ee0239_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i385417946a284bda98679e20b7d7ac2b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if136e8c77c874676bf740b0c46fce4aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b54ebecbc5445c08be0b579b40354c4_I20170612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i327905247cf740c896e4c6b8ec6ba29b_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76005d853c2c4c6c974ae1790121a19c_D20170601-20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-06-01</xbrli:startDate><xbrli:endDate>2017-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceb839a717174e39b3fba3bd84bba52e_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94022d7303af424b83b5e28a7c9159c2_I20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="id4d936cb81684c6d951a9c9586de7935_D20170101-20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0f4cf90dbd54f36b16e48026ad767b8_D20170101-20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b82c1d246504bdc9b052ed1631c170d_D20170101-20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02ce6fa21a4c467b932127bbab4129a9_D20170101-20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i144fe05e631d4754b752fbaffcb88425_D20170101-20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib331a0829e1642b19cf7b81d2e144de8_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5dcc4f82db040e08f0392a1b34637e4_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia18646096f2f4313b85666436e60e864_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c37e038885d460caf56e886ef183fc3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i171e86410669489fbef485118636de53_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia48631aa96ef4bdd85a3f1e83f1deeb1_D20200629-20200629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65563331cccc49e1b2ae4e75a627ad93_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b3a6150f8924f1287825cc009c6b717_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i690dc51114b644a9afb0024fdbd293c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7282b108e48d4eabac8748333920ce52_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46cf6aa4cbc04a0f82d9a6b0fe29ad48_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1faeacf9c3314fe59169bdbee5cb8ae9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d77c5b3b87a4eef982cf15597f7eafd_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30b4cc8b7cfc464280fc946085b32af4_D20181101-20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5355d4cf31264d86bc5dda86afa70ac2_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99523a59b6a94e9f91658f912ad40913_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="trading_day"><xbrli:measure>dxcm:trading_day</xbrli:measure></xbrli:unit><xbrli:context id="ia1cdadf83f4347a1992e2190665bfc6b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b263bb73db749f7903f4d16dee3cfc9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39aadb9741cd47b79480d481f086db3c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i899bc18f65524335a7458c45e6a54130_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e7080d6571940faabaa2f8e843f5374_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7929e0a0d324cfd8fe012a9b24af6b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99455d005fdd42b5914e278f7116ad83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3f6f2593e742d39815ab135c1351cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5665c7a7af04c72b799bc76e98ac16e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaab87bfd0d144699b9389facb5c03069_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7106fbb087b843a4a42d39cd22960c2e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8fb79f3ea0d43d29986396d56c2e1f4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if444b8bc180c4613992a636bbb38e095_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70c1c83392ba4ac79884df02cce79fb8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77366a73d9404bcfb0249f49a6494d32_D20170601-20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-06-01</xbrli:startDate><xbrli:endDate>2017-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87bd51729d3940a5b519f98ea0248948_D20181101-20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0763f994d3d4e1caba905e8a1c1bf92_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib49c1f2854e540609bb2322a657f82ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69abd3c86e1942d8a6591c6630a96ad8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacc146a3fcd448f9843cfc23757a5620_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8faa2bf597984c30b119197a6a7e086d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e773841aaec4c8f8602ad4486565e5d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36128ee14a734888bc09fffd96a8030b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a1a9074faa14cd1aaebc1917a4bf806_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3136d780e4b54c5c8c992096d59c7865_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e11745d3934aeba348c054954eb311_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f646d2021741ceb895186d3d836104_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5f9e39f0909482a94b926033b0fa78d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfebefd71d743d7bb8817b29e995207_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i584812d31d074a4d9c695bd53995b5d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i910cc468fb184823bb85a75afc8cbcc5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:CALIFORNIAAndNonUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90a1a747b94545808a4f6dc903487330_D20200622-20200622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-22</xbrli:startDate><xbrli:endDate>2020-06-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a547859b60a43fc9dc18e7cd1125a02_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i344d8f8e50c34a90b390f141b61876c0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eaa2ff3c84445059ce87f458fcf8f69_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd1e8d507834f608ee1745f0ca4b27d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic71d9325f84947ab8e12f76111648564_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7ad3a0859c04e32a8c6428b8ba0f02b_I20190530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-05-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fe8680967ea40c7b595ca27e03b1bbb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47532d047d3644c781d52180df17ad05_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9504f38e9d964a7e8248536f0d74412a_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127a151fc6454b089e250685716d7352_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1723155f583c4254a40179612feb0ea3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa8a47c445384ea284b35965e4852a2c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1db1c7118a14990b87107147de1cb98_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01d87f1cf80c435ead42c507b8eda281_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8fd4570b25642ea8b04ea92713cb66e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ba655b237cf441f820842a13b7eb463_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic56e441b6e7d4ef4b7b31fa77f81e1dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24efa051b28f4003a6f3ad6646ccd0dc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dbec2aacc9441d089e0d26423888121_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadfae12ea15548f8aca74a4ee79890a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bc01fa170ab4896aa6b4a5277b3b1e7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cf1e522d2c04404b83cebc9cf795440_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95b164774729468997a9b3662aa8c9f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if89d6cfc919b4446a315489302b1219e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ddc9d9a1baa4ed59713cfb3cc17c270_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0049bf4214214416a8f099e71e710193_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29a3f0bb53204d2799a1664c7a293bc5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac621cbdae3640dfb12f31f495628cf4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63af19991b6d4963a2316839da7e8a70_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7ed14556556429fa016d4abae113d69_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0764697150b3465c88c53e155b29e37f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34b608918eb7402ab4f47dba3669f52f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55cba84e376a4aecb83de5d1d311be56_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i688e9ce83e1c4d8f995dfcb32a30399c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>dxcm:segment</xbrli:measure></xbrli:unit><xbrli:context id="ifa840b26370a49c1a7d4e9c32b365ada_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3efb05cdfec5469584069bfe20b97f34_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fe068ff6a8d447aa24bbe067484df80_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5438637b49ce4764914c810d05bc68a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66896da671864b0a8fd51f13e20833f9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i931962e264f448fb93ed19b0f908c9dd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ef105fbc7ec4827bdf560993cb05f98_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba28294146894fc4a844398fae9b899e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7260e40093964fda96288a1c159934c9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie028a8fb3e7348b9881b8512b4a4860b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38178bb74286401ba0308f4e347b9fd1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i698887039b694543ab8c5c785c1d2f8f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i889b093251984bfb881a094ef59c54bd_1"></div><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.&#160;20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDYx_b7409b4b-b595-4a54-83e9-40a99d4b6f38">10-K</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.768%"><tr><td style="width:1.0%"></td><td style="width:1.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NGE3ZjAwNTdiNWNiNGE5ZDgyNmViYzU4Yzk1ZmY2MWUvdGFibGVyYW5nZTo0YTdmMDA1N2I1Y2I0YTlkODI2ZWJjNThjOTVmZjYxZV8wLTAtMS0xLTA_dc7e3c50-0b94-4538-a2a5-e20d86382ae8">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8xODc_ef9246ee-0dac-45e7-b512-7720e3679060">December 31, 2020</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.768%"><tr><td style="width:1.0%"></td><td style="width:1.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6ZDM0NzQwMzBlZjAwNDJmMWI1MjgyYjcwYjIzZTExNWIvdGFibGVyYW5nZTpkMzQ3NDAzMGVmMDA0MmYxYjUyODJiNzBiMjNlMTE1Yl8wLTAtMS0xLTA_90c679b0-7f6b-4a0f-a7d7-4e7b7d3f99fe">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number&#160;<ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDYy_ed5e2ec6-1cdd-4291-9b0f-7b5f8f609863">000-51222</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-align:center"><img src="dxcm-20201231_g1.jpg" alt="dxcm-20201231_g1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:190px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU2_d6c50084-f8b5-4445-a732-8278bee9fc89">DEXCOM, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.801%"><tr><td style="width:1.0%"></td><td style="width:43.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NmEzYWI4ZWE5MTViNDI4Nzk1MjQ4ZWI4MDQ1MTlkMGQvdGFibGVyYW5nZTo2YTNhYjhlYTkxNWI0Mjg3OTUyNDhlYjgwNDUxOWQwZF8wLTAtMS0xLTA_586bbfe6-96a0-48b0-8bf4-934331e4894e">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NmEzYWI4ZWE5MTViNDI4Nzk1MjQ4ZWI4MDQ1MTlkMGQvdGFibGVyYW5nZTo2YTNhYjhlYTkxNWI0Mjg3OTUyNDhlYjgwNDUxOWQwZF8wLTItMS0xLTA_4485cff0-804d-43b5-afc5-2c75d2d7083f">33-0857544</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDQ4_b2ca1933-02db-4214-bceb-2cdc489830c2">6340 Sequence Drive</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDQ5_3a280200-3227-4faf-a325-201bf27aecea">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU1_4c1b99a8-64d0-49ba-a335-7f391fb1892e">CA</ix:nonNumeric> <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDQ2_540f9a30-d698-42f2-83d5-a4f39ecdd262">92121</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> (<ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU0_5577d95e-7363-42bb-b5b9-15b7722b19b7">858</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDUw_a7eeca33-ae6c-4f71-8502-eac668535e18">200-0200</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code) </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:40.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NzUzNTU3YTMxYmIyNGNhN2FmMjZlZjdiM2U0ZjU0YzUvdGFibGVyYW5nZTo3NTM1NTdhMzFiYjI0Y2E3YWYyNmVmN2IzZTRmNTRjNV8xLTAtMS0xLTA_3834045f-7b45-4838-ad06-30468f788b70">Common Stock, $0.001 Par Value Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NzUzNTU3YTMxYmIyNGNhN2FmMjZlZjdiM2U0ZjU0YzUvdGFibGVyYW5nZTo3NTM1NTdhMzFiYjI0Y2E3YWYyNmVmN2IzZTRmNTRjNV8xLTEtMS0xLTA_d24a1120-6641-4e24-b291-d339d60ba907">DXCM</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NzUzNTU3YTMxYmIyNGNhN2FmMjZlZjdiM2U0ZjU0YzUvdGFibGVyYW5nZTo3NTM1NTdhMzFiYjI0Y2E3YWYyNmVmN2IzZTRmNTRjNV8xLTItMS0xLTA_9378338a-4e1c-46c8-b562-acf801bcb664">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Nasdaq Global Select Market)</span></td></tr></table></div><div style="margin-bottom:10pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU3_104644dd-6794-471b-a185-32b5676c7e38">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160; &#9744;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes&#160;&#160;&#9744;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU4_23cd37bb-9345-4075-aa1a-c0af2ba6b110">No</ix:nonNumeric>&#160;&#160; &#9746;</span></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.   <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDUx_dd8706bc-96d9-42e7-82c6-aea7b9fcbe3c">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160; &#9744;</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDQ3_05288810-129e-454b-ba16-80ea32ba7edf">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160; &#9744;</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDUy_775fa1fa-a701-42e6-be41-4abb8709cb1c">Large accelerated filer</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;  Accelerated filer&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160; Non-accelerated filer&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160; Smaller reporting company&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU5_b440fe5a-561f-448d-bb60-1d1b70c782e7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDUz_9b752d8e-9a1c-4dcf-93b7-3e7c14f8fd22">&#9744;</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.     <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl83MTQ2ODI1NTg0OTY2_0b8a867c-9090-47e1-bdb3-21608ee78658">&#9746;</ix:nonNumeric></span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).   Yes&#160;<ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDYw_e093b6d8-bae8-4a61-977b-7df7e2d83ad8">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160; &#9746;</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2020, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="id874e873187245ef8983f0949a6da29c_I20200630" decimals="-8" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8yNzQ2_6da1d08d-dd22-4fe8-a5ce-2bb956e7940b">38.5</ix:nonFraction> billion based on the closing sales price of $405.40 per share as reported on the Nasdaq Global Select Market.</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the registrant&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.801%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Outstanding at February 4, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $0.001 par value per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib306ec0bfb0d4471a50748795fd3e82b_I20210204" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NDc2ZTMzYWUyOWUzNDNkYWFlNjhiMGI3ZjQ2ZTk1MTUvdGFibGVyYW5nZTo0NzZlMzNhZTI5ZTM0M2RhYWU2OGIwYjdmNDZlOTUxNV8xLTItMS0xLTA_d895f7db-6eb0-4035-9c8a-2f65e117f231">96,177,363</ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8xMTU0NDg3MjA5NTg2Mg_0dfbc027-8052-4db7-971e-8e9a8f4a0003" escape="true">Portions of the registrant&#8217;s definitive proxy statement relating to its 2021 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;) are incorporated by reference in Part&#160;III, Items 10 through 14 of this Annual Report on Form 10-K, as specified in the responses to those item numbers. Except with respect to information specifically incorporated by reference in the Form 10-K, the Proxy Statement is not deemed to be filed as part hereof.</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;border-bottom:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Table of Contents</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="9" style="background-color:#58a618;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_13">ITEM&#160;1.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_13">Business</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_13">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_16">ITEM&#160;1A.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_16">Risk Factors </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_16">23</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_19">ITEM&#160;1B.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_19">64</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_22">ITEM&#160;2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_22">Properties</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_22">65</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_25">ITEM&#160;3.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_25">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_25">65</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_28">ITEM&#160;4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_28">65</a></span></div></td></tr><tr><td colspan="9" style="background-color:#58a618;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;II </span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_34">ITEM&#160;5.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_34">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_34">66</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_37">ITEM&#160;6.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_37">Selected Financial Data</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_37">68</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_40">ITEM&#160;7.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_40">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_40">68</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_43">ITEM&#160;7A.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_43">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_43">78</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_46">ITEM&#160;8.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_46">Consolidated Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_46">78</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_49">ITEM&#160;9.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_49">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_49">79</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_52">ITEM&#160;9A.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_52">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_52">79</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_55">ITEM&#160;9B.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_55">Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_55">81</a></span></div></td></tr><tr><td colspan="9" style="background-color:#58a618;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;III</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_61">ITEM&#160;10.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_61">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_61">81</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_64">ITEM&#160;11.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_64">Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_64">81</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_67">ITEM&#160;12.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_67">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_67">81</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_70">ITEM&#160;13.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_70">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_70">81</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_73">ITEM&#160;14.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_73">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_73">81</a></span></div></td></tr><tr><td colspan="9" style="background-color:#58a618;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART IV</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_79">ITEM&#160;15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_79">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_79">82</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_82">ITEM 16.</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_82">Form 10-K Summary</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_82">86</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Except for historical financial information contained herein, the matters discussed in this Form 10-K may be considered forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, and subject to the safe harbor created by the Securities Litigation Reform Act of 1995. Such statements include declarations regarding our intent, belief, or current expectations and those of our management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks, uncertainties and other factors, some of which are beyond our control; actual results could differ materially from those indicated by such forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to: (i)&#160;that the information is of a preliminary nature and may be subject to further adjustment; (ii)&#160;those risks and uncertainties identified under &#8220;Risk Factors&#8221;; and (iii)&#160;the other risks detailed from time-to-time in our reports and registration statements filed with the Securities and Exchange Commission, or SEC. Except as required by law, we undertake no obligation to revise or update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I </span></div><div style="text-align:center"><span><br/></span></div><div id="i889b093251984bfb881a094ef59c54bd_13"></div><div style="margin-bottom:10pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1 - BUSINESS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for use by people with diabetes and by healthcare providers. We received approval from the United States (U.S.) Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation system, the Dexcom G6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> integrated Continuous Glucose Monitoring System, or G6, in 2018. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries. The mailing address of our headquarters is 6340 Sequence Drive, San Diego, California, 92121 and our telephone number at that location is (858) 200-0200. Our Internet website address is www.dexcom.com. We provide free access to various reports that we file with or furnish to the SEC through our website, as soon as reasonably practicable after they have been filed or furnished. These reports include, but are not limited to, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports. Information on our website does not constitute part of this Annual Report on Form 10-K or other report we file or furnish with the SEC. The reports are also available at www.sec.gov. Also available on our website are printable versions of our Audit Committee charter, Compensation Committee charter, Nominating and Corporate Governance Committee charter, and Code of Conduct and Business Ethics. Stockholders may request copies of these documents by mail or telephone, at the address or phone number provided above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexcom G7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are pursuing regulatory approvals for our next generation G7 CGM system. The G7 carries forward many of the same features as our G6 CGM system and adds several new or improved features, including</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Reduced size</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A 60% reduction in size of the on-body wearable.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Fully disposable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Sensor and transmitter combined into a single, disposable wearable.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Simple application</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New application process streamlines the number of steps required.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Faster warmup</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Warmup period expected to be reduced from the current two-hour warmup for G6.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Reduced packaging waste</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Significant reduction to the product packaging waste profile on a per unit basis. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexcom G6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, we obtained marketing authorization from the FDA for the G6 via the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process. The G6 is the first type of CGM system permitted by the FDA to be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. G6 and substantially equivalent devices of this generic type that may later receive marketing authorization are referred to as integrated continuous glucose monitoring systems, or iCGMs, and have been classified as Class II devices by the FDA. Along with this classification, the FDA established criteria, called special controls, which outline requirements for assuring CGM accuracy, reliability and clinical relevance, and which also describe the type of studies and data required to demonstrate acceptable CGM performance. The G6 is designed to allow our transmitter to run an algorithm to generate a glucose value and to communicate directly to a patient&#8217;s compatible mobile device, including iPhone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, iPod touch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, iPad</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and certain Android</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mobile devices. A patient&#8217;s glucose data can also be displayed on wearable devices, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">like the Apple Watch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Wear OS by Google devices. The G6 transmitter has a labeled useful life of three months. Data from the G6 can be integrated with Dexcom CLARITY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our cloud-based reporting software, for personalized, easy-to-understand analysis of trends that may improve diabetes management. In the United States, the G6 is covered by Medicare and Medicaid in the majority of states and by commercial insurers, subject to satisfaction of certain eligibility and coverage criteria for individuals with both Type 1 and Type 2 diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, we received Conformit&#233; Europ&#233;enne Marking, or CE Mark, approval for the G6, which allows us to market the system in the European Union and the countries in Asia and Latin America that recognize the CE Mark, as well as New Zealand, though certain countries may require compliance with certain local administrative requirements and/or additional marketing authorizations (for example, the inclusion of medical devices on the Australian Register of Therapeutic Goods in Australia).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, we also received marketing authorization from the FDA for the Dexcom G6 Pro, or G6 Pro, which allows healthcare professionals to purchase the G6 for use with their patients. The G6 Pro has many of same features as the G6 and is intended for healthcare professionals to use with their patients ages two years and up. The G6 Pro may be used in a blinded or unblinded mode for up to 10 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the G6, the sensor is inserted by the user and is intended to be used continuously for up to 10 days, after which it may be replaced with a new disposable sensor. Our transmitter is reusable until it reaches the end of its use life. Our receiver is also reusable. As we establish an installed base of customers using our products, we expect to generate an increasing portion of our revenues through recurring sales of our disposable sensors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The G6 carries forward important features of prior generation Dexcom CGM systems:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Continuous glucose readings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Automatically sends glucose readings to a Dexcom receiver or compatible mobile device every five minutes.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Mobile app and sharing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compatibility with mobile device applications allows for sharing glucose information with other people for added support and care coordination.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Customizable alarms and alerts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personalized alert schedule immediately warns the user of pending dangerous high and low blood sugars.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The G6 also has a number of new or improved features compared to our prior generation devices:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Finger stick elimination.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No finger sticks are needed for calibration or diabetes treatment decisions, consistent with the instructions for use.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Easy sensor application.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Complete redesign of the sensor applicator allows for one-touch, simple self-insertion.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Discreet and low profile.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A redesigned transmitter with a 28% lower profile than the previous generation Dexcom CGM system makes the device comfortable and easy to wear under clothing.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Medication blocking.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> New feature allows for more accurate glucose readings without interference from common medications taken at typical indication doses, such as acetaminophen.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Predictive low alert.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> New alert feature intended to predict hypoglycemia before it hits to help avoid dangerous low blood sugar events.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Extended 10-day disposable sensor.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Up to 10-day sensor use allows for 43% longer wear than previous generation Dexcom CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the foregoing, the features of the G6 are generally consistent with our prior generation CGM systems in its technical capabilities and its indications. Since the G6 is classified by the FDA as a Class II device, it is subject to special controls and modifications of, or revisions to, the device may be made under the 510(k) process.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global revenues associated with the sales of our previous commercial products, the Dexcom G4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Platinum CGM system and G5&#174; Mobile CGM system, or G5 Mobile, amount to less than 10% of our revenue for the fiscal year ended 2020 and we anticipate phasing out these commercial products by the end of 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexcom Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dexcom Share remote monitoring system, offered for use with any current Dexcom system, uses an app on the patient&#8217;s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, or &#8220;followers,&#8221; who can remotely monitor a patient&#8217;s glucose information and receive alert notifications anywhere they have a wireless connection. A patient&#8217;s glucose data can also be displayed on a patient&#8217;s or follower&#8217;s wearable device, such as the Apple Watch and Wear OS by Google devices, when used in conjunction with the patient&#8217;s or follower&#8217;s iPhone or Android mobile device.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data and Insulin Delivery Collaborations</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into multiple collaboration agreements that leverage our technology platform to integrate our CGM products with insulin delivery systems. The general purpose of these development and commercial relationships is to integrate our technology into the insulin pump or pen product offerings of the respective partner, enabling the partner&#8217;s insulin delivery device to receive and display glucose readings from our transmitter and, in some cases, use the glucose readings for semi-automated insulin delivery. Currently, we have announced significant insulin delivery partnerships with Eli Lilly, Insulet, Novo Nordisk, Tandem Diabetes and The Ypsomed Group. In addition to these major partners, we are working with other companies that are pursuing varying strategies surrounding semi-automated insulin delivery and data analytics to improve outcomes and ease-of-use in diabetes management. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also entered into collaborations with several organizations that are currently using, or are developing, programs for the treatment of Type 2 diabetes that utilize our current CGM systems. These collaborations align with the strategy to seek broader access to our CGM systems for people with Type 2 diabetes, including those who are not treated with intensive insulin therapy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verily Collaboration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Restated Collaboration Agreement with Verily Life Science LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily) provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture, and commercialize those kinds of glucose monitoring products and certain CGM product companion software functionalities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we have made upfront and incentive payments, and will make potential additional milestone payments of up to $275.0 million that may become due and payable by us upon the achievement of future product regulatory approval and revenue milestones. At our election, we may make these milestone payments in shares of our common stock or cash. See Note 2 to the consolidated financial statements in Part II, Item 8 and Exhibit 10.31 of this Annual Report for a further description of the Restated Collaboration Agreement. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Opportunity</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diabetes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diabetes is a chronic, life-threatening disease for which there is no known cure and which has other significant adverse consequences for human health throughout the world. The disease is caused by the body&#8217;s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. Glucose, the primary source of energy for cells, must be maintained at certain concentrations in the blood in order to permit optimal cell function and health. Normally, the pancreas provides control of blood glucose levels by secreting the hormone insulin to decrease blood glucose levels when concentrations are too high. In people with diabetes, the body does not produce sufficient levels of insulin, or fails to utilize insulin effectively, causing blood glucose levels to rise above normal. This condition is called hyperglycemia and often results in acute complications as well as chronic long-term complications such as heart disease, limb amputations, loss of kidney function and blindness. When blood glucose levels are high, people with diabetes often administer insulin in an effort to decrease blood glucose levels. Unfortunately, insulin administration can drive blood glucose levels below the normal range, resulting in hypoglycemia. In cases of severe hypoglycemia, people with diabetes risk acute complications, such as loss of consciousness or death. Due to the drastic nature of acute complications associated with hypoglycemia, many people with diabetes are reluctant to reduce blood glucose levels. Consequently, these individuals often remain in a hyperglycemic state, increasing their odds of developing long-term chronic complications. Diabetes is typically classified into two major groups: Type 1 and Type 2.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The International Diabetes Federation, or IDF, estimates that in 2019, 463&#160;million adults (aged 20-79) around the world had diabetes. IDF estimates that by 2045, the worldwide incidence of people suffering from diabetes will reach 700 million. According to the Centers for Disease Control and Prevention, or CDC, in its National Diabetes Statistics Report, 2020, or the 2020 CDC Report, crude estimates for the prevalence of diabetes in the United States as of 2018 include 34 million people with diabetes, of which 26.9 million people have diagnosed diabetes. The 2020 CDC Report also lists diabetes as the seventh leading cause of death by disease in the United States, excluding comorbidities associated with the disease. According to the Congressional Diabetes Caucus website, diabetes is the leading cause of kidney failure, adult-onset blindness, lower-limb amputations, and a significant cause of heart disease, stroke, high blood pressure and nerve damage. According to the IDF, there were an estimated 4.2 million deaths attributable to diabetes globally in 2019 between the ages of 20 and 79 years. The American Diabetes Association, or ADA, Fast Facts, revised in February 2020, states that diabetes is the primary cause of death for more than 83,000 Americans each year, and contributes to the death of more than 270,000 Americans annually.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the ADA, one in every four healthcare dollars was spent on treating people with diabetes in 2017, and the direct medical costs and indirect expenditures attributable to diabetes in the United States were an estimated $327 billion, an inflation-adjusted increase of approximately 26% since 2012. Of the $327 billion in overall expenses, the ADA estimated that approximately $237 billion were direct costs associated with diabetes care, chronic complications and excess general medical costs, and $90 billion were indirect costs. The ADA also found that in 2017, average medical expenditures among people with diagnosed diabetes were 2.3 times higher than for people without diabetes. According to the IDF, 2019 expenditures attributable to diabetes were estimated to be $760 billion globally. The IDF estimates that expenditures attributable to diabetes will grow to $845 billion globally by 2045.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Type 1 Diabetes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the 2020 CDC Report, as of 2018 there were an estimated 1.6 million adults and youth with diagnosed Type 1 diabetes in the United States. Type 1 diabetes is an autoimmune disorder that usually develops during childhood and is characterized by an absence of insulin, resulting from destruction of the insulin producing cells of the pancreas. Individuals with Type&#160;1 diabetes must rely on frequent insulin injections in order to regulate and maintain blood glucose levels. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to JDRF, greater than 60,000 people are diagnosed with Type 1 diabetes each year in the United States and 5 million people in the U.S. are expected to have Type 1 diabetes by 2050. In addition, according to the ADA in 2019, nearly 18,000 youth are newly diagnosed with Type 1 diabetes every year in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Type 2 Diabetes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Type 2 diabetes is a metabolic disorder which results when the body is unable to produce sufficient amounts of insulin or becomes insulin resistant. Depending on the severity of Type 2 diabetes, individuals may require diet and nutrition management, exercise, oral medications or insulin injections to regulate blood glucose levels. We estimate that approximately 6.0&#160;million Type 2 patients must use insulin to manage their diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Type 2 diabetes is occurring with increasing frequency in young people, with the increase in prevalence related to an increase in obesity amongst children. According to the CDC, as of 2016, approximately 18.5% of children and adolescents aged 2-19 years, or 13.7 million children, in the United States were obese. Childhood obesity has more than doubled in children and quadrupled in adolescents in the past 30 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Importance of Glucose Monitoring</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blood glucose levels can be affected by many factors, including the carbohydrate and fat content of meals, exercise, stress, illness or impending illness, hormonal releases, variability in insulin absorption and changes in the effects of insulin in the body. Given the many factors that affect blood glucose levels, maintaining glucose within a normal range is difficult, resulting in frequent and unpredictable excursions above or below normal blood glucose levels. People with diabetes administer insulin or ingest carbohydrates throughout the day in order to maintain blood glucose levels within normal ranges. People with diabetes frequently overcorrect and fluctuate between hyperglycemic and hypoglycemic states, often multiple times during the same day. As a result, many people with diabetes are routinely outside the normal blood glucose range. Failure to maintain blood glucose levels within the normal range leads to numerous and significant health risks. These risks include eye disease, nerve disease, kidney disease, cardiovascular disease and potentially hypoglycemic events.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations of Existing Glucose Monitoring Products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Single-point finger stick devices are the most prevalent devices for glucose monitoring. These devices require taking a blood sample with a finger stick, placing a drop of blood on a test strip and inserting the strip into a glucose meter that yields a single point in time blood glucose measurement. We believe that these devices suffer from several limitations, including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Limited Information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Even if people with diabetes test several times each day, each measurement represents a single blood glucose value at a single point in time. Given the many factors that can affect blood glucose levels, excursions above and below the normal range often occur between these discrete measurement points in time. Without the ability to determine whether their blood glucose level is rising, falling or holding constant, and the rate at which their blood glucose level is changing, the individual&#8217;s ability to effectively manage and maintain blood glucose levels within normal ranges is severely limited. Further, people with diabetes cannot test themselves during sleep, when the risk of hypoglycemia is significantly increased.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The illustrative graph below shows the limited information provided by four single-point measurements during a single day using a traditional single-point finger stick device, compared to the data provided by our continuous sensor. The continuous data indicates that, even with four finger sticks in one day, the patient&#8217;s blood glucose levels were above the target range of 80-140 milligrams per deciliter (&#8220;mg/dl&#8221;) for a period of 13.5 hours.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Single Day Continuous Data</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;padding-right:22.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">       </span><img src="dxcm-20201231_g2.jpg" alt="dxcm-20201231_g2.jpg" style="height:276px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"/></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:46.98pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Inconvenience.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The process of measuring blood glucose levels with single-point finger stick devices can cause significant disruption in the daily activities of people with diabetes and their families. People with diabetes using single-point finger stick devices must stop whatever they are doing several times per day, self-inflict a painful prick and draw blood to measure blood glucose levels. To do so, people with diabetes must always carry a fully supplied kit that may include a spring-loaded needle, or lancet, disposable test strips, cleansing wipes and the meter, and then safely dispose of the used supplies. This process is inconvenient and may cause uneasiness in social situations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:46.98pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Difficulty of Use.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To obtain a sample with single-point finger stick devices, people with diabetes generally prick one of their fingertips or, occasionally, a forearm with a lancet. They then squeeze the area to produce the blood sample and another prick may be required if a sufficient volume of blood is not obtained the first time. The blood sample is then placed on a disposable test strip that is inserted into a blood glucose meter. This task can be difficult for individuals with decreased tactile sensation and visual acuity, which are common complications of diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:46.98pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Pain.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Although the fingertips are rich in blood flow and provide a good site to obtain a blood sample, they are also densely populated with highly sensitive nerve endings. This makes the lancing and subsequent manipulation of the finger to draw blood painful. The pain and discomfort are compounded by the fact that fingers offer limited surface area, so tests are often performed on areas that are sore from prior tests. People with diabetes may also suffer pain when the finger prick site is disturbed during regular activities.</span></div><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Dexcom Solution</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe continuous glucose monitoring has the potential to enable more people with diabetes to achieve and sustain tight glycemic control with minimal disruption to their daily lives.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The landmark 1993 Diabetes Control and Complications Trial, or DCCT, demonstrated that improving blood glucose control lowers the risk of developing diabetes-related complications by up to 50%. The study also demonstrated that people with Type 1 diabetes achieved sustained benefits with intensive management. However, according to an article published in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The New England Journal of Medicine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in November 2014, in two national registries, only 13% to 15% of people with diabetes met treatment guidelines for good glycemic control, and more than 20% had very poor glycemic control.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various clinical studies and real-world evidence also demonstrate the benefits of continuous glucose monitoring in the management of Type 1 diabetes and insulin-requiring Type-2 diabetes, when compared to regimens relying on self-monitoring of blood glucose. Results of several early clinical trials established that CGM usage was associated with improved glycemic outcomes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real-time alerts and multi-device integration further differentiate CGM-based and self-monitoring of blood glucose, or SMBG, based diabetes regimens. Alerts triggered by existing or impending abnormal glucose values are associated with less exposure to hypo- and hyperglycemia in large real-world data sets, and multi-device integration allows some CGM systems to communicate with automated insulin delivery systems. One such automated insulin delivery system that uses the G6 was studied in a large clinical trial that associated its use with numerous quality-of-life and glycemic benefits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current target market consists primarily of people with Type 1 and Type 2 diabetes who utilize insulin pump therapy or who utilize multiple daily insulin injections. We also believe that our CGM systems are beginning to have a positive impact </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the broader Type 2 population that does not utilize mealtime insulin, a group that we estimate to be greater than 30 million people in the United States alone. We are extending our commercial efforts for this population through several channels, including through strategic partnerships. In the future, we expect to expand our product offering to address people with pre-diabetes, people who are obese, people who are pregnant, and people in the hospital setting. Although the majority of our revenue has been generated in the United States, we have expanded our operations to include certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current CGM systems offer the following advantages to people with diabetes:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Improved Outcomes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Randomized clinical trials and peer reviewed published data have demonstrated that patients with diabetes who used continuous glucose monitoring devices to help manage their disease experienced significant improvements in glucose control, including when compared to patients relying solely on single-point finger stick measurements (i.e., less time in hypoglycemia and hyperglycemia) and reductions in A1c levels when compared to baseline. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Access to Real-Time Values, Trend Information and Alerts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At their fingertips, people with diabetes can view their current glucose value, along with a graphical display of the historical trend information on our receiver or alternate display device. Without continuous monitoring, the individual is often unaware if his or her glucose is rising, declining or remaining constant. Access to continuous real-time glucose measurements provides people with diabetes information that may aid in attaining better glucose control. Additionally, our current CGM systems alert people with diabetes when their glucose levels approach inappropriately high or low levels so that they may intervene.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Intuitive User Interface.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have developed a user interface that we believe is intuitive and easy to use. Our current CGM system receivers are compact with an easy-to-read color display, simple navigation tools, audible alerts and graphical display of trend information. Similar benefits are available via the interfaces we have made available on compatible mobile devices. These devices can serve as substitutes for our receivers or alternate display units in certain geographies.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Convenience and Comfort.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our current CGM systems provide people with diabetes with the benefits of continuous monitoring, without having to perform finger stick tests for every measurement. Additionally, the disposable sensor that is inserted under the skin is a very thin wire, minimizing potential discomfort associated with inserting or wearing the disposable sensor. The external portion of the sensor, attached to the transmitter, is small, has a low profile and is designed to be easily worn under clothing. The wireless receiver is the size of a small smart phone and can be carried discreetly in a pocket or purse. We believe that convenience is an important factor in achieving widespread adoption of a CGM system.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Connectivity to Wearables and Others. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patients can monitor their glucose levels and trends on compatible wearable devices, such as Apple Watch and Wear OS by Google devices, when used with a compatible mobile device. Also, our Share remote monitoring systems enable users of our current CGM systems to have their sensor glucose information remotely monitored by their family, friends or designated recipient, or follower, by wirelessly transmitting data from the user&#8217;s smart phone to the cloud and then to the follower&#8217;s mobile device. Several followers can remotely monitor a patient&#8217;s glucose information and receive secondary alert notifications from almost anywhere with an Internet connection via each follower&#8217;s mobile device.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strategy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our objective is to remain a leading provider of CGM systems and related products to enable people with diabetes to more effectively and conveniently manage their condition. We are also developing and commercializing products that integrate our CGM technologies into the insulin delivery systems or data platforms of our respective partners. In addition, we continue to pursue development partnerships with other insulin delivery companies, including automated insulin delivery systems, as well as other players in the disease management sector. To achieve these objectives, we are focusing on the following business strategies:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Establishing and maintaining our technology platform as the leading approach to CGM and leveraging our development expertise to rapidly bring products to market, including for expanded indications.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Driving the adoption of our ambulatory products through a direct sales and marketing effort, as well as key distribution arrangements. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Driving additional adoption through technology integration partnerships such as our current partnerships with Eli Lilly, Insulet, Novo Nordisk, Tandem Diabetes, The Ypsomed Group and others.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Seeking broad coverage policies and reimbursement for our products from private third-party payors and national health systems.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Driving increased utilization and adoption of our products through a cloud-based data repository platform that enables people with diabetes to aggregate and analyze data from numerous diabetes devices and share the data with their healthcare providers and other individuals involved in their diabetes management and care.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Expanding the use of our products to other patient care settings and patient demographics, including use for people with Type 2 diabetes who are not on intensive insulin therapy, population health, patient monitoring including in the hospital setting, and people who are pregnant.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Providing a high level of customer support, service and education.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Pursuing the highest safety and quality levels for our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Technology Platform</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have a broad technology platform that will support the development of multiple products for continuous glucose monitoring.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sensor Technology</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key enabling technologies for our sensors include biomaterials, membrane systems, electrochemistry and low power microelectronics. Our membrane technology consists of multiple polymer layers configured to selectively allow the appropriate mix of glucose and oxygen to travel through the membrane and react with a glucose specific enzyme to create an extremely low electrical signal, measured in pico-amperes. This electrical signal is then translated into glucose values. We believe that the capability to measure very low levels of an electrical signal and to accurately translate those measurements into glucose values is also a unique and distinguishing feature of our technology. We have also developed technology to allow sensitive electronics to be packaged in a small, fully contained, lightweight sealed unit that minimizes inconvenience and discomfort for the user.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receiver and Transmitter Technology</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current CGM systems wirelessly transmit information from the transmitter, which sits in a pod atop the sensor, to our receiver or to a compatible mobile device. We have developed technology for reliable transmission and reception and have consistently demonstrated a high rate of successful transmissions from transmitter to receiver or compatible mobile device in our clinical trials. Our receiver or the mobile device, via our apps, then displays both real-time and trended glucose values, and provides alerts and alarms. We have used our extensive database of continuous glucose data to create and refine software, algorithms and other technology for the display of data to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products in Development </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have gained our technology expertise by learning to design implants that can withstand the rigors of functioning within the human body for extended periods of time, as well as other issues such as device sealing, miniaturization, durability and sensor geometry.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are leveraging this technology platform to enhance the capabilities of our current products (including obtaining expanded indications of use) and to develop additional CGM products. We plan to develop future generations of technologies focused on improved performance and convenience and that will enable intelligent insulin administration. Over the longer term, we plan to continue to develop and improve networked platforms with open architecture, connectivity and transmitters capable of communicating with other devices. We intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to pursue and support development partnerships with insulin pump companies and companies or institutions developing insulin delivery systems, including automated insulin delivery systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exploring how to extend our offerings to other populations, including for people with Type 2 diabetes that are non-insulin using, people with pre-diabetes, people who are obese, people who are pregnant, and people in the hospital setting. Eventually, we may apply our technological expertise to products beyond glucose monitoring.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disposable Sensor&#160;and Reusable Transmitter</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sensor includes a tiny wire-like electrode coated with our sensing membrane system. This disposable sensor comes packaged with an integrated insertion device and is contained in a small plastic housing platform, or pod. The base of the pod has adhesive that attaches it to the skin. The sensor is intended to be easily and reliably inserted by the user by exposing the adhesive, placing the pod against the surface of the skin of the abdomen or upper buttocks for people ages 2-17, and pushing down on the insertion device. The insertion device first extends a narrow gauge needle containing the sensor into the subcutaneous tissue and then retracts the needle, leaving behind the sensor in the tissue and the pod adhered to the skin. The user then disposes of the insertion device and snaps the transmitter to the pod. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a stabilization period with the G6, the user will begin receiving CGM data on his or her mobile device or dedicated receiver through the ten-day usage period. After a stabilization period with the G5 Mobile, the user is required to calibrate the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sensor with two measurements from a single-point finger stick device and the disposable sensor begins wirelessly transmitting the continuous glucose data at specific intervals to the handheld receiver or compatible mobile device. Users are prompted by the receiver or mobile app, if using the G5 Mobile, to calibrate the system twice per day with finger stick measurements throughout the use period to ensure reliable operation. Calibration may be accomplished by using any FDA cleared blood glucose meter. Our G6 system has labeling from the FDA and CE Mark permitting their use as a replacement for finger sticks for making therapeutic adjustments, although the G5 Mobile still requires two daily finger stick calibrations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disposable sensor contained in the G6 system is intended to function for up to ten days, after which the sensor should be replaced. To replace a sensor, the user simply removes the pod and attached sensor from the skin and discards them while retaining the reusable transmitter. A new sensor and pod can then be inserted and used with the same receiver and transmitter for a subsequent use period. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Handheld Receiver</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our small handheld receiver is carried by the user and wirelessly receives continuous glucose values from the transmitter. Proprietary algorithms and software, developed from our extensive database of continuous glucose data from clinical trials, are programmed into the G6 transmitter to process the glucose data from the sensor, which then sends the processed glucose data to the receiver and displays it on a user-friendly graphical user interface. With a push of a button, the user can access their current glucose value and one-, three-, six-, twelve- and twenty-four-hour trended data. Additionally, when glucose values are inappropriately high or low, the receiver provides an audible alert or vibrates. The receiver is a self-contained, durable unit with a rechargeable battery.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compatible Mobile Devices</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With our G6 system, the functionalities of our proprietary receiver can be obtained through the use of a compatible mobile device, such as an iOS or Android device, and our mobile applications, depending on the patient&#8217;s geographic location. A receiver may be required as the primary display device or a backup to the mobile device in some jurisdictions, including the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Operations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a direct sales organization in the United States, Canada and certain countries in Europe to call on health care professionals, such as endocrinologists, physicians and diabetes educators, who can educate and influence patient adoption of continuous glucose monitoring. We believe that focusing efforts on these participants is important given the instrumental role they each play in the decision-making process for diabetes therapy, and to ensure that health care professionals and patients are knowledgeable about our products and their functionality. We focus on delivering this important information to participants to drive adoption of our current CGM systems. We directly market our products in the United States, Austria, Canada, Germany, Ireland, Switzerland, and the United Kingdom primarily to endocrinologists, physicians and diabetes educators. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To complement our direct sales efforts, we have entered into distribution arrangements in the United States, Australia and New Zealand, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East that allow distributors to sell our products. We expect to continue investing in our field sales force and believe our direct, highly specialized and focused sales organization and our domestic and international distribution agreements are sufficient for us to support our sales efforts for at least the next twelve months. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct to consumer marketing is one of our key initiatives to increase awareness of our CGM systems and drive new patient leads to our website. We target people with Type 1 and insulin intensive Type 2 diabetes. We advertise on television, in print, digital and video media, CRM, offer sponsorships, host or participate in diabetes related events, conduct public relations and maintain a brand ambassador program. Our campaigns target people with diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a variety of marketing tools to drive adoption, ensure continued usage and establish brand loyalty for our continuous glucose monitoring systems by:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">creating awareness of the benefits of continuous glucose monitoring and the advantages of our technology with endocrinologists, physicians, diabetes educators and people with diabetes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">providing strong and simple educational and training programs to healthcare providers and people with diabetes to ensure easy, safe and effective use of our systems; and</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">maintaining a readily accessible telephone and web-based technical and customer support infrastructure, which includes clinicians, diabetes educators and reimbursement specialists, to help referring physicians, diabetes educators and people with diabetes as necessary.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for blood glucose monitoring devices is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants. In selling our current CGM systems, we compete directly with the Diabetes Care division of Abbott Laboratories; Medtronic plc&#8217;s Diabetes Group; Roche Diabetes Care, a division of Roche Diagnostics; privately-held LifeScan, Inc.; and Ascensia Diabetes Care, each of which manufactures and markets products for the single-point finger stick device market. Collectively, these companies currently account for the majority of the worldwide sales of self-monitored glucose testing systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several companies are developing or commercializing products for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin that compete directly with our products. We have competed with Abbott and their Libre family of CGM products for many years. Medtronic markets and sells a standalone glucose monitoring product called Guardian Connect, both internationally and in the United States. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic and other third parties have developed or are developing, insulin pumps integrated with continuous glucose monitoring systems that provide, among other things, the ability to suspend insulin administration while the user&#8217;s glucose levels are low and to automate basal or bolus insulin dosing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have begun to become aware of companies outside the traditional medical device sector that are attempting to develop competitive products and services, including for the general health and wellness, or population health space. Some of the companies developing or marketing competing devices are large and well-known publicly traded companies. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the principal competitive factors in our market include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">safe, reliable and high-quality performance of products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">cost of products and eligibility for reimbursement;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comfort and ease of use of products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effective sales, marketing and distribution networks;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">brand awareness and strong acceptance by healthcare professionals and people with diabetes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">customer service and support and comprehensive education for people with diabetes and diabetes care providers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">speed of product innovation and time to market;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory expertise; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">technological leadership and superiority.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on competition, please see our Risk Factor entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently manufacture our products at our headquarters in San Diego, California and at our manufacturing facility in Mesa, Arizona. As of December&#160;31, 2020, our headquarters facilities had approximately 31,000 square feet of laboratory space and approximately 28,000 square feet of controlled environment rooms. Our Mesa, Arizona facility has approximately 14,000 square feet of laboratory space and approximately 33,000 square feet of controlled environment rooms. In 2020, we commenced construction of a new facility in Malaysia that we anticipate will add substantial manufacturing capacity. There are technical challenges to increasing manufacturing capacity, including FDA qualification of new manufacturing facilities, equipment design and automation, material procurement, problems with production yields, and quality control and assurance. We have focused significant effort on continual improvement programs in our manufacturing operations intended to improve quality, yields and throughput. We have made progress in manufacturing to enable us to supply adequate amounts of product to support our commercialization efforts, however we cannot guarantee that supply will not be constrained going forward. Additionally, the production of our continuous glucose monitoring systems must occur in a highly controlled and clean environment to minimize particles and other yield- and quality-limiting contaminants. Developing and maintaining commercial-scale manufacturing facilities has and will continue to require the investment of substantial additional funds and the hiring and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">retaining of additional management, quality assurance, quality control and technical personnel who have the necessary manufacturing experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture our current CGM systems with certain components supplied by outside vendors and other components that we manufacture internally. Key components that we manufacture internally include our wire-based sensors. The remaining components and assemblies are purchased from outside vendors. We then assemble, test, package and ship the finished systems, which may include a reusable transmitter, a receiver and disposable sensors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain components and materials used in manufacturing from single sources due to quality considerations, costs or constraints resulting from regulatory or other requirements. As of December&#160;31, 2020, those single sources include suppliers of application-specific integrated circuits used in our transmitters, seals used for the applicator and certain polymers used to synthesize polymeric membranes for our sensors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third-Party Reimbursement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device company, reimbursement from Medicare, Medicaid or other governmental healthcare programs or systems, and private third-party healthcare payors is an important element of our success. In January 2017, the Centers for Medicare and Medicaid, or CMS, established a classification of &#8220;Therapeutic Continuous Glucose Monitors&#8221; as durable medical equipment under Medicare Part B, subject to payment by Medicare under certain coverage conditions to be determined by CMS, by local Medicare Administrative Contractors or on a patient claim by claim basis. In September 2016, Germany&#8217;s Federal Joint Committee agreed to provide reimbursement for continuous glucose monitoring systems under certain conditions which we believe we meet.&#160;We also have coverage under certain international markets and Medicaid coverage in 40 states.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the seven largest private third-party payors, in terms of the number of covered lives, have issued coverage policies for the category of continuous glucose monitoring devices. In addition, we have negotiated contracted rates with all seven of those third-party payors for the purchase of our current CGM systems by their members. We have personnel with reimbursement expertise to assist customers in obtaining reimbursement from private third-party payors. We also maintain a field-based reimbursement team charged with calling on third-party private payors to obtain coverage decisions and contracts. We have continued our efforts to create and liberalize coverage policies with third-party payors, including obtaining reimbursement for our products under pharmacy benefits and for more people with diabetes. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on third-party reimbursement, please see our see Risk Factors entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protection of our intellectual property is a strategic priority for our business. We rely on a combination of patents, copyrights, trademarks, tradenames, trade secrets, nondisclosure agreements and other measures to establish and protect our proprietary rights. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our patent portfolio includes numerous issued and pending patent applications in the U.S. and other parts of the world, which in the aggregate, we believe to be of material importance in the operation of our business. U.S. patents, as well as most foreign patents, are generally effective for 20 years from the date the earliest application was filed. In some cases, the patent term may be extended. Our issued patents as of December 31, 2020 are set to expire over a range of years, from 2021 with respect to some of our earlier patents, to 2039, subject to any extensions. We also have various registered U.S. trademarks, registered European Community trademarks, and many other trademark registrations and pending trademark applications around other parts of the world. In addition, we have entered into exclusive and non-exclusive licenses in the ordinary course of business relating to a wide array of technologies or other intellectual property rights or assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patents and patent applications seek to protect aspects of our core membrane and sensor technologies and our product concepts for continuous glucose monitoring. We believe that our patent position provides us with sufficient rights to protect our current and proposed commercial products. However, our patent applications may not result in issued patents, and any patents that have been issued or might be issued may not protect our intellectual property rights. Furthermore, we operate in an industry characterized by extensive patent litigation, and our patents may not be upheld if challenged. Any patents issued to us may be challenged by third parties as being invalid or unenforceable, and patent litigation may result in significant damage awards and injunctions that could prevent the manufacture and sale of affected products or result in significant royalty payments in order to continue selling the products. Third parties may also independently develop similar or competing technology that avoids our patents. The steps we have taken may not prevent the misappropriation of our intellectual property, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. We also face risks associated with intellectual property infringement.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on trade secrets, technical know-how and continuing innovation to develop and maintain our competitive position. We seek to protect our proprietary information and other intellectual property by generally requiring our employees, consultants, contractors, suppliers, outside scientific collaborators and other advisors to execute non-disclosure and assignment of invention agreements on commencement of their employment or engagement. Agreements with our employees also forbid them from bringing the proprietary rights of third parties to us. We also generally require confidentiality or material transfer agreements from third parties that receive our confidential data or materials. We cannot guarantee that employees and third parties will abide by the confidentiality or assignment terms of these agreements. Despite measures taken to protect our intellectual property, unauthorized parties might copy aspects of our products or obtain and use information that we regard as proprietary.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Responsibility</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to advance the interests of all our stakeholders &#8211; including patients, caregivers, employees, investors, and our communities &#8211; by operating in an ethical and sustainable way. We do this by holding true to our core values: Listen, Think Big, Be Dependable, and Serve with Integrity. These values are at the heart of our sustainability activities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.3pt">Listen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; We believe in listening to our customers and our employees. We have launched a number of programs to advocate for individuals living with diabetes and we support our employees and their families through a number of benefit programs that are available. In addition, we promote diversity, practice fairness, and treat everyone with respect and dignity.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.3pt">Think Big -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We seek to expand global healthcare access for people with diabetes and actively work to increase access to our products. We also have committed to operate our business in a manner that is protective of the environment and conserves natural resources and reduces waste.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.3pt">Be Dependable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; We are committed to quality and believe that is best achieved through a safe and healthy workplace as well as a Quality Management System that is compliant with all applicable regulatory requirements and which is continuously being improved.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.3pt">Serve with Integrity &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> While oversight of our ethics and governance structure begins with our Board of Directors and Executive Leadership Team, we expect all employees to foster a culture of accountability in line with our Code of Conduct and Business Ethics. We also maintain a compliance program to help enforce ethical conduct and adherence to applicable laws and regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Nominating and Governance Committee of the Board of Directors oversees and reviews annually (a) our policies and programs concerning (i) corporate social responsibility and (ii) our participation and visibility as a global corporate citizen; (b) our sustainability performance; and (c) the assessment and management of environmental, sustainability and governance risks affecting our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Sustainability Report is available at https://investors.dexcom.com/corporate-governance, which is provided for reference only and is not incorporated by reference into this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical devices that we manufacture are subject to regulation by numerous regulatory bodies, including the FDA and comparable international regulatory agencies. These agencies require manufacturers of medical devices to comply with applicable laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of medical devices. Devices are generally subject to varying levels of regulatory control, the most comprehensive of which requires that a clinical evaluation program be conducted before a device receives approval for commercial distribution. In addition, healthcare regulatory bodies in the United States and around the world impose a range of requirements related to the payment for medical devices and the procedures in which they are used, including laws intended to prevent fraud, waste, and abuse of healthcare dollars.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Laws and Regulations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the U.S. federal level, our products are medical devices subject to extensive and ongoing regulation by the FDA. The U.S. Federal Food, Drug and Cosmetic Act, referred to as the FDCA, and the FDA&#8217;s implementing regulations govern product design and development, pre-clinical and clinical testing, pre-market clearance, authorization or approval, establishment registration and product listing, product manufacturing, product labeling, product storage, advertising and promotion, product sales, distribution, recalls and field actions, servicing and post-market clinical surveillance. A number of U.S. states also impose licensing and compliance regimes on companies that manufacture or distribute prescription devices in the state.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the delivery of our devices in the U.S market is subject to regulation by various U.S. Department of Health and Human Services divisions including CMS, the DHHS Office of the Inspector General, or OIG, the Department of Veterans Affairs, and comparable state agencies responsible for reimbursement and regulation of payment for health care items and services. U.S. laws and regulations are imposed primarily in connection with the Medicare, Medicaid, and TRICARE programs, as well as the government&#8217;s interest in regulating the quality and cost of health care.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA Regulation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless an exemption applies, each medical device we wish to commercially distribute in the United States will require either prior 510(k) clearance, prior </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> down-classification and a related grant of marketing authorization, or prior approval from the FDA through the premarket approval, or PMA process. The FDA classifies medical devices into one of three classes. Devices requiring fewer controls because they are deemed to pose lower risk are placed in Class I or II. Class I devices are subject to general controls such as labeling, pre-market notification, and adherence to the FDA&#8217;s manufacturing requirements, which are contained in the Quality System Regulation, or QSR. Class II devices are subject to special controls such as performance standards, post-market surveillance, FDA guidelines, or particularized labeling, as well as general controls. Some Class I and Class II devices are exempted by regulation from the pre-market notification (i.e., 510(k) clearance) requirement, and/or the requirement of compliance with substantially all of the QSR. As an example, the mobile applications that comprise the Share System were classified by the FDA as Class II exempt. With the mobile applications classified as Class II exempt, we must comply with certain general and special controls required by the FDA but we do not need prior FDA review to commercialize changes to the mobile applications. Some devices are placed in Class III, which requires approval of a PMA application, if they are deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting or certain implantable devices, or to be &#8220;not substantially equivalent&#8221; either to a previously 510(k) cleared device or to a &#8220;preamendment&#8221; Class III device in commercial distribution before May&#160;28, 1976 for which PMA applications have not been required.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a previously unclassified new medical device does not qualify for the 510(k) pre-market notification process because no predicate device to which it is substantially equivalent can be identified, the device is automatically classified into Class III. The Food and Drug Administration Modernization Act of 1997 established a new route to market for low to moderate risk medical devices that are automatically placed into Class III due to the absence of a predicate device, called the &#8220;Request for Evaluation of Automatic Class III Designation,&#8221; or the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification procedure. This procedure allows a manufacturer whose novel device is automatically classified into Class III to request down-classification of its medical device into Class I or Class II on the basis that the device presents low or moderate risk, rather than requiring the submission and approval of a PMA. Prior to the enactment of the Food and Drug Administration Safety and Innovation Act, or FDASIA, in July 2012, a medical device could only be eligible for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification if the manufacturer first submitted a 510(k) pre-market notification and received a determination from the FDA that the device was not substantially equivalent. FDASIA streamlined the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification pathway by permitting (under Section 513(f)(2) of the FDCA) manufacturers to request </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification directly without first submitting a 510(k) pre-market notification to the FDA and receiving a not substantially equivalent determination. FDASIA sets a review time for FDA of 120 days following receipt of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> application, but FDA does not always meet this timeline and has publicly only committed to a review goal of 150 days for 50% of applications. If the manufacturer seeks reclassification into Class II, the manufacturer must include a draft proposal for special controls that are necessary to provide a reasonable assurance of the safety and effectiveness of the medical device. The FDA may reject the reclassification petition if it identifies a legally marketed predicate device that would be appropriate for a 510(k) or determines that the device is not low to moderate risk or that general controls would be inadequate to control the risks and special controls cannot be developed. If the FDA agrees with the down-classification, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applicant will then receive authorization to market the device, and a classification regulation will be established for the device type. The device can then be used as a predicate device for future 510(k) submissions by the manufacturer or a competitor. In December 2018, the FDA issued proposed regulations to govern the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">classification process, which if finalized would further impact this path to market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an alternative to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">process, a company could also file a reclassification petition, or the FDA could initiate such a process, seeking to change the automatic Class III designation of a novel postamendment device under Section 513(f)(3) of the FDCA. The FDA issued a final rule (to take effect March 17, 2019) to clarify the process where the FDA initiates such reclassification (issuance of a proposed reclassification order; optional panel consultation; and final reclassification order published in the Federal Register).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our G4 PLATINUM and G5 Mobile systems (excluding associated Share System functionalities and mobile applications) were classified as devices requiring PMA approval. A PMA application must be supported by valid scientific evidence, which typically requires extensive data, including technical, pre-clinical, clinical, manufacturing and labeling data, to demonstrate to the FDA&#8217;s satisfaction the safety and efficacy of the device. A PMA application also must include a complete description of the device and its components, a detailed description of the methods, facilities and controls used to manufacture the device, and proposed labeling. After a PMA application is submitted and found to be sufficiently complete, the FDA begins an in-depth review of the submitted information. During this review period, the FDA may request additional information or clarification of information already provided. Also during the review period, an advisory panel of experts from outside the FDA may be </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">convened to review and evaluate the application and provide recommendations to the FDA. In addition, the FDA generally will conduct a pre-approval inspection of the manufacturing facility to evaluate compliance with QSR, which requires manufacturers to implement and follow design, testing, control, documentation and other quality assurance procedures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA review of a PMA application generally takes between one and three years, but may take significantly longer. The FDA can delay, limit or deny approval of a PMA application for many reasons, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our systems may not be safe or effective to the FDA&#8217;s satisfaction;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the data from our pre-clinical studies and clinical trials may be insufficient to support approval;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the manufacturing process or facilities we use may not meet applicable requirements; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in FDA approval policies or adoption of new regulations may require additional data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an FDA evaluation of a PMA application or manufacturing facilities is favorable, the FDA will either issue an approval letter, or approvable letter, which usually contains a number of conditions which must be met in order to secure final approval of the PMA. When and if those conditions have been fulfilled to the satisfaction of the FDA, the agency will issue a PMA approval letter authorizing commercial marketing of a device, subject to the conditions of approval and the limitations established in the approval letter. If the FDA&#8217;s evaluation of a PMA application or manufacturing facilities is not favorable, the FDA will deny approval of the PMA or issue a not approvable letter. The FDA may also determine that additional trials are necessary, in which case the PMA approval may be delayed for several months or years while the trials are conducted and data is submitted in an amendment to the PMA. The PMA process can be expensive, uncertain and lengthy and a number of devices for which FDA approval has been sought by other companies have never been approved by the FDA for marketing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New PMA applications or PMA supplements may be required for modifications to the manufacturing process, labeling, device specifications, materials or design of a device that is approved through the PMA process. PMA supplements often require submission of the same type of information as an initial PMA application, except that the supplement is limited to information needed to support any changes from the device covered by the approved PMA application and may or may not require as extensive clinical data or the convening of an advisory panel.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials are almost always required to support a PMA application and are sometimes required for a 510(k) clearance. These trials generally require submission of an application for an investigational device exemption, or IDE to the FDA. The IDE application must be supported by appropriate data, such as animal and laboratory testing results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. The IDE application must be approved in advance by the FDA for a specified number of patients, unless the product is deemed a non-significant risk device and eligible for abbreviated IDE requirements. Generally, clinical trials for a significant risk device may begin once the IDE application is approved by the FDA and the study protocol and informed consent are approved by appropriate institutional review boards at the clinical trial sites. The FDA&#8217;s approval of an IDE allows clinical testing to go forward, but does not bind the FDA to accept the results of the trial as sufficient to prove the product&#8217;s safety and efficacy, even if the trial meets its intended success criteria. All clinical trials must be conducted in accordance with the FDA&#8217;s IDE regulations, which govern investigational device labeling, prohibit promotion, and specify an array of Good Clinical Practice requirements, which include among other things, recordkeeping, reporting and monitoring responsibilities of study sponsors and study investigators. Clinical trials must further comply with the FDA&#8217;s regulations for institutional review board approval and for informed consent and other human subject protections. Required records and reports are subject to inspection by the FDA. The results of clinical testing may be unfavorable or, even if the intended safety and efficacy success criteria are achieved, may not be considered sufficient for the FDA to grant approval or clearance of a product. The commencement or completion of any of our clinical trials may be delayed or halted, or be inadequate to support approval of a PMA application, for numerous reasons, including, but not limited to, the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients do not enroll in clinical trials at the rate we expect;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients do not comply with trial protocols;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient follow-up is not at the rate we expect;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients experience adverse side effects;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients die during a clinical trial, even though their death may not be related to our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">institutional review boards and third-party clinical investigators may delay or reject our trial protocol;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators decline to participate in a trial or do not perform a trial on our anticipated schedule or consistent with the clinical trial protocol, good clinical practices or other FDA requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Dexcom or third-party organizations do not perform data collection, monitoring and analysis in a timely or accurate manner or consistent with the clinical trial protocol or investigational or statistical plans;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators have significant financial interests related to Dexcom or the study that the FDA deems to make the study results unreliable, or Dexcom or investigators fail to disclose such interests;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory inspections of our clinical trials or manufacturing facilities, which may, among other things, require us to undertake corrective action or suspend or terminate our clinical trials;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in governmental regulations or administrative actions applicable to our trial protocols;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the interim or final results of the clinical trial are inconclusive or unfavorable as to safety or effectiveness; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA concludes that the results from our trial and/or trial design are inadequate to demonstrate safety and effectiveness of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have a Class I data management service which we market to clinics. This service helps healthcare providers and patients see, understand and use blood glucose meter data to diagnose and manage diabetes. The service also allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The infrastructure of the data management service is considered &#8220;medical device data systems,&#8221; or MDDS, and does not require 510(k) clearance. MDDS are hardware or software products that transfer, store, convert formats, and display medical device data. An MDDS does not modify the data or modify the display of the data, and it does not by itself control the functions or parameters of any other medical device. MDDS are not intended to be used for active patient monitoring. In 2016, the 21st Century Cures Act amended the Food, Drug, and Cosmetic Act&#8217;s definition of &#8220;device&#8221; to exclude certain software functions, thus products meeting the definition of MDDS are no longer considered devices and thus are not subject to FDA regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional functions of, or intended uses for, our software platform may require us to obtain either 510(k) clearance or PMA approval from the FDA. To obtain 510(k) clearance, we must submit a pre-market notification demonstrating that the software system is substantially equivalent to a previously cleared 510(k) device or a pre-amendment device that was in commercial distribution before May 28, 1976 for which the FDA has not yet called for the submission of a PMA application. The FDA&#8217;s 510(k) clearance pathway generally takes from three to twelve months from the date the application is completed, but can take significantly longer. After a medical device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a significant change in its intended use, requires a new 510(k) clearance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, we obtained marketing authorization for our G6 as an iCGM system for determining glucose (sugar) levels in children aged two and older and adults with diabetes, via the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is authorized for marketing and placed in commercial distribution, numerous regulatory requirements apply. These include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">establishment registration and device listing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">QSR, which requires manufacturers to follow design, testing, control, storage, supplier/contractor selection, complaint handling, documentation and other quality assurance procedures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">labeling regulations, which prohibit the promotion of products for unapproved or off-label uses or indications and impose other restrictions on labeling, advertising and promotion;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">medical device reporting regulations, which require that manufacturers report to the FDA if a device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">voluntary and mandatory device recalls to address problems when a device is defective and/or could be a risk to health; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">corrections and removal reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, the FDA may require us to conduct post-market surveillance studies or order us to establish and maintain a system for tracking our products through the chain of distribution to the patient level. The FDA and the Food and Drug Branch of the California Department of Health Services enforce regulatory requirements by conducting periodic, unannounced inspections and market surveillance. Inspections may include the manufacturing facilities of our subcontractors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable regulatory requirements, including those applicable to the conduct of our clinical trials, can result in enforcement action by the FDA, which may lead to any of the following sanctions:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">warning letters or untitled letters that require corrective action;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fines and civil penalties;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">unanticipated expenditures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">delays in approving or refusal to approve our future continuous glucose monitoring systems or other products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA refusal to issue certificates to foreign governments needed to export our products for sale in other countries;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">suspension or withdrawal of FDA approval;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product recall or seizure;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">operating restrictions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">injunctions; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">criminal prosecution.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our contract manufacturers, specification developers, and some suppliers of components or device accessories, are also required to manufacture our products in compliance with current Good Manufacturing Practice requirements set forth in the QSR. The QSR requires a quality system for the design, manufacture, packaging, labeling, storage, installation and servicing of marketed devices, and includes extensive requirements with respect to quality management and organization, device design, buildings, equipment, purchase and handling of components or services, production and process controls, packaging and labeling controls, device evaluation, distribution, installation, complaint handling, servicing, and record keeping. The FDA evaluates compliance with the QSR through periodic unannounced inspections that may include the manufacturing facilities of our subcontractors. If the FDA believes we or any of our contract manufacturers or regulated suppliers are not in compliance with these requirements, it can shut down our manufacturing operations, require recall of our products, refuse to approve new marketing applications, institute legal proceedings to detain or seize products, enjoin future violations, or assess civil and criminal penalties against us or our officers or other employees. Any such action by the FDA would have a material adverse effect on our business. We may be unable to comply with all applicable FDA regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Fraud and Abuse Laws and Other Compliance Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is subject to various U.S. federal and state laws pertaining to healthcare fraud and abuse. Violations of these laws are punishable by criminal and civil sanctions, including, in some instances, exclusion from participation in U.S. federal and state healthcare programs, including Medicare and Medicaid.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-kickback Laws.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The federal Anti-Kickback Statute prohibits persons from knowingly and willfully soliciting, receiving, offering or providing remuneration directly or indirectly to induce either the referral of an individual, or the furnishing, recommending, or arranging of a good or service, for which payment may be made under a federal healthcare program such as Medicare and Medicaid. The definition of &#8220;remuneration&#8221; has been broadly interpreted to include anything of value, including such items as gifts, discounts, the furnishing of supplies or equipment, credit arrangements, waiver of payments, and providing anything at less than its fair market value. Given the breadth of this prohibition, Congress has issued a number of exceptions and has granted authority to the OIG to issue safe harbor regulations, each of which set forth certain provisions which, if satisfied in their entirety, will assure parties to the arrangement that they will not be prosecuted under the federal Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more exceptions or safe harbors is not per se illegal; rather, each arrangement is subject to a facts and circumstances analysis to determine whether the requisite improper intent exists. Therefore, conduct and business arrangements that do not fully satisfy each applicable exception or safe harbor element may result in increased scrutiny by government enforcement authorities or invite litigation by private citizens under federal whistleblower laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Civil False Claims Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The federal Civil False Claims Act prohibits knowingly presenting, or causing to be presented a false claim or the knowing use of false statements or records to obtain payment from the federal government. When an entity is determined to have violated the False Claims Act, it must pay three times the actual damages sustained by the government, plus mandatory civil penalties of between $11,181 and $22,363 (adjusted for inflation) for each separate false claim. Suits filed under the False Claims Act can be brought by any individual on behalf of the government and such individuals (known as &#8220;relators&#8221; or, more commonly, as &#8220;whistleblowers&#8221;) may share in any amounts paid by the entity to the government in fines or settlement. These whistleblower-initiated False Claims Act cases are commonly referred to as &#8220;qui tam&#8221; actions. False Claims Act cases may also be initiated by the U.S. Department of Justice or any of its local U.S. Attorneys&#8217; Offices. In addition, certain states have enacted laws modeled after the federal False Claims Act. Qui tam actions have increased significantly in recent years, causing greater numbers of healthcare companies to have to defend a false claim action, even before the validity of the claim is established and even if the government decides not to intervene in the lawsuit. Healthcare companies may decide to agree to large settlements with the government and/or whistleblowers to avoid the cost and negative publicity associated with litigation. Federal enforcement agencies also have showed increased interest in pharmaceutical companies&#8217; product promotion, health care professional engagements, and patient assistance programs, including reimbursement and co-pay support services, and a number of investigations into these programs have resulted in significant civil and criminal settlements. In addition, the Affordable Care Act amended federal law to provide that the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">government may assert that a claim for items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. Criminal prosecution is also possible for knowingly making or presenting a false or fictitious or fraudulent claim to the federal government.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Physician Self-Referral Law. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Federal Physician Self-Referral Law, also referred to as the Stark Law, prohibits a physician (or an immediate family member of a physician) who has a financial relationship with an entity from referring patients to that entity for certain designated health services, including durable medical equipment such as the CGM receiver and supplies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payable by Medicare, unless an exception applies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stark Law also prohibits such an entity from presenting or causing to be presented a claim to the Medicare program for such designated health services provided pursuant to a prohibited referral, and provides that certain collections related to any such claims must be refunded in a timely manner. Exceptions to the Stark Law include, among other things, exceptions for certain financial relationships, including both ownership and compensation arrangements. The Stark Law is a strict liability statute, therefore, to the extent that the statute is implicated and an exception does not apply, the statute is violated. Violations of the Stark Law must be reported and returned to Medicare in order to avoid potential liability under the federal False Claims Act for avoiding a known obligation to return identified overpayments. In the fall of 2020, we transitioned our Medicare business to distributors and no longer bill Medicare directly for DME and related supplies. In doing so, we have limited our exposure under the Stark Law. In addition to the Stark Law, many states have implemented similar physician self-referral prohibitions that may extend to Medicaid, third party payors, and self-pay patients, and may be applicable to our relationships with physicians and other health care providers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Civil Monetary Penalties Law</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Civil Monetary Penalties Law, or CMPL, authorizes the imposition of substantial civil money penalties against an entity that engages in certain prohibited activities including but not limited to violations of the Stark Law or Anti-Kickback Statute, knowing submission of a false or fraudulent claim, employment of an excluded individual, and the provision or offer of anything of value to a Medicare or Medicaid beneficiary that the transferring party knows or should know is likely to influence beneficiary selection of a particular provider for which payment may be made in whole or part by a federal health care program, commonly known as the Beneficiary Inducement CMP. Remuneration is defined under the CMPL as any transfer of items or services for free or for less than fair market value. There are certain exceptions to the definition of remuneration for offerings that meet the Financial Need, Preventative Care, or Promoting Access to Care exceptions. Sanctions for violations of the CMPL include civil monetary penalties and administrative penalties up to and including exclusion from participation in federal health care programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the Stark Law, the Anti-Kickback Statute, the Civil Monetary Penalties Law and/or the federal False Claims Act can also form the basis for exclusion from participation in federal and state healthcare programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Analogs of Federal Fraud and Abuse Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Many U.S. states have their own laws intended to protect against fraud and abuse in the health</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">care industry and more broadly. In some cases these laws prohibit or regulate additional conduct beyond that covered under federal law. Penalties for violating these laws can range from fines to criminal sanctions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurance Portability and Accountability Act of 1996 (HIPAA). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Portability and Accountability Act of 1996, as amended by the American Recovery and Reinvestment Act of 2009, and implementing regulations, collectively HIPAA, created two new federal crimes: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from government sponsored programs. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HIPAA and Other U.S. Privacy Laws and Regulations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA, as well as a number of other federal and state privacy-related laws, also extensively regulate the use and disclosure of individually identifiable health information, known as &#8220;protected health information,&#8221; and require covered entities, including health plans and most health care providers, to implement administrative, physical and technical safeguards to protect the security of such information. Certain provisions of the security and privacy regulations apply to business associates (entities that handle protected health information on behalf of covered entities), and business associates are subject to direct liability for violation of these provisions. In addition, a covered entity may be subject to criminal and civil penalties as a result of a business associate violating HIPAA, if the business associate is found to be an agent of the covered entity. Covered entities must report breaches of unsecured protected health information to affected individuals without unreasonable delay and notification must also be made to the U.S. Department of Health &amp; Human Services, Office for Civil Rights, or OCR and, in certain situations involving large breaches, to the media. Various U.S. state laws and regulations may also require us to notify affected individuals and state agencies in the event of a data breach involving individually identifiable information. The OCR enforces the regulations and performs compliance audits. In addition to enforcement by OCR, state attorneys general are authorized to bring civil actions seeking either injunction or damages in response to violations that threaten the privacy of state residents. Dexcom is a covered entity under HIPAA and in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain circumstances, may also be a business associate of another covered entity. The HIPAA privacy regulations and security regulations impose and will continue to impose significant costs on us in order to comply with these standards.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous other laws and legislative and regulatory initiatives at the federal and state levels addressing privacy and security concerns. We also remain subject to federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. These laws vary and could impose additional penalties. For example, the Federal Trade Commission uses its consumer protection authority to initiate enforcement actions in response to alleged privacy and data security violations. Further, certain states have proposed or enacted legislation that will create new data privacy and security obligations for certain entities, such a the California Consumer Privacy Act, or CCPA, which came into effect January 1, 2020 and was recently amended and expanded by the California Privacy Rights Act (CPRA) passed on November 3, 2020. The CCPA and CPRA, among other things, create new data privacy obligations for covered companies and provides new privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also created a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. It remains unclear what, if any, additional modifications will be made to the CPRA by the California legislature or how it will be interpreted. Therefore the effects of the CCPA and CPRA are significant and will likely require us to modify our data processing practices, and may cause us to incur substantial costs and expenses to comply, particularly given our base of operations in California.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws discussed above, we may see more stringent state and federal privacy legislation passed in 2021 and beyond, as the increased cyber-attacks during the COVID-19 pandemic have once again put a spotlight on data privacy and security in the U.S. and other jurisdictions. We cannot predict where new legislation might arise, the scope of such legislation, or the potential impact to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FCPA and Other Anti-Bribery and Anti-Corruption Laws. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Foreign Corrupt Practices Act, or FCPA, prohibits U.S. corporations and their representatives from offering, promising, authorizing or making payments to any foreign government official, government staff member, political party or political candidate in an attempt to obtain or retain business abroad. The scope of the FCPA would include interactions with certain healthcare professionals in many countries, either directly or through our contracted distributors. Our present and future business has been and will continue to be subject to various other U.S. and foreign laws, rules and/or regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Physician Payment Sunshine Act. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Patient Protection and Affordable Care Act that was signed into law in March 2010, the federal government enacted the Physician Payment Sunshine Act. As a manufacturer of U.S. FDA&#8209;regulated devices reimbursable by federal healthcare programs, we are subject to this law, which requires us to track and annually report certain payments and other transfers of value we make to U.S.-licensed physicians or U.S. teaching hospitals. We are also required to report certain ownership interests held by physicians and their immediate family members. In 2018, the law was extended to require tracking and reporting of transfers of value to physician assistants, nurse practitioners, and other mid-level practitioners. Reporting requirements will go into effect in 2022 for payments and transfers of value made to these additional practitioner-types in 2021. CMS has the potential to impose penalties of up to $1.15 million per year for violations of the Physician Payment Sunshine Act, depending on the circumstances, and reported payments also have the potential to draw scrutiny to our relationships with physicians, which may have implications under the Anti-Kickback Statute and and other healthcare laws. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there has been a recent trend of increased federal and state regulation of payments and other transfers of value provided to healthcare professionals and entities. Similar to the federal law, certain states also have adopted marketing and/or transparency laws relevant to device manufacturers, some of which are broader in scope. Certain states also mandate that device manufacturers implement compliance programs. Other states impose restrictions on device manufacturer marketing practices and require tracking and reporting of gifts, compensation, and other remuneration to healthcare professionals and entities. The need to build and maintain a robust compliance program with different compliance and/or reporting requirements increases the possibility that a healthcare company may violate one or more of the requirements, resulting in fines and penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Regulation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales of medical devices are subject to foreign government regulations, which may vary substantially from country to country. The time required to obtain approval in a foreign country may be longer or shorter than that required for FDA approval, and the requirements may differ. There is a trend towards harmonization of quality system standards among the European Union, United States, Canada and various other industrialized countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory framework governing medical devices is largely harmonized within the European Union, which includes most of the major countries in Europe (please note that the UK is effectively no longer part of the European Union as of January 1, 2021). Other countries, such as Switzerland, have voluntarily adopted laws and regulations that mirror those of the European Union with respect to medical devices. The European Union has adopted numerous directives and standards regulating the design, manufacture, clinical trials, labeling and adverse event reporting for medical devices. To be placed on the European Union market, devices must undergo a conformity assessment and bear the CE mark, indicating that the device </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">conforms to the essential requirements of the applicable rules. The method of assessing conformity varies depending on the class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a &#8220;Notified Body.&#8221; This third-party assessment, which may consist of an audit of the manufacturer&#8217;s quality system and specific testing of the manufacturer&#8217;s product, is always required in order for a manufacturer to commercially distribute the product throughout the European Union, except in case of Class I medical devices (those entailing the lowest level of risk). Outside of the European Union, regulatory approval needs to be sought on a country-by-country basis in order for us to market our products. The new European Union Medical Device Regulation (MDR) went into force in 2017, replacing the existing Directive and providing three years for transition and compliance, which has been extended by one additional year. The MDR will become fully applicable in the European Union on May 26, 2021, changing several aspects of the existing regulatory framework. Other countries have adopted medical device regulatory regimes, such as the Classification Rules for Medical Devices published by the Hong Kong Department of Health, the Health Sciences Authority of Singapore regulation of medical devices under the Health Products Act, and Health Canada&#8217;s risk classification system for invasive devices, among others. Each country may have its own processes and requirements for medical device licensing, approval, and regulation, therefore requiring us to seek regulatory approvals on a country-by-country basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outside the United States a range of anti-bribery and anti-corruption laws, as well and some industry-specific laws and codes of conduct, apply to the medical device industry and interactions with government officials and entities and healthcare professionals. Laws include the UK Bribery Act of 2010. Further, the EU member countries have emphasized a greater focus on healthcare fraud and abuse and have indicated greater attention to the industry by the European Anti-Fraud Office. MedTech Europe, the medical device industry association, also introduced the Code of Ethical Business Practices, which came into effect on January 1, 2017. Countries in Asia have also become more active in their enforcement of anti-bribery laws and with respect to procurement and supply chain fraud.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of patient data across the healthcare industry became effective in May 2018. The EU General Data Protection Regulation, or GDPR, applies across the European Union and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20 million euros, or up to 4 % of the company&#8217;s total global turnover of the preceding fiscal year, whichever is higher. The GDPR also requires companies processing personal data of individuals residing in the European Union to comply with EU privacy and data protection rules, even if the company itself does not have a physical presence in the European Union. Noncompliance could result in the imposition of fines, penalties, or orders to stop noncompliant activities. Due to the strong consumer protection aspects of the GDPR, companies subject to its purview are allocating substantial legal costs to the development of necessary policies and procedures and overall compliance efforts. We expect continued costs associated with maintaining compliance with GDPR into the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Regulation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development and clinical processes involve the handling of potentially harmful biological materials as well as hazardous materials. We are subject to federal, state and local laws and regulations governing the use, handling, storage and disposal of hazardous and biological materials and we incur expenses relating to compliance with these laws and regulations. If violations of environmental, health and safety laws occur, we could be held liable for damages, penalties and costs of remedial actions. These expenses or this liability could have a significant negative impact on our financial condition. We may violate environmental, health and safety laws in the future as a result of human error, equipment failure or other causes. Environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We are subject to potentially conflicting and changing regulatory agendas of political, business and environmental groups. Changes to or restrictions on permitting requirements or processes, hazardous or biological material storage or handling might require an unplanned capital investment or relocation. Failure to comply with new or existing laws or regulations could harm our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advisory Boards and Consultants</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relied upon the advice of experts in the development and commercialization of our products. Since 2005, we have used experts in various disciplines on a consulting basis as needed to solve problems or accelerate development pathways. We may continue to engage advisors from the academic, consultancy, governmental or other areas to assist us as necessary. Relationships between manufacturers and physicians, including in consultancy and advisory board roles, is subject to scrutiny under the Stark Law, the federal Anti-Kickback Statute, and their state law equivalents. Due to this scrutiny, we incur legal and consulting fees to ensure our relationships with physicians meet regulatory requirements, including that compensation paid to such physicians is within fair market value.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we have approximately 5,500 full-time employees and approximately 900 contract and temporary employees around the globe. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:82.017%"><tr><td style="width:1.0%"></td><td style="width:30.985%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Female</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Male</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grand Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,100&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States (&#8220;OUS&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Total</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our employees are represented by a labor union or covered by a collective bargaining agreement, except for our employees in our Mainz, Germany location that are represented by a Works Council. We have never experienced any employment-related work stoppages and we consider our employee relations to be good.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the COVID-19 pandemic has disrupted business and operations for companies around the globe, the resilience of our employees has enabled us to minimize disruption to our sales, research, clinical studies and operations. Our onsite employees, particularly in manufacturing and operations, have rapidly adjusted to numerous stringent safety protocols. Thousands of other employees have shifted to work-from-home status since March 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are optimistic about the potential to expand our global workforce and create a more inclusive environment for all of our employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity and Inclusion</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global company, we understand the importance of diversity in our workforce. This year, we made progress in our commitment to Diversity, Equity &amp; Inclusion (DEI) by formally establishing a DEI Council responsible for coordinating efforts around the organization, and securing resources to drive necessary change. At the same time, we expanded our Employee Resource Group (ERG) network to better reflect the diversity of our workforce and drive grassroots change. We now have multiple ERGs, including Dexcom PRIDE, Dexcom African American Network, LatinX, and ABLE, which help build our company community and enable opportunities for development. Together, these groups helped allocate our initial donation of $250,000 to support organizations dedicated to diversity, equity and inclusion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The work we have done to date represents the beginning of our DEI journey. We will continue to focus on building a pipeline of opportunities for both the hiring and advancement of qualified individuals, including for women, persons with disabilities, and minority groups that are underrepresented in science and engineering industries. We believe that diverse perspectives will help empower our employees, patients and industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Communications and Engagement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on employees understanding our strategic vision as well as our day-to-day objectives. To that end, we employ a mix of communication and engagement channels, including global, regional and functional town halls, regular leadership forums, and quarterly updates on our progress against our strategic goals. We have also created a cross-functional team focused on improving the employee experience and driving engagement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A central part of our communications and engagement efforts are connecting people to purpose. To this end, we regularly invite Dexcom users, called Warriors, to share their stories with our employees. Whether the Warrior is a professional athlete whose performance depends on Dexcom, or a parent who no longer has to stick their child&#8217;s fingers during the night, their experiences reinforce our commitment to expand our reach into new patient populations, geographies and markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health, Safety and Wellness</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are deeply committed to the safety, health and wellness of our employees. The Dexcom Environmental, Health &amp; Safety team develops global safety practices and procedures, trains employees, and monitors compliance. Through these efforts, along with leadership commitment and investment of resources in support of workplace safety initiatives, our total US injury rate has consistently tracked below industry averages. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also provide comprehensive wellbeing programs that support our employees and their families. For example, Inspire, our newly launched global wellness platform, helps employees and their family members develop and achieve their physical, emotional, and financial wellbeing goals.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation</span><span style="color:#58a618;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize that our employees are our most valuable asset. Our total rewards package includes market competitive pay, comprehensive and competitive global benefits and retirement offerings, paid time off and family leave, tuition reimbursement and on-site services. To foster a stronger sense of ownership and align the interests of employees with shareholders, we offer an Employee Stock Purchase Plan, and restricted stock units are provided to eligible employees under our broad-based stock incentive programs. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we began proactive reviews of both gender and minority pay equity for our global employees in the same or similar roles. The goal of these reviews is to identify and close any gaps in average pay, after accounting for legitimate business factors that may explain differences, such as performance, time in role, and tenure with the company. We have incorporated the findings into our compensation assessment cycles, and we recognize the need to regularly review pay equity to maintain our pay equity goals.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Growth and Development </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that investing in our talent&#8217;s growth and development will directly enhance our overall company performance. Our career development site, includes employee resources focusing on the advancement of six core competencies: collaboration, effective communication, talent development, driving results, demonstrating self-awareness, and strategic mindset. The internal site includes several training videos on a wide variety of topics, providing necessary resources for employees to grow in accord with their personal goals. The site also serves as a hub for our virtual and in-person sessions that align with the development of our six core competencies. </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently, we enhanced our internal careers platform to more effectively match an employee&#8217;s experience with potential career paths at Dexcom. By providing an easy way for employees to explore new roles, we can increase internal mobility, develop great talent, and reduce turnover.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A - RISK FACTORS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our short and long-term success is subject to numerous risks and uncertainties, many of which involve factors that are difficult to predict or beyond our control. Before making a decision to invest in, hold or sell our common stock, stockholders and potential stockholders should carefully consider the risks and uncertainties described below, in addition to the other information contained in or incorporated by reference into this Annual Report on Form 10-K, as well as the other information we file with the Securities and Exchange Commission. If any of the following risks are realized, our business, financial condition, results of operations and prospects could be materially and adversely affected. In that case, the value of our common stock could decline and stockholders may lose all or part of their investment. Furthermore, additional risks and uncertainties of which we are currently unaware, or which we currently consider to be immaterial, could have a material adverse effect on our business, financial condition or results of operations. Refer to our disclaimer regarding forward-looking statements at the beginning of Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Item 7 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Risk Factors </span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below summary of risk factors provides an overview of many of the risks we are exposed to in the normal course of our business activities. As a result, the below summary risks do not contain all of the information that may be important to you, and you should read the summary risks together with the more detailed discussion of risks set forth following this section under the heading &#8220;Risk Factors,&#8221; as well as elsewhere in this Annual Report on Form 10-K.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional risks, beyond those summarized below or discussed elsewhere in this Annual Report on Form 10-K, may apply to our activities or operations as currently conducted or as we may conduct them in the future or in the markets in which we operate or may in the future operate. Consistent with the foregoing, we are exposed to a variety of risks, including risks associated with the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to cost-containment efforts that could result in reduced product pricing and/or sales of our products and cause a reduction in future revenue.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">If we are unable to obtain adequately broad reimbursement at acceptable prices for our products or any future products from third-party payors, our revenue may be negatively impacted.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">The research and development efforts we undertake independently, and in some instances in connection with our collaborations with third parties, may not result in the development of commercially viable products, the generation of significant future revenues or adequate profitability. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our products may not achieve market acceptance.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, we may not be able to meet market demand or our growth could be limited and our business could be harmed.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">Manufacturing difficulties and/or any disruption at our facilities may adversely affect our manufacturing operations and related product sales and increase our expenses.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">If we are unable to continue the development of an adequate sales and marketing organization and/or if our direct sales organization is not successful, or enter into and maintain arrangements with third parties to sell, market or distribute our products, we may have difficulty achieving market awareness and selling our products in the future.</span></div><div style="padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The outbreak of the SARS-CoV-2 virus and the COVID-19 disease that it causes, or similar public health crises, could have a material adverse impact on our business, financial condition and results of operations, including our manufacturing, commercial operations and sales.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to a variety of risks due to our international operations that could adversely affect our business, our operations or profitability and operating results. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">We have incurred significant losses in the past and may incur losses in the future.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">We are subject to complex and evolving U.S. and foreign laws and regulations regarding privacy, data protection, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from participation in government programs, and/or be required to make significant changes to our operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">Managed care trends, consolidation in the health care industry and health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support additional PMA, de novo, or 510(k) applications or supplements, we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">We are subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We could become the subject of governmental investigations, claims and litigation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">Our stock price is highly volatile and investing in our stock involves a high degree of risk, which could result in substantial losses for investors. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We have indebtedness in the form of convertible senior notes, which could adversely affect our financial health and our ability to respond to changes in our business.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Our Business and Operations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risks Related to Pricing and Reimbursement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced, and anticipate that we will continue to experience, decreasing prices for our products due to pricing pressure from managed care organizations and other third-party payors, increased market power of our payors, as the medical device industry consolidates, and increased competition among suppliers, including manufacturing services providers. If the prices for our products and services decrease and we are unable to reduce our expenses, including the cost of sourcing materials, logistics and the cost to manufacture our products, our business, results of operations, financial condition and cash flows will be adversely affected. The global COVID-19 pandemic may result in increased costs for manufacturing and outsourced services while also causing additional pressure to reduce the prices for our products if a recession or depression occurs and people are unable to afford our products. We cannot predict the ultimate impact that the COVID-19 pandemic and its effects could have on our business operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to cost-containment efforts that could result in reduced product pricing and/or sales of our products and cause a reduction in future revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and other countries, government and private sector access to health care products continues to be a subject of focus, and efforts to reduce health care costs are being made by third-party payors. Most of our customers rely on third-party payors, including government programs and private health insurance plans, to cover the cost of our products. We </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expect that the continuing cost reduction and containment measures may reduce the cost or utilization of health care products and could lead to patients being unable to obtain approval for coverage or payment from these third-party payors. Additionally, as a result of COVID-19, some customers have and others may lose access to their private health insurance plan if they lose their job, and an impact to job status may extend for a prolonged period of time, beyond possible coverage periods through COBRA, or where the cost to maintain coverage may not be affordable to our customer. As most of our customers rely on third-party payors, including government programs and private health insurance plans, to cover the cost of our products, our customers may lose coverage for our products, which may harm our business and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced, and anticipate that we will continue to experience, downward pressure on product pricing. To the extent these cost containment efforts are not offset by greater patient access to our products, our future revenue may be reduced and our business may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Although many third-party payors have adopted some form of coverage policy on continuous glucose monitoring devices, our products do not always have some form of coverage, including simple broad-based contractual coverage, with third-party payors and we frequently experience administrative challenges in obtaining reimbursement for our customers. If we are unable to obtain adequately broad reimbursement at acceptable prices for our products or any future products from third-party payors, our revenue may be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device company, reimbursement from government and/or commercial third-party healthcare payors, including Medicare and Medicaid, is an important element of our success. In January 2017, the Centers for Medicare &amp; Medicaid Services, or CMS, established a classification of &#8220;Therapeutic Continuous Glucose Monitors&#8221; as durable medical equipment eligible for coverage under Medicare Part B. Coverage criteria for therapeutic CGMs is determined by CMS under national coverage determinations as well as by local Medicare Administrative Contractors under local coverage determinations. Therefore, Medicare reimbursement for our CGM devices is subject to various coverage conditions and often requires a patient-specific coverage analysis. In May 2017, CMS Medicare Administrative Contractors issued a revision to an existing joint Local Coverage Determination, which establishes the Medicare conditions of coverage for therapeutic CGM, including our G5 Mobile and G6 systems. On October 27, 2020, CMS proposed changes to Medicare Durable Medical Equipment, Prosthetics, Orthotic Devices, and Supplies (DMEPOS) coverage and payment policies that would expand Medicare coverage for CGM devices and supplies by classifying all CGMs (not just therapeutic CGMs) as DME and establishing payment amounts for these items and related supplies. If finalized, beginning April 2021, additional manufacturers would be able to obtain Medicare coverage and payment for their CGM devices and some of the new CGM options may be cheaper for Medicare beneficiaries, potentially resulting in decreased sales and resulting revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, in September 2016, Germany&#8217;s Federal Joint Committee agreed to provide reimbursement for continuous glucose monitoring systems under certain conditions, which we believe are met by our current CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of regulatory and commercial hurdles remain relating to wide-scale sales where a government or commercial third-party payor provides reimbursement, including sales to Medicare beneficiaries. If we are unable to successfully address these hurdles, reimbursement of our products may be limited to a smaller subset of people with diabetes covered by Medicare or to those people with diabetes covered by other third-party payors that have adopted policies for CGM devices allowing for coverage of these devices if certain conditions are met. Adverse coverage or reimbursement decisions relating to our products by CMS, its Medicare Administrative Contractors, other state, federal or international payors, and/or third-party commercial payors could significantly reduce reimbursement, which could have an impact on the acceptance of, and demand for, our products and the prices that our customers are willing to pay for them.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the seven largest private third-party payors, in terms of the number of covered lives, have issued coverage policies for the category of CGM devices. In addition, we have negotiated contracted rates with all seven of those third-party payors for the purchase of our current CGM systems by their members. However, people with diabetes without insurance that covers our products will have to bear the financial cost of them. In the United States, people with diabetes using existing single-point finger stick devices are generally reimbursed all or part of the product cost by Medicare or other third-party payors. The commercial success of our products in both domestic and international markets will substantially depend on whether timely and comprehensive third-party reimbursement is widely available for individuals that use them. While many third-party payors have adopted some form of coverage policy on CGM devices, in a sizeable percentage of cases, under durable medical equipment benefits, those coverage policies frequently are restrictive and require significant medical documentation and other requirements in order for policy holders to obtain reimbursement, and as a result, we have difficulty improving the efficiency of our customer service group. Moreover, it is not uncommon for governmental, including federal and/or state, agencies and their contractors to conduct periodic routine billing and compliance reviews that may entail extensive documentation requests, cooperation with which may require significant time and resources, and may result in identification of overpayments that may need to be refunded.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Medicare, Medicaid, other governmental health programs, health maintenance organizations and other third-party payors are increasingly attempting to contain healthcare costs by limiting both coverage and the level of reimbursement of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new and existing medical devices, and, as a result, they may be restrictive, or they may not cover or provide adequate payment for our products. Many of these programs impose documentation and other eligibility requirements that make it more difficult to obtain reimbursement. In order to obtain additional reimbursement arrangements, including under pharmacy benefits, we may have to agree to a net sales price lower than the net sales price we might charge in other sales channels. Our revenue may be limited by the continuing efforts of government and third-party payors to contain or reduce the costs of healthcare through various increasingly sophisticated means, such as leveraging increased competition, increasing eligibility requirements such as second opinions and other documentation, purchasing in a bundle, or redesigning benefits. We are unable to predict what effect the current or any future healthcare reform will have on our business, or the effect these matters will have on our customers. Our dependence on the commercial success of our current CGM systems makes us particularly susceptible to any cost containment or reduction efforts. Accordingly, unless government and other third-party payors provide adequate coverage and reimbursement for our current CGM systems, people without coverage who have diabetes may not use our products. Furthermore, payors are increasingly basing reimbursement rates on factors such as prior approvals and the effectiveness of the product, clinical outcomes associated with the product, and any factors that negatively impact the effectiveness or clinical outcomes (or cause a perception of any such negative impact), such as the results of a clinical trial, a product defect, or a product recall, which could negatively impact the reimbursement rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare does not cover any items or services that are not &#8220;reasonable and necessary.&#8221; Medicare covers the CGM system, which includes supplies necessary for the use of the device, under the Durable Medical Equipment (DME) benefit category. In order to be covered under this benefit, one component of the CGM system must meet the criteria for a durable medical device. To date, the receiver satisfied this criteria. To the extent that a receiver is not used by a Medicare beneficiary or CMS otherwise determines that the items and supplies ordered are not medically necessary, Medicare may not cover that CGM system or any associated supplies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some foreign markets, pricing and profitability of medical devices are subject to government control. In the United States, we expect that there will continue to be federal and state proposals for similar controls. Also, the trends toward managed healthcare in the United States and legislative efforts intended to reduce the cost of government insurance programs could significantly influence the purchase of healthcare services and products and may result in lower prices for our products or the exclusion of our products from reimbursement programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risks Related to Product Development</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The research and development efforts we undertake independently, and in some instances in connection with our collaborations with third parties, may not result in the development of commercially viable products, the generation of significant future revenues or adequate profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to address the anticipated needs of our customers, pursue new markets for our existing products, and remain competitive, we focus our research and development efforts and strategic third-party collaboration activities on the enhancement of our current CGM products, the development of next-generation products and the development of novel technologies and services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of new products, or novel technologies and services and the enhancement of our current CGM products (including obtaining new indications for use), requires significant investment in research and development, intellectual property protection, clinical trials, regulatory approvals and third party reimbursement. The results of our product development and commercialization efforts may be affected by a range of factors, including our ability to anticipate customer needs, innovate and develop new products, and launch those products cost effectively into multiple markets and geographies. If we are unable to successfully anticipate customer needs, innovate, develop new products and successfully launch them, we may not be able to generate significant future revenues or profits from these efforts. Failing to timely launch our products may cause them to become obsolete and materially and adversely affect our business and financial position.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development and commercial launch timelines for our products depend a great deal on our ability to achieve clinical endpoints and regulatory requirements and to overcome technology challenges, and may be delayed due to scheduling issues with patients and investigators, requests from institutional review boards, or inquiries from regulators about our independent and collaborative product development activities, product performance and manufacturing supply constraints, among other factors. In addition, support of these clinical trials requires significant resources from employees involved in the production of our products, including research and development, manufacturing, quality assurance, and clinical and regulatory personnel. Even if our development and clinical trial efforts succeed, the FDA may not approve the products or may require additional product testing and clinical trials before approving the products, which would result in product launch delays and additional expense. If approved by the FDA, the products may not be accepted in the marketplace by physicians and people with diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we enter into collaborative arrangements to develop new products and to pursue new markets, such as our agreements with Eli Lilly, Insulet, Novo Nordisk, Tandem Diabetes and The Ypsomed Group, to integrate our CGM technology into their insulin delivery systems, and our amended agreement with Verily to develop one or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">more next-generation CGM products. Our Eli Lilly, Insulet, Novo Nordisk, Verily and Ypsomed collaborations have not yet resulted in a commercial product. In December 2019, Tandem received FDA approval for its second sensor-augmented insulin delivery system, the t:slim X2&#8482; Insulin Pump with Control-IQ&#8482; technology, which integrates with our G6 system. We have also entered into collaborations with several organizations that are currently using, or are developing, programs for the treatment of Type 2 diabetes that utilize our current CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these relationships, our operating results depend, to some extent, on the ability of our partners to successfully commercialize their insulin delivery systems or monitoring products. Any factors that may limit our partners&#8217; ability to achieve widespread adoption of their systems, including competitive pressures, technological breakthroughs for the treatment or prevention of diabetes, adverse regulatory or legal actions relating to insulin pump products, or changes in reimbursement rates or policies of third-party payors relating to insulin pumps or similar products, could have an adverse impact on our operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the companies that we collaborate with are also competitors or potential competitors who may decide to terminate our collaborative arrangement. In the event of such a termination, we may be required to devote additional resources to product development and commercialization, we may need to cancel some development programs and we may face increased competition. Additionally, collaborations may not result in the development of products that achieve commercial success and could be terminated prior to developing any products. Former collaborators may use the experience and insights they develop in the course of their collaborations with us to initiate or accelerate their development of products that compete with our products, which may create competitive disadvantages for us. Accordingly, we cannot provide assurance that any of our collaborations will result in the successful development of a commercially viable product or result in significant additional future revenues.</span></div><div style="margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products may not achieve market acceptance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that sales of our current CGM systems will account for substantially all of our product revenue for the foreseeable future. If and when we receive FDA or other regulators&#8217; approval for, and begin commercialization of, our next-generation CGM systems, we expect most patients will migrate onto those systems. In the periods leading up to the launch of new or upgraded versions of our CGM systems, however, our customers&#8217; anticipation of the release of those products may cause them to cancel, change or delay current period purchases of our current products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding our prior experience in marketing and selling our products, we might be unable to successfully expand the commercialization of our existing products or begin commercialization of our next-generation CGM systems on a wide-scale for a number of reasons, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our G6 system prompts the user to replace the sensor no later than the tenth day, which might make it expensive for users;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">widespread market acceptance of our products by physicians and people with diabetes will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the limited size of our sales force;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may not have sufficient financial or other resources to adequately expand the commercialization efforts for our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our FDA and other regulatory authority marketing application submissions and reviews may be delayed, or cleared or approved with limited product indications and labeling;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may not be able to manufacture our products in commercial quantities commensurate with demand or at an acceptable cost;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">people with Type 2 diabetes do not generally receive broad reimbursement from third-party payors for their purchase of CGM products in the United States, since many payors require that a policy holder meet specific medical criteria to qualify for reimbursement, which may reduce widespread access to or use of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the uncertainties associated with establishing and qualifying new manufacturing facilities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">people with diabetes may need to incur the costs of single-point finger stick devices, in addition to our systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the relative immaturity of the CGM market internationally, and limited international reimbursement of CGM systems by third-party payors and government healthcare providers outside the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the introduction and market acceptance of competing products and technologies, which may have a lower cost or  price, allow for a convenience improvement and allow for improved accuracy and reliability;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater name or brand recognition and more established medical product distribution channels by some of our competitors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to obtain sufficient quantities of supplies at appropriate quality levels from our single- or sole-source and other key suppliers;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to manufacture products that perform in accordance with expectations of consumers; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">rapid technological change may make our technology and our products obsolete.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the risks outlined above, our G6 systems are more invasive than many other self-monitored glucose testing systems, including single-point finger stick devices, and people with diabetes may be unwilling to insert a sensor in their body, especially if their current diabetes management involves no more than two finger sticks per day. Moreover, people with diabetes may not perceive the benefits of CGM and may be unwilling to change their current treatment regimens. Physicians may not recommend or prescribe our products unless and until (i)&#160;there is more long-term clinical evidence to convince them to alter their existing treatment methods, (ii)&#160;there are additional recommendations from prominent physicians that our products are effective in monitoring glucose levels, and (iii)&#160;reimbursement or insurance coverage is more widely available. In addition, market acceptance of our products by physicians and people with diabetes in Europe or other countries will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use. If we are unable to do so, we may not be able to generate product revenue from our sales efforts in Europe or other countries. We cannot predict when, if ever, healthcare professionals, including physicians, and people with diabetes may adopt more widespread use of CGM systems, including our systems. If our CGM systems do not achieve and maintain an adequate level of acceptance by people with diabetes, healthcare professionals, including physicians, and third party payors, our future revenue may be reduced and our business may be harmed.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Manufacturing, Commercial Operations and Commercialization</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our existing manufacturing facilities are designed to manufacture current and next-generation sensors and transmitters, but may not be scaled quickly enough to permit us to manufacture one or more of our CGM systems in quantities sufficient to meet market demand. In the past, we have had difficulty scaling our manufacturing operations to provide a sufficient supply of product to support market demand and our commercialization efforts. From time to time, we have also experienced brief periods of backorder and, at times, have had to limit the efforts of our sales force to introduce our products to new customers. We have focused significant effort on continual improvement programs in our manufacturing operations intended to improve quality, yields and throughput. We have made progress in manufacturing to enable us to supply adequate amounts of product to support our commercialization efforts; however, we cannot guarantee that supply will not be constrained in the future. We may not adequately predict the market demand for our products, in order to produce our products in the quantities we anticipate will be necessary to meet market demand. We will need to adequately predict the market demand for our products and increase our manufacturing capacity by a significant factor over the current level to meet or exceed the anticipated market demand. In addition, we will have to modify our manufacturing design, reliability and process if and when our next-generation CGM, technologies are approved, cleared or otherwise authorized by the applicable regulatory body and commercialized. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are technical challenges to increasing manufacturing capacity, including equipment design, automation, validation and installation, contractor issues and delays, licensing and permitting delays or rejections, materials procurement, manufacturing site expansion, problems with production yields and quality control and assurance. Continuing to develop commercial-scale manufacturing facilities will require the investment of substantial additional funds and the hiring and retention of additional management, quality assurance, quality control and technical personnel who have the necessary manufacturing experience. Delays in the launch of next-generation products may result in unanticipated continuing increases in demand for current-generation products (to substitute for the unavailability of the next-generation products) which, if not adequately prepared for, may result in deficits in our ability to produce adequate amounts of the prior-generation products to meet demand at appropriate prices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scaling of manufacturing capacity is subject to numerous risks and uncertainties, and may lead to variability in product quality or reliability, increased construction timelines, as well as resources required to design, install and maintain manufacturing equipment, among others, all of which can lead to unexpected delays in manufacturing output. In addition, any changes to our manufacturing processes may trigger the need for submissions or notifications to, and in some cases advance approval from, the FDA or other regulatory authorities because of the potential impact of changes on our previously cleared, approved and/or authorized devices. Our facilities are subject to inspections by the FDA and corresponding state agencies on an ongoing basis, and we must comply with Good Manufacturing Practices and FDA Quality Systems Regulations, as well as certain state requirements. We may be unable to adequately maintain, develop and expand our manufacturing process and operations or maintain compliance with FDA and state agency requirements, and manufacturing issues could impact our cleared and approved products. If we are unable to manufacture a sufficient supply of our current products or any future products for which we may receive approval or clearance, maintain control over expenses or otherwise adapt to anticipated growth, or if we underestimate growth, we may not have the capability to satisfy market demand, contractual obligations, and our business will suffer.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing difficulties and/or any disruption at our facilities may adversely affect our manufacturing operations and related product sales, and increase our expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are manufactured at certain facilities, with limited alternate facilities. If an event occurs at one of our facilities that results in damage to, or closure of, one or more of such facilities, we may be unable to manufacture the relevant products at the previous levels or at all. Because of the time required to approve and lease a manufacturing facility, an alternate facility and/or a third-party may not be available on a timely basis to replace production capacity in the event manufacturing capacity is lost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the majority of our operations are conducted at facilities located in San Diego, California and Mesa, Arizona. We take precautions to safeguard our facilities, which include manufacturing protocols, insurance, health and safety protocols, and off-site storage of data. However, a natural or man-made disaster, such as fire, flood, earthquake, act of terrorism, cyber-attack or other disruptive event, such as the COVID-19 pandemic or another public health emergency, could cause substantial delays in our operations, damage, destroy or limit our manufacturing equipment, inventory, or records and cause us to incur additional expenses. Earthquakes are of particular significance since our manufacturing facilities in California are located in an earthquake-prone area. In the event our existing manufacturing facilities or equipment are affected by man-made or natural disasters, we may be unable to manufacture products for sale or meet customer demands or sales projections. If our manufacturing operations were curtailed or ceased, it would seriously harm our business. The insurance we maintain against fires, floods, earthquakes and other natural disasters and similar events may not be adequate to cover our losses in any particular case. Further, insurance coverage may not be available or successfully secured for loss profits or business interruption relating to the COVID-19 pandemic and its impacts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture the majority of our products and procure important third-party services, such as sterilization services, at numerous facilities worldwide. We purchase many of the components, materials and services needed to manufacture these products from numerous suppliers in various countries. We have generally been able to obtain adequate supplies of such materials, components and services. However, we also rely on single and/or sole sources for certain components and materials used in manufacturing, such as for the application-specific integrated circuit that is incorporated into the transmitter and certain polymers used to synthesize the polymeric biointerface membranes for our products. In some cases, our agreements with these and other suppliers can be terminated by either party upon short notice. Our contract manufacturers may also rely on single-or sole- source suppliers to manufacture some of the components used in our products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we work with our suppliers to try to ensure continuity of supply while maintaining quality, timeliness and reliability, the supply of these components, materials and services may be impacted, interrupted or insufficient. Our manufacturers and suppliers may also encounter problems during manufacturing for a variety of reasons. They may fail to follow specific protocols and procedures, fail to comply with applicable regulations, or be the subject of FDA or other regulatory authority audits or inspections that result in allegations of non-compliance (for example, resulting in Form 483 Observations, Warning Letters, or other FDA enforcement actions). Our manufacturers and suppliers may also experience or be impacted by equipment malfunction, environmental factors, and public health emergencies including but not limited to the global COVID-19 pandemic, any of which could delay or impede their ability to meet our demand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if our sole- or single-source suppliers shift their manufacturing and assembly sites to other locations, depending on the circumstances and nature of the item supplied, in addition to quality system activities such as verification and validation, there could be a need for FDA notifications or submissions, and the new locations could be subject to regulatory inspections. If there are regulatory delays or impediments impacting our suppliers or us for any reason, we may not be able to quickly establish additional or replacement suppliers, particularly for our single-source components, in part because of the custom nature of various parts we design. Any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products. For supply risks related to COVID-19, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;The outbreak of the SARS-Cov-2 virus and the COVID-19 disease that it causes, or similar public health crises, could have a material adverse impact on our business, financial condition and results of operations, including our manufacturing, commercial operations and sales.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on these outside manufacturers and suppliers also subjects us to other risks that could harm our business, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may experience a reduction or interruption in supply, and may not be able to obtain adequate supply in a timely manner or on commercially reasonable terms from additional or replacement sources; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our products are technologically complex and it is difficult to develop alternative supply sources; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we are not a major customer of many of our suppliers, and these suppliers may therefore give other customers&#8217; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">needs higher priority than ours; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may make errors in manufacturing components that could negatively affect the quality, effectiveness or safety of our products or cause delays in shipment of our products; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may have difficulty locating and qualifying alternative suppliers for our single-source supplies; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">switching components may require product redesign and submission to the FDA of new applications (such as new 510(k) submissions or PMA supplements) which could significantly delay production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers manufacture products for a range of customers, and fluctuations in demand for the products these suppliers manufacture for others may affect their ability to deliver components to us in a timely manner; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may discontinue the production of components that are critical to our products; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may encounter financial and/or other hardships unrelated to our demand for components, including those related to changes in global economic conditions and/or disease outbreaks, which could inhibit their ability to fulfill our orders and meet our requirements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also outsource certain services to other parties, including inside sales, certain transaction processing, accounting, information technology, manufacturing, and other areas. Outsourcing of services to third parties could expose us to suboptimal quality of service delivery or deliverables and potentially result in repercussions such as missed deadlines or other timeliness issues, erroneous data, supply disruptions, non-compliance (including with applicable legal or regulatory requirements and industry standards) and/or reputational harm, with potential negative effects on our results. Closure of non-essential businesses and shelter-in-place orders occurring in the U.S. and globally as a result of the COVID-19 pandemic may also adversely impact our outsourced operations. We continue to monitor this situation closely.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also require the suppliers, service providers and business partners of components or services for our products and related services to comply with law and certain of our policies regarding sourcing practices, but we do not control them or their practices. If any supplier, service provider or business partner violates laws or implements unethical practices, there could be disruptions to our supply chain, cancellation of our orders, a termination of the relationship with the partner or damage to our reputation, and the FDA or other regulators could seek to hold us responsible for such violations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish and maintain adequate sales, marketing and distribution capabilities or enter into and maintain arrangements with third parties to sell, market and distribute our products, we may have difficulty achieving market awareness and selling our products in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must continue to develop and grow our sales and marketing organization and enter into partnerships or other arrangements to market and sell our products and/or collaborate with third parties, including distributors and others, to market and sell our products to maintain the commercial success of our current systems and to achieve commercial success for any of our future products. If we are unable to establish and maintain adequate sales, marketing and distribution capabilities, independently or with others, our future revenue may be reduced and our business may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing and managing a direct sales organization is a difficult, expensive and time-consuming process. Although we have shifted our sales and marketing activity to be conducted virtually and remotely, restrictions in connection with the COVID-19 outbreak may have a substantial impact on our customers and sales cycles and have impacted and/or interrupted our sales and marketing activity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To continue to develop our sales and marketing organization to successfully achieve market awareness and sell our products, we must:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">recruit and retain adequate numbers of effective and experienced sales and marketing personnel; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effectively train our sales and marketing personnel in the benefits and risks of our products; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">establish and maintain successful sales, marketing, training and education programs that educate health care professionals, including endocrinologists, physicians and diabetes educators, so they can appropriately inform their patients about our products; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">manage geographically dispersed sales and marketing operations; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effectively train our sales and marketing personnel on the applicable advertising and promotion, and fraud and abuse laws that govern interactions with healthcare practitioners as well as current and prospective patients and maintain active oversight and auditing measures to ensure continued compliance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently employ sales and marketing personnel for the direct sale and marketing of our products in the United States, Canada and certain countries in Europe. Our direct sales and marketing team calls on healthcare providers and people with diabetes throughout the applicable country to initiate sales of our products. Our sales and marketing organization competes with the experienced, larger and well-funded marketing and sales operations of our competitors. We may not be able to successfully manage our dispersed sales force or increase our product sales at acceptable rates. Current shelter-in-place orders limit or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prohibit our sales force from having in-person interactions with healthcare providers and people with diabetes, which may result in decreased sales of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also entered into distribution arrangements to leverage existing distributors (including wholesalers) already engaged in the distribution of drugs, devices and/or products in the diabetes marketplace. Some of our U.S distributors are focused on accessing underrepresented regions and or third-party payors that contract exclusively with distributors in the United States, while some of our international distributors call directly on healthcare providers and patients to market and sell our products. Because of the competition for their services, we may&#160;be unable to partner with or retain additional qualified distributors. Further, we may&#160;not be able to enter into agreements with distributors on commercially reasonable terms, if at all. Our distributors might not have the resources to continue to support our recent rapid growth.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our distribution agreements with Byram and affiliates, Cardinal Health and affiliates (including Edgepark Medical Supplies), AmerisourceBergen, and McKesson, our four most significant distributors, each generated 10% or more of our total revenue during the twelve months ended December&#160;31, 2020. We cannot guarantee that these relationships will continue or that we will be able to maintain this volume of sales from these relationships in the future. Moreover our shift of durable medical equipment sales from our direct sales force to distributors could result in negative impacts on the quality or efficacy of our customer sales and support experience. A substantial decrease or loss of these sales could have a material adverse effect on our financial results and operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we enter into additional arrangements with third parties to perform sales, marketing, distribution and billing services, our product margins could be lower than if we directly marketed and sold our products. To the extent that we enter into co-promotion or other marketing and sales arrangements with other companies, any revenue received will depend on the skills and efforts of others, and we cannot predict whether these efforts will be successful.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not adequately predict market demand or otherwise optimize and operate our distribution channel successfully, it could result in excess or insufficient inventory or fulfillment capacity, increased costs, immediate shortages in product or component supply, or harm our business in other ways. In addition, if we do not adequately expand and update certain aging and/or outdated infrastructure that help us, among other things, manage our purchasing and inventory, it could negatively impact our operating results and customer experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The market for glucose monitoring devices is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants, including enhanced software capabilities, and related data and IT platforms. Our products are based on our proprietary technology, but a number of companies and medical researchers are pursuing new technologies for the monitoring of glucose levels. FDA or other regulatory approval of a commercially viable continuous glucose monitor or sensor produced by one of our competitors could significantly reduce market acceptance of our systems. In addition, certain development efforts throughout the diabetes industry, including that of the National Institutes of Health and other supporters of diabetes research are continually seeking ways to prevent, cure or improve treatment of diabetes. Therefore, our products may be rendered obsolete by technological breakthroughs in diabetes monitoring, treatment, prevention or cure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In selling our current CGM systems, we compete directly with the Diabetes Care division of Abbott Laboratories; Medtronic plc&#8217;s Diabetes Group; Roche Diabetes Care, a division of Roche Diagnostics; privately-held LifeScan, Inc.; and Ascensia Diabetes Care, each of which manufactures and markets products for the single-point finger stick device market. Collectively, these companies currently account for the majority of the worldwide sales of self-monitored glucose testing systems. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several companies are developing and/or commercializing products for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin that compete directly with our products. We have competed with Abbott for several years and their Libre family of CGM products. Medtronic markets and sells a standalone glucose monitoring product called Guardian Connect both internationally and in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic and other third parties have developed or are developing insulin pumps integrated with CGM systems that provide, among other things, the ability to suspend insulin administration while the user&#8217;s glucose levels are low and to automate basal and bolus insulin dosing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have begun to become aware of companies outside the traditional medical device sector that are attempting to develop competitive products and services, including for the general health and wellness, or population health space. Some of the companies developing or marketing competing devices are large and well-known publicly traded companies, and these companies may possess competitive advantages over us, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater name recognition;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">established relations with healthcare professionals, customers and third-party payors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">established distribution networks;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">additional lines of products, and the ability to bundle products to offer higher discounts or incentives to gain a competitive advantage;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater experience in conducting research and development, manufacturing, clinical trials, obtaining regulatory approval for products and marketing approved products; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">duration of sensor life;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the ability to integrate multiple products to provide additional features beyond CGM systems; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater financial and human resources for product development, manufacturing, sales and marketing, and patent litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we may not be able to compete effectively against these companies or their products, which may adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The outbreak of the SARS-CoV-2 virus and the COVID-19 disease that it causes, or similar public health crises, could have a material adverse impact on our business, financial condition and results of operations, including our manufacturing, commercial operations and sales. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outbreak of the SARS-CoV-2 virus and the COVID-19 disease that it causes is a global pandemic. The novel coronavirus has spread to most regions of the world, including the United States and Europe. The extent to which this coronavirus impacts our business and operating results will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning the virus and the actions to contain it or to mitigate the COVID-19 impact, among others. The COVID-19 pandemic and its adverse effects have become more prevalent in the locations where we, our customers, suppliers or third-party business partners conduct business and as a result, we may begin to experience more pronounced disruptions in our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19, which has caused a broad impact globally, including restrictions on travel and quarantine policies put into place by businesses and governments, may have a material economic effect on our business. For example, such restrictions may have a substantial impact on our customers and sales cycles. They have impacted our sales and marketing activity including quite significantly in Europe where more restrictive health protection measures and greater reliance on in-person sales efforts at doctors&#8217; offices create a greater impediment to our selling efforts. Furthermore, changes in hospital or physician policies, federal, state or local regulations, prioritization of hospital or medical resources toward pandemic efforts may negatively affect the demand for our devices. The COVID-19 pandemic has, and may continue to, put pressure on global economic conditions and overall spending for medical device products, and may cause our customers to modify spending priorities or delay or abandon purchasing decisions. Further, if the spread of the coronavirus pandemic continues and our operations are adversely impacted, we risk a delay, default and/or nonperformance under existing agreements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severe respiratory symptoms, infections and deaths related to the pandemic may disrupt healthcare delivery in the United States as well as the operations of regulatory bodies with responsibility for oversight of healthcare and health and medical products. Such disruptions could result in the focus and prioritization of regulatory resources on emergent matters, which could divert regulatory resources away from more routine regulatory matters that are not COVID-19 related but that have the potential to impact our business. For example, there could be delays in FDA review of applications for marketing authorization, including those which may be necessary for or in connection with proposed changes to our products or the changes to the processes by which they are manufactured. It is unknown how long these disruptions could continue, were they to occur. Any elongation or de-prioritization or delay in regulatory review resulting from such disruptions could materially affect our ongoing device design, development, and commercialization plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the COVID-19 pandemic and associated shelter-in-place orders have and may continue to limit or restrict our ability to initiate, conduct or continue our clinical trials. Delays and disruptions in our clinical trials has and may continue to result in delays for new or expanded marketing authorizations for our products, which could materially affect our development and commercialization plans for our products. For example, we have experienced some delays in certain pivotal clinical trials for our next-generation CGM product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as a result of the impact of the COVID-19 pandemic, some customers have lost, and others may lose, access to their private health insurance plan if they have lost or lose their job. Any prolonged economic downturn or recession as a result of the COVID-19 pandemic could result in layoffs of employees and a significant increase in unemployment in the United States and elsewhere, which may continue even after the COVID-19 pandemic is contained. An impact to job status may extend for a prolonged period of time, beyond possible coverage periods through COBRA, or where the cost to maintain coverage may not be affordable to our customer. As most of our customers rely on third-party payors, including government programs and private health insurance plans, to cover the cost of our products, our customers may lose coverage to our products, which may harm our business and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently utilize third parties to, among other things, manufacture components and materials for our devices, and to provide services such as sterilization services and we purchase these materials and services from numerous suppliers worldwide. The global COVID-19 pandemic has and may continue to have an adverse impact on our manufacturing and distribution capabilities. Disruptions relating to the COVID-19 pandemic, including current shelter-in-place orders in the U.S. and other countries, could prevent employees, suppliers, distributors, and others from accessing manufacturing facilities and from transporting our products or the components required to manufacture our products. For example, we have experienced some supply chain disruption due to the global restrictions resulting from the COVID-19 pandemic in the manufacture of our next-generation CGM product. Further, worldwide supply chain disruption relating to the COVID-19 pandemic has resulted in product shortages that has and may continue to impact our ability to manufacture our devices. If either we or any third-party parties in the supply chain for materials used in the production of our devices continue to be adversely impacted by, and/or the restrictions resulting from, the COVID-19 pandemic, our supply chain may be continue disrupted, limiting our ability to manufacture our devices. These disruptions may, among other things, impact our ability to produce and supply products in quantities necessary to meet market demand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reduction in our manufacturing and shipping capabilities may have a material economic effect on our business and the results of our operations. If either we or any third-parties in the supply chain for components, materials or services used in the production of our devices are adversely impacted by the disruptions caused by, or restrictions resulting from, the COVID-19 pandemic, our supply chain may be disrupted, which may impact and/or limit our ability to manufacture and distribute our devices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device manufacturer, we fall within a &#8220;critical essential infrastructure&#8221; sector, specifically the &#8220;Healthcare/Public Health&#8221; sector, and is considered exempt under various stay at home/shelter in place orders, including the California Executive Order N-33-20 (&#8220;Stay at Home Order&#8221;) dated March 19, 2020, as amended from time to time.&#160;Accordingly, our employees in California and other locations may continue to work because of the importance of our operations to the health and well-being of citizens in the states in which we operate.&#160;Consistent with these Stay at Home Orders, we have implemented telework policies wherever possible for appropriate categories of &#8220;nonessential&#8221; employees.&#160;&#8220;Essential&#8221; employees that are unable to telework continue to work at our facilities, and we have implemented appropriate safety measures, including social distancing, face covering, and increased sanitation standards.&#160;We have also suspended any requirement for an employee to obtain a doctor&#8217;s note to be absent from or return to the workplace, and are following guidance from the Center for Disease Control and the Occupational Safety and Health Administration regarding suspension of nonessential travel, self-isolation recommendations for employees returning from certain geographic areas, confirmed reports of any COVID-19 diagnosis among our employees, and the return of such employees to our workplace.&#160;Pursuant to updated guidance from the Equal Employment Opportunity Commission, we are engaging in limited and appropriate inquiries of employees regarding potential COVID-19 exposure, based on the direct threat that such exposure may present to our workforce. We continue to address other unique situations that arise among our workforce due to the COVID-19 pandemic on a case-by-case basis.&#160;While we believe that we have taken appropriate measures to ensure the health and well-being of our &#8220;essential&#8221; employees, there can be no assurances that our measures will be sufficient to protect our employees in our workplace or that they may otherwise be exposed to COVID-19 outside of our workplace.&#160;If a number of our essential employees become ill, incapacitated or are otherwise unable to continue working during the current or any future epidemic, our operations may be adversely impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the potential economic impact brought by, and the duration of, the pandemic is difficult to assess or predict, it has already caused, and is likely to result in further, significant disruption of global financial markets. The trading prices for our common stock and other medical device companies have been highly volatile as a result of the COVID-19 pandemic, which may reduce our ability to access capital on favorable terms or at all. In addition, a recession, depression or other sustained adverse market event resulting from the impact of the COVID-19 pandemic could materially and adversely affect our business and the value of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of the current pandemic, or any other health epidemic, is highly uncertain and subject to change. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, our research programs, healthcare systems or the global economy as a whole. However, these effects could have a material impact on our business, and we will continue to monitor the situation closely.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to our International Operations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to a variety of risks due to our international operations that could adversely affect our business, our operations or profitability and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in countries outside the United States, which accounted for approximately 22% of our revenues for the twelve months ended December&#160;31, 2020, are accompanied by certain financial and other risks. In addition to opening offices in Austria, Canada, Germany, the Philippines, Switzerland and the United Kingdom, in connection with distributor acquisitions and otherwise, we intend to continue to pursue growth opportunities in sales outside the United States, especially in Asia (including Japan and Korea) and Europe, and we may increase our use of administrative and support functions from locations </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">outside the United States, which could expose us to greater risks associated with our sales and operations. As we pursue opportunities outside the United States, we may become more exposed to these risks and our ability to scale our operations effectively may be affected. For example, we are building out a manufacturing facility in Malaysia.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our international expansion efforts, including our proposed manufacturing facility in Malaysia, may not be successful and we may experience difficulties in scaling these functions from locations outside the United States and may not experience the expected cost efficiencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability and international operations are, and will continue to be, subject to a number of risks and potential costs, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">local product preferences and product requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">longer-term receivables than are typical in the United States; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fluctuations in foreign currency exchange rates;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">less intellectual property protection in some countries outside the United States than exists in the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">trade protection measures and import and export licensing requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">workforce instability;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fluctuations in trade policy and tariff regulations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">political and economic instability; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the potential payment of U.S. income taxes on certain earnings of our subsidiaries outside the United States upon repatriation. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is impossible for us to predict whether these and other proposals will be implemented, or how they will ultimately impact us, they may materially impact our results of operations if, for example, our profits earned abroad are subject to U.S. income tax, or we are otherwise disallowed deductions as a result of these profits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in foreign currency exchange rates may reduce the reported value of our foreign currency denominated revenues, expenses, and cash flows. We cannot predict changes in currency exchange rates, the impact of exchange rate changes, nor the degree to which we will be able to manage the impact of currency exchange rate changes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2016, the United Kingdom, or U.K., held a referendum in which voters approved an exit from the European Union, commonly referred to as &#8220;Brexit.&#8221; On June 23, 2016, the United Kingdom, or U.K., held a referendum in which voters approved an exit from the European Union, commonly referred to as &#8220;Brexit.&#8221; As a result, the U.K. left the European Union on January 31, 2020, and this began a transition period that is set to end on December 31, 2020, during which the U.K. government will negotiate the terms of the U.K.&#8217;s future relationship with the E.U. In December 2020, the U.K. and E.U. agreed on a trade and cooperation agreement that will apply provisionally after the end of the transition period until it is ratified by the parties to the agreement. On December 31, 2020, the U.K. passed legislation giving effect to the trade and cooperation agreement, with the E.U. expected to formally adopt the agreement in early 2021. The agreement sets out certain procedures for approval and recognition of medical products in each jurisdiction. Any delay in obtaining, or an inability to obtain, any marketing approvals, as a result of the trade and cooperation agreement or otherwise, could prevent us from marketing our CGM systems in the U.K. and/or the E.U. and restrict our ability to generate revenue and achieve and sustain profitability. Under the trade and cooperation agreement, U.K. service suppliers no longer benefit from automatic access to the entire E.U. single market, U.K. goods no longer benefit from the free movement of goods and there is no longer the free movement of people between the U.K. and the E.U. Depending on the application of the terms of the trade and cooperation agreement, we could face new regulatory costs and challenges which could have a material adverse effect on our business, results of operations, or financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and regulations governing the export of our products could adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, and the Bureau of Industry and Security at the U.S. Department of Commerce, administer certain laws and regulations that restrict U.S. persons and, in some instances, non-U.S. persons, in conducting activities, and transacting business with or making investments in certain countries, governments, entities and individuals subject to U.S. economic sanctions. Due to our international operations, we are subject to such laws and regulations, which are complex, restrict our business dealings with certain countries and individuals, and are constantly changing. Further restrictions may be enacted, amended, enforced or interpreted in a manner that materially impacts our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of these regulations are punishable by civil penalties, including fines, denial of export privileges, injunctions, asset seizures, debarment from government contracts and revocations or restrictions of licenses, as well as criminal fines and imprisonment. We have established procedures designed to assist with our compliance with such laws and regulations. However, we have only limited experience dealing with these laws and regulations and we cannot guarantee that our procedures </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will effectively prevent us from violating these regulations in every transaction in which we may engage. Any such violation could adversely affect our reputation, business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outbreak of the SARS-CoV-2 virus and the COVID-19 disease that it causes has also led to healthcare equipment shortages in the U.S. and around the world. Certain U.S. federal government orders have limited companies from exporting certain equipment (such as ventilators) to other countries. Currently, no such orders have been issued with respect to CGMs, however, if supply chain disruption causes significant shortages in CGMs or other equipment, it is possible that we could face additional barriers to exporting our devices outside of the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The failure to comply with U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions could materially adversely affect our business and result in civil and/or criminal sanctions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Foreign Corrupt Practices Act, the UK Bribery Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions generally prohibit companies and their intermediaries from making improper payments to non-U.S. government officials and, in some instances, other persons for the purpose of obtaining or retaining business. Because of the predominance of government-sponsored healthcare systems around the world, most of our customer relationships outside of the United States are with governmental entities and are therefore potentially subject to such anti-bribery laws. Global enforcement of anti-corruption laws has increased substantially in recent years, with more frequent voluntary self-disclosures by companies, aggressive investigations and enforcement proceedings by U.S. and foreign governmental agencies, and assessment of significant fines and penalties against companies and individuals. Our international operations create the risk of unauthorized payments or offers of payments by one of our employees, consultants, sales agents, or distributors, because these parties are not always subject to our direct oversight and control. It is our policy to implement safeguards to educate our employees and agents on these legal requirements and discourage improper practices. However, our existing safeguards and any future improvements may prove to be less than effective, and our employees, consultants, sales agents, or distributors may engage in conduct for which we might be held responsible. In addition, the government agencies may seek to hold us liable for successor liability for anti-corruption law violations committed by any companies in which we invest or that we acquire. Any alleged or actual violations of these regulations may subject us to government scrutiny, severe criminal or civil sanctions and other liabilities, including exclusion from government contracting, and could disrupt our business, and result in a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current uncertainty in global economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty, political instability and military hostilities in multiple geographies, concerns over the potential downgrade of U.S. sovereign debt and continued sovereign debt, monetary and financial uncertainties in Europe and other foreign countries, and global health pandemics such as the COVID-19 pandemic. These include potential reductions in the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. These conditions have made and may continue to make it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products or to use them less frequently. If that were to occur, our revenue may decrease and our performance may be negatively impacted. In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles and limits on durable medical equipment, which may cause seasonality in purchasing patterns. Furthermore, during economic uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. While the potential economic impact brought by and the duration of the COVID-19 pandemic may be difficult to assess or predict, it has already caused, and is likely to result in further, significant disruption of global financial markets, which may reduce our ability to access capital on favorable terms or at all. In addition, a recession, depression or other sustained adverse market event resulting from the spread of COVID-19 could materially and adversely affect our business and the value of our common stock. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United States, or in our industry. These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to obtain any required regulatory authorization in foreign jurisdictions will prevent us from marketing our products abroad.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct limited commercial and marketing efforts in Africa, Asia, Australia, Canada, Europe, Latin America, the Middle East and New Zealand with respect to our CGM systems and may seek to market our products in other regions in the future. Outside the United States, we can market a product only if we receive a marketing authorization and, in some cases, pricing approval, from the appropriate regulatory authorities. The marketing authorization procedures vary among countries and can involve additional testing, and the time required to obtain any required authorization or approval may differ from that </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">required to obtain FDA marketing authorization(s). Foreign regulatory authorization or approval processes may include all of the risks associated with obtaining FDA marketing authorization(s) in addition to other risks. We may not obtain foreign regulatory authorizations or approvals on a timely basis, if at all. Obtaining a marketing authorization from the FDA does not ensure authorization or approval by regulatory authorities in other countries will follow, and authorization or approval by one foreign regulatory authority does not ensure authorization or approval by regulatory authorities in other foreign countries or by the FDA. In addition, in order to obtain the authorization to market our products in certain foreign jurisdictions, we may need to obtain a Certificate to Foreign Government from the FDA. The FDA may refuse to issue a Certificate to Foreign Government in certain instances, including without limitation, during the pendency of any outstanding warning letter. As a result, we may not be able to file for regulatory approvals or marketing authorizations and may not receive necessary approvals or authorizations to commercialize our products in any market outside the United States on a timely basis, or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Privacy and Security</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to complex and evolving U.S. and foreign laws and regulations regarding privacy, data protection, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a number of foreign, federal and state laws and regulations protecting the use and confidentiality of certain patient health and personal information, including patient records, and restricting the use and disclosure of that protected information. These laws include foreign, federal and state medical privacy laws, breach notification laws and consumer protection laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, foreign data protection, privacy, and other laws and regulations can be more restrictive than those in the United States. For example, data localization laws in some countries generally mandate that certain types of data collected in a particular country be stored and/or processed within that country. We may be subject to inquiries, investigations and audits in Europe and around the world, particularly in the areas of consumer and data protection, which will arise in the ordinary course of business and may increase in frequency as we continue to grow and expand our operations. Legislators and regulators may make legal and regulatory changes, or interpret and apply existing laws, in ways that make our products less useful to our customers, require us to incur substantial costs, expose us to unanticipated civil or criminal liability, or cause us to change our business practices. These changes or increased costs could negatively impact our business and results of operations in material ways.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, such as our proprietary business information and that of our clients, contractors, vendors and others as well as personally identifiable information of our customers, vendors and others, which data may include full names, social security numbers, addresses, and birth dates, in our data centers and on our networks. Our employees, contractor and vendors may also have access to and may use personal health information in the ordinary course of our business. The secure processing, maintenance and transmission of this information is critical to our operations. Despite our security measures and business controls, our information technology and infrastructure may be vulnerable to attacks by hackers, breaches due to employee, contractor or vendor error, or malfeasance or other disruptions or subject to the inadvertent or intentional unauthorized release of information. Any such occurrence could compromise our networks and the information stored thereon could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other loss of information could (i) result in legal claims or proceedings, and liability under laws that protect the privacy of personal information and regulatory penalties, (ii) disrupt our operations and the services we provide to our clients or (iii) damage our reputation, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we grow and expand our administrative, customer support or IT support services, we may also utilize the services of personnel and contractors located outside of the United States to perform certain functions. While we make every effort to review our applicable contracts and other payor requirements, a local, state, or federal government agency or one of our customers may find the use of offshore resources to be a violation of a legal or contractual requirement, which could result in termination of the contractual relationship, penalties, or changes in our business operations that could adversely affect our business, financial condition, and results of operations. Additionally, while we have implemented industry standard security measures for offshore access to protected health information and other personal information, unauthorized access or disclosure of such information by offshore personnel could (i) result in legal claims or proceedings, and liability under laws that protect the privacy of personal information and regulatory penalties, (ii) disrupt our operations and the services we provide to our clients, (iii) damage to our reputation or (iv) result in the termination of contractual relationships, penalties or the loss of coverage, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches and other disruptions could compromise our information and expose us to liability, which would cause our business and reputation to suffer and could subject us to substantial liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrative Simplification Provisions of the Health Insurance Portability and Accountability Act of 1996, as amended, and implementing regulations, or HIPAA, extensively regulate the use and disclosure of individually identifiable health information, known as &#8220;protected health information,&#8221; and require covered entities, including health plans and most health care providers, to implement administrative, physical and technical safeguards to protect the security of such information. Certain provisions of the security and privacy regulations apply to business associates (entities that handle protected health information on behalf of covered entities), and business associates are subject to direct liability for violation of these provisions. In addition, a covered entity may be subject to penalties as a result of a business associate violating HIPAA, if the business associate is found to be an agent of the covered entity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covered entities must report breaches of unsecured protected health information to affected individuals without unreasonable delay and notification must also be made to the U.S. Department of Health &amp; Human Services, Office for Civil Rights, or OCR and, in certain situations involving large breaches, to the media. Various U.S. state laws and regulations may also require us to notify affected individuals and state agencies in the event of a data breach involving individually identifiable information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the HIPAA privacy and security regulations may result in criminal and civil penalties. The OCR enforces the regulations and performs compliance audits. In addition to enforcement by OCR, state attorneys general are authorized to bring civil actions seeking either injunction or damages in response to violations that threaten the privacy of state residents. We follow and maintain a HIPAA compliance plan, which we believe complies with the HIPAA privacy and security regulations, but there can be no assurance that OCR or other regulators will agree. The HIPAA privacy regulations and security regulations have and will continue to impose significant costs on us in order to comply with these standards.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous other laws and legislative and regulatory initiatives at the federal and state levels addressing privacy and security concerns. We also remain subject to federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. These laws vary and could impose additional penalties. For example, the Federal Trade Commission uses its consumer protection authority to initiate enforcement actions in response to alleged privacy and data security violations. California recently enacted the California Consumer Privacy Act, or CCPA, which came into effect January 1, 2020, was recently amended and expanded by the California Privacy Rights Act (CPRA) passed on November 3, 2020. The CCPA and CPRA, among other things, create new data privacy obligations for covered companies and provide new privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. It remains unclear what, if any, additional modifications will be made to this legislation or how it will be interpreted. Therefore the effects of the CCPA and CPRA are significant and will likely require us to modify our data processing practices, and may cause us to incur substantial costs and expenses to comply, particularly given our base of operations in California.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to laws and regulations in foreign countries covering data privacy and other protection of health and employee information that may be more onerous than corresponding U.S. laws, including in particular the laws of Europe.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, in the European Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of patient data across the healthcare industry became effective in May 2018. The EU General Data Protection Regulation, or GDPR, applies across the European Union and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20 million euros, or up to 4 % of the company&#8217;s total global turnover of the preceding fiscal year, whichever is higher. The GDPR also requires companies processing personal data of individuals residing in the European Union to comply with EU privacy and data protection rules, even if the company itself does not have a physical presence in the European Union. Noncompliance could result in the imposition of fines, penalties, or orders to stop noncompliant activities. Due to the strong consumer protection aspects of the GDPR, companies subject to its purview are allocating substantial legal costs to the development of necessary policies and procedures and overall compliance efforts. For example, following a decision of the Court of Justice of the EU in October 2015, the transfer of personal data to US companies that had certified as members of the US Safe Harbor Scheme was declared invalid. In July 2016, the European Commission adopted the EU-US Privacy Shield Framework, or the Privacy Shield Framework, which replaced the US Safe Harbor Scheme. On July 16, 2020, the Court of Justice of the European Union issued a decision that declared the Privacy Shield Framework invalid, and will also result in additional compliance obligations for companies that implement standard contractual clauses to ensure a valid basis for the transfer of personal data outside of Europe. We expect continued costs associated with maintaining compliance with GDPR into the future, and these provisions as interpreted by EU agencies, could negatively impact our business, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws discussed above, we may see more stringent state and federal privacy legislation in 2021 and beyond, as the increased cyber attacks during the pandemic have once again put a spotlight on data privacy and security in the U.S. and other jurisdictions. We cannot predict where new legislation might arise, the scope of such legislation, or the potential impact to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cyber incidents can result from deliberate attacks or unintentional events. We collect and store on our networks sensitive information, including intellectual property, proprietary business information and personally identifiable information of individuals, such as our customers and employees. The secure maintenance of this information and technology is critical to our business operations. We have implemented multiple layers of security measures to protect the confidentiality, integrity and availability of this data and the systems and devices that store and transmit such data. We utilize current security technologies, and our defenses are monitored and routinely tested internally and by external parties. Despite these efforts, threats from malicious persons and groups, new vulnerabilities and advanced new attacks against information systems create risk of cybersecurity incidents. These incidents can include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may not immediately produce signs of intrusion, we may be unable to anticipate these incidents or techniques, timely discover them, or implement adequate preventative measures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, we have modified our business practices and implemented telework policies wherever possible for appropriate categories of &#8220;nonessential&#8221; employees to minimize the disruption to our operations, to the extent possible. The continuation of these telework policies for &#8220;nonessential employees&#8221; also introduces additional operational risk, including increased cybersecurity risk. These cyber risks may include, among other risks, greater phishing, malware, and other cybersecurity attacks, vulnerability to or disruptions of our information technology infrastructure and systems to support remote operations, increased risk of unauthorized access, use or dissemination of confidential information, limited ability to restore the systems in the event of a systems failure or interruption, greater risk of a security breach resulting in destruction, alteration or misuse of valuable information, including proprietary business information and personally identifiable information of individuals, all of which could expose us to risks of data or financial loss, litigation and liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These threats can come from a variety of sources, ranging in sophistication from an individual hacker to malfeasance by employees, consultants or other service providers to state-sponsored attacks. Cyber threats may be generic, or they may be custom-crafted against our information systems. Over the past several years, cyber attacks have become more prevalent and much harder to detect and defend against. Our network and storage applications, as well as those of our contractors, may be vulnerable to cyber-attack, malicious intrusion, malfeasance, loss of data privacy or other significant disruption and may be subject to unauthorized access by hackers, employees, consultants or other service providers. In addition, hardware, software or applications we develop or procure from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security. Unauthorized parties may also attempt to gain access to our systems or facilities through fraud, trickery or other forms of deceiving our employees, contractors and temporary staff.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that we will not be subject to cybersecurity incidents that bypass our security measures, impact the integrity, availability or privacy of personal health information or other data subject to privacy laws or disrupt our information systems, devices or business, including our ability to deliver services to our customers. As a result, cybersecurity, physical security and the continued development and enhancement of our controls, processes and practices designed to protect our enterprise, information systems and data from attack, damage or unauthorized access remain a priority for us. As cyber threats continue to evolve, we may be required to expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate any cybersecurity vulnerabilities. The occurrence of any of these events could result in:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">harm to customers; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">business interruptions and delays; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the loss, misappropriation, corruption or unauthorized access of data; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">litigation, including potential class action litigation, and potential liability under privacy, security and consumer protection laws or other applicable laws; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reputational damage; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increase to insurance premiums; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">foreign, federal and state governmental inquiries, any of which could have a material, adverse effect on our financial position and results of operations and harm our business reputation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to protect our information technology infrastructure against cyber-based attacks, network security breaches, service interruptions, or data corruption could significantly disrupt our operations and adversely affect our business and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, including sales, billing, customer service, procurement and supply chain, manufacturing, and distribution. We use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting, legal, and tax requirements. System failures or outages, including any potential disruptions due to significantly increased global demand on certain cloud based systems during or as a result of the COVID-19 pandemic, or failures to adequately scale our data platforms and architectures support patient care could compromise our ability to perform these functions in a timely manner, which could harm our ability to conduct business or delay our financial reporting. Such failures could materially adversely affect our operating results and financial condition. Our information technology systems, some of which are managed by third-parties, may be susceptible to damage, disruptions or shutdowns due to computer viruses, ransomware or other malware, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors or catastrophic events. Although we have developed systems and processes that are designed to protect customer information and prevent data loss and other security breaches, including systems and processes designed to reduce the impact of a security breach at a third-party vendor, such measures cannot provide absolute security. If our systems are breached or suffer severe damage, disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may significantly suffer and we may be subject to litigation, government enforcement actions and other actions for which we could face financial liability and other adverse consequences which may include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">additional government oversight of our operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">loss of existing customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">difficulty in attracting new customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">problems in determining product cost estimates and establishing appropriate pricing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">difficulty in preventing, detecting, and controlling fraud;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">disputes with customers, physicians, and other health care professionals; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increases in operating expenses, incurrence of expenses, including notification and remediation costs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory fines or penalties;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">individual actions or class actions for damages;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">loss of revenues (including through loss of coverage or reimbursement); </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product development delays;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">disruption of key business operations; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">diversion of attention of management and key information technology resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unauthorized third parties may seek to access our devices or other products and services, or related devices, products, and services, and modify or use them in a way inconsistent with our FDA clearances and approvals, which may create risks to users.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical devices are increasingly connected to the internet, hospital networks, and other medical devices to provide features that improve healthcare and increase the ability of healthcare providers to treat patients and patients to manage their conditions. For example, we are pursuing collaborations to enable the connectivity and interoperability of our current and next-generation sensors and transmitters with third-party patient monitoring products, which may in turn be connected with the internet, hospital networks and in some cases, other medical devices. These same features may also increase cybersecurity risks and the risks of unauthorized access and use by third parties. As such, unauthorized third parties may seek to access our devices or other products and services, or related devices, products, and services, and modify or use them in a way inconsistent with our FDA clearances and approvals, which may create risks to users and potential exposure to the company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Non-Compliance with Laws, Regulations and Contractual Requirements and Healthcare Industry Shifts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from participation in government programs, and/or be required to make significant changes to our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry generally, and our business specifically, is subject to extensive foreign, federal, state and local laws and regulations, including those relating to: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">authorizations necessary for the clinical investigation and commercial marketing of products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the pricing of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the distribution of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">billing for products and services; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the obligation to report and return identified overpayments;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">financial relationships with physicians and other referral sources; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inducements and courtesies given to physicians and other health care providers and patients; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">labeling and promoting products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the characteristics and quality of our products and services; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">confidentiality, maintenance and security issues associated with medical records and individually identifiable health and other personal information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">medical device adverse event reporting;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">prohibitions on kickbacks, including the Anti-Kickback Statute and related laws and/or regulations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">any scheme to defraud any healthcare benefit program;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">physician and other healthcare professional payment disclosure requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">use and disclosure of personal health information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">privacy of health information and personal information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">data protection and data localization;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">mobile communications;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient access and non-discrimination;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient consent;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">false claims; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">professional licensure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations are extremely complex and, in many cases, still evolving. If our operations are found to violate any of the foreign, federal, state or local laws and regulations which govern our activities, we may be subject to litigation, government enforcement actions, and applicable penalties associated with the violation, potentially including civil and criminal penalties, damages, fines, exclusion from participation in certain payor programs or curtailment of our operations. Compliance obligations under these various laws are oftentimes detailed and onerous, further contributing to the risk that we could be found to be out of compliance with particular requirements. The risk of being found in violation of these laws and regulations is further increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, particularly with respect to new and emerging technologies and remote delivery of services, and their provisions are open to a variety of interpretations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, CMS, OIG, Department of Justice, states&#8217; attorneys general and other governmental authorities actively enforce the laws and regulations discussed above. In the United States, medical device manufacturers have been the target of numerous government prosecutions and investigations alleging violations of law, including claims asserting impermissible off-label promotion of medical devices, payments intended to influence the referral of federal or state healthcare business, and submission of false claims for government reimbursement. While we make every effort to comply with applicable laws, we cannot rule out the possibility that the government or other third parties could interpret these laws differently and challenge our practices under one or more of these laws. This likelihood of allegations of non-compliance is increased by the fact that under certain federal and state laws applicable to our business, individuals, known as relators, may bring an action on behalf of the government alleging violations of such laws, and potentially be awarded a share of any damages or penalties ultimately awarded to the applicable government body.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the United States Federal Food, Drug, and Cosmetic Act, medical devices are classified into one of three classes &#8211; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class I, Class II or Class III &#8211; depending on the degree of risk associated with each medical device and the extent of control needed to ensure safety and effectiveness. Our G6 has been classified as a Class II device. Class II devices are subject to various general and special controls, including the Quality System Regulation and 510(k) pre-market notification requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the FDA may disagree with the classification of a new Class II medical device and require the manufacturer of that device to apply for approval as a Class III medical device. In the event that the FDA determines that our Class II medical products should be classified as Class III medical devices, we could be precluded from marketing the devices for clinical use within the United States for months, years or longer, depending on the specific change in the classification. Reclassification of our Class II medical products as Class III medical devices could significantly increase our regulatory costs, including the timing and expense associated with required clinical trials and other costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA and the Federal Trade Commission, or FTC, share oversight of medical device promotion. FDA has broad authority over device marketing (including assessment and oversight of safety and effectiveness) and over &#8220;promotional labeling,&#8221; while FTC has authority over &#8220;advertising&#8221; for most medical devices (i.e., non-&#8220;restricted&#8221; devices, such as ours).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any action against us alleging a violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s time and attention from the operation of our business, and have a material effect on our business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the laws and regulations impacting or affecting our business may change significantly in the future. Any new laws or regulations may adversely affect our business, including any changes in laws and regulations due to the COVID-19 pandemic. A review of our business by courts or regulatory authorities may result in a determination that could adversely affect our operations. Also, the regulatory environment applicable to our business may change in a way that restricts or adversely impacts our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our suppliers or distributors fail to comply with ongoing regulatory requirements, or if we have unanticipated problems with our products, the products could be subject to restrictions or withdrawal from the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product for which we obtain marketing approval, clearance or authorization (and the activities related to its production, distribution, and promotion, sale, and marketing)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will be subject to continual review and periodic inspections by the FDA and other regulatory bodies, which may include inspection of our manufacturing processes, complaint handling and adverse event reporting, post-approval clinical data and promotional activities for such product. The FDA&#8217;s Medical Device Reporting, or MDR, regulations require that we report to the FDA any incident in which our product may have caused or contributed to a death or serious injury, or in which our product malfunctioned and, if the malfunction were to recur, it would likely cause or contribute to a death or serious injury.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If FDA determines that there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, the agency may issue a cease distribution and notification order and a mandatory recall order. We may also decide to recall a product voluntarily if we find a material deficiency, including unacceptable risks to health, manufacturing defects, design errors, component failures, labeling defects, or other issues. Recalls of our products could divert the attention of our management and have an adverse effect on our reputation, financial condition, and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and certain of our suppliers are also required to comply with the FDA&#8217;s Quality System Regulation, or QSR, and other regulations which cover the methods and documentation of the design, testing, production, control, selection and oversight of suppliers or contractors, quality assurance, labeling, packaging, storage, complaint handling, shipping and servicing of our products. The FDA may enforce the QSR through announced (through prior notification) or unannounced inspections.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with ongoing regulatory requirements can be complex, expensive and time-consuming. Failure by us or one of our suppliers or distributors to comply with statutes and regulations administered by the FDA, competent authorities and other regulatory bodies, or failure to take adequate response to any observations, could result in, among other things, any of the following actions:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">warning letters or untitled letters that require corrective action; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">delays in approving, or refusal to approve, our CGM systems; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fines and civil or criminal penalties; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">unanticipated expenditures; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA refusal to issue certificates to foreign governments needed to export our products for sale in other countries;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">suspension or withdrawal of clearance or approval by the FDA or other regulatory bodies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product recall or seizure; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">administrative detention;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of production, partial suspension, or complete shutdown of production; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of the supply of components from our key component suppliers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">operating restrictions; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">court consent decrees;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA orders to repair, replace, or refund the cost of devices;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">injunctions; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">criminal prosecution. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect of these events can in some cases be difficult to quantify. If any of these actions were to occur, it would harm our reputation and cause our product sales and profitability to suffer. In addition, we believe events that could be classified as reportable events pursuant to MDR regulations are generally underreported by physicians and users, and any underlying problems could be of a larger magnitude than suggested by the number or types of MDRs filed by us. Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with applicable regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if regulatory approval or clearance of a product is granted, the approval or clearance may be subject to limitations on the indicated uses for which the product may be marketed or contain requirements for costly post-marketing testing or surveillance to monitor the safety or effectiveness of the product. Later discovery of previously unknown problems with our products, including software bugs, unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as the QSR, MDR reporting, or other post-market requirements may result in restrictions on such products or manufacturing processes, withdrawal of the products from the market, voluntary or mandatory recalls, fines, suspension of regulatory approvals, product seizures, injunctions, the imposition of civil or criminal penalties, or criminal prosecution. In addition, our distributors have rights to create marketing materials for their sales of our products, and may not adhere to contractual, legal or regulatory limitations that are imposed on their marketing efforts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quality problems could lead to recalls or safety alerts, reputational harm, and could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality is very important to us and our customers due to the serious and costly consequences of product failure, and our business exposes us to potential product liability risks that are inherent in the design, manufacture, and marketing of medical devices. Since the first commercial launch of our products in 2006, we have had periodic field failures related to our products and associated services, including reports of sensor errors, sensor failures, broken sensors, receiver malfunctions, audible alarms and alert failures, as well as server and transmitter failures. To comply with the FDA&#8217;s medical device reporting requirements, for example, we have filed reports of applicable field failures. Although we believe we have taken and are taking appropriate action aimed at reducing and/or eliminating field failures, we may have other product failures in the future. Product or component failures, manufacturing nonconformances, design defects, off-label use, or inadequate disclosure of product-related risks or product-related information with respect to our products, if they were to occur, could result in an unsafe condition or injury to, or death of, a patient. These problems could lead to recalls, corrections or removals of, or issuance of a safety alert relating to, our products, and could result in product liability claims and lawsuits. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the production of our products must occur in a highly controlled and clean environment to minimize particles and other yield- and quality-limiting contaminants. Weaknesses in process control or minute impurities in materials may cause a substantial percentage of defective products. If we are not able to maintain stringent quality controls, or if contamination problems arise, our clinical development and commercialization efforts could be delayed, which would harm our business and our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to meet any applicable product quality standards and our products are the subject of recalls or safety alerts, our reputation could be damaged, we could lose customers, our reputation could be harmed and our revenue and results of operations could decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential long-term complications from our current or future products or other CGM systems under development may not be revealed by our clinical experience to date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our experience, complications from use of our products may include sensor errors, sensor failures, broken sensors, lodged sensors or skin irritation under the adhesive dressing of the sensor. Inflammation or redness, swelling, minor infection, and minor bleeding at the sensor insertion site are also possible risks with an individual&#8217;s use of our products. However, if unanticipated long-term side-effects result from the use of our products or other glucose monitoring systems we have under development, we could be subject to liability and the adoption of our systems may become more limited. With respect to our G6 systems, our clinical trials have been limited to ten days of continuous use. It is possible that the results from our clinical studies and trials may not be indicative of the clinical data obtained when we later examine patient outcomes. We </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cannot assure you that repeated, long-term use would not result in unanticipated adverse effects, potentially even after the sensor is removed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may never receive approval, marketing authorization or clearance from the U.S. FDA and other governmental agencies to market additional CGM systems, expanded indications for use of current and future generation CGM systems, future software platforms, or any other products under development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, via the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process, the FDA classified the G6 and substantially equivalent devices of this generic type (i.e., &#8220;integrated continuous glucose monitoring systems&#8221; or &#8220;iCGMs&#8221;) into Class II, meaning that going forward products of this generic type may utilize the 510(k) pathway. Since then we have received 510(k) clearances for modifications to the G6.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any subsequent modification of our G6 that could significantly affect its safety or effectiveness (for example, a significant change in design or manufacture), or that would constitute a major change in its intended use, will require us to obtain a new 510(k) clearance or could require a new </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> submission or a PMA. The FDA requires each manufacturer to make this determination initially, but the FDA may review any such decision and may disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination, the FDA may require the manufacturer to cease marketing and/or recall the modified device until appropriate clearance or approval is obtained. Under these circumstances, the FDA may also subject a manufacturer to significant regulatory fines or other penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If future product candidates are not deemed by the FDA to meet the criteria for submission under the 510(k) pathway, or for down-classification under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process or otherwise, we would need to pursue a PMA. The PMA process requires us to prove the safety and effectiveness of our systems to the FDA&#8217;s satisfaction. This process can be expensive, prolonged and uncertain, requires detailed and comprehensive scientific and human clinical data, and may never result in the FDA granting a PMA. The FDA&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification of our G6 system under the generic name </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">integrated continuous glucose monitoring system,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> makes it a predicate device for future 510(k) submissions. Complying with this classification requires ongoing compliance with the general controls required by the federal Food Drug and Cosmetic Act and the special controls specified by the FDA&#8217;s G6 order as a Class II device. Any future system or expanded indications for use of current generation systems will require approval of the applicable regulatory authorities. In addition, we intend to seek either 510(k) clearances or PMA approvals for certain changes and modifications to our existing software platform, but cannot predict when, if ever, those changes and modifications will be approved.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA can refuse to grant a 510(k) clearance or a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> request for marketing authorization, or delay, limit or deny approval of a PMA application or supplement for many reasons, including: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the system may not be deemed by the FDA to be substantially equivalent to appropriate predicate devices under the 510(k) pathway; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the system may not satisfy the FDA&#8217;s safety or effectiveness requirements; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the data from pre-clinical studies and clinical trials may be insufficient to support clearance or approval; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the manufacturing process or facilities used may not meet applicable requirements; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in FDA approval policies or adoption of new regulations may require additional data. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if approved or cleared by the FDA or foreign regulatory agencies, future generations of our CGM systems, expanded indications for use of current and future generation CGM systems, our software platforms or any other CGM system under development, may not be cleared or approved for the indications that are necessary or desirable for successful commercialization. We may not obtain the necessary regulatory approvals or clearances to market these CGM systems in the United States or outside of the United States. Any delay in, or failure to receive or maintain, clearance or approval for our products could prevent us from generating revenue from these products. The uncertain timing of regulatory approvals for future generations of our products could subject our current inventory to excess or obsolescence charges, which could have an adverse effect on our business, financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to comply with laws, regulations and contract requirements relating to reimbursement of health care goods and services may subject us to penalties and adversely impact our reputation, business, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws, regulations and contractual requirements regulating the provision of, and reimbursement for, health care goods and services, both in our capacity as a medical device manufacturer and/or as a supplier of covered items and services to federal health care program beneficiaries, with respect to which items and services we submit claims for reimbursement from such programs. The laws and regulations of health care goods and services that apply to us, including those described above, are subject to evolving interpretations and enforcement discretion. As part of our compliance program, we have reviewed our sales contracts, marketing materials, referral source relationships, and billing practices (among others) to reduce the risk of non-compliance with these and other foreign, federal and state laws. If a governmental authority was to conclude that we are not in compliance with applicable laws and regulations, we and our officers, directors and employees could be subject to criminal and civil penalties, including, for example, exclusion from participation as a supplier of product to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beneficiaries covered by federal healthcare programs, including but not limited to Medicare and Medicaid. Any failure to comply with laws, regulations or contractual requirements relating to reimbursement and health care goods and services could adversely affect our reputation, business, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are purchased principally by individual patients, who may be eligible for insurance coverage of their devices from various third-party payors, such as governmental programs (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Medicare, Medicaid, TRICARE, other federal and state health benefit plans, and comparable non-U.S. programs), private insurance plans, and managed care plans. The ability of our customers to obtain appropriate reimbursement for products and services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from third-party payors is critical because it affects which products customers purchase and the prices they are willing to pay. As a result, our products are subject to regulation regarding quality and cost by the U.S. Department for Health &amp; Human Services, including CMS, as well as comparable state and non-U.S. agencies responsible for reimbursement and regulation of health care goods and services. The principal U.S. federal laws that implicate reimbursement issues include those that prohibit (i) the filing of false or improper claims for federal payment, known as the federal civil False Claims Act, (ii) unlawful inducements for the referral of business reimbursable under federally-funded health care programs, known as the federal Anti-Kickback Statute, and (iii) health care service providers from seeking reimbursement for providing certain services to a patient who was referred by a physician who has certain types of direct or indirect financial relationships with the service provider, known as the federal Physician Self-Referral law, or commonly referred to as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stark Law.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Many states have similar laws that apply to reimbursement by state Medicaid and other government-funded programs, as well as, in some cases, to all payors, including self-pay patients. In addition, the federal civil False Claims Act requires the reporting and returning of identified overpayments received from federal health care programs within 60 days of identification and quantification, and requires the exercise of reasonable diligence to investigate credible information regarding potential overpayments. Failure to timely refund known overpayments from federal healthcare programs, such as Medicare and Medicaid, would subject a company to civil False Claims Act liability. Insurance companies can also bring a private cause of action claiming treble damages against a manufacturer for causing a false claim to be filed under the federal Racketeer Influenced and Corrupt Organizations Act, or RICO. Additionally, as a manufacturer of FDA&#8209;approved devices reimbursable by federal healthcare programs, we are subject to the federal Physician Payments Sunshine Act, which requires us to annually report certain payments and other transfers of value we make to U.S.-licensed physicians or U.S. teaching hospitals, and under an expansion of the law we will also need to begin tracking and reporting payments to physician assistants, nurse practitioners, and other mid-level practitioners. Reporting requirements will go into effect in 2022 for payments and transfers of value made to these additional practitioner-types in 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the federal Anti-Kickback Statute, Congress and the OIG have established a large number of statutory exceptions and regulatory safe harbors. An arrangement that fits squarely into an exception or safe harbor is immune from prosecution under the Anti-Kickback Statute.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We train and educate employees and marketing representatives on the Anti-Kickback Statute and their obligations thereunder, and we endeavor to comply with the applicable safe harbors. However, some of our arrangements, like many other common and non-abusive arrangements, may implicate the Anti-Kickback Statute and are not covered by a safe harbor, but nevertheless do not present a material risk to beneficiaries or federal healthcare programs and, as such, would not likely invite government scrutiny or prosecution or warrant the imposition of sanctions. However, we cannot offer assurance that arrangements that do not squarely meet an exception or safe harbor will not be found to violate the Anti-Kickback Statute. Allegations of violations of the Anti-Kickback Statute can also trigger liability under the federal Civil Monetary Penalty Law and federal civil False Claims Act, thereby increasing the penalty structure for these violations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period in which we directly billed Medicare, our financial relationships with referring physicians and their immediate family members were required to comply with the Stark Law by meeting an applicable exception. Unlike the Anti-Kickback Statute, failure to meet an exception under the Stark Law results in a violation of the Stark Law, even if such violation is technical in nature. Violations of the Stark Law create overpayment liability under the federal civil False Claims Act and can also trigger separate penalties under the Civil Monetary Penalties Law. Knowing violations of the Stark Law carry increased civil monetary penalties and would likely be classified as the knowing submission of a false claim or knowingly making a false statement to the government, triggering liability under the federal civil False Claims Act. Certain Stark Law violations can also trigger exclusion from federal healthcare programs. Historical violations of the Stark Law, if any, could continue to give rise to liability during the statute of limitations period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we violate the Anti-Kickback Statute or Stark Law, or if we improperly bill for our services, or retain overpayments longer than 60 days after identification, or fail to act with reasonable diligence to investigate credible information regarding potential overpayments, we may be found to violate the federal civil False Claims Act, either under a suit brought by the government or by a private person under a&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relator, or &#8220;whistleblower,&#8221; suit.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private third-party payors and other managed care organizations, such as pharmacy benefit managers, continue to take action to manage utilization and control cost. Consolidation among managed care organizations has increased the negotiating power of managed care organizations and other private third-party payors. Private third-party payors, as well as governments, increasingly employ formularies to control costs by taking into account discounts in connection with decisions about formulary inclusion or favorable formulary placement. Failure to obtain or maintain timely adequate pricing or favorable formulary placement for our products, or failure to obtain such formulary placement at favorable pricing, could adversely impact revenue. Private third-party payors, including self-insured employers, often implement formularies with copayment tiers to encourage utilization of certain products and have also been raising co-payments required from beneficiaries, particularly for higher cost products. Private third-party payors also use additional measures such as value-based pricing/contracting to improve their cost containment efforts. Private third-party payors also are increasingly imposing utilization management tools, such as requiring prior authorization or requiring the patient to first fail on a lower cost product before permitting access to a higher cost product. In addition, on November 20, 2020, the OIG released a Final Rule, &#8220;Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor for Certain Point of Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manage Service Fees&#8221; which revises the federal Anti-Kickback Statute&#8217;s Discount Safe Harbor at 42 CFR 1001.952(h) to explicitly exclude reductions in price offered by drug manufacturers to pharmacy benefit managers (PBMs) and Part D plans from the safe harbor's definition of a "discount." OIG expressed concern that the retroactive rebate framework incentivizes manufacturers to increase list prices and provide larger rebates on the backend, preventing beneficiaries and the Medicare Program from sharing in savings. The new rule goes into effect January 1, 2022 but would likely impact PBM rebate negotiations this year. While the new rule does not impact us since it is narrowly tailored to drug rather than device manufacturers, it may have a larger impact on the PBM industry. Notably, however, the Final Rule may not have followed proper administrative steps and therefore, may face legal challenges. We cannot be certain whether the Final Rule will remain in place but if it does, it is possible that our PBM arrangements may be restructured.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many health care industry companies, including health care systems, distributors, manufacturers, providers, and insurers, are also consolidating or vertically integrating, or have formed strategic alliances. As the health care industry consolidates, competition to provide goods and services to industry participants may become more intense. This consolidation will continue to create larger enterprises with greater negotiating power, which they can try to use to negotiate price concessions or reductions for medical devices and components produced by us. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the U.S. payor market consolidates further and we face greater pricing pressure from private third-party payors, who will continue to drive more of their patients to use lower cost alternatives, we may lose customers, our revenues may decrease and our business, financial condition, results of operations and cash flows may suffer </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support additional PMA, de novo,&#160;or&#160;510(k) applications or supplements, we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating results.</span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support current and any future additional PMA, 510(k), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applications or supplements, we together with our partners, must successfully complete pre-clinical studies, bench-testing, and in some cases clinical trials that will demonstrate that the product is safe and effective. Product development, including pre-clinical studies and clinical trials, is a long, expensive and uncertain process and is subject to delays (including any potential delays due to the ongoing COVID-19 pandemic) and failure at any stage. Furthermore, the data obtained from the studies and trials may be inadequate to support approval of an application and the FDA may request additional clinical data in support of those applications, which may result in significant additional clinical expenses and may delay product approvals. While we have in the past obtained, and may in the future obtain, an investigational device exemption, or IDE, prior to commencing clinical trials for our products, FDA approval of an IDE application permitting us to conduct testing does not mean that the FDA will consider the data gathered in the trial to be sufficient to support approval of a PMA, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or 510(k) application or supplement, even if the trial&#8217;s intended safety and effectiveness endpoints are achieved.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to the regulatory landscape may impact our ability to obtain marketing authorization for future product developments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development or changes to the FDA or foreign regulatory approval standards and processes, including both legal and policy changes, could also delay or prevent the approval of our products submitted for review. For example, as part of the 21st Century Cures Act passed in 2016, Congress enacted several reforms that further affect medical device regulation both pre- and post-approval, and FDA implementation and development of guidance in many areas is still ongoing. In addition, the FDA is in the process of reviewing the 510(k) approval process and criteria and has announced initiatives to improve the current pre- and post-market regulatory processes and requirements associated with infusion pumps and other home use medical devices. As part of this effort, the FDA is reviewing the adverse event reporting and recall processes for insulin pumps. Any change in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">laws or regulations that govern the clearance and approval processes relating to our current and future products could make it more difficult and costly to obtain clearance or approval for new products, or to produce, market and distribute existing products. The data contained in our submissions, including data drawn from our clinical trials, may not be sufficient to support approval of our products or additional or expanded indications. Medical device company stock prices have declined significantly in certain circumstances where companies have failed to meet expectations in regards to the timing of regulatory approval. If the FDA&#8217;s response causes product approval delays, or is not favorable for any of our products, our stock price (and the market price of our senior convertible notes) could decline substantially. It is uncertain how these potential changes may impact our ability to gain clearance or approval from FDA for our products in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The commencement or completion of any of our clinical trials may be delayed or halted, or be inadequate to support approval of FDA marketing applications</span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">or supplements, for numerous reasons, including, but not limited to, the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients do not enroll in clinical trials at the rate we expect; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients or study site personnel who do not comply with clinical trial protocols; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient follow-up does not occur at the rate we expect; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients experience adverse side effects; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients die during a clinical trial, even though their death may not be related to our products; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">institutional review boards and third-party clinical investigators may delay or reject our clinical trial protocol; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators decline to participate in a trial or do not perform a trial on our anticipated schedule or consistent with the investigator agreements, clinical trial protocol, good clinical practices or other FDA or institutional review board requirements; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we or third-party organizations do not perform data collection, monitoring or analysis in a timely or accurate manner or consistent with the clinical trial protocol or investigational or statistical plans; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators have significant financial interests related to us or the study that the FDA deems to make the study results unreliable, or we or clinical investigators fail to disclose such interests; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory inspections of our clinical trials or manufacturing facilities may results in allegations or findings of noncompliance and, among other things, require us to undertake corrective action or suspend or terminate our clinical trials; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in governmental regulations, policies or administrative actions applicable to our trial protocols; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the interim or final results of the clinical trial are inconclusive or unfavorable as to safety or efficacy; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA concludes that the results from our trial and/or trial design are inadequate to demonstrate safety and effectiveness of the product. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the COVID-19 pandemic and associated shelter-in-place orders could limit or restrict our ability to initiate, conduct or continue our clinical trials. Delays and disruption in our clinical trials could results in delays for expanded FDA clearance or approval of our products. We are unable to predict the length of such delays or the scope of the impact of COVID-19 on our clinical trials at this time. We are continuing to monitor this situation and to explore methods of remote monitoring, remote clinical assessments and other similar delivery methods to permit continuation of clinical trial activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of pre-clinical studies or other forms of early product testing do not necessarily predict future clinical trial results, and prior clinical trial results might not be repeated in subsequent clinical trials. Additionally, the FDA may disagree with our interpretation of the data from our pre-clinical studies, product testing, and clinical trials, or may find the clinical trial design, conduct or results inadequate to prove safety or effectiveness, and may require us to pursue the development of additional data, which could further delay the approval of our products. If we are unable to demonstrate the safety and effectiveness of our products in our clinical trials to the FDA&#8217;s satisfaction, where clinical data are required, we will be unable to obtain regulatory approval to market our products in the United States. In addition, the data we collect from our current clinical trials, our pre-clinical studies and other clinical trials may not be sufficient to support FDA approval, even if our endpoints are met.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also conduct clinical studies to demonstrate the relative or comparative effectiveness of CGM systems for the treatment of diabetes. These types of studies, which often require substantial investment and effort, may not show adequate, or any, clinical benefit or value for the use of CGM systems.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our CGM systems currently have regulatory marketing authorization limited to individual patient home-use, and have otherwise not received clearance or approval from the FDA or other regulators for use in hospital or other in-patient facility settings, although the FDA has advised us that it will not object to the use of our CGM systems in such settings during the COVID-19 pandemic. Our potential supply of our CGM systems for use in this environment during the COVID-19 pandemic may present risks to our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received, and may continue to receive, numerous inquiries from hospitals around the country about the use of our CGM devices to remotely monitor COVID-19 patients admitted into the hospital. Extension of CGM system use to hospitalized patients during the COVID-19 pandemic allows hospital staff to&#160;monitor glucose&#160;remotely&#160;in&#160;patients and may reduce patient/provider interactions, which could help limit viral exposure for hospital staff&#160;and help conserve personal protective equipment (PPE).&#160;In the context of the COVID-19 pandemic, the FDA has permitted for regulatory flexibility in a variety of specific circumstances, to expedite the development and availability of critical medical products that may be helpful in COVID-19-related efforts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following direct communication with the FDA regarding the potential use of our CGM devices in a hospital or other in-patient setting, the FDA notified us on April 1, 2020 that in an exercise of its enforcement discretion it will not object, in the context of the COVID-19 pandemic, to Dexcom providing CGM devices and support to users to enable real-time remote patient monitoring in hospitals and other healthcare facilities, to support COVID-19 healthcare related efforts, so long as we provide certain FDA-specified information with respect to the unique challenges that CGM technologies can raise in the hospital environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of its exercise of enforcement discretion, the FDA has advised that we communicate the following information related to implementing the use of CGM systems for remote monitoring of hospitalized patients:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Hospitals should consider whether they have the resources and expertise necessary to adequately implement CGM use and provide appropriate training to healthcare providers.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">CGM glucose results are less accurate than blood glucose results obtained using traditional testing methods (e.g., lab glucose, blood glucose meters). Users should consider all CGM glucose information (e.g., trend) along with individual glucose values, and interpret CGM results in the context of the full clinical picture.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">CGM systems are subject to interferences that may generate falsely high and falsely low glucose readings. Levels of interference depend on drug concentration; substances that may not significantly interfere in non-hospitalized patients may interfere when used in the hospital setting because of higher dose levels. Most drugs used in hospital or critical care settings have not been evaluated and their interference with CGM systems is unknown. Known interferences vary by CGM brand, and can include Acetaminophen, Ascorbic acid, Hydroxyurea, or other reducing drugs/ compounds.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Poor peripheral blood perfusion may cause inaccurate sensor readings.&#160;CGM results should be interpreted considering accompanying patient conditions and medications. Other clinical conditions may also cause inaccurate readings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision of our CGM systems to hospitals and other healthcare facilities for use during the COVID-19 pandemic have and will continue to have the above notice. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not actively promoting nor do we plan to actively promote our CGM devices (and related support) for inpatient use, but if we supply them to such facilities as currently permitted by the FDA, this supply could present an increased risk of product liability claims and associated damages should an adverse event occur. Given that our CGM devices have not yet been fully evaluated or tested by either us or the FDA to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA can also decide, at any time, to change its position regarding enforcement discretion for our devices, and require that we seek marketing authorization for this additional intended use by submitting a 510(k) premarket notification, or that we seek and obtain Emergency Use Authorization. The FDA may determine this policy has expired if the impact of the COVID-19 pandemic subsides or the federal public health emergency declaration is lifted and there is no longer an urgent need to use our CGM systems for remote patient monitoring during the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we are unable to predict the duration or ultimate impact of the provision of our CGM systems to hospitals and other healthcare facilities for use during the COVID-19 pandemic at this time, we do not yet know the ultimate impact to our business or financial results. We will continue to monitor the situation closely.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on clinical investigators and clinical sites to enroll patients in our clinical trials and other third parties to manage the trials and to perform related data collection and analysis, and, as a result, we may face costs and delays that are outside of our control.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on clinical investigators and clinical sites to enroll patients in our clinical trials, and other third parties to manage the trial and to perform related data collection and analysis. However, we may not be able to control the amount and timing of resources that clinical sites may devote to our clinical trials. If these clinical investigators and clinical sites fail to enroll a sufficient number of patients in our clinical trials or fail to ensure compliance by patients with clinical protocols or fail to comply with regulatory requirements, we will be unable to complete these trials, which could prevent us from obtaining regulatory approvals for our products. Our agreements with clinical investigators and clinical sites for clinical testing place substantial responsibilities on these parties and, if these parties fail to perform as expected, our trials could be delayed or terminated. If these clinical investigators, clinical sites or other third parties do not carry out their contractual duties or obligations or fail to meet expected deadlines, or if the quality or accuracy of the clinical data they obtain is compromised due to their failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated, or the clinical data may be rejected by the FDA, and we may be unable to obtain regulatory approval for, or successfully commercialize, our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the COVID-19 pandemic, many healthcare facilities were or remain closed or available on a limited basis for non-emergent and elective services. Accordingly, our clinical investigators may not have an opportunity to recruit and enroll patients in our clinical trials. We cannot predict the length of current shelter-in-place orders or the impact of such orders and the COVID-19 pandemic more generally on the provision of non-emergent health services or the normal operation of our clinical sites, therefore, we cannot predict the ultimate impact that such restrictions may have on our clinical trial enrollment and results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to perceived increases in health care costs in recent years, there have been and continue to be proposals by the federal government, state governments, regulators, and third-party payors to control these costs and, more generally, to reform the U.S. health care system. Certain of these proposals could limit the prices we are able to charge for our products or the amounts of reimbursement available for our products and could limit the acceptance and availability of our products. Further, while the United States has begun shifting to pay-for-performance rather than fee-for-service models and has been embracing many shared-risk arrangements, CMS and OIG specifically excluded medical device manufacturers from utilizing the new, more flexible Stark Law exceptions and Anti-Kickback Statute safe harbors under the Final Rules, part of the U.S. Department of Health and Human Services&#8217; Regulatory Sprint to Coordinated Care, which were published on December 2, 2020 in the Federal Register and will be effective January 19, 2021. The exclusion of manufacturers from utilizing these exceptions and safe harbors will not allow us to avail ourselves of immunity from liability laws, potentially inviting greater scrutiny over our shared risk arrangements. Changes under these Final Rules could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on November 16, 2020 the OIG published a Special Fraud Alert addressing manufacturer Speaker Programs signaling both a more narrow government view of AKS compliance with respect to such programs as well as the potential for increased enforcement in this space by government oversight agencies such as the OIG and DOJ. This development may cause us to assess and consider modification to certain aspects of our speaker programs, which may have a detrimental impact on our ability to educate healthcare providers about our products and to promote use of our products, which may lead to decreased product sales and negatively impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive healthcare legislation, signed into law in the United States in March 2010, titled the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act of 2010, collectively, the ACA, imposes certain stringent compliance, recordkeeping, and reporting requirements on companies in various sectors of the life sciences industry, with which we may need to comply, and enhanced penalties for non-compliance with the new and revised healthcare laws. Despite the ACA going into effect over a decade ago, continuous legal and Congressional challenges to the law&#8217;s provisions and persisting uncertainty with respect to the scope and effect of certain provisions have made compliance costly. A case challenging the constitutionality of the ACA&#8217;s individual mandate is currently before the Supreme Court.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether the ACA will be repealed, replaced, or modified, or how such repeal, replacement or modification may be timed or structured. The change in Presidential Administration may also result in new agency priorities, rulemakings, and legislation, the scope and effect of which cannot be predicted. As a result, we cannot quantify or predict what the effect of such repeal, replacement, or modification might have on our business and results of operations. However, any changes that lower reimbursement for our products could materially and adversely affect our business, financial condition and results of operations. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are pending federal Congressional proposals that would significantly expand government-provided health insurance coverage. Proposals range from establishing a single-payor, national health insurance system (e.g., Medicare for All Act of 2019 (H.R. 1384), to more limited buy-in options that would be available to individuals above a certain age (e.g., Medicare at 50 Act (S. 470). There is also legislation that would authorize states to permit individuals to &#8220;buy-in&#8221; to their state Medicaid program (e.g., State Public Option Act (S. 489, H.R. 1277)). If enacted, these proposals will likely have a significant impact on the healthcare industry. At this stage, we cannot predict how future legislation will affect our business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legal, regulatory and commercial policy influences are subjecting our industry to significant changes, and we cannot predict whether new regulations or policies will emerge from U.S. federal or state governments, foreign governments, or third-party payors. Government and commercial payors may, in the future, consider healthcare policies and proposals intended to curb rising healthcare costs, including those that could significantly affect reimbursement for healthcare products such as our systems. These policies have included, and may in the future include: basing reimbursement policies and rates on clinical outcomes, the comparative effectiveness, and costs, of different treatment technologies and modalities; imposing price controls and taxes on medical device providers; and other measures. Future significant changes in the healthcare systems in the United States or elsewhere could also have a negative impact on the demand for our current and future products. These include changes that may reduce reimbursement rates for our products and changes that may be proposed or implemented by the current or future laws or regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Intellectual Property Protection and Use</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties have asserted, and may assert, infringement or misappropriation claims against us with respect to our current or future products. We are aware of numerous patents issued to third parties that may relate to aspects of our business, including the design and manufacture of CGM sensors and membranes, as well as methods for continuous glucose monitoring. Whether a product infringes a patent involves complex legal and factual issues, the determination of which is often uncertain. Therefore, we cannot be certain that we have not infringed the intellectual property rights of such third parties or others. Our competitors may assert that our CGM systems or the methods we employ in the use of our systems are covered by U.S. or foreign patents held by them. We have in the past settled some such allegations and may need to do so again in the future. For example, in July 2014, we entered into a Settlement and License Agreement with Abbott to settle all pending patent infringement legal proceedings brought by Abbott against us which is set to expire on March 31, 2021. This risk is exacerbated by the fact that there are numerous issued patents and pending patent applications relating to self-monitored glucose testing systems in the medical technology field. Because patent applications may take years to issue, there may be applications now pending of which we are unaware that may later result in issued patents that our products infringe. There could also be existing patents of which we are unaware that one or more components of our system may inadvertently infringe. As the number of competitors in the market for CGM systems grows, the possibility of patent infringement by us or a patent infringement claim against us increases. If we are unable to successfully defend any such claims as they may arise or enter into or extend settlement and license agreements on acceptable terms or at all, our business operations may be harmed. We have been involved in various patent infringement actions in the past. For example, in March 2020, we settled certain patent infringement litigation and proceedings between us and AgaMatrix, Inc. and WaveForm Technologies, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any infringement or misappropriation claim could cause us to incur significant costs, place significant strain on our financial resources, divert management&#8217;s attention from our business and harm our reputation. In addition, if the relevant patents are upheld as valid and enforceable and we are found to infringe such patents, we could be prohibited from selling any of our products that is found to infringe unless we could obtain licenses to use the technology covered by the patent or are able to design around the patent. We may be unable to obtain a license on terms acceptable to us, if at all, and we may not be able to redesign our products to avoid infringement. We may be unable to maintain or renew licenses on terms acceptable to us, if at all, and we may be prohibited from selling any of our products that required the technology covered by the relevant licensed patents. Even if we are able to redesign our products to avoid an infringement claim, we may not receive FDA approval for such changes in a timely manner or at all. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any adverse determination in litigation or interference proceedings to which we are or may become a party relating to patents or other intellectual property rights could subject us to significant liabilities to third parties or require us to seek licenses from other third parties. If we are found to infringe third-party patents, a court could order us to pay damages to compensate the patent owner for the infringement, such as a reasonable royalty amount and/or profits lost by the patent owners, along with prejudgment and/or post-judgment interest. Furthermore, if we are found to willfully infringe third-party patents, we could, in addition to other penalties, be required to pay treble damages; and if the court finds the case to be exceptional, we may be required to pay attorneys&#8217; fees for the prevailing party. If we are found to infringe third-party copyrights or trademarks or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">misappropriate third-party trade secrets, based on the intellectual property at issue, a court could order us to pay statutory damages, actual damages, or profits, such as reasonably royalty, lost profits of the owners, unjust enrichment, disgorgement of profits, and/or a reasonable royalty, and the court could potentially award attorneys&#8217; fees or exemplary or enhanced damages. Although patent and intellectual property disputes in the medical device area have often been settled through licensing or similar arrangements, costs associated with such arrangements may be substantial and would likely include ongoing royalties. We may be unable to obtain necessary intellectual property licenses on satisfactory terms. If we do not obtain any such necessary licenses, we may not be able to redesign our products to avoid infringement and any redesign may not receive FDA approval or other requisite marketing authorization in a timely manner or at all. Adverse determinations in a judicial or administrative proceeding or failure to obtain necessary intellectual property licenses could prevent us from manufacturing and selling our products, which would have a significant adverse impact on our business. If litigation were to be initiated by intellectual property owners, there could significant legal fees and costs incurred in defending litigation (which may include filing administrative actions to attack the intellectual property) as well as a potential monetary settlement payment to the owners, even if the matter is resolved before going to trial. Moreover, the owners may take an overly aggressive approach and/or include multiple allegations in a single litigation. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, we are subject to various claims, complaints and legal actions arising out of the ordinary course of business, including commercial insurance, product liability or employment related matters. Also, from time to time, we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. We do not believe we are party to any currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success and our ability to compete depend, in part, upon our ability to maintain the proprietary nature of our technologies. We rely on a combination of patent, copyright and trademark law, and trade secrets and nondisclosure agreements to protect our intellectual property. However, such methods may not be adequate to protect us or permit us to gain or maintain a competitive advantage. Our patent applications may not issue as patents in a form that will be advantageous to us, or at all. Our issued patents, and those that may issue in the future, may be challenged, invalidated or circumvented, which could limit our ability to stop competitors from marketing related products. In addition, there are numerous recent changes to the patent laws and proposed changes to the rules of the U.S. Patent and Trademark Office, which may have a significant impact on our ability to protect our technology and enforce our intellectual property rights. For example, in September 2011, the United States enacted sweeping changes to its patent system under the Leahy-Smith America Invents Act, including changes that would transition the United States from a &#8220;first-to-invent&#8221; system to a &#8220;first-to-file&#8221; system and alter the processes for challenging issued patents. These changes could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect our proprietary rights, we may in the future need to assert claims of infringement against third parties. The outcome of litigation to enforce our intellectual property rights in patents, copyrights, trade secrets or trademarks is highly unpredictable, could result in substantial costs and diversion of resources, and could have a material adverse effect on our business, financial condition and results of operations regardless of the final outcome of such litigation. In the event of an adverse judgment, a court could hold that some or all of our asserted intellectual property rights are not infringed, or are invalid or unenforceable, and could award attorney fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts to safeguard our unpatented and unregistered intellectual property rights, we may not succeed in doing so or the steps taken by us in this regard may not be adequate to detect or deter misappropriation of our technology or to prevent an unauthorized third party from copying or otherwise obtaining and using our products, technology or other information that we regard as proprietary. In addition, third parties may be able to design around our patents. Furthermore, the laws of foreign countries may not protect our proprietary rights to the same extent as the laws of the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Litigation Risks</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exposes us to the risk of product liability claims that is inherent in the testing, manufacturing and marketing of medical devices, including those which may arise from the misuse (including system hacking or other unauthorized access by third parties to our systems) or malfunction of, or design flaws in, our products. This liability may vary based on the FDA classification associated with our devices. Notably, the classification of our G6 system as a Class II medical device is likely to weaken our ability to rely on federal preemption of state law claims that assert liability against us for harms arising from use of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the G6. We may be subject to product liability claims if our products cause, or merely appear to have caused, an injury. Claims may be made by customers, healthcare providers or others selling our products. The risk of product liability claims may increase now that our G5 Mobile system has obtained indications and approved labeling in the United States, in Canada, and in the countries utilizing the CE Mark that allow for our patients to make diabetes treatment decisions with our CGM system in conjunction with only two finger sticks required for calibration of the system and our G6 does not require confirmatory finger sticks when making treatment decisions or finger stick tests each day for calibration, although it does require finger stick tests when symptoms do not match readings and when readings are unavailable.The risk of claims may also increase if our products are subject to a product recall or seizure. An example of the difficulty of complying with the regulatory requirements associated with the manufacture of our products, we issued notifications to our customers regarding the audible alarms and alerts associated with our receivers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have insurance at levels that we believe is appropriate, this insurance is subject to deductibles and coverage limitations. Our current product liability insurance may not continue to be available to us on acceptable terms, if at all, and, if available, the coverage may not be adequate to protect us against any future product liability claims. Further, if additional products are approved for marketing, we may seek additional insurance coverage. If we are unable to obtain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability claims, we will be exposed to significant liabilities, which may harm our business. A product liability claim, recall or other claim with respect to uninsured liabilities or for amounts in excess of insured liabilities could result in significant costs and significant harm to our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims against us even if the apparent injury is due to the actions of others or misuse of the device or a partner device. Our customers, either on their own or following the advice of their physicians, may use our products in a manner not described in the products&#8217; labeling and that differs from the manner in which it was used in clinical studies and approved by the FDA. For example, our current systems are designed to be used by an individual continuously for up to seven days for our G5 Mobile system and up to 10 days for our G6 system, but the individual might be able to circumvent the safeguards designed into the systems and use the products for longer than seven or 10 days. Off-label use of products by customers is common, and any such off-label use of our products could subject us to additional liability, or require design changes to limit this potential off-label use once discovered. The CE Mark and the HealthCanada and FDA approvals for our G5 Mobile system include indications that allow patients to make diabetes treatment decisions based on the information generated by such system, although both regulators still require finger stick calibrations two times per day. In addition, other regulatory agencies may in the future approve similar diabetes treatment indications. We expect that such diabetes treatment indications could expose us to additional liability. These liabilities could prevent or interfere with our product commercialization efforts. Defending a suit, regardless of merit, could be costly, could divert management attention and might result in adverse publicity, which could result in the withdrawal of, or inability to recruit, clinical trial volunteers or result in reduced acceptance of our products in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the COVID-19 pandemic, we have received and continue to receive, numerous requests from hospitals and healthcare facilities around the country regarding the use of our CGM devices to remotely monitor COVID-19 patients admitted into the hospital. As noted above, the FDA has informed us that they intend to exercise enforcement discretion and will not object to Dexcom&#8217;s provision of its G6 CGM systems to such facilities for use in the inpatient setting during the pandemic. However, our CGM devices are currently approved only for in-home use by patients for the purpose of personal diabetes management and have not otherwise been cleared or approved by the FDA for hospital use. Given that the G6 CGM has not yet been fully evaluated or tested (by Dexcom or by the FDA) to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment. To the extent that inpatient use of our CGM systems cause or contribute to an adverse event, we may be subjected to additional product liability lawsuits. Defending a suit, regardless of merit, could be costly, could divert management attention and might result in adverse publicity, which could result in reduced acceptance of our products in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could become the subject of governmental investigations, claims and litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care companies are subject to numerous investigations by various governmental agencies. Further, under the False Claims Act, private parties have the right to bring&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or &#8220;whistleblower,&#8221; suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Depending upon whether the underlying conduct alleged in such inquiries or investigations could be considered systemic, the resolution could have a material, adverse effect on our financial position and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental agencies and their agents, such as CMS Medicare Administrative Contractors and other CMS contractors, as well as the OIG, state Medicaid programs, and other state and federal agencies may conduct audits of our operations, relating to covered items and services including those furnished to beneficiaries, health care providers and distributors. Commercial and government-funded managed care payors may conduct similar post-payment audits. Depending on the nature of the conduct found in such audits and whether the underlying conduct could be considered systemic, the resolution of these audits could have </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a material adverse effect on our financial position and results of operations. Our compliance program includes internal audit and monitoring functions designed to identify potential issues and to facilitate remediation as appropriate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS contracts with Recovery Audit Contractors, or RACs, on a contingency fee basis to conduct post-payment reviews to detect and correct improper payments in the&#160;fee-for-service&#160;Medicare program. The ACA expanded the RAC program&#8217;s scope to include managed Medicare plans and Medicaid claims. RAC denials are appealable; however, there currently are significant delays in the assignment of new Medicare appeals to Administrative Law Judges, which negatively impacts our ability to appeal RAC payment denials. In addition, CMS employs various other program integrity contractors &#8211; including zone program integrity contractors, or ZPICs, Medicaid integrity contractors, or MICs, and unified program integrity contractors, or UPICs &#8211; to perform post-payment audits of claims and identify overpayments, and state Medicaid agencies and other contractors have increased their review and audit activities as well.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not presently aware of any governmental investigations involving our executives or us. However, any future investigations of our executives, our managers or us could result in significant liabilities or penalties to us, as well as adverse publicity. Even if we are found to have complied with applicable law, the investigation or litigation may pose a considerable expense and would divert management&#8217;s attention, and have a potentially negative impact on the public&#8217;s perception of us, all of which could negatively impact our financial position and results of operations. Further, should we be found out of compliance with any of these laws, regulations or programs, depending on the nature of the findings, our business, our financial position and our results of operations could be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to fines, penalties and injunctions if we are determined to be promoting the use of our products for unapproved or improper off-label uses or determined to have made claims that untruthful or misleading or not adequately substantiated or determined to have made claims that untruthful or misleading or not adequately substantiated.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our marketing, promotional and educational materials and practices comply with FDCA, Federal Trade Commission Act, and other applicable laws and regulations, as may be amended from time to time, if the FDA, FTC or other regulatory body with competent jurisdiction over us, our activities or products takes the position that our marketing, promotional or other materials or activities constitute improper promotion or marketing of an unapproved or improper use, or that they contain untruthful, misleading, or inadequately substantiated statements or claims, such regulatory body could request that we modify our materials or practices, or subject us to regulatory enforcement actions, including the issuance, depending on the regulatory body and the nature of the alleged violation, of a warning letter, injunction, seizure, civil fine and criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider promotional, marketing or other materials or activities to constitute improper promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. Recent court decisions have impacted the FDA&#8217;s enforcement activity regarding off-label promotion in light of First Amendment considerations; however, there are still significant risks in this area in part due to the potential False Claims Act exposure and the FDA&#8217;s continued focus on ensuring devices are marketed in a manner consistent with their FDA-required labeling.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not actively promoting nor do we plan to actively promote our G6 CGM systems for inpatient use, but if we supply them to such facilities as currently permitted by FDA, this supply could present an increased risk of product liability claims and associated damages should an adverse event occur. Given that the G6 CGM system has not yet been fully evaluated or tested (by Dexcom or by the FDA) to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In some instances in our advertising and promotion, we may make claims regarding our product as compared to competing products, which may subject us to heightened regulatory scrutiny, enforcement risk, and litigation risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA applies a heightened level of scrutiny to comparative claims when applying its statutory standards for advertising and promotion, including with regard to its requirement that promotional labeling be truthful and not misleading. There is potential for differing interpretations of whether certain communications are consistent with a product&#8217;s FDA-required labeling, and FDA will evaluate communications on a fact-specific basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, making comparative claims may draw concerns from our competitors. Where a company makes a claim in advertising or promotion that its product is superior to the product of a competitor (or that the competitor&#8217;s product is inferior), this creates a risk of a lawsuit by the competitor under federal and state false advertising or unfair and deceptive trade practices law, and possibly also state libel law.&#160;Such a suit may seek injunctive relief against further advertising, a court order directing corrective advertising, and compensatory and punitive damages where permitted by law.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct-to-consumer marketing and social media efforts may expose us to additional regulatory scrutiny.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our efforts to promote our products via direct-to-consumer marketing and social media initiatives may subject us to additional scrutiny of our practices of effective communication of risk information, benefits or claims, under the oversight of the FDA, FTC, or both.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Other Risks Related to our Business and Financial Condition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant losses in the past and may incur losses in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses in the past. As of December&#160;31, 2020, we had an accumulated deficit of $202.1 million. We have financed our operations primarily through private and public offerings of equity securities and debt and the sales of our products. We have devoted substantial resources to:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">research and development relating to our continuous glucose monitoring systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">sales and marketing and manufacturing expenses associated with the commercialization of our G5 Mobile and G6 systems; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expansion of our workforce.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our research and development expenses to increase in connection with our clinical trials and other development activities related to our products, including our next-generation sensors, transmitters and receivers, as well as other collaborations. We also expect that our general and administrative expenses will continue to increase due, among other things, to the additional operational and regulatory burdens applicable to public healthcare and medical device companies. As a result, it is possible that we could incur operating losses in the future. These losses, among other things, may have an adverse effect on our stockholders&#8217; equity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our success will depend on our ability to attract and retain our personnel and manage our human capital, while controlling labor costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend to a significant degree on our senior management, especially Kevin Sayer, our President and Chief Executive Officer. Our success will depend on our ability to retain our senior management and to attract and retain qualified personnel in the future, including salespersons, scientists, clinicians, engineers and other highly skilled personnel. Competition for senior management personnel, as well as salespersons, scientists, clinicians and engineers, is intense and we may not be able to retain our personnel. The loss of the services of members of our senior management, scientists, clinicians or engineers could prevent the implementation and completion of our objectives, including the commercialization of our current products and the development and introduction of additional products. The loss of a member of our senior management or our professional staff would require the remaining executive officers to divert immediate and substantial attention to seeking a replacement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our officers may terminate their employment at any time without notice and without cause or good reason. Additionally, volatility or a lack of positive performance in our stock price may adversely affect our ability to retain key employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to expand our operations and grow our research and development, manufacturing, sales and marketing, product development and administrative operations. We expect this expansion to place a significant strain on our management and it will require hiring a significant number of qualified personnel. Accordingly, recruiting and retaining such personnel will be critical to our success. There is intense competition from other companies and research and academic institutions for qualified personnel in the areas of our activities. If we fail to identify, attract, retain and motivate these skilled personnel, we may be unable to continue our development and commercialization activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may undertake reorganizations of our workforce, which may result in a temporary reduction in the number of employees in certain locations. We would undertake a reorganization to reduce operating expenses or achieve other business objectives, though we cannot guarantee any specific amount of long-term cost savings. Further, the turnover in our employee base could result in operational and administrative inefficiencies, which could adversely impact the results of our operations, stock price and customer relationships, and could make recruiting for future management and other positions more difficult.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may conduct additional financings to continue the development or commercialization of our current or future generation CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations have consumed substantial amounts of cash since inception. We expect to continue to spend substantial amounts on commercialization of our products, including growth of our manufacturing capacity, on research and development, and conducting clinical trials for our next-generation ambulatory CGM sensors and systems. Although we raised substantial net proceeds through the private sale of our convertible notes, we could need funds to continue the commercialization of our current products and to develop and commercialize our next-generation sensors and systems or pursue other strategic initiatives. Additional financing may not be available on a timely basis on terms acceptable to us, or at all. Any additional financing may be dilutive to stockholders or may require us to grant a lender a security interest in our assets. The amount of funding we may need will depend on many factors, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the revenue generated by sales of our products and other future products;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs, timing and risks of delay of additional regulatory approvals;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the expenses we incur in manufacturing, developing, selling and marketing our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to scale our manufacturing operations to meet demand for our current and any future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs to produce our continuous glucose monitoring systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the rate of progress and cost of our clinical trials and other development activities; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the success of our research and development efforts;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the emergence of competing or complementary technologies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the terms and timing of any collaborative, licensing and other arrangements that we may establish;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the cost of ongoing compliance with legal and regulatory requirements, and third-party payors&#8217; policies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the cost of obtaining and maintaining regulatory or payor clearance or approval for our current or future products including those integrated with other companies&#8217; products; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the acquisition of business, products and technologies, although we currently have no commitments or agreements relating to any of these types of transactions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If adequate funds are not available, we may not be able to commercialize our products at the rate we desire and/or we may have to delay the development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce sales, marketing, customer support or other resources devoted to our products. Any of these factors could harm our business and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncollectible uninsured and patient due accounts could adversely affect our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary collection risks for our accounts receivable relate to the uninsured patient accounts and patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (exclusions, deductibles and copayments) remain outstanding. In addition, as a result of the impact of the COVID-19 pandemic, some customers have, and others may, lose access to their private health insurance plan if they lose their job. As most of our customers rely on third-party payors, including private health insurance plans, to cover the cost of our products, there has been, and may continue to be, a shift in financial responsibility to our customers for the amounts previously covered by their primary insurance carrier.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we are unsuccessful in collecting payments owed by patients, and/or experience increases in the amount, or deterioration in the collectability, of uninsured and patient due accounts receivable, this could adversely affect our cash flows and results of operations. We may also be adversely affected by the growth in patient responsibility accounts, as a result of increases in the adoption of plan structures, due to evolving health care policy and insurance landscapes that shift greater responsibility for care to individuals through greater exclusions, prior authorizations, and copayment and deductible amounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in our business strategy or restructuring of our businesses may increase our costs or otherwise affect the profitability of our businesses or the value of our assets.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As changes in our business environment occur we have adjusted, and may further, adjust our business strategies to meet these changes and we may otherwise decide to further restructure our operations or particular businesses or assets. Our new organization and strategies may not produce the anticipated benefits, such as supporting our growth strategies and enhancing shareholder value. Our new organization and strategies could be less successful than our previous organizational structure and strategies. In addition, external events including changing technology, changing consumer patterns, acceptance of our products and changes in macroeconomic conditions may impair the value of our assets. When these changes or events occur, we may incur costs to change our business strategy and may need to write-down the value of assets. For example, current conditions, including COVID-19 and our business decisions, may reduce the value of some of our assets. We also make investments in existing or new businesses, including investments in international expansion of our sales efforts and the build out of our future manufacturing facility in Malaysia. Additionally, we also invest in early to late stage companies for strategic reasons and to support key business initiatives, and we may not realize a return on our equity investments. Many such companies generate net losses and the market for their products, services, or technologies may be slow to develop or never materialize. We are subject to risks associated with our equity investments including partial or complete loss of invested capital, and significant changes in the fair value of this portfolio could adversely impact our financial results, Some of these investments may have returns that are negative or low, the ultimate business prospects of the businesses related to these investments may be uncertain, and these risks may be exacerbated by COVID-19. In any of these events, our costs may increase or returns on new investments may be lower than prior to the change in strategy or restructuring.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Relating to Our Public Company Status, Tax Laws and Growth Through Acquisition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face risks associated with acquisitions of companies, products and technologies and our business could be harmed if we are unable to address these risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are presented with appropriate opportunities, we could acquire or make other investments in complementary companies, products or technologies. We may not realize the anticipated benefit of our acquisitions, or the realization of the anticipated benefits may require greater expenditures than anticipated by us. We will likely face risks, uncertainties and disruptions associated with the integration process, including difficulties in the integration of the operations and services of any acquired company, integration of acquired technology with our products, diversion of our management&#8217;s attention from other business concerns, the potential loss of key employees or customers of the acquired businesses and impairment charges if future acquisitions are not as successful as we originally anticipate. If we fail to successfully integrate other companies, products or technologies that we acquire, our business could be harmed. Furthermore, we may have to incur debt or issue equity or equity-linked securities to pay for any future acquisitions or investments, the issuance of which could be dilutive to our existing stockholders. In addition, our operating results may suffer because of acquisition-related costs or amortization expenses or charges relating to acquired intangible assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with regulations relating to public company corporate governance matters and reporting may strain our resources and divert management&#8217;s attention.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many laws and regulations, notably those adopted in connection with the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, new SEC regulations and The Nasdaq Stock Market listing rules, impose obligations on public companies, such as ours, which have increased the scope, complexity and cost of corporate governance, reporting and disclosure practices. Compliance with these laws and regulations, including enhanced new disclosures, has required and will continue to require substantial management time and oversight and the incurrence of significant accounting and legal costs. The effects of new laws and regulations remain unclear and will likely require substantial management time and oversight and require us to incur significant additional accounting and legal costs. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may require us to incur greater accounting fees. These laws, regulations, and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to continue to invest resources to comply with evolving laws, regulations, and standards, and this investment may result in increased general and administrative expenses and a diversion of management&#8217;s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to changes in our tax rates, new U.S. or international tax legislation or additional tax liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxes in the United States and numerous foreign jurisdictions, where a number of our subsidiaries are organized. Due to economic and political conditions, tax rates in various jurisdictions may be subject to change. Our effective tax rates could be affected by numerous factors, including changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, and changes in tax laws or their interpretation, both in and outside the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. government has recently enacted comprehensive tax legislation that includes significant changes to the taxation of business entities. These changes include, among others, (i) a permanent reduction to the corporate income tax rate, (ii) a partial limitation on the deductibility of business interest expense, (iii) a shift of the U.S. taxation of multinational corporations from a tax on worldwide income to a territorial system (along with certain rules designed to prevent erosion of the U.S. income tax base) and (iv) a one-time tax on accumulated offshore earnings held in cash and illiquid assets, with the latter taxed at a lower rate. The overall impact of this tax reform is uncertain, and our business and financial condition could be adversely affected.&#160;In addition, it is uncertain if and to what extent various states will conform to the newly enacted federal tax law.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax returns and other tax matters also are subject to examination by the U.S. Internal Revenue Service and other tax authorities and governmental bodies. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes. We cannot guarantee the outcome of these examinations. If our effective tax rates were to increase, particularly in the United States, or if the ultimate determination of our taxes owed is for an amount in excess of amounts previously accrued, our financial condition, operating results and cash flows could be adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations which could subject our business to higher tax liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to use our net operating losses, or NOLs, to offset future taxable income may be subject to certain limitations which could subject our business to higher tax liability. We may be limited in the portion of NOL carryforwards that we can use in the future to offset taxable income for U.S. federal and state income tax purposes, and federal tax credits to offset federal tax liabilities. Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state law provisions, limit the use of NOLs and tax credits after a cumulative change in corporate ownership of more than 50% occurs within a three-year period. The statutes place a formula limit on how much NOLs and tax credits a corporation can use in a tax year after a change in ownership. Avoiding an ownership change is generally beyond our control. Although the ownership changes we experienced in the past have not prevented us from using all NOLs and tax credits accumulated before such ownership changes, we could experience another ownership change that might limit our use of NOLs and tax credits in the future. In addition, realization of deferred tax assets, including net operating loss carryforwards, depends upon our future earnings in applicable tax jurisdictions. If we have insufficient future taxable income in the applicable tax jurisdiction for any reason, including any future corporate reorganization or restructuring activities, we may be limited in our ability to utilize some or all of our net operating losses to offset such income and reduce our tax liability in that jurisdiction. See Note 8 to the consolidated financial statements in Part II, Item 8 of this Annual Report for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that due to regulatory changes or changes to federal or state law, such as suspensions on the use of NOLs, or other unforeseen reasons, our existing NOLs could expire or otherwise be unavailable either in whole or in part to offset future income tax liabilities. For example, under the Coronavirus Aid, Relief, and Economic Security Act of 2020, or CARES Act, which amended certain provisions of the Tax Cuts and Jobs Act of 2017, or TCJA, NOLs arising in taxable years beginning after December 31, 2017 and before January 1, 2021 may be carried back to each of the five taxable years preceding the tax year of such loss, but NOLs arising in taxable years beginning after December 31, 2020 may not be carried back.The TCJA, as amended by the CARES Act, also provides that NOLs from tax years that began after December 31, 2017 may offset no more than 80% of current taxable income annually for taxable years beginning after December 31, 2020. Accordingly, although we have generated NOLs after the tax year ended December 31, 2017, we might have to pay more federal income taxes in a future tax year as a result of the 80% taxable income limitation than we would have had to pay under the law in effect before the TCJA as amended by the CARES Act. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of share-based payments, which we are required to perform for purposes of recording compensation expense under authoritative guidance for share-based payment, involves assumptions that are subject to change and difficult to predict.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record compensation expense in the consolidated statements of operations for share-based payments, such as employee stock options, restricted stock units and employee stock purchase plan shares, using the fair value method. The requirements of the authoritative guidance for share-based payment have and will continue to have a material effect on our future financial results reported under U.S. generally accepted accounting principles, or GAAP, and make it difficult for us to accurately predict the impact on our future financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, estimating the fair value of share-based payments is highly dependent on assumptions regarding the future exercise behavior of our employees and changes in our stock price. If there are errors in our input assumptions for our valuations models, we may inaccurately calculate actual or estimated compensation expense for share-based payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance for share-based payment could also adversely impact our ability to provide accurate guidance on our future financial results as assumptions that are used to estimate the fair value of share-based payments are based on estimates and judgments that may differ from period to period. We may also be unable to accurately predict the amount and timing of the recognition of tax benefits associated with share-based payments as they are highly dependent on the exercise behavior of our employees and the price of our stock relative to the exercise price of each outstanding stock option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For those reasons, among others, the authoritative guidance for share-based payment may create variability and uncertainty in the share-based compensation expense we will record in future periods, which could adversely impact our stock price and increase our expected stock price volatility as compared to prior periods. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Our Common Stock</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is highly volatile and investing in our stock involves a high degree of risk, which could result in substantial losses for investors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the market price of our common stock, like the securities of many other medical products companies, fluctuates and could continue to be volatile in the future, especially as our business continues to grow and our business plan continues to evolve. From January&#160;1, 2020 through February&#160;4, 2021, the closing price of our common stock on the Nasdaq </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Select Market was as high as $451.79 per share and as low as $191.16 per share. In addition, the trading prices for our common stock and other medical device companies have been highly volatile as a result of the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock is influenced by many factors that are beyond our control, including the following: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">securities analyst coverage or lack of coverage of our common stock or changes in their estimates of our financial performance; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">variations in quarterly operating results; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">future sales of our common stock by our stockholders; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">investor perception of us and our industry; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">announcements by us or our competitors of significant agreements, acquisitions, or capital commitments or product launches or discontinuations; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in market valuation or earnings of our competitors; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">negative business or financial announcements regarding our partners; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">general economic conditions; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory actions; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">legislation and political conditions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global health pandemics, such as COVID-19; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">terrorist acts. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please also refer to the factors described elsewhere in this &#8220;Risk Factors&#8221; section. In addition, the stock market in general has experienced extreme price and volume fluctuations that have often been unrelated and disproportionate to the operating performance of companies in our industry. These broad market and industry factors may materially reduce the market price of our common stock, regardless of our operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities class action litigation has often been brought against public companies that experience periods of volatility in the market prices of their securities. Securities class action litigation could result in substantial costs and a diversion of our management&#8217;s attention and resources. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The issuance of shares by us in the future or sales of shares by our stockholders may cause the market price of our common stock to drop significantly, even if our business is performing well. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This issuance of shares by us in the future, including by conversion of our senior convertible notes in certain circumstances, the issuance of shares of our common stock to partners, including up to 2,025,036 shares of our common stock that we may issue to Verily and Onduo LLC pursuant to the Restated Collaboration Agreement, or sales of shares by our stockholders may cause the market price of our common stock to decline, perhaps significantly, even if our business is performing well. The market price of our common stock could also decline if there is a perception that sales of our shares are likely to occur in the future. This might also make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. Also, we may issue securities in connection with future financings and acquisitions, and those shares could dilute the holdings of other stockholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not intend to pay dividends for the foreseeable future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future and the terms of our credit agreement restrict our ability to declare or pay any dividends. As a result, stockholders (including holders of our senior convertible notes who receive shares of our common stock, if any, upon conversion of their notes) may only receive a return on their investment in our common stock if the market price of our common stock increases.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover effects of our charter documents and Delaware law could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock.</span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are provisions in our certificate of incorporation and bylaws, as well as provisions in the Delaware General Corporation Law, that may discourage, delay or prevent a change of control that might otherwise be beneficial to stockholders. For example: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our Board of Directors may, without stockholder approval, issue shares of preferred stock with special voting or economic rights; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our stockholders do not have cumulative voting rights and, therefore, each of our directors can only be elected by holders of a majority of our outstanding common stock; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a special meeting of stockholders may only be called by a majority of our Board of Directors, the Chairman of our Board of Directors, our Chief Executive Officer, our President or our Lead Independent Director; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our stockholders may not take action by written consent; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our Board of Directors is divided into three classes, only one of which is elected each year; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we require advance notice for nominations for election to the Board of Directors or for proposing matters that can be acted upon by stockholders at stockholder meetings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all claims brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. In September 2020, we amended and restated our restated bylaws to provide that the federal district courts of the United States will, to the fullest extent permitted by law, be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, or a Federal Forum Provision. Our decision to adopt a Federal Forum Provision followed a decision by the Supreme Court of the State of Delaware holding that such provisions are facially valid under Delaware law. While there can be no assurance that federal or state courts will follow the holding of the Delaware Supreme Court or determine that the Federal Forum Provision should be enforced in a particular case, application of the Federal Forum Provision means that suits brought by our stockholders to enforce any duty or liability created by the Securities Act must be brought in federal court and cannot be brought in state court. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all claims brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Neither the exclusive forum provision nor the Federal Forum Provision applies to suits brought to enforce any duty or liability created by the Exchange Act. Accordingly, actions by our stockholders to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder must be brought in federal court.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, our stockholders will not be deemed to have waived our compliance with the federal securities laws and the regulations promulgated thereunder.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person or entity purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have notice of and consented to our exclusive forum provisions, including the Federal Forum Provision. The exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the choice of forum provisions contained in our restated certificate of incorporation or amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results, and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, Section 203 of the Delaware General Corporation Law may discourage, delay, or prevent a change of control of our company. Section 203 imposes certain restrictions on mergers, business combinations, and other transactions between us and holders of 15% or more of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Our Debt</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing our financial leverage could affect our operations and profitability</span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we entered into a five-year $200.0 million revolving credit agreement, which was subsequently amended on May 11, 2020. As of December&#160;31, 2020, we had no outstanding borrowings, $6.3 million in outstanding letters of credit, and a total available balance of $193.7 million under our multi-currency revolving credit facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leverage ratio may affect the availability to us of additional capital resources as well as our operations in several ways, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the terms on which credit may be available to us could be less attractive, both in the economic terms of the credit and the legal covenants;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possible lack of availability of additional credit;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the potential for higher levels of interest expense to service or maintain our outstanding debt;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possibility of additional borrowings in the future to repay our indebtedness when it comes due; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possible diversion of capital resources from other uses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe we will have the ability to service our debt and obtain additional resources in the future if and when needed, that will depend upon our results of operations and financial position at the time, the then-current state of the credit and financial markets, and other factors that may be beyond our control. Therefore, we cannot give assurances that sufficient credit will be available on terms that we consider attractive, or at all, if and when necessary or beneficial to us.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with covenants in our revolving credit agreement with JPMorgan Chase Bank and other syndicate lenders could result in our inability to borrow additional funds and adversely impact our business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into a revolving credit agreement and a pledge and security agreement with JPMorgan Chase Bank and four other lenders to fund our business operations. These agreements impose numerous financial and other restrictive covenants on our operations, including covenants relating to our general profitability and our liquidity. As of December&#160;31, 2020, we were in compliance with the covenants imposed by the loan and security agreement. If we violate these or any other covenants, any outstanding amounts under these agreements could become due and payable prior to their stated maturity dates, each lender could proceed against any collateral in our operating accounts and our ability to borrow funds in the future may be restricted or eliminated. These restrictions may also limit our ability to borrow additional funds and pursue other business opportunities or strategies that we would otherwise consider to be in our best interests. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have indebtedness in the form of convertible senior notes, which could adversely affect our financial health and our ability to respond to changes in our business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2017, we completed an offering of $400.0 million aggregate principal amount of 0.75% convertible senior notes due 2022, or 2022 Notes, which offering we refer to as the 2017 Notes Offering. In November 2018, we completed an offering of $850.0 million aggregate principal amount of 0.75% convertible senior notes due 2023, or 2023 Notes, which offering we refer to as the 2018 Notes Offering. In May 2020, we completed an offering of approximately $1.21 billion aggregate principal amount of 0.25% convertible senior notes due 2025, or 2025 notes, which offering we refer to as the 2020 Notes Offering. As of the date hereof, there are no 2022 Notes outstanding. We refer to the 2018 Notes Offering and the 2020 Notes Offering, collectively, as the Notes Offerings, and we refer to the 2023 Notes and the 2025 Notes, collectively, as the Notes. As a result of the Notes Offerings, we incurred $2.06 billion principal amount of indebtedness, the principal amount of which we may be required to pay at maturity. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require us to repurchase their notes upon the occurrence of a fundamental change (as defined in the indenture for each of the Notes) at a purchase price equal to 100% of the principal amount of the notes to be purchased, plus accrued and unpaid interest, if any. In addition, each indenture for the Notes provides that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to maturity date for the Notes. There can be no assurance that we will be able to repay this indebtedness when due, or that we will be able to refinance this indebtedness on acceptable terms or at all. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our level of increased debt after the completion of the Notes Offerings: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our vulnerability to adverse general economic conditions and competitive pressures will be heightened;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we will be required to dedicate a larger portion of our cash flow from operations to interest payments, limiting the availability of cash for other purposes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our flexibility in planning for, or reacting to, changes in our business and industry may be more limited; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate purposes or other purposes may be impaired.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot be sure that our leverage resulting from the level of increased debt after the completion of the Notes Offerings will not materially and adversely affect our ability to finance our operations or capital needs or to engage in other business activities. In addition, we cannot be sure that additional financing will be available when required or, if available, will be on terms satisfactory to us. Further, even if we are able to obtain additional financing, we may be required to use such proceeds to repay a portion of our debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to repurchase the Notes upon a fundamental change when required by the holders or repay prior to maturity any accelerated amounts due under the notes upon an event of default or redeem the Notes unless specified conditions are met under our credit facility, and our future debt may contain additional limitations on our ability to pay cash upon conversion, repurchase or repayment of the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require us to repurchase their Notes upon the occurrence of a fundamental change at a purchase price equal to 100% of the principal amount of the Notes to be purchased, plus accrued and unpaid interest, if any, to, but not including, the fundamental change purchase date. In addition, each indenture for the Notes provides that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to maturity date for the Notes. In addition, upon conversion of the Notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than cash in lieu of any fractional share), we will be required to make cash payments in respect of the Notes being converted. However, we may not have enough available cash or be able to obtain financing at the time we are required to repurchase Notes </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">surrendered upon a fundamental change or repay prior to maturity any accelerated amounts or pay cash for Notes being converted. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our ability to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes upon an event of default or pay cash upon conversions of the Notes may be limited by law, by regulatory authority or by agreements governing our indebtedness outstanding at the time, including our credit facility. Under our current credit facility we are only permitted to use cash to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes if we meet certain conditions that are defined under the Credit Agreement. We may not meet these conditions in the future. Our failure to repurchase Notes at a time when the repurchase is required by the respective indenture (whether upon a fundamental change or otherwise under each indenture) or pay cash payable on future conversions of the Notes as required by the indenture would constitute a default under each indenture. A default under each indenture or the fundamental change itself could also lead to a default under agreements governing our existing or future indebtedness, including our credit facility. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness, repurchase the Notes or make cash payments upon conversions thereof.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may still incur substantially more debt or take other actions which would intensify the risks discussed above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may incur substantial additional debt in the future, subject to the restrictions contained in our debt instruments, some of which may be secured debt. We are not restricted under the terms of the indentures governing the Notes from incurring additional debt, securing existing or future debt, recapitalizing our debt, or taking a number of other actions that are not limited by the terms of the indenture governing the convertible senior notes that could have the effect of diminishing our ability to make payments on the Notes when due.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The convertible note hedge and warrant transactions may affect the value of the 2023 Notes and our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the 2023 Notes, we entered into convertible note hedge, or the 2023 Note Hedge, transactions with certain financial institutions, or option counterparties. We also entered into warrant transactions with the option counterparties pursuant to which we sold warrants for the purchase of our common stock, or the 2023 Warrants. The 2023 Note Hedge transactions are expected generally to reduce the potential dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes. The 2023 Warrant transactions could separately have a dilutive effect to the extent that the market price per share of our common stock exceeds the exercise price of the 2023 Warrants, which is $198.38.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock in secondary market transactions prior to the maturity of 2023 Notes (and are likely to do so during any observation period related to a conversion of 2023 Notes, or following any repurchase of Notes by us on any fundamental change repurchase date (as defined in the indenture for the 2023 Notes) or otherwise). This activity could also cause or avoid an increase or a decrease in the market price of our common stock or the 2023 Notes, which could affect note holders&#8217; ability to convert the 2023 Notes and, to the extent the activity occurs during any observation period related to a conversion of the 2023 Notes, it could affect the amount and value of the consideration that note holders will receive upon conversion of the 2023 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect, if any, of these transactions and activities on the market price of our common stock or the 2023 Notes will depend in part on market conditions and cannot be ascertained at this time. Any of these activities could adversely affect the value of our common stock and the value of the 2023 Notes (and as a result, the value of the consideration, the amount of cash and/or the number of shares, if any, that note holders would receive upon the conversion of the 2023 Notes) and, under certain circumstances, the ability of the note holders to convert the 2023 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not make any representation or prediction as to the direction or magnitude of any potential effect that the transactions described above may have on the price of the 2023 Notes or our common stock. In addition, we do not make any representation that the option counterparties will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to counterparty risk with respect to the 2023 Note Hedge transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties are financial institutions, and we will be subject to the risk that any or all of them may default under the 2023 Note Hedge transactions. Our exposure to the credit risk of the option counterparties will not be secured by any collateral. Recent global economic conditions have resulted in the actual or perceived failure or financial difficulties of many financial institutions. If an option counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings, with a claim equal to our exposure at that time under our transactions with that option counterparty. Our exposure will depend on many factors but, generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our common stock. In addition, upon a default by an option counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the option counterparties.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the Notes, depends on our future financial condition and operating performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to satisfy our obligations under the Notes, our existing indebtedness and any future indebtedness we may incur and to make necessary capital expenditures. We may not maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on (as well as any cash due upon conversion of) our debt, including the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as reducing or delaying investments or capital expenditures, selling assets, refinancing or obtaining additional equity capital on terms that may be onerous or highly dilutive. These alternative measures may not be successful and may not permit us to meet our scheduled debt servicing obligations. Further, we may need to refinance all or a portion of our debt on or before maturity, and our ability to refinance the Notes, existing indebtedness or future indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities on commercially reasonable terms or at all, which could result in a default on the Notes or our current and future indebtedness.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our credit facility imposes restrictions on us that may adversely affect our ability to operate our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facility contains restrictive covenants relating to our capital raising activities and other financial and operational matters which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. In addition, our credit facility and the agreements governing the notes each contain cross-default provisions whereby a default under one agreement would likely result in cross defaults under agreements covering other borrowings. For example, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $25.0 million, in the case of the 2023 Notes, and $50.0 million, in the case of the 2025 Notes, that causes such indebtedness to become due prior to its scheduled maturity date would cause a cross default under the indenture governing the Notes. In addition, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $15.0 million that causes such indebtedness to become due prior to its scheduled maturity date would cause a default under our credit facility. The occurrence of a default under any of these borrowing arrangements would permit the holders of the Notes or the lenders under our credit facility to declare all amounts outstanding under those borrowing arrangements to be immediately due and payable. If the Note holders or the trustee under the indenture governing the Notes or the lenders under our credit facility accelerate the repayment of borrowings, we cannot assure you that we will have sufficient assets to repay those borrowings.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of the Notes will, to the extent we deliver shares upon conversion of such Notes, dilute the ownership interest of existing stockholders, including holders who had previously converted their Notes, or may otherwise depress our stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion of some or all of the Notes will dilute the ownership interests of existing stockholders to the extent we deliver shares upon conversion of any of the Notes. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Notes may encourage short selling by market participants because the conversion of the Notes could be used to satisfy short positions, or anticipated conversion of the Notes into shares of our common stock could depress our stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the Notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the conditional conversion feature of the Notes is triggered, holders of the Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than cash in lieu of any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders of the Notes do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The accounting method for convertible debt securities that may be settled in cash, such as the Notes, may have a material effect on our reported financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under GAAP, an entity must separately account for the debt component and the embedded conversion option of convertible debt instruments that may be settled entirely or partially in cash upon conversion, such as the Notes, in a manner that reflects the issuer&#8217;s economic interest cost. The effect of the accounting treatment for such instruments is that the value of such embedded conversion option would be treated as original issue discount for purposes of accounting for the debt component of the Notes, and that original issue discount is amortized into interest expense over the term of the Notes using an </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effective yield method. As a result, we will be required to record a greater amount of non-cash interest expense because of the amortization of the original issue discount to the Notes&#8217; face amount over the term of the Notes and because of the amortization of the debt issuance costs. Accordingly, we will report greater interest expense and lower net income in our financial results because of the recognition of both the current period&#8217;s amortization of the debt discount and the Notes&#8217; coupon interest, which could adversely affect our reported or future financial results, the trading price of our common stock and the trading price of the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if the conditional conversion feature of the Notes is triggered, even if holders do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The fundamental change repurchase feature of the Notes may delay or prevent an otherwise beneficial attempt to take over Dexcom.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Notes require us to repurchase the Notes in the event of a fundamental change. A takeover of Dexcom would trigger an option of the holders of the Notes to require us to repurchase the Notes. In addition, if a make-whole fundamental change occurs prior to the maturity date of the Notes, we will in some cases be required to increase the conversion rate for a holder that elects to convert its Notes in connection with such make-whole fundamental change. Furthermore, each indenture for the Notes prohibits us from engaging in certain mergers or acquisitions unless, among other things, the surviving entity assumes our obligations under the notes. These and other provisions of each indenture may have the effect of delaying or preventing a takeover of Dexcom.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">General Risk Factors</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current uncertainty in global economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty, political instability and military hostilities in multiple geographies, concerns over the potential downgrade of U.S. sovereign debt and continued sovereign debt, monetary and financial uncertainties in Europe and other foreign countries, and global health pandemics such as the COVID-19 pandemic. These include potential reductions in the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. These conditions have made and may continue to make it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products or to use them less frequently. If that were to occur, our revenue may decrease and our performance may be negatively impacted. In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles and limits on durable medical equipment, which may cause seasonality in purchasing patterns. Furthermore, during economic uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. While the potential economic impact brought by and the duration of the COVID-19 pandemic may be difficult to assess or predict, it has already caused, and is likely to result in further, significant disruption of global financial markets, which may reduce our ability to access capital on favorable terms or at all. In addition, a recession, depression or other sustained adverse market event resulting from the spread of COVID-19 could materially and adversely affect our business and the value of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United States, or in our industry. These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully maintain effective internal control over financial reporting, investors may lose confidence in our reported financial information and our stock price and our business may be adversely impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we are required to maintain internal control over financial reporting and our management is required to evaluate the effectiveness of our internal control over financial reporting as of the end of each fiscal year. If we are not successful in maintaining effective internal control over financial reporting, there could be inaccuracies or omissions in the consolidated financial information we are required to file with the SEC. Additionally, even if there are no inaccuracies or omissions, we will be required to publicly disclose the conclusion of our management that our internal control over financial reporting or disclosure controls and procedures are not effective. These events could cause investors to lose confidence in our reported financial information, adversely impact our stock price, result in increased costs to remediate any deficiencies, attract regulatory scrutiny or lawsuits that could be costly to resolve and distract management&#8217;s attention, limit our ability to access the capital markets or cause our stock to be delisted from The Nasdaq Stock Market or any other securities exchange on which it is then listed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in financial accounting standards or practices or existing taxation rules or practices may cause adverse unexpected revenue and/or expense fluctuations and affect our reported results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change in accounting standards or practices or a change in existing taxation rules or practices can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change is effective. New accounting pronouncements and taxation rules and varying interpretations of accounting pronouncements and taxation practice have occurred and may occur in the future. The method in which we market and sell our products may have an impact on the manner in which we recognize revenue. In addition, changes to existing rules or the questioning of current practices may adversely affect our reported financial results or the way we conduct our business. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may further require us to incur greater accounting fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our financial performance fails to meet the expectations of investors and public market analysts, the market price of our common stock could decline. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues and operating results may fluctuate significantly from quarter to quarter. We believe that period-to-period comparisons of our operating results may not be meaningful and should not be relied on as an indication of our future performance. If quarterly revenues or operating results fall below the expectations of investors or public market analysts, the trading price of our common stock could decline substantially. Factors that might cause quarterly fluctuations in our operating results include: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to manufacture an adequate supply of product at appropriate quality levels and acceptable costs; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">possible delays in our research and development programs or in the completion of any clinical trials; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a lack of acceptance of our products in the marketplace by physicians and people with diabetes; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the inability of customers to receive reimbursements from third-party payors; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">the purchasing patterns of our customers, including as a result of seasonality; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failures to comply with regulatory requirements, which could lead to withdrawal of products from the market; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our failure to continue the commercialization of any of our CGM systems; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">competition;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inadequate financial and other resources; and</span></div><div style="margin-bottom:9pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global and political economic conditions, political instability and military hostilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be liable for contamination or other harm caused by materials that we handle, and changes in environmental regulations could cause us to incur additional expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development and clinical processes involve the handling of potentially harmful biological materials as well as hazardous materials. We are subject to international and domestic (including federal, state and local) laws, rules and regulations governing the use, handling, storage and disposal of hazardous and biological materials and we incur expenses relating to compliance with these laws and regulations. If violations of environmental, health and safety laws occur, we could be held liable for damages, penalties and costs of remedial actions. These expenses or this liability could have a significant negative impact on our financial condition. We may violate environmental, health and safety laws in the future as a result of human error, equipment failure or other causes. Environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We are subject to potentially conflicting and changing regulatory agendas of political, business and environmental groups. Changes to or restrictions on permitting requirements or processes, hazardous or biological material storage or handling might require an unplanned capital investment or relocation. Failure to comply with new or existing laws or regulations could harm our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental, social and corporate governance (ESG) regulations, policies and provisions may make our supply chain more complex and may adversely affect our relationships with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is an increasing focus on the governance of environmental and social risks. A number of our customers who are payors or distributors have adopted, or may adopt, procurement policies that include ESG provisions that their suppliers or manufacturers must comply with, or they may seek to include such provisions in their terms and conditions. An increasing number of participants in the medical device industry are also joining voluntary ESG groups or organizations, such as the Responsible Business Alliance. These ESG provisions and initiatives are subject to change, can be unpredictable, and may be difficult and expensive for us to comply with, given the complexity of our supply chain and the outsourced manufacturing of certain components of our products. If we are unable to comply, or are unable to cause our suppliers to comply, with such </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">policies or provisions, a customer may stop purchasing products from us, and may take legal action against us, which could harm our reputation, revenue and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be negatively impacted by corporate citizenship and ESG matters and/or our reporting of such matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is an increasing focus from certain investors, customers, consumers, employees, and other stakeholders concerning corporate citizenship and sustainability matters. From time to time, we communicate certain initiatives, including goals, regarding environmental matters, responsible sourcing and social investments, including pursuant to our Sustainability Report. We could fail, or be perceived to fail, in our achievement of such initiatives or goals, or we could fail in fully and accurately reporting our progress on such initiatives and goals. In addition, we could be criticized for the scope of such initiatives or goals or perceived as not acting responsibly in connection with these matters. Our business could be negatively impacted by such matters. Any such matters, or related corporate citizenship and sustainability matters, could have a material adverse effect on our business.</span></div><div id="i889b093251984bfb881a094ef59c54bd_19"></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B - UNRESOLVED STAFF COMMENTS</span></td></tr></table></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i889b093251984bfb881a094ef59c54bd_22"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2 - PROPERTIES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real property to support our business, including manufacturing, research and development, sales, marketing and administration. The following lists those properties that we believe are material to our business. We believe our facilities are suitable and adequate for our current and near-term needs, and that we will be able to locate additional facilities as needed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:23.567%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.688%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Approximate<br/>Square Feet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purpose</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Lease Expiration Dates</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, CA</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633,100</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory, Manufacturing, Research and Development, Warehouse, General and Administrative, Sales and Marketing</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2028</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mesa, AZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634,700</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and Administrative, Laboratory, Manufacturing, Warehouse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2030 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Excludes renewals that would be at our option to extend the term of a lease for approximately 351,400 square feet of space expiring in 2023 for two additional three to five-year terms and also excludes renewals that would be at our option to extend the term of a lease for approximately 126,700 square feet of space expiring in 2028 for one additional five-year term.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excludes renewals that would be at our option to extend the term of a lease for approximately 148,800 square feet of space expiring in 2028 for four additional five-year terms and also excludes renewals that would be at our option to extend the term of a lease for approximately 485,900 square feet of space expiring in 2030 for two additional five-year terms.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also lease various administrative, warehouse and customer support real properties throughout the world including the U.S., Canada, Germany, the Philippines, Switzerland, Lithuania and the United Kingdom. During 2020, we entered into a 60-year lease for approximately 28 acres of land in Penang, Malaysia, for the build out of our international manufacturing facility.</span></div><div id="i889b093251984bfb881a094ef59c54bd_25"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3 - LEGAL PROCEEDINGS</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. We do not believe we are party to any currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><div id="i889b093251984bfb881a094ef59c54bd_28"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4 - MINE SAFETY DISCLOSURES</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i889b093251984bfb881a094ef59c54bd_31"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="i889b093251984bfb881a094ef59c54bd_34"></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5 - MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Information for Common Stock</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom&#8217;s common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;DXCM.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had fewer than 40 stockholders of record as of December&#160;31, 2020. The number of beneficial owners of our common stock at that date was substantially greater than the number of record holders because a large portion of our common stock is held of record through brokerage firms in &#8220;street name.&#8221; </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Policy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no unregistered sales of equity securities which have not been previously disclosed in a quarterly report on Form 10-Q or a current report on Form 8-K during the year ended December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither we nor any affiliated purchaser repurchased any of our equity securities during the year ended December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company Stock Price Performance</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below compares the cumulative total stockholder return on our common stock with the cumulative total returns on the Nasdaq Composite Index and the Nasdaq Medical Equipment Index over the five-year period ended December&#160;31, 2020. The graph assumes that $100 was invested in Dexcom common stock and in each of the other indices on December&#160;31, 2015 and that all dividends were reinvested. The comparisons in the graph below are based on historical data and are not intended to forecast the possible future performance of Dexcom&#8217;s common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below and related information shall not be deemed &#8220;soliciting material&#8221; or be deemed to be &#8220;filed&#8221; with the SEC, nor shall such information be incorporated by reference into any future filing, except to the extent that we specifically incorporate it by reference into such filing.</span></div><div style="margin-top:4.5pt;text-align:center;text-indent:24.75pt"><img src="dxcm-20201231_g3.jpg" alt="dxcm-20201231_g3.jpg" style="height:500px;margin-bottom:5pt;vertical-align:text-bottom;width:669px"/></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* $100 invested on December&#160;31, 2015 in stock or index, including reinvestment of any dividends.</span></div><div style="margin-bottom:5pt;margin-top:9.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:22.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#e1ede6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">72.89</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">70.07</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">146.28</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">267.08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">451.43</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Nasdaq Composite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">108.87</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">141.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">137.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">187.44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">271.64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e1ede6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Nasdaq Medical Equipment</span></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">106.07</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">153.41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">171.99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">209.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e1ede6;padding:0 1pt"></td><td style="background-color:#e1ede6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e1ede6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">300.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e1ede6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 6 - SELECTED FINANCIAL DATA</span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Omitted pursuant to amendments to Item 301 of Regulation S-K effective February 10, 2021.</span></div><div id="i889b093251984bfb881a094ef59c54bd_40"></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 7 - MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This document, including the following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements that are not purely historical regarding Dexcom&#8217;s or its management&#8217;s intentions, beliefs, expectations and strategies for the future. These forward-looking statements fall within the meaning of the federal securities laws that relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other comparable terminology. Forward-looking statements are made as of the date of this report, deal with future events, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in those forward looking statements. The risks and uncertainties include, among other things, impacts on our business due to health pandemics or other contagious outbreaks, such as the current COVID-19 pandemic. The risks and uncertainties that could cause actual results to differ materially are more fully described under &#8220;Risk Factors&#8221; and elsewhere in this report and in our other reports filed with the SEC. We assume no obligation to update any of the forward-looking statements after the date of this report or to conform these forward-looking statements to actual results. You should read the following discussion and analysis together with &#8220;Selected Financial Data&#8221; in Part II, Item 6 and our consolidated financial statements and related notes in Part II, Item 8 of this Annual Report. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Overview</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for use by people with diabetes and by healthcare providers. We received approval from the Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation system, the Dexcom G6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> integrated Continuous Glucose Monitoring System, or G6, in 2018. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a direct sales organization in the United States, Canada and certain countries in Europe to call on health care professionals, such as endocrinologists, physicians and diabetes educators, who can educate and influence patient adoption of continuous glucose monitoring. To complement our direct sales efforts, we have entered into distribution arrangements in the United States, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand that allow distributors to sell our products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to develop future generations of technologies that are focused on improved performance and convenience and that will enable intelligent insulin administration. Over the longer term, we plan to continue to develop and improve networked platforms with open architecture, connectivity and transmitters capable of communicating with other devices. We also intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also continue to pursue and support development partnerships with insulin pump companies and companies or institutions developing insulin delivery systems, including automated insulin delivery systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exploring how to extend our offerings to other opportunities, including for people with Type 2 diabetes that are non-insulin using, people with pre-diabetes, people who are obese, people who are pregnant, and people in the hospital setting. Eventually, we may apply our technological expertise to products beyond glucose monitoring.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For discussion related to the results of operations and changes in financial condition for&#160;fiscal 2019&#160;compared to&#160;fiscal 2018&#160;refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of our&#160;fiscal 2019&#160;Form 10-K, which was filed with the United States Securities and Exchange Commission on February&#160;13, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we were subject to challenging social and economic conditions created as a result of the novel strain of coronavirus, SARS-CoV-2 (&#8220;COVID-19&#8221;). The resulting impact of the COVID-19 outbreak created various financial impacts to our operations as a result of taking necessary precautions for essential personnel to operate safely both in person as well as remotely.&#160;Costs incurred include items like incremental payroll costs, consulting support, IT infrastructure and facilities-related costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the result of the COVID-19 pandemic, we have made Dexcom CGM systems available for use in hospital settings and other healthcare facilities to assist frontline workers. The extent of the impact of the COVID-19 outbreak on our operational and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers and our sales cycles, employee or industry events, and effect on our vendors, all of which are uncertain and cannot be predicted. The COVID-19 pandemic and its adverse effects have become more prevalent in the locations where we, our customers, suppliers or third-party business partners conduct business and as a result, we have begun to experience more pronounced disruptions in our operations. We have experienced and may experience constrained supply or curtailed customer demand, including due to loss of coverage to our products, that could materially adversely impact our business, results of operations and overall financial performance in future periods. We currently utilize third parties to, among other things, manufacture components and materials for our devices, and to provide services such as sterilization services and we purchase these materials and services from numerous suppliers worldwide. The global COVID-19 pandemic has and may continue to have an adverse impact on our manufacturing and distribution capabilities. Disruptions relating to the COVID-19 pandemic, including current shelter-in-place orders in the U.S. and other countries, could prevent employees, suppliers, distributors, and others from accessing manufacturing facilities and from transporting our products or the components required to manufacture our products. For example, we have experienced some supply chain disruption due to the global restrictions resulting from the COVID-19 pandemic in the manufacture of our next-generation CGM product. Further, worldwide supply chain disruption relating to the COVID-19 pandemic has resulted in product shortages that has and may continue to impact our ability to manufacture our devices. As of the filing date of this Form 10-K, the extent to which COVID-19 may impact our financial condition or results of operations or guidance is uncertain. The effect of the COVID-19 pandemic will not be fully reflected in our results of operations and overall financial performance until future periods. See &#8220;Risk Factors&#8221; in Part I, Item 1A of this Annual Report for further discussion of the possible impact of the COVID-19 pandemic on our business.</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which we have prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements as well as the reported revenue and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our significant accounting policies are more fully described in Note 1 to the consolidated financial statements in Part II, Item 8 of this Annual Report, we believe that the following accounting policies and estimates are most critical to a full understanding and evaluation of our reported financial results. Members of our senior management have discussed the development and selection of these critical accounting policies and their disclosure in this Annual Report with the Audit Committee of our Board of Directors.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate our revenue primarily from the sale of our Reusable Hardware and disposable sensors. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exercise significant judgment when we determine the transaction price, including variable consideration adjustments. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. Variable consideration includes but is not limited to rebates, chargebacks, consideration payable to customers such as specialty distributor and wholesaler fees, product returns allowance, prompt payment discounts, and various other promotional or incentive arrangements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Calculating certain of these items involves significant estimates and judgments based on sales or invoice data, contractual terms and historical utilization rates. We estimate provisions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data. Estimates associated with rebates on products sold through our distributors under pharmacy benefits are the most significant component of our variable consideration estimates and most at risk for changes between the recording of the accrual estimate and its ultimate settlement, an interval that can generally range up to one year. Due to this time lag, in any given period, our adjustments to actuals can incorporate changes of estimates related to prior periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review the adequacy of our estimates for transaction price adjustments and variable consideration at each reporting date. If the actual amounts of consideration that we receive differ from our estimates, we would adjust our estimates and that would affect reported revenue in the period that such variances become known. If any of these judgments were to change, it could cause a material increase or decrease in the amount of revenue we report in a particular period.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Revenue Recognition&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 1 to the consolidated financial statements in Part II, Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. We value time-based Restricted Stock Units or RSUs at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of performance-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Uses inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Uses unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of most of our cash equivalents using Level 1 inputs. We estimate the fair value of our marketable equity securities using Level 1 inputs and we estimate the fair value of our marketable debt securities using Level 2 inputs. We carry our other financial instruments, such as cash, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. See Note 1 and Note 3 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information about fair value measurements. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable, Net and Related Valuation Accounts</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. We evaluate the collectability of our accounts receivable based on a combination of factors. We regularly analyze customer accounts, review the length of time receivables are outstanding, review historical loss rates and assess current economic trends that may impact the level of credit losses in the future. Our allowance for doubtful accounts has generally been adequate to cover our actual credit losses. However, since we cannot reliably predict future changes in the financial stability of our customers, we may need to increase our reserves if the financial conditions of our customers deteriorate. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Excess and Obsolete Inventory</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value. We record adjustments to inventory for potentially excess, obsolete, or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Historically, our inventory reserves have been adequate to cover our actual losses. However, if actual product life cycles, product quality or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market conditions differ from our assumptions, additional inventory adjustments that would increase cost of goods sold could be required. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate our income taxes based on the various jurisdictions where we conduct business. Significant judgment is required in determining our worldwide income tax provision. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations and the potential for future adjustment of our uncertain tax positions by the Internal Revenue Service or other taxing jurisdictions. While we believe we have appropriate support for the positions taken on our tax returns, we regularly assess the potential outcomes of examinations by tax authorities in determining the adequacy of our provision for income taxes. We continually assess the likelihood and amount of potential adjustments and adjust the income tax provision, income taxes payable, and deferred taxes in the period in which the facts that give rise to a revision become known. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the asset and liability approach to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our US operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years cumulative income and expect to continue that profitability in future years. We analyzed both positive and negative evidence, and as a result released our valuation allowance on our deferred tax assets. We maintain the valuation allowance on our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize and measure benefits for uncertain tax positions using a two-step approach. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained upon audit, including resolution of any related appeals or litigation processes. For tax positions that are more likely than not of being sustained upon audit, the second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. Significant judgment is required to evaluate uncertain tax positions and is based upon a number of factors, including changes in facts or circumstances, changes in tax law, correspondence with tax authorities during the course of audits and effective settlement of audit issues. Changes in the recognition or measurement of uncertain tax positions could result in material increases or decreases in our income tax expense in the period in which we make the change, which could have a material impact on our effective tax rate and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. We review the status of each significant matter quarterly and assess our potential financial exposure. If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our consolidated financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, we do not record a liability or an expense but we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. We base our judgments on the best information available at the time. As additional information becomes available, we reassess the potential liability related to our pending claims and litigation and may revise our estimates. Any revision of our estimates of potential liability could have a material impact on our financial position and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Financial Overview</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.134%"><tr><td style="width:1.0%"></td><td style="width:39.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.017%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.786%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 - 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926.7</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.0</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.7</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,280.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931.5</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.5</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.3</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.2</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.06</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.96</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:67.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Not meaningful </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revenue, Cost of Sales and Gross Profit</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><img src="dxcm-20201231_g4.jpg" alt="dxcm-20201231_g4.jpg" style="height:341px;margin-bottom:5pt;vertical-align:text-bottom;width:682px"/></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:71.783%"><tr><td style="width:1.0%"></td><td style="width:47.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.920%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 - 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926.7</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.0</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.7</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544.5</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,280.1</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931.5</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348.6</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit as a percent of total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes direct labor and materials costs related to each product sold or produced, including assembly, test labor and scrap, as well as factory overhead supporting our manufacturing operations. Factory overhead includes facilities, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">material procurement and control, manufacturing engineering, quality assurance, supervision and management. These costs are primarily salary, fringe benefits, share-based compensation, facility expense, supplies and purchased services. All of our manufacturing costs are included in cost of sales. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020 Compared to Fiscal 2019 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased $450.7 million or 31% for the twelve months ended December&#160;31, 2020 compared to the twelve months ended December&#160;31, 2019. The 2020 revenue increase was primarily driven by increased sales volume of our disposable sensors due to the continued growth of our worldwide customer base, partially offset by pricing pressure due to the evolution of our channel strategy and product mix. Disposable sensor and other revenue comprised approximately 81% of total revenue and Reusable Hardware revenue comprised approximately 19% of total revenue for the twelve months ended December&#160;31, 2020. Disposable sensor and other revenue comprised approximately 78% of total revenue and Reusable Hardware revenue comprised approximately 22% of total revenue for the twelve months ended December&#160;31, 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased $102.1 million or 19% for the twelve months ended December&#160;31, 2020 compared to the twelve months ended December&#160;31, 2019 primarily due to increased sales volume. The gross profit of $1.28 billion or 66% of total revenue for the twelve months ended December&#160;31, 2020 increased $348.6 million compared to $931.5 million or 63% of total revenue for the same period in 2019. The increase in gross profit and gross profit margin in 2020 compared to 2019 were primarily driven by increased revenues and cost savings associated with incremental improvements to product design and manufacturing efficiencies. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Operating Expenses</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:73.830%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.187%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.584%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 - 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.9</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273.5</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">as a % of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.7</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.7</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">as a % of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.6</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789.2</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.4&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">as a % of total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses are primarily related to employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials including clinical site reimbursement, clinical trial product and associated travel expenses. Our research and development expenses also include fees for design services, contractors and development materials.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our selling, general and administrative expenses primarily consist of salary, fringe benefits and share-based compensation for our executive, financial, sales, marketing, information technology and administrative functions. Other significant expenses include commissions, marketing and advertising, IT software license costs, insurance, professional fees for our outside legal counsel and independent auditors, litigation expenses, patent application expenses and consulting expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020 Compared to Fiscal 2019 </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Research and Development Expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Research and development expense increased $86.4 million or 32% for the twelve months ended December&#160;31, 2020 compared to the same period of 2019. The increase was primarily due to $38.6 million in additional salaries, bonus, and payroll-related costs, $14.1 million in additional consulting fees, $7.5 million from losses on the disposal of assets primarily driven by automation of our production capabilities, and $7.4 million in additional software costs. We continue to believe that focused investments in research and development are critical to our future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to our core business strategy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative expense increased $105.0 million or 20% for the twelve months ended December&#160;31, 2020 compared to the same period of 2019. Significant elements of the increase in selling, general, and administrative expenses included $60.1 million in additional advertising and marketing costs, $35.0 million in additional salaries, bonuses, and payroll-related costs, and $16.5 million in additional consulting fees, partially offset by $7.8 million in lower restructuring charges associated with our 2019 Restructuring Plan and $6.5&#160;million in lower travel and entertainment costs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Non-Operating Income and Expenses</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $24.4 million to $84.7 million for the twelve months ended December&#160;31, 2020 compared to $60.3 million for the same period of 2019. The increase was primarily due to the May 2020 issuance of our 2025 Notes, partially offset by the repurchase, conversion and redemption of all of our 2022 Notes during the first seven months of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on Extinguishment of Debt</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a loss on extinguishment of debt of $5.9 million during the twelve months ended December&#160;31, 2020 in connection with the repurchase and conversions of our 2022 Notes. See Note 5 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information about these transactions. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income/Loss from Equity Investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from equity investments of $4.2 million for the twelve months ended December&#160;31, 2019 consisted solely of realized losses on our equity investment in Tandem Diabetes Care, Inc. We sold all of our remaining equity investment in Tandem during the first quarter of 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest and Other Income (Expense), Net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Interest income is related to our marketable debt securities portfolio. Interest income was $13.2 million and $28.4 million for the twelve months ended December&#160;31, 2020 and 2019, respectively. The decrease in interest income was primarily related to a decrease in market interest rates, partially offset by an increase in average invested balances during 2020 compared to 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) for the twelve months ended December&#160;31, 2020 and December&#160;31, 2019 consists primarily of foreign currency transaction gains and losses due to the effects of foreign currency fluctuations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Expense/Benefit </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded pre-tax income for the twelve months ended December&#160;31, 2020 and December&#160;31, 2019. The income tax benefit we recorded for 2020 is primarily attributable to the release of our valuation allowance on specific deferred tax assets. The nominal income tax expense we recorded for 2019 is primarily due to withholding and other income tax expenses in profitable jurisdictions. </span></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liquidity and Capital Resources</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Overview, Capital Resources, and Capital Requirements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of liquidity are our existing cash, cash equivalents and marketable securities, cash generated from operations, proceeds from our convertible notes issuances, and access to our revolving line of credit. Our primary uses of cash have been for research and development programs, selling and marketing activities, capital expenditures, acquisitions of businesses, and debt service costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that cash provided by our operations may fluctuate in future periods as a result of a number of factors, including fluctuations in our operating results, working capital requirements and capital deployment decisions. We have historically invested our cash primarily in U.S. dollar-denominated, investment grade, highly liquid obligations of U.S. government-sponsored enterprises, commercial paper, corporate debt, and money market funds. Certain of these investments are subject to general credit, liquidity and other market risks. The general condition of the financial markets and the economy may increase those risks and may affect the value and liquidity of investments and restrict our ability to access the capital markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including but not limited to:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the revenue generated by sales of our approved products and other future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the expenses we incur in manufacturing, developing, selling and marketing our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the quality levels of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the third-party reimbursement of our products for our customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to efficiently scale our operations to meet demand for our current and any future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs, timing and risks of delays of additional regulatory approvals;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the rate of progress and cost of our clinical trials and other development activities;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the success of our research and development efforts;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the emergence of competing or complementary technological developments;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the terms and timing of any collaborative, licensing and other arrangements that we may establish;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the acquisition of businesses, products and technologies and our ability to integrate and manage any acquired businesses, products and technologies; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the evolution of the international expansion of our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that existing cash and cash flows from our future operations will generally be sufficient to fund our ongoing core business. As current borrowing sources become due, we may be required to access the capital markets for additional funding. As we assess inorganic growth strategies, we may need to supplement our internally generated cash flow with outside sources. In the event that we are required to access the debt market, we believe that we will be able to secure reasonable borrowing rates. As part of our liquidity strategy, we will continue to monitor our current level of earnings and cash flow generation as well as our ability to access the market in light of those earning levels. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in U.S. dollars. Accordingly, our assessment is that we have no material net exposure to foreign currency exchange rate fluctuations at this time. However, as our business in markets outside of the United States continues to increase, we will be exposed to foreign currency exchange risk related to our foreign operations. Fluctuations in the rate of exchange between the U.S. dollar and foreign currencies, primarily the British Pound, the Euro, and the Canadian Dollar, could adversely affect our financial results, including our revenues, revenue growth rates, gross margins, income and losses as well as assets and liabilities. We currently engage in hedging transactions to reduce foreign currency risks. We will continue to monitor and manage our financial exposures due to exchange rate fluctuations as an integral part of our overall risk management program. Our cash, cash equivalents and short-term marketable securities totaled $2.71 billion as of December&#160;31, 2020. None of those funds were restricted and approximately 98% of those funds were located in the United States. We intend to reinvest a substantial portion of our foreign earnings in those businesses, and we currently do not anticipate that we will need funds generated by foreign operations to fund our domestic ones.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents and short-term marketable securities as of December&#160;31, 2020 increased by $1.18 billion from December&#160;31, 2019 due to the factors described in &#8220;Cash Flows&#8221; below. We believe that our cash, cash equivalents, and marketable securities balances, projected cash contributions from our commercial operations, and our $200.0 million revolving line of credit, of which $193.7 million remains available, will be sufficient to meet our anticipated seasonal working capital needs, capital expenditure requirements, contractual obligations, commitments, debt service requirements, and other liquidity requirements associated with our operations for at least the next 12 months. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we entered into an amended and restated five-year $200.0 million revolving Credit Agreement, including a sub-facility of up to $10.0 million for letters of credit. Subject to customary conditions and the approval of any lender whose commitment would be increased, we have the option to increase the maximum principal amount available under the Credit Agreement by up to an additional $300.0 million, resulting in a maximum available principal amount of $500.0 million. However, at this time none of the lenders have committed to provide any such increase in their commitments. Revolving loans under the Credit Agreement will be available for general corporate purposes, including working capital and capital expenditures. As of December&#160;31, 2020, we had no outstanding borrowings, $6.3 million in outstanding letters of credit, and a total available balance of $193.7 million under the Credit Agreement. We monitor counterparty risk associated with the institutional lenders that are providing the credit facility. We currently believe that the credit facility will be available to us should we choose to borrow under it. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following&#160;table summarizes our outstanding&#160;senior convertible note obligations as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:15.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.775%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Principal (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Conversion Rate per Share of Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Conversion Price per Share of Common Stock</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2018</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2023</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0869</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$164.29</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 15, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6655</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600.42</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:0 1pt;text-indent:9pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,057.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used a portion of the net proceeds from the offering of the 2023 Notes to repurchase 0.8 million shares of our common stock for $100.0 million in 2018. We used $282.6 million of the net proceeds from the offering of the 2025 Notes to repurchase a portion of our 2022 Notes; the remaining 2022 Notes were converted for shares of our common stock during 2020. We intend </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to use the remainder of the net proceeds from the Notes offerings for general corporate purposes and capital expenditures, including working capital needs. We may also use the net proceeds to expand our current business through in-licensing or acquisitions of, or investments in, other businesses, products or technologies; however, we do not have any significant commitments with respect to any such acquisitions or investments at this time. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Note Hedge</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions (the 2023 Note Hedge) with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to 5.2 million&#160;shares of our common stock at an initial price of&#160;$164.29&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$218.9 million and it will expire on December 1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we also sold warrants (the 2023 Warrants) to the 2023 Counterparties to acquire up to&#160;5.2 million shares of our common stock for cash proceeds of $183.8 million. The 2023 Warrants require net share settlement and a pro-rated number of warrants will expire on each of the 60 scheduled trading days starting on March 1, 2024. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information about the terms of the Credit Agreement, the 2023 Notes and the 2025 Notes, the 2023 Note Hedge, and the 2023 Warrants.</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash Flows</span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span></div></td></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of our cash flows for the periods indicated. See the consolidated financial statements in Part II, Item 8 of this Annual Report for complete statements of cash flows for these periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.105%"><tr><td style="width:1.0%"></td><td style="width:64.138%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.852%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.852%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.172%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 - 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.6&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,018.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,015.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(690.7)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had $2.71 billion in cash, cash equivalents and short-term marketable securities, which is an an increase of $1.18 billion compared to $1.53 billion as of December&#160;31, 2019. The primary cash flows during the twelve months ended December&#160;31, 2020 and 2019 are described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities during 2020 was comprised of net income of $493.6 million and net adjustments of $288.3 million primarily related to share-based compensation, depreciation and amortization, non-cash interest expense for our senior convertible notes and loss on extinguishment of debt on our 2022 Notes, partially offset by $285.5 million net benefit to tax expense associated with the release of the valuation allowance related to deferred tax assets and $20.8 million of changes in working capital balances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities during 2019 was comprised of a net income of $101.1 million, offset by $207.3 million of net adjustments and $6.1 million of changes in working capital balances. Net adjustments were primarily related to share-based compensation, depreciation and amortization, non-cash interest expense for our senior convertible notes, and a loss on the sale of our remaining equity investment in Tandem Diabetes Care, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities during 2020 was primarily comprised of $807.7 million for net purchases of marketable securities and $199.0 million for capital expenditures.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities during 2019 was primarily comprised of $834.0 million for net purchases of marketable securities and $180.0 million for capital expenditures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities during 2020 was primarily comprised of $1.19 billion in net proceeds from the issuance of our 2025 Notes and $15.3 million in proceeds from the issuance of common stock under our employee stock plans, partially offset by $282.6 million for the repurchase of a portion of our 2022 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities during 2019 was primarily comprised of $11.9 million in proceeds from the issuance of common stock under our employee stock plans. </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Contractual Obligations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various leasing arrangements, primarily for office, manufacturing and warehouse space that expire at various times through December 2030. We also have one land lease that expires in 2080.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our outstanding contractual obligations as of December&#160;31, 2020 and the effect those obligations are expected to have on our liquidity and cash flows in future periods: </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less<br/>than<br/>1&#160;Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-3<br/>Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3-5<br/>Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">More<br/>than<br/>5&#160;Years</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,091.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263.4&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued senior convertible notes in November 2018 and May 2020. The obligations presented above include both principal and interest for these notes. Although these notes mature in 2023 and 2025, they may be converted into cash and shares of our common stock prior to maturity if certain conditions are met. Any conversion prior to maturity can result in repayment of the principal amounts sooner than the scheduled repayment as indicated in the table. See Note 5 to the consolidated financial statements in Part II, Item 8 of this Annual Report for further discussion of the terms of our senior convertible notes. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes finance lease obligations related to our Mesa, Arizona and Malaysia facilities. See Note 6 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also party to various purchase arrangements related to components used in manufacturing and research and development activities. As of December&#160;31, 2020, we had approximately $335.6 million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have $1.2 million of unrecognized tax benefits, including estimated interest and penalties, that have been recorded as liabilities for which we are uncertain as to if or when such amounts may be settled. As a result, such amounts are excluded from the table above. </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Off-Balance Sheet Arrangements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we did not have any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K. </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:15pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of recently issued accounting guidance that is applicable to our financial statements, see Note 1 to the consolidated financial statements in Part II, Item 8 of this Annual Report. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 7A - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary objective of our investment activities is to preserve our capital for the purpose of funding operations while at the same time maximizing the income we receive from our investments without significantly increasing risk. To achieve these objectives, our investment policy allows us to maintain a portfolio of cash equivalents and short-term investments in a variety of securities, including money market funds, U.S. Treasury debt and corporate debt securities. Due to the short-term nature of our investments, we believe that we have no material exposure to interest rate risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market Price Sensitive Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to reduce potential equity dilution, in connection with the issuance of the 2023 Notes we entered into the 2023 Hedge which entitles us to purchase shares of our common stock. Upon conversion of the 2023 Notes, the 2023 Hedge is expected to reduce the equity dilution if the daily volume-weighted average price per share of our common stock exceeds the strike price of the hedge. We also entered into warrant transactions with the counterparties of the 2023 Hedge entitling them to acquire shares of our common stock. The warrant transactions could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given quarterly or annual measurement period exceeds the strike price of the warrants. See Note 5 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in U.S. dollars. Accordingly, our assessment is that we have no material net exposure to foreign currency exchange rate fluctuations at this time. However, as our business in markets outside of the United States continues to increase, we will be exposed to foreign currency exchange risk related to our foreign operations. Fluctuations in the rate of exchange between the U.S. dollar and foreign currencies, primarily the British Pound, the Euro, and the Canadian Dollar, could adversely affect our financial results, including our revenues, revenue growth rates, gross margins, income and losses as well as assets and liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate the financial statements of our foreign subsidiaries with functional currencies other than the U.S. dollar into the U.S. dollar for consolidation using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. We record net gains or losses resulting from the translation of foreign financial statements and the effect of exchange rate changes on intercompany receivables and payables of a long-term nature as a separate component of stockholders&#8217; equity. These adjustments will affect net income only upon sale or liquidation of the underlying investment in foreign subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record exchange rate fluctuations resulting from the translation of the short-term intercompany balances between domestic entities and our foreign subsidiaries as foreign currency transaction gains or losses and include them in interest and other income (expense), net in our consolidated statements of operations. We occasionally enter into foreign currency forward contracts in order to partially offset the impact from fluctuation of the foreign currency rates. As of December&#160;31, 2020, we had foreign currency forward contracts outstanding with a notional amount of $48.0 million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs, and the derivative instruments are recorded in other current assets or other current liabilities in our balance sheets consistent with the nature of the instrument at period end. Derivative gains and losses are included in interest and other income, net in our consolidated statements of operations.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notional principal amounts provide one measure of the transaction volume outstanding as of period end, but they do not represent the amount of our exposure to market loss. Estimates of fair value are based on applicable and commonly used pricing models using prevailing financial market information. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. We monitor and manage our financial exposures due to exchange rate fluctuations as an integral part of our overall risk management program, which recognizes the unpredictability of financial markets and seeks to reduce potentially adverse effects on our financial results.</span></div><div id="i889b093251984bfb881a094ef59c54bd_46"></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 8 - CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required is set forth under &#8220;Report of Independent Registered Public Accounting Firm,&#8221; &#8220;Consolidated Balance Sheets,&#8221; &#8220;Consolidated Statements of Operations,&#8221; &#8220; Consolidated Statements of Comprehensive Income (Loss),&#8221; &#8220;Consolidated Statements of Stockholders&#8217; Equity,&#8221; &#8220;Consolidated Statements of Cash Flows&#8221; and &#8220;Notes to Consolidated Financial Statements&#8221; on pages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i889b093251984bfb881a094ef59c54bd_112">F-2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i889b093251984bfb881a094ef59c54bd_169">F-42</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report and is incorporated into this Item 8 by reference.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i889b093251984bfb881a094ef59c54bd_52"></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9A - CONTROLS AND PROCEDURES</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulations under the Securities Exchange Act of 1934 require public companies to maintain &#8220;disclosure controls and procedures,&#8221; which are defined to mean a company&#8217;s controls and other procedures that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and timely communicated to management, including our Chief Executive Officer and Chief Financial Officer, recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms. Our management, including our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation as of the end of the period covered by this report of the effectiveness of our disclosure controls and procedures. Based on their evaluation as of December&#160;31, 2020, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of such date for this purpose. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the COVID-19 pandemic, certain employees began working remotely in March 2020. We have not identified any material changes in our internal control over financial reporting as a result of these changes to the working environment. We are continually monitoring and assessing the COVID-19 situation to determine any potential impacts on the design and operating effectiveness of our internal controls over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934. Our internal control over financial reporting is designed to provide reasonable assurance to our management and Board of Directors regarding the preparation and fair presentation of published financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of the Chief Executive and Chief Financial Officers, assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2020. In making this assessment, our management used the criteria set forth by the 2013 Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control&#8212;Integrated Framework. Based on this assessment, our management, with the participation of the Chief Executive and Chief Financial Officers, believes that, as of December&#160;31, 2020, our internal control over financial reporting is effective based on those criteria. The effectiveness of our internal control over financial reporting as of December&#160;31, 2020 has been audited by Ernst&#160;&amp; Young LLP an Independent Registered Public Accounting Firm, as stated in their report which is included herein.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certifications of our Chief Executive Officer and Chief Financial Officer required under Section&#160;302 of the Sarbanes-Oxley Act have been filed as Exhibits 31.01 and 31.02 to this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Effectiveness of Controls</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. The design of any control system is based, in part, upon the benefits of the control system relative to its costs. Control systems can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. In addition, over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of these and other inherent limitations of control systems, we cannot guaranty that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors and Stockholders of DexCom, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited DexCom, Inc.&#8217;s internal control over financial reporting as of December&#160;31, 2020, based on criteria established in Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) (the COSO criteria). In our opinion, DexCom, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2020, based on the COSO criteria. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of DexCom, Inc. as of December&#160;31, 2020 and 2019, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2020, and the related notes and financial statement schedule listed in the Index at Item 15(a) and our report dated February&#160;11, 2021 expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;11, 2021</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9B - OTHER INFORMATION</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i889b093251984bfb881a094ef59c54bd_58"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="i889b093251984bfb881a094ef59c54bd_61"></div><div style="margin-bottom:10pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 10 - DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning our directors required by this Item is incorporated by reference to the section in our Proxy Statement entitled &#8220;Proposal No.&#160;1 &#8211; Election of Directors.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning our executive officers required by this Item is incorporated by reference to the section in our Proxy Statement entitled &#8220;Executive Officers.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a written code of ethics for financial employees that applies to our principal executive officer, principal financial officer, principal accounting officer, controller and other employees of the finance department designated by our Chief Financial Officer. This code of ethics, titled the &#8220;Code of Conduct and Ethics for Chief Executive Officer and Senior Finance Personnel,&#8221; is publicly available on our Internet website at https://dexcom.gcs-web.com/corporate-governance. The information contained on our Internet website is not incorporated by reference into this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning the audit committee of the Board of Directors required by this Item is incorporated by reference to information set forth in the Proxy Statement.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning material changes to the procedures by which stockholders may recommend nominees to the Board of Directors required by this Item is incorporated by reference to information set forth in the Proxy Statement.</span></div><div id="i889b093251984bfb881a094ef59c54bd_64"></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 11 - EXECUTIVE COMPENSATION</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item concerning executive compensation and our Compensation Committee is incorporated by reference to information set forth in the Proxy Statement under the heading &#8220;Executive Compensation.&#8221;</span></div><div id="i889b093251984bfb881a094ef59c54bd_67"></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 12 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated by reference to information set forth in the Proxy Statement under the headings &#8220;Principal Stockholders and Stock Ownership by Management&#8221; and &#8220;Equity Compensation Plan Information.&#8221;</span></div><div id="i889b093251984bfb881a094ef59c54bd_70"></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 13 - CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item with respect to director independence is incorporated by reference to information set forth in the Proxy Statement.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning certain relationships and related transactions required by the Item is incorporated by reference to the section in our Proxy Statement entitled &#8220;Certain Transactions.&#8221;</span></div><div id="i889b093251984bfb881a094ef59c54bd_73"></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 14 - PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning principal accountant fees and services required by this Item is incorporated by reference to the section in our Proxy Statement entitled &#8220;Ratification of Selection of Independent Registered Public Accounting Firm.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="i889b093251984bfb881a094ef59c54bd_79"></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 15 - EXHIBITS, FINANCIAL STATEMENT SCHEDULES </span></div></td></tr></table></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">The following documents are filed as part of this Annual Report:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. Financial Statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements listed in Part II, Item&#160;8 of this Annual Report. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Financial Statement Schedules. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three fiscal years ended December&#160;31, 2020, Schedule II &#8211; Valuation and Qualifying Accounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statement schedules not listed above have been omitted because information required to be set forth therein is not applicable, not required, or the information required by such schedules is shown in the consolidated financial statements or the notes thereto.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Exhibits.</span></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.977%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provided<br/>Herewith</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date of<br/>First Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905005246/a2152786zex-3_03.htm">3.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905005246/a2152786zex-3_03.htm">Registrant&#8217;s Restated Certificate of Incorporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-122454</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 3, 2005</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517130445/d348320ddef14a.htm">3.02</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517130445/d348320ddef14a.htm">Amendment No. 1 to Registrant&#8217;s Restated Certificate of Incorporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEF 14 A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 20, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312520242202/d847783dex31.htm">3.03</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312520242202/d847783dex31.htm">Registrant&#8217;s Amended and Restated Bylaws.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 9, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905007514/a2153933zex-4_01.htm">4.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905007514/a2153933zex-4_01.htm">Form of Specimen Certificate for Registrant&#8217;s common stock.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-122454</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 24, 2005</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.01</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312518340482/d667223dex41.htm">4.0</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312518340482/d667223dex41.htm">2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312518340482/d667223dex41.htm">Indenture, dated as of November 30, 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312518340482/d667223dex41.htm">8</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312518340482/d667223dex41.htm">, between DexCom, Inc. and U.S. Bank National Association (including the form of 0.75% Convertible Senior Notes due 2023)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312520143408/d926678dex41.htm">4.03</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312520143408/d926678dex41.htm">Indenture, dated as of May 14, 2020, between DexCom, Inc. and U.S. Bank National Association (including the form of 0.25% Convertible Senior Notes due 2025)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">May 15, 2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex404securitie.htm">4.04</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex404securitie.htm">Description of Securities Registered Under Section 12 of the Exchange Act.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000110465906023702/a06-8554_1ex99d01.htm">10.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000110465906023702/a06-8554_1ex99d01.htm">Office Lease Agreement, dated March 31, 2006, between DexCom, Inc. and Kilroy Realty, L.P.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 7, 2006</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.01</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000110465906025014/a06-8874_1ex99d01.htm">10.02</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000110465906025014/a06-8874_1ex99d01.htm">Offer letter between DexCom, Inc. and Steven R. Pacelli dated April 10, 2006.*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 13, 2006</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.01</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312509046182/dex1020.htm">10.03</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312509046182/dex1020.htm">Form of Amended and Restated Executive Change of Control &amp; Severance Agreement.*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 5, 2009</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312509162218/dex1023.htm">10.04</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312509162218/dex1023.htm">Non-Exclusive Distribution Agreement, between RGH Enterprises, Inc. and DexCom, Inc., dated April 30, 2008.**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2009</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312510051468/dex1025.htm">10.05</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312510051468/dex1025.htm">Amended and Restated Development, Manufacturing, Licensing and Supply Agreement, between DSM PTG, Inc. and DexCom, Inc., dated February&#160;19, 2010.**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 9, 2010</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312510248085/dex1027.htm">10.06</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312510248085/dex1027.htm">First Amendment to Office Lease between DexCom, Inc. and Kilroy Realty, L.P., dated August 18, 2010.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2010</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312511179874/dex1026.htm">10.07</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312511179874/dex1026.htm">Amendment Number One to Non-Exclusive Distribution Agreement, between RGH Enterprises, Inc. and DexCom, Inc., dated March&#160;29, 2011.**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2011</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.977%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provided<br/>Herewith</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date of<br/>First Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312511208448/dex1028.htm">10.08</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312511208448/dex1028.htm">Offer letter between DexCom, Inc. and Kevin Sayer dated May&#160;3, 2011.*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2011</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355713000036/dxcm03312013ex1027.htm">10.09</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355713000036/dxcm03312013ex1027.htm">Amendment Number Two to Non-Exclusive Distribution Agreement between RGH Enterprises, Inc. and DexCom, Inc., dated March 28, 2013.**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1028.htm">10.10</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1028.htm">Amendment Number Three to Non-Exclusive Distribution Agreement between RGH Enterprises, Inc. and DexCom, Inc., dated December 4, 2013.**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 20, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1029.htm">10.11</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1029.htm">Non-Exclusive Distribution Agreement between Dex</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1029.htm">C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1029.htm">om, Inc. and Diabetes Specialty Center, LLC dated October 12, 2009, as amended on September 30, 2010, October 11, 2011, November 14, 2012 and November 1, 2013.**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 20, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355714000220/dxcm06302014ex1031.htm">10.12</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000220/dxcm06302014ex1031.htm">Settlement and License Agreement by and among Abbott Diabetes Care, Inc. and DexCom, Inc., dated July 2, 2014.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 6, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355714000220/dxcm06302014ex1032.htm">10.13</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000220/dxcm06302014ex1032.htm">Amendment No. 5 to Non-Exclusive Distribution Agreement between DexCom, Inc. and Diabetes Specialty Center, LLC, dated March 14, 2014.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 6, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355715000040/dxcm-12312014ex1033.htm">10.14</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355715000040/dxcm-12312014ex1033.htm">Second Amendment to Office Lease between DexCom, Inc. and Kilroy Realty, L.P., dated October 1, 2014.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 25, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312515127507/d878103ddef14a.htm">10.15</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312515127507/d878103ddef14a.htm">2015 Employee Stock Purchase Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEF 14A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 13, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355715000171/exhibit104.htm">10.16</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355715000171/exhibit104.htm">Form of Subscription Agreement under 2015 Employee Stock Purchase Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355716000511/dxcm03312016ex1036.htm">10.17</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000511/dxcm03312016ex1036.htm">Sublease between DexCom, Inc. and Entropic Communications, LLC dated February 1, 2016.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355716000511/dxcm03312016ex1037.htm">10.18</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000511/dxcm03312016ex1037.htm">Amended and Restated Non-Exclusive Distribution Agreement with Byram Healthcare dated February 1, 2016.**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016exhibit1039.htm">10.19</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016exhibit1039.htm">Industrial Net Lease, Broadway dated April 28, 2016, by and between PRA/LB, L.L.C. and DexCom, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016ex1040.htm">10.20</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016ex1040.htm">Standard Form of Agreement dated May 2, 2016, by and between DexCom, Inc. and Skanska USA Building Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016exhibit1041.htm">10.21</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016exhibit1041.htm">Amendment to Non-Exclusive Distribution Agreement dated April 30, 2016 by and between RGH Enterprises, Inc. d/b/a Cardinal Health at Home and DexCom, Inc. **</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355717000048/dxcm12312016ex1042.htm">10.22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000048/dxcm12312016ex1042.htm">Amendment No. 1 to Collaboration and License Agreement dated October 25, 2016 by and between DexCom, Inc. and Verily Life Sciences LLC (formerly Google Life Sciences LLC).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312517195938/d361061dex102.htm">10.23</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517195938/d361061dex102.htm">Severance and Change in Control Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 6, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312517195938/d361061dex103.htm">10.24</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517195938/d361061dex103.htm">Form of Participation Agreement to the Severance and Change in Control Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 6, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.977%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provided<br/>Herewith</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date of<br/>First Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm6302017exhibit1046.htm">10.25</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm6302017exhibit1046.htm">First Amendment to Credit Agreement dated June 17, 2016 by and among DexCom, Inc., the Lenders, and JPMorgan Chase Bank, as Administrative Agent.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm06302017ex1047.htm">10.26</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm06302017ex1047.htm">Standard Form of Agreement dated May 1, 2017, by and between DexCom, Inc. and Skanska USA Building Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355717000168/dxcm080117ex101.htm">10.27</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000168/dxcm080117ex101.htm">Offer Letter for Quentin S. Blackford dated July 28, 2017. *</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm6302017exhibit1043.htm">10.28</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm6302017exhibit1043.htm">Form of Indemnity Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355718000018/dxcm12312017exhibit1051.htm">10.29</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355718000018/dxcm12312017exhibit1051.htm">Form of RSU Grant Agreement 2015 Plan Global Double Trigger</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355718000018/dxcm12312017exhibit1052.htm">10.30</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355718000018/dxcm12312017exhibit1052.htm">Form of RSU Grant Agreement 2015 Plan Global General</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355719000041/dxcm12312018exhibit1060.htm">10.31</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000041/dxcm12312018exhibit1060.htm">Amended and Restated Collaboration and License Agreement dated November 20, 2018 by and between DexCom, Inc., Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited.**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355719000041/dxcm12312018exhibit1061.htm">10.32</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000041/dxcm12312018exhibit1061.htm">Amended and Restated Credit Agreement dated December 19, 2018 by and among DexCom, Inc., Bank of America, Silicon Valley Bank and Union Bank, and JPMorgan Chase Bank, as Administrative Agent.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.61</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355719000103/dxcm-2019xdef14a.htm#sc05aea42c3974fe2883a04a695d7a7ff">10.33</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000103/dxcm-2019xdef14a.htm#sc05aea42c3974fe2883a04a695d7a7ff">Amended and Restated 2015 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 4, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.01</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355719000137/exhibit1002dexcomincexecut.htm">10.34</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000137/exhibit1002dexcomincexecut.htm">Executive Deferred Compensation Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 4, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.02</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1036.htm">10.35</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1036.htm">Form of RSU Grant Agreement 2015 Plan (Board Members - Annual Grant)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1037.htm">10.36</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1037.htm">Form of RSU Grant Agreement 2015 Plan (Board Members - Incoming Grant)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1038.htm">10.37</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1038.htm">Distribution Services Agreement dated November 7, 2015 between DexCom, Inc. and AmerisourceBergen Drug Corporation.****</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1039.htm">10.38</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1039.htm">Amendment to the Distribution Services Agreement between Dex</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1039.htm">C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1039.htm">om Inc. and AmerisourceBergen Drug Corporation.****</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1040.htm">10.39</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1040.htm">Third Amendment to Office Lease between DexCom, Inc. and John Hancock Life Insurance Company, dated January 9, 2019.****</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1041.htm">10.40</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1041.htm">Fourth Amendment to Office Lease between DexCom, Inc. and Sequence Tech. Center CA LLC, dated September 9, 2019.****</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1042.htm">10.41</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1042.htm">Fifth Amendment to Office Lease between DexCom, Inc. and Sequence Tech. Center CA LLC, dated October 21, 2019.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000217/dxcm6302020exhibit1001.htm">10.42</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355720000217/dxcm6302020exhibit1001.htm">First Amendment to Amended and Restated Credit Agreement by and among DexCom, Inc., the Lenders, and JPMorgan Chase Bank as Administrative Agent, dated May 11, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 28, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.01</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex1043doindemn.htm">10.43</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex1043doindemn.htm">Form of Indemnity Agreement between Registrant and each of its directors and executive officers.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.977%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provided<br/>Herewith</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date of<br/>First Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex10442015espp.htm">10.44</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex10442015espp.htm">2015 Employee Stock Purchase Plan, amended on December 13, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex10442015espp.htm"> </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex10452015espp.htm">10.45</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex10452015espp.htm">Form of Subscription Agreement under 2015 Employee Stock Purchase Plan amended on December 13, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit1046moy.htm">10.46</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="dxcm12312020exhibit1046moy.htm">Incentive Agreement between Dex</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="dxcm12312020exhibit1046moy.htm">C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="dxcm12312020exhibit1046moy.htm">om, Inc. and Jeffrey Moy dated April 28, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020ex1047doubleda.htm">10.47</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="dxcm12312020ex1047doubleda.htm">Transition and Consulting Agreement between Dex</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="dxcm12312020ex1047doubleda.htm">C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="dxcm12312020ex1047doubleda.htm">om, Inc. and Richard B. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="dxcm12312020ex1047doubleda.htm">Doubleday dated December 10, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit2101.htm">21.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit2101.htm">List of Subsidiaries</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit2301.htm">23.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit2301.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney (see signature page of this Form 10-K)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit3101.htm">31.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit3101.htm">Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit3102.htm">31.02</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit3102.htm">Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit3201.htm">32.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit3201.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).***</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit3202.htm">32.02</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm12312020exhibit3202.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).***</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:15pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:4.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Represents a management contract or compensatory plan.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential treatment has been requested for certain portions of this document pursuant to an application for confidential treatment sent to the Securities and Exchange Commission. Such portions are omitted from this filing and were filed separately with the Securities and Exchange Commission.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">***</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This certification is not deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that Dexcom specifically incorporates it by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">****</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</span></td></tr></table></div><div style="margin-bottom:15pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 16 - FORM 10-K SUMMARY</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i889b093251984bfb881a094ef59c54bd_85"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEXCOM, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February&#160;11, 2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;QUENTIN S. BLACKFORD</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quentin S. Blackford,<br/>Chief Operating Officer and Chief Financial Officer (Principal Financial Officer)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kevin Sayer and Quentin Blackford, jointly and severally, his attorneys-in-fact, each with the power of substitution, for him in any and all capacities, to sign any amendments to this Report on Form 10-K and to file same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitutes, may do or cause to be done by virtue hereof.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:41.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;KEVIN R. SAYER &#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors, President and Chief&#160;Executive&#160;Officer (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kevin R. Sayer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;QUENTIN S. BLACKFORD &#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer and Chief Financial Officer (Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quentin S. Blackford</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;MARK FOLETTA&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lead Independent Director<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark Foletta</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;STEVE ALTMAN &#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Steve Altman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;NICHOLAS AUGUSTINOS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nicholas Augustinos</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;RICHARD COLLINS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard Collins</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;KAREN DAHUT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen Dahut</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;BRIDGETTE HELLER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bridgette Heller</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;BARBARA KAHN &#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Barbara Kahn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;KYLE MALADY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kyle Malady</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;JAY SKYLER &#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jay Skyler, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;ERIC TOPOL &#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eric Topol, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_91">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_91">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_94">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_94">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_100">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_100">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_103">Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_103">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_106">Consolidated Statements of Stockholders&#8217; Equity </a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_106">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_109">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_109">9</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_112">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i889b093251984bfb881a094ef59c54bd_112">11</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">The Board of Directors and Stockholders of DexCom, Inc.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of DexCom, Inc. (the Company) as of December&#160;31, 2020 and 2019, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2020, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2020, in conformity with U.S. generally accepted accounting principles. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) and our report dated February&#160;11, 2021 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing a separate opinion on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Estimation of transaction price and variable consideration for revenue recognition</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1 of the consolidated financial statements, the Company recognizes revenue based on a transaction price which reflects the net consideration to which the Company expects to be entitled. The transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. The Company estimates reductions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data. </span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management&#8217;s determination of transaction price including variable consideration involved a high degree of subjectivity in evaluating management&#8217;s estimates. In determining transaction price, management develops estimates based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor. In estimating rebates, management applies contracted rates to estimates of products sold subject to rebate, known market events or trends and channel inventory data.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s processes to determine transaction price and rebates, including the underlying assumptions. </span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures also included, among others, evaluating the significant assumptions and the accuracy and completeness of the underlying data used in management&#8217;s calculations. For transaction price, this included testing management&#8217;s estimate of the claim denials and historical reimbursement experience through a combination of underlying data validation by inspection of source documents and independent recalculation of management&#8217;s analysis. For rebates, this included testing contractual rates, management&#8217;s estimates of products sold subject to rebate, and inventory held by third parties at the end of the period, through a combination of underlying data validation by inspection of source documents, agreement to underlying contracts, review for consistency against historical data, and trending of inventory held at third parties versus inventory sold into the channel. In addition, we inspected the results of the Company&#8217;s retrospective review analysis of rebates claimed, evaluated the estimates made based on historical experience and performed sensitivity analyses over the Company's significant assumptions.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Valuation allowances on deferred tax assets</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of the Matter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 8, significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. The Company reviews all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings. Prior to 2020, due to the Company&#8217;s U.S. operating losses and earnings volatility in previous years, which did not allow sustainable profitability, the Company had established and maintained a full valuation allowance on its deferred tax assets. In 2020, the Company achieved three years of cumulative income. The Company analyzed both positive and negative evidence, and as a result, released its valuation allowance of $287.2 million on its deferred tax assets. The Company maintains a valuation allowance of $55.5 million against its California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized. </span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management's analysis of the realizability of the deferred tax assets was complex and highly judgmental because the assessment process involves significant judgment and subjective evaluation of assumptions that may be affected by future operations of the Company, market or economic conditions.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s process to assess the realizability of the deferred tax assets and measurement of the valuation allowances, including controls over management&#8217;s scheduling of the future reversal of existing taxable temporary differences, identification and use of available tax planning strategies and projections of future taxable income.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other audit procedures performed, we tested the reversal of the existing taxable temporary differences, including assessment of the completeness and accuracy of related schedules. We evaluated the assumptions used by the Company to develop projections of future taxable income by jurisdiction. For example, we compared the projections of future taxable income with the actual results from prior periods, as well as management&#8217;s consideration of current trends. We also considered the relevant tax laws and regulations in the various jurisdictions, including considering whether the estimated future sources of taxable income were of the appropriate character to utilize the deferred tax assets. We also considered the accuracy of management&#8217;s historical projections and performed sensitivity analyses of the significant assumptions to evaluate the changes in realizability of deferred tax assets that would result from changes in the assumptions. In addition, we evaluated the Company&#8217;s income tax disclosures related to the matters described above.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2000</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;11, 2021</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheets</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except par value data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNC0xLTEtMS0w_2e96f4c5-234c-4da4-90e9-cb66a18465f3">817.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNC0zLTEtMS0w_d954f1bc-0612-4739-897d-6c572d651a67">446.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNS0xLTEtMS0w_6296e92c-c511-475e-bd70-f488cb367e4d">1,890.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNS0zLTEtMS0w_6a85d4f7-2f93-45e7-b24b-ac06e1133b82">1,087.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNi0xLTEtMS0w_9e24945b-505d-4988-aab9-1da9760e0943">428.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNi0zLTEtMS0w_bce91ec0-a4ed-4338-b7be-490566210d10">286.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNy0xLTEtMS0w_284dc3bc-ac04-4ad2-ac69-74e7233627fd">234.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNy0zLTEtMS0w_cf2066d0-c5a6-45a7-9dbe-540d8886a0e0">119.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfOC0xLTEtMS0w_df07558c-e794-4aa4-92dc-c289ebd41aeb">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfOC0zLTEtMS0w_220de994-692e-42ff-b433-26b4c1262fc4">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfOS0xLTEtMS0w_bb8b3235-bdef-4140-bf98-247ba930e5b3">3,424.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfOS0zLTEtMS0w_6f589d71-c87c-43c7-8153-4a5392994f6d">1,969.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTAtMS0xLTEtMA_4b97e4c6-05be-4882-898b-fbc5f1e8e4ec">515.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTAtMy0xLTEtMA_961e432d-a8a7-4e17-bbe9-b656ab9a5316">321.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTEtMS0xLTEtMA_7443fad1-1535-4909-9098-52b0dfb1e319">93.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTEtMy0xLTEtMA_0f323bb4-a3ae-49f2-87c3-86cc8e0b7b1c">71.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTItMS0xLTEtMA_90d9041d-cb6b-4890-b38a-b45b276b6090">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTItMy0xLTEtMA_7cadb2ca-df7f-4afb-870e-9f91f8b979a7">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTMtMS0xLTEtNzg0OQ_111b0c0b-1082-4bc1-a6ed-bfe28fdad00d">216.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTMtMy0xLTEtNzg1MA_c0a5e6eb-0190-465b-9df1-c48a2458200b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTMtMS0xLTEtMA_1e07262b-f2c7-4f98-ab11-9658fc1692f3">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTMtMy0xLTEtMA_79245cf2-a575-45fe-9e92-fc651845b42a">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTQtMS0xLTEtMA_433e7f9c-232b-48b8-8920-e1c26741dd8b">4,290.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTQtMy0xLTEtMA_44c1376c-ab2b-4bab-bc06-4cb47671b2ad">2,395.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTctMS0xLTEtMA_ed1fae60-146a-4d33-a22f-69633052de3b">481.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTctMy0xLTEtMA_a4883eb9-d7e0-4e46-a6ff-c1031398e206">256.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTgtMS0xLTEtMA_30edecff-36ca-42bc-9dfd-d923439d2eef">114.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTgtMy0xLTEtMA_59084707-2746-4b5e-a464-5fbf3fc4eb9f">88.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTktMS0xLTEtMA_1ca379ac-0068-490d-8701-3b078e955f72">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTktMy0xLTEtMA_edc796f1-d6b3-4b90-960a-d6cc3c368b61">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjAtMS0xLTEtMA_8670f08c-da36-4f67-aa1e-56707807c53c">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjAtMy0xLTEtMA_887b86f8-91c1-41e6-8033-ed4c4ce7370c">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjEtMS0xLTEtMA_2006ea07-0c8e-4449-9f20-9e5fbb43ae07">614.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjEtMy0xLTEtMA_a06b9abe-a7c4-4dc7-ad21-5c3f30bd30a8">360.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term senior convertible notes</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleLongTermNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjMtMS0xLTEtMA_2e3a79c5-d3e4-4ca9-ba90-392e782a2666">1,667.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleLongTermNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjMtMy0xLTEtMA_66615455-529c-4d6f-92d1-fa2ea6a40a5c">1,059.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjQtMS0xLTEtMA_6bf87147-8375-4931-a777-1cb41430d996">101.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjQtMy0xLTEtMA_63c21ce3-5fca-49a1-ad4f-f7bd78a80e31">72.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjUtMS0xLTEtMA_25bb3c57-dbd5-4b1f-8b07-82073338c552">80.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjUtMy0xLTEtMA_7a99cf63-0198-4915-afb2-3879a6737a62">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjYtMS0xLTEtMA_d9c095e1-75bc-4164-a84c-2c5237b8e2d7">2,464.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjYtMy0xLTEtMA_85c469a9-e7cf-4ee7-9a74-d563acd7c74c">1,512.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjctMS0xLTEtMA_a420e53c-e050-4558-ae30-b7b102540b40"></ix:nonFraction></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjctMy0xLTEtMA_84ce9171-9c81-457e-a0d9-2cb8732803a9"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2Mjc5NjE_52053023-10f5-436d-9e27-285cd53f5bfe"><ix:nonFraction unitRef="usdPerShare" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2Mjc5NjE_e762ae33-fb14-44e0-a7b3-d69f1ec40d76">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2Mjc5NzU_63628aee-a934-4422-a5e8-7c05aa5bdde1"><ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2Mjc5NzU_99ece1ac-7260-4306-8b09-38f712a1749e">5.0</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2MjgwNzU_1be79280-6324-413a-8d0b-4c6ad0e7fb42"><ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2MjgwNzU_826eb6b6-39ee-46b3-a14d-c4b09dbcd7fe"><ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2MjgwNzU_909bb149-453a-45bd-9942-2bf7c7622ae4"><ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2MjgwNzU_b967db93-96d5-469a-bde6-4a61d361c4ca">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2020 and December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMS0xLTEtMA_6eb217fc-1521-4d85-8b70-a892a8aa960a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMy0xLTEtMA_e80f7def-1947-494d-baeb-fc83a9a47205">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgyMjI_3d2023af-f8bf-448a-992d-3ad54daff8f1"><ix:nonFraction unitRef="usdPerShare" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgyMjI_78ea120a-b0c8-45af-a439-77dd042df9f7">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxMDQ_49770822-6bdc-4890-bace-743a2aa6b722"><ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxMDQ_8785b2c3-cbb8-4104-ac20-4609d8641d63">200.0</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxMjA_eee4fe34-f5ca-4e4c-add5-b411baabaeed">96.9</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxMzU_e3d1f3f6-6bbe-4108-8e6b-dd0bcba56b19">96.1</ix:nonFraction> million shares issued and outstanding, respectively, at December&#160;31, 2020; and <ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxOTU_22e686be-8b05-4778-a713-43e2797b7026">92.4</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgyMTA_e65bf1a0-777c-4998-9a3d-16d7f32cccfd">91.6</ix:nonFraction> million shares issued and outstanding, respectively, at December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMS0xLTEtMA_22099e46-bf49-4575-b997-59d468baa469">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMy0xLTEtMA_4f7e83ad-b0cb-43b0-b1b6-8b229e5789cf">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzEtMS0xLTEtMA_641f5001-dfeb-44e1-b388-bf03cc3f0667">2,125.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzEtMy0xLTEtMA_3fe86223-1899-44a4-abab-030944d14048">1,675.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzItMS0xLTEtMA_7a93dc4b-b841-4575-bc08-44751e7f24ea">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzItMy0xLTEtMA_47d4ad09-2c18-4d56-8bfe-4d9a9568e228">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzMtMS0xLTEtMA_e97ec17f-f53c-4bec-9cb5-45829763849b">202.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzMtMy0xLTEtMA_f5ce3686-fdb2-4612-818f-e1bbd37985b6">695.7</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjQzZWQwMzNhZmU1NDRlZGI5NTQ1ZjA5MTBhZWVmNzhmXzEwOTk1MTE2Mjc4NjY_08d6ba31-dc6b-483d-a027-e8425be9aa13"><ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjQzZWQwMzNhZmU1NDRlZGI5NTQ1ZjA5MTBhZWVmNzhmXzEwOTk1MTE2Mjc4NjY_1d714dbf-9412-4495-9280-7c5b1fac2b56">0.8</ix:nonFraction></ix:nonFraction> million shares at December&#160;31, 2020 and December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzQtMS0xLTEtMA_fc2d5ffd-a9a2-4613-8a54-bdf827a1cf0f">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzQtMy0xLTEtMA_3be50350-c2b3-4c90-a354-28f46100e18b">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzUtMS0xLTEtMA_efabd01b-7053-428f-b44e-7fa806f0bff3">1,826.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzUtMy0xLTEtMA_37132a8f-941a-4210-9d95-3fbb3a45ff72">882.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzYtMS0xLTEtMA_8658393b-e5e2-47f0-8836-a944039e662a">4,290.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzYtMy0xLTEtMA_24b0c9b1-2f1a-469f-9277-63c5fb4ddb43">2,395.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Operations</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:66.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzItMS0xLTEtMA_a5684236-65ad-487a-bbf9-4f6475f588a3">1,926.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzItMy0xLTEtMA_b5f8094c-42fb-4733-8bd9-9bba3725dda9">1,476.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzItNS0xLTEtMA_e7653b0c-5956-4ff8-919d-c15838ad4314">1,031.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzMtMS0xLTEtMA_2b93c630-1e83-477f-87ba-25a63ad24dae">646.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzMtMy0xLTEtMA_23062e74-7260-46c7-ad2b-ccb1a53554ce">544.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzMtNS0xLTEtMA_8fc6e5eb-4967-4dd4-8d15-b09c1b401d7b">367.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzQtMS0xLTEtMA_5d7123b6-16b6-4706-88a0-77a99547b969">1,280.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzQtMy0xLTEtMA_ce324ccf-f6f7-4ddd-9b60-c11022fcd28d">931.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzQtNS0xLTEtMA_4e10543f-3167-465a-b2f4-c826f03cbcf9">663.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzYtMS0xLTEtMA_250ae920-841b-4a8a-8e44-cebb6e01130d">359.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzYtMy0xLTEtMA_3244b203-6adb-4095-b4e4-9c4cd53a9954">273.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzYtNS0xLTEtMA_16aad443-20e6-484a-be6d-cb6321a97bcb">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative research and development fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzctMS0xLTEtMA_60b47aeb-b6ee-4a9c-916b-5f38fed39ea8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzctMy0xLTEtMA_c1b0f859-613e-4055-997e-d8f99a83310a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzctNS0xLTEtMA_e0cd18ed-103b-4faa-91bd-8aea4c35bd8c">217.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzgtMS0xLTEtMA_83ded88a-1d73-420c-afb7-914e76aa24a5">620.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzgtMy0xLTEtMA_871f7921-9d2b-4fb7-8ba8-8e92fa55d32e">515.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzgtNS0xLTEtMA_a1938a8a-94c8-44fd-9476-b8c51352b1ef">432.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzktMS0xLTEtMA_a18d10b7-363f-472a-b407-07c285e3fede">980.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzktMy0xLTEtMA_322f75f1-ea1c-49e0-af14-d1c9b863c46f">789.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzktNS0xLTEtMA_b50ba3bc-de52-4247-9504-a9e2ab41ac87">850.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEwLTEtMS0xLTA_f6cb453a-f32c-406f-8c56-d566708e7995">299.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEwLTMtMS0xLTA_15d79182-4892-443e-8ffa-ebb738d64442">142.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEwLTUtMS0xLTA_d0a985cf-a187-43e7-b1eb-e29f17a8656f">186.3</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzExLTEtMS0xLTA_29aa1c9f-42e1-4aa2-b3ab-593be20152a3">84.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzExLTMtMS0xLTA_69cf15a9-df5a-414e-9b59-336ad74b66cf">60.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzExLTUtMS0xLTA_213e8c39-8c99-4b30-a8ca-12c0699310fd">22.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTEtMS0xLTIxNjk_3e95e6b0-c965-4b2d-bb9c-4fefabee79ca">5.9</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTMtMS0xLTIxNjk_833659b6-5806-4550-acec-3dbbadbaf64b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTUtMS0xLTIxNzI_e38ff275-f0e3-49c0-9b3f-b73f8fdcd28a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTEtMS0xLTA_7f8ac220-acd1-4dc0-ae73-1e7da61e4e6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTMtMS0xLTA_49220926-ca3e-41bf-b165-ef78167861a4">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTUtMS0xLTA_fde02420-5a89-4175-857f-384230f512d0">80.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEzLTEtMS0xLTA_450ad993-cf42-4785-b572-0b17f91bc83d">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEzLTMtMS0xLTA_5fbe4024-44c8-444f-abaf-d77580b5de3e">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEzLTUtMS0xLTA_c29073bd-477d-42e4-806d-261187ef6838">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE0LTEtMS0xLTA_df6d567b-a0fe-474c-b417-e13022e8b292">225.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE0LTMtMS0xLTA_392ded4d-576f-4b0d-9754-bd548b9d41a8">104.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE0LTUtMS0xLTA_31987793-779d-4a27-a0f1-3617d07b29dc">126.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE1LTEtMS0xLTA_66909a47-84c4-4783-a3cb-117625f8da80">268.6</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE1LTMtMS0xLTA_5a5676ff-5917-4110-b808-ca34f9cb86af">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE1LTUtMS0xLTA_ccd91e8b-a04b-48ba-9d8a-a963867a6abb">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE2LTEtMS0xLTA_07f90a0f-4426-4917-a04c-e796bffecb93">493.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE2LTMtMS0xLTA_f8809458-d42b-40c5-a99f-9d4a9e4b3c70">101.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE2LTUtMS0xLTA_bc988401-e1fd-4e2a-81ab-bf307fae05ea">127.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE4LTEtMS0xLTA_2dc00efc-e0cc-446f-a898-fc7353820cf4">5.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE4LTMtMS0xLTA_aecd2171-3223-481b-a262-a6bb70d9a4de">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE4LTUtMS0xLTA_1cbfe2d8-25c5-4990-9ea1-d82db433040a">1.44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute basic net income (loss) per share</span></td><td colspan="2" style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE5LTEtMS0xLTA_1a98c5c6-8fc0-4aa7-ae38-408f06b0a25c">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE5LTMtMS0xLTA_41259d21-e212-4c70-84db-a1c5f02370c5">91.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE5LTUtMS0xLTA_36da7472-9d6b-4c6c-b1ef-f980e2fd082d">88.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIwLTEtMS0xLTA_3ead4283-15d9-4e29-93ac-31e90f7a8644">5.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIwLTMtMS0xLTA_467af9ea-0081-4ca8-8784-19677aa50a87">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIwLTUtMS0xLTA_772d5213-9ac3-4b86-bfae-1e32c8cd936d">1.44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted net income (loss) per share</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIxLTEtMS0xLTA_20dd85e1-339a-49f1-aad4-40e29f9ffe03">97.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIxLTMtMS0xLTA_cd477407-a9d0-4470-b368-75902bb61381">92.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIxLTUtMS0xLTA_1a3ddea5-b0d1-4d16-b9ef-b4f9931cbf26">88.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DexCom, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Comprehensive Income (Loss)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:66.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.034%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzItMi0xLTEtMA_5481ff9d-cde3-4a45-b0e6-02c42d3538a6">493.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzItNC0xLTEtMA_57a290bc-cf2a-4f78-a8af-bd0b1f7e385d">101.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzItNi0xLTEtMA_67a7349a-f2d8-4ade-856b-d89b392d4d94">127.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzQtMi0xLTEtMA_f52eb213-42b0-457d-b911-9f0fb6925b5d">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzQtNC0xLTEtMA_dc9a2d62-774e-49c4-aa43-e5ac9d058022">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzQtNi0xLTEtMA_01d2b0ae-5a60-46c5-8af7-d63445f499de">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzUtMi0xLTEtMA_ca9a6745-dc70-44c7-ac25-2bd05c94b6d2">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzUtNC0xLTEtMA_1e43c056-03af-4c00-a0d5-612184505850">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzUtNi0xLTEtMA_490dca32-b27d-4bba-837c-41a901427ce0">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzYtMi0xLTEtMA_d3344de3-3c58-4533-837d-71f02758560b">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzYtNC0xLTEtMA_dab96daa-1214-4e7e-90be-8b56a93b73d0">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzYtNi0xLTEtMA_fa17ad4d-78c2-4ff0-931b-13ad1622dcda">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzctMi0xLTEtMA_7f856f7b-507f-445d-84fc-889d3bd5b36a">494.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzctNC0xLTEtMA_5a5afabf-33d8-4d29-b242-7b2ff1be197d">101.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzctNi0xLTEtMA_41566117-c2a6-4073-91e8-8fead81cd575">123.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_106"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.675%"><tr><td style="width:1.0%"></td><td style="width:13.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.140%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Stockholders&#8217; Equity</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.458%"><tr><td style="width:1.0%"></td><td style="width:35.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.610%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance at December 31, 2017</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62ab2abda0de42659a37b9c9f8196c4a_I20171231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItMi0xLTEtMA_ead213f5-69ca-4096-983b-de24fa0f7e54">87.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62ab2abda0de42659a37b9c9f8196c4a_I20171231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItNC0xLTEtMA_c74d2f4a-e519-4120-ad0a-4e61fc060540">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7f9f30a2abc40808a41b3885af720d9_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItNi0xLTEtMA_9ce9c918-c20e-4273-ad9f-4b377549ae97">1,093.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a3a2bd79c1246d89a94242e2cd12c96_I20171231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItOC0xLTEtMA_53baa695-46d1-4745-82f3-777579c77373">2.6</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d1e7482b0864e9f85af3dff1a4430f1_I20171231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItMTAtMS0xLTA_d1a79955-ca9e-4533-a2a0-2bb007ffee65">671.8</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9fd427acdbc486a9e8edee4ccc7110c_I20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItMTItMS0xLTA_dc17f7ba-ef2c-4bf2-a26f-2f4ebb978061">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic82615128e2c4fc99ac6cee2560ef199_I20171231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItMTQtMS0xLTA_f04fb938-cddb-4bba-ab90-4aa2b04055b0">419.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMtMi0xLTEtMA_7a97157d-d9fe-484d-a64d-c358e762287f">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMtNi0xLTEtMA_4c4aa270-9ba4-4661-ac09-8a990205a11a">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMtMTQtMS0xLTA_85af78e5-d8c7-4b48-8c47-c05418a528d1">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzQtMi0xLTEtMA_8761a523-535e-49d2-8a97-a09a59e91478">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzQtNi0xLTEtMA_f1a4b650-4a23-4383-8112-518e7f82f2a6">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzQtMTQtMS0xLTA_5939cf77-d6d2-4dee-8325-fc4bef05163a">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for collaborative research and development fee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzYtMi0xLTEtMjc4NA_61280fec-e849-4cc6-81eb-394edc16eb67">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzYtNi0xLTEtMjc4NA_5987016a-d263-413f-902a-8b559a18bed6">217.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzUtMTQtMS0xLTI4MDM_a435fa97-14d1-44a9-8342-d945823496b9">217.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Convertible note hedge</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtNi0xLTEtMjMwNw_48acd873-0b9c-47a5-9c67-972868962814">218.9</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTQtMS0xLTIzMDc_d6eba7f1-4e94-4bd3-bb59-f4c94d19396f">218.9</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity component of convertible 2023 Note issuance, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtNi0xLTEtMjMzMQ_cf7527c7-ef97-47db-8d81-f9ff0d83ad29">171.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzctMTQtMS0xLTI4MDM_ed97caa3-1138-4a1c-9e96-a6f113af79e4">171.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMi0xLTEtMjMxNA_31678846-5dbf-4ce8-b703-c742747b8c1c">0.8</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i334065d7da4c4bbd8735b1a9237ca649_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTItMS0xLTIzMTQ_26b70c7c-f695-40b1-9264-c5d1f1631b25">100.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTQtMS0xLTI4MDM_c5e56f47-7edf-4750-b9f8-d2de675631c3">100.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sale of warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzktNi0xLTEtMjMxNw_1d4cba1a-3826-4d25-b779-6bdb948de60a">183.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzktMTQtMS0xLTI4MDM_ea7c6361-502c-4675-88fb-f980703f27a3">183.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzUtNi0xLTEtMA_a12ec452-2855-4de4-946e-68dc9baf0630">101.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzUtMTQtMS0xLTA_3303f25a-b358-4f8a-a268-3480aa00d786">101.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd8fb94803f34b96a82fb0ebc3e1cba8_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTAtMS0xLTA_91d9701e-cbbd-41c1-9ea9-79c773ec6814">127.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTQtMS0xLTA_9367c808-e474-4564-a456-299ad6eeea99">127.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddc2ad90e3a745f583d12c18ce94e654_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzktOC0xLTEtMA_a4cfd7e6-a614-4b7c-8920-6725d7954823">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzktMTQtMS0xLTA_c652cc9b-349c-4119-ae6e-b371eab63c0c">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2c0cbd5c0f241d4985442b984220cf7_I20181231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTItMS0xLTA_7a79f2cd-f075-4256-9a62-27135e8f249c">90.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c0cbd5c0f241d4985442b984220cf7_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTQtMS0xLTA_e851ed60-3781-46a5-a4a5-51853e6ed6ca">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4859a89543554757a0237d357c2029c8_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTYtMS0xLTA_cce5376b-7276-4b62-a8a6-d8c1e0f4714a">1,560.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f94c40295974007abccd11273ce6988_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTgtMS0xLTA_f7eda9a0-2d9b-4de3-97d3-0c4b840d4c54">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3afb9980ee644d22897fe66e8e9f3621_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTEwLTEtMS0w_b4099040-b5e5-4317-ada5-fb3d050c04f6">798.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc3e8df174cb41c9a8ef16f4487803b8_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTEyLTEtMS0w_e29cc810-94f4-4c17-95db-cd9066322f14">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTE0LTEtMS0w_ce5f3911-8623-45cf-8254-4f5c75850362">663.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE0LTAtMS0xLTc4NjY_fb45f1c2-c2da-492b-84ee-10fe91b82ae4">Cumulative-effect adjustment from adoption of new lease accounting standard (Note 6)</span></span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb937d881cb42d6a0f935a924001c2f_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzExLTEwLTEtMS0w_59f4cbb3-c5fe-4613-b9f3-d59e8b76324c">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f5c2cc37a5477db6d781d12fe77f0f_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzExLTE0LTEtMS0w_c5e80aa3-c401-41a9-8eaa-8ff3208ba0e2">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice5479f1e1694af1aafc253e8cf22247_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEyLTItMS0xLTA_843ba749-8339-4669-af68-635abd51376c">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEyLTYtMS0xLTA_3db5064b-4a22-47f8-9dca-e353e6ff7349">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEyLTE0LTEtMS0w_f91cc5db-fc08-44e3-9178-15e789b930a2">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice5479f1e1694af1aafc253e8cf22247_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEzLTItMS0xLTA_91d4e3cd-a6c0-499b-a8c3-02649b14ec78">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEzLTYtMS0xLTA_3a825b1d-2b07-4414-ab51-bfe9ad8279f2">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEzLTE0LTEtMS0w_bc09364a-6351-4c51-aef9-1afdf2e1946c">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Realization of tax benefit related to 2023 Note Hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231" decimals="-5" sign="-" name="dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE3LTYtMS0xLTIzMzY_fc9b3e72-a497-4b5d-a7e5-981550000777">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE3LTE0LTEtMS0yMzM2_52259af0-72e0-40bd-a117-ad4514e09e35">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE0LTYtMS0xLTA_077b88e3-dc55-4828-af16-bec353ecaff9">102.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE0LTE0LTEtMS0w_95e11528-6b96-4eb3-a4f2-e8a9a0f78993">102.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06733029c370448ba5d57587ce16bda1_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE5LTEwLTEtMS0w_03f9804e-6bc6-4a68-9fc8-77270fb0e351">101.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE5LTE0LTEtMS0w_9f5c3dfe-97ad-4408-94fd-d019a6bd1b87">101.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc1828a50774882930e3febccea7246_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIwLTgtMS0xLTA_ed5d16ab-e68c-45ac-9cb4-a81f538dee2e">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIwLTE0LTEtMS0w_6863a7f2-f366-4b2e-9036-fa9fe0b91136">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3962ec3ca47246e5afc8c09df3185349_I20191231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTItMS0xLTA_09ec41b9-513f-4014-81ed-07abff1abf45">91.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3962ec3ca47246e5afc8c09df3185349_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTQtMS0xLTA_790c8b6b-910b-47d0-9def-9b74746b6311">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08750c5e7ec4f89a130804838db3915_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTYtMS0xLTA_3cb24c06-7d5d-4858-b124-a55ef34957ac">1,675.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50619200f7264c2d9ac57a9f7ac26a68_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTgtMS0xLTA_db04d939-6267-4a0d-894a-8d077c07c1b3">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91ff836d4cc04bac915b60eb3b0276b8_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTEwLTEtMS0w_86e4d41d-0b57-45c6-9ce7-66d658627fb7">695.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53e29bb6e76c4d0abc2e92543b07c60d_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTEyLTEtMS0w_b2c280d1-00ce-4906-a758-14ee06b05cac">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTE0LTEtMS0w_0d767c5b-f086-43e2-a48d-1772494ae2da">882.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie43b7f8664fd4e7fa1c96e2b2325534a_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIzLTItMS0xLTA_c2019848-d4c1-4f25-9e01-127267dd2c36">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIzLTYtMS0xLTA_c58ad55e-d058-4c93-a78d-8cf64383ca87">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIzLTE0LTEtMS0w_bfc65a48-732a-4cc5-9de3-36a3bdb9604d">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI0LTYtMS0xLTA_134cee8b-0c89-4d8f-90af-db4c7c937da4">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI0LTE0LTEtMS0w_07620002-2d31-405c-a8e0-61fd3d328cff">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity component of 2025 Notes issuance, net of issuance costs</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI5LTYtMS0xLTUwMw_4242fb12-27b9-4efe-80a8-e8a401f2eafa">289.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI3LTE0LTEtMS0yODA4_5066d701-0dd1-49d4-9985-ea8bc23296e5">289.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax benefit related to Senior Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTYtMS0xLTk2MzY_92b2018a-dcba-4967-bd99-dda0ca67cae9">62.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTE0LTEtMS0xMTQ1Nw_c8b99ef5-4fb2-4b39-a067-c97576503c70">62.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repurchase and conversions of 2022 Notes</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie43b7f8664fd4e7fa1c96e2b2325534a_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTItMS0xLTUwMw_0caf6dc4-57d0-4a86-9a90-c505d1d95aa2">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTYtMS0xLTUwMw_c80fbfb5-f3ad-43fe-96a5-03fac10c7182">87.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTE0LTEtMS0yODE0_3f08e5b8-8ea8-4e3b-b8dc-5ee146da5743">87.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMyLTYtMS0xLTIzNDQ_5f753b1f-7538-4916-bc82-1164afc8e673">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMyLTE0LTEtMS0yMzQ0_937bf41f-2744-4205-99c9-b7db12d608df">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c875e94a27c489ca8dbc61fe476e69f_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI3LTEwLTEtMS0w_78736f7f-9dee-4fd9-aead-0942300c70bb">493.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI3LTE0LTEtMS0w_adb975c6-08ab-48ca-81d2-7a5d7a35ba4c">493.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8815ef6d44b14de195293c0935f6df41_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTgtMS0xLTA_b09fca61-9cf1-4ec9-9e83-9a5a89838b0c">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTE0LTEtMS0w_568b02c4-6ba0-492a-b2c2-1c0e8bfd362f">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf189edb39e14e54937ee10b5be44dd1_I20201231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTItMS0xLTA_970167a5-ae2e-46c5-9477-6d54068eeb81">96.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf189edb39e14e54937ee10b5be44dd1_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTQtMS0xLTA_fbc0123f-18b8-4bfa-a4e0-abc29cc0d42c">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2202fad57c63453e9b1b404a15b6e82d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTYtMS0xLTA_299e8f5d-c301-4dac-b858-bef931a2df27">2,125.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3351b0dd70c24b04bc98a96abb444375_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTgtMS0xLTA_eb69f7da-8c35-4354-8b0d-12c395ee1882">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0eec6c3ccfc41bebe1fab61a4e0fc10_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTEwLTEtMS0w_b8389f2f-ac2a-48ed-9b92-0a0336343a4a">202.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i341885eacad94bbc9b111e97938ab5d5_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTEyLTEtMS0w_6a944a29-3f0d-4ba9-b313-ee518bd9d8fe">100.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTE0LTEtMS0w_b896952f-e99e-473b-941b-f6b0e763aaaa">1,826.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_109"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Cash Flows</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:66.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMtMS0xLTEtMA_5ee92b64-9048-4a85-af05-e11110c40332">493.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMtMy0xLTEtMA_d1578184-b21b-4cd2-b6bb-200736ab60f7">101.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMtNS0xLTEtMA_901ec72f-150b-4230-a539-3038e2562d27">127.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUtMS0xLTEtMA_73b0b4ef-f4bf-4da7-b21b-88cee96ca7ec">67.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUtMy0xLTEtMA_4b59aee6-08f9-4921-bd8b-29570aabf0dc">48.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUtNS0xLTEtMA_fb39ce01-3921-4361-8e5b-0b751e4624f0">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzYtMS0xLTEtMA_825e99fb-ddee-4946-b3cd-9c643a63e138">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzYtMy0xLTEtMA_37fe073f-bfc3-4fe1-826a-9271d47cf099">102.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzYtNS0xLTEtMA_8d15e547-83e9-4441-b4ab-717399d2f566">101.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctMS0xLTEtNDE4Nw_a0113f84-06e8-490d-8099-e0e39442b57b">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctMy0xLTEtNDE4Nw_dc854b0b-b4ba-4021-b0a3-a5587b99056c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctNS0xLTEtNDE5MQ_849413d8-1a98-48bc-b135-1de976dfae7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctMS0xLTEtMA_c903f773-8e11-4ad9-8809-782e05c13116">74.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctMy0xLTEtMA_8c33c3ae-8612-44ca-855d-a9947f2fa453">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctNS0xLTEtMA_aa7af08e-7704-422c-a6f0-5b3170acc742">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash collaborative research and development fee through issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="dxcm:RDexpensethroughissuanceofcommonstock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzgtMS0xLTEtMA_0f9f02e0-4796-4c1e-a9be-c90d7e6cbafc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="dxcm:RDexpensethroughissuanceofcommonstock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzgtMy0xLTEtMA_cd1f597a-b400-448b-b680-0fa1d8c13be9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="dxcm:RDexpensethroughissuanceofcommonstock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzgtNS0xLTEtMA_7aa930e2-3d1e-4acf-9e18-afb1f972dc9d">217.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on equity investment</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzktMS0xLTEtMA_e03bb84e-ba95-4fc6-b638-5202386b9820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzktMy0xLTEtMA_73314d28-581e-477f-8d83-33df8b3e98a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzktNS0xLTEtMA_8a99e0ad-1092-4361-86c3-9fe5fce43625">36.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized (gain) loss on equity investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEwLTEtMS0xLTA_61552e1f-288c-4c10-b3e6-b47ee3949ccb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEwLTMtMS0xLTA_2822c764-0f7f-487a-a4f7-928cee09295b">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEwLTUtMS0xLTA_5c64aabd-b56b-49ee-a19c-6444e3528236">44.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes (including benefit from valuation allowance release)</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEyLTEtMS0xLTYxMDM_f1d43e78-8905-4ae7-8469-a6ac0a1a7e5e">277.3</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEyLTMtMS0xLTYxMTI_037a0944-f5c7-4c5c-a54b-6a0c1b05b530">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEyLTUtMS0xLTYxMDk_52b7a52d-7111-4434-93d2-2c19515a7ea9">2.2</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash income and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzExLTEtMS0xLTA_bbf42f26-dad3-466f-8849-6bb0a5e5b139">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzExLTMtMS0xLTA_ab278c1b-4ecb-44ce-8b13-b63ffffcd293">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzExLTUtMS0xLTA_fc1b5765-9e7c-4f90-be6f-593e0f413b66">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEzLTEtMS0xLTA_e64b71ac-50d1-40ee-982a-9add486975e3">142.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEzLTMtMS0xLTA_d21d5c35-6dc7-4709-b979-3f09f5f5b139">60.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEzLTUtMS0xLTA_97eef0e9-08f6-4488-8aed-1458b3afc1c4">93.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE0LTEtMS0xLTA_db63a577-59fa-494a-84b5-bdd969cbe661">114.5</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE0LTMtMS0xLTA_f7bcd096-d16a-4a74-9b9a-5a84c4ea4144">49.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE0LTUtMS0xLTA_f5424f1e-3b3c-4fa4-b40e-39e1150e2408">25.5</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE1LTEtMS0xLTA_1ab2bb01-631f-44b9-a16b-1d721600c1c5">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE1LTMtMS0xLTA_7bdf2ef2-afa3-4bae-ae1c-44a7fbb4387f">7.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE1LTUtMS0xLTA_a725a9ad-dd99-43c3-9cd5-e4ddc267fa27">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE2LTEtMS0xLTA_7436e107-27f2-4ccb-9a99-8d360f690314">0.8</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE2LTMtMS0xLTA_0d2cb3ba-9b42-43c1-91d8-e805a3d191f2">2.4</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE2LTUtMS0xLTA_b8558b3d-b5b2-4c35-a034-26bcddfbec35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE3LTEtMS0xLTA_5e4e45ff-a627-4b42-b3be-15175f633ea1">194.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE3LTMtMS0xLTA_55f56836-457c-47da-821a-c0e5c806fdf6">109.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE3LTUtMS0xLTA_4e4e91b2-2cd7-4f45-a901-969592c2cb58">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related expenses</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE4LTEtMS0xLTA_00a16996-9066-4c12-9270-e587b73a9cf3">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE4LTMtMS0xLTA_ea6ecbc6-5b16-4210-85f6-41ca1c2b5428">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE4LTUtMS0xLTA_e3fff31d-12fd-4f9f-99ce-03a40cc19f9d">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE5LTEtMS0xLTA_9da21157-1340-414c-91fa-e3c19d080cbd">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE5LTMtMS0xLTA_2b6aca8f-18d0-4274-a49a-59fcfd41333b">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE5LTUtMS0xLTA_fd6b2cb6-4429-4ee0-942b-dc419d636a1a">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIwLTEtMS0xLTA_abea792f-71a6-4d64-9d89-9ed1b62ca560">475.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIwLTMtMS0xLTA_25eaeada-bd52-4f20-8f30-6813a2731514">314.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIwLTUtMS0xLTA_71233f87-7e54-477c-9ea4-417ecd38cc97">123.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of marketable securities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIyLTEtMS0xLTA_1b3c771e-e109-444d-baa3-2144b9ea092b">3,058.2</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIyLTMtMS0xLTA_dab3dbd9-7c6c-4bbf-8398-398d96262136">2,030.4</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIyLTUtMS0xLTA_c5686cc7-3c27-4898-9fb8-c60c7de97a0b">452.5</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale and maturity of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIzLTEtMS0xLTA_73b9e8d7-1672-4088-928b-3e354c90f04e">2,250.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIzLTMtMS0xLTA_63852484-662e-4591-87d9-0c2270c8c9f9">1,196.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIzLTUtMS0xLTA_8d1c34ce-78ca-4dd8-841d-bb03c46d4dfb">392.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI1LTEtMS0xLTA_6cf6c2e1-788b-49c2-a568-201d1cf868e6">199.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI1LTMtMS0xLTA_978cea10-b016-4b93-9548-95a1dcf39dab">180.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI1LTUtMS0xLTA_ff2e3f7c-7fd5-42f3-a34f-ed58e0709382">67.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI2LTEtMS0xLTA_c45333a5-b5d8-4d1f-bea6-296683d99ab0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI2LTMtMS0xLTA_0ce3ae79-5a1b-4b09-b664-2694f6e27d0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI2LTUtMS0xLTA_ebe11e2f-19fc-41a1-84d1-30dfe13795c8">11.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI4LTEtMS0xLTQyNzM_38ad8322-9d68-4b04-8b6f-84876f32cf54">11.3</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI4LTMtMS0xLTQyNzY_c84526de-1ec5-4189-863c-d21cea353611">1.2</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI4LTUtMS0xLTQyODM_2e726c77-cd25-4216-9a9d-298f9c23fa1a">1.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI3LTEtMS0xLTA_bd2afbad-2b41-41b1-b710-f31b222339c8">1,018.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI3LTMtMS0xLTA_da74396e-575a-4b05-aa90-ae98ac133b97">1,015.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI3LTUtMS0xLTA_e231d0cd-1f5a-4803-aefc-23aa50731cbc">139.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI5LTEtMS0xLTA_fc286bab-5972-41f1-add3-2b544390e591">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI5LTMtMS0xLTA_1fc1171e-86f6-4252-8a28-ab85af74c18c">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI5LTUtMS0xLTA_2dc3f90a-71ec-40f0-970d-d9b8b0ebc599">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMwLTEtMS0xLTA_a30a6d06-9a12-41be-bf02-a82b1638b582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMwLTMtMS0xLTA_a0c8a745-8ad5-47d8-b618-99bf2a973dd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMwLTUtMS0xLTA_dfa9b62b-b4fc-4e48-8c37-7237a0bcbc83">100.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of convertible notes, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMxLTEtMS0xLTA_22897998-c601-4fe2-8851-c56d27f2cf34">1,188.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMxLTMtMS0xLTA_075d39fc-653c-4ae8-9b91-6c3a50fae273">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMxLTUtMS0xLTA_08ea566c-dc56-420b-863a-bcac8cf30ea4">836.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of convertible notes</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="dxcm:PaymentsForRepurchaseOfConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTEtMS0xLTIxOTk_018ba9ac-2ac2-4dd1-b1b4-8f6ee1f68c47">282.6</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="dxcm:PaymentsForRepurchaseOfConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTMtMS0xLTIxOTk_e42f33ef-8c2b-44aa-a9dd-8cabda4d1907">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="dxcm:PaymentsForRepurchaseOfConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTUtMS0xLTIyMDM_a16c7bca-6ab6-4ae9-af0f-7830bae058e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMyLTEtMS0xLTA_64edb5ff-2bcc-4fa8-be1e-d1f7a43a0eb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMyLTMtMS0xLTA_3875e900-2810-49cb-a728-2f5c422df8b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMyLTUtMS0xLTA_28aef87a-6d68-48bb-bbab-e9659f9a00e5">183.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of convertible note hedge</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="dxcm:PurchaseofConvertibleNoteHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTEtMS0xLTA_9b09089a-c168-4568-af6b-61cd6b48b931">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="dxcm:PurchaseofConvertibleNoteHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTMtMS0xLTA_e82c34e9-282d-4d3c-afab-d216dd63e945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="dxcm:PurchaseofConvertibleNoteHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTUtMS0xLTA_b8dc230d-2dd8-4ba0-83e1-f15179f55aaf">218.9</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM2LTEtMS0xLTA_43d3d527-fbf9-47ac-abb7-ae013984376b">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM2LTMtMS0xLTA_861cb12a-bb60-4f95-a58a-a098a6aa6b27">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM2LTUtMS0xLTA_43c3f7e0-6b39-41a8-b9ae-39beda36c285">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM3LTEtMS0xLTA_2744fac7-db9a-4a55-a433-0b044207a970">912.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM3LTMtMS0xLTA_fca7b59d-4250-42c0-b829-3e9af6ee070e">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM3LTUtMS0xLTA_e7cd552f-f597-4cdc-b3d2-30377fabb061">710.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM4LTEtMS0xLTA_c580c996-d5ad-4d27-9721-28586b239e5f">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM4LTMtMS0xLTA_500f95a5-a42b-4e84-8a9f-214117443929">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM4LTUtMS0xLTA_c885d577-337b-46f1-978b-3c23d5899aac">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM5LTEtMS0xLTA_46203753-424a-4010-b835-ed2ba10bd885">371.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM5LTMtMS0xLTA_7fedd049-21e7-4f83-859a-6da4c28d9445">690.7</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM5LTUtMS0xLTA_32fbd5ff-3968-41e5-ac3e-c1e513d5f343">695.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQwLTEtMS0xLTA_cfcfe3b4-7641-4c17-b161-494e557e35da">446.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQwLTMtMS0xLTA_c861950e-9874-4a48-850a-3921957c56b7">1,137.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic82615128e2c4fc99ac6cee2560ef199_I20171231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQwLTUtMS0xLTA_245e004f-e02d-4063-aa14-79ad5337bfa2">441.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQxLTEtMS0xLTA_f62e469f-2407-43b6-b6ba-dcac379d0c80">818.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQxLTMtMS0xLTA_7ad69ad0-4215-49ad-969f-25d7880e29c6">446.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQxLTUtMS0xLTA_cf722d74-ac4d-4698-aebf-4b329894ea97">1,137.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of cash, cash equivalents and restricted cash, end of period:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ0LTEtMS0xLTA_d9f26a4c-0efc-4057-a6b4-55174ad43a6f">817.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ0LTMtMS0xLTA_8a36c6c3-b19b-43cd-ab7f-9f2b7df3dd3c">446.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ0LTUtMS0xLTA_83b86683-c4ce-41cb-8445-053b1e339106">1,137.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ1LTEtMS0xLTA_84fbb5f8-3c97-4b89-bc14-6a8f071d3796">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ1LTMtMS0xLTA_0a038a9f-bddc-4df9-83bc-3593d5c9da08">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ1LTUtMS0xLTA_3c8da507-73f1-4dd7-b643-d1bb6847af3a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ2LTEtMS0xLTA_dd83098a-795c-4daf-8d61-66fcb91cd798">818.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ2LTMtMS0xLTA_35fd2ab3-9c99-425e-ba2d-2c1fea9c6029">446.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ2LTUtMS0xLTA_d65fba0f-d480-45ba-8505-b6eb7f69c892">1,137.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:66.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for repurchase and conversions of senior convertible notes</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUyLTEtMS0xLTc4ODA_dab5114d-6406-4f4e-9830-383de325451a">1,350.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUyLTMtMS0xLTc4ODE_b87ca912-fcc5-449d-9415-e53c46a96e9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUyLTUtMS0xLTc4ODM_94ec3930-4cf2-4d2e-88ae-01cddf5bd1c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of property and equipment included in accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUxLTEtMS0xLTA_777d91f1-e94a-4a68-a2de-aae00e970352">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUxLTMtMS0xLTA_19fa6918-e909-474c-b474-cf4099543d82">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUxLTUtMS0xLTA_1f760aae-b3d2-4a0d-8d08-f95aec65abb3">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUzLTEtMS0xLTA_97bcb3b9-2936-4917-a74a-e79af3cfa156">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUzLTMtMS0xLTA_942766fb-d27f-4b70-8982-5c91614c491a">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUzLTUtMS0xLTA_6cd73cf8-416c-4246-b099-ba419b24e517">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for income taxes</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzU0LTEtMS0xLTA_b0e1db97-94bc-4b6e-a56e-cf1ca7505139">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzU0LTMtMS0xLTA_8ef98895-5440-47de-a4e3-e2e33367ad77">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzU0LTUtMS0xLTA_912f57da-27e7-479a-b654-81be2686efcb">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:15pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Consolidated Financial Statements</span></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr></table></div><div id="i889b093251984bfb881a094ef59c54bd_115"></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzExNTQ0ODcyMTMzNzYw_59064810-17b9-469c-8ec4-d3d9b7a22d2f" continuedAt="i61a58f62c4b545258bcca94a1ee14ed6" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1. Organization and Significant Accounting Policies</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Organization and Business</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DexCom, Inc. is a medical device company that develops and markets continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjA1_482fa93c-61af-4155-bad9-a62de0caec23" escape="true"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTI4_b9fd6df0-a599-4f61-8269-251d666d9731" continuedAt="i57897ca3ea2b4b0889d9234039aa247b" escape="true"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i57897ca3ea2b4b0889d9234039aa247b">The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income (loss) and in accumulated other comprehensive income in the equity section of our consolidated balance sheets. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in interest and other income, net in our consolidated statements of operations</ix:continuation>.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDcw_74867536-2eea-4ecf-b8dc-d2c934eed634" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDc2_bfb38e88-b36b-4c2b-a81a-99e6489ea9d7" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#8220;Fair Value Measurements.&#8221;</span></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTU2_bd702221-5d1f-4520-89b5-eec3fd0baac5" continuedAt="ic04e46db44294b42b094951999b83b14" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i61a58f62c4b545258bcca94a1ee14ed6" continuedAt="ia6f6bf7bfdf14532bcb78e2d34afa1d3"><ix:continuation id="ic04e46db44294b42b094951999b83b14"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider highly liquid investments with a maturity of <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:durday" name="dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzQxNjU_329360f7-bb0f-4fc7-b1c6-516696ccac17">90</ix:nonNumeric> days or less at the time of purchase to be cash equivalents.</span></div></ix:continuation><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjIz_fa476d1f-3d05-4f4a-8a12-71a6c99a8b5e" continuedAt="i43146e87bb3640788eb2dbf4c37ec099" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#8217; equity in our consolidated balance sheets and included in comprehensive income (loss). Realized gains and losses on marketable debt securities are included in interest and other income, net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i43146e87bb3640788eb2dbf4c37ec099">We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</ix:continuation> See Note 3, &#8220;Fair Value Measurements&#8221; and Note 4, &#8220;Balance Sheet Details &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-Term Marketable Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for more information on our marketable debt securities and our marketable equity securities.</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTQz_963e05b4-4c0e-490e-a6d7-9e96560f38b5" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Accounts Receivable and Allowance for Doubtful Accounts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are generally recorded at the invoiced amount for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.</span></div></ix:nonNumeric><div style="margin-bottom:11pt;margin-top:11pt"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDY3_d30bf48b-9ef4-495a-a89a-0f0a6a5c29fc" continuedAt="i14c2004fe7f94e0db7685bebbd603934" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk and Significant Customers</span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i14c2004fe7f94e0db7685bebbd603934">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</ix:continuation> </span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTA3_d1150cbe-7868-4e24-8768-a4ad14aee936" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Accounts Receivable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor A</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9cff1bc2dac48ea90553b980fd2c925_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtMS0xLTEtMA_12545b3f-b61d-43e8-89ed-889594e7a0d2">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i96dbf53aa4aa48419562b1d395e1f854_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtMy0xLTEtMA_68c5a54c-3519-479d-b2b4-1dc5e6dd14ac">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icaed968ca04841ac838a9395b4ddde38_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtNS0xLTEtMA_29eec3f8-4a18-4063-b092-73b90ed568ea">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iadc9086aefb444be9c59339767825b54_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtNy0xLTEtMA_4f20448a-aa36-448a-b1a5-df1b911ad6bc">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1042cfd24eb042868d75c1ab948d9274_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtOS0xLTEtMA_a9bea1d2-81b8-451b-b355-65e47dec05c2">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e33652311eb4e57bd6bfd8727b45672_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzQtMS0xLTEtMA_453d80eb-b8b1-45eb-867a-a149d97f54d7">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9910d7cdf82d4d41af4edfbba713867d_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzQtMy0xLTEtMA_756d9b57-a0b0-4811-8341-ffad05fa3660">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib53ea3ab72fb4434808baeb3dbdd3757_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzQtNS0xLTEtMA_da0452fc-fb9a-47ed-82ea-af919a20c240">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6bcd786fb0b4ea9b8f9951d9cf922c9_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzQtNy0xLTEtMA_f6b786a9-d6f0-41e3-87f1-a18635fb4b43">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor C</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51c0e602241341029dd0c585c07f2640_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzUtMS0xLTEtMA_64769daf-a356-45de-b45d-5851529cc98c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e8e542173bc421a8ea7fcba19440c37_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzUtMy0xLTEtMA_3849168f-892c-4236-9210-4329fba8111f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idddb7ec6794e442290c8762383c2f014_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzUtNy0xLTEtMA_8a7ca4fb-4153-4f68-b0d3-9ce15c7890c3">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b3da214a5bd4cd99d307ec8fba40242_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzYtMS0xLTEtMTE5OQ_b92bce76-d812-4e9a-a0ca-10d9da8df4fa">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Less than 10%</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDMy_ba6a0a99-083f-486c-a7f5-94c5426f8a8e" continuedAt="iffea0a8ac40c472fa9632400f0347622" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia6f6bf7bfdf14532bcb78e2d34afa1d3" continuedAt="i2effa03cafe440bbac007e79b5c53660"><ix:continuation id="iffea0a8ac40c472fa9632400f0347622" continuedAt="i1eacec25eed94e83b31eb2d1ed817a79"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inventory</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1eacec25eed94e83b31eb2d1ed817a79">Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements.</ix:continuation> </span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDg2_11a525b7-fb95-40a9-8f9b-4d55dd08d4d0" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property and Equipment</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally <ix:nonNumeric contextRef="i0a50a7ab68a24d07a8592dacb3cb2ed5_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzg3MDY_faa763c2-f947-43dd-ae5d-4e4a1051655a">three years</ix:nonNumeric> for computer software and hardware, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE3MDQyNDMwMjk0NDM5_2fca5438-1d1d-4e75-bbcb-835f55e20811">four</span> to <ix:nonNumeric contextRef="i937ac9769efb417fa531b7ef2eaf0b5b_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzg3NTM_571d3b94-9af9-49be-82eb-29892664d919">fifteen years</ix:nonNumeric> for machinery and equipment, and <ix:nonNumeric contextRef="i5136399a37e14cb998f33ad3100276b8_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzg3ODk_82001563-6764-4ff6-b4f0-2abdea54356a">five years</ix:nonNumeric> for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or <ix:nonNumeric contextRef="ie05ee9ac1ff14752904b83c729c90efe_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE3MDQyNDMwMjk0NDI4_a64f6aa2-4858-4069-89f0-261f8e910103">forty years</ix:nonNumeric>. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTg3_9e506438-dfc3-4066-b52b-f8d412207031" continuedAt="if15edc6f49914c348dbefc4d381a4436" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Goodwill</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#8217;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#8217;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#8217;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#8217;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#8217;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#8217;s market capitalization as a part of our analysis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2effa03cafe440bbac007e79b5c53660" continuedAt="ia4b18de53adc49e8a953e2d88b910daa"><ix:continuation id="if15edc6f49914c348dbefc4d381a4436"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#8217;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded <ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzEzNDgy_1705bdaf-9d87-4d96-b1fc-5afb43a02269"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzEzNDgy_587c299e-905a-46f4-9086-3ea368a8a1e9"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzEzNDgy_7267c085-e9f2-4568-ad60-b505c824dffb">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> goodwill impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in goodwill for the twelve months ended December&#160;31, 2020 and December 31, 2019 consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the twelve months ended December 31, 2018 consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Intangible Assets and Other Long-Lived Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are included in other assets in our consolidated balance sheets. We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE0MDk5_34699fb7-9374-4f8a-8afb-b91db71681d7">two</span> to <ix:nonNumeric contextRef="ibbb84a4a26f3410fb9ecbca78f99e413_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE0MTA1_15dfcdf7-bb98-476b-a93b-d94b28e866bc">seven years</ix:nonNumeric>. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. We recorded no intangible asset impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.</span></div></ix:continuation><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDk0_97e5d9e9-73f3-44c6-a1a8-c066cd311956" continuedAt="i0a374702b1a2438cb7302a4d455125c8" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our US operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years cumulative income and expect to continue that profitability in future years. We analyzed both positive and negative evidence, and as a result released our valuation allowance on our deferred tax assets. We maintain the valuation allowance on our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0a374702b1a2438cb7302a4d455125c8">We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense.</ix:continuation> </span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:StandardProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjE1_a21f6721-6cc7-4ef6-834f-db8dfc8a55ea" escape="true"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Warranty Accrual</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.</span></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDI5_5cdf27b4-1e0c-4c22-8750-0a94d463bdd2" continuedAt="iad2e85e993394c5cb41e2f7f326f85a1" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia4b18de53adc49e8a953e2d88b910daa" continuedAt="i55bc29cfd88747218a1eca607ab85173"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><ix:continuation id="iad2e85e993394c5cb41e2f7f326f85a1" continuedAt="ic6a8f0853ab64074981127617e3d733b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Loss Contingencies</span></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic6a8f0853ab64074981127617e3d733b">If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable.</ix:continuation> </span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjAx_ef8e6c3b-dc4d-4790-8ade-b37d4951770c" escape="true"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Comprehensive Income (Loss)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two elements, net income (loss) and other comprehensive income. We report all components of comprehensive income (loss), including net income (loss), in our financial statements in the period in which they are recognized. Total comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income (loss) and the components of other comprehensive income, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income (loss).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDY0_b7430e99-da44-4251-a093-e05578538481" continuedAt="i61baf8918d614f7eaa6311f7fc45a014" escape="true"><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revenue Recognition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate our revenue from the sale of our reusable transmitter and receiver, collectively referred to as Reusable Hardware, and disposable sensors. We refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining how revenue should be recognized, a five-step process is used which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Policy Elections and Practical Expedients Taken</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our Dexcom Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes but is not limited to rebates, chargebacks, consideration payable to customers such as specialty distributor and wholesaler fees, product returns provision, prompt payment discounts, and various other promotional or incentive arrangements. We classify our provisions related to variable consideration </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i55bc29cfd88747218a1eca607ab85173" continuedAt="i896fd8959e3d40a49b7c4b2f7d93aade"><ix:continuation id="i61baf8918d614f7eaa6311f7fc45a014" continuedAt="i54415b0a52f348efb0bd6142680878e0"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a reduction of accounts receivable when we are not required to make a payment or as a liability when we are required to make a payment. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rebates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate provisions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate provisions for chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consideration Payable to the Customer</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pay administrative and service fees to certain of our distributors based on a fixed percentage of the product price. These fees are not in exchange for a distinct good or service and therefore are recognized as a reduction of the transaction price. We accrue for these fees based on actual net sales and contractual fee rates negotiated with the customer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#8220;<ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:durday" name="dxcm:RevenueRecognitionSalesReturnsCoveragePeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzIwNjAw_9435f26a-3d07-4097-bb5a-a0d9efdfc7ae">30</ix:nonNumeric>-day money back guarantee&#8221; program whereby first-time end-user customers may return Reusable Hardware. We estimate our product returns provision principally based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prompt Payment Discounts</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customers with prompt payment discounts which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discount accruals based on actual net sales and contractual discount rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Various Other Promotional or Incentive Arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other promotional or incentive arrangements are periodically offered to customers, including but not limited to co-payment assistance we provide to patients with commercial insurance, promotional programs related to the launch of products or other targeted promotions. We record a provision for the incentive earned based on the number of estimated claims and our estimate of the cost per claim related to product sales that we have recognized as revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain sales transactions, control transfers at delivery of the product to the customer. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related Reusable Hardware component. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales of Components include an assurance-type warranty.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from <ix:nonNumeric contextRef="i25599498524d40f9acb652bfbaa12e50_D20200101-20201231" format="ixt-sec:durday" name="dxcm:ContractPaymentTermsNumberofDays" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzIyNjA2_cd00d82e-1dac-4c59-9067-cd54a6e87ec1">30</ix:nonNumeric> to <ix:nonNumeric contextRef="ibbb84a4a26f3410fb9ecbca78f99e413_D20200101-20201231" format="ixt-sec:durday" name="dxcm:ContractPaymentTermsNumberofDays" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzIyNjEy_a7ac51f1-a86d-48ba-b0ec-63dbaee0e70f">90</ix:nonNumeric> days. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of December&#160;31, 2020 included unbilled accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzIyNjky_69bb966e-45e7-457e-ba01-9780deecccc0">10.4</ix:nonFraction> million. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i896fd8959e3d40a49b7c4b2f7d93aade" continuedAt="iec5b985b67884dae99e93c529678c571"><ix:continuation id="i54415b0a52f348efb0bd6142680878e0" continuedAt="i345e66b42da94a65b0cb01dc987995c2"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within 12 months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after 12 months was $<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE2NDkyNjc0NDc0OTg3_61c95047-fd29-4f39-a049-3f441ace4dad">8.2</ix:nonFraction> million as of December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE2NDkyNjc0NDc0OTk1_4c533bfb-63c0-45f6-8c56-a0d2e8dbc211">2.1</ix:nonFraction> million as of December 31, 2019. These balances are included in other long-term liabilities in our consolidated balance sheets. Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Cost of Sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Compensation Costs</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i345e66b42da94a65b0cb01dc987995c2">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI0MTYy_26f15051-f810-463e-bb6f-d6109b4adecc">one</span> year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations.</ix:continuation> </span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dxcm:ProductShipmentCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjIw_d35be888-ed8c-431e-8309-2747f3ee0a59" escape="true"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Product Shipment Costs</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjI4_15e81964-09d2-4e3c-809b-b5bc95799804" continuedAt="idffac4c5d54c47eabb39a61bcddd651a" escape="true"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Research and Development</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idffac4c5d54c47eabb39a61bcddd651a">Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs.</ix:continuation> </span></div><div style="text-align:center"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDM5_a5a38808-2e41-401b-ba7a-cb3b026d9230" continuedAt="if6acdf8f797a457e8f88fb57bdc467f7" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Advertising Costs</span></td></tr></table></ix:nonNumeric></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"><ix:continuation id="if6acdf8f797a457e8f88fb57bdc467f7">We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses.</ix:continuation> Advertising expense was $<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI1ODQz_7b84c1c9-1830-4546-88a0-400c6882c366">76.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI1ODQ3_1802488a-8981-4cb2-ab05-2478a2a5befa">33.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI1ODU0_e91b3e5c-060a-4384-893f-0bd169576905">24.0</ix:nonFraction> million for the twelve months ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDg4_0b9c5b0e-a8b1-47d4-bd0f-895c98eba9d8" escape="true"><div style="margin-bottom:11pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Leases</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.</span></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjM2_19cf9e31-2209-4d44-bf56-fc98af6da962" continuedAt="ic32883b609634d1d9bc8949ae4f760ad" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iec5b985b67884dae99e93c529678c571" continuedAt="id67836aca03a4c39a71cd4ef035b738b"><ix:continuation id="ic32883b609634d1d9bc8949ae4f760ad" continuedAt="i0ff811138dab46629953234c05ada1b4"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Share-Based Compensation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value time-based Restricted Stock Units or RSUs at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0ff811138dab46629953234c05ada1b4">We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest.</ix:continuation> </span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjI0_e9ba7db4-6c74-424e-884f-1052aa279517" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Net Income (Loss) Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from stock options, restricted stock units, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of stock options and restricted stock units and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjI1_154d3e24-a96e-4c27-b28c-8059460e53a2" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per share for the periods shown.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:61.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzItMi0xLTEtMA_7faf1fba-a626-4d6a-b501-6883aed9113c">493.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzItNC0xLTEtMA_de85833e-178c-4b4f-a835-5b4425746591">101.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzItNi0xLTEtMA_b459e8e0-01b6-462f-94b0-0f7aaa90b932">127.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzUtMi0xLTEtMA_8b5ab769-9cdb-4036-b021-be22c3aa7564">5.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzUtNC0xLTEtMA_b9ef48aa-3296-4f84-8894-f5b4f44838f0">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzUtNi0xLTEtMA_0d991c9d-c45d-4fde-af24-66f2b3d6ee6a">1.44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzYtMi0xLTEtMA_c46791e6-e09a-4f11-9f8e-4f090b64aa1d">5.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzYtNC0xLTEtMA_532a904b-eed8-40e4-8897-c0908a2b1449">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzYtNi0xLTEtMA_67c1d59d-086c-4c5a-94d1-a22519d939a7">1.44</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzgtMi0xLTEtMA_03cba042-0eb4-423a-8c9b-0f0e44b10f75">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzgtNC0xLTEtMA_4773fc58-b048-492d-abf5-20126da1adcf">91.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzgtNi0xLTEtMA_0edc9cc3-ca7a-451d-a8f8-167190c14893">88.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and employee stock purchase plan</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i623dc723c3654d6f84c0203133743a3c_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEwLTItMS0xLTA_3a72722e-e7fd-4610-a6c3-8cb90ef7875c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i487acee9456946cdb9c4c15b15b58728_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEwLTQtMS0xLTA_3c2c25b9-4f2f-41d6-894a-2b44229de960">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1e6715852d34c6d9cf08a930ee3485b_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEwLTYtMS0xLTA_af07f9ba-554e-49f1-8178-2197f93157d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i954b8f3c51d640ac8ab5dd40a78b5387_D20200101-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzExLTItMS0xLTA_3e22e34f-2f16-45a8-af36-d3ce0f546276">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib32ce2a545784b15ac52d142f35bd1ca_D20190101-20191231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzExLTQtMS0xLTA_2f071cbb-db6e-4434-96d8-9a6191866cc3">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9471ca1928864644924a2ba32d88cc1f_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzExLTYtMS0xLTA_d6570cca-726a-4ef2-9ab1-89628ccb4125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic931fab80e0d492e975aaa6194f8e114_D20200101-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEyLTItMS0xLTA_eee6238b-1d89-41b2-a9db-924e2913cfeb">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4966c3d9c394b12bda5b16597859370_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEyLTQtMS0xLTA_fdeff149-260e-491f-b347-71ffe7dcc258">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaa97d31ed824316b5f9b802f7fbd276_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEyLTYtMS0xLTA_b7d178fa-fc5e-4d7e-907b-3de7dbbd359e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf74b07e99d94f2c93e41b91727019c7_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE0LTItMS0xLTA_8540d086-f95c-48f4-8b50-014110597949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife10a97075fb4eaebce519044eed7ce7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE0LTQtMS0xLTA_dd2b91d2-2cf7-459f-8476-bd0719b1acb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idcf57f15378a4158b986a2e96c250eea_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE0LTYtMS0xLTA_89f96377-4154-4169-8798-7598a3b9e53b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE1LTItMS0xLTA_e0bea499-204e-43e1-9e06-a92013451510">97.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE1LTQtMS0xLTA_f2b44bef-f40c-4ef6-98fc-a346d7e386e4">92.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE1LTYtMS0xLTA_9cfcd43f-c658-4c4b-af22-bd5db5121f04">88.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTA0_72f4972b-89b0-4eeb-b938-d675b05a4900" continuedAt="i7488c35601de4a28b80fa84607b7e509" escape="true">Outstanding anti-dilutive securities not included in the diluted net income (loss) per share attributable to common stockholders calculations were as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id67836aca03a4c39a71cd4ef035b738b" continuedAt="i7998128a2bdc495caacb59277cc538ef"><div style="margin-bottom:11pt;margin-top:11pt"><ix:continuation id="i7488c35601de4a28b80fa84607b7e509"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i623dc723c3654d6f84c0203133743a3c_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzItMS0xLTEtMA_84f5321e-2791-442f-87f5-0bb131e76018">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i487acee9456946cdb9c4c15b15b58728_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzItMy0xLTEtMA_b751c013-03e9-44e4-947f-a913ab371c59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1e6715852d34c6d9cf08a930ee3485b_D20180101-20181231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzItNS0xLTEtMA_3c375f51-4697-4588-b842-8352df81b10b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i954b8f3c51d640ac8ab5dd40a78b5387_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzMtMS0xLTEtMA_05973e34-6e53-488b-842a-35be1bd5b6b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib32ce2a545784b15ac52d142f35bd1ca_D20190101-20191231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzMtMy0xLTEtMA_214b642e-78cb-4cc2-9ffd-c94bcf15086d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9471ca1928864644924a2ba32d88cc1f_D20180101-20181231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzMtNS0xLTEtMA_25da209d-6a18-405e-9d46-24495bb191ce">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic931fab80e0d492e975aaa6194f8e114_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzQtMS0xLTEtMA_4e6961da-bd03-47c6-9734-b9d0eb60779d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4966c3d9c394b12bda5b16597859370_D20190101-20191231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzQtMy0xLTEtMA_287c94f2-eeef-45d3-b65f-6ee559993b16">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaa97d31ed824316b5f9b802f7fbd276_D20180101-20181231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzQtNS0xLTEtMA_eb80364d-af4e-4be4-8283-d2e39c4238d4">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf74b07e99d94f2c93e41b91727019c7_D20200101-20201231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzYtMS0xLTEtMA_1b71e86f-4d3b-4ebd-a0e8-7a7363a7e1f9">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife10a97075fb4eaebce519044eed7ce7_D20190101-20191231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzYtMy0xLTEtMA_3d83dc6e-006e-4c9c-bf33-2b05991b3a46">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idcf57f15378a4158b986a2e96c250eea_D20180101-20181231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzYtNS0xLTEtMA_20d507b8-8da2-4103-abea-13eda18ae1ab">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzctMS0xLTEtMA_169b3012-6508-492e-b9b5-ca9ca0cb311c">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzctMy0xLTEtMA_66691ddb-b273-434e-b8ec-ab12faf09559">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzctNS0xLTEtMA_356140f2-9f67-4a11-a530-2244976148ad">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzExNTQ0ODcyMTMzNzYx_3618d09e-5aed-4cc9-9168-e056a3aeceb5" continuedAt="i8eeee772061f43af96f7f93f39b6eef2" escape="true"><div style="margin-bottom:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. Our adoption of ASU 2016-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. In addition, the outbreak of the novel strain of coronavirus, SARS-CoV-2 (&#8220;COVID-19&#8221;), has not had a significant impact on our expected credit losses or our consolidated financial statements during 2020. We are continuing to monitor the impact of COVID-19 on expected credit losses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU No. 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-04)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Our adoption of ASU 2017-04 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;Our adoption of ASU 2018-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (ASU 2018-15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This new guidance requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We adopted the new standard on January 1, 2020 on a prospective basis. Our adoption of ASU 2018-15 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently evaluating the impact that this guidance will have on our consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><ix:continuation id="i7998128a2bdc495caacb59277cc538ef"><ix:continuation id="i8eeee772061f43af96f7f93f39b6eef2"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This new guidance is intended to reduce the complexity of accounting for convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation and requires enhanced disclosures about the terms of convertible instruments. Entities may adopt ASU 2020-06 using either a partial retrospective or fully retrospective method of transition. This </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU is effective for public business entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently evaluating the impact that this guidance will have on our consolidated financial statements.</span></ix:continuation></ix:continuation></div><div id="i889b093251984bfb881a094ef59c54bd_121"></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dxcm:DevelopmentAndOtherAgreementsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzQxNTY_a0337f15-1ff6-4746-b03e-b5bc304a169b" escape="true"><div style="margin-bottom:14pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2. Development and Other Agreements</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Collaboration with Verily Life Sciences</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of Dexcom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we have made upfront and incentive payments and we will make potential future milestone payments upon the achievement of certain goals. In the fourth quarter of 2018, we made an initial payment of $<ix:nonFraction unitRef="usd" contextRef="i615df7321c9348c998d7e063f8bd67aa_I20181120" decimals="-5" name="dxcm:CollaborativeArrangementUpfrontFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzIyNzA_eaed3a41-f654-47c3-a889-701ca585cd9e">250.0</ix:nonFraction> million through the issuance of <ix:nonFraction unitRef="shares" contextRef="ifcc7e8952bad4da2bbf8948b84f5ae8d_D20181120-20181120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzIyOTc_8e60cc8e-d543-4b10-b9ac-7edb2b1442aa">1,840,943</ix:nonFraction> shares of our common stock. We recorded a $<ix:nonFraction unitRef="usd" contextRef="idcad237c07544045a0efa52e0443d72f_D20180101-20181231" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzIzNDI_3ecca2bf-6cf9-4479-9eae-b5d240fa24f2">217.7</ix:nonFraction> million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The amount of the charge was based on our closing stock price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i31d2218e16f24d919d743df0127d21f8_I20181228" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzI1OTI_0daa15c9-2e56-4624-90eb-54fd25008b58">118.28</ix:nonFraction> per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and the transaction closed. During 2020 we made <ix:nonFraction unitRef="usd" contextRef="ib4b6d430ae4d4e93bade0e1a590f3f1e_D20200101-20201231" decimals="-5" format="ixt-sec:numwordsen" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzYwNDczMTM5NTcxMTg_78eb2e56-065b-4200-a422-002d89c4d38a">no</ix:nonFraction> incentive payments, while in 2019 we made incentive payments of $<ix:nonFraction unitRef="usd" contextRef="i4df6a91f5c464feda5d61246887477e0_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzI3NjM_94b3d2df-08da-4bdd-a44d-dd1968373d65">3.2</ix:nonFraction> million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations. Additional milestone payments of up to a total of $<ix:nonFraction unitRef="usd" contextRef="iceaf0df0d90548128c251bbadb05470c_I20181120" decimals="-5" name="dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzI5NTk_6175a3f2-691c-4641-8638-ffd2a314103c">275.0</ix:nonFraction> million may become due and payable by us upon the achievement of future development, product regulatory approval and revenue milestones. These payments may be paid in cash or shares of our common stock, at our election. If we elect to make all $<ix:nonFraction unitRef="usd" contextRef="iceaf0df0d90548128c251bbadb05470c_I20181120" decimals="-5" name="dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzMxOTg_5f5488bf-79a8-4c99-8f6f-91d8271d3527">275.0</ix:nonFraction> million of these payments in shares, we will issue a total of <ix:nonFraction unitRef="shares" contextRef="ib24f50ea0be64889a78368325e28c1b8_I20201231" decimals="INF" format="ixt:numdotdecimal" name="dxcm:PotentialFutureCommonStockIssuableSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzMyNTU_ff3c0e6b-4f61-443c-ba3b-4f346e843d1b">2,025,036</ix:nonFraction> shares of our common stock, based on the volume weighted average trading price during the <ix:nonNumeric contextRef="ib8927c59d45b409899e39263bc914622_D20181120-20181120" format="ixt-sec:durday" name="dxcm:WeightedAverageSharePriceConsecutiveDaysEvaluated" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzMzNDg_df5d84a4-0796-48c8-8da2-358f0dc1770c">15</ix:nonNumeric> consecutive days ending on the date of the Restated Collaboration Agreement. Alternatively, if we elect to make all $<ix:nonFraction unitRef="usd" contextRef="iceaf0df0d90548128c251bbadb05470c_I20181120" decimals="-5" name="dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzM0Njc_5f5488bf-79a8-4c99-8f6f-91d8271d3527">275.0</ix:nonFraction> million of these payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, adjusted for stock splits, dividends, and the like.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first revenue milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033.</span></div></ix:nonNumeric><div id="i889b093251984bfb881a094ef59c54bd_124"></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzU0MTU_f63f93db-2817-4ba6-9f9e-bfaef760723b" continuedAt="i57ca815cd6784a67b6a9fd721d37fec8" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3. Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i57ca815cd6784a67b6a9fd721d37fec8" continuedAt="i686f84e49134404aa3db6d4f15738ace"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values of our Level 2 marketable securities portfolio balance provided by our investment managers.</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzU0MjM_40f3c899-f4cc-4383-b6ce-a1903a2efc59" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2020, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ebe15ea5354284a29045fe47fb46b1_I20201231" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzItMS0xLTEtMA_e24b2b7b-5071-4628-b1a5-ad552b43b246">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09bae00ae8514ff08a6985ab2ac96d46_I20201231" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzItMy0xLTEtMA_5e4d437e-870f-40b7-a9f6-a0959b509ffa">150.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e343c46b6194f4380e1fe7c51520054_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzItNS0xLTEtMA_09fe5e9d-40e4-4166-8299-85051a8804bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzItNy0xLTEtMA_d88ffbc1-7fd0-4297-b055-c20ab77476f6">641.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5cda91bc024f7090c90466831fa67a_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzUtMS0xLTEtMA_ba6371d1-be4f-41fa-8674-9444a58e8b61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5aff7c546d45ba9ec38abb08822d8d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzUtMy0xLTEtMA_e8369551-6304-4665-8a74-3da7254c2d8b">1,570.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id92b9c26d62a4ca287002134a8a256e6_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzUtNS0xLTEtMA_78993183-1bb3-4551-96f1-3a5ef7196c7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzUtNy0xLTEtMA_f973e7c4-7bf4-4e98-ab30-0276c4db40ec">1,570.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib910a32cb01f4e5390ee06e908c61c31_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzYtMS0xLTEtMA_82db8cbc-9176-476b-accf-7e1fce2a23bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8535192ed8644f5582f70c23c1378c5b_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzYtMy0xLTEtMA_b725f82b-88a9-47d2-a05a-cb29c3eab92f">258.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8276529a58434a7b813dcb46b73073f2_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzYtNS0xLTEtMA_19856bc0-1845-4bfc-bbc0-47caa31fa2cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3265a756884edc835fa906c7740171_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzYtNy0xLTEtMA_b11d8bdb-cf88-4d9d-b1f5-532f910c4c47">258.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6072b512879424581f8888ccf4b1714_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzctMS0xLTEtMA_a1510473-c51e-4a84-a9c9-041fc0062b33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce4bc5e66a842608d994966881082ce_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzctMy0xLTEtMA_d07cf4cb-2cb4-4ee8-acbb-c1cea209c32b">60.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7749c1aed641479a3729499651b209_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzctNS0xLTEtMA_23b71855-f514-4187-8bec-9ee60c383e12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzctNy0xLTEtMA_fc23d175-1a7a-4494-a0ac-c3e5078e4c75">60.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ebe15ea5354284a29045fe47fb46b1_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzgtMS0xLTEtMA_8dc1d8f9-7a34-41f2-9ec7-857e69b1860a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09bae00ae8514ff08a6985ab2ac96d46_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzgtMy0xLTEtMA_dce45626-09ef-4d70-a7a0-f83898f2a350">1,890.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e343c46b6194f4380e1fe7c51520054_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzgtNS0xLTEtMA_951c1758-614b-46ee-be8d-f1256609105d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzgtNy0xLTEtMA_eedc8b58-5f7a-44a5-ad44-3bd1d0a74f8c">1,890.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ebe15ea5354284a29045fe47fb46b1_I20201231" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEwLTEtMS0xLTA_777667ce-dbb0-441a-94ae-23e5a7c332cb">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09bae00ae8514ff08a6985ab2ac96d46_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEwLTMtMS0xLTA_5dd65c30-d38a-4663-8fc6-280cdcbe4f14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e343c46b6194f4380e1fe7c51520054_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEwLTUtMS0xLTA_34aebe5e-3176-4f73-ab83-0ff7920e4aac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEwLTctMS0xLTA_da517278-3b13-4706-b05e-e3956d0e88f1">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ebe15ea5354284a29045fe47fb46b1_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEyLTEtMS0xLTA_ef272950-6f9a-4298-8b03-96255746cd63">494.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09bae00ae8514ff08a6985ab2ac96d46_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEyLTMtMS0xLTA_620d8a76-7732-457a-aa11-426fb7135d0a">2,040.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e343c46b6194f4380e1fe7c51520054_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEyLTUtMS0xLTA_e5596f40-035f-468a-a415-27c520819942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEyLTctMS0xLTA_bb2e489d-6482-407b-ad41-80266ad849cf">2,535.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2019, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cac588c14d54e36b24ced9f8983c608_I20191231" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzItMS0xLTEtMA_1a1d19c5-8f22-4b11-be66-206fb58d3ccc">110.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c17b8f03144e119934ea6043ba9473_I20191231" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzItMy0xLTEtMA_a89d7cba-cbbc-4c51-94a7-7fb1e71bd81c">144.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5b87038a814ec1a6c4020d34fb75fb_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzItNS0xLTEtMA_17cb85d7-03b8-4dee-8022-ceb502258600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzItNy0xLTEtMA_6568580b-1990-4a85-bcbc-3626d461ef5d">255.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a704f3be5c848d5b0eb7eca70324e2b_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzctMS0xLTEtMA_65d6f31f-90da-4cce-a705-fe598484bff5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0905eace1d084bdbae0f064671806ef4_I20191231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzctMy0xLTEtMA_88b941d8-fc1f-47ba-8ef3-8f04bfacd9f4">676.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1de93377374c41ad096882be863dc4_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzctNS0xLTEtMA_28f42e76-dbd2-44fb-9b11-d7031251b6f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzctNy0xLTEtMA_5e05fbad-436e-4e7b-953d-b38f496babb4">676.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i370e2a274e894e17830c5dd4de2f0b14_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzgtMS0xLTEtMA_b5a095c0-0d21-42c3-8b57-0ef04067dbe5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebd5d2f1c504a48ad99159aa9507fc7_I20191231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzgtMy0xLTEtMA_63fc8d75-7fd4-4f15-b141-771fc6d24c3a">248.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0632744de077450ba1f1cc509a18cf6e_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzgtNS0xLTEtMA_7325d45a-6e15-42fe-b936-f7f8f409c0f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzgtNy0xLTEtMA_fccf2312-243f-43c8-9c4e-ec9d2a31cc45">248.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57f0d5e88a4997a01dff3a6ac5d84f_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzktMS0xLTEtMA_3097601a-eb52-408e-be5f-ce50e5cbb882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61493ab0d7cc4e5d840ceb144efade0b_I20191231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzktMy0xLTEtMA_445c9941-84e6-494a-9c94-3fe68ca11d84">162.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i667ef1514f464c018ac2d87ad6fd7fb4_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzktNS0xLTEtMA_7c53add8-f4a2-48f0-8d48-3d7198f876d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzktNy0xLTEtMA_1e667111-305c-4d82-b19c-e46e47a4abf8">162.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cac588c14d54e36b24ced9f8983c608_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTEtMS0xLTA_eddbaf64-38c3-4a14-9841-ab46e76e6b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c17b8f03144e119934ea6043ba9473_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTMtMS0xLTA_86c4f503-5b67-4244-9019-cf5d1a9dc62e">1,087.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5b87038a814ec1a6c4020d34fb75fb_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTUtMS0xLTA_7848d9f1-a666-45d9-87ea-f4b0172e6045">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTctMS0xLTA_8c0f672d-54f6-43a8-8375-06ef8468b702">1,087.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cac588c14d54e36b24ced9f8983c608_I20191231" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTEtMS0xLTEyNjA_03892bec-154c-474d-8621-7f06297e5fde">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c17b8f03144e119934ea6043ba9473_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTMtMS0xLTEyNjA_5dbc8830-ebea-4025-b684-541c66ed8d19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5b87038a814ec1a6c4020d34fb75fb_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTUtMS0xLTEyNjA_46d1cb39-6d8b-4fd6-99b6-da9016371eea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTctMS0xLTI4NjY_e0d54398-daf5-4367-84ea-8d2f6ec1c9f6">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cac588c14d54e36b24ced9f8983c608_I20191231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTEtMS0xLTA_62dfdaee-97cf-4870-a981-0af9f3bc9ebc">110.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c17b8f03144e119934ea6043ba9473_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTMtMS0xLTA_a1d70069-105c-48d7-beb9-6f691521f515">1,232.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5b87038a814ec1a6c4020d34fb75fb_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTUtMS0xLTA_10022f19-d2ea-4933-9f91-4b1a0d0c084d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTctMS0xLTA_020e043d-58ec-4ee6-b2cb-dff7a4980054">1,342.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzE3NzM_24bf6180-4494-45d2-8db2-91e6a55c6080"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzE3NzM_498a2069-b5fa-41c4-b591-3660adc7ec00">no</ix:nonFraction></ix:nonFraction> transfers between Level 1 and Level 2 securities during the years ended December&#160;31, 2020 and 2019. There were <ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="dxcm:FairValueAssetsLevel3TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzE4NzA_54a2d8a3-ba2c-412d-8b85-dda439a265f3"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="dxcm:FairValueAssetsLevel3TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzE4NzA_fff86e0a-68e5-43ca-8b16-1dcb695d7424">no</ix:nonFraction></ix:nonFraction> transfers into or out of Level 3 securities during the years ended December&#160;31, 2020 and 2019.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i686f84e49134404aa3db6d4f15738ace" continuedAt="i7ca2db543d714dd6b8f6f179d52a3a0f"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments are not significant and we include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are often privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant adverse effect on the fair values.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Senior Convertible Notes</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzU0MjA_f0b6d6a0-0031-4dae-a02f-56af03a94e8a" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:69.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824914321cdf4eb3bab58c165184aebe_I20191231" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzItMy0xLTEtMA_ee327d07-d683-441c-aa57-471c257fec50">890.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea63bf6b583842f8afb95e80d99e8bb1_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzMtMS0xLTEtMA_2e2295fc-b29a-4d4d-a66a-69bb7932b830">1,936.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094a2a8c50c44667a8ed8cffec42dee4_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzMtMy0xLTEtMA_4084f57f-732c-4d36-998b-81e7f48375f6">1,260.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91b53fe18c4c4ea50245a93565fd7d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzQtMS0xLTEtMTI5MQ_de20a369-1994-487f-9078-f586fe97ce5e">1,219.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzQtMS0xLTEtMA_6e937f16-7b55-4b80-8782-8a0eb78128cc">3,155.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzQtMy0xLTEtMA_fe418e24-eec2-45f8-8ec7-05769a4bfbae">2,150.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Not applicable as no notes were outstanding at this date.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the carrying values of our senior convertible notes, see Note 5, &#8220;Debt.&#8221;</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency and Derivative Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we engage in hedging transactions to reduce foreign currency risks. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs, and the derivative instruments are recorded in current assets or current liabilities in our consolidated balance sheets consistent with the nature of the instrument at period end. Derivative gains and losses are included in interest and other income, net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2020 and December&#160;31, 2019, notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i4a7900a1db994a859636735a0f0324a1_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzM0MTI_60d936cd-ce54-47ee-93ce-c7c4d3ecb275">48.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i833d598aaf8f47baa412832261515cfc_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzM2NjA_99735ea5-ee93-433e-a364-860eeb0709bf">8.0</ix:nonFraction> million, respectively, were outstanding to hedge certain foreign currency risk. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the twelve months ended December&#160;31, 2020, 2019 and 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exposures vary but are primarily concentrated in the British Pound, the Euro, and the Canadian Dollar. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ca2db543d714dd6b8f6f179d52a3a0f">In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when any impairment is recognized. We recorded <ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzUzMzQ_43bfcf36-447d-4162-8891-d62fb7323f40"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzUzMzQ_64a6082c-9d7b-4604-a774-118d21f6f071"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzUzMzQ_d305f979-ab96-4311-a536-0ca28f38289d">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> significant impairment losses during the twelve months ended December&#160;31, 2020, 2019 and 2018.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3Mjc_9168de44-ff61-400b-aa23-fcfbaa65df3e" continuedAt="i53cc5b04d4894d45860e3355a74f4113" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4. Balance Sheet Details</span></td></tr></table></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td></tr></table></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3Mjk_f3e39617-15c9-4da4-9db5-0632134dcf98" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:46.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></div></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzMtMS0xLTEtMA_03619ea8-f464-475a-86db-2b8e7ecfbe83">1,570.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzMtMy0xLTEtMA_3628969c-20b8-41cc-b377-9f17ac09d5d6">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzMtNS0xLTEtMA_af242655-8d75-420a-bbc6-ea85c250da38">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzMtNy0xLTEtMA_179b2d20-4246-4ec1-b93d-8be9def6fa9a">1,570.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3265a756884edc835fa906c7740171_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzQtMS0xLTEtMA_bc7f1113-2906-4105-9f2c-5c5c0ae4f9c4">258.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3265a756884edc835fa906c7740171_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzQtMy0xLTEtMA_fc5cb654-bf80-4ee2-9d67-9414bc57daa5">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3265a756884edc835fa906c7740171_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzQtNS0xLTEtMA_9329a252-8330-45f1-a04e-b33fa7554ad1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3265a756884edc835fa906c7740171_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzQtNy0xLTEtMA_fd2952f3-8fd8-486d-b93d-1df3b6031daf">258.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzUtMS0xLTEtMA_0bec0228-1d7a-4b98-b648-d61b51d362ee">60.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzUtMy0xLTEtMA_1bc6e79a-9d02-4814-9694-4aa2c279e51b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzUtNS0xLTEtMA_1ecc0b08-dc24-4508-ac31-74a4b541b9d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzUtNy0xLTEtMA_15e1070f-35b2-477e-ba4d-7e6768722da3">60.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzYtMS0xLTEtMA_f81093e6-7846-4c87-ad3a-3bd76f6ad212">1,890.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzYtMy0xLTEtMA_3a5f4f79-8f94-4be0-be69-7951a98a4fed">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzYtNS0xLTEtMA_2fc244dc-c820-44ad-90cd-d2725dd3fe08">0.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzYtNy0xLTEtMA_436b8eaa-bb58-48e9-9097-8cb489c29283">1,890.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzUtMS0xLTEtMA_510f7b78-1c46-4f3a-944a-2995ed84a7d8">675.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzUtMy0xLTEtMA_6e018e51-6992-4aca-809d-fc11d7440347">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzUtNS0xLTEtMA_445f163f-14ed-400e-a8e8-1bb45e81a16b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzUtNy0xLTEtMA_29b93efd-1695-47de-b516-b8fc24582bb5">676.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzYtMS0xLTEtMA_8b5b99b6-4d3d-4958-b3ac-9d62ecaa098f">248.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzYtMy0xLTEtMA_a24f525d-4850-4559-b989-a572069a4f64">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzYtNS0xLTEtMA_ca6a9881-9efd-4841-9000-eb6e6950541b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzYtNy0xLTEtMA_2833388d-5ad2-42c7-9f05-8fa5996a7b0a">248.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzctMS0xLTEtMA_77652f2b-cba8-4d97-867f-21730cf4e84a">163.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzctMy0xLTEtMA_fce8b2aa-7bfc-4d65-b3a8-cce5ee0a333e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzctNS0xLTEtMA_62ed2cb9-da07-47d4-8ac5-a43e05d97c4c">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzctNy0xLTEtMA_5f864f5a-3c69-48fd-b3a4-f3a16461b0fc">162.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzgtMS0xLTEtMA_89abcc26-cbbd-4b51-82be-6092aeabfc9d">1,086.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzgtMy0xLTEtMA_5d7203c0-50c7-48d1-b3a4-18787c04b3f3">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzgtNS0xLTEtMA_c1bc5662-356f-4dd5-a3fa-4fcd54aecc6e">0.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzgtNy0xLTEtMA_b1de3a29-14a3-4038-9523-2f5ae1adca53">1,087.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and 2019, all of our debt securities had contractual maturities of less than <ix:nonNumeric contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" format="ixt-sec:durwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzIzMg_aeb46a35-8c89-462a-b367-6c1f0ce8e4b0">twelve months</ix:nonNumeric>. Gross realized gains and losses on sales of our debt securities for the twelve months ended December&#160;31, 2020, 2019 and 2018 were not significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at December&#160;31, 2020 were not significant and were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:GainLossOnInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MzM_f5093ef5-3c52-4281-8a5f-46ee257241bd" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the net gain recognized on marketable equity securities during the twelve months ended December&#160;31, 2020, 2019 and 2018 to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:59.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended&#160;<br/>&#160;December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains and losses recognized during the period on equity securities</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzItMS0xLTEtMA_9620999d-2260-4f44-8833-be0978a84c68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzItMy0xLTEtMA_0c3774a4-5d63-41ac-886b-573d0dbf0946">4.2</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzItNS0xLTEtMA_91c59c99-959d-4697-a9db-4672d99aa6fa">80.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net gains and losses recognized during the period on equity securities sold during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzMtMS0xLTEtMA_c8111f2b-b4b4-446b-81a1-fad6cfe3d804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzMtMy0xLTEtMA_d77707b5-6ab9-4e86-8cdc-1c771fdd1c92">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzMtNS0xLTEtMA_cc84dda1-6ac1-416c-a948-68fed6814aac">44.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzQtMS0xLTEtMA_93fd32bc-cea1-44d3-a43c-badac2512070">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzQtMy0xLTEtMA_051e2a22-8220-4048-b254-cecc29f1f6a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzQtNS0xLTEtMA_194cbd5e-5b97-4f62-804b-2ff4d673ab71">36.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i53cc5b04d4894d45860e3355a74f4113" continuedAt="i9869afe1cf0f42b1a0ad11e408d7ae20"><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Accounts Receivable</span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MDI_c73275c2-7ad7-4da3-9269-892ea8a65d83" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:72.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AccountsReceivableGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzItMS0xLTEtMA_2142f836-cbd3-49aa-85ab-7e6eb9f25755">435.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AccountsReceivableGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzItMy0xLTEtMA_77d60d9c-737a-4957-9f06-886d00708b8b">292.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzMtMS0xLTEtMA_623996ac-b698-4977-9a1d-be111b1c7017">7.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzMtMy0xLTEtMA_945ab3d3-7a3f-46da-a63b-08ed703589d8">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzQtMS0xLTEtMA_a8249151-da26-409a-85e7-a48d7388bea0">428.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AccountsReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzQtMy0xLTEtMA_cefa0140-a001-48ae-8596-3f23592bce3a">286.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inventory</span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MDk_6e5bedde-be4d-4a32-a886-dc28946a627a" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:72.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzItMS0xLTEtMA_7c9a2bfa-f598-44db-8e42-d5c04f1af1f4">69.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzItMy0xLTEtMA_4ea6400a-98b3-4754-8d1d-a3cea56ae861">64.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzMtMS0xLTEtMA_8f873c52-dae4-409b-b682-3b3e7aa70fec">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzMtMy0xLTEtMA_1922983f-704b-471e-8139-634853570366">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzQtMS0xLTEtMA_a21c8f3d-7316-4a21-a121-1e00537a69c9">150.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzQtMy0xLTEtMA_57968b81-282f-447f-b2ea-f481ee641499">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzUtMS0xLTEtMA_c780b8b6-c29e-4370-b1da-c2cef5ba6c6b">234.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzUtMy0xLTEtMA_fbb7b104-4ee3-4444-ba4c-a1100f8bf344">119.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2020 and 2019, we recorded excess and obsolete inventory charges of $<ix:nonFraction unitRef="usd" contextRef="i3fb0b180cb694f118960ccc9da9e7d85_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzEzNTk_51c7e2ff-0479-4561-9bbc-17611339abb7">24.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7f7515fed1ce4589adbabde6cf4f20cd_D20190101-20191231" decimals="-5" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI3NDg3NzkwNzQwMjA_ad1042ae-c983-4c44-a170-084db713a309">14.1</ix:nonFraction> million, respectively, in cost of sales as a result of our ongoing assessment of sales demand, inventory on hand for each product and the continuous improvement and innovation of our products. During the twelve months ended December 31, 2018, we recorded excess and obsolete inventory charges of $<ix:nonFraction unitRef="usd" contextRef="ic9decf99cba94ae588c9c036d46e7a88_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI3NDg3NzkwNzQwNDQ_cd9eb62f-61ed-4761-ada3-c51cc05536fc">7.3</ix:nonFraction> million in cost of sales primarily as a result of the approval and launch of our G6 system and our ongoing assessment of sales demand and the continuous improvement and innovation of our products. </span></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property and Equipment</span></td></tr></table></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MzA_888763af-c671-4a08-91d7-8dc7e119981a" escape="true"><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:72.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad228cd33024cad88643caf07e6164a_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzItMS0xLTEtODcxMA_7da9e706-1ef0-492c-8210-73243cf4d632">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057d34c5ad2a4be99a734d6e91c1a7fe_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzItMy0xLTEtODcxNQ_32908a9f-2491-4293-89cd-2705cace9dfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300b1ce4d8494fc99011c04df98671bf_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzItMS0xLTEtMA_21075992-e4c0-45bd-9eb3-f34546d94c56">49.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b55a585c4b242df8b97a38b585d21d1_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzItMy0xLTEtMA_4676bf10-0427-4904-a060-5ecdba47ba0f">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib254b46104664cc0bea561395f6e1d0a_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzMtMS0xLTEtMA_9f6a7bab-9d6e-4af8-9661-733abb78fbc3">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ff6f9c8a1c4dc49b7be4fa6bfb4e0a_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzMtMy0xLTEtMA_34ab009e-0c4a-4b99-a89a-1098ae549e87">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65cdf0bbb534ff8b54804c8c04e4d6b_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzQtMS0xLTEtMA_22d3ab2c-9a63-4e96-a73a-8d0a3b773d79">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifba7e8356ca14d2ba58dddba2df2d708_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzQtMy0xLTEtMA_ff328170-96b5-44c8-acf7-56833daabf7c">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab58e138022469894bc21a0ced86296_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzUtMS0xLTEtMA_bc7ed14b-d318-4736-bf74-8a8674c4bafc">198.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d744ae1b6b4be5bcb2a6eeb386c04b_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzUtMy0xLTEtMA_59c39b82-2370-48dc-a121-e36ca88879f2">130.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa80ff42b6994adb90d475cddbd0d364_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzYtMS0xLTEtMA_e975483a-9084-4309-8928-3729cfaf0a24">135.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd00f21e56f5451794ad6ac6c3bfa468_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzYtMy0xLTEtMA_640c6988-4993-46c2-9dc8-b43d5102ddff">102.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cbe832d48b7469fadfd20a7d4174a82_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzctMS0xLTEtMA_3e68938e-431c-4262-896e-384f0964b84d">219.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01240eeff3424399ac46617dff38a60e_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzctMy0xLTEtMA_8ef48547-9a54-4946-9386-177b6b94e622">132.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzgtMS0xLTEtMA_65ea73a3-c5c5-4886-80c3-c193aa5fa114">669.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzgtMy0xLTEtMA_48a02730-7932-403e-8315-28665ff92515">426.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzktMS0xLTEtMA_31f0e0eb-880c-4503-8648-a562d023ce2d">154.2</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzktMy0xLTEtMA_945528c9-c62b-498b-bf45-f6a3600dcd00">105.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzEwLTEtMS0xLTA_70dcf791-7e3c-47f0-a7f6-624af046387c">515.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzEwLTMtMS0xLTA_9b39f50a-7306-4e91-aade-a1c5da13c6ee">321.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents our finance lease right-of-use assets.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for the twelve months ended December&#160;31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI2NzQ_76122c07-3942-4120-ab56-9e674f44a792">64.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI2Nzg_2956544e-a162-4954-9f3a-ed2045680574">46.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI2ODY_92ce26af-a76d-44bf-8453-4bed1db20eb9">28.6</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on disposal of property and equipment during the twelve months ended December&#160;31, 2020, 2019 and 2018 recorded in operating expenses was $<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI4MTI_3a16aa16-b13e-44d2-8d47-3b172a5e246b">13.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI4MTY_cbadefe5-094c-4f23-8a41-5b26e7999def">10.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI4MjM_d04c1024-ee1d-4e5f-a590-3e1576f9ed2d">5.4</ix:nonFraction> million, respectively. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9869afe1cf0f42b1a0ad11e408d7ae20"><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Accounts Payable and Accrued Liabilities</span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MDM_2eea50be-5475-4aa6-a29e-5da10e8e1c09" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:72.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable trade</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzItMS0xLTEtMA_0808798e-b70f-4d31-b2d9-1dc39ac7cd57">163.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzItMy0xLTEtMA_b53a74d2-3367-4c6c-9ba1-085cfff031ef">102.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="dxcm:AccruedTaxAuditAndLegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzMtMS0xLTEtMA_02b1e566-d879-49d3-9c34-4644c7798712">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="dxcm:AccruedTaxAuditAndLegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzMtMy0xLTEtMA_65bc70ba-3e6d-4f11-8b3d-bb6f0b467686">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="dxcm:PharmacyRebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzQtMS0xLTEtMA_117d7b63-95fc-43b8-856f-5abad0db85da">247.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="dxcm:PharmacyRebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzQtMy0xLTEtMA_cf776677-4fc1-4ed6-b9c4-4bdba83e196d">93.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzUtMS0xLTEtMA_4258ba0d-b461-4c15-9e4a-aa461b78bb86">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzUtMy0xLTEtMA_eb8deb2f-541f-4616-b4dd-7e068f05a125">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzctMS0xLTEtMA_b11c5498-c171-4684-9b7d-332b99d22842">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzctMy0xLTEtMA_92e59cc7-01f5-4cf1-a3f9-bf8182a8d1fe">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzgtMS0xLTEtMA_4fa9f2a5-2b35-4e3d-828f-7c537c3b1d4b">481.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzgtMy0xLTEtMA_fe866d50-2b0f-4ae2-9fa7-e246936d43c4">256.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:14pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Accrued Warranty</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warranty costs are reflected in our statements of operations as cost of sales. <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3NTM_e4d727b3-cbe0-4a17-b3d8-2d5f1c94d087" continuedAt="i7e17e7074cf14042bcfcf0e42f6a8505" escape="true">Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2020 and 2019 were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><ix:continuation id="i7e17e7074cf14042bcfcf0e42f6a8505"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:72.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.649%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzItMS0xLTEtMA_de7b6076-92b1-4e9e-b053-f6eb792b6f98">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzItMy0xLTEtMA_cecd8c15-6bbb-46d9-b24a-803c97ac4c93">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzMtMS0xLTEtMA_8190913f-cb01-4138-b4fc-8588db7a9ad5">41.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzMtMy0xLTEtMA_690e7d66-ed58-4fa9-866c-a386c7c9a560">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzQtMS0xLTEtMA_701fdea9-6239-4948-90d5-351d169167b0">37.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzQtMy0xLTEtMA_0f4eac86-311f-4bb1-b384-c2d76c2874dd">32.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzUtMS0xLTEtMA_42daa923-e808-4a7d-b6ba-d2c3a60e7a37">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzUtMy0xLTEtMA_657cd4a3-573b-41ba-bdd5-e90e44170657">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3NDU_a2613c2d-04d9-49d4-b39b-18d93589e01b" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:72.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="dxcm:FinancingLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzItMS0xLTEtMA_2749d9a4-2eec-4e87-b268-d40d74c33cde">54.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="dxcm:FinancingLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzItMy0xLTEtMA_55f65feb-440c-4555-a706-03d9e0012d0f">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:ContractualObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzMtMS0xLTEtMTgwNA_65d1767e-4ccb-42ec-b7b2-bcdb3e06dc59">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ContractualObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzMtMy0xLTEtMTgwNA_142006d7-794e-4a54-a940-b0e6fb9ef546">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzQtMS0xLTEtMA_078d195d-252a-4d60-9563-a8232ea36c7f">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzQtMy0xLTEtMA_98115bb1-105b-4a2d-98d4-c3f2e8b9023f">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzUtMS0xLTEtMA_7bf67181-4362-49c2-808b-02dba2879bf8">80.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzUtMy0xLTEtMA_fc65eaee-a473-467c-adb6-7f9b6e1dabed">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-bottom:12pt;margin-top:6pt;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTUz_0e285be5-0e37-4f3c-9f51-1ce7ea67583b" continuedAt="i130e65d174134493b81097d3a3d7026a" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5. Debt</span></td></tr></table></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Senior Convertible Notes</span></td></tr></table></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTQz_c48ccea5-f090-4eb8-9057-dd5b1697122b" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42d67ad56d484dbfa64dbb92ac7c6053_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzMtMS0xLTEtMzI0Ng_fd7514e3-1adf-4246-9073-09a646ded00b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824914321cdf4eb3bab58c165184aebe_I20191231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzMtMy0xLTEtMzI0Ng_8affd03a-0b48-457c-b91f-473e0b9b4f84">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea63bf6b583842f8afb95e80d99e8bb1_I20201231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzQtMS0xLTEtMzI0OQ_572dff13-6723-4cc3-88ed-3093a2662ad9">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094a2a8c50c44667a8ed8cffec42dee4_I20191231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzQtMy0xLTEtMzI0OQ_840e1382-94f3-4b05-9bd0-2d5e68fef6b7">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91b53fe18c4c4ea50245a93565fd7d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzUtMS0xLTEtMzI1Mg_43e6f82f-2ffe-4cb7-9fc8-5d41f7979eef">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b70c30dde844758d39245d643825b8_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzUtMy0xLTEtMzI1Mg_0dec03a9-a4e2-4bd5-8f86-b124d208f72f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzYtMS0xLTEtMzc5MQ_6f8a4ca0-508e-409b-8dbb-3eec8312ce6e">2,057.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzYtMy0xLTEtMzc5NA_2622f726-1e7d-4097-9e39-2d49a43ac363">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzctMS0xLTEtMzI1NQ_35d97a2c-fabf-46a8-91cc-a5430542e904">371.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzctMy0xLTEtMzI1NQ_cfa6436a-e7ca-4aec-990b-dfabebacd93d">177.2</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzgtMS0xLTEtMzI1NQ_da353514-9b14-4d46-863e-e808c47b29d8">19.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzgtMy0xLTEtMzI1NQ_cbed89e2-3e6a-4e5a-b72a-d0f6295c7103">13.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of liability component</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleLongTermNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzktMS0xLTEtMzc5MQ_2ee18951-45c9-463c-8db1-e1498b6c3243">1,667.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleLongTermNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzktMy0xLTEtMzgwNA_a80804b6-03b2-4c7b-b2e8-4cd4be95a76b">1,059.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity component</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231" decimals="-5" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzEyLTEtMS0xLTMyNTg_f5f425d9-8ac4-49fd-9ed9-03d618ba0127">461.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231" decimals="-5" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzEyLTMtMS0xLTMyNTg_1d8b7dc4-a741-4e06-bdc9-edee64a4a81c">242.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i87fbc88d23bd4515b69081936e2c024c_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzE0LTMtMS0xLTMyNjU_b302a5ec-326b-4d7b-93af-2b17308643e5">2.5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzE1LTEtMS0xLTMyNjg_3da243cf-e67c-483a-a531-40aec077ba1b">2.9</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1297bc3abcfa4f7382b94f81ed19c05b_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzE1LTMtMS0xLTMyNjg_b5f50bf8-6e76-4bd0-bb54-601668aed256">4.0</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i63f56e49768249e5b7989f94f1d74990_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzE2LTEtMS0xLTMyNzE_1604ba9a-fe11-4fe5-ac70-0d30e09c386b">4.9</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding at this date.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ConvertibleDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTQ2_baefa3a8-c3f3-4dab-9159-8f5d819ff2be" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal is as follows as of the dates indicated:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87fbc88d23bd4515b69081936e2c024c_D20190101-20191231" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzItMy0xLTEtMA_65a9fb83-4d6d-4539-be9c-3ad990588138">486.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzMtMS0xLTEtMA_f70935ab-573c-454a-910e-4b0435b0e90a">1,077.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1297bc3abcfa4f7382b94f81ed19c05b_D20190101-20191231" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzMtMy0xLTEtMA_38cd956e-a6b3-4dd4-b918-93faee9a7343">372.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total by which the notes&#8217; if-converted value exceeds their principal amount</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb9d3f521d5d48a9a1710727f9c1ed43_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzQtMS0xLTEtMA_07c82b30-0741-40f6-8cb4-4db058c139ee">1,077.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6a74eecb57e41acb0aa286caff969ec_D20190101-20191231" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzQtMy0xLTEtMA_e91dd569-a304-4d13-9612-e12e25ae3c63">858.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding at this date.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span><br/></span></div><ix:continuation id="i130e65d174134493b81097d3a3d7026a" continuedAt="i43d29b9295f149399417c0d88c443b32"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTQ3_00ca5d39-acf3-48e7-bd3f-39902258cdd1" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzQtMS0xLTEtMzMxNw_ebfef830-e09c-4a4e-87cf-87ed2a26107a">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzQtMy0xLTEtMzMxNw_e6683a08-d6d6-431a-96cd-ad65b4d90684">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzQtNS0xLTEtMzMyMA_cf6973d6-f321-42f7-8a6b-a674de330718">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzYtMS0xLTEtMzMyNA_c9b25af0-1dec-4b90-89f6-0ea2998b435f">68.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzYtMy0xLTEtMzMyNA_435a382b-17e1-42b5-a1df-85ee76c51d85">45.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzYtNS0xLTEtMzMyNw_f82a09ae-6651-4faf-b6fc-d5616764e4c4">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzctMS0xLTEtMzMzOA_fa052c90-e6b9-4ed9-aeeb-50cc92cbb1b8">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzctMy0xLTEtMzMzOA_0d9ea6a4-e31f-4859-935c-af7f9eb5c047">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzctNS0xLTEtMzM0MQ_8b05e099-e001-482d-a6c8-751359a7f299">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense recognized on senior notes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzgtMS0xLTEtMzMzMQ_f0c3e8d0-f510-445c-9f32-96a0d3a1e970">81.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzgtMy0xLTEtMzMzMQ_e5a98ef4-ce22-4cc0-9300-c266197a1955">58.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzctNS0xLTEtODA4OA_8a0aea92-c91c-4455-bec8-e13512da24a3">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rates:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic50af612698747bfbe32dc206df1497b_I20201231" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzExLTEtMS0xLTMzNDg_80464eba-82c7-4935-b144-c675b0b7e188">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a9055ea7e814dc08a48a9cc25b0a3e7_I20191231" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzExLTMtMS0xLTMzNDg_74165233-9e4e-4fa6-adb7-ca9b26139152">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id11ec3fd242a40cfb175758ef847aa82_I20181231" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzExLTUtMS0xLTMzNDU_b3c82baf-5d0b-407c-a713-5bb5e941752d">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d4ba8ee71d445d38e472a82695ac35e_I20201231" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzEyLTEtMS0xLTMzNTE_f21bde70-bd5e-4317-b64b-727442d6ed9f">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa27edbf751044d38c98cc6490ee0239_I20191231" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzEyLTMtMS0xLTMzNTE_0ffa7992-53f7-44b1-9845-59d63fefac9d">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i385417946a284bda98679e20b7d7ac2b_I20181231" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzEyLTUtMS0xLTMzNjA_022f1dde-4157-46d0-a589-53b91a95e36d">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if136e8c77c874676bf740b0c46fce4aa_I20201231" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzEzLTEtMS0xLTMzNjc_80de2be7-b7db-4138-a4a1-4e19e616685d">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest on the 2022 Notes began accruing upon issuance and was payable semi-annually on May 15 and November 15 of each year. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The effective interest rate presented represents the rate applicable for the period outstanding. The Senior Convertible Notes due 2022 were fully redeemed by July 31, 2020, as described below.</span></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding at this date.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Senior Convertible Notes due 2022 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2017, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="i2b54ebecbc5445c08be0b579b40354c4_I20170612" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzg4MQ_0841d4b0-4379-45e1-a959-92bf99b995b0">400.0</ix:nonFraction> million aggregate principal amount of unsecured senior convertible notes with a stated interest rate of <ix:nonFraction unitRef="number" contextRef="i327905247cf740c896e4c6b8ec6ba29b_I20171231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzk4MA_dfeff239-94f8-44f6-9fda-f627befdb62f">0.75</ix:nonFraction>% and a maturity date of May&#160;15, 2022 (the 2022 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately $<ix:nonFraction unitRef="usd" contextRef="i76005d853c2c4c6c974ae1790121a19c_D20170601-20170630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExNzI_08067ca5-a626-41dd-ab21-1538ed55a118">389.0</ix:nonFraction> million. The initial conversion rate of the 2022 Notes was 10.0918 shares per $1,000 principal amount of notes, which was equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i327905247cf740c896e4c6b8ec6ba29b_I20171231" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEzMjg_4b43a8fb-ecf0-4720-a468-33f357fd68da">99.09</ix:nonFraction> per share, subject to adjustments. The 2022 Notes could be settled in cash, stock, or a combination thereof, solely at our discretion. We used the if-converted method for assumed conversion of the 2022 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since upon conversion by the holders we could elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized $<ix:nonFraction unitRef="usd" contextRef="iceb839a717174e39b3fba3bd84bba52e_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE2NDkyNjc0NDU1MjA5_12f882a5-d4d7-4c7d-8e1a-536b080a9649">70.6</ix:nonFraction> million in additional paid-in-capital, net of debt issuance costs, during 2017.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments were due on the 2022 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2022 Notes included customary terms and covenants, including certain events of default after which the 2022 Notes could be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2022 Notes), holders of the 2022 Notes had the right to require us to repurchase for cash all or a portion of their notes at a price equal to <ix:nonFraction unitRef="number" contextRef="i94022d7303af424b83b5e28a7c9159c2_I20170630" decimals="INF" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI2MTg_010019b4-3baa-4be8-9e23-41fce54731a8">100</ix:nonFraction>% of the principal amount of the 2022 Notes, plus any accrued and unpaid interest. Holders of the 2022 Notes who would convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption were, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2022, holders of the 2022 Notes could convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during any calendar quarter commencing after September&#160;30, 2017 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="d" contextRef="id4d936cb81684c6d951a9c9586de7935_D20170101-20170630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzMzOTM_282550fb-ac7e-45d7-83f0-b2031e4ab42d">20</ix:nonFraction> trading days (whether or not consecutive) during </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i43d29b9295f149399417c0d88c443b32" continuedAt="iff22120427e9480080c74451c86a663b"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the period of <ix:nonFraction unitRef="d" contextRef="ie0f4cf90dbd54f36b16e48026ad767b8_D20170101-20170630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM0NTk_8994abd4-41d3-474f-917a-85beeeb30540">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="id4d936cb81684c6d951a9c9586de7935_D20170101-20170630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM1OTI_d6e75e0a-b28d-4c1f-a42a-6c8ef0596036">130</ix:nonFraction>% of the applicable conversion price of the 2022 Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during the <ix:nonFraction unitRef="d" contextRef="i6b82c1d246504bdc9b052ed1631c170d_D20170101-20170630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM2ODA_b386542a-ff69-4edb-8b51-241e24186dac">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="d" contextRef="i02ce6fa21a4c467b932127bbab4129a9_D20170101-20170630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM3MTM_47a52083-968e-4a26-b72b-81da263532c1">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the 2022 Notes for each day of that <ix:nonFraction unitRef="d" contextRef="i02ce6fa21a4c467b932127bbab4129a9_D20170101-20170630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM4MzI_a3890cc4-cb09-403d-af7d-b25106100790">five</ix:nonFraction> day consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="i02ce6fa21a4c467b932127bbab4129a9_D20170101-20170630" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM4ODQ_ace11ed3-1bb8-4982-bc1c-9e26c1f09d02">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">if we called any or all of the Notes for redemption, at any time prior to the close on business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On or after February&#160;15, 2022, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2022 Notes could convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Circumstance (1) listed above occurred during the quarters ended December 31, 2019 and March 31, 2020. As a result, the 2022 Notes became convertible at the option of the holder from January 1, 2020 through June 30, 2020. On June 29, 2020, Dexcom issued a notice of redemption to the holders of its outstanding 2022 Notes which is described below. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after May 15, 2020, Dexcom could redeem for cash all or part of the 2022 Notes, at its option, if the last reported sale price of our common stock had been at least <ix:nonFraction unitRef="number" contextRef="i144fe05e631d4754b752fbaffcb88425_D20170101-20170630" decimals="INF" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzU1NTk_d08f71bb-b3e4-4312-9aa7-2805caab6a7d">140</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="d" contextRef="id4d936cb81684c6d951a9c9586de7935_D20170101-20170630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzU2MTQ_cf8f4c15-c24c-46ed-b9ab-74172fe7a754">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="ie0f4cf90dbd54f36b16e48026ad767b8_D20170101-20170630" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzU2NzA_1b32987f-03ef-46db-ae3e-c4f7ee857525">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provided notice of redemption. The redemption price would be equal to <ix:nonFraction unitRef="number" contextRef="i144fe05e631d4754b752fbaffcb88425_D20170101-20170630" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzU4NjI_f01d7015-7e77-4b6e-ac08-8b4974e7dc41">100</ix:nonFraction>% of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Repurchase, Conversion, and Redemption of 2022 Notes </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we used approximately $<ix:nonFraction unitRef="usd" contextRef="ib331a0829e1642b19cf7b81d2e144de8_D20200501-20200531" decimals="-5" format="ixt:numdotdecimal" name="dxcm:PaymentsForRepurchaseOfConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODc2MTU_315b95cd-fdef-4a44-bb02-87533282c812">282.6</ix:nonFraction> million of the net proceeds from the 2025 Notes offering described below and issued <ix:nonFraction unitRef="shares" contextRef="ib331a0829e1642b19cf7b81d2e144de8_D20200501-20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODc2OTU_df499a35-cf8e-4848-a048-5b6b8d9fcf4b">1,953,067</ix:nonFraction> shares of Dexcom common stock to repurchase $<ix:nonFraction unitRef="usd" contextRef="if5dcc4f82db040e08f0392a1b34637e4_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODc3NDM_57efcdb2-b426-4beb-a89c-3423973649e3">260.0</ix:nonFraction> million principal amount outstanding of the 2022 Notes and the associated conversion feature of the repurchased notes (which was recorded in additional paid-in capital). In addition, holders of 2022 Notes with a principal amount of $<ix:nonFraction unitRef="usd" contextRef="ia18646096f2f4313b85666436e60e864_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="dxcm:DebtInstrumentConvertiblePrincipalAmountExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODgwMjA_a5270320-68c2-4736-be3b-f447210b2a1c">140.0</ix:nonFraction> million exercised their option to convert their 2022 Notes during the twelve months ended December 31, 2020. We settled these conversions by issuing <ix:nonFraction unitRef="shares" contextRef="i5c37e038885d460caf56e886ef183fc3_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODgxMTY_16941385-6a66-4ecf-91be-df7355988f42">1,412,497</ix:nonFraction> shares of our common stock. As a result of the repurchase and conversions of the 2022 Notes, we recorded a loss on extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i171e86410669489fbef485118636de53_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODgzMTU_92dd0cca-973b-4a44-ba51-c96a2e2df27b">5.9</ix:nonFraction>&#160;million for the twelve months ended December 31, 2020. The loss on extinguishment of debt included the unamortized debt issuance costs for the 2022 Notes. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, we issued a notice of redemption to the holders of our outstanding 2022 Notes pursuant to which we would redeem the outstanding 2022 Notes for cash at a price of <ix:nonFraction unitRef="number" contextRef="ia48631aa96ef4bdd85a3f1e83f1deeb1_D20200629-20200629" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODg2NDg_b806e6c5-e7f9-40e8-bc37-611001f71cc0">100</ix:nonFraction>% of the principal amount of the 2022 Notes plus accrued and unpaid interest, if any, on July&#160;31, 2020, unless earlier converted. The principal amount of 2022 Notes actually redeemed for cash was not significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.75% Senior Convertible Notes due 2023</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we completed an offering of&#160;$<ix:nonFraction unitRef="usd" contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzYwODE_c0f3b941-4bd5-4856-8b07-4cd186a80ddd">850.0</ix:nonFraction> million&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;<ix:nonFraction unitRef="number" contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzYxODA_e0fe5484-0c71-49f3-b186-804f56d3701d">0.75</ix:nonFraction>%&#160;and a maturity date of&#160;December&#160;1, 2023&#160;(the 2023 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzYzNzI_7ba12d6a-6fa0-4f0c-b07f-3ebe36cdb8d0">836.6</ix:nonFraction> million. The initial conversion rate of the 2023 Notes is&#160;6.0869&#160;shares per&#160;$1,000 principal amount of notes, which is equivalent to a conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzY1Mjg_bb2d22d5-16bd-40c8-9175-f9eff47a18e1">164.29</ix:nonFraction>&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the 2023 Note Hedge) and warrants (the 2023 Warrants) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized $<ix:nonFraction unitRef="usd" contextRef="i8b3a6150f8924f1287825cc009c6b717_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzcyNjk_ddf9e187-7ccd-4934-be29-a9f017cd5ea8">171.6</ix:nonFraction> million in additional paid-in capital, net of debt issuance costs, during 2018. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iff22120427e9480080c74451c86a663b" continuedAt="i88761c5ae3754e65956582b6b57389a7"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at <ix:nonFraction unitRef="number" contextRef="iea63bf6b583842f8afb95e80d99e8bb1_I20201231" decimals="INF" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzc4NzM_981de89e-7580-46e1-b6d9-68f9293be840">100</ix:nonFraction>% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during any calendar quarter commencing after March 31, 2019 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="d" contextRef="i690dc51114b644a9afb0024fdbd293c1_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzg3MTA_edb8f56b-03a5-4452-af7f-ab0e7f7dc47f">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="d" contextRef="i7282b108e48d4eabac8748333920ce52_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzg3NzY_8373fe3f-716b-48dc-9500-46fa10ed6547">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="i690dc51114b644a9afb0024fdbd293c1_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzg5MDk_a1916fc8-25e0-4472-8658-d07b8136c40e">130</ix:nonFraction>% of the applicable conversion price of the 2023 Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during the <ix:nonFraction unitRef="d" contextRef="i46cf6aa4cbc04a0f82d9a6b0fe29ad48_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzkwMDI_bfdd4051-d817-49e6-ba4a-5f8a95b8e762">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="d" contextRef="i1faeacf9c3314fe59169bdbee5cb8ae9_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzkwMzU_70aeb761-a4cd-432d-a068-716ff5e66e51">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that <ix:nonFraction unitRef="d" contextRef="i1faeacf9c3314fe59169bdbee5cb8ae9_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzkxNTk_82e69477-bae4-48bb-ac9d-764421d9d632">five</ix:nonFraction>-day consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="i1faeacf9c3314fe59169bdbee5cb8ae9_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzkyMTE_6ac0e282-8e76-4327-b6f1-393cdc3ec35d">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the 2023 Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after September&#160;1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Circumstance (1) listed above occurred during the quarters ended December 31, 2019, March 1, 2020, June 30, 2020, and September 30, 2020. As a result, the 2023 Notes were convertible at the option of the holder from January 1, 2020 through December 31, 2020; actual conversions during that period were not significant. Circumstance (1) listed above also occurred during the quarter ended December 31, 2020 and as a result, the 2023 Notes will be convertible at the option of the holder from January 1, 2021 through March 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2023 Notes prior to December 1, 2021. On or after December 1, 2021 and prior to September 1, 2023, Dexcom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231" decimals="INF" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEwNTY5_af3c4c13-031a-482c-a3d3-c81094d0a60d">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="d" contextRef="i690dc51114b644a9afb0024fdbd293c1_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEwNjI0_b8e597e5-1cdc-4c6b-b907-493b3e180c7a">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="i7282b108e48d4eabac8748333920ce52_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEwNjgw_1638402e-f687-4ca6-a7e7-756146fda05d">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to <ix:nonFraction unitRef="number" contextRef="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEwODcy_95eb4027-c04a-4638-b70d-e3d5526615f2">100</ix:nonFraction>% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Note Hedge</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to&#160;<ix:nonFraction unitRef="shares" contextRef="i2d77c5b3b87a4eef982cf15597f7eafd_I20181130" decimals="INF" format="ixt:numdotdecimal" name="dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExMjUx_4932fdc8-81a6-4ce7-9479-a139498a2571">5.2</ix:nonFraction> million&#160;shares of our common stock at an initial price of&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExMzA0_64615acf-0184-4849-b62f-c3bbf6a45f34">164.29</ix:nonFraction>&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$<ix:nonFraction unitRef="usd" contextRef="i30b4cc8b7cfc464280fc946085b32af4_D20181101-20181130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExMzk0_0add96f5-650c-4d34-b070-8945005cd3e1">218.9</ix:nonFraction> million and we accounted for it as an equity instrument by recognizing $<ix:nonFraction unitRef="usd" contextRef="i30b4cc8b7cfc464280fc946085b32af4_D20181101-20181130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExNDYw_0add96f5-650c-4d34-b070-8945005cd3e1">218.9</ix:nonFraction> million in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on December&#160;1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;<ix:nonFraction unitRef="shares" contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEyMzc1_9b74bcb2-bd36-429a-9730-aedb0db6fdf6">5.2</ix:nonFraction> million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the <ix:nonFraction unitRef="d" contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEyNTE1_66e54347-ff0e-4c1b-b453-295c1e81a0c6">60</ix:nonFraction> scheduled trading days starting on March&#160;1, 2024. We received&#160;$<ix:nonFraction unitRef="usd" contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEyNTY5_f7229f67-bf49-42bc-99df-ba6979195859">183.8</ix:nonFraction> million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i88761c5ae3754e65956582b6b57389a7" continuedAt="i9dad43e9415a4686948a1c5d19d600f5"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $<ix:nonFraction unitRef="usdPerShare" contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEyOTQw_a43d66dd-5a01-4cd4-bba3-cb986a7d9f8a">198.38</ix:nonFraction> per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.25% Senior Convertible Notes due 2025 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="i5355d4cf31264d86bc5dda86afa70ac2_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODk2NTE_28a828d0-a40c-4d3b-a0a2-958edd3be7a6">1.21</ix:nonFraction> billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of <ix:nonFraction unitRef="number" contextRef="i5355d4cf31264d86bc5dda86afa70ac2_I20200531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODk3MzA_b501c84e-f363-4145-b3eb-6b59ee6a29cb">0.25</ix:nonFraction>% and a maturity date of November&#160;15, 2025 (the 2025 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to the offering, were approximately $<ix:nonFraction unitRef="usd" contextRef="i99523a59b6a94e9f91658f912ad40913_D20200501-20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODk5MzQ_d5d1aee2-04b9-4172-ab68-fa30ce8d1e5f">1.19</ix:nonFraction> billion. The initial conversion rate of the 2025 Notes is 1.6655 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $<ix:nonFraction unitRef="number" contextRef="i99523a59b6a94e9f91658f912ad40913_D20200501-20200531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTAwOTM_77765f72-edee-4161-a145-5768be896a48">600.42</ix:nonFraction> per share, subject to adjustments, with a maximum conversion rate of 2.3732. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized $<ix:nonFraction unitRef="usd" contextRef="i63f56e49768249e5b7989f94f1d74990_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTA3MTA_758572da-1d53-40ba-b92f-06f09a866f96">289.4</ix:nonFraction> million in additional paid-in-capital, net of debt issuance costs, during 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2025 Notes includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2025 Notes), holders of the 2025 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to <ix:nonFraction unitRef="number" contextRef="i9b91b53fe18c4c4ea50245a93565fd7d_I20201231" decimals="2" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTE0MjQ_57e62c2f-6382-41b5-a77c-2c88a5040742">100</ix:nonFraction>% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest. Holders of the 2025 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025, holders of the 2025 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during any calendar quarter commencing after September&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="trading_day" contextRef="ia1cdadf83f4347a1992e2190665bfc6b_D20200101-20201231" decimals="0" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTIxOTU_4455e1f3-6e07-4c87-a092-6088b4440d48">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="trading_day" contextRef="i8b263bb73db749f7903f4d16dee3cfc9_D20200101-20201231" decimals="0" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTIyNjI_8b3b0989-cc3e-49f0-ad9b-397af20dc0ff">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="ia1cdadf83f4347a1992e2190665bfc6b_D20200101-20201231" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTIzOTY_5943125c-8ecc-4a01-83b4-0d36edf20b29">130</ix:nonFraction>% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during the <ix:nonFraction unitRef="trading_day" contextRef="i39aadb9741cd47b79480d481f086db3c_D20200101-20201231" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTI0ODU_db65b3e8-9003-49f3-93b9-da86b91e7917">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="trading_day" contextRef="i899bc18f65524335a7458c45e6a54130_D20200101-20201231" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTI1MTk_e588cfcb-62d1-4436-9664-13e34556f13c">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that <ix:nonFraction unitRef="trading_day" contextRef="i899bc18f65524335a7458c45e6a54130_D20200101-20201231" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTI2NDA_8582564f-f4d0-4b1e-b96c-e5f840136791">five</ix:nonFraction> day consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="i899bc18f65524335a7458c45e6a54130_D20200101-20201231" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTI2OTM_fbf55c34-7f39-4107-b926-35571f1b3b5c">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On or after August&#160;15, 2025, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2025 Notes prior to May&#160;20, 2023. On or after May&#160;20, 2023 and prior to August 15, 2025, Dexcom may redeem for cash all or part of the 2025 Notes, at its option, if the last reported sale price of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="i63f56e49768249e5b7989f94f1d74990_D20200101-20201231" decimals="2" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTM1NjY_356e6929-0b41-48a7-b19d-28215a2bddd2">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="trading_day" contextRef="ia1cdadf83f4347a1992e2190665bfc6b_D20200101-20201231" decimals="0" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTM2MjI_f7887e75-d817-4a5d-b918-d76177ebb662">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="trading_day" contextRef="i8b263bb73db749f7903f4d16dee3cfc9_D20200101-20201231" decimals="0" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTM2Nzk_3e2ab255-e387-4536-b90b-e0e290c2ed5b">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to <ix:nonFraction unitRef="number" contextRef="i144fe05e631d4754b752fbaffcb88425_D20170101-20170630" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTM4NzI_f01d7015-7e77-4b6e-ac08-8b4974e7dc41">100</ix:nonFraction>% of the principal amount of the 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9dad43e9415a4686948a1c5d19d600f5"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revolving Credit Agreement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Terms of the Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2018, we entered into an amended and restated revolving credit agreement which was subsequently amended on May 11, 2020 (as amended, the Credit Agreement). The Credit Agreement provides for available principal amount of $<ix:nonFraction unitRef="usd" contextRef="i1e7080d6571940faabaa2f8e843f5374_I20181219" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEzNDA4_d628862f-033a-4b53-a1ea-8bf47a8cb8aa">200.0</ix:nonFraction> million which can be increased up to $<ix:nonFraction unitRef="usd" contextRef="i1e7080d6571940faabaa2f8e843f5374_I20181219" decimals="INF" format="ixt:numdotdecimal" name="dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEzNDQw_c7712ad9-4d69-4bc7-a26b-a94e3eeef0dc">500.0</ix:nonFraction> million at our option subject to customary conditions and approval of our lenders. Borrowings under the Credit Agreement are available for general corporate purposes, including working capital and capital expenditures. </span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTUw_0c4e347a-1b56-44b6-baf7-085eb71487af" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Credit Agreement is as follows as of the date indicated: </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available principal amount </span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7929e0a0d324cfd8fe012a9b24af6b7_I20201231" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzItMS0xLTEtMA_f8747d12-7d0c-403e-aa35-92a29ed632fe">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99455d005fdd42b5914e278f7116ad83_I20201231" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzMtMS0xLTEtMA_a69d3946-0bc7-4ba6-8d52-fa456f2793e3">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7929e0a0d324cfd8fe012a9b24af6b7_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzQtMS0xLTEtMA_d5ef175b-50c8-496f-8457-842d9196876f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99455d005fdd42b5914e278f7116ad83_I20201231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzUtMS0xLTEtMA_fcb34560-8897-4a46-bed4-22b61ddda44e">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available balance</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzYtMS0xLTEtMA_1a569972-3a6c-40b5-8983-634a35b4b5e6">193.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans under the Credit Agreement bear interest at our choice of one of two base rates plus a range of applicable margin rates that are based on our leverage ratio. The first base rate is the highest of (a) the publicly announced JPMorgan Chase prime rate, (b) the federal funds rate, or (c) the overnight bank funding rate, and the applicable margin rate ranges from <ix:nonFraction unitRef="number" contextRef="ifb3f6f2593e742d39815ab135c1351cf_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0MTM4_a62370a0-83ca-4c52-8b08-2295d2949c91">0.375</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ie5665c7a7af04c72b799bc76e98ac16e_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0MTQ0_57434091-370b-45ef-b47c-4021a964ad00">1.000</ix:nonFraction>%. The second base rate is a LIBOR-based rate, and the applicable margin rate ranges from <ix:nonFraction unitRef="number" contextRef="iaab87bfd0d144699b9389facb5c03069_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0MjM1_66ff2658-29eb-437b-ac63-b5ae42fbf18f">1.375</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7106fbb087b843a4a42d39cd22960c2e_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0MjQx_30004682-8645-4ef3-a12c-a1d6b6de3d7a">2.000</ix:nonFraction>%. We will also pay a commitment fee of between <ix:nonFraction unitRef="number" contextRef="id8fb79f3ea0d43d29986396d56c2e1f4_D20200101-20201231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0Mjkw_990630e7-7307-43eb-97c8-f6bb8b20c500">0.2</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if444b8bc180c4613992a636bbb38e095_D20200101-20201231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0Mjk3_ab182913-9c5d-4ed7-9a0c-fd62e9346f21">0.3</ix:nonFraction>%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement will mature on the earlier to occur of (i) December 19, 2023 or (ii) 91 days prior to the maturity date of the 2022 Notes or (iii) 91 days prior to the maturity date of the 2023 Notes if both (a) the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, is greater than EBITDA for the period of four consecutive fiscal quarters ending prior to such date and (b) unrestricted domestic cash on hand is less than the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, plus $<ix:nonFraction unitRef="usd" contextRef="i70c1c83392ba4ac79884df02cce79fb8_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="dxcm:LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0OTkw_47391aa6-d315-4ee7-859f-876f4b3b60fd">100.0</ix:nonFraction> million.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of December&#160;31, 2020.</span></div></ix:continuation><div id="i889b093251984bfb881a094ef59c54bd_139"></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4MDg_f03e2345-da39-4fa6-93dd-c732168f4383" continuedAt="if077d6c4c70448eba43210dc92ded402" escape="true"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4Mjg_fc58652d-69a3-4a2d-b717-949175d89364" continuedAt="i21e3bea35d8e494fbefd26234375a73c" escape="true"><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6. Leases And Other Commitments</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Leases</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease office, manufacturing and warehouse space facilities under various domestic and international non-cancellable operating lease arrangements that expire at various times through December 2030. We also have one land lease that expires in 2080. Certain of our leases have renewal options which allow us to extend the lease term typically between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzI4Mg_e822fe76-398d-4dc9-abc3-bdd5759fa7f2">three</span> and <ix:nonNumeric contextRef="ib49c1f2854e540609bb2322a657f82ee_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzI4OQ_2bf3ee24-357d-44e7-a7d9-ef447d9fbeba">five years</ix:nonNumeric> per option and some of our leases have multiple options to extend. The remaining lease terms of our leases range from less than <ix:nonNumeric contextRef="if0763f994d3d4e1caba905e8a1c1bf92_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzc3MA_25d51c12-7f40-49fd-aeb0-a64149797048">one year</ix:nonNumeric> to approximately <ix:nonNumeric contextRef="ib49c1f2854e540609bb2322a657f82ee_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzc5MA_a2452a35-3fdd-4b80-af90-3ffe7dcd5303">twenty years</ix:nonNumeric> and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. Leases are classified as operating or financing at lease commencement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASC 842 utilizing the modified retrospective transition method through a $<ix:nonFraction unitRef="usd" contextRef="i69abd3c86e1942d8a6591c6630a96ad8_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzEwMjM_72db6f09-904a-4b26-97f2-f4ea84c7bef8">2.1</ix:nonFraction> million cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if077d6c4c70448eba43210dc92ded402" continuedAt="i8e1eadfb956143f8993d0b46cf18e253"><ix:continuation id="i21e3bea35d8e494fbefd26234375a73c" continuedAt="i6ea21f392af34193a3c181ad539274f5"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of $<ix:nonFraction unitRef="usd" contextRef="iacc146a3fcd448f9843cfc23757a5620_I20190101" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzIwODI_b5a99d58-7a9e-4bb5-90bd-069788457c12">26.7</ix:nonFraction> million, finance lease right-of-use assets of $<ix:nonFraction unitRef="usd" contextRef="iacc146a3fcd448f9843cfc23757a5620_I20190101" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzIxMjM_1c45e0b9-3cac-465a-b7f4-a3ecac6d4f0d">15.3</ix:nonFraction> million, operating lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="iacc146a3fcd448f9843cfc23757a5620_I20190101" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzIxNTg_9da9e9b2-5438-400b-880c-43e7ab864453">40.4</ix:nonFraction> million and finance lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="iacc146a3fcd448f9843cfc23757a5620_I20190101" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzIxOTQ_1262a3d8-5c3e-437d-9019-9ce7bc4cc2ed">15.9</ix:nonFraction> million in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statements of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4MTc_8379a804-9348-4972-b224-cb19f5ba1e30" escape="true"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4MzA_43171904-1c5c-42be-974a-5019b9279465" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEtMS0xLTEtMA_669b53db-5795-4186-abdd-87ddb2933b10">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEtMy0xLTEtMA_f85fddd4-1e04-497a-ba6f-74bebe1c710d">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzItMS0xLTEtMA_4b905cbc-8c10-497c-a8c9-85f442d7ea10">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzItMy0xLTEtMA_e48053f3-7a57-495a-9167-2b7ff1744453">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzMtMS0xLTEtMA_ed915208-53e9-405b-b484-dae4e427b4ab">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzMtMy0xLTEtMA_89128af8-6cc5-4be4-9017-c2666e3ee3e2">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzQtMS0xLTEtMA_dface545-6b2b-455e-a1c1-ec0ecb5bf5d3">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzQtMy0xLTEtMA_45c5861a-2753-42f8-871c-fe15d655fdc2">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzUtMS0xLTEtMA_37c7da9a-ba37-4651-9ef5-da823c52fafb">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzUtMy0xLTEtMA_828837c3-a060-468b-a279-399f47fb0831">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzYtMS0xLTEtMA_e9446492-d6d6-4f03-9f96-e2816850b322">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzYtMy0xLTEtMA_1c5e1962-74bf-4c98-8b7f-19011c3edab4">68.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzctMS0xLTEtMA_09b86db6-dc62-4793-92f3-d4f90f88a920">138.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzctMy0xLTEtMA_bcb59080-f888-402b-b6a9-0c3d450456aa">97.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:  Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzgtMS0xLTEtMA_87765a62-d4b4-4113-a93e-45578c6ef436">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzgtMy0xLTEtMA_36f6e49c-afb8-46c0-b0ce-7977c6224362">34.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzExLTEtMS0xLTA_4f679e74-4572-4243-9a30-2db1cf09ca82">118.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzExLTMtMS0xLTA_9a6669c0-453f-4a23-a7a2-433ddeeb9874">62.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEyLTEtMS0xLTA_7dbc9ee2-85a4-4eb7-826e-6c88d5f3f69b">16.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEyLTMtMS0xLTA_e8299b3e-5890-4735-8aaf-03b46b951047">8.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEzLTEtMS0xLTA_00bbc717-6d79-4980-80cc-9d9bb6693339">101.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEzLTMtMS0xLTA_6d8a31be-3bfd-435a-844b-0bb73f23e646">54.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease cost excludes $<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="dxcm:LesseeFutureLeaseCostLeaseNotyetCommenced" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzE2NDkyNjc0NDI4MjYz_e5972a23-e10f-435c-86c7-afa5bb1a75ec">16.3</ix:nonFraction> million of legally binding minimum lease payments for leases signed but not yet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">commenced</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetRetirementObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzgyNDYzMzcyMTg3MDQ_80a7cb8b-d3b1-406a-b62a-c783302b3fb7">4.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetRetirementObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzgyNDYzMzcyMTg3MTU_b740e978-511a-40ee-a6fe-be70a093e3f3">2.6</ix:nonFraction>&#160;million as of December&#160;31, 2020 and 2019, respectively, are included under &#8220;Other long-term liabilities&#8221; in our consolidated balance sheets. </span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8e1eadfb956143f8993d0b46cf18e253" continuedAt="i8a44d19cc0744fe7aca74309f0c95db5"><ix:continuation id="i6ea21f392af34193a3c181ad539274f5" continuedAt="i356e3f1be79a4ec48df009264a2009a7"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4MTA_3c254ffa-a82f-4fd2-9227-91a13ab55071" continuedAt="i3895bdf52a744058bba15319ae687c0f" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the twelve months ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.380%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzMtMy0xLTEtMA_0597967f-b8e2-4a34-ab91-c903f717241b">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzMtNS0xLTEtMjY3Nw_2edfb5b2-ba3d-4071-9779-4bd9a05716d5">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzQtMy0xLTEtMA_ccd76f7b-1358-4063-936d-1bc806b693ee">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzQtNS0xLTEtMjY3Nw_ae73bc48-d020-4c02-b2f4-632a5da6e54d">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzUtMy0xLTEtMA_2fa3b9ae-30c1-4329-ba37-a28e21a76bd1">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzUtNS0xLTEtMjY3Nw_947d7f46-2b35-420a-bb82-ca0b5cd3c4d5">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzYtMy0xLTEtMA_aedf1853-642e-4a59-b626-38b8de23737c">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzYtNS0xLTEtMjY3Nw_d3947d47-7e3d-4640-ba04-c6379438f37b">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzctMy0xLTEtMA_4494d320-c04a-49aa-a31f-d2f18c4406bd">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzctNS0xLTEtMjY3Nw_81c86006-b191-4502-8ee4-2ae01b721cf8">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzgtMy0xLTEtMA_1e2e5d5f-aaa1-476d-b455-62f6f7cee3a4">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzgtNS0xLTEtMjY3Nw_832463da-20ca-41ea-a9f4-c302fab95dec">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. </span></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease costs are primarily related to common area maintenance charges and property taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the twelve months ended December&#160;31, 2018 was </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:LeaseAndRentalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzgyNDYzMzcyMjQyNDA_9dc91c9f-a48d-4507-82c5-c1e801726258">12.5</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><ix:continuation id="i3895bdf52a744058bba15319ae687c0f"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzMtMS0xLTEtMjY2NQ_b37c18ac-b294-4184-a2b3-11bec4c96249">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzMtMS0xLTEtMjQ0Mw_4b3cfbab-ec91-42e6-bc03-b9932239c60c">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzQtMS0xLTEtMjY2NQ_f0c90e62-e804-4d47-b787-f3b579f69fdb">0.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzQtMS0xLTEtMjQ0Mw_226575fb-391b-4765-8249-2308af0edda9">0.8</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzUtMS0xLTEtMjY2NQ_e44147c0-553d-43f8-8646-637f28409736">8.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzUtMS0xLTEtMjQ0Mw_299edf06-a544-4917-8d02-f9ca3736f12c">0.5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzctMS0xLTEtMjY2NQ_53c38d71-da9c-4ca2-bb2a-f5019d9abd7d">33.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzctMS0xLTEtMjQ1MA_2e6d4b4b-8a1d-4f34-956c-50ed3d60be94">80.6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzgtMS0xLTEtMjY2NQ_3aa8cab7-9a88-4b69-aa04-b21c80414372">41.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzgtMS0xLTEtMjQ1MA_56980c47-9b80-49a6-b044-442236cdd308">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzEwLTEtMS0xLTI2NjU_ca4fd646-4316-44a1-80fe-591d70b2c9c7">6.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzEwLTEtMS0xLTI0NTA_219fe22e-2cd4-40a8-9aa1-e27def115449">6.2</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzExLTEtMS0xLTI2NjU_1019387f-754c-4bd1-8745-2080fa1cbcf9">23.3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzExLTEtMS0xLTI0NTA_9cec0813-6819-4420-ac5d-a6e87e03cd28">13.3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="2" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzEzLTEtMS0xLTI2NjU_62d8b9cf-2b74-496a-8a54-ebc15587c1a4">5.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="2" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzEzLTEtMS0xLTI0NTA_42c2c62b-3cf5-4010-a1e6-656323bb1841">5.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="2" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzE0LTEtMS0xLTI2NjU_ed551392-6d40-46c7-813b-5ea572647dc1">5.2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="2" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzE0LTEtMS0xLTI0NTA_caf52e7f-3196-475d-9049-f0d62ac06a88">5.0</ix:nonFraction>%</span></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="dxcm:LesseeOperatingLeasesLeaseCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM3OTE_805210e6-c923-4a54-96b0-f08ed6482cbb">12.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the twelve months ended December&#160;31, 2020 and </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="dxcm:LesseeOperatingLeasesLeaseCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzgyNDYzMzcyMTI2NDY_78cb5771-71a9-4261-87be-644c9e4f17f1">9.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the twelve months ended December 31, 2019.</span></div></ix:continuation></ix:continuation><div id="i889b093251984bfb881a094ef59c54bd_145"></div><ix:continuation id="i8a44d19cc0744fe7aca74309f0c95db5"><ix:continuation id="i356e3f1be79a4ec48df009264a2009a7"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Purchase Commitments</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various purchase arrangements related to our manufacturing and research and development activities. As of December&#160;31, 2020, we had approximately $<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNDUvZnJhZzo3MjJiMjg1YWE0ZGU0MTQ0ODIxMmNjZGFjZjA1ZTIwMS90ZXh0cmVnaW9uOjcyMmIyODVhYTRkZTQxNDQ4MjEyY2NkYWNmMDVlMjAxXzgyNDYzMzcyMDg2MDU_56926cec-8292-4e72-8be2-45a2aa2a315d">335.6</ix:nonFraction> million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:durwordsen" name="dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNDUvZnJhZzo3MjJiMjg1YWE0ZGU0MTQ0ODIxMmNjZGFjZjA1ZTIwMS90ZXh0cmVnaW9uOjcyMmIyODVhYTRkZTQxNDQ4MjEyY2NkYWNmMDVlMjAxXzI3NQ_ed76a9e0-9fc9-4405-bbdd-4aef6520538e">one year</ix:nonNumeric>.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNDgvZnJhZzowZDM1NDVlNzJiZjc0NTdkOThhYTgzZTNiNzVmMGNiNS90ZXh0cmVnaW9uOjBkMzU0NWU3MmJmNzQ1N2Q5OGFhODNlM2I3NWYwY2I1XzcxNDY4MjU1ODI4MjY_7adcf6a8-10d7-4e6f-9e98-3f342ef3bdaf" escape="true"><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7. Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Litigation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. We do not believe we are party to any currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div></ix:nonNumeric><div id="i889b093251984bfb881a094ef59c54bd_154"></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NDY_d4381528-31fc-41d5-a6a8-fcfeb7423509" continuedAt="i6cf408c5f25749d8a0ae3c9841140548" escape="true"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8. Income Taxes</span></td></tr></table></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NTY_5cebefcb-aacf-4314-9f62-8a3df57d0a19" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzItMS0xLTEtMA_f625d528-2347-40fc-af90-aab735e9a070">270.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzItMy0xLTEtMA_ed718b3f-09d1-452a-a44a-7e275c9c4e79">119.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzItNS0xLTEtMA_b92172a2-3b06-4242-88a9-b5fbf98b7776">28.3</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzMtMS0xLTEtMA_5202c969-de3a-4851-8d93-a08adcd82442">45.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzMtMy0xLTEtMA_29bb28cd-bf35-49e0-96fa-3fd51565861a">14.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzMtNS0xLTEtMA_d1a0941a-67f5-4796-806c-dad8a9d42169">98.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzQtMS0xLTEtMA_1e439776-52ad-427a-a09b-3a5210da421e">225.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzQtMy0xLTEtMA_98edfa3f-5ee8-4155-9fcb-7ce5f8b3a239">104.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzQtNS0xLTEtMA_0ef60eee-3a11-4e46-ba1a-602ca0d284b6">126.5</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NDc_aa403c95-ce30-40b0-a6bd-747dc8262b06" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the provision for income taxes are as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzMtMS0xLTEtMA_4276feb6-0032-41be-a48b-b7525fcb06b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzMtMy0xLTEtMA_340c400b-361d-42d0-a864-1ff33de1559d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzMtNS0xLTEtMA_19dca42e-27b6-4760-b54a-a4c9e00f039c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzQtMS0xLTEtMA_d773b9c9-1b8d-4038-b4bf-dd17fbaf8668">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzQtMy0xLTEtMA_cb09fc9f-8655-4ff4-b403-127e7f2c0856">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzQtNS0xLTEtMA_cdad9d67-7389-4907-a5d8-6d8c606d3e78">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzUtMS0xLTEtMA_0ff15e1c-f67b-437a-8783-5f7e9ed9e151">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzUtMy0xLTEtMA_8de7c9f8-4d83-4c83-af8e-fbc32b89489b">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzUtNS0xLTEtMA_ba58f455-0b68-4974-a5f9-a9b4b17051d7">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current income taxes</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzYtMS0xLTEtMA_b6c9ec07-db14-4aae-b5d0-a53329d68287">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzYtMy0xLTEtMA_f394da78-786e-4232-9dcc-9e51fbeb6364">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzYtNS0xLTEtMA_313ea53c-eef4-444c-a69c-2783ff77b912">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzgtMS0xLTEtMA_a91cb266-d217-49b8-9755-ad09ec6f8713">198.8</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzgtMy0xLTEtMA_5f5130f3-1b78-42b9-9a4b-f5ea1b66a26f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzgtNS0xLTEtMA_0f2c91f8-cec5-4798-87ca-e62b478f44a9">1.7</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzktMS0xLTEtMA_2e6bb2eb-2e76-4b5d-b79b-4fcd0dc418dc">51.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzktMy0xLTEtMA_e627b5d7-d5ba-45b1-8acc-eeb3363212ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzktNS0xLTEtMA_a04531df-81bd-439a-a4d5-10476851be6b">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEwLTEtMS0xLTA_e8e94acf-69f7-4f0f-a65e-f9a02c6d3345">27.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEwLTMtMS0xLTA_ff4eabc5-fb77-4128-9ede-e2c18e24547e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEwLTUtMS0xLTA_a6af7734-c6eb-4444-9f4d-7a42823d7080">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzExLTEtMS0xLTA_fb03b46c-f965-45ef-a0f3-4f0fb187d0f7">277.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzExLTMtMS0xLTA_02f71f0c-400a-432f-9024-75d5eb25b9a6">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzExLTUtMS0xLTA_ad91e84c-4b5b-496e-85fc-745f2e766a45">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEyLTEtMS0xLTA_6d43193a-5436-4b46-9001-3917e5d09d4f">268.6</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEyLTMtMS0xLTA_01a6593b-7ad6-4add-83a5-f5cdbdbe566f">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEyLTUtMS0xLTA_2f148efc-7652-4ddf-a5ee-5434d3a8c135">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6cf408c5f25749d8a0ae3c9841140548" continuedAt="i95dff5c2a41b4670895505e9f6cfb729"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU1OTk1OTI_444e9c61-4a7f-4d25-a95e-f250d4d7235d" escape="true"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU1OTk1OTI_976b5686-8bc1-4fe1-81c7-16aa96f4dacb" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant loss and tax credit carryforwards and years of expiration are as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Expiration</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Operating Loss:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faa2bf597984c30b119197a6a7e086d_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzMtMS0xLTEtMzM5OQ_8fd197b4-ea44-4bb8-839f-8464f15b4db3">169.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e773841aaec4c8f8602ad4486565e5d_I20191231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzMtMy0xLTEtMzM5OQ_2e37a1c6-ff2b-4eed-8fb6-51f22cd3b1bf">438.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36128ee14a734888bc09fffd96a8030b_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzQtMS0xLTEtMzM5OQ_ab03b3d3-80b4-4577-a640-0bf0f413f795">236.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a1a9074faa14cd1aaebc1917a4bf806_I20191231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzQtMy0xLTEtMzM5OQ_5813f766-60b8-4f6e-871e-b182e082f290">235.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3136d780e4b54c5c8c992096d59c7865_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzUtMS0xLTEtMzM5OQ_160b7407-b1ca-4321-9b09-02f362f5561c">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e11745d3934aeba348c054954eb311_I20191231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzUtMy0xLTEtMzM5OQ_6d120771-57e2-4cc9-b2de-fdb8db835a03">88.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25f646d2021741ceb895186d3d836104_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzYtMS0xLTEtNzk3NQ_b726243c-289e-4765-84e2-6f2fda5701fd">113.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f9e39f0909482a94b926033b0fa78d_I20191231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzYtMy0xLTEtNzk3OQ_f9b15b3b-ca93-4565-ac60-68530c633189">124.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Credits:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faa2bf597984c30b119197a6a7e086d_I20201231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzgtMS0xLTEtMzM5OQ_a987c0df-2b82-4c37-a6be-33264fb20882">73.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e773841aaec4c8f8602ad4486565e5d_I20191231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzgtMy0xLTEtMzM5OQ_d0489f57-d83a-4449-b5f1-b179bbf16734">54.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36128ee14a734888bc09fffd96a8030b_I20201231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzktMS0xLTEtMzM5OQ_b6d6a037-4d19-46c2-be15-083dc4a5d3fc">66.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a1a9074faa14cd1aaebc1917a4bf806_I20191231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzktMy0xLTEtMzM5OQ_625658c9-12f5-4c73-98e5-5eaddafa14e5">52.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, California&#8217;s Governor Newsom signed AB 85 into law, suspending California net operating loss utilization and imposing a $5.0&#160;million cap on the amount of business incentive tax credits companies can utilize, effective for tax years 2020 through 2022. As a result of the legislation, we are utilizing $<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="dxcm:ResearchAndDevelopmentTaxCreditsUtilized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzE2NDkyNjc0NDM1MTgz_6fa54ce4-ce7d-47ae-b924-94362bff0766">2.4</ix:nonFraction> million of California research and development credits for the tax year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of net operating losses and credit carryforwards is subject to an annual limitation due to ownership change limitations provided by Section&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state provisions. An ownership change limitation occurred as a result of the stock offering completed in February 2009. The limitation will result in approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="dxcm:UnusedExpiredFederalIncomeTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzEyMjc_3b681bf2-acd6-42e6-a5dd-4ce33e38f4f9">1.9</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of U.S. research and development tax credits that will expire unused. The related deferred tax assets have been removed from the components of our deferred tax assets as summarized in the table below. The tax benefits related to the remaining federal and state net operating losses and tax credit carryforwards may be further limited or lost if future cumulative changes in ownership exceed 50% within any three-year period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NDg_1b658704-a8d1-4685-a3e1-bb13180f9f9b" continuedAt="i7b9b9b30199d48a68ad233bbce04953a" escape="true">Significant components of our deferred tax assets and liabilities as of December 31, 2020 and 2019 are shown below. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our U.S. operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years of cumulative income. We analyzed both positive and negative evidence, and as a result, we released our valuation allowance on our deferred tax assets, with the exception of our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i95dff5c2a41b4670895505e9f6cfb729" continuedAt="i0fbbd2b3f99c4ae29959391bfd7a5491"><div style="margin-bottom:11pt;margin-top:11pt"><ix:continuation id="i7b9b9b30199d48a68ad233bbce04953a"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzMtMS0xLTEtMA_c7b86331-e7ae-45f3-9397-7758eb2aa601">69.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzMtMy0xLTEtMA_3059821e-b262-45a1-85c3-91b0cbe84335">127.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzQtMS0xLTEtMA_83657134-87c1-4c1c-a318-6abfd925c81c">53.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzQtMy0xLTEtMA_cf51313e-604c-4177-9bab-928c35ffb38f">57.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzUtMS0xLTEtMA_8df6ce77-efd5-43ea-b077-2e3b39401ff8">101.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzUtMy0xLTEtMA_9481b26e-20c2-4140-9c59-f7b7e0330549">78.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Share-based compensation</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzYtMS0xLTEtMA_512ecef7-373b-46fd-8036-45a35fb07b14">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzYtMy0xLTEtMA_4108f877-19af-4909-87d5-030aeb37a9b3">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzctMS0xLTEtMA_7c181062-96dc-46f8-8909-b1cef5437b6e">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzctMy0xLTEtMA_cf60579d-d994-4e77-9082-e4df6d00e7a4">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzgtMS0xLTEtMA_b5a2cf89-a83d-4e30-87db-bbbda047a886">110.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzgtMy0xLTEtMA_ad5a1e41-857b-455a-bafb-9e3920b00e99">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:zerodash" name="dxcm:DeferredTaxAssetsConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzktMS0xLTEtMA_7d226f54-dc57-4d91-bfe9-74943d2a7385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="dxcm:DeferredTaxAssetsConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzktMy0xLTEtMA_9d9dfaf3-99cd-4796-8dec-2b6853f1be55">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzEwLTEtMS0xLTA_e38d10aa-4592-4a52-9cc3-2ee63c2769d4">364.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzEwLTMtMS0xLTA_42bb4c0b-0a8b-4945-bfaa-ba97b59e549f">351.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzExLTEtMS0xLTA_0fa5b82b-2b31-4cc4-8f9d-e981e198c462">55.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzExLTMtMS0xLTA_8f94eec1-d5fb-4c68-9e92-99f90f47109b">332.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzEyLTEtMS0xLTA_349be53d-7d66-47aa-a7b8-8fd7a57382e6">308.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzEyLTMtMS0xLTA_153ed426-b319-40a6-9df4-897ba932d1a9">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE0LTEtMS0xLTA_1779a735-dcdd-4ffe-92c1-3a4a6c22c699">36.3</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE0LTMtMS0xLTA_ec0e9451-39b0-4cbe-972c-3bd31c356f89">19.6</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE1LTEtMS0xLTA_89713440-6aa7-4bc1-8a52-c1ea9b08a077">55.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" format="ixt:zerodash" name="dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE1LTMtMS0xLTA_3b72678e-b8b9-43a5-adf9-0dd0275f36c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE2LTEtMS0xLTA_a9f277ee-267a-4b3f-ae24-914e69bb0c38">92.2</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE2LTMtMS0xLTA_d1e247ba-91bf-41ca-8dba-63865f8f6b50">19.6</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE3LTEtMS0xLTA_89340d3a-cb9f-4dc2-87de-6d7fe9840381">216.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE3LTMtMS0xLTA_fbe08125-209f-47ad-9c01-ba1ddff22d02">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We released $<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzE2NDkyNjc0NDM1ODk3_82d6657f-03fb-410e-93c8-0809293dc1e2">287.2</ix:nonFraction> million of valuation allowance related to our deferred tax assets, of which $<ix:nonFraction unitRef="usd" contextRef="i2cfebefd71d743d7bb8817b29e995207_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzEwOTk1MTE2NTUwODg_44e34306-d035-4eb7-add1-c3f694e23f4c">285.5</ix:nonFraction> million was recorded to income tax benefit and $<ix:nonFraction unitRef="usd" contextRef="i584812d31d074a4d9c695bd53995b5d1_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzEwOTk1MTE2NTUxMDQ_8b085765-1d93-40c3-8ad8-aa23ecf1395e">1.7</ix:nonFraction> million was recorded to additional paid-in capital. We maintain a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i910cc468fb184823bb85a75afc8cbcc5_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzEwOTk1MTE2NTUxNjk_c2f8b91b-7195-4aa4-8999-1c119ea3c8c7">55.5</ix:nonFraction> million against our California research and development tax credits and certain foreign intangible assets.</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NzY_5de7f5ae-ac3e-488c-8438-33faebd11429" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:</span></div><div style="margin-bottom:9pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory tax rate</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzItMS0xLTEtMA_fef3e685-6349-4718-8f58-6fca00032353">47.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzItMy0xLTEtMA_cf9f6e54-e061-4566-96a1-17416c03ec84">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzItNS0xLTEtMA_f02e453a-5b81-4e9e-8769-e8818b280e93">26.6</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzMtMS0xLTEtMA_e32a919e-61cc-4ef2-993e-7da4d4cd44c0">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzMtMy0xLTEtMA_0f3710a8-081c-4b21-be94-f9d8020e201e">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzMtNS0xLTEtMA_96e34d83-4c53-4357-9807-5bc95d675e29">5.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent items</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="dxcm:EffectiveIncomeTaxReconciliationPermanentItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzQtMS0xLTEtMA_c040998e-394d-496c-9dba-28a15ba37fe9">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="dxcm:EffectiveIncomeTaxReconciliationPermanentItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzQtMy0xLTEtMA_7da41625-fdca-498f-9b8c-bae09c0fe9b9">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="dxcm:EffectiveIncomeTaxReconciliationPermanentItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzQtNS0xLTEtMA_d50a4065-71e9-4369-99b0-47a8c4c92013">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzUtMS0xLTEtMA_69548417-f771-40e4-abde-dd526a73d246">24.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzUtMy0xLTEtMA_dcbdf908-801c-48f6-a489-33668b3a1e9c">10.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzUtNS0xLTEtMA_c72f02ab-becc-4ed0-b3c3-05f3a3d4be44">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzYtMS0xLTEtMA_b015d178-5f1c-433d-9d9c-3a0227c0128e">0.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzYtMy0xLTEtMA_d0fa3f90-4fd2-4cd7-97c1-4fb4545189bb">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzYtNS0xLTEtMA_dd6e669a-ef2e-4814-b505-dd56b09b74ec">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock and officers compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzctMS0xLTEtMA_64cab451-4b36-420b-8a9b-7c81b43d647c">28.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzctMy0xLTEtMA_7e7bf9fb-0cfe-4c8a-b0ff-fff2b7db7028">14.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzctNS0xLTEtMA_c9aa8e6d-6ed6-4998-88cd-8942dbc2dfa0">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in statutory tax rates</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzgtMS0xLTEtMA_94306c1e-b90d-4fc5-9c2f-5ea8cf6df5c2">4.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzgtMy0xLTEtMA_7087703a-e88b-4e17-8f1a-8e0d4ad08435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzgtNS0xLTEtMA_325b344d-dced-4d0e-80f6-21e7eaf563b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of adoption of ASU 2016-16</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEwLTEtMS0xLTA_6eae32fd-a42c-43ab-8869-471138a8b643">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEwLTMtMS0xLTA_cbf859d7-a76d-479d-b4f6-9738f2d77787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEwLTUtMS0xLTA_a7a6bb65-2729-4fd8-8ef7-7899455389b8">13.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Tax Cuts and Jobs Act of 2017</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzExLTEtMS0xLTA_fc4b58e1-3087-4944-b806-30c74652a442">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzExLTMtMS0xLTA_360e8ee6-be8d-4c91-b161-edcf4f1d8294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" sign="-" name="dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzExLTUtMS0xLTA_fab66040-51f5-4e88-8b08-48db35ae6a6e">0.4</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEyLTEtMS0xLTA_f62b3944-63f9-42b6-8177-bbc60475df9d">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEyLTMtMS0xLTA_0cb3d89a-5f04-4edd-8f58-1b8eb0865070">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEyLTUtMS0xLTA_72f03489-8f9c-4eba-a4b2-561bacedff94">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEzLTEtMS0xLTA_990c405b-a89d-4be9-a1e6-a082807e4b11">275.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEzLTMtMS0xLTA_5c27f87e-e311-482c-b1a5-23ca40ef3076">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEzLTUtMS0xLTA_974df852-9bab-4f9d-b7da-5fa3c3e2308f">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes at effective rates</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzE0LTEtMS0xLTA_c5937f71-26e7-4911-bfd9-6dc9cf2b18d8">268.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzE0LTMtMS0xLTA_0e0f0bd7-8f8e-4d49-8bc7-3e8c3a7b1937">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzE0LTUtMS0xLTA_c769b3de-e858-4bc9-b21c-cc4205c6d052">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2020, the Supreme Court effectively resolved the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altera Corp. v. Commissioner</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case when it denied its petition to hear the case. Altera Corp. argued that the Treasury Department&#8217;s regulation requiring related companies to share the cost of stock-based employee compensation is arbitrary, and thus invalid. The denial to hear the case supports that related companies should share in the cost of stock-based employee compensation. Pursuant to an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> clause in our cost-sharing agreement, we recalculated and retroactively billed stock-based compensation for years 2016-2020, resulting in an additional $<ix:nonFraction unitRef="usd" contextRef="i90a1a747b94545808a4f6dc903487330_D20200622-20200622" decimals="-5" format="ixt:numdotdecimal" name="dxcm:ShareBasedCompensationIntercompanyCrossCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU1OTk1NzQ_d1b126c8-7ea3-4c2a-8e5f-9586a4355136">32.0</ix:nonFraction>&#160;million cost-share payment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Tax Cuts and Jobs Act included provisions for tax on Global Intangible Low-taxed Income (&#8220;GILTI&#8221;) effective for tax years of foreign corporations beginning after December 31, 2017. We have elected to account for GILTI in the period the tax is incurred.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0fbbd2b3f99c4ae29959391bfd7a5491"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NzM_78117cf9-fbc1-4a5c-bbe5-c3fe9f588c5c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to our gross unrecognized tax benefits:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January&#160;1, 2018</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic82615128e2c4fc99ac6cee2560ef199_I20171231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzEtMS0xLTEtMA_6eb6d3e2-d6a6-42dd-96b9-a62e19e6dafb">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzItMS0xLTEtMA_55397884-73fa-4ffa-98a3-0a6a40e58513">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzMtMS0xLTEtMA_4779d516-43a8-493a-b15a-67e0dfb57393">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to Tax Cuts and Jobs Act of 2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="dxcm:UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzQtMS0xLTEtMA_beb9c621-04f3-4a1b-bda6-fe1377d694d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzUtMS0xLTEtMA_e4253920-51ef-4911-84d3-33956af44ab6">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzYtMS0xLTEtMA_e2e820d8-2881-43d1-87fa-25c1ad3432c0">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzctMS0xLTEtMA_ebac0fa1-2e29-44d5-b027-48f41b39c2a1">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzgtMS0xLTEtMA_704e9d0a-69d8-4bf2-afc2-0f9536bcc5a7">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzktMS0xLTEtMA_2b78ccfb-b8b8-40d5-a296-c9c22c57f6eb">0.9</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzEwLTEtMS0xLTA_fd32a55a-197e-43a6-bf5b-c2c67aac49b4">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzExLTEtMS0xLTA_11b0e35e-e979-4539-a185-94e86e5a4cda">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the total unrecognized tax benefits at December 31, 2020, 2019, and 2018, $<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU2MDc2MDM_74b9d006-f8f7-4a22-8fa6-744064eede5d">23.5</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU2MDc2MTg_7e85987a-c69c-44b3-85bc-fc78ed455837">0</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU2MDc2MjU_85b4bebb-c196-4153-b612-81fbeaf4070a">0</ix:nonFraction>, respectively, would reduce our annual effective tax rate if recognized. Interest and penalties are classified as a component of income tax expense and were not material for any period presented. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business globally and consequently file income tax returns and are subject to routine compliance audits in numerous jurisdictions including those material jurisdictions listed in the following table. We are currently under a routine examination by the Federal Central Office in Germany for fiscal years 2016-2018. We do not expect any material adjustments as a result of this audit. The U.S. net operating losses generated since 1999 and utilized in recent years are open for examination. The years remaining subject to audit, by major jurisdiction, are as follows:</span></div><div style="margin-bottom:6pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Fiscal Year</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States (Federal and state)</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;1999 - 2020 </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;2016 - 2020 </span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;2017 - 2020 </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;2015 - 2020 </span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate under a tax holiday in the Philippines, which is effective through December 31, 2023, and may be extended for another <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" format="ixt-sec:durwordsen" name="dxcm:PossibleExtensionPeriodofTaxHoliday" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQyNjg_601596cb-1091-4077-96c9-4526680ddd6b">three years</ix:nonNumeric> if certain additional requirements are satisfied. The tax holiday is conditional upon remaining in good standing, committing no violation of PEZA Rules and Regulations, pertinent circulars and directives. The impact of this tax holiday decreased foreign taxes by $<ix:nonFraction unitRef="usd" contextRef="i6a547859b60a43fc9dc18e7cd1125a02_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1MzQ_2b2efc9e-339b-4cbe-9cc7-944c370834a2">0.1</ix:nonFraction> million in 2020. We have been granted an investment tax allowance incentive by the Malaysian Investment Development Authority (MIDA) in Malaysia, which is effective through December 31, 2025. The tax incentive had no effect on foreign taxes during 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have approximately $<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU2MDc2MzM_e6ef1e97-8609-45cc-b834-c1797af57ead">1.4</ix:nonFraction>&#160;million of undistributed earnings attributable to operations in our controlled foreign corporations as of December 31, 2020. We assert that any foreign earnings will be indefinitely reinvested. Accordingly, we have not recorded a liability for taxes associated with any future distributions of these undistributed earnings as any distribution would be immaterial.</span></div></ix:continuation><div id="i889b093251984bfb881a094ef59c54bd_157"></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2NTc_0b3b0f02-7e65-4362-bcca-e9a730a4c5df" continuedAt="i5234c56c01c144d09633438b67b89ac4" escape="true"><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9. Employee Benefit Plans and Stockholders&#8217; Equity</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a defined contribution 401(k) retirement plan (the 401(k) Plan) covering substantially all employees in the United States that meet certain age requirements. Employees who participate in the 401(k) Plan may contribute up to <ix:nonFraction unitRef="number" contextRef="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzMwMg_487c01f4-6bc2-4831-bd08-ce90d1c4d41a">75</ix:nonFraction>% of their compensation each year, subject to Internal Revenue Service limitations and the terms and conditions of the plan. Under the terms of the 401(k) Plan, we may elect to match a discretionary percentage of contributions. We match <ix:nonFraction unitRef="number" contextRef="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzU0MA_7ad8bd99-72e2-4882-b4c3-7f49a91667c5">50</ix:nonFraction>% of contributions up to <ix:nonFraction unitRef="number" contextRef="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzU2Ng_f9b7257f-7469-40f9-a620-c38c97d54275">5</ix:nonFraction>% of annual compensation. Total matching contributions were $<ix:nonFraction unitRef="usd" contextRef="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzYyNw_12005ae6-5b6f-4bf7-8735-c57177383f58">6.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i344d8f8e50c34a90b390f141b61876c0_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzYzNA_56317991-e45d-4790-9fd4-d8cc7e22c89d">4.8</ix:nonFraction> million for the twelve months ended December&#160;31, 2020, and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan, or ESPP</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2015 Employee Stock Purchase Plan (the 2015 ESPP), amended in December 2019, eligible employees can purchase shares of our common stock at semi-annual intervals through periodic payroll deductions during defined Offering </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5234c56c01c144d09633438b67b89ac4" continuedAt="i4d09c9feb4b448fdbd013d61ebcc0682"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periods. A total of up to <ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="INF" name="dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5Xzk0Mw_21ad78b1-8848-4733-94c1-b6300bb7b351">1.5</ix:nonFraction> million shares may be issued under the 2015 ESPP and it expires upon the earliest to occur of (a) termination of the 2015 ESPP by our board of directors, (b) issuance of all of the shares of common stock reserved for issuance under the plan, or (c) May 28, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payroll deductions may not exceed <ix:nonFraction unitRef="number" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzEyMzU_c270ea3f-0bc5-458c-97b6-3df8636497be">10</ix:nonFraction>% of the participant&#8217;s cash compensation subject to certain limitations, and the purchase price will not be less than <ix:nonFraction unitRef="number" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="INF" name="dxcm:EmployeePurchasePriceFloorPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzEzNTQ_33a47924-ea18-4225-b367-e4eee5b2c13f">85</ix:nonFraction>% of the lower of the fair market value of the common stock at either the beginning of the applicable Offering Period or the Purchase Date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued <ix:nonFraction unitRef="shares" contextRef="i3eaa2ff3c84445059ce87f458fcf8f69_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzE1MDY_10dea317-76e6-4f6c-abdd-57900478321d">89,194</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6fd1e8d507834f608ee1745f0ca4b27d_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzE1MTM_54d10e73-5a98-43be-8538-50fac8e36ec7">150,408</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic71d9325f84947ab8e12f76111648564_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzE1MjA_1d3b5d02-b131-4520-95ff-a3faee709740">189,904</ix:nonFraction> shares of common stock under the 2015 ESPP during the twelve months ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Incentive Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2015, we adopted the Amended and Restated 2015 Equity Incentive Plan (the 2015 Plan), which replaced our 2005 Equity Incentive Plan and provides for the grant of incentive and nonstatutory stock options, restricted stock, stock bonuses, stock appreciation rights, and restricted stock units to employees, directors or consultants of the Company. On May 30, 2019 our stockholders approved an increase to the maximum number of shares that may be issued under the 2015 Plan. We are permitted to issue up to&#160;<ix:nonFraction unitRef="shares" contextRef="ib7ad3a0859c04e32a8c6428b8ba0f02b_I20190530" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzIwNzM_81310d60-65c2-440d-960a-e4c422713db3">9.8</ix:nonFraction> million&#160;shares under the 2015 Plan. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. When we reissue treasury stock, if the proceeds from the sale are more than the average price we paid to acquire the shares we record an increase in additional paid-in capital. Conversely, if the proceeds from the sale are less than the average price we paid to acquire the shares, we record a decrease in additional paid-in capital to the extent of increases previously recorded for similar transactions and a decrease in retained earnings for any remaining amount. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue new shares of common stock to satisfy RSU vesting under our employee equity incentive plans. We have not yet determined the ultimate disposition of the <ix:nonFraction unitRef="shares" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzI4NjY_7620bfff-bfd7-4926-957a-f3f5c7df84d1">0.8</ix:nonFraction> million shares that we repurchased in 2018, and consequently we continue to hold them as treasury shares rather than retiring them. <ix:nonFraction unitRef="shares" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzI5OTM_10df1fa3-b286-4ff3-bf63-3f29aaa075f9"><ix:nonFraction unitRef="shares" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzI5OTM_681f6402-04e3-4585-821b-be7fa7b10382">No</ix:nonFraction></ix:nonFraction> shares of our common stock were repurchased during 2019 or 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not granted any stock options since 2010. As of December&#160;31, 2020, we have <ix:nonFraction unitRef="shares" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="dxcm:OptionsInMoneyNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzMxMzM_186dd2f2-a0df-4f2e-99f4-860e04d80eb3">no</ix:nonFraction> stock options outstanding.</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2NjI_b2d7dc08-cd8e-45e0-85bb-7ed0816a546c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised as of the date of exercise was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of options exercised</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo1NGVkN2Q4MjI3OWQ0YzY0OTAxYTdjOGUwNGIwM2VlNy90YWJsZXJhbmdlOjU0ZWQ3ZDgyMjc5ZDRjNjQ5MDFhN2M4ZTA0YjAzZWU3XzItMS0xLTEtMA_389a75c7-3ecf-436b-9e0f-1a776ae9f0d6">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo1NGVkN2Q4MjI3OWQ0YzY0OTAxYTdjOGUwNGIwM2VlNy90YWJsZXJhbmdlOjU0ZWQ3ZDgyMjc5ZDRjNjQ5MDFhN2M4ZTA0YjAzZWU3XzItMy0xLTEtMA_556a1c7d-3b7a-4241-b0db-694254363922">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo1NGVkN2Q4MjI3OWQ0YzY0OTAxYTdjOGUwNGIwM2VlNy90YWJsZXJhbmdlOjU0ZWQ3ZDgyMjc5ZDRjNjQ5MDFhN2M4ZTA0YjAzZWU3XzItNS0xLTEtMA_470af8e7-df19-4866-90f7-99e63c51bfc9">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4d09c9feb4b448fdbd013d61ebcc0682" continuedAt="i2e1ec29115754b08ad018754df767d4c"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units (RSUs)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU awards typically vest annually over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM3NDA_edbeb2b1-17ac-466a-946c-e20c5a225c47">three</span> or <ix:nonNumeric contextRef="i47532d047d3644c781d52180df17ad05_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM3NDY_f2c1dc21-3d5e-417e-b11a-9dabfdac8ddd">four years</ix:nonNumeric> and vesting is subject to continued services. <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2ODc_7da76acc-2c91-4c19-a987-c3dbee09bd9c" continuedAt="i207f2edb83f844d8b75233225620d855" escape="true">A summary of our RSU activity for the twelve months ended December&#160;31, 2020, 2019 and 2018 is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i207f2edb83f844d8b75233225620d855"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions except weighted average grant date fair value)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;<br/>Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2017</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9504f38e9d964a7e8248536f0d74412a_I20171231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEtMS0xLTEtMA_bc52a9d0-2a3e-427e-9f29-9c14e9445139">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9504f38e9d964a7e8248536f0d74412a_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEtMy0xLTEtMA_aacdf552-09f4-42b1-88c7-3aadf2ea77bd">70.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzItMS0xLTEtMA_3ff6b81e-c011-431f-9ca2-2e6b6e91d02d">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzItMy0xLTEtMA_7f5f69ec-27fd-4567-8bc0-6e55e4375d67">66.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzMtMS0xLTEtMA_fc0226cb-5e97-484b-b959-620d8e49a932">1.4</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzMtMy0xLTEtMA_331a4975-0a48-4898-ba7f-7802587472ab">68.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzQtMS0xLTEtMA_e23b1093-f73a-4cbc-8231-dc864f20857a">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzQtMy0xLTEtMA_35a0c144-9025-4592-8513-f80751584265">68.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2018</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1723155f583c4254a40179612feb0ea3_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzUtMS0xLTEtMA_82d41048-b2c9-495d-944f-3e2d6b85377f">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1723155f583c4254a40179612feb0ea3_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzUtMy0xLTEtMA_46b6a205-52b2-481b-8c1c-df5754097b03">69.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1723155f583c4254a40179612feb0ea3_I20181231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzUtNS0xLTEtMA_ef643c44-2edb-4a47-a82e-a9effef62dd7">319.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzYtMS0xLTEtMA_77fcdcd3-6e28-4027-906b-f3cae25e8df0">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzYtMy0xLTEtMA_269738e6-4774-47ce-8698-e4578b04d308">144.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzctMS0xLTEtMA_f62ddf67-dd98-4db7-8418-e12d8e6810b5">1.4</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzctMy0xLTEtMA_2390874b-fe22-4758-8fc9-1d0f445e4897">69.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzgtMS0xLTEtMA_ac60520a-7fd6-4244-9e22-bde38b779904">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzgtMy0xLTEtMA_d14c224d-f1de-463d-8c5b-01045f5490d7">83.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa8a47c445384ea284b35965e4852a2c_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzktMS0xLTEtMA_447ebba0-b64c-4565-a493-0a43f4606d15">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa8a47c445384ea284b35965e4852a2c_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzktMy0xLTEtMA_364c0b7a-6008-4963-86e7-a005bc65d9dd">96.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa8a47c445384ea284b35965e4852a2c_I20191231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzktNS0xLTEtMA_3b73a3b3-b5f5-4ab9-afa1-b0b39e28bca1">392.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEwLTEtMS0xLTA_16a0f92d-9d12-4e07-81ca-603ed6d9957d">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEwLTMtMS0xLTA_f42ae732-a908-4c19-9c22-851a8e1db4f8">300.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzExLTEtMS0xLTA_0d61b0d5-4c3a-453c-a0ad-d96223718250">1.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzExLTMtMS0xLTA_98a1277d-2dda-4efa-8981-adfcf84ebe61">92.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEyLTEtMS0xLTA_055da916-28d4-44a7-aa7c-d46e8fbb7bb0">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEyLTMtMS0xLTA_3d89217a-3e32-469a-b78b-f6773545a91d">137.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1db1c7118a14990b87107147de1cb98_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEzLTEtMS0xLTA_02dd3ef6-7bc8-4823-8d9d-29e0ed6b5fe2">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia1db1c7118a14990b87107147de1cb98_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEzLTMtMS0xLTA_46d38ebe-1edc-4bfc-80ff-266da79a49c4">183.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1db1c7118a14990b87107147de1cb98_I20201231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEzLTUtMS0xLTA_a144d899-ac50-48af-be34-98089e22a0d2">430.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vest-date fair value of RSUs vested was $<ix:nonFraction unitRef="usd" contextRef="i01d87f1cf80c435ead42c507b8eda281_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM5MjE_190d9cb8-dd05-4ef6-ab68-3a07321ebdd2">331.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia8fd4570b25642ea8b04ea92713cb66e_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM5MjU_37006e25-dea4-4aed-a654-309cfbc091ef">207.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2ba655b237cf441f820842a13b7eb463_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM5MzI_7654be02-414c-4c94-9c97-e5ca5c15c972">120.9</ix:nonFraction> million for the twelve months ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock Reserved for Future Issuance</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ3MDI_54e22a2c-e1bd-4db1-8b16-84f5e36cb8ab" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of common stock reserved for future issuance were as follows as of the dated indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards under our plans:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzQtMS0xLTEtMA_3a56ad45-adcc-4573-9f6d-b57d583ebf7c">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzQtMy0xLTEtMA_5174d20b-be4d-4722-aa03-06f4d658e0fd">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserved for future grant</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="dxcm:StockOptionsReservedForFutureGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzUtMS0xLTEtMA_85e6acc1-dc20-47e6-b43a-43980b15c08b">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="dxcm:StockOptionsReservedForFutureGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzUtMy0xLTEtMA_876fab7f-87bb-4afe-9f7c-c67d0ce994d2">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="dxcm:EmployeeStockPurchasePlanEsppSharesInEspp" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzYtMS0xLTEtMA_b1e788de-eb54-4db2-9e75-b9fd2e680dcd">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="dxcm:EmployeeStockPurchasePlanEsppSharesInEspp" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzYtMy0xLTEtMA_efbfdf73-4f49-458b-be35-fa47a2230d93">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzctMS0xLTEtMA_66d6e2ca-de98-4797-b8a0-bdd838e544cb">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzctMy0xLTEtMA_ba3c832e-fd18-4656-b1a4-18783bce2a86">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-based Compensation </span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2ODM_91942bef-f7fe-4c08-a8f9-4733fc06a97b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the twelve months ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic56e441b6e7d4ef4b7b31fa77f81e1dc_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzItMS0xLTEtMA_c962841b-1344-4b2d-8399-17298c51f955">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24efa051b28f4003a6f3ad6646ccd0dc_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzItMy0xLTEtMA_f71f610c-fd76-4908-9514-fd2020ebd5f9">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dbec2aacc9441d089e0d26423888121_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzItNS0xLTEtMA_f05f16ca-d711-4547-9af1-a02bec6d351a">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfae12ea15548f8aca74a4ee79890a1_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzMtMS0xLTEtMA_bc8a0b53-3657-4466-8284-8812cfe7c00b">37.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bc01fa170ab4896aa6b4a5277b3b1e7_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzMtMy0xLTEtMA_7f145007-cdd9-477b-95f3-66a6eae72fc6">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cf1e522d2c04404b83cebc9cf795440_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzMtNS0xLTEtMA_e880d9ca-6747-4de0-938a-d8974bbd7f9a">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b164774729468997a9b3662aa8c9f9_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzQtMS0xLTEtMA_ed296b31-6784-4c0a-a7f8-38b41bd32e64">67.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89d6cfc919b4446a315489302b1219e_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzQtMy0xLTEtMA_58032ec8-4718-4e64-9301-05e5c39f7699">60.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddc9d9a1baa4ed59713cfb3cc17c270_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzQtNS0xLTEtMA_310a70ea-554d-49ef-8e9a-ded4d462eb8b">59.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzUtMS0xLTEtMA_e97c5c76-ceab-4c99-b352-d1784e75d685">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzUtMy0xLTEtMA_1334a368-e485-4d91-bf3e-f58a0eccc98d">102.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzUtNS0xLTEtMA_a8ce68eb-b477-4390-9527-124eedafff28">101.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2ODI_8cb73f11-a78c-46f7-8836-27825dda2c61" continuedAt="i991267872b1b4a60b6e7a4ae664c943b" escape="true">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i2e1ec29115754b08ad018754df767d4c" continuedAt="i6787a70bdb5e45198785fe22290f8459"><ix:continuation id="i991267872b1b4a60b6e7a4ae664c943b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0049bf4214214416a8f099e71e710193_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItMS0xLTEtMC90ZXh0cmVnaW9uOjZkZTBhZmU3MGM4ZTRmNDE5YzJhNDJkOGJmMmUwNjM1XzEwOTk1MTE2Mjc3OTU_78fd4be6-c72a-45d5-95f8-410a624717a2">0.13</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="i29a3f0bb53204d2799a1664c7a293bc5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItMS0xLTEtMC90ZXh0cmVnaW9uOjZkZTBhZmU3MGM4ZTRmNDE5YzJhNDJkOGJmMmUwNjM1XzEwOTk1MTE2Mjc4MDQ_b581c186-481f-4992-b6c4-3acf1114fd54">0.95</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac621cbdae3640dfb12f31f495628cf4_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItMy0xLTEtMC90ZXh0cmVnaW9uOjEzOTVhMDM5YzFkNzQ3ZTlhYjU2NDhkMmU2MDNlOWZiXzEwOTk1MTE2Mjc3OTU_64f77fba-3114-4723-a066-15f3b73fc9c5">1.72</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="i63af19991b6d4963a2316839da7e8a70_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItMy0xLTEtMC90ZXh0cmVnaW9uOjEzOTVhMDM5YzFkNzQ3ZTlhYjU2NDhkMmU2MDNlOWZiXzEwOTk1MTE2Mjc4MDQ_d7fb5b87-7245-4a3a-a66c-d1663604482d">2.55</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7ed14556556429fa016d4abae113d69_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItNS0xLTEtMC90ZXh0cmVnaW9uOmY2MDdkM2Y2MzE5MTQzMjBiNzJiNTAyMDBkZGQxODU1XzEwOTk1MTE2Mjc3OTU_21869464-c4ff-42b0-b5e4-98b17e8604be">1.55</ix:nonFraction>&#160;- <ix:nonFraction unitRef="number" contextRef="i0764697150b3465c88c53e155b29e37f_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItNS0xLTEtMC90ZXh0cmVnaW9uOmY2MDdkM2Y2MzE5MTQzMjBiNzJiNTAyMDBkZGQxODU1XzEwOTk1MTE2Mjc4Mjc_f161a2eb-4c34-42c9-ab4e-26290700fc98">2.25</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34b608918eb7402ab4f47dba3669f52f_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzMtMS0xLTEtMA_4351be3e-01ad-45cc-a14d-cae78b5eee44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55cba84e376a4aecb83de5d1d311be56_D20191001-20191231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzMtMy0xLTEtMA_eba29c22-b043-4218-8ca8-5846ae3bf277">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i688e9ce83e1c4d8f995dfcb32a30399c_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzMtNS0xLTEtMA_26511085-b7bf-4a94-ad60-035bc55b0d9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of Dexcom common stock</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0049bf4214214416a8f099e71e710193_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjBhZWVkYWNkNTYwNTRhYmRhNzA1ZDZjZjY4ZTU4MmY5XzEwOTk1MTE2Mjc3OTU_bec9ab20-4114-495d-b657-63d3cca3f57a">0.51</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="i29a3f0bb53204d2799a1664c7a293bc5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjBhZWVkYWNkNTYwNTRhYmRhNzA1ZDZjZjY4ZTU4MmY5XzEwOTk1MTE2Mjc4MDI_df570c2a-84ed-4ce2-9570-09c7897ad0a2">0.63</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac621cbdae3640dfb12f31f495628cf4_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtMy0xLTEtMC90ZXh0cmVnaW9uOmRlZGVkYzdiMzJkMDQ5Njk5ODgyNTA3YmM5ZTU1MWI4XzEwOTk1MTE2Mjc3OTU_1be4df0d-47bf-4f0c-bf6e-2dd8f1b5b959">0.40</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="i63af19991b6d4963a2316839da7e8a70_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtMy0xLTEtMC90ZXh0cmVnaW9uOmRlZGVkYzdiMzJkMDQ5Njk5ODgyNTA3YmM5ZTU1MWI4XzEwOTk1MTE2Mjc4MDI_743d1c81-72be-4f3e-a115-4e9dd87f2676">0.51</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7ed14556556429fa016d4abae113d69_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtNS0xLTEtMC90ZXh0cmVnaW9uOjA0MmUzMjE5OGNhZjRmZDg4MWFlZjk3ZjM2YmViZGE5XzEwOTk1MTE2Mjc3OTU_c46bd9e9-f029-4e17-b474-23b947318078">0.50</ix:nonFraction>&#160;- <ix:nonFraction unitRef="number" contextRef="i0764697150b3465c88c53e155b29e37f_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtNS0xLTEtMC90ZXh0cmVnaW9uOjA0MmUzMjE5OGNhZjRmZDg4MWFlZjk3ZjM2YmViZGE5XzEwOTk1MTE2Mjc4MDQ_c49d004c-0d5e-4929-ac0a-7a11b09a7648">0.67</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i34b608918eb7402ab4f47dba3669f52f_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzUtMS0xLTEtMA_5a94e047-ca34-4bce-85c9-00a89eb7427f">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i55cba84e376a4aecb83de5d1d311be56_D20191001-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzUtMy0xLTEtMA_249deb92-a11e-4940-863a-ae0697714997">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i688e9ce83e1c4d8f995dfcb32a30399c_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzUtNS0xLTEtMA_09641ed7-9f71-40c9-8785-8cac5cb56842">1</ix:nonNumeric></span></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6787a70bdb5e45198785fe22290f8459">At December&#160;31, 2020, unrecognized estimated compensation costs related to unvested restricted stock units and ESPP shares totaled $<ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2MDg_69b32815-2578-4b55-beb8-4821a4933162">147.6</ix:nonFraction> million and are expected to be recognized through 2024.</ix:continuation> </span></div><div id="i889b093251984bfb881a094ef59c54bd_163"></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90ZXh0cmVnaW9uOjZkODAzOWI5M2MyMDQxZWFiNjg1ZDVmNmJjMDkwYzUwXzE3Nzk_b1114cb5-d466-452c-ad5d-f135d7dd9b5a" continuedAt="ib84a129c375a4a359b8aab8d34cdf0be" escape="true"><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10. Business Segment and Geographic Information</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reportable Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently consider our operations to be, and manage our business globally within, <ix:nonFraction unitRef="segment" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90ZXh0cmVnaW9uOjZkODAzOWI5M2MyMDQxZWFiNjg1ZDVmNmJjMDkwYzUwXzUwOQ_79fbf9f3-26bf-4534-bc7d-be32b2334ada">one</ix:nonFraction> reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom is domiciled in the United States. We sell our CGM systems through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the United States, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand. We disaggregate our revenue from contracts by geography and by major sales channel as we believe they best depict how the nature, amount and timing of revenues and cash flows are affected by economic factors. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues by geographic region</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2020, 2019 and 2018, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. <ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90ZXh0cmVnaW9uOjZkODAzOWI5M2MyMDQxZWFiNjg1ZDVmNmJjMDkwYzUwXzE3ODE_022d7f18-e45a-48ee-964b-4d4eeba2db69" continuedAt="i37e37a1612bb4f518d3f43679d38315e" escape="true">The table below sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product. The majority of our long-lived assets are located in the United States.</ix:nonNumeric></span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><ix:continuation id="i37e37a1612bb4f518d3f43679d38315e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa840b26370a49c1a7d4e9c32b365ada_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtMS0xLTEtMA_5b0c07c7-f7aa-42c5-b076-57c26cf26836">1,509.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa840b26370a49c1a7d4e9c32b365ada_D20200101-20201231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtMy0xLTEtMA_34c86adc-f51d-4b30-a5a2-746c7797a01f">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3efb05cdfec5469584069bfe20b97f34_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtNS0xLTEtMA_2f8d25f4-0596-4cf5-9da1-a84b6824eeb2">1,161.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3efb05cdfec5469584069bfe20b97f34_D20190101-20191231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtNy0xLTEtMA_fe62df87-1390-4364-8251-a427b7ab1de9">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe068ff6a8d447aa24bbe067484df80_D20180101-20181231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtOS0xLTEtMA_0cc1e033-de4f-4028-b9a0-f13f075bd36a">818.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1fe068ff6a8d447aa24bbe067484df80_D20180101-20181231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtMTEtMS0xLTA_3b16d26e-37ec-4194-b93d-bb7637f9e55d">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5438637b49ce4764914c810d05bc68a1_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtMS0xLTEtMA_044c4aa1-bc59-454f-8356-26c72822a3c6">417.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5438637b49ce4764914c810d05bc68a1_D20200101-20201231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtMy0xLTEtMA_fe78e7eb-e278-4e17-8bcb-69a4f04659ef">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66896da671864b0a8fd51f13e20833f9_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtNS0xLTEtMA_49021d77-6f60-4b81-ae62-f4661c16d9a1">314.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i66896da671864b0a8fd51f13e20833f9_D20190101-20191231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtNy0xLTEtMA_7d3d2ae2-f664-4547-85a9-a6e84ac31d05">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931962e264f448fb93ed19b0f908c9dd_D20180101-20181231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtOS0xLTEtMA_d5675af6-1236-43f6-8bbb-23b620da106d">213.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i931962e264f448fb93ed19b0f908c9dd_D20180101-20181231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtMTEtMS0xLTA_7feed622-568a-4e7f-9930-c6d593b61627">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtMS0xLTEtMA_4fee8edc-8507-4ffb-a347-dc1fb8cff65b">1,926.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtMy0xLTEtMA_79cdaa10-a122-4f75-bd58-7e9ac41a221c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtNS0xLTEtMA_f371c67b-78e2-4c27-b7b8-6a7adc0efd3a">1,476.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtNy0xLTEtMA_fc581cf5-67cf-47cd-b309-4a7f3233011f">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtOS0xLTEtMA_7ed1b31a-4a7a-4ab4-9f27-6e18e01a23d5">1,031.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtMTEtMS0xLTA_76bc9438-51eb-4767-b547-e67ef07b7775">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib84a129c375a4a359b8aab8d34cdf0be"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues by customer sales channel</span></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90ZXh0cmVnaW9uOjZkODAzOWI5M2MyMDQxZWFiNjg1ZDVmNmJjMDkwYzUwXzE3ODQ_7e6b6ed5-4892-4bc6-bf06-e142a7483a51" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth revenues by major sales channel for the twelve months ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ef105fbc7ec4827bdf560993cb05f98_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtMS0xLTEtMA_a2742ed8-9704-4815-a97e-769deaac5df9">1,437.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ef105fbc7ec4827bdf560993cb05f98_D20200101-20201231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtMy0xLTEtMA_a5c24044-ed67-4a9f-b6a0-a4dac18f8c6d">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba28294146894fc4a844398fae9b899e_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtNS0xLTEtMA_1c8e9f63-7cd6-4837-90bc-9ee587486501">1,011.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba28294146894fc4a844398fae9b899e_D20190101-20191231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtNy0xLTEtMA_31ec1cb7-9354-4a60-8c05-f8e1048a34c6">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7260e40093964fda96288a1c159934c9_D20180101-20181231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtOS0xLTEtMA_9484b1f6-f61e-4122-afac-2fd6f09ccd99">652.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7260e40093964fda96288a1c159934c9_D20180101-20181231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtMTEtMS0xLTA_f8ab22ee-94a6-4b18-a57f-ab948b29e983">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie028a8fb3e7348b9881b8512b4a4860b_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtMS0xLTEtMA_fa4d1605-3788-43d3-9d18-8a8b27592447">489.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie028a8fb3e7348b9881b8512b4a4860b_D20200101-20201231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtMy0xLTEtMA_0a6ff843-7ec0-44f1-9964-8601e2974330">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38178bb74286401ba0308f4e347b9fd1_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtNS0xLTEtMA_e7615903-5d4b-469e-9674-97901eb80946">464.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i38178bb74286401ba0308f4e347b9fd1_D20190101-20191231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtNy0xLTEtMA_9bb587f1-2f78-4baa-bbfe-6f5b869c124d">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698887039b694543ab8c5c785c1d2f8f_D20180101-20181231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtOS0xLTEtMA_4b552778-e423-4ca7-91ab-a79a3dfc8639">378.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i698887039b694543ab8c5c785c1d2f8f_D20180101-20181231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtMTEtMS0xLTA_eec59702-f407-4398-9efe-87dd43c73fce">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtMS0xLTEtMA_d97e01cd-9d3b-4d1a-9873-4d7c61d8bed5">1,926.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtMy0xLTEtMA_0bcc49b0-eff6-41c1-9cff-9392cd1debdc">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtNS0xLTEtMA_77f18f9d-8092-4321-8677-7aa6324fe677">1,476.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtNy0xLTEtMA_0b527c01-ecf0-40f6-b388-82096dc35c27">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtOS0xLTEtMA_7376f010-04c5-4852-8852-51ee3bdeddf0">1,031.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtMTEtMS0xLTA_51403742-6c0b-47ea-b173-fc05907b412a">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><div id="i889b093251984bfb881a094ef59c54bd_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90ZXh0cmVnaW9uOmVmZDcxNmJiZGE3YjQxOTk4OWEyNTI2MTZlN2FjYjc4XzE5_a92ba432-bdb0-4c3c-94e7-d18afee22b22" escape="true"><div style="margin-bottom:15pt;margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SCHEDULE II</span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8211; </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VALUATION AND QUALIFYING ACCOUNTS</span></div></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In millions)</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2017</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic82615128e2c4fc99ac6cee2560ef199_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzItMS0xLTEtMA_b64fc608-e927-40bc-9aad-1a10004bc453">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzMtMS0xLTEtMA_bbb1ef2e-0df6-4414-a3a2-7027f65b19e3">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs and adjustments</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzQtMS0xLTEtMA_07121288-9b64-476f-ada9-f990f660a5b2">8.3</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzUtMS0xLTEtMA_a8a51fde-dd3d-4d7b-b5ec-79c1044a388f">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzYtMS0xLTEtMA_8cdc5661-2e63-4c1c-be5a-bc31ad8bf29c">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzItMS0xLTEtMA_4fb32194-97f1-474c-9aa3-4a6ce66ff427">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzMtMS0xLTEtMA_ab0b20e4-1058-42b1-b4a7-a3b269a38d29">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs and adjustments</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzQtMS0xLTEtMA_fad15339-0a7a-4497-8644-132b0ea19572">3.0</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzUtMS0xLTEtMA_0d4568bd-f061-4574-918d-73fe611f1a3d">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzYtMS0xLTEtMA_39f50348-9cb9-4015-8c36-65792708c88c">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzItMS0xLTEtMA_00b13d08-d541-4553-9803-be88178006c4">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzMtMS0xLTEtMA_1f78fa3a-5d40-43c3-a02e-7f403f6166d2">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs and adjustments</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzQtMS0xLTEtMA_c3236bf2-e7db-4aa6-be61-1d3dd6d01900">2.1</ix:nonFraction>)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzUtMS0xLTEtMA_3dc2d33e-efbf-40e5-8ffa-7214aaff89b0">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzYtMS0xLTEtMA_a5561720-4aaa-41f2-8dc7-e856320d8714">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.04
<SEQUENCE>2
<FILENAME>dxcm12312020ex404securitie.htm
<DESCRIPTION>EX-4.04
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i314860f89e3c431f8acc064bc9cb41ee_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 4.04</font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">As of December 31, 2020, DexCom, Inc. (the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934&#58; our common stock. </font></div><div style="margin-top:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Capital Stock</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following summary of the terms of our capital stock is based upon our restated certificate of incorporation, as amended, and our restated bylaws. The summary is not complete, and is qualified by reference to our restated certificate of incorporation, the certificate of amendment to the certificate of incorporation and our restated bylaws, which are filed as exhibits to this Annual Report on Form 10-K and are incorporated by reference herein. We encourage you to read our restated certificate of incorporation, the certificate of amendment to the certificate of incorporation, our restated bylaws and the applicable provisions of the Delaware General Corporation Law, or DGCL, for additional information.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have authorized capital stock consisting of 200,000,000 shares of common stock, $0.001 par value per share, and 5,000,000 shares of undesignated preferred stock, $0.001 par value per share. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Common Stock </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Dividend rights </font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Voting rights </font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">No preemptive or similar rights </font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our common stock is not entitled to preemptive rights, and is not subject to conversion, redemption or sinking fund provisions. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Right to receive liquidation distributions </font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon our liquidation, dissolution or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Preferred Stock </font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our board of directors is authorized, subject to limitations prescribed by the DGCL, to issue from time to time up to 5,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each series and to fix the designation, powers, preferences and rights of the shares of each series and any of their qualifications, limitations or restrictions, in each case without further vote or action by our stockholders. Our board of directors is also able to increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding, without any further vote or action by our stockholders. Our board of directors may be able to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and might adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. We have no current plan to issue any shares of preferred stock. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exclusive Forum</font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a breach of fiduciary duty, any action asserting a claim against us arising pursuant to the DGCL, our restated certificate of incorporation, or our amended and restated bylaws, any action to interpret, apply, enforce or determine the validity of  our restated certificate of incorporation, or our amended and restated bylaws, or any action asserting a claim against us that is governed by the internal affairs doctrine. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. Our amended and restated bylaws further provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complain asserting a cause of action arising under the Securities Act.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Anti-Takeover Provisions </font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The provisions of the DGCL, our restated certificate of incorporation, as amended, and our restated bylaws could have the effect of delaying, deferring or discouraging another person from acquiring control of our company. These provisions, which are summarized below, may have the effect of discouraging takeover bids. They are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Delaware Law </font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. In general, DGCL Section 203 prohibits a publicly held Delaware corporation from engaging in a business combination with an interested stockholder for a period of three years following the date on which the person became an interested stockholder unless&#58; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (i) shares owned by persons who are directors and also officers and (ii) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">at or subsequent to the date of the transaction, the business combination is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders, and not by </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">written consent, by the affirmative vote of at least 66.67% of the outstanding voting stock that is not owned by the interested stockholder. Generally, a business combination includes a merger, asset or stock sale, or other transaction or series of transactions together resulting in a financial benefit to the interested stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of a corporation&#8217;s outstanding voting stock. We expect the existence of this provision to have an anti-takeover effect with respect to transactions our board of directors does not approve in advance. We also anticipate that DGCL Section 203 may also discourage attempts that might result in a premium over the market price for the shares of common stock held by stockholders.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Restated Certificate of Incorporation and Restated Bylaws Provisions </font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our restated certificate of incorporation, as amended, and our restated bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our company, including the following&#58; </font></div><div style="margin-top:5pt;padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"></td><td style="width:98.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Board of directors vacancies.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Our restated certificate of incorporation, as amended, and restated bylaws authorize only our board of directors to fill vacant directorships, including newly created seats. In addition, the number of directors constituting our board of directors is permitted to be set only by a resolution adopted by a majority vote of our entire board of directors. These provisions would prevent a stockholder from increasing the size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees. This makes it more difficult to change the composition of our board of directors but promotes continuity of management. </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Classified board.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Our restated certificate of incorporation, as amended, and restated bylaws provide that our board of directors will be classified into three classes of directors, each with staggered three-year terms. A third party may be discouraged from making a tender offer or otherwise attempting to obtain control of us as it is more difficult and time consuming for stockholders to replace a majority of the directors on a classified board of directors. </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Stockholder action&#59; special meetings of stockholders.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Our restated certificate of incorporation, as amended, provides that our stockholders may not take action by written consent, but may only take action at annual or special meetings of our stockholders. As a result, a holder controlling a majority of our capital stock would not be able to amend our restated bylaws or remove directors without holding a meeting of our stockholders called in accordance with our restated bylaws. Further, our restated bylaws and restated certificate of incorporation, as amended, provide that special meetings of our stockholders may be called only by a majority of our board of directors, the chairman of our board of directors, our Chief Executive Officer, our President or our Lead Independent Director, thus prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal or for stockholders controlling a majority of our capital stock to take any action, including the removal of directors. </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Advance notice requirements for stockholder proposals and director nominations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Our restated bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at our annual meeting of stockholders. Our restated bylaws also specify certain requirements regarding the form and content of a stockholder&#8217;s notice. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders if the proper procedures are not followed. We expect that these provisions might also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of our company. </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">No cumulative voting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless a corporation&#8217;s certificate of incorporation provides otherwise. Our restated certificate of incorporation, as amended, does not provide for cumulative voting. </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Directors removed only for cause.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Our restated certificate of incorporation, as amended, provides that stockholders may remove directors only for cause and only by the affirmative vote of the holders of at least two-thirds of our outstanding common stock. </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Issuance of undesignated preferred stock.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Our board of directors has the authority, without further action by the stockholders, to issue up to 5,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock would enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or other means. </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exchange Listing </font></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#8220;DXCM.&#8221;</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.43
<SEQUENCE>3
<FILENAME>dxcm12312020ex1043doindemn.htm
<DESCRIPTION>EX-10.43
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i35e416c4ed4a460c888ea8541ff956ac_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.43</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INDEMNIFICATION AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Indemnification Agreement, dated as of ____________, 20__, is made by and between DEXCOM, INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and _______________ ___________________, a director, officer or key employee of the Company or one of the Company&#8217;s Subsidiaries or other service provider who satisfies the definition of Indemnifiable Person set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A.&#160;&#160;&#160;&#160;The Company is aware that competent and experienced persons are increasingly reluctant to serve as representatives of corporations unless they are protected by comprehensive liability insurance and&#47;or indemnification, due to increased exposure to litigation costs and risks resulting from their service to such corporations, and due to the fact that the exposure frequently bears no reasonable relationship to the compensation of such representatives&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;The members of the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) have concluded that, to retain and attract talented and experienced individuals to serve as representatives of the Company and its Subsidiaries and Affiliates and to encourage such individuals to take the business risks necessary for the success of the Company and its Subsidiaries and Affiliates, it is necessary for the Company to contractually indemnify its representatives and the representatives of its Subsidiaries and Affiliates, and to assume for itself maximum liability for Expenses and Other Liabilities in connection with claims against such representatives in connection with their service to the Company and its Subsidiaries and Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C.&#160;&#160;&#160;&#160;Section 145 of the General Corporation Law of Delaware, under which the Company is organized (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 145</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), empowers the Company to indemnify by agreement its officers, directors, employees and agents, and persons who serve, at the request of the Company, as directors, officers, employees or agents of other corporations or enterprises, and expressly provides that the indemnification provided by Section 145 is not exclusive&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">D.&#160;&#160;&#160;&#160;The Company desires and has requested the Indemnitee to serve or continue to serve as a representative of the Company and&#47;or the Subsidiaries or Affiliates of the Company free from undue concern about inappropriate claims for damages arising out of or related to such services to the Company and&#47;or the Subsidiaries or Affiliates of the Company.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the parties hereto, intending to be legally bound, hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Definitions</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; of the Company means any corporation, partnership, limited liability company, joint venture, trust or other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">enterprise in respect of which the Indemnitee is or was or will be serving as a director, officer, advisory director, trustee, manager, member, partner, employee, agent, attorney, consultant, member of the entity&#8217;s governing body (whether constituted as a board of directors, board of managers, general partner or otherwise), fiduciary, or in any other similar capacity at the direct or indirect request of the Company, and including, but not limited to, any employee benefit plan of the Company or a Subsidiary or Affiliate of the Company.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (i) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than a Subsidiary or a trustee or other fiduciary holding securities under an employee benefit plan of the Company or Subsidiary, is or becomes the &#8220;Beneficial Owner&#8221; (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company&#8217;s then outstanding capital stock or (ii) during any period of two consecutive years, individuals who at the beginning of such period constitute the Board and any new director whose election by the Board or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least two-thirds (2&#47;3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority of the Board, or (iii) the stockholders of the Company approve a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the outstanding capital stock of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into capital stock of the surviving entity) more than 50% of the total voting power represented by the capital stock of the Company or such surviving entity outstanding immediately after such merger or consolidation, or the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company (in one transaction or a series of transactions) of all or substantially all of the Company&#8217;s assets.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all direct and indirect costs of any type or nature whatsoever (including, without limitation, all attorneys&#8217; fees and related disbursements, and other out-of-pocket costs) paid or  incurred by the Indemnitee in connection with either the investigation, defense or appeal of, or being a witness in, a Proceeding (as defined below) or establishing or enforcing a right to indemnification under this Agreement, Section 145 or otherwise&#59; provided, however, that Expenses shall not include any judgments, fines, ERISA excise taxes or penalties or amounts paid in settlement of a Proceeding.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Indemnifiable Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indemnifiable Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any event or occurrence related to Indemnitee&#8217;s service for the Company or any Subsidiary or Affiliate as an Indemnifiable Person (as defined below), or by reason of anything done or not done, or any act or omission, by Indemnitee in any such capacity.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Indemnifiable Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For the purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indemnifiable Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any person who is or was a director, officer, trustee, manager, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">member, partner, employee, attorney, consultant, member of an entity&#8217;s governing body (whether constituted as a board of directors, board of managers, general partner or otherwise) or other agent or fiduciary of the Company or a Subsidiary or Affiliate of the Company.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Independent Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Independent Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means legal counsel that has not performed services for the Company or Indemnitee in the five years preceding the time in question and that would not, under applicable standards of professional conduct, have a conflict of interest in representing either the Company or Indemnitee.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a member of the Board who is not a party to the Proceeding for which a claim is made under this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Other Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Other Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any and all liabilities of any type whatsoever (including, but not limited to, judgments, fines, ERISA (or other benefit plan related) excise taxes or penalties, and amounts paid in settlement and all interest, taxes, assessments and other charges paid or payable in connection with or in respect of any Expenses or any such judgments, fines, ERISA (or other benefit plan related) excise taxes or penalties, or amounts paid in settlement).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt;text-decoration:underline">Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For the purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any threatened, pending, or completed action, suit or other proceeding, whether civil, criminal, administrative, investigative or any other type whatsoever, preliminary, informal or formal, including any arbitration or other alternative dispute resolution and including any appeal of any of the foregoing.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any corporation of which more than 50% of the outstanding voting securities is owned directly or indirectly by the Company, by the Company and one or more other subsidiaries, or by one or more other subsidiaries.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Agreement to Serve</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Indemnitee agrees to serve and&#47;or continue to serve as an Indemnifiable Person in the capacity or capacities in which the Indemnitee currently serves the Company as an Indemnifiable Person, and any additional capacity in which Indemnitee may agree to serve, until such time as Indemnitee&#8217;s service in a particular capacity shall end according to the terms of an agreement, the Company&#8217;s Certificate of Incorporation or Bylaws, governing law, or otherwise.  Nothing contained in this Agreement is intended to create any right to continued employment or other form of service for the Company or a Subsidiary or Affiliate of the Company by the Indemnitee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Mandatory Indemnification</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Agreement to Indemnify</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event Indemnitee is a person who was or is a party to or witness in or is threatened to be made a party to or witness in any Proceeding by reason of an Indemnifiable Event, the Company shall indemnify Indemnitee from and against </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any and all Expenses and Other Liabilities incurred by Indemnitee in connection with (including in preparation for) such Proceeding to the fullest extent not prohibited by the Delaware General Corporation Law (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">DGCL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), as the same may be amended from time to time (but only to the extent that such amendment permits the Company to provide broader indemnification rights than the DGCL permitted prior to the adoption of such amendment).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Exception for Amounts Covered by Insurance and Other Sources</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, the Company shall not be obligated to indemnify Indemnitee for Expenses or Other Liabilities of any type whatsoever (including, but not limited to judgments, fines, penalties, ERISA excise taxes or penalties and amounts paid in settlement) to the extent such have been paid directly to the Indemnitee (or paid directly to a third party on Indemnitee&#8217;s behalf) by any directors and officers or other type of insurance  maintained by the Company or pursuant to other indemnity arrangements with third parties.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Partial Indemnification</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of any Expenses or Other Liabilities, but not entitled, however, to indemnification for the total amount of such Expenses or Other Liabilities, the Company shall nevertheless indemnify the Indemnitee for such total amount except as to the portion thereof for which indemnification is prohibited by the provisions of the DGCL.  In any review or Proceeding to determine the extent of indemnification, the Company shall bear the burden to establish, by clear and convincing evidence, the lack of a successful resolution of a particular claim, issue or matter and which amounts sought in indemnity are allocable to claims, issues or matters which were not successfully resolved.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Liability Insurance</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  So long as Indemnitee shall continue to serve the Company or a Subsidiary or Affiliate of the Company as an Indemnifiable Person and thereafter so long as Indemnitee shall be subject to any possible claim or threatened, pending or completed Proceeding as a result of an Indemnifiable Event, the Company shall use reasonable efforts to maintain in full force and effect for the benefit of Indemnitee as an insured (i) liability insurance issued by one or more reputable insurers and having the policy amount and deductible deemed appropriate by the Board and providing in all respects coverage at least comparable to and in the same amount as that provided to the Chairman of the Board or the Chief Executive Officer of the Company and (ii) any replacement or substitute policies issued by one or more reputable insurers providing in all respects coverage at least comparable to and in the same amount as that being provided to the Chairman of the Board or the Chief Executive Officer of the Company.  The purchase, establishment and maintenance of any such insurance or other arrangements shall not in any way limit or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights and obligations of the Company or the other party or parties thereto under any such insurance or other arrangement.  In the event of a Change in Control subsequent to the date of this Agreement, or the Company&#8217;s becoming insolvent, including being placed into receivership or entering the federal bankruptcy process, the Company shall maintain in force any directors&#8217; and officers&#8217; liability insurance policies then maintained by the Company in providing insurance in respect of Indemnitee, for a period of six years thereafter.  To the extent that the Company maintains an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">insurance policy or policies providing liability insurance for directors, officers, trustees, partners, managing members, fiduciaries, employees, or agents of the Company or a Subsidiary or Affiliate of the Company, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, trustee, partner, managing member, fiduciary, employee or agent under such policy or policies.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Mandatory Advancement of Expenses</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If requested by Indemnitee, the Company shall advance prior to the final disposition of the Proceeding all Expenses reasonably incurred by the Indemnitee in connection with (including in preparation for) a Proceeding related to an Indemnifiable Event.  The Indemnitee hereby undertakes to repay such amounts advanced if, and only if and to the extent that it shall ultimately be determined that the Indemnitee is not entitled to be indemnified by the Company under the provisions of this Agreement, the Company&#8217;s Bylaws or the DGCL, and no additional form of undertaking with respect to such obligation to repay shall be required.  The advances to be made hereunder shall be paid by the Company to the Indemnitee or directly to a third party designated in writing by the Indemnitee within thirty (30) days following delivery of a written request therefor by the Indemnitee to the Company.  Indemnitee&#8217;s undertaking to repay any Expenses advanced to Indemnitee hereunder shall be unsecured and shall not be subject to the accrual or payment of any interest thereon.  In the event that Indemnitee&#8217;s request for the advancement of expenses shall be accompanied by an affidavit of counsel to Indemnitee to the effect that such counsel has reviewed such Expenses and that such Expenses are reasonable in such counsel&#8217;s view, then such Expenses shall be deemed reasonable in the absence of clear and convincing evidence to the contrary as determined by the Reviewing Party.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Notice and Other Indemnification Procedures</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Promptly after receipt by the Indemnitee of notice of the commencement of or the threat of commencement of any Proceeding, the Indemnitee shall, if the Indemnitee believes that indemnification or advancement of Expenses with respect thereto may be sought from the Company under this Agreement, notify the Company of the commencement or threat of commencement thereof.  The failure to promptly notify the Company of the commencement of, or the threat of commencement of, any Proceeding, or the Indemnitee&#8217;s request for indemnification will not relieve the Company from any obligation that it may have to the Indemnitee hereunder, except to the extent that the Company is materially prejudiced in its defense of such Proceeding as a result of such failure. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Insurance and Other Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If, at the time of the receipt of a notice of the commencement of a Proceeding pursuant to Section 7(a) above, the Company has D&#38;O Insurance in effect, the Company shall give prompt notice of the commencement of such Proceeding to the issuers in accordance with the procedures set forth in the respective policies.  The Company shall thereafter take all reasonable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such D&#38;O Insurance policies.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Assumption of Defense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event the Company shall be obligated to advance the Expenses for any Proceeding against the Indemnitee, the Company, if deemed appropriate by the Company, shall be entitled to assume the defense of such Proceeding as provided herein.  Such defense by the Company may include the representation of two or more parties by one attorney or law firm as permitted under the ethical rules and legal requirements related to joint representations.  Following delivery of written notice to the Indemnitee of the Company&#8217;s election to assume the defense of such Proceeding, the approval by the Indemnitee (which approval shall not be unreasonably withheld) of counsel designated by the Company and the retention of such counsel by the Company, the Company will not be liable to the Indemnitee under this Agreement for any fees and expenses of counsel subsequently incurred by the Indemnitee with respect to the same Proceeding.  If (A) the employment of counsel by the Indemnitee has been previously authorized by the Company, (B) the Indemnitee shall have notified the Board in writing that notwithstanding counsel&#8217;s determination that joint representation is permitted under the ethical rules and legal requirements related to such representations, the Indemnitee has reasonably concluded that there may be a conflict of interest between the Company and the Indemnitee, or between Indemnitee and any other current or former director, officer or employee of the Company who is a named defendant in such Proceeding and is represented by such counsel, in the conduct of any such defense, or (C) the Company fails to employ counsel to assume the defense of such Proceeding within 30 days, the fees and expenses of the Indemnitee&#8217;s counsel shall be subject to indemnification and&#47;or advancement pursuant to the terms of this Agreement.  Nothing herein shall prevent the Indemnitee from employing counsel for any such Proceeding at the Indemnitee&#8217;s expense.  For the avoidance of doubt, in any Proceeding brought by or in the right of the Company, Indemnitee shall be deemed to have a reasonable basis to conclude that a conflict of interest between the Company and the Indemnitee exists for the purposes of clause (B) of this paragraph.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall not be liable to indemnify Indemnitee under this Agreement or otherwise for any amounts paid in settlement of any Proceeding effected without the Company&#8217;s written consent&#59; provided, however, that if a Change in Control has occurred subsequent to the date of this Agreement, the Company shall be liable for indemnification of Indemnitee for amounts paid in settlement if the Independent Counsel has approved the settlement.  Neither the Company nor any Subsidiary or Affiliate shall enter into a settlement of any Proceeding that might result in the imposition of any Expense, Other Liability, penalty, limitation or detriment on Indemnitee, whether indemnifiable under this Agreement or otherwise, without Indemnitee&#8217;s written consent.  Neither the Company nor Indemnitee shall unreasonably withhold consent from any settlement of any Proceeding.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Determination of Right to Indemnification</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Success on the Merits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent the Indemnitee has been successful on the merits or otherwise in defense of any Proceeding referred to in Section 3(a) of this Agreement or in the defense of any claim, issue or matter described therein, the Company shall indemnify the Indemnitee against Expenses actually and reasonably incurred by him or her in connection therewith.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;6</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Right to Indemnification in Other Situations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that Section 8(a) is inapplicable, the Company shall also indemnify the Indemnitee if he or she has not failed to meet the applicable standard of conduct for indemnification.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Forum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Indemnitee shall be entitled to select the forum in which determination of whether or not the Indemnitee has met the applicable standard of conduct will be made from among the following&#58;</font></div><div style="margin-bottom:12pt;text-indent:96.69pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Those members of the Board who are Independent Directors, even though less than a quorum&#59;</font></div><div style="margin-bottom:12pt;text-indent:93.36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A committee of Independent Directors designated by a majority vote of Independent Directors, even though less than a quorum&#59; or</font></div><div style="margin-bottom:12pt;text-indent:90.03pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Independent Counsel selected by the Indemnitee, and approved by the Board, which approval may not be unreasonably withheld, which counsel shall make such determination in a written opinion.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If Indemnitee is an officer or a director of the Company at the time that Indemnitee is selecting the forum, then Indemnitee shall not select Independent Counsel as such forum unless there are no Independent Directors or unless the Independent Directors agree to the selection of Independent Counsel as the forum.  The selected forum shall be referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reviewing Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, following any Change in Control subsequent to the date of this Agreement, the Reviewing Party shall be Independent Counsel selected in the manner provided in (3) above.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">As soon as practicable, and in no event later than 30 days after written notice of the Indemnitee&#8217;s choice of forum pursuant to Section 8(c) above, the Company and the Indemnitee shall each submit to the Reviewing Party such information as they believe is appropriate for the Reviewing Party to consider.  The Reviewing Party shall arrive at its decision within a reasonable period of time following the receipt of all such information from the Company and Indemnitee, but in no event later than thirty (30) days following the receipt of all such information, provided that the time by which the Reviewing Party must reach a decision may be extended by mutual agreement of the Company and Indemnitee.  All Expenses associated with the process set forth in this Section 8(d), including but not limited to the Expenses of the Reviewing Party, shall be paid by the Company.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Delaware Court of Chancery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding a final determination by any Reviewing Party that the Indemnitee is not entitled to indemnification with respect to a specific Proceeding, the Indemnitee shall have the right to apply to the Court of Chancery of Delaware for the purpose of enforcing the Indemnitee&#8217;s right to indemnification pursuant to this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;7</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall indemnify the Indemnitee against all Expenses incurred by the Indemnitee in connection with any hearing or Proceeding under this Section 8 involving the Indemnitee and against all Expenses and Other Liabilities incurred by the Indemnitee in connection with any other Proceeding between the Company and the Indemnitee involving the interpretation or enforcement of the rights of the Indemnitee under this Agreement unless a court of competent jurisdiction finds that each of the material claims and&#47;or defenses of the Indemnitee in any such Proceeding was frivolous or not made in good faith.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Determination of &#8220;Good Faith&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of any determination of whether Indemnitee acted in &#8220;good faith&#8221; hereunder, the Indemnitee shall be deemed to have acted in good faith if in taking or failing to take the action in question, the Indemnitee relied on the records or books of account of the Company or a Subsidiary or Affiliate of the Company, including financial statements, or on information, opinions, reports or statements provided to the Indemnitee by the officers or other employees of the Company or a Subsidiary or Affiliate of the Company in the course of their duties, or on the advice of legal counsel for the Company or a Subsidiary or Affiliate of the Company, or on information or records given or reports made to the Company or a Subsidiary or Affiliate of the Company by an independent certified public accountant or by an appraiser or other expert selected by the Company or a Subsidiary or Affiliate of the Company, or by any other person (including legal counsel, accountants and financial advisors) as to matters the Indemnitee reasonably believes are within such other person&#8217;s professional or expert competence and who has been selected with reasonable care by or on behalf of the Company or a Subsidiary or Affiliate.  In connection with any determination as to whether the Indemnitee is entitled to be indemnified hereunder, or to advancement of Expenses, the Reviewing Party or court shall presume that the Indemnitee has satisfied the applicable standard of conduct and shall be entitled to indemnification or advancement of Expenses, and the burden of proof shall be on the Company to establish by clear and convincing evidence that the Indemnitee is not so entitled.  The provisions of this Section 8 shall not be deemed to be exclusive or to limit in any way the other circumstances in which the Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.  In addition, the knowledge and&#47;or actions, or failures to act, of any other person serving the Company or a Subsidiary or Affiliate of the Company as an indemnifiable person shall not be imputed to the Indemnitee for purposes of determining the right to indemnification hereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Exceptions</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any other provision herein to the contrary notwithstanding, </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Claims Initiated by Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall not be obligated pursuant to the terms of this Agreement to indemnify or advance Expenses to the Indemnitee with respect to Proceedings or claims initiated or brought voluntarily by the Indemnitee and not by way of counterclaim or affirmative defense, except with respect to (1) Proceedings brought to establish or enforce a right to indemnification under this Agreement, any other statute or law, as permitted under Section 145, or otherwise, (2) where the Board has consented to the initiation of such Proceeding, or (3) with respect to Proceedings brought to discharge the Indemnitee&#8217;s fiduciary responsibilities, whether under ERISA or otherwise, but such indemnification or advancement of Expenses may be provided by the Company in specific cases if the Board finds it to be appropriate&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;8</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Actions Based on Federal Statutes Regarding Profit Recovery and Return of Bonus Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall not be obligated pursuant to the terms of this Agreement to indemnify Indemnitee on account of (i) any suit in which judgment is rendered against Indemnitee for an accounting of profits made from the purchase or sale by Indemnitee of securities of the Company pursuant to the provisions of Section 16(b) of the Securities Exchange Act of 1934 and amendments thereto or similar provisions of any federal, state or local statutory law, or (ii) any reimbursement of the Company by the Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by the Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act)&#59; or </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Unlawful Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall not be obligated pursuant to the terms of this Agreement to indemnify the Indemnitee for Other Liabilities if such indemnification is prohibited by law as determined by a court of competent jurisdiction in a final adjudication not subject to further appeal.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Non-Exclusivity</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions for indemnification and advancement of Expenses set forth in this Agreement shall not be deemed exclusive of any other rights which the Indemnitee may have under any provision of law, the Company&#8217;s Certificate of Incorporation or Bylaws, the vote of the Company&#8217;s stockholders or disinterested directors, other agreements, or otherwise, both as to acts or omissions in his or her official capacity and to acts or omissions in another capacity while serving the Company or Subsidiary or Affiliate as an Indemnifiable Person and the Indemnitee&#8217;s rights hereunder shall continue after the Indemnitee has ceased serving the company or a Subsidiary or Affiliate as an Indemnifiable Person and shall inure to the benefit of the heirs, executors and administrators of the Indemnitee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever, (i) the validity, legality and enforceability of the remaining provisions of the Agreement (including, without limitation, all portions of any paragraphs of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby, and (ii) to the fullest extent possible, the provisions of this Agreement (including, without limitation, all portions of any paragraphs of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Supersession, Modification and Waiver</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement supersedes any prior indemnification agreement between the Indemnitee and the Company, its Subsidiaries or its Affiliates.  If the Company and Indemnitee have previously entered into an indemnification agreement providing for the indemnification of Indemnitee by the Company, the parties&#8217; entry into this Agreement shall be deemed to amend and restate such prior agreement to read in its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;9</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">entirety as, and be superseded by, this Agreement.  No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto.  No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision hereof (whether or not similar) and except as expressly provided herein, no such waiver shall constitute a continuing waiver.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Successors and Assigns</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The terms of this Agreement shall bind, and shall inure to the benefit of, the successors and assigns of the parties hereto.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Notice</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed duly given (i) if delivered by hand and receipt is provided by the party to whom such communication is delivered or (ii) if mailed by certified or registered mail with postage prepaid, return receipt requested, on the signing by the recipient of an acknowledgment of receipt form accompanying deliver through the U.S. mail, (iii) personal service by a process server, or (iv) delivery to the recipient&#8217;s address by overnight delivery (e.g. FedEx, UPS or DHL) or other commercial delivery service.  Addresses for notice to either party are as shown on the signature page of this Agreement, or as subsequently modified by written notice complying with the provisions of this Section 14.  Delivery of communications to the Company with respect to this Agreement shall be sent to the attention of the Company&#8217;s General Counsel.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">No Presumptions</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, the termination of any Proceeding, by judgment, order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the Indemnitee did not meet any particular standard of conduct or have any particular belief or that a court has determined that indemnification is not permitted by applicable law or otherwise.  In addition, neither the failure of the Company or a Reviewing Party to have made a determination as to whether the Indemnitee has met any particular standard of conduct or had any particular belief, nor an actual determination by the Company or a Reviewing Party that the Indemnitee has not met such standard of conduct or did not have such belief, prior to the commencement of Proceedings by the Indemnitee to secure a judicial determination by exercising the Indemnitee&#8217;s rights under Section 7 of this Agreement shall be a defense to the Indemnitee&#8217;s claim or create a presumption that the Indemnitee has failed to meet any particular standard of conduct or did not have any particular belief or is not entitled to indemnification under applicable law or otherwise.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Survival of Rights</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The rights conferred on the Indemnitee by this Agreement shall continue after the Indemnitee has ceased to serve the Company or a Subsidiary or Affiliate of the Company as an Indemnifiable Person and shall inure to the benefit of the Indemnitee&#8217;s heirs, executors and administrators.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Subrogation and Contribution</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">Except as otherwise expressly provided herein, in the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of the Indemnitee, who shall execute all documents required and shall do </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;10</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">all acts that may be necessary to secure such rights and to enable the Company effectively to bring suit to enforce such rights.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by or on behalf of Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and&#47;or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and&#47;or transaction(s) giving cause to such Proceeding&#59; and&#47;or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and&#47;or transaction(s).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Specific Performance</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The parties recognize that if any provision of this Agreement is violated by the Company, the Indemnitee may be without an adequate remedy at law.  Accordingly, in the event of any such violation, the Indemnitee shall be entitled, if the Indemnitee so elects, to institute Proceedings, either in law or at equity, to obtain damages, to enforce specific performance, to enjoin such violation, or to obtain any relief or any combination of the foregoing as the Indemnitee may elect to pursue.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Counterparts</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be executed in counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same agreement.  Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Headings</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The headings of the sections and paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction of interpretation thereof. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Governing Law</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be governed exclusively by and construed according to the laws of the State of Delaware, as applied to contracts between Delaware residents entered into and to be performed entirely with Delaware.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Consent to Jurisdiction</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company and the Indemnitee each hereby irrevocably consent to the jurisdiction of the courts of the State of Delaware for all purposes in connection with any Proceeding which arises out of or relates to this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The parties hereto have entered into this Indemnification Agreement effective as of the date first above written.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DEXCOM, INC.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6340 Sequence Drive</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">San Diego, California 92121</font></div><div style="margin-top:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:24pt;margin-top:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Its&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">INDEMNITEE</font></div><div style="margin-top:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;11</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.44
<SEQUENCE>4
<FILENAME>dxcm12312020ex10442015espp.htm
<DESCRIPTION>EX-10.44
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8b0f5bf74ed04fe5959d0db95203d497_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.44</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEXCOM, INC. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2015 EMPLOYEE STOCK PURCHASE PLAN </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective on May 28, 2015, as amended on December 13, 2019</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;PURPOSE.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The purpose of this Plan is to provide eligible employees of the Company and the Participating Corporations with a means of acquiring an equity interest in the Company through payroll deductions, to enhance such employees&#8217; sense of participation in the affairs of the Company. Capitalized terms not defined elsewhere in the text are defined in Section 28. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;ESTABLISHMENT OF PLAN.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Company proposes to grant rights to purchase shares of Common Stock to eligible employees of the Company and its Participating Corporations pursuant to this Plan. The Company intends this Plan to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Code (including any amendments to or replacements of such Section), and this Plan shall be so construed. Any term not expressly defined in this Plan but defined for purposes of Section 423 of the Code shall have the same definition herein. In addition, with regard to offers of options to purchase shares of the Common Stock under the Plan to employees working for a Subsidiary or an Affiliate outside the United States, the Board or Committee (as defined herein) may offer a subplan or an option that is not intended to meet the Code Section 423 requirements, provided, if necessary under Code Section 423, that the other terms and conditions of the Plan are met. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to Section 14, a total of 1,500,000 Shares are reserved for issuance under this Plan. The number of shares initially reserved for issuance under this Plan and the maximum number of shares that may be issued under this Plan shall be subject to adjustments effected in accordance with Section 14. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;ADMINISTRATION.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Plan will be administered by the Committee. Subject to the provisions of this Plan and the limitations of Section 423 of the Code or any successor provision in the Code, all questions of interpretation or application of this Plan shall be determined by the Committee and its decisions shall be final and binding upon all Participants. The Committee will have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, to determine eligibility, to designate the Participating Corporations, to determine when to grant options that are not intended to meet the Code Section 423 requirements and to decide upon any and all claims filed under the Plan. Every finding, decision and determination made by the Committee will, to the full extent permitted by law, be final and binding upon all parties. Notwithstanding any provision to the contrary in this Plan, the Committee may adopt rules, sub-plans, and&#47;or procedures relating to the operation and administration of the Plan designed to comply with local laws, regulations or customs or to achieve tax, securities law or other objectives for eligible employees outside of the United States. The Committee will have the authority to determine the Fair Market Value of the Common Stock (which determination shall be final, binding and conclusive for all purposes) in accordance with Section 8 below and to interpret Section 8 of the Plan in connection with circumstances that impact the Fair Market Value. Members of the Committee shall receive no compensation for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">                                   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">their services in connection with the administration of this Plan, other than standard fees as established from time to time by the Board for services rendered by Board members serving on Board committees. All expenses incurred in connection with the administration of this Plan shall be paid by the Company. For purposes of this Plan, the Committee may designate separate offerings under the Plan (the terms of which need not be identical) in which eligible employees of one or more Participating Corporations will participate, even if the dates of the applicable Offering Periods of each such offering are identical. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;ELIGIBILITY. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Any employee of the Company or the Participating Corporations is eligible to participate in an Offering Period under this Plan, except that one or more of the following categories of employees may be excluded from coverage under the Plan by the Committee (other than where prohibited by applicable law)&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Employees who are not employed by the Company or a Participating Corporation prior to the beginning of such Offering Period or prior to such other time period as specified by the Committee&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;employees who are customarily employed for twenty (20) hours or less per week&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;employees who are customarily employed for five (5) months or less in a calendar year&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;employees who have been an employee of the Company for less than thirty (30) days prior to the first day of an Offering Period (or such longer period of time, not to exceed two (2) years, as determined by the Committee)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;employees who do not meet any other eligibility requirements that the Committee may choose to impose (within the limits permitted by the Code). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing notwithstanding, an individual shall not be eligible if his or her participation in the Plan is prohibited by the law of any country that has jurisdiction over him or her, if complying with the laws of the applicable country would cause the Plan to violate Section 423 of the Code, or if he or she is subject to a collective bargaining agreement that does not provide for participation in the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;No employee who, together with any other person whose stock would be attributed to such employee pursuant to Section 424(d) of the Code, owns stock or holds options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or its Parent or Subsidiary or who, as a result of being granted an option under this Plan with respect to such Offering Period, would own stock or hold options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or its Parent or Subsidiary shall be granted an option to purchase Common Stock under the Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;OFFERING DATES.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The offering periods of this Plan (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Offering Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) are described below.  Each Offering Period shall consist of one or more purchase periods (individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) during which payroll deductions of the Participants are accumulated under this Plan. The first business day of each Offering Period is referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Offering Date.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; The last business day of each Purchase Period is referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; The Committee shall have the power to change the Offering Dates, the Purchase Dates, the duration of Offering Periods (provided that an Offering Period will in no event be longer than twenty-seven (27) months), and the Purchase Periods, in each case without stockholder approval if such change is announced prior to the relevant Offering Period or prior to such other time period as specified by the Committee.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;All Offering Periods that commence following the Amendment Date shall be of six (6) months duration commencing on March 1 and September 1 of each year and respectively ending on August 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and February 28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (or the 29th if February has 29 days) of each year.  Each such Offering Period shall consist of one six (6)-month Purchase Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Offering Periods that commenced on March 1, 2019 and September 1, 2019 shall continue in accordance with the terms of the Plan prior to the Amendment Date and shall respectively end on February 29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or August 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;PARTICIPATION IN THIS PLAN. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Any employee who is an eligible employee determined in accordance with Section 4 immediately prior to an Offering Period will be eligible to participate in this Plan, subject to the requirement of Section 6(b) hereof and the other terms and provisions of this Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;With respect to each Offering Period, a Participant may elect to participate in this Plan by submitting an enrollment agreement (or any electronic or online enrollment form provided by the Company) prior to the commencement of the Offering Period (or such earlier date as the Committee may determine) to which such agreement (or any electronic or online enrollment form provided by the Company) relates. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Once an employee becomes a Participant in an Offering Period, then such Participant will automatically participate in each subsequent Offering Period commencing immediately following the last day of the prior Offering Period unless the Participant withdraws or is deemed to withdraw from this Plan or terminates further participation in an Offering Period as set forth in Section 11 below. A Participant who is continuing participation pursuant to the preceding sentence is not required to file any additional enrollment agreement in order to continue participation in this Plan&#59; a Participant who is not continuing participation pursuant to the preceding sentence is required to file an enrollment agreement (or any electronic or online enrollment form provided by the Company) prior to the commencement of the Offering Period (or such earlier date as the Committee may determine) to which such agreement (or any electronic or online enrollment form provided by the Company) relates. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;GRANT OF OPTION ON ENROLLMENT.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Becoming a Participant with respect to an Offering Period will constitute the grant (as of the Offering Date) by the Company to such Participant of an option to purchase on the Purchase Date up to that number of shares of Common Stock of the Company determined by a fraction, the numerator of which is the amount accumulated in such Participant&#8217;s payroll deduction account during such Purchase Period and the denominator of which is the lower of (i) eighty-five percent (85%) of the Fair Market Value of a share of Common Stock on the Offering Date (but in no event less than the par value of a share of the Common Stock), or (ii) eighty-five percent (85%) of the Fair Market Value of a share of the Common Stock on the Purchase Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the number of shares of Common Stock subject to any option granted pursuant to this Plan shall not exceed the lesser of (x) the maximum number of shares set by the Committee pursuant to Section 10(b) below with respect to the applicable Purchase Date, or (y) the maximum number of shares which may be purchased pursuant to Section 10(a) below with respect to the applicable Purchase Date. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;PURCHASE PRICE.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Purchase Price per share at which a share of Common Stock will be sold in any Offering Period shall be eighty-five percent (85%) of the lesser of&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Fair Market Value on the Offering Date&#59; or </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Fair Market Value on the Purchase Date. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;PAYMENT OF PURCHASE PRICE&#59; PAYROLL DEDUCTION CHANGES&#59; SHARE ISSUANCES. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Purchase Price shall be accumulated by regular payroll deductions made during each Offering Period, unless the Committee determines with respect to categories of Participants outside the United States that contributions may be made in another form due to local legal requirements. The deductions are made as a percentage of the Participant&#8217;s compensation in one percent (1%) increments not less than one percent (1%), nor greater than ten percent (10%) after taking into account any such lower limit set by the Committee. Compensation shall mean base salary or regular hourly wages (or in foreign jurisdictions, equivalent cash compensation)&#59; however, the Committee may at any time prior to the beginning of an Offering Period determine that for that and future Offering Periods, Compensation shall mean solely base salary or all W-2 cash compensation, including without limitation base salary or regular hourly wages, bonuses, incentive compensation, commissions, overtime, shift premiums, plus draws against commissions (or in foreign jurisdictions, equivalent cash compensation) but excluding any W-2 non-cash compensation which includes a disqualifying dispositions, equity grants, equity exercises or settlements. For purposes of determining a Participant&#8217;s Compensation, any election by such Participant to reduce his or her regular cash remuneration under Sections 125 (i.e. pre-tax cafeteria plan contributions) or 401(k) (i.e. pre-tax retirement contributions) of the Code (or in foreign jurisdictions, equivalent salary deductions) shall be treated as if the Participant did not make such election and as if such reductions were not made. Payroll deductions shall commence on the first payday following the last Purchase Date and shall continue to the end of the Offering Period unless sooner altered or terminated as provided in this Plan. Notwithstanding the foregoing, the terms of any sub-plan may permit matching shares without the payment of any purchase price. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;A Participant may decrease (but not increase) the rate of payroll deductions during an Offering Period by filing with the Company a new authorization (or any electronic or online authorization form provided by the Company) for payroll deductions , with the new rate to become effective no later than the second payroll period commencing after the Company&#8217;s receipt of the authorization or once any trading restrictions are lifted and continuing for the remainder of the Offering Period unless changed as described below. A decrease in the rate of payroll deductions may be made once during a Purchase Period or more frequently under rules determined by the Committee. A Participant may increase or decrease the rate of payroll deductions for any subsequent Purchase Period by filing with the Company a new authorization for payroll deductions prior to the beginning of the Offering Period for such applicable Purchase Period, or such other time period as specified by the Committee. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;A Participant may reduce his or her payroll deduction percentage to zero during an Offering Period by filing with the Company a request (or any electronic or online request form provided by the Company) for cessation of payroll deductions. Such reduction shall be effective beginning no later than the second payroll period after the Company&#8217;s receipt of the request or once any trading restrictions are lifted and no further payroll deductions will be made for the duration of the Offering Period. Payroll deductions credited to the Participant&#8217;s account prior to the effective date of the request shall be used to purchase shares of Common Stock in accordance with Subsection (e) below. A reduction of the payroll deduction percentage to zero shall be treated as such Participant&#8217;s withdrawal from such Offering Period and the Plan, effective as of the day after the next Purchase Date following the filing date of such request with the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;All payroll deductions made for a Participant are credited to his or her account under this Plan and are deposited with the general funds of the Company, except to the extent local legal restrictions outside the United States require segregation of such payroll deductions. No interest accrues on the payroll deductions, except to the extent required due to local legal requirements. All payroll deductions received or held by the Company may be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate such payroll deductions, except to the extent necessary to comply with local legal requirements outside the United States. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;On each Purchase Date, so long as this Plan remains in effect and provided that the Participant has not submitted a signed and completed withdrawal form before that date which notifies the Company that the Participant wishes to withdraw from that Offering Period under this Plan and have all payroll deductions accumulated in the account maintained on behalf of the Participant as of that date returned to the Participant, the Company shall apply the funds then in the Participant&#8217;s account to the purchase of whole shares of Common Stock reserved under the option granted to such Participant with respect to the Offering Period to the extent that such option is exercisable on the Purchase Date. The Purchase Price per share shall be as specified in Section 8 of this Plan. Any fractional share, as calculated under this Subsection (e), shall be rounded down to the next lower whole share, unless the Committee determines with respect to all Participants that any fractional share shall be credited as a fractional share. Any amount remaining in a Participant&#8217;s account on a Purchase Date which is less than the amount </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">necessary to purchase a full share of Common Stock shall be returned to the Participant, without interest (except to the extent necessary to comply with local legal requirements outside of the United States), unless the Committee determines that such amount shall be applied to the Participant&#8217;s account, without interest (except to the extent necessary to comply with local legal requirements outside the United States). In the event that this Plan has been oversubscribed, all funds not used to purchase shares on the Purchase Date shall be returned to the Participant, without interest (except to the extent required due to local legal requirements outside the United States). No Common Stock shall be purchased on a Purchase Date on behalf of any employee whose participation in this Plan has terminated prior to such Purchase Date, except to the extent required due to local legal requirements outside the United States. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;As promptly as practicable after the Purchase Date, the Company shall issue shares for the Participant&#8217;s benefit representing the shares purchased upon exercise of his or her option. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;Unless determined otherwise by the Committee, the shares issued pursuant to Section 9(f) above shall be deposited into an account established in the Participant&#8217;s name at the ESPP Broker.  Subject to any applicable insider trading policy, a Participant shall be free to undertake a disposition (as that term is defined in Section 424(c) of the Code) of the shares in his or her ESPP Broker account at any time, whether by sale, exchange, gift or other transfer of legal title but in the absence of such a disposition of the shares, the shares must remain in the Participant&#8217;s ESPP Broker account until the holding period set forth in Section&#160;423(a) of the Code has been satisfied.  With respect to shares for which the Section&#160;423(a) holding period has been satisfied, the Participant may move those shares to another brokerage account of Participant&#8217;s choosing.  Notwithstanding the above, a Participant who is not subject to income taxation under the Code may move his or her shares to another brokerage account of his or her choosing at any time, without regard to the satisfaction of the Section&#160;423(a) holding period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;During a Participant&#8217;s lifetime, his or her option to purchase shares hereunder is exercisable only by him or her. The Participant will have no interest or voting right in shares covered by his or her option until such option has been exercised. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;To the extent required by applicable federal, state, local or foreign law, a Participant shall make arrangements satisfactory to the Company for the satisfaction of any withholding tax obligations that arise in connection with the Plan. The Company or any Subsidiary or Affiliate, as applicable, may withhold, by any method permissible under the applicable law, the amount necessary for the Company or Subsidiary or Affiliate, as applicable, to meet applicable withholding obligations, including any withholding required to make available to the Company or Subsidiary or Affiliate, as applicable, any tax deductions or benefits attributable to the sale or early disposition of shares of Common Stock by a Participant. The Company shall not be required to issue any shares of Common Stock under the Plan until such obligations are satisfied. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;LIMITATIONS ON SHARES TO BE PURCHASED. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Any other provision of the Plan notwithstanding, no Participant shall purchase Common Stock with a Fair Market Value in excess of the following limit&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;In the case of Common Stock purchased during an Offering Period that commenced in the current calendar year, the limit shall be equal to (A) $25,000 minus (B) the Fair Market Value of the Common Stock that the Participant previously purchased in the current calendar year (under this Plan and all other employee stock purchase plans of the Company or any parent or Subsidiary of the Company). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;In the case of Common Stock purchased during an Offering Period that commenced in the immediately preceding calendar year, the limit shall be equal to (A) $50,000 minus (B) the Fair Market Value of the Common Stock that the Participant previously purchased (under this Plan and all other employee stock purchase plans of the Company or any parent or Subsidiary of the Company) in the current calendar year and in the immediately preceding calendar year. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;In the case of Common Stock purchased during an Offering Period that commenced two calendar years prior, the limit shall be equal to (A) $75,000 minus (B) the Fair Market Value of the Common Stock that the Participant previously purchased (under this Plan and all other employee stock purchase plans of the Company or any parent or Subsidiary of the Company) in the current calendar year and in the two immediately preceding calendar years. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Initially, a Participant shall not be permitted to purchase more than 5,000 shares on any one Purchase Date. The Committee may, in its sole discretion, set a new maximum number of shares which may be purchased by any employee at any single Purchase Date, which shall then be the Maximum Share Amount for subsequent Offering Periods. If a lower limit is set under this Subsection (b), then all Participants will be notified of such limit prior to the commencement of the next Offering Period for which it is to be effective. If a new Maximum Share Amount is set, then all participants must be notified of such Maximum Share Amount prior to the commencement of the next Offering Period for which it is to be effective. The Maximum Share Amount shall continue to apply with respect to all succeeding Purchase Dates and Offering Periods unless revised by the Committee as set forth above. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;If the number of shares to be purchased on a Purchase Date by all employees participating in this Plan exceeds the number of shares then available for issuance under this Plan, then the Company will make a pro rata allocation of the remaining shares in as uniform a manner as shall be reasonably practicable and as the Committee shall determine to be equitable. In such event, the Company shall give written notice of such reduction of the number of shares to be purchased under a participant&#8217;s option to each participant affected. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Any payroll deductions accumulated in a participant&#8217;s account which are not used to purchase stock due to the limitations in this Section 10 shall be returned to the participant as soon as practicable after the end of the applicable Purchase Period, without interest. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;If a Participant is precluded by this Subsection (a) from purchasing additional Common Stock under the Plan, then his or her employee contributions may be automatically discontinued by the Company and shall automatically resume at the beginning of the earliest Purchase Period that will end in the next calendar year (if he or she then is an eligible employee), provided that when the Company automatically resumes such payroll deductions, the Company must apply the rate in effect immediately prior to such suspension. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;If the number of shares to be purchased on a Purchase Date by all Participants exceeds the number of shares then available for issuance under this Plan, then the Company will make a pro rata allocation of the remaining shares in as uniform a manner as shall be reasonably practicable and as the Committee shall determine to be equitable. In such event, the Company will give notice of such reduction of the number of shares to be purchased under a Participant&#8217;s option to each Participant affected. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;Any payroll deductions accumulated in a Participant&#8217;s account which are not used to purchase stock due to the limitations in this Section 10, and not covered by Section 9(e), shall be returned to the Participant as soon as practicable after the end of the applicable Purchase Period, without interest (except to the extent required due to local legal requirements outside the United States). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;WITHDRAWAL. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each Participant may withdraw from an Offering Period under this Plan pursuant to a method specified for such purpose by the Company. Such withdrawal may be elected at any time prior to the end of an Offering Period, or such other time period as specified by the Committee. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Upon withdrawal from this Plan, the accumulated payroll deductions shall be returned to the withdrawn Participant, without interest (except to the extent required due to local legal requirements outside the United States), and his or her interest in this Plan shall terminate. In the event a Participant voluntarily elects to withdraw from this Plan, he or she may not resume his or her participation in this Plan during the same Offering Period, but he or she may participate in any Offering Period under this Plan which commences on a date subsequent to such withdrawal by filing a new authorization for payroll deductions in the same manner as set forth in Section 6 above for initial participation in this Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;TERMINATION OF EMPLOYMENT.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Termination of a Participant&#8217;s employment for any reason, including retirement, death, disability, or the failure of a Participant to remain an eligible employee of the Company or of a Participating Corporation, immediately terminates his or her participation in this Plan. In such event, accumulated payroll deductions credited to the Participant&#8217;s account will be returned to him or her or, in the case of his or her death, to his or her legal representative, without interest (except to the extent required due to local legal requirements outside the United States). For purposes of this Section 12, an employee will not be deemed to have terminated employment or failed to remain in the continuous employ of the Company or of a Participating Corporation in the case of sick leave, military leave, or any other leave of absence approved by the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such leave is for a period of not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">more than ninety (90) days or reemployment upon the expiration of such leave is guaranteed by contract or statute. The Company will have sole discretion to determine whether a Participant has terminated employment and the effective date on which the Participant terminated employment, regardless of any notice period or garden leave required under local law. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;RETURN OF PAYROLL DEDUCTIONS.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> In the event a Participant&#8217;s interest in this Plan is terminated by withdrawal, termination of employment or otherwise, or in the event this Plan is terminated by the Board, the Company shall deliver to the Participant all accumulated payroll deductions credited to such Participant&#8217;s account. No interest shall accrue on the payroll deductions of a Participant in this Plan (except to the extent required due to local legal requirements outside the United States). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;CAPITAL CHANGES.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> If the number of outstanding shares is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then the Committee shall adjust the number and class of Common Stock that may be delivered under the Plan, the Purchase Price per share and the number of shares of Common Stock covered by each option under the Plan which has not yet been exercised, and the numerical limits of Sections 2 and 10 shall be proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and in compliance with the applicable securities laws&#59; provided that fractions of a share will not be issued. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;NONASSIGNABILITY.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Neither payroll deductions credited to a Participant&#8217;s account nor any rights with regard to the exercise of an option or to receive shares under this Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in Section 22 below) by the Participant. Any such attempt at assignment, transfer, pledge or other disposition shall be void and without effect. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;USE OF PARTICIPANT FUNDS AND REPORTS.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Company may use all payroll deductions received or held by it under the Plan for any corporate purpose, and the Company will not be required to segregate Participant payroll deductions (except to the extent required due to local legal requirements outside the United States). Until shares are issued, a Participant will only have the rights of an unsecured creditor unless otherwise required under local law. Each Participant shall receive promptly after the end of each Purchase Period a report of his or her account setting forth the total payroll deductions accumulated, the number of shares purchased, the per share price thereof and the remaining cash balance, if any, carried forward to the next Purchase Period or Offering Period, as the case may be. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;NOTICE OF DISPOSITION.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Each U.S. taxpayer Participant shall notify the Company in writing if the Participant disposes of any of the shares purchased in any Offering Period pursuant to this Plan if such disposition occurs within the Notice Period. The Company may, at any time during the Notice Period, place a legend or legends on any certificate representing shares acquired pursuant to this Plan requesting the Company&#8217;s transfer agent to notify the Company of any transfer of the shares. The obligation of the Participant to provide such notice shall continue notwithstanding the placement of any such legend on the certificates. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;NO RIGHTS TO CONTINUED EMPLOYMENT.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Neither this Plan nor the grant of any option hereunder shall confer any right on any employee to remain in the employ of the Company or any Participating Corporation, or restrict the right of the Company or any Participating Corporation to terminate such employee&#8217;s employment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;EQUAL RIGHTS AND PRIVILEGES.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> All eligible employees granted an option under this Plan that is intended to meet the Code Section 423 requirements shall have equal rights and privileges with respect to this Plan or within any separate offering under the Plan so that this Plan qualifies as an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423 or any successor provision of the Code and the related regulations. Any provision of this Plan which is inconsistent with Section 423 or any successor provision of the Code, without further act or amendment by the Company, the Committee or the Board, shall be reformed to comply with the requirements of Section 423. This Section 19 shall take precedence over all other provisions in this Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;NOTICES.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> All notices or other communications by a Participant to the Company under or in connection with this Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;TERM&#59; STOCKHOLDER APPROVAL.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> This Plan will become effective on the Effective Date. This Plan shall be approved by the stockholders of the Company, in any manner permitted by applicable corporate law, within twelve (12) months before or after the date this Plan is adopted by the Board. No purchase of shares that are subject to such stockholder approval before becoming available under this Plan shall occur prior to stockholder approval of such shares and the Board or Committee may delay any Purchase Date and postpone the commencement of any Offering Period subsequent to such Purchase Date as deemed necessary or desirable to obtain such approval (provided that if a Purchase Date would occur more than twelve (12) months after commencement of the Offering Period to which it relates, then such Purchase Date shall not occur and instead such Offering Period shall terminate without the purchase of such shares and Participants in such Offering Period shall be refunded their contributions without interest). This Plan shall continue until the earlier to occur of (a) termination of this Plan by the Board (which termination may be effected by the Board at any time pursuant to Section 25 below), (b) issuance of all of the shares of Common Stock reserved for issuance under this Plan, or (c) the tenth anniversary of the Effective Date under the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">22.&#160;&#160;&#160;&#160;DESIGNATION OF BENEFICIARY. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Unless otherwise determined by the Committee, a Participant may file a written designation of a beneficiary who is to receive any cash from the Participant&#8217;s account under this Plan in the event of such Participant&#8217;s death prior to a Purchase Date. Such form shall be valid only if it was filed with the Company at the prescribed location before the Participant&#8217;s death. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Such designation of beneficiary may be changed by the Participant at any time by written notice filed with the Company at the prescribed location before the Participant&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">death. In the event of the death of a Participant and in the absence of a beneficiary validly designated under this Plan who is living at the time of such Participant&#8217;s death, the Company shall deliver such cash to the executor or administrator of the estate of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such cash to the spouse or, if no spouse is known to the Company, then to any one or more dependents or relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">23.&#160;&#160;&#160;&#160;CONDITIONS UPON ISSUANCE OF SHARES&#59; LIMITATION ON SALE OF SHARES.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Shares shall not be issued with respect to an option unless the exercise of such option and the issuance and delivery of such shares pursuant thereto shall comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act of 1933, the Securities Exchange Act of 1934, as amended, the rules and regulations promulgated thereunder, and the requirements of any stock exchange or automated quotation system upon which the shares may then be listed, exchange control restrictions and&#47;or securities law restrictions outside the United States, and shall be further subject to the approval of counsel for the Company with respect to such compliance. Shares may be held in trust or subject to further restrictions as permitted by any subplan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">24.&#160;&#160;&#160;&#160;APPLICABLE LAW.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Plan shall be governed by the substantive laws (excluding the conflict of laws rules) of the State of Delaware. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">25.&#160;&#160;&#160;&#160;AMENDMENT OR TERMINATION.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Committee, in its sole discretion, may amend, suspend, or terminate the Plan, or any part thereof, at any time and for any reason. If the Plan is terminated, the Committee, in its discretion, may elect to terminate all outstanding Offering Periods either immediately or upon completion of the purchase of shares of Common Stock on the next Purchase Date (which may be sooner than originally scheduled, if determined by the Committee in its discretion), or may elect to permit Offering Periods to expire in accordance with their terms (and subject to any adjustment pursuant to Section 14). If an Offering Period is terminated prior to its previously-scheduled expiration, all amounts then credited to Participants&#8217; accounts for such Offering Period, which have not been used to purchase shares of Common Stock, shall be returned to those Participants (without interest thereon, except as otherwise required under local laws) as soon as administratively practicable. Further, the Committee will be entitled to change the Purchase Periods and Offering Periods, limit the frequency and&#47;or number of changes in the amount withheld during an Offering Period, establish the exchange ratio applicable to amounts withheld or contributed in a currency other than U.S. dollars, permit payroll withholding in excess of the amount designated by a Participant in order to adjust for delays or mistakes in the administration of the Plan, establish reasonable waiting and adjustment periods and&#47;or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each Participant properly correspond with amounts withheld from the Participant&#8217;s base salary and other eligible compensation, and establish such other limitations or procedures as the Committee determines in its sole discretion advisable which are consistent with the Plan. Such actions will not require stockholder approval or the consent of any Participants. However, no amendment shall be made without approval of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the stockholders of the Company (obtained in accordance with Section 21 above) within twelve (12) months of the adoption of such amendment (or earlier if required by Section 21) if such amendment would&#58; (a) increase the number of shares that may be issued under this Plan&#59; or (b) change the designation of the employees (or class of employees) eligible for participation in this Plan. In addition, in the event the Board or Committee determines that the ongoing operation of the Plan may result in unfavorable financial accounting consequences, the Board or Committee may, in its discretion and, to the extent necessary or desirable, modify, amend or terminate the Plan to reduce or eliminate such accounting consequences including, but not limited to&#58; (i) amending the definition of compensation, including with respect to an Offering Period underway at the time&#59; (ii) altering the Purchase Price for any Offering Period including an Offering Period underway at the time of the change in Purchase Price&#59; (iii) shortening any Offering Period by setting a Purchase Date, including an Offering Period underway at the time of the Committee&#8217;s action&#59; (iv) reducing the maximum percentage of compensation a participant may elect to set aside as payroll deductions&#59; and (v) reducing the maximum number of shares a Participant may purchase during any Offering Period. Such modifications or amendments will not require approval of the stockholders of the Company or the consent of any Participants. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">26.&#160;&#160;&#160;&#160;CORPORATE TRANSACTIONS.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> In the event of a Corporate Transaction, the Offering Period for each outstanding right to purchase Common Stock will be shortened by setting a new Purchase Date and will end on the new Purchase Date (unless otherwise specified in the agreement effecting the applicable Corporate Transaction). The new Purchase Date shall occur on or prior to the consummation of the Corporate Transaction, as determined by the Board or Committee, and the Plan shall terminate on the consummation of the Corporate Transaction (unless otherwise specified in the agreement effecting the applicable Corporate Transaction). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">27.&#160;&#160;&#160;&#160;CODE SECTION 409A&#59; TAX QUALIFICATION. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Options granted under the Plan generally are exempt from the application of Section 409A of the Code. However, options granted to U.S. taxpayers which are not intended to meet the Code Section 423 requirements are intended to be exempt from the application of Section 409A of the Code under the short-term deferral exception and any ambiguities shall be construed and interpreted in accordance with such intent. Subject to Subsection (b), options granted to U.S. taxpayers outside of the Code Section 423 requirements shall be subject to such terms and conditions that will permit such options to satisfy the requirements of the short-term deferral exception available under Section 409A of the Code, including the requirement that the shares of Common Stock subject to an option be delivered within the short-term deferral period. Subject to Subsection (b), in the case of a Participant who would otherwise be subject to Section 409A of the Code, to the extent the Committee determines that an option or the exercise, payment, settlement or deferral thereof is subject to Section 409A of the Code, the option shall be granted, exercised, paid, settled or deferred in a manner that will comply with Section 409A of the Code, including Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective Date. Notwithstanding the foregoing, the Company shall have no liability to a Participant or any other party if the option that is intended to be exempt from or compliant with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 409A of the Code is not so exempt or compliant or for any action taken by the Committee with respect thereto. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Although the Company may endeavor to (i) qualify an option for favorable tax treatment under the laws of the United States or jurisdictions outside of the United States or (ii) avoid adverse tax treatment (e.g., under Section 409A of the Code), the Company makes no representation to that effect and expressly disavows any covenant to maintain favorable or avoid unfavorable tax treatment, notwithstanding anything to the contrary in this Plan, including Subsection (a). The Company shall be unconstrained in its corporate activities without regard to the potential negative tax impact on Participants under the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">28.&#160;&#160;&#160;&#160;DEFINITIONS. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (i) any entity that, directly or indirectly, is controlled by, controls or is under common control with, the Company and (ii) any entity in which the Company has a significant equity interest, in either case as determined by the Committee, whether now or hereafter existing. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Amendment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means December 13, 2019. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Board of Directors of the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Internal Revenue Code of 1986, as amended. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Compensation Committee of the Board that consists exclusively of one or more members of the Board appointed by the Board. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the common stock of the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean Dexcom, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Corporate Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58; (i) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or (ii) the consummation of the sale or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; or (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean May 28, 2015, the date on which the Company obtained the stockholder approval pursuant to Section 21. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ESPP Broker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a stock brokerage or other entity designated by the Company to establish account for  stock purchased under the Plan by Participants. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, as of any date, the value of a share of Common Stock determined as follows&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;if such Common Stock is then quoted on the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Nasdaq Market</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), its closing price on the Nasdaq Market on the date of determination, or if there are no sales for such date, then the last preceding business day on which there were sales, as reported in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or such other source as the Board or the Committee deems reliable&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;if such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or such other source as the Board or the Committee deems reliable&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;if such Common Stock is publicly traded but is neither quoted on the Nasdaq Market nor listed or admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or such other source as the Board or the Committee deems reliable&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;if none of the foregoing is applicable, by the Board or the Committee in good faith. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean within two (2) years from the Offering Date or within one (1) year from the Purchase Date on which such shares were purchased. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Offering Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the first business day of each Offering Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Offering Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a period with respect to which the right to purchase Common Stock may be granted under the Plan, as determined by the Committee pursuant to Section 5(a). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the same meaning as &#8220;parent corporation&#8221; in Sections 424(e) and 424(f) of the Code. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an eligible employee who meets the eligibility requirements set forth in Section 4 and who is either automatically enrolled in the initial Offer Period or who elects to participate in this Plan pursuant to Section 6(b). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Participating Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any Parent, Subsidiary or Affiliate that the Committee designates from time to time as eligible to participate in this Plan, provided, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">however, that employees of Affiliates that are designated for participation may be granted only options that do not intend to comply with the Code Section 423 requirements. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean this Dexcom, Inc. 2015 Employee Stock Purchase Plan, as amended from time to time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.36pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the last business day of each Purchase Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a period during which contributions may be made toward the purchase of Common Stock under the Plan, as determined by the Committee pursuant to Section 5(b). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the price at which Participants may purchase shares of Common Stock under the Plan, as determined pursuant to Section 8. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the same meaning as &#8220;subsidiary corporation&#8221; in Sections 424(e) and 424(f) of the Code. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.45
<SEQUENCE>5
<FILENAME>dxcm12312020ex10452015espp.htm
<DESCRIPTION>EX-10.45
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib3a97e4d379d439ea4d8a96e7b406172_1"></div><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.45</font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.944%"><tr><td style="width:1.0%"></td><td style="width:57.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2015 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enrollment&#47;Change Form</font></div><div><font><br></font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:15.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 1&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Actions</font></div></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Check Desired Action&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;                and Complete Sections&#58;</font></div><div><font style="font-family:'Wingdings 2',sans-serif;font-size:12pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Enroll in the ESPP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;                    2 + 3 + 4 + 17</font></div><div><font style="font-family:'Wingdings 2',sans-serif;font-size:12pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Elect &#47; Change Contribution Percentage&#160;&#160;&#160;&#160;        2 + 4 + 17</font></div><div><font style="font-family:'Wingdings 2',sans-serif;font-size:12pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Withdraw from Plan&#47;Discontinue Contributions    2 + 5 + 17</font></div><div><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 2&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Personal Data</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Home Address&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Social Security No&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Department</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enroll</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;I hereby elect to participate in the ESPP, effective at the beginning of the next Offering Period. I elect to purchase shares of the Common Stock of Dexcom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) pursuant to the ESPP.  I understand that the shares purchased on my behalf will be issued in street name and deposited directly into my brokerage account at the Company&#8217;s captive broker (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP Broker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  I hereby agree to take all steps, and sign all forms, required to establish an account with the Company&#8217;s ESPP Broker for this purpose.  I understand and agree that I will be required to utilize the ESPP Broker with respect to the shares purchased under this ESPP until the end of the time period described in Section 6 below. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">My participation will continue as long as I remain eligible, unless I withdraw from the ESPP by filing a new Enrollment&#47;Change Form with the Company. I understand that if I am subject to U.S. taxation, I must notify the Company of any disposition of shares purchased under the ESPP.</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elect&#47;Change Contribution Percentage</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I hereby authorize the Company or the Parent, Subsidiary or Affiliate employing me (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to withhold a percentage of my bi-weekly payroll that will total ___% of my compensation (as defined in the ESPP) for the Purchase Period. That amount will be applied to the purchase of shares of the Company&#8217;s Common Stock pursuant to the ESPP.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The percentage compensation to purchase common stock must be a whole number (from 1%, up to a maximum of 10%).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:-40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may decrease your contribution percentage once within a six-month Purchase Period. Each change will become effective as soon as reasonably practicable after the form is received by the Company.</font></div><div style="margin-bottom:6pt;padding-left:39.6pt;text-align:justify;text-indent:-39.6pt"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 5&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinue Contributions </font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;I hereby elect to stop my contributions under the ESPP, effective as soon as reasonably practicable after this form is received by the Company. The contributions that I have made to date during this Offering Period should be applied as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;       &#160;&#160;</font><font style="font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; Purchase shares of the Company&#8217;s Common Stock at the end of the Purchase Period.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Refund all contributions to me in cash, without interest.&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I understand that I cannot resume participation until the start of the next Offering Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify;text-indent:-22.5pt"><font><br></font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESPP Broker</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I hereby agree the shares issued to me under the ESPP shall be deposited into an account established in my name at the ESPP Broker.  Subject to any applicable insider trading policy, I shall be free to undertake a disposition (as that term is defined in Section&#160;424(c) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of the shares in my ESPP Broker account at any time, whether by sale, exchange, gift, or other transfer of legal title, but in the absence of such a disposition of the shares, the shares must remain in my ESPP Broker account until the holding period set forth in Section&#160;423(a) of the Code has been satisfied.  With respect to shares for which the Section&#160;423(a) holding period has been satisfied, I may move those shares to another brokerage account of my choosing.  Notwithstanding the above, if I am not subject to income taxation under the Code, I may move my shares to another brokerage account of my choosing at any time, without regard to the satisfaction of the Section&#160;423(a) holding period.</font></div></td></tr></table></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:43.2pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:15.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Grant</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By enrolling in the ESPP, I understand, acknowledge and agree that (a) the ESPP is established voluntarily by the Company, it is discretionary in nature and it may be amended, terminated or modified at any time, to the extent permitted by the ESPP&#59; (b) the grant of the right to purchase shares of Common Stock under the ESPP is voluntary and does not create any contractual or other right to receive future rights to purchase shares of Common Stock, or benefits in lieu of rights to purchase shares, even if rights to purchase shares have been granted in the past&#59; (c) all decisions with respect to future grants of rights to purchase shares of Common Stock under the ESPP, if any, will be at the sole discretion of the Company&#59; (d) the grant of rights to purchase shares of Common Stock under the ESPP and my participation in the ESPP will not create a right to employment or be interpreted as forming an employment or service agreement with the Company&#59; (e) the grant of rights to purchase shares of Common Stock under the ESPP and my participation in the ESPP will not interfere with the ability of the Employer to terminate my employment relationship at any time with or without cause&#59; (f) I am voluntarily participating in the ESPP&#59; (g) the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not intended to replace any pension rights or compensation&#59; (h) the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not part of normal or expected compensation for purposes of, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59; (i) unless otherwise agreed with the Company, the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not granted as consideration for, or in connection with, any service I may provide as a director of the Subsidiary or Affiliate&#59; (j) the future value of the underlying shares purchased or to be purchased under the ESPP is unknown, indeterminable and cannot be predicted with certainty, and the value of the shares of Common Stock purchased under the ESPP may increase or decrease in the future, even below the Purchase Price&#59; (k) no claim or entitlement to compensation or damages will arise from termination of the right to purchase shares of Common Stock under the ESPP resulting from termination of my employment (for any reason whatsoever and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where I am employed or the terms of my employment agreement, if any) and in consideration of the grant of rights to purchase shares of Common Stock under the ESPP, I irrevocably agree never to institute any claim against the Company, the Parent, the Employer or any other Subsidiary or Affiliate, I hereby waive my ability, if any, to bring any such claim, and I release the Company, the Parent, the Employer or any other Subsidiary or Affiliate from any such claim&#59; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by enrolling in the ESPP, I will be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claims&#59; (l) in the event of termination of my employment (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where I am employed or the terms of my employment agreement, if any), my right to participate in the ESPP and my right to purchase shares of Common Stock, if any, will terminate effective as of the date I cease to actively provide services and will not be extended by any notice period (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, employment would not include any contractual notice or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where I am employed or the terms of my employment agreement, if any)&#59; the Committee will have exclusive discretion to determine when I am no longer actively employed for purposes of my participation in the ESPP (including whether I may still be considered to be providing services while on a leave of absence)&#59; (m) unless otherwise provided in the ESPP or by the Company in its discretion, the right to purchase shares of Common Stock and the benefits evidenced by this Enrollment&#47;Change Form do not create any entitlement to have the ESPP or any such benefits granted thereunder transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any Corporate Transaction affecting the Common Stock&#59; and (n) if I am providing services outside the United States&#58; (1) the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not part of normal or expected compensation or salary for any purpose, and (2) neither the Company, the Parent, the Employer nor any other Subsidiary or Affiliate will be liable for any foreign exchange rate fluctuation between my local currency and the United States Dollar that may affect the value of the rights to purchase shares of Common Stock, the shares purchased under the ESPP or any amounts due to me pursuant to the sale of any shares of Common Stock acquired under the ESPP.</font></div></td></tr></table></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:43.2pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:15.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 8&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Privacy</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">I hereby explicitly, voluntarily and unambiguously consent to the collection, use and transfer, in electronic or other form, of my personal data as described in this Enrollment&#47;Change Form and any other ESPP grant materials by and among, as applicable, the Company, the Parent and any of their respective Subsidiaries or Affiliates or any third parties assisting in the implementation, administration and management of my participation in the ESPP.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">I understand that the Company may hold certain personal information about me, including, but not limited to, my name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, the fact and conditions of my participation in the ESPP, details of all rights to purchase shares or any other entitlement to shares of Common Stock awarded, cancelled, exercised, vested, unvested or outstanding in my favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the ESPP.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">I also authorize any transfer of Data, as may be required, to the stock plan service provider that may be designated by the Company from time to time, which is assisting the Company with the implementation, administration and management of the ESPP and&#47;or with whom any shares of Common Stock acquired under the ESPP are deposited.  I acknowledge that these recipients may be located in my country or elsewhere, and that the recipient&#8217;s country (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">, the United States) may have different data privacy laws and protections to my country, which may not give the same level of protection to Data.  I understand that, if I reside outside the United States, I may request a list with the names and addresses of any potential recipients of Data by contacting my local human resources representative. I authorize the Company, the designated broker and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing my participation in the ESPP to receive, possess, use, retain and transfer Data, in electronic or other form, for the sole purpose of implementing, administering and managing my participation in the ESPP.  I understand that Data will be held only as long as is necessary to implement, administer and manage my participation in the ESPP. I understand that, if I reside outside the United States, I may at any time view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case, without cost, by contacting in writing my local human resources representative.  Further, I understand that I am providing the consents herein on a purely voluntary basis.  If I do not consent, or if I later seek to revoke my consent, my employment status or service and career with the Company will not be adversely affected&#59; the only adverse consequence of refusing or withdrawing my consent is that the Company would not be able to grant future rights to purchase shares of Common Stock or other equity awards to me or administer or maintain such awards.  Therefore, I understand that refusing or withdrawing my consent may affect my ability to participate in the ESPP.  For more information on the consequences of my refusal to consent or withdrawal of consent, I understand that I may contact my local human resources representative.  </font></div></td></tr></table></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:43.2pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:15.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 9&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Responsibility for Taxes</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I acknowledge that, regardless of any action taken by the Company or the Employer, the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to my participation in the ESPP and legally applicable to me (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is and remains my responsibility and may exceed the amount actually withheld by the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the Employer.  I further acknowledge that the Company and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the ESPP, including, but not limited to, my enrollment in the ESPP, the grant of rights to purchase shares of Common Stock, the purchase of shares of Common Stock, the issuance of Common Stock purchased, the sale of shares of Common Stock purchased under the ESPP or the receipt of any dividends&#59; and (2) do not commit to and are under no obligation to structure the terms of the ESPP to reduce or eliminate my liability for Tax-Related Items or achieve any particular tax result.  Further, if I am subject to Tax-Related Items in more than one jurisdiction, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, I agree to make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy all Tax-Related Items.  In this regard, I authorize the Company and&#47;or the Employer to satisfy their withholding obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (a) withholding from my wages or other cash compensation payable to me by the Company and&#47;or the Employer, (b) withholding from proceeds of the sale of shares of Common Stock purchased under the ESPP, either through a voluntary sale or through a mandatory sale arranged by the Company (on my behalf pursuant to this authorization without further consent), and (c) withholding in shares to be issued upon purchase under the ESPP.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates, including up to the maximum applicable rates, in which case I will receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent.  If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, I am deemed to have been issued the full number of shares of Common Stock, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, I agree to pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of my participation in the ESPP that cannot be satisfied by the means previously described.  The Company may refuse to purchase or deliver the shares or the proceeds from the sale of shares of Common Stock, if I fail to comply with my obligations in connection with the Tax-Related Items.</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 10&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governing Law &#38; Language</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights to purchase shares and the provisions of this Enrollment&#47;Change Form are governed by, and subject to, the laws of the State of Delaware, without regard to any conflict of law provisions.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If I have received this or any other document related to the ESPP translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 11&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Appendix &#38; Imposition of Other Requirements</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provision herein, my participation in the ESPP will be subject to any special terms and conditions as set forth in the Appendix for my country, if any.  Moreover, if I relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to me, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  The Appendix constitutes part of this Enrollment&#47;Change Form.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reserves the right to impose other requirements on my participation in the ESPP or on any shares of Common Stock purchased under the ESPP, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require me to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div></td></tr></table></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:43.2pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:15.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 12&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Electronic Delivery and Acceptance</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the ESPP by electronic means.  I hereby consent to receive such documents by electronic delivery and agree to participate in the ESPP through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Severability &#38; Waiver</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of this Enrollment&#47;Change Form are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions will nevertheless be binding and enforceable.  I acknowledge that a waiver by the Company of breach of any provision of this Enrollment&#47;Change Form will not operate or be construed as a waiver of any other provision herein, or of any subsequent breach by me or any other Participant.</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 14&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider Trading Restrictions&#47;Market Abuse Laws</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I acknowledge that I may be subject to insider trading restrictions and&#47;or market abuse laws, which may affect my ability to acquire or sell shares of Common Stock or my rights to purchase shares under the ESPP during such times as I am considered to have &#8220;inside information&#8221; regarding the Company (as defined by or determined under the laws in my country).&#160; Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable the Company insider trading policy.&#160; I acknowledge that it is my responsibility to comply with any applicable restrictions, and that I am advised to speak to my personal advisor on this matter.</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 15&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Advice Regarding Grant</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding my participation in the ESPP, or my purchase or sale of the shares of Common Stock.  I am hereby advised to consult with my own personal tax, legal and financial advisors regarding my participation in the ESPP before taking any action related to the ESPP.</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 16&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compliance With Law</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless there is an available exemption from any registration, qualification or other legal requirement applicable to the shares of Common Stock, the Company will not be required to deliver any shares under the ESPP prior to the completion of any registration or qualification of the shares under any local, state, federal or foreign securities or exchange control law or under rulings or regulations of the U.S. Securities and Exchange Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or approval the Company will, in its absolute discretion, deem necessary or advisable.  I understand that the Company is under no obligation to register or qualify the shares with the SEC or any state or foreign securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the shares.  Further, I agree that the Company will have unilateral authority to amend the ESPP and the Enrollment&#47;Change Form without my consent to the extent necessary to comply with securities or other laws applicable to issuance of shares. </font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 17&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acknowledgment and Signature</font></div></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I acknowledge that I have received a copy of the Prospectus summarizing the major features of the ESPP. I have read the Prospectus and this form and hereby agree to be bound by the terms of the ESPP.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.46
<SEQUENCE>6
<FILENAME>dxcm12312020exhibit1046moy.htm
<DESCRIPTION>EX-10.46
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia793906f46a94948bf2f1387048aa877_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:right;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 10.46</font></div></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DexCom, Inc.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Retention Incentive Agreement</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Retention Incentive Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is made and entered into effective as of April 28, 2020 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), by and between Jeffrey Moy (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and DexCom, Inc., a Delaware corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).     </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">RECITALS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to provide Executive with enhanced security and encouragement to remain with the Company, the Compensation Committee of the Board of Directors of the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) believes it is important to provide Executive with certain retention incentive benefits as set forth in this Agreement.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW THEREFORE, in consideration of the above-recited facts, the mutual agreements of the Company and Executive contained herein and the continued employment of Executive by the Company, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Retention Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Qualifying Retirement Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event of a Qualifying Retirement in the same calendar year in which the Retirement Eligible Date occurs, Executive will be entitled to receive a lump sum cash payment equal to 12 months of Executive&#8217;s base salary as of the date of such termination, subject to all applicable withholdings and deductions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cash Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Subject to the foregoing, the Cash Payment will be paid within thirty (30) days following the Qualifying Retirement (but no later than the last day of calendar year 2021), to the extent Executive is eligible to receive such Cash Payment and has entered into a Release, and such Release has become effective within such thirty (30) day period (but the Release must be effective no later than the last day of calendar year 2021).  In no event shall any pro rata payment of the Cash Payment be made.  Upon a Qualifying Retirement after the Retirement Eligible Date, any of Executive&#8217;s outstanding Company equity awards will be accelerated and receive additional vesting as if Executive had provided an additional 18 months of service to the Company following such termination date for purposes of any time-based vesting schedules (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Vesting Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Such Vesting Acceleration shall be made within thirty (30) days following the Qualifying Retirement, provided Executive has entered into a Release, and such Release has become effective within such thirty (30) day period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Termination Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event of Executive&#8217;s Termination Without Cause during the Effectiveness Period and either (i) prior to the Retirement Eligible Date or (ii) after the Retirement Eligible Date but prior to Executive&#8217;s Qualifying Retirement or other resignation, Executive will be entitled to receive the Cash Payment and the Vesting Acceleration, as defined above.   The Cash Payment and Vesting Acceleration will be paid within thirty (30) days following the Termination Without Cause date (but no later than the last day of calendar year 2021), provided Executive has entered into a Release, and such Release has become effective within such thirty (30) day period (but no later than the last day of calendar year 2021).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Without regard to the reason for, or the timing of, Executive&#8217;s termination of employment&#58; (i) the Company shall pay Executive any unpaid base salary due for periods prior to the Executive&#8217;s termination of employment&#59; (ii) the Company shall pay Executive all of Executive&#8217;s accrued and unused vacation through the Executive&#8217;s termination of employment in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">accordance with applicable law&#59; (iii) provided Executive remains employed through the end of the applicable annual incentive bonus plan performance period, the Company shall pay any annual incentive bonus that has been earned with respect such bonus period, but remains unpaid as of the date of termination, and such payment shall be made at the same time the Company pays any annual incentive bonus payments to other officers of the Company, however, Executive shall not be entitled to receive any new restricted stock or equity grants after December 31, 2020, and (iv) following submission of proper written expense reports by Executive, the Company shall reimburse Executive for all expenses reasonably and necessarily incurred by Executive in connection with the business of the Company prior to the Executive&#8217;s termination of employment in accordance with the Company&#8217;s expense reimbursement policy.  These payments shall be made promptly upon termination and within the period of time mandated by law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Other Retention &#38; Termination Benefits&#59; Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  During the Effectiveness Period, the retention and termination benefits set forth in this Section 1 shall be in lieu of Executive&#8217;s Amended and Restated Executive Change of Control &#38; Severance Agreement with the Company dated December 17, 2008 and any successor Change of Control Agreement with the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Change of Control Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), provided, however, that in the event of a Change of Control (as defined in the Change of Control Agreement), the terms of the operable Change of Control Agreement shall apply in lieu of this Agreement.  During the Effectiveness Period, Executive shall only be eligible for either the benefits under this Agreement in the event of no Change of Control or the benefits under the Change of Control Agreement if there is a Change of Control, but in no event shall Executive be eligible to receive benefits under both agreements.  If Executive receives the Cash Payment and&#47;or Vesting Acceleration as set forth in this Agreement outside of a Change of Control during the Effectiveness Period, then the receipt of such benefits shall be the sole entitlement to benefits and Executive shall not be entitled to any such benefits under any policies and plans of the Company or other agreements between the Company and Executive, and Executive hereby waives the receipt of such benefits, including with respect to the Change of Control Agreement. After the end of the Effectiveness Period, this Agreement will become null and void and the Change of Control Agreement will provide Executive&#8217;s sole rights with respect to retention and termination benefits, to the extent applicable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Certain Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  As used in this Agreement, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means Executive has engaged in (i) willful misconduct or gross negligence in the performance of Executive&#8217;s duties&#59; (ii) material breach of Executive&#8217;s Proprietary Information and Inventions Agreement or Executive&#8217;s offer letter&#59; or (iii) the commission of a felony affecting the Company or its business.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the United States Internal Revenue Code of 1986, as amended and the regulations promulgated thereunder. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 409A of the Code, and the related regulations.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effectiveness Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the date beginning as of the effective date of this agreement and continuing until the end of the calendar year in which the Retirement Eligible Date occurs, unless the Retirement Eligible Date occurs in December, in which case the Effectiveness Period will be the end of the calendar year following the year in which the Retirement Eligible Date occurs. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Qualifying Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means Executive resigns from the Company on or after the Retirement Eligible Date while in good standing (and at a time there is not grounds for the Company to terminate Executive for Cause).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a general release of claims in favor of the Company in a form reasonably acceptable to the Company.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Retirement Eligible Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means January 1, 2021, or such later date that is no later than June 30, 2021 mutually agreed by the Company and Executive in writing.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Termination Without Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a termination of Executive&#8217;s employment by the Company which is not effected for Cause (except for terminations due to Executive&#8217;s death or Disability, either of which shall not constitute a Termination Without Cause).  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Company and Executive acknowledge that Executive&#8217;s employment is and shall continue to be at-will.  Notwithstanding the at-will nature of employment, Executive will endeavor to provide at least 3 months&#8217; notice to the Company prior to any resignation of employment.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Limitation on Payments Under Code Section 280G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event that the severance and other benefits provided for in this Agreement or otherwise payable to the Executive (i) constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code and (ii) but for this Section, would be subject to the excise tax imposed by Section 4999 of the Code, then, at Executive&#8217;s discretion, Executive&#8217;s severance and other benefits under this Agreement and under any other applicable agreements shall be payable either (i) in full, or (ii) as to such lesser amount, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of severance or termination benefits, notwithstanding&#160; that all or some portion of such severance or termination benefits may be taxable under Section 4999 of the Code.&#160;  Any reduction shall be made in the following manner&#58;  first a pro rata reduction of (i) cash payments subject to Section 409A of the Code as deferred compensation and (ii) cash payments not subject to Section 409A of the Code, and second a pro rata cancellation of (i) equity-based compensation subject to Section 409A of the Code as deferred compensation and (ii) equity-based compensation not subject to Section 409A of the Code.  Reduction in either cash payments or equity compensation benefits shall be made prorata between and among benefits which are subject to Section 409A of the Code and benefits which are exempt from Section 409A of the Code.  Unless the Company and Executive otherwise agree in writing, any determination required under this Section shall be made in writing by the Company&#8217;s independent public accountants (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accountants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), whose determination shall be conclusive and binding upon Executive and the Company for all purposes.&#160; For purposes of making the calculations required by this Section, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code.&#160; The Company and Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section.&#160; The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent (a) any payments or benefits to which Executive becomes entitled under this Agreement, or under any agreement or plan referenced herein, in connection with Executive&#8217;s termination of employment with the Company constitute deferred compensation subject to Section 409A of the Code and (b) Executive is deemed at the time of such termination of employment to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be a &#8220;specified employee&#8221; under Section 409A of the Code, then such payments shall not be made or commence until the earliest of (i) the expiration of the six (6)-month period measured from the date of Executive&#8217;s &#8220;separation from service&#8221; (as such term is at the time defined in Treasury Regulations under Section 409A of the Code) from the Company&#59; or (ii) the date of Executive&#8217;s death following such separation from service&#59; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Executive, including (without limitation) the additional twenty percent (20%) tax for which Executive would otherwise be liable under Section 409A(a)(1)(B) of the Code in the absence of such deferral.  Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the absence of this paragraph shall be paid to Executive or Executive&#8217;s beneficiary in one lump sum (without interest).  Any termination of Executive&#8217;s employment is intended to constitute a &#8220;separation from service&#8221; and will be determined consistent with the rules relating to a &#8220;separation from service&#8221; as such term is defined in Treasury Regulation Section 1.409A-1.  It is intended that each installment of the payments provided hereunder constitute separate &#8220;payments&#8221; for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i).  It is further intended that payments hereunder satisfy, to the greatest extent possible, the exemption from the application of Section 409A of the Code (and any state law of similar effect) provided under Treasury Regulation Section 1.409A-1(b)(4) (as a &#8220;short-term deferral&#8221;).  To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision will be read in such a manner so that all payments hereunder comply with Section 409A of the Code.  Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit under this Agreement is determined to be subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in which you incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Company&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) or any purchaser of all or substantially all of the Company&#8217;s business and&#47;or assets shall assume the Company&#8217;s obligations under this Agreement and agree expressly to perform the Company&#8217;s obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession, unless otherwise agreed upon in writing by Executive and such successor.  For all purposes under this Agreement, the term &#8220;Company&#8221; shall include any successor to the Company&#8217;s business and&#47;or assets.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Executive&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Without the written consent of the Company, Executive shall not assign or transfer this Agreement or any right or obligation under this Agreement to any other person or entity.  Notwithstanding the foregoing, the terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable by, Executive&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid.  In the case of Executive, mailed notices shall be addressed to Executive at the home address which Executive most recently </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">communicated to the Company in writing.  In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of its Chief Executive Officer.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive agrees to keep the retention and termination benefits and the provisions of this Agreement confidential and not to reveal its contents to anyone except to his or her lawyer, spouse or other immediate family member, and&#47;or his or financial consultant, or as required by legal process or applicable law. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The parties understand and agree that this Agreement may not be amended, modified or waived, in whole or in part, expect in a writing executed by Executive and the Company&#8217;s Chief Executive Officer.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  No provision of this Agreement may be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by the Chief Executive Officer.  No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Integration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  During the Effectiveness Period, this Agreement represents the entire agreement and understanding between the parties as to the subject matter herein regarding the Cash Payment and Vesting Acceleration and supersedes all prior or contemporaneous agreements, whether written or oral, with respect to this Agreement, including the Change of Control Agreement (except in the case of a Change of Control, in which case the Change of Control Agreement will supersede this Agreement).  For the avoidance of doubt, after the Effectiveness Period, the terms of the Change of Control Agreement will be reinstated and will no longer be limited by this Agreement. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The validity, interpretation, construction and performance of this Agreement shall be governed by the internal substantive laws, but not the conflicts of law rules, of the State of California.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt;text-decoration:underline">Employment Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  All payments made pursuant to this Agreement shall be subject to withholding of applicable income and employment taxes.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;Signature Page to Retention Incentive Agreement Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><div id="ia793906f46a94948bf2f1387048aa877_4"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, each of the parties has executed this Retention Incentive Agreement, in the case of the Company by its duly authorized officer, as of the day and year first above written.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.760%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COMPANY&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DEXCOM, INC. </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s&#47; Quentin S. Blackford</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COO</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXECUTIVE&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s&#47; Jeffrey Moy</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Jeffrey Moy Signature</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12&#47;20&#47;20</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;Signature Page to Retention Incentive Agreement&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%">6</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.47
<SEQUENCE>7
<FILENAME>dxcm12312020ex1047doubleda.htm
<DESCRIPTION>EX-10.47
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ieeb339041c234fbeae9194038c15f20f_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 10.47</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRANSITION AND CONSULTING AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Transition And Consulting Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is between Richard Doubleday (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">you</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) (collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; or individually referred to as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) concerning the terms of your retirement and continued services as a consultant as provided herein.  This Agreement is effective is as of the date it is signed by the Parties (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Retirement from Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  You have notified the Company that you will retire and resign your employment with the Company effective March 31, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Employment Resignation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) as set forth herein.  You agree to execute any documentation deemed reasonably necessary by the Company to confirm your resignation from employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Continued Employment Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Beginning on the Effective Date of this Agreement through December 31, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Final Full-Time Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and such period, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Full-Time Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), you agree to continue to serve on a full-time basis as the Company&#8217;s Executive Vice President and Chief Commercial Officer and to assist with the transition of your responsibilities (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and you shall continue to receive your salary at the same rate that you were receiving your salary immediately prior to the Effective Date (your &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) during this Full-Time Period.  Beginning on January 1, 2021 through the Employment Resignation Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Transition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), you agree to continue to provide the Services on a part-time basis, and you shall receive your salary at fifty percent (50%) of your Salary during this Transition Period.  Until your Employment Resignation Date, you shall continue to be eligible to participate in then-available Company benefit programs at the same level as you would have been eligible to participate in such programs as of immediately prior to the Effective Date, subject to the terms and conditions, including eligibility requirements, of such programs.  You will be eligible to receive a cash bonus payment under the 2020 Management Bonus Plan pursuant to its terms and conditions, but you will not be eligible to receive any cash bonus payment under our 2021 Management Bonus Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Equity Acceleration &#38; Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the Final Full-Time Date, and subject to (i) your continued employment on the Final Full-Time Date&#59; (ii) your execution of this Agreement, including but not limited to Section 5 (Waiver of Change in Control and Severance Benefits) and (iii) your signing a release of claims in substantially the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) no later than the Final Full-Time Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Release Deadline</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the vesting of each of your then-outstanding restricted stock units (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) will accelerate as to such number of shares that would have vested through March 31, 2022, the contemplated final day of your Consulting Period (as defined below) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Equity Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Your Equity Awards will continue to be governed by the terms and conditions of the applicable award agreement (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Equity Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the Company&#8217;s equity plans under which the Equity Awards were granted except as explicitly set forth in this Agreement, including Sections 3, 4 and 5.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Termination of Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary herein or in any other agreement, all remaining then-outstanding unvested Equity Awards after giving effect to the Equity Acceleration (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Unvested Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) will remain outstanding through the Employment Resignation Date and the Unvested Equity Awards will automatically terminate and forfeit to the Company on the day immediately following the Employment Resignation Date even if you continue to provide additional services to the Company on and after such date.  You will not be eligible to receive additional equity awards from the Company prior to your Employment Resignation Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Waiver of Change in Control and Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In consideration of the Equity Acceleration and in connection with the completion of your employment (i) upon your receipt of the Equity Acceleration, you shall no longer be eligible for any separation benefits, including, but not limited to, any severance payments, equity acceleration benefits or any other severance benefits outside of a change in control of the Company as may be provided for in your Amended and Restated Change of Control and Severance Agreement effective as of 2009 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2009 CIC Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the Severance and Change in Control Plan, adopted June 1, 2017 and any participation agreement thereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2017 CIC Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;, and together with the 2009 Change of Control Agreement, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">CIC Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) or any equity acceleration benefits that may be provided in your Equity Award Agreements and (ii) from the Effective Date through your Employment Resignation Date, you shall remain eligible for any separation benefits, including, but not limited to, any severance payments, equity acceleration benefits or any other severance benefits in the event of a termination of your employment without &#8220;cause&#8221; in connection with a change in control of the Company as may be provided for in the CIC Severance Agreements or any equity acceleration benefits that may be provided in your Equity Award Agreements.  You also hereby immediately waive the ability to terminate your employment as a result of a &#8220;constructive termination&#8221; or for &#8220;Good Reason&#8221; whether or not in connection with a change in control of the Company and receive any payments or benefits under the CIC Severance Agreements and Equity Award Agreements.  You further acknowledge and agree that the Severance CIC Agreements shall terminate on March 31, 2021 (subject to your receipt of the Equity Acceleration).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Post-Employment Consulting Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Commencing on the day immediately following the Employment Resignation Date, you will provide consulting services (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Consulting Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) to the Company pursuant to the Consulting Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Consulting Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) through March 31, 2022 or such earlier date pursuant to the terms of the Consulting Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Consulting Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Confidential Information and Other Company Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  You will continue to be bound by and comply fully with your Confidential Information and Invention Assignment Agreement with the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), insider trading policy, code of conduct, and any other policies and programs adopted by the Company regulating the behavior of its employees, as such policies and programs may be amended from time to time to the extent the same are not inconsistent with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. For the avoidance of doubt, you will continue to be covered by any indemnification agreement in place between you and the Company, and remain named as an insured on the director and officer liability insurance policy currently maintained by the Company, or as may be maintained by the Company from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Except for any claim for injunctive relief arising out of a breach of a party&#8217;s obligations to protect the other&#8217;s proprietary information, the parties agree to arbitrate, in San Diego County, California through JAMS, any and all disputes or claims arising out of or related to the validity, enforceability, interpretation, performance or breach of this Agreement, whether sounding in tort, contract, statutory violation or otherwise, or involving the construction or application or any of the terms, provisions, or conditions of this Agreement.  Any arbitration may be initiated by a written demand to the other party.  The arbitrator&#8217;s decision shall be final, binding, and conclusive.  The parties further agree that this Agreement is intended to be strictly construed to provide for arbitration as the sole and exclusive means for resolution of all disputes hereunder to the fullest extent permitted by law.  The parties expressly waive any entitlement to have such controversies decided by a court or a jury. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If any action is brought to enforce the terms of this Agreement, the prevailing party will be entitled to recover its reasonable attorneys&#8217; fees, costs and expenses from the other party, in addition to any other relief to which the prevailing party may be entitled.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Complete and Voluntary Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement, together with the Consulting Agreement, the Release and the Confidentiality Agreement constitute the entire agreement between you and the Company with respect to the subject matter hereof and supersede all prior negotiations and agreements, whether written or oral, relating to such subject matter, including your CIC Severance Agreements, except as set forth herein.  You acknowledge that neither the Company nor its agents or attorneys have made any promise, representation or warranty whatsoever, either express or implied, written or oral, which is not contained in this Agreement for the purpose of inducing you to execute the Agreement, and you acknowledge that you have executed this Agreement in reliance only upon such promises, representations and warranties as are contained herein, and that you are executing this Agreement voluntarily, free of any duress or coercion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The provisions of this Agreement are severable, and if any part of it is found to be invalid or unenforceable, the other parts shall remain fully valid and enforceable.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Modification&#59; Counterparts&#59; Digital Signatures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  It is expressly agreed that this Agreement may not be altered, amended, modified, or otherwise changed in any respect except by another written agreement that specifically refers to this Agreement, executed by authorized representatives of each of the parties to this Agreement.  This Agreement may be executed in any number of counterparts, each of which shall constitute an original and all of which together shall constitute one and the same instrument.  Execution of a digital copy shall have the same force and effect as execution of an original, and a copy of a signature will be equally admissible in any legal proceeding as if an original.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by and construed in accordance with the laws of the State of California.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Taxes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  All payments made under this Agreement will be subject to reduction to reflect taxes or other charges required to be withheld by law.  Each payment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 409A of the Internal Revenue Code of 1986, as amended.  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;Signature Page Follows&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><div id="ieeb339041c234fbeae9194038c15f20f_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.794%"><tr><td style="width:1.0%"></td><td style="width:41.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RICHARD DOUBLEDAY</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s&#47; Richard Doubleday</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s&#47; Patrick M. Murphy</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Patrick M. Murphy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EVP, Chief Legal Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12&#47;10&#47;2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12&#47;10&#47;2020</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;SIGNATURE PAGE TO TRANSITION &#38; CONSULTING AGREEMENT&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="ieeb339041c234fbeae9194038c15f20f_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RELEASE</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This General Release of All Claims and Covenant Not to Sue (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is entered into between Richard Doubleday (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">the parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, on December 10, 2020 Executive and the Company entered into an agreement regarding Executive&#8217;s resignation, transitional employment and continued consulting services with the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Transition &#38; Consulting Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) to which this Release is attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this agreement serves as the Release pursuant to the Transition &#38; Consulting Agreement&#59; </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOW THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in consideration for the mutual promises and undertakings of the parties as set forth below, Executive and the Company hereby enter into this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  In exchange for Executive&#8217;s agreement to this Release and his other promises in the Transition &#38; Consulting Agreement and herein, the Company agrees to provide Executive with the Equity Acceleration (as defined in the Transition &#38; Consulting Agreement).  By signing below, Executive acknowledges that he is receiving the consideration in exchange for waiving his rights to claims referred to in this Release and he would not otherwise be entitled to the consideration.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">General Release and Waiver of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.37pt">To the fullest extent permitted by law, Executive hereby releases and waives any claims he may have against the Company and its owners, agents, officers, shareholders, employees, directors, attorneys, subscribers, subsidiaries, affiliates, successors and assigns (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), whether known or not known, including, without limitation, claims under any employment laws, including, but not limited to, claims of unlawful discharge, breach of contract, breach of the covenant of good faith and fair dealing, fraud, violation of public policy, defamation, physical injury, emotional distress, claims for additional compensation or benefits arising out of his employment or separation of employment, claims under Title VII of the 1964 Civil Rights Act, as amended, the California Fair Employment and Housing Act and any other laws and&#47;or regulations relating to employment or employment discrimination, including, without limitation, claims based on disability or under the Americans with Disabilities Act, up through the date of Executive&#8217;s execution of the Release. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.37pt">By signing below, Executive expressly waives any benefits of Section 1542 of the Civil Code of the State of California, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, AND THAT IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASING PARTY.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt">This Release does not extend to, and has no effect upon, any benefits that have accrued or equity that has vested, and to which Executive has become vested or otherwise entitled to, under any employee benefit plan, program or policy sponsored or maintained by the Company, or to his rights to indemnification by the Company, and continued coverage by the Company&#8217;s director&#8217;s and officer&#8217;s insurance, or any claims that he may not release as a matter of law, including but not limited to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">claims for indemnity under California Labor Code Section 2802, or any claims for enforcement of this Release.  To the fullest extent permitted by law, any dispute regarding the scope of this Release shall be determined by an arbitrator under the procedures set forth in the arbitration clause set forth in the Transition &#38; Consulting Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Covenant Not to Sue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.37pt">To the fullest extent permitted by law, at no time subsequent to the execution of this Release will Executive pursue, or cause or knowingly permit the prosecution, in any state, federal or foreign court, or before any local, state, federal or foreign administrative agency, or any other tribunal, of any charge, claim or action of any kind, nature and character whatsoever, known or unknown, which he may now have, have ever had, or may in the future have against Releasees, which is based in whole or in part on any matter released by this Release.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt">Nothing in this paragraph shall prohibit or impair Executive or the Company from complying with all applicable laws, nor shall this Release be construed to obligate either party to commit (or aid or abet in the commission of) any unlawful act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Protected Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  Executive understands that nothing in the General Release and Waiver of Claims and Covenant Not to Sue sections above, or otherwise in this Release, limits his ability to file a charge or complaint with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state or local government agency or commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Government Agencie</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s&#8221;).  Executive further understands that this Release does not limit his ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  This Release does not limit Executive&#8217;s right to receive an award for information provided to any Government Agencies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">No Right to Revoke</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  Executive acknowledges and understands that this Release is irrevocable once it is signed and returned to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Other Terms of Transition &#38; Consulting Agreement and Consulting Agreement Incorporated Herein</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  All other terms of the Transition &#38; Consulting Agreement to the extent not inconsistent with the terms of this Release are hereby incorporated in this Release as though fully stated herein and apply with equal force to this Release, including, without limitation, the provisions on Arbitration, Governing Law, and Attorneys&#8217; Fees set forth in the Transition &#38; Consulting Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">12&#47;10&#47;2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s&#47; Patrick M. Murphy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Patrick M. Murphy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; EVP, Chief Legal Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the Company</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;12&#47;10&#47;2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s&#47; Richard Doubleday</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Richard Doubleday</font></td></tr></table></div><div style="margin-bottom:6pt;padding-left:252pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><div id="ieeb339041c234fbeae9194038c15f20f_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT B</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONSULTING AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">This Consulting Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221;) is effective as of April 1, 2021 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221;), by and between DexCom, Inc., (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221;) and Richard Doubleday, an individual (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Consultant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">1.&#160;&#160;&#160;&#160;SERVICES &#38; COMPENSATION.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Performance of Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Consultant will provide executive advisory, transition and such other consulting services as reasonably requested by the Company, including, but not limited to, the transition of knowledge, experience and insight obtained during Consultant&#8217;s prior employment with the Company, at a rate of approximately 30 hours per month, in such manner (including by telephone) and at such time and place as Consultant and the Company may mutually agree (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221;).  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  In exchange for the Services, the Company will pay Consultant $5,000 per month (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221;).  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Company will reimburse Consultant for reasonable and necessary expenses incurred by Consultant directly in connection with the performance of the services set forth in Section 1 above, to be incurred with the Company&#180;s prior approval.  In addition, the Company specifically agrees to bear the costs of reasonable travel expenses incurred by Consultant pursuant to this Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">2.&#160;&#160;&#160;&#160;RELATIONSHIP&#160;OF&#160;PARTIES.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Independent&#160;Contractor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Consultant is an independent contractor and is not an agent or employee of, and has no authority to bind, Company by contract or otherwise.  Consultant will perform the Services under the general direction of Company, but Consultant will determine, in Consultant&#8217;s sole discretion, the manner and means by which the Services are accomplished, subject to the requirement that Consultant will at all times comply with applicable law.  Company has no right or authority to control the manner or means by which the Services are accomplished.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Employment&#160;Taxes&#160;and&#160;Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Consultant will report as income all compensation received by Consultant pursuant to this Agreement.  Consultant will indemnify Company and hold it harmless from and against all claims, damages, losses, costs and expenses, including reasonable fees and expenses of attorneys and other professionals, relating to any obligation imposed by law on Company to pay any withholding taxes, social security, unemployment or disability insurance, or similar items in connection with compensation received by Consultant pursuant to this Agreement.  Consultant will not be entitled to receive any vacation or illness payments or to participate in any plans, arrangements, or distributions by Company pertaining to any bonus, stock option, profit sharing, insurance or similar benefits for Company&#8217;s employees.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">3.&#160;&#160;&#160;&#160;OWNERSHIP AND INTELLECTUAL PROPERTY&#160;RIGHTS.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Definition of Innovations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Consultant agrees to disclose in writing to Company all inventions, products, designs, drawings, notes, documents, information, documentation, improvements, works of authorship, processes, techniques, know-how, algorithms, technical and business plans, specifications, hardware, circuits, computer languages, computer programs, databases, user interfaces, encoding techniques, and other materials or innovations of any kind that Consultant may make, conceive, develop or reduce to practice, alone or jointly with others, in connection with performing Services or that result from or that are related to such Services, whether or not they are eligible for patent, copyright, mask work, trade secret, trademark or other legal protection (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Innovations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221;).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Ownership of Innovations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Consultant and Company agree that, to the fullest extent legally possible, all Innovations will be works made for hire owned exclusively by Company.  Consultant agrees that, regardless of whether the Innovations are legally works made for hire, all Innovations will be the sole and exclusive property of Company.  Consultant hereby irrevocably transfers and assigns to Company, and agrees to irrevocably transfer and assign to Company, all right, title and interest in and to the Innovations, including all worldwide patent rights (including patent applications and disclosures), copyright rights, mask work rights, trade secret rights, know-how, and any and all other intellectual property or proprietary rights (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Intellectual Property Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221;) therein.  At Company&#8217;s request and expense, during and after the term of this Agreement, Consultant will assist and cooperate with Company in all respects and will execute documents, and, subject to the reasonable availability of Consultant, give testimony and take such further acts reasonably requested by Company to enable Company to acquire, transfer, maintain, perfect and enforce its Intellectual Property Rights and other legal protections for the Innovations.  Consultant hereby appoints the officers of Company as Consultant&#8217;s attorney-in-fact to execute documents on behalf of Consultant for this limited purpose.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Moral Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Consultant also hereby irrevocably transfers and assigns to Company, and agrees to irrevocably transfer and assign to Company, and waives and agrees never to assert, any and all Moral Rights (as defined below) that Consultant or its agents may have in or with respect to any Innovation, during and after the term of this Agreement.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Moral Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221; mean any rights to claim authorship of any Innovation, to object to or prevent the modification or destruction of any Innovation, to withdraw from circulation or control the publication or distribution of any Innovation, and any similar right, existing under judicial or statutory law of any country in the world, or under any treaty, regardless of whether or not such right is called or generally referred to as a &#8220;moral right.&#8221;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Related Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  To the extent that Consultant owns or controls (presently or in the future) any patent rights, copyright rights, mask work rights, trade secret rights, or any other intellectual property or proprietary rights that block or interfere with the rights assigned to Company under this Agreement (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Related Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221;), Consultant hereby grants or will cause to be granted to Company a non-exclusive, royalty-free, irrevocable, perpetual, transferable, worldwide license (with the right to sublicense) to make, have made, use, offer to sell, sell, import, copy, modify, create derivative works based upon, distribute, sublicense, display, perform and transmit any products, software, hardware, methods or materials of any kind that are covered by such Related Rights, to the extent necessary to enable Company to exercise all of the rights assigned to Company under this Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">4.&#160;&#160;&#160;&#160;CONFIDENTIAL&#160;INFORMATION.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:109%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">&#8221; means and will include&#58; (i) any information, materials or knowledge regarding Company and its business, financial condition, products, programming techniques, customers, suppliers, technology or research and development that is disclosed to Consultant or to which Consultant has access in connection with performing Services&#59; (ii)&#160;the Innovations&#59; and (iii)&#160;the existence and terms and conditions of this Agreement.  Confidential Information will not include, however, any information that is or becomes part of the public domain through no fault of Consultant or that Company regularly gives to third parties without restrictions on use or disclosure.  Consultant agrees to hold all Confidential Information in strict confidence, not to use it in any way, commercially or otherwise, except in performing the Services, and not to disclose it to others, except disclosure may be made to Consultant&#8217;s agents who have a bona fide need to know and who have executed a written agreement that includes use and nondisclosure restrictions at least as protective of the Confidential Information as those set forth herein.  Consultant further agrees to take all action reasonably necessary to protect the confidentiality of all Confidential Information including, without limitation, implementing and enforcing procedures to minimize the possibility of unauthorized use or disclosure of Confidential Information.  Both parties agree and acknowledge that Consultant&#8217;s production of Confidential Information pursuant to an order from a court or agency of competent jurisdiction shall not be a breach of this Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">5.&#160;&#160;&#160;&#160;WARRANTIES.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Competitive&#160;Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  During the term of this Agreement, Consultant will not, directly or indirectly, in any individual or representative capacity, including but not limited to as an employee, consultant or director, engage or participate in or provide services to any business that is directly competitive with the types and kinds of business being conducted by Company. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Pre-existing&#160;Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Consultant represents and warrants that Consultant has no pre-existing obligations or commitments (and will not assume or otherwise undertake any obligations or commitments) that would be in conflict or inconsistent with, or that would hinder Consultant&#8217;s performance of its obligations under this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Solicitation&#160;of&#160;Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Because of the trade secret subject matter of Company&#8217;s business, Consultant agrees that, during the term of this Agreement and for a period of one (1) year thereafter, Consultant will not solicit the services of any of Company&#8217;s employees and consultants for Consultant&#8217;s own benefit or for the benefit of any other person or entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">6.&#160;&#160;&#160;&#160;TERM AND TERMINATION.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  This Agreement will commence on the Effective Date and, unless terminated earlier in accordance with the terms of this Agreement, will remain in force and effect until and including March 31, 2022.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Termination for Breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Either party may terminate this Agreement if the other party breaches any material term of this Agreement and fails to cure such breach within ten (10) days following written notice thereof from the non-breaching party.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Termination for Convenience</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  The parties hereto may terminate this Agreement with not less than 14 days&#8217; advance written notice to the other party prior to termination.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">(a)&#160;&#160;&#160;&#160;Upon the expiration or any termination of this Agreement for any reason, Consultant will promptly deliver to Company all Innovations, including all work in progress on any Innovations and all versions and portions thereof.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">(b)&#160;&#160;&#160;&#160;Upon the expiration or any termination of this Agreement (except termination of this Agreement pursuant by Company pursuant to Section 6.2), Company will pay Consultant any Fees amounts that are due and payable for Services performed by Consultant prior to the effective date of expiration or termination.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">(c)&#160;&#160;&#160;&#160;Upon the expiration or termination of this Agreement for any reason, Consultant will promptly notify Company of all Confidential Information in Consultant&#8217;s possession or control and will promptly deliver all such Confidential Information to Company, at Consultant&#8217;s expense and in accordance with Company&#8217;s instructions.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  The provisions of Sections 2.2, 3, 4, 5.3, 6.3, 6.4, 7 and 8 will survive the expiration or termination of this Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:109%">MUTUAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:109%">LIMITATION&#160;OF&#160;LIABILITY.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">  IN NO EVENT WILL COMPANY OR CONSULTANT BE LIABLE FOR ANY SPECIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES OF ANY KIND IN CONNECTION WITH THIS AGREEMENT, EVEN IF COMPANY OR CONSULTANT HAS BEEN INFORMED IN ADVANCE OF THE POSSIBILITY OF SUCH DAMAGES.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.&#160;&#160;&#160;&#160;GENERAL.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">No&#160;Election&#160;of&#160;Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Except as expressly set forth in this Agreement, the exercise by Company or Consultant of any of its remedies under this Agreement will be without prejudice to its other remedies under this Agreement or available at law or in equity.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Neither party may assign or transfer any of its rights or delegate any of its obligations under this Agreement, in whole or in part, without the other party&#8217;s express prior written consent.  Any attempted assignment, transfer or delegation, without such consent, will be void.  Subject to the foregoing, this Agreement will be binding upon and will inure to the benefit of the parties permitted successors and assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Equitable&#160;Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  Because the Services are personal and unique and because Consultant will have access to Confidential Information of Company, Company will have the right to enforce this Agreement and any of its provisions by injunction, specific performance or other equitable relief, without having to post a bond or other consideration, in addition to all other remedies that Company may have for a breach of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Attorneys&#8217;&#160;Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  If any action is necessary to enforce the terms of this Agreement, the substantially prevailing party will be entitled to reasonable attorneys&#8217; fees, costs and expenses in addition to any other relief to which such prevailing party may be entitled.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Governing&#160;Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  This Agreement will be governed by and construed in accordance with the laws of the State of California, excluding that body of law pertaining to conflict of laws.  Any legal action or proceeding arising under this Agreement will be brought exclusively in the federal or state courts located in the State of California, and the parties hereby irrevocably consent to the personal jurisdiction and venue therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:109%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%"> If any provision of this Agreement is held invalid or unenforceable by a court of competent jurisdiction, the remaining provisions of the Agreement will remain in full force and effect, and the provision affected will be construed so as to be enforceable to the maximum extent permissible by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  All notices required or permitted under this Agreement will be in writing and delivered by confirmed facsimile transmission, by courier or overnight delivery service, or by certified mail, and in each instance will be deemed given upon receipt.  All notices will be sent to the addresses set forth above or to such other address as may be specified by either party to the other in accordance with this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  This Agreement constitutes the complete and exclusive understanding and agreement of the parties with respect to the subject matter hereof and supersedes all prior understandings and agreements, whether written or oral, with respect to the subject matter hereof.  Any waiver, modification or amendment of any provision of this Agreement will be effective only if in writing and signed by the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Waiver.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">  The waiver of any breach of any provision of this Agreement will not constitute a waiver of any subsequent breach of the same other provisions hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">8.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">.  This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:109%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div id="ieeb339041c234fbeae9194038c15f20f_13"></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IN WITNESS WHEREOF, the parties have executed this Agreement on the respective dates set forth below&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RICHARD DOUBLEDAY</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s&#47; Richard Doubleday</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s&#47; Patrick M. Murphy</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Patrick M. Murphy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EVP, Chief Legal Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12&#47;10&#47;2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12&#47;10&#47;2020</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;SIGNATURE PAGE TO CONSULTING AGREEMENT&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.01
<SEQUENCE>8
<FILENAME>dxcm12312020exhibit2101.htm
<DESCRIPTION>EX-21.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0a9e0c3d22da462ca392daaf9ea0cafa_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 21.01</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">DEXCOM, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.373%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUBSIDIARY</font></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">(Name under which subsidiary does business)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:11.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">JURISDICTION&#160;OF INCORPORATION</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SweetSpot Diabetes Care, Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TypeZero Technologies, Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCapital, LLC</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Glucose Program, LLC</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nintamed Handels GmbH</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom Canada, Co.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom (Canada) Inc. </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom Deutschland GmbH</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom Lithuania UAB</font></td><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lithuania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom (Malayisa) Sdn Bhd.</font></td><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom Philippines, Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Philippines</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom Asia Pacific Operations PTE Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom Kommanditbolag</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom Suisse GmbH</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom (UK) Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom (UK) Intermediate Holdings Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom Operating Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom International Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DexCom (UK) Distribution Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></div></td></tr></table></div><div style="margin-top:9pt"><font><br></font></div><div style="margin-top:9pt;text-align:right"><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.01
<SEQUENCE>9
<FILENAME>dxcm12312020exhibit2301.htm
<DESCRIPTION>EX-23.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i12c6ef6c8ed14160af2de9ee11e931a1_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 23.01</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:173%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Registration Statement (Form S-3 Nos. 333-206619, 333-211101 and 333-228495) of DexCom, Inc.,</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Registration Statement (Form S-8 No. 333-204699) pertaining to the 2015 Equity Incentive Plan and the 2015 Employee Stock Purchase Plan of DexCom, Inc., and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Registration Statement (Form S-8 Nos. 333-218562 and 333-234682) pertaining to the Amended and Restated 2015 Equity Incentive Plan of DexCom, Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated February 11, 2021, with respect to the consolidated financial statements and schedule of DexCom, Inc., and the effectiveness of internal control over financial reporting of DexCom, Inc., included in this Annual Report (Form 10-K) of DexCom, Inc. for the year ended December 31, 2020.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:166%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">San Diego, California</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.01
<SEQUENCE>10
<FILENAME>dxcm12312020exhibit3101.htm
<DESCRIPTION>EX-31.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id04f3af4b07f4388859122cc4419230c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.01</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin R. Sayer, certify that&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 10-K of DexCom, Inc.&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors, President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.02
<SEQUENCE>11
<FILENAME>dxcm12312020exhibit3102.htm
<DESCRIPTION>EX-31.02
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8ee80969a3e649e9a9947b7db72a74d1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.02</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Quentin S. Blackford, certify that&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 10-K of DexCom, Inc.&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Quentin S. Blackford</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quentin S. Blackford</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.01
<SEQUENCE>12
<FILENAME>dxcm12312020exhibit3201.htm
<DESCRIPTION>EX-32.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie00c746497f641c2818bb4d0d3e3cf6f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.01</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C SECTION 1350</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned, Kevin R. Sayer, President and Chief Executive Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the annual Report on Form 10-K for the period ended December&#160;31, 2020 of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934.</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font><br></font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;11, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:46.637%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors, President and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.02
<SEQUENCE>13
<FILENAME>dxcm12312020exhibit3202.htm
<DESCRIPTION>EX-32.02
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2ce8ce9ebf7245868a5ded90fb463a9d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.02</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned, Quentin S. Blackford, Chief Operating Officer and Chief Financial Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the annual Report on Form 10-K for the period ended December&#160;31, 2020 of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) and 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;11, 2021</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:46.637%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Quentin S. Blackford</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quentin S. Blackford</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>dxcm-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:50830476-969b-49ba-9748-d2c55f5055b8,g:ea51fe61-a1e0-4e98-8988-a47cbbc74de5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dxcm="http://www.dexcom.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dexcom.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.dexcom.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1004005 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPolicies" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Organization and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesPolicies" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Organization and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesTables" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Organization and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails">
        <link:definition>2405402 - Disclosure - Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails">
        <link:definition>2406403 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails">
        <link:definition>2407404 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentandOtherAgreements" roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements">
        <link:definition>2108102 - Disclosure - Development and Other Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentandOtherAgreementsNarrativeDetails" roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails">
        <link:definition>2409405 - Disclosure - Development and Other Agreements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.dexcom.com/role/FairValueMeasurements">
        <link:definition>2110103 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables">
        <link:definition>2311302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails">
        <link:definition>2412406 - Disclosure - Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2413407 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails">
        <link:definition>2414408 - Disclosure - Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetails">
        <link:definition>2115104 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables">
        <link:definition>2316303 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails">
        <link:definition>2417409 - Disclosure - Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsNarrativeDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails">
        <link:definition>2418410 - Disclosure - Balance Sheet Details - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails">
        <link:definition>2419411 - Disclosure - Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccountsReceivableDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails">
        <link:definition>2420412 - Disclosure - Balance Sheet Details - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsInventoryDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails">
        <link:definition>2421413 - Disclosure - Balance Sheet Details - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsPropertyandEquipmentDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails">
        <link:definition>2422414 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails">
        <link:definition>2423415 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccruedWarrantyDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails">
        <link:definition>2424416 - Disclosure - Balance Sheet Details - Accrued Warranty (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsOtherLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails">
        <link:definition>2425417 - Disclosure - Balance Sheet Details - Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.dexcom.com/role/Debt">
        <link:definition>2126105 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.dexcom.com/role/DebtTables">
        <link:definition>2327304 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails">
        <link:definition>2428418 - Disclosure - Debt - Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConversionValueofConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails">
        <link:definition>2429419 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails">
        <link:definition>2430420 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.dexcom.com/role/DebtNarrativeDetails">
        <link:definition>2431421 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails">
        <link:definition>2432422 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitments" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitments">
        <link:definition>2133106 - Disclosure - Leases And Other Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsTables" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables">
        <link:definition>2334305 - Disclosure - Leases And Other Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsNarrativeDetails" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails">
        <link:definition>2435423 - Disclosure - Leases And Other Commitments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails">
        <link:definition>2436424 - Disclosure - Leases And Other Commitments - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1">
        <link:definition>2436424 - Disclosure - Leases And Other Commitments - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsLeaseCostDetails" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails">
        <link:definition>2437425 - Disclosure - Leases And Other Commitments - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsOtherInformationDetails" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails">
        <link:definition>2438426 - Disclosure - Leases And Other Commitments - Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.dexcom.com/role/Contingencies">
        <link:definition>2139107 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.dexcom.com/role/IncomeTaxes">
        <link:definition>2140108 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.dexcom.com/role/IncomeTaxesTables">
        <link:definition>2341306 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails">
        <link:definition>2442427 - Disclosure - Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofProvisionDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails">
        <link:definition>2443428 - Disclosure - Income Taxes - Components of Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails">
        <link:definition>2444429 - Disclosure - Income Taxes - Significant Loss and Tax Credit Carryforwards and Years of Expiration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2445430 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>2446431 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails">
        <link:definition>2447432 - Disclosure - Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>2448433 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquity" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity">
        <link:definition>2149109 - Disclosure - Employee Benefit Plans and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityTables" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables">
        <link:definition>2350307 - Disclosure - Employee Benefit Plans and Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails">
        <link:definition>2451434 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails">
        <link:definition>2452435 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails">
        <link:definition>2453436 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails">
        <link:definition>2454437 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails">
        <link:definition>2455438 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails">
        <link:definition>2456439 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformation" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation">
        <link:definition>2157110 - Disclosure - Business Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationTables" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables">
        <link:definition>2358308 - Disclosure - Business Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationNarrativeDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails">
        <link:definition>2459440 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationSummaryDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails">
        <link:definition>2460441 - Disclosure - Business Segment and Geographic Information - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS">
        <link:definition>2161111 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
        <link:definition>2462442 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dxcm_CustomerBMember" abstract="true" name="CustomerBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_PurchaseofConvertibleNoteHedge" abstract="false" name="PurchaseofConvertibleNoteHedge" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_RevenuePercentage" abstract="false" name="RevenuePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dxcm_RDexpensethroughissuanceofcommonstock" abstract="false" name="RDexpensethroughissuanceofcommonstock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_OptionsInMoneyNumber" abstract="false" name="OptionsInMoneyNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" abstract="false" name="UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CustomerDMember" abstract="true" name="CustomerDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" abstract="false" name="IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" abstract="false" name="EffectiveIncomeTaxReconciliationImpactofTCJA" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementMilestonePaymentsMember" abstract="true" name="CollaborativeArrangementMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermTwoMember" abstract="true" name="DebtInstrumentConversionTermTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_IncomeTaxExpenseBenefitMember" abstract="true" name="IncomeTaxExpenseBenefitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_EffectiveIncomeTaxReconciliationPermanentItems" abstract="false" name="EffectiveIncomeTaxReconciliationPermanentItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_ResearchAndDevelopmentTaxCreditsUtilized" abstract="false" name="ResearchAndDevelopmentTaxCreditsUtilized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LesseeOperatingLeasesLeaseCostAmortization" abstract="false" name="LesseeOperatingLeasesLeaseCostAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_A401kPlanMember" abstract="true" name="A401kPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_ProductShipmentCostsPolicyTextBlock" abstract="false" name="ProductShipmentCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dxcm_DevelopmentAgreementsTable" abstract="true" name="DevelopmentAgreementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2025Member" abstract="true" name="ConvertibleNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_PossibleExtensionPeriodofTaxHoliday" abstract="false" name="PossibleExtensionPeriodofTaxHoliday" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" abstract="false" name="MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_AccruedTaxAuditAndLegalFees" abstract="false" name="AccruedTaxAuditAndLegalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CustomerAMember" abstract="true" name="CustomerAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_EmployeeStockPurchasePlan2015Member" abstract="true" name="EmployeeStockPurchasePlan2015Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" abstract="false" name="CollaborativeArrangementDevelopmentRegulatoryMilestones" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermAxis" abstract="true" name="DebtInstrumentConversionTermAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_ReceiverProductComponentMember" abstract="true" name="ReceiverProductComponentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" abstract="false" name="CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" abstract="false" name="RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_VerilyLifeSciencesMember" abstract="true" name="VerilyLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_NonCashInterestExpenseAbstract" abstract="true" name="NonCashInterestExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementInitialPaymentMember" abstract="true" name="CollaborativeArrangementInitialPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_OtherStatesMember" abstract="true" name="OtherStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_SellingGeneralAndAdministrativeMember" abstract="true" name="SellingGeneralAndAdministrativeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_FinancingLeaseObligation" abstract="false" name="FinancingLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" abstract="false" name="DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" abstract="false" name="SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" abstract="false" name="DeferredTaxLiabilitiesConvertibleDebtDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CashInterestExpenseAbstract" abstract="true" name="CashInterestExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertiblePrincipalAmountExercised" abstract="false" name="DebtInstrumentConvertiblePrincipalAmountExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DevelopmentAndOtherAgreementsTextBlock" abstract="false" name="DevelopmentAndOtherAgreementsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" abstract="false" name="StandardProductWarrantyAccrualChargesToCostsAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" abstract="false" name="LesseeFutureLeaseCostLeaseNotyetCommenced" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" abstract="false" name="DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dxcm_UnusedExpiredFederalIncomeTaxCredits" abstract="false" name="UnusedExpiredFederalIncomeTaxCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" abstract="false" name="EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CustomerCMember" abstract="true" name="CustomerCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" abstract="false" name="EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_DevelopmentAgreementsLineItems" abstract="true" name="DevelopmentAgreementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_AmortizationPeriodForIncentiveCompensationCosts" abstract="false" name="AmortizationPeriodForIncentiveCompensationCosts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_CALIFORNIAAndNonUSMember" abstract="true" name="CALIFORNIAAndNonUSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_DebtInstrumentCovenantRepurchasePricePercentage" abstract="false" name="DebtInstrumentCovenantRepurchasePricePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dxcm_PaymentsUnderCollaborationAgreementsDomain" abstract="true" name="PaymentsUnderCollaborationAgreementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" abstract="false" name="WeightedAverageSharePriceConsecutiveDaysEvaluated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_PaymentsUnderCollaborationAgreementsAxis" abstract="true" name="PaymentsUnderCollaborationAgreementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_ContractPaymentTermsNumberofDays" abstract="false" name="ContractPaymentTermsNumberofDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_FairValueAssetsLevel3TransfersAmount" abstract="false" name="FairValueAssetsLevel3TransfersAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementUpfrontFee" abstract="false" name="CollaborativeArrangementUpfrontFee" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_FinancialStatementDetailsTable" abstract="true" name="FinancialStatementDetailsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" abstract="false" name="EmployeeStockPurchasePlanEsppSharesInEspp" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_PharmacyRebates" abstract="false" name="PharmacyRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2023Member" abstract="true" name="ConvertibleNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" abstract="false" name="RevenueRecognitionSalesReturnsCoveragePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_ShareBasedCompensationIntercompanyCrossCharge" abstract="false" name="ShareBasedCompensationIntercompanyCrossCharge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" abstract="false" name="ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dxcm_EmployeePurchasePriceFloorPercentage" abstract="false" name="EmployeePurchasePriceFloorPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dxcm_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" abstract="false" name="ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermOneMember" abstract="true" name="DebtInstrumentConversionTermOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2022Member" abstract="true" name="ConvertibleNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" abstract="false" name="PotentialFutureCommonStockIssuableSharesNewIssues" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_PaymentsForRepurchaseOfConvertibleNotes" abstract="false" name="PaymentsForRepurchaseOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DeferredTaxAssetsConvertibleDebt" abstract="false" name="DeferredTaxAssetsConvertibleDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_StockOptionsReservedForFutureGrant" abstract="false" name="StockOptionsReservedForFutureGrant" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_FinancialStatementDetailsLineItems" abstract="true" name="FinancialStatementDetailsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermDomain" abstract="true" name="DebtInstrumentConversionTermDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dxcm_CollaborativeResearchAndDevelopmentFee" abstract="false" name="CollaborativeResearchAndDevelopmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" abstract="false" name="LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>dxcm-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:50830476-969b-49ba-9748-d2c55f5055b8,g:ea51fe61-a1e0-4e98-8988-a47cbbc74de5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dexcom.com/role/CoverPage" xlink:type="simple" xlink:href="dxcm-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0c5801df-19b2-4d43-8040-e32c75be9a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_62e8a1d5-e37d-428e-865b-ae01875789e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0c5801df-19b2-4d43-8040-e32c75be9a48" xlink:to="loc_us-gaap_Goodwill_62e8a1d5-e37d-428e-865b-ae01875789e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5c4066e4-3663-4c29-80e8-ece0ea44f0f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0c5801df-19b2-4d43-8040-e32c75be9a48" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5c4066e4-3663-4c29-80e8-ece0ea44f0f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_a7d2d75e-f67a-4b97-9e9f-1a5260bfb175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0c5801df-19b2-4d43-8040-e32c75be9a48" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_a7d2d75e-f67a-4b97-9e9f-1a5260bfb175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_de56f093-4d6a-4b4a-9edf-38f97cbf34fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0c5801df-19b2-4d43-8040-e32c75be9a48" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_de56f093-4d6a-4b4a-9edf-38f97cbf34fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_099ba9c8-39c8-486b-8a83-a65208d87fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0c5801df-19b2-4d43-8040-e32c75be9a48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_099ba9c8-39c8-486b-8a83-a65208d87fa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_754d6a45-b3eb-4d32-a026-239635dfec1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0c5801df-19b2-4d43-8040-e32c75be9a48" xlink:to="loc_us-gaap_AssetsCurrent_754d6a45-b3eb-4d32-a026-239635dfec1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a6b07be2-e4bb-4a0b-87c9-cf2882f9e98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b0d01f99-fa66-45f5-895d-28ea10c98f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a6b07be2-e4bb-4a0b-87c9-cf2882f9e98f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b0d01f99-fa66-45f5-895d-28ea10c98f69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_8a817ba7-8f45-4b9c-ab9d-d8a76a164570" xlink:href="dxcm-20201231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a6b07be2-e4bb-4a0b-87c9-cf2882f9e98f" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_8a817ba7-8f45-4b9c-ab9d-d8a76a164570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5b6b0c17-cf98-4d3b-9e7f-aab32998d3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a6b07be2-e4bb-4a0b-87c9-cf2882f9e98f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5b6b0c17-cf98-4d3b-9e7f-aab32998d3f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_543bd464-d679-45e1-8f9b-09415b6c2127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a6b07be2-e4bb-4a0b-87c9-cf2882f9e98f" xlink:to="loc_us-gaap_InventoryNet_543bd464-d679-45e1-8f9b-09415b6c2127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_682036c7-8f0a-4edc-a795-379a828c2a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a6b07be2-e4bb-4a0b-87c9-cf2882f9e98f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_682036c7-8f0a-4edc-a795-379a828c2a6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1dd0c2b2-00f4-4976-84b6-b78b85fd9613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f813021f-fd00-447e-a32b-72a42f293a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1dd0c2b2-00f4-4976-84b6-b78b85fd9613" xlink:to="loc_us-gaap_Liabilities_f813021f-fd00-447e-a32b-72a42f293a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b0a83adb-f95f-413c-9c73-b710f6e53268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1dd0c2b2-00f4-4976-84b6-b78b85fd9613" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b0a83adb-f95f-413c-9c73-b710f6e53268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b8cc373c-d8c2-44f8-a7ba-3553becf0ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1dd0c2b2-00f4-4976-84b6-b78b85fd9613" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b8cc373c-d8c2-44f8-a7ba-3553becf0ae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dc923915-225d-40ff-9279-73b50c61e6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_bbd66f49-cfa7-4ae1-aee2-b74a5c677695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dc923915-225d-40ff-9279-73b50c61e6e4" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_bbd66f49-cfa7-4ae1-aee2-b74a5c677695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8862940f-ae45-4fd7-a2ad-e12beea14d39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dc923915-225d-40ff-9279-73b50c61e6e4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8862940f-ae45-4fd7-a2ad-e12beea14d39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ab65a2c2-b3bf-4a5f-9c5b-007f712c8bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dc923915-225d-40ff-9279-73b50c61e6e4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ab65a2c2-b3bf-4a5f-9c5b-007f712c8bf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_abfd0615-a63d-4019-9c6f-1d296d59222f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dc923915-225d-40ff-9279-73b50c61e6e4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_abfd0615-a63d-4019-9c6f-1d296d59222f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bb3645c-7cc6-450e-8a1c-48b8dae505e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_207f7d3b-416d-4136-abca-9ac7a1d94133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bb3645c-7cc6-450e-8a1c-48b8dae505e0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_207f7d3b-416d-4136-abca-9ac7a1d94133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_befaa3ae-d28a-4424-b376-2971e0402e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bb3645c-7cc6-450e-8a1c-48b8dae505e0" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_befaa3ae-d28a-4424-b376-2971e0402e46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_3549e59e-44b0-4073-b66a-8048fe526a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bb3645c-7cc6-450e-8a1c-48b8dae505e0" xlink:to="loc_us-gaap_CommonStockValueOutstanding_3549e59e-44b0-4073-b66a-8048fe526a6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6bb0cdf2-2e7c-4ee7-aca9-dc1d4ebabd76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bb3645c-7cc6-450e-8a1c-48b8dae505e0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6bb0cdf2-2e7c-4ee7-aca9-dc1d4ebabd76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_505e9dd8-4499-4e39-b867-9a01b3d78f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bb3645c-7cc6-450e-8a1c-48b8dae505e0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_505e9dd8-4499-4e39-b867-9a01b3d78f24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5a22aba5-b93e-4edc-af61-c46016c3bfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bb3645c-7cc6-450e-8a1c-48b8dae505e0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5a22aba5-b93e-4edc-af61-c46016c3bfeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_74475974-fa7a-40da-b58f-c881b48a2231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bb3645c-7cc6-450e-8a1c-48b8dae505e0" xlink:to="loc_us-gaap_TreasuryStockValue_74475974-fa7a-40da-b58f-c881b48a2231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e94e3454-5c1b-43d0-8485-4982be453cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a68089cb-cde6-476f-9768-61987aa79886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e94e3454-5c1b-43d0-8485-4982be453cce" xlink:to="loc_us-gaap_LiabilitiesCurrent_a68089cb-cde6-476f-9768-61987aa79886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_8df3803b-e935-4ca1-9acc-e8378edbe371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e94e3454-5c1b-43d0-8485-4982be453cce" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_8df3803b-e935-4ca1-9acc-e8378edbe371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_84c00364-3ba1-41cf-8eea-887d997511c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e94e3454-5c1b-43d0-8485-4982be453cce" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_84c00364-3ba1-41cf-8eea-887d997511c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c25195aa-6d20-415b-8567-f53c391f4c07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e94e3454-5c1b-43d0-8485-4982be453cce" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c25195aa-6d20-415b-8567-f53c391f4c07" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_7df1f0ce-94d4-4d34-9990-1a73ae5a81e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6320b709-563a-408e-ab0f-9463233366d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_7df1f0ce-94d4-4d34-9990-1a73ae5a81e9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6320b709-563a-408e-ab0f-9463233366d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0c34cb44-4d53-48f7-8751-e04a4b3595a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_7df1f0ce-94d4-4d34-9990-1a73ae5a81e9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0c34cb44-4d53-48f7-8751-e04a4b3595a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_94e60648-3dd4-4dfa-837e-df88041f6464" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7c0edd1e-f1f5-4004-aecb-407d4cc6c95a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_94e60648-3dd4-4dfa-837e-df88041f6464" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7c0edd1e-f1f5-4004-aecb-407d4cc6c95a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_d105ea87-8aaf-4af6-99a5-477b251b4b6c" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_94e60648-3dd4-4dfa-837e-df88041f6464" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_d105ea87-8aaf-4af6-99a5-477b251b4b6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_708f6245-e248-4420-b36a-2e44dabb5827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_94e60648-3dd4-4dfa-837e-df88041f6464" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_708f6245-e248-4420-b36a-2e44dabb5827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9b3dbd3e-36ee-4011-af0b-a317f02b8eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0a8c38a3-9bf5-4034-bb41-bb5f2f93dedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9b3dbd3e-36ee-4011-af0b-a317f02b8eb0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0a8c38a3-9bf5-4034-bb41-bb5f2f93dedf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_283641af-7127-47d9-ab4b-61bb2f8ab5f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9b3dbd3e-36ee-4011-af0b-a317f02b8eb0" xlink:to="loc_us-gaap_InterestExpense_283641af-7127-47d9-ab4b-61bb2f8ab5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9eace9bc-9037-44fd-8676-6bad7adf416d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9b3dbd3e-36ee-4011-af0b-a317f02b8eb0" xlink:to="loc_us-gaap_OperatingIncomeLoss_9eace9bc-9037-44fd-8676-6bad7adf416d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0a575e46-cdfb-4ffb-83bc-ce6ff3c5d827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9b3dbd3e-36ee-4011-af0b-a317f02b8eb0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0a575e46-cdfb-4ffb-83bc-ce6ff3c5d827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_0c6f1102-4fff-461f-bdc9-7220e0d9a2a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9b3dbd3e-36ee-4011-af0b-a317f02b8eb0" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_0c6f1102-4fff-461f-bdc9-7220e0d9a2a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_77d6e26a-648c-4c14-b231-43c36f65df12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2e1422fa-4316-4d9f-9c6d-2dba9a65d690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_77d6e26a-648c-4c14-b231-43c36f65df12" xlink:to="loc_us-gaap_GrossProfit_2e1422fa-4316-4d9f-9c6d-2dba9a65d690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e72d6229-7975-40ac-b501-4f795f3829f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_77d6e26a-648c-4c14-b231-43c36f65df12" xlink:to="loc_us-gaap_OperatingExpenses_e72d6229-7975-40ac-b501-4f795f3829f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8308cc46-94a9-417e-80cd-9221e0241f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aa40b675-2011-45e1-ad1c-6073354bed59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8308cc46-94a9-417e-80cd-9221e0241f0c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aa40b675-2011-45e1-ad1c-6073354bed59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_54f02116-def7-4353-9431-c0d385fdf537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8308cc46-94a9-417e-80cd-9221e0241f0c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_54f02116-def7-4353-9431-c0d385fdf537" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c36f22b8-bea4-4480-8b8a-23fa7b901fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5b808e6d-060d-4025-9e3a-cc3a21516733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c36f22b8-bea4-4480-8b8a-23fa7b901fb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5b808e6d-060d-4025-9e3a-cc3a21516733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ea3c9b30-d176-463b-99ce-46a583f7bff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c36f22b8-bea4-4480-8b8a-23fa7b901fb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ea3c9b30-d176-463b-99ce-46a583f7bff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6d80b095-9aa8-4da8-b6f1-854e98ab4769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c246ec34-490a-4af9-9e85-91dae016a651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6d80b095-9aa8-4da8-b6f1-854e98ab4769" xlink:to="loc_us-gaap_NetIncomeLoss_c246ec34-490a-4af9-9e85-91dae016a651" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0fffa904-996b-46c4-8b2e-2c68e2761992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6d80b095-9aa8-4da8-b6f1-854e98ab4769" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0fffa904-996b-46c4-8b2e-2c68e2761992" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_110699cd-ce70-49e9-9473-46934178c3f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2d1b9d-ae3f-467f-8116-024479c36f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_110699cd-ce70-49e9-9473-46934178c3f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2d1b9d-ae3f-467f-8116-024479c36f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce81910a-0547-4e72-80b1-d721683e9682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_110699cd-ce70-49e9-9473-46934178c3f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce81910a-0547-4e72-80b1-d721683e9682" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d220abe4-fc87-4898-8a05-d660c03345da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_110699cd-ce70-49e9-9473-46934178c3f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d220abe4-fc87-4898-8a05-d660c03345da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91962ec8-0c78-4d34-b9c7-671e4a323b49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_110699cd-ce70-49e9-9473-46934178c3f6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91962ec8-0c78-4d34-b9c7-671e4a323b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c5892fb-907c-4867-9b87-c4c282960a23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1eace8b0-9a60-4e72-b6de-b3faa3221999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c5892fb-907c-4867-9b87-c4c282960a23" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1eace8b0-9a60-4e72-b6de-b3faa3221999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_395ebe40-3886-4f83-a4f9-1225b384e14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c5892fb-907c-4867-9b87-c4c282960a23" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_395ebe40-3886-4f83-a4f9-1225b384e14a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_85664457-d1dd-4b23-800a-2a10846da1d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c5892fb-907c-4867-9b87-c4c282960a23" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_85664457-d1dd-4b23-800a-2a10846da1d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2e6b58db-b31a-4c80-9f0b-9c9cd8da2b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c5892fb-907c-4867-9b87-c4c282960a23" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2e6b58db-b31a-4c80-9f0b-9c9cd8da2b2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_799034c5-52a5-47ed-946f-b2b4b33ce2f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c5892fb-907c-4867-9b87-c4c282960a23" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_799034c5-52a5-47ed-946f-b2b4b33ce2f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a7ae917-d524-49de-83c7-77a1a0ffa0bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0182d400-a4e9-475b-a101-cf6c0d6a82fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a7ae917-d524-49de-83c7-77a1a0ffa0bb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0182d400-a4e9-475b-a101-cf6c0d6a82fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_f23f0949-654f-46e0-9763-c750452aa712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a7ae917-d524-49de-83c7-77a1a0ffa0bb" xlink:to="loc_us-gaap_RestrictedCash_f23f0949-654f-46e0-9763-c750452aa712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_cf6a2f66-de18-446d-85ee-da8e7b014550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_cf6a2f66-de18-446d-85ee-da8e7b014550" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_d213e80c-036b-4281-8cf2-02c5886eb179" xlink:href="dxcm-20201231.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_d213e80c-036b-4281-8cf2-02c5886eb179" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4cce2d5c-4710-4e30-b060-74cc8a329e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4cce2d5c-4710-4e30-b060-74cc8a329e7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_23348e9b-24e6-476d-bf44-c46c844a8279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_23348e9b-24e6-476d-bf44-c46c844a8279" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_2a8c7d27-f2a6-4f09-bbc5-13431cf826d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_PaidInKindInterest_2a8c7d27-f2a6-4f09-bbc5-13431cf826d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_39c66773-ea16-438e-a9cb-0d59c6bd6bf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_39c66773-ea16-438e-a9cb-0d59c6bd6bf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_eb3f21fe-05b9-46b0-8032-f08d86fe043e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_eb3f21fe-05b9-46b0-8032-f08d86fe043e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_77a56066-536c-473a-8714-6d1ccacee5b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_77a56066-536c-473a-8714-6d1ccacee5b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_ef61d5a1-98fc-4f5d-a6d5-6085bf55fd82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_ef61d5a1-98fc-4f5d-a6d5-6085bf55fd82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6dd555b8-1ba5-497c-bc48-034dee909440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_ShareBasedCompensation_6dd555b8-1ba5-497c-bc48-034dee909440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_29933a37-5d59-4146-ad3c-e6e67c4550a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_29933a37-5d59-4146-ad3c-e6e67c4550a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_86290f63-fc71-4e3b-aade-b9796e4bf9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_86290f63-fc71-4e3b-aade-b9796e4bf9fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_7968b719-43a0-4075-8d4a-bb1021dae52c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_7968b719-43a0-4075-8d4a-bb1021dae52c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RDexpensethroughissuanceofcommonstock_e76d0a04-cb5d-4d3c-be97-a285e8802c53" xlink:href="dxcm-20201231.xsd#dxcm_RDexpensethroughissuanceofcommonstock"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_dxcm_RDexpensethroughissuanceofcommonstock_e76d0a04-cb5d-4d3c-be97-a285e8802c53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3ff1f4ed-68bb-4ddc-9e85-ce0a2b536bc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3ff1f4ed-68bb-4ddc-9e85-ce0a2b536bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_86454fdf-d8df-4a84-9315-075bfe352b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_86454fdf-d8df-4a84-9315-075bfe352b2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_64abf0eb-e02d-4cb0-ad75-225cc30f72d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c30e5efc-92b7-4581-9184-6efe8c3e5150" xlink:to="loc_us-gaap_NetIncomeLoss_64abf0eb-e02d-4cb0-ad75-225cc30f72d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b14fcdad-0179-4eff-a6bd-10777ad06885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_39558656-2da5-4124-91de-95e8d09bab7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b14fcdad-0179-4eff-a6bd-10777ad06885" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_39558656-2da5-4124-91de-95e8d09bab7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_c68e7b21-e75e-4701-ba6c-b6221c66d4b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b14fcdad-0179-4eff-a6bd-10777ad06885" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_c68e7b21-e75e-4701-ba6c-b6221c66d4b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes_eb7a26b8-4232-41a3-a8db-6a97f7b079f3" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsForRepurchaseOfConvertibleNotes"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b14fcdad-0179-4eff-a6bd-10777ad06885" xlink:to="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes_eb7a26b8-4232-41a3-a8db-6a97f7b079f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5d8a528b-62e8-4bbe-8c6a-409d094f15e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b14fcdad-0179-4eff-a6bd-10777ad06885" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5d8a528b-62e8-4bbe-8c6a-409d094f15e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_782cf76d-fdb6-40c3-a100-38b055f2b688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b14fcdad-0179-4eff-a6bd-10777ad06885" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_782cf76d-fdb6-40c3-a100-38b055f2b688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_ad874d99-b426-4ec5-aa6b-825088e53cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b14fcdad-0179-4eff-a6bd-10777ad06885" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_ad874d99-b426-4ec5-aa6b-825088e53cf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PurchaseofConvertibleNoteHedge_9a990621-878d-4404-946e-6bc86b6ba165" xlink:href="dxcm-20201231.xsd#dxcm_PurchaseofConvertibleNoteHedge"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b14fcdad-0179-4eff-a6bd-10777ad06885" xlink:to="loc_dxcm_PurchaseofConvertibleNoteHedge_9a990621-878d-4404-946e-6bc86b6ba165" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DevelopmentandOtherAgreements"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DevelopmentandOtherAgreementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b20c65fb-91f9-4afd-80b3-49f111af50d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_ea8aa502-7335-4d3f-be57-74ab1b635b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b20c65fb-91f9-4afd-80b3-49f111af50d0" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_ea8aa502-7335-4d3f-be57-74ab1b635b22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49d3ad2e-e6ab-4506-8349-f632bde9ace7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b20c65fb-91f9-4afd-80b3-49f111af50d0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49d3ad2e-e6ab-4506-8349-f632bde9ace7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_c4fd79e3-b64c-480e-891e-5e56c30a9446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b20c65fb-91f9-4afd-80b3-49f111af50d0" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_c4fd79e3-b64c-480e-891e-5e56c30a9446" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsTables"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_98cc3225-0ff4-4682-ba46-9f8d3e43ac8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3976099e-9895-4d18-8c4f-4623d9fd9b9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_98cc3225-0ff4-4682-ba46-9f8d3e43ac8f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3976099e-9895-4d18-8c4f-4623d9fd9b9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_90e8791d-a9c4-4c28-be9a-e429f44ae149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_98cc3225-0ff4-4682-ba46-9f8d3e43ac8f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_90e8791d-a9c4-4c28-be9a-e429f44ae149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38a962b9-a39c-4406-8bc0-97a2c25019ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_98cc3225-0ff4-4682-ba46-9f8d3e43ac8f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38a962b9-a39c-4406-8bc0-97a2c25019ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_fa7accac-98fe-4fb9-abff-7f5a482eed2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_f389afd8-3bab-4e86-84a0-e68da349f1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_fa7accac-98fe-4fb9-abff-7f5a482eed2f" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_f389afd8-3bab-4e86-84a0-e68da349f1cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_30b38724-8336-4d83-aa5b-bfa6d79eb60d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_fa7accac-98fe-4fb9-abff-7f5a482eed2f" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_30b38724-8336-4d83-aa5b-bfa6d79eb60d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_9c9a35cd-e4e1-4882-acb5-00fa825decb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_53ddb166-a2d0-45dd-96c5-f36acc013879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNet_9c9a35cd-e4e1-4882-acb5-00fa825decb3" xlink:to="loc_us-gaap_AccountsReceivableGross_53ddb166-a2d0-45dd-96c5-f36acc013879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e96a093d-360d-4c28-8a36-0a91b33cece1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNet_9c9a35cd-e4e1-4882-acb5-00fa825decb3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e96a093d-360d-4c28-8a36-0a91b33cece1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0235c842-d2dc-4ff1-bad9-8e5f22d36505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_cfb9bf36-f78a-41a4-badb-452a0eacf3fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0235c842-d2dc-4ff1-bad9-8e5f22d36505" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_cfb9bf36-f78a-41a4-badb-452a0eacf3fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0ff712a0-3e16-4892-a83f-2a56da686e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0235c842-d2dc-4ff1-bad9-8e5f22d36505" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0ff712a0-3e16-4892-a83f-2a56da686e24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f610d99c-cb75-41a6-a0ed-3dae71a4e8c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0235c842-d2dc-4ff1-bad9-8e5f22d36505" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f610d99c-cb75-41a6-a0ed-3dae71a4e8c0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_67b74a4e-37b3-46cb-a8ad-b679c631bff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_7e2d799e-284e-440d-b9a4-9e7f66095e86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_67b74a4e-37b3-46cb-a8ad-b679c631bff0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_7e2d799e-284e-440d-b9a4-9e7f66095e86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_af69a3e0-38f6-45c4-8cab-4c5ba7c17aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_67b74a4e-37b3-46cb-a8ad-b679c631bff0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_af69a3e0-38f6-45c4-8cab-4c5ba7c17aa2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_666b6ca5-cecc-4900-81de-ace84ae8bad7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_408ae9d7-174c-4ee2-8468-177ea3a8b467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_666b6ca5-cecc-4900-81de-ace84ae8bad7" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_408ae9d7-174c-4ee2-8468-177ea3a8b467" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees_c0445c25-95d9-4a4f-9b01-1b4d17b2ffb5" xlink:href="dxcm-20201231.xsd#dxcm_AccruedTaxAuditAndLegalFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_666b6ca5-cecc-4900-81de-ace84ae8bad7" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFees_c0445c25-95d9-4a4f-9b01-1b4d17b2ffb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebates_20e4a7f8-ded9-4a4b-a3fa-96d2795fbc8f" xlink:href="dxcm-20201231.xsd#dxcm_PharmacyRebates"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_666b6ca5-cecc-4900-81de-ace84ae8bad7" xlink:to="loc_dxcm_PharmacyRebates_20e4a7f8-ded9-4a4b-a3fa-96d2795fbc8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1b3aaa8b-03bc-44b0-8b7d-c0b20c7124c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_666b6ca5-cecc-4900-81de-ace84ae8bad7" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_1b3aaa8b-03bc-44b0-8b7d-c0b20c7124c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3b872825-9f00-450a-8000-3a42138694f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_666b6ca5-cecc-4900-81de-ace84ae8bad7" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3b872825-9f00-450a-8000-3a42138694f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsAccruedWarrantyDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a0c34812-4fe0-4907-8ce0-9055d01f51ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_1147c792-bb44-428e-9116-ec0cbfd69f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_a0c34812-4fe0-4907-8ce0-9055d01f51ba" xlink:to="loc_us-gaap_ContractualObligation_1147c792-bb44-428e-9116-ec0cbfd69f15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_a78bfe8f-d7c3-4c84-9e1a-307e9bcbaf48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_a0c34812-4fe0-4907-8ce0-9055d01f51ba" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_a78bfe8f-d7c3-4c84-9e1a-307e9bcbaf48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FinancingLeaseObligation_a752d792-fa84-4b84-a256-6405e7507a21" xlink:href="dxcm-20201231.xsd#dxcm_FinancingLeaseObligation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_a0c34812-4fe0-4907-8ce0-9055d01f51ba" xlink:to="loc_dxcm_FinancingLeaseObligation_a752d792-fa84-4b84-a256-6405e7507a21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt" xlink:type="simple" xlink:href="dxcm-20201231.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtSeniorConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_f17063a4-f916-41b7-9b20-cb9113c53e73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9f906564-4da9-471e-98c5-5bce871cb24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable_f17063a4-f916-41b7-9b20-cb9113c53e73" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9f906564-4da9-471e-98c5-5bce871cb24c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_04d93151-5623-47b5-8a8a-20f594012df9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable_f17063a4-f916-41b7-9b20-cb9113c53e73" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_04d93151-5623-47b5-8a8a-20f594012df9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8632eeea-2604-438a-8f93-8b7bc4bd3b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable_f17063a4-f916-41b7-9b20-cb9113c53e73" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_8632eeea-2604-438a-8f93-8b7bc4bd3b43" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtConversionValueofConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitments"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsTables"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4e2cb24a-f61b-465c-bf49-5809e7e74fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1c15cbb2-11be-49f8-a670-e0d63dba4da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_4e2cb24a-f61b-465c-bf49-5809e7e74fc1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1c15cbb2-11be-49f8-a670-e0d63dba4da9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5b7c716c-b285-48f4-9a7e-e523a1bf529f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_4e2cb24a-f61b-465c-bf49-5809e7e74fc1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5b7c716c-b285-48f4-9a7e-e523a1bf529f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_32ebac63-177d-4c5d-9b96-339d32b5328c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_32427587-8480-49fb-89a4-1c9faa501d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_32ebac63-177d-4c5d-9b96-339d32b5328c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_32427587-8480-49fb-89a4-1c9faa501d5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_cde5241b-1d29-45dc-a2eb-90f712aa1a11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_32ebac63-177d-4c5d-9b96-339d32b5328c" xlink:to="loc_us-gaap_OperatingLeaseLiability_cde5241b-1d29-45dc-a2eb-90f712aa1a11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_36432de0-0268-4641-a915-a7b28a0d334f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_1564e325-bdbe-4580-92e0-9896d00f173f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_36432de0-0268-4641-a915-a7b28a0d334f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_1564e325-bdbe-4580-92e0-9896d00f173f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2b49b902-6ed5-4c6b-a22a-36e3fcce503b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_36432de0-0268-4641-a915-a7b28a0d334f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2b49b902-6ed5-4c6b-a22a-36e3fcce503b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_d3849117-480f-4494-96d1-5af7ddc7f1a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_36432de0-0268-4641-a915-a7b28a0d334f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_d3849117-480f-4494-96d1-5af7ddc7f1a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_787bf9cb-b2be-4ab3-b754-ee98ab90f226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_36432de0-0268-4641-a915-a7b28a0d334f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_787bf9cb-b2be-4ab3-b754-ee98ab90f226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fb3c59dc-1965-4a1d-b12c-54ca9fe8701a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_36432de0-0268-4641-a915-a7b28a0d334f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fb3c59dc-1965-4a1d-b12c-54ca9fe8701a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_34211437-9acc-4ae9-a5df-c867c6a8987a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_36432de0-0268-4641-a915-a7b28a0d334f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_34211437-9acc-4ae9-a5df-c867c6a8987a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_9c50ca8d-8ae1-472d-9523-de3b424d1272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5a0f3bf3-1ac9-4647-a690-571499109cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_9c50ca8d-8ae1-472d-9523-de3b424d1272" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5a0f3bf3-1ac9-4647-a690-571499109cea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6f0f1306-cd3b-499a-8270-daddfd489c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_9c50ca8d-8ae1-472d-9523-de3b424d1272" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6f0f1306-cd3b-499a-8270-daddfd489c2d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0822f8d-eede-4ac5-ad27-a752f4364505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_be7da0af-e766-428f-9914-456437cf7f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0822f8d-eede-4ac5-ad27-a752f4364505" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_be7da0af-e766-428f-9914-456437cf7f8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_148b490e-4f21-426a-ac5a-5134d8cb6036" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0822f8d-eede-4ac5-ad27-a752f4364505" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_148b490e-4f21-426a-ac5a-5134d8cb6036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d0d16787-ff0c-488b-b8b1-634756fe212e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0822f8d-eede-4ac5-ad27-a752f4364505" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d0d16787-ff0c-488b-b8b1-634756fe212e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1bdf9127-34f3-4b06-a7ee-e36bd9e1bca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0822f8d-eede-4ac5-ad27-a752f4364505" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1bdf9127-34f3-4b06-a7ee-e36bd9e1bca9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_09f6e165-2ff0-4c76-9bd1-12209974e5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0822f8d-eede-4ac5-ad27-a752f4364505" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_09f6e165-2ff0-4c76-9bd1-12209974e5ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5f305985-69bf-41cf-a2f2-78eb0b15f7b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0822f8d-eede-4ac5-ad27-a752f4364505" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5f305985-69bf-41cf-a2f2-78eb0b15f7b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3807a2a2-8ad3-41fb-8f10-2e38223887fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b3e88bfd-5393-486e-9b78-5dfc8e239d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3807a2a2-8ad3-41fb-8f10-2e38223887fc" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b3e88bfd-5393-486e-9b78-5dfc8e239d74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_77f78d6e-34cd-47d1-b2e9-0002e74d2b74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3807a2a2-8ad3-41fb-8f10-2e38223887fc" xlink:to="loc_us-gaap_FinanceLeaseLiability_77f78d6e-34cd-47d1-b2e9-0002e74d2b74" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_4a08d3e6-0731-488d-bb71-0589b831a4b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_1479fc68-0c36-4edc-aa04-4fa9c16ec9a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_4a08d3e6-0731-488d-bb71-0589b831a4b6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_1479fc68-0c36-4edc-aa04-4fa9c16ec9a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_a105e8ab-3be5-4251-a01f-dc8df7e92cde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_4a08d3e6-0731-488d-bb71-0589b831a4b6" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_a105e8ab-3be5-4251-a01f-dc8df7e92cde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_7ef309ed-a1c2-4aa1-95bc-86533f85b28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_4a08d3e6-0731-488d-bb71-0589b831a4b6" xlink:to="loc_us-gaap_OperatingLeaseCost_7ef309ed-a1c2-4aa1-95bc-86533f85b28a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_f12e4eb8-2e7a-4486-9f28-0ba99eb3b8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_4a08d3e6-0731-488d-bb71-0589b831a4b6" xlink:to="loc_us-gaap_ShortTermLeaseCost_f12e4eb8-2e7a-4486-9f28-0ba99eb3b8a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_ae9616fd-7604-445d-ad90-44051f39e02f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_4a08d3e6-0731-488d-bb71-0589b831a4b6" xlink:to="loc_us-gaap_VariableLeaseCost_ae9616fd-7604-445d-ad90-44051f39e02f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsOtherInformationDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/Contingencies" xlink:type="simple" xlink:href="dxcm-20201231.xsd#Contingencies"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/Contingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0cee89aa-0d47-4237-ad63-181f4d8b416c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_18821716-e316-4fff-8280-d427441c68e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0cee89aa-0d47-4237-ad63-181f4d8b416c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_18821716-e316-4fff-8280-d427441c68e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_65ad0090-97cb-4bf8-9179-a4858cdeaac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0cee89aa-0d47-4237-ad63-181f4d8b416c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_65ad0090-97cb-4bf8-9179-a4858cdeaac7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesComponentsofProvisionDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_17836e4f-5b76-4cbc-b62d-8476c5337732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ecb59df4-42f5-4327-be1a-0fa404e61f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_17836e4f-5b76-4cbc-b62d-8476c5337732" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ecb59df4-42f5-4327-be1a-0fa404e61f3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_515bace2-1a15-401d-a891-0bd2d976fcf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_17836e4f-5b76-4cbc-b62d-8476c5337732" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_515bace2-1a15-401d-a891-0bd2d976fcf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_fb1cf24a-4e6f-425f-a48a-cc8357519d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_17836e4f-5b76-4cbc-b62d-8476c5337732" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_fb1cf24a-4e6f-425f-a48a-cc8357519d3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_167ce0a6-a146-4d0d-a6fc-90d06e4698a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_42ab5fb2-b0f9-4210-a7a4-27aab0bd5373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_167ce0a6-a146-4d0d-a6fc-90d06e4698a5" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_42ab5fb2-b0f9-4210-a7a4-27aab0bd5373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_12cafae5-dedb-4271-ba65-c7bc4ac7008a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_167ce0a6-a146-4d0d-a6fc-90d06e4698a5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_12cafae5-dedb-4271-ba65-c7bc4ac7008a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4856eb5d-513c-408c-8abf-39e193cd3473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d24e7d93-2c2b-4e08-bf1c-b6e3dd05cccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4856eb5d-513c-408c-8abf-39e193cd3473" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d24e7d93-2c2b-4e08-bf1c-b6e3dd05cccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9e0ae071-877c-458f-958a-77734e8bcfc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4856eb5d-513c-408c-8abf-39e193cd3473" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9e0ae071-877c-458f-958a-77734e8bcfc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_3a825227-3902-41d0-ab75-a8d0c7e4f601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4856eb5d-513c-408c-8abf-39e193cd3473" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_3a825227-3902-41d0-ab75-a8d0c7e4f601" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_98563540-303d-4137-b664-22aad60aa451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d50ef896-f58a-443c-ac2d-9f86137c8ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_98563540-303d-4137-b664-22aad60aa451" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d50ef896-f58a-443c-ac2d-9f86137c8ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_e8ab859c-26c3-4a3a-831c-2317cab58ed6" xlink:href="dxcm-20201231.xsd#dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_98563540-303d-4137-b664-22aad60aa451" xlink:to="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_e8ab859c-26c3-4a3a-831c-2317cab58ed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_75703360-7da7-442a-8f2c-72e624dfc293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5bc54d12-b066-4c03-a333-80eb8a354283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_75703360-7da7-442a-8f2c-72e624dfc293" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5bc54d12-b066-4c03-a333-80eb8a354283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0c7e6202-c793-40b5-a0c8-14cbd259e1bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_75703360-7da7-442a-8f2c-72e624dfc293" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_0c7e6202-c793-40b5-a0c8-14cbd259e1bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_310d317c-862a-47b2-afe3-d0cbbcedfe45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_938f30e9-7e4d-43b5-a338-4acf38119520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_310d317c-862a-47b2-afe3-d0cbbcedfe45" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_938f30e9-7e4d-43b5-a338-4acf38119520" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_4788377f-e199-45af-a6f1-7ffefca895f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_310d317c-862a-47b2-afe3-d0cbbcedfe45" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_4788377f-e199-45af-a6f1-7ffefca895f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_74b19bb9-b6ca-4d6f-a75d-17fa4181aead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_310d317c-862a-47b2-afe3-d0cbbcedfe45" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_74b19bb9-b6ca-4d6f-a75d-17fa4181aead" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_859ed17d-5d2a-4815-a831-09ef0e6c4525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_310d317c-862a-47b2-afe3-d0cbbcedfe45" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_859ed17d-5d2a-4815-a831-09ef0e6c4525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_86616874-231f-466e-98ce-b9ec3855d83e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_310d317c-862a-47b2-afe3-d0cbbcedfe45" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_86616874-231f-466e-98ce-b9ec3855d83e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_68a85a09-5821-4734-90c4-ea582d650337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_310d317c-862a-47b2-afe3-d0cbbcedfe45" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_68a85a09-5821-4734-90c4-ea582d650337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxAssetsConvertibleDebt_6be26173-5034-4dce-ad7e-04c354745785" xlink:href="dxcm-20201231.xsd#dxcm_DeferredTaxAssetsConvertibleDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_310d317c-862a-47b2-afe3-d0cbbcedfe45" xlink:to="loc_dxcm_DeferredTaxAssetsConvertibleDebt_6be26173-5034-4dce-ad7e-04c354745785" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_b92b6b07-ac14-44b7-b273-2d70b62a6093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2e388ce8-fc5c-4eb3-aecb-30a6c4f27346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b92b6b07-ac14-44b7-b273-2d70b62a6093" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2e388ce8-fc5c-4eb3-aecb-30a6c4f27346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_39bdea4f-bbed-45b3-b266-edf9db3aac96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b92b6b07-ac14-44b7-b273-2d70b62a6093" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_39bdea4f-bbed-45b3-b266-edf9db3aac96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_aa001da0-ac58-4ab6-a189-3d4fcf67e912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_c2ea1311-74b5-4857-bf37-03869c07a692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_aa001da0-ac58-4ab6-a189-3d4fcf67e912" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_c2ea1311-74b5-4857-bf37-03869c07a692" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_27de3feb-fbb3-4e04-ae42-3a1c0e8a6489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_aa001da0-ac58-4ab6-a189-3d4fcf67e912" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_27de3feb-fbb3-4e04-ae42-3a1c0e8a6489" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_6d72e0cf-3796-40ce-8f86-057b413166ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_6d72e0cf-3796-40ce-8f86-057b413166ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_205611be-e433-44e7-9fe0-0914f73da2f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_205611be-e433-44e7-9fe0-0914f73da2f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_2981e52c-8738-4fb9-8155-eab290f02f37" xlink:href="dxcm-20201231.xsd#dxcm_EffectiveIncomeTaxReconciliationPermanentItems"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_2981e52c-8738-4fb9-8155-eab290f02f37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_7516f5fd-3ce6-4d33-9e7d-923c985c57d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_7516f5fd-3ce6-4d33-9e7d-923c985c57d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1f4730cd-0fbc-4e25-9359-7e9af3d97d61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1f4730cd-0fbc-4e25-9359-7e9af3d97d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_34908aa0-f351-4a61-9d43-6f9951195b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_34908aa0-f351-4a61-9d43-6f9951195b8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_70653fbf-0fcd-4467-98df-2732f6929ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_70653fbf-0fcd-4467-98df-2732f6929ab2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_1d812654-4b62-4315-b571-df2b042a9d95" xlink:href="dxcm-20201231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_1d812654-4b62-4315-b571-df2b042a9d95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_7b69e16d-c132-4579-9b7a-574adc062f75" xlink:href="dxcm-20201231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_7b69e16d-c132-4579-9b7a-574adc062f75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6058e6ea-db8e-4ea5-85a1-d62814fe3621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6058e6ea-db8e-4ea5-85a1-d62814fe3621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_00f51401-f7c7-4b37-bd4f-c76cc8b66638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_843dd98d-ebe8-4880-bb5b-aa626fbb8fbf" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_00f51401-f7c7-4b37-bd4f-c76cc8b66638" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_18b4913a-e5ab-4ef9-82dc-80d4dd6afea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e8931cb-93b4-44f1-b474-3783f89d18da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_18b4913a-e5ab-4ef9-82dc-80d4dd6afea8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e8931cb-93b4-44f1-b474-3783f89d18da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockOptionsReservedForFutureGrant_16d2fbcc-bb5c-43e2-b971-20a9f353af8b" xlink:href="dxcm-20201231.xsd#dxcm_StockOptionsReservedForFutureGrant"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_18b4913a-e5ab-4ef9-82dc-80d4dd6afea8" xlink:to="loc_dxcm_StockOptionsReservedForFutureGrant_16d2fbcc-bb5c-43e2-b971-20a9f353af8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_32600482-6f3f-47c9-8404-ad6fccb621ab" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlanEsppSharesInEspp"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_18b4913a-e5ab-4ef9-82dc-80d4dd6afea8" xlink:to="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_32600482-6f3f-47c9-8404-ad6fccb621ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformation"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformationTables"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformationSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="dxcm-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>dxcm-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:50830476-969b-49ba-9748-d2c55f5055b8,g:ea51fe61-a1e0-4e98-8988-a47cbbc74de5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/CoverPage" xlink:type="simple" xlink:href="dxcm-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/CoverPage" xlink:type="extended" id="i260e7c966df14e43aa9196258c6d9325_CoverPage"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i137da9f1c66340eaa501dc54afcb3d62_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i68ed9deb3c5d481fbfe03e985df1ef1f_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i83a31b3193614a328c15f6c860b07c38_ConsolidatedStatementsofOperations"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="iaec5d747316a4f3e9a9a7465eda65af2_ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i7455991c11c645fcb6453d968468017e_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3eeeecd6-fd27-4988-9962-1087af9c3c22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_86d19861-b8f5-4a55-bf1f-5820f6442ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3eeeecd6-fd27-4988-9962-1087af9c3c22" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_86d19861-b8f5-4a55-bf1f-5820f6442ae5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3eeeecd6-fd27-4988-9962-1087af9c3c22" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ef292cd2-5243-411b-ae57-25dce9eef8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_SharesOutstanding_ef292cd2-5243-411b-ae57-25dce9eef8ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c724aa1-1c20-45f9-b8f9-439af6a3b989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c724aa1-1c20-45f9-b8f9-439af6a3b989" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_d66bd7b2-df86-4c7b-8676-acf805e55edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_d66bd7b2-df86-4c7b-8676-acf805e55edf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_ff293084-80c4-4a55-9551-fad76716fb9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_ff293084-80c4-4a55-9551-fad76716fb9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_154fdacb-6322-40fe-833a-3cdfb8a7e1ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_154fdacb-6322-40fe-833a-3cdfb8a7e1ad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_532f27fe-d55c-4d80-a32c-6efd26fd06a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_532f27fe-d55c-4d80-a32c-6efd26fd06a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_1c6387d8-47a4-4632-8e6f-de4a586d66ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_1c6387d8-47a4-4632-8e6f-de4a586d66ca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_2e8ff8a8-9f17-436b-8290-1d4c3b7a8a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_2e8ff8a8-9f17-436b-8290-1d4c3b7a8a2f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_fc8a81f2-b0a9-472b-ae4d-daec4760fcdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_fc8a81f2-b0a9-472b-ae4d-daec4760fcdd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_d9d3f8a4-10a3-4a33-a5a7-e7fc21bd4cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_d9d3f8a4-10a3-4a33-a5a7-e7fc21bd4cb1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_4ebc6f46-313d-47dd-b54e-13bd824075f2" xlink:href="dxcm-20201231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_4ebc6f46-313d-47dd-b54e-13bd824075f2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f84257c9-008f-44bb-abef-ba64028ea841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f84257c9-008f-44bb-abef-ba64028ea841" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_0e023ee9-1c2d-46c3-87c8-8867e109c05d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_0e023ee9-1c2d-46c3-87c8-8867e109c05d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_69dedbea-36c7-4e03-9929-673280c77be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_69dedbea-36c7-4e03-9929-673280c77be0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_23b389ce-9b5d-4116-b2a2-4addce651413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_23b389ce-9b5d-4116-b2a2-4addce651413" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_68ec6604-efef-441b-b3d8-b96e8e131d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_68ec6604-efef-441b-b3d8-b96e8e131d1f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e66df650-6e37-4166-b139-9d8de36b9c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e66df650-6e37-4166-b139-9d8de36b9c23" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_817f836f-6080-415f-b2f6-e12bc5f596ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_NetIncomeLoss_817f836f-6080-415f-b2f6-e12bc5f596ec" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5c4274e1-f636-406e-85d5-94b3c8b47b50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5c4274e1-f636-406e-85d5-94b3c8b47b50" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2fbef799-0e95-4ae0-86fc-8ffc1d60f30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c04f7751-e948-4e36-b0d4-4e8bf5e4437c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8f798994-1c96-492a-aba6-709151d2daf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3eeeecd6-fd27-4988-9962-1087af9c3c22" xlink:to="loc_us-gaap_StatementTable_8f798994-1c96-492a-aba6-709151d2daf5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_753653f6-c509-4ef9-aedb-b63024ebcd67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8f798994-1c96-492a-aba6-709151d2daf5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_753653f6-c509-4ef9-aedb-b63024ebcd67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_753653f6-c509-4ef9-aedb-b63024ebcd67_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_753653f6-c509-4ef9-aedb-b63024ebcd67" xlink:to="loc_us-gaap_EquityComponentDomain_753653f6-c509-4ef9-aedb-b63024ebcd67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_753653f6-c509-4ef9-aedb-b63024ebcd67" xlink:to="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d9a69f67-01ff-4508-94ff-b89c32d0652f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_CommonStockMember_d9a69f67-01ff-4508-94ff-b89c32d0652f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_08762ac0-73a9-44b1-b1ae-d030d405da65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_08762ac0-73a9-44b1-b1ae-d030d405da65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af7aed21-eba3-491e-8ae6-b39d2be08fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af7aed21-eba3-491e-8ae6-b39d2be08fdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ccac9f72-2d39-48d7-9f25-cf502fee1783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_RetainedEarningsMember_ccac9f72-2d39-48d7-9f25-cf502fee1783" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e261cae5-40be-4a14-983e-d92266c162f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_TreasuryStockMember_e261cae5-40be-4a14-983e-d92266c162f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_34cd8425-423f-4a19-acd4-6e2274255ac8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8f798994-1c96-492a-aba6-709151d2daf5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_34cd8425-423f-4a19-acd4-6e2274255ac8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_34cd8425-423f-4a19-acd4-6e2274255ac8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_34cd8425-423f-4a19-acd4-6e2274255ac8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_34cd8425-423f-4a19-acd4-6e2274255ac8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_28577f3c-856f-456f-8378-5b312c6beeb6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_34cd8425-423f-4a19-acd4-6e2274255ac8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_28577f3c-856f-456f-8378-5b312c6beeb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1c6a5b7e-97b4-4b47-b845-36950667fb06" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_28577f3c-856f-456f-8378-5b312c6beeb6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1c6a5b7e-97b4-4b47-b845-36950667fb06" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="iceedee4120194b589b7956bf8497f954_ConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="extended" id="i89534f909b1f44fd84f4c3a35510b282_OrganizationandSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="extended" id="ia730156c71d24c01878eee23d33ecd8c_OrganizationandSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="extended" id="i8918076a31bb4f509989ac955c12978f_OrganizationandSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i9a639470b04948239e02d506c3f788e5_OrganizationandSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:href="dxcm-20201231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_b4fe4674-556c-46c4-9972-7e43a9afe322" xlink:href="dxcm-20201231.xsd#dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_b4fe4674-556c-46c4-9972-7e43a9afe322" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_697a6719-be01-47f5-9b32-b1c71a1942cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_697a6719-be01-47f5-9b32-b1c71a1942cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d0bd053d-2495-4d51-86fc-52559f2cdbb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d0bd053d-2495-4d51-86fc-52559f2cdbb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_006637d6-704e-45c2-a6ff-fe344bf90104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_006637d6-704e-45c2-a6ff-fe344bf90104" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_2ce170a2-25fb-431a-b8fd-ed98e3367777" xlink:href="dxcm-20201231.xsd#dxcm_RevenueRecognitionSalesReturnsCoveragePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_2ce170a2-25fb-431a-b8fd-ed98e3367777" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_d83e5b55-582d-414b-a398-c770308a7b93" xlink:href="dxcm-20201231.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_d83e5b55-582d-414b-a398-c770308a7b93" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_16515fa5-ab4c-41bb-82f7-20dfe7cbc7fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_UnbilledContractsReceivable_16515fa5-ab4c-41bb-82f7-20dfe7cbc7fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d7e258d0-8933-45ae-8834-9a3fe21bf103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d7e258d0-8933-45ae-8834-9a3fe21bf103" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_5329980b-9642-4eff-88aa-b0571e49580c" xlink:href="dxcm-20201231.xsd#dxcm_AmortizationPeriodForIncentiveCompensationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_5329980b-9642-4eff-88aa-b0571e49580c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_7e518f68-450b-42bc-8626-08f1ada3bb9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_AdvertisingExpense_7e518f68-450b-42bc-8626-08f1ada3bb9a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_8de61422-ba71-4596-9ae2-3201abb10124" xlink:href="dxcm-20201231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_8de61422-ba71-4596-9ae2-3201abb10124" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7516f7a4-067a-4382-aab7-624c6b0c00c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_8de61422-ba71-4596-9ae2-3201abb10124" xlink:to="loc_srt_RangeAxis_7516f7a4-067a-4382-aab7-624c6b0c00c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7516f7a4-067a-4382-aab7-624c6b0c00c5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7516f7a4-067a-4382-aab7-624c6b0c00c5" xlink:to="loc_srt_RangeMember_7516f7a4-067a-4382-aab7-624c6b0c00c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db9770cd-46cc-413e-9cc7-48676d06eff7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7516f7a4-067a-4382-aab7-624c6b0c00c5" xlink:to="loc_srt_RangeMember_db9770cd-46cc-413e-9cc7-48676d06eff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f1a22a44-d1d0-4b6c-8a92-f806e99646e2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db9770cd-46cc-413e-9cc7-48676d06eff7" xlink:to="loc_srt_MinimumMember_f1a22a44-d1d0-4b6c-8a92-f806e99646e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0efa10d3-14ef-4885-b8fd-6197fe22a512" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db9770cd-46cc-413e-9cc7-48676d06eff7" xlink:to="loc_srt_MaximumMember_0efa10d3-14ef-4885-b8fd-6197fe22a512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_da5af5e5-7fb3-40de-b4a4-8cb731d24afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_8de61422-ba71-4596-9ae2-3201abb10124" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_da5af5e5-7fb3-40de-b4a4-8cb731d24afa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da5af5e5-7fb3-40de-b4a4-8cb731d24afa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_da5af5e5-7fb3-40de-b4a4-8cb731d24afa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da5af5e5-7fb3-40de-b4a4-8cb731d24afa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_da5af5e5-7fb3-40de-b4a4-8cb731d24afa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_51223665-d237-4b6d-ac81-a88c7a166727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:to="loc_us-gaap_ComputerEquipmentMember_51223665-d237-4b6d-ac81-a88c7a166727" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_bc688d6e-8062-43dd-8099-44b2ffc3ea8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_bc688d6e-8062-43dd-8099-44b2ffc3ea8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_74efc3d0-cf35-4a1d-b2a3-50f22deb38b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_74efc3d0-cf35-4a1d-b2a3-50f22deb38b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_e5ca5b7d-4db0-4a6c-b9bd-14c4c0b6435b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:to="loc_us-gaap_BuildingMember_e5ca5b7d-4db0-4a6c-b9bd-14c4c0b6435b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails" xlink:type="extended" id="i877696e6000547e6a349bdcc2b66f0b8_OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_cc959112-368c-40bb-b701-b2b630975cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ee48a7b8-a346-44e8-bf78-9ba781345e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cc959112-368c-40bb-b701-b2b630975cb0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ee48a7b8-a346-44e8-bf78-9ba781345e08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_7a9ed2e7-3a4a-4e78-9b62-a1ff6cac6b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cc959112-368c-40bb-b701-b2b630975cb0" xlink:to="loc_us-gaap_ConcentrationRiskTable_7a9ed2e7-3a4a-4e78-9b62-a1ff6cac6b6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4dc0df3-9639-4481-b513-008722ca9884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_7a9ed2e7-3a4a-4e78-9b62-a1ff6cac6b6f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4dc0df3-9639-4481-b513-008722ca9884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c4dc0df3-9639-4481-b513-008722ca9884_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4dc0df3-9639-4481-b513-008722ca9884" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c4dc0df3-9639-4481-b513-008722ca9884_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b70fd8a9-9574-40c5-b954-bcfba21b7145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4dc0df3-9639-4481-b513-008722ca9884" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b70fd8a9-9574-40c5-b954-bcfba21b7145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_0dac5338-270e-43f5-b4d2-d667edbc1248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b70fd8a9-9574-40c5-b954-bcfba21b7145" xlink:to="loc_us-gaap_SalesRevenueNetMember_0dac5338-270e-43f5-b4d2-d667edbc1248" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_a1ec6f51-48ea-4a1e-804b-47efa9a15a1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b70fd8a9-9574-40c5-b954-bcfba21b7145" xlink:to="loc_us-gaap_AccountsReceivableMember_a1ec6f51-48ea-4a1e-804b-47efa9a15a1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d8e6b167-48b2-49f9-b457-7282fab3780f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_7a9ed2e7-3a4a-4e78-9b62-a1ff6cac6b6f" xlink:to="loc_srt_MajorCustomersAxis_d8e6b167-48b2-49f9-b457-7282fab3780f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d8e6b167-48b2-49f9-b457-7282fab3780f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_d8e6b167-48b2-49f9-b457-7282fab3780f" xlink:to="loc_srt_NameOfMajorCustomerDomain_d8e6b167-48b2-49f9-b457-7282fab3780f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_d8e6b167-48b2-49f9-b457-7282fab3780f" xlink:to="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerAMember_868a39ab-ced5-40c5-bafa-6425c918c382" xlink:href="dxcm-20201231.xsd#dxcm_CustomerAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:to="loc_dxcm_CustomerAMember_868a39ab-ced5-40c5-bafa-6425c918c382" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerBMember_243e8225-c4bd-4c8d-863b-678cb56dae31" xlink:href="dxcm-20201231.xsd#dxcm_CustomerBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:to="loc_dxcm_CustomerBMember_243e8225-c4bd-4c8d-863b-678cb56dae31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerCMember_d0b511e5-ce55-4494-892c-6678a1d7d5c3" xlink:href="dxcm-20201231.xsd#dxcm_CustomerCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:to="loc_dxcm_CustomerCMember_d0b511e5-ce55-4494-892c-6678a1d7d5c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerDMember_25953ce3-aa2c-4fb3-b73b-dd65578abb16" xlink:href="dxcm-20201231.xsd#dxcm_CustomerDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:to="loc_dxcm_CustomerDMember_25953ce3-aa2c-4fb3-b73b-dd65578abb16" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended" id="ifaa6556151924253be6407c35857ffd8_OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_20d6f4c7-8f96-420e-b486-e5e3416905f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_NetIncomeLoss_20d6f4c7-8f96-420e-b486-e5e3416905f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_27bc140d-939a-4f76-ba5a-d257d7db71ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_EarningsPerShareBasic_27bc140d-939a-4f76-ba5a-d257d7db71ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_52874e42-3e79-446e-bb93-5c9bc864edea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_52874e42-3e79-446e-bb93-5c9bc864edea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9ac12086-9b6d-4880-9f99-c695ecd92f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9ac12086-9b6d-4880-9f99-c695ecd92f46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_083bae99-9f41-480c-8639-2e4df2618c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_083bae99-9f41-480c-8639-2e4df2618c17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e4d32ff4-0fb2-4f1a-b43d-afd0ff631034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e4d32ff4-0fb2-4f1a-b43d-afd0ff631034" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8bcce8ae-b883-4eb6-9121-ebf7efb1a51a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8bcce8ae-b883-4eb6-9121-ebf7efb1a51a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e83b048d-5a55-4ed6-80d2-1d9c71131a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8bcce8ae-b883-4eb6-9121-ebf7efb1a51a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e83b048d-5a55-4ed6-80d2-1d9c71131a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e83b048d-5a55-4ed6-80d2-1d9c71131a35_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e83b048d-5a55-4ed6-80d2-1d9c71131a35" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e83b048d-5a55-4ed6-80d2-1d9c71131a35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e83b048d-5a55-4ed6-80d2-1d9c71131a35" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5cb6bd6f-9fe2-4d5d-a495-35a7f3d6c14b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5cb6bd6f-9fe2-4d5d-a495-35a7f3d6c14b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_91bb3f48-0258-43ef-9ad7-e0e2ebe20c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_91bb3f48-0258-43ef-9ad7-e0e2ebe20c7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_94f08a9a-759e-4540-bb61-a335ca34fcd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:to="loc_us-gaap_WarrantMember_94f08a9a-759e-4540-bb61-a335ca34fcd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_55a1c560-4f2f-46a2-9e4f-ec2fe06189a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_55a1c560-4f2f-46a2-9e4f-ec2fe06189a6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails" xlink:type="extended" id="i142a780de810496d896f439a25bee657_OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3d133426-0e39-49c2-8593-e4ade5802f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f0d8e03c-83ac-4d54-8712-4591945aaeed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3d133426-0e39-49c2-8593-e4ade5802f16" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f0d8e03c-83ac-4d54-8712-4591945aaeed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_781e59b9-3c67-4ad2-ba9c-f491dd3496ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3d133426-0e39-49c2-8593-e4ade5802f16" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_781e59b9-3c67-4ad2-ba9c-f491dd3496ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_805c8f9a-9c8e-44af-8805-86f73c5ca289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_781e59b9-3c67-4ad2-ba9c-f491dd3496ea" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_805c8f9a-9c8e-44af-8805-86f73c5ca289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_805c8f9a-9c8e-44af-8805-86f73c5ca289_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_805c8f9a-9c8e-44af-8805-86f73c5ca289" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_805c8f9a-9c8e-44af-8805-86f73c5ca289_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_805c8f9a-9c8e-44af-8805-86f73c5ca289" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c1a12800-bb0a-41bf-8a9b-2e15f10b8a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c1a12800-bb0a-41bf-8a9b-2e15f10b8a1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_aefbd355-9b3c-4abf-9bdc-ed9765074b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_aefbd355-9b3c-4abf-9bdc-ed9765074b27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_38d4580d-ec61-475b-bbdd-a5f809b2d7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:to="loc_us-gaap_WarrantMember_38d4580d-ec61-475b-bbdd-a5f809b2d7ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_4cdd9b58-1794-44b9-9f42-e7d5066c72b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_4cdd9b58-1794-44b9-9f42-e7d5066c72b6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DevelopmentandOtherAgreements"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="extended" id="ied1183557c984b7eb2d9eae90f6268af_DevelopmentandOtherAgreements"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DevelopmentandOtherAgreementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails" xlink:type="extended" id="i3333625ea9ab428e88d02040d5f94e38_DevelopmentandOtherAgreementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:href="dxcm-20201231.xsd#dxcm_DevelopmentAgreementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_f12ac472-1d17-44a0-a3db-fbcee8b921cd" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_f12ac472-1d17-44a0-a3db-fbcee8b921cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e950df04-ec04-4082-b520-04f9c44ae239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e950df04-ec04-4082-b520-04f9c44ae239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_186a75ab-587b-4aae-81d0-a4bc58874825" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_186a75ab-587b-4aae-81d0-a4bc58874825" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_acd61456-9061-48de-8394-a17393fd2726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_us-gaap_SharePrice_acd61456-9061-48de-8394-a17393fd2726" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_7557ffac-ab0f-4b6d-840a-5b9fa43ed0c4" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_7557ffac-ab0f-4b6d-840a-5b9fa43ed0c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_0abc89c6-7c3f-4eaa-91dd-c5a06339598f" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_0abc89c6-7c3f-4eaa-91dd-c5a06339598f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_5dd2a78c-9000-48d2-a9d1-46b1eb270e2c" xlink:href="dxcm-20201231.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_5dd2a78c-9000-48d2-a9d1-46b1eb270e2c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_0411359c-b86c-4eed-8b6d-86f1cd5c3e65" xlink:href="dxcm-20201231.xsd#dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_0411359c-b86c-4eed-8b6d-86f1cd5c3e65" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:href="dxcm-20201231.xsd#dxcm_DevelopmentAgreementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_cd6433e0-8be9-4f5a-b6f7-91b5a5c99de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_cd6433e0-8be9-4f5a-b6f7-91b5a5c99de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cd6433e0-8be9-4f5a-b6f7-91b5a5c99de7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_cd6433e0-8be9-4f5a-b6f7-91b5a5c99de7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cd6433e0-8be9-4f5a-b6f7-91b5a5c99de7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0c7c1681-7360-49f7-8829-aa782a695ee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_cd6433e0-8be9-4f5a-b6f7-91b5a5c99de7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0c7c1681-7360-49f7-8829-aa782a695ee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_19463a49-52a5-4375-b49d-a0a7748fed19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0c7c1681-7360-49f7-8829-aa782a695ee7" xlink:to="loc_us-gaap_CollaborativeArrangementMember_19463a49-52a5-4375-b49d-a0a7748fed19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_4cdfe930-6289-421a-9747-850c6bb0bd33" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:to="loc_srt_CounterpartyNameAxis_4cdfe930-6289-421a-9747-850c6bb0bd33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4cdfe930-6289-421a-9747-850c6bb0bd33_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_4cdfe930-6289-421a-9747-850c6bb0bd33" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4cdfe930-6289-421a-9747-850c6bb0bd33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fdc58467-ab43-40ee-93be-ea7702b2db0d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_4cdfe930-6289-421a-9747-850c6bb0bd33" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fdc58467-ab43-40ee-93be-ea7702b2db0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_e09ce99d-0514-4eb0-a4da-8328ee455bfc" xlink:href="dxcm-20201231.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fdc58467-ab43-40ee-93be-ea7702b2db0d" xlink:to="loc_dxcm_VerilyLifeSciencesMember_e09ce99d-0514-4eb0-a4da-8328ee455bfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6e7f5976-bc81-4cf7-bcf1-b0df7dc2e577" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6e7f5976-bc81-4cf7-bcf1-b0df7dc2e577" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_6e7f5976-bc81-4cf7-bcf1-b0df7dc2e577_default" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6e7f5976-bc81-4cf7-bcf1-b0df7dc2e577" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_6e7f5976-bc81-4cf7-bcf1-b0df7dc2e577_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_24e96c45-c117-4f44-b670-29877b86568b" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6e7f5976-bc81-4cf7-bcf1-b0df7dc2e577" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_24e96c45-c117-4f44-b670-29877b86568b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_d3dac385-3ad4-4cbd-a67f-1ee4e116f094" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_24e96c45-c117-4f44-b670-29877b86568b" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_d3dac385-3ad4-4cbd-a67f-1ee4e116f094" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_64046102-4a8b-42f8-b13e-f97c35dc0aef" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_24e96c45-c117-4f44-b670-29877b86568b" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_64046102-4a8b-42f8-b13e-f97c35dc0aef" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="extended" id="i93f53445dca34f02ab61e1de2b4cbc7a_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i8703641abf894cc9b7027dd4127f5ee8_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails" xlink:type="extended" id="ie6107d9ae24b4137bdff795027dbabc0_FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_5d1d9b09-d55c-49d5-a071-4f7904e28f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_5d1d9b09-d55c-49d5-a071-4f7904e28f36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_145e3bd0-d855-45b4-bee0-4a8d6728e13e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_145e3bd0-d855-45b4-bee0-4a8d6728e13e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_d5a60c45-150a-4238-a035-0d6b1d35900e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_d5a60c45-150a-4238-a035-0d6b1d35900e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6a634bc1-9886-424b-9a27-9f672bca9d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6a634bc1-9886-424b-9a27-9f672bca9d5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_df8e4248-adaf-487d-88c7-e8e08bb8205b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_df8e4248-adaf-487d-88c7-e8e08bb8205b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d03c8eef-fece-4036-9a6f-6892979efb0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_df8e4248-adaf-487d-88c7-e8e08bb8205b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d03c8eef-fece-4036-9a6f-6892979efb0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d03c8eef-fece-4036-9a6f-6892979efb0d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d03c8eef-fece-4036-9a6f-6892979efb0d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d03c8eef-fece-4036-9a6f-6892979efb0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d03c8eef-fece-4036-9a6f-6892979efb0d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3028bb71-9cd9-4759-93ed-633b9bb25c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3028bb71-9cd9-4759-93ed-633b9bb25c15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9ed4f51f-b9f3-43d7-9434-b17fdd51bc76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:to="loc_us-gaap_CommercialPaperMember_9ed4f51f-b9f3-43d7-9434-b17fdd51bc76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a5496550-41c8-4937-9613-3e2cd9f21f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a5496550-41c8-4937-9613-3e2cd9f21f99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b80451e4-c717-4aeb-9687-6d1bcaf3b465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_df8e4248-adaf-487d-88c7-e8e08bb8205b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b80451e4-c717-4aeb-9687-6d1bcaf3b465" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b80451e4-c717-4aeb-9687-6d1bcaf3b465_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b80451e4-c717-4aeb-9687-6d1bcaf3b465" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b80451e4-c717-4aeb-9687-6d1bcaf3b465_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b80451e4-c717-4aeb-9687-6d1bcaf3b465" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_77c7d997-0a33-4f9a-bbc7-ef2e88a229c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_77c7d997-0a33-4f9a-bbc7-ef2e88a229c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1254ee36-45a7-4ee2-9df2-2b4b1ef29dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1254ee36-45a7-4ee2-9df2-2b4b1ef29dad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d8b196f1-a7b6-4cc6-9a57-b1440ee520a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d8b196f1-a7b6-4cc6-9a57-b1440ee520a4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i0258889db1ba4e22a975b58a03de43fd_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_124eafec-5f33-44d4-8a66-d08cac0b7e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:to="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_124eafec-5f33-44d4-8a66-d08cac0b7e09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_b2b8f2d9-cef6-4e4c-80b7-2aa5d4374aed" xlink:href="dxcm-20201231.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_b2b8f2d9-cef6-4e4c-80b7-2aa5d4374aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cfb6fbf0-ea95-4073-9423-2f5d27638051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cfb6fbf0-ea95-4073-9423-2f5d27638051" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_09af5928-4e8a-4f7f-acc6-81b888a7448f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_09af5928-4e8a-4f7f-acc6-81b888a7448f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9be4652d-b595-428b-950b-d304e8783ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9be4652d-b595-428b-950b-d304e8783ddf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d4d99af7-de6a-4e05-8c19-2ed43abfde54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9be4652d-b595-428b-950b-d304e8783ddf" xlink:to="loc_us-gaap_HedgingDesignationAxis_d4d99af7-de6a-4e05-8c19-2ed43abfde54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d4d99af7-de6a-4e05-8c19-2ed43abfde54_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d4d99af7-de6a-4e05-8c19-2ed43abfde54" xlink:to="loc_us-gaap_HedgingDesignationDomain_d4d99af7-de6a-4e05-8c19-2ed43abfde54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ce8a8fdd-5722-4fef-a185-5c7a5815f6c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d4d99af7-de6a-4e05-8c19-2ed43abfde54" xlink:to="loc_us-gaap_HedgingDesignationDomain_ce8a8fdd-5722-4fef-a185-5c7a5815f6c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_779fe796-430a-401a-bdf0-da5bbd5e437f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ce8a8fdd-5722-4fef-a185-5c7a5815f6c4" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_779fe796-430a-401a-bdf0-da5bbd5e437f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3eec09a0-c1e7-4c55-aea6-3fedba95e3bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9be4652d-b595-428b-950b-d304e8783ddf" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3eec09a0-c1e7-4c55-aea6-3fedba95e3bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3eec09a0-c1e7-4c55-aea6-3fedba95e3bc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3eec09a0-c1e7-4c55-aea6-3fedba95e3bc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3eec09a0-c1e7-4c55-aea6-3fedba95e3bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_622060f6-a013-4a57-b2a7-98e3c00a687f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3eec09a0-c1e7-4c55-aea6-3fedba95e3bc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_622060f6-a013-4a57-b2a7-98e3c00a687f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_12ab07ec-8924-4707-9a84-ff58d2203864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_622060f6-a013-4a57-b2a7-98e3c00a687f" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_12ab07ec-8924-4707-9a84-ff58d2203864" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails" xlink:type="extended" id="if18b6197a3d34a60a3be7eeb03993d77_FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a58bf347-6d11-4c80-aa2a-df62d40b00eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_702ae15d-c24c-4379-b0dd-2ab013b069bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a58bf347-6d11-4c80-aa2a-df62d40b00eb" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_702ae15d-c24c-4379-b0dd-2ab013b069bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c15af2f6-e55e-4ab1-8b6c-a46ea60a8463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a58bf347-6d11-4c80-aa2a-df62d40b00eb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c15af2f6-e55e-4ab1-8b6c-a46ea60a8463" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_88eb8b32-982f-4f31-bbed-426537dba54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c15af2f6-e55e-4ab1-8b6c-a46ea60a8463" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_88eb8b32-982f-4f31-bbed-426537dba54a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_88eb8b32-982f-4f31-bbed-426537dba54a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_88eb8b32-982f-4f31-bbed-426537dba54a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_88eb8b32-982f-4f31-bbed-426537dba54a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a6343a7e-5ac6-4bab-b3e9-1c2b407d285a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_88eb8b32-982f-4f31-bbed-426537dba54a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a6343a7e-5ac6-4bab-b3e9-1c2b407d285a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0edc4843-0f6b-4386-9ab8-d786e966ca0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a6343a7e-5ac6-4bab-b3e9-1c2b407d285a" xlink:to="loc_us-gaap_SeniorNotesMember_0edc4843-0f6b-4386-9ab8-d786e966ca0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9d89ba79-b76c-4e34-84a6-4d442adc72e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c15af2f6-e55e-4ab1-8b6c-a46ea60a8463" xlink:to="loc_us-gaap_DebtInstrumentAxis_9d89ba79-b76c-4e34-84a6-4d442adc72e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9d89ba79-b76c-4e34-84a6-4d442adc72e4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9d89ba79-b76c-4e34-84a6-4d442adc72e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9d89ba79-b76c-4e34-84a6-4d442adc72e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9d89ba79-b76c-4e34-84a6-4d442adc72e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_e675c82d-7c3f-4342-88c7-cb8e0a42eb41" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_e675c82d-7c3f-4342-88c7-cb8e0a42eb41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_85382726-c5bb-4706-a87d-317934bde8f6" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_85382726-c5bb-4706-a87d-317934bde8f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_4a6b1873-0a29-4af3-990b-1cd7794b32b6" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_4a6b1873-0a29-4af3-990b-1cd7794b32b6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="extended" id="idda102fa62c04a368e63f764b65e3c66_BalanceSheetDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsTables"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="extended" id="ibc93234d27a94da1adb94c65020ecec1_BalanceSheetDetailsTables"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails" xlink:type="extended" id="i0c13ce690cbe409a81b309abdb09aa59_BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:href="dxcm-20201231.xsd#dxcm_FinancialStatementDetailsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_18402f72-6d89-404e-b0d8-5ca8285e0526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_18402f72-6d89-404e-b0d8-5ca8285e0526" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b300c59f-61e6-4be1-b48c-1b1b211e3e1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b300c59f-61e6-4be1-b48c-1b1b211e3e1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3b30d772-7c80-479a-9bee-c040d13695db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3b30d772-7c80-479a-9bee-c040d13695db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_09aaa945-5b71-44d6-8ce3-8ffa0b17ae7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_09aaa945-5b71-44d6-8ce3-8ffa0b17ae7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FinancialStatementDetailsTable_78fbd9e7-7fc8-46a2-a4c9-1df0c4a5368f" xlink:href="dxcm-20201231.xsd#dxcm_FinancialStatementDetailsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:to="loc_dxcm_FinancialStatementDetailsTable_78fbd9e7-7fc8-46a2-a4c9-1df0c4a5368f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_bae668e5-4cd8-4520-822f-dc42448eb1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_FinancialStatementDetailsTable_78fbd9e7-7fc8-46a2-a4c9-1df0c4a5368f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_bae668e5-4cd8-4520-822f-dc42448eb1d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bae668e5-4cd8-4520-822f-dc42448eb1d3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bae668e5-4cd8-4520-822f-dc42448eb1d3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bae668e5-4cd8-4520-822f-dc42448eb1d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bae668e5-4cd8-4520-822f-dc42448eb1d3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_4cdd0644-27ea-44b5-8704-4436de44a0a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_4cdd0644-27ea-44b5-8704-4436de44a0a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6211d20f-9b53-430f-884a-bf062a5400cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:to="loc_us-gaap_CommercialPaperMember_6211d20f-9b53-430f-884a-bf062a5400cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_861305b2-127b-44d1-8300-6cdda2189e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_861305b2-127b-44d1-8300-6cdda2189e0e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="extended" id="iebe55f5f4d77434d96013fe74b9393a6_BalanceSheetDetailsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_859e2a16-42b4-4084-ad30-bfd4d6d57114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_859e2a16-42b4-4084-ad30-bfd4d6d57114" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_2e01893d-9ff2-4bf5-9aba-aa7f301f8c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:to="loc_us-gaap_InventoryWriteDown_2e01893d-9ff2-4bf5-9aba-aa7f301f8c79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9e8a8e1f-c85a-4d18-b542-71ddc7802b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:to="loc_us-gaap_Depreciation_9e8a8e1f-c85a-4d18-b542-71ddc7802b8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b87a53a4-7cf8-4e18-95d9-6f166eff0cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b87a53a4-7cf8-4e18-95d9-6f166eff0cff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_1f724236-fe53-49d9-a5f2-be1e144dc01c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_1f724236-fe53-49d9-a5f2-be1e144dc01c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_67e98ad4-97be-47c2-9458-9bee52075523" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_1f724236-fe53-49d9-a5f2-be1e144dc01c" xlink:to="loc_srt_ProductOrServiceAxis_67e98ad4-97be-47c2-9458-9bee52075523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_67e98ad4-97be-47c2-9458-9bee52075523_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_67e98ad4-97be-47c2-9458-9bee52075523" xlink:to="loc_srt_ProductsAndServicesDomain_67e98ad4-97be-47c2-9458-9bee52075523_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_49bfc2b1-c19b-4719-af8f-52e2685e4782" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_67e98ad4-97be-47c2-9458-9bee52075523" xlink:to="loc_srt_ProductsAndServicesDomain_49bfc2b1-c19b-4719-af8f-52e2685e4782" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ReceiverProductComponentMember_79766a92-f212-4384-9491-51b528aad3e9" xlink:href="dxcm-20201231.xsd#dxcm_ReceiverProductComponentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_49bfc2b1-c19b-4719-af8f-52e2685e4782" xlink:to="loc_dxcm_ReceiverProductComponentMember_79766a92-f212-4384-9491-51b528aad3e9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails" xlink:type="extended" id="i39f5d2ae80324c8cbea2a4ae299a2fd0_BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:type="extended" id="i32419fade001406eb31525b1015706f1_BalanceSheetDetailsAccountsReceivableDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsInventoryDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="extended" id="i0229348be1c44af8a2c050a0a7ec3348_BalanceSheetDetailsInventoryDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended" id="iaa3f0fd4295b4ff980dfa9ed0f9e4473_BalanceSheetDetailsPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_daf294bc-7c93-4574-a927-07f6a37ddab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_daf294bc-7c93-4574-a927-07f6a37ddab4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_837f0b63-dadf-41ef-b155-4eb622ba5fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_837f0b63-dadf-41ef-b155-4eb622ba5fae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_88e37b49-1c05-4101-a885-4ab78d591940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_88e37b49-1c05-4101-a885-4ab78d591940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c67c4bf6-bd4a-4f5c-851d-f86b9c0b3aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c67c4bf6-bd4a-4f5c-851d-f86b9c0b3aa0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f932c295-8710-431a-8425-43bdc58a114e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c67c4bf6-bd4a-4f5c-851d-f86b9c0b3aa0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f932c295-8710-431a-8425-43bdc58a114e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f932c295-8710-431a-8425-43bdc58a114e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f932c295-8710-431a-8425-43bdc58a114e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f932c295-8710-431a-8425-43bdc58a114e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f932c295-8710-431a-8425-43bdc58a114e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_563c53ba-a602-4cec-ad21-8ab9b30ea15e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_LandMember_563c53ba-a602-4cec-ad21-8ab9b30ea15e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_f33b9d2e-f3bc-4d27-b719-fba5edb223bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_BuildingMember_f33b9d2e-f3bc-4d27-b719-fba5edb223bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_4c28a5fc-c076-4f3d-929b-b4a0885a5e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_4c28a5fc-c076-4f3d-929b-b4a0885a5e44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_552e3e7b-113a-4c5d-b5c1-aa32f10876eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_ComputerEquipmentMember_552e3e7b-113a-4c5d-b5c1-aa32f10876eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_2b1f94d9-36c2-45a1-aead-735e2d5796b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_EquipmentMember_2b1f94d9-36c2-45a1-aead-735e2d5796b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_420b4fa6-6602-4750-af02-d8b0bb6fef2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_420b4fa6-6602-4750-af02-d8b0bb6fef2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_3a24caf9-456b-40fa-a5d0-89f19a6cdb36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_ConstructionInProgressMember_3a24caf9-456b-40fa-a5d0-89f19a6cdb36" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended" id="ied7848ef41bd41d4a5345a165ad43899_BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsAccruedWarrantyDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="extended" id="id426216a0f6a41778813c6b418078242_BalanceSheetDetailsAccruedWarrantyDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsOtherLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="extended" id="i62aede6aa5324aec95625a1679831800_BalanceSheetDetailsOtherLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt" xlink:type="simple" xlink:href="dxcm-20201231.xsd#Debt"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/Debt" xlink:type="extended" id="i672d938b99bd403699e3f94e1e55cb2f_Debt"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtTables"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtTables" xlink:type="extended" id="i04204b946e91466c8190d8ab06912fac_DebtTables"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended" id="id590b2a6610743bdbc20b11e632f4db3_DebtSeniorConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4db9eeb0-60c3-4521-9061-310dc204b2a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4db9eeb0-60c3-4521-9061-310dc204b2a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d176d577-e1f5-4e86-a520-36405f2edb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d176d577-e1f5-4e86-a520-36405f2edb67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_819574e3-5fc6-4b94-a807-531462435d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_819574e3-5fc6-4b94-a807-531462435d3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_db833025-5e6b-45a3-b82f-33c568c650b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_db833025-5e6b-45a3-b82f-33c568c650b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_c3da7750-7cd9-4192-8ae6-34adb88c1f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_c3da7750-7cd9-4192-8ae6-34adb88c1f25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_f687d622-9eb4-4cc0-8107-04096e5cc04e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_f687d622-9eb4-4cc0-8107-04096e5cc04e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fcbafdcb-c032-4510-afe3-449f72086c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:to="loc_us-gaap_DebtInstrumentTable_fcbafdcb-c032-4510-afe3-449f72086c82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2106f191-43c2-4107-9607-ae496c1804f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fcbafdcb-c032-4510-afe3-449f72086c82" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2106f191-43c2-4107-9607-ae496c1804f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2106f191-43c2-4107-9607-ae496c1804f6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2106f191-43c2-4107-9607-ae496c1804f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2106f191-43c2-4107-9607-ae496c1804f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bd5dd2e3-7ff3-4376-8e7f-b930898ad12b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2106f191-43c2-4107-9607-ae496c1804f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bd5dd2e3-7ff3-4376-8e7f-b930898ad12b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7f41c475-13e0-4089-9480-c0d0949ad9f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bd5dd2e3-7ff3-4376-8e7f-b930898ad12b" xlink:to="loc_us-gaap_SeniorNotesMember_7f41c475-13e0-4089-9480-c0d0949ad9f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_303ec871-0396-4b6d-8ba4-e945339f8211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fcbafdcb-c032-4510-afe3-449f72086c82" xlink:to="loc_us-gaap_DebtInstrumentAxis_303ec871-0396-4b6d-8ba4-e945339f8211" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_303ec871-0396-4b6d-8ba4-e945339f8211_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_303ec871-0396-4b6d-8ba4-e945339f8211" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_303ec871-0396-4b6d-8ba4-e945339f8211_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_303ec871-0396-4b6d-8ba4-e945339f8211" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_fca85079-c653-4123-85a7-15323f41c4ad" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_fca85079-c653-4123-85a7-15323f41c4ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_d766bc02-8b69-49dd-b91b-4afceae60a64" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_d766bc02-8b69-49dd-b91b-4afceae60a64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_a8e602c4-0b20-47e2-9731-a80b163b7e43" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_a8e602c4-0b20-47e2-9731-a80b163b7e43" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtConversionValueofConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="extended" id="i6c7ea582d8404e868d58d13bece63885_DebtConversionValueofConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_38f31e01-d1e7-4ef7-9014-66f9e6b71730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8d7fb39b-9efc-480a-8f87-bf19e814febb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_38f31e01-d1e7-4ef7-9014-66f9e6b71730" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8d7fb39b-9efc-480a-8f87-bf19e814febb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_706284e5-5baa-4b51-9e0c-1cd18c7ba944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_38f31e01-d1e7-4ef7-9014-66f9e6b71730" xlink:to="loc_us-gaap_DebtInstrumentTable_706284e5-5baa-4b51-9e0c-1cd18c7ba944" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_662dac8e-9ecc-48de-a800-4c854dbe36c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_706284e5-5baa-4b51-9e0c-1cd18c7ba944" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_662dac8e-9ecc-48de-a800-4c854dbe36c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_662dac8e-9ecc-48de-a800-4c854dbe36c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_662dac8e-9ecc-48de-a800-4c854dbe36c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_662dac8e-9ecc-48de-a800-4c854dbe36c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8df64ba8-b0c8-43eb-8bdf-c3f896315ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_662dac8e-9ecc-48de-a800-4c854dbe36c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8df64ba8-b0c8-43eb-8bdf-c3f896315ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c4113b85-7a1f-4950-bb78-c555f58397f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8df64ba8-b0c8-43eb-8bdf-c3f896315ef3" xlink:to="loc_us-gaap_SeniorNotesMember_c4113b85-7a1f-4950-bb78-c555f58397f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_84657638-2117-4c28-8395-6c440edaf622" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_706284e5-5baa-4b51-9e0c-1cd18c7ba944" xlink:to="loc_us-gaap_DebtInstrumentAxis_84657638-2117-4c28-8395-6c440edaf622" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_84657638-2117-4c28-8395-6c440edaf622_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_84657638-2117-4c28-8395-6c440edaf622" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_84657638-2117-4c28-8395-6c440edaf622_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_656ddb6b-123f-47b5-9f4b-388f1de736b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_84657638-2117-4c28-8395-6c440edaf622" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_656ddb6b-123f-47b5-9f4b-388f1de736b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_68f0bad7-13c0-4086-8697-6b4c36488549" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_656ddb6b-123f-47b5-9f4b-388f1de736b3" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_68f0bad7-13c0-4086-8697-6b4c36488549" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6bf7a53d-8824-4646-86bb-6ce370c9ef7c" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_656ddb6b-123f-47b5-9f4b-388f1de736b3" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6bf7a53d-8824-4646-86bb-6ce370c9ef7c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended" id="i5dbc535021b040a69e95eae5b5cf58d3_DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract_5f721a86-7f52-4a88-8ed8-f63ba46d704f" xlink:href="dxcm-20201231.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:to="loc_dxcm_CashInterestExpenseAbstract_5f721a86-7f52-4a88-8ed8-f63ba46d704f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_f0822617-768a-4e00-89e0-d1c368eb0cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_CashInterestExpenseAbstract_5f721a86-7f52-4a88-8ed8-f63ba46d704f" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_f0822617-768a-4e00-89e0-d1c368eb0cd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:href="dxcm-20201231.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:to="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_1caba485-5974-4cd2-b49e-4365d19c16a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_1caba485-5974-4cd2-b49e-4365d19c16a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_26bcc88a-5c9b-4f97-bc9a-dcc96c34c858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_26bcc88a-5c9b-4f97-bc9a-dcc96c34c858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_c21cb0b1-c9a9-4f07-9aaa-50766df83cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:to="loc_us-gaap_InterestExpenseDebt_c21cb0b1-c9a9-4f07-9aaa-50766df83cbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_73f6d44a-15fd-4e39-8c4f-ae4f5d3bf4d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_73f6d44a-15fd-4e39-8c4f-ae4f5d3bf4d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4743d95a-ce43-4af4-8bf9-b659042ede74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:to="loc_us-gaap_DebtInstrumentTable_4743d95a-ce43-4af4-8bf9-b659042ede74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d10d00cf-48a2-4e40-984f-99bb1b388810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4743d95a-ce43-4af4-8bf9-b659042ede74" xlink:to="loc_us-gaap_DebtInstrumentAxis_d10d00cf-48a2-4e40-984f-99bb1b388810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d10d00cf-48a2-4e40-984f-99bb1b388810_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d10d00cf-48a2-4e40-984f-99bb1b388810" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d10d00cf-48a2-4e40-984f-99bb1b388810_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d10d00cf-48a2-4e40-984f-99bb1b388810" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_0faab4f1-0dd4-47c4-b0a6-7788cc29435e" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_0faab4f1-0dd4-47c4-b0a6-7788cc29435e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_65758312-81a2-4bbc-b836-e9cdbddde442" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_65758312-81a2-4bbc-b836-e9cdbddde442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_dd3fd60a-a919-4d23-bc94-5d980f8a36ad" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_dd3fd60a-a919-4d23-bc94-5d980f8a36ad" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended" id="ia7ed13d034f5423696d918520f5f3192_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c2fce154-9e5a-4322-bd28-23d7e18b4244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c2fce154-9e5a-4322-bd28-23d7e18b4244" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c7cf8bb0-1336-4521-a6b4-a2edc280afcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c7cf8bb0-1336-4521-a6b4-a2edc280afcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_41fac7e6-c038-4376-974b-152de24919b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_41fac7e6-c038-4376-974b-152de24919b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6a3df72a-5031-4386-bdbb-32d901eb022d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6a3df72a-5031-4386-bdbb-32d901eb022d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_8f661ce2-2df0-4663-8f16-542c421f9de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_8f661ce2-2df0-4663-8f16-542c421f9de2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_8e635230-75c2-48be-b8a5-fe8d3bef99ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_8e635230-75c2-48be-b8a5-fe8d3bef99ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_e4131ff7-53db-4d01-88a6-f430462dd0c5" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_e4131ff7-53db-4d01-88a6-f430462dd0c5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b3e7f864-8b74-494c-91a1-8daf743e4d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b3e7f864-8b74-494c-91a1-8daf743e4d3d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6553fc08-3ca5-46e7-acca-6d2985ff703a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6553fc08-3ca5-46e7-acca-6d2985ff703a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_cdee8ee6-3672-4abd-b5f0-df3d40f03642" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_cdee8ee6-3672-4abd-b5f0-df3d40f03642" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5c87897e-6dd0-491b-a8a0-d411e28979ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5c87897e-6dd0-491b-a8a0-d411e28979ce" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes_464ed7f3-1dba-45a9-8f18-7fd372878e73" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsForRepurchaseOfConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes_464ed7f3-1dba-45a9-8f18-7fd372878e73" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4c5ece08-25e4-4f71-a1d0-674c25f990ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4c5ece08-25e4-4f71-a1d0-674c25f990ca" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised_032f3157-4b27-456c-91cd-89bc1bbf6578" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised_032f3157-4b27-456c-91cd-89bc1bbf6578" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a18147ff-3716-496e-975f-1600c6ea4080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a18147ff-3716-496e-975f-1600c6ea4080" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_08b2010e-1917-41f1-aacb-929677c7135b" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_08b2010e-1917-41f1-aacb-929677c7135b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5f0a828a-fa74-4f46-8b20-bad649abeaf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5f0a828a-fa74-4f46-8b20-bad649abeaf6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1c758157-92bb-4698-b0fc-c5e24f9ff49e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1c758157-92bb-4698-b0fc-c5e24f9ff49e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_381c0b23-44c6-4720-ab42-822c9324159b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_381c0b23-44c6-4720-ab42-822c9324159b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1d4145ab-60dc-4d99-ab26-4616b16d070e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1d4145ab-60dc-4d99-ab26-4616b16d070e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5fd6dbbc-8788-4d67-836d-a8d4170c10fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5fd6dbbc-8788-4d67-836d-a8d4170c10fa" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_af745178-4069-4c06-a33a-c33b2484af0e" xlink:href="dxcm-20201231.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_af745178-4069-4c06-a33a-c33b2484af0e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a04c62fc-1a05-44ae-949a-ca7af5e5222a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a04c62fc-1a05-44ae-949a-ca7af5e5222a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5f4d5e0c-3683-43ff-b2d7-f2e09ec52aef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5f4d5e0c-3683-43ff-b2d7-f2e09ec52aef" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_46b3f43f-1819-4e2d-a08c-4018733fe6a8" xlink:href="dxcm-20201231.xsd#dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_46b3f43f-1819-4e2d-a08c-4018733fe6a8" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_da47c330-b304-4207-b9a5-f47144e10e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_VariableRateAxis_da47c330-b304-4207-b9a5-f47144e10e62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_da47c330-b304-4207-b9a5-f47144e10e62_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_da47c330-b304-4207-b9a5-f47144e10e62" xlink:to="loc_us-gaap_VariableRateDomain_da47c330-b304-4207-b9a5-f47144e10e62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_89aac599-5051-495a-9d30-913a7983c1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_da47c330-b304-4207-b9a5-f47144e10e62" xlink:to="loc_us-gaap_VariableRateDomain_89aac599-5051-495a-9d30-913a7983c1b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6ff8c5e3-c5aa-41f0-8fcb-9542a6958d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_89aac599-5051-495a-9d30-913a7983c1b3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6ff8c5e3-c5aa-41f0-8fcb-9542a6958d88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_743f4b0d-c168-401f-b83d-22fafa8e4bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_HedgingDesignationAxis_743f4b0d-c168-401f-b83d-22fafa8e4bfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_743f4b0d-c168-401f-b83d-22fafa8e4bfa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_743f4b0d-c168-401f-b83d-22fafa8e4bfa" xlink:to="loc_us-gaap_HedgingDesignationDomain_743f4b0d-c168-401f-b83d-22fafa8e4bfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f4c9a57a-b757-4f86-a0cf-ce5dee222946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_743f4b0d-c168-401f-b83d-22fafa8e4bfa" xlink:to="loc_us-gaap_HedgingDesignationDomain_f4c9a57a-b757-4f86-a0cf-ce5dee222946" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0e791351-8583-4228-a542-1bcbb586d501" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f4c9a57a-b757-4f86-a0cf-ce5dee222946" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0e791351-8583-4228-a542-1bcbb586d501" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_52a7df97-39ab-4b38-8894-73abaad3192b" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_52a7df97-39ab-4b38-8894-73abaad3192b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_52a7df97-39ab-4b38-8894-73abaad3192b_default" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_52a7df97-39ab-4b38-8894-73abaad3192b" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_52a7df97-39ab-4b38-8894-73abaad3192b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_4320e924-78ea-40b2-a041-c8d78b827724" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_52a7df97-39ab-4b38-8894-73abaad3192b" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_4320e924-78ea-40b2-a041-c8d78b827724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_dc83b2e3-d1d6-4efa-81f3-e45ffa8658bb" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_4320e924-78ea-40b2-a041-c8d78b827724" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_dc83b2e3-d1d6-4efa-81f3-e45ffa8658bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_4b25c05c-e725-4042-95cd-35aecbbd9251" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_4320e924-78ea-40b2-a041-c8d78b827724" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_4b25c05c-e725-4042-95cd-35aecbbd9251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9f187bb-06b3-4774-84ab-9abc8e918095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9f187bb-06b3-4774-84ab-9abc8e918095" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d9f187bb-06b3-4774-84ab-9abc8e918095_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9f187bb-06b3-4774-84ab-9abc8e918095" xlink:to="loc_us-gaap_EquityComponentDomain_d9f187bb-06b3-4774-84ab-9abc8e918095_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_266a8c63-139c-4bdd-b30c-3b315d211933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9f187bb-06b3-4774-84ab-9abc8e918095" xlink:to="loc_us-gaap_EquityComponentDomain_266a8c63-139c-4bdd-b30c-3b315d211933" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6305b01b-5a71-4723-ac92-89469f1f139d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_266a8c63-139c-4bdd-b30c-3b315d211933" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6305b01b-5a71-4723-ac92-89469f1f139d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a705bad3-3e87-4db9-8ee1-b00b9cc0c42e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_266a8c63-139c-4bdd-b30c-3b315d211933" xlink:to="loc_us-gaap_CommonStockMember_a705bad3-3e87-4db9-8ee1-b00b9cc0c42e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_57d67781-2c44-4e5f-bbd2-e191441371a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_57d67781-2c44-4e5f-bbd2-e191441371a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_57d67781-2c44-4e5f-bbd2-e191441371a4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_57d67781-2c44-4e5f-bbd2-e191441371a4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_57d67781-2c44-4e5f-bbd2-e191441371a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9e49ef24-fc69-4cd5-a533-240eaa5b562f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_57d67781-2c44-4e5f-bbd2-e191441371a4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9e49ef24-fc69-4cd5-a533-240eaa5b562f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8a387c25-9bf1-49f9-8280-df939d10380c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e49ef24-fc69-4cd5-a533-240eaa5b562f" xlink:to="loc_us-gaap_SeniorNotesMember_8a387c25-9bf1-49f9-8280-df939d10380c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_6485b059-6219-419a-ab3e-e21da2480334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e49ef24-fc69-4cd5-a533-240eaa5b562f" xlink:to="loc_us-gaap_LineOfCreditMember_6485b059-6219-419a-ab3e-e21da2480334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e756ec0b-df17-4b4e-bdb2-bba643ae396f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_e756ec0b-df17-4b4e-bdb2-bba643ae396f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e756ec0b-df17-4b4e-bdb2-bba643ae396f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e756ec0b-df17-4b4e-bdb2-bba643ae396f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e756ec0b-df17-4b4e-bdb2-bba643ae396f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e756ec0b-df17-4b4e-bdb2-bba643ae396f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_c80297b6-a3fd-4fee-89b1-c93105d3a0ea" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_c80297b6-a3fd-4fee-89b1-c93105d3a0ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_93d55254-d758-445d-865e-f4520621ab26" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_93d55254-d758-445d-865e-f4520621ab26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_35c924bc-8a95-4157-b6a2-5ed2763344df" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_35c924bc-8a95-4157-b6a2-5ed2763344df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_079d580b-8d4c-480f-9e11-ee39fa194e7f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_srt_RangeAxis_079d580b-8d4c-480f-9e11-ee39fa194e7f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_079d580b-8d4c-480f-9e11-ee39fa194e7f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_079d580b-8d4c-480f-9e11-ee39fa194e7f" xlink:to="loc_srt_RangeMember_079d580b-8d4c-480f-9e11-ee39fa194e7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_606759f0-80ba-4b35-980f-5742e5afc383" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_079d580b-8d4c-480f-9e11-ee39fa194e7f" xlink:to="loc_srt_RangeMember_606759f0-80ba-4b35-980f-5742e5afc383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c3178d5a-37c8-4bf3-9006-cd008bcd0b7c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_606759f0-80ba-4b35-980f-5742e5afc383" xlink:to="loc_srt_MinimumMember_c3178d5a-37c8-4bf3-9006-cd008bcd0b7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3deb6072-bd15-4633-8789-2d000e0e9bbd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_606759f0-80ba-4b35-980f-5742e5afc383" xlink:to="loc_srt_MaximumMember_3deb6072-bd15-4633-8789-2d000e0e9bbd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="extended" id="i93474ad4a00b42e2985c0040b5ae4228_DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a5cb632-3e7f-4e86-9ba3-05ebc1399024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a5cb632-3e7f-4e86-9ba3-05ebc1399024" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_af78d74f-c250-4360-92c4-0ac0314efd49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:to="loc_us-gaap_LineOfCredit_af78d74f-c250-4360-92c4-0ac0314efd49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c18aba86-fdf3-45d7-8a60-12ec2eda5b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c18aba86-fdf3-45d7-8a60-12ec2eda5b53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_72c3ee60-d1b6-4d31-bd89-283876f4b39b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_72c3ee60-d1b6-4d31-bd89-283876f4b39b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c6178894-87db-4df4-aefb-bf617f0ff88b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c6178894-87db-4df4-aefb-bf617f0ff88b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ad91042e-4e38-447e-a3b2-32855cc65ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c6178894-87db-4df4-aefb-bf617f0ff88b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ad91042e-4e38-447e-a3b2-32855cc65ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ad91042e-4e38-447e-a3b2-32855cc65ad9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ad91042e-4e38-447e-a3b2-32855cc65ad9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ad91042e-4e38-447e-a3b2-32855cc65ad9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dbd7a1de-bd6e-406c-b963-2796f17f16ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ad91042e-4e38-447e-a3b2-32855cc65ad9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dbd7a1de-bd6e-406c-b963-2796f17f16ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_451372c4-6d92-4cc6-a76e-a0abf7133d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dbd7a1de-bd6e-406c-b963-2796f17f16ae" xlink:to="loc_us-gaap_LineOfCreditMember_451372c4-6d92-4cc6-a76e-a0abf7133d5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a9109742-3feb-418a-b30b-a600b0197277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c6178894-87db-4df4-aefb-bf617f0ff88b" xlink:to="loc_us-gaap_CreditFacilityAxis_a9109742-3feb-418a-b30b-a600b0197277" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a9109742-3feb-418a-b30b-a600b0197277_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a9109742-3feb-418a-b30b-a600b0197277" xlink:to="loc_us-gaap_CreditFacilityDomain_a9109742-3feb-418a-b30b-a600b0197277_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3b9c0fc2-1b7f-475e-b219-48e0b219d2b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a9109742-3feb-418a-b30b-a600b0197277" xlink:to="loc_us-gaap_CreditFacilityDomain_3b9c0fc2-1b7f-475e-b219-48e0b219d2b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_8b39f05a-27f1-4372-8b16-2ac15a0b2cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3b9c0fc2-1b7f-475e-b219-48e0b219d2b6" xlink:to="loc_us-gaap_LetterOfCreditMember_8b39f05a-27f1-4372-8b16-2ac15a0b2cbd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitments"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:type="extended" id="iec2f2e7b7b5542f88d196112db17beb7_LeasesAndOtherCommitments"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsTables"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:type="extended" id="i5c6155f16e624a4190587a572e0c04b1_LeasesAndOtherCommitmentsTables"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="extended" id="iab90e88221df43098ca000cba5b41d5b_LeasesAndOtherCommitmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1e67bafe-754f-466d-b76c-e89290be16df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1e67bafe-754f-466d-b76c-e89290be16df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_bd837673-84d9-439f-a148-155a9f56814d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_bd837673-84d9-439f-a148-155a9f56814d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c04e94c-26f3-4c43-9af3-d68845e622e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c04e94c-26f3-4c43-9af3-d68845e622e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fe9efc86-75b2-402f-ba28-7dbcf990b1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fe9efc86-75b2-402f-ba28-7dbcf990b1ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_d9aa34ce-3785-47cb-acfd-c3aa2592ee2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_d9aa34ce-3785-47cb-acfd-c3aa2592ee2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ad91d5d4-cd54-4d8e-a2b0-200913735969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_OperatingLeaseLiability_ad91d5d4-cd54-4d8e-a2b0-200913735969" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_83a746ba-3731-4e2c-a7b6-cc50cccdf7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_FinanceLeaseLiability_83a746ba-3731-4e2c-a7b6-cc50cccdf7f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_f4bc0521-0b45-4e08-99e2-51beae1f4b15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_AssetRetirementObligation_f4bc0521-0b45-4e08-99e2-51beae1f4b15" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_c960b49b-b83b-44d3-a138-16ef16c3b66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_LeaseAndRentalExpense_c960b49b-b83b-44d3-a138-16ef16c3b66f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_f18c50c0-38e0-4135-8081-cc46cc03b639" xlink:href="dxcm-20201231.xsd#dxcm_LesseeOperatingLeasesLeaseCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_f18c50c0-38e0-4135-8081-cc46cc03b639" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_70ba10d5-75c0-4c30-9fc3-0f6b9b355f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_70ba10d5-75c0-4c30-9fc3-0f6b9b355f50" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_68f0dd10-664d-4942-9ffc-102a8e9d559c" xlink:href="dxcm-20201231.xsd#dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_68f0dd10-664d-4942-9ffc-102a8e9d559c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_07318d96-3170-4b55-9743-7b20a316f619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_07318d96-3170-4b55-9743-7b20a316f619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_07318d96-3170-4b55-9743-7b20a316f619_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_07318d96-3170-4b55-9743-7b20a316f619" xlink:to="loc_us-gaap_EquityComponentDomain_07318d96-3170-4b55-9743-7b20a316f619_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a24c891a-ae18-48ca-8dda-4ef1909837d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_07318d96-3170-4b55-9743-7b20a316f619" xlink:to="loc_us-gaap_EquityComponentDomain_a24c891a-ae18-48ca-8dda-4ef1909837d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_af9ca316-9525-4e7f-979f-be7bb19bf4cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a24c891a-ae18-48ca-8dda-4ef1909837d0" xlink:to="loc_us-gaap_RetainedEarningsMember_af9ca316-9525-4e7f-979f-be7bb19bf4cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7d141b49-63e6-4330-acce-1e3d40138129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7d141b49-63e6-4330-acce-1e3d40138129" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7d141b49-63e6-4330-acce-1e3d40138129_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7d141b49-63e6-4330-acce-1e3d40138129" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7d141b49-63e6-4330-acce-1e3d40138129_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_24bdd5fd-03d8-4a84-9e2e-7f0ebdb8f0da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7d141b49-63e6-4330-acce-1e3d40138129" xlink:to="loc_us-gaap_TypeOfAdoptionMember_24bdd5fd-03d8-4a84-9e2e-7f0ebdb8f0da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_05a43526-5125-410a-9b59-962b87478efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_24bdd5fd-03d8-4a84-9e2e-7f0ebdb8f0da" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_05a43526-5125-410a-9b59-962b87478efe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bffc597a-d332-4423-bce8-d009a2d04648" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:to="loc_srt_RangeAxis_bffc597a-d332-4423-bce8-d009a2d04648" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bffc597a-d332-4423-bce8-d009a2d04648_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bffc597a-d332-4423-bce8-d009a2d04648" xlink:to="loc_srt_RangeMember_bffc597a-d332-4423-bce8-d009a2d04648_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_82bdd86d-f484-4c50-9493-89916950c498" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bffc597a-d332-4423-bce8-d009a2d04648" xlink:to="loc_srt_RangeMember_82bdd86d-f484-4c50-9493-89916950c498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d8a7f4dc-5b36-4b17-abfb-677349cb7ed7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_82bdd86d-f484-4c50-9493-89916950c498" xlink:to="loc_srt_MinimumMember_d8a7f4dc-5b36-4b17-abfb-677349cb7ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e6faa51b-2758-4832-b21c-607a371daae0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_82bdd86d-f484-4c50-9493-89916950c498" xlink:to="loc_srt_MaximumMember_e6faa51b-2758-4832-b21c-607a371daae0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30070bbd-6b1f-40fe-b208-b5e0d6cfbe0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30070bbd-6b1f-40fe-b208-b5e0d6cfbe0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_30070bbd-6b1f-40fe-b208-b5e0d6cfbe0c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30070bbd-6b1f-40fe-b208-b5e0d6cfbe0c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_30070bbd-6b1f-40fe-b208-b5e0d6cfbe0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0c34b842-fc15-4615-978a-41a2a5ce023f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30070bbd-6b1f-40fe-b208-b5e0d6cfbe0c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0c34b842-fc15-4615-978a-41a2a5ce023f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_50653d9b-4d15-4efd-aedc-10b70fb1bbd6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0c34b842-fc15-4615-978a-41a2a5ce023f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_50653d9b-4d15-4efd-aedc-10b70fb1bbd6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails" xlink:type="extended" id="id34c1ca7f8ef463e8ee423d20bf142d9_LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsLeaseCostDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="extended" id="iba5c8b3921d44a55a424aebed2c79024_LeasesAndOtherCommitmentsLeaseCostDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsOtherInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="extended" id="ieffca4bec1b34a0490130baa1a0b1149_LeasesAndOtherCommitmentsOtherInformationDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/Contingencies" xlink:type="simple" xlink:href="dxcm-20201231.xsd#Contingencies"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/Contingencies" xlink:type="extended" id="if3b79c8be2144b42b3e6c4ac6bd12391_Contingencies"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxes" xlink:type="extended" id="ib6bdc0af579a4e2d9f9cd442ea67f2f0_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="extended" id="ie9b81f3982fd4769b09af2f4d6ddf45b_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails" xlink:type="extended" id="i8ed45fd5fe67434e88876274dc906483_IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesComponentsofProvisionDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails" xlink:type="extended" id="i50f935e9bd9742dfb636854bccc7a0d1_IncomeTaxesComponentsofProvisionDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails" xlink:type="extended" id="idd15314ab32841a5ac1756fcd26de89b_IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_cb81e3a4-322b-4051-9782-8fc5cd150f8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_d28c57db-ea60-4457-aaf0-914fa051955d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cb81e3a4-322b-4051-9782-8fc5cd150f8d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_d28c57db-ea60-4457-aaf0-914fa051955d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_0c6ebb82-6c2a-4bc6-9707-dfa29c55825f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cb81e3a4-322b-4051-9782-8fc5cd150f8d" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_0c6ebb82-6c2a-4bc6-9707-dfa29c55825f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_6d491e04-f755-48e6-bb0a-8c559ed676fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cb81e3a4-322b-4051-9782-8fc5cd150f8d" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_6d491e04-f755-48e6-bb0a-8c559ed676fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_48ba90af-9f0a-479e-9906-837daa44410b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6d491e04-f755-48e6-bb0a-8c559ed676fd" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_48ba90af-9f0a-479e-9906-837daa44410b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_48ba90af-9f0a-479e-9906-837daa44410b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_48ba90af-9f0a-479e-9906-837daa44410b" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_48ba90af-9f0a-479e-9906-837daa44410b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_48ba90af-9f0a-479e-9906-837daa44410b" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_9b8058ec-32a2-4604-957f-4a4084c6cdfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:to="loc_us-gaap_DomesticCountryMember_9b8058ec-32a2-4604-957f-4a4084c6cdfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_af929991-9a2d-4d95-8f99-0a0cb4a6a6aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_af929991-9a2d-4d95-8f99-0a0cb4a6a6aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2b43a9f4-630e-4b50-bff7-64e58169c6bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:to="loc_us-gaap_ForeignCountryMember_2b43a9f4-630e-4b50-bff7-64e58169c6bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c2c7b352-199e-49e6-a377-87ba8cd6cf87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6d491e04-f755-48e6-bb0a-8c559ed676fd" xlink:to="loc_srt_StatementGeographicalAxis_c2c7b352-199e-49e6-a377-87ba8cd6cf87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c2c7b352-199e-49e6-a377-87ba8cd6cf87_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c2c7b352-199e-49e6-a377-87ba8cd6cf87" xlink:to="loc_srt_SegmentGeographicalDomain_c2c7b352-199e-49e6-a377-87ba8cd6cf87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c2c7b352-199e-49e6-a377-87ba8cd6cf87" xlink:to="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_992b4d3a-a348-4137-b430-746c163b439d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:to="loc_stpr_CA_992b4d3a-a348-4137-b430-746c163b439d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherStatesMember_1cf3d024-bfab-4157-8051-086885b39315" xlink:href="dxcm-20201231.xsd#dxcm_OtherStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:to="loc_dxcm_OtherStatesMember_1cf3d024-bfab-4157-8051-086885b39315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_dd80e340-bb1c-4616-9373-a15538d03692" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:to="loc_country_GB_dd80e340-bb1c-4616-9373-a15538d03692" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i242c519d151342e0b4817b5f70c32e85_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ResearchAndDevelopmentTaxCreditsUtilized_41cb579b-3223-4b10-938c-5fe6a17e240a" xlink:href="dxcm-20201231.xsd#dxcm_ResearchAndDevelopmentTaxCreditsUtilized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_dxcm_ResearchAndDevelopmentTaxCreditsUtilized_41cb579b-3223-4b10-938c-5fe6a17e240a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_c5904599-3e05-4ee2-9217-65137c939c7c" xlink:href="dxcm-20201231.xsd#dxcm_UnusedExpiredFederalIncomeTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_c5904599-3e05-4ee2-9217-65137c939c7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_5d06381d-30d7-4f4a-8982-940f791ea823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_5d06381d-30d7-4f4a-8982-940f791ea823" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dc5e8583-2529-4fe9-ab20-b813070ebef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dc5e8583-2529-4fe9-ab20-b813070ebef8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedCompensationIntercompanyCrossCharge_b7c31a19-837c-4f3a-b149-becd9edb3bd0" xlink:href="dxcm-20201231.xsd#dxcm_ShareBasedCompensationIntercompanyCrossCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_dxcm_ShareBasedCompensationIntercompanyCrossCharge_b7c31a19-837c-4f3a-b149-becd9edb3bd0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_5fb41699-47d4-4351-9163-ac067a36545d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_5fb41699-47d4-4351-9163-ac067a36545d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_e034c13e-823b-4b70-8b8b-e637fde8aec0" xlink:href="dxcm-20201231.xsd#dxcm_PossibleExtensionPeriodofTaxHoliday"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_e034c13e-823b-4b70-8b8b-e637fde8aec0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_3e7cf085-8e61-47d2-9b42-916f8329596c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_3e7cf085-8e61-47d2-9b42-916f8329596c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_c5d8e32a-63c2-4073-bb58-e386c200ec60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_c5d8e32a-63c2-4073-bb58-e386c200ec60" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_a34336fb-5e40-4fb7-9b0f-4f5db90af91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_a34336fb-5e40-4fb7-9b0f-4f5db90af91e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_a34336fb-5e40-4fb7-9b0f-4f5db90af91e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a34336fb-5e40-4fb7-9b0f-4f5db90af91e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_a34336fb-5e40-4fb7-9b0f-4f5db90af91e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_75afa832-ef53-464e-94a2-5cf359c3be1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a34336fb-5e40-4fb7-9b0f-4f5db90af91e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_75afa832-ef53-464e-94a2-5cf359c3be1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_c306386a-f11c-43f5-a291-bd94031b114d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_75afa832-ef53-464e-94a2-5cf359c3be1d" xlink:to="loc_us-gaap_ForeignCountryMember_c306386a-f11c-43f5-a291-bd94031b114d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_26cbfe0a-265f-478f-bbfd-af61c160b2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_26cbfe0a-265f-478f-bbfd-af61c160b2ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_26cbfe0a-265f-478f-bbfd-af61c160b2ef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_26cbfe0a-265f-478f-bbfd-af61c160b2ef" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_26cbfe0a-265f-478f-bbfd-af61c160b2ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_69860ce1-f780-4f22-8b4a-54f69fd6f695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_26cbfe0a-265f-478f-bbfd-af61c160b2ef" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_69860ce1-f780-4f22-8b4a-54f69fd6f695" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncomeTaxExpenseBenefitMember_e5edf631-7719-44ac-9d06-128da26b172c" xlink:href="dxcm-20201231.xsd#dxcm_IncomeTaxExpenseBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_69860ce1-f780-4f22-8b4a-54f69fd6f695" xlink:to="loc_dxcm_IncomeTaxExpenseBenefitMember_e5edf631-7719-44ac-9d06-128da26b172c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9418d709-ce1b-4046-9362-5d236393157b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9418d709-ce1b-4046-9362-5d236393157b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9418d709-ce1b-4046-9362-5d236393157b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9418d709-ce1b-4046-9362-5d236393157b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9418d709-ce1b-4046-9362-5d236393157b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d594a26b-b7aa-4c6e-bb80-91dd3cbdb267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9418d709-ce1b-4046-9362-5d236393157b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d594a26b-b7aa-4c6e-bb80-91dd3cbdb267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5eeddf66-f0f0-435b-8600-4e29c74d94f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d594a26b-b7aa-4c6e-bb80-91dd3cbdb267" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5eeddf66-f0f0-435b-8600-4e29c74d94f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dd11294d-44fb-4aff-bd78-3d9307d1c374" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:to="loc_srt_StatementGeographicalAxis_dd11294d-44fb-4aff-bd78-3d9307d1c374" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dd11294d-44fb-4aff-bd78-3d9307d1c374_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_dd11294d-44fb-4aff-bd78-3d9307d1c374" xlink:to="loc_srt_SegmentGeographicalDomain_dd11294d-44fb-4aff-bd78-3d9307d1c374_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5df0bca1-4f00-4708-bd6e-3592bb1955b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_dd11294d-44fb-4aff-bd78-3d9307d1c374" xlink:to="loc_srt_SegmentGeographicalDomain_5df0bca1-4f00-4708-bd6e-3592bb1955b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CALIFORNIAAndNonUSMember_f1723e73-d311-467b-9059-32bf7ef0c1ad" xlink:href="dxcm-20201231.xsd#dxcm_CALIFORNIAAndNonUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5df0bca1-4f00-4708-bd6e-3592bb1955b4" xlink:to="loc_dxcm_CALIFORNIAAndNonUSMember_f1723e73-d311-467b-9059-32bf7ef0c1ad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="ic40c295045c34d4c9a062fcffb8e27ba_IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="extended" id="i1fc7ee15e2264568ac0675245d09df86_IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" id="i20b316c19a004e71941b3c8a8cd3d15f_IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity" xlink:type="extended" id="i591a8208e58c43f0af2684d01d17ebc0_EmployeeBenefitPlansandStockholdersEquity"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables" xlink:type="extended" id="i29da59c0e5be40a1819960df13f1f378_EmployeeBenefitPlansandStockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="extended" id="id6672869488b4525b6be9ef4c591c582_EmployeeBenefitPlansandStockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_b5e030be-2424-426f-951e-4d15b48b0006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_b5e030be-2424-426f-951e-4d15b48b0006" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_551280b4-9097-49de-b3d7-9a8b0cc911bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_551280b4-9097-49de-b3d7-9a8b0cc911bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fdb7bf24-59f0-4ab4-af32-9a7b8a75680c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fdb7bf24-59f0-4ab4-af32-9a7b8a75680c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_cec42d0d-7786-48d9-b2fa-90969f3d6101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_cec42d0d-7786-48d9-b2fa-90969f3d6101" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_5588d4b6-3fd3-496d-a53d-8f31c73d1f52" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_5588d4b6-3fd3-496d-a53d-8f31c73d1f52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_92f46573-e641-4e9e-bdf7-90952ce30ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_92f46573-e641-4e9e-bdf7-90952ce30ffd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeePurchasePriceFloorPercentage_56de6df1-786f-447d-b5a1-58a001937a8a" xlink:href="dxcm-20201231.xsd#dxcm_EmployeePurchasePriceFloorPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_dxcm_EmployeePurchasePriceFloorPercentage_56de6df1-786f-447d-b5a1-58a001937a8a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f9bd3a45-6910-4d02-b6ee-2b1e6e2bcc54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f9bd3a45-6910-4d02-b6ee-2b1e6e2bcc54" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0b39b3e5-f398-4bb1-8300-8ce2e5608452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0b39b3e5-f398-4bb1-8300-8ce2e5608452" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_22a2b5fa-f1e5-4ae6-a3b8-665a4812f0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_22a2b5fa-f1e5-4ae6-a3b8-665a4812f0ee" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OptionsInMoneyNumber_863f1b44-bb4f-4f95-b205-d12651d52cba" xlink:href="dxcm-20201231.xsd#dxcm_OptionsInMoneyNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_dxcm_OptionsInMoneyNumber_863f1b44-bb4f-4f95-b205-d12651d52cba" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d24b24a4-dc34-4447-8507-6beff211eaf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d24b24a4-dc34-4447-8507-6beff211eaf8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8e0b7312-9521-411a-abda-a3dbd80beb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8e0b7312-9521-411a-abda-a3dbd80beb1f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1ed8bc74-18fb-4cbc-a5eb-9717430c9eaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1ed8bc74-18fb-4cbc-a5eb-9717430c9eaa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3b7d6a69-beb2-40ef-bc0f-9374e5fced12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:to="loc_us-gaap_AwardTypeAxis_3b7d6a69-beb2-40ef-bc0f-9374e5fced12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b7d6a69-beb2-40ef-bc0f-9374e5fced12_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3b7d6a69-beb2-40ef-bc0f-9374e5fced12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b7d6a69-beb2-40ef-bc0f-9374e5fced12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19effb0-21a3-4334-ac76-8ba0925214a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3b7d6a69-beb2-40ef-bc0f-9374e5fced12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19effb0-21a3-4334-ac76-8ba0925214a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_68e1e154-a718-4828-a744-93656b14c80b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19effb0-21a3-4334-ac76-8ba0925214a2" xlink:to="loc_us-gaap_RestrictedStockMember_68e1e154-a718-4828-a744-93656b14c80b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_876351d2-5d32-41f1-95f0-45537ef5e69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:to="loc_us-gaap_PlanNameAxis_876351d2-5d32-41f1-95f0-45537ef5e69e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_876351d2-5d32-41f1-95f0-45537ef5e69e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_876351d2-5d32-41f1-95f0-45537ef5e69e" xlink:to="loc_us-gaap_PlanNameDomain_876351d2-5d32-41f1-95f0-45537ef5e69e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b2f8f981-4385-44c1-8cec-cb486f93b455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_876351d2-5d32-41f1-95f0-45537ef5e69e" xlink:to="loc_us-gaap_PlanNameDomain_b2f8f981-4385-44c1-8cec-cb486f93b455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A401kPlanMember_c68126ec-c7cb-4a1a-9d01-4c4a2f2f2bf1" xlink:href="dxcm-20201231.xsd#dxcm_A401kPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b2f8f981-4385-44c1-8cec-cb486f93b455" xlink:to="loc_dxcm_A401kPlanMember_c68126ec-c7cb-4a1a-9d01-4c4a2f2f2bf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlan2015Member_9c8b731b-807c-4015-8470-eeca3bdd86ef" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlan2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b2f8f981-4385-44c1-8cec-cb486f93b455" xlink:to="loc_dxcm_EmployeeStockPurchasePlan2015Member_9c8b731b-807c-4015-8470-eeca3bdd86ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_aac3a4c1-56ea-4616-8c20-3490fec01a63" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:to="loc_srt_RangeAxis_aac3a4c1-56ea-4616-8c20-3490fec01a63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aac3a4c1-56ea-4616-8c20-3490fec01a63_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_aac3a4c1-56ea-4616-8c20-3490fec01a63" xlink:to="loc_srt_RangeMember_aac3a4c1-56ea-4616-8c20-3490fec01a63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2e0417af-84d1-4706-8c0a-8dbad54deff3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_aac3a4c1-56ea-4616-8c20-3490fec01a63" xlink:to="loc_srt_RangeMember_2e0417af-84d1-4706-8c0a-8dbad54deff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2c94d0e3-5288-4e68-a8e0-bd5e19b3de41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2e0417af-84d1-4706-8c0a-8dbad54deff3" xlink:to="loc_srt_MinimumMember_2c94d0e3-5288-4e68-a8e0-bd5e19b3de41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_31a76896-b0b3-4b82-a92e-014d9453347f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2e0417af-84d1-4706-8c0a-8dbad54deff3" xlink:to="loc_srt_MaximumMember_31a76896-b0b3-4b82-a92e-014d9453347f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails" xlink:type="extended" id="i75c5126a6f1f4a3988a7aca8a12d2ddc_EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="extended" id="icbcd106819bf4191adede495e59bc248_EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1dabe99d-5f23-4ed8-b88c-cf3e13411ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1dabe99d-5f23-4ed8-b88c-cf3e13411ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e9bdd9d9-8124-4d6c-bc9d-249072100f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e9bdd9d9-8124-4d6c-bc9d-249072100f22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f3ab70c9-c817-49e6-afa3-665083a62c72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f3ab70c9-c817-49e6-afa3-665083a62c72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_77bbd70c-9da8-4b98-b2e3-c1d9cdb13e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_77bbd70c-9da8-4b98-b2e3-c1d9cdb13e7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51b0ced1-5b13-40b1-b520-bea7fa45b147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c23ac10f-0920-4cf8-94a9-924363467141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c23ac10f-0920-4cf8-94a9-924363467141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_142b75b7-7dce-4f3a-b5d5-9e27b5dacb88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_142b75b7-7dce-4f3a-b5d5-9e27b5dacb88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_14485a52-f7e4-40e5-a69b-f8a67d2d7ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_14485a52-f7e4-40e5-a69b-f8a67d2d7ab4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2278db93-a5a3-4534-90ac-2b42f7933d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2278db93-a5a3-4534-90ac-2b42f7933d2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_010764ba-ad27-4186-89f9-5a87ecd8062a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_eafeab48-f22d-47bd-945b-debf9c608165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_eafeab48-f22d-47bd-945b-debf9c608165" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ffc15642-4be5-443f-913c-8fde2f31647d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ffc15642-4be5-443f-913c-8fde2f31647d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c13c3aa3-29ec-4646-bb6f-a06bf8db03b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ffc15642-4be5-443f-913c-8fde2f31647d" xlink:to="loc_us-gaap_AwardTypeAxis_c13c3aa3-29ec-4646-bb6f-a06bf8db03b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c13c3aa3-29ec-4646-bb6f-a06bf8db03b2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c13c3aa3-29ec-4646-bb6f-a06bf8db03b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c13c3aa3-29ec-4646-bb6f-a06bf8db03b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cde49e86-e46f-4295-94f0-259d0a61f16f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c13c3aa3-29ec-4646-bb6f-a06bf8db03b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cde49e86-e46f-4295-94f0-259d0a61f16f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_52260585-47fd-4c9e-9aa3-bced63e2201b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cde49e86-e46f-4295-94f0-259d0a61f16f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_52260585-47fd-4c9e-9aa3-bced63e2201b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails" xlink:type="extended" id="ie9e9c2228d6b4c2285b8833896c81f46_EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails" xlink:type="extended" id="id19a6d55273a4c6aac1a5d095ed0b568_EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5b91a8cf-5000-4de5-8489-24331b6fbb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e14f31ee-0e22-483f-904b-730967aaedf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5b91a8cf-5000-4de5-8489-24331b6fbb1f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e14f31ee-0e22-483f-904b-730967aaedf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b6fc9b34-a104-4f37-b899-71f8944bb50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5b91a8cf-5000-4de5-8489-24331b6fbb1f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b6fc9b34-a104-4f37-b899-71f8944bb50a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d321867b-0f78-45c7-a644-4d14387dfb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b6fc9b34-a104-4f37-b899-71f8944bb50a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d321867b-0f78-45c7-a644-4d14387dfb87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d321867b-0f78-45c7-a644-4d14387dfb87_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d321867b-0f78-45c7-a644-4d14387dfb87" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d321867b-0f78-45c7-a644-4d14387dfb87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d321867b-0f78-45c7-a644-4d14387dfb87" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d7dde077-c436-4644-afdb-67fcddd14a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:to="loc_us-gaap_CostOfSalesMember_d7dde077-c436-4644-afdb-67fcddd14a80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_88e7da1e-db62-4d14-833c-c9d4845e14a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_88e7da1e-db62-4d14-833c-c9d4845e14a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember_4a0596c9-6ffc-4635-ba72-5b26d8e9a443" xlink:href="dxcm-20201231.xsd#dxcm_SellingGeneralAndAdministrativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:to="loc_dxcm_SellingGeneralAndAdministrativeMember_4a0596c9-6ffc-4635-ba72-5b26d8e9a443" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="extended" id="ibab61ad147d2427cb977af919795614d_EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a9369f0e-1809-43c1-93ba-f233edd74596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a9369f0e-1809-43c1-93ba-f233edd74596" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_46a00e9b-e374-404a-a2c2-9e06eb72c048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_46a00e9b-e374-404a-a2c2-9e06eb72c048" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3fd4c983-38f6-4d45-989d-ab5811bb0c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3fd4c983-38f6-4d45-989d-ab5811bb0c76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ade6e5a4-7ca5-4bdb-94a6-213b62bf90a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ade6e5a4-7ca5-4bdb-94a6-213b62bf90a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_076a4947-e74b-4227-b311-d68ed0e07923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_076a4947-e74b-4227-b311-d68ed0e07923" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_72dbbce7-6f1b-4bb2-ab1c-176fc247c3e0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_076a4947-e74b-4227-b311-d68ed0e07923" xlink:to="loc_srt_RangeAxis_72dbbce7-6f1b-4bb2-ab1c-176fc247c3e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_72dbbce7-6f1b-4bb2-ab1c-176fc247c3e0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_72dbbce7-6f1b-4bb2-ab1c-176fc247c3e0" xlink:to="loc_srt_RangeMember_72dbbce7-6f1b-4bb2-ab1c-176fc247c3e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87839f62-1c4d-4e5b-875b-14310b0daa41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_72dbbce7-6f1b-4bb2-ab1c-176fc247c3e0" xlink:to="loc_srt_RangeMember_87839f62-1c4d-4e5b-875b-14310b0daa41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55ad34a4-c95a-467b-a5b5-980c56801caa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_87839f62-1c4d-4e5b-875b-14310b0daa41" xlink:to="loc_srt_MinimumMember_55ad34a4-c95a-467b-a5b5-980c56801caa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_44b3e6f7-4aac-4ee6-9588-022e1ba2b06b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_87839f62-1c4d-4e5b-875b-14310b0daa41" xlink:to="loc_srt_MaximumMember_44b3e6f7-4aac-4ee6-9588-022e1ba2b06b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_49fcb319-9522-49e8-ab0e-8cdbba5765a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_076a4947-e74b-4227-b311-d68ed0e07923" xlink:to="loc_us-gaap_PlanNameAxis_49fcb319-9522-49e8-ab0e-8cdbba5765a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_49fcb319-9522-49e8-ab0e-8cdbba5765a4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_49fcb319-9522-49e8-ab0e-8cdbba5765a4" xlink:to="loc_us-gaap_PlanNameDomain_49fcb319-9522-49e8-ab0e-8cdbba5765a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_db60c0c8-53cd-4598-b0ec-fdc440573b48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_49fcb319-9522-49e8-ab0e-8cdbba5765a4" xlink:to="loc_us-gaap_PlanNameDomain_db60c0c8-53cd-4598-b0ec-fdc440573b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanMember_ab9bc492-9fa4-4b44-bd23-b2b1831bd2f6" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_db60c0c8-53cd-4598-b0ec-fdc440573b48" xlink:to="loc_dxcm_EmployeeStockPurchasePlanMember_ab9bc492-9fa4-4b44-bd23-b2b1831bd2f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformation"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="extended" id="i8a91347bbb9945eb9294b63f02712001_BusinessSegmentandGeographicInformation"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformationTables"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="extended" id="ia7565c8f6d5a490caa9dce79acdc7ee7_BusinessSegmentandGeographicInformationTables"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="extended" id="i4719900d10a24a3188f5abdd69203aa1_BusinessSegmentandGeographicInformationNarrativeDetails"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformationSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="extended" id="i62ed278da28c4b63a8528cdedd9baa55_BusinessSegmentandGeographicInformationSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8257a2c4-1b8d-43b4-a2d9-0a52fdfaaa66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62241238-4e38-4ba3-8d3f-cc696f62a698" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8257a2c4-1b8d-43b4-a2d9-0a52fdfaaa66" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62241238-4e38-4ba3-8d3f-cc696f62a698" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage_f805fa92-a3a0-4e32-bc18-0b37560ee803" xlink:href="dxcm-20201231.xsd#dxcm_RevenuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8257a2c4-1b8d-43b4-a2d9-0a52fdfaaa66" xlink:to="loc_dxcm_RevenuePercentage_f805fa92-a3a0-4e32-bc18-0b37560ee803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43b7afef-51ea-455e-bc31-84791f45efc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8257a2c4-1b8d-43b4-a2d9-0a52fdfaaa66" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43b7afef-51ea-455e-bc31-84791f45efc8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f0a071f8-715e-4392-8cf8-5c97fa280daf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43b7afef-51ea-455e-bc31-84791f45efc8" xlink:to="loc_srt_StatementGeographicalAxis_f0a071f8-715e-4392-8cf8-5c97fa280daf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f0a071f8-715e-4392-8cf8-5c97fa280daf_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f0a071f8-715e-4392-8cf8-5c97fa280daf" xlink:to="loc_srt_SegmentGeographicalDomain_f0a071f8-715e-4392-8cf8-5c97fa280daf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b762fd71-63ff-4fef-9a40-30fd165a573e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f0a071f8-715e-4392-8cf8-5c97fa280daf" xlink:to="loc_srt_SegmentGeographicalDomain_b762fd71-63ff-4fef-9a40-30fd165a573e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4aefd522-8a17-4459-832a-f4f70d869ca9" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b762fd71-63ff-4fef-9a40-30fd165a573e" xlink:to="loc_country_US_4aefd522-8a17-4459-832a-f4f70d869ca9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_d1c4f7aa-8958-4332-b718-36361f53fb3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b762fd71-63ff-4fef-9a40-30fd165a573e" xlink:to="loc_us-gaap_NonUsMember_d1c4f7aa-8958-4332-b718-36361f53fb3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_14cb2b14-c8b4-48b7-ad51-d7821c193b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43b7afef-51ea-455e-bc31-84791f45efc8" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_14cb2b14-c8b4-48b7-ad51-d7821c193b9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_14cb2b14-c8b4-48b7-ad51-d7821c193b9a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_14cb2b14-c8b4-48b7-ad51-d7821c193b9a" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_14cb2b14-c8b4-48b7-ad51-d7821c193b9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_301c7fa8-334f-4523-8261-b48361c84fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_14cb2b14-c8b4-48b7-ad51-d7821c193b9a" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_301c7fa8-334f-4523-8261-b48361c84fdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_de0f587c-bced-4bad-820d-37500a74379a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_301c7fa8-334f-4523-8261-b48361c84fdd" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_de0f587c-bced-4bad-820d-37500a74379a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_691c8f3b-8c78-4d3a-a3b6-d27c5b648fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_301c7fa8-334f-4523-8261-b48361c84fdd" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_691c8f3b-8c78-4d3a-a3b6-d27c5b648fad" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="dxcm-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended" id="iaaa90994251648ea84f465e9d932c1ac_SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended" id="i1988385028684e5a8d3d459f4b5aa886_SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>dxcm-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:50830476-969b-49ba-9748-d2c55f5055b8,g:ea51fe61-a1e0-4e98-8988-a47cbbc74de5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_913ede32-9622-47e7-bb48-f2d1e8e6304e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_65d4f227-a896-4342-8bbe-a8d158de4f16_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets and acquired intangibles assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c65b1306-cf05-49e8-bf56-78db525518b6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e2e594ea-e0ba-4699-a67a-e35aa1fa0d49_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a522ac02-be5e-4b5a-a93c-ce637aeaa76a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_b841081d-7f7e-4ba7-aa9d-71fc5be90ff4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Warranty</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_c4c7bc2c-f1f8-4118-b930-8c4b48aa8af8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net, Classification [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesClassificationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_3b9246d8-99f6-4904-932a-ef993c0c79e3_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_83168d81-5d6a-4e60-bbda-43b0c19f49ac_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_765c7f43-0410-49ae-81c5-3ee87b12c9a3_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CustomerCMember_737e453b-5363-4f80-80d4-8a685a7be162_terseLabel_en-US" xlink:label="lab_dxcm_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributor C</link:label>
    <link:label id="lab_dxcm_CustomerCMember_label_en-US" xlink:label="lab_dxcm_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer C [Member]</link:label>
    <link:label id="lab_dxcm_CustomerCMember_documentation_en-US" xlink:label="lab_dxcm_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer C [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerCMember" xlink:href="dxcm-20201231.xsd#dxcm_CustomerCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerCMember" xlink:to="lab_dxcm_CustomerCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_285201ba-8653-4165-a358-07ebc752c174_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_0b14c190-e7eb-4038-8f53-0e07c5da03ec_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_1e709ec9-c095-4684-a599-c21eb42d2576_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_fbc3e36f-8f3b-4d0c-8ba6-f0b86ad82e25_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a801ce5b-b624-44ad-b6ee-901bf8a74dc9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in statutory tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_24214bf7-dccc-498d-846d-27110f514ec4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_2d8af848-aebb-4346-a4e2-caa09010f528_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_33ecd76d-1062-46db-be3b-445dc70a9217_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_dd29fa3e-b726-4edb-8040-11b939d1c584_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb2816c0-6ea5-44ea-b986-d1f68c89592c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c6e178db-7130-4a76-994d-8787e8014c1c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_397673ce-e0f9-4894-9eb3-cc25f8a566e9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of convertible note issuance, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7bf71a59-3e36-4f30-b296-4f1007b3b2b1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_1085a845-e713-4ab7-a6d7-512f76a7c52b_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_e7b5cd26-3902-465b-8fae-c39c966dd1a1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible notes, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7c3dce81-dfb1-467b-b90b-25b384a28e4e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_55ef9db1-f38b-4da9-8fe7-1388c57e7df4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d5254cb9-b284-43f9-9666-1df7a8dd601e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1c3c92b9-0b3d-4992-90e8-2e6d69900758_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0d8015f6-fd93-4ac3-8041-74ec62049f1c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_b4189879-0a91-4b53-b4ea-de8aa2adf3dc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_17ec5d7d-def7-4163-919f-fbc25ef8346f_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued upon conversion of senior notes (shares)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:to="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_7bc95627-83d5-4f33-90f3-f9e7c516bd5d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_9a855ca6-c312-4cdf-ae49-76abdf2493ae_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_6f75929f-9a95-4909-8811-004aaea27411_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee contribution (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_7e22d461-67d2-460d-a557-eccfcb0a14d5_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_7c334e96-59b8-4779-ad49-cad7f0b53285_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d4eea9d7-6e37-41c9-b8eb-4122b533e9d4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_97d03cb5-46d6-4a05-b330-0c3ab3e90cb6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2b497dbc-5bda-4c47-9351-94d9d0b5549b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_72ad9a78-01e1-44ed-8446-f14eb9ed99df_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_caff1c27-31e6-4bed-b34a-5ff1c19e626c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_5951c221-0848-4819-81af-660684a031ad_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_6aefd7be-4222-4eb5-920d-00fb58cfd1b2_totalLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of liability component</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_dcb8b82a-770f-44aa-a5e4-2349f060887e_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b653abdc-1a72-4418-9579-6abaf5258679_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_05c5c6c4-ec6e-42a3-bfd9-5e049646c552_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_45c140bb-93ef-43f1-b9c0-ff4188a0d5ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal statutory tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_695268e0-a263-47f8-97d8-c49ebf57abe4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_78fc9e36-3a03-4c0d-9576-7f8fd3895553_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c4f0d0b6-8b05-427c-ba24-e3554d614baa_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_fe88b303-7b03-4922-9764-32f603c6f5b3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_a253ed35-39a5-4c93-83d1-4e194125aac2_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash, end of period:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PurchaseofConvertibleNoteHedge_9332f123-5c16-4e3a-851c-3418ed09ce00_negatedTerseLabel_en-US" xlink:label="lab_dxcm_PurchaseofConvertibleNoteHedge" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of convertible note hedge</link:label>
    <link:label id="lab_dxcm_PurchaseofConvertibleNoteHedge_label_en-US" xlink:label="lab_dxcm_PurchaseofConvertibleNoteHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of Convertible Note Hedge</link:label>
    <link:label id="lab_dxcm_PurchaseofConvertibleNoteHedge_documentation_en-US" xlink:label="lab_dxcm_PurchaseofConvertibleNoteHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of Convertible Note Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PurchaseofConvertibleNoteHedge" xlink:href="dxcm-20201231.xsd#dxcm_PurchaseofConvertibleNoteHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PurchaseofConvertibleNoteHedge" xlink:to="lab_dxcm_PurchaseofConvertibleNoteHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_382e017d-36fa-4157-a179-1772c44f8c96_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9ba69be3-8bfe-4c74-aef3-2f6bea5d7965_verboseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_7ec81c89-3897-47af-b36f-4fed5fa3b834_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_b12b716f-700a-470d-b010-52b8f26799ad_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_fb94821f-3def-49d9-ba66-b593629937f6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property and equipment included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9ea5ff89-079e-4a2a-8444-8f8c8b64a75f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_371afde8-8c28-4572-ab2f-ff9737312b21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_3252f14f-ae47-4285-a48c-c940d7601d75_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_f861e4e0-7d7c-4e94-b618-91c31866c36f_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Converted Value of Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_fff11a36-963b-47e0-8d51-83b894dfa081_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the year for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_fa1fa240-fbf4-43bb-838c-f24ed923c663_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3f32a1b6-2386-452a-a979-5b4538d502f3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_e9b81314-63b0-4c47-9b65-16c0da9d0cae_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term Two</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermTwoMember" xlink:to="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_13efebac-074e-404b-9940-5d2e5adf2b19_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_026547c1-458e-4497-bde4-f081b0d43c33_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_99ad5504-c1ff-4cb2-9474-e8d736015fbe_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_5ee3795a-2a82-4559-8110-08f0dcec2881_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credits</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_db7012c4-7369-4247-8939-d79a10409cbd_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_4df02efb-cafb-4c3b-8d04-27bef0dbb7a6_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_8f7c0e37-1915-4cd0-be96-3d541a378791_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_ec276d03-02a0-4036-b2d2-58a59ed08690_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_84da10cd-72ae-4e44-80d3-ddfc9baeb687_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_4dec94a0-6953-4f97-b6b6-4c7297e86413_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_39acde6e-b686-4ea0-898e-75541c919e20_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d1ecddb7-6296-4e0b-821d-fcb8d016c699_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0aa0fd86-d76b-4d2a-833b-ed2176f5b329_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_75605efd-bb0d-4674-b0a5-f834796cab36_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis" xlink:to="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d984bdc4-7b6b-44c1-9228-8415fd53f2a6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_c2d98bb5-af83-466b-9430-4e3725e36151_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_cad0e217-9347-45c5-9a5e-37aa2ecb6829_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3834c36b-7940-4f91-9a76-7b5ab84ce0e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_184bbcea-f099-4679-953a-90c991648662_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_9880680c-8eb9-44e0-9e9c-980a29a4c9ec_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under equity incentive plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_515e197f-b65b-470e-8e49-e6999d3cfef4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_a649161a-b05f-4d32-a251-502cf4990e63_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ffeec7c3-5339-4148-b0ab-74713d6714c8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_77b74cdc-048c-43c3-8431-e9b9942c698b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributor</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockOptionsReservedForFutureGrant_793a5f87-d01f-4a31-a6ff-10c595aa792d_terseLabel_en-US" xlink:label="lab_dxcm_StockOptionsReservedForFutureGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserved for future grant (shares)</link:label>
    <link:label id="lab_dxcm_StockOptionsReservedForFutureGrant_label_en-US" xlink:label="lab_dxcm_StockOptionsReservedForFutureGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Reserved For Future Grant</link:label>
    <link:label id="lab_dxcm_StockOptionsReservedForFutureGrant_documentation_en-US" xlink:label="lab_dxcm_StockOptionsReservedForFutureGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stock options and awards reserved for future grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockOptionsReservedForFutureGrant" xlink:href="dxcm-20201231.xsd#dxcm_StockOptionsReservedForFutureGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockOptionsReservedForFutureGrant" xlink:to="lab_dxcm_StockOptionsReservedForFutureGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligation_43ddc766-a692-4c99-a5dd-7e2b2c0a5a4c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement obligations</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligation_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligation" xlink:to="lab_us-gaap_AssetRetirementObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ae4cf00-c10b-43be-afaa-04f80ed6963c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_dfdb3793-227e-4dbe-8c2a-5b5662f0d215_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_0d03c79f-eab2-466f-adf3-46e22e98d81b_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_121d22ce-ee29-4346-999f-dea2f8f5cc96_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34643c29-136b-4de0-adf9-a25dd6e559de_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_57b26bb7-ed5c-49f9-a349-0ec4eb58280b_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CALIFORNIAAndNonUSMember_a5205ebe-ca41-4190-b9b1-d4aa23f66eb8_terseLabel_en-US" xlink:label="lab_dxcm_CALIFORNIAAndNonUSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California and Foreign</link:label>
    <link:label id="lab_dxcm_CALIFORNIAAndNonUSMember_label_en-US" xlink:label="lab_dxcm_CALIFORNIAAndNonUSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA and Non-US [Member]</link:label>
    <link:label id="lab_dxcm_CALIFORNIAAndNonUSMember_documentation_en-US" xlink:label="lab_dxcm_CALIFORNIAAndNonUSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA and Non-US</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CALIFORNIAAndNonUSMember" xlink:href="dxcm-20201231.xsd#dxcm_CALIFORNIAAndNonUSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CALIFORNIAAndNonUSMember" xlink:to="lab_dxcm_CALIFORNIAAndNonUSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_c91ed388-c3bd-49df-9c6b-afe1f70c8fd8_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing stock price (USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_8ba3b4b7-4832-4aa3-aa11-045d91e464d1_negatedLabel_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_label_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_documentation_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:href="dxcm-20201231.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:to="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_fe70fca2-5307-4d90-9a7e-8f8f3b2494da_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_b6df5bfa-a36f-4e56-9475-009be3534d28_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_3eeaaebc-493e-47e2-b87c-bbcc7f22f00e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_13ad7730-5e4c-4d15-bf68-197fcabbe797_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_564df727-e7e8-4f78-a361-09b5c60923f9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_969273cd-7ff5-4910-b296-bac054ca632a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_3448a53a-6a8c-4cfc-8115-ad340ba7a071_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software and hardware</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_d78faebc-39d2-4c0a-a7eb-6579b4940439_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on equity investment</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_ac219bb7-de24-4a0f-84ab-a37fadf4af37_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f9b411e4-dc15-4bd1-83f9-26920f538e90_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_878a9c91-4984-4014-9ef5-a185c0b89f73_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Accrual</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_39ab6d01-562f-4bcf-80a2-6da2b72783f1_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_6891e541-734a-4e66-b2e6-b898bf780950_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_9cd1d3e8-afa2-486b-9a64-94717acea89d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_b59d59ad-113e-4d9c-a313-c944386a8c8d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_bb318bad-be79-4eb2-89ec-e49132a70e7d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets and Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_256b8734-5cb5-4f7f-af28-60508a893731_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and conversions of 2022 Notes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_a78c924e-b34c-4c83-8750-c466db64e310_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contractual maturities of debt securities held</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_f839fcc3-6e4e-48c9-a96f-cf67c8ad6ae0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible note hedge</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_d28ca090-cc2f-46e0-b49a-6ce49b4eb49f_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_80c41787-036d-4bf6-ae36-1f35ceaa2bd4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d2a039be-ed8d-44f8-b800-47e3f25a81f5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of warrants or rights (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_8f5e2a0e-f68d-4a64-b16a-0e265b071741_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a9bcb123-58f1-48a4-9282-424598ee53e5_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_fefa77d5-7bd9-4a84-9f0d-969edf05c05d_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_97c5b0f0-d01d-4e06-b9a3-892a64c11876_terseLabel_en-US" xlink:label="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of unrestricted cash on hand threshold</link:label>
    <link:label id="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_label_en-US" xlink:label="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold</link:label>
    <link:label id="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_documentation_en-US" xlink:label="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" xlink:href="dxcm-20201231.xsd#dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" xlink:to="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_7be79116-9a43-4546-89d0-4b0524d7c6e4_terseLabel_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_label_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling General And Administrative [Member]</link:label>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_documentation_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The allocation of expenses to selling, general and administrative</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember" xlink:href="dxcm-20201231.xsd#dxcm_SellingGeneralAndAdministrativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SellingGeneralAndAdministrativeMember" xlink:to="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_1b71065c-8307-4551-8d31-323ed0ca40fc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd472e3d-1b5f-4429-aa28-fd69e84f791e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_f22f6ba7-18b1-4294-9044-a592843ae529_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_0e9799ef-b0b8-4bf2-846f-164de436019e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_1f3f1975-884b-4e22-9386-b8573d727050_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e1207d5b-d05d-4fe1-b02d-9ef3fa50a63b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_c208eeca-a516-4f3d-a5a4-a37dc5dae535_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_a80d407f-f260-4bb2-affd-d98c7b334cdc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0e4a3e2b-2171-41af-8f32-bbce0950bff4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale and maturity of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bca069e6-6786-452a-935f-c388f5e4f29a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3eceee4e-a3b5-4af7-a9d3-0b92c17557cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6331ffc1-948f-429a-9dea-7830ca859a1f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock reserved for issuance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_4e4c2c23-1a26-4958-98be-9ffb697d40f0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases And Other Commitments</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_6575b1f0-cb82-4bb8-be32-7f0e089ab699_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_da707004-96e2-420e-bd74-48300a5c6de9_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of conversion price (as a percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_label_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:to="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_32adfa1f-b97e-43d7-a14e-75238af3a4ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hierarchy for Financial Assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_0d9b41fa-021f-43fd-a809-4b2126eb79a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_966e1108-8f07-42fc-8fac-15aa25a59bdb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4a93805f-5918-4c38-814e-c9619ceb68be_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_aca9381c-050d-4489-a723-f4cd17586c85_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_5f4b431b-db42-4961-859a-d12c17765104_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_048268cc-a971-4e18-b5cd-ec5406a14d15_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UK</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_bdd193e7-4317-4d5c-a8b4-b4dfc9f99740_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_34a90d68-c350-44aa-b319-c339aa5d0c9b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under equity incentive plans (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9355cba6-c301-43ef-a9af-d02fdb4a3523_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d6d9a7f7-3e71-4cfe-8bff-212625ca99a8_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_69d6c1a6-36ea-43fd-b129-36d8565a91ed_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_2519d95b-f5d2-4ec4-be43-1687bd1c710d_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_d5c21b84-ecd5-4a19-9077-996ce9e085cc_terseLabel_en-US" xlink:label="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales return period</link:label>
    <link:label id="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_label_en-US" xlink:label="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Sales Returns, Coverage Period</link:label>
    <link:label id="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_documentation_en-US" xlink:label="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Sales Returns, Coverage Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" xlink:href="dxcm-20201231.xsd#dxcm_RevenueRecognitionSalesReturnsCoveragePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" xlink:to="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_f62a28a5-5941-49ba-8c56-efbbb591d293_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_befbee7b-8f1b-4ef9-8baa-eec1bf3205bb_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_0f9b3b72-0636-486e-9d1c-0320c094fbd2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain recognized on equity securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_d81c7e8c-50c4-4af9-bae8-f87a8ac3ac6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_afa415a2-4dda-4707-8231-6677193d6ed3_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_5d1f5a16-cbbe-412c-9527-e1c7dc299ec1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9dc335ee-e0e9-4416-88b7-d1f9b33d5212_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f9e4f1a0-adba-4bb9-8495-caf546519914_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_5b8f02ba-f919-4054-9cf5-0bd9130b00cf_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cd171665-791a-44e3-b8e7-5042bd8d6ad2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_97d25195-c591-4776-9cde-5cb4aa140164_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Availability and Outstanding Borrowings on Credit Agreement</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_e27c9f2d-c031-4ae8-8e8b-5e2f528b9972_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_94ee7175-5600-4835-a6f7-4623e97deebb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_57f5c3fd-189d-492f-a6bd-fa403d18b6f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_8ce28932-6892-477f-9fdc-668cff964f1b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ca16d3a8-14cf-4057-ba6d-ac15ce900c91_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_feb385ea-9330-452a-b4a9-801ad9c355c2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d49d1a32-dd48-4a87-8c25-c13e7f886426_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_e5b8c7ff-2ee0-4ed6-83df-0d81a17cf1b7_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Payments Under Collaboration Agreements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_9348a463-4059-4cdd-a61c-b0db5a021039_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from equity investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_6ec7bfe3-5338-4ee2-ae14-dfe937d754bb_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains and losses recognized during the period on equity securities</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_3d79b690-21a6-4b74-852b-3f7280965174_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6c721e51-de77-4565-b8b3-dc6de3060cf4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_d4330e02-1e44-42ca-a8a8-4d0380070614_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da778b7f-591d-4f26-a703-7861f52286c1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_31227fb2-a057-4c48-aba5-7ac56f08f231_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivables and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_222df67d-6645-4358-88d7-19e4d58c38f5_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_3ec6fb13-46b8-4430-8b23-f1235a16e881_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_b2cc7a87-d1d1-4d2e-b608-1c89b9d3b76c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of outstanding hedge to currency risk</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_8c801f9d-b7ab-4864-8f3b-50b007559ba3_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Lease Expense and Other Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_392a4f11-a7ad-4cb9-9674-bbb4d00098b8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_dd170780-a83b-4674-b17b-ebfb53b50ae4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2a466251-0c33-4c9e-98cf-b6b0fbbec03f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e18e885b-26c0-439e-afe0-86b772968f39_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_adb4d71e-fd2a-4484-913c-c551f545be4b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of applicable conversion price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_475979ff-d056-4c9f-b3c1-d762f8fbc443_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_b442ee1f-b163-4a6d-b5c4-5988dc529bd8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for repurchase and conversions of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_cbf2cb37-d4b1-4281-82d6-f50df71d075b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_840acb77-ca67-4622-adf0-79fff8a86aa8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_2f902171-c28a-40ff-ae0b-5d3bdd51da6e_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_5457e7e6-b496-432a-b7ba-2af4b685a29a_terseLabel_en-US" xlink:label="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period for incentive compensation costs</link:label>
    <link:label id="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_label_en-US" xlink:label="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Period For Incentive Compensation Costs</link:label>
    <link:label id="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_documentation_en-US" xlink:label="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Period For Incentive Compensation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:href="dxcm-20201231.xsd#dxcm_AmortizationPeriodForIncentiveCompensationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:to="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_28c97586-d190-4bc2-8ee6-e968ca8af1f9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense recognized on senior notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PharmacyRebates_b9f700c2-524c-489b-bf00-b18e1cc8a2c9_terseLabel_en-US" xlink:label="lab_dxcm_PharmacyRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates</link:label>
    <link:label id="lab_dxcm_PharmacyRebates_label_en-US" xlink:label="lab_dxcm_PharmacyRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebates</link:label>
    <link:label id="lab_dxcm_PharmacyRebates_documentation_en-US" xlink:label="lab_dxcm_PharmacyRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebates" xlink:href="dxcm-20201231.xsd#dxcm_PharmacyRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PharmacyRebates" xlink:to="lab_dxcm_PharmacyRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8cec3c9-811a-4511-927a-368ea187ab3d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bdb36452-dfbf-4e54-a0aa-0de92c1a5700_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c7c7b8ec-cc4b-4505-a5ce-7de08b4af74a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock units (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e1860afb-7797-47d5-b324-9cf03c4aa7cf_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_a54b995b-6155-495c-8499-9ad6c27cddad_terseLabel_en-US" xlink:label="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges to costs and expenses</link:label>
    <link:label id="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_label_en-US" xlink:label="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual Charges To Costs And Expenses</link:label>
    <link:label id="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_documentation_en-US" xlink:label="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual Charges To Costs And Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:href="dxcm-20201231.xsd#dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:to="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_be115a88-4143-4a26-b521-9fccaa3d0c9b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_98dbcd9c-6861-46c6-837b-25656a1441cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock counterparties to acquire with warrants purchased (shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ReceiverProductComponentMember_d8785ca6-8175-4782-ba58-3e0dc97ef045_terseLabel_en-US" xlink:label="lab_dxcm_ReceiverProductComponentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receiver Product Component</link:label>
    <link:label id="lab_dxcm_ReceiverProductComponentMember_label_en-US" xlink:label="lab_dxcm_ReceiverProductComponentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receiver Product Component [Member]</link:label>
    <link:label id="lab_dxcm_ReceiverProductComponentMember_documentation_en-US" xlink:label="lab_dxcm_ReceiverProductComponentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receiver Product Component [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ReceiverProductComponentMember" xlink:href="dxcm-20201231.xsd#dxcm_ReceiverProductComponentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ReceiverProductComponentMember" xlink:to="lab_dxcm_ReceiverProductComponentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_22b2fdab-2803-4912-8824-9e373e06acf5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_36775be0-e3d0-46fb-803d-1c2e606b68ee_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherStatesMember_ae2d83ed-6f6d-4386-86f9-3e72ff59e875_terseLabel_en-US" xlink:label="lab_dxcm_OtherStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other States</link:label>
    <link:label id="lab_dxcm_OtherStatesMember_label_en-US" xlink:label="lab_dxcm_OtherStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other States [Member]</link:label>
    <link:label id="lab_dxcm_OtherStatesMember_documentation_en-US" xlink:label="lab_dxcm_OtherStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherStatesMember" xlink:href="dxcm-20201231.xsd#dxcm_OtherStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherStatesMember" xlink:to="lab_dxcm_OtherStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_fc8a15ca-d4e1-42e9-a439-f1ebe9ec11d4_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_a416d1e6-5a4d-4d9f-9ac5-38fc1f843c67_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_e50ec551-a39b-41ea-826a-e165e6fc18da_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk and Significant Customers</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_b4c76759-219c-470f-b9a6-b312c6c4722d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Finance Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_d6618c58-b578-4175-8949-a247bc880f9e_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_931f89c8-dbd2-4b41-bc80-d435920427d6_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_19a9cda3-3aff-49b3-b546-e7d01f3ebe5f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_589ba35d-2690-4e6a-aeb8-ef962dc78946_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock and officers compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_ba7f23ea-1035-4c53-a175-943361bc57d7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized research and development expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8f892a5e-0d87-474a-b9b6-fb3856985b1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_741d86ed-f0b7-47ce-8b29-4602ba49a192_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_0094fdb7-a0da-47aa-b06f-1debb83137e7_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_0cc376e1-3940-4223-a7c7-ce9bbd339ec4_terseLabel_en-US" xlink:label="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive days used to calculate volume weighted average trading price</link:label>
    <link:label id="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_label_en-US" xlink:label="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Share Price, Consecutive Days Evaluated</link:label>
    <link:label id="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_documentation_en-US" xlink:label="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Share Price, Consecutive Days Evaluated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" xlink:href="dxcm-20201231.xsd#dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" xlink:to="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_aada1421-670e-4c57-9439-4eefb3f3464a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_026db351-2ca4-4af9-94f3-8a4ee59b93b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility of common stock (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_504478b7-a14e-4dd0-b9e5-31361bede6e4_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside of the United States</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e0ebbb70-28f1-41a5-9f69-15ec549c8e3a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_ed28e8ee-bca0-450c-860d-eb9b5d749d91_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Impact of TCJA</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Impact of TCJA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" xlink:href="dxcm-20201231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" xlink:to="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_5a228811-7b87-49ba-b2bc-3d5883a799e0_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:href="dxcm-20201231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_271b75a1-d250-4c93-8aa0-33da232ca0fb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net, Classification [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_59a1fa01-0134-4b35-8139-d6c5fab4c34d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_6e47f85d-5047-4d70-9e73-3b4552c12b67_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_634304b5-21c7-41b8-9620-6f10e95b707a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb0e0164-5735-424d-a086-79a07b4ea234_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_c72b260e-ca3d-404f-bcda-47247f59c718_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_363e073b-a0a7-4b2d-b350-47ce53d06d49_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional milestones and incentive payments</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" xlink:to="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_ef363c2d-ac1b-44c5-8ab4-675fa57cdc4c_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Loss Carryforwards</link:label>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Operating Loss Carryforwards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_0cfe614f-91b5-43c7-8590-4ee2396ac0e5_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_895dcd94-b8ac-4ec7-861f-1573a51f9ca2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Release of valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_195e0efb-3975-4031-b772-b7b835782206_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_b4c9bdcc-16d2-4adc-b75d-4a4d8b892088_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_86fe5724-b1eb-438a-97cf-0dcaef4897b5_negatedTerseLabel_en-US" xlink:label="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease related to Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_label_en-US" xlink:label="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017</link:label>
    <link:label id="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_documentation_en-US" xlink:label="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" xlink:href="dxcm-20201231.xsd#dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" xlink:to="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_bfa9aaf9-e6df-451a-b549-50cf1fe16c16_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_85d9d0c4-2a85-4722-8c72-09efbd799edc_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_4c6153d8-5fcb-4806-82ea-1f14ca8e97b8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed and intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_1ec92fd2-701b-4e77-af9a-f47ba29dfc83_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_2fb14db2-8f5f-489b-b093-9196388ceca0_terseLabel_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential future common stock issuable (shares)</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_label_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_documentation_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:href="dxcm-20201231.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:to="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_53626058-bce9-4b14-81ea-cee327c90702_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled accounts receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6bf0c597-93cb-43c2-80e8-0eb9f0629c73_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_2bc5c1fb-2638-4f44-afb1-3d2ff5cefdfc_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized additional paid-in capital from cash conversion option</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" xlink:to="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_fb51dac4-3a0c-4db9-a61a-f72ed4fe466e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_9a140f49-c2e9-4315-9bbb-b42bcd074f06_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative research and development fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_label_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Research And Development Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_documentation_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Research and Development Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:to="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_a21e6433-0cab-4a0d-b4f5-58d975ec3d9c_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1d47757e-6e48-43cc-b1fe-acd37f0660f5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_74990c5b-8a60-4354-aa13-b128efbb0245_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_4e111e45-6254-43c9-aabe-0d760083c391_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_e020b951-fbe0-49b6-b892-2ad78f978565_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of outstanding senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_523bdf43-000f-45f8-819c-cb2a79814bfc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income tax, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5fb8105e-828a-4004-ab02-76d16b1c6b4c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_5beb0b99-88b3-4888-90c7-893f472fb5e7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_695a5351-7641-4ad4-b5f6-1866322e917c_terseLabel_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use asset</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_label_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases, Lease Cost, Amortization</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_documentation_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases, Lease Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:href="dxcm-20201231.xsd#dxcm_LesseeOperatingLeasesLeaseCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:to="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_92b00f37-5809-4e4c-b8db-6ab2600496a3_terseLabel_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash interest expense:</link:label>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_label_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Interest Expense [Abstract]</link:label>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_documentation_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract" xlink:href="dxcm-20201231.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CashInterestExpenseAbstract" xlink:to="lab_dxcm_CashInterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1b3cc884-24f1-4e96-906c-4360c43b2f1d_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_a4d8db6d-0af2-44d7-b7bf-488f76efa4b7_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_7bb5031a-6d9f-4802-bfef-955a19908048_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_38454061-7318-4603-ba4e-f4e6798f1b76_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_05a72bac-e384-4720-a6cd-154312c30ed7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_a5496361-e9bb-4083-aaf1-7d3f8f25c9e8_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments due upon achievement of future development</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Development &amp; Regulatory Milestones</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Development &amp; Regulatory Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" xlink:to="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_3d62a1bb-574d-4d84-ab22-cbfc7c0ee5c1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_b9e344ea-1597-46b1-91a1-9f66be6c89c3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ed904640-0d93-4779-9cce-436ba3c4bf36_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_20b95f8b-8db4-49b5-acaf-ec8e06174d68_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_2887b57b-19d1-4e20-a406-37ba87c2816b_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued warranty</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_368f5b57-f6fa-4674-be52-6edf5ed71a19_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_96bf8d74-4e52-4bbc-a437-2df97abff850_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_7d1d40a7-acce-4476-a1a7-53697070e0a9_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligations</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_fbe82cae-1f41-4314-95d2-af8f04c7ed72_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual coupon interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b8b836bf-051e-44f7-a3ca-e0560d2ad9f3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_85eb1d3b-b05e-4d36-bfe4-728da6dd812f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ee42c458-de71-4d2b-b002-879ae3eb72c6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_438939f0-df11-4305-a485-54440707b342_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f71e08d6-875c-4267-83ca-42e844a3fe46_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5cfdff91-97e4-4f51-9e24-dc08e9193566_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_c85ec30d-d4ae-4fb7-9a7b-f5a782e02534_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for collaborative research and development fee</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Purchase of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_f121aab5-94c7-40c5-887b-d8edffa7833d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_label_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense" xlink:to="lab_us-gaap_LeaseAndRentalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a5ccb32-8d53-4786-895b-052d932a53cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_a2ab4564-cea9-495c-8941-12c8f8c19ca5_terseLabel_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contract payment terms</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_label_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_documentation_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays" xlink:href="dxcm-20201231.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ContractPaymentTermsNumberofDays" xlink:to="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_210b2116-1c4c-4b0f-93ea-a28e7aabef8d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4a8fd5cb-1af1-43a0-ad0e-5ba7ae975114_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_994f3581-5b0d-41f2-acb1-57dfd44fb244_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_7b75f442-5a22-49c1-88f2-3fbccd05bf20_negatedTerseLabel_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from Notes</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_documentation_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:href="dxcm-20201231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:to="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_75483092-3e17-417b-b31d-e9b1cc57db3d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_9ff64dc8-a473-4c3a-8adc-8073e16b2747_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c0d66c1c-c51c-4683-bbcf-4c3e2fe605a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_e39b9430-2d12-4069-85f3-25bf878f414f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_95385cb6-4fcd-4ace-a278-4cd4e59ada26_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents incorporated by reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_96f0b430-b8d8-43c4-8b51-487b9763c021_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation between Effective Tax Rate and Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_577edb8b-9f7a-4585-9a23-9aed36bb52af_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a6c1a493-dc26-4180-9389-f64ae96fafad_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_be245e0b-ce23-4074-9660-e0b3ed9b6ac8_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_e0a41f70-6676-4ef8-aefb-dddaca13077f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3a767622-9e83-44a3-8939-fffb8c45c0a0_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_44433cbb-3cc1-4fbc-a583-6bda70c8d3a2_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_d5e67be0-a7be-4f25-ac04-e2ebaf5b301b_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Initial Payment</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:to="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_60bbf93d-4724-4dd7-8b76-12630e9d6a86_totalLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsForRepurchaseOfConvertibleNotes_2dd36e6b-5d6d-4ec7-915a-68554757dbdd_negatedTerseLabel_en-US" xlink:label="lab_dxcm_PaymentsForRepurchaseOfConvertibleNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of convertible notes</link:label>
    <link:label id="lab_dxcm_PaymentsForRepurchaseOfConvertibleNotes_666ad6c7-6a24-4ac9-98fb-57a2ec4984ed_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsForRepurchaseOfConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of convertible notes</link:label>
    <link:label id="lab_dxcm_PaymentsForRepurchaseOfConvertibleNotes_label_en-US" xlink:label="lab_dxcm_PaymentsForRepurchaseOfConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Convertible Notes</link:label>
    <link:label id="lab_dxcm_PaymentsForRepurchaseOfConvertibleNotes_documentation_en-US" xlink:label="lab_dxcm_PaymentsForRepurchaseOfConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsForRepurchaseOfConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes" xlink:to="lab_dxcm_PaymentsForRepurchaseOfConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_01504060-381c-4bbd-a356-f95744a579e4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bc00b1e5-859b-4fda-b114-c7ba9d017723_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_20e85b62-cee5-44be-a064-f439339f9c91_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_634f3dd1-1096-454f-bda3-e5e74e6e6ba3_terseLabel_en-US" xlink:label="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity threshold of investments classified to cash equivalents</link:label>
    <link:label id="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_label_en-US" xlink:label="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Threshold Of Investments Classified To Cash Equivalents</link:label>
    <link:label id="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_documentation_en-US" xlink:label="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Threshold Of Investments Classified To Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:href="dxcm-20201231.xsd#dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:to="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_b0c01ff5-b275-456c-9b85-bf29a73eb2aa_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_7d65cd23-cb3e-4292-9f98-4bfe720ccc02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ab6e4f8b-8b12-47e4-b020-9c80c6fc9277_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_3ebf2e0f-6e8a-4905-ac83-00396b870f26_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ProductShipmentCostsPolicyTextBlock_9c85729d-7c07-4515-a9e0-fabc57935156_terseLabel_en-US" xlink:label="lab_dxcm_ProductShipmentCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Shipment Costs</link:label>
    <link:label id="lab_dxcm_ProductShipmentCostsPolicyTextBlock_label_en-US" xlink:label="lab_dxcm_ProductShipmentCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Shipment Costs [Policy Text Block]</link:label>
    <link:label id="lab_dxcm_ProductShipmentCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_dxcm_ProductShipmentCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Shipment Costs [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ProductShipmentCostsPolicyTextBlock" xlink:href="dxcm-20201231.xsd#dxcm_ProductShipmentCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ProductShipmentCostsPolicyTextBlock" xlink:to="lab_dxcm_ProductShipmentCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_93614927-8857-4ad3-b657-402e1d6b9e51_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_28531731-a908-4d2b-95ef-4c71665f78a2_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Tax Credit Carryforwards</link:label>
    <link:label id="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Tax Credit Carryforwards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:to="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_20f6c7a5-0486-4702-9d79-e2e51b6d148d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4494fdff-d971-484e-8325-2bf11ee67884_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_44044e58-04ac-44de-8035-f8bbf7211851_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_b4d3fb01-778e-4ee6-bcdf-fd6ada88a118_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total by which the notes&#8217; if-converted value exceeds their principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, If-converted Value in Excess of Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:to="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_fea03ac5-b7d2-48b0-a9a2-18a9cfe5472f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Marketable Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_03aa8bf9-1b03-47b0-b503-51a97fe356ae_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contribution (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_0f706577-0da0-4d5c-a684-cf6b7049e7c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income (Loss) before Income Taxes Subject to Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_383bbf29-24f8-474c-ad8e-c03b701481c6_terseLabel_en-US" xlink:label="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum lease payments for leases not yet commenced</link:label>
    <link:label id="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_label_en-US" xlink:label="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Future Lease Cost, Lease Not yet Commenced</link:label>
    <link:label id="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_documentation_en-US" xlink:label="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Future Lease Cost, Lease Not yet Commenced</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" xlink:href="dxcm-20201231.xsd#dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" xlink:to="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_e4d47fee-fa07-41ca-ae81-3134a02abe24_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_460dbf1a-540e-4f33-a862-27d42ee46338_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component:</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Remaining Discount Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_de07db53-8a58-41cb-abc2-80a47b9ca839_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_94b9eced-8fb6-45f6-add2-90f41e3adb85_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases And Other Commitments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_ceb87d64-fcb1-433c-b794-1ce2d57f4bf9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_fde170cf-91f0-4d36-a17b-b9e985f0e133_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term One</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermOneMember" xlink:to="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_727375ae-b467-4276-aabf-26180a5b5968_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_a12e73fd-8ad8-4d04-8361-4e4db54c9b01_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_a7837e93-cc8d-471c-bf49-232626051c9c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_603e0189-b244-4696-a0ff-8314a437361e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_56a27a0c-62eb-47c4-a27e-89d957311eff_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89243f00-0857-48c1-b3ed-8a33dbc11683_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holder's repurchase price percentage in event of fundamental change (as a percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_label_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:to="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_99530ac1-3ddf-47a3-a7c0-f89c421e5652_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dbf4271d-bad3-484b-b63f-f42d5d86a9e3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_44984a85-27e7-44c3-b6be-2e8c834e71a2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_109757a8-e8b0-443a-9d4a-461d6ebeaa87_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_eaf8c8f0-5687-490c-9a0a-b9074345efed_terseLabel_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_label_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_documentation_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:href="dxcm-20201231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:to="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_bacdda5f-2b1e-458f-ae5e-ab3783b3d281_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs incurred</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_86d4dd5e-ffe9-4528-91b5-d664457bd535_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5bfccce1-b04c-4bf2-ab4d-a087d8db21d9_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_83393509-6311-43a5-b3a5-75b3f9fed595_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_f30d3cfc-e6ea-46e4-98fc-3a6d61903dfa_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_be6326f4-80e2-4bf0-a5eb-6f25796707da_terseLabel_en-US" xlink:label="lab_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible extension period of tax holiday</link:label>
    <link:label id="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_label_en-US" xlink:label="lab_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible Extension Period of Tax Holiday</link:label>
    <link:label id="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_documentation_en-US" xlink:label="lab_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible Extension Period of Tax Holiday</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:href="dxcm-20201231.xsd#dxcm_PossibleExtensionPeriodofTaxHoliday"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:to="lab_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_2241f9fd-d08f-4e92-a1b2-60a3690e788a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_74ab4800-3c0b-4429-b5ab-fce76636cca4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_d9609311-a29a-457c-b101-a04284dbc5a4_terseLabel_en-US" xlink:label="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of purchase obligations</link:label>
    <link:label id="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_label_en-US" xlink:label="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term</link:label>
    <link:label id="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_documentation_en-US" xlink:label="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation Due Within One Year, Maximum Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:href="dxcm-20201231.xsd#dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:to="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_36f63420-80d9-43dc-8d99-afe6b9c33c12_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_890cff89-d161-41ab-91ff-4ff91b44a37a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_0ab0685c-fee0-4ef7-b344-55d7ec66d575_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_8adf8762-5177-45cb-bd23-3a7ca58502ac_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs related to unvested restricted stock units</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_faeceedd-98d4-4a27-958f-43b9e14176c2_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fb5dfc34-0be2-481e-9d3c-a11af858dc1c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_486b9e99-7748-4a03-83e8-1c0ae0b0f22e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_44b95798-18c7-4cf5-97be-305c0663d6fe_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_b2e6e96b-1fca-47ba-a0e9-da27a29d7a20_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_adc52005-c1a2-4525-8693-e4f71baadf8d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FinancialStatementDetailsTable_babbde88-7959-4fad-9426-0238e795819d_terseLabel_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Statement Details [Table]</link:label>
    <link:label id="lab_dxcm_FinancialStatementDetailsTable_label_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Statement Details [Table]</link:label>
    <link:label id="lab_dxcm_FinancialStatementDetailsTable_documentation_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Statement Details [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FinancialStatementDetailsTable" xlink:href="dxcm-20201231.xsd#dxcm_FinancialStatementDetailsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FinancialStatementDetailsTable" xlink:to="lab_dxcm_FinancialStatementDetailsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_af5d40a6-1a99-4604-b4d1-dc20548e905c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DevelopmentAgreementsTable_08959b2e-29e8-445d-ad1a-a113682ba4e1_terseLabel_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreements [Table]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsTable_label_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreements [Table]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsTable_documentation_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsTable" xlink:href="dxcm-20201231.xsd#dxcm_DevelopmentAgreementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DevelopmentAgreementsTable" xlink:to="lab_dxcm_DevelopmentAgreementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2334e961-8c41-4826-90f6-308a31d96c4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_1752504d-7938-4eef-8a6b-a186299ba000_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_16ee742c-0b06-48ed-bbbc-b675ee015867_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_dc51a4db-451e-46ed-be16-2d33d17bce49_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_54778ed9-d28e-4721-ba16-00cfef89f8aa_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e37393a9-400e-4354-80ea-d60a1deeb801_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_7a0db00f-6e47-4790-9b8f-c03254037ec6_terseLabel_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense:</link:label>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_label_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Interest Expense [Abstract]</link:label>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_documentation_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract" xlink:href="dxcm-20201231.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract" xlink:to="lab_dxcm_NonCashInterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f0048cd1-8c17-4977-855a-1d4b9217088d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_00560df8-e096-4124-aa4c-6ca65d354c0d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_75e7c7c8-1f82-4906-baad-56f499436ac1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate of operating leases (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_17b4c033-f9ce-42d0-8153-4cade511b33d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_1df0f8c2-aaf6-4d18-8c45-7b5a2b3cc529_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RDexpensethroughissuanceofcommonstock_846b027d-f5d4-40b3-ba38-ab13871f60bd_terseLabel_en-US" xlink:label="lab_dxcm_RDexpensethroughissuanceofcommonstock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash collaborative research and development fee through issuance of common stock</link:label>
    <link:label id="lab_dxcm_RDexpensethroughissuanceofcommonstock_label_en-US" xlink:label="lab_dxcm_RDexpensethroughissuanceofcommonstock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D expense through issuance of common stock</link:label>
    <link:label id="lab_dxcm_RDexpensethroughissuanceofcommonstock_documentation_en-US" xlink:label="lab_dxcm_RDexpensethroughissuanceofcommonstock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash R&amp;D expense through issuance of common stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RDexpensethroughissuanceofcommonstock" xlink:href="dxcm-20201231.xsd#dxcm_RDexpensethroughissuanceofcommonstock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RDexpensethroughissuanceofcommonstock" xlink:to="lab_dxcm_RDexpensethroughissuanceofcommonstock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_b5d93258-249e-4873-9821-1ae65567b203_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_2dbafa6d-ae96-4ca9-b6eb-533c7d1f2129_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_91dbe044-46aa-4b64-92bb-c882a4f4440c_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes due 2025</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2025 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2025Member" xlink:to="lab_dxcm_ConvertibleNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_601e182a-50ab-460b-a09f-5396342c82b6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e95ea311-6894-4cb7-be16-8c52eaaf5977_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EmployeePurchasePriceFloorPercentage_923ca765-c261-4bc7-8d82-3b0ba0ced2a1_terseLabel_en-US" xlink:label="lab_dxcm_EmployeePurchasePriceFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee purchase price floor (as a percent)</link:label>
    <link:label id="lab_dxcm_EmployeePurchasePriceFloorPercentage_label_en-US" xlink:label="lab_dxcm_EmployeePurchasePriceFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Purchase Price Floor Percentage</link:label>
    <link:label id="lab_dxcm_EmployeePurchasePriceFloorPercentage_documentation_en-US" xlink:label="lab_dxcm_EmployeePurchasePriceFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee purchase price floor, percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeePurchasePriceFloorPercentage" xlink:href="dxcm-20201231.xsd#dxcm_EmployeePurchasePriceFloorPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeePurchasePriceFloorPercentage" xlink:to="lab_dxcm_EmployeePurchasePriceFloorPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_2ae358a9-669c-478d-8392-c0bfc1bf6437_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_eecf69c9-16d3-4e36-a1e3-aaecd073248b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CustomerDMember_736c9e85-5a0a-4b30-b1f2-866855a20fb9_terseLabel_en-US" xlink:label="lab_dxcm_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributor D</link:label>
    <link:label id="lab_dxcm_CustomerDMember_label_en-US" xlink:label="lab_dxcm_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer D [Member]</link:label>
    <link:label id="lab_dxcm_CustomerDMember_documentation_en-US" xlink:label="lab_dxcm_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerDMember" xlink:href="dxcm-20201231.xsd#dxcm_CustomerDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerDMember" xlink:to="lab_dxcm_CustomerDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DevelopmentAgreementsLineItems_3c3cdb8a-d1fb-4724-a971-3f4f8fcaf4be_terseLabel_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreements [Line Items]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsLineItems_label_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreements [Line Items]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsLineItems_documentation_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsLineItems" xlink:href="dxcm-20201231.xsd#dxcm_DevelopmentAgreementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems" xlink:to="lab_dxcm_DevelopmentAgreementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_59515f02-7481-41cb-9733-6f92237b5753_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_3c843100-13ed-4ef0-95e5-5767e06e7934_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_66797c0e-af9c-4d43-b394-4db68a45a6a1_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaidInKindInterest_c87dae88-0673-4678-9772-db4ae91a4133_terseLabel_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_PaidInKindInterest_label_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in-Kind Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaidInKindInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest" xlink:to="lab_us-gaap_PaidInKindInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_fcd5e91e-0b6a-4fe5-b30c-1f7152745085_terseLabel_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers in or out of Level 3 securities</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_label_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_documentation_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:href="dxcm-20201231.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:to="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4f7570a0-24fe-4fce-87e1-f1e53aa7350f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_9cd4d608-954d-4214-a272-0c7aedf9d85c_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:to="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a3a5c50e-509d-4c75-a189-20b365be68bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_29de159d-e8a2-4034-beb0-34ab0b7462be_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease cost</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_281cd710-e00b-4ba5-8999-2a65021ef9bd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_fc92aa2d-daaf-4b35-8b88-54fa98c17044_terseLabel_en-US" xlink:label="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and Other Agreements</link:label>
    <link:label id="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_label_en-US" xlink:label="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development And Other Agreements [Text Block]</link:label>
    <link:label id="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_documentation_en-US" xlink:label="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development And Other Agreements [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAndOtherAgreementsTextBlock" xlink:href="dxcm-20201231.xsd#dxcm_DevelopmentAndOtherAgreementsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DevelopmentAndOtherAgreementsTextBlock" xlink:to="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ee8ada05-170b-4dfe-88d7-e2d46614641f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b7785031-d08e-489e-a8fa-a9dc8366ebc6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_7bf9760f-7e42-4158-9931-7e6fb4ac90ba_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_2937e00f-140c-4840-b3b9-1aee0f94e824_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5bd2fbc2-bae8-4edf-830f-2d93708f04d7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_e2fb6b06-da46-4425-ac33-219d5ab4781b_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_9dcfedee-5bf8-41bb-bd46-ebaa20206875_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_abf35331-e3fc-469d-9b0c-4bd15e60aa11_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_73b137dd-c866-46d9-b08c-e3f9adb03b40_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised_e0d0d070-89db-4537-afbb-8e6e66d17239_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Convertible Principal Amount Exercised</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Convertible Principal Amount Exercised</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Convertible Principal Amount Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised" xlink:to="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5b389de0-6b78-4d40-8dbb-31962506b699_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_657f566b-a7a0-452e-89af-f9b34697936d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_48541fd7-3e66-4534-ac75-398de841da4e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_93fd5672-336f-45b2-b349-80616f399a0d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation Assumptions for Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1619f334-c838-4e47-96fa-40f04e787f6b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8f3b761e-f3ac-42f2-bae1-2e2fd9caa928_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_df4cc19b-4f1b-4d47-b961-d405b62a26f8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_2c7be040-198f-4ed8-8b4f-593c5785fdba_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e32e8b6d-7ba1-4a3f-9a50-bc5bb9a1b1ec_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DeferredTaxAssetsConvertibleDebt_f56fcda9-c14c-4c13-ac9b-d4e82366c505_terseLabel_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsConvertibleDebt_label_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Convertible Debt</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsConvertibleDebt_documentation_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:href="dxcm-20201231.xsd#dxcm_DeferredTaxAssetsConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:to="lab_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_d68e74d5-688e-4c66-b51f-2af8a9d33735_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4bfaf7bf-ef6e-4c89-83be-7a3be47787f2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_9bda5b52-c4b9-407a-8960-6d55797bd9c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Deferred Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fe529b7c-1967-4f7f-a027-0beaf8525d5b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_b50add90-e97d-4107-9606-bb42565f25a7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3db8950c-5bad-4a58-8274-c164c10d8a2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_e49c080a-8de3-40eb-ad59-c49907dc7ead_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Net Gain (Loss) Recognized on Equity Securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_4010f900-6dec-4316-ae9b-5c9d9dff0480_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_2234bd45-b3c7-4e9d-bfbe-412707cb282f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_6e193915-68f8-43e6-ad73-76254f9edd56_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_7b079561-f2d4-4976-93ae-ba70260205ee_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_c3729691-5440-4971-8172-302d3d1de0be_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_e3691d37-6618-4b19-b30a-f7f9898965c9_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_192c283d-de05-4a34-b5fc-a514ae10b6df_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price of convertible notes (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_3c0eabcc-bcac-474e-abd4-78ad0e6954c4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39dfeabd-5a49-4a27-942f-d32cfa592c4e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted net income (loss) per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b1bc5b2c-f3d2-49a6-8b19-aef1411c376e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_f1e2c877-b045-4f37-b041-4bfb549adcdc_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_6aea4156-cef6-4743-aa3a-0c7808ac7d6f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_94633c01-e82e-465b-a23a-63981595c273_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b5864cc3-32ef-42cc-a067-97430e0b18c1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_45b10d42-337d-4f19-96ba-43bd5f7a279f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_d126b110-d966-4e98-b6a7-010b83022902_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9a2905fe-3d4a-4627-a153-bdca3264706a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_bc95558c-823a-4980-9eba-f83175364e88_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4603cf8a-0e39-45a1-baf2-e1d1ee31e959_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_5a54f89f-007f-4381-8f94-687b3dd4105f_negatedTerseLabel_en-US" xlink:label="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs and adjustments</link:label>
    <link:label id="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_label_en-US" xlink:label="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction, Write-offs and Adjustments</link:label>
    <link:label id="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_documentation_en-US" xlink:label="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total of the write-offs and adjustments in a given period to allowances and reserves for doubtful accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:href="dxcm-20201231.xsd#dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:to="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_85aa20ea-1185-4744-94c7-9daf2f544eb6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_7a95faad-82d4-493f-84ad-4802fb1658a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value, 200.0 million shares authorized; 96.9 million and 96.1 million shares issued and outstanding, respectively, at December&#160;31, 2020; and 92.4 million and 91.6 million shares issued and outstanding, respectively, at December&#160;31, 2019</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_08b1dcdf-52e7-4eff-a098-2eb8c7a69b09_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1e6812be-ba2e-4edf-bce6-dc5434a81720_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_6033d6b6-44af-4bfd-bf0c-4261c2d1c42d_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense included in operating expenses</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_abd9496c-346e-4ef0-a4b5-fdf7a235a98e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recoveries</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_1c25fdaf-cb51-4e32-9078-3de8a4f36df0_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_32929602-492e-4c27-a980-7a123de7ec66_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_7755c461-456e-4afb-90bf-692881215e08_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_db216471-014e-4f25-ae1c-63c322358a38_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_8199a173-f9ce-4264-8a0a-851171531d30_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_10c5d10d-b951-41b0-9f95-0f56954c60b7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_d3cc5fd2-a3fa-4d61-9c66-9cd4a8822ac8_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_e6e0b3b3-469f-47a6-8161-1b8cbdc5f0ad_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_da58c854-d3ca-4fc2-9b76-2134d8358ab6_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e2d991a7-62c1-400d-93c2-a6baa7a97d25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_c0a1f5cd-e392-4d8c-9516-bf3f48235ed8_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_67d983a8-5f26-404f-968d-b57905e8ce27_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1152eed1-ebac-4eec-be40-ba25de7e312a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_a8de6f18-39b6-418e-9643-856ea86494dc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_3e92ed87-eff4-4834-bb73-8ed68a38675a_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5d6d26ab-297f-4b8a-b44b-422839339e3c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6aed0247-85a1-49f6-8c96-0e0af627ab6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_f5075c12-3018-45b6-b16b-445f93e4381b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_99fc081a-f037-406d-904f-1ad5dec08f4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5cfdebb9-fb15-46a2-a11f-6d88c6b1f3d3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_95c07f5c-f669-4960-9514-5d68cadd7d25_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b19057d3-06b6-4efc-bb2c-877c63fefa33_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_67700e33-b3dc-4210-b115-ed461597a97d_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_04be28b0-dc85-4bc0-8b39-ec96a1ccac62_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_5dcce3c7-4ee0-4d50-a3fd-b69cec7fe52c_terseLabel_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued tax, audit, and legal fees</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_label_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Tax Audit And Legal Fees</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_documentation_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees" xlink:href="dxcm-20201231.xsd#dxcm_AccruedTaxAuditAndLegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AccruedTaxAuditAndLegalFees" xlink:to="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_456ac3c4-de9b-4988-b8b7-f8c29f83ff84_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_53a940c1-3965-4c72-9cb8-aec6842809eb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_693cd35b-e9ad-4426-b2af-cc6daa6affce_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_b2280177-54f3-4eb8-b010-782d8c5fbcc2_terseLabel_en-US" xlink:label="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options Reserved for Future Issuance</link:label>
    <link:label id="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_label_en-US" xlink:label="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Shares Reserved For Future Issuance Table [Table Text Block]</link:label>
    <link:label id="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shares Reserved For Future Issuance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" xlink:href="dxcm-20201231.xsd#dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" xlink:to="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_9087f5f3-183d-44c0-acfd-b24fc1c532ed_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_ebc6d700-0c8c-4d32-af3e-87d23d6ecf2d_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_a6b07e78-b07d-42ab-aa67-79383f05bc6b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_391e561e-a664-484f-8167-a84a42c03c19_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_76b1ee14-ffd8-4942-83a2-820d5d330e03_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_064a192a-4078-4bf6-b106-875129701cd4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_695a6407-24e7-4a72-b3cd-b0698b295158_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3e8a1371-ae89-4c33-96d0-2eedf3b91339_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d79f62cd-f024-4c7b-ac45-d7e70d570f1d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2022Member_2b110602-84b4-4ef5-b15f-45a317837e62_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes due 2022</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2022Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2022 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2022Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2022Member" xlink:to="lab_dxcm_ConvertibleNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0a9d38f8-a6fe-4fed-8476-0719bdbf993f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_5c60d058-127f-4c9b-8676-ab303dbc3ec6_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Percentage of Total Revenues and Accounts Receivable by Customer</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7e3f843e-f8d3-4c04-91c2-06c2537d9960_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_18acb825-574d-4b72-9302-feba7a9a4858_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_5fbea36e-cd4a-4379-98c2-292fbbdb9fb0_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_a8c11507-feaf-4b2f-bb08-b5b4a21a2f8b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_6b54d664-1ba3-4f5f-87f9-f5320d2f4510_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_5397a701-e535-4b01-896d-3c8666b824b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum payroll deductions (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_bb21544b-fd18-4793-aea3-8e1fc5237a75_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_067e7b31-7ae5-4953-aade-ca695af2ed6d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_539b2b60-b071-4a89-bf0f-3d050b641d6a_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed foreign earnings</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_1f87b67a-e4cb-4d89-961d-d52fdf61c8fe_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12563e6f-6b22-405c-aa40-d5f9c252a3ae_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0aa007ed-afcf-45c9-8fbd-3b00e5bb1d3c_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_d3c0ae53-34b7-43cf-a566-c530ca97d71b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_a2b566a6-4dc6-4ea6-9c35-971a1a2c4bce_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_617c25f9-ec9b-4f37-a720-251c8309007e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash income and expenses</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_34c1e3db-6c1f-4243-a42b-5ec7cf635473_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d6033370-d932-4128-a738-9974a89fd1ed_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on disposal of machinery and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b8049b23-ffde-452f-add8-12ae617c1ba5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bff4f77d-f687-409a-bc71-96e029a6b1ab_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_3d23e959-c5a7-4b5e-a5c5-09b545b04f20_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlan2015Member_750c6577-1d0e-4cf5-8ca4-5185d3017ba3_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan 2015</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlan2015Member_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan 2015 [Member]</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlan2015Member_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan 2015</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlan2015Member" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlan2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlan2015Member" xlink:to="lab_dxcm_EmployeeStockPurchasePlan2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_a1ab53e3-03aa-4440-b076-644cacb27bb9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance amount</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_621e9cf1-09ae-42cd-81b3-2a39b85bb38f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_3f35837f-23d5-4266-90bd-302ce0d63a79_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes due 2023</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2023Member" xlink:to="lab_dxcm_ConvertibleNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_4db9a641-6bed-406d-9d6c-dd9a0d672ffd_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_fb225667-67f8-40b3-bc1e-2aff4c22262e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_07204f39-4d8b-4aea-867c-4b73c2eedd8b_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_d0cb6f6e-2daf-4ca8-a9d8-d5d4a6e966fc_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_94b9e89b-5bba-485a-936f-45f0c93429b1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_160231bc-ee5d-40a2-8f52-0a7be6646d74_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_3beda112-eadf-4cbd-a546-9fae1f070788_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b7358b1b-00b9-4f85-a545-e6569e204e71_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_8a94fc06-4942-4823-9052-9452391f35e6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cfd927ee-2a45-47b6-b0a4-ca0fab2cb0bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_d2c6c1b8-9445-4631-b152-fcb3796a0344_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of equity component</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_8b0b8e6f-e04c-4e48-8a44-e48c62c2748c_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_cad08219-bfbf-4ef0-8e3a-8bc5da9db0c7_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_4cec8bd5-bbf1-47b3-8f00-63c8de11e921_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_2a91bccc-8289-4255-b061-fb66d8388992_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_6565eb66-cdf3-4f23-a82a-432ce1f9aaa6_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_f232e44a-0f22-4b23-9390-fdb797eba02a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_00776c8a-0351-4755-8188-68878a2847f5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9762e3c2-6269-4fe7-808e-5536ec95e4af_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_0822e61a-1b99-46a3-9254-95d5b02974b0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6c287890-2dfd-4c57-a403-ab89dbeffb34_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1b6a83c8-ef7b-483f-9e48-9c0ab14a352d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_ced6ecd8-4424-4c92-ad4a-f14dab16a859_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_eddfeac7-5b84-4872-a5fb-d2d18f7b4857_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers between Level 1 and Level 2 securities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets, Level 1 to Level 2 Transfers, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:to="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_9c114974-04eb-43f9-bdf3-a03e50ce2ee3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_793a4156-4bb0-465c-bbb8-d65bbbe51e85_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_d8d48cad-b041-4830-85d7-f3f3b3cd95f8_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_a0199f52-2b4d-4619-bee5-36a451702b06_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for collaborative research and development fee (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Purchase of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_2656dad7-5d94-444a-b1eb-670200e0ac03_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible asset impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_b886e1e6-1204-4905-8528-45793c869ff6_terseLabel_en-US" xlink:label="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards subject to expiration</link:label>
    <link:label id="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_label_en-US" xlink:label="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused Expired Federal Income Tax Credits</link:label>
    <link:label id="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_documentation_en-US" xlink:label="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal income tax credits likely to expire unused as a result of limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:href="dxcm-20201231.xsd#dxcm_UnusedExpiredFederalIncomeTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:to="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_ae891bb1-b15d-4a08-b81c-dae4c05ae8cd_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent items</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Permanent Items</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Permanent Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:href="dxcm-20201231.xsd#dxcm_EffectiveIncomeTaxReconciliationPermanentItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:to="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_317632ab-19a1-4761-8dd2-0fcaebd041ac_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_45fc8abd-3cf1-4e94-adf7-bc52ba73f1cb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue that will be satisfied after 12 months</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_8891850a-1779-4d6e-a9c4-686e1754027a_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial payment on collaborative agreement</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementUpfrontFee" xlink:to="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_bcdba7f4-3e32-44dc-bbc9-611590a7ee62_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_4db4f4fc-9ed7-41dc-965a-0aca91adf8ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d85f4dbd-621a-440b-9224-d54bfe90fbfd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for Employee Stock Purchase Plan (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_20a5842c-c234-446b-9223-8ddfbfbc61d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_afedf45f-add9-49b8-a2fc-372c901099aa_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_329125a3-e365-456d-9ad4-84880c0deb04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_8c03c63a-bc1a-43a2-9686-e1bb10b63389_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net gains and losses recognized during the period on equity securities sold during the period</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5ba58044-5d19-4455-9c74-ea15a531b6ea_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0ba8d769-bed1-4523-a026-f6eabe416410_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0d37fb0d-099b-42f8-8ba8-5138295e3eab_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_28925b3e-d0d8-4fad-a3f7-703fa07f0e52_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_09549248-7c0a-4abf-9b06-805036423cc5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_1de5e8d0-ae3c-4acf-8ccc-6070e626744c_terseLabel_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to increase revolving line of credit</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_label_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_documentation_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:href="dxcm-20201231.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:to="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_0fc7083f-1be0-498f-8ae3-34ade4abea70_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total matching contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2dec7e28-d013-403b-8fe0-6a82d097e64c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate of finance leases (as a percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_8cfb5f56-8430-4954-a0cf-d171ebfaddd7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_33db83b4-957e-4097-bc79-d5db4053517b_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock authorized in ESPP (shares)</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP), Number of Shares Authorized</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP), Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:to="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RevenuePercentage_c9dd4c12-2828-4fda-b19b-bdbf1999b43e_terseLabel_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">% of&#160;Total</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_label_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_documentation_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage" xlink:href="dxcm-20201231.xsd#dxcm_RevenuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RevenuePercentage" xlink:to="lab_dxcm_RevenuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_IncomeTaxExpenseBenefitMember_2c396cf2-b68e-4bd8-b2ac-a4630ce611c2_terseLabel_en-US" xlink:label="lab_dxcm_IncomeTaxExpenseBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_dxcm_IncomeTaxExpenseBenefitMember_label_en-US" xlink:label="lab_dxcm_IncomeTaxExpenseBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) [Member]</link:label>
    <link:label id="lab_dxcm_IncomeTaxExpenseBenefitMember_documentation_en-US" xlink:label="lab_dxcm_IncomeTaxExpenseBenefitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncomeTaxExpenseBenefitMember" xlink:href="dxcm-20201231.xsd#dxcm_IncomeTaxExpenseBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_IncomeTaxExpenseBenefitMember" xlink:to="lab_dxcm_IncomeTaxExpenseBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9ed68621-7f82-4733-8e6e-58a3180e6ea7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total available balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d9148cc0-0b7f-406a-beff-1cc7f03190ed_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with acquisition, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_f46a1f10-81ba-4f71-8bc8-2626203dfb79_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_A401kPlanMember_44c3c902-59bb-465c-8984-3618cc1375d1_terseLabel_en-US" xlink:label="lab_dxcm_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan</link:label>
    <link:label id="lab_dxcm_A401kPlanMember_label_en-US" xlink:label="lab_dxcm_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan [Member]</link:label>
    <link:label id="lab_dxcm_A401kPlanMember_documentation_en-US" xlink:label="lab_dxcm_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A401kPlanMember" xlink:href="dxcm-20201231.xsd#dxcm_A401kPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_A401kPlanMember" xlink:to="lab_dxcm_A401kPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_97781974-cf3d-40ab-8f33-a4f004359755_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_5c95b3bb-8237-4f20-9788-96e4a75acb0c_terseLabel_en-US" xlink:label="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intrinsic Value of Options Exercised and Fair Value of Options Vested</link:label>
    <link:label id="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_label_en-US" xlink:label="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intrinsic Value Of Options Exercised Table [Table Text Block]</link:label>
    <link:label id="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of intrinsic value of options exercised and fair value of options vested table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" xlink:href="dxcm-20201231.xsd#dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" xlink:to="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6bdb1ff5-c6f8-43da-ab64-be068444105d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on convertible notes (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_701d4a2b-59aa-469c-a407-67a43e092e69_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and conversions of 2022 notes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7e01d9df-e5c8-41f2-8eb8-6fe812c2cac5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_eaacd8b6-23d9-48ec-be5e-81479aa97f98_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December&#160;31, 2020 and December&#160;31, 2019</link:label>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding" xlink:to="lab_us-gaap_PreferredStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_182d4f4f-d6b5-4544-8106-309b27eaaf44_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing transactions:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c4e0702a-1f2d-4cb8-b942-b639a9c82ba6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_819c7bff-d200-40cf-a54c-8976bb389c6f_negatedTerseLabel_en-US" xlink:label="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt discount</link:label>
    <link:label id="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_label_en-US" xlink:label="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Convertible Debt Discount</link:label>
    <link:label id="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_documentation_en-US" xlink:label="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Convertible Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" xlink:href="dxcm-20201231.xsd#dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" xlink:to="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_a3e48502-8ab5-4615-911d-6506bad001c6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1a31f8c2-0cfa-4985-9992-9874607bac47_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_89d7243a-7652-42bf-9f87-90bf6bc66b44_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_7a9943bb-c5d3-411b-8c8c-da9510936c8a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_be95a4ab-c5c0-4155-8101-592e2ad9b8f4_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_18d693fd-39a7-4fc9-8ab4-427d0cc17c17_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_86afe3f6-9b5f-43e2-8f8f-8720037272a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4eccdc25-7545-4c2a-82f0-1abdff65b4ad_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute basic net income (loss) per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_112e040d-6b1f-4947-8360-ce3fb14f0b6a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_05738e52-cb3e-44ea-b26a-8d3b5bb10e50_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ce614040-4858-4e91-955c-9d2262e634e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_ad665bfe-59db-44c7-8f8d-ce945fbcbc78_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_label_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_dff32aa3-2fbe-4d16-9856-3adbc776b60e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_e2b89ee6-d07c-408b-8861-50dd58c9089e_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of adoption of ASU 2016-16</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" xlink:href="dxcm-20201231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" xlink:to="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_91ea5115-0197-4630-8c7c-db5b7ca89f44_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d69900a7-636b-45a0-bce5-269136fbf065_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e3a0f21e-5047-4993-962d-3623ae99a5a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_8af6e7d8-fff5-4c05-b0fd-de6f521e1843_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_9476d8e8-5a79-4dd8-bc79-db1db4b057bd_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the year for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_30176326-e7d0-452b-9867-256e0820396d_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ResearchAndDevelopmentTaxCreditsUtilized_690a286f-df25-4d05-8f9a-afacb050bf2a_terseLabel_en-US" xlink:label="lab_dxcm_ResearchAndDevelopmentTaxCreditsUtilized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credits utilized</link:label>
    <link:label id="lab_dxcm_ResearchAndDevelopmentTaxCreditsUtilized_label_en-US" xlink:label="lab_dxcm_ResearchAndDevelopmentTaxCreditsUtilized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Tax Credits Utilized</link:label>
    <link:label id="lab_dxcm_ResearchAndDevelopmentTaxCreditsUtilized_documentation_en-US" xlink:label="lab_dxcm_ResearchAndDevelopmentTaxCreditsUtilized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Tax Credits Utilized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ResearchAndDevelopmentTaxCreditsUtilized" xlink:href="dxcm-20201231.xsd#dxcm_ResearchAndDevelopmentTaxCreditsUtilized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ResearchAndDevelopmentTaxCreditsUtilized" xlink:to="lab_dxcm_ResearchAndDevelopmentTaxCreditsUtilized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a7b793a-3f59-410d-a13e-27969cb5880b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5821db31-2067-43c6-a406-f46f2db225a5_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6b531df9-398c-40f3-be12-0d6300754bf4_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f6be800b-852a-42e3-96c6-ed92c2e2e31f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9639d8b6-ac42-4437-a9b4-1bdee72c4791_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_62926ff7-1657-43b8-9bed-5da1103961ee_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4425a56b-beea-4b18-81a5-692a10cf4706_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_de292ab1-08bd-4d75-934b-b305b844c763_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_24ab0d99-387c-4fa4-9fda-323672b7a4cc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5a104bdb-6db1-4fd1-91ba-da7b94323020_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes at effective rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_3e56398d-baf6-451f-8979-9712d549b347_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_bed8e656-f41d-463f-8251-5ca4a5d80ddc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in foreign taxes from tax holiday</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Aggregate Dollar Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:to="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fda6b1eb-774c-45b1-899c-f7a752b71857_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_946e6955-5e6c-4ef2-8326-3d1212a3157b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c5a68530-935c-4249-9397-afcb44ad1f54_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_42348c37-41ef-4dcd-abb7-609851e238bf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_51916640-d67b-483d-91aa-0ef2b0d8a0d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized (gain) loss on equity investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6fe0f131-024d-4744-8f8f-c472803d481e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_87ffbc4d-b10d-4d04-ac0b-741eeaa22286_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8c0b6e78-977a-45d9-b961-617110a745fb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_bad2aecf-a048-42e8-bda7-0e9da34d9812_terseLabel_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verily Life Sciences</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_label_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verily Life Sciences [Member]</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_documentation_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verily Life Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember" xlink:href="dxcm-20201231.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_VerilyLifeSciencesMember" xlink:to="lab_dxcm_VerilyLifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_77039dd9-2b13-4465-a490-e6dd3256a30c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_b2d91b67-67bb-459e-9e53-dde08dde874f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9a1ba686-9095-4a1c-ab1c-571cb3c3ebc6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3b9913ad-ed56-44c2-8963-226176dbcbd3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets and Other Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_61c56b38-a59a-4577-aeaa-af361134d9e2_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b96dd202-045a-43ac-b4e9-501a07d32e85_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_9d023176-b93b-4509-8e14-0931875ed7ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_68414051-d05f-4ca4-bab3-9ad2ce68517c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_f557ed5d-3ae3-4b92-bb98-e2fa00e0e35b_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_234c8982-c646-4c96-a984-99b53c9e4c49_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CustomerBMember_c766dca2-40b9-4ad9-9445-b5cae9ac04e1_terseLabel_en-US" xlink:label="lab_dxcm_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributor B</link:label>
    <link:label id="lab_dxcm_CustomerBMember_label_en-US" xlink:label="lab_dxcm_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer B [Member]</link:label>
    <link:label id="lab_dxcm_CustomerBMember_documentation_en-US" xlink:label="lab_dxcm_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerBMember" xlink:href="dxcm-20201231.xsd#dxcm_CustomerBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerBMember" xlink:to="lab_dxcm_CustomerBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_269878fb-e502-45f6-9c3a-b48e31f4ec42_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes (including benefit from valuation allowance release)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_cccbd664-3188-49a3-919a-049a0bfaad45_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_72cec6c1-2889-41f1-9ccd-9143fe597356_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity of revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ee4d65ac-2df9-4394-bbb0-a41499d7c8bc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_08c528be-a1cb-415b-b393-281d05b15b80_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ShareBasedCompensationIntercompanyCrossCharge_5ecede58-6d71-45c9-b5ad-79288fc705ef_terseLabel_en-US" xlink:label="lab_dxcm_ShareBasedCompensationIntercompanyCrossCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional stock-based compensation expense</link:label>
    <link:label id="lab_dxcm_ShareBasedCompensationIntercompanyCrossCharge_label_en-US" xlink:label="lab_dxcm_ShareBasedCompensationIntercompanyCrossCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation - Intercompany Cross-Charge</link:label>
    <link:label id="lab_dxcm_ShareBasedCompensationIntercompanyCrossCharge_documentation_en-US" xlink:label="lab_dxcm_ShareBasedCompensationIntercompanyCrossCharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation - Intercompany Cross-Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedCompensationIntercompanyCrossCharge" xlink:href="dxcm-20201231.xsd#dxcm_ShareBasedCompensationIntercompanyCrossCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ShareBasedCompensationIntercompanyCrossCharge" xlink:to="lab_dxcm_ShareBasedCompensationIntercompanyCrossCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_16c0c928-c150-44f6-8f1e-03684ff1c31a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160; Average Grant&#160;Date Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b86400fa-75ad-4137-891f-82babbcc4b35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of RSUs vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_9b8d51de-9720-4cb8-a1af-4143c4d14ef9_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FinancingLeaseObligation_ea3eacb1-a134-4d5c-875f-756d6a379954_terseLabel_en-US" xlink:label="lab_dxcm_FinancingLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_dxcm_FinancingLeaseObligation_label_en-US" xlink:label="lab_dxcm_FinancingLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Lease Obligation</link:label>
    <link:label id="lab_dxcm_FinancingLeaseObligation_documentation_en-US" xlink:label="lab_dxcm_FinancingLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FinancingLeaseObligation" xlink:href="dxcm-20201231.xsd#dxcm_FinancingLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FinancingLeaseObligation" xlink:to="lab_dxcm_FinancingLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_7cc3e816-4d58-48a1-91c8-5dd288c12dc5_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_36e13a98-5532-4b81-9fc3-c6f1633c7d01_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_3d4e48fd-7c12-461c-8655-83a91a7be07e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic&#160;Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_fa4dabd4-b2a8-41c5-8507-400001992cc8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_bb2bb5ee-7d6e-403a-9bb5-c13126628ec6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_49f3ecaf-5463-441c-8f97-1f429f2e100f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OptionsInMoneyNumber_6010d5d0-f10c-4220-8743-3f0a3f2e0aa6_terseLabel_en-US" xlink:label="lab_dxcm_OptionsInMoneyNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options in-the-money (shares)</link:label>
    <link:label id="lab_dxcm_OptionsInMoneyNumber_label_en-US" xlink:label="lab_dxcm_OptionsInMoneyNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options In Money Number</link:label>
    <link:label id="lab_dxcm_OptionsInMoneyNumber_documentation_en-US" xlink:label="lab_dxcm_OptionsInMoneyNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options that were in-the-money at the balance sheet date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OptionsInMoneyNumber" xlink:href="dxcm-20201231.xsd#dxcm_OptionsInMoneyNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OptionsInMoneyNumber" xlink:to="lab_dxcm_OptionsInMoneyNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_6ba897d8-f482-492f-8de6-fa1f78116c3c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_8ccf6bcb-188c-424b-ade5-6a20c766159c_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_72f62457-7f99-43df-81ab-e4bb8198c242_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain" xlink:to="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_90d997c8-74aa-429c-90f1-187fa1f23c42_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_10a032a5-2605-45dc-b44c-c50e0a7cf396_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_77780400-17cc-4e57-ab48-37fea12953f2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_69e184b5-9f88-47a5-af51-f4df53566588_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_979e76a2-b241-4a58-9938-9e0b5b3342c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ccd6c81d-0317-45b1-a810-2e676ba4b7df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_cb29e622-5a87-4e51-9c10-44b2b2b1740c_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (shares)</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Espp Shares In Espp</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan ESPP Shares In ESPP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlanEsppSharesInEspp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" xlink:to="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ff9cfb4-dc4b-4e3c-8476-5c05b1b80f46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CustomerAMember_62cfc895-cfa6-4d20-8b08-3358faf7de34_terseLabel_en-US" xlink:label="lab_dxcm_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributor A</link:label>
    <link:label id="lab_dxcm_CustomerAMember_label_en-US" xlink:label="lab_dxcm_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A [Member]</link:label>
    <link:label id="lab_dxcm_CustomerAMember_documentation_en-US" xlink:label="lab_dxcm_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerAMember" xlink:href="dxcm-20201231.xsd#dxcm_CustomerAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerAMember" xlink:to="lab_dxcm_CustomerAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c3fe9927-6a39-413f-95a9-a0957d647c4f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_d1d38462-212e-48ce-80a9-a7723d97c1a9_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_7ecf00d4-e175-483f-925c-c929afcb8703_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f848ce80-0ba0-4e12-97fa-754e645c2851_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FinancialStatementDetailsLineItems_37f5931d-e6c2-48f2-8189-bb8eb85d7dc5_terseLabel_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Statement Details [Line Items]</link:label>
    <link:label id="lab_dxcm_FinancialStatementDetailsLineItems_label_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Statement Details [Line Items]</link:label>
    <link:label id="lab_dxcm_FinancialStatementDetailsLineItems_documentation_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Statement Details [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FinancialStatementDetailsLineItems" xlink:href="dxcm-20201231.xsd#dxcm_FinancialStatementDetailsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems" xlink:to="lab_dxcm_FinancialStatementDetailsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_f907ec8c-e80e-41d0-9681-4e2a70bbb061_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity fee (as a percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_1329f125-19b7-4eab-8162-c3f3f4499b94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 0.8 million shares at December&#160;31, 2020 and December&#160;31, 2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_20491e1b-09f2-4927-8c40-7577ce339129_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_4dd25759-4660-4752-8ad2-70b109450e9c_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:href="dxcm-20201231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_0d8b82b2-76d1-47f7-8645-0d452218131d_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_400e1e21-41cb-4bd4-bb83-9ac34d685114_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c2f7f982-47f9-46e2-bde4-a50a38a3b22a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside of the United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e627efba-9ac4-4831-9aaf-f158187eee19_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_37b3b5d4-6aa3-4b5d-bdb5-104c58a3bb60_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7e078aed-7191-4040-a484-b1fbf63957c1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a5d697f9-7c17-4b37-aeb1-8bbd5a592507_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Guidance</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_f659090a-4409-472a-9903-8b5b87154833_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_a7878170-cbca-4479-ab25-a4a09d5c1a3d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanMember_457d7a15-3430-4cfa-89f4-57e5c45efb2c_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanMember" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlanMember" xlink:to="lab_dxcm_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>dxcm-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:50830476-969b-49ba-9748-d2c55f5055b8,g:ea51fe61-a1e0-4e98-8988-a47cbbc74de5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dexcom.com/role/CoverPage" xlink:type="simple" xlink:href="dxcm-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4cbe588b-c04b-442a-a419-997d2f070006" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_DocumentType_4cbe588b-c04b-442a-a419-997d2f070006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_92571763-76e7-47b1-be6d-32c7a9d4ae33" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_DocumentAnnualReport_92571763-76e7-47b1-be6d-32c7a9d4ae33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4faf00e7-df2a-4b99-8d18-430fa3db911b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_DocumentPeriodEndDate_4faf00e7-df2a-4b99-8d18-430fa3db911b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5cf377be-d1ee-49bf-8413-d219cb54ec7a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_DocumentTransitionReport_5cf377be-d1ee-49bf-8413-d219cb54ec7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_321f8d84-0c53-4454-95a2-71e7c65470e6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityFileNumber_321f8d84-0c53-4454-95a2-71e7c65470e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_97c6058d-682d-474f-86e6-489b34a4c343" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityRegistrantName_97c6058d-682d-474f-86e6-489b34a4c343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f6f5c7a0-8047-4573-9828-2a2b1a4d5ec4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f6f5c7a0-8047-4573-9828-2a2b1a4d5ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d474c604-d412-4c95-bc24-40f41a116dca" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityTaxIdentificationNumber_d474c604-d412-4c95-bc24-40f41a116dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f6e28d7c-6636-4b8c-88b9-9d8d2be75257" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityAddressAddressLine1_f6e28d7c-6636-4b8c-88b9-9d8d2be75257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7004190e-b213-4f0e-8904-7cd0f13d5efe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityAddressCityOrTown_7004190e-b213-4f0e-8904-7cd0f13d5efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8cd875bd-0d6e-4b17-a6b0-a502b342e85c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityAddressStateOrProvince_8cd875bd-0d6e-4b17-a6b0-a502b342e85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d5ec3974-b31a-48d5-a298-1644811bcd43" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityAddressPostalZipCode_d5ec3974-b31a-48d5-a298-1644811bcd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_40532c00-9008-4056-8f7a-fb1ef3a6caa1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_CityAreaCode_40532c00-9008-4056-8f7a-fb1ef3a6caa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_9151480c-4958-4511-a067-b7271ff7bd04" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_LocalPhoneNumber_9151480c-4958-4511-a067-b7271ff7bd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_58459aa5-20e5-4da9-b875-d167aaae78e8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_Security12bTitle_58459aa5-20e5-4da9-b875-d167aaae78e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_feb7c305-a5b3-497a-b58a-e21ea7dd72c0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_TradingSymbol_feb7c305-a5b3-497a-b58a-e21ea7dd72c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a9779cb7-8dbd-4acb-9207-7ef6cb6e37a8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_SecurityExchangeName_a9779cb7-8dbd-4acb-9207-7ef6cb6e37a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_9e70e4c8-435d-41b7-840c-a3386854cbcb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_9e70e4c8-435d-41b7-840c-a3386854cbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_3df1b33a-ee99-41b3-8350-f6dcc7564070" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityVoluntaryFilers_3df1b33a-ee99-41b3-8350-f6dcc7564070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b9dae427-5d61-4985-86be-5348876b5f51" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityCurrentReportingStatus_b9dae427-5d61-4985-86be-5348876b5f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_2661bffc-2770-492b-b09f-69a01d50fc7d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityInteractiveDataCurrent_2661bffc-2770-492b-b09f-69a01d50fc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2bea3224-3912-4258-bf6f-3602c83f5136" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityFilerCategory_2bea3224-3912-4258-bf6f-3602c83f5136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_bf46ba1d-c54d-4bab-81a1-72efd01e8b6b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntitySmallBusiness_bf46ba1d-c54d-4bab-81a1-72efd01e8b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d508d9c9-42b1-4921-a7db-bbb7980a7aa0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityEmergingGrowthCompany_d508d9c9-42b1-4921-a7db-bbb7980a7aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_2905fbd0-0717-4700-b457-31727a3f622e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_IcfrAuditorAttestationFlag_2905fbd0-0717-4700-b457-31727a3f622e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_0ac14479-40d5-4c43-8c63-88d4e5ac6067" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityShellCompany_0ac14479-40d5-4c43-8c63-88d4e5ac6067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_d3239a53-54c5-4efb-bd82-5cd9cbfdfcef" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityPublicFloat_d3239a53-54c5-4efb-bd82-5cd9cbfdfcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2443c5b8-c04e-4596-9ad6-8f73b072d017" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2443c5b8-c04e-4596-9ad6-8f73b072d017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_99be9f13-36fe-4e3d-b297-bbab1566a3e6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_99be9f13-36fe-4e3d-b297-bbab1566a3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9097abfb-224e-46fc-8a08-f31d2a121a46" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_AmendmentFlag_9097abfb-224e-46fc-8a08-f31d2a121a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5c79a8b4-4f98-42c5-9b63-eb3b2ab9e180" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_DocumentFiscalYearFocus_5c79a8b4-4f98-42c5-9b63-eb3b2ab9e180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_521ace42-c90a-4e99-a6d9-e19a07e497b9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_DocumentFiscalPeriodFocus_521ace42-c90a-4e99-a6d9-e19a07e497b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_816066c0-ddc9-474b-b420-2ce697ce7cd3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_EntityCentralIndexKey_816066c0-ddc9-474b-b420-2ce697ce7cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4e58c27f-58ce-49c2-9939-98b9a1c23244" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b17d2fe-3d05-4b90-8059-6b7e4d4ab6f3" xlink:to="loc_dei_CurrentFiscalYearEndDate_4e58c27f-58ce-49c2-9939-98b9a1c23244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_142ea50c-08df-4857-9995-6897f4f552f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_861b2c95-2a76-45ab-9167-d445c6142946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_142ea50c-08df-4857-9995-6897f4f552f3" xlink:to="loc_us-gaap_AssetsAbstract_861b2c95-2a76-45ab-9167-d445c6142946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8246d6cd-e5ca-48ab-a88d-f09ea05d3d48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_861b2c95-2a76-45ab-9167-d445c6142946" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8246d6cd-e5ca-48ab-a88d-f09ea05d3d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4d6ca8a1-667a-46cf-8249-44c1c0438e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8246d6cd-e5ca-48ab-a88d-f09ea05d3d48" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4d6ca8a1-667a-46cf-8249-44c1c0438e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_394ddfff-c496-4c30-af4a-e02db22cd8ac" xlink:href="dxcm-20201231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8246d6cd-e5ca-48ab-a88d-f09ea05d3d48" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_394ddfff-c496-4c30-af4a-e02db22cd8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_bb013d6e-edd2-472d-b475-b2a413d07d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8246d6cd-e5ca-48ab-a88d-f09ea05d3d48" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_bb013d6e-edd2-472d-b475-b2a413d07d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ba467aed-15ef-4b69-ba64-05823e858331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8246d6cd-e5ca-48ab-a88d-f09ea05d3d48" xlink:to="loc_us-gaap_InventoryNet_ba467aed-15ef-4b69-ba64-05823e858331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8daa39df-4baf-4417-9f15-c567c7723c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8246d6cd-e5ca-48ab-a88d-f09ea05d3d48" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8daa39df-4baf-4417-9f15-c567c7723c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9574f68e-79c7-4277-ad2d-2cb0a1943077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8246d6cd-e5ca-48ab-a88d-f09ea05d3d48" xlink:to="loc_us-gaap_AssetsCurrent_9574f68e-79c7-4277-ad2d-2cb0a1943077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_42310426-13ae-47d9-b12a-4aa055b6cb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_861b2c95-2a76-45ab-9167-d445c6142946" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_42310426-13ae-47d9-b12a-4aa055b6cb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6de9df5e-e08d-4b40-b080-f47e46ed79ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_861b2c95-2a76-45ab-9167-d445c6142946" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6de9df5e-e08d-4b40-b080-f47e46ed79ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_348a5c03-00f4-4946-8295-ec5fc8068f33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_861b2c95-2a76-45ab-9167-d445c6142946" xlink:to="loc_us-gaap_Goodwill_348a5c03-00f4-4946-8295-ec5fc8068f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_6d888eaf-009a-4a6e-9884-fce32708e903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_861b2c95-2a76-45ab-9167-d445c6142946" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_6d888eaf-009a-4a6e-9884-fce32708e903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3d3d63f8-7f05-4f7e-a732-d63532366b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_861b2c95-2a76-45ab-9167-d445c6142946" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3d3d63f8-7f05-4f7e-a732-d63532366b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8c786229-8693-49cf-92c1-cf8e5968d21c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_861b2c95-2a76-45ab-9167-d445c6142946" xlink:to="loc_us-gaap_Assets_8c786229-8693-49cf-92c1-cf8e5968d21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_142ea50c-08df-4857-9995-6897f4f552f3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b4325289-ad96-4ffb-ad16-c22f36df0d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b4325289-ad96-4ffb-ad16-c22f36df0d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_55205b13-342d-41b3-883a-189d6396a631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b4325289-ad96-4ffb-ad16-c22f36df0d16" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_55205b13-342d-41b3-883a-189d6396a631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a3881a91-5f16-44b4-bb89-526aa3b1c0a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b4325289-ad96-4ffb-ad16-c22f36df0d16" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a3881a91-5f16-44b4-bb89-526aa3b1c0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_68993e41-53d5-4aff-803d-17b7e08ad40f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b4325289-ad96-4ffb-ad16-c22f36df0d16" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_68993e41-53d5-4aff-803d-17b7e08ad40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_87e30da8-79ac-4781-9612-bf69d62c053f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b4325289-ad96-4ffb-ad16-c22f36df0d16" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_87e30da8-79ac-4781-9612-bf69d62c053f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e540004d-d062-4021-a879-6d2969016304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b4325289-ad96-4ffb-ad16-c22f36df0d16" xlink:to="loc_us-gaap_LiabilitiesCurrent_e540004d-d062-4021-a879-6d2969016304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_03fd387d-065c-47d5-a438-b90aefbaaddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_03fd387d-065c-47d5-a438-b90aefbaaddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9fb0ac86-3347-457e-b493-e4324e808d97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9fb0ac86-3347-457e-b493-e4324e808d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cbedaef8-7910-4422-865b-e5dfc1614afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cbedaef8-7910-4422-865b-e5dfc1614afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c66382a3-bf6c-4e44-b453-7c18f235a7a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:to="loc_us-gaap_Liabilities_c66382a3-bf6c-4e44-b453-7c18f235a7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d009ea95-59ff-4fd8-9b82-d168915bbf63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d009ea95-59ff-4fd8-9b82-d168915bbf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_41b99e00-463a-43f2-b8b3-f507d91ca2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_41b99e00-463a-43f2-b8b3-f507d91ca2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_6c6e2cae-c42a-4f53-af8f-91921f7c3a05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41b99e00-463a-43f2-b8b3-f507d91ca2b4" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_6c6e2cae-c42a-4f53-af8f-91921f7c3a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_df072cc8-6416-4065-a98a-3cf6f4236712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41b99e00-463a-43f2-b8b3-f507d91ca2b4" xlink:to="loc_us-gaap_CommonStockValueOutstanding_df072cc8-6416-4065-a98a-3cf6f4236712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0a273eac-63e4-4773-a4f0-e0132be217b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41b99e00-463a-43f2-b8b3-f507d91ca2b4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0a273eac-63e4-4773-a4f0-e0132be217b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_da0c3314-a8e1-4a1a-8272-a09fd8dc130b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41b99e00-463a-43f2-b8b3-f507d91ca2b4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_da0c3314-a8e1-4a1a-8272-a09fd8dc130b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6d5a6f90-122e-477f-b09f-a808aee45b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41b99e00-463a-43f2-b8b3-f507d91ca2b4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6d5a6f90-122e-477f-b09f-a808aee45b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ee301cf6-bb1e-4d97-a066-c4f16f578a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41b99e00-463a-43f2-b8b3-f507d91ca2b4" xlink:to="loc_us-gaap_TreasuryStockValue_ee301cf6-bb1e-4d97-a066-c4f16f578a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3550a6f7-36c3-4d48-b117-a3f59f6dc99c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41b99e00-463a-43f2-b8b3-f507d91ca2b4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3550a6f7-36c3-4d48-b117-a3f59f6dc99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3f7b9531-d87a-4a30-ad76-75fc0e19e23d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e3b48ee-54c9-4723-9cf7-fda67816d05e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_3f7b9531-d87a-4a30-ad76-75fc0e19e23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7102aede-dee5-466e-9d3e-53690399d7d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7102aede-dee5-466e-9d3e-53690399d7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d68ffac8-9032-47c2-8a31-7751be9e3d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d68ffac8-9032-47c2-8a31-7751be9e3d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_424bcefb-2e3c-4fa5-8127-c1b7ae5071fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_424bcefb-2e3c-4fa5-8127-c1b7ae5071fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_e3870fef-f4ac-433c-8f08-f06687160261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_e3870fef-f4ac-433c-8f08-f06687160261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c3e5dfb4-f62a-4f10-8a2d-ad82c5fca3e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c3e5dfb4-f62a-4f10-8a2d-ad82c5fca3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_02d0d697-7951-406e-a592-e025da03019a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_02d0d697-7951-406e-a592-e025da03019a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8fb6983f-8d10-4eab-a76f-8b5fb1b85c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:to="loc_us-gaap_CommonStockSharesIssued_8fb6983f-8d10-4eab-a76f-8b5fb1b85c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bc0c8c78-d068-4a16-924e-9dc8e59459fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bc0c8c78-d068-4a16-924e-9dc8e59459fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_4bb31003-d5a0-46b9-b5f1-a3b1684ebf26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_95e71005-037d-4279-be66-dfcfd849336c" xlink:to="loc_us-gaap_TreasuryStockShares_4bb31003-d5a0-46b9-b5f1-a3b1684ebf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43e387b7-1eb8-4cde-9091-4ba7fcb8d5ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43e387b7-1eb8-4cde-9091-4ba7fcb8d5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_08f01922-324f-4486-972f-8f8647cb5633" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_08f01922-324f-4486-972f-8f8647cb5633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_51840e06-cb87-4869-95ab-97937e298001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_GrossProfit_51840e06-cb87-4869-95ab-97937e298001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_8ea09d7c-9e9b-4e3c-b0d2-a90243ae146c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_OperatingExpensesAbstract_8ea09d7c-9e9b-4e3c-b0d2-a90243ae146c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_822c8031-2432-4cf6-8a55-40dfe180254f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8ea09d7c-9e9b-4e3c-b0d2-a90243ae146c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_822c8031-2432-4cf6-8a55-40dfe180254f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_514e912e-a367-40b8-a5b9-b52b27abeea5" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8ea09d7c-9e9b-4e3c-b0d2-a90243ae146c" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_514e912e-a367-40b8-a5b9-b52b27abeea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_df58ca34-ee63-4b9b-8fed-506dd3339e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8ea09d7c-9e9b-4e3c-b0d2-a90243ae146c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_df58ca34-ee63-4b9b-8fed-506dd3339e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b483f0e8-fe04-4722-a975-aeca8243706c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8ea09d7c-9e9b-4e3c-b0d2-a90243ae146c" xlink:to="loc_us-gaap_OperatingExpenses_b483f0e8-fe04-4722-a975-aeca8243706c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5a9f43d7-ebbb-4cd3-a9ad-34f40e858ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_OperatingIncomeLoss_5a9f43d7-ebbb-4cd3-a9ad-34f40e858ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e4d0e4b1-0832-4d79-88e5-e671b4ab32a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_InterestExpense_e4d0e4b1-0832-4d79-88e5-e671b4ab32a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bd69e34e-a77d-4338-bbab-3fd575dd9237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bd69e34e-a77d-4338-bbab-3fd575dd9237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_9f6c857a-fc50-4002-9770-bd8f676c2b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_9f6c857a-fc50-4002-9770-bd8f676c2b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e0239a6e-135e-4f1f-9a01-3a008baa16d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e0239a6e-135e-4f1f-9a01-3a008baa16d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d630947-8a10-4ff7-bb54-62c4922da316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d630947-8a10-4ff7-bb54-62c4922da316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_57b43bd5-aff5-4132-aa2c-3c25f00607f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_57b43bd5-aff5-4132-aa2c-3c25f00607f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_29257de9-de43-4c6a-9b2c-830a5ae2302a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_NetIncomeLoss_29257de9-de43-4c6a-9b2c-830a5ae2302a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f2bbae07-4fcd-4417-a8f6-eba3d919f54f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_EarningsPerShareBasic_f2bbae07-4fcd-4417-a8f6-eba3d919f54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cdaf6a40-a29c-451c-a22c-7e9377bdac55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cdaf6a40-a29c-451c-a22c-7e9377bdac55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_387d622c-630a-475b-babd-d24d84e75d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_EarningsPerShareDiluted_387d622c-630a-475b-babd-d24d84e75d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_beb57009-a876-408c-ae72-feae4ee063d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_abb1af55-a663-4594-932b-3bcd96909348" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_beb57009-a876-408c-ae72-feae4ee063d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a5354e08-14fe-4dff-bc25-0edd7ee66490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c5eb720d-9e1f-4afb-8d55-0e98bf3062e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a5354e08-14fe-4dff-bc25-0edd7ee66490" xlink:to="loc_us-gaap_NetIncomeLoss_c5eb720d-9e1f-4afb-8d55-0e98bf3062e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3b0738a5-d7b0-4acc-8cef-5bf919ae4bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a5354e08-14fe-4dff-bc25-0edd7ee66490" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3b0738a5-d7b0-4acc-8cef-5bf919ae4bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a70b6300-4439-4dde-93a4-bd9fc9982466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3b0738a5-d7b0-4acc-8cef-5bf919ae4bae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a70b6300-4439-4dde-93a4-bd9fc9982466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f9b0b07b-db66-427c-b678-159899fa3904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3b0738a5-d7b0-4acc-8cef-5bf919ae4bae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f9b0b07b-db66-427c-b678-159899fa3904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_906c89f4-3498-48f3-b9ed-b1d1d586c150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3b0738a5-d7b0-4acc-8cef-5bf919ae4bae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_906c89f4-3498-48f3-b9ed-b1d1d586c150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f20c6d56-c308-4971-93e4-3d2b26db484a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a5354e08-14fe-4dff-bc25-0edd7ee66490" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f20c6d56-c308-4971-93e4-3d2b26db484a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_67385422-0b52-4bb4-b776-95373d13c0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8f798994-1c96-492a-aba6-709151d2daf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_67385422-0b52-4bb4-b776-95373d13c0bd" xlink:to="loc_us-gaap_StatementTable_8f798994-1c96-492a-aba6-709151d2daf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_753653f6-c509-4ef9-aedb-b63024ebcd67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8f798994-1c96-492a-aba6-709151d2daf5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_753653f6-c509-4ef9-aedb-b63024ebcd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_753653f6-c509-4ef9-aedb-b63024ebcd67" xlink:to="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d9a69f67-01ff-4508-94ff-b89c32d0652f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_CommonStockMember_d9a69f67-01ff-4508-94ff-b89c32d0652f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_08762ac0-73a9-44b1-b1ae-d030d405da65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_08762ac0-73a9-44b1-b1ae-d030d405da65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af7aed21-eba3-491e-8ae6-b39d2be08fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af7aed21-eba3-491e-8ae6-b39d2be08fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ccac9f72-2d39-48d7-9f25-cf502fee1783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_RetainedEarningsMember_ccac9f72-2d39-48d7-9f25-cf502fee1783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e261cae5-40be-4a14-983e-d92266c162f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f5822-b474-4044-a601-dc1020337b5d" xlink:to="loc_us-gaap_TreasuryStockMember_e261cae5-40be-4a14-983e-d92266c162f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_34cd8425-423f-4a19-acd4-6e2274255ac8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8f798994-1c96-492a-aba6-709151d2daf5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_34cd8425-423f-4a19-acd4-6e2274255ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_28577f3c-856f-456f-8378-5b312c6beeb6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_34cd8425-423f-4a19-acd4-6e2274255ac8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_28577f3c-856f-456f-8378-5b312c6beeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1c6a5b7e-97b4-4b47-b845-36950667fb06" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_28577f3c-856f-456f-8378-5b312c6beeb6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1c6a5b7e-97b4-4b47-b845-36950667fb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3eeeecd6-fd27-4988-9962-1087af9c3c22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8f798994-1c96-492a-aba6-709151d2daf5" xlink:to="loc_us-gaap_StatementLineItems_3eeeecd6-fd27-4988-9962-1087af9c3c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_86d19861-b8f5-4a55-bf1f-5820f6442ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3eeeecd6-fd27-4988-9962-1087af9c3c22" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_86d19861-b8f5-4a55-bf1f-5820f6442ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3eeeecd6-fd27-4988-9962-1087af9c3c22" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ef292cd2-5243-411b-ae57-25dce9eef8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_SharesOutstanding_ef292cd2-5243-411b-ae57-25dce9eef8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c724aa1-1c20-45f9-b8f9-439af6a3b989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c724aa1-1c20-45f9-b8f9-439af6a3b989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_d66bd7b2-df86-4c7b-8676-acf805e55edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_d66bd7b2-df86-4c7b-8676-acf805e55edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_ff293084-80c4-4a55-9551-fad76716fb9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_ff293084-80c4-4a55-9551-fad76716fb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_154fdacb-6322-40fe-833a-3cdfb8a7e1ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_154fdacb-6322-40fe-833a-3cdfb8a7e1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_532f27fe-d55c-4d80-a32c-6efd26fd06a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_532f27fe-d55c-4d80-a32c-6efd26fd06a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_1c6387d8-47a4-4632-8e6f-de4a586d66ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_1c6387d8-47a4-4632-8e6f-de4a586d66ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_2e8ff8a8-9f17-436b-8290-1d4c3b7a8a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_2e8ff8a8-9f17-436b-8290-1d4c3b7a8a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_fc8a81f2-b0a9-472b-ae4d-daec4760fcdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_fc8a81f2-b0a9-472b-ae4d-daec4760fcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_d9d3f8a4-10a3-4a33-a5a7-e7fc21bd4cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_d9d3f8a4-10a3-4a33-a5a7-e7fc21bd4cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_4ebc6f46-313d-47dd-b54e-13bd824075f2" xlink:href="dxcm-20201231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_4ebc6f46-313d-47dd-b54e-13bd824075f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f84257c9-008f-44bb-abef-ba64028ea841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f84257c9-008f-44bb-abef-ba64028ea841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_0e023ee9-1c2d-46c3-87c8-8867e109c05d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_0e023ee9-1c2d-46c3-87c8-8867e109c05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_69dedbea-36c7-4e03-9929-673280c77be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_69dedbea-36c7-4e03-9929-673280c77be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_23b389ce-9b5d-4116-b2a2-4addce651413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_23b389ce-9b5d-4116-b2a2-4addce651413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_68ec6604-efef-441b-b3d8-b96e8e131d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_68ec6604-efef-441b-b3d8-b96e8e131d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e66df650-6e37-4166-b139-9d8de36b9c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e66df650-6e37-4166-b139-9d8de36b9c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_817f836f-6080-415f-b2f6-e12bc5f596ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_NetIncomeLoss_817f836f-6080-415f-b2f6-e12bc5f596ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5c4274e1-f636-406e-85d5-94b3c8b47b50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5c4274e1-f636-406e-85d5-94b3c8b47b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2fbef799-0e95-4ae0-86fc-8ffc1d60f30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_SharesOutstanding_2fbef799-0e95-4ae0-86fc-8ffc1d60f30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c04f7751-e948-4e36-b0d4-4e8bf5e4437c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff25b3d7-8e4f-4547-b8e2-ff45ac2a509a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c04f7751-e948-4e36-b0d4-4e8bf5e4437c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dxcm-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_348eb667-6ea4-44c3-b455-45f865ccb24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_348eb667-6ea4-44c3-b455-45f865ccb24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a535ebca-b2ce-4225-bc28-851e2290cc33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_348eb667-6ea4-44c3-b455-45f865ccb24d" xlink:to="loc_us-gaap_NetIncomeLoss_a535ebca-b2ce-4225-bc28-851e2290cc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_348eb667-6ea4-44c3-b455-45f865ccb24d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b186debb-c060-4f4f-a456-41cdaa824702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b186debb-c060-4f4f-a456-41cdaa824702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b7883471-9d38-4443-8265-25086acb0bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:to="loc_us-gaap_ShareBasedCompensation_b7883471-9d38-4443-8265-25086acb0bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8e5ce8ae-b7cf-4dc2-8fbe-369b8d605c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8e5ce8ae-b7cf-4dc2-8fbe-369b8d605c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_37e7ef0a-c4df-4548-aaaa-f61b5b20cb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaidInKindInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:to="loc_us-gaap_PaidInKindInterest_37e7ef0a-c4df-4548-aaaa-f61b5b20cb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RDexpensethroughissuanceofcommonstock_c5f78c9d-a236-4aa1-9fda-c04a8a6ad982" xlink:href="dxcm-20201231.xsd#dxcm_RDexpensethroughissuanceofcommonstock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:to="loc_dxcm_RDexpensethroughissuanceofcommonstock_c5f78c9d-a236-4aa1-9fda-c04a8a6ad982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_e2ac8891-d223-47e0-aacb-36bd590bc084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_e2ac8891-d223-47e0-aacb-36bd590bc084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_d4530e5b-894f-428b-a68a-098701bfd258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_d4530e5b-894f-428b-a68a-098701bfd258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6031234d-56de-4a4e-8916-7457ba0ea0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6031234d-56de-4a4e-8916-7457ba0ea0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_8322f91b-1305-44ed-b9a3-a8244b0758c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_105d87e9-4d61-4e88-9914-cc69843ec71d" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_8322f91b-1305-44ed-b9a3-a8244b0758c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_348eb667-6ea4-44c3-b455-45f865ccb24d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5a19f36f-28d7-4d53-96f0-0a1363042449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5a19f36f-28d7-4d53-96f0-0a1363042449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_34eb65f6-23c6-46a3-b7f2-df57703d4474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_34eb65f6-23c6-46a3-b7f2-df57703d4474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0fcf9401-7604-493e-9e78-a080d6a80252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0fcf9401-7604-493e-9e78-a080d6a80252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_6269ac21-06f0-4af8-9657-7e2a0f6d4c9d" xlink:href="dxcm-20201231.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_6269ac21-06f0-4af8-9657-7e2a0f6d4c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_581ed977-ddfd-48d8-bef4-d50de9971ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_581ed977-ddfd-48d8-bef4-d50de9971ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0bfc4382-77e3-45ea-a154-6778405d8a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0bfc4382-77e3-45ea-a154-6778405d8a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_74028917-4920-4028-8480-17720bf37fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_74028917-4920-4028-8480-17720bf37fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cedba693-0da8-454f-a6f6-04ad35dedbaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e28d312c-6480-4e4c-90bf-ff56d6a3f833" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cedba693-0da8-454f-a6f6-04ad35dedbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8f9ec10-790d-4bc3-8d02-85267bec2114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8f9ec10-790d-4bc3-8d02-85267bec2114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1a8cac5d-af45-4a30-a5c8-41a714b84d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8f9ec10-790d-4bc3-8d02-85267bec2114" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1a8cac5d-af45-4a30-a5c8-41a714b84d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2dcf394a-2b59-414a-be3b-fd1bfaf53db6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8f9ec10-790d-4bc3-8d02-85267bec2114" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2dcf394a-2b59-414a-be3b-fd1bfaf53db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ba799554-059b-414d-9f3e-2eb37dd0251d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8f9ec10-790d-4bc3-8d02-85267bec2114" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ba799554-059b-414d-9f3e-2eb37dd0251d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e46cb155-bcf0-4a4f-88f8-ec7d7c1b50c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8f9ec10-790d-4bc3-8d02-85267bec2114" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e46cb155-bcf0-4a4f-88f8-ec7d7c1b50c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e1a3044b-411e-4772-9d67-2d18d24a7c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8f9ec10-790d-4bc3-8d02-85267bec2114" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e1a3044b-411e-4772-9d67-2d18d24a7c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cd840e47-9e74-4ead-bf92-84ed99d2d953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8f9ec10-790d-4bc3-8d02-85267bec2114" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cd840e47-9e74-4ead-bf92-84ed99d2d953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1f13fa7c-68e8-4e3b-8b6c-4b9539b55f3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1f13fa7c-68e8-4e3b-8b6c-4b9539b55f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ac69f42b-60a2-463b-8ee6-68c83a816700" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ac69f42b-60a2-463b-8ee6-68c83a816700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_6e619da1-060b-449d-9888-92dfc33a9e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_6e619da1-060b-449d-9888-92dfc33a9e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes_402dfec7-a62e-48af-a5a8-c2aad3c7c32d" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsForRepurchaseOfConvertibleNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:to="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes_402dfec7-a62e-48af-a5a8-c2aad3c7c32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_afc5acb6-3c69-4d27-a4d4-56da77569754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_afc5acb6-3c69-4d27-a4d4-56da77569754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PurchaseofConvertibleNoteHedge_ef2ba8a8-25ce-4a38-bfed-16103085872e" xlink:href="dxcm-20201231.xsd#dxcm_PurchaseofConvertibleNoteHedge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:to="loc_dxcm_PurchaseofConvertibleNoteHedge_ef2ba8a8-25ce-4a38-bfed-16103085872e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b59adbdd-5512-43e8-a141-49b4ed45a912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b59adbdd-5512-43e8-a141-49b4ed45a912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2f4f009-5155-45ec-ad36-83145e00ee7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8937b5c8-ee3a-4344-ac6f-2adcb74468e4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2f4f009-5155-45ec-ad36-83145e00ee7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d7c2a83f-1bec-4b8f-a681-5bf78788dead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d7c2a83f-1bec-4b8f-a681-5bf78788dead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_63ed14af-1976-4ee7-9cd1-e06eeb437217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_63ed14af-1976-4ee7-9cd1-e06eeb437217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_076c08b8-9273-4a20-84c9-a491161c40fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_076c08b8-9273-4a20-84c9-a491161c40fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_71f0d800-ac35-4467-bb27-9e1b8106c209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_71f0d800-ac35-4467-bb27-9e1b8106c209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_0481325f-1543-4e0f-8e81-fb9f49a6e392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_0481325f-1543-4e0f-8e81-fb9f49a6e392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_57f4533d-c5b6-4baa-a035-a4eb3f576e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_0481325f-1543-4e0f-8e81-fb9f49a6e392" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_57f4533d-c5b6-4baa-a035-a4eb3f576e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_026390c5-f709-4b6a-b72a-76e206732646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_0481325f-1543-4e0f-8e81-fb9f49a6e392" xlink:to="loc_us-gaap_RestrictedCash_026390c5-f709-4b6a-b72a-76e206732646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_462e22ff-4249-49cd-8e35-bc9c34d2d14e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_0481325f-1543-4e0f-8e81-fb9f49a6e392" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_462e22ff-4249-49cd-8e35-bc9c34d2d14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_29db81d9-f35b-4ef1-a8d5-8c5fc910cecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_29db81d9-f35b-4ef1-a8d5-8c5fc910cecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_149313e6-75d9-4654-9e4d-c1babd40d92f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_29db81d9-f35b-4ef1-a8d5-8c5fc910cecc" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_149313e6-75d9-4654-9e4d-c1babd40d92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_13e35ac1-7169-4037-8267-0817a0694fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_29db81d9-f35b-4ef1-a8d5-8c5fc910cecc" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_13e35ac1-7169-4037-8267-0817a0694fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9b994d6-248f-4679-85be-802b5058703a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_362d62c1-3c8b-4f80-a101-c803d91d651d" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9b994d6-248f-4679-85be-802b5058703a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_78df2c87-de59-4008-a718-369bfb2c8255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9b994d6-248f-4679-85be-802b5058703a" xlink:to="loc_us-gaap_InterestPaidNet_78df2c87-de59-4008-a718-369bfb2c8255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_571277cd-e921-49ce-98f2-8b5d9e379ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9b994d6-248f-4679-85be-802b5058703a" xlink:to="loc_us-gaap_IncomeTaxesPaid_571277cd-e921-49ce-98f2-8b5d9e379ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_94c6c5e1-3f9c-4768-8674-878fce18f2e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_464110f4-0b68-4879-a7ce-f4b2335ccd75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_94c6c5e1-3f9c-4768-8674-878fce18f2e4" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_464110f4-0b68-4879-a7ce-f4b2335ccd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_03be53cf-3876-42bf-abee-49debc0a68dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_03be53cf-3876-42bf-abee-49debc0a68dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_3b2e0651-30ce-41bf-a749-73cde93c8a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_3b2e0651-30ce-41bf-a749-73cde93c8a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a564e880-b3ef-4ca6-80cb-1123da88e52a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_UseOfEstimates_a564e880-b3ef-4ca6-80cb-1123da88e52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_847338ce-3b92-4e92-9fa9-e1e0c5b1a339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_847338ce-3b92-4e92-9fa9-e1e0c5b1a339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_41e89168-9ef2-4453-8abc-9ecabb42b8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_41e89168-9ef2-4453-8abc-9ecabb42b8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_d4b87fe3-5449-4bf8-862a-35416e1c2cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_d4b87fe3-5449-4bf8-862a-35416e1c2cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_86cc4ef6-7ecc-4390-9b49-2caff3dfce2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_86cc4ef6-7ecc-4390-9b49-2caff3dfce2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_46ead21f-4e8c-4bde-86c3-6ca442cceb3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_46ead21f-4e8c-4bde-86c3-6ca442cceb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_9715cf2a-844f-4abb-bf9d-e81d8877a72c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_9715cf2a-844f-4abb-bf9d-e81d8877a72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d11a81dc-e0f8-4dcc-a76a-c11af369e389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d11a81dc-e0f8-4dcc-a76a-c11af369e389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_4d55408e-fc57-44ae-94bc-6e3b2e8c7cc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_4d55408e-fc57-44ae-94bc-6e3b2e8c7cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_26ccfe21-33bc-4fcd-9ce5-5655db84dc06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_26ccfe21-33bc-4fcd-9ce5-5655db84dc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_2e6fd422-6390-4e6c-9956-2e8ea10eae7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_2e6fd422-6390-4e6c-9956-2e8ea10eae7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_ae81fc64-adba-4348-981a-8412325a1166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_ae81fc64-adba-4348-981a-8412325a1166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_d0de1f4e-690b-4410-8461-2dd743de142f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_d0de1f4e-690b-4410-8461-2dd743de142f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_95f84d6c-756f-4081-899e-c68c062f370c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_95f84d6c-756f-4081-899e-c68c062f370c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ProductShipmentCostsPolicyTextBlock_a6f8d8f5-571c-4e0e-b9bd-0fb6852a26e2" xlink:href="dxcm-20201231.xsd#dxcm_ProductShipmentCostsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_dxcm_ProductShipmentCostsPolicyTextBlock_a6f8d8f5-571c-4e0e-b9bd-0fb6852a26e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_c6489dd8-ba81-4e1f-b36b-59357ce17f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_c6489dd8-ba81-4e1f-b36b-59357ce17f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_8fe05824-2fce-40ac-9c99-dcfc34f99e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_8fe05824-2fce-40ac-9c99-dcfc34f99e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_70795cd6-d1e7-4b4d-907d-4a7ad4001611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_70795cd6-d1e7-4b4d-907d-4a7ad4001611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b5f668fe-1a57-4c82-88ef-f632a1cd9ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b5f668fe-1a57-4c82-88ef-f632a1cd9ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_9d95ebf7-a5e0-4b88-a846-a81bc75c65d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_9d95ebf7-a5e0-4b88-a846-a81bc75c65d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_94c6db64-7784-4893-8e7e-2e112dcf10e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ed430ce-3bbc-4bc6-891e-48331e877ad7" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_94c6db64-7784-4893-8e7e-2e112dcf10e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7e74fb5-0689-48b4-aef1-8d9e80075e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_642b95f9-f149-4147-89f1-cd37c3f504f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7e74fb5-0689-48b4-aef1-8d9e80075e0a" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_642b95f9-f149-4147-89f1-cd37c3f504f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_72bf61bd-7eca-407e-a1c7-e1a9c753f117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7e74fb5-0689-48b4-aef1-8d9e80075e0a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_72bf61bd-7eca-407e-a1c7-e1a9c753f117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ba759d4c-5595-4a04-a357-27f3c3df28d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7e74fb5-0689-48b4-aef1-8d9e80075e0a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ba759d4c-5595-4a04-a357-27f3c3df28d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1cbabf37-d342-42e7-88f3-ccd09bc5143c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_8de61422-ba71-4596-9ae2-3201abb10124" xlink:href="dxcm-20201231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1cbabf37-d342-42e7-88f3-ccd09bc5143c" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_8de61422-ba71-4596-9ae2-3201abb10124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7516f7a4-067a-4382-aab7-624c6b0c00c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_8de61422-ba71-4596-9ae2-3201abb10124" xlink:to="loc_srt_RangeAxis_7516f7a4-067a-4382-aab7-624c6b0c00c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db9770cd-46cc-413e-9cc7-48676d06eff7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7516f7a4-067a-4382-aab7-624c6b0c00c5" xlink:to="loc_srt_RangeMember_db9770cd-46cc-413e-9cc7-48676d06eff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f1a22a44-d1d0-4b6c-8a92-f806e99646e2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db9770cd-46cc-413e-9cc7-48676d06eff7" xlink:to="loc_srt_MinimumMember_f1a22a44-d1d0-4b6c-8a92-f806e99646e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0efa10d3-14ef-4885-b8fd-6197fe22a512" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db9770cd-46cc-413e-9cc7-48676d06eff7" xlink:to="loc_srt_MaximumMember_0efa10d3-14ef-4885-b8fd-6197fe22a512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_da5af5e5-7fb3-40de-b4a4-8cb731d24afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_8de61422-ba71-4596-9ae2-3201abb10124" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_da5af5e5-7fb3-40de-b4a4-8cb731d24afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_da5af5e5-7fb3-40de-b4a4-8cb731d24afa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_51223665-d237-4b6d-ac81-a88c7a166727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:to="loc_us-gaap_ComputerEquipmentMember_51223665-d237-4b6d-ac81-a88c7a166727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_bc688d6e-8062-43dd-8099-44b2ffc3ea8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_bc688d6e-8062-43dd-8099-44b2ffc3ea8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_74efc3d0-cf35-4a1d-b2a3-50f22deb38b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_74efc3d0-cf35-4a1d-b2a3-50f22deb38b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_e5ca5b7d-4db0-4a6c-b9bd-14c4c0b6435b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_21e181b2-fab6-46d6-99f4-26e54a7f4a37" xlink:to="loc_us-gaap_BuildingMember_e5ca5b7d-4db0-4a6c-b9bd-14c4c0b6435b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:href="dxcm-20201231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_8de61422-ba71-4596-9ae2-3201abb10124" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_b4fe4674-556c-46c4-9972-7e43a9afe322" xlink:href="dxcm-20201231.xsd#dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_b4fe4674-556c-46c4-9972-7e43a9afe322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_697a6719-be01-47f5-9b32-b1c71a1942cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_697a6719-be01-47f5-9b32-b1c71a1942cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d0bd053d-2495-4d51-86fc-52559f2cdbb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d0bd053d-2495-4d51-86fc-52559f2cdbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_006637d6-704e-45c2-a6ff-fe344bf90104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_006637d6-704e-45c2-a6ff-fe344bf90104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_2ce170a2-25fb-431a-b8fd-ed98e3367777" xlink:href="dxcm-20201231.xsd#dxcm_RevenueRecognitionSalesReturnsCoveragePeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_2ce170a2-25fb-431a-b8fd-ed98e3367777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_d83e5b55-582d-414b-a398-c770308a7b93" xlink:href="dxcm-20201231.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_d83e5b55-582d-414b-a398-c770308a7b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_16515fa5-ab4c-41bb-82f7-20dfe7cbc7fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_UnbilledContractsReceivable_16515fa5-ab4c-41bb-82f7-20dfe7cbc7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d7e258d0-8933-45ae-8834-9a3fe21bf103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d7e258d0-8933-45ae-8834-9a3fe21bf103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_5329980b-9642-4eff-88aa-b0571e49580c" xlink:href="dxcm-20201231.xsd#dxcm_AmortizationPeriodForIncentiveCompensationCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_5329980b-9642-4eff-88aa-b0571e49580c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_7e518f68-450b-42bc-8626-08f1ada3bb9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_29ba1fe8-df0f-4479-9e98-c44c1ac27820" xlink:to="loc_us-gaap_AdvertisingExpense_7e518f68-450b-42bc-8626-08f1ada3bb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3883a34e-b756-4ee5-857f-7887af651628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_7a9ed2e7-3a4a-4e78-9b62-a1ff6cac6b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3883a34e-b756-4ee5-857f-7887af651628" xlink:to="loc_us-gaap_ConcentrationRiskTable_7a9ed2e7-3a4a-4e78-9b62-a1ff6cac6b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4dc0df3-9639-4481-b513-008722ca9884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_7a9ed2e7-3a4a-4e78-9b62-a1ff6cac6b6f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4dc0df3-9639-4481-b513-008722ca9884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b70fd8a9-9574-40c5-b954-bcfba21b7145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4dc0df3-9639-4481-b513-008722ca9884" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b70fd8a9-9574-40c5-b954-bcfba21b7145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_0dac5338-270e-43f5-b4d2-d667edbc1248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b70fd8a9-9574-40c5-b954-bcfba21b7145" xlink:to="loc_us-gaap_SalesRevenueNetMember_0dac5338-270e-43f5-b4d2-d667edbc1248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_a1ec6f51-48ea-4a1e-804b-47efa9a15a1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b70fd8a9-9574-40c5-b954-bcfba21b7145" xlink:to="loc_us-gaap_AccountsReceivableMember_a1ec6f51-48ea-4a1e-804b-47efa9a15a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d8e6b167-48b2-49f9-b457-7282fab3780f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_7a9ed2e7-3a4a-4e78-9b62-a1ff6cac6b6f" xlink:to="loc_srt_MajorCustomersAxis_d8e6b167-48b2-49f9-b457-7282fab3780f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_d8e6b167-48b2-49f9-b457-7282fab3780f" xlink:to="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerAMember_868a39ab-ced5-40c5-bafa-6425c918c382" xlink:href="dxcm-20201231.xsd#dxcm_CustomerAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:to="loc_dxcm_CustomerAMember_868a39ab-ced5-40c5-bafa-6425c918c382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerBMember_243e8225-c4bd-4c8d-863b-678cb56dae31" xlink:href="dxcm-20201231.xsd#dxcm_CustomerBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:to="loc_dxcm_CustomerBMember_243e8225-c4bd-4c8d-863b-678cb56dae31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerCMember_d0b511e5-ce55-4494-892c-6678a1d7d5c3" xlink:href="dxcm-20201231.xsd#dxcm_CustomerCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:to="loc_dxcm_CustomerCMember_d0b511e5-ce55-4494-892c-6678a1d7d5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerDMember_25953ce3-aa2c-4fb3-b73b-dd65578abb16" xlink:href="dxcm-20201231.xsd#dxcm_CustomerDMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5450da2f-14ee-4045-81f3-48972689452b" xlink:to="loc_dxcm_CustomerDMember_25953ce3-aa2c-4fb3-b73b-dd65578abb16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_cc959112-368c-40bb-b701-b2b630975cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_7a9ed2e7-3a4a-4e78-9b62-a1ff6cac6b6f" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_cc959112-368c-40bb-b701-b2b630975cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ee48a7b8-a346-44e8-bf78-9ba781345e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cc959112-368c-40bb-b701-b2b630975cb0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ee48a7b8-a346-44e8-bf78-9ba781345e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76a50dd5-2863-4d11-aa66-e226a350b422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8bcce8ae-b883-4eb6-9121-ebf7efb1a51a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76a50dd5-2863-4d11-aa66-e226a350b422" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8bcce8ae-b883-4eb6-9121-ebf7efb1a51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e83b048d-5a55-4ed6-80d2-1d9c71131a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8bcce8ae-b883-4eb6-9121-ebf7efb1a51a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e83b048d-5a55-4ed6-80d2-1d9c71131a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e83b048d-5a55-4ed6-80d2-1d9c71131a35" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5cb6bd6f-9fe2-4d5d-a495-35a7f3d6c14b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5cb6bd6f-9fe2-4d5d-a495-35a7f3d6c14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_91bb3f48-0258-43ef-9ad7-e0e2ebe20c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_91bb3f48-0258-43ef-9ad7-e0e2ebe20c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_94f08a9a-759e-4540-bb61-a335ca34fcd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:to="loc_us-gaap_WarrantMember_94f08a9a-759e-4540-bb61-a335ca34fcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_55a1c560-4f2f-46a2-9e4f-ec2fe06189a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfe414e8-d383-47d9-ba2c-b8f8ca23871e" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_55a1c560-4f2f-46a2-9e4f-ec2fe06189a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8bcce8ae-b883-4eb6-9121-ebf7efb1a51a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_20d6f4c7-8f96-420e-b486-e5e3416905f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_NetIncomeLoss_20d6f4c7-8f96-420e-b486-e5e3416905f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_27bc140d-939a-4f76-ba5a-d257d7db71ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_EarningsPerShareBasic_27bc140d-939a-4f76-ba5a-d257d7db71ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_52874e42-3e79-446e-bb93-5c9bc864edea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_52874e42-3e79-446e-bb93-5c9bc864edea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9ac12086-9b6d-4880-9f99-c695ecd92f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9ac12086-9b6d-4880-9f99-c695ecd92f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_083bae99-9f41-480c-8639-2e4df2618c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_083bae99-9f41-480c-8639-2e4df2618c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e4d32ff4-0fb2-4f1a-b43d-afd0ff631034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ddd5dfa-faac-4656-b4f6-dcd68bbabef7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e4d32ff4-0fb2-4f1a-b43d-afd0ff631034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3464b2a8-38e8-46c3-be5e-26892c16660d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_71db9505-bdcc-46e7-bb2b-ced4382f7be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3464b2a8-38e8-46c3-be5e-26892c16660d" xlink:to="loc_us-gaap_AccountingPoliciesAbstract_71db9505-bdcc-46e7-bb2b-ced4382f7be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_781e59b9-3c67-4ad2-ba9c-f491dd3496ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_71db9505-bdcc-46e7-bb2b-ced4382f7be9" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_781e59b9-3c67-4ad2-ba9c-f491dd3496ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_805c8f9a-9c8e-44af-8805-86f73c5ca289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_781e59b9-3c67-4ad2-ba9c-f491dd3496ea" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_805c8f9a-9c8e-44af-8805-86f73c5ca289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_805c8f9a-9c8e-44af-8805-86f73c5ca289" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c1a12800-bb0a-41bf-8a9b-2e15f10b8a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c1a12800-bb0a-41bf-8a9b-2e15f10b8a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_aefbd355-9b3c-4abf-9bdc-ed9765074b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_aefbd355-9b3c-4abf-9bdc-ed9765074b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_38d4580d-ec61-475b-bbdd-a5f809b2d7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:to="loc_us-gaap_WarrantMember_38d4580d-ec61-475b-bbdd-a5f809b2d7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_4cdd9b58-1794-44b9-9f42-e7d5066c72b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_620e870c-3dcc-495f-90b9-56f2bc5572d7" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_4cdd9b58-1794-44b9-9f42-e7d5066c72b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3d133426-0e39-49c2-8593-e4ade5802f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_781e59b9-3c67-4ad2-ba9c-f491dd3496ea" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3d133426-0e39-49c2-8593-e4ade5802f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f0d8e03c-83ac-4d54-8712-4591945aaeed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3d133426-0e39-49c2-8593-e4ade5802f16" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f0d8e03c-83ac-4d54-8712-4591945aaeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DevelopmentandOtherAgreements"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c69354bd-2666-4926-aa7c-25ab606ae78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAndOtherAgreementsTextBlock_198bd857-0a51-49d6-9410-512ce0b8b2db" xlink:href="dxcm-20201231.xsd#dxcm_DevelopmentAndOtherAgreementsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c69354bd-2666-4926-aa7c-25ab606ae78a" xlink:to="loc_dxcm_DevelopmentAndOtherAgreementsTextBlock_198bd857-0a51-49d6-9410-512ce0b8b2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DevelopmentandOtherAgreementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_40f61db9-923f-4e99-acf0-f30d95de28ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:href="dxcm-20201231.xsd#dxcm_DevelopmentAgreementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_40f61db9-923f-4e99-acf0-f30d95de28ed" xlink:to="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_cd6433e0-8be9-4f5a-b6f7-91b5a5c99de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_cd6433e0-8be9-4f5a-b6f7-91b5a5c99de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0c7c1681-7360-49f7-8829-aa782a695ee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_cd6433e0-8be9-4f5a-b6f7-91b5a5c99de7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0c7c1681-7360-49f7-8829-aa782a695ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_19463a49-52a5-4375-b49d-a0a7748fed19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0c7c1681-7360-49f7-8829-aa782a695ee7" xlink:to="loc_us-gaap_CollaborativeArrangementMember_19463a49-52a5-4375-b49d-a0a7748fed19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_4cdfe930-6289-421a-9747-850c6bb0bd33" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:to="loc_srt_CounterpartyNameAxis_4cdfe930-6289-421a-9747-850c6bb0bd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fdc58467-ab43-40ee-93be-ea7702b2db0d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_4cdfe930-6289-421a-9747-850c6bb0bd33" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fdc58467-ab43-40ee-93be-ea7702b2db0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_e09ce99d-0514-4eb0-a4da-8328ee455bfc" xlink:href="dxcm-20201231.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fdc58467-ab43-40ee-93be-ea7702b2db0d" xlink:to="loc_dxcm_VerilyLifeSciencesMember_e09ce99d-0514-4eb0-a4da-8328ee455bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6e7f5976-bc81-4cf7-bcf1-b0df7dc2e577" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6e7f5976-bc81-4cf7-bcf1-b0df7dc2e577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_24e96c45-c117-4f44-b670-29877b86568b" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6e7f5976-bc81-4cf7-bcf1-b0df7dc2e577" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_24e96c45-c117-4f44-b670-29877b86568b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_d3dac385-3ad4-4cbd-a67f-1ee4e116f094" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_24e96c45-c117-4f44-b670-29877b86568b" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_d3dac385-3ad4-4cbd-a67f-1ee4e116f094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_64046102-4a8b-42f8-b13e-f97c35dc0aef" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_24e96c45-c117-4f44-b670-29877b86568b" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_64046102-4a8b-42f8-b13e-f97c35dc0aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:href="dxcm-20201231.xsd#dxcm_DevelopmentAgreementsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_cab6c0af-327e-4a3c-9114-319ea1f7ab1b" xlink:to="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_f12ac472-1d17-44a0-a3db-fbcee8b921cd" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_f12ac472-1d17-44a0-a3db-fbcee8b921cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e950df04-ec04-4082-b520-04f9c44ae239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e950df04-ec04-4082-b520-04f9c44ae239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_186a75ab-587b-4aae-81d0-a4bc58874825" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_186a75ab-587b-4aae-81d0-a4bc58874825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_acd61456-9061-48de-8394-a17393fd2726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_us-gaap_SharePrice_acd61456-9061-48de-8394-a17393fd2726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_7557ffac-ab0f-4b6d-840a-5b9fa43ed0c4" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_7557ffac-ab0f-4b6d-840a-5b9fa43ed0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_0abc89c6-7c3f-4eaa-91dd-c5a06339598f" xlink:href="dxcm-20201231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_0abc89c6-7c3f-4eaa-91dd-c5a06339598f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_5dd2a78c-9000-48d2-a9d1-46b1eb270e2c" xlink:href="dxcm-20201231.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_5dd2a78c-9000-48d2-a9d1-46b1eb270e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_0411359c-b86c-4eed-8b6d-86f1cd5c3e65" xlink:href="dxcm-20201231.xsd#dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_1f40aeab-3de0-48e8-8a49-033aeeb36102" xlink:to="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_0411359c-b86c-4eed-8b6d-86f1cd5c3e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f4515dcf-b282-40f8-9eb9-bb53210958c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_89bab328-8931-4c98-b00d-90b9169be1cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f4515dcf-b282-40f8-9eb9-bb53210958c1" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_89bab328-8931-4c98-b00d-90b9169be1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e94233f4-7597-4530-94f7-ba54677d9fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_d156703a-ba54-4cb5-9fb6-eddf7e3a7e92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e94233f4-7597-4530-94f7-ba54677d9fb2" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_d156703a-ba54-4cb5-9fb6-eddf7e3a7e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_3d29d019-cd72-4326-a4c2-c986a2ef4fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e94233f4-7597-4530-94f7-ba54677d9fb2" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_3d29d019-cd72-4326-a4c2-c986a2ef4fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b22e6176-d829-4663-9ec1-72a93607aea9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_df8e4248-adaf-487d-88c7-e8e08bb8205b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b22e6176-d829-4663-9ec1-72a93607aea9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_df8e4248-adaf-487d-88c7-e8e08bb8205b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d03c8eef-fece-4036-9a6f-6892979efb0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_df8e4248-adaf-487d-88c7-e8e08bb8205b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d03c8eef-fece-4036-9a6f-6892979efb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d03c8eef-fece-4036-9a6f-6892979efb0d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3028bb71-9cd9-4759-93ed-633b9bb25c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3028bb71-9cd9-4759-93ed-633b9bb25c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9ed4f51f-b9f3-43d7-9434-b17fdd51bc76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:to="loc_us-gaap_CommercialPaperMember_9ed4f51f-b9f3-43d7-9434-b17fdd51bc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a5496550-41c8-4937-9613-3e2cd9f21f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74940d33-15c2-4fa2-92ca-95c95aefc057" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a5496550-41c8-4937-9613-3e2cd9f21f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b80451e4-c717-4aeb-9687-6d1bcaf3b465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_df8e4248-adaf-487d-88c7-e8e08bb8205b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b80451e4-c717-4aeb-9687-6d1bcaf3b465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b80451e4-c717-4aeb-9687-6d1bcaf3b465" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_77c7d997-0a33-4f9a-bbc7-ef2e88a229c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_77c7d997-0a33-4f9a-bbc7-ef2e88a229c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1254ee36-45a7-4ee2-9df2-2b4b1ef29dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1254ee36-45a7-4ee2-9df2-2b4b1ef29dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d8b196f1-a7b6-4cc6-9a57-b1440ee520a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d0f5462-8ef1-4f82-9c17-4907253fb800" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d8b196f1-a7b6-4cc6-9a57-b1440ee520a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_df8e4248-adaf-487d-88c7-e8e08bb8205b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_5d1d9b09-d55c-49d5-a071-4f7904e28f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_5d1d9b09-d55c-49d5-a071-4f7904e28f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_145e3bd0-d855-45b4-bee0-4a8d6728e13e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_145e3bd0-d855-45b4-bee0-4a8d6728e13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_d5a60c45-150a-4238-a035-0d6b1d35900e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_d5a60c45-150a-4238-a035-0d6b1d35900e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6a634bc1-9886-424b-9a27-9f672bca9d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a47290a9-8bf8-4e75-b066-bdc4ee5b1454" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6a634bc1-9886-424b-9a27-9f672bca9d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_347a6051-0ac8-48b7-8659-fabce5010726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9be4652d-b595-428b-950b-d304e8783ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_347a6051-0ac8-48b7-8659-fabce5010726" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9be4652d-b595-428b-950b-d304e8783ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d4d99af7-de6a-4e05-8c19-2ed43abfde54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9be4652d-b595-428b-950b-d304e8783ddf" xlink:to="loc_us-gaap_HedgingDesignationAxis_d4d99af7-de6a-4e05-8c19-2ed43abfde54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ce8a8fdd-5722-4fef-a185-5c7a5815f6c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d4d99af7-de6a-4e05-8c19-2ed43abfde54" xlink:to="loc_us-gaap_HedgingDesignationDomain_ce8a8fdd-5722-4fef-a185-5c7a5815f6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_779fe796-430a-401a-bdf0-da5bbd5e437f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ce8a8fdd-5722-4fef-a185-5c7a5815f6c4" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_779fe796-430a-401a-bdf0-da5bbd5e437f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3eec09a0-c1e7-4c55-aea6-3fedba95e3bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9be4652d-b595-428b-950b-d304e8783ddf" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3eec09a0-c1e7-4c55-aea6-3fedba95e3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_622060f6-a013-4a57-b2a7-98e3c00a687f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3eec09a0-c1e7-4c55-aea6-3fedba95e3bc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_622060f6-a013-4a57-b2a7-98e3c00a687f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_12ab07ec-8924-4707-9a84-ff58d2203864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_622060f6-a013-4a57-b2a7-98e3c00a687f" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_12ab07ec-8924-4707-9a84-ff58d2203864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9be4652d-b595-428b-950b-d304e8783ddf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_124eafec-5f33-44d4-8a66-d08cac0b7e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:to="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_124eafec-5f33-44d4-8a66-d08cac0b7e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_b2b8f2d9-cef6-4e4c-80b7-2aa5d4374aed" xlink:href="dxcm-20201231.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_b2b8f2d9-cef6-4e4c-80b7-2aa5d4374aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cfb6fbf0-ea95-4073-9423-2f5d27638051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cfb6fbf0-ea95-4073-9423-2f5d27638051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_09af5928-4e8a-4f7f-acc6-81b888a7448f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_204f8a96-f36d-4664-9cce-cb1f748b8555" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_09af5928-4e8a-4f7f-acc6-81b888a7448f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_99fb1bcf-10e6-4c8f-bd95-a44fa609cb91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c15af2f6-e55e-4ab1-8b6c-a46ea60a8463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_99fb1bcf-10e6-4c8f-bd95-a44fa609cb91" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c15af2f6-e55e-4ab1-8b6c-a46ea60a8463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_88eb8b32-982f-4f31-bbed-426537dba54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c15af2f6-e55e-4ab1-8b6c-a46ea60a8463" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_88eb8b32-982f-4f31-bbed-426537dba54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a6343a7e-5ac6-4bab-b3e9-1c2b407d285a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_88eb8b32-982f-4f31-bbed-426537dba54a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a6343a7e-5ac6-4bab-b3e9-1c2b407d285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0edc4843-0f6b-4386-9ab8-d786e966ca0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a6343a7e-5ac6-4bab-b3e9-1c2b407d285a" xlink:to="loc_us-gaap_SeniorNotesMember_0edc4843-0f6b-4386-9ab8-d786e966ca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9d89ba79-b76c-4e34-84a6-4d442adc72e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c15af2f6-e55e-4ab1-8b6c-a46ea60a8463" xlink:to="loc_us-gaap_DebtInstrumentAxis_9d89ba79-b76c-4e34-84a6-4d442adc72e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9d89ba79-b76c-4e34-84a6-4d442adc72e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_e675c82d-7c3f-4342-88c7-cb8e0a42eb41" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_e675c82d-7c3f-4342-88c7-cb8e0a42eb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_85382726-c5bb-4706-a87d-317934bde8f6" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_85382726-c5bb-4706-a87d-317934bde8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_4a6b1873-0a29-4af3-990b-1cd7794b32b6" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d899bec5-8375-4b93-a13f-5702a9b2171d" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_4a6b1873-0a29-4af3-990b-1cd7794b32b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a58bf347-6d11-4c80-aa2a-df62d40b00eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c15af2f6-e55e-4ab1-8b6c-a46ea60a8463" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a58bf347-6d11-4c80-aa2a-df62d40b00eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_702ae15d-c24c-4379-b0dd-2ab013b069bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a58bf347-6d11-4c80-aa2a-df62d40b00eb" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_702ae15d-c24c-4379-b0dd-2ab013b069bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_663547a5-c7b2-43da-bc8b-d1f03b969804" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_23b0236b-c8f7-4b85-94ac-71700fa093f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_663547a5-c7b2-43da-bc8b-d1f03b969804" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_23b0236b-c8f7-4b85-94ac-71700fa093f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_54b7c19c-14ac-4cd6-af3e-aeb3b660eadd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_f3dd0c33-01c6-47c6-9320-d52767887c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_54b7c19c-14ac-4cd6-af3e-aeb3b660eadd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_f3dd0c33-01c6-47c6-9320-d52767887c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_db5283aa-28fd-46b9-a415-a46cc315a948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_54b7c19c-14ac-4cd6-af3e-aeb3b660eadd" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_db5283aa-28fd-46b9-a415-a46cc315a948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_70d3e1bc-29fd-4831-abd7-69d947f8f3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_54b7c19c-14ac-4cd6-af3e-aeb3b660eadd" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_70d3e1bc-29fd-4831-abd7-69d947f8f3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9d6093b6-d525-45ae-bcf8-e086a95fdb54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_54b7c19c-14ac-4cd6-af3e-aeb3b660eadd" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9d6093b6-d525-45ae-bcf8-e086a95fdb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_41f9bb8f-355f-4ae3-a658-84a309689e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_54b7c19c-14ac-4cd6-af3e-aeb3b660eadd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_41f9bb8f-355f-4ae3-a658-84a309689e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_84e8b16a-c453-4546-a05c-02257ea164fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_54b7c19c-14ac-4cd6-af3e-aeb3b660eadd" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_84e8b16a-c453-4546-a05c-02257ea164fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_f59f3cae-2d30-4f84-8dd5-a4b04f0c6781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_54b7c19c-14ac-4cd6-af3e-aeb3b660eadd" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_f59f3cae-2d30-4f84-8dd5-a4b04f0c6781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_3d155a50-cf56-4b9b-af2f-ddf999c63adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_54b7c19c-14ac-4cd6-af3e-aeb3b660eadd" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_3d155a50-cf56-4b9b-af2f-ddf999c63adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_8dbf8f03-940c-444d-9ae0-cfe88577c07b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FinancialStatementDetailsTable_78fbd9e7-7fc8-46a2-a4c9-1df0c4a5368f" xlink:href="dxcm-20201231.xsd#dxcm_FinancialStatementDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_8dbf8f03-940c-444d-9ae0-cfe88577c07b" xlink:to="loc_dxcm_FinancialStatementDetailsTable_78fbd9e7-7fc8-46a2-a4c9-1df0c4a5368f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_bae668e5-4cd8-4520-822f-dc42448eb1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FinancialStatementDetailsTable_78fbd9e7-7fc8-46a2-a4c9-1df0c4a5368f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_bae668e5-4cd8-4520-822f-dc42448eb1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bae668e5-4cd8-4520-822f-dc42448eb1d3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_4cdd0644-27ea-44b5-8704-4436de44a0a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_4cdd0644-27ea-44b5-8704-4436de44a0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6211d20f-9b53-430f-884a-bf062a5400cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:to="loc_us-gaap_CommercialPaperMember_6211d20f-9b53-430f-884a-bf062a5400cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_861305b2-127b-44d1-8300-6cdda2189e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65795e55-cf8e-41f8-b6f6-408be6c78ced" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_861305b2-127b-44d1-8300-6cdda2189e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:href="dxcm-20201231.xsd#dxcm_FinancialStatementDetailsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FinancialStatementDetailsTable_78fbd9e7-7fc8-46a2-a4c9-1df0c4a5368f" xlink:to="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_18402f72-6d89-404e-b0d8-5ca8285e0526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_18402f72-6d89-404e-b0d8-5ca8285e0526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b300c59f-61e6-4be1-b48c-1b1b211e3e1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b300c59f-61e6-4be1-b48c-1b1b211e3e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3b30d772-7c80-479a-9bee-c040d13695db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3b30d772-7c80-479a-9bee-c040d13695db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_09aaa945-5b71-44d6-8ce3-8ffa0b17ae7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_01406fcf-a186-4318-b1ed-488ce374a136" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_09aaa945-5b71-44d6-8ce3-8ffa0b17ae7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_b3e228c1-5f6a-485e-8c28-808b12e2cd9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_1f724236-fe53-49d9-a5f2-be1e144dc01c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_b3e228c1-5f6a-485e-8c28-808b12e2cd9d" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_1f724236-fe53-49d9-a5f2-be1e144dc01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_67e98ad4-97be-47c2-9458-9bee52075523" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_1f724236-fe53-49d9-a5f2-be1e144dc01c" xlink:to="loc_srt_ProductOrServiceAxis_67e98ad4-97be-47c2-9458-9bee52075523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_49bfc2b1-c19b-4719-af8f-52e2685e4782" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_67e98ad4-97be-47c2-9458-9bee52075523" xlink:to="loc_srt_ProductsAndServicesDomain_49bfc2b1-c19b-4719-af8f-52e2685e4782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ReceiverProductComponentMember_79766a92-f212-4384-9491-51b528aad3e9" xlink:href="dxcm-20201231.xsd#dxcm_ReceiverProductComponentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_49bfc2b1-c19b-4719-af8f-52e2685e4782" xlink:to="loc_dxcm_ReceiverProductComponentMember_79766a92-f212-4384-9491-51b528aad3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_1f724236-fe53-49d9-a5f2-be1e144dc01c" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_859e2a16-42b4-4084-ad30-bfd4d6d57114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_859e2a16-42b4-4084-ad30-bfd4d6d57114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_2e01893d-9ff2-4bf5-9aba-aa7f301f8c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:to="loc_us-gaap_InventoryWriteDown_2e01893d-9ff2-4bf5-9aba-aa7f301f8c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9e8a8e1f-c85a-4d18-b542-71ddc7802b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:to="loc_us-gaap_Depreciation_9e8a8e1f-c85a-4d18-b542-71ddc7802b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b87a53a4-7cf8-4e18-95d9-6f166eff0cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_67ebee0b-f294-4edb-abe7-536222e1db7b" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b87a53a4-7cf8-4e18-95d9-6f166eff0cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_b126d816-7aaa-4dbf-93a6-4525c0af3f6e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_d7d00988-25b4-478c-bef9-ea845b825917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_b126d816-7aaa-4dbf-93a6-4525c0af3f6e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_d7d00988-25b4-478c-bef9-ea845b825917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_64ef0066-b9c8-4072-b9ee-1c9ed7cf9c44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_d7d00988-25b4-478c-bef9-ea845b825917" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_64ef0066-b9c8-4072-b9ee-1c9ed7cf9c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_4f3f863b-a4ad-470e-b5bb-487f987bbd43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_d7d00988-25b4-478c-bef9-ea845b825917" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_4f3f863b-a4ad-470e-b5bb-487f987bbd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_512e025e-1053-48eb-81b5-5e72ee3390de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_d7d00988-25b4-478c-bef9-ea845b825917" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_512e025e-1053-48eb-81b5-5e72ee3390de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_63f95dd7-8638-4779-af3d-250924988390" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_58ec530c-d61f-4a1b-80c3-85bba6e231fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_63f95dd7-8638-4779-af3d-250924988390" xlink:to="loc_us-gaap_AccountsReceivableGross_58ec530c-d61f-4a1b-80c3-85bba6e231fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cea3a640-79ba-4f79-b0f4-6dbca054e3b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_63f95dd7-8638-4779-af3d-250924988390" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cea3a640-79ba-4f79-b0f4-6dbca054e3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_4df3b015-c38e-445f-8236-90a75fcb5401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_63f95dd7-8638-4779-af3d-250924988390" xlink:to="loc_us-gaap_AccountsReceivableNet_4df3b015-c38e-445f-8236-90a75fcb5401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_ba66ebfc-c646-430b-9535-f3241733c42a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_1ed71179-5951-4142-8845-7f40268d4aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_ba66ebfc-c646-430b-9535-f3241733c42a" xlink:to="loc_us-gaap_InventoryDisclosureAbstract_1ed71179-5951-4142-8845-7f40268d4aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_03ffb848-21ef-4812-b8cc-43558f5ca886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1ed71179-5951-4142-8845-7f40268d4aff" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_03ffb848-21ef-4812-b8cc-43558f5ca886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a11e5a64-9e7a-496c-8ab7-f1660fa4757b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1ed71179-5951-4142-8845-7f40268d4aff" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a11e5a64-9e7a-496c-8ab7-f1660fa4757b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_90f2add2-4eb0-4998-a8fa-272d25cf4ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1ed71179-5951-4142-8845-7f40268d4aff" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_90f2add2-4eb0-4998-a8fa-272d25cf4ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a365bcb6-6268-44a5-9d41-1caba87e2ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1ed71179-5951-4142-8845-7f40268d4aff" xlink:to="loc_us-gaap_InventoryNet_a365bcb6-6268-44a5-9d41-1caba87e2ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_5351e9e6-4f25-48e6-b58b-d38afce9bd21" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c67c4bf6-bd4a-4f5c-851d-f86b9c0b3aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_5351e9e6-4f25-48e6-b58b-d38afce9bd21" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c67c4bf6-bd4a-4f5c-851d-f86b9c0b3aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f932c295-8710-431a-8425-43bdc58a114e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c67c4bf6-bd4a-4f5c-851d-f86b9c0b3aa0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f932c295-8710-431a-8425-43bdc58a114e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f932c295-8710-431a-8425-43bdc58a114e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_563c53ba-a602-4cec-ad21-8ab9b30ea15e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_LandMember_563c53ba-a602-4cec-ad21-8ab9b30ea15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_f33b9d2e-f3bc-4d27-b719-fba5edb223bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_BuildingMember_f33b9d2e-f3bc-4d27-b719-fba5edb223bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_4c28a5fc-c076-4f3d-929b-b4a0885a5e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_4c28a5fc-c076-4f3d-929b-b4a0885a5e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_552e3e7b-113a-4c5d-b5c1-aa32f10876eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_ComputerEquipmentMember_552e3e7b-113a-4c5d-b5c1-aa32f10876eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_2b1f94d9-36c2-45a1-aead-735e2d5796b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_EquipmentMember_2b1f94d9-36c2-45a1-aead-735e2d5796b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_420b4fa6-6602-4750-af02-d8b0bb6fef2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_420b4fa6-6602-4750-af02-d8b0bb6fef2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_3a24caf9-456b-40fa-a5d0-89f19a6cdb36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43c00dd8-97c6-44ac-8ecc-8df2ee6b6ca4" xlink:to="loc_us-gaap_ConstructionInProgressMember_3a24caf9-456b-40fa-a5d0-89f19a6cdb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c67c4bf6-bd4a-4f5c-851d-f86b9c0b3aa0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_daf294bc-7c93-4574-a927-07f6a37ddab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_daf294bc-7c93-4574-a927-07f6a37ddab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_837f0b63-dadf-41ef-b155-4eb622ba5fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_837f0b63-dadf-41ef-b155-4eb622ba5fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_88e37b49-1c05-4101-a885-4ab78d591940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6167618b-b930-4c07-9f12-7e04550c7e6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_88e37b49-1c05-4101-a885-4ab78d591940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_a6e4cb84-a9d1-4c8f-a9d2-27c29b1f4b0b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_5edda368-22ac-426b-9129-221a1b990655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_a6e4cb84-a9d1-4c8f-a9d2-27c29b1f4b0b" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_5edda368-22ac-426b-9129-221a1b990655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees_3debf12e-5796-41d0-b1a5-2efa07fe67b8" xlink:href="dxcm-20201231.xsd#dxcm_AccruedTaxAuditAndLegalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_a6e4cb84-a9d1-4c8f-a9d2-27c29b1f4b0b" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFees_3debf12e-5796-41d0-b1a5-2efa07fe67b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebates_5d3dbd81-9fb6-4ca3-9531-53f0a47b0235" xlink:href="dxcm-20201231.xsd#dxcm_PharmacyRebates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_a6e4cb84-a9d1-4c8f-a9d2-27c29b1f4b0b" xlink:to="loc_dxcm_PharmacyRebates_5d3dbd81-9fb6-4ca3-9531-53f0a47b0235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_dd66c1ec-9468-481c-8529-5f4a17d0488b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_a6e4cb84-a9d1-4c8f-a9d2-27c29b1f4b0b" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_dd66c1ec-9468-481c-8529-5f4a17d0488b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_efa9ad50-12d4-4225-a512-0541650743ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_a6e4cb84-a9d1-4c8f-a9d2-27c29b1f4b0b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_efa9ad50-12d4-4225-a512-0541650743ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_3e239930-227c-4bdd-9ff5-ed8fe14505be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_a6e4cb84-a9d1-4c8f-a9d2-27c29b1f4b0b" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_3e239930-227c-4bdd-9ff5-ed8fe14505be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsAccruedWarrantyDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_9d86008f-a916-4808-ad4f-0aa92e6cac61" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_2402ec80-ef96-48c2-ae1c-1a6d6570a51b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_9d86008f-a916-4808-ad4f-0aa92e6cac61" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_2402ec80-ef96-48c2-ae1c-1a6d6570a51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_7389ab76-1264-4615-8bbd-a2bdb886700e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_2402ec80-ef96-48c2-ae1c-1a6d6570a51b" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_7389ab76-1264-4615-8bbd-a2bdb886700e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_f687104b-2779-40f4-82f9-628fff5de661" xlink:href="dxcm-20201231.xsd#dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_2402ec80-ef96-48c2-ae1c-1a6d6570a51b" xlink:to="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_f687104b-2779-40f4-82f9-628fff5de661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_bc752c29-9df2-44a3-9a50-87ffd71e1522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_2402ec80-ef96-48c2-ae1c-1a6d6570a51b" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_bc752c29-9df2-44a3-9a50-87ffd71e1522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_224d35ac-9e58-42d7-91c2-768c89c33fd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_2402ec80-ef96-48c2-ae1c-1a6d6570a51b" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_224d35ac-9e58-42d7-91c2-768c89c33fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BalanceSheetDetailsOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3edf7ee5-4d2a-4dc7-a4ec-ffed70fd45b5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FinancingLeaseObligation_9a7f9052-6c0f-4c27-89c4-5b3bc47c7ad0" xlink:href="dxcm-20201231.xsd#dxcm_FinancingLeaseObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3edf7ee5-4d2a-4dc7-a4ec-ffed70fd45b5" xlink:to="loc_dxcm_FinancingLeaseObligation_9a7f9052-6c0f-4c27-89c4-5b3bc47c7ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_a4a2c8f1-9e19-4f35-a6a5-445c51f33875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3edf7ee5-4d2a-4dc7-a4ec-ffed70fd45b5" xlink:to="loc_us-gaap_ContractualObligation_a4a2c8f1-9e19-4f35-a6a5-445c51f33875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_1a744fa4-5ef8-4cbf-adbc-972a5890eca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3edf7ee5-4d2a-4dc7-a4ec-ffed70fd45b5" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_1a744fa4-5ef8-4cbf-adbc-972a5890eca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b66443c5-b904-4db4-9cf4-aac7f4d12461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3edf7ee5-4d2a-4dc7-a4ec-ffed70fd45b5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b66443c5-b904-4db4-9cf4-aac7f4d12461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt" xlink:type="simple" xlink:href="dxcm-20201231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0e417777-1e20-47e5-ab8d-93e3bd01ad05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_35e9c751-a00b-4b1b-9c96-6f8440f87e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0e417777-1e20-47e5-ab8d-93e3bd01ad05" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_35e9c751-a00b-4b1b-9c96-6f8440f87e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2520857b-551b-4c11-a813-af918ab07733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0d09fad1-c714-4dff-b2e5-068075dbf931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2520857b-551b-4c11-a813-af918ab07733" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0d09fad1-c714-4dff-b2e5-068075dbf931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_ad381c0c-a5af-4d37-9f67-f85f70c55170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2520857b-551b-4c11-a813-af918ab07733" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_ad381c0c-a5af-4d37-9f67-f85f70c55170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_ce797c80-6034-4d6c-9575-41dacadb8969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2520857b-551b-4c11-a813-af918ab07733" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_ce797c80-6034-4d6c-9575-41dacadb8969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9ad91bc2-e59d-4881-8140-a58f22037e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2520857b-551b-4c11-a813-af918ab07733" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9ad91bc2-e59d-4881-8140-a58f22037e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fd1a86ee-4eef-48a5-b949-c0bb595ce2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fcbafdcb-c032-4510-afe3-449f72086c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd1a86ee-4eef-48a5-b949-c0bb595ce2e7" xlink:to="loc_us-gaap_DebtInstrumentTable_fcbafdcb-c032-4510-afe3-449f72086c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2106f191-43c2-4107-9607-ae496c1804f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fcbafdcb-c032-4510-afe3-449f72086c82" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2106f191-43c2-4107-9607-ae496c1804f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bd5dd2e3-7ff3-4376-8e7f-b930898ad12b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2106f191-43c2-4107-9607-ae496c1804f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bd5dd2e3-7ff3-4376-8e7f-b930898ad12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7f41c475-13e0-4089-9480-c0d0949ad9f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bd5dd2e3-7ff3-4376-8e7f-b930898ad12b" xlink:to="loc_us-gaap_SeniorNotesMember_7f41c475-13e0-4089-9480-c0d0949ad9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_303ec871-0396-4b6d-8ba4-e945339f8211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fcbafdcb-c032-4510-afe3-449f72086c82" xlink:to="loc_us-gaap_DebtInstrumentAxis_303ec871-0396-4b6d-8ba4-e945339f8211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_303ec871-0396-4b6d-8ba4-e945339f8211" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_fca85079-c653-4123-85a7-15323f41c4ad" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_fca85079-c653-4123-85a7-15323f41c4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_d766bc02-8b69-49dd-b91b-4afceae60a64" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_d766bc02-8b69-49dd-b91b-4afceae60a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_a8e602c4-0b20-47e2-9731-a80b163b7e43" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cb0cd6ce-f6ce-4804-b22f-875bd7c05ed6" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_a8e602c4-0b20-47e2-9731-a80b163b7e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fcbafdcb-c032-4510-afe3-449f72086c82" xlink:to="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4db9eeb0-60c3-4521-9061-310dc204b2a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4db9eeb0-60c3-4521-9061-310dc204b2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d176d577-e1f5-4e86-a520-36405f2edb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d176d577-e1f5-4e86-a520-36405f2edb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_819574e3-5fc6-4b94-a807-531462435d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_819574e3-5fc6-4b94-a807-531462435d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_db833025-5e6b-45a3-b82f-33c568c650b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_6e3e162e-119c-40a0-86c1-6da465fd8cc6" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_db833025-5e6b-45a3-b82f-33c568c650b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_c3da7750-7cd9-4192-8ae6-34adb88c1f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_c3da7750-7cd9-4192-8ae6-34adb88c1f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_f687d622-9eb4-4cc0-8107-04096e5cc04e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_af7c3c76-f631-452c-92df-44e61aa6ec6b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_f687d622-9eb4-4cc0-8107-04096e5cc04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtConversionValueofConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_96f70495-cce0-42af-bb1b-149c672a3515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_706284e5-5baa-4b51-9e0c-1cd18c7ba944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_96f70495-cce0-42af-bb1b-149c672a3515" xlink:to="loc_us-gaap_DebtInstrumentTable_706284e5-5baa-4b51-9e0c-1cd18c7ba944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_662dac8e-9ecc-48de-a800-4c854dbe36c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_706284e5-5baa-4b51-9e0c-1cd18c7ba944" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_662dac8e-9ecc-48de-a800-4c854dbe36c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8df64ba8-b0c8-43eb-8bdf-c3f896315ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_662dac8e-9ecc-48de-a800-4c854dbe36c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8df64ba8-b0c8-43eb-8bdf-c3f896315ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c4113b85-7a1f-4950-bb78-c555f58397f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8df64ba8-b0c8-43eb-8bdf-c3f896315ef3" xlink:to="loc_us-gaap_SeniorNotesMember_c4113b85-7a1f-4950-bb78-c555f58397f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_84657638-2117-4c28-8395-6c440edaf622" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_706284e5-5baa-4b51-9e0c-1cd18c7ba944" xlink:to="loc_us-gaap_DebtInstrumentAxis_84657638-2117-4c28-8395-6c440edaf622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_656ddb6b-123f-47b5-9f4b-388f1de736b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_84657638-2117-4c28-8395-6c440edaf622" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_656ddb6b-123f-47b5-9f4b-388f1de736b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_68f0bad7-13c0-4086-8697-6b4c36488549" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_656ddb6b-123f-47b5-9f4b-388f1de736b3" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_68f0bad7-13c0-4086-8697-6b4c36488549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6bf7a53d-8824-4646-86bb-6ce370c9ef7c" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_656ddb6b-123f-47b5-9f4b-388f1de736b3" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6bf7a53d-8824-4646-86bb-6ce370c9ef7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_38f31e01-d1e7-4ef7-9014-66f9e6b71730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_706284e5-5baa-4b51-9e0c-1cd18c7ba944" xlink:to="loc_us-gaap_DebtInstrumentLineItems_38f31e01-d1e7-4ef7-9014-66f9e6b71730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8d7fb39b-9efc-480a-8f87-bf19e814febb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_38f31e01-d1e7-4ef7-9014-66f9e6b71730" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8d7fb39b-9efc-480a-8f87-bf19e814febb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2af87d4b-b371-451f-9094-d24adaaaecaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4743d95a-ce43-4af4-8bf9-b659042ede74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2af87d4b-b371-451f-9094-d24adaaaecaf" xlink:to="loc_us-gaap_DebtInstrumentTable_4743d95a-ce43-4af4-8bf9-b659042ede74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d10d00cf-48a2-4e40-984f-99bb1b388810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4743d95a-ce43-4af4-8bf9-b659042ede74" xlink:to="loc_us-gaap_DebtInstrumentAxis_d10d00cf-48a2-4e40-984f-99bb1b388810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d10d00cf-48a2-4e40-984f-99bb1b388810" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_0faab4f1-0dd4-47c4-b0a6-7788cc29435e" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_0faab4f1-0dd4-47c4-b0a6-7788cc29435e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_65758312-81a2-4bbc-b836-e9cdbddde442" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_65758312-81a2-4bbc-b836-e9cdbddde442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_dd3fd60a-a919-4d23-bc94-5d980f8a36ad" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4d8d70f2-58ab-4d5c-9b03-c3e03343aa1a" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_dd3fd60a-a919-4d23-bc94-5d980f8a36ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4743d95a-ce43-4af4-8bf9-b659042ede74" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract_5f721a86-7f52-4a88-8ed8-f63ba46d704f" xlink:href="dxcm-20201231.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:to="loc_dxcm_CashInterestExpenseAbstract_5f721a86-7f52-4a88-8ed8-f63ba46d704f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_f0822617-768a-4e00-89e0-d1c368eb0cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_CashInterestExpenseAbstract_5f721a86-7f52-4a88-8ed8-f63ba46d704f" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_f0822617-768a-4e00-89e0-d1c368eb0cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:href="dxcm-20201231.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:to="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_1caba485-5974-4cd2-b49e-4365d19c16a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_1caba485-5974-4cd2-b49e-4365d19c16a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_26bcc88a-5c9b-4f97-bc9a-dcc96c34c858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_26bcc88a-5c9b-4f97-bc9a-dcc96c34c858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_c21cb0b1-c9a9-4f07-9aaa-50766df83cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_117adca3-882c-4702-8b1a-39ae4e687211" xlink:to="loc_us-gaap_InterestExpenseDebt_c21cb0b1-c9a9-4f07-9aaa-50766df83cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_73f6d44a-15fd-4e39-8c4f-ae4f5d3bf4d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ce86565-540c-40f8-b1e1-56a99b0778cc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_73f6d44a-15fd-4e39-8c4f-ae4f5d3bf4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_882b9378-2a5d-48de-a68f-384f2c5def28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_882b9378-2a5d-48de-a68f-384f2c5def28" xlink:to="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_da47c330-b304-4207-b9a5-f47144e10e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_VariableRateAxis_da47c330-b304-4207-b9a5-f47144e10e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_89aac599-5051-495a-9d30-913a7983c1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_da47c330-b304-4207-b9a5-f47144e10e62" xlink:to="loc_us-gaap_VariableRateDomain_89aac599-5051-495a-9d30-913a7983c1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6ff8c5e3-c5aa-41f0-8fcb-9542a6958d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_89aac599-5051-495a-9d30-913a7983c1b3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6ff8c5e3-c5aa-41f0-8fcb-9542a6958d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_743f4b0d-c168-401f-b83d-22fafa8e4bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_HedgingDesignationAxis_743f4b0d-c168-401f-b83d-22fafa8e4bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f4c9a57a-b757-4f86-a0cf-ce5dee222946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_743f4b0d-c168-401f-b83d-22fafa8e4bfa" xlink:to="loc_us-gaap_HedgingDesignationDomain_f4c9a57a-b757-4f86-a0cf-ce5dee222946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0e791351-8583-4228-a542-1bcbb586d501" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f4c9a57a-b757-4f86-a0cf-ce5dee222946" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0e791351-8583-4228-a542-1bcbb586d501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_52a7df97-39ab-4b38-8894-73abaad3192b" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_52a7df97-39ab-4b38-8894-73abaad3192b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_4320e924-78ea-40b2-a041-c8d78b827724" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_52a7df97-39ab-4b38-8894-73abaad3192b" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_4320e924-78ea-40b2-a041-c8d78b827724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_dc83b2e3-d1d6-4efa-81f3-e45ffa8658bb" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_4320e924-78ea-40b2-a041-c8d78b827724" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_dc83b2e3-d1d6-4efa-81f3-e45ffa8658bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_4b25c05c-e725-4042-95cd-35aecbbd9251" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_4320e924-78ea-40b2-a041-c8d78b827724" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_4b25c05c-e725-4042-95cd-35aecbbd9251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9f187bb-06b3-4774-84ab-9abc8e918095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9f187bb-06b3-4774-84ab-9abc8e918095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_266a8c63-139c-4bdd-b30c-3b315d211933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9f187bb-06b3-4774-84ab-9abc8e918095" xlink:to="loc_us-gaap_EquityComponentDomain_266a8c63-139c-4bdd-b30c-3b315d211933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6305b01b-5a71-4723-ac92-89469f1f139d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_266a8c63-139c-4bdd-b30c-3b315d211933" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6305b01b-5a71-4723-ac92-89469f1f139d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a705bad3-3e87-4db9-8ee1-b00b9cc0c42e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_266a8c63-139c-4bdd-b30c-3b315d211933" xlink:to="loc_us-gaap_CommonStockMember_a705bad3-3e87-4db9-8ee1-b00b9cc0c42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_57d67781-2c44-4e5f-bbd2-e191441371a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_57d67781-2c44-4e5f-bbd2-e191441371a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9e49ef24-fc69-4cd5-a533-240eaa5b562f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_57d67781-2c44-4e5f-bbd2-e191441371a4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9e49ef24-fc69-4cd5-a533-240eaa5b562f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8a387c25-9bf1-49f9-8280-df939d10380c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e49ef24-fc69-4cd5-a533-240eaa5b562f" xlink:to="loc_us-gaap_SeniorNotesMember_8a387c25-9bf1-49f9-8280-df939d10380c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_6485b059-6219-419a-ab3e-e21da2480334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e49ef24-fc69-4cd5-a533-240eaa5b562f" xlink:to="loc_us-gaap_LineOfCreditMember_6485b059-6219-419a-ab3e-e21da2480334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e756ec0b-df17-4b4e-bdb2-bba643ae396f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_e756ec0b-df17-4b4e-bdb2-bba643ae396f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e756ec0b-df17-4b4e-bdb2-bba643ae396f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_c80297b6-a3fd-4fee-89b1-c93105d3a0ea" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_c80297b6-a3fd-4fee-89b1-c93105d3a0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_93d55254-d758-445d-865e-f4520621ab26" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_93d55254-d758-445d-865e-f4520621ab26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_35c924bc-8a95-4157-b6a2-5ed2763344df" xlink:href="dxcm-20201231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_926413b0-d702-465e-9109-164d75f7676f" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_35c924bc-8a95-4157-b6a2-5ed2763344df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_079d580b-8d4c-480f-9e11-ee39fa194e7f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_srt_RangeAxis_079d580b-8d4c-480f-9e11-ee39fa194e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_606759f0-80ba-4b35-980f-5742e5afc383" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_079d580b-8d4c-480f-9e11-ee39fa194e7f" xlink:to="loc_srt_RangeMember_606759f0-80ba-4b35-980f-5742e5afc383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c3178d5a-37c8-4bf3-9006-cd008bcd0b7c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_606759f0-80ba-4b35-980f-5742e5afc383" xlink:to="loc_srt_MinimumMember_c3178d5a-37c8-4bf3-9006-cd008bcd0b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3deb6072-bd15-4633-8789-2d000e0e9bbd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_606759f0-80ba-4b35-980f-5742e5afc383" xlink:to="loc_srt_MaximumMember_3deb6072-bd15-4633-8789-2d000e0e9bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_091643bb-2ac0-4b09-828c-826858f1a2e7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c2fce154-9e5a-4322-bd28-23d7e18b4244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c2fce154-9e5a-4322-bd28-23d7e18b4244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c7cf8bb0-1336-4521-a6b4-a2edc280afcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c7cf8bb0-1336-4521-a6b4-a2edc280afcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_41fac7e6-c038-4376-974b-152de24919b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_41fac7e6-c038-4376-974b-152de24919b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6a3df72a-5031-4386-bdbb-32d901eb022d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6a3df72a-5031-4386-bdbb-32d901eb022d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_8f661ce2-2df0-4663-8f16-542c421f9de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_8f661ce2-2df0-4663-8f16-542c421f9de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_8e635230-75c2-48be-b8a5-fe8d3bef99ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_8e635230-75c2-48be-b8a5-fe8d3bef99ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_e4131ff7-53db-4d01-88a6-f430462dd0c5" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_e4131ff7-53db-4d01-88a6-f430462dd0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b3e7f864-8b74-494c-91a1-8daf743e4d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b3e7f864-8b74-494c-91a1-8daf743e4d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6553fc08-3ca5-46e7-acca-6d2985ff703a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6553fc08-3ca5-46e7-acca-6d2985ff703a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_cdee8ee6-3672-4abd-b5f0-df3d40f03642" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_cdee8ee6-3672-4abd-b5f0-df3d40f03642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5c87897e-6dd0-491b-a8a0-d411e28979ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5c87897e-6dd0-491b-a8a0-d411e28979ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes_464ed7f3-1dba-45a9-8f18-7fd372878e73" xlink:href="dxcm-20201231.xsd#dxcm_PaymentsForRepurchaseOfConvertibleNotes"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_PaymentsForRepurchaseOfConvertibleNotes_464ed7f3-1dba-45a9-8f18-7fd372878e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4c5ece08-25e4-4f71-a1d0-674c25f990ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4c5ece08-25e4-4f71-a1d0-674c25f990ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised_032f3157-4b27-456c-91cd-89bc1bbf6578" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercised"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised_032f3157-4b27-456c-91cd-89bc1bbf6578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a18147ff-3716-496e-975f-1600c6ea4080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a18147ff-3716-496e-975f-1600c6ea4080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_08b2010e-1917-41f1-aacb-929677c7135b" xlink:href="dxcm-20201231.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_08b2010e-1917-41f1-aacb-929677c7135b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5f0a828a-fa74-4f46-8b20-bad649abeaf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5f0a828a-fa74-4f46-8b20-bad649abeaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1c758157-92bb-4698-b0fc-c5e24f9ff49e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1c758157-92bb-4698-b0fc-c5e24f9ff49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_381c0b23-44c6-4720-ab42-822c9324159b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_381c0b23-44c6-4720-ab42-822c9324159b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1d4145ab-60dc-4d99-ab26-4616b16d070e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1d4145ab-60dc-4d99-ab26-4616b16d070e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5fd6dbbc-8788-4d67-836d-a8d4170c10fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5fd6dbbc-8788-4d67-836d-a8d4170c10fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_af745178-4069-4c06-a33a-c33b2484af0e" xlink:href="dxcm-20201231.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_af745178-4069-4c06-a33a-c33b2484af0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a04c62fc-1a05-44ae-949a-ca7af5e5222a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a04c62fc-1a05-44ae-949a-ca7af5e5222a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5f4d5e0c-3683-43ff-b2d7-f2e09ec52aef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5f4d5e0c-3683-43ff-b2d7-f2e09ec52aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_46b3f43f-1819-4e2d-a08c-4018733fe6a8" xlink:href="dxcm-20201231.xsd#dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b02479b-7522-4749-b14c-b8156a635099" xlink:to="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_46b3f43f-1819-4e2d-a08c-4018733fe6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0e704834-6f80-40a4-87c2-84dfc485b742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c6178894-87db-4df4-aefb-bf617f0ff88b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0e704834-6f80-40a4-87c2-84dfc485b742" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c6178894-87db-4df4-aefb-bf617f0ff88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ad91042e-4e38-447e-a3b2-32855cc65ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c6178894-87db-4df4-aefb-bf617f0ff88b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ad91042e-4e38-447e-a3b2-32855cc65ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dbd7a1de-bd6e-406c-b963-2796f17f16ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ad91042e-4e38-447e-a3b2-32855cc65ad9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dbd7a1de-bd6e-406c-b963-2796f17f16ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_451372c4-6d92-4cc6-a76e-a0abf7133d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dbd7a1de-bd6e-406c-b963-2796f17f16ae" xlink:to="loc_us-gaap_LineOfCreditMember_451372c4-6d92-4cc6-a76e-a0abf7133d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a9109742-3feb-418a-b30b-a600b0197277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c6178894-87db-4df4-aefb-bf617f0ff88b" xlink:to="loc_us-gaap_CreditFacilityAxis_a9109742-3feb-418a-b30b-a600b0197277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3b9c0fc2-1b7f-475e-b219-48e0b219d2b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a9109742-3feb-418a-b30b-a600b0197277" xlink:to="loc_us-gaap_CreditFacilityDomain_3b9c0fc2-1b7f-475e-b219-48e0b219d2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_8b39f05a-27f1-4372-8b16-2ac15a0b2cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3b9c0fc2-1b7f-475e-b219-48e0b219d2b6" xlink:to="loc_us-gaap_LetterOfCreditMember_8b39f05a-27f1-4372-8b16-2ac15a0b2cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c6178894-87db-4df4-aefb-bf617f0ff88b" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a5cb632-3e7f-4e86-9ba3-05ebc1399024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a5cb632-3e7f-4e86-9ba3-05ebc1399024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_af78d74f-c250-4360-92c4-0ac0314efd49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:to="loc_us-gaap_LineOfCredit_af78d74f-c250-4360-92c4-0ac0314efd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c18aba86-fdf3-45d7-8a60-12ec2eda5b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c18aba86-fdf3-45d7-8a60-12ec2eda5b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_72c3ee60-d1b6-4d31-bd89-283876f4b39b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cb5d6ebe-fd61-4d89-b035-57b5718651ec" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_72c3ee60-d1b6-4d31-bd89-283876f4b39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitments"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0a50897b-d1fb-4c6b-880a-35f1b5313701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_3c0e6b2d-dfa8-45d6-accf-d8fb72f15146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a50897b-d1fb-4c6b-880a-35f1b5313701" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_3c0e6b2d-dfa8-45d6-accf-d8fb72f15146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_7ad4cbb6-f4a2-487e-816b-b77a8c48d6d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a50897b-d1fb-4c6b-880a-35f1b5313701" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_7ad4cbb6-f4a2-487e-816b-b77a8c48d6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1bd654c7-7682-4e70-9b45-9fdc9fb42579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d860dace-be0f-494f-b3aa-b6daf3556932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1bd654c7-7682-4e70-9b45-9fdc9fb42579" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d860dace-be0f-494f-b3aa-b6daf3556932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0d4cd816-c5e4-4e8b-830c-2f55b55a1c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1bd654c7-7682-4e70-9b45-9fdc9fb42579" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0d4cd816-c5e4-4e8b-830c-2f55b55a1c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_d37efbbf-fb70-4d90-919d-62934c6459ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1bd654c7-7682-4e70-9b45-9fdc9fb42579" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_d37efbbf-fb70-4d90-919d-62934c6459ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8062d19a-a958-45c0-998a-02a61d3284b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8062d19a-a958-45c0-998a-02a61d3284b6" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_07318d96-3170-4b55-9743-7b20a316f619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_07318d96-3170-4b55-9743-7b20a316f619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a24c891a-ae18-48ca-8dda-4ef1909837d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_07318d96-3170-4b55-9743-7b20a316f619" xlink:to="loc_us-gaap_EquityComponentDomain_a24c891a-ae18-48ca-8dda-4ef1909837d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_af9ca316-9525-4e7f-979f-be7bb19bf4cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a24c891a-ae18-48ca-8dda-4ef1909837d0" xlink:to="loc_us-gaap_RetainedEarningsMember_af9ca316-9525-4e7f-979f-be7bb19bf4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7d141b49-63e6-4330-acce-1e3d40138129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7d141b49-63e6-4330-acce-1e3d40138129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_24bdd5fd-03d8-4a84-9e2e-7f0ebdb8f0da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7d141b49-63e6-4330-acce-1e3d40138129" xlink:to="loc_us-gaap_TypeOfAdoptionMember_24bdd5fd-03d8-4a84-9e2e-7f0ebdb8f0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_05a43526-5125-410a-9b59-962b87478efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_24bdd5fd-03d8-4a84-9e2e-7f0ebdb8f0da" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_05a43526-5125-410a-9b59-962b87478efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bffc597a-d332-4423-bce8-d009a2d04648" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:to="loc_srt_RangeAxis_bffc597a-d332-4423-bce8-d009a2d04648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_82bdd86d-f484-4c50-9493-89916950c498" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bffc597a-d332-4423-bce8-d009a2d04648" xlink:to="loc_srt_RangeMember_82bdd86d-f484-4c50-9493-89916950c498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d8a7f4dc-5b36-4b17-abfb-677349cb7ed7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_82bdd86d-f484-4c50-9493-89916950c498" xlink:to="loc_srt_MinimumMember_d8a7f4dc-5b36-4b17-abfb-677349cb7ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e6faa51b-2758-4832-b21c-607a371daae0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_82bdd86d-f484-4c50-9493-89916950c498" xlink:to="loc_srt_MaximumMember_e6faa51b-2758-4832-b21c-607a371daae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30070bbd-6b1f-40fe-b208-b5e0d6cfbe0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30070bbd-6b1f-40fe-b208-b5e0d6cfbe0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0c34b842-fc15-4615-978a-41a2a5ce023f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30070bbd-6b1f-40fe-b208-b5e0d6cfbe0c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0c34b842-fc15-4615-978a-41a2a5ce023f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_50653d9b-4d15-4efd-aedc-10b70fb1bbd6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0c34b842-fc15-4615-978a-41a2a5ce023f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_50653d9b-4d15-4efd-aedc-10b70fb1bbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8c8f4a3-b4a9-4263-b2d9-a2ccf26f5b74" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1e67bafe-754f-466d-b76c-e89290be16df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1e67bafe-754f-466d-b76c-e89290be16df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_bd837673-84d9-439f-a148-155a9f56814d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_bd837673-84d9-439f-a148-155a9f56814d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c04e94c-26f3-4c43-9af3-d68845e622e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c04e94c-26f3-4c43-9af3-d68845e622e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fe9efc86-75b2-402f-ba28-7dbcf990b1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fe9efc86-75b2-402f-ba28-7dbcf990b1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_d9aa34ce-3785-47cb-acfd-c3aa2592ee2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_d9aa34ce-3785-47cb-acfd-c3aa2592ee2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ad91d5d4-cd54-4d8e-a2b0-200913735969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_OperatingLeaseLiability_ad91d5d4-cd54-4d8e-a2b0-200913735969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_83a746ba-3731-4e2c-a7b6-cc50cccdf7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_FinanceLeaseLiability_83a746ba-3731-4e2c-a7b6-cc50cccdf7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_f4bc0521-0b45-4e08-99e2-51beae1f4b15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_AssetRetirementObligation_f4bc0521-0b45-4e08-99e2-51beae1f4b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_c960b49b-b83b-44d3-a138-16ef16c3b66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_LeaseAndRentalExpense_c960b49b-b83b-44d3-a138-16ef16c3b66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_f18c50c0-38e0-4135-8081-cc46cc03b639" xlink:href="dxcm-20201231.xsd#dxcm_LesseeOperatingLeasesLeaseCostAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_f18c50c0-38e0-4135-8081-cc46cc03b639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_70ba10d5-75c0-4c30-9fc3-0f6b9b355f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_70ba10d5-75c0-4c30-9fc3-0f6b9b355f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_68f0dd10-664d-4942-9ffc-102a8e9d559c" xlink:href="dxcm-20201231.xsd#dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_561bfebc-7518-4e36-8969-58a873d6959e" xlink:to="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_68f0dd10-664d-4942-9ffc-102a8e9d559c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_84aad7ae-2e80-4139-9ef9-3c55cc4b5712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_84aad7ae-2e80-4139-9ef9-3c55cc4b5712" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_05e4065c-f401-4bb7-994c-1225575a1ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_05e4065c-f401-4bb7-994c-1225575a1ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_92bf2c92-70d7-44b6-be69-2c3fcd24c7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_92bf2c92-70d7-44b6-be69-2c3fcd24c7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f11ed336-3d55-47d8-893a-f6b8e02ba870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f11ed336-3d55-47d8-893a-f6b8e02ba870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5b41641f-b48c-4781-a95f-bbf3bded7a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5b41641f-b48c-4781-a95f-bbf3bded7a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1fc24932-9acc-48f2-b931-36942325ad89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1fc24932-9acc-48f2-b931-36942325ad89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d5e2d67c-c995-4d52-b1be-e61d8f213a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d5e2d67c-c995-4d52-b1be-e61d8f213a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8adba8a6-7217-49b0-811d-a57a59578108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8adba8a6-7217-49b0-811d-a57a59578108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_15835bc7-6ca0-4706-ae0d-665613dc1b39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_15835bc7-6ca0-4706-ae0d-665613dc1b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_31e3880a-40eb-47ec-93aa-2f9bd4277049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_OperatingLeaseLiability_31e3880a-40eb-47ec-93aa-2f9bd4277049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c2d7bd17-a6ed-4eb2-8dad-55fa0d081203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c2d7bd17-a6ed-4eb2-8dad-55fa0d081203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0ab3b0de-495b-4b4c-bfef-7e63dae57b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_972910d0-f6b4-4fa0-b75b-10d80ec9471e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0ab3b0de-495b-4b4c-bfef-7e63dae57b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_84aad7ae-2e80-4139-9ef9-3c55cc4b5712" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_24191587-1641-4b1f-9ef1-339b81c7cc53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_24191587-1641-4b1f-9ef1-339b81c7cc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3f983d9e-c6d4-4c7b-88e4-c149a7ed87ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3f983d9e-c6d4-4c7b-88e4-c149a7ed87ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_546075de-8085-452c-a7ba-d4b97f092e83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_546075de-8085-452c-a7ba-d4b97f092e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_784204f1-1d6e-4239-873c-dfa0971dbe00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_784204f1-1d6e-4239-873c-dfa0971dbe00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_466c1cb3-272a-49bd-b1ad-d6881c494038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_466c1cb3-272a-49bd-b1ad-d6881c494038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_30beab4b-e88e-4497-9e3b-9352c02b4a10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_30beab4b-e88e-4497-9e3b-9352c02b4a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_8bb9205e-bc9a-4399-b4fe-516952dc6295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_8bb9205e-bc9a-4399-b4fe-516952dc6295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2f832dd1-7cbf-42a0-a04c-227294f3b7e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2f832dd1-7cbf-42a0-a04c-227294f3b7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d1fe84ea-68d9-458e-99bf-5e5603a6b923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiability_d1fe84ea-68d9-458e-99bf-5e5603a6b923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_473f3849-0367-4722-a18b-8a541ff32ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_473f3849-0367-4722-a18b-8a541ff32ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9f986a49-ea7f-4483-ae35-43185b58f135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70c934ce-88d6-4a8d-8178-bb2573b4783e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9f986a49-ea7f-4483-ae35-43185b58f135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_0aa7efe0-4f0b-40a0-a568-1c228393a821" xlink:href="dxcm-20201231.xsd#dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_84aad7ae-2e80-4139-9ef9-3c55cc4b5712" xlink:to="loc_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_0aa7efe0-4f0b-40a0-a568-1c228393a821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b5f0f566-11ea-40fe-bdb6-170f0df1f8dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_d6dd0dc1-1a76-4824-b1e8-0493f8be6906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5f0f566-11ea-40fe-bdb6-170f0df1f8dd" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_d6dd0dc1-1a76-4824-b1e8-0493f8be6906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_a0c5725d-b1c2-4f2f-a9c9-c2cb4f2251d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5f0f566-11ea-40fe-bdb6-170f0df1f8dd" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_a0c5725d-b1c2-4f2f-a9c9-c2cb4f2251d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_9c9b90b3-dd81-4db6-8ec6-c61ca7ae8a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5f0f566-11ea-40fe-bdb6-170f0df1f8dd" xlink:to="loc_us-gaap_OperatingLeaseCost_9c9b90b3-dd81-4db6-8ec6-c61ca7ae8a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_2f2c2a06-11be-4eb1-b3bd-3a0980e250e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5f0f566-11ea-40fe-bdb6-170f0df1f8dd" xlink:to="loc_us-gaap_ShortTermLeaseCost_2f2c2a06-11be-4eb1-b3bd-3a0980e250e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_3b0abd5d-7b75-4556-8808-49da902badee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5f0f566-11ea-40fe-bdb6-170f0df1f8dd" xlink:to="loc_us-gaap_VariableLeaseCost_3b0abd5d-7b75-4556-8808-49da902badee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_c9cf2f7f-8ef8-4741-9fee-029fc8fb31d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5f0f566-11ea-40fe-bdb6-170f0df1f8dd" xlink:to="loc_us-gaap_LeaseCost_c9cf2f7f-8ef8-4741-9fee-029fc8fb31d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#LeasesAndOtherCommitmentsOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_bbc4d1dd-c08b-4a11-8a46-9b95ee53d47b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:to="loc_us-gaap_OperatingLeasePayments_bbc4d1dd-c08b-4a11-8a46-9b95ee53d47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_8c644994-63b1-4305-b191-c956e7e33aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_8c644994-63b1-4305-b191-c956e7e33aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_1c61060c-52e0-4fe0-a48d-d945ececda65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_1c61060c-52e0-4fe0-a48d-d945ececda65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_032e2fb2-7386-4679-a880-8474b9163f43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_032e2fb2-7386-4679-a880-8474b9163f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_61a7e859-c7fc-47bc-bb05-20e0b480a976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_61a7e859-c7fc-47bc-bb05-20e0b480a976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_af2ac100-8191-4a63-bff1-1f737226c8fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_af2ac100-8191-4a63-bff1-1f737226c8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5ae0ca15-edeb-4cbc-8248-4dfb2c826e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5ae0ca15-edeb-4cbc-8248-4dfb2c826e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_60a4ad36-344d-4612-aed4-8fc693726ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_60a4ad36-344d-4612-aed4-8fc693726ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_86985268-bd70-4b23-a236-4cf4d7de48cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ef3e61-0198-4b89-a830-87bd7b5564ff" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_86985268-bd70-4b23-a236-4cf4d7de48cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Contingencies" xlink:type="simple" xlink:href="dxcm-20201231.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e7b757d9-a1f9-4711-972f-63590be48050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_69f5d73b-9a18-47ac-82a7-b154f5301f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e7b757d9-a1f9-4711-972f-63590be48050" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_69f5d73b-9a18-47ac-82a7-b154f5301f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5f01526a-dda2-4d88-a9cb-8ce285615452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_5ff3883d-d3da-4d69-94ef-bd4232d9c5ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5f01526a-dda2-4d88-a9cb-8ce285615452" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_5ff3883d-d3da-4d69-94ef-bd4232d9c5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d73353a7-c2f3-4a5c-b086-0bd3d33cf5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_3016c5f1-219b-4740-9bf0-fa09994abea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d73353a7-c2f3-4a5c-b086-0bd3d33cf5ee" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_3016c5f1-219b-4740-9bf0-fa09994abea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_bf6bcc86-83ca-4f13-a759-aaa52e42e7a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d73353a7-c2f3-4a5c-b086-0bd3d33cf5ee" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_bf6bcc86-83ca-4f13-a759-aaa52e42e7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_87328006-885d-4a0c-9a5d-ee5323934e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d73353a7-c2f3-4a5c-b086-0bd3d33cf5ee" xlink:to="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_87328006-885d-4a0c-9a5d-ee5323934e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_72d12404-51a1-480a-a375-1ba8e08888b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d73353a7-c2f3-4a5c-b086-0bd3d33cf5ee" xlink:to="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_72d12404-51a1-480a-a375-1ba8e08888b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d82a9551-7b26-4859-836e-680b3051bf03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d73353a7-c2f3-4a5c-b086-0bd3d33cf5ee" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d82a9551-7b26-4859-836e-680b3051bf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8a8c1e53-6879-471e-a137-563a1d0a4731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d73353a7-c2f3-4a5c-b086-0bd3d33cf5ee" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8a8c1e53-6879-471e-a137-563a1d0a4731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_91e6ebfb-85c2-4edb-a696-b968ff8dae25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d73353a7-c2f3-4a5c-b086-0bd3d33cf5ee" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_91e6ebfb-85c2-4edb-a696-b968ff8dae25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_36ad3132-35fc-49d0-8550-dd1d2c45bc58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c00271a1-a90f-4899-8b16-de19449e7943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36ad3132-35fc-49d0-8550-dd1d2c45bc58" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c00271a1-a90f-4899-8b16-de19449e7943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ab3698c2-8459-44bd-99b8-c9161a502e22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36ad3132-35fc-49d0-8550-dd1d2c45bc58" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ab3698c2-8459-44bd-99b8-c9161a502e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0865797f-9be6-406a-bbf2-cbc4a7e2adab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36ad3132-35fc-49d0-8550-dd1d2c45bc58" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0865797f-9be6-406a-bbf2-cbc4a7e2adab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesComponentsofProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5c9d2e0c-c09d-4ef8-bd54-9aff5bab3299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a84225f2-e7c8-45a6-bdda-150a2bf63511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5c9d2e0c-c09d-4ef8-bd54-9aff5bab3299" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a84225f2-e7c8-45a6-bdda-150a2bf63511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_655c2b79-8a2d-4740-8b00-e8a1b3006335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a84225f2-e7c8-45a6-bdda-150a2bf63511" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_655c2b79-8a2d-4740-8b00-e8a1b3006335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_fbd604aa-765c-438a-8171-53b10b94b3be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a84225f2-e7c8-45a6-bdda-150a2bf63511" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_fbd604aa-765c-438a-8171-53b10b94b3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_069010ca-5517-441b-ac7e-7a27c844597b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a84225f2-e7c8-45a6-bdda-150a2bf63511" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_069010ca-5517-441b-ac7e-7a27c844597b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ee5117eb-cd0b-4dff-8b61-0dc1a7166c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a84225f2-e7c8-45a6-bdda-150a2bf63511" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ee5117eb-cd0b-4dff-8b61-0dc1a7166c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ba3c0158-1095-46f4-88b8-f2631570ec7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5c9d2e0c-c09d-4ef8-bd54-9aff5bab3299" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ba3c0158-1095-46f4-88b8-f2631570ec7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b95bfa09-0e06-40d8-b533-ffa63dae528d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ba3c0158-1095-46f4-88b8-f2631570ec7b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b95bfa09-0e06-40d8-b533-ffa63dae528d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4a254fac-d737-43ec-adae-32fd889eddcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ba3c0158-1095-46f4-88b8-f2631570ec7b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4a254fac-d737-43ec-adae-32fd889eddcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_5d0ddbf9-20be-46a9-8b24-9e7f64f9e69c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ba3c0158-1095-46f4-88b8-f2631570ec7b" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_5d0ddbf9-20be-46a9-8b24-9e7f64f9e69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1daaf21a-f443-42d6-af5b-53035f0aeefb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ba3c0158-1095-46f4-88b8-f2631570ec7b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1daaf21a-f443-42d6-af5b-53035f0aeefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f40de227-e36f-4802-bdd9-a29bdfd905bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5c9d2e0c-c09d-4ef8-bd54-9aff5bab3299" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f40de227-e36f-4802-bdd9-a29bdfd905bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eb4930e0-baa9-4bf6-a012-e37076d93bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_6d491e04-f755-48e6-bb0a-8c559ed676fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb4930e0-baa9-4bf6-a012-e37076d93bfa" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_6d491e04-f755-48e6-bb0a-8c559ed676fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_48ba90af-9f0a-479e-9906-837daa44410b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6d491e04-f755-48e6-bb0a-8c559ed676fd" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_48ba90af-9f0a-479e-9906-837daa44410b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_48ba90af-9f0a-479e-9906-837daa44410b" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_9b8058ec-32a2-4604-957f-4a4084c6cdfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:to="loc_us-gaap_DomesticCountryMember_9b8058ec-32a2-4604-957f-4a4084c6cdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_af929991-9a2d-4d95-8f99-0a0cb4a6a6aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_af929991-9a2d-4d95-8f99-0a0cb4a6a6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2b43a9f4-630e-4b50-bff7-64e58169c6bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9e3c43e8-14c4-4ed0-9ba5-7fbe4b36f7f2" xlink:to="loc_us-gaap_ForeignCountryMember_2b43a9f4-630e-4b50-bff7-64e58169c6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c2c7b352-199e-49e6-a377-87ba8cd6cf87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6d491e04-f755-48e6-bb0a-8c559ed676fd" xlink:to="loc_srt_StatementGeographicalAxis_c2c7b352-199e-49e6-a377-87ba8cd6cf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c2c7b352-199e-49e6-a377-87ba8cd6cf87" xlink:to="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_992b4d3a-a348-4137-b430-746c163b439d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:to="loc_stpr_CA_992b4d3a-a348-4137-b430-746c163b439d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherStatesMember_1cf3d024-bfab-4157-8051-086885b39315" xlink:href="dxcm-20201231.xsd#dxcm_OtherStatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:to="loc_dxcm_OtherStatesMember_1cf3d024-bfab-4157-8051-086885b39315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_dd80e340-bb1c-4616-9373-a15538d03692" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7d4a651-11e0-43c9-8a87-021b05dbac6a" xlink:to="loc_country_GB_dd80e340-bb1c-4616-9373-a15538d03692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_cb81e3a4-322b-4051-9782-8fc5cd150f8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6d491e04-f755-48e6-bb0a-8c559ed676fd" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_cb81e3a4-322b-4051-9782-8fc5cd150f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_d28c57db-ea60-4457-aaf0-914fa051955d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cb81e3a4-322b-4051-9782-8fc5cd150f8d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_d28c57db-ea60-4457-aaf0-914fa051955d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_0c6ebb82-6c2a-4bc6-9707-dfa29c55825f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cb81e3a4-322b-4051-9782-8fc5cd150f8d" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_0c6ebb82-6c2a-4bc6-9707-dfa29c55825f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0a83d81e-03da-4f5b-9e8c-33839786f8c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a83d81e-03da-4f5b-9e8c-33839786f8c5" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_a34336fb-5e40-4fb7-9b0f-4f5db90af91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_a34336fb-5e40-4fb7-9b0f-4f5db90af91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_75afa832-ef53-464e-94a2-5cf359c3be1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a34336fb-5e40-4fb7-9b0f-4f5db90af91e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_75afa832-ef53-464e-94a2-5cf359c3be1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_c306386a-f11c-43f5-a291-bd94031b114d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_75afa832-ef53-464e-94a2-5cf359c3be1d" xlink:to="loc_us-gaap_ForeignCountryMember_c306386a-f11c-43f5-a291-bd94031b114d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_26cbfe0a-265f-478f-bbfd-af61c160b2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_26cbfe0a-265f-478f-bbfd-af61c160b2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_69860ce1-f780-4f22-8b4a-54f69fd6f695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_26cbfe0a-265f-478f-bbfd-af61c160b2ef" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_69860ce1-f780-4f22-8b4a-54f69fd6f695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncomeTaxExpenseBenefitMember_e5edf631-7719-44ac-9d06-128da26b172c" xlink:href="dxcm-20201231.xsd#dxcm_IncomeTaxExpenseBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_69860ce1-f780-4f22-8b4a-54f69fd6f695" xlink:to="loc_dxcm_IncomeTaxExpenseBenefitMember_e5edf631-7719-44ac-9d06-128da26b172c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9418d709-ce1b-4046-9362-5d236393157b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9418d709-ce1b-4046-9362-5d236393157b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d594a26b-b7aa-4c6e-bb80-91dd3cbdb267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9418d709-ce1b-4046-9362-5d236393157b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d594a26b-b7aa-4c6e-bb80-91dd3cbdb267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5eeddf66-f0f0-435b-8600-4e29c74d94f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d594a26b-b7aa-4c6e-bb80-91dd3cbdb267" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5eeddf66-f0f0-435b-8600-4e29c74d94f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dd11294d-44fb-4aff-bd78-3d9307d1c374" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:to="loc_srt_StatementGeographicalAxis_dd11294d-44fb-4aff-bd78-3d9307d1c374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5df0bca1-4f00-4708-bd6e-3592bb1955b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_dd11294d-44fb-4aff-bd78-3d9307d1c374" xlink:to="loc_srt_SegmentGeographicalDomain_5df0bca1-4f00-4708-bd6e-3592bb1955b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CALIFORNIAAndNonUSMember_f1723e73-d311-467b-9059-32bf7ef0c1ad" xlink:href="dxcm-20201231.xsd#dxcm_CALIFORNIAAndNonUSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5df0bca1-4f00-4708-bd6e-3592bb1955b4" xlink:to="loc_dxcm_CALIFORNIAAndNonUSMember_f1723e73-d311-467b-9059-32bf7ef0c1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_bbc7c02d-c157-4835-94ba-df5ade716e5b" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ResearchAndDevelopmentTaxCreditsUtilized_41cb579b-3223-4b10-938c-5fe6a17e240a" xlink:href="dxcm-20201231.xsd#dxcm_ResearchAndDevelopmentTaxCreditsUtilized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_dxcm_ResearchAndDevelopmentTaxCreditsUtilized_41cb579b-3223-4b10-938c-5fe6a17e240a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_c5904599-3e05-4ee2-9217-65137c939c7c" xlink:href="dxcm-20201231.xsd#dxcm_UnusedExpiredFederalIncomeTaxCredits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_c5904599-3e05-4ee2-9217-65137c939c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_5d06381d-30d7-4f4a-8982-940f791ea823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_5d06381d-30d7-4f4a-8982-940f791ea823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dc5e8583-2529-4fe9-ab20-b813070ebef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dc5e8583-2529-4fe9-ab20-b813070ebef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedCompensationIntercompanyCrossCharge_b7c31a19-837c-4f3a-b149-becd9edb3bd0" xlink:href="dxcm-20201231.xsd#dxcm_ShareBasedCompensationIntercompanyCrossCharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_dxcm_ShareBasedCompensationIntercompanyCrossCharge_b7c31a19-837c-4f3a-b149-becd9edb3bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_5fb41699-47d4-4351-9163-ac067a36545d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_5fb41699-47d4-4351-9163-ac067a36545d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_e034c13e-823b-4b70-8b8b-e637fde8aec0" xlink:href="dxcm-20201231.xsd#dxcm_PossibleExtensionPeriodofTaxHoliday"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_e034c13e-823b-4b70-8b8b-e637fde8aec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_3e7cf085-8e61-47d2-9b42-916f8329596c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_3e7cf085-8e61-47d2-9b42-916f8329596c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_c5d8e32a-63c2-4073-bb58-e386c200ec60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_d26c8793-7c1c-44ad-8844-22e51e39af92" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_c5d8e32a-63c2-4073-bb58-e386c200ec60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5ba00c07-0055-402a-b5b9-6e954677705a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_05f7e1e7-2f24-4ad5-a0b3-e833b5e47395" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5ba00c07-0055-402a-b5b9-6e954677705a" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_05f7e1e7-2f24-4ad5-a0b3-e833b5e47395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_61983ff5-9587-4d35-8480-7a8231cc86fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_05f7e1e7-2f24-4ad5-a0b3-e833b5e47395" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_61983ff5-9587-4d35-8480-7a8231cc86fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_7a87d681-aa0c-499a-9729-daef3e67285a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_05f7e1e7-2f24-4ad5-a0b3-e833b5e47395" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_7a87d681-aa0c-499a-9729-daef3e67285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_3e0a6679-8e41-4e17-91d8-8f8f03e1db84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_05f7e1e7-2f24-4ad5-a0b3-e833b5e47395" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_3e0a6679-8e41-4e17-91d8-8f8f03e1db84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_bd84407f-0543-4002-96cc-f0438d6ef4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_05f7e1e7-2f24-4ad5-a0b3-e833b5e47395" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_bd84407f-0543-4002-96cc-f0438d6ef4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_41b2533f-a261-4374-a63d-8cd6fe1c5a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_05f7e1e7-2f24-4ad5-a0b3-e833b5e47395" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_41b2533f-a261-4374-a63d-8cd6fe1c5a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c55c9f82-1dc9-4fe8-aba8-a8b5f3f682e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_05f7e1e7-2f24-4ad5-a0b3-e833b5e47395" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c55c9f82-1dc9-4fe8-aba8-a8b5f3f682e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxAssetsConvertibleDebt_4383e2b4-48eb-4968-99ec-ec50a45f2105" xlink:href="dxcm-20201231.xsd#dxcm_DeferredTaxAssetsConvertibleDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_05f7e1e7-2f24-4ad5-a0b3-e833b5e47395" xlink:to="loc_dxcm_DeferredTaxAssetsConvertibleDebt_4383e2b4-48eb-4968-99ec-ec50a45f2105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_957ac890-9992-4f6c-93e9-dcc9b5c67edb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5ba00c07-0055-402a-b5b9-6e954677705a" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_957ac890-9992-4f6c-93e9-dcc9b5c67edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0debeb50-a975-4f02-8214-3650bccbe8e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5ba00c07-0055-402a-b5b9-6e954677705a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0debeb50-a975-4f02-8214-3650bccbe8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_8de42ce5-d425-4071-aa8c-b7d69e1a624d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5ba00c07-0055-402a-b5b9-6e954677705a" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_8de42ce5-d425-4071-aa8c-b7d69e1a624d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_050e6a6e-d9be-4324-8c13-2fec060d9b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesClassificationAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5ba00c07-0055-402a-b5b9-6e954677705a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_050e6a6e-d9be-4324-8c13-2fec060d9b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_c4b55198-d9a6-49fd-adc5-21453391a1a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_050e6a6e-d9be-4324-8c13-2fec060d9b1a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_c4b55198-d9a6-49fd-adc5-21453391a1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_082e9d2a-db99-4d4e-9498-c6a51455825d" xlink:href="dxcm-20201231.xsd#dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_050e6a6e-d9be-4324-8c13-2fec060d9b1a" xlink:to="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_082e9d2a-db99-4d4e-9498-c6a51455825d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_83ee39c4-64d7-47fc-95b1-3b8b8a7f5ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5ba00c07-0055-402a-b5b9-6e954677705a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_83ee39c4-64d7-47fc-95b1-3b8b8a7f5ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4be7f92e-62b0-48e0-bfd7-3cb6993c9827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5ba00c07-0055-402a-b5b9-6e954677705a" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4be7f92e-62b0-48e0-bfd7-3cb6993c9827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_8f756c4f-2d7f-4ca8-9080-6d6a5facc8e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5ba00c07-0055-402a-b5b9-6e954677705a" xlink:to="loc_us-gaap_DeferredTaxLiabilities_8f756c4f-2d7f-4ca8-9080-6d6a5facc8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ee51f149-678a-41c2-98aa-ed65303dd812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ee51f149-678a-41c2-98aa-ed65303dd812" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e1ccd2ec-8952-4888-92a0-bdac5a031fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e1ccd2ec-8952-4888-92a0-bdac5a031fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_7b47baad-c512-46ef-9711-a96a0c79c8ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_7b47baad-c512-46ef-9711-a96a0c79c8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_a4ba43fd-587a-4fd7-945c-985b5ffa920c" xlink:href="dxcm-20201231.xsd#dxcm_EffectiveIncomeTaxReconciliationPermanentItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_a4ba43fd-587a-4fd7-945c-985b5ffa920c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_522d91eb-bdd0-45d9-a5f3-e29f994c9f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_522d91eb-bdd0-45d9-a5f3-e29f994c9f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_98acd5ca-7eed-48a7-9316-f3775c37bb8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_98acd5ca-7eed-48a7-9316-f3775c37bb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_6a462beb-efa6-40b8-941f-9c52937dc961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_6a462beb-efa6-40b8-941f-9c52937dc961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_ed977042-205a-4629-8bfd-1dfc354a3db0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_ed977042-205a-4629-8bfd-1dfc354a3db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_e45b2eb9-84e2-46eb-ba9b-6424fbc7fd86" xlink:href="dxcm-20201231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_e45b2eb9-84e2-46eb-ba9b-6424fbc7fd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_c26b7344-8f87-47d3-a2cd-9a8d0bcc586c" xlink:href="dxcm-20201231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_c26b7344-8f87-47d3-a2cd-9a8d0bcc586c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c029a4df-1dde-45dd-b0be-c7afb81c2ea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c029a4df-1dde-45dd-b0be-c7afb81c2ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_33215986-94b1-4e17-88de-61200a11b783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_33215986-94b1-4e17-88de-61200a11b783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b2df8440-86e8-46d4-84e6-1feff60818e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_6d8c2f34-b491-40e3-aa08-2e5c8a1371fe" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b2df8440-86e8-46d4-84e6-1feff60818e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4d8ee904-fe6a-41a4-8cda-978c75dd72d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b6341d56-2f1b-4c7f-a2b4-f6e3bc094116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4d8ee904-fe6a-41a4-8cda-978c75dd72d5" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b6341d56-2f1b-4c7f-a2b4-f6e3bc094116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_2ab16293-626e-4510-92cb-5da5b81cd010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b6341d56-2f1b-4c7f-a2b4-f6e3bc094116" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_2ab16293-626e-4510-92cb-5da5b81cd010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_30aa5122-92ef-4404-a065-d969c3ca9679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b6341d56-2f1b-4c7f-a2b4-f6e3bc094116" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_30aa5122-92ef-4404-a065-d969c3ca9679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ce7bb3f6-5e33-4e24-b68f-5794845ff594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b6341d56-2f1b-4c7f-a2b4-f6e3bc094116" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ce7bb3f6-5e33-4e24-b68f-5794845ff594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_2937754f-289f-49c7-b593-af2218896abb" xlink:href="dxcm-20201231.xsd#dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b6341d56-2f1b-4c7f-a2b4-f6e3bc094116" xlink:to="loc_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_2937754f-289f-49c7-b593-af2218896abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_b1883715-55b8-48e9-b292-52649ccecb28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b6341d56-2f1b-4c7f-a2b4-f6e3bc094116" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_b1883715-55b8-48e9-b292-52649ccecb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b93406eb-1c30-4a04-8ff4-fe7fbbb2e947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_31520c15-c1e5-4975-88ab-2ca34b9221f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b93406eb-1c30-4a04-8ff4-fe7fbbb2e947" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_31520c15-c1e5-4975-88ab-2ca34b9221f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd861f3e-452c-446c-8277-b1b241f320e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_054de9cd-1178-470a-8c06-ffa6eaa706f5" xlink:href="dxcm-20201231.xsd#dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd861f3e-452c-446c-8277-b1b241f320e5" xlink:to="loc_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_054de9cd-1178-470a-8c06-ffa6eaa706f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_dab70cdb-33cd-4fa6-a6b9-1094d3034ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd861f3e-452c-446c-8277-b1b241f320e5" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_dab70cdb-33cd-4fa6-a6b9-1094d3034ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_46031686-b172-4be5-be2a-a2b2b055f613" xlink:href="dxcm-20201231.xsd#dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd861f3e-452c-446c-8277-b1b241f320e5" xlink:to="loc_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_46031686-b172-4be5-be2a-a2b2b055f613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e6d36d0b-3200-4996-9f4c-de0bee24b203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd861f3e-452c-446c-8277-b1b241f320e5" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e6d36d0b-3200-4996-9f4c-de0bee24b203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_befa1269-591c-4fbe-9871-b19f697149c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd861f3e-452c-446c-8277-b1b241f320e5" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_befa1269-591c-4fbe-9871-b19f697149c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_323ffd9e-ef8d-4550-9c9e-e7487a014a05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_323ffd9e-ef8d-4550-9c9e-e7487a014a05" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3b7d6a69-beb2-40ef-bc0f-9374e5fced12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:to="loc_us-gaap_AwardTypeAxis_3b7d6a69-beb2-40ef-bc0f-9374e5fced12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19effb0-21a3-4334-ac76-8ba0925214a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3b7d6a69-beb2-40ef-bc0f-9374e5fced12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19effb0-21a3-4334-ac76-8ba0925214a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_68e1e154-a718-4828-a744-93656b14c80b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19effb0-21a3-4334-ac76-8ba0925214a2" xlink:to="loc_us-gaap_RestrictedStockMember_68e1e154-a718-4828-a744-93656b14c80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_876351d2-5d32-41f1-95f0-45537ef5e69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:to="loc_us-gaap_PlanNameAxis_876351d2-5d32-41f1-95f0-45537ef5e69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b2f8f981-4385-44c1-8cec-cb486f93b455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_876351d2-5d32-41f1-95f0-45537ef5e69e" xlink:to="loc_us-gaap_PlanNameDomain_b2f8f981-4385-44c1-8cec-cb486f93b455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A401kPlanMember_c68126ec-c7cb-4a1a-9d01-4c4a2f2f2bf1" xlink:href="dxcm-20201231.xsd#dxcm_A401kPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b2f8f981-4385-44c1-8cec-cb486f93b455" xlink:to="loc_dxcm_A401kPlanMember_c68126ec-c7cb-4a1a-9d01-4c4a2f2f2bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlan2015Member_9c8b731b-807c-4015-8470-eeca3bdd86ef" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlan2015Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b2f8f981-4385-44c1-8cec-cb486f93b455" xlink:to="loc_dxcm_EmployeeStockPurchasePlan2015Member_9c8b731b-807c-4015-8470-eeca3bdd86ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_aac3a4c1-56ea-4616-8c20-3490fec01a63" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:to="loc_srt_RangeAxis_aac3a4c1-56ea-4616-8c20-3490fec01a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2e0417af-84d1-4706-8c0a-8dbad54deff3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_aac3a4c1-56ea-4616-8c20-3490fec01a63" xlink:to="loc_srt_RangeMember_2e0417af-84d1-4706-8c0a-8dbad54deff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2c94d0e3-5288-4e68-a8e0-bd5e19b3de41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2e0417af-84d1-4706-8c0a-8dbad54deff3" xlink:to="loc_srt_MinimumMember_2c94d0e3-5288-4e68-a8e0-bd5e19b3de41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_31a76896-b0b3-4b82-a92e-014d9453347f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2e0417af-84d1-4706-8c0a-8dbad54deff3" xlink:to="loc_srt_MaximumMember_31a76896-b0b3-4b82-a92e-014d9453347f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b1ebc7a-4be5-4375-86c0-b3811423cb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_b5e030be-2424-426f-951e-4d15b48b0006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_b5e030be-2424-426f-951e-4d15b48b0006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_551280b4-9097-49de-b3d7-9a8b0cc911bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_551280b4-9097-49de-b3d7-9a8b0cc911bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fdb7bf24-59f0-4ab4-af32-9a7b8a75680c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fdb7bf24-59f0-4ab4-af32-9a7b8a75680c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_cec42d0d-7786-48d9-b2fa-90969f3d6101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_cec42d0d-7786-48d9-b2fa-90969f3d6101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_5588d4b6-3fd3-496d-a53d-8f31c73d1f52" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_5588d4b6-3fd3-496d-a53d-8f31c73d1f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_92f46573-e641-4e9e-bdf7-90952ce30ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_92f46573-e641-4e9e-bdf7-90952ce30ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeePurchasePriceFloorPercentage_56de6df1-786f-447d-b5a1-58a001937a8a" xlink:href="dxcm-20201231.xsd#dxcm_EmployeePurchasePriceFloorPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_dxcm_EmployeePurchasePriceFloorPercentage_56de6df1-786f-447d-b5a1-58a001937a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f9bd3a45-6910-4d02-b6ee-2b1e6e2bcc54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f9bd3a45-6910-4d02-b6ee-2b1e6e2bcc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0b39b3e5-f398-4bb1-8300-8ce2e5608452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0b39b3e5-f398-4bb1-8300-8ce2e5608452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_22a2b5fa-f1e5-4ae6-a3b8-665a4812f0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_22a2b5fa-f1e5-4ae6-a3b8-665a4812f0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OptionsInMoneyNumber_863f1b44-bb4f-4f95-b205-d12651d52cba" xlink:href="dxcm-20201231.xsd#dxcm_OptionsInMoneyNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_dxcm_OptionsInMoneyNumber_863f1b44-bb4f-4f95-b205-d12651d52cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d24b24a4-dc34-4447-8507-6beff211eaf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d24b24a4-dc34-4447-8507-6beff211eaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8e0b7312-9521-411a-abda-a3dbd80beb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8e0b7312-9521-411a-abda-a3dbd80beb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1ed8bc74-18fb-4cbc-a5eb-9717430c9eaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d53a446-b117-4f1a-a1d9-f52672a113f0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1ed8bc74-18fb-4cbc-a5eb-9717430c9eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9d045d59-5289-4384-921f-9138789a46b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_ccc491f6-4aaf-4c92-92ba-41c7a5e68aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9d045d59-5289-4384-921f-9138789a46b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_ccc491f6-4aaf-4c92-92ba-41c7a5e68aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ef2f932-68bc-4ec0-a81a-c60b772e5c1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ffc15642-4be5-443f-913c-8fde2f31647d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ef2f932-68bc-4ec0-a81a-c60b772e5c1f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ffc15642-4be5-443f-913c-8fde2f31647d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c13c3aa3-29ec-4646-bb6f-a06bf8db03b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ffc15642-4be5-443f-913c-8fde2f31647d" xlink:to="loc_us-gaap_AwardTypeAxis_c13c3aa3-29ec-4646-bb6f-a06bf8db03b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cde49e86-e46f-4295-94f0-259d0a61f16f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c13c3aa3-29ec-4646-bb6f-a06bf8db03b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cde49e86-e46f-4295-94f0-259d0a61f16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_52260585-47fd-4c9e-9aa3-bced63e2201b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cde49e86-e46f-4295-94f0-259d0a61f16f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_52260585-47fd-4c9e-9aa3-bced63e2201b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ffc15642-4be5-443f-913c-8fde2f31647d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1dabe99d-5f23-4ed8-b88c-cf3e13411ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1dabe99d-5f23-4ed8-b88c-cf3e13411ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e9bdd9d9-8124-4d6c-bc9d-249072100f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e9bdd9d9-8124-4d6c-bc9d-249072100f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f3ab70c9-c817-49e6-afa3-665083a62c72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f3ab70c9-c817-49e6-afa3-665083a62c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_77bbd70c-9da8-4b98-b2e3-c1d9cdb13e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_77bbd70c-9da8-4b98-b2e3-c1d9cdb13e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51b0ced1-5b13-40b1-b520-bea7fa45b147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2e5699c7-ea4d-46cb-a4c2-c7d943cf3456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51b0ced1-5b13-40b1-b520-bea7fa45b147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c23ac10f-0920-4cf8-94a9-924363467141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c23ac10f-0920-4cf8-94a9-924363467141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_142b75b7-7dce-4f3a-b5d5-9e27b5dacb88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_142b75b7-7dce-4f3a-b5d5-9e27b5dacb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_14485a52-f7e4-40e5-a69b-f8a67d2d7ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_14485a52-f7e4-40e5-a69b-f8a67d2d7ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2278db93-a5a3-4534-90ac-2b42f7933d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2278db93-a5a3-4534-90ac-2b42f7933d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_010764ba-ad27-4186-89f9-5a87ecd8062a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f0658ede-be11-464e-bd7c-8a185d901ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_010764ba-ad27-4186-89f9-5a87ecd8062a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_eafeab48-f22d-47bd-945b-debf9c608165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de6256a2-a08e-4155-aa6f-943e5aefaf4e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_eafeab48-f22d-47bd-945b-debf9c608165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b44aa9b-5cf9-4118-b13e-e5360d20298b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3452287b-b0af-4836-9d7c-648e2f0c1fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b44aa9b-5cf9-4118-b13e-e5360d20298b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3452287b-b0af-4836-9d7c-648e2f0c1fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockOptionsReservedForFutureGrant_edd6cfa5-b39a-467a-86fc-e72d4adfb866" xlink:href="dxcm-20201231.xsd#dxcm_StockOptionsReservedForFutureGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b44aa9b-5cf9-4118-b13e-e5360d20298b" xlink:to="loc_dxcm_StockOptionsReservedForFutureGrant_edd6cfa5-b39a-467a-86fc-e72d4adfb866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0ac335fb-3df3-4677-8764-76b2651b465c" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlanEsppSharesInEspp"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b44aa9b-5cf9-4118-b13e-e5360d20298b" xlink:to="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0ac335fb-3df3-4677-8764-76b2651b465c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2446d016-2384-40eb-8baf-4e302c838b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b44aa9b-5cf9-4118-b13e-e5360d20298b" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2446d016-2384-40eb-8baf-4e302c838b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c5c96f2-a721-4bff-84b2-18f5eb76a096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b6fc9b34-a104-4f37-b899-71f8944bb50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c5c96f2-a721-4bff-84b2-18f5eb76a096" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b6fc9b34-a104-4f37-b899-71f8944bb50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d321867b-0f78-45c7-a644-4d14387dfb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b6fc9b34-a104-4f37-b899-71f8944bb50a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d321867b-0f78-45c7-a644-4d14387dfb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d321867b-0f78-45c7-a644-4d14387dfb87" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d7dde077-c436-4644-afdb-67fcddd14a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:to="loc_us-gaap_CostOfSalesMember_d7dde077-c436-4644-afdb-67fcddd14a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_88e7da1e-db62-4d14-833c-c9d4845e14a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_88e7da1e-db62-4d14-833c-c9d4845e14a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember_4a0596c9-6ffc-4635-ba72-5b26d8e9a443" xlink:href="dxcm-20201231.xsd#dxcm_SellingGeneralAndAdministrativeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f140b3b-5444-4bf9-9bfd-e52bd8ec6a2d" xlink:to="loc_dxcm_SellingGeneralAndAdministrativeMember_4a0596c9-6ffc-4635-ba72-5b26d8e9a443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5b91a8cf-5000-4de5-8489-24331b6fbb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b6fc9b34-a104-4f37-b899-71f8944bb50a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5b91a8cf-5000-4de5-8489-24331b6fbb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e14f31ee-0e22-483f-904b-730967aaedf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5b91a8cf-5000-4de5-8489-24331b6fbb1f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e14f31ee-0e22-483f-904b-730967aaedf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cdc15cfa-580f-410c-9996-3f6f04923e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_076a4947-e74b-4227-b311-d68ed0e07923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cdc15cfa-580f-410c-9996-3f6f04923e09" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_076a4947-e74b-4227-b311-d68ed0e07923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_72dbbce7-6f1b-4bb2-ab1c-176fc247c3e0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_076a4947-e74b-4227-b311-d68ed0e07923" xlink:to="loc_srt_RangeAxis_72dbbce7-6f1b-4bb2-ab1c-176fc247c3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87839f62-1c4d-4e5b-875b-14310b0daa41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_72dbbce7-6f1b-4bb2-ab1c-176fc247c3e0" xlink:to="loc_srt_RangeMember_87839f62-1c4d-4e5b-875b-14310b0daa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55ad34a4-c95a-467b-a5b5-980c56801caa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_87839f62-1c4d-4e5b-875b-14310b0daa41" xlink:to="loc_srt_MinimumMember_55ad34a4-c95a-467b-a5b5-980c56801caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_44b3e6f7-4aac-4ee6-9588-022e1ba2b06b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_87839f62-1c4d-4e5b-875b-14310b0daa41" xlink:to="loc_srt_MaximumMember_44b3e6f7-4aac-4ee6-9588-022e1ba2b06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_49fcb319-9522-49e8-ab0e-8cdbba5765a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_076a4947-e74b-4227-b311-d68ed0e07923" xlink:to="loc_us-gaap_PlanNameAxis_49fcb319-9522-49e8-ab0e-8cdbba5765a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_db60c0c8-53cd-4598-b0ec-fdc440573b48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_49fcb319-9522-49e8-ab0e-8cdbba5765a4" xlink:to="loc_us-gaap_PlanNameDomain_db60c0c8-53cd-4598-b0ec-fdc440573b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanMember_ab9bc492-9fa4-4b44-bd23-b2b1831bd2f6" xlink:href="dxcm-20201231.xsd#dxcm_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_db60c0c8-53cd-4598-b0ec-fdc440573b48" xlink:to="loc_dxcm_EmployeeStockPurchasePlanMember_ab9bc492-9fa4-4b44-bd23-b2b1831bd2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_076a4947-e74b-4227-b311-d68ed0e07923" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a9369f0e-1809-43c1-93ba-f233edd74596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a9369f0e-1809-43c1-93ba-f233edd74596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_46a00e9b-e374-404a-a2c2-9e06eb72c048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_46a00e9b-e374-404a-a2c2-9e06eb72c048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3fd4c983-38f6-4d45-989d-ab5811bb0c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3fd4c983-38f6-4d45-989d-ab5811bb0c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ade6e5a4-7ca5-4bdb-94a6-213b62bf90a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbc2058d-10a1-4eff-a09a-4f45437093a9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ade6e5a4-7ca5-4bdb-94a6-213b62bf90a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_847df723-8e02-4909-ad01-20e00bc8262c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1a1a6e48-6e2c-43c7-914f-5492c4f9e5f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_847df723-8e02-4909-ad01-20e00bc8262c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1a1a6e48-6e2c-43c7-914f-5492c4f9e5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0f01ab19-8fd8-49c2-b9a6-85dee4acd942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_4f3cedec-0055-4bc0-8b45-fb8ddeec9f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0f01ab19-8fd8-49c2-b9a6-85dee4acd942" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_4f3cedec-0055-4bc0-8b45-fb8ddeec9f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_5473f7fe-6f87-48e2-9770-5cfd4beb7e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0f01ab19-8fd8-49c2-b9a6-85dee4acd942" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_5473f7fe-6f87-48e2-9770-5cfd4beb7e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3f552d24-491e-404a-b4bd-fd9f2e6d0c9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ed30b903-d87d-46db-a1c8-19df90675d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3f552d24-491e-404a-b4bd-fd9f2e6d0c9a" xlink:to="loc_us-gaap_NumberOfReportableSegments_ed30b903-d87d-46db-a1c8-19df90675d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#BusinessSegmentandGeographicInformationSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e3cd914a-3b91-45d3-b125-84c372f517b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43b7afef-51ea-455e-bc31-84791f45efc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e3cd914a-3b91-45d3-b125-84c372f517b7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43b7afef-51ea-455e-bc31-84791f45efc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f0a071f8-715e-4392-8cf8-5c97fa280daf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43b7afef-51ea-455e-bc31-84791f45efc8" xlink:to="loc_srt_StatementGeographicalAxis_f0a071f8-715e-4392-8cf8-5c97fa280daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b762fd71-63ff-4fef-9a40-30fd165a573e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f0a071f8-715e-4392-8cf8-5c97fa280daf" xlink:to="loc_srt_SegmentGeographicalDomain_b762fd71-63ff-4fef-9a40-30fd165a573e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4aefd522-8a17-4459-832a-f4f70d869ca9" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b762fd71-63ff-4fef-9a40-30fd165a573e" xlink:to="loc_country_US_4aefd522-8a17-4459-832a-f4f70d869ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_d1c4f7aa-8958-4332-b718-36361f53fb3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b762fd71-63ff-4fef-9a40-30fd165a573e" xlink:to="loc_us-gaap_NonUsMember_d1c4f7aa-8958-4332-b718-36361f53fb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_14cb2b14-c8b4-48b7-ad51-d7821c193b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43b7afef-51ea-455e-bc31-84791f45efc8" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_14cb2b14-c8b4-48b7-ad51-d7821c193b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_301c7fa8-334f-4523-8261-b48361c84fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_14cb2b14-c8b4-48b7-ad51-d7821c193b9a" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_301c7fa8-334f-4523-8261-b48361c84fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_de0f587c-bced-4bad-820d-37500a74379a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_301c7fa8-334f-4523-8261-b48361c84fdd" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_de0f587c-bced-4bad-820d-37500a74379a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_691c8f3b-8c78-4d3a-a3b6-d27c5b648fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_301c7fa8-334f-4523-8261-b48361c84fdd" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_691c8f3b-8c78-4d3a-a3b6-d27c5b648fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8257a2c4-1b8d-43b4-a2d9-0a52fdfaaa66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43b7afef-51ea-455e-bc31-84791f45efc8" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_8257a2c4-1b8d-43b4-a2d9-0a52fdfaaa66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62241238-4e38-4ba3-8d3f-cc696f62a698" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8257a2c4-1b8d-43b4-a2d9-0a52fdfaaa66" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62241238-4e38-4ba3-8d3f-cc696f62a698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage_f805fa92-a3a0-4e32-bc18-0b37560ee803" xlink:href="dxcm-20201231.xsd#dxcm_RevenuePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8257a2c4-1b8d-43b4-a2d9-0a52fdfaaa66" xlink:to="loc_dxcm_RevenuePercentage_f805fa92-a3a0-4e32-bc18-0b37560ee803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="dxcm-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_268c2203-312e-4a0f-8e44-92643a892390" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_5b51c7bd-a524-44b4-a5ee-b7b4edfcbf07" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_268c2203-312e-4a0f-8e44-92643a892390" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_5b51c7bd-a524-44b4-a5ee-b7b4edfcbf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="dxcm-20201231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_b6b6d1ae-2a2e-4efc-a3c2-259c9f0607f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1490a8b2-b726-4717-9989-276da309fe7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_b6b6d1ae-2a2e-4efc-a3c2-259c9f0607f3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1490a8b2-b726-4717-9989-276da309fe7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_3556d774-77ef-46be-9b62-3ede5a12401f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1490a8b2-b726-4717-9989-276da309fe7d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_3556d774-77ef-46be-9b62-3ede5a12401f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_7873ccd1-b3ae-467b-a882-ddc199754073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1490a8b2-b726-4717-9989-276da309fe7d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_7873ccd1-b3ae-467b-a882-ddc199754073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_b4a2ac6c-fb4c-43fb-a839-b4a2e189f8f3" xlink:href="dxcm-20201231.xsd#dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1490a8b2-b726-4717-9989-276da309fe7d" xlink:to="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_b4a2ac6c-fb4c-43fb-a839-b4a2e189f8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_f9ee5b7d-d99d-4208-a04c-561b1fca30d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1490a8b2-b726-4717-9989-276da309fe7d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_f9ee5b7d-d99d-4208-a04c-561b1fca30d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_81257d65-dc21-40ec-97f0-f4c9f5350b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1490a8b2-b726-4717-9989-276da309fe7d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_81257d65-dc21-40ec-97f0-f4c9f5350b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>dxcm-20201231_g1.jpg
<TEXT>
begin 644 dxcm-20201231_g1.jpg
M_]C_X0KZ17AI9@  34T *@    @ # $   ,    ! W\   $!  ,    ! (4
M  $"  ,    $    G@$&  ,    !  4   $2  ,    !  $   $5  ,    !
M  0   $:  4    !    I@$;  4    !    K@$H  ,    !  (   $Q  (
M   D    M@$R  (    4    VH=I  0    !    \    2@ "  (  @ "  6
MXV   "<0 !;C8   )Q!!9&]B92!0:&]T;W-H;W @0T,@,C Q.2 H36%C:6YT
M;W-H*0 R,#$Y.C T.C$P(#$P.C(P.C4V      20   '    !# R,C&@ 0 #
M     0 !  "@ @ $     0   W^@ P $     0   (4         !@$#  ,
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M    %0!# &$ ;@!O &X ( !- %@ -  Y #  ( !S &4 <@!I &4 <P @ #,
M      ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4
M= !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL
M=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M   2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB
M<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M     $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN
M=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @
M9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6)
M;^            !"<F1456YT1B-2;'0               !";&0@56YT1B-2
M;'0               !2<VQT56YT1B-0>&Q 8L            IV96-T;W)$
M871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15
M;G1&(U)L=                %1O<"!5;G1&(U)L=                %-C
M;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L
M  YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M        #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO
M;F<      #A"24T#[0      $ "6     0 ! )8    !  $X0DE-!"8
M  X             /X   #A"24T$#0      !    !XX0DE-!!D       0
M   >.$))30/S       )           ! #A"24TG$       "@ !
M  $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M      $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE-
M _@      '   /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z   .$))300(       0
M 0   D    )      #A"24T$'@      !      X0DE-!!H      U$    &
M              "%   #?P    X 9 !E '@ 8P!O &T +0!N &\ +0!M &$
M<@!K     0                         !              -_    A0
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG    A0
M  !29VAT;&]N9P   W\    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   (4     4F=H=&QO;F<   -_
M     W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%
M6%0    !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-
M3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M
M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N
M=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y
M<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T
M<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U
M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3004       $     3A"24T$#      )B
M  $   "@    &    >   "T    );  8  '_V/_M  Q!9&]B95]#30 !_^X
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M &\ = !O ', : !O '     7 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@
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M     $E%0R!S4D="               !  #VU@ !     -,M2% @(
M                                                        $6-P
M<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M%')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4
M    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D
M  /X    %&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=4
M4D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q
M.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="
M($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M
M  !865H@        \U$  0    $6S%A96B                      6%E:
M(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M   DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                             &1E<V,
M+DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'
M0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R
M('-P86-E("T@<U)'0@                            !D97-C
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%
M0S8Q.38V+3(N,0                                  =FEE=P
M$Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7
M'^=M96%S          $                        "CP    )S:6<@
M $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!
M $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X
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M_P"OOW[XW;_HZ7'_ #E?_H+KW[]WS_H\W?\ SFD_Z"Z[/9/8OT_O]O47Y/\
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M[T\^SZA'?01$C\$*&GV:P_V9Q\JYZ3__  Y=\VN/^,T_[;KCJ7_[ _Z>TO\
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M1?!H]JM;>RB(P:>+(/\ ;. G_5+CGH.>G_YFWR>ZRR\T^Y=S1=M8"MJGJ*[
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ME8YJYX9 &C^RII/HZGWC?[^\T"*VV_E*UE_5D(FGI_ I(B0_Z9@SD'(T(>#
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MD+: ?+6%KT".8/;WFWEF)KG=-J;Z('^UC(D0?-BI)0?-U7/18N+_ .W/^O\
M2Y]@SH%=>Y_!O_OK\^_?X.O=='^O%[_T_P!Y^A]^Z]UZYN/\?\?Q_L/K:WOW
M7NC._%CY1[Z^+?8--NG;51+D-L9.6DI=\[+GF88W<V&AENQ5&.BCSN.CE=Z&
MK U0R,5;7#)+&XRY)YTW/DK=DOK-BUFY FB)[9$_R.M24?R.#52RD:<D\Z[E
MR7NBW5JQ>PD($T7X77U'D'7)5OR-037;6ZT[&VEVYL;;78VQLFN6VONG'1Y+
M&5*V2:.Y>&JH*^!6?[7)XVLCDIZF DF&>)E/(]YV[/N]AOVVV>[[9,)+*=-2
MGS]"K#R92"K#R8$=9Q;3NECO6VVFZ[=,)+*9-2G_  @CR93567BK CRZ7?LS
MZ,>O>_=>Z][]U[KWOW7NO>_=>ZIS_F4_.&OZQ@J>@^I,NU'O[+T*/O[=6.G*
MU6S\'D*<M!M_%S(-5+N?,TLJS25"LKT-(ZF.TTZR08_>\7N5+LZORKL-QHW.
M1?UY5/=$C#$:GRD<$$M6J)33W,"D#^[GN-)LB-RUL=QIW:1?UI <PHPPJD<)
M'&:\40U%&92NN^26.HDL3<LQ-R;W-R?S>_O$ZO6*)))J>N/ _']?]]^??OMZ
MUUV/QS_O7/\ C^?K?W[KW7?T_P!;_>;_ /&_>NM]&]Z?^"7R=[KH*7-;5ZXK
M,1MJM6.6EW/O2JI]J8BKIYBOBJL?%DBF7R]'(A+":DI:B(@'U7L"/N7_ &SY
MSYCC2XL=I:.S85$DQ$2$'@5U=SKZ%%(QT/MA]L><N88TN+3:C%9L*B28^&I'
MD0#WL#Q!5"#ZUIT;2E_DY?(&2")ZSL?IZFJ74F2"'(;SJHXB6]*B=MG4QD.B
MVJR !K@$@ D=I]W[FID4ON^WAO0-,?Y^".AQ'[ \R% 9=YL5D/$#Q2!^9C6O
M[/EGH,>Q/Y5?RLV/1S9'"XW9W9=+%')-)#L;<4HRL<"%KZL5NK&[9J*JI**#
MXJ0U3FX"ZC<>R7=O9'GG;8VEMX;>\C&2(9.ZG^EE6,D_)-1S05Z)MU]DN==O
MC>6U6WO%](G(>G^ED6,5^2ECZ5ZKMS.%S&W,K7X+<&*R.#S>+J9:+)XC+T53
MCLGCJN$VFI:VAK(H:FFJ(V^J2(&%_I[B>XMKBTGEM;J!XKE#1E=2K*1Y,IH0
M1Z'/KU%%S;7-E/+:W=N\5S&:,C JRGT((!!^T>?3;_MO]Z_UO]Y]L=,=>MQ_
MMOR?]]^?>^O=++K[L#=W5N\L#OW8N:JL!NC;E='78S(TDA4JZDK-2U47^;J\
M?7P.T-3!(&BGA=D8%6(]F&U[I?;)N%KNFV7#17L+:E8?S!' J14,IPRD@BA/
M1EM.[7^Q[C;;IMEPT5Y$U01_-6'FK## X(-.MN'XH_)#;_R@ZDQ6_L5'!C=P
M4C#"[YVW'(S';^Z::".2JB@\CO.^(R*3"HHI6+%H) C'RQRA<\>1N<+3G788
M-T@ 2[4Z)HP?@D %0/Z#89#YJ:$Z@0,Y^2N;+3G'8[?=;<!;@=DL?^^Y !J'
MJ5-=2'S4CS! ,U[&/0NZ][]U[J)6T5)DZ.KQV0IH*V@KJ:HHJZCJHDFIJNDJ
MHG@J::HAD!26&>"1D=2"&5B"+'W22-)8Y(94#1.""#D$$4((\P0:=4=$E1XY
M%!1@0014$'!!'S''K49^:_QJK_C-W5F=LTU-4-L+<K5&X^N<E)Y)$FV_4SGR
MX6:I9 LF3VU4R?:S\ZVC\,Q"^=1[P-]QN3Y.3>8[BR12=KEK);L:YC)^ GS:
M,]I\Z:6/Q#K!GW&Y/DY0YAGMHD/[KG)D@/\ 0)RE?XHR=)S73I8TU=%#'^]?
MZ]C_ %X]@+H ]>_WU_\ ?#GW[KW7OP/Z"W^-O^1>_=>ZMJ_E2_)2/KKLNOZ.
MW17B#:G:]93S;8FJ)BM-BNQ*>$4U+3*K$1H-X4")2$W+-64](@'J8B=?8[G!
M=GWB7EN^DI8W[ QDG"W P!_S=%$]2ZQ@#/4Z^R/-XVS=I>6;V6EG>M6(DX6<
M"FG_ )NJ O'XU0 $L>MD/WE[UEEU[W[KW7O?NO=>]^Z]T@.T>Q]L=0[ W7V3
MO&L6BV]M'#U66KFNBSU;Q +1XRA#LJS9+*ULB4U-%?\ <GE5>+W]E6];Q9;!
MM5]N^X2Z;2",L?4^BK7!9F(51YL0//HMW?=;/9-LO=VW"4):01EF/K3@H]68
MT51YD@=:;W<G:FX^[.SMX]H;KE+9K=^8FR#P!VDAQM#$D='B,-2,]F^SP^)I
MH:6*_)2($W-R>?7,&]WG,>\[CO=\:W%Q(6(\E'!4'R1 J#Y 5ZP$YBWVZYCW
MG<-YO3^M/(33B%44"(/DJ@*/LKQKT&/X_P!>WTL?]X')^G^V]D_1+UW^/Z?[
MQ[UU[RZ]]?\ ?#\6^OO?^#KW6P/_ "GOBRVV\!5?)/>F-,>;W325&(ZQHZN'
M3+CMKNS0YC=(25=<=1N.5/MZ1QH(H(Y'!:.K6V5'L9R2;.U?G#<8J7,ZE+<$
M96,_'+]LGPH<=@8Y$@/64WLCR8;&S?FS<8:75PI6W!&5B_%)GSD.%_H"H-'Q
M=-[R*ZR!Z][]U[KWOW7NO>_=>ZKX^>/S6QWQ?VE#MO:4E#E.YMW44K[=QU0$
MJ:;:N)<R4[[PS=*=2RI'.C1T%+)9:JH1F8-##(K13[G>XT/)=@+.P*/S%<*?
M#4Y$2Y'BN//(I&IPS UJJL.HP]RO<*#DRP6VLRK[_.I\-#D1KP\5QZ X13\;
M5\E;K5UW)N;<.\L_EMT[KS62W%N+.5DE=ELUF*R:NR60JI+ S5-34,\KD*H5
M039$4*H"@ 85WEY=;A=37M]</+=RMJ9W)9F)\R3^SY#AUAE>WUYN-U/?7]R\
MUY*Q+.QJS'YD^G #@ *#  Z8K_7_ %^./]M;_7]I^DG7OJ/Z_P"P)O;_ 'OC
MW[KW7?\ O8_UN??NO=9J>EJ:RHAI*.">KJJF:."FIJ:*2>HGGE8)%##!$&EE
MED<@*J@DDBP)]V17=UCC4L[&@ %23Y ?,GRZND<DKI%$C-*Q   )))\@!DD_
M+HSFU?A1\KMY4T59A.B.P$IIT22";.XI-I)-%(R^*:([KJ,,7BD#@JXNK*=0
M)7GV,[+VZYYW%!);<L7>@\"Z^%7Y_J%,'!KPID8Z&=E[<<\W\:RV_+5R%/#Q
M (OSI*R'[/49X9Z7M=_+@^:>/A%1/TE6R(7$=J'>W6F3G#,";FFQN\JNHT>D
MW;1I!L">1<SE]HO<2)=3<MM2OX9K=C^Q9B>C%_:3W#C 9N76I\IK<_R$Q/Y]
M!QGOAE\J]MQS29/H+LR2.$NTLF'VS6;D5%0QZW+;=7*@HHE!U"ZV#&]E8@IN
MO;WG>SU&;E:](''1&9.'G^GJ_P U*GR/17=>W?/%DK--RS=%1_ GB^G^^R_K
M_A\@>B\9;#9? UTV,SF+R6&R=.=-1CLM0U..KH&)(TS4M9#%/$01:Q7ZCV$I
M[>>UE>"Y@>.9>*L"K#[0:$?GT%+BUN+.5H;NVDBG'%74JP_)@#TW?[;_ !Y/
M^MP?]?VUTGZ&OIGX[]R=_9C^#]6['RVXUBF2+(9LQ"@VUA]5F+9?<-:8<51.
ML9UK"9#42 'QQN>/8BY>Y3Y@YIN/ V3;9):&C/\ #&G^GD-%&,TKJ(^$$]"7
MEWE'F'FF?P=FVYY4!HTA[8E_TSGM!\Z ECY*>KX_B1_+(PO1VY-N]H=B;[RN
MX>Q<#415^-Q6S:[);=VGAZO20T%77QFDSNZZ>0'3)'+]E1SQLT,]--&Q!R=Y
M$]F+?EN[L]ZW?='FW>)M2K"S1Q(?0MAY1Y$'0C*2K(RGK)GD;V?M>6;NVWC<
MMRDFW>/($3-'$I]"11Y!ZAM*,"0R$<;7_<Y]33U[W[KW7O?NO= OWUWELCX\
M=;YSLK?52XH,:J4V+Q-*T7\4W)G*A7..P.)CELKUE8Z$LQ]$$"/,]D1C[#W-
M',VV\I[/<[SN;_I)A5'Q2.1VHOS-,G@H!8X'1#S)S#MW*^TW6\;FY\%!0**:
MI&/PHH/%F/Y 58T )ZU-/D3\B>P?DMV#6[[WY6A(T,M)MK;-'+*V$VEA3*9(
M<5BH7MJE:RO4U+CS54WK>P"(F"O-O-N[<X[M)NFZ24 Q'&#V1)Y*H_X\W%CD
M^0&#_-G-FZ<X;I)N6Y/2,5$40/9$G\*^I."[D5<Y. J@!?I_K7_WO_6^EO87
MZ"W77TY/'U_XW_L../>^O==WY_WUOZ_XV(/OW7NO?U_WG_B+CWK_  =>Z?\
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M0V 0K-U%?NER+:\T;+<[A:P ;]:QEHV'&15RT3>M1717X7I0@,U=6T_C^O\
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MJ=+)18O&TD;SU$I!T1H; MI!-=DV;<>8=SM-HVN R7LS4 X >99CY*HJ6/D
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M2*$,#0@@\""""#P/'J+]?]['''XY]M_X>F^NOZ?7\?T_'^O?WOKW7?\ OO\
M??3WKKW5Y7\IOY2U"5M3\8]ZY-Y:6ICK\YU-4U<S,U+40+-D-R;,B+:K4]3
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M $5A3_2*:_$137<_/^/^\\_UM^/>)GV=8G]>_P 3_CS8#W[KW7C_ *]A^?\
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MF5N7^3[F&"33?7S> E#D*P)E;[ @*U&0SJ>HP]VN9#R]RA=K!)IOKP^!'3B
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MMMMVWVS2WLS!41>))_D !4DD@**DD $A;MVW7F[7UMMNW6[2WTS:44<2?\
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M_??X6_K[]U[KKZ_C_;_['WKKW7N/I_O%O]C_ *UP?>^O=;J7Q_\ ^9#])_\
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MVQL:R1BI,!/F/6(G@>*<#BAZJH_WUK?C_'CZV]PAU"'7C]/ZCZ&Q_H;WYO\
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M9B2;W)//OF^2222<_P ^N=#,78LS$L<DG)/S/K7S_;UPM_QHG^O'OW6NN_\
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MO _\E7ES_GGD_P"/CJFD?X?7^MK'\@'GWCWUCWUW?_ 6_K_O9_VWOW7NNO\
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M+F><6W+?,-R2:1V-PV./;$YQPSC'S\^M+7_8_P!?Z?U^H^OY]\[.N>O71O\
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M;H-423.U:4KJ8GAY<>'3+^?P/Z?UX_V'T'M/TDZ]S_KC_D7^WM[UU[KW]?\
M>1]?]C_L1[WU[H<OC!1QUWR4^/M'+ M5!4=V]515%.4\B2TQWS@ON5E0 ZHO
MM@VN_ 2_XO[$O)B"7G#E2-EU*=RMJCY>,E?RIQZ$O)D?B<W\K)HU [C;5''
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M_K>]];Z__]<2[_[S_@?]A[YF]<V.O?X?G_'G_8\F_/OW6^O'\?T_H/\ ;_\
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MO_.)R@IOCCL3%K)(DV3[FPL[(JWCEH\=LS?)G61K@#35U5.RCZG3_@?<$_>
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ML^Z.>O>_=>Z][]U[K7G_ )S/_,U>G!?_ )I]F+#D?\Q'-_3WBC]X7_DM\O\
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MWE_:G4O[(] /S'1Y/<E=2)U[W[KW7O?NO=:<7R^V&W6WR=[NVG]M]G34^_\
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MY1Y=W'7J=[5 QX]Z#PY/^-JW70+D_<QO/*VP[D&J\MLFH\>]1I?]CJP_P]&
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MD^>A?TT_FK,/DU>K1?<T]3%U[W[KW7O?NO=>]^Z]T!/RC_[)E^17_B">W/\
MWW^X/89YU_Y4WFW_ *5EU_U8DZ#7.?\ RI_-?_2MNO\ JP_6F/QQ_7ZBQ^H)
M_P!@#[YY\.N?O7?TXL?\".?^-_CW[KW77X%N/];_ !_'!^GOW7NO<_3\?[XC
MW[KW6T#_ "GO^R2:#_Q(.]?^MN/'O-#V,_Y42+_GKF_PKUF=[*?\J':?\]$W
M_'^K+?<Q=2SU[W[KW7O?NO=5<?S=O^R5\3_XES:7_N@WA_O?N%/?K_E2;?\
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MF0O<2NSLQXLS$LQ/S))/Y]8#75S/>7-Q>7+EKB61G=CYLQ)8_F23TV'\&_\
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M[\H>Y?D"^V-N5JUVT>GZ*IV?15,$HFI*_=%15)4[RR-(RG3XDK((,>6%U?\
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MZ?F__&A^#]/?NO=7:?R7O^/N[Z_\-S8O_NSW)_O/O(W[N_\ N?S1_P T8?\
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M4@<?&+8>395"T>4[;R%#,07$BQUF%V-Y8VOHT-'7Y!0.;TT6KBH0XR>^//3
MCDS:YZ8#73 \?-(?\#R>O8M?B'6-_O;SP4 Y.VR:C$!KEE/D<K#CUP[CTT#(
M+#JBD?\ %/\ ??C^OO&CK&CKO_??XWM?_>O>NO=>_P!?_B?]\?>^O=/NV-M9
MS>>XL'M/;&-J<SN+<F5H<+A,52+JJ:_)Y*HCIJ2FC#%45GED U,55!ZF(4$A
M396=UN%W;6%E TEW,X1%'%F8T _,GSQZD=*K*RN=RO+6PLH3)=S.$11Q+,:
M?+[3@#)P*];=7Q(^,^WOB_U1C-ET7VU?NW)_;YC?^Y8(RK9W<;P@2Q4\DBK,
M,+A4D--1(VG]H-(566:6^>?(?)MIR5L4.WQ:6OI*//(/QR4X#ST(.U!C U$:
MF;K.WDCE&TY.V.#;8:-=M1II*?')3/\ M5^%!Z9XD]&F]C;H8=>]^Z]U[W[K
MW5%O\T_X>HT57\GNNL6J2(:>#MW"T,0"RHVBEH=_00H% E5O'394+?4&BJ2M
MQ52G&?WM]OUTOSIM$.<"Z11^2S@?L62G]%R/[1CCC[T\A"1).<=JA_46@ND
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MGKWJMYK:?:N4"^IP5:Y(*T'GX2FC5(_&P4K^$$T84:$W)9N2Q-R?J2?J3?\
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M_P /?NO=>_J/]<_\3[]U[KU[#_6_XBW_ !'OW7NMH#^4]_V23C__ !(.]/\
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M1_Q(_'^V]^Z]U[_??3^O_&_?NO=7/?R_?Y>63W3DL#WAWS@)*+9M']OE]D;
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MWU]@'H =>O\ CZ<V_K?_ (US[]U[KH?3_7^G^/\ 3C^@]ZZ]U[Z?[#_7^O\
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M]_QJ_P#R+_'WX=>Z]_O7^Q/_ "/WKK?7N/R>?]M^>./\#[WUKKK_ 'PYX_'
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M24WGLG:G8FVLIL_>^ QFYMM9J#[;)X;+P"JHJF/4LBG2=+Q3P2('BEC*RPN
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M]V<]_#?[S?WW\7\,M1?QG^&?WF_R#^)_8W_3^]]KY[<:O8Y]O?\ 6E_K$O\
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M_P"Q.7_?QO\ V+/^']>/?O\ P'[_ )?/^SKK7_@/_P#R\?\ 9YU[_L3E8_\
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MNO>_=>Z#OM[^YO\ HG[0_P!(OW7^C[_1WO3^_?V7WGW?]S?[MY/^\_VG\/\
M\N^Y_@GGT>#][5;1ZK>RG?\ ]W_N+>OWMJ_=7TDWC4K7PO#;Q*:>ZNC52F?3
M-.BO?/W?^Y-X_>U?W5]++XU-5?"\-O$II[JZ*TTY],]43?\ 8G'_ +^+^/\
MG[/]?\/\?>,O_@/W_+W_ -G76-__ (#_ /\ +Q_V>=>_[$Y?C_2+_L/]+'OW
M_@/W_+Y_V==;_P# ?_\ EX_[/.O?]B<OS_I&_/U_TL_['_8?\1[]_P" _?\
M+Y_V==:_\!__ .7C_L\Z[/\ PSE?_FHU['Z?Z6/\/Z^_?^ _?\O?_9UUO_F
M'_+Q_P!GG5M_PU_T ?Z%J;_9:OXM_HR_O+GO!_&OX[]Y_&]=-_%_^/B_W(>+
M5HTW]'^I_/N>/;W^JW]7$_J?XG[F\9Z:]>K7C5_:=U.'RZG'D3^K']7H?ZHZ
M_P!R^*^G5XE=6KO_ +3NX\*X],=&M]CCH9=>]^Z]U[W[KW10OFO_ ++K_H?H
M_P#9GOXQ_HY_OKA?M?X)_'_O?[S_ ,.SG\,O_=S_ '(>'[+[J]_V[VO^/8"]
MQOZI?N"/^N?B?NCZE*:-=?$TOI_L^ZFG5\N%<TZ _N!_53]PC^N.O]S^.GP^
M)7Q*-I_LN[U^753_ /V)RX_YF-_[%FWT_/N#/_ ?O^7O_LYZA3_P'_\ Y>/^
MSSKO_L3E_P!_%_\ 8L_[Q;W[_P !^_Y>_P#LZZU_X#__ ,O'_9YU[_L3E_W\
M;Z?]_9]^_P# ?O\ E[_[.NM_\P _Y>/^SSKK_L3C_P!_&^O_ ']FW^/^PO\
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BR_[^-^/^?LV_V%_?O_ ?O^7O_LYZU_X#_P#\O'_9YU__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>dxcm-20201231_g2.jpg
<TEXT>
begin 644 dxcm-20201231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAJ***!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWCC5--U/Q?K\"6*QZ:CK9:=:J0?*CWX9LLJDEAGY>Y)->NT4 %%%% !1110
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M#7O]%% !1110 4444 %%%% 'A_[?_P"SY>?M _ >:WTBW%QKVASKJ%C'T:?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+X"T2S^ 7[?-[X9T.&.P\.^.O#HU;^SX!LM[:\BD=2R(.%!1&.!M'SX_A H
M^D:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *^(?\ @JAJ<WQ!^+_PY\ V39N+EO-9%YR]S,D$61ZCRW_[
MZK[>KX3^!DLG[6O_  4>U;Q@J[] \)LTL#=59(@8;?'NSYE_!O:@3/N73-.A
MT?3;>SMU\NWM8EAB4?PJH  _(5/110,**** "BBB@ HHHH **** "BBB@ HH
MHH **** .)^/'P!\.?M$^")-$\16OF*,O:W4>%N+*0C[\;=NV0>& P0:^/=$
M_P""37C74[Z'3]<\9Z7'X=T^X<VJP--/($9AO9(F"I&S@#.&/(&<X%??%% %
M?2=)M=!TNWL;*WAM;.UC6*&&) B1(!@* .  *^7_ /@K-\.6\3? 33=?AB,D
MWAG45,C!<^7!./+;_P B"&OJBL;XB>!K'XF^!=6\/ZDNZQUBUDM9<=5# C</
M<'!!]0* .4_90^)J_%W]GCPIK?F+)<2V*071#;B)XOW<F>X)92<'L1U')]$K
MXE_X)J>-=0^$'QC\8?"'7F*S0SRW%H#]WSXL+*%]I(PKCMB,GO7VU0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M /RM_P#<@_XA;_U$_P#DG_VY^AE%?GG11_Q,=_U+_P#RM_\ <@_XA;_U$_\
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M_>C_ (F._P"I?_Y6_P#N0?\ $+?^HK_R3_[<_1BBOSSHH_XF._ZE_P#Y6_\
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M5_3GT<?^9A_W!_\ <I^2^*7_ ##?]O\ _M@4445_3A^2A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-R@C!#-VQW-0Q_&'Q5+&K+XH\1;6&1_Q,9O_ (JLG5]:O/$%\UU?W=U?74@
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M6,PPR"\DWPH<913G(7@<#CBO0H^,%%<BJ4):.BW9KWI4YW<O64(PCZK4YJG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 <K\;;WQ1I_P *M:D\%6<-_P"*?(VZ
M=#*Z(OF,P4MF0A/E4LP#'!*@<YQ7A/Q&^ _C#X3_  *OO&G_  MKQROC#0;
MZI<I>ZD)-*FE1=[P"V(*88C8HR021P<XKZ5UW7;/PQHMUJ.H74-G8V,337$\
MK;4B11DL3Z 5\RSRZ]_P4-U=88TN_#_P;L;K=)*P\N[\3O&W0=UA_D1W880
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M_N7^8?ZV9/\ ]!$3QNBO9/\ AA[Q9_T$/#O_ '_F_P#C5'_##WBS_H(>'?\
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M-4?\,/>+/^@AX=_[_P W_P :H_XAEQ3_ - 4_N7^8?ZV9/\ ]!$3QNBO9/\
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M -!$3QNBO9/^&'O%G_00\._]_P";_P"-4?\ ##WBS_H(>'?^_P#-_P#&J/\
MB&7%/_0%/[E_F'^MF3_]!$3QNBO9/^&'O%G_ $$/#O\ W_F_^-4?\,/>+/\
MH(>'?^_\W_QJC_B&7%/_ $!3^Y?YA_K9D_\ T$1/&Z*]D_X8>\6?]!#P[_W_
M )O_ (U1_P ,/>+/^@AX=_[_ ,W_ ,:H_P"(9<4_] 4_N7^8?ZV9/_T$1/&Z
M*]D_X8>\6?\ 00\._P#?^;_XU1_PP]XL_P"@AX=_[_S?_&J/^(9<4_\ 0%/[
ME_F'^MF3_P#01$\;HKV3_AA[Q9_T$/#O_?\ F_\ C5'_  P]XL_Z"'AW_O\
MS?\ QJC_ (AEQ3_T!3^Y?YA_K9D__01$\;K]#*^5_P#AA[Q9_P!!#P[_ -_Y
MO_C5?5%?T!X&<,YKE'UW^TZ$J7/[+EYNMO:7MZ77WGYMXA9M@\;]7^J5%/EY
M[VZ7Y;?DPHHHK]^/S8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** ./^.?P9T_X_?#JZ\,:I?ZMI^GWLD;SMIT
MJ1RR!&W!"71QM+ $C'85YOI?[!]KH>FP6=E\5/C19V=K&(H8(/$PCCA0# 55
M$6  . !P*]XHH X'Q=^SAX>^(GPCL_!WB235/$%G8JIBOKZZ,FH"5<A9C, #
MYG)YQ@@X((R*P_ /[''AWP9XYT_Q%J&M>+?&&J:/'Y>FOXAU(7BZ=[Q*$4!O
M<YQUZ@$>M44 >=_&3]F;0?C/XATW6KB^U[0?$&DH8;;5M%O/LMVD1))C+%6!
M7))P1W/J:L_!3]GC0?@4NJ3:;)JFI:KK<HFU'5=4N?M-]>L,XWO@<#)X ')-
M=W10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %?!?BT']M[_@HK#I8S<>%?!;F.8=8WAMGS+GL1+.0F>ZE>>*^O_P!H
MWXCGX1_ OQ5XB1ML^FZ?(UN?29ALB_\ (C+7S]_P24^&(T?X4ZYXNN5+7OB*
M^-O%(QRQ@AZG/^U(SY]=@H$?6U%%% PHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /AG]OQ9/@9^VAX
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M[?6M,M[RUD6:UNXEFAD7I(C %2/J"#4]?J\9*2YH['Y]*+3LPHHHJA!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!^ H \7_ .'L_P"U]X64WGB#]GGRM,C_ -8__"'ZU9X_[:/*RC\17L7[-O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,\0?LN?!'Q7_ ,%CKCX4:UX=T7PAX)\,Z-%)8Z?;RO;+XDU"2"WN DLI??\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH _.3_@K#+-J_[4.DV<0>1X]"MH8XQSEFGG/
M]3N'Z5^@_@GP\OA'P9I&DK]W2[*&T&/2-%3^E?$W[1NAP^._^"IOA/3;CYH8
M7T]G7^\(P9]I]CC!]C7W;0(****!A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #9HEN(FCD562
M0%64C@@]17P]_P $YVD^#_[6OQ(^'K,WV4"819.=[6MP40_\"CE8_A7W'7P[
M#_Q;[_@K^R_ZNWUHGVW>=I^?_1HH$S[BHHHH&%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ^']=_XF_P#P6-LX>OV79^&W23)_6ON"OAGX.77_
M  LW_@K+XBUBQ7SK71VNQ+(IW*JQ6PL]V?=R!^/>ON:@2"BBB@84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1)C;%%$I(C08' )Z+Z"@#TRBBB@84444 %%%% !1110 4444 %%%% !1110
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MQ]\.]2D$=Y:3_:8HB<8EA=H+C ]?]5^"FOMJOB']O;X3ZQ^SM\9=,^-7@TM
MLET@U1%^['.1MRP'_+.9<HW^T3SEQCZS^"?Q>TOXZ_#+2_$^DMBVU&++PE@S
MVLHX>)L?Q*V1[C!Z$4"1U=%%% PHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS/_;R^.W[0W[07_!0
M/5_@?\&-8N_#MOX4TR"]N7M+E;)IUD@AF>XEG^^$4W,<053C=V).1^F%?DW_
M ,%)?BE\0-;_ ."J4.F_ CP[J5K\2O!FCQ0ZAJ6EQ^=<:I'+#%/B:-\PF"..
M:)<NIRS<DX0  M_\,(?MY?\ 17+W_P +.Y_^)K] _P!B+P'X\^&7[,'AC0_B
M=J\FO>.+'[5_:5\]ZUXT^^[F>+]ZP!;$+1KSTVX[5^?G_"X?^"C7_0OWO_@F
MTG_"OT#_ &(M8^(VO_LP>&+OXM6\EK\09OM7]JQ/#%"RXNYA#\L7R#, B/R]
M<Y/.: /5J*** "BBN7LOC=X+U/Q NDV_B[PO<:I(_E+9QZK ]PS]-HC#;L^V
M* .HHJ#4M3MM&L)KJ\N(+2UMU+RS32"..-1U+,> /<UD^#_BCX9^(4DRZ!XB
MT+7&MQF5=/OXKDQC_:V,<?C0!NT5E^+/'.B> K!;K7=8TO1;5VV+-?W<=M&S
M>@9R!GVJ7PUXJTOQGI27VCZE8:M8R'"W%G<)/$Q]F4D?K0!?HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".\NX]/M);B9UCAA0
MR2.>BJ!DG\!7P[_P3LTV3XZ_M4^//B;J"._V5Y#:E_\ EE)<LP4#_<A1D]@P
MKZI_:E\1-X5_9O\ '%]&VR2+1+I8V_NN\;(I_-A7B_\ P24\-KI?[.>IZ@5_
M>ZIK<IW>J)%$H'X-O_.@#ZEHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M >=T4YADC'7@[B#QSUH \Z_X?1?M.?\ 1"[+_P )_5?_ (Y7Z!_L1?&GQ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /%?^"B&I_P!E_L=>,G!PTD=M
M"/??=0J?T)JE_P $UM-_L_\ 8Z\+OMVM=RWDQ_\  J51^BBJ?_!3V[^S?LB:
MPG_/Q>VD?_D96_\ 9:Z;]@RT^Q?LB>!T_O6;R?\ ?4TC?UH%U/7:***!A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP^<?!_[)OQ@_;3M)/$WC;Q5=^']+U!_-M+6Z61\H>0T=J&58X^F"2">O.<D
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M1110 4444 %%%% &7XX\)6OC[P9JNAWT:R6>K6DMI*K#(VNI4G\,Y^HKX_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA\1127E\#-<#-O)>-RJ*H0EA$,EV+;<8!(&W-:R_L2_M$^"EWZ+\3OM"J/\
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M\3/+=?N_Z%+:_JDK5BVOQ1^,'_!/#QM#:^,9+KQCX/U*0!9GN9+B(^ODRO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117DO[
M;/QN_P"%#_L\ZUJD$WDZK?K_ &=IN#AA/*"-P]T0._\ P"@#YS_9.;_A>?\
MP4@\;>,1^\L]%-V]O+UR.+2'\XMQ_ U]S5\R_P#!+?X*'X<_ >3Q%=1E-1\8
MRBY&1REK'N6$?\"R[^X=?2OIJ@2"BBB@84444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9
M6N>.M#\,7:V^I:QI6GSN@D6.YNXX7922 P#$'&01GV-:M?*_[<'_ "5C3_\
ML$Q_^CIJ^(\0>*JO#V4/,J--3:E%6;:6OH?0<,Y/#,\:L+4DXJS=UY'T-_PM
MWPG_ -#1X=_\&,/_ ,51_P +=\)_]#1X=_\ !C#_ /%5\*T5^#?\3$9C_P!
MD/\ P*1^C?\ $,<+_P _Y?<C[J_X6[X3_P"AH\._^#&'_P"*H_X6[X3_ .AH
M\._^#&'_ .*KX5HH_P")B,Q_Z!(?^!2#_B&.%_Y_R^Y$FH^(;S]B;]L;4?$/
MAM;7Q-X-\4.\DT6G3"XV022!WC^0G9)$_*[OO+QGEL?<D7QB\)31*Z^*/#^U
M@&&=0B!P?8MFO@S6[7[58-C[T?S"DT*Z^TV*J?O1_*?Z4?\ $Q&8_P#0)#_P
M*0O^(887_G_+[D?>W_"W?"?_ $-'AW_P8P__ !5'_"W?"?\ T-'AW_P8P_\
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M^Y'U#^R1\)OAW^S!X'CMQXD\(ZAXDNLO?ZH+N 2.3C]TA+;A&N ,<9(+$ G
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M_@QA_P#BJ/\ A;OA/_H:/#O_ (,8?_BJ^%:*/^)B,Q_Z!(?^!2#_ (ACA?\
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M"[MH_$7B3"WCVY_TB".1@D42,/NO(2V3]X*%QC<#0!Y_^U%\2/$G[:_[1_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.+;Y91CHMW.W+;NFFFGV//Z*]X\0_ WX9>!;33?[>\0>(+&YU"V6X5% D!!
MSC; V.?4YKROXHZ9X9TKQ'''X5U"\U/33 K-+<J5<29;*\HG&-O;OUJL^X-Q
M>44W/%U:7,FDX1J1E-75U>"?,M/(679[1QLN6C"=G?WG!J+M_>V.;JOJ=@M_
M;[?XUY4^]>M? C]G"3XG"WU'5;Q=/T6=WBA$<JBYNY%!RJ @@8VL22,X4X&/
MF'#W7A":[\?W&AZ;'+<S?;GM+=3RSX<J,GIT&2> .3Q7#B>%\RP^#H8ZK3:A
M7=H+[4M$TU'>SNN7ONM+-]%+-\+4KU,/"7O4U>79;]=M+:]CD]"OFR;:3AH_
MNY_E6E7I7QH_9=C\%^*/!>GZ/=W-UJ7B&1H+J20JT*.IB!=% !"C<Q.23@#W
MK6U_X#>&KRV\3:?X?U36+CQ!X0A6:]6Y2/[/=@(2ZQ!1O!!'?//'.=P]BKX>
M9U3K5J$X14J;2:YEK)T_:\L?YI*&K2]-VK\,.)L!.$*D9.T[M.ST7-R7?9.6
MB_X<\?HK>^&'A>W\:_$#2=)NGFCM[^X6*1HB X!]"01GZ@UZIXE^$WPC\(:Y
M<:;J/BCQ%;WMJP66/87VD@'JMN0>".AKAR;A'%YEA)8Z%2E3IQER7J5(P3E:
M]ES6OIK]YT8[.Z.%KK#RC.4FN:T8N6E[7T\SPVBO4OAK\#]$U#P=-XH\6:S+
MH_A]IF@L_*QYUT02-P^5NX8;0I8[6/ &3)\0?@7H+^ +KQ1X*UR76-,TU?\
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M06NJUMY'"T5W'[/OPTL?BOX^.EZC->0V_P!E>;=;,JON4J!RRL,<^E;GPY^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPO\ !/0Y-.\+Z/;Z3:S2>;*$9I))FQC+NY+L?]XG% '3T444 %%%% !1110
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M27/C_P"T>*M/M=-U.ZMHW$5NX:,Q@L@/#OW4]3VZ5CQ?%CQ5!$L<?B7Q B(
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MN!WD@ <<\*IC*4*L:$G[TKM))O16NW9:)76KLKNP2K1C)0>[/H:BOE[X\?\
M!3"S^&GQ9OO!_A7P;J'CC4M'W+J+Q79MHX'12TB+MBE9RBC+'  P>>#7IW[+
M'[6GAW]JSPG/?:.LMEJ%@56]L)F#/!NSM96'#H<$!N#P<@5GA\QP]>;A2E=J
M_1VT=G9M6=GIHWJ33Q%.<N6+_/\ I_(]3HHHKM-@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KGOBS\0+?X4_#+7O$EUM,.BV,MUM/_+1E4[4^K-A
M?J:Z&OE/_@K%\5V\,_!S2_"-MN:Z\67>Z4+_ ,\("CD8]3(T6/\ =- '-_\
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M_F_^-4?\0RXI_P"@*?W+_,/];,G_ .@B)XW17LG_  P]XL_Z"'AW_O\ S?\
MQJC_ (8>\6?]!#P[_P!_YO\ XU1_Q#+BG_H"G]R_S#_6S)_^@B)XW17LG_##
MWBS_ *"'AW_O_-_\:H_X8>\6?]!#P[_W_F_^-4?\0RXI_P"@*?W+_,/];,G_
M .@B)XW17LG_  P]XL_Z"'AW_O\ S?\ QJC_ (8>\6?]!#P[_P!_YO\ XU1_
MQ#+BG_H"G]R_S#_6S)_^@B)XW7LG[#__ "5C4/\ L$R?^CH:/^&'O%G_ $$/
M#O\ W_F_^-5Z!^SG^SGKGPA\;W6I:E=:5/!/8O;*MM+(SAC)&P)#(HQA#W]*
M^PX!X!XAP7$.$Q6*PDXPC--MI62L_,\/B3B3+*^65J-&M&4I1T2ZGM%>;^,/
MV/\ X9>/-:DU#5/!FBSWLS;I)8XS"9#ZMY94,?<\UZ117]G'X2>;^'_V/_A?
MX8E$EKX%\-EU.0T]FMP0?;S-U>@Z;I=KHUDEO9V\%K;QC"10QB-%^@' J>B@
M HHHH **** "BBB@ HHHH **** .#^/G[-_A7]I'PS'IOB:SDD:UW-:7<#^7
M<63-C<4;D<[1D,"#@<<"OA#]G[]JG4?V"/%GC;PCJ.E3>((8=3\E8?M/V=89
M(G=))5.UOOIM.,<[5Y]?TKKS+XF?L?\ P]^*NHZSJ6I>'+!M:UJU:VEU *?-
M0E-JRJ,[1(N!AL9XQG% CK?A9\2]+^,'P_TOQ)HLWG:?JL(E3^]&>C(WHRL"
MI'J#705\0?\ !-/XH3?"/XH^*_A+XBO(X9H[V4Z>LC$*UU$QCFC0G^^JJP'?
M8>I-?;] PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#Y]_X*0_";XM_&3X':5I?P9\12^&?%%OKL-U=74>IOIY
MDLQ;W"O'YB DYD>$[>AVY[5\4?\ #"'[>7_17+W_ ,+.Y_\ B:^\_P!OC]KB
MV_8G_9IUCQQ)9IJ6H1O'8Z79NVV.YNY<A Y'.Q0&=@.2J$ @G-?+?[&W[2'Q
MP^+'_!.OX]_$/Q]>:A;M-H6IZIX1U:-8K5D,=A<!_LZQX9$BDBC*L1RQ8@DA
MC0!YA_PPA^WE_P!%<O?_  L[G_XFOT#_ &(O ?CSX9?LP>&-#^)VKR:]XXL?
MM7]I7SWK7C3[[N9XOWK %L0M&O/3;CM7XW^"?VFOVH-%^!T?QKM?B9XJU+PG
MH/B>/1)XKO69;@-<K''.!+ Q*M"RNBDG.2V,=Z_:_P#9L^-MC^T?\!?"?CG3
MX_)M_$VG17AASG[/(1B6+/?9('7/?;0!V]%%% '$_M%_!^3X]_!K6?",6LW&
M@-K A5KZ!"\D:)/'(R@!ER'5"A^8<.>O0_%OP4^".F_LZ?\ !3_PQX1TFXN;
MJSTZQ=S-/@-+(^FW#.V% "C)X'8 <DY)_0BOD_7_ (/^*+?_ (*J:'XN.AZB
M_AFYLF5=2CB,EO&5T^:,B1ESY9WL% ?;N)&,UY>)PR6+I8B$?>;M)_W5&;2?
MES/[[>1RU:?[V%2*UO9ORM+\+O[['*_\%2?VFI+[4;7X/Z#?0V,NI&*3Q%>S
MS"VA@A?!BMVE8A55\AW8G 4 9Y85YW_P3;USPW\(_P!KSQ78WGBC0/[-BL+G
M2-/U%[Z*.UU*075J$$+EMKE]K,JJ22,XSBOJSXZ_\$]OA]^T)X_N?$FN#6H=
M2OHXX[G[)=*L<YC4(K%71\':%7Y<#Y0<9))^:_@;_P $Z&C_ &L/$.B^(]#\
M1Z7X1T7SM1T#4H"JI.4N8A;YG52GF&,NQ4;7&W.%Q7E_4<;3Q[Q":;ES=)62
M3]V+MHDDV_.;D]K'+[&M&O[2Z=[]^FR]+:^;;.F_X)4Z)_;GQK^+7B2\=I-4
MCNC#([Y+N;FZN))"3G^] N<@GW'.?//^":>LR>&OVZO%6E6O[NQNI]5LS$#\
MJHDOF*/P*#WY/X]O\6_@E\6?V//CEXF\8?"G2%\0:7XN\]C$EB]XUDTTGF,A
MB0[\I)\R, 4P0&!Y%:'_  2T_9(\5?#GQ=K'C;QCIUYIEU<P/;VT-Y&T-Q-)
M*ZM)*4.&4 *%&X#)=C@8KEPN%Q*QN#IJFXQHTY*4M+.ZBK)[MW3>W1/JC.E2
MJ*M2CRM*$7=]-DOS1]N4445]D>P<_P".OBUX5^%WV7_A)O$WA_P[]NW_ &;^
MT]1AL_M&S;OV>8PW;=RYQG&X>HH\"_%KPK\4?M7_  C/B;P_XB^P[/M/]F:C
M#>?9]^[9O\MCMW;6QG&=I]#7G_CK7/"OQ1_:IM?AGXF\"^'_ !%]A\*/XGMM
M2U.WAO/L^^\6V>!(I(CMW;58N'&=H&W@&O0/ OPF\*_"[[5_PC/AGP_X=^W;
M/M/]F:=#9_:-F[9O\M1NV[FQG.-Q]37DT,5B*V)E[-Q=*+<7\7-=+5=M_E;S
M.6G4J3J/EMRIVZWO^6YG^*?VAO '@;7KC2];\<^#]'U2UV^=9WVLVUO<0[E#
M+N1W##*LK#(Y!!Z&N@\+>+=*\<Z#;ZIHFIZ?K&EW6[R;RQN$N+>;:Q5MKH2I
MPRLIP>"".HKG_%/[//@#QSKUQJFM^!O!^L:I=;?.O+[1K:XN)MJA5W.Z%CA5
M51D\  =!70>%O"6E>!M!M]+T33-/T?2[7=Y-G8VR6]O#N8LVU$ 499F8X'))
M/4UT4/KOMI>VY?9ZVM?FWTO?3;>W4TI^VYWSVY>EKW^9Q_\ PUG\*_\ HIGP
M_P#_  HK/_XY78>*?%NE>!M!N-4UO4]/T?2[7;YUY?7"6]O#N8*NYW(499E4
M9/)('4UQ_P#PR9\*_P#HF?P__P#"=L__ (W78>*?"6E>.=!N-+UO3-/UC2[K
M;YUG?6R7%O-M8,NY'!4X9589'! /45GA_P"T.2?M^3FM[MN:U]?BOTVV\R:?
MM[/GM?I:_P")S_A;]H;P!XYUZWTO1/'/@_6-4NMWDV=CK-M<7$VU2S;41RQP
MJLQP. ">@K0\=?%KPK\+OLO_  DWB;P_X=^W;_LW]IZC#9_:-FW?L\QANV[E
MSC.-P]16?X6_9Y\ >!M>M]4T3P-X/T?5+7=Y-Y8Z-;6]Q#N4JVUT0,,JS*<'
MD$CH:T/'7PF\*_%'[+_PDWAGP_XB^P[_ +-_:>G0WGV??MW[/,4[=VU<XQG:
M/040_M#ZO+FY/:7TMS<MM-^M]_P"/M_9N]N;IO;_ #[AX%^+7A7XH_:O^$9\
M3>'_ !%]AV?:?[,U&&\^S[]VS?Y;';NVMC.,[3Z&L_Q3^T-X \#:]<:7K?CG
MP?H^J6NWSK.^UFVM[B'<H9=R.X895E89'((/0UH>!?A-X5^%WVK_ (1GPSX?
M\._;MGVG^S-.AL_M&S=LW^6HW;=S8SG&X^IK/\4_L\^ /'.O7&J:WX&\'ZQJ
MEUM\Z\OM&MKBXFVJ%7<[H6.%55&3P !T%$_[0^KQY>3VE];\W+;7;K?;\0E[
M?V:M;FZ[V_S.@\+>+=*\<Z#;ZIHFIZ?K&EW6[R;RQN$N+>;:Q5MKH2IPRLIP
M>"".HKC_ /AK/X5_]%,^'_\ X45G_P#'*[#PMX2TKP-H-OI>B:9I^CZ7:[O)
ML[&V2WMX=S%FVH@"C+,S' Y))ZFN/_X9,^%?_1,_A_\ ^$[9_P#QNC$?VAR0
M]AR<UO>OS6OI\-NF^_D%3V]ER6OUO?\  [#Q3XMTKP-H-QJFMZGI^CZ7:[?.
MO+ZX2WMX=S!5W.Y"C+,JC)Y) ZFN?\+?M#> /'.O6^EZ)XY\'ZQJEUN\FSL=
M9MKBXFVJ6;:B.6.%5F.!P 3T%=!XI\):5XYT&XTO6],T_6-+NMOG6=];)<6\
MVU@R[D<%3AE5AD<$ ]17/^%OV>? '@;7K?5-$\#>#]'U2UW>3>6.C6UO<0[E
M*MM=$##*LRG!Y!(Z&M*_UWVT?8\OL]+WOS;ZVMIMM?J54]MSKDMR];WO\C0\
M=?%KPK\+OLO_  DWB;P_X=^W;_LW]IZC#9_:-FW?L\QANV[ESC.-P]11X%^+
M7A7XH_:O^$9\3>'_ !%]AV?:?[,U&&\^S[]VS?Y;';NVMC.,[3Z&CQU\)O"O
MQ1^R_P#"3>&?#_B+[#O^S?VGIT-Y]GW[=^SS%.W=M7.,9VCT%'@7X3>%?A=]
MJ_X1GPSX?\._;MGVG^S-.AL_M&S=LW^6HW;=S8SG&X^IH_VWZS]GV7SYMONW
M_#S#]][3IR_._P#EN9_BG]H;P!X&UZXTO6_'/@_1]4M=OG6=]K-M;W$.Y0R[
MD=PPRK*PR.00>AKH/"WBW2O'.@V^J:)J>GZQI=UN\F\L;A+BWFVL5;:Z$J<,
MK*<'@@CJ*Y_Q3^SSX \<Z]<:IK?@;P?K&J76WSKR^T:VN+B;:H5=SNA8X554
M9/  '05T'A;PEI7@;0;?2]$TS3]'TNUW>39V-LEO;P[F+-M1 %&69F.!R23U
M-%#Z[[:7MN7V>MK7YM]+WTVWMU"G[;G?/;EZ6O?YG'_\-9_"O_HIGP__ /"B
ML_\ XY78>*?%NE>!M!N-4UO4]/T?2[7;YUY?7"6]O#N8*NYW(499E49/)('4
MUQ__  R9\*_^B9_#_P#\)VS_ /C==AXI\):5XYT&XTO6],T_6-+NMOG6=];)
M<6\VU@R[D<%3AE5AD<$ ]16>'_M#DG[?DYK>[;FM?7XK]-MO,FG[>SY[7Z6O
M^)S_ (6_:&\ >.=>M]+T3QSX/UC5+K=Y-G8ZS;7%Q-M4LVU$<L<*K,<#@ GH
M*T/'7Q:\*_"[[+_PDWB;P_X=^W;_ +-_:>HPV?VC9MW[/,8;MNY<XSC</45G
M^%OV>? '@;7K?5-$\#>#]'U2UW>3>6.C6UO<0[E*MM=$##*LRG!Y!(Z&M#QU
M\)O"OQ1^R_\ "3>&?#_B+[#O^S?VGIT-Y]GW[=^SS%.W=M7.,9VCT%$/[0^K
MRYN3VE]+<W+;3?K??\ C[?V;O;FZ;V_S[AX%^+7A7XH_:O\ A&?$WA_Q%]AV
M?:?[,U&&\^S[]VS?Y;';NVMC.,[3Z&L_Q3^T-X \#:]<:7K?CGP?H^J6NWSK
M.^UFVM[B'<H9=R.X895E89'((/0UH>!?A-X5^%WVK_A&?#/A_P ._;MGVG^S
M-.AL_M&S=LW^6HW;=S8SG&X^IK/\4_L\^ /'.O7&J:WX&\'ZQJEUM\Z\OM&M
MKBXFVJ%7<[H6.%55&3P !T%$_P"T/J\>7D]I?6_-RVUVZWV_$)>W]FK6YNN]
MO\SH/"WBW2O'.@V^J:)J>GZQI=UN\F\L;A+BWFVL5;:Z$J<,K*<'@@CJ*X__
M (:S^%?_ $4SX?\ _A16?_QRNP\+>$M*\#:#;Z7HFF:?H^EVN[R;.QMDM[>'
M<Q9MJ( HRS,QP.22>IKC_P#ADSX5_P#1,_A__P"$[9__ !NC$?VAR0]AR<UO
M>OS6OI\-NF^_D%3V]ER6OUO?\#L/%/BW2O V@W&J:WJ>GZ/I=KM\Z\OKA+>W
MAW,%7<[D*,LRJ,GDD#J:Y_PM^T-X \<Z];Z7HGCGP?K&J76[R;.QUFVN+B;:
MI9MJ(Y8X568X' !/05T'BGPEI7CG0;C2];TS3]8TNZV^=9WULEQ;S;6#+N1P
M5.&56&1P0#U%<_X6_9Y\ >!M>M]4T3P-X/T?5+7=Y-Y8Z-;6]Q#N4JVUT0,,
MJS*<'D$CH:TK_7?;1]CR^STO>_-OK:VFVU^I53VW.N2W+UO>_P C0\=?%KPK
M\+OLO_"3>)O#_AW[=O\ LW]IZC#9_:-FW?L\QANV[ESC.-P]11X%^+7A7XH_
M:O\ A&?$WA_Q%]AV?:?[,U&&\^S[]VS?Y;';NVMC.,[3Z&CQU\)O"OQ1^R_\
M)-X9\/\ B+[#O^S?VGIT-Y]GW[=^SS%.W=M7.,9VCT%'@7X3>%?A=]J_X1GP
MSX?\._;MGVG^S-.AL_M&S=LW^6HW;=S8SG&X^IH_VWZS]GV7SYMONW_#S#]]
M[3IR_._^6YG^*?VAO '@;7KC2];\<^#]'U2UV^=9WVLVUO<0[E#+N1W##*LK
M#(Y!!Z&N@\+>+=*\<Z#;ZIHFIZ?K&EW6[R;RQN$N+>;:Q5MKH2IPRLIP>"".
MHKG_ !3^SSX \<Z]<:IK?@;P?K&J76WSKR^T:VN+B;:H5=SNA8X5549/  '0
M5T'A;PEI7@;0;?2]$TS3]'TNUW>39V-LEO;P[F+-M1 %&69F.!R23U-%#Z[[
M:7MN7V>MK7YM]+WTVWMU"G[;G?/;EZ6O?YG'_P##6?PK_P"BF?#_ /\ "BL_
M_CE=AXI\6Z5X&T&XU36]3T_1]+M=OG7E]<);V\.Y@J[G<A1EF51D\D@=37'_
M /#)GPK_ .B9_#__ ,)VS_\ C==AXI\):5XYT&XTO6],T_6-+NMOG6=];)<6
M\VU@R[D<%3AE5AD<$ ]16>'_ +0Y)^WY.:WNVYK7U^*_3;;S)I^WL^>U^EK_
M (G/^%OVAO 'CG7K?2]$\<^#]8U2ZW>39V.LVUQ<3;5+-M1'+'"JS' X )Z"
MM#QU\6O"OPN^R_\ "3>)O#_AW[=O^S?VGJ,-G]HV;=^SS&&[;N7.,XW#U%9_
MA;]GGP!X&UZWU31/ W@_1]4M=WDWECHUM;W$.Y2K;71 PRK,IP>02.AK0\=?
M";PK\4?LO_"3>&?#_B+[#O\ LW]IZ=#>?9]^W?L\Q3MW;5SC&=H]!1#^T/J\
MN;D]I?2W-RVTWZWW_ (^W]F[VYNF]O\ /N'@7XM>%?BC]J_X1GQ-X?\ $7V'
M9]I_LS48;S[/OW;-_EL=N[:V,XSM/H:S_%/[0W@#P-KUQI>M^.?!^CZI:[?.
ML[[6;:WN(=RAEW([AAE65AD<@@]#6AX%^$WA7X7?:O\ A&?#/A_P[]NV?:?[
M,TZ&S^T;-VS?Y:C=MW-C.<;CZFL_Q3^SSX \<Z]<:IK?@;P?K&J76WSKR^T:
MVN+B;:H5=SNA8X5549/  '043_M#ZO'EY/:7UOS<MM=NM]OQ"7M_9JUN;KO;
M_,Z#PMXMTKQSH-OJFB:GI^L:7=;O)O+&X2XMYMK%6VNA*G#*RG!X((ZBN/\
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M*\<Z#;ZIHFIZ?K&EW6[R;RQN$N+>;:Q5MKH2IPRLIP>"".HKC_\ AK/X5_\
M13/A_P#^%%9__'*[#PMX2TKP-H-OI>B:9I^CZ7:[O)L[&V2WMX=S%FVH@"C+
M,S' Y))ZFN/_ .&3/A7_ -$S^'__ (3MG_\ &Z,1_:')#V')S6]Z_-:^GPVZ
M;[^05/;V7):_6]_P.P\4^+=*\#:#<:IK>IZ?H^EVNWSKR^N$M[>'<P5=SN0H
MRS*HR>20.IKG_"W[0W@#QSKUOI>B>.?!^L:I=;O)L['6;:XN)MJEFVHCECA5
M9C@< $]!70>*?"6E>.=!N-+UO3-/UC2[K;YUG?6R7%O-M8,NY'!4X9589'!
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M]F_M/3H;S[/OV[]GF*=N[:N<8SM'H*/ OPF\*_"[[5_PC/AGP_X=^W;/M/\
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M;?5-$U/3]8TNZW>3>6-PEQ;S;6*MM="5.&5E.#P01U%<?_PUG\*_^BF?#_\
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M.5V'A;PEI7@;0;?2]$TS3]'TNUW>39V-LEO;P[F+-M1 %&69F.!R23U-<?\
M\,F?"O\ Z)G\/_\ PG;/_P"-T8C^T.2'L.3FM[U^:U]/AMTWW\@J>WLN2U^M
M[_@=AXI\6Z5X&T&XU36]3T_1]+M=OG7E]<);V\.Y@J[G<A1EF51D\D@=37/^
M%OVAO 'CG7K?2]$\<^#]8U2ZW>39V.LVUQ<3;5+-M1'+'"JS' X )Z"N@\4^
M$M*\<Z#<:7K>F:?K&EW6WSK.^MDN+>;:P9=R."IPRJPR." >HKG_  M^SSX
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MDGJ:*'UWVTO;<OL];6OS;Z7OIMO;J%/VW.^>W+TM>_S./_X:S^%?_13/A_\
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M@@CJ*Y_Q3^SSX \<Z]<:IK?@;P?K&J76WSKR^T:VN+B;:H5=SNA8X5549/
M'05T'A;PEI7@;0;?2]$TS3]'TNUW>39V-LEO;P[F+-M1 %&69F.!R23U-%#Z
M[[:7MN7V>MK7YM]+WTVWMU"G[;G?/;EZ6O?YG'_\-9_"O_HIGP__ /"BL_\
MXY78>*?%NE>!M!N-4UO4]/T?2[7;YUY?7"6]O#N8*NYW(499E49/)('4UQ__
M  R9\*_^B9_#_P#\)VS_ /C==AXI\):5XYT&XTO6],T_6-+NMOG6=];)<6\V
MU@R[D<%3AE5AD<$ ]16>'_M#DG[?DYK>[;FM?7XK]-MO,FG[>SY[7Z6O^)S_
M (6_:&\ >.=>M]+T3QSX/UC5+K=Y-G8ZS;7%Q-M4LVU$<L<*K,<#@ GH*T/'
M7Q:\*_"[[+_PDWB;P_X=^W;_ +-_:>HPV?VC9MW[/,8;MNY<XSC</45G^%OV
M>? '@;7K?5-$\#>#]'U2UW>3>6.C6UO<0[E*MM=$##*LRG!Y!(Z&M#QU\)O"
MOQ1^R_\ "3>&?#_B+[#O^S?VGIT-Y]GW[=^SS%.W=M7.,9VCT%$/[0^KRYN3
MVE]+<W+;3?K??\ C[?V;O;FZ;V_S[AX%^+7A7XH_:O\ A&?$WA_Q%]AV?:?[
M,U&&\^S[]VS?Y;';NVMC.,[3Z&L_Q3^T-X \#:]<:7K?CGP?H^J6NWSK.^UF
MVM[B'<H9=R.X895E89'((/0UH>!?A-X5^%WVK_A&?#/A_P ._;MGVG^S-.AL
M_M&S=LW^6HW;=S8SG&X^IK/\4_L\^ /'.O7&J:WX&\'ZQJEUM\Z\OM&MKBXF
MVJ%7<[H6.%55&3P !T%$_P"T/J\>7D]I?6_-RVUVZWV_$)>W]FK6YNN]O\SH
M/"WBW2O'.@V^J:)J>GZQI=UN\F\L;A+BWFVL5;:Z$J<,K*<'@@CJ*X__ (:S
M^%?_ $4SX?\ _A16?_QRNP\+>$M*\#:#;Z7HFF:?H^EVN[R;.QMDM[>'<Q9M
MJ( HRS,QP.22>IKS_P 6_L[?!SP-X5U/6]4^'?P_M=+T>TEOKR;_ (1JV?R8
M8D+NVU8BQPJDX ).. 34XJ6.C2C*DX)I>\Y<UMEM;IOOTL35==13CR^=[V^7
MX[GJ%%9_A+Q38>.?"NF:WI<_VK2]8M(KZSFV,GG0RH'1MK ,,JP." 1GD UH
M5Z491E%2B[I[,Z5)-7044450PHHHH **** "BBB@ HHHH **** "BBB@#X;_
M .#@GP??^)_V$;.\LX9IH?#_ (IL]0O2BEA%"8;FW#-Z#S)XQGU(KO/^"=/C
MKP/^UQ_P3A\.^#X9[6:WA\+#PEXBTVVF\JXMR+<VTI8##*95S(''7S,YSFOI
M+QWX%TCXG>#-4\/:_I]OJFBZS;/:7MI,,I/$XPRG'(]B""#@@@@&OS,^+7_!
MO-KFB>-9M2^%'Q(ATNPF=FBM=6$T-Q9J3]P7$ 8R #C)13QSGK0!M_\ !4+P
M9\)/V"?^">6O?!_P?LAU+QYKEOJ4.FSWIN[N!T>V>6Y.XED3R[6.,9QDR'&?
MFKZ@_P""1W@Z_P# O_!.CX7V.I1S0W,EC<7P612K>5<W<]Q$<'L8Y4(]B*^8
M?V:/^#?"TT#QU;Z_\6O&$7BR.WE6=M)TZ.18;QASB:>3#LG3*JJDC^(=*_2B
MSLX=.M(K>WBC@MX$$<<<:A4C4# 4 <  < "@"2BBB@ HHHH **** "BBB@ H
MHHH \_\ ^%%?\94_\+,_M3_F5/\ A&/[-^S?]/GVGS_-W_\  =FSWW=J] KQ
M_P#X6GKW_#?O_"$_;O\ BF/^%?\ ]N?8O)C_ ./S^T?)\WS-OF?ZOY=N[;WQ
MGFO8*\W+9X>7M?J\6K3DI7ZRTNUJ]'\O0Y\/*F^;D5M7?UZA1117I'0%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7P_\.O]._X*\:])U\G[1^&+)4K[?=UC0LQ"
MJHR23P!7PM^QK?M\9/\ @H?XW\8::OFZ+;K=R"XZ*4=A%#Z\LJEOHI^E F?=
M5%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"$V^P_\5/_ &5_8?VWSI/^//SO.\KR]WE_ZSYMVW=VSCBN@KY^_P"<J/\
MW2G_ -R]?0->;EN(A5]KR04>6<D[=6K>\]%J_GZG/AZBES65K-KU\PHHHKTC
MH"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBJ^KZM;:#I-U?7DT=O9V4+SSRN<+%&H+,
MQ]@ 30!XG_P4+^.*_!C]G34H[><1ZQXE!TNR ;#J''[V0=_ECW#/9F3VJE_P
M3:^"?_"I?V=+._NH?+U7Q8PU.<D?,L)&($^FSY_8RM7@'PK\+7?_  4>_:PU
M7Q+KPN?^$&\.L/*M6)"F($^3;C'0O@NY'/49&5Q]^V]O':01Q11I'%&H1$1=
MJH!P !V H$/HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^6_^"J/QM;P
M+\&;7PG92E=2\7RE)0A^9;6,@O\ ]],47W&\>M?0WQ+^)6C_  B\$WWB#7KQ
M;+3-/3?(YY9ST5%'\3,<  =2:^)?@QI^L?\ !07]L!?'>IZ?):>#?"LD9ABD
M^9 (COAM\]&=G/F/C@ D="N03/J;]C?X&1_ #X!Z+H\D(CU6Z3[=J9Q\S7,@
M!93_ +@VI]$KU*BB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=>YC1]I[WM.[MZ= HHHKN-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P")'BFW\4^-KA76(VH8PPL\?EM(795+'R_D50BJJD]>,8OQH_X)T^,='_:
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MJ*.  !T ]*?117N'<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!G>*_".E^.M!N-+UG3[35-.NEVRV]S$)(W'T/<=CU!Z5\7?
MM#?L*:Y^SAJ[?$/X/ZAJ5O\ V63-/IJ.9)[:/JQC)SYL6!\T;Y./[W0?<5%
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M?[$\0>(OL/E_\2_0[/[9?W&^14_=Q9&[;NW'D856/:O)-._X*!Z)'J,*^(/
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MO7.Q_2O0**(87%K#RIRK7FWI+E6BTTML^OW^01IU?9N+GKWLOR//_@5\?_\
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MT/PW]LL+C?&K_NY?,&[;NVG@896':O0/A9X__P"%H^ ['7?[$\0>'?MWF?\
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M_P#^%&?V7_Q1/Q \8?VIYO\ R+&C_P!H?9/+V?Z[YUV;M_R]<[']*/@5\?\
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MZ9>/S+^Y7YI8Y&!<,@)!=E8#"L_RO%6*S7#8;VN7V>NMHWDEW6K3\]/,_</
M#AOA#.^)7@N,ZW)2<&Z:<O9QG437NRG=-7C>R3C=Z<U[)^+?LT?MD^*/@7^T
MIX;\976N?#N^T/3+L?;=*6:.0R6S?+)Y3NNY9@I)1PPPP&?E)4_O)\4_'_\
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M?.NS=O\ EZYV/Z4? KX__P#"\_[4_P"*)^('@_\ LORO^1GT?^S_ +7YF_\
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M43\0/!_]E^5_R,^C_P!G_:_,W_ZGYVW[=GS=,;T]:Y_XI_M??\*N\>7VA?\
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MNX<G*LI[UT%%%##XF%:4ZE7FB[VCRI6UTUW=EIY[A3IU%-RE*Z[6V^9\_?\
M#?O_ %13]H'_ ,(__P"W5[#\4_'_ /PJ[P'?:[_8GB#Q%]A\O_B7Z'9_;+^X
MWR*G[N+(W;=VX\C"JQ[5T%%9X?"XN$)QJUN9M:/E2Y7KK9;]-^Q-.G52:E.[
MZ:)6_P SQ_X6?M??\+1\>6.A?\*O^,/AW[=YG_$PUSPW]CL+?9&S_O)?,.W=
MMVC@Y9E'>N@^.OQ__P"%&?V7_P 43\0/&']J>;_R+&C_ -H?9/+V?Z[YUV;M
M_P O7.Q_2O0**(87%K#RIRK7FWI+E6BTTML^OW^01IU?9N+GKWLOR//_ (%?
M'_\ X7G_ &I_Q1/Q \'_ -E^5_R,^C_V?]K\S?\ ZGYVW[=GS=,;T]:Y_P"*
M?[7W_"KO'E]H7_"K_C#XB^P^7_Q,-#\-_;+"XWQJ_P"[E\P;MN[:>!AE8=J]
M@HHGA<6\/&G&M::>LN5:K72VRZ?=YA*G5]FHJ>O>R_(Y_P"%GC__ (6CX#L=
M=_L3Q!X=^W>9_P 2_7+/['?V^R1D_>19.W=MW#DY5E/>O'O^&_?^J*?M _\
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ME;737=V6GGN%.G44W*4KKM;;YGS]_P -^_\ 5%/V@?\ PC__ +=7L/Q3\?\
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M7Q__ .%Y_P!J?\43\0/!_P#9?E?\C/H_]G_:_,W_ .I^=M^W9\W3&]/6N?\
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M/UGVOM?W?\O*NUOBWWU_ /9U/:<W-[O:WZ_B>/\ Q3_:^_X5=X\OM"_X5?\
M&'Q%]A\O_B8:'X;^V6%QOC5_W<OF#=MW;3P,,K#M7H'PL\?_ /"T? =CKO\
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M)X_\4_VOO^%7>/+[0O\ A5_QA\1?8?+_ .)AH?AO[987&^-7_=R^8-VW=M/
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MM>/*G?777=76GEN54IU'-2C*R[6W^9Y_\=?C_P#\*,_LO_BB?B!XP_M3S?\
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M9NW_ "]<[']*] HHAA<6L/*G*M>;>DN5:+32VSZ_?Y!&G5]FXN>O>R_(\_\
M@5\?_P#A>?\ :G_%$_$#P?\ V7Y7_(SZ/_9_VOS-_P#J?G;?MV?-TQO3UKG_
M (I_M??\*N\>7VA?\*O^,/B+[#Y?_$PT/PW]LL+C?&K_ +N7S!NV[MIX&&5A
MVKV"BB>%Q;P\:<:UIIZRY5JM=+;+I]WF$J=7V:BIZ][+\CG_ (6>/_\ A:/@
M.QUW^Q/$'AW[=YG_ !+]<L_L=_;[)&3]Y%D[=VW<.3E64]Z\>_X;]_ZHI^T#
M_P"$?_\ ;J^@:*,1A<7.$(TJW*TM7RI\STUL]NNW<*E.JTE&=FM]%K_D<_\
M%/Q__P *N\!WVN_V)X@\1?8?+_XE^AV?VR_N-\BI^[BR-VW=N/(PJL>U>?\
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M%%%%;%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?-7[7_[ $?QQ\3+XN\)ZE%X=\71@-*S!EAOW7&Q
MRZG=%( ,;P&S@<#&:\1B_;M^+7[+<.L>#?'FEMJFL0V[IIM_=MB2%R#LE+@%
M;F/.#U#<$%NP_0.J>M^'M/\ $UBUKJ5C9ZA;-UBN85EC/_ 6!% 'Q3^Q=^Q8
MOQZC3XI?$RZGUYM:F:XM+*=R?M.UROFSGNN5.V,?+M SD';7V];6T=E;1PPQ
MQPPPJ$1$7:J*!@  <  =J+.SATZSBM[>&."W@01Q11J%2-0,!0!P !P *DH
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M=U[1F^E[&?\ V:KNG>(]/U>39:7UG=,!DK#,KD#\#0!<HHHH **** "BBB@
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M&X?@K_T5_P"%W_A56'_QVCZ]A_\ GY'[T'^J^<_] E7_ ,%S_P CU&BO+O\
MAN'X*_\ 17_A=_X55A_\=H_X;A^"O_17_A=_X55A_P#':/KV'_Y^1^]!_JOG
M/_0)5_\ !<_\CU&BO+O^&X?@K_T5_P"%W_A56'_QVC_AN'X*_P#17_A=_P"%
M58?_ !VCZ]A_^?D?O0?ZKYS_ - E7_P7/_(]1HKR[_AN'X*_]%?^%W_A56'_
M ,=H_P"&X?@K_P!%?^%W_A56'_QVCZ]A_P#GY'[T'^J^<_\ 0)5_\%S_ ,CU
M&BO+O^&X?@K_ -%?^%W_ (55A_\ ':/^&X?@K_T5_P"%W_A56'_QVCZ]A_\
MGY'[T'^J^<_] E7_ ,%S_P CU&BO+O\ AN'X*_\ 17_A=_X55A_\=H_X;A^"
MO_17_A=_X55A_P#':/KV'_Y^1^]!_JOG/_0)5_\ !<_\CU&BO+O^&X?@K_T5
M_P"%W_A56'_QVC_AN'X*_P#17_A=_P"%58?_ !VCZ]A_^?D?O0?ZKYS_ - E
M7_P7/_(]1HKR[_AN'X*_]%?^%W_A56'_ ,=H_P"&X?@K_P!%?^%W_A56'_QV
MCZ]A_P#GY'[T'^J^<_\ 0)5_\%S_ ,CU&BO+O^&X?@K_ -%?^%W_ (55A_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK?\ ;O\ Z1$_U9^C7_R;C+O^XW_I^J%%%%?,'[F%%%% !1110 4444 %%%%
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MA7\&?"_P3T.33O"^CV^DVLTGFRA&:229L8R[N2['_>)Q73T4 %%%% !1110
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M48JKCI.6+E..'Q^(3ER0P[C'VU2"FW%-N-/E:O)V=Y,^:_C;_P $@_#/B?\
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M38\,_#34_P!J[PWXVL?^$DU+X5^$FUCPSJ?G7%F 7L[JXAGV1NJN?EC#*V]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW_Q#:?\ 59__ "T?_NVC_B&T_P"JS_\ EH__ ';7ZB44?ZFY/_SY_P#)I_\
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MS_\ EH__ ';7ZB44?ZFY/_SY_P#)I_\ R0?\3*>(_P#T,?\ RC0_^5'Y=_\
M$-I_U6?_ ,M'_P"[:/\ B&T_ZK/_ .6C_P#=M?J)11_J;D__ #Y_\FG_ /)!
M_P 3*>(__0Q_\HT/_E1^7?\ Q#:?]5G_ /+1_P#NVC_B&T_ZK/\ ^6C_ /=M
M?J)11_J;D_\ SY_\FG_\D'_$RGB/_P!#'_RC0_\ E1^7?_$-I_U6?_RT?_NV
MC_B&T_ZK/_Y:/_W;7ZB44?ZFY/\ \^?_ ":?_P D'_$RGB/_ -#'_P HT/\
MY4?EW_Q#:?\ 59__ "T?_NVC_B&T_P"JS_\ EH__ ';7ZB44?ZFY/_SY_P#)
MI_\ R0?\3*>(_P#T,?\ RC0_^5'Y=_\ $-I_U6?_ ,M'_P"[:/\ B&T_ZK/_
M .6C_P#=M?J)11_J;D__ #Y_\FG_ /)!_P 3*>(__0Q_\HT/_E1^7?\ Q#:?
M]5G_ /+1_P#NVC_B&T_ZK/\ ^6C_ /=M?J)11_J;D_\ SY_\FG_\D'_$RGB/
M_P!#'_RC0_\ E1^7?_$-I_U6?_RT?_NVC_B&T_ZK/_Y:/_W;7ZB44?ZFY/\
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MZK/_ .6C_P#=M?J)11_J;D__ #Y_\FG_ /)!_P 3*>(__0Q_\HT/_E1^7?\
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M\FG_ /)!_P 3*>(__0Q_\HT/_E1^7?\ Q#:?]5G_ /+1_P#NVC_B&T_ZK/\
M^6C_ /=M?J)11_J;D_\ SY_\FG_\D'_$RGB/_P!#'_RC0_\ E1^7?_$-I_U6
M?_RT?_NVC_B&T_ZK/_Y:/_W;7ZB44?ZFY/\ \^?_ ":?_P D'_$RGB/_ -#'
M_P HT/\ Y4?!G[%__!$?_AD/]I;PW\1/^%G?\)#_ ,(]]J_XE_\ PCOV3[1Y
MUK-;_P"M^U/MV^;N^Z<[<<9R/O.BBO9R_+<-@:;I86/+%N]KMZZ+JWV1^;\8
M<<9WQ3C8YAGU;VM6,5!/EA&T4Y22M",5O*3O:^N]D@HHHKN/E HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>L,XWO@<#)X ')- '=T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<=\6?V@/!_P
M,AM6\5:Y;Z6U\2+>+RY)IIL=2L<:LY R.<8YJU\*_C/X7^-FAR:CX7UBWU:U
MAD\J4HK1R0MC.'1P'4_[P&: .GHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M</AS_H(_^2\O_P 37344 <S_ ,+A\.?]!'_R7E_^)H_X7#X<_P"@C_Y+R_\
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M-10!S/\ PN'PY_T$?_)>7_XFC_A</AS_ *"/_DO+_P#$UTU% ',_\+A\.?\
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M/_DO+_\ $UTU% ',_P#"X?#G_01_\EY?_B:/^%P^'/\ H(_^2\O_ ,37344
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M_"X?#G_01_\ )>7_ .)H_P"%P^'/^@C_ .2\O_Q-=-10!S/_  N'PY_T$?\
MR7E_^)H_X7#X<_Z"/_DO+_\ $UTU% ',_P#"X?#G_01_\EY?_B:/^%P^'/\
MH(_^2\O_ ,37344 <S_PN'PY_P!!'_R7E_\ B:/^%P^'/^@C_P"2\O\ \373
M44 <S_PN'PY_T$?_ "7E_P#B:/\ A</AS_H(_P#DO+_\37344 <S_P +A\.?
M]!'_ ,EY?_B:/^%P^'/^@C_Y+R__ !-=-10!S/\ PN'PY_T$?_)>7_XFC_A<
M/AS_ *"/_DO+_P#$UTU% ',_\+A\.?\ 01_\EY?_ (FC_A</AS_H(_\ DO+_
M /$UTU% ',_\+A\.?]!'_P EY?\ XFC_ (7#X<_Z"/\ Y+R__$UTU% ',_\
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M_A</AS_H(_\ DO+_ /$UTU% ',_\+A\.?]!'_P EY?\ XFC_ (7#X<_Z"/\
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M'_R7E_\ B:/^%P^'/^@C_P"2\O\ \37344 <S_PN'PY_T$?_ "7E_P#B:/\
MA</AS_H(_P#DO+_\37344 <S_P +A\.?]!'_ ,EY?_B:/^%P^'/^@C_Y+R__
M !-=-10!S/\ PN'PY_T$?_)>7_XFC_A</AS_ *"/_DO+_P#$UTU% ',_\+A\
M.?\ 01_\EY?_ (FC_A</AS_H(_\ DO+_ /$UTU% ',_\+A\.?]!'_P EY?\
MXFC_ (7#X<_Z"/\ Y+R__$UTU% ',_\ "X?#G_01_P#)>7_XFC_A</AS_H(_
M^2\O_P 37344 <S_ ,+A\.?]!'_R7E_^)H_X7#X<_P"@C_Y+R_\ Q-=-10!S
M/_"X?#G_ $$?_)>7_P")H_X7#X<_Z"/_ )+R_P#Q-=-10!S/_"X?#G_01_\
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M%   9".IY]\_8VUSP3XB^&5[>>"='N/#L5QJ<SZKI4\CM)87V%$J;68A!PN
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M-V$;RHJN3V"DD]LUYC_P4B\:6NCM\-M'U:WN[[P]JNN_:=2L;9-\NH)!L*P
M<$[VDQC(YQTQFF?$CXIV>KWGA+3?BU\'[GPQX9DOH5T;5$U=)5TRXQ^Z63R
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "O!8_V1O%^@_%#Q5XH\/\
MQ4N-&NO%5VUQ.&\.VMX\<88^5"))26V(I"@# .T'%>]44 ?)_P#P3<\)>)(X
M_%VH/XNDDT:T\5ZA;7FE'380+^Y$<.;DR_?0G*_(OR_+[FOK"BB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J'4]/CU?3;BUF4M#=1M%( <$JP(//T-344
M?(G[,7QOT7]BWP=JWP]^(BWVAZAH]_<3V%Q]AEDAUF%R"K0L@(9B>QP,$#.0
MP'H?[#'A'5HM/\;>,M5TZXT9?B!KTNKV5A.,2PVY+%&<=F;<>H&0 >A%>\44
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'DO[<?PRUCXM_LR^(M'T%9
MIM298KF.VC/-V(I5=H_<D*2!W8**\R\>_MH^!_'?[.U]X5TO3=3NO%FK:4VD
M0^%4TN8W%K.\?EA2"FW:C$$$$G &.>!]3T4 <)^S%X"U+X8? #PGH.K,#J6F
MZ>D=PH;=Y;'+;,]]N=O''R\<5W=%% !1110 4444 %%%% !1110 4444 %%%
M% !7SQX;_P"4GWB#_L1$_P#2JWKZ'HH ^;_C3J/_  S=^U_IOQ*U"UNV\'^)
M-$.AZO>0PM,--F60/'*ZH,A2$1<X/ ?O@56\->*[?]K3]L3PSXE\/1W%YX*^
M'=A<G^T9[=X[>[O)U,>V(.HR5&ULX&/+_P!W/TS10 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?._\ P33_ .2,>)O^QLO_ /T&*O&_B5^U7X,_:3^,
MM]I?C?Q7)X<^&?ARXVP:9;VUS+-XDE5B/,E:*-ML0(R%)!P1@9)9?NRB@#SW
MX _';P!\8-*NK'P#J%O=6?AY(8Y8(;":TCM5DW^6 LD:#!\M_NYQCG&1GT*B
MB@ HHHH **** "BBB@ HHHH **** "BBB@#R3]N[_DT?QQ_UXK_Z-2J.H_!B
M?X__ +&GA7PO#KEQX?COM%TUIYXH!,98U@0F,KN7@G&>>V.]>TT4 ?%/[:?P
M=\;?#WX.>&8=3^)$FO:3!KMC9VEBOAZTLDM&"2"-U:,9.Q1@*>#GVKZ\^'VA
MZMX;\(6=EKFN-XDU2'?Y^HM9QVAN<NS+^ZC^5=JE5XZ[<]2:VJ* "BBB@ HH
MHH **** "BBB@ HHHH **** "OG?]M;_ )+/\"?^QL3_ -"BKZ(HH \!_;M\
M"ZQ=V_@;QQHVFSZU-\/-;34[FP@7=--;[D+E!U)4QKP,X!)Z UPG[3'QST+]
ML[P3H_P_^'_]H:QK&M:C;SWKFREA31(4)+O,S !64\8&1UYSM!^N:* "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#YW\!?\ *2_QS_V*=M_Z';UE^/\
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MQ_\ $#4M/N-+7X@:P+JQM;E=LZVD0<1,P/(SO; ]!D<$5[U10 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %<?\2/VA/ /P;U"WM/%_CCP?X5NKR,S00ZQK-O8R3H#@LJRNI9<
M\9'&:["OG']MC_@F#X!_;Q\7Z+K7B_5_&&FW6AV;64":/=6\,;HSER6$L$A+
M9/8@8[4 =W_PW-\$_P#HL7PL_P#"KL/_ ([6C:?M<?"G4/#5YK5O\3OA[-H^
MFRQV]W?Q^([-K:UDDW>6DD@DVJS[6V@D$[3C.#7XR_"C]@/P=X[_ ."J>K_
MV\U+Q-'X3T^]O[:.[AN(%U%E@MGE0ES"8\EE .(QQTQUK[&_::_8P^#7_!,7
M]B_Q1<77ACQ1\5O#WB;7-,-WI.L^(O[.99HA.(I$GM($88\Q\J00>.F.0#]!
MO"GB[2?'?AVUUC0]3T_6=)OD\RVO;&Y2XM[A<D;DD0E6&01D$]*T*^*9_P!O
M70?V/?\ @F!\-_B/X7^&_EZ!J<L.G67AK_A()&_LY)#<-_Q]R12/)@Q'[R G
M?U&.?/\ Q!_P7\:T\&Z?XFTKX&^+]2\*LMO!J6M2WK6]A9WKQJTMM'-]F9)2
MC%E!9HR^W.U0: /T6HKX!^(?_!>G18/#L>L?#_X5>,O'6BV-K#<:[J+L]C::
M%)(,^3)(L,R[QT))52>C&OI[]D#]M+PK^V%^STOQ"TD2Z/8VCS6^JV]ZZ[M+
MFA57D5W'RE0C(X;C*NI(4Y4 'L%%?G]XK_X+MKJWBC6U^&OP7\9?$;PKX=8B
M^UVWFDMXHD!YE*);S;(S@E3(R$C&0O('T_\ L6?MM^#OVYOAA+XC\*-=VLUA
M,MKJ6FWBJMSI\Q4, =I(9&YVN.&VGH0R@ ]BKG]1^+/A71_'UEX4N_$WA^U\
M4:E$9[31YM1A34+J,!B7C@+>8ZX1SD*1\C>AK:U"_ATJPFNKF1(;>VC:661S
MA8T49+$^@ )K\VO^"26L77[:'[>'QA^/6M*TD>GHFEZ'%*/^/.*=F$83L&CM
MX%0^IG8]230!^@&E?'CP/KOQ!N/"-CXR\*7GBNU+K/HL&KV\FH0E!EPT <R+
MM')RO'>NKK\9;?\ :*TS]EK_ (+6?$SQ=J>G:MK @O=2M;33M,@,UU?W,L:I
M%$@]68]3T&>"< _6_P  ?^"U-K\0?VDM-^&?C_X6^)/A;K6M7,=E8'4;EI)#
M/*<0I-$\$+Q^82JJ0&&6';F@#[CHKY^_;O\ ^"C'@G]@OP]8-KT-[K7B'659
MM.T:RP)9U4@-([MQ'&"<9())X"G!Q\^^'_\ @N^OAGQ9I-O\4O@KXU^&NAZW
MAK75+B62X#QG@2B.2WA+QCC)C+D#. Q&" ?H'17SQ^WS^W]9_L5?L[^'_B)I
M^@P^.=/\1ZK;:?;1Q:I]CC>*>VGN$G67RI=RE81@;1D/G/&#TOB/]K+_ (1_
M]A:/XU?V!YWF>$K?Q3_8WV[;CS;=)_(\_P L]-^W?Y?.,[1TH ]BHKYA_9J_
MX*/?\-#_ +#OCGXS?\(;_8__  A<.IR_V/\ VM]H^V?8K1;G'G^2NS?NV_ZM
MMN,\]*\'^'/_  7GUSXRV4</@W]GOQ=XMUR%V?4+'1]2EO%L+?(5)2\=F3EF
M+#!15&!\Q)P #]%J*^,/VEO^"P=O\&OC&OPX\(_#'Q)\2O'MG#&VJ:9I=P=E
MC,R*[0*\<,KS,@;YBL84' SG(%K]CW_@KYI'[1WQT?X9^+O NM?"_P ;/O6V
ML=2N#*)I44NT#%HHGCEV@L%9 #@C.< @'U/I7Q4\+Z[XZU#PO8^)-!O/$VD1
M":^TB#4(I+ZRC(4AY8 QD12'3!8 '>OJ*WJ_-/\ X*PZU=?L5?\ !0'X0?'C
M2=T=KJT;:7KT43$?;(H&42J_49>VGVKP<&W4XR!G]*+6[BOK6.>"2.:&90\<
MB,&5U(R""."".<B@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R4_9S_
M .5A_P 2_P#85UG_ -(9:^E?^"^O_)@%Q_V,%A_[4KH/AS_P2V_X0#_@HAJ7
MQ[_X3K[7_:%U>7/]A?V+Y?E_:('BV_://.=N[.?+&<8XZUZ7^WU^Q[_PW'\
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M\<?LWW,_P3^*7P^\*^%X=8G2YT[4;6*2[2[V1%G<FPG/S)Y>,OT X&*^I_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHW.Y"KDD#D]2!7+:3^TS\-]?U&&SL?B#X(O;NX8)%!!KMK))(QX 55<DGV%
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M+$ LS$ #J2<"L[QM\5_"_P ,Q#_PDGB30/#_ -HR8O[2U"&T\W'7;YC#/X4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,O$7A"'3_%GB?P?;7EEKVG-="TCU>.[E:5S#*X 5D=R 7P&"IP,8.U=_L_\
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M._!OQ4_9-E\7>'?"O@2S\<>']6U:YU?0[X:U;V1L#/R8;E)"&8(P',>21GU
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M?['U;P_JK6ZN"KEX[J![@&(.,A2./E&!]XD '3?LT?M/:E\2?B1XB\#>)O\
MA&9_$F@V\>H17WAVY:?3=2M7(7<FYF9'1R%96)^\,5:_:L_:9O?@KJOA7PYH
M$.A3>*/&5Q+';2ZS=_9]/TZ&(!I9YV!#;1N  !!8YQDC!ROV4O@WKWAKXB^)
M/%.K>"?!WPYTZ_@CL=+T#2;&Q-U"@PTDL]U;Q@MN91A Y4>@(!,7[97[.&H_
M$SQGX)\::+X<T'QE?>$))X;SP]J_EBWUBUF4 J&E#1K(A!92PQELG.T @%;X
M6?M4>)M1^,9^'OB2]^'^H:UK>ES7V@ZOX;EEN+ RQ@EH;B%I"X91\_#@,H(!
M!/'-:/\ MR^-O$5S9_#RW\,Z3;_&O^V'TZ_M9HIFTBQM8\2-?G#AS$8F&U0^
M2<G)^56T?A-\)/%&F?%RX\90_"'P=\/=)T'29DL="T^VTJ35=:O&5@"+N) (
M$VG;CS #GG()QS-A^R]\4_#<ME\9+=VO/C%<ZF]SJ^@&^C6TN-,D*Q_V:LA;
MR_W<:JX8M@-G!)520#T_XM_&GXB:;\2KS0?#MGX-\/:3HME#-=^(_%PG@L-1
MGE&?*M%1UW; /G.]MI(!Q\I;A;?]OG7V_95^(7BS^S_#-]XH^'NNPZ/,=/DD
MN-)U-7NX(O.@.X/M9)7VY;JJDY!VU3^(?P \4:A^TOXC\7:[\)[7XL:7K5O9
MMHB:AK5K;KX<"1XDM9()6:-@7.2R!P<$_,7:N<TW]DCXC0_LV_&?P_-X5TVS
MUCQ?XCL-5TNRTV\MULFB%U;RR)"2Z[%B5& #A,A1@'.* .]\:?M'?&KX5^/O
M!^@ZYH'P[O+SXB&6UTF"SN+J/^R;E!&Q^U2,6$L:+)SY2@MM.,<9OZ+^U+X\
M\*^*_B9X3\86/A&7Q%X.\*R>)].NM(6X6SNHU1B$DCD<OD/M!PPR,^QKH_VD
M/A'XA\??M#?!?7-)T_[7I?A/4[VXU6?SXX_LJ211JAVLP9\E2,(&(QSBN+^-
M_P (_$-A\</C!XVFT_;X9OOA==Z9!>^?&=]PJERGEAO,&%!.2H''6@"J/VJ?
MC-H'P+T[XJZQX7\$_P#"'O;P7MYI=N]RNK"T<J#<(Q8Q#(;>(R"0I&6)S57P
MU\4])\+?MR?%CQI-*S:+9^ ++5RX&UI(0D<@P#CYF& !W) K)\,V7Q@^._[&
M_A7X>IX,T[3]+\0:%I]O)XL;687@73S'$X86H_?><8L*5QMW;B#@C'53?L<Z
MGKOQQ^)5G<6DMKX,\2>!;7PUIVI/<1R/YL<:("45@^4*AN5"MMQT.* ,)OVY
M_B!IOPTA^(-XOPG;PZRK>R^&X-4D/B".T9A_&7\LS!#NV;!QQP<@?5_A?Q':
M^,/#6G:M8R&2QU2VCO+=R,%XY%#J<>X(KXUL/V:_'%M\+K+P7!\!_A?:^)+5
M(K ^-YHM+NK1D0@&Z:W>)IGD9!R&4Y8EN^T?4NDW7B#P=XH\-^%[3PS%>^&8
M=*$=UKT5W!:)9RQ+M2);-5!PVT8V85,XQ@4 =G1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<_\3/A7H/QB\-+H_B.P_M'3EN(KL1>?
M)#B6)@R-NC96X8 XS@]\UT%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !65XW\#Z1\2O"E[H>O:?;ZII.HIY=S:
MSKNCE (89]P0"".00",$5JT4 >9?#;]CGX;_  D\56^N:%X:2#5K1&CMKFYO
M;F]:U5A@B+SI'$>1Q\@'!(Z&O3:** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@##\=?#;1?B3;Z?'K5E]K_ +)OHM2LW65X9+:X
MB.4D1T96!'((S@@D$$$BMRBB@ HHHH **** "BBB@#/\6^%K'QQX8U#1]2CE
MFT_5('M;F..>2!I(W&UEWQLKKD$C*D'FI/#^@6?A30K/3--MHK/3]/A2WMH(
MAA(8U 55 ]  !5RB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ JEXE\.V?B_PYJ&DZC#]HT_5+:2TNHM[)YL4BE'7*D$94D9!!'8U=HH
M S_"?A:Q\#>%=,T32[?[+I>CVD5C9P[V?R88D"(NYB6.%4#)))QR2:T*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>dxcm-20201231_g3.jpg
<TEXT>
begin 644 dxcm-20201231_g3.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@#
MZ 4Z P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZMCF;3K"Y1Y=8U( <A;;2X;R3>/NR&+N1D VQ_P6&_X)1,0J_P#!2+X($D\
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M/4/_  6T_P""34\X1/V^OARL!N?LXU*36PED9/[OVI@(?_'Z_ ;X'?'7XO\
M_!S/_P %PO!?@S]IK5]1B^$5CJM[J]G\/(+YEL])T*RB>86^U" T]RRPPSW
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ME-^T)9R2VJPJ(W::\MY)<KC!W.[D^I8YZU_4U^T-\(/V%=.T70? 7QT_9O\
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MR$?\%7M#T;3/^#CSQSI>GZ5;PVTOQUT:66WCB 1WE>RDE8CH2[N[-ZEB3UH
M_IW\._\ !5__ ()>^++Y=,\/?\%%O@?<W+L%CME^*FDB20GH%4W +'Z9KW?1
M]9TCQ%I5OKOA_5;:^L;R%9K2\LYUEBGC895T=20RD<@@X-?&7_!;C]@/]DW]
MHS_@FQ\8M2\??!GPQ#K/A#X;ZSXA\+^)X-&AAO=*O;&SENXGCG10ZQLT(61
M=KHS @U^2O\ P9??MD?'6W_:H\9_L/:AXFO]3^'U_P"!+KQ+8Z3<SO)%HVH6
M]W:Q&6 '(A25;IED48#.L1ZCD _I HHKX_\ ^"WW_!3[3?\ @E-^POK'QXTJ
MSM+_ ,:ZU>)H?P]TF\YBFU.9';SI5!R88(DDF8<;BB1Y4R!@ >Z?M)?MG?LF
M_L>:%#XC_:C_ &B_!_@.VN@39#Q+KL-M-=XZB")F\R<CN(U8UY5\'?\ @M;_
M ,$G_CSXHB\%?#+]O;X<W6JW#A+6QU'6QI[W+GHD7VL1>:Q[*F2?2OQ\_P"#
M:;_@GW!_P5B^-/Q"_P""JW_!2F_NOBM/H?B5-)\.V7B\B[M+_5A"EQ/-/"X\
MMH;>*:V6&W"^2IF/R#RD%?O=\5OV:_V?/CG\+YO@I\8/@KX7\2>$IK8VY\/:
MMHD,UI&A&/W<97$1'563#*0""" : +=_\<O@_I>J^)=%U+XC:3!<>#M)M=4\
M5+-=JJZ5:7(F,$TS'Y45Q;S,,G.U,D %2?'[O_@KY_P2KL+N6PO_ /@HU\$X
M)X)&CFAF^)>FJ\;@X*L#-D$$8(->"_\ !&/_ ()?R_\ !+;]I[]I[X7>#;'5
M7^''B?5?#.L_#G4M1620?8V@OUEL?/88EDM9 8S\Q?RS [X,@S_/]_P<[Z-I
M6A?\%S?CK8Z/816T+W/A^X>.% H,LWAW3)97P.[2.[$]RQ/>@#^M#X,_M)_L
M_?M%:%<>*/@+\:?#'C+3;1(WN=0\-:U#>PQK(&9"7B9EPP5B#GD UYO/_P %
M5_\ @F=:^)!X,N?V^OA#'K!F6$:5)\0+ 7)D.,)Y1EW;CD8&,G->[:1I&F>'
M])M=!T2PBM;*RMTM[2U@0*D,2*%1% Z *  /05\.?$7X:?#^\_X.,OAGX]N_
M!VG2:S'^RKXBECU)[53,DD6N6$,<@;&0RQ7=S&&Z[9G7H<4 ?0OQ3_X**_L$
M_ W58]"^,_[9/PT\)WDT,4T-KXC\9V=D\D<D*31LHED4D-%+&X(ZJZGH16K\
M OVWOV./VJM9O_#G[,_[4WP_\?ZAI5JMSJ5EX/\ %MIJ,MK"S;1)(D$C%%+<
M;CQGBOF+_@X(^"/@+]HS]EKX5?!/XDZ8+C1_%7[3?@#1+]D $L5O>ZLEI.8G
M(RCF&>1=P[,?6OY]/^"97QJ\??\ !#/_ (+A6_@KXU:@;#3M!\7W?@/XE2$&
M.&?2;B98OMO/)A5A;7RG^)8E]: /Z^:\3^+7_!2?_@GM\!/B!?\ PG^-W[;G
MPJ\)>)]*,8U/P]XB\=V%G>6GF1K+'YD,LJNFZ-T<9 RK@]"*[WX^_&[P)^S=
M\#?%W[0?Q,U$6WA[P9X<O-:U>92-WV>WA:5E3)^9V"[57JS, .37\A__  7D
M^"WQ$^%7[4W@OQS\<;>2+XC_ !8^%EK\0_B-!(S?Z)JNK:MJLPL@#]P6ML+6
MS"C@"UXXH _K%\%?MZ_L3?$CP1JGQ,^'O[6'P^USP[HD<<FL:[I/BNUN+2S2
M240HTDL;E4#2D(,G[QQUKBC_ ,%AO^"42DJW_!2+X( @\@_$[3/_ (]6O_P2
MTTC2]"_X)F_L\Z9HVGQ6MNGP1\*LL,"!5W-I-LS-QU)8EB>I))/)K^5W]L_P
MWX?/_!Q+XU\,G1+0Z=<?M5F.>P-NODR))KJ;U*8P0VYLC&#DT ?UU?#[]H/X
M&?%CX?WGQ7^&/Q<\/:_X9T\2&^U_2-6BN+2 1Q+,Y:5&*C;$Z.>?NL#T->9Z
M=_P53_X)I:QXG'@G2?V]_A%=:RTS0C2;?X@6#W)D7.Y/*$N[<,'(QD8->^
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M0_VCOC3X7\":#<:@EC!K/BW7(-/M9+IT=TA$D[*I<K'(P7.2$8]C7:5\M_\
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M?A!ICVNE^%/&=KXT^'D )CBO-"NI&D^PYZF(*;FP<]Q$_K7]#O[%/Q4\%?\
M!2S]N+6_V_\ P!J7]J_#'X9>"K7P=\)KQAF.ZU75+>VU/7+Y03\KQQ-IMAG&
M0\-VF>M?+'_!W'_P3HU?]KW]E3P)^UW\!O"[:]XN\":Y;:5-%I*B635-&U6:
M*&+85SYOEWCVQ3' 6ZF;.*^]/V*O@G\!?^"2G_!/;X=? +XB_$WPOX4TGPAH
M,5MKGB+7]9@L+.[U>4/<WLWFSLB_O)S<2*"<A!CHM '\RG[+?_*S3H7_ &=_
M=?\ J02U_5=^V[_R9?\ %[_LE^O_ /INGK^1[]F7]H+X1:7_ ,%\/#?[3.O^
M-['3_ \O[3K:[)XBO)O+M8-/EUMY5N9';&R,1N'+' 5<DXP:_J4_X*!?MH?L
MB^$?V ?B1X\U[]IOP%#I'B#X;>((/#M\OBRS=-8F%E+%Y-IMD/VJ3S'1-D6Y
MMSJN,D"@#^;_ /X-:X_VHY?^"E>HI^R'>> 8/%I^%VK9E^)%M?3:<+;[39;_
M );)TE,F[R\?,%QNSSBOU:3_ (-?/'W[7W[;%W^W%_P5M_;'L_B+J%]>0377
M@;P+X;DTW3I(H%58;+SY96>.T15"F-(Q(X+,9=[,Q_+;_@T[^/7P7_9]_P""
MK(\0_''XHZ%X1TS5_AOJVEV&J>(]3BL[5[QYK25(3-*RHC,L,FW<1N("C)(!
M_K$TK5=,UW3+;6]$U*"\LKR!)[2[M9EDBGB=0R2(ZDAE92""#@@@B@ TS3-.
MT73;?1]'L(;6TM($AM;6VB"1PQJ JHJCA5    X %?F5\/4_8_\ ^"H6K_M.
M_'7]HSXW>"[7PW\2=,O/A'\+(-3\1V:3Z?X8TV619=5B2212KW6K^==H6 .R
MRLSV%=O_ ,%__P#@J_\ !K]AC]E36O@=H?QNTK2_BU\1H(] T.RM;H2WOA^S
MO#Y5SK4\49+PQP6[2O&S >9*$"@@.5]8_9F_8#_X(W>.?@IH+?L^?LR_L^_$
M'PUH^G6^E6OBC3O".AZT;HP01KF>[2)_.G*['=F8NQ?<W+4 ?S;_ /!#G]K7
M7O\ @DG_ ,%C]/\ !_Q0\1VD7AS4?$-U\/?B-<6=ZLMD89+D0QWJ2 E7BBNH
MX)Q*,YA$FTX>OZ]:_E7_ .#L?]ES]C?X!_ML>%O&G[(&K_#[3H_$WAZXLO&7
M@#P')9QKH&J:=*L!DFM;7"VAFCD1-A529+2=CDEJ_9?_ ((*_P#!8OX&?MI_
M\$]_#<GQD^.GAS2OB5\.M"32_B+9>(->@MKAX[4)#'JS><ZEH9XS"SS8V"9Y
M$SD#(!^#O_!P_P#;O^(@OXL?V681<_\ "5^&?LQN ?+\S^QM+V[L<[<XSCG%
M?6O_  <6_P#!73_@LK\$=2\0_P#!-_\ :%\(_#?PAX;\9>'T>3Q=\.-,OS_P
MD^D3#;-#%/>SOY498/!-&(UD^5AN,<@+_#__  7"^/?PF^,?_!<+XI?''X9>
M.=-U[PHWC31Q;Z]HMVMU:W*6=A8V\TD4D>5E4/!( RY!QP2,$_T4_P#!5O\
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M-4<:'K<=S]CO+62"]LVF$+[H9([FU1_+?!W0E67AA0![17\>7[9__*R#XO\
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MVA/COX)LM-^-EG<_#KX5)JOB2T2;1_"NCS2I::BD<D@9'N=6$^I!6'*QVAY
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M?%GPSH<>G_$CPY)>H-0^TV^R$ZD8<[S!<9CE$H&P/*T>=R$#J/\ @MI^TE\
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MB:>9->T.V:ZDTW1+R.6WNM/O@/\ 53PP3OY<LFV*9HXF#*V](P#^FFOY2O\
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MNF^+[3Q]\-[K0=3BN+6*VFG,[6#&%F CCF6XM3&3EHD&>'K]UO\ @BQ\.O\
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M>76AV]EKFAWR7-I<26V@Z=:SB.5"5<)-#*A*DC*'!- '[1>-OV;?^"H/@/\
MX+2?L:_%W]K/]J71_B?\+Y=3U[3?#(\-^$!H%OH>IR>&=1E,<]H)I]\DL,3E
M)FFD.()%Q&,!_P!?J^%)/^"WW_!$+Q3\/?!WQ&\<_MO^ Y'\,+!KFC6\MU<F
M^T^\-C-;EOLL2&4RB&YGC,91C^\(VY QY;_P3C_X*R^%O^"P'_!6_P 2ZM\
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MKP\!:G:F[@N["VOHBT7]JOL=8[E$8!B-RDC@BOZ$*_D"_P"#H[_E.O\ '/\
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MFL['Q GP_P!1NC)?^4QMK0!]615::0"-68XW,J@$L*_6;_@L#^TI^T/^QO\
ML6^)OVHOV=_B'X'TO4_"5H'30?&_A2ZU)/$5U-/##;6-NUM>6[PSN[LB ++O
M>1!A0"U?@I_P=%_\$A=0_8'_ &GH/VX?V<=$FT[X:_$C6VN)TTI3$OA?Q'S,
M\2%,>5'.5>>'&-K+,@"A(\_H?_P0=_:VU[_@N-J.A_'']LCQYHVHZU^SA;6%
MMH7PVM-V+[77@9?^$SOD90DLS*'AMXUREM*MS( K21%0#[I_X)P7_P#P4_\
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MX-5_AKHG@#_@B5\+]:TNVC2Z\6:IK^LZM)&/];/_ &M=6J,?4B"U@7_@..U
M'*_\%(?VVO\ @KY_P1Q\$:?^U!X^O_AK^T5\'8]4M[/QC]E\'W'A?7=#,SA(
MI!)#=7-NT+N1'YIB)#R1*4^;<?L/_@G/_P %&_V;?^"GO[.MG^T5^S=KTSVI
MF^R:]H&I*J7^AWP4,UK<HI(#88,KJ2CJ0RD\@9?_  6 ^'^B?$[_ ()6_M$>
M$M?M8Y83\&_$-Y")5RJW%K8374#_ / 9H8V^JU_/A_P9Y_M+>,/A3_P5,?X
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M[_AOI7Q&T7PI#8?%7QII?B#65=C/J>CZ ^F0.I/R@0/<7!4@<$^8<^U;U%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#+__ (* ?\(3\8O&W_!.?QSK>S3_ !G"_B?P+%-)PNJ6T2I>P(.[2VJ1RXZ
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MQ,\-^"]!72?#-[:_#6;1-2BMXRHMXYYO[4NHI4BB#1@+"C%1&2Q*MO /P?\
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MBAU[P9XYT%;O3+V(X\ZVF0JR..J2*=T;H<,CJRG!4U_(3\'_  CXE_X(W_\
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MC<S2':6+ ;0$!/W#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS2+D8W*A&>*XSX"?\%@?^"8/[3OB>/P3\$OVX_AYJ^M3N$M='FUU;*ZNF/\
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M3H^-'CO3?A=\(OVZ/A-XG\2:S.8=)T'0?'UA=7=Y(%+%(HHY2SG:K' !X!-
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MQSZMN0^"]:9O+,S!\&*VD<!)T.!&P$ORXEW_ +R_M(_\I@?V6?\ LE_Q2_\
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M3KB14O[=!V6*Y>*8#DDWLAZ+7VE%\4/V;_VPO^"H7Q$\3?'3XF>#H_ '[/\
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M\$G/!OBN2#XM:YXQM?"/P<N-Q:2UTO7Y)3J%XH!W;=-C34;UGZ#S(5 KN?\
M@\H^$_@?X#?LH_LG_!'X::0MAX=\(G6-'T2S7_EC:VUEIL,2D]SM09/<Y/>@
M#[-_X-'=.T^R_P"",7A>ZL[&&*6\\:Z_+=R1QA6FD%V8P[D?>;8B+D\X51T
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MN_&W@#1-8E@\>Z>D$NJZ5#<-&ILB2%,BD@9["OHO_@\+_P"4/TO_ &5#1/\
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M;+5/$4_@71=+^PQW \@2+=F%/L\FZ10CA@0Y7!SBOY8_^";O[8%I_P $?O\
M@KA9?$K1_']MXG\%^%?&FH^%?%FM>'YA/:Z]X>:Y>UFNX#&2)DVI'>1!20[0
MQ<X-?V9T4 ?(_P#P42_8_P#V<?\ @N)_P3JU'X7> ?BSH.K:=K8CUGX=>/M"
MO8[ZTL=6@#B&</$6#(0\L$JCY@DL@&' Q^4?_! SX]_$3_@@G^TS\0/^"??_
M  58\+W?PO\ #?CZ_@O_  AXZUM2N@-JD"M$[)? >2T%Q 8SYVX"-K95DV%B
M%_H4KB?VC_V>OA7^U=\"_%/[.GQK\.IJGACQ?HT^FZM:G <1R(5\R-B#Y<J$
MAT<<JZJPY% 'Q'_P5_\ ^"X_[(_[/7[(/BCP;^S)\?\ PO\ $CXO>.=%GT3X
M>^%?AYK<.LW2W=U&85O)%LVD\M(@YD4-@RLBHH.21\L?\&N?_!!+XJ?LF^)6
M_P""AO[:?@N;P_XSN=*EL_AWX)U&/;>:-;SILGO[M#S#<21%HDA.&2.27S &
M<*GS5\+?^"4/_!8;_@WP_P""A$/[4'[)W[/=Y\?OA\J7&FSMX3C\VYUG19W5
MFM;FTC#W%I<J4BD$D<<L0DC7YI%WQG]O?V,_^"A?B?\ :XU*VT/7O^"?G[0/
MPJN#9O+?WGQ0\%0:;8V\B@?NUE-R9)MQX4K%SU8)0!](U\'_ /!P#_P2$_X>
MU_LCVOAKX?7UEI_Q.\!7DVJ> +Z_;9#=&1%6YTZ5_P#EFDZQQ$/_  R0Q$_+
MNK[PHH _GE_X-^/^"H,W_!&C4?%7_!,;_@K-X-\1_">SN/$4FL>#M>\3:-.+
M:RN9%2*YMY&16S;2&..6*XCWP[GE+.%=6K]9_'G_  7$_P""8/A?38$\ _M3
MZ'\3?$.H#9H/@?X2.?$NMZM.1E;>"TL?,8.W3,AC0?Q,H!-?3?C;X>> /B7H
MY\/?$?P-H_B#3RVXV.MZ9%=PD],[)59?TJA\//@C\&/A&9C\*/A%X7\,?:!B
MX_X1[0+:R\T9SAO)1=WXT <1^RKK?[17QK^!=]XC_;/^#NC>$M0\57]X]K\/
MH;M;U]*T255C@L[^49CFNF0.\VS,8,I0<+7\^?QD_P""=7[2G_!MS_P5C\)_
MM[?#7X8:_P"-?V>]+\3SSIKVAVSW4FFZ)>1RV]WI]\!_JIX8)W\J63$4S1Q,
M&5MZ1_TU4C*KJ4=001@@C@B@#YC'_!:'_@E.?@A_PT*/V^?AC_PCHT_[68_^
M$KM_[1QMW>3_ &?N^U_:,?\ +#RO-S_#7X>? W_@G-^T9_P<?_\ !63Q7_P4
M$^+'PMU[P7^SQJ?B:"X_M?7;9[675]&LXX[:TTZQ!_ULLL,">=-&3%$7E.\O
ML1_Z(C^RG^RZ?$/_  EQ_9M\ G5A+Y@U,^#K+[1O_O>9Y6[/OFN]5510B*
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MSEUS\K?\&CG_  4;_8A_8V^!WQ@^'O[5'[2'ASP%JFK>*]/U'2H_$ET;=+R
M6SQ,8W(VL59>5SD!E.,&OZ*J* /QU_X*4_\ !R%^P-^S+^RWJG[,/_!+KQU;
M^.?B+XC@NM+\,OX8AN#IOAV:]ED+WK74RA99!),[Q11%QYFW=L0 '[._;/\
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M_P"RK\0O!.FZCX&\%:GKKZ+XT\'7&I0ZJ]I;O<>2)8+^V-ON2-D#;9,,P)&
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MRDJ>: /2J*_G[_X*M?\ !R/_ ,%9O^"9W[=GC3]CEM.^"'BFV\-?89].U]O
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M  6<_97_ ."NGPUOO$'P;-YX>\7^'XXSXL\ :Y*C7FGA^%GB=/EN;9F!42J
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M(?\ P:X_\IU_@9_W,W_J,:M7]-W_  6'_P"44'[27_9#_$__ *;+B@#\(/\
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M6OBZW\.6,9DN-6MX;6[MIX84'+RK%=M*J#+/Y)106< _C;_P2(_X.A/VG/\
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M&IO$&I1NQE76-5.H2FS/.W$5K:VLAXSFZP?NT >TU_.#_P 'O/\ R=-\#_\
MLG^H_P#I<*_H^K^<'_@]Y_Y.F^!__9/]1_\ 2X4 >P? S_@MQ^RC\!/^")GP
M!_8T^$?QIAU;XT>)+70O#$^@:$TOFZ#'-JB"[GN9E4)"5MRZJ@;S&>5,+M#L
MO[;ZC\'O &J_&;1OC]>:+GQ3H/AC4_#^G:BLA&W3[^XL+FXB91P^9=-M64G)
M7:^,;VS^9_[*'[ ?@7]N_P#X-[?V==&D\ Z=?^./"?A_1M?\":Q)'%'=6=W:
M:F)VB2=\;$FB26)U)VD29ZJI'Z%?M%?M0>#?V>=;^'G@S588[[Q!\3/'EGX9
M\,:,+P123LX::[N?NL2EO:13S-\N"RQQED,H8 '\S?\ P=Y_M*>,?B[_ ,%:
M]4^!FIZG-_8?PG\*Z7IFDZ?N/E)/>V<.I7%P%Z;W%U"C-W6WC'\-?T9_\$J?
MA?H_P:_X)H_ 3X<Z)9+;QV'PDT![A%7&^YEL8IKB0CU>:21S[L:_GW_X/%/V
M,O&OPB_X**6G[8-OHDTGA7XM^';)'U5(R8XM7T^W2SEMG/16-M#:R+G&X&3
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M%"77U'F12+]4-?U5_!/4K'6?@UX1U?2[E)[:[\,6$UO-&<K)&UO&RL/8@@T
M?,_QG_Y3B? C_LW_ ,>_^G+P_7C_ /P=@?\ *$KXC?\ 8P>'?_3M;5ZQ\0-0
MA\6?\%Z/AGX:TF19)O!O[,?BC5-9V\^3'J&MZ3;VRM_=+M:3E0>HB?TKR?\
MX.P/^4)7Q&_[&#P[_P"G:VH ^,/^#&O_ )%7]I;_ +"'A+_T#5Z]0_X/:/\
MDP7X4?\ 98%_]-5]7E__  8U_P#(J_M+?]A#PE_Z!J]>H?\ ![1_R8+\*/\
MLL"_^FJ^H P_^#>3_@IG^Q3^P)_P0ND\7_M$?M!>%=+U31/%6OWD/@TZ] =:
MU)RZM##;V08S.TI&%.S: 2S$*K,/AK_@U>_X)[_M&_M _P#!27PM^V[_ ,(+
MJ>D?#7X=W&H:E?\ BBXMGAM=1O9;6>WBL+60X$S[Y]\FW<J1QL'*ET#?I?\
M\&G?[.O[/OC_ /X)+:'XZ\>? KP;K>MKX\UM%UG5_#%I<W0594"KYLD9? !(
M SQ7ZV6=E9Z=:16&GVD4$$,82&&&,*D:@8"J!P !V% 'Q%^VI\#/ 7[3?_!3
MSP;^SQ\4-/\ M7A[QK^R;\1M&U:( ;A#<:KX;C+H3]UUW;E;JK*I'(K^>O\
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MW9_P6/\  ?CVUT6=M(\#>+E^(/C#5(T8PV0M+C[5;HS=-TMX((U7.2"[=$;
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNSU6\BT_X1W%_?W4]O$RA&G?6HT$1E=Y-HB##$:[SM8O]MT4 ?EE_P $V/\
M@@)^V]_P2IT?Q3X;_97_ ."L7AT:9XON;>YU;3_$G[.HO(Q/"KHDL9&NHR,5
M<J?F(("\9&:M?MW_ /!"?_@HG_P4BTFU\"?M2_\ !:HW'@F"^BN9O WA?X"Q
M:5I]RR,&!E\K62\Y&,KYS2!& 90#7ZAT4 ,MK:WL[:.SM(5CBB0)%&@P%4#
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M6< @0W*OJ5XDSF-(AF-80"K':=V%]IHH ^(O^"S7_!)3XE?\%>OA'IOP"O\
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MW)MYED966+5FWR,H=%FF$S1B1MHP2I^@?^"HW[ W[9?_  4*^&.J_L^_"_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^V/XQ3QKH7@WQM^S%XG\.'Q#?_9+"ZU2^M@KR;2Q"J&RQP.@KUW_ (275_\
MH4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^
MA0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O
M?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0
MO?\ OI:/^$EU?_H4+W_OI: -BBL.V\7WUY&9;7PM=2*&*EDD4C(ZCK4G_"2Z
MO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#P
MDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_
M -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )
M+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2Z
MO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#P
MDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_
M -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )
M+J__ $*%[_WTM1VWB^^O(S+:^%KJ10Q4LDBD9'4=: -RBL?_ (275_\ H4+W
M_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -B
MBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^
M$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_
M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
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MX275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\
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M944,T8D7(!Z'&: -RBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^!_\
MD$2_]?LW_H5;%8_@?_D$2_\ 7[-_Z%0!L4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% &/X'_ .01+_U^S?\ H5;%8_@?_D$2
M_P#7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %8]E_R.][_ ->47\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!CV7_([WO_ %Y1?S-;
M%8]E_P CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %8]E_R.][_ ->47\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!X7^UA_P EL^!__8]R_P#I
M,U>Z5X7^UA_R6SX'_P#8]R_^DS5[I0 4444 %%%% !1110 4444 %%%% &/X
M'_Y!$O\ U^S?^A5L5C^!_P#D$2_]?LW_ *%6Q0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %8_@?_D$2_\ 7[-_Z%6Q6/X'_P"0
M1+_U^S?^A4 ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0Z#\:_$/AJ'1M#4&#3K6S, 2V\S/[]HS(ZF;C?@' Z5Y)\:O^"I_[+FB?\%
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M_P"\F*!_,(,49=2YD7Y2_P""BO\ P0G^!'[+?PK\3_\ !0[_ ()6:GK/P/\
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M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
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MO_7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %8_@?\ Y!$O_7[-_P"A5L5C^!_^01+_ -?LW_H5 &Q1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8_@?_D$2_\ 7[-_
MZ%6Q6/X'_P"01+_U^S?^A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !6/9?\CO>_]>47\S6Q6/9?\CO>_P#7E%_,T ;%%%%
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M110 4444 8_@?_D$2_\ 7[-_Z%6Q6/X'_P"01+_U^S?^A5L4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/X'_ .01+_U^S?\
MH5;%8_@?_D$2_P#7[-_Z%0!L4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% &/X'_Y!$O_ %^S?^A5L5C^!_\ D$2_]?LW_H5;
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5CV7
M_([WO_7E%_,UL5CV7_([WO\ UY1?S- &Q1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 8]E_R.][_ ->47\S6Q6/9?\CO>_\
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MO*+^9K]-/I#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M *\HOYFMBL>R_P"1WO?^O*+^9H V**** "BBB@ HHHH **** "BBB@ HHHH
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M/RPQ]@[!=D:]%52<83%?KIX0\(^&_ /A>P\%^#]'AT_2]+M4M[&SMUPD4:C
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M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
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M9HGPC\#:E\1O'^DW%AI.E6YFN[B1UZ= JC/S,S$*JCDD@=Z_*+XK?$7XU?\
M!1W]IN"#0M)FDFOI3:^']&1RT6EV2DL6<CC@9>1\<GIP%4=E_P %$/VS]:_:
MU^)MO\*?A6]S<>$=+U 0Z3;6J,7UF])V"?:.6!)VQ+C.&)ZO@?:W_!/']B?3
M_P!E/X<_V[XKM8I?&VOP*VLW PWV*+AELXV'93@N1]YQW"K7XOFF)Q'B-GW]
MF8.36"HN]2:^V_+\5'YSULD?'XFI4XAQWU:D[48?$^_]=/O['8_LS?!KP_\
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MC_9?AG0K/3K8R-(;>PM4ACWL<LVU !DGDGO5RBB@ HHHH \+_:P_Y+9\#_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!X7^UA_R6SX'_ /8]R_\ I,U>Z5X7^UA_R6SX'_\ 8]R_
M^DS5[I0 4444 %%%% !1110 4444 %%%% &/X'_Y!$O_ %^S?^A5L5C^!_\
MD$2_]?LW_H5;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A4 ;%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^!_^01+_P!?
MLW_H5;%8_@?_ )!$O_7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %8]E_R.][_UY1?S-;%8]E_R.][_ ->47\S0!L44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/9?
M\CO>_P#7E%_,UL5CV7_([WO_ %Y1?S-;% !1110 4444 %%%% !1110 4444
M %>4?MA_M6>$/V2_A//XWUKR[K5[O=!X=T<OAKVYQWQR(TR&=NPP!\S*#V7Q
M?^+?@?X&_#O4_B?\0]5%II>EP%Y6&"\KGA(HU)&YV;"J.Y/89-?DIXX\7_''
M_@I1^U%!:Z78LUSJ$I@TC3MY-MH]@IR6=L<*H)9WQEF. .56OA.-N*Y9%AHX
M3!KFQ=;2$5JU?3F:]=(KJ_),\/.<T>"IJE1UJST2[>?^7F6?V;O@/\6/^"A_
M[1E]KWC'6;J2UENQ?>,?$++_ *F(G"PQ_P (=@NR-!PJKG&U,5^N?@GP7X7^
M'/A+3_ O@K1H=/TK2K5;>QLX%PL:*/S)/4DY))))))-<K^S7^SOX%_9A^%-C
M\+_ T&Y81YNHZ@Z 2W]TP&^=_<X  R=JA5'2N^K;@KA2/#F"=2N^;$U=:DM]
M7KRI]D]W]IZ]K7D^5K+Z+E/6I+63_3^MV%%%%?:GLA1110 4444 %8]E_P C
MO>_]>47\S6Q6/9?\CO>_]>47\S0!L4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45\Z?\ !4;]
MNB7_ ()]?LN#XS:5H>FWVLZSXMTGPQX=_MVX>'3;6]U"Y6%;J]=/G6VA3S)G
M"X9A'L#)NWKY1\'/'7_!2#P7X^\3>(-3^-'A+XE^'M-_:"L?"GB_0[SP7/I]
MS9:;=PZ5&U[I<L=[((4@DO/,-M,LP,8D;S0P^8 ^XJ*^=?VNM,_X*7_$?6[C
MPC^P]XW^'7PYT_2;)99?%GQ T&?5YM;O6&X6UO;PRHMK;(NT27$GF2,[LJ1*
M(]\G-_\ !'/]MOX[?MS_ +*>J^,_VG?AMIOAKX@^!_B'K/@CQ='H6_\ L^_O
MM-D1);JU#LQ$9+["-S#S(I,$#"@ ^KJ*^ ?B/^TQ_P %>?VJOC7XSE_X)4^*
M?V6%^&W@K7YO#-Q-\6+_ %F?5[[5;1C'?7"IIBND-L+CS;:,/AW:TDD&4="?
M4_VY/VX?BE^Q5\"_A3X%DL?#/B?X[_%WQ5HW@?PM9QP3P:+)KMR$6[U*2+S#
M.NGV_P"\F*!_,(,49=2YD4 ^JZ*^0[O]KCXU_L@_MO?"W]D3]K'Q_I/C+0/C
MEIVI1>!/'-AX=&DSZ=X@L$CEFTVZA262-X+B&56MY!MD61&B?S=PD7Z\H **
M** /"_VL/^2V? __ +'N7_TF:O=*\+_:P_Y+9\#_ /L>Y?\ TF:O=* "BBB@
M HHHH **** "BBB@ HHHH Q_ _\ R")?^OV;_P!"K8K'\#_\@B7_ *_9O_0J
MV* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\
M#_\ ((E_Z_9O_0JV*Q_ _P#R")?^OV;_ -"H V**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\#_P#((E_Z_9O_ $*MBL?P
M/_R")?\ K]F_]"K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "L>R_Y'>]_P"O*+^9K8K'LO\ D=[W_KRB_F: -BBBB@ HHHH
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M9I&B&953 < ^N/VD?!'QT^(WPAU?P;^SI\;[+X=>*;^V>*P\77OA1=9-@2I
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M_NV]\_5_PW_8I_X*$?$'X32_LZ_M_P#[<_A3X@>"+B$V>OR^#_AG)H>N>*[
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
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MC;./]8,UC:C%_N:;VT>[[I/K]J7]U)/YC+\-6SG%_7\4O<7P1_7^MWY(S?\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJV**_8CZXQ_P#A!](_Y^;W_P "VH_X
M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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MYFGU2T1 Z.@5925'#+QG[9O[<GQA_8\_X):>!_\ @I1)\0X]1N?#WA3PK?\
MC+P?JEG:I;>+DU![*&Z5)%C66VO!]HDEA:)O*#(1)"ZG* 'W+1571-7M-?T6
MTUZPW^1>VL=Q!YB[6V.H89'8X(XJU0 4444 %%%% !1110 4444 %%%% 'A?
M[6'_ "6SX'_]CW+_ .DS5[I7A?[6'_);/@?_ -CW+_Z3-7NE !1110 4444
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MHHH **** "BBB@ HHHH \+_:P_Y+9\#_ /L>Y?\ TF:O=*\+_:P_Y+9\#_\
ML>Y?_29J]TH **** "BBB@ HHHH **** "BBB@#'\#_\@B7_ *_9O_0JV*Q_
M _\ R")?^OV;_P!"K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "L?P/\ \@B7_K]F_P#0JV*Q_ __ "")?^OV;_T*@#8HHHH
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M+\)_V.?@U>_&_P",=[>C3;:\M;"QT_2K3[1?:K?W4R06MC:P@CS9Y971%7(
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MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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M%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\
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M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
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MWO?^O*+^9H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*?Q+\2VNC>'O#FESZEK>K7K[8K2UAC,DLK$9.%52> 2<< F@#:HHHH ****
M"BBB@ HHHH **** "BBB@#PO]K#_ )+9\#_^Q[E_])FKW2O"_P!K#_DMGP/_
M .Q[E_\ 29J]TH **** "BBB@ HHHH **** "BBB@#'\#_\ ((E_Z_9O_0JV
M*Q_ _P#R")?^OV;_ -"K8H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#-%\4_!+QIX0T9_B]I*R.UYH5MJOV:-+^T1E87*V\]S&Q ,4T:IYT3.\8C8
M^SZ*CM+NUO[2*^L;A)H9HUDAEC8%74C(8$=00<YJ2@ HHJMI^L:1JTES#I>J
M6UR]E<FWO%MYU<P3!58QN ?E;:RG:<'# ]Q0!9HHHH **** "BBB@ HHHH \
M+_:P_P"2V? __L>Y?_29J]TKPO\ :P_Y+9\#_P#L>Y?_ $F:O=* "BBB@ HH
MHH **** "BBB@ HHHH Q_ __ "")?^OV;_T*MBL?P/\ \@B7_K]F_P#0JV*
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MX)M_\$X-?^"^NQ?'KX\6447B&.%ET'01(LG]G;U*M/*RDJ92I*JH)"!B2=Q
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M-U %O_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\ ?H4?
MV=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ
M%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
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M_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\
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M_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\
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M#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\
M0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'P
MQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\
MOJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T
M&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_
MT&H/^^J^1_\ @H-_P4PTGX065S\(/@%J\-[XLF0QZCK$6'BT8'@JN>'G]NB=
M3D_+7/\ _!0__@I-I'@87WP+_9RO;:76_F@USQ/:A2FG]FAMV'WINQD'$?09
M?)3Q_P#X)^_\$YM=_:*U*#XS?&VVNK7P8LQEM[>5F2XUV3.3@]5@SG=)U;D+
MW9?RKB7BS'YICGD7#WO5GI.HMH+K9]&NLNFT;RV^7S'-:^)K_4LOUF]Y=%WU
M_-]-EJ<]^P[^Q'JG[47BMOBC\9]:N++PBEXTUW=7$S?:M<GWY=$8_-M)SOFZ
MYR%RV2GZE>&+KX;>"_#]GX4\)FPT[3=/@6&RL;2,)'#&HP%50.*T])\,^'-!
MTRWT71- L[2SM(5BM;6VME2.*-1A550,  < "K']G:?_ ,^,/_?H5]7PKPG@
M.%L'R4O>JR^.;WD_TBNB^;NSU,KRNAEE'ECK)[OO_P  Y^T\2Z"GBV[O7U2(
M1/:QJDF>"03D5J?\)CX8_P"@U!_WU52SLK,^,[V(VD6T6<9"^6, Y-:_]G:?
M_P ^,/\ WZ%?5'J%/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_
M -^A1_9VG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:
M?_SXP_\ ?H4?V=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_
M9VG_ //C#_WZ%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J
MN?V=I_\ SXP_]^A7"_&WX_?!+]GW1O[5^)&MVL$SH6M-+MXEDN[K_<C'.,\;
MFPH[D5R8['X++,++$XNI&G3CJY2:27S9T87"8K'8B-##P<YRV45=OY(Z[_A,
M?#'_ $&H/^^J\4_:*_X*%_!KX)P3:+X:NE\3^(5RHT^PEQ#;M_TVFP0N/[J[
MFXP0N<U\H_M!_M[_ !9^/5ZW@SX<:4_AW1KF3R8K'2QNOKW)P%DD4;N?^>:8
M'."7KK/V;O\ @E_XV\:FW\5?'BZF\/Z8V'31H"/MTXZX<G*P ^AR_4%5/-?A
M6:>*F?<5XR65\#X9U);2KS5H1\TI:+R<]7JE!GZQ@. <IX?PT<?Q574%NJ,7
M>4O)M:OS4=%UDCRCQI\3OVDOVV?',>F7<MQJ6)-UKI%E^YL+!3QN()VIW'F.
M2QZ9/ KZ>_9I_P""?GP9^'/V?Q9\:O$%CXEUI,.FFKDZ?;-[JP!G(]6 7_9.
M :^E?A[\)/AM\*?#D7A3X?\ @VQTVRB _=PP@M(V,;W<Y:1O]IB3[UN_V=I_
M_/C#_P!^A7M<*^#^7X'%_P!J<057C<9+5N=W"+\D_BMT<M%I:,;'E\0>(^,Q
M>'^H9/3^JX9:)1LI->;7PWZJ.O>3*,7BOPG;Q+!!JUNB(H5$3@*!T &.!3O^
M$Q\,?]!J#_OJKG]G:?\ \^,/_?H5X+^V'_P4._92_8MTV2W^(_B"#4?$9BW6
MGA'1$CFOY,CY3(N0L"'^_(5R,[0Q&*_<,#@,9F.(CA\+3<YO915_^&7GLC\G
MQ^88++,-+$XNHH06[D[+_@OLMWT/;6\9^%D4N^N0  9)+=*^./VT_P#@MW^S
MK^SO%=>#?@FT/Q"\6Q[D(L9]NEV+]/WUP/\ 6D'_ )9Q9S@@NAK\^OVIO^"E
M_P"UU^WWXG'PI\ Z+=:+H6JS>18>!O!T,DMQ?@]$GD11)=$CJ@"Q\9V9&:]^
M_8E_X(#>)/$7V3X@_MI:Q)I-D=LD7@C1[E3=2CJ!<W"Y6$'ND>Y\'[\9&*_4
ML)P1DG#5".,XGK*^ZHQ=V_)VU?GRVBNL['Y)C./<^XIQ$L#PI0;6TJTU9+S2
M>B\N:\GTA<^6?$WCK]NS_@JK\6DL[^YU'Q+-%+NAL+?_ $;1]$C8XW8)$4(Q
MQO8F1\8RYQ7Z!_L1?\$8/V:?@9]C\>_M)>(=.\?>*8]LB:8\9_L>Q?T$3@&Z
M(_O2@(?^>8(S7V]\,?@Q\*/@OX/MO 'PJ^'NDZ#H]H/W-CIUFJ+GN['&7<XY
M=B6)Y)-=!_9VG_\ /C#_ -^A7DY]XB8[&T/J65P6&PZT2CI)KS:VOVC\VSV>
M'O#/+\!B/K^;3>*Q+U<IZQ3\D[W:[R^210M_%/A"T@2UM=4MHHHD"1QQC:J*
M!@  #  ':G_\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\ Y\8?^_0K\YW/
MT[8I_P#"8^&/^@U!_P!]5EVGB704\6W=Z^J1")[6-4DSP2"<BN@_L[3_ /GQ
MA_[]"LBSLK,^,[V(VD6T6<9"^6, Y- %O_A,?#'_ $&H/^^J/^$Q\,?]!J#_
M +ZJY_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$
MQ\,?]!J#_OJKG]G:?_SXP_\ ?H4?V=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC
M_A,?#'_0:@_[ZJY_9VG_ //C#_WZ%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJ
MC_A,?#'_ $&H/^^JN?V=I_\ SXP_]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H
M/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A0!3_ .$Q
M\,?]!J#_ +ZK11UD02(V589!'<5%_9VG_P#/C#_WZ%3  # & .@% !1110 4
M444 %%%% !1110 4444 %%%% !1110!\D_\ !7O]J#_@GK\%?@?I7P9_X* _
M"^^^(FG?$V]FLO#GPUT/PI+K&I:W-;JDDLEM#&5,;0"2-O.#HR%UVMN(K\HO
M!GB;_@AO^Q7KFH?M7_"K_@B-^UY<>*_"&GS:GX4G^)G@#4)]&TB[A1G@EE-S
MJ#I''&X4^;(LC1!=Z_,H-?IA_P %=?'GQW^"?QR_9Q^.W[,/[#.I?&;QUI/B
MC7M,TI=/\5P::+2VNM-$EY92>?"ZE;BVM995E#QF*73HN)5D>)O*OVEO^"H7
M_!8W2?V=?&^IZC_P;]:MI]JOA+4#<:AJ/QNT/5;>TB-M)OFFLHH"]U&BY9H
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MIW6:8=5@[A>#)UX3&_\ 2:UM;6QM8[&QMHX888PD,,2!510,!0!P !P *D
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MP>#PF7X>-##4U"$=E%))?)!1117.=(4444 %8]E_R.][_P!>47\S6Q6/9?\
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M ,%_!5I\/OAGX9M]*TJR7$5O;KRS'J[L>7<]V8DGUK\QPV6Y]XCXF.+S*]'
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METW6;*7S;:215Y,9.Y&*_,H?< 2H!^(_^"7W_!3/6O O[1GB_P#X)P?\%>?
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MD?[6'_);/@?_ -CW+_Z3-7NE &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
M8_XUL44 8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\
M]!NR_P# 8_XUL44 8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!R
MGA6U\4R:=(UAJEM&GVF0%9("3NW<FM/[%XW_ .@W9?\ @,?\:/ __((E_P"O
MV;_T*MB@#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,
M?\:/L7C?_H-V7_@,?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@
M#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:/L7C?
M_H-V7_@,?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^
M@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,
M?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^@W9?^ Q_
MQH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:S/"MKXIDTZ1K#5+:-/M,@
M*R0$G=NY-=76/X'_ .01+_U^S?\ H5 !]B\;_P#0;LO_  &/^-'V+QO_ -!N
MR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O
M&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V
M+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6
MQ10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_
M  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+
M_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;
M_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O
M&_\ T&[+_P !C_C6Q10!RGA6U\4R:=(UAJEM&GVF0%9("3NW<FM/[%XW_P"@
MW9?^ Q_QH\#_ /((E_Z_9O\ T*MB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@
M,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9
M?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@
M,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9
M?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@
M,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9
M?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@
M,?\ &MBB@#'^Q>-_^@W9?^ Q_P :S+6U\4GQ3=1QZI;"X%M&9)# =I7)P *Z
MNL>R_P"1WO?^O*+^9H /L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:V** ,?[%X
MW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?
M^ Q_QK8HH Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:V** ,?[%XW_Z#=E_X
M#'_&N<^*?Q,LO@IX-N?'_P 3_B)I.D:7:CYY[B YD;!Q'&H^:1S@X502?2O/
M_P!L'_@H'\(?V4+"70Y)TU[Q=)%FU\.64XS%D9#W+C(A7H<8+MD87&6'YT:A
MJW[6G_!2CXR+;)'<:S=(V8K:+,.F:) QZGJL2\<L<R/M ^=L"O@.)^.\+D]7
MZC@8^WQ<M%".J3_O6Z_W5KWMN>%F6>4L)+V-!<]5]%T]?\M_0Z[]K?\ X*.?
M&+]J"ZD^%OPX^VZ5X7NY_(CL+*+%[J^3A5EV$G#<8A4D'/)?C'K?[&/_  26
MU=5LOBE^TI9VR296:P\'W +@=U:[QP?7R0?9^Z5]"?L:?\$\?A7^RG8Q>)=0
M6+Q!XRDC_P!(UZY@^2UR.8[5#GRQU!<_.W/(!VCWG6_$7A_PS9'4O$FNV>GV
MZ_>GOKI(D'_ F(%>3DW!6(Q6*_MCB>HJE7=0;7)!>?33^5>ZNO,V<^7Y%B,5
MB%B,?[]1[1W2^2W]%IZF?::/XLL+6*PL-2TZ"""-8X88;/:D: 8"J!P  , "
MI/L7C?\ Z#=E_P" Q_QKS?QU^WI^RKX"WQ7GQ6M-2G7I;Z'&]YN^CQ@QC\6%
M>,>//^"NWA6V#V_PR^$E_>-R$NM;O4MU4^OEQ>86'MN6O<S;Q*X$R--8G'T[
MK[,'[1^EH<S7SL?I^7<#\5YI;V&$G;O)<B^^5K_(^K_L7C?_ *#=E_X#'_&L
M_P 2:_?>#=-;6?%_C_0]*M$^]=:BZP1C_@3L!7YZ>-?^"B/[67Q.NO[)T'Q#
M%HRW#;8[+PUIVV1O0!VWRY_W6%4/#O['W[9?Q]U-==U_PKK1,OWM6\87KQ$
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M10!C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\
MP&/^-'V+QO\ ]!NR_P# 8_XUL44 8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_
M ,!C_C6Q10!C_8O&_P#T&[+_ ,!C_C6O&'$:B5@6VC<0.":6B@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /"_VL/^2V? _P#['N7_ -)FKW2O"_VL/^2V? __ +'N7_TF:O=* "BB
MB@ HHHH **** "BBB@ HHHH Q_ __((E_P"OV;_T*MBL?P/_ ,@B7_K]F_\
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MK??:WXGO]%?'/BG_ (*]^#[?<G@KX,ZE>?W9-4U2.VQ[E8UES],_C7G/B?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PO]K#_ )+9\#_^Q[E_])FK
MW2O"_P!K#_DMGP/_ .Q[E_\ 29J]TH **** "BBB@ HHHH **** "BBB@#'\
M#_\ ((E_Z_9O_0JV*Q_ _P#R")?^OV;_ -"K8H **** "BBB@ HHHH ****
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M_#7@KP[>^+_&7B&QTC2=,M7N=2U34[M+>WM(4!9Y9)'(6-% )+,0 !DUXO\
M!3_@I?\ L-_M ^/+GX9?#7]H[PS<:ZFL/IVF:;=:K%!)K4BPQ2F2P#L/ML>V
M9/FBW=SC&"?+_P#@NQ^S]^TG^T7_ ,$^]4\/?LK>'(O$7B?PYXMT3Q._@JX?
M]WXHM-.O4NI=-920)0^Q7$1_UAB"#YF%>._\$M_VJ_V2O^"L6C?$'3]9T_\
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M\U?HS0 445P?Q!_:>^ 'PJ\1MX2^(GQ4TO2-22%)6L[N1@X1N5;@'@T </\
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MJ;_A,?#'_0:@_P"^JR_"7B70;'3)(;O5(HV-U*P5CV+<&@#IJ*S?^$Q\,?\
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MU@&I7%NJR$;2Q$,B;CC@;LXR<8R<[O\ PF/AC_H-0?\ ?5?+'_!6#]N7P_\
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MY^RE_P $R?C7^TO>Q_$7XLWE[X:\-WDGGRZAJ"EM1U/<<EHHWY ;KYLG!R"
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M_LP]U?.VK^;9]?DWA[PED;4J.&4IK[4_??JKZ)^B16MM%T>SMTM+/2;:**)
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M#_WZ%344 0_V=I__ #XP_P#?H5,  , 8 Z 444 %%%% !1110 4444 %%%%
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M"\E;^^Q(./=L#W-?E7$GBUX;<-3^KT\6\?B-E3PD>:-^SKRM#YTE6]#[[(^
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ME%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_([WO_7E%_,UL5CV7_([WO\ UY1?S-;% !1110 4444 %%%% !1110 4444
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MAUZ4:7_S,C-XSP>C\&6UWZUJO_S0S\[M1_;1_;FUC*ZA^UOX@13T6PT#1[?
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M:*_*?P7_ ,%B_P!KSPULC\1-X:\1(/\ 6-J6C^4[#V-L\:@_\!(]J];\%_\
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M@4444 %%%% !1110 5CV7_([WO\ UY1?S-;%8]E_R.][_P!>47\S0!L4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/9?\CO
M>_\ 7E%_,UL5CV7_ ".][_UY1?S-;% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5CV7_([WO\ UY1?S-;%8]E_R.][_P!>47\S
M0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A?[6'_ "6S
MX'_]CW+_ .DS5[I7A?[6'_);/@?_ -CW+_Z3-7NE !1110 4444 %%%% !11
M10 4444 8_@?_D$2_P#7[-_Z%6Q6/X'_ .01+_U^S?\ H5;% !1110 4444
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M_!2?3?W<7@[XE)NY(@U&<@_7;)1_Q$C-(_'E%9?^!?\ RM!_K%BEOA)_C_\
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M\4>#_ /_ ()P?LM? +R=3T_P2/$&LQ8/]L^)=MS(K#O''@11X/0JNX?WC7O
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MXP_"=/A2GQVF^)>@Q^"9-$365\73:M"FFG3FB$JW?VEF$?DF,AQ)NV[2#G%
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M*,9Q<9*Z8FDU9GYQ?M'_ /!&7QWINNW/B#]FCQ!9ZEI4SEX] UBZ\FZML_\
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MHH **** "BBB@ HHHH **** "L>R_P"1WO?^O*+^9K8K'LO^1WO?^O*+^9H
MV**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9X5A9F'*8<YR.]>H44 ?)WQ;^(WQT^*/CKP+XPA_9#\:V*^#-<DU.2&4P/\
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M ($P5[U10!X+_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,%>]44 >"_\
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M\;?%?P;\-?A[XNT&3X1^+T\-Z[_PF.E"QGN+SRV=RD!9I$C&, R!&.<[0,9
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M+PSXB\&:VVC>/? /C/3A9ZQX=OUW#RKB(,PVL4DVL#R8W5@KHZ+W7Q$_:?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"?@+^T1^SKKN@>-?ASH&HK=Z NKZ7?'59#>7ES&EK)97<Z$NCQK^\*$,^,$
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MQZ1X8L;MD+P^%-$@^QZ<P"D[1<3-?WNTD'%ZN0I!  /I*BBB@ HHHH ****
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M</E#[!/ DD V?\LR(V4%#RI!!Y%?#W_! +_D:OVX?^S[_'O_ *';5]E_LZ?
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M^#GA.Q^($DCZ]#X9L(];>9MSM>"W03%CW/F;LFNFHHH **** "BBB@ HHHH
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M3PTLJO?&V@<O-)-Y$;KY@A\N!7\UB0AQ]7_L=_%;X)?'#]E7X>?%?]FV+RO
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MXQ^*/B&3Q5XG\-V[C'A^+Q!KVGVTFEG!ZQ:>Z02!<CS#(!E?F/T7^T?\:?\
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M TLZ?XLMI=-@GAU&>:_MWEOC+=2S)]FM)[=TAB0C>[.P](^(O[6G[0T?QQ^
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MKC+>YT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7Y_?\'&7[,_[6O[:/[#=O\ LU?LA_LW:IXYUZ\\
M::3JUQ<Q>(]'TZTM;>UDDD=7>_O(7+DA  B,,/G/!%?H#10!D^"/$6L^*_#%
MKKVO^ ]5\,W=Q&&FT76I[22YMC_==K.>>$G_ ')&'O7Q1^V%\!?VI?&__!:3
M]F+]J'X>_LS:]KOP[^%6@>*;+Q;XIM/$&B0JDFK:>;>$Q6]S?Q7$BQN!YA\L
M$ Y0/C!^[:* /SL_X* _LV?\-X^"_BO\!OVQ_P#@F;XC\8:GIE_J$7P#^)?A
M?^R?M$UO)"K6I6[^UQS::\5T75TN52"6..-V\S+ >:_'/_@G]_P4W_9CM/V2
MOV[_ -G^UL_C-\9O@3\-QX,^+W@VZU];=_%VE31#S5MKNXQODA=IL2/\\C"*
M78Y5HW_5VB@#X\T7Q=_P4\_:]_9]^)OC"X^"I_9WUV\^%^L:+\*O"VJ^*[;4
MM2EU^Y@S#J][-;IY=DD$D<4<$:EW_?3R2 8B4?$/CW]F#_@I5X__ ."3/P>_
M9N\'_P#!+Z]\.^+OA1\2?"NO>.8;_P"(&CF]\9:E8W&Z\U*V,<[+,US(6N)Y
M[J:)PTA"+.H,B?M#10!^?_[=GP4_;.^-/_!0']C#]H_PE^R)J^I:-\)-5\0Z
ME\1Y-)\7Z(8],_M.PM[:*&$W=Y;RW3Q,CF0K$%POR%\@5]_J2RABI!(Y!ZBE
MHH \@_;[T7XD^+_V,?B?\._A#\*M4\8^)/%/@'6-%T;1M+U"PM6>YNK&:&)G
MEOKB")(P[KN;<6 .0K8Q7D'_  0N^"7[0/[+O_!,_P"&W[,'[3/P0U3P5XM\
M$:?=VFI6][K&F7T%R9-0NIT>&6PNYP5\N5,[]A!)&#C-?7U% 'YY_P#!33]G
M;]O3X*_M]_#_ /X*R_\ !/'X3V7Q.U72/ 4W@'XI?"J?6(M/GUK03>/>PS6T
MTI""5)W8D\N#'#A)%+J.K\<:M_P5@_;._8O^+OB31/A"?V??&&K?#R\TCX5>
M"+GQ?;7NK2ZC( \FH75Y JQ63LJBWMD5MT1DEFE8$QB+[AHH _'+XJ?LV_\
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M$3/B!X_\"_%KXA:KXCUC_A4?QSMK+P=XMMY+UQ;7-OIB21$6LUM#;EW/RWX
MEDWQS*H_9SXF?#SPQ\7/AOX@^%'C>VFGT7Q/HEWI.KPV]R\,DEK<PO#*JR(0
MR,4=@&4@@\@@BOD+X*?\$L?VM/V<?#FF?!KX+_\ !87XLZ=\,=#MX[+0?#&J
M^"/#.J:EIMA&NR.UAU.[L)'VH@5$W1,$55"J * />OV(OVE/#7[3_P #(/%>
M@_!;Q%\-[K0=0E\/ZW\/O%6E1V=YX>O+54!M3'$3&8_+>)XVC.UHI$("\J/7
MJY?X._"#P=\#O T/@/P6M[)"MQ-=7VH:I?/=7NHWDTADGNKF>0EI9I'9F9CP
M,A5"JJJ.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK[6? WQ<U/4'\(ZA#]IL4M8#.UG?!E!VID861"=V.\:<<DU];?\ #WW]C/\
MZ#?B#_P0O_C7[)D?B!P_F>60KXFO"C4?Q1E)*S7:_1[K_,^NP6?8#$X:,ZDU
M"75-]?\ (^H:*^7O^'OO[&?_ $&_$'_@A?\ QH_X>^_L9_\ 0;\0?^"%_P#&
MO7_UQX5_Z#:?_@:.O^U\K_Y_1^]'U#7EOQT_;?\ V.?V8-4@T7]H_P#:A\!^
M [JZS]E@\7^*+;3FFP QV>>Z[L!E)QG (]:](T/6++Q#HMGK^FLQM[ZUCN("
MZX)1U#+D=C@BOS7_ .#EJVMY?#'[(<LL",P_;,\((&903M9+O(^AP,CO@5]'
M&2E%-;,]!--71]D^ ?\ @I!_P3X^*?B6U\&?#G]N+X2:UK-\RK8Z1IWQ#TZ2
MZNB>!Y40FWR9_P!D&O::\L_;"_8Q_9T_;M^"&K_ +]I7X;:?X@T75+22*":X
MMD-UIDS*0MU:3$%K>=#AE=<'C!RI(/YW?\$'O^"COB?X2?L-?'?X3_MQ_$?4
M-=G_ &2OB!=>%I/$<D;W%[J.GB9[>RM%5B7GN#<PRV\*DY8/!'VR6,_62BOC
MOXP_\%2/B#^R9\7_ (5^%/VU/V3U\#^#?C%XEA\.>&/&>C^/8M7?2-8G&;:R
MU>V%K"MJSC<#);S7<*E&S(5!:G^(?^"J6L_"[_@HWIG_  3Z_:"_9]LO R>(
MO#&HZ_X1^)&J^.E.CZ[:VD;2210$VBE;E%5FEAD*>6B.^YP8O- /L&O+?B[^
MVS^RA\"O&\'PO^*'QUT'3_%-S;?:8O"L$[7>J&#_ )[&SMU>=8N?]84"GUKY
MY^-G_!3KXR^!?^"2GQ._X*+ZQ^SS%X(GTGPG<7OP[T_4-<.H/J)E?[/87\T7
MV>$Q6\DLL$R1M^\:%OG6(G%+_P $!OV?],^&/_!.'P-\=?$MT^M_$;XUZ5%X
MZ^)'C?4F\[4=<O=0!N8O/F/S,L4$L<2)G:NUB "[$@'TK\*OVL_V9?CEK5OX
M9^#WQX\*^)-4N+"[O%TO1]9BGNHX;66WBN6DA4[XC%)=6Z.KA65IE! )KT*O
M)-6_8]^%D_[:.B?MT:'I5KIOC.Q\#:CX3UV]MK4*^LZ;<SV=Q$D[C!8P2V8,
M9.<+-(/[N/(H?^"EOQ.^*WP8\5_M3?L??LF?\++^%_A/4=2MDUK_ (3==.U/
MQ1'ITKQ7MSHME]DFCO(DDBFCC,UQ;-,T+!%(*%P#ZXHKX@_:3_X+D_!#X1?\
M$WO#7_!3?X*?!WQ+\3/ ?BB6WABDTV^L['^R9Y;D6ODW_FRM+&ZW!:%A!#/A
MT.2%*LT_QZ_X*^>-?V7/VBO '@'X_?L&>.="^&WQ1\0OH'@GXB0:M;7U_=ZJ
M8R]M;RZ);![F#[1C]VK/YW.'A1U=% /MBBOD'X9_\%0?B3+^WIX;_86_:A_8
MFU[X4WWQ%\.ZCJ_PMUV]\9:?JZZTMBOFW-M<Q66Y;*X2',A42S+Q@.<@GZ^H
M Q/B%\2? 'PE\*7/CKXG>,=.T'1;)"UYJNJW2P6\"@$EG=B H !)).  :Y;X
M$?M<_LN?M107%W^S=^T)X.\>0VA874_A'Q!;ZA'$5V[@SP,R@C>F03GYAZUV
M?B]5?PGJB.H(.G3@@C@CRVK\L/\ @VC^*5S\"/\ @WWM/C#IOPQUGQ:^@:UX
MGU&?0?#LEI'>7:Q74C-L:[FABR$3N^<+A0QPI /U@HK\Y-6_X+X>/U_8/\._
M\%(/"G_!-SQMJWPJDLHKWQUKA\7V-K)HEN]Z;4M9P3()M4,?R-(RI%""^%E?
MRY6C^K/C5^W)X#^'MU\,_!/PRT&;QMXU^,J22_#?PU:70M$O+2*V6ZN-1NKA
MU;[)90PO&TDFR1]TL:)%([!: /;Z*^:/V7?^"@^M?&+]K[XB?L&_&WX"S^!O
MB3\/-#L==F?2=;DUC0]8TJZ"".YM+Y[6U<LKN(VCD@C.Y6VE]CE?I>@ HHHH
M **** "BO)?VL_VU/@=^Q9X=TCQ1\<;_ %*"TUN]>UL3ING-<,9$3>=P!&!C
MO7AG_#^7_@GY_P!#%XI_\)F3_P"*KVL%PYGV8X=5\+AIS@]G&+:TT>IX6.XG
MX=RS$O#XO%4Z<U:\922:OJM/0^S:*^,O^'\O_!/S_H8O%/\ X3,G_P 51_P_
ME_X)^?\ 0Q>*?_"9D_\ BJZO]3N*O^@*I_X SC_UWX0_Z#J7_@:_S/&?'/\
MP<6_\(7XVUCP=_PQW]I_LG5;BS^T_P#"P=GF^5(R;]O]GG;G;G&3C/4UE?\
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M4]>FO?&&I^'_  [H&D[5FU+5;[Q-?06T'F/\L*%CEI&SM56(#-M1OMKX=?\
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MF._?5]L5O9Q(=HD#AGRZI&LT@:-0#[FHKXZ_9M_X*TWWQL^!OQK\:>,OV/\
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MV>UGD;5KU$5VB5HXV6/ =!ND**6=%!W, ?#/%?\ P4P^(NI_#+XL?'S]G/\
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M[0W[0/@[P1=>*+B2#PW;>*?$5O8R:K+&8PZ6ZS.IF93+$"$!(,B#^(9^0?\
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MS^T/I_[&7QB_8._X*M:QYWB/X%6'P/3X?_$3Q-X:C.HQ>&9+RRMFANY%@W$
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MU_Q#A_!3_HY#Q3_X*;;_ !H_XAP_@I_T<AXI_P#!3;?XU^C]%?C?_$0N,O\
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MZQO[6:TU":.2.+=!*769,,&!0)@ AR20 #@_^#A7]C/X\?&'PA\%OVZ?V5_
M]QXM^(/[,/Q(A\767@VS4M/K6F^=:SW<$"@$R3!K&V81@%G190H9]J-] _ ?
M_@K]_P $W?V@?A=;_%'P]^U_X$T-/)!U?0/&'B:UTG5=%G&!);7EI=2))#(C
MY0Y!5B/D9@03]*UA3_"[X9W7BU/']U\.M"DUZ+_5ZW)I$)NTZ=)BN\=!W[4
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M\*?#?P%=^)-<UOPO?Z9I>EVE[;6V^>XMI(D9Y+F6-$C#,-Q!+ 9(5CQ7A/\
MP1H_98^(?[+O[!?PS^!G[2'P,LM!\?\ P\T.32KG5Q<6%\+E&N;B56MKF"1Y
M FR4!E<1D,S !A\Q /@"[_9R^,/_  2?\1?\$W_VJ_VB]/N!X&^$OA'5/!OQ
MAO80TL/@N\URVE6.YN60E4@CENS%)/\ <'V0#.9(\_3O[:V@^$_V_P#_ (*L
M?L>2?LQ^.='\5VGP8U?7O&GQ#\2^&;^*]M-$T^6"S6SMY;B%F19;R:+;'#NW
MM''))MV)NK]%[JUMKZVDLKVWCFAFC*2Q2H&5U(P5(/!!'!!JGX<\+>&?!^F+
MHOA+P[8:79JY=;33K-((@QZD*@ R>YQ0!^+_ .UCX4^!&AVGQG_X*F_\$F?V
MW;CX+?''P?XYUJT^*'P?&O1W>F^-=9L=2FM6MI])D^9KN^9!) R(ZRO<J%59
M':5?7?\ @J9\>]$3]L+_ ()OZ_\ 'C6]"\'^*I?B$VJ^+_#M[JT<;:+/<:9;
M+(D@=LI&MQ(80[<$C&2:_3V?P+X)NM>M_%-UX.TJ34[,$6FHR:?$9X <YV2%
M=RYR>A[GUK5H _,3]I+XX?#']F;_ (.9?!GQ9^-GB/\ L70/%/[&DOAWPO?M
M:2S#6-7'B>:X&GVJQ*S3W+1E2L2 LQD15!9U!\=^&W[2/[$'_!-W_@HO^TI^
MS?\ \%<_@]X<TJU^(_Q7U#XC_";XH>,/ *ZK9ZIINH1P^9IZW @E=/(,:J!]
MP/YZDH=@?]E[C3M/N[B"[N[&&66V<M;2R1!FB8@J2I/*D@D<=C53Q%X0\)^+
MXH(/%GA?3M42VF$ULFHV4<XBD'1U#@[6]QS0!Y1^PEXC^#7C?X+3^/\ ]G3X
M!Z=X \ Z[KDUYX0AL/#"Z,=<LC#"@U62R$430>>Z2>7YBAW@C@D(7>$7VBBB
M@ HHHH *\L_:E_9:T#]J30-*T#7_ !5>:4FE7CW$<EG"CF0LFW!W=*]3HKS\
MURK+\[R^I@L;3YZ4])1=U>S3Z-/=+J=F Q^,RO&0Q6%GRU([/332W6ZV9\A?
M\.AOAQ_T5_6__ &&C_AT-\./^BOZW_X PU]>T5\-_P 0A\./^A?'_P "J?\
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M[^U2:)\'(RC@@X(!Y':I[>QLK.RCTVTLXHK:*(116\<85$0# 4*.  .,=,4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>dxcm-20201231_g4.jpg
<TEXT>
begin 644 dxcm-20201231_g4.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
MJ@54 P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /COP)^UQ\=?%<&JWE_XJ@B^S:_>6D,=OIL 58XI2B_>0DG
M Y)/6MX?M'_&0_\ ,Y?^4ZW_ /C=>*?!YB--US'_ $-NI_\ I0U=>''>@3.]
M'[1OQE[^,?\ RGV__P ;IP_:-^,1_P"9Q_\ *?;_ /QNN"#>AIP?U% CO/\
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M_P#$4O\ PM_XB?\ 0P_^2D/_ ,17*!QWIP;T- :G4_\ "W_B)_T,/_DI#_\
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M/!P>M+0&IT(^)?C7OK/_ )+1_P#Q-.'Q*\9'_F-?^2T?_P 37.AB.AI0_J*
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M!+$P((. Z@E3\K=&!'% ['S%_P $5/@9XW\!>!OBOHWPRCUJ_P#@F/B?=_\
M"D[C4I7E673-H\][220YELC/D12@E9-LD@)+ECS/P(\>^!-8_P""^GQ<T32/
M'NA7-W=?!W1;*UMX-9MW:>Z2XC+P)A_GD4.I*+EAD9%?=*:QJB*%&HS@ 8 $
MS<?K3AK&J'IJ=Q_W^;_&@1Y9\=?VS/@'^S9^T+\/OV7?C+XGN-(\8?$Z<0^$
MK-]/E>*>1I1#$KRJ"D9DF81H">6(S@$&N._;L^$'['.D:YIOQ@^/7P6C\2?$
MFPM6M/!6C>&YYD\3:W(P)2PMHK.1)[A&+'(?,4:N[OM3>:](^+_PFF^-6O>'
MD\7:O VA:%J]IJTEG]D+W=W=VEU%=VR>>S?NH$N(+>9D5=TC0H"RH&63LK*Q
MT[3]7N?$&GV4-O?WH O+V&()-.!C&]Q\S8P.I/2@-#Y1_8)_9*C_ ."8?[,/
MQ#_:F_:YAT'P3K/C36)?%?Q$:S,<6F^';<LPM-*AV<.(!,8U5 2\LY1-_P A
M;R/P-_P6=_X)A^/?B)#^TE\=?VFK6SU#1X+B+P'X./AK5)SX?MY%VRW,ICM6
M2349T^5F1F2&,^3&S;II)OT:&L:J/^8E/_W^;_&E&L:D?^8E<?\ ?YO\: /A
MG]M[PKXJT7]I_P#91_X*IZKX%U>P^'WAP7UAXW?4[?9)X=LM:L##:7UVJEA!
M%$]P1.Y.V([,G'(W?VAOA1-^U=_P5-_9Q\5_ 2:UUS_A4UCX@UKX@^(-#N4N
M(=/LKNW@BL;26:)BGFSR>:4A)W>7YLF-O)^R9=0O[B)H)[V9T=2KH\I(8'J"
M.XJMHEM;>&;!=*\.6T=A:JQ9;:R011@GDD*N!DT!<X_X*?M'_"O]H3XO?$?X
M%_"K4[S4/$OPHU2WT_QM92:;-"MG/.LAC57D4+*"891E"<%#V()\\^/'A/Q'
M\</^"@?PF_9Y71Y9M.^'.E7?Q,\4VY V_:/GTS1D;'<S2W\X![V2GM7O%H4L
M;NYOK)1#/>.KW<T0VO.P4*&<CEB%  )S@#%.A;R-0FU>W.R[N(TCGNDXDD1,
ME59NI W-@'IN..M :=#;'@SQ5WT.?\A2CP=XK'_,%G_(5F#5]2[ZA/\ ]_F_
MQIPU743TU&?_ +^M_C0!ICP?XH[Z)/\ D*7_ (0WQ1_T!9OR%9@U74N]_-_W
M]/\ C3AJFH'IJ$__ ']/^- [FD/!WBD=-&F_(4H\(>*.^B3?D/\ &LX:KJ7>
M_F_[^G_&E&JZ@?\ F(3_ /?T_P"- M#1'A#Q..FCS?D*</"?B?OHTWY"L[^T
MM1_Y_P"?_OZ?\:!J>HC_ )?YO^_I_P :!FD/"7B7J-'F_(4X>%/$PZZ/+^0K
M-&J7_>^F_P"_IIPU/4!TOYO^_IH%H:(\*>(^^CS?D*7_ (1/Q'_T")OR%9PU
M2_[WTW_?T_XTX:E?GD7\W_?TT 7QX6\2#_F$S?E3AX7\1=](F_(5GC4[_O>3
M?]_#3AJ-Z>E]+_W\- [F@/"WB,=-*E_(4H\,>(>^DR_D*S_[0O\ _G]F_P"_
MAI1J6H=[V7_OX:!:&@/#/B$=-+E_*G#PWX@[Z5+^59PU*]/_ "^S?]_#3AJ-
M\/\ E\E_[^&@+&@/#.O'_F%R_D*7_A&=?_Z!DOZ50&HWAZWDO_?PTX:A?#I>
MR_\ ?PT!Z%X>'-?[Z7)^0I1X<UW_ *!DOY"J(U&\[W<O_?PTX7]Z>EY+_P!_
M#0!>'A[7A_S#9?RI1X>UL]=,E_*J'VZ]_P"?R7_OX:4:A>=[J3_OX:!F@/#^
MN#_F'24HT#6^^FR50%_=]KR3_OX:<-0O>]U)_P!_#0&A?&@ZT.FGR?E2C0]9
M[Z=)^541?W1_Y>Y?^_AI1?7@ZW4G_?9H$7O[!UC_ *!\GY4O]@ZP.EA)5(7U
MR?\ EZD_[[-.%]>#_EZD_P"^S0'H7!HFL]]/>G#1-7Z_8)/RJF+ZY[W,G_?9
MI?MET>EU)_WV:!W+@T;5QUL'_*E&C:J?^7&3\JI?;+L?\O,G_?9IPO;GO<2?
M]]F@-&71H^K#_ER>G#2-4[V+U16\N?X;E_\ OLTX7MUWN'_[[- 6+G]CZG_S
MY/\ E2C2=4'2S?\ *J@N[@]+E_\ OLTX7ESWG?\ [Z- BT-+U/O9/^5.&E:D
M.1:/507<Q_Y>'_[Z-+]HN/\ GN__ 'T: ]"V-,U+O9M3AIFH?\^KU3%W<C_E
MX?\ [Z-.%Y/WG?\ [Z- [EL:=J/>T:G#3KX_\NKU3%S<=IW_ .^C3A=3=Y7_
M .^C0&C+7]FW_P#S[-2C3]0'_+LU5A<S]IV_[Z-.%U/WE?\ [Z- 6+(L+[O:
MM2BQOA_R[M587$QZ3M_WT:7SY_\ GL__ 'T: V+(LKSO;-3A97@Z0-547,W>
M1O\ OJE%Q(?^6K?]]4!<M"TO.]N:<+2Z'2%JJBXG'_+5O^^J<+B0_P#+5O\
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MI8:<C)9N'<K!!<M((8HH8\D1K7O'[?W[%7Q+^(7QS^"?[07PE_:P^*FB^+?
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M4.>]*'![U$''>G9!Z&@-R4.13@X/6H02.AI0_J* )PY'0TH<=ZA#>AIP<]Z
M)@0>E )'0U$&!Z&G!R.M $HD]13@P[&H@X-+0!,'/>E#@]#4(9AWI0X[T!N3
MAR.M.#@U &(Z&G!_44 34H9AWJ(-Z&G!_44 2!QWIP8CH:B# ]#2T 3!_44Y
M6_NFH Y[TX./6@"</ZBG!@>AJ .13@X/6@"<.>]*&4]ZA#$=#2AQWH FI0[#
MO40;T-.#^HH E#CO3@Q'0U$"#T-&2.AH'<F#CO3@WH:A#GO2AQV- :,G#^HI
MP(/0U '(ZTX.#0%B7)'0TX.>]1!R.].#CO0(D#@]Z<'(J+(/0TH8CH: O8F#
M@TX.1WJ 2>HIP;T- [DX<=Z7(/0U"'/<4H8=C0&C)@2.AI0_J*C#GO2AE/>@
M+$H;T-.#GN*AI0S#O0*[)@P/0TX.>]0AQWIP8]C0.Y,''K3@Y%0!QW%.#>AH
M&3AP>M+4(D]13@P[&@5B4,1T-*']148<]Z4,#WH"S)5;^Z:<)/45#2AR*!7)
MPP[&G!SWJ .#UIP<]C0.Y,&![TM0AQWIP8CH:!DH<BG!P>M1!_44X$'H:!61
M*'(Z&E#CO4()'0TX.>] K,F#'L:<)/45 &!Z&G!R.M 7)P0>AH!(Z5$'!IP<
M^M [DH<]Z4.#T-1AQWI:!DH<CK3@X-0AB.AI0_J*!61.'/K3@X[U &]#3@_J
M* U)PQ'0TH<=Q4(8'H:<'/>@+HF!!Z&@$CH:B#@]Z<'(H&2A_44X,#T-1!P:
M6@"8.>]*'![U"&([TH<=Z!6)PY%.#@U &]#3@_J* U)J4,1WJ(-Z&G!SW% 7
M1(''>G!O0U$&![TM R8/ZBG!O0U '(ZTX.#0*Q.'/>E# ]#4(<CO3@X[T"U)
M@Y[TX.I[U"&(Z&E#^HH'<FI0S#O42M_=-.$GJ*!W)0X[TX,1T-0A@>AI<D=#
M0!,']13E;^Z:A#GO2AP>] K$X?U%*&!Z&H0Y%.#@]: U):4.>]1AR.AI0X[T
M#NB4./6G!R*B!!Z4 D=#0!.'!ZTX.1T-0"3U%.##L: )@X[TX$'I4(<]Z4.#
MT- K$H)'0TX2>HJ(.1UIP<&@+LE##L:<'/>H:4,P[T#N3!P>AIP<CK4 <=Z<
M&(Z&@#4M#FW4_7^=25#8'-JA/O\ SJ:@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\X/A<Q%
MKKN#_P S7J7_ *4-74B3U%<G\,3B#7>?^9KU+_TH:NG#D=:"2<$'H: 2.E1!
MP:<'/K0%CYM_;P8GQ)X>S_SXS?\ H:UX)7O/[=IW>)/#Y_Z<9O\ T-:\&K^2
M_$3_ )+/%^L?_2(GY;G_ /R-ZOJOR04445\6>.%%%% !1110 4444 %%%% !
M7W7^S"P'P&\-#/\ RY-_Z,>OA2ON?]F1Q_PHCPV#_P ^3?\ HQZ_7/!S_D?U
M_P#KT_\ TN)]5PE_O\_\/ZH]"#D4X.#4 ;T-.#^HK^C#] )J4,1WJ(-Z&G!S
MW% $@<=Z<&]#408'O2T!J3!_44X-Z&H Y'6G!P: W)PY[TH8'H:A#D=Z<''>
M@"8.>].#J>]0AB.AI0_J* O8FI0S#O42M_=-.$GJ* )0X[TX,1T-0A@>AI<D
M=#0!,']13E;^Z:A#GO2AP>] $X?U%*&!Z&H0Y%.#@]: ):4.>]1AR.AI0X[T
M!<E#CUIP<BH@0>E )'0T!H3AP>M.#D=#4 D]13@P[&@+$P<=Z<"#TJ$.>]*'
M!Z&@"4$CH:<)/45$'(ZTX.#0!*&'8TX.>]0TH9AWH#4F#@]#3@Y'6H X[TX,
M1T- :$X<&G!R.]0!_44Y6_NF@+$X<=Z7(/0U"']13@P/0T 2AB.AI1)ZBHPY
M[TH93WH"Y*K?W33@_J*AI0[#O0.Y.&!Z&G!SWJ ..].#$=#0%B8,I[TM0AQW
MIP;T- K$H=AWIP<=ZB#^HIP(/0T 2AB.AI0X[BH<D=#3@Y[T!<F#>AIP?U%0
M!P>].#D4#NB<$'H:,D=#40<&G!R.] 6)0Y[TH<'O48<=Z7(/0T"M8E#D4X.#
M4()'0TH?U% [LG#D=Z4..]0AO0TX.>XH"Z)@Q'0TX/ZBH P/0TX.>] R<$'H
M: 2.AJ(./6G!R*!6)0Y[TH8'H:C#@]:6@6I*'/>G!QZU"&(Z&E#^HH'<G#D4
MX.#UJ!6_NFG"3U% [DU*&(Z&H@P[&G!SWH D#^HIRM_=-1!@>]+0*Q,']13@
MP/0U '(IP<'K0+4G#GO2AE/>H0Y'0TH<=Z!W)J4.1408]C3A)ZB@=R4.#UIP
M<CH:B!!Z&@$CI0!,''>G!CV-0ASWI0X/0T"L3B3U%.#>AJ .1UIP<&@+LG#G
MN*4,#WJ$.?6G!QWH'<EI0Y'6HPQ'0TH<=Q0!*'!IP<CO40(/0T D=#0!.''>
MG!CV-0!_44X,#T- K$P<=Q3@0>AJ$.>]*'![T!<E!(Z&G!_45$'(IP<&@9*&
M!Z&G!SWJ&E#$=Z )@X/>G!R*@#CO3@WH:!6)PX/6G!SV-0!_44X-Z&@6J)@X
M[T[(/0U"'/>E# ]#0.Y,"1T-*']140<]Z<'4]Z!DH;T-.#GO4-*&8=Z LB8,
M#T-.#D=:A#CO3@Q'0T"U)@X-+4(?U%.5O[IH"Y*&8=Z4..]1A_44H8'H:!DH
M8CH:<']14-*'/>@"<-Z&G!_45 ''K3@Y% K(F# ]#2U$'!ZTX.1T- :FQIQ)
MLD)]_P"9J>J^F'-BA^O\S5B@84444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^;7PU8"'70?^AJU
M+_TH:NF#$=#7+?#<CRM=&?\ F:M2_P#2AJZ3)'0T$O<F#^HIRM_=-0ASWI0X
M/>@-#YS_ &Z6)\1^'\_\^,W_ *&M>$5[K^W*2?$6@9_Y\IO_ $-:\*K^2_$3
M_DL\7ZQ_](B?EN?_ /(WJ^J_)!1117Q9XX4444 %%%% !1110 4444 %?<O[
M,I'_  HGPV,_\N3?^C'KX:K[A_9H8#X%^' ?^?)O_1CU^N>#G_(_K_\ 7I_^
MEQ/JN$O]_G_A_5'?TH<CK488CH:4..XK^C#] T)0X-.#D=ZB!!Z&@$CH: L3
MAQWIP8]C4 ?U%.# ]#0!,''<4X$'H:A#GO2AP>] $H)'0TX/ZBH@Y%.#@T!L
M2A@>AIP<]ZAI0Q'>@-B8.#WIP<BH X[TX-Z&@"<.#UIP<]C4 ?U%.#>AH F#
MCO3L@]#4(<]Z4,#T- 7)@2.AI0_J*B#GO3@ZGO0&A*&]#3@Y[U#2AF'>@-28
M,#T-.#D=:A#CO3@Q'0T 3!P:6H0_J*<K?W30!*&8=Z4..]1A_44H8'H: N2A
MB.AIP?U%0TH<]Z T)PWH:<']14 <>M.#D4!8F# ]#2U$'!ZTX.1T- $@<]Z<
M''K40<=Z<"#TH E#D4X.#UJ $CH:<)/44 3AB.AI0X[U"&'8TX.>] $P;T-.
M#^HJ .#T-.#D=: )P0>AHR1T-1!P:<'([T 2ASWI0X[&HPX[TN0>AH'<E#D=
M:<'!J$,1T-*)/44!HR<.1WIP<=Z@5O[IIP?U% 6)L@]#2AB.AJ(,#T-.#GO0
M(D$GJ*<&]#4093WI: )@Y[BE##L:A#L.].#CO0.Y.'/>E#*>]0AB.AI0X[B@
M-&34H9AWJ(-Z&G!_44!8E#CO3@Q[&H@0>AHR1T- MB8..XIP;T-0ASWI0X/>
M@=R<2>HIP8=C4 <BG!P:!DX<]Z4,#WJ$.1WI0X[T 34H<BH@Q'0TX/ZB@5B4
M.#UIP<]C40(/0T D=#0+5$P<=Z<&(Z&H0Y[TH8'H:!W)P_J*<"#T-0!SWIP<
M>M R4$CH:<'/>H@Y%.#@]: LB0,#T-.#D=:BI0Q'0T"L3!P:<'/K4 ?U%.5O
M[IH%J3AQWI:A#^HIP8'H:!W)0Q'0TH?U%1ASWI0RGO0,E#>AIP?U%0TH<B@5
MD3A@>AIP<]Z@#@]:<'(Z&@-28.#WIP<BH X[TX,>QH"Y.'!I:A$GJ*<&]#0,
ME#$=Z4..]1ASW%*&![T 2AO0TX/ZBH:4.1UH%9$X;T-.#GN*@#@TX.1WH#4F
M# ]Z6H@X[TX,>QH"Y('(ZTX.#40<=Q3@0>AH&2AR.].#CO4 )'0TX/ZB@5B<
M,1T-*']14(8'H:<'/>@+,F5O[IIPD]14 <'O3@Y% KDP8'H:7)'0U$'!ZTX.
M>QH'<E#GO2AP>]1!QWIV0>AH&2AR*<'!ZU""1T-*']10*R)PY'0TH<=ZA#>A
MIP<]Z U)@0>E )'0U$&!Z&G!R.M 71*)/44X,.QJ(.#2T#-_223I\9/O_,U9
MJKHW.FQY_P!K_P!"-6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** /S4^'; )KH/_ $-6H_\
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M% R<,1T-*''<5"&!Z&G!SWH F!!Z&@$CH:B#@]Z<'(H E#^HIP8'H:B#@TM
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MX2\.W?QD_8Q\%_L]>$#]KUGXF_&'P_H>A16Q#M(TGG2F48_@5$+,_P!T Y)
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M/8T"2R/2)O\ OJE$EH.D3_\ ?5 ; ''>G!B.AI/.M?\ GD_YT"6U/2-O^^J
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M_455VW?_ #U7_OFC_3/^>R_]\T"LBX&]#3@Y[BJ0%X?^6Z?]\TX"_'_+=/\
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M\$T.EZ=:?:;JTMYD(DA%PZ21^:C!U2-@&!;- 'V('!IP<^M?'&O>.Y/V)O\
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MAP>]0AB.]*''>@"<.17Y\_& Y^+?BD_]3'??^E#U^@(;T-?G[\7^?BSXH/\
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MBC_B7+_J:?\ E#_[L'_$RW_4J_\ *_\ ]Q/T>#^HIP;T-?F_11_Q+E_U-/\
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M'R'%_P#N]+U?Y'/4445_/Q\(%%%% !1110 4444 %%%% !74?!$X^,WA(_\
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M_P#0VK5K(\"G/A6U/^__ .AM6O0,**** "BBB@ HHHH **** "BBB@ HHHH
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MXX4444 %%%% !1110 4444 %8WB;_D,/_P!<HO\ T6M;-8WB;_D,/_URB_\
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M]UO-O*LH*!V\T,/F U/L,..].#$=#7SQ_P %._VC_CU^R9^QKXS_ &A?V?\
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M.#D=: N3@@]#0"1TJ(.#3@Y]:!W/2_ 1)\)VA/\ TT_]&-6Q6/X .?"5H?\
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M*** "O(/V[OB!^U9\+/V8/$/Q _8J^&V@>,/B'IKVCZ1X:\2^<+6^B:YBCN
M6AD1E9(7DD!SC]W@CFO7Z\M_;)\,?M7>+_@)J6@_L5?%GPQX)^(,M[9'2_$'
MB_1S?6,4(N8S.C1 '+/%O13M/+ ?*2'4 ^0_^%N?\'/7_1I/[)__ (6>K_\
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M;,I<=3_=93^-=&/@7\7^_@"__P"^5_QH(:=SF Y'>G!QWKIA\"_B\.G@*_\
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MI1X'\7C_ )@4_P"0_P : ,\.#WIP<BKX\$>+>^@S_D/\:</!/BT=-#G_ "%
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MM.#@U*-"UD=+"2G#1-8[Z?)7KG7HR(.1WIP<=ZD&B:N.EC)^5*-'U?O8/^5
M6(\@]#2AB.AJ4:-JO:RDIPTC5N]B] B$2>HIP;T-2_V1J?\ SY/^5']CZG_S
MY/\ E0 P.>XI0P[&GC2M4'_+F_Y4X:5J7>R?\J!ZC0Y[TH93WIPTO4Q_RZ/3
MAIFH][-Z T8RE#,.]/&F:B.EJ_Y4X:?J'>T?\J L,#CO3@Q[&G?V;?'_ )=F
MH_LV_'2V:@6J$#CN*<&]#2BPU#O:M2BPO?\ GV:@=P$GJ*<&'8T@LKX?\N[4
MX65V?^7=J!BASWI0P/>D%G>C_E@U.%I==[=J "E#D4"UNQTA:G"VN>\#4"L
M<'K3@Y[&D^RW'_/(T"UN1TB- M1P<=Z<&(Z&FB"Y[PFE$$_7RS0.YZK\.#GP
M99G_ *Z?^C&K<K"^&K9\&6B$_,ID##T/F,?Y$5NT#"BBB@ HHHH **** "BB
MB@ HHHH **** "O)?VZOAE\>/C#^R9XU\ ?LN^,[#P[\1[G3HI_ ^N:HY6WL
MM4M[B*XMY9"(Y?E$D2]8W'JI&17K5% 'XD^%?C=_P<5Z-XOMOA7^U;_P4C^&
M/P/\5WES]FTNU^)7PGM(=+UF3.%%CK%O:R:?<NPP1!YRW'S<PKTKV'XP_LE?
M\'-=U\,]63Q-_P %'OA+XGT1K-CK_AWP_P##^.TO]4TX#-S:VTJV)*S2P[T3
M!4EG&'0X8?17_!1__@L/_P $QOV1=(U#X&_M%^+-.^(WB;5D^Q2?!GPMI$7B
M#4]2=R +:>TYBAW'&%N63=_"&/%?+?\ P3K^''_!9WQU^T59?%[X"_!32_V3
MOV;)'1C\'_BGJEYXBNKV#=S)::;))&^C$KP+>)[.*,G/ES#J ?K?1110 5Y;
M^V1^UM\-_P!B/]GSQ%^T1\3]&\0:KI_A[3)[QM'\*Z++J%_>"*)I7$<40.U5
M1&9YI"D42*SR.BJ6'J54O$?A[1?%WAZ_\*>)-.CO-.U2REM+^TF&4G@D0HZ,
M/0JQ!^M ''_LM?M ^$_VKOV;? G[3'@6!X=)\>>$[#7+*UDD#O;+<P)*8'(X
M+QEC&W^TAKC/^"F'QP\:?LU_\$]?C5\>OAQ*T7B'PI\,M9U'0KA4#?9[Q+20
MPS$'@B-]KD'J$-?,_P#P;AZ_K7@;]D'QW^PAXTU&2;7/V;?C-XC\#.;@_O)]
M/6[:[M+CWC<7$BH?[L0QP!7V]\=/A#X5_:"^"?C#X#^.HV?1/&OA>_T+5UCQ
MN^S7=O);RXSWV2''O0!^<?CG]D#PM\:O^"!7PN_:*_93@'ASXQ?#_P"#>D?$
M;X>>/]&15UAM=CTV.]OTFN -]RU\3=17"2EDEDFW2!BHKQOX2_\ !0&[_:+_
M ."H_P#P3Y_X* ^)8X=.T+XY_!/Q%X'U-8B1;VGB2WFG%W!'N)P'OA;1H#\Q
M5TZU]'?\$%OBAK/[._[,_BO_ ();?MFZA8Z%\0OV<;V_MKP:S.(8-:\(S32W
M%GK4#RD+)9;7EA+#B-84$FUFQ7CG[ W_  1SN_VCO^"%?P^^%-_XIOO GCC1
M/B)J/Q&^!7C"6S+7/AN;^TI9M+N&C;#-#/;B.5D/.V='QO10 #T+_@L1H5[^
MSU_P5T_8;_;A\&VOES>)_'\GPC\9E5^6_L-698[2&0?Q*C7%]( <_,%(P5H_
MX-VX]6_8X\3_ !\_X(\_%)I;37_A%\1;KQ!X$CO"5.K>$=293;7<&?\ 6()%
MW2,,A'NU0_,#7N_B#]FO]JC]MWQO\"K_ /;5^$_A/P?:?!+QQ!XWU>7PWXF.
MI)XD\1V=K/;61L5,*/;6(DN'NV,^)=T<,6QOFE'N7QV_8O\ V>OVBO''A[XJ
M_$+PI?VWC#PI'+#X>\9^%_$5[HNKV4$O^MMA>6$T,SV[Y.Z!V:,DYVYYH ^0
M_P#@A;\(-7^$'Q__ &X-)TB$)X-N/VIM3E\.K&,1+<O!'/=QIVQ'Y]O$<=#&
M5)R,#]$*YKX1_!_X;? CP):_#7X3^%8='T:TEFF2VCEDE>6>:5I9KB:65FDG
MGEE=Y))I&:21W9W9F8D]+0!%?6%CJEI)I^IV45Q;RKME@GC#HX]"IX(K'_X5
M=\,_^B=Z%_X*(?\ XFMVB@#\I]"UC5=%U+7K'2-2N+6%?$M_MAMIFC4?OF'1
M2!T 'X5ICQ;XG/\ S,NH?^!C_P"-8-NQ&O:_C_H9;_\ ]'M5D..]!+-;_A*_
M%/\ T,NH?^!C_P"- \6>*1_S,E__ .!C_P"-98;T-.#^HH%8\H_:JU34M4UG
M2'U'4)[@I:RA3/*7Q\PZ9->45Z?^TT0=7TK'_/M)_P"A"O,*_DOQ$_Y+/%^L
M?_2(GY=G_P#R-ZOJOR04445\6>.%%%% !1110 4444 %%%% !6+XD).KN2<_
MNXNO_7-:VJQ?$?\ R%W_ .N<?_HM:_MOZ"__ "<7,O\ L$?_ *>I'Y/XO_\
M)/T/^OJ_](F4:***_P!13^=PHHHH **** "BBB@ HHHH *M:$2NN6;*2"+N/
M!'^\*JU:T/\ Y#5G_P!?4?\ Z$*QQ'^[S]'^1MAO]YAZK\S]"!XEU_OKEY_X
M%/\ XTX>(]?[:]>?^!3_ .-9@<CK3@X-?YFG^HAI?\)'XA_Z#MY_X%/_ (TH
M\2^(.^N7G_@2_P#C6<'/K3@X[T"L: \1Z\?^8[>?^!+_ .-.'B/7QUUN[_\
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M]!!K6KGIJUS_ -_V_P :4:WJ_?4[G_O^W^->1_\ #9'[-_\ T4;_ ,I%Y_\
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M,>9C=C'&,UYD/VSOV;._Q'_\H]Y_\9IP_;/_ &;!T^)/_E'O/_C-'^I/&?\
MT+<1_P"":G_R(?Z\\$_]#/#_ /@ZG_\ )'KPUG5#_P Q.X_[_-_C2_VMJO\
MT$[C_O\ -_C7D(_;1_9K[_$?_P H]Y_\9I1^VC^S4.GQ*_\ */>?_&:/]2>,
M_P#H6XC_ ,$U/_D0_P!>N"O^AGA__!U/_P"2/5KAVO+VVU&\/G7%FS-:3R_,
M\!9=K%&/*DJ2#C&1Q45S8Z=?:U!XDOK"&74;9"MM?RQ!IHE[A7(W*.3P#WKS
M ?MI_LU=_B1_Y1[S_P",TO\ PVE^S/\ ]%*_\HU[_P#&:/\ 4GC/_H6XC_P3
M4_\ D0_UYX)_Z&F'_P#!U/\ ^2/7AK&J=M3N/^_S?XTX:QJG?4;C_O\ -_C7
MC_\ PVG^S1_T4K_RC7O_ ,9I1^VK^S2.OQ*_\HU[_P#&:/\ 4GC/_H6XC_P3
M4_\ D0_UYX)7_,SP_P#X/I__ "1[ -7U/MJ=Q_W^;_&G#6-4[ZC/_P!_F_QK
MSWX=?M#_  ?^+&MR^'/ 'B_[?>PVK7,D/V"XBQ$&52V9(U'5U&,YY^M=L'([
MUXF.R[,,KQ'L,;1E2G:_+.+C*SV=I).S/<P&99=FN'^L8&M"K3O;FA)3C=;J
M\6U=%X:OJ1_YB4__ '^;_&E_M75/^@E<?]_F_P :I!QWIP8]C7&=NA;&K:H.
MNHS_ /?YO\:<-6U$_P#,1G_[_'_&J8<=Q3@0>AH#4N#5M4'_ #$9_P#O\W^-
M.&KZCWU"?_O\W^-402.AIP?U% 7+HU74NVHS_P#?T_XTX:KJ/>_G_P"_I_QJ
MD&!Z&G!SWH NKJFH_P .HS_]_3_C2C5M1[W\W_?T_P"-4@X/>G!R* +HU34#
MTU";_OZ?\:7^TM1_Y_Y_^_I_QJF'!ZTX.>QH MC5-1[WTW_?TTHU.^/_ "_S
M?]_3_C50..].R#T- %L:GJ(_Y?IO^_IIPU2_/6^F_P"_IJF"1T-*']10!<&I
M:AVOI?\ OX:<-3ON][-_W\-4PWH:<'/>@"V-0OCTO9?^_AKSC]KN]O)/V<?%
M,<EW*RFTBRK2$@_OXZ[T,#T->=_M;,3^SIXH!_Y](O\ T?'7C<1_\D]C/^O5
M3_TAG)C_ /<*O^&7Y,^ ****_C _( HHHH **** "BBB@ HHHH **** /J/_
M ()C3R0^)?%ICD9<V-IG:V/XY*^P1>W1Z74G_?9KXZ_X)FG'B3Q8?^G&U_\
M0Y*^O X/6OZI\,?^2,P_K/\ ]+D?IW#?_(GI_/\ ]*9;%]=][F3_ +[-*+ZY
M/_+U)_WV:JAB.AI0X[U]^>X6OM=W_P _,G_?9I1>78_Y>7_[[-5@WH:<']10
M!8%[<=[B3_OLTX7ET.ER_P#WV:K@@]#1DCH:!W+0O;GO<2?]]FE%W<]KE_\
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M&G!R.M0!QWIP8CH: T)PX-.#D=Z@#^HIRM_=- 6)PX[TN0>AJ$/ZBG!@>AH
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M /[5'PNT/2OB-\#/ ]WXPBF\,74SZ3XDT9+4SI<0B;]["1NB1T9FPTF <JP
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M\02RQ!KB/[*HWQ>6Y9>?^>?^VM>FAB.AIP?U% CYF_:V^'OQX_;T\*R_LO\
MA/P]K'P^^&FN2+'\1?&^L&.#4=4TT,#)IFF6@9I(VGQLEN+E8U2,L$28N=OT
M3\/_  +X2^%G@71OAI\/]"@TO0O#^F0:=H^FVPQ';6T,8CCC7/.%50.>>.:T
M@WH:<']10!(''>G!B.AJ(,#T-+0!,']13E;^Z:@#GO3@X]: )P_J*<&!Z&H
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M$Y4XY7=N&2H!^6_V#/VZ]3\*?&GQ)^Q-_P %'?"4'A[XEZY\04N]*\1P1?\
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M_P#E@O\ B-7B9_T'_P#E*C_\K/K@?\%33W^!7_ES_P#W-1_P]._ZH5_Y<_\
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MB@ K$\0_\A:3_<C_ /0%K;K$\0_\A:3_ '(__0%K^V_H+_\ )Q<R_P"P1_\
MIZD?D_B__P D_0_Z^K_TB92HHHK_ %%/YW"BBB@ HHHH **** "BBB@ JYX<
M_P"1AL/^OV+_ -#%4ZN>'O\ D/V/_7Y%_P"ABO/S;_D58C_!/_TEGH91_P C
M;#_XX?\ I2/IBBBBO^9\_P"E0**** "BBB@ HHHH **** "BBB@#5\&''B"(
M_P"PW_H)KM@X/>N(\'G&O1'_ &6_D:[(..XK^R/ #_DB:O\ U_G_ .D4S^2?
M'/\ Y+&G_P!>8?\ I=0G#D4X.#UJ -Z&G!_45^X'XU<G#D=#2AQWJ$-Z&G!S
MWH"Y,"#TH!(Z&H@P/0TX.1UH"R)1)ZBOD;XB?\E UW_L,W7_ *-:OK8.#7R1
M\0_^1_US_L,7/_HUJ_&/&7_D6X3_ !R_(^0XN_W>EZO\C'HHHK^?CX4****
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ME\0?^@+_ ,J4O_EAZ4']13@P/0UYH/C\1_S*G_D__P#84O\ PO\ _P"I2_\
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M:***_C _( HHHH **** "BBB@ HHHH **** *FO_ /(&/_7TG_H+UA5NZ_\
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M?^O\_P#TBF?R5XY?\EC3_P"O,/\ TNH=Z->^ 0_YD'7/_!HO^%._X2'X!?\
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M<N;^XLX[JZTZ:U?SH7V."DRJV.A!Q@@COD#S7X*N/CG_ ,%$?BC\;7_>Z/\
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M_-O^15B/\$__ $EGH91_R-L/_CA_Z4CZ8HHHK_F?/^E0**** "BBB@ HHHH
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MK_%+Z<__ "?NM_V#T/\ TEG^TGT'?^3#T?\ L(K_ /I2"BBBOX\/[ "BBB@
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M#CL:C#CO2Y!Z&@5B4.1UIP<&H0Q'0THD]10(G#D=Z^7/'G_(\:S_ -A:X_\
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MJ_&/&7_D6X3_ !R_(^0XN_W>EZO\C+HHHK^?CX0**** "BBB@ HHHH ****
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M]&I7C<1_\D]C/^O53_TAG)F'^X5?\,OR9\>T445_&!^0!1110 4444 %%%%
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /QC\;.!X^\0@_\
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M% !1110 4444 %%%% %G23B^7/H?Y5L!R.AK&TPXNU/L?Y5J!AV-?V1X ?\
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MLU?XI?3G_P"3]UO^P>A_Z2S_ &E^@[_R8:C_ -A%?_TI!1117\>']?A1110
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M)[&?]>JG_I#.3,'_ +!5_P ,OR9\E4445_&!^0A1110 4444 %%%% !1110
M4444 4_$'_(*_P"WA/\ T%ZPZW/$'_(*_P"WA/\ T%ZPZ_V1^B7_ ,F%RO\
MQ8C_ -2*I_+OB9_R6-?TA_Z0@HHHK^CSX$**** "BBB@ HHHH **** "O8?A
MK_R(6F?]<Y?_ $?)7CU>P_#7_D0M,_ZYR_\ H^2OX8_:#?\ )D,+_P!AU'_T
MSB#^T?H)?\GCQ7_8%5_]/8<VZ***_P 8C_7,**** "BBB@ HHHH **** "BB
MB@#[+T!Q_85ED?\ +I'_ .@BKH(/0UG: Y_L*RS_ ,^D?_H(JX'![U_J'@_]
MTI_X5^1_!>)_WB?J_P R4$CH:<']140<BG!P:Z3'8^I/V=CGX.:.1_T\?^E$
MM=K7$_LZ?\D;T?\ [>/_ $HEKMJ"@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@"OJVJ66B:5<ZUJ4NRWL[=YYWQG:B
M*68_D#7YE?L9>%?BY_P56_X);M_P4&\!_'WQIX5^/OC34_$>L^!-<TGQ?=QV
M/AV>SU:\M].T;^SS*;.2P\FU@BFBEA<3>;),VZ0JX_3N:&&YA>WN(E>.12KH
MPR&!X((]*_,3_@W;CU;]CCQ/\?/^"//Q2:6TU_X1?$6Z\0>!([PE3JWA'4F4
MVUW!G_6()%W2,,A'NU0_,#0!]-?\$=?^"@\G_!2S]A;P[^T)XCT*+2/&%C>7
M'A_XAZ)#&R)8:Y9E5N%56)**ZO%.J$DHLZJ22I-?4=?G?_P0M^$&K_"#X_\
M[<&DZ1"$\&W'[4VIR^'5C&(EN7@CGNXT[8C\^WB..AC*DY&!^B% &?XK\5^'
M/ WAR[\6^+=7AL--L(3+>7DYPD2=-QQVYKSC_AN?]D?_ *+UH/\ W^?_ .)K
MU*^L+'5+233]3LHKBWE7;+!/&'1QZ%3P16/_ ,*N^&?_ $3O0O\ P40__$T
M?C!\4_'?@K2/B)K1U'QGI$(NM4N;FWWZG%\\3S.5;[W0BL$?%+X;=_'^C?\
M@SB_^*K]JM6_9Y^ .O7?V_7/@;X/O9RH7SKOPS:R/@=!EHR<56_X9?\ V:?^
MC>/ O_A)6?\ \:H%9'XOCXI_#8?\U T;_P &<7_Q5.'Q4^&G?Q_HW_@SB_\
MBJ_9[_AE_P#9I_Z-X\"_^$E9_P#QJC_AE_\ 9I_Z-X\"_P#A)6?_ ,:H%RH_
M$+QEXY\#:M/ ^G^-]%D"(P8_VM",<CU:L7_A(_"W_0WZ+_X.+?\ ^+K]U_\
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M +-/_1O'@7_PDK/_ .-4?\,O_LT_]&\>!?\ PDK/_P"-4?\ $P?&?_0/A_\
MP"I_\M#_ (ETX)_Z",1_X'3_ /E)^!7VG2?^AFT7_P '=M_\<JSI&H:):ZM:
MW,_BG152.X1G;^VK8X 8$G_65^]G_#+_ .S3_P!&\>!?_"2L_P#XU1_PR_\
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M_$=>+O\ GQ0_\!J?_+3\AO\ A>7P=_Z*7HO_ ('I_C1_PO+X._\ 12]%_P#
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M_P"S3_T;QX%_\)*S_P#C5'_#+_[-/_1O'@7_ ,)*S_\ C5?5'S-C\E?^%_\
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MHO\ X.+?_P"+H_X2/PM_T-^B_P#@XM__ (NOW7_X9?\ V:?^C>/ O_A)6?\
M\:H_X9?_ &:?^C>/ O\ X25G_P#&J^._X@]PS_S^K?\ @4/_ )6>3_JEEO\
M//[U_P#(GX4?\)'X6_Z&_1?_  <6_P#\71_PD?A;_H;]%_\ !Q;_ /Q=?NO_
M ,,O_LT_]&\>!?\ PDK/_P"-4?\ #+_[-/\ T;QX%_\ "2L__C5'_$'N&?\
MG]6_\"A_\K#_ %2RW^>?WK_Y$_"C_A(_"W_0WZ+_ .#BW_\ BZ/^$C\+?]#?
MHO\ X.+?_P"+K]U_^&7_ -FG_HWCP+_X25G_ /&J/^&7_P!FG_HWCP+_ .$E
M9_\ QJC_ (@]PS_S^K?^!0_^5A_JEEO\\_O7_P B?A1_PD?A;_H;]%_\'%O_
M /%T?\)'X6_Z&_1?_!Q;_P#Q=?NO_P ,O_LT_P#1O'@7_P )*S_^-4?\,O\
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M5G_\:H_X9?\ V:?^C>/ O_A)6?\ \:H_XF#XS_Z!\/\ ^ 5/_EH?\2Z<$_\
M01B/_ Z?_P I/P*^TZ3_ -#-HO\ X.[;_P".4?:=)_Z&;1?_  =VW_QROWU_
MX9?_ &:?^C>/ O\ X25G_P#&J/\ AE_]FG_HWCP+_P"$E9__ !JC_B8/C/\
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M%_\ !Q;_ /Q=?NO_ ,,O_LT_]&\>!?\ PDK/_P"-4?\ #+_[-/\ T;QX%_\
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M'NC^$;'2]1\>:+'/"L@D3^U(3C,KL.0Q'0BOVL_X9?\ V:?^C>/ O_A)6?\
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MT7_P91__ !5'_"V?A?\ ]%"T7_P91_\ Q5?LO_PR_P#LT_\ 1O'@7_PDK/\
M^-4?\,O_ +-/_1O'@7_PDK/_ .-4?\2Z<$_]!&(_\#I__*0_XC1Q3_SYH_\
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M1_PR_P#LT_\ 1O'@7_PDK/\ ^-5^]4Z:I4XP6R27W'Y).3J3<GUU/@0?MO\
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M'>+_  U\0?".E>/?!>LPZCH^MZ;!J&DZA;-F.ZMIHUDBE4]U9&5A[&O&)_\
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M @BNAH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR0MK/A/PG$FOBW</&FHSN]U=HC#AU6XGE4-_$ #WH ^@:*** "BBB@ HHHH
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MPLJK("%<!F 88(W'!YKPG_@WB_Y0N?L__P#8GR_^EUS7O7[<7COP3\.OV/\
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M:* J(JJ%50    *Y;]M?]J;Q)_P1\_X*VZK^W7^U%X0U#7/V?_CAX)T7P?\
M\)OI-L;JY\!ZGIYN)5MF@7+FUG\R:X81@L[$E0S0['T_^#>+XN_"KQ9\0OVU
M/#_A?XE:#J-]J7[:7C;6]-M+'5H99+O39Y(!#>Q*K$R0/L;;*N5..#78:I?>
M"]<_X+,_%_P!_P %!HM%/@[5?@YHVG_L_6/C7RAHVI:;.LW_  DT47G_ +B2
M]:X%JLJ?ZXVR1Y'EC- 'HG_!)GX7^)I;7XN_MKZIJ5A:Z/\ M&?$!/&?A/PI
MI&K07MOI6EBQ@M8)Y9;=W@:\N4A$\XA=T5BJ;W*L:^O:_/7_ ((<?L^C]F+X
ML_M._"+X!>*[W6/V:[/X@Z9/\$IYKUKJUM[J:R>77+6QG8GS[6"Y>" .I9?,
MBE!9I5E8_H50 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %0V&G:?I5HEAI=C#;01Y\N"WB"(N22< <#DD_C4U% &5%X
M&\$P>)'\9P>#]*36)%VR:JFGQBY88Q@R[=Q&..M:M%% !4-IIVGV#SR6%A#
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M;'5+,N'-KJ-HD\98=#M<$9'K5ZB@!EO;V]G;QVEI D442!(HHU"JB@8  '
M':GT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#J?P1L==_9D\7>(M/^,_B_2O#]EK.AW5L]OIMQ>8/DB%&>[N9UC#.L26X23
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MC3\._@/XF\"^(?A-KB/;Z]_:%MIEY K16)7SIT:,)+))&K+"#(92@C<C[?\
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MA&XH<G*YQSTJ_:VMK8VL=C8VT<,,,82&&) JHH& H X  X % 'Y2_P#!7_\
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M?B7P=+''XK\):SHE[H^L:29!F-KC3]0A@N8D8?==HPK=B: /5:*** "BBB@
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MGP/^)7PJ^+/COPAK'B+]H[P]X5URY\'^/M4TH7NDW5IJ#S6[I:7$:\M;Q$.
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M_P"U;VT\0M;6\_V*"#9$((7VXA1 ?F9CDC//6OS0K]!/^"2'_)#/$7_8V/\
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M_P#C.;6P\.ZNNE>)O$UKX;U*[T/0[XLJFVOM5M[9[&RE5F562>9&0LH8*2*
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M4X;5K,7(F80F'SO,$I\LJ'^6O;* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** //\
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M\$'_ /@FQX>\*>,_A[I7PGUU/#/C5+U;GPI)XXU.32=(-YG[3)IMF\Y@L)9
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MM7^*T5N,6[ZNFK/:6#R@<&X^SP+L)^;RVFQP6K1_X(Z_\I%?^"@/_9<-+_\
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M,:I\1-$_9O\ B#K7PA@EE\66?@C5I_"\4$>]WU%+.5K8*O\ $3*$P.YKXO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
=44 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>dxcm-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:dxcm="http://www.dexcom.com/20201231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dxcm-20201231.xsd" xlink:type="simple"/>
    <context id="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id874e873187245ef8983f0949a6da29c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib306ec0bfb0d4471a50748795fd3e82b_I20210204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2021-02-04</instant>
        </period>
    </context>
    <context id="i1697460f2cd94010a9df70dc435b1690_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09e2f6d29705425da4375d800e0c8257_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i62ab2abda0de42659a37b9c9f8196c4a_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ib7f9f30a2abc40808a41b3885af720d9_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i3a3a2bd79c1246d89a94242e2cd12c96_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i1d1e7482b0864e9f85af3dff1a4430f1_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia9fd427acdbc486a9e8edee4ccc7110c_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ic82615128e2c4fc99ac6cee2560ef199_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i334065d7da4c4bbd8735b1a9237ca649_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifd8fb94803f34b96a82fb0ebc3e1cba8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iddc2ad90e3a745f583d12c18ce94e654_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib2c0cbd5c0f241d4985442b984220cf7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4859a89543554757a0237d357c2029c8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2f94c40295974007abccd11273ce6988_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3afb9980ee644d22897fe66e8e9f3621_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibc3e8df174cb41c9a8ef16f4487803b8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="idd074ca304794ce49a646d4278e77cdd_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5bb937d881cb42d6a0f935a924001c2f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i84f5c2cc37a5477db6d781d12fe77f0f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ice5479f1e1694af1aafc253e8cf22247_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i06733029c370448ba5d57587ce16bda1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3cc1828a50774882930e3febccea7246_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3962ec3ca47246e5afc8c09df3185349_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib08750c5e7ec4f89a130804838db3915_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50619200f7264c2d9ac57a9f7ac26a68_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91ff836d4cc04bac915b60eb3b0276b8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i53e29bb6e76c4d0abc2e92543b07c60d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie43b7f8664fd4e7fa1c96e2b2325534a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i999d507de85644e59daac2a6a6a98654_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c875e94a27c489ca8dbc61fe476e69f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8815ef6d44b14de195293c0935f6df41_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idf189edb39e14e54937ee10b5be44dd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2202fad57c63453e9b1b404a15b6e82d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3351b0dd70c24b04bc98a96abb444375_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id0eec6c3ccfc41bebe1fab61a4e0fc10_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i341885eacad94bbc9b111e97938ab5d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9cff1bc2dac48ea90553b980fd2c925_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i96dbf53aa4aa48419562b1d395e1f854_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icaed968ca04841ac838a9395b4ddde38_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iadc9086aefb444be9c59339767825b54_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1042cfd24eb042868d75c1ab948d9274_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2e33652311eb4e57bd6bfd8727b45672_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9910d7cdf82d4d41af4edfbba713867d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib53ea3ab72fb4434808baeb3dbdd3757_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib6bcd786fb0b4ea9b8f9951d9cf922c9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i51c0e602241341029dd0c585c07f2640_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2e8e542173bc421a8ea7fcba19440c37_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idddb7ec6794e442290c8762383c2f014_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2b3da214a5bd4cd99d307ec8fba40242_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0a50a7ab68a24d07a8592dacb3cb2ed5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia434b2a9257449fd8249cceb27254ff0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i937ac9769efb417fa531b7ef2eaf0b5b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5136399a37e14cb998f33ad3100276b8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie05ee9ac1ff14752904b83c729c90efe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i25599498524d40f9acb652bfbaa12e50_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibbb84a4a26f3410fb9ecbca78f99e413_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i623dc723c3654d6f84c0203133743a3c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i487acee9456946cdb9c4c15b15b58728_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if1e6715852d34c6d9cf08a930ee3485b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i954b8f3c51d640ac8ab5dd40a78b5387_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib32ce2a545784b15ac52d142f35bd1ca_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9471ca1928864644924a2ba32d88cc1f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic931fab80e0d492e975aaa6194f8e114_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4966c3d9c394b12bda5b16597859370_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idaa97d31ed824316b5f9b802f7fbd276_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icf74b07e99d94f2c93e41b91727019c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife10a97075fb4eaebce519044eed7ce7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idcf57f15378a4158b986a2e96c250eea_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i615df7321c9348c998d7e063f8bd67aa_I20181120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-20</instant>
        </period>
    </context>
    <context id="ifcc7e8952bad4da2bbf8948b84f5ae8d_D20181120-20181120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-20</startDate>
            <endDate>2018-11-20</endDate>
        </period>
    </context>
    <context id="idcad237c07544045a0efa52e0443d72f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i31d2218e16f24d919d743df0127d21f8_I20181228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-28</instant>
        </period>
    </context>
    <context id="ib4b6d430ae4d4e93bade0e1a590f3f1e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4df6a91f5c464feda5d61246887477e0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iceaf0df0d90548128c251bbadb05470c_I20181120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-20</instant>
        </period>
    </context>
    <context id="ib24f50ea0be64889a78368325e28c1b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8927c59d45b409899e39263bc914622_D20181120-20181120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-20</startDate>
            <endDate>2018-11-20</endDate>
        </period>
    </context>
    <context id="ie6ebe15ea5354284a29045fe47fb46b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09bae00ae8514ff08a6985ab2ac96d46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e343c46b6194f4380e1fe7c51520054_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a5cda91bc024f7090c90466831fa67a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb5aff7c546d45ba9ec38abb08822d8d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id92b9c26d62a4ca287002134a8a256e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib910a32cb01f4e5390ee06e908c61c31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8535192ed8644f5582f70c23c1378c5b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8276529a58434a7b813dcb46b73073f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf3265a756884edc835fa906c7740171_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6072b512879424581f8888ccf4b1714_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ce4bc5e66a842608d994966881082ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf7749c1aed641479a3729499651b209_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9cac588c14d54e36b24ced9f8983c608_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i33c17b8f03144e119934ea6043ba9473_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ica5b87038a814ec1a6c4020d34fb75fb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3a704f3be5c848d5b0eb7eca70324e2b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0905eace1d084bdbae0f064671806ef4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifd1de93377374c41ad096882be863dc4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i88a4128e1836441785ef95ceb6d9f5ef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i370e2a274e894e17830c5dd4de2f0b14_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieebd5d2f1c504a48ad99159aa9507fc7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0632744de077450ba1f1cc509a18cf6e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i314750f344f946b9bb09c3930fd9d8f7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icd57f0d5e88a4997a01dff3a6ac5d84f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i61493ab0d7cc4e5d840ceb144efade0b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i667ef1514f464c018ac2d87ad6fd7fb4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib8f2e89c0f47427ca284b54295ee9475_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i824914321cdf4eb3bab58c165184aebe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iea63bf6b583842f8afb95e80d99e8bb1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i094a2a8c50c44667a8ed8cffec42dee4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9b91b53fe18c4c4ea50245a93565fd7d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6352fa03b74e459290adcf2b8f29d7e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57670ce42c9048fd998b9d1f66f24047_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a7900a1db994a859636735a0f0324a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i833d598aaf8f47baa412832261515cfc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3fb0b180cb694f118960ccc9da9e7d85_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7f7515fed1ce4589adbabde6cf4f20cd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic9decf99cba94ae588c9c036d46e7a88_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iaad228cd33024cad88643caf07e6164a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i057d34c5ad2a4be99a734d6e91c1a7fe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i300b1ce4d8494fc99011c04df98671bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b55a585c4b242df8b97a38b585d21d1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib254b46104664cc0bea561395f6e1d0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45ff6f9c8a1c4dc49b7be4fa6bfb4e0a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id65cdf0bbb534ff8b54804c8c04e4d6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifba7e8356ca14d2ba58dddba2df2d708_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icab58e138022469894bc21a0ced86296_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24d744ae1b6b4be5bcb2a6eeb386c04b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaa80ff42b6994adb90d475cddbd0d364_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd00f21e56f5451794ad6ac6c3bfa468_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cbe832d48b7469fadfd20a7d4174a82_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01240eeff3424399ac46617dff38a60e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i42d67ad56d484dbfa64dbb92ac7c6053_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id9b70c30dde844758d39245d643825b8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i87fbc88d23bd4515b69081936e2c024c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1297bc3abcfa4f7382b94f81ed19c05b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i63f56e49768249e5b7989f94f1d74990_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifb9d3f521d5d48a9a1710727f9c1ed43_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib6a74eecb57e41acb0aa286caff969ec_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic50af612698747bfbe32dc206df1497b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a9055ea7e814dc08a48a9cc25b0a3e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id11ec3fd242a40cfb175758ef847aa82_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0d4ba8ee71d445d38e472a82695ac35e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa27edbf751044d38c98cc6490ee0239_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i385417946a284bda98679e20b7d7ac2b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if136e8c77c874676bf740b0c46fce4aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b54ebecbc5445c08be0b579b40354c4_I20170612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-12</instant>
        </period>
    </context>
    <context id="i327905247cf740c896e4c6b8ec6ba29b_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i76005d853c2c4c6c974ae1790121a19c_D20170601-20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="iceb839a717174e39b3fba3bd84bba52e_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i94022d7303af424b83b5e28a7c9159c2_I20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="id4d936cb81684c6d951a9c9586de7935_D20170101-20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="ie0f4cf90dbd54f36b16e48026ad767b8_D20170101-20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="i6b82c1d246504bdc9b052ed1631c170d_D20170101-20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="i02ce6fa21a4c467b932127bbab4129a9_D20170101-20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="i144fe05e631d4754b752fbaffcb88425_D20170101-20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="ib331a0829e1642b19cf7b81d2e144de8_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="if5dcc4f82db040e08f0392a1b34637e4_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="ia18646096f2f4313b85666436e60e864_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5c37e038885d460caf56e886ef183fc3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i171e86410669489fbef485118636de53_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia48631aa96ef4bdd85a3f1e83f1deeb1_D20200629-20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="i65563331cccc49e1b2ae4e75a627ad93_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="i8b3a6150f8924f1287825cc009c6b717_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i690dc51114b644a9afb0024fdbd293c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7282b108e48d4eabac8748333920ce52_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46cf6aa4cbc04a0f82d9a6b0fe29ad48_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1faeacf9c3314fe59169bdbee5cb8ae9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d77c5b3b87a4eef982cf15597f7eafd_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="i30b4cc8b7cfc464280fc946085b32af4_D20181101-20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="i5355d4cf31264d86bc5dda86afa70ac2_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i99523a59b6a94e9f91658f912ad40913_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="ia1cdadf83f4347a1992e2190665bfc6b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b263bb73db749f7903f4d16dee3cfc9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i39aadb9741cd47b79480d481f086db3c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i899bc18f65524335a7458c45e6a54130_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1e7080d6571940faabaa2f8e843f5374_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="ic7929e0a0d324cfd8fe012a9b24af6b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99455d005fdd42b5914e278f7116ad83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb3f6f2593e742d39815ab135c1351cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie5665c7a7af04c72b799bc76e98ac16e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaab87bfd0d144699b9389facb5c03069_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7106fbb087b843a4a42d39cd22960c2e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8fb79f3ea0d43d29986396d56c2e1f4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if444b8bc180c4613992a636bbb38e095_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i70c1c83392ba4ac79884df02cce79fb8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i77366a73d9404bcfb0249f49a6494d32_D20170601-20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="i87bd51729d3940a5b519f98ea0248948_D20181101-20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="if0763f994d3d4e1caba905e8a1c1bf92_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib49c1f2854e540609bb2322a657f82ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69abd3c86e1942d8a6591c6630a96ad8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iacc146a3fcd448f9843cfc23757a5620_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i8faa2bf597984c30b119197a6a7e086d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4e773841aaec4c8f8602ad4486565e5d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i36128ee14a734888bc09fffd96a8030b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a1a9074faa14cd1aaebc1917a4bf806_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3136d780e4b54c5c8c992096d59c7865_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63e11745d3934aeba348c054954eb311_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i25f646d2021741ceb895186d3d836104_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie5f9e39f0909482a94b926033b0fa78d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2cfebefd71d743d7bb8817b29e995207_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i584812d31d074a4d9c695bd53995b5d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i910cc468fb184823bb85a75afc8cbcc5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:CALIFORNIAAndNonUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90a1a747b94545808a4f6dc903487330_D20200622-20200622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2020-06-22</startDate>
            <endDate>2020-06-22</endDate>
        </period>
    </context>
    <context id="i6a547859b60a43fc9dc18e7cd1125a02_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i344d8f8e50c34a90b390f141b61876c0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3eaa2ff3c84445059ce87f458fcf8f69_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6fd1e8d507834f608ee1745f0ca4b27d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic71d9325f84947ab8e12f76111648564_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib7ad3a0859c04e32a8c6428b8ba0f02b_I20190530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2019-05-30</instant>
        </period>
    </context>
    <context id="i8fe8680967ea40c7b595ca27e03b1bbb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i47532d047d3644c781d52180df17ad05_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9504f38e9d964a7e8248536f0d74412a_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i127a151fc6454b089e250685716d7352_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1723155f583c4254a40179612feb0ea3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifa8a47c445384ea284b35965e4852a2c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia1db1c7118a14990b87107147de1cb98_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01d87f1cf80c435ead42c507b8eda281_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia8fd4570b25642ea8b04ea92713cb66e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2ba655b237cf441f820842a13b7eb463_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic56e441b6e7d4ef4b7b31fa77f81e1dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i24efa051b28f4003a6f3ad6646ccd0dc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4dbec2aacc9441d089e0d26423888121_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iadfae12ea15548f8aca74a4ee79890a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2bc01fa170ab4896aa6b4a5277b3b1e7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5cf1e522d2c04404b83cebc9cf795440_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i95b164774729468997a9b3662aa8c9f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if89d6cfc919b4446a315489302b1219e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6ddc9d9a1baa4ed59713cfb3cc17c270_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0049bf4214214416a8f099e71e710193_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29a3f0bb53204d2799a1664c7a293bc5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac621cbdae3640dfb12f31f495628cf4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i63af19991b6d4963a2316839da7e8a70_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia7ed14556556429fa016d4abae113d69_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0764697150b3465c88c53e155b29e37f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i34b608918eb7402ab4f47dba3669f52f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55cba84e376a4aecb83de5d1d311be56_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i688e9ce83e1c4d8f995dfcb32a30399c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifa840b26370a49c1a7d4e9c32b365ada_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3efb05cdfec5469584069bfe20b97f34_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1fe068ff6a8d447aa24bbe067484df80_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5438637b49ce4764914c810d05bc68a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i66896da671864b0a8fd51f13e20833f9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i931962e264f448fb93ed19b0f908c9dd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2ef105fbc7ec4827bdf560993cb05f98_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iba28294146894fc4a844398fae9b899e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7260e40093964fda96288a1c159934c9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie028a8fb3e7348b9881b8512b4a4860b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i38178bb74286401ba0308f4e347b9fd1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i698887039b694543ab8c5c785c1d2f8f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="trading_day">
        <measure>dxcm:trading_day</measure>
    </unit>
    <unit id="segment">
        <measure>dxcm:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl8zLTEtMS0xLTA_20e7cdfd-1d69-430f-a409-697916b46f5b">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl80LTEtMS0xLTA_e9a9a873-59e6-478e-a2d7-1380ee612351">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl81LTEtMS0xLTA_2eefece5-d704-4bd9-8373-8363eb1c115b">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl82LTEtMS0xLTA_93691ceb-370f-4a0f-a9db-0e510827285a">0001093557</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF80L2ZyYWc6NjQzZGEzM2M4OWRjNDgxNmI5NjcwMzQ3MDIzZDFmNzQvdGFibGU6NTBjZmVjMTBiMjNjNDQwNDk0ODhjMmFmYThiOGJjMzIvdGFibGVyYW5nZTo1MGNmZWMxMGIyM2M0NDA0OTQ4OGMyYWZhOGI4YmMzMl83LTEtMS0xLTA_a5970f47-52e7-4ce2-a766-087955421373">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE0LTAtMS0xLTc4NjY_fb45f1c2-c2da-492b-84ee-10fe91b82ae4">us-gaap:AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia434b2a9257449fd8249cceb27254ff0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE3MDQyNDMwMjk0NDM5_2fca5438-1d1d-4e75-bbcb-835f55e20811">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i25599498524d40f9acb652bfbaa12e50_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE0MDk5_34699fb7-9374-4f8a-8afb-b91db71681d7">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <dxcm:AmortizationPeriodForIncentiveCompensationCosts
      contextRef="ibbb84a4a26f3410fb9ecbca78f99e413_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI0MTYy_26f15051-f810-463e-bb6f-d6109b4adecc">P1Y</dxcm:AmortizationPeriodForIncentiveCompensationCosts>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i77366a73d9404bcfb0249f49a6494d32_D20170601-20170630"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzYvZnJhZzo1NzdiZDcyM2JmZDk0Y2JjYmM5YTViYTc5NzJkYWI4Yi90YWJsZTo1NzcwNjYyNTU3Nzg0ZWQyYWEzYzVhYTQwNTMwZWExNS90YWJsZXJhbmdlOjU3NzA2NjI1NTc3ODRlZDJhYTNjNWFhNDA1MzBlYTE1XzMtMS0xLTEtMA_c0c182de-8828-4746-91be-84d2f630acd2"
      unitRef="number">0.0100918000</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzYvZnJhZzo1NzdiZDcyM2JmZDk0Y2JjYmM5YTViYTc5NzJkYWI4Yi90YWJsZTo1NzcwNjYyNTU3Nzg0ZWQyYWEzYzVhYTQwNTMwZWExNS90YWJsZXJhbmdlOjU3NzA2NjI1NTc3ODRlZDJhYTNjNWFhNDA1MzBlYTE1XzMtMi0xLTEtMA_9b4e6a53-a2be-4b47-b45a-71f3c9ae8818"
      unitRef="number">0.0060869000</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i87bd51729d3940a5b519f98ea0248948_D20181101-20181130"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzYvZnJhZzo1NzdiZDcyM2JmZDk0Y2JjYmM5YTViYTc5NzJkYWI4Yi90YWJsZTo1NzcwNjYyNTU3Nzg0ZWQyYWEzYzVhYTQwNTMwZWExNS90YWJsZXJhbmdlOjU3NzA2NjI1NTc3ODRlZDJhYTNjNWFhNDA1MzBlYTE1XzMtMy0xLTEtODEyMg_8ace8083-93ac-4d97-b952-333b060a3cfd"
      unitRef="number">0.0016655000</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="if0763f994d3d4e1caba905e8a1c1bf92_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzI4Mg_e822fe76-398d-4dc9-abc3-bdd5759fa7f2">P3Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8fe8680967ea40c7b595ca27e03b1bbb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM3NDA_edbeb2b1-17ac-466a-946c-e20c5a225c47">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDYx_b7409b4b-b595-4a54-83e9-40a99d4b6f38">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NGE3ZjAwNTdiNWNiNGE5ZDgyNmViYzU4Yzk1ZmY2MWUvdGFibGVyYW5nZTo0YTdmMDA1N2I1Y2I0YTlkODI2ZWJjNThjOTVmZjYxZV8wLTAtMS0xLTA_dc7e3c50-0b94-4538-a2a5-e20d86382ae8">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8xODc_ef9246ee-0dac-45e7-b512-7720e3679060">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6ZDM0NzQwMzBlZjAwNDJmMWI1MjgyYjcwYjIzZTExNWIvdGFibGVyYW5nZTpkMzQ3NDAzMGVmMDA0MmYxYjUyODJiNzBiMjNlMTE1Yl8wLTAtMS0xLTA_90c679b0-7f6b-4a0f-a7d7-4e7b7d3f99fe">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDYy_ed5e2ec6-1cdd-4291-9b0f-7b5f8f609863">000-51222</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU2_d6c50084-f8b5-4445-a732-8278bee9fc89">DEXCOM, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NmEzYWI4ZWE5MTViNDI4Nzk1MjQ4ZWI4MDQ1MTlkMGQvdGFibGVyYW5nZTo2YTNhYjhlYTkxNWI0Mjg3OTUyNDhlYjgwNDUxOWQwZF8wLTAtMS0xLTA_586bbfe6-96a0-48b0-8bf4-934331e4894e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NmEzYWI4ZWE5MTViNDI4Nzk1MjQ4ZWI4MDQ1MTlkMGQvdGFibGVyYW5nZTo2YTNhYjhlYTkxNWI0Mjg3OTUyNDhlYjgwNDUxOWQwZF8wLTItMS0xLTA_4485cff0-804d-43b5-afc5-2c75d2d7083f">33-0857544</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDQ4_b2ca1933-02db-4214-bceb-2cdc489830c2">6340 Sequence Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDQ5_3a280200-3227-4faf-a325-201bf27aecea">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU1_4c1b99a8-64d0-49ba-a335-7f391fb1892e">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDQ2_540f9a30-d698-42f2-83d5-a4f39ecdd262">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU0_5577d95e-7363-42bb-b5b9-15b7722b19b7">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDUw_a7eeca33-ae6c-4f71-8502-eac668535e18">200-0200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NzUzNTU3YTMxYmIyNGNhN2FmMjZlZjdiM2U0ZjU0YzUvdGFibGVyYW5nZTo3NTM1NTdhMzFiYjI0Y2E3YWYyNmVmN2IzZTRmNTRjNV8xLTAtMS0xLTA_3834045f-7b45-4838-ad06-30468f788b70">Common Stock, $0.001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NzUzNTU3YTMxYmIyNGNhN2FmMjZlZjdiM2U0ZjU0YzUvdGFibGVyYW5nZTo3NTM1NTdhMzFiYjI0Y2E3YWYyNmVmN2IzZTRmNTRjNV8xLTEtMS0xLTA_d24a1120-6641-4e24-b291-d339d60ba907">DXCM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NzUzNTU3YTMxYmIyNGNhN2FmMjZlZjdiM2U0ZjU0YzUvdGFibGVyYW5nZTo3NTM1NTdhMzFiYjI0Y2E3YWYyNmVmN2IzZTRmNTRjNV8xLTItMS0xLTA_9378338a-4e1c-46c8-b562-acf801bcb664">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU3_104644dd-6794-471b-a185-32b5676c7e38">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU4_23cd37bb-9345-4075-aa1a-c0af2ba6b110">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDUx_dd8706bc-96d9-42e7-82c6-aea7b9fcbe3c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDQ3_05288810-129e-454b-ba16-80ea32ba7edf">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDUy_775fa1fa-a701-42e6-be41-4abb8709cb1c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDU5_b440fe5a-561f-448d-bb60-1d1b70c782e7">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDUz_9b752d8e-9a1c-4dcf-93b7-3e7c14f8fd22">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl83MTQ2ODI1NTg0OTY2_0b8a867c-9090-47e1-bdb3-21608ee78658">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8zNDYw_e093b6d8-bae8-4a61-977b-7df7e2d83ad8">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="id874e873187245ef8983f0949a6da29c_I20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8yNzQ2_6da1d08d-dd22-4fe8-a5ce-2bb956e7940b"
      unitRef="usd">38500000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib306ec0bfb0d4471a50748795fd3e82b_I20210204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGFibGU6NDc2ZTMzYWUyOWUzNDNkYWFlNjhiMGI3ZjQ2ZTk1MTUvdGFibGVyYW5nZTo0NzZlMzNhZTI5ZTM0M2RhYWU2OGIwYjdmNDZlOTUxNV8xLTItMS0xLTA_d895f7db-6eb0-4035-9c8a-2f65e117f231"
      unitRef="shares">96177363</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xL2ZyYWc6NTk0MmI5YWY4ODA3NGZlYWEzMzJkNjg1Y2JhZjkyZmYvdGV4dHJlZ2lvbjo1OTQyYjlhZjg4MDc0ZmVhYTMzMmQ2ODVjYmFmOTJmZl8xMTU0NDg3MjA5NTg2Mg_0dfbc027-8052-4db7-971e-8e9a8f4a0003">Portions of the registrant&#x2019;s definitive proxy statement relating to its 2021 Annual Meeting of Stockholders (the &#x201c;Proxy Statement&#x201d;) are incorporated by reference in Part&#160;III, Items 10 through 14 of this Annual Report on Form 10-K, as specified in the responses to those item numbers. Except with respect to information specifically incorporated by reference in the Form 10-K, the Proxy Statement is not deemed to be filed as part hereof.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNC0xLTEtMS0w_2e96f4c5-234c-4da4-90e9-cb66a18465f3"
      unitRef="usd">817600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNC0zLTEtMS0w_d954f1bc-0612-4739-897d-6c572d651a67"
      unitRef="usd">446200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNS0xLTEtMS0w_6296e92c-c511-475e-bd70-f488cb367e4d"
      unitRef="usd">1890100000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNS0zLTEtMS0w_6a85d4f7-2f93-45e7-b24b-ac06e1133b82"
      unitRef="usd">1087100000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNi0xLTEtMS0w_9e24945b-505d-4988-aab9-1da9760e0943"
      unitRef="usd">428500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNi0zLTEtMS0w_bce91ec0-a4ed-4338-b7be-490566210d10"
      unitRef="usd">286300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNy0xLTEtMS0w_284dc3bc-ac04-4ad2-ac69-74e7233627fd"
      unitRef="usd">234700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfNy0zLTEtMS0w_cf2066d0-c5a6-45a7-9dbe-540d8886a0e0"
      unitRef="usd">119800000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfOC0xLTEtMS0w_df07558c-e794-4aa4-92dc-c289ebd41aeb"
      unitRef="usd">53900000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfOC0zLTEtMS0w_220de994-692e-42ff-b433-26b4c1262fc4"
      unitRef="usd">30000000.0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfOS0xLTEtMS0w_bb8b3235-bdef-4140-bf98-247ba930e5b3"
      unitRef="usd">3424800000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfOS0zLTEtMS0w_6f589d71-c87c-43c7-8153-4a5392994f6d"
      unitRef="usd">1969400000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTAtMS0xLTEtMA_4b97e4c6-05be-4882-898b-fbc5f1e8e4ec"
      unitRef="usd">515300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTAtMy0xLTEtMA_961e432d-a8a7-4e17-bbe9-b656ab9a5316"
      unitRef="usd">321300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTEtMS0xLTEtMA_7443fad1-1535-4909-9098-52b0dfb1e319"
      unitRef="usd">93300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTEtMy0xLTEtMA_0f323bb4-a3ae-49f2-87c3-86cc8e0b7b1c"
      unitRef="usd">71500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTItMS0xLTEtMA_90d9041d-cb6b-4890-b38a-b45b276b6090"
      unitRef="usd">19300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTItMy0xLTEtMA_7cadb2ca-df7f-4afb-870e-9f91f8b979a7"
      unitRef="usd">18600000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTMtMS0xLTEtNzg0OQ_111b0c0b-1082-4bc1-a6ed-bfe28fdad00d"
      unitRef="usd">216400000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTMtMy0xLTEtNzg1MA_c0a5e6eb-0190-465b-9df1-c48a2458200b"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTMtMS0xLTEtMA_1e07262b-f2c7-4f98-ab11-9658fc1692f3"
      unitRef="usd">21400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTMtMy0xLTEtMA_79245cf2-a575-45fe-9e92-fc651845b42a"
      unitRef="usd">14200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTQtMS0xLTEtMA_433e7f9c-232b-48b8-8920-e1c26741dd8b"
      unitRef="usd">4290500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTQtMy0xLTEtMA_44c1376c-ab2b-4bab-bc06-4cb47671b2ad"
      unitRef="usd">2395000000.0</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTctMS0xLTEtMA_ed1fae60-146a-4d33-a22f-69633052de3b"
      unitRef="usd">481100000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTctMy0xLTEtMA_a4883eb9-d7e0-4e46-a6ff-c1031398e206"
      unitRef="usd">256400000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTgtMS0xLTEtMA_30edecff-36ca-42bc-9dfd-d923439d2eef"
      unitRef="usd">114300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTgtMy0xLTEtMA_59084707-2746-4b5e-a464-5fbf3fc4eb9f"
      unitRef="usd">88500000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTktMS0xLTEtMA_1ca379ac-0068-490d-8701-3b078e955f72"
      unitRef="usd">16500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMTktMy0xLTEtMA_edc796f1-d6b3-4b90-960a-d6cc3c368b61"
      unitRef="usd">13600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjAtMS0xLTEtMA_8670f08c-da36-4f67-aa1e-56707807c53c"
      unitRef="usd">2200000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjAtMy0xLTEtMA_887b86f8-91c1-41e6-8033-ed4c4ce7370c"
      unitRef="usd">1700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjEtMS0xLTEtMA_2006ea07-0c8e-4449-9f20-9e5fbb43ae07"
      unitRef="usd">614100000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjEtMy0xLTEtMA_a06b9abe-a7c4-4dc7-ad21-5c3f30bd30a8"
      unitRef="usd">360200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjMtMS0xLTEtMA_2e3a79c5-d3e4-4ca9-ba90-392e782a2666"
      unitRef="usd">1667200000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjMtMy0xLTEtMA_66615455-529c-4d6f-92d1-fa2ea6a40a5c"
      unitRef="usd">1059700000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjQtMS0xLTEtMA_6bf87147-8375-4931-a777-1cb41430d996"
      unitRef="usd">101800000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjQtMy0xLTEtMA_63c21ce3-5fca-49a1-ad4f-f7bd78a80e31"
      unitRef="usd">72400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjUtMS0xLTEtMA_25bb3c57-dbd5-4b1f-8b07-82073338c552"
      unitRef="usd">80900000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjUtMy0xLTEtMA_7a99cf63-0198-4915-afb2-3879a6737a62"
      unitRef="usd">20100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjYtMS0xLTEtMA_d9c095e1-75bc-4164-a84c-2c5237b8e2d7"
      unitRef="usd">2464000000.0</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjYtMy0xLTEtMA_85c469a9-e7cf-4ee7-9a74-d563acd7c74c"
      unitRef="usd">1512400000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjctMS0xLTEtMA_a420e53c-e050-4558-ae30-b7b102540b40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjctMy0xLTEtMA_84ce9171-9c81-457e-a0d9-2cb8732803a9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2Mjc5NjE_52053023-10f5-436d-9e27-285cd53f5bfe"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2Mjc5NjE_e762ae33-fb14-44e0-a7b3-d69f1ec40d76"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2Mjc5NzU_63628aee-a934-4422-a5e8-7c05aa5bdde1"
      unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2Mjc5NzU_99ece1ac-7260-4306-8b09-38f712a1749e"
      unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2MjgwNzU_1be79280-6324-413a-8d0b-4c6ad0e7fb42"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2MjgwNzU_826eb6b6-39ee-46b3-a14d-c4b09dbcd7fe"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2MjgwNzU_909bb149-453a-45bd-9942-2bf7c7622ae4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjg2ODJjYTJhM2U3ODQ2NDBiZTM1ZDdkNWVmZmExNzU0XzEwOTk1MTE2MjgwNzU_b967db93-96d5-469a-bde6-4a61d361c4ca"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMS0xLTEtMA_6eb217fc-1521-4d85-8b70-a892a8aa960a"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMjktMy0xLTEtMA_e80f7def-1947-494d-baeb-fc83a9a47205"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgyMjI_3d2023af-f8bf-448a-992d-3ad54daff8f1"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgyMjI_78ea120a-b0c8-45af-a439-77dd042df9f7"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxMDQ_49770822-6bdc-4890-bace-743a2aa6b722"
      unitRef="shares">200000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxMDQ_8785b2c3-cbb8-4104-ac20-4609d8641d63"
      unitRef="shares">200000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxMjA_eee4fe34-f5ca-4e4c-add5-b411baabaeed"
      unitRef="shares">96900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxMzU_e3d1f3f6-6bbe-4108-8e6b-dd0bcba56b19"
      unitRef="shares">96100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgxOTU_22e686be-8b05-4778-a713-43e2797b7026"
      unitRef="shares">92400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmQxMTE1ZmY2MGZjNjRlM2NiYzJhZGYzM2NkNDM4NTJkXzEwOTk1MTE2MjgyMTA_e65bf1a0-777c-4998-9a3d-16d7f32cccfd"
      unitRef="shares">91600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMS0xLTEtMA_22099e46-bf49-4575-b997-59d468baa469"
      unitRef="usd">100000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzAtMy0xLTEtMA_4f7e83ad-b0cb-43b0-b1b6-8b229e5789cf"
      unitRef="usd">100000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzEtMS0xLTEtMA_641f5001-dfeb-44e1-b388-bf03cc3f0667"
      unitRef="usd">2125300000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzEtMy0xLTEtMA_3fe86223-1899-44a4-abab-030944d14048"
      unitRef="usd">1675900000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzItMS0xLTEtMA_7a93dc4b-b841-4575-bc08-44751e7f24ea"
      unitRef="usd">3200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzItMy0xLTEtMA_47d4ad09-2c18-4d56-8bfe-4d9a9568e228"
      unitRef="usd">2300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzMtMS0xLTEtMA_e97ec17f-f53c-4bec-9cb5-45829763849b"
      unitRef="usd">-202100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzMtMy0xLTEtMA_f5ce3686-fdb2-4612-818f-e1bbd37985b6"
      unitRef="usd">-695700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjQzZWQwMzNhZmU1NDRlZGI5NTQ1ZjA5MTBhZWVmNzhmXzEwOTk1MTE2Mjc4NjY_08d6ba31-dc6b-483d-a027-e8425be9aa13"
      unitRef="shares">800000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjQzZWQwMzNhZmU1NDRlZGI5NTQ1ZjA5MTBhZWVmNzhmXzEwOTk1MTE2Mjc4NjY_1d714dbf-9412-4495-9280-7c5b1fac2b56"
      unitRef="shares">800000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzQtMS0xLTEtMA_fc2d5ffd-a9a2-4613-8a54-bdf827a1cf0f"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzQtMy0xLTEtMA_3be50350-c2b3-4c90-a354-28f46100e18b"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzUtMS0xLTEtMA_efabd01b-7053-428f-b44e-7fa806f0bff3"
      unitRef="usd">1826500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzUtMy0xLTEtMA_37132a8f-941a-4210-9d95-3fbb3a45ff72"
      unitRef="usd">882600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzYtMS0xLTEtMA_8658393b-e5e2-47f0-8836-a944039e662a"
      unitRef="usd">4290500000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF85NC9mcmFnOmI0YzA1NzY1ZmQ1MTQ1ODlhMmY3YTMxZThjYjdmNDM4L3RhYmxlOjZkZGQzMDA5NWQzNzQzYjc4ODRjMzRjYjEzN2JlNTNiL3RhYmxlcmFuZ2U6NmRkZDMwMDk1ZDM3NDNiNzg4NGMzNGNiMTM3YmU1M2JfMzYtMy0xLTEtMA_24b0c9b1-2f1a-469f-9277-63c5fb4ddb43"
      unitRef="usd">2395000000.0</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzItMS0xLTEtMA_a5684236-65ad-487a-bbf9-4f6475f588a3"
      unitRef="usd">1926700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzItMy0xLTEtMA_b5f8094c-42fb-4733-8bd9-9bba3725dda9"
      unitRef="usd">1476000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzItNS0xLTEtMA_e7653b0c-5956-4ff8-919d-c15838ad4314"
      unitRef="usd">1031600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzMtMS0xLTEtMA_2b93c630-1e83-477f-87ba-25a63ad24dae"
      unitRef="usd">646600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzMtMy0xLTEtMA_23062e74-7260-46c7-ad2b-ccb1a53554ce"
      unitRef="usd">544500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzMtNS0xLTEtMA_8fc6e5eb-4967-4dd4-8d15-b09c1b401d7b"
      unitRef="usd">367700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzQtMS0xLTEtMA_5d7123b6-16b6-4706-88a0-77a99547b969"
      unitRef="usd">1280100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzQtMy0xLTEtMA_ce324ccf-f6f7-4ddd-9b60-c11022fcd28d"
      unitRef="usd">931500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzQtNS0xLTEtMA_4e10543f-3167-465a-b2f4-c826f03cbcf9"
      unitRef="usd">663900000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzYtMS0xLTEtMA_250ae920-841b-4a8a-8e44-cebb6e01130d"
      unitRef="usd">359900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzYtMy0xLTEtMA_3244b203-6adb-4095-b4e4-9c4cd53a9954"
      unitRef="usd">273500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzYtNS0xLTEtMA_16aad443-20e6-484a-be6d-cb6321a97bcb"
      unitRef="usd">199700000</us-gaap:ResearchAndDevelopmentExpense>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzctMS0xLTEtMA_60b47aeb-b6ee-4a9c-916b-5f38fed39ea8"
      unitRef="usd">0</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzctMy0xLTEtMA_c1b0f859-613e-4055-997e-d8f99a83310a"
      unitRef="usd">0</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzctNS0xLTEtMA_e0cd18ed-103b-4faa-91bd-8aea4c35bd8c"
      unitRef="usd">217700000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzgtMS0xLTEtMA_83ded88a-1d73-420c-afb7-914e76aa24a5"
      unitRef="usd">620700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzgtMy0xLTEtMA_871f7921-9d2b-4fb7-8ba8-8e92fa55d32e"
      unitRef="usd">515700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzgtNS0xLTEtMA_a1938a8a-94c8-44fd-9476-b8c51352b1ef"
      unitRef="usd">432800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzktMS0xLTEtMA_a18d10b7-363f-472a-b407-07c285e3fede"
      unitRef="usd">980600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzktMy0xLTEtMA_322f75f1-ea1c-49e0-af14-d1c9b863c46f"
      unitRef="usd">789200000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzktNS0xLTEtMA_b50ba3bc-de52-4247-9504-a9e2ab41ac87"
      unitRef="usd">850200000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEwLTEtMS0xLTA_f6cb453a-f32c-406f-8c56-d566708e7995"
      unitRef="usd">299500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEwLTMtMS0xLTA_15d79182-4892-443e-8ffa-ebb738d64442"
      unitRef="usd">142300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEwLTUtMS0xLTA_d0a985cf-a187-43e7-b1eb-e29f17a8656f"
      unitRef="usd">-186300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzExLTEtMS0xLTA_29aa1c9f-42e1-4aa2-b3ab-593be20152a3"
      unitRef="usd">84700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzExLTMtMS0xLTA_69cf15a9-df5a-414e-9b59-336ad74b66cf"
      unitRef="usd">60300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzExLTUtMS0xLTA_213e8c39-8c99-4b30-a8ca-12c0699310fd"
      unitRef="usd">22700000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTEtMS0xLTIxNjk_3e95e6b0-c965-4b2d-bb9c-4fefabee79ca"
      unitRef="usd">-5900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTMtMS0xLTIxNjk_833659b6-5806-4550-acec-3dbbadbaf64b"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTUtMS0xLTIxNzI_e38ff275-f0e3-49c0-9b3f-b73f8fdcd28a"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTEtMS0xLTA_7f8ac220-acd1-4dc0-ae73-1e7da61e4e6f"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTMtMS0xLTA_49220926-ca3e-41bf-b165-ef78167861a4"
      unitRef="usd">-4200000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEyLTUtMS0xLTA_fde02420-5a89-4175-857f-384230f512d0"
      unitRef="usd">80100000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEzLTEtMS0xLTA_450ad993-cf42-4785-b572-0b17f91bc83d"
      unitRef="usd">16100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEzLTMtMS0xLTA_5fbe4024-44c8-444f-abaf-d77580b5de3e"
      unitRef="usd">26400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzEzLTUtMS0xLTA_c29073bd-477d-42e4-806d-261187ef6838"
      unitRef="usd">2400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE0LTEtMS0xLTA_df6d567b-a0fe-474c-b417-e13022e8b292"
      unitRef="usd">225000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE0LTMtMS0xLTA_392ded4d-576f-4b0d-9754-bd548b9d41a8"
      unitRef="usd">104200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE0LTUtMS0xLTA_31987793-779d-4a27-a0f1-3617d07b29dc"
      unitRef="usd">-126500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE1LTEtMS0xLTA_66909a47-84c4-4783-a3cb-117625f8da80"
      unitRef="usd">-268600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE1LTMtMS0xLTA_5a5676ff-5917-4110-b808-ca34f9cb86af"
      unitRef="usd">3100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE1LTUtMS0xLTA_ccd91e8b-a04b-48ba-9d8a-a963867a6abb"
      unitRef="usd">600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE2LTEtMS0xLTA_07f90a0f-4426-4917-a04c-e796bffecb93"
      unitRef="usd">493600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE2LTMtMS0xLTA_f8809458-d42b-40c5-a99f-9d4a9e4b3c70"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE2LTUtMS0xLTA_bc988401-e1fd-4e2a-81ab-bf307fae05ea"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE4LTEtMS0xLTA_2dc00efc-e0cc-446f-a898-fc7353820cf4"
      unitRef="usdPerShare">5.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE4LTMtMS0xLTA_aecd2171-3223-481b-a262-a6bb70d9a4de"
      unitRef="usdPerShare">1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE4LTUtMS0xLTA_1cbfe2d8-25c5-4990-9ea1-d82db433040a"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE5LTEtMS0xLTA_1a98c5c6-8fc0-4aa7-ae38-408f06b0a25c"
      unitRef="shares">94400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE5LTMtMS0xLTA_41259d21-e212-4c70-84db-a1c5f02370c5"
      unitRef="shares">91100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzE5LTUtMS0xLTA_36da7472-9d6b-4c6c-b1ef-f980e2fd082d"
      unitRef="shares">88200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIwLTEtMS0xLTA_3ead4283-15d9-4e29-93ac-31e90f7a8644"
      unitRef="usdPerShare">5.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIwLTMtMS0xLTA_467af9ea-0081-4ca8-8784-19677aa50a87"
      unitRef="usdPerShare">1.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIwLTUtMS0xLTA_772d5213-9ac3-4b86-bfae-1e32c8cd936d"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIxLTEtMS0xLTA_20dd85e1-339a-49f1-aad4-40e29f9ffe03"
      unitRef="shares">97500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIxLTMtMS0xLTA_cd477407-a9d0-4470-b368-75902bb61381"
      unitRef="shares">92300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDAvZnJhZzowZGQ0N2U2OTQxM2Y0NzUwOTA5YjA5MmM0MjE1MWRmNi90YWJsZTo2YmZmZWRmM2Q5OGU0ODk4YmMwNzkyZDdlMWVmOGVjMi90YWJsZXJhbmdlOjZiZmZlZGYzZDk4ZTQ4OThiYzA3OTJkN2UxZWY4ZWMyXzIxLTUtMS0xLTA_1a3ddea5-b0d1-4d16-b9ef-b4f9931cbf26"
      unitRef="shares">88200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzItMi0xLTEtMA_5481ff9d-cde3-4a45-b0e6-02c42d3538a6"
      unitRef="usd">493600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzItNC0xLTEtMA_57a290bc-cf2a-4f78-a8af-bd0b1f7e385d"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzItNi0xLTEtMA_67a7349a-f2d8-4ade-856b-d89b392d4d94"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzQtMi0xLTEtMA_f52eb213-42b0-457d-b911-9f0fb6925b5d"
      unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzQtNC0xLTEtMA_dc9a2d62-774e-49c4-aa43-e5ac9d058022"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzQtNi0xLTEtMA_01d2b0ae-5a60-46c5-8af7-d63445f499de"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzUtMi0xLTEtMA_ca9a6745-dc70-44c7-ac25-2bd05c94b6d2"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzUtNC0xLTEtMA_1e43c056-03af-4c00-a0d5-612184505850"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzUtNi0xLTEtMA_490dca32-b27d-4bba-837c-41a901427ce0"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzYtMi0xLTEtMA_d3344de3-3c58-4533-837d-71f02758560b"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzYtNC0xLTEtMA_dab96daa-1214-4e7e-90be-8b56a93b73d0"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzYtNi0xLTEtMA_fa17ad4d-78c2-4ff0-931b-13ad1622dcda"
      unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzctMi0xLTEtMA_7f856f7b-507f-445d-84fc-889d3bd5b36a"
      unitRef="usd">494500000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzctNC0xLTEtMA_5a5afabf-33d8-4d29-b242-7b2ff1be197d"
      unitRef="usd">101900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDMvZnJhZzoyNWFkNThlZjgwZDQ0ZDcyODY1OWMxODk5ZjBkYTY0OC90YWJsZTpiZjhmOTViMmE4MmM0ZTJiYWY3YzZiZGQyZGRiMGI0ZC90YWJsZXJhbmdlOmJmOGY5NWIyYTgyYzRlMmJhZjdjNmJkZDJkZGIwYjRkXzctNi0xLTEtMA_41566117-c2a6-4073-91e8-8fead81cd575"
      unitRef="usd">-123000000.0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i62ab2abda0de42659a37b9c9f8196c4a_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItMi0xLTEtMA_ead213f5-69ca-4096-983b-de24fa0f7e54"
      unitRef="shares">87000000.0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62ab2abda0de42659a37b9c9f8196c4a_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItNC0xLTEtMA_c74d2f4a-e519-4120-ad0a-4e61fc060540"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7f9f30a2abc40808a41b3885af720d9_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItNi0xLTEtMA_9ce9c918-c20e-4273-ad9f-4b377549ae97"
      unitRef="usd">1093700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a3a2bd79c1246d89a94242e2cd12c96_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItOC0xLTEtMA_53baa695-46d1-4745-82f3-777579c77373"
      unitRef="usd">-2600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d1e7482b0864e9f85af3dff1a4430f1_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItMTAtMS0xLTA_d1a79955-ca9e-4533-a2a0-2bb007ffee65"
      unitRef="usd">-671800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia9fd427acdbc486a9e8edee4ccc7110c_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItMTItMS0xLTA_dc17f7ba-ef2c-4bf2-a26f-2f4ebb978061"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic82615128e2c4fc99ac6cee2560ef199_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzItMTQtMS0xLTA_f04fb938-cddb-4bba-ab90-4aa2b04055b0"
      unitRef="usd">419400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMtMi0xLTEtMA_7a97157d-d9fe-484d-a64d-c358e762287f"
      unitRef="shares">1800000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMtNi0xLTEtMA_4c4aa270-9ba4-4661-ac09-8a990205a11a"
      unitRef="usd">1900000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMtMTQtMS0xLTA_85af78e5-d8c7-4b48-8c47-c05418a528d1"
      unitRef="usd">1900000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzQtMi0xLTEtMA_8761a523-535e-49d2-8a97-a09a59e91478"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzQtNi0xLTEtMA_f1a4b650-4a23-4383-8112-518e7f82f2a6"
      unitRef="usd">8900000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzQtMTQtMS0xLTA_5939cf77-d6d2-4dee-8325-fc4bef05163a"
      unitRef="usd">8900000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzYtMi0xLTEtMjc4NA_61280fec-e849-4cc6-81eb-394edc16eb67"
      unitRef="shares">1800000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzYtNi0xLTEtMjc4NA_5987016a-d263-413f-902a-8b559a18bed6"
      unitRef="usd">217700000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzUtMTQtMS0xLTI4MDM_a435fa97-14d1-44a9-8342-d945823496b9"
      unitRef="usd">217700000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtNi0xLTEtMjMwNw_48acd873-0b9c-47a5-9c67-972868962814"
      unitRef="usd">-218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTQtMS0xLTIzMDc_d6eba7f1-4e94-4bd3-bb59-f4c94d19396f"
      unitRef="usd">-218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtNi0xLTEtMjMzMQ_cf7527c7-ef97-47db-8d81-f9ff0d83ad29"
      unitRef="usd">171600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzctMTQtMS0xLTI4MDM_ed97caa3-1138-4a1c-9e96-a6f113af79e4"
      unitRef="usd">171600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="iebac1f4dcb494387a4335beb06a10a2a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMi0xLTEtMjMxNA_31678846-5dbf-4ce8-b703-c742747b8c1c"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i334065d7da4c4bbd8735b1a9237ca649_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTItMS0xLTIzMTQ_26b70c7c-f695-40b1-9264-c5d1f1631b25"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTQtMS0xLTI4MDM_c5e56f47-7edf-4750-b9f8-d2de675631c3"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzktNi0xLTEtMjMxNw_1d4cba1a-3826-4d25-b779-6bdb948de60a"
      unitRef="usd">183800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzktMTQtMS0xLTI4MDM_ea7c6361-502c-4675-88fb-f980703f27a3"
      unitRef="usd">183800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i716e3afb77fb41d7baf51d975c121fe4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzUtNi0xLTEtMA_a12ec452-2855-4de4-946e-68dc9baf0630"
      unitRef="usd">101900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzUtMTQtMS0xLTA_3303f25a-b358-4f8a-a268-3480aa00d786"
      unitRef="usd">101900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="ifd8fb94803f34b96a82fb0ebc3e1cba8_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTAtMS0xLTA_91d9701e-cbbd-41c1-9ea9-79c773ec6814"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzgtMTQtMS0xLTA_9367c808-e474-4564-a456-299ad6eeea99"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iddc2ad90e3a745f583d12c18ce94e654_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzktOC0xLTEtMA_a4cfd7e6-a614-4b7c-8920-6725d7954823"
      unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzktMTQtMS0xLTA_c652cc9b-349c-4119-ae6e-b371eab63c0c"
      unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ib2c0cbd5c0f241d4985442b984220cf7_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTItMS0xLTA_7a79f2cd-f075-4256-9a62-27135e8f249c"
      unitRef="shares">90000000.0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib2c0cbd5c0f241d4985442b984220cf7_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTQtMS0xLTA_e851ed60-3781-46a5-a4a5-51853e6ed6ca"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4859a89543554757a0237d357c2029c8_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTYtMS0xLTA_cce5376b-7276-4b62-a8a6-d8c1e0f4714a"
      unitRef="usd">1560600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f94c40295974007abccd11273ce6988_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTgtMS0xLTA_f7eda9a0-2d9b-4de3-97d3-0c4b840d4c54"
      unitRef="usd">1500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3afb9980ee644d22897fe66e8e9f3621_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTEwLTEtMS0w_b4099040-b5e5-4317-ada5-fb3d050c04f6"
      unitRef="usd">-798900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc3e8df174cb41c9a8ef16f4487803b8_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTEyLTEtMS0w_e29cc810-94f4-4c17-95db-cd9066322f14"
      unitRef="usd">-100000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEwLTE0LTEtMS0w_ce5f3911-8623-45cf-8254-4f5c75850362"
      unitRef="usd">663300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bb937d881cb42d6a0f935a924001c2f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzExLTEwLTEtMS0w_59f4cbb3-c5fe-4613-b9f3-d59e8b76324c"
      unitRef="usd">2100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84f5c2cc37a5477db6d781d12fe77f0f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzExLTE0LTEtMS0w_c5e80aa3-c401-41a9-8eaa-8ff3208ba0e2"
      unitRef="usd">2100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="ice5479f1e1694af1aafc253e8cf22247_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEyLTItMS0xLTA_843ba749-8339-4669-af68-635abd51376c"
      unitRef="shares">1400000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEyLTYtMS0xLTA_3db5064b-4a22-47f8-9dca-e353e6ff7349"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEyLTE0LTEtMS0w_f91cc5db-fc08-44e3-9178-15e789b930a2"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ice5479f1e1694af1aafc253e8cf22247_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEzLTItMS0xLTA_91d4e3cd-a6c0-499b-a8c3-02649b14ec78"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEzLTYtMS0xLTA_3a825b1d-2b07-4414-ab51-bfe9ad8279f2"
      unitRef="usd">11600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzEzLTE0LTEtMS0w_bc09364a-6351-4c51-aef9-1afdf2e1946c"
      unitRef="usd">11600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt
      contextRef="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE3LTYtMS0xLTIzMzY_fc9b3e72-a497-4b5d-a7e5-981550000777"
      unitRef="usd">-700000</dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE3LTE0LTEtMS0yMzM2_52259af0-72e0-40bd-a117-ad4514e09e35"
      unitRef="usd">-700000</dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1f19096fc4f34174a8547228e2da1701_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE0LTYtMS0xLTA_077b88e3-dc55-4828-af16-bec353ecaff9"
      unitRef="usd">102700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE0LTE0LTEtMS0w_95e11528-6b96-4eb3-a4f2-e8a9a0f78993"
      unitRef="usd">102700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i06733029c370448ba5d57587ce16bda1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE5LTEwLTEtMS0w_03f9804e-6bc6-4a68-9fc8-77270fb0e351"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzE5LTE0LTEtMS0w_9f5c3dfe-97ad-4408-94fd-d019a6bd1b87"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3cc1828a50774882930e3febccea7246_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIwLTgtMS0xLTA_ed5d16ab-e68c-45ac-9cb4-a81f538dee2e"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIwLTE0LTEtMS0w_6863a7f2-f366-4b2e-9036-fa9fe0b91136"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i3962ec3ca47246e5afc8c09df3185349_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTItMS0xLTA_09ec41b9-513f-4014-81ed-07abff1abf45"
      unitRef="shares">91600000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3962ec3ca47246e5afc8c09df3185349_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTQtMS0xLTA_790c8b6b-910b-47d0-9def-9b74746b6311"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib08750c5e7ec4f89a130804838db3915_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTYtMS0xLTA_3cb24c06-7d5d-4858-b124-a55ef34957ac"
      unitRef="usd">1675900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i50619200f7264c2d9ac57a9f7ac26a68_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTgtMS0xLTA_db04d939-6267-4a0d-894a-8d077c07c1b3"
      unitRef="usd">2300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91ff836d4cc04bac915b60eb3b0276b8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTEwLTEtMS0w_86e4d41d-0b57-45c6-9ce7-66d658627fb7"
      unitRef="usd">-695700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53e29bb6e76c4d0abc2e92543b07c60d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTEyLTEtMS0w_b2c280d1-00ce-4906-a758-14ee06b05cac"
      unitRef="usd">-100000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIxLTE0LTEtMS0w_0d767c5b-f086-43e2-a48d-1772494ae2da"
      unitRef="usd">882600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="ie43b7f8664fd4e7fa1c96e2b2325534a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIzLTItMS0xLTA_c2019848-d4c1-4f25-9e01-127267dd2c36"
      unitRef="shares">1100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIzLTYtMS0xLTA_c58ad55e-d058-4c93-a78d-8cf64383ca87"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzIzLTE0LTEtMS0w_bfc65a48-732a-4cc5-9de3-36a3bdb9604d"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI0LTYtMS0xLTA_134cee8b-0c89-4d8f-90af-db4c7c937da4"
      unitRef="usd">15000000.0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI0LTE0LTEtMS0w_07620002-2d31-405c-a8e0-61fd3d328cff"
      unitRef="usd">15000000.0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI5LTYtMS0xLTUwMw_4242fb12-27b9-4efe-80a8-e8a401f2eafa"
      unitRef="usd">289400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI3LTE0LTEtMS0yODA4_5066d701-0dd1-49d4-9985-ea8bc23296e5"
      unitRef="usd">289400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt
      contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTYtMS0xLTk2MzY_92b2018a-dcba-4967-bd99-dda0ca67cae9"
      unitRef="usd">62500000</dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTE0LTEtMS0xMTQ1Nw_c8b99ef5-4fb2-4b39-a067-c97576503c70"
      unitRef="usd">62500000</dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ie43b7f8664fd4e7fa1c96e2b2325534a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTItMS0xLTUwMw_0caf6dc4-57d0-4a86-9a90-c505d1d95aa2"
      unitRef="shares">3400000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTYtMS0xLTUwMw_c80fbfb5-f3ad-43fe-96a5-03fac10c7182"
      unitRef="usd">87800000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTE0LTEtMS0yODE0_3f08e5b8-8ea8-4e3b-b8dc-5ee146da5743"
      unitRef="usd">87800000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i999d507de85644e59daac2a6a6a98654_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMyLTYtMS0xLTIzNDQ_5f753b1f-7538-4916-bc82-1164afc8e673"
      unitRef="usd">119400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMyLTE0LTEtMS0yMzQ0_937bf41f-2744-4205-99c9-b7db12d608df"
      unitRef="usd">119400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i3c875e94a27c489ca8dbc61fe476e69f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI3LTEwLTEtMS0w_78736f7f-9dee-4fd9-aead-0942300c70bb"
      unitRef="usd">493600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI3LTE0LTEtMS0w_adb975c6-08ab-48ca-81d2-7a5d7a35ba4c"
      unitRef="usd">493600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8815ef6d44b14de195293c0935f6df41_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTgtMS0xLTA_b09fca61-9cf1-4ec9-9e83-9a5a89838b0c"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzI4LTE0LTEtMS0w_568b02c4-6ba0-492a-b2c2-1c0e8bfd362f"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="idf189edb39e14e54937ee10b5be44dd1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTItMS0xLTA_970167a5-ae2e-46c5-9477-6d54068eeb81"
      unitRef="shares">96100000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idf189edb39e14e54937ee10b5be44dd1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTQtMS0xLTA_fbc0123f-18b8-4bfa-a4e0-abc29cc0d42c"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2202fad57c63453e9b1b404a15b6e82d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTYtMS0xLTA_299e8f5d-c301-4dac-b858-bef931a2df27"
      unitRef="usd">2125300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3351b0dd70c24b04bc98a96abb444375_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTgtMS0xLTA_eb69f7da-8c35-4354-8b0d-12c395ee1882"
      unitRef="usd">3200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0eec6c3ccfc41bebe1fab61a4e0fc10_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTEwLTEtMS0w_b8389f2f-ac2a-48ed-9b92-0a0336343a4a"
      unitRef="usd">-202100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i341885eacad94bbc9b111e97938ab5d5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTEyLTEtMS0w_6a944a29-3f0d-4ba9-b313-ee518bd9d8fe"
      unitRef="usd">-100000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDYvZnJhZzozZTg4NzI3ZTUxYzQ0OTE1OGM1MTc2OWNmNTQ2YTE0My90YWJsZTo0ZWRjNzIwMDNhNjE0N2QwOWQ4NGIwMmJlZTgyOWMyNC90YWJsZXJhbmdlOjRlZGM3MjAwM2E2MTQ3ZDA5ZDg0YjAyYmVlODI5YzI0XzMwLTE0LTEtMS0w_b896952f-e99e-473b-941b-f6b0e763aaaa"
      unitRef="usd">1826500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMtMS0xLTEtMA_5ee92b64-9048-4a85-af05-e11110c40332"
      unitRef="usd">493600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMtMy0xLTEtMA_d1578184-b21b-4cd2-b6bb-200736ab60f7"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMtNS0xLTEtMA_901ec72f-150b-4230-a539-3038e2562d27"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUtMS0xLTEtMA_73b0b4ef-f4bf-4da7-b21b-88cee96ca7ec"
      unitRef="usd">67100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUtMy0xLTEtMA_4b59aee6-08f9-4921-bd8b-29570aabf0dc"
      unitRef="usd">48700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUtNS0xLTEtMA_fb39ce01-3921-4361-8e5b-0b751e4624f0"
      unitRef="usd">29100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzYtMS0xLTEtMA_825e99fb-ddee-4946-b3cd-9c643a63e138"
      unitRef="usd">119400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzYtMy0xLTEtMA_37fe073f-bfc3-4fe1-826a-9271d47cf099"
      unitRef="usd">102700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzYtNS0xLTEtMA_8d15e547-83e9-4441-b4ab-717399d2f566"
      unitRef="usd">101900000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctMS0xLTEtNDE4Nw_a0113f84-06e8-490d-8099-e0e39442b57b"
      unitRef="usd">-5900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctMy0xLTEtNDE4Nw_dc854b0b-b4ba-4021-b0a3-a5587b99056c"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctNS0xLTEtNDE5MQ_849413d8-1a98-48bc-b135-1de976dfae7e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:PaidInKindInterest
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctMS0xLTEtMA_c903f773-8e11-4ad9-8809-782e05c13116"
      unitRef="usd">74000000.0</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctMy0xLTEtMA_8c33c3ae-8612-44ca-855d-a9947f2fa453"
      unitRef="usd">49600000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzctNS0xLTEtMA_aa7af08e-7704-422c-a6f0-5b3170acc742"
      unitRef="usd">17900000</us-gaap:PaidInKindInterest>
    <dxcm:RDexpensethroughissuanceofcommonstock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzgtMS0xLTEtMA_0f9f02e0-4796-4c1e-a9be-c90d7e6cbafc"
      unitRef="usd">0</dxcm:RDexpensethroughissuanceofcommonstock>
    <dxcm:RDexpensethroughissuanceofcommonstock
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzgtMy0xLTEtMA_cd1f597a-b400-448b-b680-0fa1d8c13be9"
      unitRef="usd">0</dxcm:RDexpensethroughissuanceofcommonstock>
    <dxcm:RDexpensethroughissuanceofcommonstock
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzgtNS0xLTEtMA_7aa930e2-3d1e-4acf-9e18-afb1f972dc9d"
      unitRef="usd">217700000</dxcm:RDexpensethroughissuanceofcommonstock>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzktMS0xLTEtMA_e03bb84e-ba95-4fc6-b638-5202386b9820"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzktMy0xLTEtMA_73314d28-581e-477f-8d83-33df8b3e98a5"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzktNS0xLTEtMA_8a99e0ad-1092-4361-86c3-9fe5fce43625"
      unitRef="usd">36000000.0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEwLTEtMS0xLTA_61552e1f-288c-4c10-b3e6-b47ee3949ccb"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEwLTMtMS0xLTA_2822c764-0f7f-487a-a4f7-928cee09295b"
      unitRef="usd">-4200000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEwLTUtMS0xLTA_5c64aabd-b56b-49ee-a19c-6444e3528236"
      unitRef="usd">44100000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEyLTEtMS0xLTYxMDM_f1d43e78-8905-4ae7-8469-a6ac0a1a7e5e"
      unitRef="usd">-277300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEyLTMtMS0xLTYxMTI_037a0944-f5c7-4c5c-a54b-6a0c1b05b530"
      unitRef="usd">200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEyLTUtMS0xLTYxMDk_52b7a52d-7111-4434-93d2-2c19515a7ea9"
      unitRef="usd">-2200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzExLTEtMS0xLTA_bbf42f26-dad3-466f-8849-6bb0a5e5b139"
      unitRef="usd">-13700000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzExLTMtMS0xLTA_ab278c1b-4ecb-44ce-8b13-b63ffffcd293"
      unitRef="usd">-1900000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzExLTUtMS0xLTA_fc1b5765-9e7c-4f90-be6f-593e0f413b66"
      unitRef="usd">-6900000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEzLTEtMS0xLTA_e64b71ac-50d1-40ee-982a-9add486975e3"
      unitRef="usd">142300000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEzLTMtMS0xLTA_d21d5c35-6dc7-4709-b979-3f09f5f5b139"
      unitRef="usd">60000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzEzLTUtMS0xLTA_97eef0e9-08f6-4488-8aed-1458b3afc1c4"
      unitRef="usd">93200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE0LTEtMS0xLTA_db63a577-59fa-494a-84b5-bdd969cbe661"
      unitRef="usd">114500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE0LTMtMS0xLTA_f7bcd096-d16a-4a74-9b9a-5a84c4ea4144"
      unitRef="usd">49100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE0LTUtMS0xLTA_f5424f1e-3b3c-4fa4-b40e-39e1150e2408"
      unitRef="usd">25500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE1LTEtMS0xLTA_1ab2bb01-631f-44b9-a16b-1d721600c1c5"
      unitRef="usd">2400000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE1LTMtMS0xLTA_7bdf2ef2-afa3-4bae-ae1c-44a7fbb4387f"
      unitRef="usd">7200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE1LTUtMS0xLTA_a725a9ad-dd99-43c3-9cd5-e4ddc267fa27"
      unitRef="usd">3000000.0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE2LTEtMS0xLTA_7436e107-27f2-4ccb-9a99-8d360f690314"
      unitRef="usd">800000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE2LTMtMS0xLTA_0d2cb3ba-9b42-43c1-91d8-e805a3d191f2"
      unitRef="usd">2400000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE2LTUtMS0xLTA_b8558b3d-b5b2-4c35-a034-26bcddfbec35"
      unitRef="usd">0</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE3LTEtMS0xLTA_5e4e45ff-a627-4b42-b3be-15175f633ea1"
      unitRef="usd">194500000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE3LTMtMS0xLTA_55f56836-457c-47da-821a-c0e5c806fdf6"
      unitRef="usd">109000000.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE3LTUtMS0xLTA_4e4e91b2-2cd7-4f45-a901-969592c2cb58"
      unitRef="usd">56200000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE4LTEtMS0xLTA_00a16996-9066-4c12-9270-e587b73a9cf3"
      unitRef="usd">26100000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE4LTMtMS0xLTA_ea6ecbc6-5b16-4210-85f6-41ca1c2b5428"
      unitRef="usd">16000000.0</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE4LTUtMS0xLTA_e3fff31d-12fd-4f9f-99ce-03a40cc19f9d"
      unitRef="usd">23800000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE5LTEtMS0xLTA_9da21157-1340-414c-91fa-e3c19d080cbd"
      unitRef="usd">18600000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE5LTMtMS0xLTA_2b6aca8f-18d0-4274-a49a-59fcfd41333b"
      unitRef="usd">-200000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzE5LTUtMS0xLTA_fd6b2cb6-4429-4ee0-942b-dc419d636a1a"
      unitRef="usd">800000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIwLTEtMS0xLTA_abea792f-71a6-4d64-9d89-9ed1b62ca560"
      unitRef="usd">475600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIwLTMtMS0xLTA_25eaeada-bd52-4f20-8f30-6813a2731514"
      unitRef="usd">314500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIwLTUtMS0xLTA_71233f87-7e54-477c-9ea4-417ecd38cc97"
      unitRef="usd">123200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIyLTEtMS0xLTA_1b3c771e-e109-444d-baa3-2144b9ea092b"
      unitRef="usd">3058200000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIyLTMtMS0xLTA_dab3dbd9-7c6c-4bbf-8398-398d96262136"
      unitRef="usd">2030400000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIyLTUtMS0xLTA_c5686cc7-3c27-4898-9fb8-c60c7de97a0b"
      unitRef="usd">452500000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIzLTEtMS0xLTA_73b9e8d7-1672-4088-928b-3e354c90f04e"
      unitRef="usd">2250500000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIzLTMtMS0xLTA_63852484-662e-4591-87d9-0c2270c8c9f9"
      unitRef="usd">1196400000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzIzLTUtMS0xLTA_8d1c34ce-78ca-4dd8-841d-bb03c46d4dfb"
      unitRef="usd">392100000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI1LTEtMS0xLTA_6cf6c2e1-788b-49c2-a568-201d1cf868e6"
      unitRef="usd">199000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI1LTMtMS0xLTA_978cea10-b016-4b93-9548-95a1dcf39dab"
      unitRef="usd">180000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI1LTUtMS0xLTA_ff2e3f7c-7fd5-42f3-a34f-ed58e0709382"
      unitRef="usd">67100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI2LTEtMS0xLTA_c45333a5-b5d8-4d1f-bea6-296683d99ab0"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI2LTMtMS0xLTA_0ce3ae79-5a1b-4b09-b664-2694f6e27d0a"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI2LTUtMS0xLTA_ebe11e2f-19fc-41a1-84d1-30dfe13795c8"
      unitRef="usd">11300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI4LTEtMS0xLTQyNzM_38ad8322-9d68-4b04-8b6f-84876f32cf54"
      unitRef="usd">11300000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI4LTMtMS0xLTQyNzY_c84526de-1ec5-4189-863c-d21cea353611"
      unitRef="usd">1200000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI4LTUtMS0xLTQyODM_2e726c77-cd25-4216-9a9d-298f9c23fa1a"
      unitRef="usd">1000000.0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI3LTEtMS0xLTA_bd2afbad-2b41-41b1-b710-f31b222339c8"
      unitRef="usd">-1018000000.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI3LTMtMS0xLTA_da74396e-575a-4b05-aa90-ae98ac133b97"
      unitRef="usd">-1015200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI3LTUtMS0xLTA_e231d0cd-1f5a-4803-aefc-23aa50731cbc"
      unitRef="usd">-139800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI5LTEtMS0xLTA_fc286bab-5972-41f1-add3-2b544390e591"
      unitRef="usd">15300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI5LTMtMS0xLTA_1fc1171e-86f6-4252-8a28-ab85af74c18c"
      unitRef="usd">11900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzI5LTUtMS0xLTA_2dc3f90a-71ec-40f0-970d-d9b8b0ebc599"
      unitRef="usd">10800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMwLTEtMS0xLTA_a30a6d06-9a12-41be-bf02-a82b1638b582"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMwLTMtMS0xLTA_a0c8a745-8ad5-47d8-b618-99bf2a973dd8"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMwLTUtMS0xLTA_dfa9b62b-b4fc-4e48-8c37-7237a0bcbc83"
      unitRef="usd">100000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMxLTEtMS0xLTA_22897998-c601-4fe2-8851-c56d27f2cf34"
      unitRef="usd">1188800000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMxLTMtMS0xLTA_075d39fc-653c-4ae8-9b91-6c3a50fae273"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMxLTUtMS0xLTA_08ea566c-dc56-420b-863a-bcac8cf30ea4"
      unitRef="usd">836600000</us-gaap:ProceedsFromConvertibleDebt>
    <dxcm:PaymentsForRepurchaseOfConvertibleNotes
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTEtMS0xLTIxOTk_018ba9ac-2ac2-4dd1-b1b4-8f6ee1f68c47"
      unitRef="usd">282600000</dxcm:PaymentsForRepurchaseOfConvertibleNotes>
    <dxcm:PaymentsForRepurchaseOfConvertibleNotes
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTMtMS0xLTIxOTk_e42f33ef-8c2b-44aa-a9dd-8cabda4d1907"
      unitRef="usd">0</dxcm:PaymentsForRepurchaseOfConvertibleNotes>
    <dxcm:PaymentsForRepurchaseOfConvertibleNotes
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTUtMS0xLTIyMDM_a16c7bca-6ab6-4ae9-af0f-7830bae058e3"
      unitRef="usd">0</dxcm:PaymentsForRepurchaseOfConvertibleNotes>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMyLTEtMS0xLTA_64edb5ff-2bcc-4fa8-be1e-d1f7a43a0eb7"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMyLTMtMS0xLTA_3875e900-2810-49cb-a728-2f5c422df8b1"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMyLTUtMS0xLTA_28aef87a-6d68-48bb-bbab-e9659f9a00e5"
      unitRef="usd">183800000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <dxcm:PurchaseofConvertibleNoteHedge
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTEtMS0xLTA_9b09089a-c168-4568-af6b-61cd6b48b931"
      unitRef="usd">0</dxcm:PurchaseofConvertibleNoteHedge>
    <dxcm:PurchaseofConvertibleNoteHedge
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTMtMS0xLTA_e82c34e9-282d-4d3c-afab-d216dd63e945"
      unitRef="usd">0</dxcm:PurchaseofConvertibleNoteHedge>
    <dxcm:PurchaseofConvertibleNoteHedge
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzMzLTUtMS0xLTA_b8dc230d-2dd8-4ba0-83e1-f15179f55aaf"
      unitRef="usd">218900000</dxcm:PurchaseofConvertibleNoteHedge>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM2LTEtMS0xLTA_43d3d527-fbf9-47ac-abb7-ae013984376b"
      unitRef="usd">-9400000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM2LTMtMS0xLTA_861cb12a-bb60-4f95-a58a-a098a6aa6b27"
      unitRef="usd">-1200000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM2LTUtMS0xLTA_43c3f7e0-6b39-41a8-b9ae-39beda36c285"
      unitRef="usd">-1900000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM3LTEtMS0xLTA_2744fac7-db9a-4a55-a433-0b044207a970"
      unitRef="usd">912100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM3LTMtMS0xLTA_fca7b59d-4250-42c0-b829-3e9af6ee070e"
      unitRef="usd">10700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM3LTUtMS0xLTA_e7cd552f-f597-4cdc-b3d2-30377fabb061"
      unitRef="usd">710400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM4LTEtMS0xLTA_c580c996-d5ad-4d27-9721-28586b239e5f"
      unitRef="usd">2100000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM4LTMtMS0xLTA_500f95a5-a42b-4e84-8a9f-214117443929"
      unitRef="usd">-700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM4LTUtMS0xLTA_c885d577-337b-46f1-978b-3c23d5899aac"
      unitRef="usd">1800000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM5LTEtMS0xLTA_46203753-424a-4010-b835-ed2ba10bd885"
      unitRef="usd">371800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM5LTMtMS0xLTA_7fedd049-21e7-4f83-859a-6da4c28d9445"
      unitRef="usd">-690700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzM5LTUtMS0xLTA_32fbd5ff-3968-41e5-ac3e-c1e513d5f343"
      unitRef="usd">695600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQwLTEtMS0xLTA_cfcfe3b4-7641-4c17-b161-494e557e35da"
      unitRef="usd">446400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQwLTMtMS0xLTA_c861950e-9874-4a48-850a-3921957c56b7"
      unitRef="usd">1137100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic82615128e2c4fc99ac6cee2560ef199_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQwLTUtMS0xLTA_245e004f-e02d-4063-aa14-79ad5337bfa2"
      unitRef="usd">441500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQxLTEtMS0xLTA_f62e469f-2407-43b6-b6ba-dcac379d0c80"
      unitRef="usd">818200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQxLTMtMS0xLTA_7ad69ad0-4215-49ad-969f-25d7880e29c6"
      unitRef="usd">446400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQxLTUtMS0xLTA_cf722d74-ac4d-4698-aebf-4b329894ea97"
      unitRef="usd">1137100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ0LTEtMS0xLTA_d9f26a4c-0efc-4057-a6b4-55174ad43a6f"
      unitRef="usd">817600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ0LTMtMS0xLTA_8a36c6c3-b19b-43cd-ab7f-9f2b7df3dd3c"
      unitRef="usd">446200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ0LTUtMS0xLTA_83b86683-c4ce-41cb-8445-053b1e339106"
      unitRef="usd">1137000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ1LTEtMS0xLTA_84fbb5f8-3c97-4b89-bc14-6a8f071d3796"
      unitRef="usd">600000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ1LTMtMS0xLTA_0a038a9f-bddc-4df9-83bc-3593d5c9da08"
      unitRef="usd">200000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ1LTUtMS0xLTA_3c8da507-73f1-4dd7-b643-d1bb6847af3a"
      unitRef="usd">100000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ2LTEtMS0xLTA_dd83098a-795c-4daf-8d61-66fcb91cd798"
      unitRef="usd">818200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ2LTMtMS0xLTA_35fd2ab3-9c99-425e-ba2d-2c1fea9c6029"
      unitRef="usd">446400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzQ2LTUtMS0xLTA_d65fba0f-d480-45ba-8505-b6eb7f69c892"
      unitRef="usd">1137100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUyLTEtMS0xLTc4ODA_dab5114d-6406-4f4e-9830-383de325451a"
      unitRef="usd">1350900000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUyLTMtMS0xLTc4ODE_b87ca912-fcc5-449d-9415-e53c46a96e9f"
      unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUyLTUtMS0xLTc4ODM_94ec3930-4cf2-4d2e-88ae-01cddf5bd1c4"
      unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUxLTEtMS0xLTA_777d91f1-e94a-4a68-a2de-aae00e970352"
      unitRef="usd">35300000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUxLTMtMS0xLTA_19fa6918-e909-474c-b474-cf4099543d82"
      unitRef="usd">14200000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUxLTUtMS0xLTA_1f760aae-b3d2-4a0d-8d08-f95aec65abb3"
      unitRef="usd">10800000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:InterestPaidNet
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUzLTEtMS0xLTA_97bcb3b9-2936-4917-a74a-e79af3cfa156"
      unitRef="usd">10600000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUzLTMtMS0xLTA_942766fb-d27f-4b70-8982-5c91614c491a"
      unitRef="usd">10400000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzUzLTUtMS0xLTA_6cd73cf8-416c-4246-b099-ba419b24e517"
      unitRef="usd">3600000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzU0LTEtMS0xLTA_b0e1db97-94bc-4b6e-a56e-cf1ca7505139"
      unitRef="usd">3600000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzU0LTMtMS0xLTA_8ef98895-5440-47de-a4e3-e2e33367ad77"
      unitRef="usd">4800000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMDkvZnJhZzo4YjE0YTE1ZWRlN2Q0ZDZmOTkzMTQ1MDFhYzFiYzE3OS90YWJsZTphNTAyMTAwYmJmYmI0ZWUzODdmZDc4ZGQ0NTg0ZmM3MS90YWJsZXJhbmdlOmE1MDIxMDBiYmZiYjRlZTM4N2ZkNzhkZDQ1ODRmYzcxXzU0LTUtMS0xLTA_912f57da-27e7-479a-b654-81be2686efcb"
      unitRef="usd">2300000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzExNTQ0ODcyMTMzNzYw_59064810-17b9-469c-8ec4-d3d9b7a22d2f">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1. Organization and Significant Accounting Policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Organization and Business&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DexCom, Inc. is a medical device company that develops and markets continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; the &#x201c;company,&#x201d; or &#x201c;Dexcom&#x201d; refer to DexCom, Inc. and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income (loss) and in accumulated other comprehensive income in the equity section of our consolidated balance sheets. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in interest and other income, net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Use of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#x201c;Fair Value Measurements.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#x2019; equity in our consolidated balance sheets and included in comprehensive income (loss). Realized gains and losses on marketable debt securities are included in interest and other income, net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. See Note 3, &#x201c;Fair Value Measurements&#x201d; and Note 4, &#x201c;Balance Sheet Details &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; for more information on our marketable debt securities and our marketable equity securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are generally recorded at the invoiced amount for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Concentration of Credit Risk and Significant Customers&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally three years for computer software and hardware, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE3MDQyNDMwMjk0NDM5_2fca5438-1d1d-4e75-bbcb-835f55e20811"&gt;four&lt;/span&gt; to fifteen years for machinery and equipment, and five years for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or forty years. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#x2019;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#x2019;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#x2019;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#x2019;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#x2019;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#x2019;s market capitalization as a part of our analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#x2019;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded no goodwill impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in goodwill for the twelve months ended December&#160;31, 2020 and December 31, 2019 consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the twelve months ended December 31, 2018 consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are included in other assets in our consolidated balance sheets. We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE0MDk5_34699fb7-9374-4f8a-8afb-b91db71681d7"&gt;two&lt;/span&gt; to seven years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. We recorded no intangible asset impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our US operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years cumulative income and expect to continue that profitability in future years. We analyzed both positive and negative evidence, and as a result released our valuation allowance on our deferred tax assets. We maintain the valuation allowance on our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Warranty Accrual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Loss Contingencies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of two elements, net income (loss) and other comprehensive income. We report all components of comprehensive income (loss), including net income (loss), in our financial statements in the period in which they are recognized. Total comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income (loss) and the components of other comprehensive income, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Revenue Recognition&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate our revenue from the sale of our reusable transmitter and receiver, collectively referred to as Reusable Hardware, and disposable sensors. We refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining how revenue should be recognized, a five-step process is used which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Policy Elections and Practical Expedients Taken&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracts and Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our Dexcom Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transaction Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes but is not limited to rebates, chargebacks, consideration payable to customers such as specialty distributor and wholesaler fees, product returns provision, prompt payment discounts, and various other promotional or incentive arrangements. We classify our provisions related to variable consideration &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as a reduction of accounts receivable when we are not required to make a payment or as a liability when we are required to make a payment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rebates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate provisions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chargebacks &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate provisions for chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consideration Payable to the Customer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We pay administrative and service fees to certain of our distributors based on a fixed percentage of the product price. These fees are not in exchange for a distinct good or service and therefore are recognized as a reduction of the transaction price. We accrue for these fees based on actual net sales and contractual fee rates negotiated with the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#x201c;30-day money back guarantee&#x201d; program whereby first-time end-user customers may return Reusable Hardware. We estimate our product returns provision principally based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prompt Payment Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide customers with prompt payment discounts which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discount accruals based on actual net sales and contractual discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Various Other Promotional or Incentive Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other promotional or incentive arrangements are periodically offered to customers, including but not limited to co-payment assistance we provide to patients with commercial insurance, promotional programs related to the launch of products or other targeted promotions. We record a provision for the incentive earned based on the number of estimated claims and our estimate of the cost per claim related to product sales that we have recognized as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain sales transactions, control transfers at delivery of the product to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related Reusable Hardware component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our sales of Components include an assurance-type warranty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of December&#160;31, 2020 included unbilled accounts receivable of $10.4 million. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally satisfied within 12 months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after 12 months was $8.2 million as of December 31, 2020 and $2.1 million as of December 31, 2019. These balances are included in other long-term liabilities in our consolidated balance sheets. Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Incentive Compensation Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI0MTYy_26f15051-f810-463e-bb6f-d6109b4adecc"&gt;one&lt;/span&gt; year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Shipment Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Research and Development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Advertising Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses. Advertising expense was $76.5 million, $33.1 million and $24.0 million for the twelve months ended December&#160;31, 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value time-based Restricted Stock Units or RSUs at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable from stock options, restricted stock units, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of stock options and restricted stock units and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income (loss) per share for the periods shown.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding anti-dilutive securities not included in the diluted net income (loss) per share attributable to common stockholders calculations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. Our adoption of ASU 2016-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. In addition, the outbreak of the novel strain of coronavirus, SARS-CoV-2 (&#x201c;COVID-19&#x201d;), has not had a significant impact on our expected credit losses or our consolidated financial statements during 2020. We are continuing to monitor the impact of COVID-19 on expected credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, the FASB issued ASU No. 2017-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-04)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#x2019;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Our adoption of ASU 2017-04 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;Our adoption of ASU 2018-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software: Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (ASU 2018-15)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This new guidance requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We adopted the new standard on January 1, 2020 on a prospective basis. Our adoption of ASU 2018-15 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently evaluating the impact that this guidance will have on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06, &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This new guidance is intended to reduce the complexity of accounting for convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation and requires enhanced disclosures about the terms of convertible instruments. Entities may adopt ASU 2020-06 using either a partial retrospective or fully retrospective method of transition. This &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU is effective for public business entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently evaluating the impact that this guidance will have on our consolidated financial statements.&lt;/span&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjA1_482fa93c-61af-4155-bad9-a62de0caec23">&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income (loss) and in accumulated other comprehensive income in the equity section of our consolidated balance sheets. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in interest and other income, net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTI4_b9fd6df0-a599-4f61-8269-251d666d9731">&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income (loss) and in accumulated other comprehensive income in the equity section of our consolidated balance sheets. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in interest and other income, net in our consolidated statements of operations</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDcw_74867536-2eea-4ecf-b8dc-d2c934eed634">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Use of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDc2_bfb38e88-b36b-4c2b-a81a-99e6489ea9d7">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#x201c;Fair Value Measurements.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTU2_bd702221-5d1f-4520-89b5-eec3fd0baac5">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzQxNjU_329360f7-bb0f-4fc7-b1c6-516696ccac17">P90D</dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjIz_fa476d1f-3d05-4f4a-8a12-71a6c99a8b5e">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#x2019; equity in our consolidated balance sheets and included in comprehensive income (loss). Realized gains and losses on marketable debt securities are included in interest and other income, net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTQz_963e05b4-4c0e-490e-a6d7-9e96560f38b5">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are generally recorded at the invoiced amount for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDY3_d30bf48b-9ef4-495a-a89a-0f0a6a5c29fc">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Concentration of Credit Risk and Significant Customers&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTA3_d1150cbe-7868-4e24-8768-a4ad14aee936">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Less than 10%&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic9cff1bc2dac48ea90553b980fd2c925_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtMS0xLTEtMA_12545b3f-b61d-43e8-89ed-889594e7a0d2"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i96dbf53aa4aa48419562b1d395e1f854_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtMy0xLTEtMA_68c5a54c-3519-479d-b2b4-1dc5e6dd14ac"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icaed968ca04841ac838a9395b4ddde38_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtNS0xLTEtMA_29eec3f8-4a18-4063-b092-73b90ed568ea"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iadc9086aefb444be9c59339767825b54_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtNy0xLTEtMA_4f20448a-aa36-448a-b1a5-df1b911ad6bc"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1042cfd24eb042868d75c1ab948d9274_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzMtOS0xLTEtMA_a9bea1d2-81b8-451b-b355-65e47dec05c2"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2e33652311eb4e57bd6bfd8727b45672_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzQtMS0xLTEtMA_453d80eb-b8b1-45eb-867a-a149d97f54d7"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9910d7cdf82d4d41af4edfbba713867d_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzQtMy0xLTEtMA_756d9b57-a0b0-4811-8341-ffad05fa3660"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib53ea3ab72fb4434808baeb3dbdd3757_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzQtNS0xLTEtMA_da0452fc-fb9a-47ed-82ea-af919a20c240"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib6bcd786fb0b4ea9b8f9951d9cf922c9_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzQtNy0xLTEtMA_f6b786a9-d6f0-41e3-87f1-a18635fb4b43"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i51c0e602241341029dd0c585c07f2640_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzUtMS0xLTEtMA_64769daf-a356-45de-b45d-5851529cc98c"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2e8e542173bc421a8ea7fcba19440c37_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzUtMy0xLTEtMA_3849168f-892c-4236-9210-4329fba8111f"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idddb7ec6794e442290c8762383c2f014_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzUtNy0xLTEtMA_8a7ca4fb-4153-4f68-b0d3-9ce15c7890c3"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2b3da214a5bd4cd99d307ec8fba40242_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo4ZWRmYjIxNWZlYmU0YTM5OGMzNTIyZWFiMzQ3OTgyYi90YWJsZXJhbmdlOjhlZGZiMjE1ZmViZTRhMzk4YzM1MjJlYWIzNDc5ODJiXzYtMS0xLTEtMTE5OQ_b92bce76-d812-4e9a-a0ca-10d9da8df4fa"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDMy_ba6a0a99-083f-486c-a7f5-94c5426f8a8e">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.&lt;/span&gt;&lt;/div&gt;Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDg2_11a525b7-fb95-40a9-8f9b-4d55dd08d4d0">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally three years for computer software and hardware, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE3MDQyNDMwMjk0NDM5_2fca5438-1d1d-4e75-bbcb-835f55e20811"&gt;four&lt;/span&gt; to fifteen years for machinery and equipment, and five years for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or forty years. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0a50a7ab68a24d07a8592dacb3cb2ed5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzg3MDY_faa763c2-f947-43dd-ae5d-4e4a1051655a">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i937ac9769efb417fa531b7ef2eaf0b5b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzg3NTM_571d3b94-9af9-49be-82eb-29892664d919">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5136399a37e14cb998f33ad3100276b8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzg3ODk_82001563-6764-4ff6-b4f0-2abdea54356a">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie05ee9ac1ff14752904b83c729c90efe_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE3MDQyNDMwMjk0NDI4_a64f6aa2-4858-4069-89f0-261f8e910103">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTg3_9e506438-dfc3-4066-b52b-f8d412207031">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#x2019;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#x2019;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#x2019;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#x2019;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#x2019;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#x2019;s market capitalization as a part of our analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#x2019;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded no goodwill impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in goodwill for the twelve months ended December&#160;31, 2020 and December 31, 2019 consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the twelve months ended December 31, 2018 consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are included in other assets in our consolidated balance sheets. We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE0MDk5_34699fb7-9374-4f8a-8afb-b91db71681d7"&gt;two&lt;/span&gt; to seven years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. We recorded no intangible asset impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzEzNDgy_1705bdaf-9d87-4d96-b1fc-5afb43a02269"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzEzNDgy_587c299e-905a-46f4-9086-3ea368a8a1e9"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzEzNDgy_7267c085-e9f2-4568-ad60-b505c824dffb"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibbb84a4a26f3410fb9ecbca78f99e413_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE0MTA1_15dfcdf7-bb98-476b-a93b-d94b28e866bc">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDk0_97e5d9e9-73f3-44c6-a1a8-c066cd311956">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our US operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years cumulative income and expect to continue that profitability in future years. We analyzed both positive and negative evidence, and as a result released our valuation allowance on our deferred tax assets. We maintain the valuation allowance on our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/div&gt;We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjE1_a21f6721-6cc7-4ef6-834f-db8dfc8a55ea">&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Warranty Accrual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDI5_5cdf27b4-1e0c-4c22-8750-0a94d463bdd2">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Loss Contingencies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjAx_ef8e6c3b-dc4d-4790-8ade-b37d4951770c">&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of two elements, net income (loss) and other comprehensive income. We report all components of comprehensive income (loss), including net income (loss), in our financial statements in the period in which they are recognized. Total comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income (loss) and the components of other comprehensive income, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDY0_b7430e99-da44-4251-a093-e05578538481">&lt;div style="margin-bottom:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Revenue Recognition&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate our revenue from the sale of our reusable transmitter and receiver, collectively referred to as Reusable Hardware, and disposable sensors. We refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining how revenue should be recognized, a five-step process is used which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Policy Elections and Practical Expedients Taken&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracts and Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our Dexcom Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transaction Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes but is not limited to rebates, chargebacks, consideration payable to customers such as specialty distributor and wholesaler fees, product returns provision, prompt payment discounts, and various other promotional or incentive arrangements. We classify our provisions related to variable consideration &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as a reduction of accounts receivable when we are not required to make a payment or as a liability when we are required to make a payment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rebates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate provisions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chargebacks &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate provisions for chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consideration Payable to the Customer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We pay administrative and service fees to certain of our distributors based on a fixed percentage of the product price. These fees are not in exchange for a distinct good or service and therefore are recognized as a reduction of the transaction price. We accrue for these fees based on actual net sales and contractual fee rates negotiated with the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#x201c;30-day money back guarantee&#x201d; program whereby first-time end-user customers may return Reusable Hardware. We estimate our product returns provision principally based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prompt Payment Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide customers with prompt payment discounts which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discount accruals based on actual net sales and contractual discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Various Other Promotional or Incentive Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other promotional or incentive arrangements are periodically offered to customers, including but not limited to co-payment assistance we provide to patients with commercial insurance, promotional programs related to the launch of products or other targeted promotions. We record a provision for the incentive earned based on the number of estimated claims and our estimate of the cost per claim related to product sales that we have recognized as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain sales transactions, control transfers at delivery of the product to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related Reusable Hardware component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our sales of Components include an assurance-type warranty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of December&#160;31, 2020 included unbilled accounts receivable of $10.4 million. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally satisfied within 12 months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after 12 months was $8.2 million as of December 31, 2020 and $2.1 million as of December 31, 2019. These balances are included in other long-term liabilities in our consolidated balance sheets. Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Incentive Compensation Costs&lt;/span&gt;&lt;/div&gt;We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI0MTYy_26f15051-f810-463e-bb6f-d6109b4adecc"&gt;one&lt;/span&gt; year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <dxcm:RevenueRecognitionSalesReturnsCoveragePeriod
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzIwNjAw_9435f26a-3d07-4097-bb5a-a0d9efdfc7ae">P30D</dxcm:RevenueRecognitionSalesReturnsCoveragePeriod>
    <dxcm:ContractPaymentTermsNumberofDays
      contextRef="i25599498524d40f9acb652bfbaa12e50_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzIyNjA2_cd00d82e-1dac-4c59-9067-cd54a6e87ec1">P30D</dxcm:ContractPaymentTermsNumberofDays>
    <dxcm:ContractPaymentTermsNumberofDays
      contextRef="ibbb84a4a26f3410fb9ecbca78f99e413_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzIyNjEy_a7ac51f1-a86d-48ba-b0ec-63dbaee0e70f">P90D</dxcm:ContractPaymentTermsNumberofDays>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzIyNjky_69bb966e-45e7-457e-ba01-9780deecccc0"
      unitRef="usd">10400000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE2NDkyNjc0NDc0OTg3_61c95047-fd29-4f39-a049-3f441ace4dad"
      unitRef="usd">8200000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE2NDkyNjc0NDc0OTk1_4c533bfb-63c0-45f6-8c56-a0d2e8dbc211"
      unitRef="usd">2100000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <dxcm:ProductShipmentCostsPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjIw_d35be888-ed8c-431e-8309-2747f3ee0a59">&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Shipment Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.&lt;/span&gt;&lt;/div&gt;</dxcm:ProductShipmentCostsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjI4_15e81964-09d2-4e3c-809b-b5bc95799804">&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Research and Development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.&lt;/span&gt;&lt;/div&gt;Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDM5_a5a38808-2e41-401b-ba7a-cb3b026d9230">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Advertising Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI1ODQz_7b84c1c9-1830-4546-88a0-400c6882c366"
      unitRef="usd">76500000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI1ODQ3_1802488a-8981-4cb2-ab05-2478a2a5befa"
      unitRef="usd">33100000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI1ODU0_e91b3e5c-060a-4384-893f-0bd169576905"
      unitRef="usd">24000000.0</us-gaap:AdvertisingExpense>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MDg4_0b9c5b0e-a8b1-47d4-bd0f-895c98eba9d8">&lt;div style="margin-bottom:11pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjM2_19cf9e31-2209-4d44-bf56-fc98af6da962">&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value time-based Restricted Stock Units or RSUs at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.&lt;/span&gt;&lt;/div&gt;We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjI0_e9ba7db4-6c74-424e-884f-1052aa279517">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable from stock options, restricted stock units, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of stock options and restricted stock units and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MjI1_154d3e24-a96e-4c27-b28c-8059460e53a2">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income (loss) per share for the periods shown.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzItMi0xLTEtMA_7faf1fba-a626-4d6a-b501-6883aed9113c"
      unitRef="usd">493600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzItNC0xLTEtMA_de85833e-178c-4b4f-a835-5b4425746591"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzItNi0xLTEtMA_b459e8e0-01b6-462f-94b0-0f7aaa90b932"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzUtMi0xLTEtMA_8b5ab769-9cdb-4036-b021-be22c3aa7564"
      unitRef="usdPerShare">5.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzUtNC0xLTEtMA_b9ef48aa-3296-4f84-8894-f5b4f44838f0"
      unitRef="usdPerShare">1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzUtNi0xLTEtMA_0d991c9d-c45d-4fde-af24-66f2b3d6ee6a"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzYtMi0xLTEtMA_c46791e6-e09a-4f11-9f8e-4f090b64aa1d"
      unitRef="usdPerShare">5.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzYtNC0xLTEtMA_532a904b-eed8-40e4-8897-c0908a2b1449"
      unitRef="usdPerShare">1.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzYtNi0xLTEtMA_67c1d59d-086c-4c5a-94d1-a22519d939a7"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzgtMi0xLTEtMA_03cba042-0eb4-423a-8c9b-0f0e44b10f75"
      unitRef="shares">94400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzgtNC0xLTEtMA_4773fc58-b048-492d-abf5-20126da1adcf"
      unitRef="shares">91100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzgtNi0xLTEtMA_0edc9cc3-ca7a-451d-a8f8-167190c14893"
      unitRef="shares">88200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i623dc723c3654d6f84c0203133743a3c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEwLTItMS0xLTA_3a72722e-e7fd-4610-a6c3-8cb90ef7875c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i487acee9456946cdb9c4c15b15b58728_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEwLTQtMS0xLTA_3c2c25b9-4f2f-41d6-894a-2b44229de960"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if1e6715852d34c6d9cf08a930ee3485b_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEwLTYtMS0xLTA_af07f9ba-554e-49f1-8178-2197f93157d0"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i954b8f3c51d640ac8ab5dd40a78b5387_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzExLTItMS0xLTA_3e22e34f-2f16-45a8-af36-d3ce0f546276"
      unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib32ce2a545784b15ac52d142f35bd1ca_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzExLTQtMS0xLTA_2f071cbb-db6e-4434-96d8-9a6191866cc3"
      unitRef="shares">1200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9471ca1928864644924a2ba32d88cc1f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzExLTYtMS0xLTA_d6570cca-726a-4ef2-9ab1-89628ccb4125"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic931fab80e0d492e975aaa6194f8e114_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEyLTItMS0xLTA_eee6238b-1d89-41b2-a9db-924e2913cfeb"
      unitRef="shares">2100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if4966c3d9c394b12bda5b16597859370_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEyLTQtMS0xLTA_fdeff149-260e-491f-b347-71ffe7dcc258"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="idaa97d31ed824316b5f9b802f7fbd276_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzEyLTYtMS0xLTA_b7d178fa-fc5e-4d7e-907b-3de7dbbd359e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="icf74b07e99d94f2c93e41b91727019c7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE0LTItMS0xLTA_8540d086-f95c-48f4-8b50-014110597949"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ife10a97075fb4eaebce519044eed7ce7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE0LTQtMS0xLTA_dd2b91d2-2cf7-459f-8476-bd0719b1acb4"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="idcf57f15378a4158b986a2e96c250eea_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE0LTYtMS0xLTA_89f96377-4154-4169-8798-7598a3b9e53b"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE1LTItMS0xLTA_e0bea499-204e-43e1-9e06-a92013451510"
      unitRef="shares">97500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE1LTQtMS0xLTA_f2b44bef-f40c-4ef6-98fc-a346d7e386e4"
      unitRef="shares">92300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTo3MGVhMThlODBmNTg0YTQwYTRkYjkyODZiNDFlNTVjZC90YWJsZXJhbmdlOjcwZWExOGU4MGY1ODRhNDBhNGRiOTI4NmI0MWU1NWNkXzE1LTYtMS0xLTA_9cfcd43f-c658-4c4b-af22-bd5db5121f04"
      unitRef="shares">88200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzM1MTA0_72f4972b-89b0-4eeb-b938-d675b05a4900">Outstanding anti-dilutive securities not included in the diluted net income (loss) per share attributable to common stockholders calculations were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i623dc723c3654d6f84c0203133743a3c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzItMS0xLTEtMA_84f5321e-2791-442f-87f5-0bb131e76018"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i487acee9456946cdb9c4c15b15b58728_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzItMy0xLTEtMA_b751c013-03e9-44e4-947f-a913ab371c59"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if1e6715852d34c6d9cf08a930ee3485b_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzItNS0xLTEtMA_3c375f51-4697-4588-b842-8352df81b10b"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i954b8f3c51d640ac8ab5dd40a78b5387_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzMtMS0xLTEtMA_05973e34-6e53-488b-842a-35be1bd5b6b5"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib32ce2a545784b15ac52d142f35bd1ca_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzMtMy0xLTEtMA_214b642e-78cb-4cc2-9ffd-c94bcf15086d"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9471ca1928864644924a2ba32d88cc1f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzMtNS0xLTEtMA_25da209d-6a18-405e-9d46-24495bb191ce"
      unitRef="shares">2700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic931fab80e0d492e975aaa6194f8e114_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzQtMS0xLTEtMA_4e6961da-bd03-47c6-9734-b9d0eb60779d"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if4966c3d9c394b12bda5b16597859370_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzQtMy0xLTEtMA_287c94f2-eeef-45d3-b65f-6ee559993b16"
      unitRef="shares">5200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idaa97d31ed824316b5f9b802f7fbd276_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzQtNS0xLTEtMA_eb80364d-af4e-4be4-8283-d2e39c4238d4"
      unitRef="shares">5200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icf74b07e99d94f2c93e41b91727019c7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzYtMS0xLTEtMA_1b71e86f-4d3b-4ebd-a0e8-7a7363a7e1f9"
      unitRef="shares">7200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ife10a97075fb4eaebce519044eed7ce7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzYtMy0xLTEtMA_3d83dc6e-006e-4c9c-bf33-2b05991b3a46"
      unitRef="shares">9200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idcf57f15378a4158b986a2e96c250eea_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzYtNS0xLTEtMA_20d507b8-8da2-4103-abea-13eda18ae1ab"
      unitRef="shares">9200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzctMS0xLTEtMA_169b3012-6508-492e-b9b5-ca9ca0cb311c"
      unitRef="shares">7200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzctMy0xLTEtMA_66691ddb-b273-434e-b8ec-ab12faf09559"
      unitRef="shares">14600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90YWJsZTpkMGJiY2E1YjY3YjA0MTk0YmIxODg4ZWY2YmU0OTRjMC90YWJsZXJhbmdlOmQwYmJjYTViNjdiMDQxOTRiYjE4ODhlZjZiZTQ5NGMwXzctNS0xLTEtMA_356140f2-9f67-4a11-a530-2244976148ad"
      unitRef="shares">17200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzExNTQ0ODcyMTMzNzYx_3618d09e-5aed-4cc9-9168-e056a3aeceb5">&lt;div style="margin-bottom:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. Our adoption of ASU 2016-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. In addition, the outbreak of the novel strain of coronavirus, SARS-CoV-2 (&#x201c;COVID-19&#x201d;), has not had a significant impact on our expected credit losses or our consolidated financial statements during 2020. We are continuing to monitor the impact of COVID-19 on expected credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, the FASB issued ASU No. 2017-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-04)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#x2019;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Our adoption of ASU 2017-04 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;Our adoption of ASU 2018-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software: Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (ASU 2018-15)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This new guidance requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We adopted the new standard on January 1, 2020 on a prospective basis. Our adoption of ASU 2018-15 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently evaluating the impact that this guidance will have on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06, &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This new guidance is intended to reduce the complexity of accounting for convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation and requires enhanced disclosures about the terms of convertible instruments. Entities may adopt ASU 2020-06 using either a partial retrospective or fully retrospective method of transition. This &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU is effective for public business entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently evaluating the impact that this guidance will have on our consolidated financial statements.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <dxcm:DevelopmentAndOtherAgreementsTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzQxNTY_a0337f15-1ff6-4746-b03e-b5bc304a169b">&lt;div style="margin-bottom:14pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2. Development and Other Agreements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Collaboration with Verily Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#x2019;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of Dexcom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In consideration of Verily&#x2019;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we have made upfront and incentive payments and we will make potential future milestone payments upon the achievement of certain goals. In the fourth quarter of 2018, we made an initial payment of $250.0 million through the issuance of 1,840,943 shares of our common stock. We recorded a $217.7 million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The amount of the charge was based on our closing stock price of $118.28 per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and the transaction closed. During 2020 we made no incentive payments, while in 2019 we made incentive payments of $3.2 million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations. Additional milestone payments of up to a total of $275.0 million may become due and payable by us upon the achievement of future development, product regulatory approval and revenue milestones. These payments may be paid in cash or shares of our common stock, at our election. If we elect to make all $275.0 million of these payments in shares, we will issue a total of 2,025,036 shares of our common stock, based on the volume weighted average trading price during the 15 consecutive days ending on the date of the Restated Collaboration Agreement. Alternatively, if we elect to make all $275.0 million of these payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, adjusted for stock splits, dividends, and the like.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first revenue milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033.&lt;/span&gt;&lt;/div&gt;</dxcm:DevelopmentAndOtherAgreementsTextBlock>
    <dxcm:CollaborativeArrangementUpfrontFee
      contextRef="i615df7321c9348c998d7e063f8bd67aa_I20181120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzIyNzA_eaed3a41-f654-47c3-a889-701ca585cd9e"
      unitRef="usd">250000000.0</dxcm:CollaborativeArrangementUpfrontFee>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ifcc7e8952bad4da2bbf8948b84f5ae8d_D20181120-20181120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzIyOTc_8e60cc8e-d543-4b10-b9ac-7edb2b1442aa"
      unitRef="shares">1840943</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="idcad237c07544045a0efa52e0443d72f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzIzNDI_3ecca2bf-6cf9-4479-9eae-b5d240fa24f2"
      unitRef="usd">217700000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <us-gaap:SharePrice
      contextRef="i31d2218e16f24d919d743df0127d21f8_I20181228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzI1OTI_0daa15c9-2e56-4624-90eb-54fd25008b58"
      unitRef="usdPerShare">118.28</us-gaap:SharePrice>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="ib4b6d430ae4d4e93bade0e1a590f3f1e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzYwNDczMTM5NTcxMTg_78eb2e56-065b-4200-a422-002d89c4d38a"
      unitRef="usd">0</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="i4df6a91f5c464feda5d61246887477e0_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzI3NjM_94b3d2df-08da-4bdd-a44d-dd1968373d65"
      unitRef="usd">3200000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments
      contextRef="iceaf0df0d90548128c251bbadb05470c_I20181120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzI5NTk_6175a3f2-691c-4641-8638-ffd2a314103c"
      unitRef="usd">275000000.0</dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments>
    <dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones
      contextRef="iceaf0df0d90548128c251bbadb05470c_I20181120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzMxOTg_5f5488bf-79a8-4c99-8f6f-91d8271d3527"
      unitRef="usd">275000000.0</dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones>
    <dxcm:PotentialFutureCommonStockIssuableSharesNewIssues
      contextRef="ib24f50ea0be64889a78368325e28c1b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzMyNTU_ff3c0e6b-4f61-443c-ba3b-4f346e843d1b"
      unitRef="shares">2025036</dxcm:PotentialFutureCommonStockIssuableSharesNewIssues>
    <dxcm:WeightedAverageSharePriceConsecutiveDaysEvaluated
      contextRef="ib8927c59d45b409899e39263bc914622_D20181120-20181120"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzMzNDg_df5d84a4-0796-48c8-8da2-358f0dc1770c">P15D</dxcm:WeightedAverageSharePriceConsecutiveDaysEvaluated>
    <dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones
      contextRef="iceaf0df0d90548128c251bbadb05470c_I20181120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjEvZnJhZzplZmEyNThiYjZkMDk0ZTM1YjI0YWEyNzVkZThmMWVlOS90ZXh0cmVnaW9uOmVmYTI1OGJiNmQwOTRlMzViMjRhYTI3NWRlOGYxZWU5XzM0Njc_5f5488bf-79a8-4c99-8f6f-91d8271d3527"
      unitRef="usd">275000000.0</dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzU0MTU_f63f93db-2817-4ba6-9f9e-bfaef760723b">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3. Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values of our Level 2 marketable securities portfolio balance provided by our investment managers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2020, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,040.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2019, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,342.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between Level 1 and Level 2 securities during the years ended December&#160;31, 2020 and 2019. There were no transfers into or out of Level 3 securities during the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments are not significant and we include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are often privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant adverse effect on the fair values.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Senior Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value, based on trading prices (Level 1), of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,936.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,155.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For more information on the carrying values of our senior convertible notes, see Note 5, &#x201c;Debt.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency and Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time we engage in hedging transactions to reduce foreign currency risks. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs, and the derivative instruments are recorded in current assets or current liabilities in our consolidated balance sheets consistent with the nature of the instrument at period end. Derivative gains and losses are included in interest and other income, net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As of December&#160;31, 2020 and December&#160;31, 2019, notional amounts of $48.0 million and $8.0 million, respectively, were outstanding to hedge certain foreign currency risk. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the twelve months ended December&#160;31, 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our foreign currency exposures vary but are primarily concentrated in the British Pound, the Euro, and the Canadian Dollar. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when any impairment is recognized. We recorded no significant impairment losses during the twelve months ended December&#160;31, 2020, 2019 and 2018.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzU0MjM_40f3c899-f4cc-4383-b6ce-a1903a2efc59">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2020, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,040.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2019, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,342.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ie6ebe15ea5354284a29045fe47fb46b1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzItMS0xLTEtMA_e24b2b7b-5071-4628-b1a5-ad552b43b246"
      unitRef="usd">491500000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i09bae00ae8514ff08a6985ab2ac96d46_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzItMy0xLTEtMA_5e4d437e-870f-40b7-a9f6-a0959b509ffa"
      unitRef="usd">150000000.0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i3e343c46b6194f4380e1fe7c51520054_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzItNS0xLTEtMA_09fe5e9d-40e4-4166-8299-85051a8804bb"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzItNy0xLTEtMA_d88ffbc1-7fd0-4297-b055-c20ab77476f6"
      unitRef="usd">641500000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8a5cda91bc024f7090c90466831fa67a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzUtMS0xLTEtMA_ba6371d1-be4f-41fa-8674-9444a58e8b61"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icb5aff7c546d45ba9ec38abb08822d8d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzUtMy0xLTEtMA_e8369551-6304-4665-8a74-3da7254c2d8b"
      unitRef="usd">1570400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id92b9c26d62a4ca287002134a8a256e6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzUtNS0xLTEtMA_78993183-1bb3-4551-96f1-3a5ef7196c7d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzUtNy0xLTEtMA_f973e7c4-7bf4-4e98-ab30-0276c4db40ec"
      unitRef="usd">1570400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib910a32cb01f4e5390ee06e908c61c31_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzYtMS0xLTEtMA_82db8cbc-9176-476b-accf-7e1fce2a23bc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8535192ed8644f5582f70c23c1378c5b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzYtMy0xLTEtMA_b725f82b-88a9-47d2-a05a-cb29c3eab92f"
      unitRef="usd">258800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8276529a58434a7b813dcb46b73073f2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzYtNS0xLTEtMA_19856bc0-1845-4bfc-bbc0-47caa31fa2cb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf3265a756884edc835fa906c7740171_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzYtNy0xLTEtMA_b11d8bdb-cf88-4d9d-b1f5-532f910c4c47"
      unitRef="usd">258800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id6072b512879424581f8888ccf4b1714_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzctMS0xLTEtMA_a1510473-c51e-4a84-a9c9-041fc0062b33"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7ce4bc5e66a842608d994966881082ce_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzctMy0xLTEtMA_d07cf4cb-2cb4-4ee8-acbb-c1cea209c32b"
      unitRef="usd">60900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf7749c1aed641479a3729499651b209_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzctNS0xLTEtMA_23b71855-f514-4187-8bec-9ee60c383e12"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzctNy0xLTEtMA_fc23d175-1a7a-4494-a0ac-c3e5078e4c75"
      unitRef="usd">60900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie6ebe15ea5354284a29045fe47fb46b1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzgtMS0xLTEtMA_8dc1d8f9-7a34-41f2-9ec7-857e69b1860a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i09bae00ae8514ff08a6985ab2ac96d46_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzgtMy0xLTEtMA_dce45626-09ef-4d70-a7a0-f83898f2a350"
      unitRef="usd">1890100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3e343c46b6194f4380e1fe7c51520054_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzgtNS0xLTEtMA_951c1758-614b-46ee-be8d-f1256609105d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzgtNy0xLTEtMA_eedc8b58-5f7a-44a5-ad44-3bd1d0a74f8c"
      unitRef="usd">1890100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="ie6ebe15ea5354284a29045fe47fb46b1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEwLTEtMS0xLTA_777667ce-dbb0-441a-94ae-23e5a7c332cb"
      unitRef="usd">3400000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i09bae00ae8514ff08a6985ab2ac96d46_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEwLTMtMS0xLTA_5dd65c30-d38a-4663-8fc6-280cdcbe4f14"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i3e343c46b6194f4380e1fe7c51520054_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEwLTUtMS0xLTA_34aebe5e-3176-4f73-ab83-0ff7920e4aac"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEwLTctMS0xLTA_da517278-3b13-4706-b05e-e3956d0e88f1"
      unitRef="usd">3400000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie6ebe15ea5354284a29045fe47fb46b1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEyLTEtMS0xLTA_ef272950-6f9a-4298-8b03-96255746cd63"
      unitRef="usd">494900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i09bae00ae8514ff08a6985ab2ac96d46_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEyLTMtMS0xLTA_620d8a76-7732-457a-aa11-426fb7135d0a"
      unitRef="usd">2040100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3e343c46b6194f4380e1fe7c51520054_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEyLTUtMS0xLTA_e5596f40-035f-468a-a415-27c520819942"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3NjI2NDE0ZTU3MTY0NzVhYTNmMjMzZDAyYzVlNjk1Ni90YWJsZXJhbmdlOjc2MjY0MTRlNTcxNjQ3NWFhM2YyMzNkMDJjNWU2OTU2XzEyLTctMS0xLTA_bb2e489d-6482-407b-ad41-80266ad849cf"
      unitRef="usd">2535000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i9cac588c14d54e36b24ced9f8983c608_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzItMS0xLTEtMA_1a1d19c5-8f22-4b11-be66-206fb58d3ccc"
      unitRef="usd">110100000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i33c17b8f03144e119934ea6043ba9473_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzItMy0xLTEtMA_a89d7cba-cbbc-4c51-94a7-7fb1e71bd81c"
      unitRef="usd">144900000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ica5b87038a814ec1a6c4020d34fb75fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzItNS0xLTEtMA_17cb85d7-03b8-4dee-8022-ceb502258600"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzItNy0xLTEtMA_6568580b-1990-4a85-bcbc-3626d461ef5d"
      unitRef="usd">255000000.0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3a704f3be5c848d5b0eb7eca70324e2b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzctMS0xLTEtMA_65d6f31f-90da-4cce-a705-fe598484bff5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0905eace1d084bdbae0f064671806ef4_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzctMy0xLTEtMA_88b941d8-fc1f-47ba-8ef3-8f04bfacd9f4"
      unitRef="usd">676000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd1de93377374c41ad096882be863dc4_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzctNS0xLTEtMA_28f42e76-dbd2-44fb-9b11-d7031251b6f0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzctNy0xLTEtMA_5e05fbad-436e-4e7b-953d-b38f496babb4"
      unitRef="usd">676000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i370e2a274e894e17830c5dd4de2f0b14_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzgtMS0xLTEtMA_b5a095c0-0d21-42c3-8b57-0ef04067dbe5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieebd5d2f1c504a48ad99159aa9507fc7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzgtMy0xLTEtMA_63fc8d75-7fd4-4f15-b141-771fc6d24c3a"
      unitRef="usd">248200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0632744de077450ba1f1cc509a18cf6e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzgtNS0xLTEtMA_7325d45a-6e15-42fe-b936-f7f8f409c0f5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzgtNy0xLTEtMA_fccf2312-243f-43c8-9c4e-ec9d2a31cc45"
      unitRef="usd">248200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icd57f0d5e88a4997a01dff3a6ac5d84f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzktMS0xLTEtMA_3097601a-eb52-408e-be5f-ce50e5cbb882"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i61493ab0d7cc4e5d840ceb144efade0b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzktMy0xLTEtMA_445c9941-84e6-494a-9c94-3fe68ca11d84"
      unitRef="usd">162900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i667ef1514f464c018ac2d87ad6fd7fb4_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzktNS0xLTEtMA_7c53add8-f4a2-48f0-8d48-3d7198f876d6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzktNy0xLTEtMA_1e667111-305c-4d82-b19c-e46e47a4abf8"
      unitRef="usd">162900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9cac588c14d54e36b24ced9f8983c608_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTEtMS0xLTA_eddbaf64-38c3-4a14-9841-ab46e76e6b79"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i33c17b8f03144e119934ea6043ba9473_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTMtMS0xLTA_86c4f503-5b67-4244-9019-cf5d1a9dc62e"
      unitRef="usd">1087100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ica5b87038a814ec1a6c4020d34fb75fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTUtMS0xLTA_7848d9f1-a666-45d9-87ea-f4b0172e6045"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTctMS0xLTA_8c0f672d-54f6-43a8-8375-06ef8468b702"
      unitRef="usd">1087100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i9cac588c14d54e36b24ced9f8983c608_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTEtMS0xLTEyNjA_03892bec-154c-474d-8621-7f06297e5fde"
      unitRef="usd">700000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i33c17b8f03144e119934ea6043ba9473_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTMtMS0xLTEyNjA_5dbc8830-ebea-4025-b684-541c66ed8d19"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="ica5b87038a814ec1a6c4020d34fb75fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTUtMS0xLTEyNjA_46d1cb39-6d8b-4fd6-99b6-da9016371eea"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEwLTctMS0xLTI4NjY_e0d54398-daf5-4367-84ea-8d2f6ec1c9f6"
      unitRef="usd">700000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9cac588c14d54e36b24ced9f8983c608_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTEtMS0xLTA_62dfdaee-97cf-4870-a981-0af9f3bc9ebc"
      unitRef="usd">110800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i33c17b8f03144e119934ea6043ba9473_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTMtMS0xLTA_a1d70069-105c-48d7-beb9-6f691521f515"
      unitRef="usd">1232000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ica5b87038a814ec1a6c4020d34fb75fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTUtMS0xLTA_10022f19-d2ea-4933-9f91-4b1a0d0c084d"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo3ZWMxMGNiNTJhMTQ0MTk5ODlmNjBmNTA3YjRkNWQwYS90YWJsZXJhbmdlOjdlYzEwY2I1MmExNDQxOTk4OWY2MGY1MDdiNGQ1ZDBhXzEyLTctMS0xLTA_020e043d-58ec-4ee6-b2cb-dff7a4980054"
      unitRef="usd">1342800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzE3NzM_24bf6180-4494-45d2-8db2-91e6a55c6080"
      unitRef="usd">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
    <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzE3NzM_498a2069-b5fa-41c4-b591-3660adc7ec00"
      unitRef="usd">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzE4NzA_54a2d8a3-ba2c-412d-8b85-dda439a265f3"
      unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzE4NzA_fff86e0a-68e5-43ca-8b16-1dcb695d7424"
      unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzU0MjA_f0b6d6a0-0031-4dae-a02f-56af03a94e8a">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value, based on trading prices (Level 1), of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,936.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,155.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For more information on the carrying values of our senior convertible notes, see Note 5, &#x201c;Debt.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i824914321cdf4eb3bab58c165184aebe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzItMy0xLTEtMA_ee327d07-d683-441c-aa57-471c257fec50"
      unitRef="usd">890800000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="iea63bf6b583842f8afb95e80d99e8bb1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzMtMS0xLTEtMA_2e2295fc-b29a-4d4d-a66a-69bb7932b830"
      unitRef="usd">1936400000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i094a2a8c50c44667a8ed8cffec42dee4_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzMtMy0xLTEtMA_4084f57f-732c-4d36-998b-81e7f48375f6"
      unitRef="usd">1260000000.0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i9b91b53fe18c4c4ea50245a93565fd7d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzQtMS0xLTEtMTI5MQ_de20a369-1994-487f-9078-f586fe97ce5e"
      unitRef="usd">1219200000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzQtMS0xLTEtMA_6e937f16-7b55-4b80-8782-8a0eb78128cc"
      unitRef="usd">3155600000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90YWJsZTo0ZDA4MjRmM2JhMmI0NzlhODU2YzZjMTBjYjNkOWY1Yi90YWJsZXJhbmdlOjRkMDgyNGYzYmEyYjQ3OWE4NTZjNmMxMGNiM2Q5ZjViXzQtMy0xLTEtMA_fe418e24-eec2-45f8-8ec7-05769a4bfbae"
      unitRef="usd">2150800000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4a7900a1db994a859636735a0f0324a1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzM0MTI_60d936cd-ce54-47ee-93ce-c7c4d3ecb275"
      unitRef="usd">48000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i833d598aaf8f47baa412832261515cfc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzM2NjA_99735ea5-ee93-433e-a364-860eeb0709bf"
      unitRef="usd">8000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzUzMzQ_43bfcf36-447d-4162-8891-d62fb7323f40"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzUzMzQ_64a6082c-9d7b-4604-a774-118d21f6f071"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMjQvZnJhZzpkZDFhMDU3MDJjZmE0MmJhYjI0ZjVmZmNiY2E4MjA5My90ZXh0cmVnaW9uOmRkMWEwNTcwMmNmYTQyYmFiMjRmNWZmY2JjYTgyMDkzXzUzMzQ_d305f979-ab96-4311-a536-0ca28f38289d"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3Mjc_9168de44-ff61-400b-aa23-fcfbaa65df3e">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4. Balance Sheet Details&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term marketable securities, consisting of debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020 and 2019, all of our debt securities had contractual maturities of less than twelve months. Gross realized gains and losses on sales of our debt securities for the twelve months ended December&#160;31, 2020, 2019 and 2018 were not significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at December&#160;31, 2020 were not significant and were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the net gain recognized on marketable equity securities during the twelve months ended December&#160;31, 2020, 2019 and 2018 to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&#160;&lt;br/&gt;&#160;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains and losses recognized during the period on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net gains and losses recognized during the period on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains recognized during the reporting period on equity securities still held at the reporting date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2020 and 2019, we recorded excess and obsolete inventory charges of $24.4 million and $14.1 million, respectively, in cost of sales as a result of our ongoing assessment of sales demand, inventory on hand for each product and the continuous improvement and innovation of our products. During the twelve months ended December 31, 2018, we recorded excess and obsolete inventory charges of $7.3 million in cost of sales primarily as a result of the approval and launch of our G6 system and our ongoing assessment of sales demand and the continuous improvement and innovation of our products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents our finance lease right-of-use assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense related to property and equipment for the twelve months ended December&#160;31, 2020, 2019 and 2018 was $64.0 million, $46.9 million, and $28.6 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss on disposal of property and equipment during the twelve months ended December&#160;31, 2020, 2019 and 2018 recorded in operating expenses was $13.6 million, $10.5 million and $5.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable trade&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Accrued Warranty&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warranty costs are reflected in our statements of operations as cost of sales. Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3Mjk_f3e39617-15c9-4da4-9db5-0632134dcf98">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term marketable securities, consisting of debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzMtMS0xLTEtMA_03619ea8-f464-475a-86db-2b8e7ecfbe83"
      unitRef="usd">1570400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzMtMy0xLTEtMA_3628969c-20b8-41cc-b377-9f17ac09d5d6"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzMtNS0xLTEtMA_af242655-8d75-420a-bbc6-ea85c250da38"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if668b89e2e9e4e07aa8d16e499ecd8e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzMtNy0xLTEtMA_179b2d20-4246-4ec1-b93d-8be9def6fa9a"
      unitRef="usd">1570400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iaf3265a756884edc835fa906c7740171_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzQtMS0xLTEtMA_bc7f1113-2906-4105-9f2c-5c5c0ae4f9c4"
      unitRef="usd">258700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaf3265a756884edc835fa906c7740171_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzQtMy0xLTEtMA_fc5cb654-bf80-4ee2-9d67-9414bc57daa5"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaf3265a756884edc835fa906c7740171_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzQtNS0xLTEtMA_9329a252-8330-45f1-a04e-b33fa7554ad1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf3265a756884edc835fa906c7740171_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzQtNy0xLTEtMA_fd2952f3-8fd8-486d-b93d-1df3b6031daf"
      unitRef="usd">258800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzUtMS0xLTEtMA_0bec0228-1d7a-4b98-b648-d61b51d362ee"
      unitRef="usd">60900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzUtMy0xLTEtMA_1bc6e79a-9d02-4814-9694-4aa2c279e51b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzUtNS0xLTEtMA_1ecc0b08-dc24-4508-ac31-74a4b541b9d1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6e1d56e1b98842fcbd5c1898e611e4a7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzUtNy0xLTEtMA_15e1070f-35b2-477e-ba4d-7e6768722da3"
      unitRef="usd">60900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzYtMS0xLTEtMA_f81093e6-7846-4c87-ad3a-3bd76f6ad212"
      unitRef="usd">1890000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzYtMy0xLTEtMA_3a5f4f79-8f94-4be0-be69-7951a98a4fed"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzYtNS0xLTEtMA_2fc244dc-c820-44ad-90cd-d2725dd3fe08"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2Y2VlYjVkNjQ5NjY0ZTU0OWYwNWQwZWIyMWEwZTlmMy90YWJsZXJhbmdlOjZjZWViNWQ2NDk2NjRlNTQ5ZjA1ZDBlYjIxYTBlOWYzXzYtNy0xLTEtMA_436b8eaa-bb58-48e9-9097-8cb489c29283"
      unitRef="usd">1890100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzUtMS0xLTEtMA_510f7b78-1c46-4f3a-944a-2995ed84a7d8"
      unitRef="usd">675600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzUtMy0xLTEtMA_6e018e51-6992-4aca-809d-fc11d7440347"
      unitRef="usd">400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzUtNS0xLTEtMA_445f163f-14ed-400e-a8e8-1bb45e81a16b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i88a4128e1836441785ef95ceb6d9f5ef_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzUtNy0xLTEtMA_29b93efd-1695-47de-b516-b8fc24582bb5"
      unitRef="usd">676000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzYtMS0xLTEtMA_8b5b99b6-4d3d-4958-b3ac-9d62ecaa098f"
      unitRef="usd">248100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzYtMy0xLTEtMA_a24f525d-4850-4559-b989-a572069a4f64"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzYtNS0xLTEtMA_ca6a9881-9efd-4841-9000-eb6e6950541b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i314750f344f946b9bb09c3930fd9d8f7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzYtNy0xLTEtMA_2833388d-5ad2-42c7-9f05-8fa5996a7b0a"
      unitRef="usd">248200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzctMS0xLTEtMA_77652f2b-cba8-4d97-867f-21730cf4e84a"
      unitRef="usd">163000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzctMy0xLTEtMA_fce8b2aa-7bfc-4d65-b3a8-cce5ee0a333e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzctNS0xLTEtMA_62ed2cb9-da07-47d4-8ac5-a43e05d97c4c"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib8f2e89c0f47427ca284b54295ee9475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzctNy0xLTEtMA_5f864f5a-3c69-48fd-b3a4-f3a16461b0fc"
      unitRef="usd">162900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzgtMS0xLTEtMA_89abcc26-cbbd-4b51-82be-6092aeabfc9d"
      unitRef="usd">1086700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzgtMy0xLTEtMA_5d7203c0-50c7-48d1-b3a4-18787c04b3f3"
      unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzgtNS0xLTEtMA_c1bc5662-356f-4dd5-a3fa-4fcd54aecc6e"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTo2NGNlODg2YTc5MGY0ZWE0OThmMjg3ZjQyMmYzMjExOC90YWJsZXJhbmdlOjY0Y2U4ODZhNzkwZjRlYTQ5OGYyODdmNDIyZjMyMTE4XzgtNy0xLTEtMA_b1de3a29-14a3-4038-9523-2f5ae1adca53"
      unitRef="usd">1087100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzIzMg_aeb46a35-8c89-462a-b367-6c1f0ce8e4b0">P12M</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MzM_f5093ef5-3c52-4281-8a5f-46ee257241bd">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the net gain recognized on marketable equity securities during the twelve months ended December&#160;31, 2020, 2019 and 2018 to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&#160;&lt;br/&gt;&#160;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains and losses recognized during the period on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net gains and losses recognized during the period on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains recognized during the reporting period on equity securities still held at the reporting date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzItMS0xLTEtMA_9620999d-2260-4f44-8833-be0978a84c68"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzItMy0xLTEtMA_0c3774a4-5d63-41ac-886b-573d0dbf0946"
      unitRef="usd">-4200000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzItNS0xLTEtMA_91c59c99-959d-4697-a9db-4672d99aa6fa"
      unitRef="usd">80100000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzMtMS0xLTEtMA_c8111f2b-b4b4-446b-81a1-fad6cfe3d804"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzMtMy0xLTEtMA_d77707b5-6ab9-4e86-8cdc-1c771fdd1c92"
      unitRef="usd">-4200000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzMtNS0xLTEtMA_cc84dda1-6ac1-416c-a948-68fed6814aac"
      unitRef="usd">44100000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzQtMS0xLTEtMA_93fd32bc-cea1-44d3-a43c-badac2512070"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzQtMy0xLTEtMA_051e2a22-8220-4048-b254-cecc29f1f6a5"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNzcwMDY2YWVmYmM0OTFlYmFkMjY1Y2QzNWMxZGUwMi90YWJsZXJhbmdlOjM3NzAwNjZhZWZiYzQ5MWViYWQyNjVjZDM1YzFkZTAyXzQtNS0xLTEtMA_194cbd5e-5b97-4f62-804b-2ff4d673ab71"
      unitRef="usd">36000000.0</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MDI_c73275c2-7ad7-4da3-9269-892ea8a65d83">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzItMS0xLTEtMA_2142f836-cbd3-49aa-85ab-7e6eb9f25755"
      unitRef="usd">435700000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzItMy0xLTEtMA_77d60d9c-737a-4957-9f06-886d00708b8b"
      unitRef="usd">292100000</us-gaap:AccountsReceivableGross>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzMtMS0xLTEtMA_623996ac-b698-4977-9a1d-be111b1c7017"
      unitRef="usd">7200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzMtMy0xLTEtMA_945ab3d3-7a3f-46da-a63b-08ed703589d8"
      unitRef="usd">5800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNet
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzQtMS0xLTEtMA_a8249151-da26-409a-85e7-a48d7388bea0"
      unitRef="usd">428500000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpkNWI3ZmM2ZTViOTQ0NjUyYjhhNGEyYTQwMjA4NzkzMS90YWJsZXJhbmdlOmQ1YjdmYzZlNWI5NDQ2NTJiOGE0YTJhNDAyMDg3OTMxXzQtMy0xLTEtMA_cefa0140-a001-48ae-8596-3f23592bce3a"
      unitRef="usd">286300000</us-gaap:AccountsReceivableNet>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MDk_6e5bedde-be4d-4a32-a886-dc28946a627a">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzItMS0xLTEtMA_7c9a2bfa-f598-44db-8e42-d5c04f1af1f4"
      unitRef="usd">69900000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzItMy0xLTEtMA_4ea6400a-98b3-4754-8d1d-a3cea56ae861"
      unitRef="usd">64900000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzMtMS0xLTEtMA_8f873c52-dae4-409b-b682-3b3e7aa70fec"
      unitRef="usd">14200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzMtMy0xLTEtMA_1922983f-704b-471e-8139-634853570366"
      unitRef="usd">11100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzQtMS0xLTEtMA_a21c8f3d-7316-4a21-a121-1e00537a69c9"
      unitRef="usd">150600000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzQtMy0xLTEtMA_57968b81-282f-447f-b2ea-f481ee641499"
      unitRef="usd">43800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzUtMS0xLTEtMA_c780b8b6-c29e-4370-b1da-c2cef5ba6c6b"
      unitRef="usd">234700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjNmE0NmJmODNmZWM0NGFmOGI0ZjIwMzhkODc1YTgwYS90YWJsZXJhbmdlOmM2YTQ2YmY4M2ZlYzQ0YWY4YjRmMjAzOGQ4NzVhODBhXzUtMy0xLTEtMA_fbb7b104-4ee3-4444-ba4c-a1100f8bf344"
      unitRef="usd">119800000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown
      contextRef="i3fb0b180cb694f118960ccc9da9e7d85_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzEzNTk_51c7e2ff-0479-4561-9bbc-17611339abb7"
      unitRef="usd">24400000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i7f7515fed1ce4589adbabde6cf4f20cd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI3NDg3NzkwNzQwMjA_ad1042ae-c983-4c44-a170-084db713a309"
      unitRef="usd">14100000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ic9decf99cba94ae588c9c036d46e7a88_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI3NDg3NzkwNzQwNDQ_cd9eb62f-61ed-4761-ada3-c51cc05536fc"
      unitRef="usd">7300000</us-gaap:InventoryWriteDown>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MzA_888763af-c671-4a08-91d7-8dc7e119981a">&lt;div style="margin-bottom:12pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents our finance lease right-of-use assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iaad228cd33024cad88643caf07e6164a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzItMS0xLTEtODcxMA_7da9e706-1ef0-492c-8210-73243cf4d632"
      unitRef="usd">15600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i057d34c5ad2a4be99a734d6e91c1a7fe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzItMy0xLTEtODcxNQ_32908a9f-2491-4293-89cd-2705cace9dfd"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i300b1ce4d8494fc99011c04df98671bf_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzItMS0xLTEtMA_21075992-e4c0-45bd-9eb3-f34546d94c56"
      unitRef="usd">49200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8b55a585c4b242df8b97a38b585d21d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzItMy0xLTEtMA_4676bf10-0427-4904-a060-5ecdba47ba0f"
      unitRef="usd">15500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib254b46104664cc0bea561395f6e1d0a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzMtMS0xLTEtMA_9f6a7bab-9d6e-4af8-9661-733abb78fbc3"
      unitRef="usd">15300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i45ff6f9c8a1c4dc49b7be4fa6bfb4e0a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzMtMy0xLTEtMA_34ab009e-0c4a-4b99-a89a-1098ae549e87"
      unitRef="usd">12800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id65cdf0bbb534ff8b54804c8c04e4d6b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzQtMS0xLTEtMA_22d3ab2c-9a63-4e96-a73a-8d0a3b773d79"
      unitRef="usd">35700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ifba7e8356ca14d2ba58dddba2df2d708_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzQtMy0xLTEtMA_ff328170-96b5-44c8-acf7-56833daabf7c"
      unitRef="usd">32700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icab58e138022469894bc21a0ced86296_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzUtMS0xLTEtMA_bc7ed14b-d318-4736-bf74-8a8674c4bafc"
      unitRef="usd">198900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i24d744ae1b6b4be5bcb2a6eeb386c04b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzUtMy0xLTEtMA_59c39b82-2370-48dc-a121-e36ca88879f2"
      unitRef="usd">130200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iaa80ff42b6994adb90d475cddbd0d364_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzYtMS0xLTEtMA_e975483a-9084-4309-8928-3729cfaf0a24"
      unitRef="usd">135800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idd00f21e56f5451794ad6ac6c3bfa468_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzYtMy0xLTEtMA_640c6988-4993-46c2-9dc8-b43d5102ddff"
      unitRef="usd">102500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6cbe832d48b7469fadfd20a7d4174a82_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzctMS0xLTEtMA_3e68938e-431c-4262-896e-384f0964b84d"
      unitRef="usd">219000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i01240eeff3424399ac46617dff38a60e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzctMy0xLTEtMA_8ef48547-9a54-4946-9386-177b6b94e622"
      unitRef="usd">132600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzgtMS0xLTEtMA_65ea73a3-c5c5-4886-80c3-c193aa5fa114"
      unitRef="usd">669500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzgtMy0xLTEtMA_48a02730-7932-403e-8315-28665ff92515"
      unitRef="usd">426300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzktMS0xLTEtMA_31f0e0eb-880c-4503-8648-a562d023ce2d"
      unitRef="usd">154200000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzktMy0xLTEtMA_945528c9-c62b-498b-bf45-f6a3600dcd00"
      unitRef="usd">105000000.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzEwLTEtMS0xLTA_70dcf791-7e3c-47f0-a7f6-624af046387c"
      unitRef="usd">515300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZToyNTYyYWYyYjZkNzc0OGE4OTJhZWZjMTg1MTEzNzQ1NS90YWJsZXJhbmdlOjI1NjJhZjJiNmQ3NzQ4YTg5MmFlZmMxODUxMTM3NDU1XzEwLTMtMS0xLTA_9b39f50a-7306-4e91-aade-a1c5da13c6ee"
      unitRef="usd">321300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI2NzQ_76122c07-3942-4120-ab56-9e674f44a792"
      unitRef="usd">64000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI2Nzg_2956544e-a162-4954-9f3a-ed2045680574"
      unitRef="usd">46900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI2ODY_92ce26af-a76d-44bf-8453-4bed1db20eb9"
      unitRef="usd">28600000</us-gaap:Depreciation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI4MTI_3a16aa16-b13e-44d2-8d47-3b172a5e246b"
      unitRef="usd">-13600000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI4MTY_cbadefe5-094c-4f23-8a41-5b26e7999def"
      unitRef="usd">-10500000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzI4MjM_d04c1024-ee1d-4e5f-a590-3e1576f9ed2d"
      unitRef="usd">-5400000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3MDM_2eea50be-5475-4aa6-a29e-5da10e8e1c09">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable trade&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzItMS0xLTEtMA_0808798e-b70f-4d31-b2d9-1dc39ac7cd57"
      unitRef="usd">163300000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzItMy0xLTEtMA_b53a74d2-3367-4c6c-9ba1-085cfff031ef"
      unitRef="usd">102300000</us-gaap:AccountsPayableTradeCurrent>
    <dxcm:AccruedTaxAuditAndLegalFees
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzMtMS0xLTEtMA_02b1e566-d879-49d3-9c34-4644c7798712"
      unitRef="usd">15300000</dxcm:AccruedTaxAuditAndLegalFees>
    <dxcm:AccruedTaxAuditAndLegalFees
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzMtMy0xLTEtMA_65bc70ba-3e6d-4f11-8b3d-bb6f0b467686"
      unitRef="usd">14000000.0</dxcm:AccruedTaxAuditAndLegalFees>
    <dxcm:PharmacyRebates
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzQtMS0xLTEtMA_117d7b63-95fc-43b8-856f-5abad0db85da"
      unitRef="usd">247000000.0</dxcm:PharmacyRebates>
    <dxcm:PharmacyRebates
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzQtMy0xLTEtMA_cf776677-4fc1-4ed6-b9c4-4bdba83e196d"
      unitRef="usd">93300000</dxcm:PharmacyRebates>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzUtMS0xLTEtMA_4258ba0d-b461-4c15-9e4a-aa461b78bb86"
      unitRef="usd">11700000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzUtMy0xLTEtMA_eb8deb2f-541f-4616-b4dd-7e068f05a125"
      unitRef="usd">7400000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzctMS0xLTEtMA_b11c5498-c171-4684-9b7d-332b99d22842"
      unitRef="usd">43800000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzctMy0xLTEtMA_92e59cc7-01f5-4cf1-a3f9-bf8182a8d1fe"
      unitRef="usd">39400000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzgtMS0xLTEtMA_4fa9f2a5-2b35-4e3d-828f-7c537c3b1d4b"
      unitRef="usd">481100000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpjOGEzOWI5NDNmMDQ0ZDMwYjI3ZjBmYmYzNzRiYjQ3YS90YWJsZXJhbmdlOmM4YTM5Yjk0M2YwNDRkMzBiMjdmMGZiZjM3NGJiNDdhXzgtMy0xLTEtMA_fe866d50-2b0f-4ae2-9fa7-e246936d43c4"
      unitRef="usd">256400000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3NTM_e4d727b3-cbe0-4a17-b3d8-2d5f1c94d087">Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2020 and 2019 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzItMS0xLTEtMA_de7b6076-92b1-4e9e-b053-f6eb792b6f98"
      unitRef="usd">7400000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzItMy0xLTEtMA_cecd8c15-6bbb-46d9-b24a-803c97ac4c93"
      unitRef="usd">6800000</us-gaap:StandardProductWarrantyAccrual>
    <dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzMtMS0xLTEtMA_8190913f-cb01-4138-b4fc-8588db7a9ad5"
      unitRef="usd">41300000</dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses>
    <dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzMtMy0xLTEtMA_690e7d66-ed58-4fa9-866c-a386c7c9a560"
      unitRef="usd">32700000</dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzQtMS0xLTEtMA_701fdea9-6239-4948-90d5-351d169167b0"
      unitRef="usd">37000000.0</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzQtMy0xLTEtMA_0f4eac86-311f-4bb1-b384-c2d76c2874dd"
      unitRef="usd">32100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzUtMS0xLTEtMA_42daa923-e808-4a7d-b6ba-d2c3a60e7a37"
      unitRef="usd">11700000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTozNjE1NzI3NzMxYjA0MzQyOTczMDlhYTVhOWU5ZDk2MC90YWJsZXJhbmdlOjM2MTU3Mjc3MzFiMDQzNDI5NzMwOWFhNWE5ZTlkOTYwXzUtMy0xLTEtMA_657cd4a3-573b-41ba-bdd5-e90e44170657"
      unitRef="usd">7400000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90ZXh0cmVnaW9uOjMxYjk5MjdiMGIxYzRjYjVhYzZhNmI1MTcwMWNhNmM4XzM3NDU_a2613c2d-04d9-49d4-b39b-18d93589e01b">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
    <dxcm:FinancingLeaseObligation
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzItMS0xLTEtMA_2749d9a4-2eec-4e87-b268-d40d74c33cde"
      unitRef="usd">54000000.0</dxcm:FinancingLeaseObligation>
    <dxcm:FinancingLeaseObligation
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzItMy0xLTEtMA_55f65feb-440c-4555-a706-03d9e0012d0f"
      unitRef="usd">14400000</dxcm:FinancingLeaseObligation>
    <us-gaap:ContractualObligation
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzMtMS0xLTEtMTgwNA_65d1767e-4ccb-42ec-b7b2-bcdb3e06dc59"
      unitRef="usd">12600000</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligation
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzMtMy0xLTEtMTgwNA_142006d7-794e-4a54-a940-b0e6fb9ef546"
      unitRef="usd">0</us-gaap:ContractualObligation>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzQtMS0xLTEtMA_078d195d-252a-4d60-9563-a8232ea36c7f"
      unitRef="usd">14300000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzQtMy0xLTEtMA_98115bb1-105b-4a2d-98d4-c3f2e8b9023f"
      unitRef="usd">5700000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzUtMS0xLTEtMA_7bf67181-4362-49c2-808b-02dba2879bf8"
      unitRef="usd">80900000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzAvZnJhZzozMWI5OTI3YjBiMWM0Y2I1YWM2YTZiNTE3MDFjYTZjOC90YWJsZTpiZTM5NjA4ZWUxYjc0OGZjOTI0NDYzYWFmMWE3OTU1ZS90YWJsZXJhbmdlOmJlMzk2MDhlZTFiNzQ4ZmM5MjQ0NjNhYWYxYTc5NTVlXzUtMy0xLTEtMA_fc65eaee-a473-467c-adb6-7f9b6e1dabed"
      unitRef="usd">20100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTUz_0e285be5-0e37-4f3c-9f51-1ce7ea67583b">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5. Debt&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Senior Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,057.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount of liability component&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal is as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total by which the notes&#x2019; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual coupon interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rates:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest on the 2022 Notes began accruing upon issuance and was payable semi-annually on May 15 and November 15 of each year. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The effective interest rate presented represents the rate applicable for the period outstanding. The Senior Convertible Notes due 2022 were fully redeemed by July 31, 2020, as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.75%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; Senior Convertible Notes due 2022 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2017, we completed an offering of $400.0 million aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.75% and a maturity date of May&#160;15, 2022 (the 2022 Notes). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and costs directly related to the offering, were approximately $389.0 million. The initial conversion rate of the 2022 Notes was 10.0918 shares per $1,000 principal amount of notes, which was equivalent to a conversion price of approximately $99.09 per share, subject to adjustments. The 2022 Notes could be settled in cash, stock, or a combination thereof, solely at our discretion. We used the if-converted method for assumed conversion of the 2022 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since upon conversion by the holders we could elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#x2019; equity. As a result, we recognized $70.6 million in additional paid-in-capital, net of debt issuance costs, during 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No principal payments were due on the 2022 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2022 Notes included customary terms and covenants, including certain events of default after which the 2022 Notes could be due and payable immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at the Option of the Holders &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of a fundamental change (as defined in the indenture related to the 2022 Notes), holders of the 2022 Notes had the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2022 Notes, plus any accrued and unpaid interest. Holders of the 2022 Notes who would convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption were, under certain circumstances, entitled to an increase in the conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2022, holders of the 2022 Notes could convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;during any calendar quarter commencing after September&#160;30, 2017 (and only during such calendar quarter), if the last reported sale price of Dexcom&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2022 Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2022 Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#x2019;s common stock and the applicable conversion rate of the Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;if we called any or all of the Notes for redemption, at any time prior to the close on business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;On or after February&#160;15, 2022, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2022 Notes could convert all or a portion of their notes regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Circumstance (1) listed above occurred during the quarters ended December 31, 2019 and March 31, 2020. As a result, the 2022 Notes became convertible at the option of the holder from January 1, 2020 through June 30, 2020. On June 29, 2020, Dexcom issued a notice of redemption to the holders of its outstanding 2022 Notes which is described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at Our Option &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after May 15, 2020, Dexcom could redeem for cash all or part of the 2022 Notes, at its option, if the last reported sale price of our common stock had been at least 140% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provided notice of redemption. The redemption price would be equal to 100% of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Repurchase, Conversion, and Redemption of 2022 Notes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we used approximately $282.6 million of the net proceeds from the 2025 Notes offering described below and issued 1,953,067 shares of Dexcom common stock to repurchase $260.0 million principal amount outstanding of the 2022 Notes and the associated conversion feature of the repurchased notes (which was recorded in additional paid-in capital). In addition, holders of 2022 Notes with a principal amount of $140.0 million exercised their option to convert their 2022 Notes during the twelve months ended December 31, 2020. We settled these conversions by issuing 1,412,497 shares of our common stock. As a result of the repurchase and conversions of the 2022 Notes, we recorded a loss on extinguishment of debt of $5.9&#160;million for the twelve months ended December 31, 2020. The loss on extinguishment of debt included the unamortized debt issuance costs for the 2022 Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 29, 2020, we issued a notice of redemption to the holders of our outstanding 2022 Notes pursuant to which we would redeem the outstanding 2022 Notes for cash at a price of 100% of the principal amount of the 2022 Notes plus accrued and unpaid interest, if any, on July&#160;31, 2020, unless earlier converted. The principal amount of 2022 Notes actually redeemed for cash was not significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.75% Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, we completed an offering of&#160;$850.0 million&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;0.75%&#160;and a maturity date of&#160;December&#160;1, 2023&#160;(the 2023 Notes). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and costs directly related to the offering, were approximately&#160;$836.6 million. The initial conversion rate of the 2023 Notes is&#160;6.0869&#160;shares per&#160;$1,000 principal amount of notes, which is equivalent to a conversion price of approximately&#160;$164.29&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the 2023 Note Hedge) and warrants (the 2023 Warrants) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#x2019; equity. As a result, we recognized $171.6 million in additional paid-in capital, net of debt issuance costs, during 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at the Option of the Holders &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;during any calendar quarter commencing after March 31, 2019 (and only during such calendar quarter), if the last reported sale price of Dexcom&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2023 Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that five-day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#x2019;s common stock and the applicable conversion rate of the 2023 Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after September&#160;1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Circumstance (1) listed above occurred during the quarters ended December 31, 2019, March 1, 2020, June 30, 2020, and September 30, 2020. As a result, the 2023 Notes were convertible at the option of the holder from January 1, 2020 through December 31, 2020; actual conversions during that period were not significant. Circumstance (1) listed above also occurred during the quarter ended December 31, 2020 and as a result, the 2023 Notes will be convertible at the option of the holder from January 1, 2021 through March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at Our Option &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dexcom may not redeem the 2023 Notes prior to December 1, 2021. On or after December 1, 2021 and prior to September 1, 2023, Dexcom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Note Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to&#160;5.2 million&#160;shares of our common stock at an initial price of&#160;$164.29&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$218.9 million and we accounted for it as an equity instrument by recognizing $218.9 million in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on December&#160;1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;5.2 million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the 60 scheduled trading days starting on March&#160;1, 2024. We received&#160;$183.8 million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $198.38 per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.25% Senior Convertible Notes due 2025 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we completed an offering of $1.21 billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.25% and a maturity date of November&#160;15, 2025 (the 2025 Notes). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and estimated costs directly related to the offering, were approximately $1.19 billion. The initial conversion rate of the 2025 Notes is 1.6655 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $600.42 per share, subject to adjustments, with a maximum conversion rate of 2.3732. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#x2019; equity. As a result, we recognized $289.4 million in additional paid-in-capital, net of debt issuance costs, during 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2025 Notes includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at the Option of the Holders &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of a fundamental change (as defined in the indenture related to the 2025 Notes), holders of the 2025 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest. Holders of the 2025 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025, holders of the 2025 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;during any calendar quarter commencing after September&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of Dexcom&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#x2019;s common stock and the applicable conversion rate of the Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;On or after August&#160;15, 2025, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at Our Option &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dexcom may not redeem the 2025 Notes prior to May&#160;20, 2023. On or after May&#160;20, 2023 and prior to August 15, 2025, Dexcom may redeem for cash all or part of the 2025 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Revolving Credit Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Terms of the Revolving Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 19, 2018, we entered into an amended and restated revolving credit agreement which was subsequently amended on May 11, 2020 (as amended, the Credit Agreement). The Credit Agreement provides for available principal amount of $200.0 million which can be increased up to $500.0 million at our option subject to customary conditions and approval of our lenders. Borrowings under the Credit Agreement are available for general corporate purposes, including working capital and capital expenditures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to availability and outstanding borrowings on our Credit Agreement is as follows as of the date indicated: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available principal amount &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding borrowings &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans under the Credit Agreement bear interest at our choice of one of two base rates plus a range of applicable margin rates that are based on our leverage ratio. The first base rate is the highest of (a) the publicly announced JPMorgan Chase prime rate, (b) the federal funds rate, or (c) the overnight bank funding rate, and the applicable margin rate ranges from 0.375% to 1.000%. The second base rate is a LIBOR-based rate, and the applicable margin rate ranges from 1.375% to 2.000%. We will also pay a commitment fee of between 0.2% and 0.3%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement will mature on the earlier to occur of (i) December 19, 2023 or (ii) 91 days prior to the maturity date of the 2022 Notes or (iii) 91 days prior to the maturity date of the 2023 Notes if both (a) the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, is greater than EBITDA for the period of four consecutive fiscal quarters ending prior to such date and (b) unrestricted domestic cash on hand is less than the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, plus $100.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our obligations under the Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTQz_c48ccea5-f090-4eb8-9057-dd5b1697122b">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,057.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount of liability component&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i42d67ad56d484dbfa64dbb92ac7c6053_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzMtMS0xLTEtMzI0Ng_fd7514e3-1adf-4246-9073-09a646ded00b"
      unitRef="usd">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i824914321cdf4eb3bab58c165184aebe_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzMtMy0xLTEtMzI0Ng_8affd03a-0b48-457c-b91f-473e0b9b4f84"
      unitRef="usd">400000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iea63bf6b583842f8afb95e80d99e8bb1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzQtMS0xLTEtMzI0OQ_572dff13-6723-4cc3-88ed-3093a2662ad9"
      unitRef="usd">850000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i094a2a8c50c44667a8ed8cffec42dee4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzQtMy0xLTEtMzI0OQ_840e1382-94f3-4b05-9bd0-2d5e68fef6b7"
      unitRef="usd">850000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9b91b53fe18c4c4ea50245a93565fd7d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzUtMS0xLTEtMzI1Mg_43e6f82f-2ffe-4cb7-9fc8-5d41f7979eef"
      unitRef="usd">1207500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id9b70c30dde844758d39245d643825b8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzUtMy0xLTEtMzI1Mg_0dec03a9-a4e2-4bd5-8f86-b124d208f72f"
      unitRef="usd">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzYtMS0xLTEtMzc5MQ_6f8a4ca0-508e-409b-8dbb-3eec8312ce6e"
      unitRef="usd">2057500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzYtMy0xLTEtMzc5NA_2622f726-1e7d-4097-9e39-2d49a43ac363"
      unitRef="usd">1250000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzctMS0xLTEtMzI1NQ_35d97a2c-fabf-46a8-91cc-a5430542e904"
      unitRef="usd">371100000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzctMy0xLTEtMzI1NQ_cfa6436a-e7ca-4aec-990b-dfabebacd93d"
      unitRef="usd">177200000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzgtMS0xLTEtMzI1NQ_da353514-9b14-4d46-863e-e808c47b29d8"
      unitRef="usd">19200000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzgtMy0xLTEtMzI1NQ_cbed89e2-3e6a-4e5a-b72a-d0f6295c7103"
      unitRef="usd">13100000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzktMS0xLTEtMzc5MQ_2ee18951-45c9-463c-8db1-e1498b6c3243"
      unitRef="usd">1667200000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzktMy0xLTEtMzgwNA_a80804b6-03b2-4c7b-b2e8-4cd4be95a76b"
      unitRef="usd">1059700000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i6352fa03b74e459290adcf2b8f29d7e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzEyLTEtMS0xLTMyNTg_f5f425d9-8ac4-49fd-9ed9-03d618ba0127"
      unitRef="usd">461000000.0</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i57670ce42c9048fd998b9d1f66f24047_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzEyLTMtMS0xLTMyNTg_1d8b7dc4-a741-4e06-bdc9-edee64a4a81c"
      unitRef="usd">242200000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="i87fbc88d23bd4515b69081936e2c024c_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzE0LTMtMS0xLTMyNjU_b302a5ec-326b-4d7b-93af-2b17308643e5">P2Y6M</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzE1LTEtMS0xLTMyNjg_3da243cf-e67c-483a-a531-40aec077ba1b">P2Y10M24D</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="i1297bc3abcfa4f7382b94f81ed19c05b_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzE1LTMtMS0xLTMyNjg_b5f50bf8-6e76-4bd0-bb54-601668aed256">P4Y</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="i63f56e49768249e5b7989f94f1d74990_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTpmMmQyZmM3NzVkMGU0MGM1YmRjNzFmZjZlMGUyZTgxOC90YWJsZXJhbmdlOmYyZDJmYzc3NWQwZTQwYzViZGM3MWZmNmUwZTJlODE4XzE2LTEtMS0xLTMyNzE_1604ba9a-fe11-4fe5-ac70-0d30e09c386b">P4Y10M24D</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTQ2_baefa3a8-c3f3-4dab-9159-8f5d819ff2be">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal is as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total by which the notes&#x2019; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="i87fbc88d23bd4515b69081936e2c024c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzItMy0xLTEtMA_65a9fb83-4d6d-4539-be9c-3ad990588138"
      unitRef="usd">486200000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzMtMS0xLTEtMA_f70935ab-573c-454a-910e-4b0435b0e90a"
      unitRef="usd">1077500000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="i1297bc3abcfa4f7382b94f81ed19c05b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzMtMy0xLTEtMA_38cd956e-a6b3-4dd4-b918-93faee9a7343"
      unitRef="usd">372400000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="ifb9d3f521d5d48a9a1710727f9c1ed43_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzQtMS0xLTEtMA_07c82b30-0741-40f6-8cb4-4db058c139ee"
      unitRef="usd">1077500000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="ib6a74eecb57e41acb0aa286caff969ec_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo5ZjdlMTM1MzVhODQ0NmU1YTIyZmNkYjRlNjg2M2E1OC90YWJsZXJhbmdlOjlmN2UxMzUzNWE4NDQ2ZTVhMjJmY2RiNGU2ODYzYTU4XzQtMy0xLTEtMA_e91dd569-a304-4d13-9612-e12e25ae3c63"
      unitRef="usd">858600000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTQ3_00ca5d39-acf3-48e7-bd3f-39902258cdd1">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual coupon interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rates:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest on the 2022 Notes began accruing upon issuance and was payable semi-annually on May 15 and November 15 of each year. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The effective interest rate presented represents the rate applicable for the period outstanding. The Senior Convertible Notes due 2022 were fully redeemed by July 31, 2020, as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzQtMS0xLTEtMzMxNw_ebfef830-e09c-4a4e-87cf-87ed2a26107a"
      unitRef="usd">9300000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzQtMy0xLTEtMzMxNw_e6683a08-d6d6-431a-96cd-ad65b4d90684"
      unitRef="usd">9300000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzQtNS0xLTEtMzMyMA_cf6973d6-f321-42f7-8a6b-a674de330718"
      unitRef="usd">3500000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzYtMS0xLTEtMzMyNA_c9b25af0-1dec-4b90-89f6-0ea2998b435f"
      unitRef="usd">-68600000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzYtMy0xLTEtMzMyNA_435a382b-17e1-42b5-a1df-85ee76c51d85"
      unitRef="usd">-45800000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzYtNS0xLTEtMzMyNw_f82a09ae-6651-4faf-b6fc-d5616764e4c4"
      unitRef="usd">-16000000.0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzctMS0xLTEtMzMzOA_fa052c90-e6b9-4ed9-aeeb-50cc92cbb1b8"
      unitRef="usd">4000000.0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzctMy0xLTEtMzMzOA_0d9ea6a4-e31f-4859-935c-af7f9eb5c047"
      unitRef="usd">3700000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzctNS0xLTEtMzM0MQ_8b05e099-e001-482d-a6c8-751359a7f299"
      unitRef="usd">1800000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzgtMS0xLTEtMzMzMQ_f0c3e8d0-f510-445c-9f32-96a0d3a1e970"
      unitRef="usd">81900000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzgtMy0xLTEtMzMzMQ_e5a98ef4-ce22-4cc0-9300-c266197a1955"
      unitRef="usd">58800000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzctNS0xLTEtODA4OA_8a0aea92-c91c-4455-bec8-e13512da24a3"
      unitRef="usd">21300000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ic50af612698747bfbe32dc206df1497b_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzExLTEtMS0xLTMzNDg_80464eba-82c7-4935-b144-c675b0b7e188"
      unitRef="number">0.051</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i4a9055ea7e814dc08a48a9cc25b0a3e7_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzExLTMtMS0xLTMzNDg_74165233-9e4e-4fa6-adb7-ca9b26139152"
      unitRef="number">0.051</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id11ec3fd242a40cfb175758ef847aa82_I20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzExLTUtMS0xLTMzNDU_b3c82baf-5d0b-407c-a713-5bb5e941752d"
      unitRef="number">0.051</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i0d4ba8ee71d445d38e472a82695ac35e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzEyLTEtMS0xLTMzNTE_f21bde70-bd5e-4317-b64b-727442d6ed9f"
      unitRef="number">0.056</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ifa27edbf751044d38c98cc6490ee0239_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzEyLTMtMS0xLTMzNTE_0ffa7992-53f7-44b1-9845-59d63fefac9d"
      unitRef="number">0.056</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i385417946a284bda98679e20b7d7ac2b_I20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzEyLTUtMS0xLTMzNjA_022f1dde-4157-46d0-a589-53b91a95e36d"
      unitRef="number">0.056</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="if136e8c77c874676bf740b0c46fce4aa_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTozOTdlYjM0NWEzYjg0ODQwOGZlZDE4OWNiOTU4NWEyYy90YWJsZXJhbmdlOjM5N2ViMzQ1YTNiODQ4NDA4ZmVkMTg5Y2I5NTg1YTJjXzEzLTEtMS0xLTMzNjc_80de2be7-b7db-4138-a4a1-4e19e616685d"
      unitRef="number">0.055</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2b54ebecbc5445c08be0b579b40354c4_I20170612"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzg4MQ_0841d4b0-4379-45e1-a959-92bf99b995b0"
      unitRef="usd">400000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i327905247cf740c896e4c6b8ec6ba29b_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzk4MA_dfeff239-94f8-44f6-9fda-f627befdb62f"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i76005d853c2c4c6c974ae1790121a19c_D20170601-20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExNzI_08067ca5-a626-41dd-ab21-1538ed55a118"
      unitRef="usd">389000000.0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i327905247cf740c896e4c6b8ec6ba29b_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEzMjg_4b43a8fb-ecf0-4720-a468-33f357fd68da"
      unitRef="usdPerShare">99.09</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
      contextRef="iceb839a717174e39b3fba3bd84bba52e_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE2NDkyNjc0NDU1MjA5_12f882a5-d4d7-4c7d-8e1a-536b080a9649"
      unitRef="usd">70600000</us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="i94022d7303af424b83b5e28a7c9159c2_I20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI2MTg_010019b4-3baa-4be8-9e23-41fce54731a8"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="id4d936cb81684c6d951a9c9586de7935_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzMzOTM_282550fb-ac7e-45d7-83f0-b2031e4ab42d"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ie0f4cf90dbd54f36b16e48026ad767b8_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM0NTk_8994abd4-41d3-474f-917a-85beeeb30540"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="id4d936cb81684c6d951a9c9586de7935_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM1OTI_d6e75e0a-b28d-4c1f-a42a-6c8ef0596036"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i6b82c1d246504bdc9b052ed1631c170d_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM2ODA_b386542a-ff69-4edb-8b51-241e24186dac"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i02ce6fa21a4c467b932127bbab4129a9_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM3MTM_47a52083-968e-4a26-b72b-81da263532c1"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i02ce6fa21a4c467b932127bbab4129a9_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM4MzI_a3890cc4-cb09-403d-af7d-b25106100790"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i02ce6fa21a4c467b932127bbab4129a9_D20170101-20170630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzM4ODQ_ace11ed3-1bb8-4982-bc1c-9e26c1f09d02"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock
      contextRef="i144fe05e631d4754b752fbaffcb88425_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzU1NTk_d08f71bb-b3e4-4312-9aa7-2805caab6a7d"
      unitRef="number">1.40</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="id4d936cb81684c6d951a9c9586de7935_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzU2MTQ_cf8f4c15-c24c-46ed-b9ab-74172fe7a754"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ie0f4cf90dbd54f36b16e48026ad767b8_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzU2NzA_1b32987f-03ef-46db-ae3e-c4f7ee857525"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i144fe05e631d4754b752fbaffcb88425_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzU4NjI_f01d7015-7e77-4b6e-ac08-8b4974e7dc41"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <dxcm:PaymentsForRepurchaseOfConvertibleNotes
      contextRef="ib331a0829e1642b19cf7b81d2e144de8_D20200501-20200531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODc2MTU_315b95cd-fdef-4a44-bb02-87533282c812"
      unitRef="usd">282600000</dxcm:PaymentsForRepurchaseOfConvertibleNotes>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ib331a0829e1642b19cf7b81d2e144de8_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODc2OTU_df499a35-cf8e-4848-a048-5b6b8d9fcf4b"
      unitRef="shares">1953067</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if5dcc4f82db040e08f0392a1b34637e4_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODc3NDM_57efcdb2-b426-4beb-a89c-3423973649e3"
      unitRef="usd">260000000.0</us-gaap:DebtInstrumentFaceAmount>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountExercised
      contextRef="ia18646096f2f4313b85666436e60e864_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODgwMjA_a5270320-68c2-4736-be3b-f447210b2a1c"
      unitRef="usd">140000000.0</dxcm:DebtInstrumentConvertiblePrincipalAmountExercised>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i5c37e038885d460caf56e886ef183fc3_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODgxMTY_16941385-6a66-4ecf-91be-df7355988f42"
      unitRef="shares">1412497</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i171e86410669489fbef485118636de53_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODgzMTU_92dd0cca-973b-4a44-ba51-c96a2e2df27b"
      unitRef="usd">5900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ia48631aa96ef4bdd85a3f1e83f1deeb1_D20200629-20200629"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODg2NDg_b806e6c5-e7f9-40e8-bc37-611001f71cc0"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzYwODE_c0f3b941-4bd5-4856-8b07-4cd186a80ddd"
      unitRef="usd">850000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzYxODA_e0fe5484-0c71-49f3-b186-804f56d3701d"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzYzNzI_7ba12d6a-6fa0-4f0c-b07f-3ebe36cdb8d0"
      unitRef="usd">836600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzY1Mjg_bb2d22d5-16bd-40c8-9175-f9eff47a18e1"
      unitRef="usdPerShare">164.29</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
      contextRef="i8b3a6150f8924f1287825cc009c6b717_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzcyNjk_ddf9e187-7ccd-4934-be29-a9f017cd5ea8"
      unitRef="usd">171600000</us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="iea63bf6b583842f8afb95e80d99e8bb1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzc4NzM_981de89e-7580-46e1-b6d9-68f9293be840"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i690dc51114b644a9afb0024fdbd293c1_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzg3MTA_edb8f56b-03a5-4452-af7f-ab0e7f7dc47f"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i7282b108e48d4eabac8748333920ce52_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzg3NzY_8373fe3f-716b-48dc-9500-46fa10ed6547"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i690dc51114b644a9afb0024fdbd293c1_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0Xzg5MDk_a1916fc8-25e0-4472-8658-d07b8136c40e"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i46cf6aa4cbc04a0f82d9a6b0fe29ad48_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzkwMDI_bfdd4051-d817-49e6-ba4a-5f8a95b8e762"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i1faeacf9c3314fe59169bdbee5cb8ae9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzkwMzU_70aeb761-a4cd-432d-a068-716ff5e66e51"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i1faeacf9c3314fe59169bdbee5cb8ae9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzkxNTk_82e69477-bae4-48bb-ac9d-764421d9d632"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i1faeacf9c3314fe59169bdbee5cb8ae9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzkyMTE_6ac0e282-8e76-4327-b6f1-393cdc3ec35d"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock
      contextRef="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEwNTY5_af3c4c13-031a-482c-a3d3-c81094d0a60d"
      unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i690dc51114b644a9afb0024fdbd293c1_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEwNjI0_b8e597e5-1cdc-4c6b-b907-493b3e180c7a"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i7282b108e48d4eabac8748333920ce52_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEwNjgw_1638402e-f687-4ca6-a7e7-756146fda05d"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="id270445d85f84adb9a8f3f420d2029f3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEwODcy_95eb4027-c04a-4638-b70d-e3d5526615f2"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares
      contextRef="i2d77c5b3b87a4eef982cf15597f7eafd_I20181130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExMjUx_4932fdc8-81a6-4ce7-9479-a139498a2571"
      unitRef="shares">5200000</dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExMzA0_64615acf-0184-4849-b62f-c3bbf6a45f34"
      unitRef="usdPerShare">164.29</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i30b4cc8b7cfc464280fc946085b32af4_D20181101-20181130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExMzk0_0add96f5-650c-4d34-b070-8945005cd3e1"
      unitRef="usd">218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i30b4cc8b7cfc464280fc946085b32af4_D20181101-20181130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzExNDYw_0add96f5-650c-4d34-b070-8945005cd3e1"
      unitRef="usd">218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEyMzc1_9b74bcb2-bd36-429a-9730-aedb0db6fdf6"
      unitRef="shares">5200000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEyNTE1_66e54347-ff0e-4c1b-b453-295c1e81a0c6"
      unitRef="d">60</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i3242c36a6ad14885a214ac3bec4d7914_D20181101-20181130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEyNTY5_f7229f67-bf49-42bc-99df-ba6979195859"
      unitRef="usd">183800000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i65563331cccc49e1b2ae4e75a627ad93_I20181130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEyOTQw_a43d66dd-5a01-4cd4-bba3-cb986a7d9f8a"
      unitRef="usdPerShare">198.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5355d4cf31264d86bc5dda86afa70ac2_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODk2NTE_28a828d0-a40c-4d3b-a0a2-958edd3be7a6"
      unitRef="usd">1210000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5355d4cf31264d86bc5dda86afa70ac2_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODk3MzA_b501c84e-f363-4145-b3eb-6b59ee6a29cb"
      unitRef="number">0.0025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i99523a59b6a94e9f91658f912ad40913_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwODk5MzQ_d5d1aee2-04b9-4172-ab68-fa30ce8d1e5f"
      unitRef="usd">1190000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i99523a59b6a94e9f91658f912ad40913_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTAwOTM_77765f72-edee-4161-a145-5768be896a48"
      unitRef="number">600.42</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
      contextRef="i63f56e49768249e5b7989f94f1d74990_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTA3MTA_758572da-1d53-40ba-b92f-06f09a866f96"
      unitRef="usd">289400000</us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="i9b91b53fe18c4c4ea50245a93565fd7d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTE0MjQ_57e62c2f-6382-41b5-a77c-2c88a5040742"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ia1cdadf83f4347a1992e2190665bfc6b_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTIxOTU_4455e1f3-6e07-4c87-a092-6088b4440d48"
      unitRef="trading_day">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i8b263bb73db749f7903f4d16dee3cfc9_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTIyNjI_8b3b0989-cc3e-49f0-ad9b-397af20dc0ff"
      unitRef="trading_day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ia1cdadf83f4347a1992e2190665bfc6b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTIzOTY_5943125c-8ecc-4a01-83b4-0d36edf20b29"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i39aadb9741cd47b79480d481f086db3c_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTI0ODU_db65b3e8-9003-49f3-93b9-da86b91e7917"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i899bc18f65524335a7458c45e6a54130_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTI1MTk_e588cfcb-62d1-4436-9664-13e34556f13c"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i899bc18f65524335a7458c45e6a54130_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTI2NDA_8582564f-f4d0-4b1e-b96c-e5f840136791"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i899bc18f65524335a7458c45e6a54130_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTI2OTM_fbf55c34-7f39-4107-b926-35571f1b3b5c"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock
      contextRef="i63f56e49768249e5b7989f94f1d74990_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTM1NjY_356e6929-0b41-48a7-b19d-28215a2bddd2"
      unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ia1cdadf83f4347a1992e2190665bfc6b_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTM2MjI_f7887e75-d817-4a5d-b918-d76177ebb662"
      unitRef="trading_day">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i8b263bb73db749f7903f4d16dee3cfc9_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTM2Nzk_3e2ab255-e387-4536-b90b-e0e290c2ed5b"
      unitRef="trading_day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i144fe05e631d4754b752fbaffcb88425_D20170101-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzI3NDg3NzkwOTM4NzI_f01d7015-7e77-4b6e-ac08-8b4974e7dc41"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1e7080d6571940faabaa2f8e843f5374_I20181219"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEzNDA4_d628862f-033a-4b53-a1ea-8bf47a8cb8aa"
      unitRef="usd">200000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount
      contextRef="i1e7080d6571940faabaa2f8e843f5374_I20181219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzEzNDQw_c7712ad9-4d69-4bc7-a26b-a94e3eeef0dc"
      unitRef="usd">500000000.0</dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE1OTUw_0c4e347a-1b56-44b6-baf7-085eb71487af">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to availability and outstanding borrowings on our Credit Agreement is as follows as of the date indicated: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available principal amount &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding borrowings &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic7929e0a0d324cfd8fe012a9b24af6b7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzItMS0xLTEtMA_f8747d12-7d0c-403e-aa35-92a29ed632fe"
      unitRef="usd">200000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i99455d005fdd42b5914e278f7116ad83_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzMtMS0xLTEtMA_a69d3946-0bc7-4ba6-8d52-fa456f2793e3"
      unitRef="usd">10000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="ic7929e0a0d324cfd8fe012a9b24af6b7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzQtMS0xLTEtMA_d5ef175b-50c8-496f-8457-842d9196876f"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i99455d005fdd42b5914e278f7116ad83_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzUtMS0xLTEtMA_fcb34560-8897-4a46-bed4-22b61ddda44e"
      unitRef="usd">6300000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90YWJsZTo0MjNjYTExYTUyMzI0ZmVjYWQ2MGQxMjQwY2M3Y2Y5Mi90YWJsZXJhbmdlOjQyM2NhMTFhNTIzMjRmZWNhZDYwZDEyNDBjYzdjZjkyXzYtMS0xLTEtMA_1a569972-3a6c-40b5-8983-634a35b4b5e6"
      unitRef="usd">193700000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifb3f6f2593e742d39815ab135c1351cf_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0MTM4_a62370a0-83ca-4c52-8b08-2295d2949c91"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie5665c7a7af04c72b799bc76e98ac16e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0MTQ0_57434091-370b-45ef-b47c-4021a964ad00"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iaab87bfd0d144699b9389facb5c03069_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0MjM1_66ff2658-29eb-437b-ac63-b5ae42fbf18f"
      unitRef="number">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7106fbb087b843a4a42d39cd22960c2e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0MjQx_30004682-8645-4ef3-a12c-a1d6b6de3d7a"
      unitRef="number">0.02000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="id8fb79f3ea0d43d29986396d56c2e1f4_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0Mjkw_990630e7-7307-43eb-97c8-f6bb8b20c500"
      unitRef="number">0.002</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="if444b8bc180c4613992a636bbb38e095_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0Mjk3_ab182913-9c5d-4ed7-9a0c-fd62e9346f21"
      unitRef="number">0.003</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <dxcm:LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold
      contextRef="i70c1c83392ba4ac79884df02cce79fb8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzMvZnJhZzo1ZTRiODllMTFjZTQ0NTlmOWM3Y2Q3OWZhNDdiOGMzNC90ZXh0cmVnaW9uOjVlNGI4OWUxMWNlNDQ1OWY5YzdjZDc5ZmE0N2I4YzM0XzE0OTkw_47391aa6-d315-4ee7-859f-876f4b3b60fd"
      unitRef="usd">100000000.0</dxcm:LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4MDg_f03e2345-da39-4fa6-93dd-c732168f4383">&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6. Leases And Other Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease office, manufacturing and warehouse space facilities under various domestic and international non-cancellable operating lease arrangements that expire at various times through December 2030. We also have one land lease that expires in 2080. Certain of our leases have renewal options which allow us to extend the lease term typically between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzI4Mg_e822fe76-398d-4dc9-abc3-bdd5759fa7f2"&gt;three&lt;/span&gt; and five years per option and some of our leases have multiple options to extend. The remaining lease terms of our leases range from less than one year to approximately twenty years and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. Leases are classified as operating or financing at lease commencement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASC 842 utilizing the modified retrospective transition method through a $2.1 million cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of $26.7 million, finance lease right-of-use assets of $15.3 million, operating lease liabilities of $40.4 million and finance lease liabilities of $15.9 million in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:  Imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future lease cost excludes $16.3 million of legally binding minimum lease payments for leases signed but not yet &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;commenced&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $4.5&#160;million and $2.6&#160;million as of December&#160;31, 2020 and 2019, respectively, are included under &#x201c;Other long-term liabilities&#x201d; in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the twelve months ended December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Variable lease costs are primarily related to common area maintenance charges and property taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the twelve months ended December&#160;31, 2018 was &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$12.5 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$12.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the twelve months ended December&#160;31, 2020 and &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$9.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the twelve months ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are party to various purchase arrangements related to our manufacturing and research and development activities. As of December&#160;31, 2020, we had approximately $335.6 million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4Mjg_fc58652d-69a3-4a2d-b717-949175d89364">&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6. Leases And Other Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease office, manufacturing and warehouse space facilities under various domestic and international non-cancellable operating lease arrangements that expire at various times through December 2030. We also have one land lease that expires in 2080. Certain of our leases have renewal options which allow us to extend the lease term typically between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzI4Mg_e822fe76-398d-4dc9-abc3-bdd5759fa7f2"&gt;three&lt;/span&gt; and five years per option and some of our leases have multiple options to extend. The remaining lease terms of our leases range from less than one year to approximately twenty years and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. Leases are classified as operating or financing at lease commencement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASC 842 utilizing the modified retrospective transition method through a $2.1 million cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of $26.7 million, finance lease right-of-use assets of $15.3 million, operating lease liabilities of $40.4 million and finance lease liabilities of $15.9 million in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:  Imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future lease cost excludes $16.3 million of legally binding minimum lease payments for leases signed but not yet &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;commenced&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $4.5&#160;million and $2.6&#160;million as of December&#160;31, 2020 and 2019, respectively, are included under &#x201c;Other long-term liabilities&#x201d; in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the twelve months ended December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Variable lease costs are primarily related to common area maintenance charges and property taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the twelve months ended December&#160;31, 2018 was &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$12.5 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$12.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the twelve months ended December&#160;31, 2020 and &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$9.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the twelve months ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are party to various purchase arrangements related to our manufacturing and research and development activities. As of December&#160;31, 2020, we had approximately $335.6 million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ib49c1f2854e540609bb2322a657f82ee_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzI4OQ_2bf3ee24-357d-44e7-a7d9-ef447d9fbeba">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="if0763f994d3d4e1caba905e8a1c1bf92_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzc3MA_25d51c12-7f40-49fd-aeb0-a64149797048">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="ib49c1f2854e540609bb2322a657f82ee_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzc5MA_a2452a35-3fdd-4b80-af90-3ffe7dcd5303">P20Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69abd3c86e1942d8a6591c6630a96ad8_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzEwMjM_72db6f09-904a-4b26-97f2-f4ea84c7bef8"
      unitRef="usd">-2100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iacc146a3fcd448f9843cfc23757a5620_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzIwODI_b5a99d58-7a9e-4bb5-90bd-069788457c12"
      unitRef="usd">26700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iacc146a3fcd448f9843cfc23757a5620_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzIxMjM_1c45e0b9-3cac-465a-b7f4-a3ecac6d4f0d"
      unitRef="usd">15300000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="iacc146a3fcd448f9843cfc23757a5620_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzIxNTg_9da9e9b2-5438-400b-880c-43e7ab864453"
      unitRef="usd">40400000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="iacc146a3fcd448f9843cfc23757a5620_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzIxOTQ_1262a3d8-5c3e-437d-9019-9ce7bc4cc2ed"
      unitRef="usd">15900000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4MTc_8379a804-9348-4972-b224-cb19f5ba1e30">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:  Imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future lease cost excludes $16.3 million of legally binding minimum lease payments for leases signed but not yet &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;commenced&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4MzA_43171904-1c5c-42be-974a-5019b9279465">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:  Imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future lease cost excludes $16.3 million of legally binding minimum lease payments for leases signed but not yet &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;commenced&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEtMS0xLTEtMA_669b53db-5795-4186-abdd-87ddb2933b10"
      unitRef="usd">21200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEtMy0xLTEtMA_f85fddd4-1e04-497a-ba6f-74bebe1c710d"
      unitRef="usd">10700000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzItMS0xLTEtMA_4b905cbc-8c10-497c-a8c9-85f442d7ea10"
      unitRef="usd">22100000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzItMy0xLTEtMA_e48053f3-7a57-495a-9167-2b7ff1744453"
      unitRef="usd">4200000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzMtMS0xLTEtMA_ed915208-53e9-405b-b484-dae4e427b4ab"
      unitRef="usd">22400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzMtMy0xLTEtMA_89128af8-6cc5-4be4-9017-c2666e3ee3e2"
      unitRef="usd">4300000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzQtMS0xLTEtMA_dface545-6b2b-455e-a1c1-ec0ecb5bf5d3"
      unitRef="usd">20800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzQtMy0xLTEtMA_45c5861a-2753-42f8-871c-fe15d655fdc2"
      unitRef="usd">4500000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzUtMS0xLTEtMA_37c7da9a-ba37-4651-9ef5-da823c52fafb"
      unitRef="usd">20000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzUtMy0xLTEtMA_828837c3-a060-468b-a279-399f47fb0831"
      unitRef="usd">4600000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzYtMS0xLTEtMA_e9446492-d6d6-4f03-9f96-e2816850b322"
      unitRef="usd">32000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzYtMy0xLTEtMA_1c5e1962-74bf-4c98-8b7f-19011c3edab4"
      unitRef="usd">68700000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzctMS0xLTEtMA_09b86db6-dc62-4793-92f3-d4f90f88a920"
      unitRef="usd">138500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzctMy0xLTEtMA_bcb59080-f888-402b-b6a9-0c3d450456aa"
      unitRef="usd">97000000.0</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzgtMS0xLTEtMA_87765a62-d4b4-4113-a93e-45578c6ef436"
      unitRef="usd">20200000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzgtMy0xLTEtMA_36f6e49c-afb8-46c0-b0ce-7977c6224362"
      unitRef="usd">34200000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzExLTEtMS0xLTA_4f679e74-4572-4243-9a30-2db1cf09ca82"
      unitRef="usd">118300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzExLTMtMS0xLTA_9a6669c0-453f-4a23-a7a2-433ddeeb9874"
      unitRef="usd">62800000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEyLTEtMS0xLTA_7dbc9ee2-85a4-4eb7-826e-6c88d5f3f69b"
      unitRef="usd">16500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEyLTMtMS0xLTA_e8299b3e-5890-4735-8aaf-03b46b951047"
      unitRef="usd">8800000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEzLTEtMS0xLTA_00bbc717-6d79-4980-80cc-9d9bb6693339"
      unitRef="usd">101800000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo3ZmU4N2ZmMmIwODA0NGExODdjNDQ1OWM1ZGY2MmFiZC90YWJsZXJhbmdlOjdmZTg3ZmYyYjA4MDQ0YTE4N2M0NDU5YzVkZjYyYWJkXzEzLTMtMS0xLTA_6d8a31be-3bfd-435a-844b-0bb73f23e646"
      unitRef="usd">54000000.0</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <dxcm:LesseeFutureLeaseCostLeaseNotyetCommenced
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzE2NDkyNjc0NDI4MjYz_e5972a23-e10f-435c-86c7-afa5bb1a75ec"
      unitRef="usd">16300000</dxcm:LesseeFutureLeaseCostLeaseNotyetCommenced>
    <us-gaap:AssetRetirementObligation
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzgyNDYzMzcyMTg3MDQ_80a7cb8b-d3b1-406a-b62a-c783302b3fb7"
      unitRef="usd">4500000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzgyNDYzMzcyMTg3MTU_b740e978-511a-40ee-a6fe-be70a093e3f3"
      unitRef="usd">2600000</us-gaap:AssetRetirementObligation>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM4MTA_3c254ffa-a82f-4fd2-9227-91a13ab55071">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the twelve months ended December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Variable lease costs are primarily related to common area maintenance charges and property taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzMtMy0xLTEtMA_0597967f-b8e2-4a34-ab91-c903f717241b"
      unitRef="usd">2000000.0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzMtNS0xLTEtMjY3Nw_2edfb5b2-ba3d-4071-9779-4bd9a05716d5"
      unitRef="usd">1100000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzQtMy0xLTEtMA_ccd76f7b-1358-4063-936d-1bc806b693ee"
      unitRef="usd">1900000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzQtNS0xLTEtMjY3Nw_ae73bc48-d020-4c02-b2f4-632a5da6e54d"
      unitRef="usd">800000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseCost
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzUtMy0xLTEtMA_2fa3b9ae-30c1-4329-ba37-a28e21a76bd1"
      unitRef="usd">18400000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzUtNS0xLTEtMjY3Nw_947d7f46-2b35-420a-bb82-ca0b5cd3c4d5"
      unitRef="usd">12200000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzYtMy0xLTEtMA_aedf1853-642e-4a59-b626-38b8de23737c"
      unitRef="usd">1300000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzYtNS0xLTEtMjY3Nw_d3947d47-7e3d-4640-ba04-c6379438f37b"
      unitRef="usd">3500000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzctMy0xLTEtMA_4494d320-c04a-49aa-a31f-d2f18c4406bd"
      unitRef="usd">4200000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzctNS0xLTEtMjY3Nw_81c86006-b191-4502-8ee4-2ae01b721cf8"
      unitRef="usd">3900000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzgtMy0xLTEtMA_1e2e5d5f-aaa1-476d-b455-62f6f7cee3a4"
      unitRef="usd">27800000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTowZmNiNjQwYWI1OGQ0MTMyYmI3MDEwYTEzNDQ2N2Q2NC90YWJsZXJhbmdlOjBmY2I2NDBhYjU4ZDQxMzJiYjcwMTBhMTM0NDY3ZDY0XzgtNS0xLTEtMjY3Nw_832463da-20ca-41ea-a9f4-c302fab95dec"
      unitRef="usd">21500000</us-gaap:LeaseCost>
    <us-gaap:LeaseAndRentalExpense
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzgyNDYzMzcyMjQyNDA_9dc91c9f-a48d-4507-82c5-c1e801726258"
      unitRef="usd">12500000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:OperatingLeasePayments
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzMtMS0xLTEtMjY2NQ_b37c18ac-b294-4184-a2b3-11bec4c96249"
      unitRef="usd">18300000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzMtMS0xLTEtMjQ0Mw_4b3cfbab-ec91-42e6-bc03-b9932239c60c"
      unitRef="usd">14300000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzQtMS0xLTEtMjY2NQ_f0c90e62-e804-4d47-b787-f3b579f69fdb"
      unitRef="usd">700000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzQtMS0xLTEtMjQ0Mw_226575fb-391b-4765-8249-2308af0edda9"
      unitRef="usd">800000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzUtMS0xLTEtMjY2NQ_e44147c0-553d-43f8-8646-637f28409736"
      unitRef="usd">8500000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzUtMS0xLTEtMjQ0Mw_299edf06-a544-4917-8d02-f9ca3736f12c"
      unitRef="usd">500000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzctMS0xLTEtMjY2NQ_53c38d71-da9c-4ca2-bb2a-f5019d9abd7d"
      unitRef="usd">33500000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzctMS0xLTEtMjQ1MA_2e6d4b4b-8a1d-4f34-956c-50ed3d60be94"
      unitRef="usd">80600000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzgtMS0xLTEtMjY2NQ_3aa8cab7-9a88-4b69-aa04-b21c80414372"
      unitRef="usd">41700000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzgtMS0xLTEtMjQ1MA_56980c47-9b80-49a6-b044-442236cdd308"
      unitRef="usd">15500000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzEwLTEtMS0xLTI2NjU_ca4fd646-4316-44a1-80fe-591d70b2c9c7">P6Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzEwLTEtMS0xLTI0NTA_219fe22e-2cd4-40a8-9aa1-e27def115449">P6Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzExLTEtMS0xLTI2NjU_1019387f-754c-4bd1-8745-2080fa1cbcf9">P23Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzExLTEtMS0xLTI0NTA_9cec0813-6819-4420-ac5d-a6e87e03cd28">P13Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzEzLTEtMS0xLTI2NjU_62d8b9cf-2b74-496a-8a54-ebc15587c1a4"
      unitRef="number">5.0</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzEzLTEtMS0xLTI0NTA_42c2c62b-3cf5-4010-a1e6-656323bb1841"
      unitRef="number">5.0</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzE0LTEtMS0xLTI2NjU_ed551392-6d40-46c7-813b-5ea572647dc1"
      unitRef="number">5.2</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90YWJsZTo4NDAyM2IyNmZiY2E0ZGQ3YTYwNzIxZjkzMTZlYTNmOS90YWJsZXJhbmdlOjg0MDIzYjI2ZmJjYTRkZDdhNjA3MjFmOTMxNmVhM2Y5XzE0LTEtMS0xLTI0NTA_caf52e7f-3196-475d-9049-f0d62ac06a88"
      unitRef="number">5.0</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <dxcm:LesseeOperatingLeasesLeaseCostAmortization
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzM3OTE_805210e6-c923-4a54-96b0-f08ed6482cbb"
      unitRef="usd">12400000</dxcm:LesseeOperatingLeasesLeaseCostAmortization>
    <dxcm:LesseeOperatingLeasesLeaseCostAmortization
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzgyNDYzMzcyMTI2NDY_78cb5771-71a9-4261-87be-644c9e4f17f1"
      unitRef="usd">9100000</dxcm:LesseeOperatingLeasesLeaseCostAmortization>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNDUvZnJhZzo3MjJiMjg1YWE0ZGU0MTQ0ODIxMmNjZGFjZjA1ZTIwMS90ZXh0cmVnaW9uOjcyMmIyODVhYTRkZTQxNDQ4MjEyY2NkYWNmMDVlMjAxXzgyNDYzMzcyMDg2MDU_56926cec-8292-4e72-8be2-45a2aa2a315d"
      unitRef="usd">335600000</us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear>
    <dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNDUvZnJhZzo3MjJiMjg1YWE0ZGU0MTQ0ODIxMmNjZGFjZjA1ZTIwMS90ZXh0cmVnaW9uOjcyMmIyODVhYTRkZTQxNDQ4MjEyY2NkYWNmMDVlMjAxXzI3NQ_ed76a9e0-9fc9-4405-bbdd-4aef6520538e">P1Y</dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNDgvZnJhZzowZDM1NDVlNzJiZjc0NTdkOThhYTgzZTNiNzVmMGNiNS90ZXh0cmVnaW9uOjBkMzU0NWU3MmJmNzQ1N2Q5OGFhODNlM2I3NWYwY2I1XzcxNDY4MjU1ODI4MjY_7adcf6a8-10d7-4e6f-9e98-3f342ef3bdaf">&lt;div style="margin-bottom:6pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7. Contingencies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Litigation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. We do not believe we are party to any currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NDY_d4381528-31fc-41d5-a6a8-fcfeb7423509">&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8. Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside of the United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of the provision for income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(277.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant loss and tax credit carryforwards and years of expiration are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year of Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Operating Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax Credits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 29, 2020, California&#x2019;s Governor Newsom signed AB 85 into law, suspending California net operating loss utilization and imposing a $5.0&#160;million cap on the amount of business incentive tax credits companies can utilize, effective for tax years 2020 through 2022. As a result of the legislation, we are utilizing $2.4 million of California research and development credits for the tax year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Utilization of net operating losses and credit carryforwards is subject to an annual limitation due to ownership change limitations provided by Section&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state provisions. An ownership change limitation occurred as a result of the stock offering completed in February 2009. The limitation will result in approximately&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $1.9 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of U.S. research and development tax credits that will expire unused. The related deferred tax assets have been removed from the components of our deferred tax assets as summarized in the table below. The tax benefits related to the remaining federal and state net operating losses and tax credit carryforwards may be further limited or lost if future cumulative changes in ownership exceed 50% within any three-year period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our deferred tax assets and liabilities as of December 31, 2020 and 2019 are shown below. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our U.S. operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years of cumulative income. We analyzed both positive and negative evidence, and as a result, we released our valuation allowance on our deferred tax assets, with the exception of our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Convertible debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We released $287.2 million of valuation allowance related to our deferred tax assets, of which $285.5 million was recorded to income tax benefit and $1.7 million was recorded to additional paid-in capital. We maintain a valuation allowance of $55.5 million against our California research and development tax credits and certain foreign intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock and officers compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in statutory tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of adoption of ASU 2016-16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of Tax Cuts and Jobs Act of 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(275.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes at effective rates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 22, 2020, the Supreme Court effectively resolved the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Altera Corp. v. Commissioner&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case when it denied its petition to hear the case. Altera Corp. argued that the Treasury Department&#x2019;s regulation requiring related companies to share the cost of stock-based employee compensation is arbitrary, and thus invalid. The denial to hear the case supports that related companies should share in the cost of stock-based employee compensation. Pursuant to an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Altera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; clause in our cost-sharing agreement, we recalculated and retroactively billed stock-based compensation for years 2016-2020, resulting in an additional $32.0&#160;million cost-share payment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2017 Tax Cuts and Jobs Act included provisions for tax on Global Intangible Low-taxed Income (&#x201c;GILTI&#x201d;) effective for tax years of foreign corporations beginning after December 31, 2017. We have elected to account for GILTI in the period the tax is incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to our gross unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January&#160;1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to Tax Cuts and Jobs Act of 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the total unrecognized tax benefits at December 31, 2020, 2019, and 2018, $23.5&#160;million, $0, and $0, respectively, would reduce our annual effective tax rate if recognized. Interest and penalties are classified as a component of income tax expense and were not material for any period presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We conduct business globally and consequently file income tax returns and are subject to routine compliance audits in numerous jurisdictions including those material jurisdictions listed in the following table. We are currently under a routine examination by the Federal Central Office in Germany for fiscal years 2016-2018. We do not expect any material adjustments as a result of this audit. The U.S. net operating losses generated since 1999 and utilized in recent years are open for examination. The years remaining subject to audit, by major jurisdiction, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:15pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States (Federal and state)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;1999 - 2020 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;2016 - 2020 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;2017 - 2020 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;2015 - 2020 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate under a tax holiday in the Philippines, which is effective through December 31, 2023, and may be extended for another three years if certain additional requirements are satisfied. The tax holiday is conditional upon remaining in good standing, committing no violation of PEZA Rules and Regulations, pertinent circulars and directives. The impact of this tax holiday decreased foreign taxes by $0.1 million in 2020. We have been granted an investment tax allowance incentive by the Malaysian Investment Development Authority (MIDA) in Malaysia, which is effective through December 31, 2025. The tax incentive had no effect on foreign taxes during 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have approximately $1.4&#160;million of undistributed earnings attributable to operations in our controlled foreign corporations as of December 31, 2020. We assert that any foreign earnings will be indefinitely reinvested. Accordingly, we have not recorded a liability for taxes associated with any future distributions of these undistributed earnings as any distribution would be immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NTY_5cebefcb-aacf-4314-9f62-8a3df57d0a19">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside of the United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzItMS0xLTEtMA_f625d528-2347-40fc-af90-aab735e9a070"
      unitRef="usd">270700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzItMy0xLTEtMA_ed718b3f-09d1-452a-a44a-7e275c9c4e79"
      unitRef="usd">119100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzItNS0xLTEtMA_b92172a2-3b06-4242-88a9-b5fbf98b7776"
      unitRef="usd">-28300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzMtMS0xLTEtMA_5202c969-de3a-4851-8d93-a08adcd82442"
      unitRef="usd">-45700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzMtMy0xLTEtMA_29bb28cd-bf35-49e0-96fa-3fd51565861a"
      unitRef="usd">-14900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzMtNS0xLTEtMA_d1a0941a-67f5-4796-806c-dad8a9d42169"
      unitRef="usd">-98200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzQtMS0xLTEtMA_1e439776-52ad-427a-a09b-3a5210da421e"
      unitRef="usd">225000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzQtMy0xLTEtMA_98edfa3f-5ee8-4155-9fcb-7ce5f8b3a239"
      unitRef="usd">104200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTphM2E2NWZjZDc0ZWQ0OTBhYmYxMjRhMmEyNTg2YTg4ZC90YWJsZXJhbmdlOmEzYTY1ZmNkNzRlZDQ5MGFiZjEyNGEyYTI1ODZhODhkXzQtNS0xLTEtMA_0ef60eee-3a11-4e46-ba1a-602ca0d284b6"
      unitRef="usd">-126500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NDc_aa403c95-ce30-40b0-a6bd-747dc8262b06">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of the provision for income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(277.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzMtMS0xLTEtMA_4276feb6-0032-41be-a48b-b7525fcb06b2"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzMtMy0xLTEtMA_340c400b-361d-42d0-a864-1ff33de1559d"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzMtNS0xLTEtMA_19dca42e-27b6-4760-b54a-a4c9e00f039c"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzQtMS0xLTEtMA_d773b9c9-1b8d-4038-b4bf-dd17fbaf8668"
      unitRef="usd">6100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzQtMy0xLTEtMA_cb09fc9f-8655-4ff4-b403-127e7f2c0856"
      unitRef="usd">1000000.0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzQtNS0xLTEtMA_cdad9d67-7389-4907-a5d8-6d8c606d3e78"
      unitRef="usd">2700000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzUtMS0xLTEtMA_0ff15e1c-f67b-437a-8783-5f7e9ed9e151"
      unitRef="usd">2600000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzUtMy0xLTEtMA_8de7c9f8-4d83-4c83-af8e-fbc32b89489b"
      unitRef="usd">1900000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzUtNS0xLTEtMA_ba58f455-0b68-4974-a5f9-a9b4b17051d7"
      unitRef="usd">100000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzYtMS0xLTEtMA_b6c9ec07-db14-4aae-b5d0-a53329d68287"
      unitRef="usd">8700000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzYtMy0xLTEtMA_f394da78-786e-4232-9dcc-9e51fbeb6364"
      unitRef="usd">2900000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzYtNS0xLTEtMA_313ea53c-eef4-444c-a69c-2783ff77b912"
      unitRef="usd">2800000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzgtMS0xLTEtMA_a91cb266-d217-49b8-9755-ad09ec6f8713"
      unitRef="usd">-198800000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzgtMy0xLTEtMA_5f5130f3-1b78-42b9-9a4b-f5ea1b66a26f"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzgtNS0xLTEtMA_0f2c91f8-cec5-4798-87ca-e62b478f44a9"
      unitRef="usd">-1700000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzktMS0xLTEtMA_2e6bb2eb-2e76-4b5d-b79b-4fcd0dc418dc"
      unitRef="usd">-51400000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzktMy0xLTEtMA_e627b5d7-d5ba-45b1-8acc-eeb3363212ae"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzktNS0xLTEtMA_a04531df-81bd-439a-a4d5-10476851be6b"
      unitRef="usd">-500000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEwLTEtMS0xLTA_e8e94acf-69f7-4f0f-a65e-f9a02c6d3345"
      unitRef="usd">-27100000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEwLTMtMS0xLTA_ff4eabc5-fb77-4128-9ede-e2c18e24547e"
      unitRef="usd">200000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEwLTUtMS0xLTA_a6af7734-c6eb-4444-9f4d-7a42823d7080"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzExLTEtMS0xLTA_fb03b46c-f965-45ef-a0f3-4f0fb187d0f7"
      unitRef="usd">-277300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzExLTMtMS0xLTA_02f71f0c-400a-432f-9024-75d5eb25b9a6"
      unitRef="usd">200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzExLTUtMS0xLTA_ad91e84c-4b5b-496e-85fc-745f2e766a45"
      unitRef="usd">-2200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEyLTEtMS0xLTA_6d43193a-5436-4b46-9001-3917e5d09d4f"
      unitRef="usd">-268600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEyLTMtMS0xLTA_01a6593b-7ad6-4add-83a5-f5cdbdbe566f"
      unitRef="usd">3100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZToyYmU1MTA5ZjU5Mzg0ZTA4OTkxNTIxOGQ5OGEyYTgwOC90YWJsZXJhbmdlOjJiZTUxMDlmNTkzODRlMDg5OTE1MjE4ZDk4YTJhODA4XzEyLTUtMS0xLTA_2f148efc-7652-4ddf-a5ee-5434d3a8c135"
      unitRef="usd">600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU1OTk1OTI_444e9c61-4a7f-4d25-a95e-f250d4d7235d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant loss and tax credit carryforwards and years of expiration are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year of Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Operating Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax Credits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU1OTk1OTI_976b5686-8bc1-4fe1-81c7-16aa96f4dacb">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant loss and tax credit carryforwards and years of expiration are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year of Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Operating Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax Credits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8faa2bf597984c30b119197a6a7e086d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzMtMS0xLTEtMzM5OQ_8fd197b4-ea44-4bb8-839f-8464f15b4db3"
      unitRef="usd">169100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i4e773841aaec4c8f8602ad4486565e5d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzMtMy0xLTEtMzM5OQ_2e37a1c6-ff2b-4eed-8fb6-51f22cd3b1bf"
      unitRef="usd">438800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i36128ee14a734888bc09fffd96a8030b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzQtMS0xLTEtMzM5OQ_ab03b3d3-80b4-4577-a640-0bf0f413f795"
      unitRef="usd">236300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i6a1a9074faa14cd1aaebc1917a4bf806_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzQtMy0xLTEtMzM5OQ_5813f766-60b8-4f6e-871e-b182e082f290"
      unitRef="usd">235300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i3136d780e4b54c5c8c992096d59c7865_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzUtMS0xLTEtMzM5OQ_160b7407-b1ca-4321-9b09-02f362f5561c"
      unitRef="usd">36100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i63e11745d3934aeba348c054954eb311_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzUtMy0xLTEtMzM5OQ_6d120771-57e2-4cc9-b2de-fdb8db835a03"
      unitRef="usd">88800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i25f646d2021741ceb895186d3d836104_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzYtMS0xLTEtNzk3NQ_b726243c-289e-4765-84e2-6f2fda5701fd"
      unitRef="usd">113200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie5f9e39f0909482a94b926033b0fa78d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzYtMy0xLTEtNzk3OQ_f9b15b3b-ca93-4565-ac60-68530c633189"
      unitRef="usd">124100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i8faa2bf597984c30b119197a6a7e086d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzgtMS0xLTEtMzM5OQ_a987c0df-2b82-4c37-a6be-33264fb20882"
      unitRef="usd">73100000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i4e773841aaec4c8f8602ad4486565e5d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzgtMy0xLTEtMzM5OQ_d0489f57-d83a-4449-b5f1-b179bbf16734"
      unitRef="usd">54400000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i36128ee14a734888bc09fffd96a8030b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzktMS0xLTEtMzM5OQ_b6d6a037-4d19-46c2-be15-083dc4a5d3fc"
      unitRef="usd">66200000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i6a1a9074faa14cd1aaebc1917a4bf806_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo4N2Y3MWE0NTBlZWM0ZjYzYjk0OTkxODEwNTRjODJmYy90YWJsZXJhbmdlOjg3ZjcxYTQ1MGVlYzRmNjNiOTQ5OTE4MTA1NGM4MmZjXzktMy0xLTEtMzM5OQ_625658c9-12f5-4c73-98e5-5eaddafa14e5"
      unitRef="usd">52700000</us-gaap:TaxCreditCarryforwardAmount>
    <dxcm:ResearchAndDevelopmentTaxCreditsUtilized
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzE2NDkyNjc0NDM1MTgz_6fa54ce4-ce7d-47ae-b924-94362bff0766"
      unitRef="usd">2400000</dxcm:ResearchAndDevelopmentTaxCreditsUtilized>
    <dxcm:UnusedExpiredFederalIncomeTaxCredits
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzEyMjc_3b681bf2-acd6-42e6-a5dd-4ce33e38f4f9"
      unitRef="usd">1900000</dxcm:UnusedExpiredFederalIncomeTaxCredits>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NDg_1b658704-a8d1-4685-a3e1-bb13180f9f9b">Significant components of our deferred tax assets and liabilities as of December 31, 2020 and 2019 are shown below. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our U.S. operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years of cumulative income. We analyzed both positive and negative evidence, and as a result, we released our valuation allowance on our deferred tax assets, with the exception of our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Convertible debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzMtMS0xLTEtMA_c7b86331-e7ae-45f3-9397-7758eb2aa601"
      unitRef="usd">69200000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzMtMy0xLTEtMA_3059821e-b262-45a1-85c3-91b0cbe84335"
      unitRef="usd">127400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzQtMS0xLTEtMA_83657134-87c1-4c1c-a318-6abfd925c81c"
      unitRef="usd">53600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzQtMy0xLTEtMA_cf51313e-604c-4177-9bab-928c35ffb38f"
      unitRef="usd">57100000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzUtMS0xLTEtMA_8df6ce77-efd5-43ea-b077-2e3b39401ff8"
      unitRef="usd">101100000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzUtMy0xLTEtMA_9481b26e-20c2-4140-9c59-f7b7e0330549"
      unitRef="usd">78600000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzYtMS0xLTEtMA_512ecef7-373b-46fd-8036-45a35fb07b14"
      unitRef="usd">13000000.0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzYtMy0xLTEtMA_4108f877-19af-4909-87d5-030aeb37a9b3"
      unitRef="usd">10900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzctMS0xLTEtMA_7c181062-96dc-46f8-8909-b1cef5437b6e"
      unitRef="usd">16900000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzctMy0xLTEtMA_cf60579d-d994-4e77-9082-e4df6d00e7a4"
      unitRef="usd">14000000.0</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzgtMS0xLTEtMA_b5a2cf89-a83d-4e30-87db-bbbda047a886"
      unitRef="usd">110300000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzgtMy0xLTEtMA_ad5a1e41-857b-455a-bafb-9e3920b00e99"
      unitRef="usd">62000000.0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <dxcm:DeferredTaxAssetsConvertibleDebt
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzktMS0xLTEtMA_7d226f54-dc57-4d91-bfe9-74943d2a7385"
      unitRef="usd">0</dxcm:DeferredTaxAssetsConvertibleDebt>
    <dxcm:DeferredTaxAssetsConvertibleDebt
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzktMy0xLTEtMA_9d9dfaf3-99cd-4796-8dec-2b6853f1be55"
      unitRef="usd">1700000</dxcm:DeferredTaxAssetsConvertibleDebt>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzEwLTEtMS0xLTA_e38d10aa-4592-4a52-9cc3-2ee63c2769d4"
      unitRef="usd">364100000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzEwLTMtMS0xLTA_42bb4c0b-0a8b-4945-bfaa-ba97b59e549f"
      unitRef="usd">351700000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzExLTEtMS0xLTA_0fa5b82b-2b31-4cc4-8f9d-e981e198c462"
      unitRef="usd">55500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzExLTMtMS0xLTA_8f94eec1-d5fb-4c68-9e92-99f90f47109b"
      unitRef="usd">332200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzEyLTEtMS0xLTA_349be53d-7d66-47aa-a7b8-8fd7a57382e6"
      unitRef="usd">308600000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzEyLTMtMS0xLTA_153ed426-b319-40a6-9df4-897ba932d1a9"
      unitRef="usd">19500000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE0LTEtMS0xLTA_1779a735-dcdd-4ffe-92c1-3a4a6c22c699"
      unitRef="usd">36300000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE0LTMtMS0xLTA_ec0e9451-39b0-4cbe-972c-3bd31c356f89"
      unitRef="usd">19600000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE1LTEtMS0xLTA_89713440-6aa7-4bc1-8a52-c1ea9b08a077"
      unitRef="usd">55900000</dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount>
    <dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE1LTMtMS0xLTA_3b72678e-b8b9-43a5-adf9-0dd0275f36c9"
      unitRef="usd">0</dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE2LTEtMS0xLTA_a9f277ee-267a-4b3f-ae24-914e69bb0c38"
      unitRef="usd">92200000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE2LTMtMS0xLTA_d1e247ba-91bf-41ca-8dba-63865f8f6b50"
      unitRef="usd">19600000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE3LTEtMS0xLTA_89340d3a-cb9f-4dc2-87de-6d7fe9840381"
      unitRef="usd">216400000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo5MzVkZTg2YzhjMWQ0ZjE5ODM3YjVjM2FhM2QzODE0ZS90YWJsZXJhbmdlOjkzNWRlODZjOGMxZDRmMTk4MzdiNWMzYWEzZDM4MTRlXzE3LTMtMS0xLTA_fbe08125-209f-47ad-9c01-ba1ddff22d02"
      unitRef="usd">100000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzE2NDkyNjc0NDM1ODk3_82d6657f-03fb-410e-93c8-0809293dc1e2"
      unitRef="usd">-287200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i2cfebefd71d743d7bb8817b29e995207_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzEwOTk1MTE2NTUwODg_44e34306-d035-4eb7-add1-c3f694e23f4c"
      unitRef="usd">-285500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i584812d31d074a4d9c695bd53995b5d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzEwOTk1MTE2NTUxMDQ_8b085765-1d93-40c3-8ad8-aa23ecf1395e"
      unitRef="usd">-1700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i910cc468fb184823bb85a75afc8cbcc5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzEwOTk1MTE2NTUxNjk_c2f8b91b-7195-4aa4-8999-1c119ea3c8c7"
      unitRef="usd">55500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NzY_5de7f5ae-ac3e-488c-8438-33faebd11429">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock and officers compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in statutory tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of adoption of ASU 2016-16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of Tax Cuts and Jobs Act of 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(275.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes at effective rates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzItMS0xLTEtMA_fef3e685-6349-4718-8f58-6fca00032353"
      unitRef="usd">47300000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzItMy0xLTEtMA_cf9f6e54-e061-4566-96a1-17416c03ec84"
      unitRef="usd">21900000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzItNS0xLTEtMA_f02e453a-5b81-4e9e-8769-e8818b280e93"
      unitRef="usd">-26600000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzMtMS0xLTEtMA_e32a919e-61cc-4ef2-993e-7da4d4cd44c0"
      unitRef="usd">3200000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzMtMy0xLTEtMA_0f3710a8-081c-4b21-be94-f9d8020e201e"
      unitRef="usd">-2300000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzMtNS0xLTEtMA_96e34d83-4c53-4357-9807-5bc95d675e29"
      unitRef="usd">-5500000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <dxcm:EffectiveIncomeTaxReconciliationPermanentItems
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzQtMS0xLTEtMA_c040998e-394d-496c-9dba-28a15ba37fe9"
      unitRef="usd">13100000</dxcm:EffectiveIncomeTaxReconciliationPermanentItems>
    <dxcm:EffectiveIncomeTaxReconciliationPermanentItems
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzQtMy0xLTEtMA_7da41625-fdca-498f-9b8c-bae09c0fe9b9"
      unitRef="usd">1000000.0</dxcm:EffectiveIncomeTaxReconciliationPermanentItems>
    <dxcm:EffectiveIncomeTaxReconciliationPermanentItems
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzQtNS0xLTEtMA_d50a4065-71e9-4369-99b0-47a8c4c92013"
      unitRef="usd">1300000</dxcm:EffectiveIncomeTaxReconciliationPermanentItems>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzUtMS0xLTEtMA_69548417-f771-40e4-abde-dd526a73d246"
      unitRef="usd">24400000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzUtMy0xLTEtMA_dcbdf908-801c-48f6-a489-33668b3a1e9c"
      unitRef="usd">10800000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzUtNS0xLTEtMA_c72f02ab-becc-4ed0-b3c3-05f3a3d4be44"
      unitRef="usd">11700000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzYtMS0xLTEtMA_b015d178-5f1c-433d-9d9c-3a0227c0128e"
      unitRef="usd">-100000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzYtMy0xLTEtMA_d0fa3f90-4fd2-4cd7-97c1-4fb4545189bb"
      unitRef="usd">5600000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzYtNS0xLTEtMA_dd6e669a-ef2e-4814-b505-dd56b09b74ec"
      unitRef="usd">3700000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzctMS0xLTEtMA_64cab451-4b36-420b-8a9b-7c81b43d647c"
      unitRef="usd">-28700000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzctMy0xLTEtMA_7e7bf9fb-0cfe-4c8a-b0ff-fff2b7db7028"
      unitRef="usd">-14700000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzctNS0xLTEtMA_c9aa8e6d-6ed6-4998-88cd-8942dbc2dfa0"
      unitRef="usd">-5100000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzgtMS0xLTEtMA_94306c1e-b90d-4fc5-9c2f-5ea8cf6df5c2"
      unitRef="usd">-4100000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzgtMy0xLTEtMA_7087703a-e88b-4e17-8f1a-8e0d4ad08435"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzgtNS0xLTEtMA_325b344d-dced-4d0e-80f6-21e7eaf563b4"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEwLTEtMS0xLTA_6eae32fd-a42c-43ab-8869-471138a8b643"
      unitRef="usd">0</dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEwLTMtMS0xLTA_cbf859d7-a76d-479d-b4f6-9738f2d77787"
      unitRef="usd">0</dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEwLTUtMS0xLTA_a7a6bb65-2729-4fd8-8ef7-7899455389b8"
      unitRef="usd">-13300000</dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzExLTEtMS0xLTA_fc4b58e1-3087-4944-b806-30c74652a442"
      unitRef="usd">0</dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzExLTMtMS0xLTA_360e8ee6-be8d-4c91-b161-edcf4f1d8294"
      unitRef="usd">0</dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzExLTUtMS0xLTA_fab66040-51f5-4e88-8b08-48db35ae6a6e"
      unitRef="usd">-400000</dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEyLTEtMS0xLTA_f62b3944-63f9-42b6-8177-bbc60475df9d"
      unitRef="usd">100000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEyLTMtMS0xLTA_0cb3d89a-5f04-4edd-8f58-1b8eb0865070"
      unitRef="usd">-1000000.0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEyLTUtMS0xLTA_72f03489-8f9c-4eba-a4b2-561bacedff94"
      unitRef="usd">1300000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEzLTEtMS0xLTA_990c405b-a89d-4be9-a1e6-a082807e4b11"
      unitRef="usd">-275000000.0</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEzLTMtMS0xLTA_5c27f87e-e311-482c-b1a5-23ca40ef3076"
      unitRef="usd">3400000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzEzLTUtMS0xLTA_974df852-9bab-4f9d-b7da-5fa3c3e2308f"
      unitRef="usd">56900000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzE0LTEtMS0xLTA_c5937f71-26e7-4911-bfd9-6dc9cf2b18d8"
      unitRef="usd">-268600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzE0LTMtMS0xLTA_0e0f0bd7-8f8e-4d49-8bc7-3e8c3a7b1937"
      unitRef="usd">3100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTozNzE4YWMxZmE4Yzk0MmEwOTNkNGM1NWNmODYwZjg5Mi90YWJsZXJhbmdlOjM3MThhYzFmYThjOTQyYTA5M2Q0YzU1Y2Y4NjBmODkyXzE0LTUtMS0xLTA_c769b3de-e858-4bc9-b21c-cc4205c6d052"
      unitRef="usd">600000</us-gaap:IncomeTaxExpenseBenefit>
    <dxcm:ShareBasedCompensationIntercompanyCrossCharge
      contextRef="i90a1a747b94545808a4f6dc903487330_D20200622-20200622"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU1OTk1NzQ_d1b126c8-7ea3-4c2a-8e5f-9586a4355136"
      unitRef="usd">32000000.0</dxcm:ShareBasedCompensationIntercompanyCrossCharge>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1NzM_78117cf9-fbc1-4a5c-bbe5-c3fe9f588c5c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to our gross unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January&#160;1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to Tax Cuts and Jobs Act of 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic82615128e2c4fc99ac6cee2560ef199_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzEtMS0xLTEtMA_6eb6d3e2-d6a6-42dd-96b9-a62e19e6dafb"
      unitRef="usd">22800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzItMS0xLTEtMA_55397884-73fa-4ffa-98a3-0a6a40e58513"
      unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzMtMS0xLTEtMA_4779d516-43a8-493a-b15a-67e0dfb57393"
      unitRef="usd">3400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <dxcm:UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzQtMS0xLTEtMA_beb9c621-04f3-4a1b-bda6-fe1377d694d0"
      unitRef="usd">0</dxcm:UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzUtMS0xLTEtMA_e4253920-51ef-4911-84d3-33956af44ab6"
      unitRef="usd">25900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzYtMS0xLTEtMA_e2e820d8-2881-43d1-87fa-25c1ad3432c0"
      unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzctMS0xLTEtMA_ebac0fa1-2e29-44d5-b027-48f41b39c2a1"
      unitRef="usd">4500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzgtMS0xLTEtMA_704e9d0a-69d8-4bf2-afc2-0f9536bcc5a7"
      unitRef="usd">29500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzktMS0xLTEtMA_2b78ccfb-b8b8-40d5-a296-c9c22c57f6eb"
      unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzEwLTEtMS0xLTA_fd32a55a-197e-43a6-bf5b-c2c67aac49b4"
      unitRef="usd">8000000.0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90YWJsZTo0NGVkNDE0MWRlMDQ0ZTFiODczMWM3ZDEyNzYzNWNhNi90YWJsZXJhbmdlOjQ0ZWQ0MTQxZGUwNDRlMWI4NzMxYzdkMTI3NjM1Y2E2XzExLTEtMS0xLTA_11b0e35e-e979-4539-a185-94e86e5a4cda"
      unitRef="usd">36600000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU2MDc2MDM_74b9d006-f8f7-4a22-8fa6-744064eede5d"
      unitRef="usd">23500000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU2MDc2MTg_7e85987a-c69c-44b3-85bc-fc78ed455837"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU2MDc2MjU_85b4bebb-c196-4153-b612-81fbeaf4070a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <dxcm:PossibleExtensionPeriodofTaxHoliday
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQyNjg_601596cb-1091-4077-96c9-4526680ddd6b">P3Y</dxcm:PossibleExtensionPeriodofTaxHoliday>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="i6a547859b60a43fc9dc18e7cd1125a02_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzQ1MzQ_2b2efc9e-339b-4cbe-9cc7-944c370834a2"
      unitRef="usd">100000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTQvZnJhZzoxZWRmZWFkM2IyYzQ0NDNiYWQ4YjkwZjRkNGM3M2EwZC90ZXh0cmVnaW9uOjFlZGZlYWQzYjJjNDQ0M2JhZDhiOTBmNGQ0YzczYTBkXzcxNDY4MjU2MDc2MzM_e6ef1e97-8609-45cc-b834-c1797af57ead"
      unitRef="usd">1400000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2NTc_0b3b0f02-7e65-4362-bcca-e9a730a4c5df">&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9. Employee Benefit Plans and Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;401(k) Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a defined contribution 401(k) retirement plan (the 401(k) Plan) covering substantially all employees in the United States that meet certain age requirements. Employees who participate in the 401(k) Plan may contribute up to 75% of their compensation each year, subject to Internal Revenue Service limitations and the terms and conditions of the plan. Under the terms of the 401(k) Plan, we may elect to match a discretionary percentage of contributions. We match 50% of contributions up to 5% of annual compensation. Total matching contributions were $6.7 million and $4.8 million for the twelve months ended December&#160;31, 2020, and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan, or ESPP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2015 Employee Stock Purchase Plan (the 2015 ESPP), amended in December 2019, eligible employees can purchase shares of our common stock at semi-annual intervals through periodic payroll deductions during defined Offering &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periods. A total of up to 1.5 million shares may be issued under the 2015 ESPP and it expires upon the earliest to occur of (a) termination of the 2015 ESPP by our board of directors, (b) issuance of all of the shares of common stock reserved for issuance under the plan, or (c) May 28, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payroll deductions may not exceed 10% of the participant&#x2019;s cash compensation subject to certain limitations, and the purchase price will not be less than 85% of the lower of the fair market value of the common stock at either the beginning of the applicable Offering Period or the Purchase Date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We issued 89,194 and 150,408 and 189,904 shares of common stock under the 2015 ESPP during the twelve months ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2015, we adopted the Amended and Restated 2015 Equity Incentive Plan (the 2015 Plan), which replaced our 2005 Equity Incentive Plan and provides for the grant of incentive and nonstatutory stock options, restricted stock, stock bonuses, stock appreciation rights, and restricted stock units to employees, directors or consultants of the Company. On May 30, 2019 our stockholders approved an increase to the maximum number of shares that may be issued under the 2015 Plan. We are permitted to issue up to&#160;9.8 million&#160;shares under the 2015 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. When we reissue treasury stock, if the proceeds from the sale are more than the average price we paid to acquire the shares we record an increase in additional paid-in capital. Conversely, if the proceeds from the sale are less than the average price we paid to acquire the shares, we record a decrease in additional paid-in capital to the extent of increases previously recorded for similar transactions and a decrease in retained earnings for any remaining amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We issue new shares of common stock to satisfy RSU vesting under our employee equity incentive plans. We have not yet determined the ultimate disposition of the 0.8 million shares that we repurchased in 2018, and consequently we continue to hold them as treasury shares rather than retiring them. No shares of our common stock were repurchased during 2019 or 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have not granted any stock options since 2010. As of December&#160;31, 2020, we have no stock options outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of stock options exercised as of the date of exercise was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of options exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Units (RSUs)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU awards typically vest annually over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM3NDA_edbeb2b1-17ac-466a-946c-e20c5a225c47"&gt;three&lt;/span&gt; or four years and vesting is subject to continued services. A summary of our RSU activity for the twelve months ended December&#160;31, 2020, 2019 and 2018 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions except weighted average grant date fair value)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total vest-date fair value of RSUs vested was $331.8 million, $207.2 million and $120.9 million for the twelve months ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Common Stock Reserved for Future Issuance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of common stock reserved for future issuance were as follows as of the dated indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards under our plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserved for future grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the twelve months ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. &lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13 - 0.95&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.72 - 2.55&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;- 2.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility of Dexcom common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.51 - 0.63&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40 - 0.51&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&#160;- 0.67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;At December&#160;31, 2020, unrecognized estimated compensation costs related to unvested restricted stock units and ESPP shares totaled $147.6 million and are expected to be recognized through 2024.</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzMwMg_487c01f4-6bc2-4831-bd08-ce90d1c4d41a"
      unitRef="number">0.75</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzU0MA_7ad8bd99-72e2-4882-b4c3-7f49a91667c5"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzU2Ng_f9b7257f-7469-40f9-a620-c38c97d54275"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i68b2a5d21f1a4c78a4097b4bbc6d4f22_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzYyNw_12005ae6-5b6f-4bf7-8735-c57177383f58"
      unitRef="usd">6700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i344d8f8e50c34a90b390f141b61876c0_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzYzNA_56317991-e45d-4790-9fd4-d8cc7e22c89d"
      unitRef="usd">4800000</us-gaap:DefinedContributionPlanCostRecognized>
    <dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5Xzk0Mw_21ad78b1-8848-4733-94c1-b6300bb7b351"
      unitRef="shares">1500000</dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzEyMzU_c270ea3f-0bc5-458c-97b6-3df8636497be"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <dxcm:EmployeePurchasePriceFloorPercentage
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzEzNTQ_33a47924-ea18-4225-b367-e4eee5b2c13f"
      unitRef="number">0.85</dxcm:EmployeePurchasePriceFloorPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i3eaa2ff3c84445059ce87f458fcf8f69_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzE1MDY_10dea317-76e6-4f6c-abdd-57900478321d"
      unitRef="shares">89194</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i6fd1e8d507834f608ee1745f0ca4b27d_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzE1MTM_54d10e73-5a98-43be-8538-50fac8e36ec7"
      unitRef="shares">150408</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ic71d9325f84947ab8e12f76111648564_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzE1MjA_1d3b5d02-b131-4520-95ff-a3faee709740"
      unitRef="shares">189904</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ib7ad3a0859c04e32a8c6428b8ba0f02b_I20190530"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzIwNzM_81310d60-65c2-440d-960a-e4c422713db3"
      unitRef="shares">9800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzI4NjY_7620bfff-bfd7-4926-957a-f3f5c7df84d1"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzI5OTM_10df1fa3-b286-4ff3-bf63-3f29aaa075f9"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzI5OTM_681f6402-04e3-4585-821b-be7fa7b10382"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <dxcm:OptionsInMoneyNumber
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzMxMzM_186dd2f2-a0df-4f2e-99f4-860e04d80eb3"
      unitRef="shares">0</dxcm:OptionsInMoneyNumber>
    <dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2NjI_b2d7dc08-cd8e-45e0-85bb-7ed0816a546c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of stock options exercised as of the date of exercise was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of options exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo1NGVkN2Q4MjI3OWQ0YzY0OTAxYTdjOGUwNGIwM2VlNy90YWJsZXJhbmdlOjU0ZWQ3ZDgyMjc5ZDRjNjQ5MDFhN2M4ZTA0YjAzZWU3XzItMS0xLTEtMA_389a75c7-3ecf-436b-9e0f-1a776ae9f0d6"
      unitRef="usd">7900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo1NGVkN2Q4MjI3OWQ0YzY0OTAxYTdjOGUwNGIwM2VlNy90YWJsZXJhbmdlOjU0ZWQ3ZDgyMjc5ZDRjNjQ5MDFhN2M4ZTA0YjAzZWU3XzItMy0xLTEtMA_556a1c7d-3b7a-4241-b0db-694254363922"
      unitRef="usd">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo1NGVkN2Q4MjI3OWQ0YzY0OTAxYTdjOGUwNGIwM2VlNy90YWJsZXJhbmdlOjU0ZWQ3ZDgyMjc5ZDRjNjQ5MDFhN2M4ZTA0YjAzZWU3XzItNS0xLTEtMA_470af8e7-df19-4866-90f7-99e63c51bfc9"
      unitRef="usd">30000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i47532d047d3644c781d52180df17ad05_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM3NDY_f2c1dc21-3d5e-417e-b11a-9dabfdac8ddd">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2ODc_7da76acc-2c91-4c19-a987-c3dbee09bd9c">A summary of our RSU activity for the twelve months ended December&#160;31, 2020, 2019 and 2018 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions except weighted average grant date fair value)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9504f38e9d964a7e8248536f0d74412a_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEtMS0xLTEtMA_bc52a9d0-2a3e-427e-9f29-9c14e9445139"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9504f38e9d964a7e8248536f0d74412a_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEtMy0xLTEtMA_aacdf552-09f4-42b1-88c7-3aadf2ea77bd"
      unitRef="usdPerShare">70.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzItMS0xLTEtMA_3ff6b81e-c011-431f-9ca2-2e6b6e91d02d"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzItMy0xLTEtMA_7f5f69ec-27fd-4567-8bc0-6e55e4375d67"
      unitRef="usdPerShare">66.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzMtMS0xLTEtMA_fc0226cb-5e97-484b-b959-620d8e49a932"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzMtMy0xLTEtMA_331a4975-0a48-4898-ba7f-7802587472ab"
      unitRef="usdPerShare">68.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzQtMS0xLTEtMA_e23b1093-f73a-4cbc-8231-dc864f20857a"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i127a151fc6454b089e250685716d7352_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzQtMy0xLTEtMA_35a0c144-9025-4592-8513-f80751584265"
      unitRef="usdPerShare">68.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1723155f583c4254a40179612feb0ea3_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzUtMS0xLTEtMA_82d41048-b2c9-495d-944f-3e2d6b85377f"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1723155f583c4254a40179612feb0ea3_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzUtMy0xLTEtMA_46b6a205-52b2-481b-8c1c-df5754097b03"
      unitRef="usdPerShare">69.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="i1723155f583c4254a40179612feb0ea3_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzUtNS0xLTEtMA_ef643c44-2edb-4a47-a82e-a9effef62dd7"
      unitRef="usd">319000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzYtMS0xLTEtMA_77fcdcd3-6e28-4027-906b-f3cae25e8df0"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzYtMy0xLTEtMA_269738e6-4774-47ce-8698-e4578b04d308"
      unitRef="usdPerShare">144.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzctMS0xLTEtMA_f62ddf67-dd98-4db7-8418-e12d8e6810b5"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzctMy0xLTEtMA_2390874b-fe22-4758-8fc9-1d0f445e4897"
      unitRef="usdPerShare">69.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzgtMS0xLTEtMA_ac60520a-7fd6-4244-9e22-bde38b779904"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ic9d8a35e73cd4b978da203a18bc12cee_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzgtMy0xLTEtMA_d14c224d-f1de-463d-8c5b-01045f5490d7"
      unitRef="usdPerShare">83.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ifa8a47c445384ea284b35965e4852a2c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzktMS0xLTEtMA_447ebba0-b64c-4565-a493-0a43f4606d15"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ifa8a47c445384ea284b35965e4852a2c_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzktMy0xLTEtMA_364c0b7a-6008-4963-86e7-a005bc65d9dd"
      unitRef="usdPerShare">96.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="ifa8a47c445384ea284b35965e4852a2c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzktNS0xLTEtMA_3b73a3b3-b5f5-4ab9-afa1-b0b39e28bca1"
      unitRef="usd">392000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEwLTEtMS0xLTA_16a0f92d-9d12-4e07-81ca-603ed6d9957d"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEwLTMtMS0xLTA_f42ae732-a908-4c19-9c22-851a8e1db4f8"
      unitRef="usdPerShare">300.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzExLTEtMS0xLTA_0d61b0d5-4c3a-453c-a0ad-d96223718250"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzExLTMtMS0xLTA_98a1277d-2dda-4efa-8981-adfcf84ebe61"
      unitRef="usdPerShare">92.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEyLTEtMS0xLTA_055da916-28d4-44a7-aa7c-d46e8fbb7bb0"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i0cb993c653c8449fbe59cebe06f699ca_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEyLTMtMS0xLTA_3d89217a-3e32-469a-b78b-f6773545a91d"
      unitRef="usdPerShare">137.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia1db1c7118a14990b87107147de1cb98_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEzLTEtMS0xLTA_02dd3ef6-7bc8-4823-8d9d-29e0ed6b5fe2"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia1db1c7118a14990b87107147de1cb98_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEzLTMtMS0xLTA_46d38ebe-1edc-4bfc-80ff-266da79a49c4"
      unitRef="usdPerShare">183.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="ia1db1c7118a14990b87107147de1cb98_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTpiZmI1NTJkMzZiZDE0NmIyOTE0MjU0YWU5ZDc3NDZiOC90YWJsZXJhbmdlOmJmYjU1MmQzNmJkMTQ2YjI5MTQyNTRhZTlkNzc0NmI4XzEzLTUtMS0xLTA_a144d899-ac50-48af-be34-98089e22a0d2"
      unitRef="usd">430600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i01d87f1cf80c435ead42c507b8eda281_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM5MjE_190d9cb8-dd05-4ef6-ab68-3a07321ebdd2"
      unitRef="usd">331800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ia8fd4570b25642ea8b04ea92713cb66e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM5MjU_37006e25-dea4-4aed-a654-309cfbc091ef"
      unitRef="usd">207200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2ba655b237cf441f820842a13b7eb463_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM5MzI_7654be02-414c-4c94-9c97-e5ca5c15c972"
      unitRef="usd">120900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ3MDI_54e22a2c-e1bd-4db1-8b16-84f5e36cb8ab">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of common stock reserved for future issuance were as follows as of the dated indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards under our plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserved for future grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzQtMS0xLTEtMA_3a56ad45-adcc-4573-9f6d-b57d583ebf7c"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzQtMy0xLTEtMA_5174d20b-be4d-4722-aa03-06f4d658e0fd"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <dxcm:StockOptionsReservedForFutureGrant
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzUtMS0xLTEtMA_85e6acc1-dc20-47e6-b43a-43980b15c08b"
      unitRef="shares">4500000</dxcm:StockOptionsReservedForFutureGrant>
    <dxcm:StockOptionsReservedForFutureGrant
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzUtMy0xLTEtMA_876fab7f-87bb-4afe-9f7c-c67d0ce994d2"
      unitRef="shares">4900000</dxcm:StockOptionsReservedForFutureGrant>
    <dxcm:EmployeeStockPurchasePlanEsppSharesInEspp
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzYtMS0xLTEtMA_b1e788de-eb54-4db2-9e75-b9fd2e680dcd"
      unitRef="shares">800000</dxcm:EmployeeStockPurchasePlanEsppSharesInEspp>
    <dxcm:EmployeeStockPurchasePlanEsppSharesInEspp
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzYtMy0xLTEtMA_efbfdf73-4f49-458b-be35-fa47a2230d93"
      unitRef="shares">900000</dxcm:EmployeeStockPurchasePlanEsppSharesInEspp>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzctMS0xLTEtMA_66d6e2ca-de98-4797-b8a0-bdd838e544cb"
      unitRef="shares">6500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToyNjM5M2MyNGViM2M0N2Q1ODY5MDY3MTY2MTBkZTFiNS90YWJsZXJhbmdlOjI2MzkzYzI0ZWIzYzQ3ZDU4NjkwNjcxNjYxMGRlMWI1XzctMy0xLTEtMA_ba3c832e-fd18-4656-b1a4-18783bce2a86"
      unitRef="shares">7600000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2ODM_91942bef-f7fe-4c08-a8f9-4733fc06a97b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the twelve months ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic56e441b6e7d4ef4b7b31fa77f81e1dc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzItMS0xLTEtMA_c962841b-1344-4b2d-8399-17298c51f955"
      unitRef="usd">14600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i24efa051b28f4003a6f3ad6646ccd0dc_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzItMy0xLTEtMA_f71f610c-fd76-4908-9514-fd2020ebd5f9"
      unitRef="usd">9000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4dbec2aacc9441d089e0d26423888121_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzItNS0xLTEtMA_f05f16ca-d711-4547-9af1-a02bec6d351a"
      unitRef="usd">9200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iadfae12ea15548f8aca74a4ee79890a1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzMtMS0xLTEtMA_bc8a0b53-3657-4466-8284-8812cfe7c00b"
      unitRef="usd">37800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2bc01fa170ab4896aa6b4a5277b3b1e7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzMtMy0xLTEtMA_7f145007-cdd9-477b-95f3-66a6eae72fc6"
      unitRef="usd">33500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5cf1e522d2c04404b83cebc9cf795440_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzMtNS0xLTEtMA_e880d9ca-6747-4de0-938a-d8974bbd7f9a"
      unitRef="usd">33000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i95b164774729468997a9b3662aa8c9f9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzQtMS0xLTEtMA_ed296b31-6784-4c0a-a7f8-38b41bd32e64"
      unitRef="usd">67000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if89d6cfc919b4446a315489302b1219e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzQtMy0xLTEtMA_58032ec8-4718-4e64-9301-05e5c39f7699"
      unitRef="usd">60200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6ddc9d9a1baa4ed59713cfb3cc17c270_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzQtNS0xLTEtMA_310a70ea-554d-49ef-8e9a-ded4d462eb8b"
      unitRef="usd">59700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzUtMS0xLTEtMA_e97c5c76-ceab-4c99-b352-d1784e75d685"
      unitRef="usd">119400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzUtMy0xLTEtMA_1334a368-e485-4d91-bf3e-f58a0eccc98d"
      unitRef="usd">102700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZTo5ZDNhOGM0YmJiYzA0ZDg3OWI5MjAxYWQ5YjUwYjYwZi90YWJsZXJhbmdlOjlkM2E4YzRiYmJjMDRkODc5YjkyMDFhZDliNTBiNjBmXzUtNS0xLTEtMA_a8ce68eb-b477-4390-9527-124eedafff28"
      unitRef="usd">101900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2ODI_8cb73f11-a78c-46f7-8836-27825dda2c61">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13 - 0.95&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.72 - 2.55&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;- 2.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility of Dexcom common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.51 - 0.63&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40 - 0.51&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&#160;- 0.67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0049bf4214214416a8f099e71e710193_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItMS0xLTEtMC90ZXh0cmVnaW9uOjZkZTBhZmU3MGM4ZTRmNDE5YzJhNDJkOGJmMmUwNjM1XzEwOTk1MTE2Mjc3OTU_78fd4be6-c72a-45d5-95f8-410a624717a2"
      unitRef="number">0.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i29a3f0bb53204d2799a1664c7a293bc5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItMS0xLTEtMC90ZXh0cmVnaW9uOjZkZTBhZmU3MGM4ZTRmNDE5YzJhNDJkOGJmMmUwNjM1XzEwOTk1MTE2Mjc4MDQ_b581c186-481f-4992-b6c4-3acf1114fd54"
      unitRef="number">0.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iac621cbdae3640dfb12f31f495628cf4_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItMy0xLTEtMC90ZXh0cmVnaW9uOjEzOTVhMDM5YzFkNzQ3ZTlhYjU2NDhkMmU2MDNlOWZiXzEwOTk1MTE2Mjc3OTU_64f77fba-3114-4723-a066-15f3b73fc9c5"
      unitRef="number">1.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i63af19991b6d4963a2316839da7e8a70_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItMy0xLTEtMC90ZXh0cmVnaW9uOjEzOTVhMDM5YzFkNzQ3ZTlhYjU2NDhkMmU2MDNlOWZiXzEwOTk1MTE2Mjc4MDQ_d7fb5b87-7245-4a3a-a66c-d1663604482d"
      unitRef="number">2.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia7ed14556556429fa016d4abae113d69_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItNS0xLTEtMC90ZXh0cmVnaW9uOmY2MDdkM2Y2MzE5MTQzMjBiNzJiNTAyMDBkZGQxODU1XzEwOTk1MTE2Mjc3OTU_21869464-c4ff-42b0-b5e4-98b17e8604be"
      unitRef="number">1.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0764697150b3465c88c53e155b29e37f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzItNS0xLTEtMC90ZXh0cmVnaW9uOmY2MDdkM2Y2MzE5MTQzMjBiNzJiNTAyMDBkZGQxODU1XzEwOTk1MTE2Mjc4Mjc_f161a2eb-4c34-42c9-ab4e-26290700fc98"
      unitRef="number">2.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i34b608918eb7402ab4f47dba3669f52f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzMtMS0xLTEtMA_4351be3e-01ad-45cc-a14d-cae78b5eee44"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i55cba84e376a4aecb83de5d1d311be56_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzMtMy0xLTEtMA_eba29c22-b043-4218-8ca8-5846ae3bf277"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i688e9ce83e1c4d8f995dfcb32a30399c_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzMtNS0xLTEtMA_26511085-b7bf-4a94-ad60-035bc55b0d9a"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0049bf4214214416a8f099e71e710193_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjBhZWVkYWNkNTYwNTRhYmRhNzA1ZDZjZjY4ZTU4MmY5XzEwOTk1MTE2Mjc3OTU_bec9ab20-4114-495d-b657-63d3cca3f57a"
      unitRef="number">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i29a3f0bb53204d2799a1664c7a293bc5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjBhZWVkYWNkNTYwNTRhYmRhNzA1ZDZjZjY4ZTU4MmY5XzEwOTk1MTE2Mjc4MDI_df570c2a-84ed-4ce2-9570-09c7897ad0a2"
      unitRef="number">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iac621cbdae3640dfb12f31f495628cf4_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtMy0xLTEtMC90ZXh0cmVnaW9uOmRlZGVkYzdiMzJkMDQ5Njk5ODgyNTA3YmM5ZTU1MWI4XzEwOTk1MTE2Mjc3OTU_1be4df0d-47bf-4f0c-bf6e-2dd8f1b5b959"
      unitRef="number">0.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i63af19991b6d4963a2316839da7e8a70_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtMy0xLTEtMC90ZXh0cmVnaW9uOmRlZGVkYzdiMzJkMDQ5Njk5ODgyNTA3YmM5ZTU1MWI4XzEwOTk1MTE2Mjc4MDI_743d1c81-72be-4f3e-a115-4e9dd87f2676"
      unitRef="number">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia7ed14556556429fa016d4abae113d69_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtNS0xLTEtMC90ZXh0cmVnaW9uOjA0MmUzMjE5OGNhZjRmZDg4MWFlZjk3ZjM2YmViZGE5XzEwOTk1MTE2Mjc3OTU_c46bd9e9-f029-4e17-b474-23b947318078"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0764697150b3465c88c53e155b29e37f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzQtNS0xLTEtMC90ZXh0cmVnaW9uOjA0MmUzMjE5OGNhZjRmZDg4MWFlZjk3ZjM2YmViZGE5XzEwOTk1MTE2Mjc4MDQ_c49d004c-0d5e-4929-ac0a-7a11b09a7648"
      unitRef="number">0.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i34b608918eb7402ab4f47dba3669f52f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzUtMS0xLTEtMA_5a94e047-ca34-4bce-85c9-00a89eb7427f">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i55cba84e376a4aecb83de5d1d311be56_D20191001-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzUtMy0xLTEtMA_249deb92-a11e-4940-863a-ae0697714997">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i688e9ce83e1c4d8f995dfcb32a30399c_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90YWJsZToxMTgxMmIzNWJmOTM0YzBkYTZjMTZjMzAyYmI0YWVmYS90YWJsZXJhbmdlOjExODEyYjM1YmY5MzRjMGRhNmMxNmMzMDJiYjRhZWZhXzUtNS0xLTEtMA_09641ed7-9f71-40c9-8785-8cac5cb56842">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzQ2MDg_69b32815-2578-4b55-beb8-4821a4933162"
      unitRef="usd">147600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90ZXh0cmVnaW9uOjZkODAzOWI5M2MyMDQxZWFiNjg1ZDVmNmJjMDkwYzUwXzE3Nzk_b1114cb5-d466-452c-ad5d-f135d7dd9b5a">&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10. Business Segment and Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reportable Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We currently consider our operations to be, and manage our business globally within, one reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dexcom is domiciled in the United States. We sell our CGM systems through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the United States, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand. We disaggregate our revenue from contracts by geography and by major sales channel as we believe they best depict how the nature, amount and timing of revenues and cash flows are affected by economic factors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues by geographic region&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2020, 2019 and 2018, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The table below sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product. The majority of our long-lived assets are located in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside of the United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues by customer sales channel&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth revenues by major sales channel for the twelve months ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90ZXh0cmVnaW9uOjZkODAzOWI5M2MyMDQxZWFiNjg1ZDVmNmJjMDkwYzUwXzUwOQ_79fbf9f3-26bf-4534-bc7d-be32b2334ada"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90ZXh0cmVnaW9uOjZkODAzOWI5M2MyMDQxZWFiNjg1ZDVmNmJjMDkwYzUwXzE3ODE_022d7f18-e45a-48ee-964b-4d4eeba2db69">The table below sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product. The majority of our long-lived assets are located in the United States.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside of the United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa840b26370a49c1a7d4e9c32b365ada_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtMS0xLTEtMA_5b0c07c7-f7aa-42c5-b076-57c26cf26836"
      unitRef="usd">1509500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="ifa840b26370a49c1a7d4e9c32b365ada_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtMy0xLTEtMA_34c86adc-f51d-4b30-a5a2-746c7797a01f"
      unitRef="number">0.78</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3efb05cdfec5469584069bfe20b97f34_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtNS0xLTEtMA_2f8d25f4-0596-4cf5-9da1-a84b6824eeb2"
      unitRef="usd">1161500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i3efb05cdfec5469584069bfe20b97f34_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtNy0xLTEtMA_fe62df87-1390-4364-8251-a427b7ab1de9"
      unitRef="number">0.79</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fe068ff6a8d447aa24bbe067484df80_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtOS0xLTEtMA_0cc1e033-de4f-4028-b9a0-f13f075bd36a"
      unitRef="usd">818400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i1fe068ff6a8d447aa24bbe067484df80_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzQtMTEtMS0xLTA_3b16d26e-37ec-4194-b93d-bb7637f9e55d"
      unitRef="number">0.79</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5438637b49ce4764914c810d05bc68a1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtMS0xLTEtMA_044c4aa1-bc59-454f-8356-26c72822a3c6"
      unitRef="usd">417200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i5438637b49ce4764914c810d05bc68a1_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtMy0xLTEtMA_fe78e7eb-e278-4e17-8bcb-69a4f04659ef"
      unitRef="number">0.22</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66896da671864b0a8fd51f13e20833f9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtNS0xLTEtMA_49021d77-6f60-4b81-ae62-f4661c16d9a1"
      unitRef="usd">314500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i66896da671864b0a8fd51f13e20833f9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtNy0xLTEtMA_7d3d2ae2-f664-4547-85a9-a6e84ac31d05"
      unitRef="number">0.21</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i931962e264f448fb93ed19b0f908c9dd_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtOS0xLTEtMA_d5675af6-1236-43f6-8bbb-23b620da106d"
      unitRef="usd">213200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i931962e264f448fb93ed19b0f908c9dd_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzUtMTEtMS0xLTA_7feed622-568a-4e7f-9930-c6d593b61627"
      unitRef="number">0.21</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtMS0xLTEtMA_4fee8edc-8507-4ffb-a347-dc1fb8cff65b"
      unitRef="usd">1926700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtMy0xLTEtMA_79cdaa10-a122-4f75-bd58-7e9ac41a221c"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtNS0xLTEtMA_f371c67b-78e2-4c27-b7b8-6a7adc0efd3a"
      unitRef="usd">1476000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtNy0xLTEtMA_fc581cf5-67cf-47cd-b309-4a7f3233011f"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtOS0xLTEtMA_7ed1b31a-4a7a-4ab4-9f27-6e18e01a23d5"
      unitRef="usd">1031600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZToxYjJiNTI2MGI3ODI0ODg0ODE1YzQwMmQ1YTIwNzg2Ny90YWJsZXJhbmdlOjFiMmI1MjYwYjc4MjQ4ODQ4MTVjNDAyZDVhMjA3ODY3XzYtMTEtMS0xLTA_76bc9438-51eb-4767-b547-e67ef07b7775"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90ZXh0cmVnaW9uOjZkODAzOWI5M2MyMDQxZWFiNjg1ZDVmNmJjMDkwYzUwXzE3ODQ_7e6b6ed5-4892-4bc6-bf06-e142a7483a51">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth revenues by major sales channel for the twelve months ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ef105fbc7ec4827bdf560993cb05f98_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtMS0xLTEtMA_a2742ed8-9704-4815-a97e-769deaac5df9"
      unitRef="usd">1437600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i2ef105fbc7ec4827bdf560993cb05f98_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtMy0xLTEtMA_a5c24044-ed67-4a9f-b6a0-a4dac18f8c6d"
      unitRef="number">0.75</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba28294146894fc4a844398fae9b899e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtNS0xLTEtMA_1c8e9f63-7cd6-4837-90bc-9ee587486501"
      unitRef="usd">1011600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="iba28294146894fc4a844398fae9b899e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtNy0xLTEtMA_31ec1cb7-9354-4a60-8c05-f8e1048a34c6"
      unitRef="number">0.69</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7260e40093964fda96288a1c159934c9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtOS0xLTEtMA_9484b1f6-f61e-4122-afac-2fd6f09ccd99"
      unitRef="usd">652900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i7260e40093964fda96288a1c159934c9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzQtMTEtMS0xLTA_f8ab22ee-94a6-4b18-a57f-ab948b29e983"
      unitRef="number">0.63</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie028a8fb3e7348b9881b8512b4a4860b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtMS0xLTEtMA_fa4d1605-3788-43d3-9d18-8a8b27592447"
      unitRef="usd">489100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="ie028a8fb3e7348b9881b8512b4a4860b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtMy0xLTEtMA_0a6ff843-7ec0-44f1-9964-8601e2974330"
      unitRef="number">0.25</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38178bb74286401ba0308f4e347b9fd1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtNS0xLTEtMA_e7615903-5d4b-469e-9674-97901eb80946"
      unitRef="usd">464400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i38178bb74286401ba0308f4e347b9fd1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtNy0xLTEtMA_9bb587f1-2f78-4baa-bbfe-6f5b869c124d"
      unitRef="number">0.31</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i698887039b694543ab8c5c785c1d2f8f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtOS0xLTEtMA_4b552778-e423-4ca7-91ab-a79a3dfc8639"
      unitRef="usd">378700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i698887039b694543ab8c5c785c1d2f8f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzUtMTEtMS0xLTA_eec59702-f407-4398-9efe-87dd43c73fce"
      unitRef="number">0.37</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtMS0xLTEtMA_d97e01cd-9d3b-4d1a-9873-4d7c61d8bed5"
      unitRef="usd">1926700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtMy0xLTEtMA_0bcc49b0-eff6-41c1-9cff-9392cd1debdc"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtNS0xLTEtMA_77f18f9d-8092-4321-8677-7aa6324fe677"
      unitRef="usd">1476000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtNy0xLTEtMA_0b527c01-ecf0-40f6-b388-82096dc35c27"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtOS0xLTEtMA_7376f010-04c5-4852-8852-51ee3bdeddf0"
      unitRef="usd">1031600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjMvZnJhZzo2ZDgwMzliOTNjMjA0MWVhYjY4NWQ1ZjZiYzA5MGM1MC90YWJsZTo1Y2NjZGY5NTk0YTA0OThiYTAwYjdjY2RlNDNlMTBhNC90YWJsZXJhbmdlOjVjY2NkZjk1OTRhMDQ5OGJhMDBiN2NjZGU0M2UxMGE0XzYtMTEtMS0xLTA_51403742-6c0b-47ea-b173-fc05907b412a"
      unitRef="number">1</dxcm:RevenuePercentage>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90ZXh0cmVnaW9uOmVmZDcxNmJiZGE3YjQxOTk4OWEyNTI2MTZlN2FjYjc4XzE5_a92ba432-bdb0-4c3c-94e7-d18afee22b22">&lt;div style="margin-bottom:15pt;margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DexCom, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;SCHEDULE II&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic82615128e2c4fc99ac6cee2560ef199_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzItMS0xLTEtMA_b64fc608-e927-40bc-9aad-1a10004bc453"
      unitRef="usd">11400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzMtMS0xLTEtMA_bbb1ef2e-0df6-4414-a3a2-7027f65b19e3"
      unitRef="usd">3600000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzQtMS0xLTEtMA_07121288-9b64-476f-ada9-f990f660a5b2"
      unitRef="usd">8300000</dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="i2fd5d276941d4073bd0908f7bf7d7a4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzUtMS0xLTEtMA_a8a51fde-dd3d-4d7b-b5ec-79c1044a388f"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZToyZDM1YTViYmE4ODI0ZWMzOGNmOTVkMDUwNWYxMzQwMi90YWJsZXJhbmdlOjJkMzVhNWJiYTg4MjRlYzM4Y2Y5NWQwNTA1ZjEzNDAyXzYtMS0xLTEtMA_8cdc5661-2e63-4c1c-be5a-bc31ad8bf29c"
      unitRef="usd">7200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idd074ca304794ce49a646d4278e77cdd_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzItMS0xLTEtMA_4fb32194-97f1-474c-9aa3-4a6ce66ff427"
      unitRef="usd">7200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzMtMS0xLTEtMA_ab0b20e4-1058-42b1-b4a7-a3b269a38d29"
      unitRef="usd">900000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzQtMS0xLTEtMA_fad15339-0a7a-4497-8644-132b0ea19572"
      unitRef="usd">3000000.0</dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="i0f604cc768c74c86bd91d9e5085e6520_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzUtMS0xLTEtMA_0d4568bd-f061-4574-918d-73fe611f1a3d"
      unitRef="usd">700000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTpkZDMwZmU4NTdiM2U0ODMzOTA5MGVkZWM3OTI0YWJlOC90YWJsZXJhbmdlOmRkMzBmZTg1N2IzZTQ4MzM5MDkwZWRlYzc5MjRhYmU4XzYtMS0xLTEtMA_39f50348-9cb9-4015-8c36-65792708c88c"
      unitRef="usd">5800000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i09e2f6d29705425da4375d800e0c8257_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzItMS0xLTEtMA_00b13d08-d541-4553-9803-be88178006c4"
      unitRef="usd">5800000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzMtMS0xLTEtMA_1f78fa3a-5d40-43c3-a02e-7f403f6166d2"
      unitRef="usd">3200000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzQtMS0xLTEtMA_c3236bf2-e7db-4aa6-be61-1d3dd6d01900"
      unitRef="usd">2100000</dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzUtMS0xLTEtMA_3dc2d33e-efbf-40e5-8ffa-7214aaff89b0"
      unitRef="usd">300000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i1697460f2cd94010a9df70dc435b1690_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNjkvZnJhZzplZmQ3MTZiYmRhN2I0MTk5ODlhMjUyNjE2ZTdhY2I3OC90YWJsZTozY2UyZjY1ODk0Nzc0ZGY3ODVmYjM0ZGU3YjkyNWNmYy90YWJsZXJhbmdlOjNjZTJmNjU4OTQ3NzRkZjc4NWZiMzRkZTdiOTI1Y2ZjXzYtMS0xLTEtMA_a5561720-4aaa-41f2-8dc7-e856320d8714"
      unitRef="usd">7200000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775290088312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 04, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DEXCOM, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0857544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6340 Sequence Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">200-0200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 Par Value Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DXCM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,177,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents incorporated by reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement relating to its 2021 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;) are incorporated by reference in Part&#160;III, Items 10 through 14 of this Annual Report on Form 10-K, as specified in the responses to those item numbers. Except with respect to information specifically incorporated by reference in the Form 10-K, the Proxy Statement is not deemed to be filed as part hereof.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001093557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775415243704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 817.6<span></span>
</td>
<td class="nump">$ 446.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities', window );">Short-term marketable securities</a></td>
<td class="nump">1,890.1<span></span>
</td>
<td class="nump">1,087.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">428.5<span></span>
</td>
<td class="nump">286.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">234.7<span></span>
</td>
<td class="nump">119.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">53.9<span></span>
</td>
<td class="nump">30.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,424.8<span></span>
</td>
<td class="nump">1,969.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">515.3<span></span>
</td>
<td class="nump">321.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">93.3<span></span>
</td>
<td class="nump">71.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">19.3<span></span>
</td>
<td class="nump">18.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">216.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">14.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4,290.5<span></span>
</td>
<td class="nump">2,395.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">481.1<span></span>
</td>
<td class="nump">256.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">114.3<span></span>
</td>
<td class="nump">88.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short-term operating lease liabilities</a></td>
<td class="nump">16.5<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">614.1<span></span>
</td>
<td class="nump">360.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Long-term senior convertible notes</a></td>
<td class="nump">1,667.2<span></span>
</td>
<td class="nump">1,059.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">101.8<span></span>
</td>
<td class="nump">72.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">80.9<span></span>
</td>
<td class="nump">20.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,464.0<span></span>
</td>
<td class="nump">1,512.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December&#160;31, 2020 and December&#160;31, 2019</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.001 par value, 200.0 million shares authorized; 96.9 million and 96.1 million shares issued and outstanding, respectively, at December&#160;31, 2020; and 92.4 million and 91.6 million shares issued and outstanding, respectively, at December&#160;31, 2019</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,125.3<span></span>
</td>
<td class="nump">1,675.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(202.1)<span></span>
</td>
<td class="num">(695.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 0.8 million shares at December&#160;31, 2020 and December&#160;31, 2019</a></td>
<td class="num">(100.0)<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,826.5<span></span>
</td>
<td class="nump">882.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 4,290.5<span></span>
</td>
<td class="nump">$ 2,395.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295769192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="nump">200,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">96,900,000<span></span>
</td>
<td class="nump">92,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">96,100,000<span></span>
</td>
<td class="nump">91,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, at cost (shares)</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775297056328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,926.7<span></span>
</td>
<td class="nump">$ 1,476.0<span></span>
</td>
<td class="nump">$ 1,031.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">646.6<span></span>
</td>
<td class="nump">544.5<span></span>
</td>
<td class="nump">367.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,280.1<span></span>
</td>
<td class="nump">931.5<span></span>
</td>
<td class="nump">663.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">359.9<span></span>
</td>
<td class="nump">273.5<span></span>
</td>
<td class="nump">199.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">217.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">620.7<span></span>
</td>
<td class="nump">515.7<span></span>
</td>
<td class="nump">432.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">980.6<span></span>
</td>
<td class="nump">789.2<span></span>
</td>
<td class="nump">850.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">299.5<span></span>
</td>
<td class="nump">142.3<span></span>
</td>
<td class="num">(186.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(84.7)<span></span>
</td>
<td class="num">(60.3)<span></span>
</td>
<td class="num">(22.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="num">(5.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Income (loss) from equity investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
<td class="nump">80.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Interest and other income, net</a></td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">26.4<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">225.0<span></span>
</td>
<td class="nump">104.2<span></span>
</td>
<td class="num">(126.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">(268.6)<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 493.6<span></span>
</td>
<td class="nump">$ 101.1<span></span>
</td>
<td class="num">$ (127.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 5.23<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used to compute basic net income (loss) per share (shares)</a></td>
<td class="nump">94.4<span></span>
</td>
<td class="nump">91.1<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 5.06<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted net income (loss) per share (shares)</a></td>
<td class="nump">97.5<span></span>
</td>
<td class="nump">92.3<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeResearchAndDevelopmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Research and Development Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeResearchAndDevelopmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296741256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 493.6<span></span>
</td>
<td class="nump">$ 101.1<span></span>
</td>
<td class="num">$ (127.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation gain</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income, net of tax</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 494.5<span></span>
</td>
<td class="nump">$ 101.9<span></span>
</td>
<td class="num">$ (123.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775299061032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201602Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2017</a></td>
<td class="nump">$ 419.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 1,093.7<span></span>
</td>
<td class="num">$ (2.6)<span></span>
</td>
<td class="num">$ (671.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock for collaborative research and development fee (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Issuance of common stock for collaborative research and development fee</a></td>
<td class="nump">217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Convertible note hedge</a></td>
<td class="num">(218.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="nump">$ 171.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (shares)</a></td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">$ (100.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Sale of warrants</a></td>
<td class="nump">183.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">101.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(127.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(127.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2018</a></td>
<td class="nump">663.3<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">1,560.6<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="num">(798.9)<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt', window );">Tax benefit from Notes</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 102.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">101.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2019</a></td>
<td class="nump">882.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">1,675.9<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="num">(695.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="nump">289.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt', window );">Tax benefit from Notes</a></td>
<td class="num">(62.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of 2022 notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Repurchase and conversions of 2022 Notes</a></td>
<td class="nump">$ 87.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 119.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">493.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2020</a></td>
<td class="nump">$ 1,826.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 2,125.3<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="num">$ (202.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295400472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 493.6<span></span>
</td>
<td class="nump">$ 101.1<span></span>
</td>
<td class="num">$ (127.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">67.1<span></span>
</td>
<td class="nump">48.7<span></span>
</td>
<td class="nump">29.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">119.4<span></span>
</td>
<td class="nump">102.7<span></span>
</td>
<td class="nump">101.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">74.0<span></span>
</td>
<td class="nump">49.6<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RDexpensethroughissuanceofcommonstock', window );">Non-cash collaborative research and development fee through issuance of common stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">217.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain on equity investment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(36.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Realized (gain) loss on equity investment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="num">(44.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes (including benefit from valuation allowance release)</a></td>
<td class="num">(277.3)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash income and expenses</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(142.3)<span></span>
</td>
<td class="num">(60.0)<span></span>
</td>
<td class="num">(93.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(114.5)<span></span>
</td>
<td class="num">(49.1)<span></span>
</td>
<td class="num">(25.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other assets</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(7.2)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">194.5<span></span>
</td>
<td class="nump">109.0<span></span>
</td>
<td class="nump">56.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued payroll and related expenses</a></td>
<td class="nump">26.1<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">23.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability', window );">Deferred revenue and other liabilities</a></td>
<td class="nump">18.6<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">475.6<span></span>
</td>
<td class="nump">314.5<span></span>
</td>
<td class="nump">123.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of marketable securities</a></td>
<td class="num">(3,058.2)<span></span>
</td>
<td class="num">(2,030.4)<span></span>
</td>
<td class="num">(452.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sale and maturity of marketable securities</a></td>
<td class="nump">2,250.5<span></span>
</td>
<td class="nump">1,196.4<span></span>
</td>
<td class="nump">392.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(199.0)<span></span>
</td>
<td class="num">(180.0)<span></span>
</td>
<td class="num">(67.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(11.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="num">(11.3)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,018.0)<span></span>
</td>
<td class="num">(1,015.2)<span></span>
</td>
<td class="num">(139.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="nump">1,188.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">836.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PaymentsForRepurchaseOfConvertibleNotes', window );">Repurchase of convertible notes</a></td>
<td class="num">(282.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of warrants</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">183.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PurchaseofConvertibleNoteHedge', window );">Purchase of convertible note hedge</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(218.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(9.4)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">912.1<span></span>
</td>
<td class="nump">10.7<span></span>
</td>
<td class="nump">710.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">371.8<span></span>
</td>
<td class="num">(690.7)<span></span>
</td>
<td class="nump">695.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">446.4<span></span>
</td>
<td class="nump">1,137.1<span></span>
</td>
<td class="nump">441.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">818.2<span></span>
</td>
<td class="nump">446.4<span></span>
</td>
<td class="nump">1,137.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash, end of period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">818.2<span></span>
</td>
<td class="nump">1,137.1<span></span>
</td>
<td class="nump">1,137.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Common stock issued for repurchase and conversions of senior convertible notes</a></td>
<td class="nump">1,350.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Acquisition of property and equipment included in accounts payable and accrued liabilities</a></td>
<td class="nump">35.3<span></span>
</td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the year for interest</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the year for income taxes</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Assets and Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsForRepurchaseOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Repurchase of Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsForRepurchaseOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PurchaseofConvertibleNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of Convertible Note Hedge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PurchaseofConvertibleNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RDexpensethroughissuanceofcommonstock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash R&amp;D expense through issuance of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RDexpensethroughissuanceofcommonstock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeferredLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289019176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Significant Accounting Policies</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1. Organization and Significant Accounting Policies</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Organization and Business</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DexCom, Inc. is a medical device company that develops and markets continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income (loss) and in accumulated other comprehensive income in the equity section of our consolidated balance sheets. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in interest and other income, net in our consolidated statements of operations.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#8220;Fair Value Measurements.&#8221;</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#8217; equity in our consolidated balance sheets and included in comprehensive income (loss). Realized gains and losses on marketable debt securities are included in interest and other income, net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. See Note 3, &#8220;Fair Value Measurements&#8221; and Note 4, &#8220;Balance Sheet Details &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-Term Marketable Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for more information on our marketable debt securities and our marketable equity securities.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Accounts Receivable and Allowance for Doubtful Accounts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are generally recorded at the invoiced amount for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk and Significant Customers</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Accounts Receivable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor A</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor C</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inventory</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements. </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property and Equipment</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally three years for computer software and hardware, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE3MDQyNDMwMjk0NDM5_2fca5438-1d1d-4e75-bbcb-835f55e20811">four</span> to fifteen years for machinery and equipment, and five years for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or forty years. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Goodwill</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#8217;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#8217;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#8217;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#8217;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#8217;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#8217;s market capitalization as a part of our analysis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#8217;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded no goodwill impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in goodwill for the twelve months ended December&#160;31, 2020 and December 31, 2019 consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the twelve months ended December 31, 2018 consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Intangible Assets and Other Long-Lived Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are included in other assets in our consolidated balance sheets. We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE0MDk5_34699fb7-9374-4f8a-8afb-b91db71681d7">two</span> to seven years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. We recorded no intangible asset impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our US operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years cumulative income and expect to continue that profitability in future years. We analyzed both positive and negative evidence, and as a result released our valuation allowance on our deferred tax assets. We maintain the valuation allowance on our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense. </span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Warranty Accrual</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Loss Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. </span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.190%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Comprehensive Income (Loss)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two elements, net income (loss) and other comprehensive income. We report all components of comprehensive income (loss), including net income (loss), in our financial statements in the period in which they are recognized. Total comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income (loss) and the components of other comprehensive income, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income (loss).</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revenue Recognition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate our revenue from the sale of our reusable transmitter and receiver, collectively referred to as Reusable Hardware, and disposable sensors. We refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining how revenue should be recognized, a five-step process is used which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Policy Elections and Practical Expedients Taken</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our Dexcom Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes but is not limited to rebates, chargebacks, consideration payable to customers such as specialty distributor and wholesaler fees, product returns provision, prompt payment discounts, and various other promotional or incentive arrangements. We classify our provisions related to variable consideration </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a reduction of accounts receivable when we are not required to make a payment or as a liability when we are required to make a payment. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rebates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate provisions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate provisions for chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consideration Payable to the Customer</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pay administrative and service fees to certain of our distributors based on a fixed percentage of the product price. These fees are not in exchange for a distinct good or service and therefore are recognized as a reduction of the transaction price. We accrue for these fees based on actual net sales and contractual fee rates negotiated with the customer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#8220;30-day money back guarantee&#8221; program whereby first-time end-user customers may return Reusable Hardware. We estimate our product returns provision principally based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prompt Payment Discounts</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customers with prompt payment discounts which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discount accruals based on actual net sales and contractual discount rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Various Other Promotional or Incentive Arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other promotional or incentive arrangements are periodically offered to customers, including but not limited to co-payment assistance we provide to patients with commercial insurance, promotional programs related to the launch of products or other targeted promotions. We record a provision for the incentive earned based on the number of estimated claims and our estimate of the cost per claim related to product sales that we have recognized as revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain sales transactions, control transfers at delivery of the product to the customer. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related Reusable Hardware component. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales of Components include an assurance-type warranty.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of December&#160;31, 2020 included unbilled accounts receivable of $10.4 million. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within 12 months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after 12 months was $8.2 million as of December 31, 2020 and $2.1 million as of December 31, 2019. These balances are included in other long-term liabilities in our consolidated balance sheets. Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Cost of Sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Compensation Costs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI0MTYy_26f15051-f810-463e-bb6f-d6109b4adecc">one</span> year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations. </span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Product Shipment Costs</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Research and Development</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs. </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Advertising Costs</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses. Advertising expense was $76.5 million, $33.1 million and $24.0 million for the twelve months ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div style="margin-bottom:11pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Leases</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Share-Based Compensation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value time-based Restricted Stock Units or RSUs at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest. </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Net Income (Loss) Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from stock options, restricted stock units, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of stock options and restricted stock units and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per share for the periods shown.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.6&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127.1)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.06&#160;</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.44)</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and employee stock purchase plan</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the diluted net income (loss) per share attributable to common stockholders calculations were as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. Our adoption of ASU 2016-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. In addition, the outbreak of the novel strain of coronavirus, SARS-CoV-2 (&#8220;COVID-19&#8221;), has not had a significant impact on our expected credit losses or our consolidated financial statements during 2020. We are continuing to monitor the impact of COVID-19 on expected credit losses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU No. 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-04)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Our adoption of ASU 2017-04 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;Our adoption of ASU 2018-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (ASU 2018-15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This new guidance requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We adopted the new standard on January 1, 2020 on a prospective basis. Our adoption of ASU 2018-15 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently evaluating the impact that this guidance will have on our consolidated financial statements.</span></div><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This new guidance is intended to reduce the complexity of accounting for convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation and requires enhanced disclosures about the terms of convertible instruments. Entities may adopt ASU 2020-06 using either a partial retrospective or fully retrospective method of transition. This </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU is effective for public business entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently evaluating the impact that this guidance will have on our consolidated financial statements.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289281208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DevelopmentAndOtherAgreementsTextBlock', window );">Development and Other Agreements</a></td>
<td class="text"><div style="margin-bottom:14pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2. Development and Other Agreements</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Collaboration with Verily Life Sciences</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of Dexcom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we have made upfront and incentive payments and we will make potential future milestone payments upon the achievement of certain goals. In the fourth quarter of 2018, we made an initial payment of $250.0 million through the issuance of 1,840,943 shares of our common stock. We recorded a $217.7 million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The amount of the charge was based on our closing stock price of $118.28 per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and the transaction closed. During 2020 we made no incentive payments, while in 2019 we made incentive payments of $3.2 million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations. Additional milestone payments of up to a total of $275.0 million may become due and payable by us upon the achievement of future development, product regulatory approval and revenue milestones. These payments may be paid in cash or shares of our common stock, at our election. If we elect to make all $275.0 million of these payments in shares, we will issue a total of 2,025,036 shares of our common stock, based on the volume weighted average trading price during the 15 consecutive days ending on the date of the Restated Collaboration Agreement. Alternatively, if we elect to make all $275.0 million of these payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, adjusted for stock splits, dividends, and the like.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first revenue milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DevelopmentAndOtherAgreementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Development And Other Agreements [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DevelopmentAndOtherAgreementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289353416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3. Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values of our Level 2 marketable securities portfolio balance provided by our investment managers.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2020, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494.9&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,040.1&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2019, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level 1 and Level 2 securities during the years ended December&#160;31, 2020 and 2019. There were no transfers into or out of Level 3 securities during the years ended December&#160;31, 2020 and 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments are not significant and we include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are often privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant adverse effect on the fair values.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Senior Convertible Notes</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"/><td style="width:69.795%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,936.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Not applicable as no notes were outstanding at this date.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the carrying values of our senior convertible notes, see Note 5, &#8220;Debt.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency and Derivative Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we engage in hedging transactions to reduce foreign currency risks. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs, and the derivative instruments are recorded in current assets or current liabilities in our consolidated balance sheets consistent with the nature of the instrument at period end. Derivative gains and losses are included in interest and other income, net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2020 and December&#160;31, 2019, notional amounts of $48.0 million and $8.0 million, respectively, were outstanding to hedge certain foreign currency risk. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the twelve months ended December&#160;31, 2020, 2019 and 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exposures vary but are primarily concentrated in the British Pound, the Euro, and the Canadian Dollar. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div>In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when any impairment is recognized. We recorded no significant impairment losses during the twelve months ended December&#160;31, 2020, 2019 and 2018.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289281208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Balance Sheet Details</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4. Balance Sheet Details</span></td></tr></table></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:46.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></div></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890.1&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086.7&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087.1&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and 2019, all of our debt securities had contractual maturities of less than twelve months. Gross realized gains and losses on sales of our debt securities for the twelve months ended December&#160;31, 2020, 2019 and 2018 were not significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at December&#160;31, 2020 were not significant and were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the net gain recognized on marketable equity securities during the twelve months ended December&#160;31, 2020, 2019 and 2018 to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:59.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended&#160;<br/>&#160;December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains and losses recognized during the period on equity securities</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net gains and losses recognized during the period on equity securities sold during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Accounts Receivable</span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.3&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inventory</span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2020 and 2019, we recorded excess and obsolete inventory charges of $24.4 million and $14.1 million, respectively, in cost of sales as a result of our ongoing assessment of sales demand, inventory on hand for each product and the continuous improvement and innovation of our products. During the twelve months ended December 31, 2018, we recorded excess and obsolete inventory charges of $7.3 million in cost of sales primarily as a result of the approval and launch of our G6 system and our ongoing assessment of sales demand and the continuous improvement and innovation of our products. </span></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property and Equipment</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154.2)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105.0)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents our finance lease right-of-use assets.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for the twelve months ended December&#160;31, 2020, 2019 and 2018 was $64.0 million, $46.9 million, and $28.6 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on disposal of property and equipment during the twelve months ended December&#160;31, 2020, 2019 and 2018 recorded in operating expenses was $13.6 million, $10.5 million and $5.4 million, respectively. </span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Accounts Payable and Accrued Liabilities</span><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable trade</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:14pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Accrued Warranty</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warranty costs are reflected in our statements of operations as cost of sales. Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.649%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.0)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289260024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5. Debt</span></td></tr></table></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Senior Convertible Notes</span></td></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,057.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177.2)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of liability component</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity component</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 years</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding at this date.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal is as follows as of the dates indicated:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total by which the notes&#8217; if-converted value exceeds their principal amount</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding at this date.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense recognized on senior notes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rates:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest on the 2022 Notes began accruing upon issuance and was payable semi-annually on May 15 and November 15 of each year. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The effective interest rate presented represents the rate applicable for the period outstanding. The Senior Convertible Notes due 2022 were fully redeemed by July 31, 2020, as described below.</span></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding at this date.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Senior Convertible Notes due 2022 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2017, we completed an offering of $400.0 million aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.75% and a maturity date of May&#160;15, 2022 (the 2022 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately $389.0 million. The initial conversion rate of the 2022 Notes was 10.0918 shares per $1,000 principal amount of notes, which was equivalent to a conversion price of approximately $99.09 per share, subject to adjustments. The 2022 Notes could be settled in cash, stock, or a combination thereof, solely at our discretion. We used the if-converted method for assumed conversion of the 2022 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since upon conversion by the holders we could elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized $70.6 million in additional paid-in-capital, net of debt issuance costs, during 2017.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments were due on the 2022 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2022 Notes included customary terms and covenants, including certain events of default after which the 2022 Notes could be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2022 Notes), holders of the 2022 Notes had the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2022 Notes, plus any accrued and unpaid interest. Holders of the 2022 Notes who would convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption were, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2022, holders of the 2022 Notes could convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during any calendar quarter commencing after September&#160;30, 2017 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least 20 trading days (whether or not consecutive) during </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2022 Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2022 Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">if we called any or all of the Notes for redemption, at any time prior to the close on business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On or after February&#160;15, 2022, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2022 Notes could convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Circumstance (1) listed above occurred during the quarters ended December 31, 2019 and March 31, 2020. As a result, the 2022 Notes became convertible at the option of the holder from January 1, 2020 through June 30, 2020. On June 29, 2020, Dexcom issued a notice of redemption to the holders of its outstanding 2022 Notes which is described below. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after May 15, 2020, Dexcom could redeem for cash all or part of the 2022 Notes, at its option, if the last reported sale price of our common stock had been at least 140% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provided notice of redemption. The redemption price would be equal to 100% of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Repurchase, Conversion, and Redemption of 2022 Notes </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we used approximately $282.6 million of the net proceeds from the 2025 Notes offering described below and issued 1,953,067 shares of Dexcom common stock to repurchase $260.0 million principal amount outstanding of the 2022 Notes and the associated conversion feature of the repurchased notes (which was recorded in additional paid-in capital). In addition, holders of 2022 Notes with a principal amount of $140.0 million exercised their option to convert their 2022 Notes during the twelve months ended December 31, 2020. We settled these conversions by issuing 1,412,497 shares of our common stock. As a result of the repurchase and conversions of the 2022 Notes, we recorded a loss on extinguishment of debt of $5.9&#160;million for the twelve months ended December 31, 2020. The loss on extinguishment of debt included the unamortized debt issuance costs for the 2022 Notes. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, we issued a notice of redemption to the holders of our outstanding 2022 Notes pursuant to which we would redeem the outstanding 2022 Notes for cash at a price of 100% of the principal amount of the 2022 Notes plus accrued and unpaid interest, if any, on July&#160;31, 2020, unless earlier converted. The principal amount of 2022 Notes actually redeemed for cash was not significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.75% Senior Convertible Notes due 2023</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we completed an offering of&#160;$850.0 million&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;0.75%&#160;and a maturity date of&#160;December&#160;1, 2023&#160;(the 2023 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately&#160;$836.6 million. The initial conversion rate of the 2023 Notes is&#160;6.0869&#160;shares per&#160;$1,000 principal amount of notes, which is equivalent to a conversion price of approximately&#160;$164.29&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the 2023 Note Hedge) and warrants (the 2023 Warrants) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized $171.6 million in additional paid-in capital, net of debt issuance costs, during 2018. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during any calendar quarter commencing after March 31, 2019 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2023 Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that five-day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the 2023 Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after September&#160;1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Circumstance (1) listed above occurred during the quarters ended December 31, 2019, March 1, 2020, June 30, 2020, and September 30, 2020. As a result, the 2023 Notes were convertible at the option of the holder from January 1, 2020 through December 31, 2020; actual conversions during that period were not significant. Circumstance (1) listed above also occurred during the quarter ended December 31, 2020 and as a result, the 2023 Notes will be convertible at the option of the holder from January 1, 2021 through March 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2023 Notes prior to December 1, 2021. On or after December 1, 2021 and prior to September 1, 2023, Dexcom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Note Hedge</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to&#160;5.2 million&#160;shares of our common stock at an initial price of&#160;$164.29&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$218.9 million and we accounted for it as an equity instrument by recognizing $218.9 million in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on December&#160;1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;5.2 million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the 60 scheduled trading days starting on March&#160;1, 2024. We received&#160;$183.8 million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $198.38 per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.25% Senior Convertible Notes due 2025 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $1.21 billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.25% and a maturity date of November&#160;15, 2025 (the 2025 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to the offering, were approximately $1.19 billion. The initial conversion rate of the 2025 Notes is 1.6655 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $600.42 per share, subject to adjustments, with a maximum conversion rate of 2.3732. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized $289.4 million in additional paid-in-capital, net of debt issuance costs, during 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2025 Notes includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2025 Notes), holders of the 2025 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest. Holders of the 2025 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025, holders of the 2025 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during any calendar quarter commencing after September&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On or after August&#160;15, 2025, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2025 Notes prior to May&#160;20, 2023. On or after May&#160;20, 2023 and prior to August 15, 2025, Dexcom may redeem for cash all or part of the 2025 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revolving Credit Agreement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Terms of the Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2018, we entered into an amended and restated revolving credit agreement which was subsequently amended on May 11, 2020 (as amended, the Credit Agreement). The Credit Agreement provides for available principal amount of $200.0 million which can be increased up to $500.0 million at our option subject to customary conditions and approval of our lenders. Borrowings under the Credit Agreement are available for general corporate purposes, including working capital and capital expenditures. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Credit Agreement is as follows as of the date indicated: </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available principal amount </span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available balance</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans under the Credit Agreement bear interest at our choice of one of two base rates plus a range of applicable margin rates that are based on our leverage ratio. The first base rate is the highest of (a) the publicly announced JPMorgan Chase prime rate, (b) the federal funds rate, or (c) the overnight bank funding rate, and the applicable margin rate ranges from 0.375% to 1.000%. The second base rate is a LIBOR-based rate, and the applicable margin rate ranges from 1.375% to 2.000%. We will also pay a commitment fee of between 0.2% and 0.3%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement will mature on the earlier to occur of (i) December 19, 2023 or (ii) 91 days prior to the maturity date of the 2022 Notes or (iii) 91 days prior to the maturity date of the 2023 Notes if both (a) the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, is greater than EBITDA for the period of four consecutive fiscal quarters ending prior to such date and (b) unrestricted domestic cash on hand is less than the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, plus $100.0 million.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296546104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases And Other Commitments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6. Leases And Other Commitments</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Leases</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease office, manufacturing and warehouse space facilities under various domestic and international non-cancellable operating lease arrangements that expire at various times through December 2030. We also have one land lease that expires in 2080. Certain of our leases have renewal options which allow us to extend the lease term typically between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzI4Mg_e822fe76-398d-4dc9-abc3-bdd5759fa7f2">three</span> and five years per option and some of our leases have multiple options to extend. The remaining lease terms of our leases range from less than one year to approximately twenty years and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. Leases are classified as operating or financing at lease commencement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASC 842 utilizing the modified retrospective transition method through a $2.1 million cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of $26.7 million, finance lease right-of-use assets of $15.3 million, operating lease liabilities of $40.4 million and finance lease liabilities of $15.9 million in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statements of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:  Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease cost excludes $16.3 million of legally binding minimum lease payments for leases signed but not yet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">commenced</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $4.5&#160;million and $2.6&#160;million as of December&#160;31, 2020 and 2019, respectively, are included under &#8220;Other long-term liabilities&#8221; in our consolidated balance sheets. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the twelve months ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. </span></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease costs are primarily related to common area maintenance charges and property taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the twelve months ended December&#160;31, 2018 was </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$12.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 years</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 years</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$12.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the twelve months ended December&#160;31, 2020 and </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$9.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the twelve months ended December 31, 2019.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Purchase Commitments</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various purchase arrangements related to our manufacturing and research and development activities. As of December&#160;31, 2020, we had approximately $335.6 million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases And Other Commitments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6. Leases And Other Commitments</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Leases</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease office, manufacturing and warehouse space facilities under various domestic and international non-cancellable operating lease arrangements that expire at various times through December 2030. We also have one land lease that expires in 2080. Certain of our leases have renewal options which allow us to extend the lease term typically between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMzkvZnJhZzo1NTM4YmMzODdjODI0MDAxYmQyMjg3NmE1MzA5M2NlZC90ZXh0cmVnaW9uOjU1MzhiYzM4N2M4MjQwMDFiZDIyODc2YTUzMDkzY2VkXzI4Mg_e822fe76-398d-4dc9-abc3-bdd5759fa7f2">three</span> and five years per option and some of our leases have multiple options to extend. The remaining lease terms of our leases range from less than one year to approximately twenty years and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. Leases are classified as operating or financing at lease commencement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASC 842 utilizing the modified retrospective transition method through a $2.1 million cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of $26.7 million, finance lease right-of-use assets of $15.3 million, operating lease liabilities of $40.4 million and finance lease liabilities of $15.9 million in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statements of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:  Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease cost excludes $16.3 million of legally binding minimum lease payments for leases signed but not yet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">commenced</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $4.5&#160;million and $2.6&#160;million as of December&#160;31, 2020 and 2019, respectively, are included under &#8220;Other long-term liabilities&#8221; in our consolidated balance sheets. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the twelve months ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. </span></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease costs are primarily related to common area maintenance charges and property taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the twelve months ended December&#160;31, 2018 was </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$12.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 years</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 years</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$12.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the twelve months ended December&#160;31, 2020 and </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$9.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the twelve months ended December 31, 2019.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Purchase Commitments</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various purchase arrangements related to our manufacturing and research and development activities. As of December&#160;31, 2020, we had approximately $335.6 million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289028968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7. Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Litigation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. We do not believe we are party to any currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775287611896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8. Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.5)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the provision for income taxes are as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current income taxes</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198.8)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268.6)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant loss and tax credit carryforwards and years of expiration are as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Expiration</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Operating Loss:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Credits:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, California&#8217;s Governor Newsom signed AB 85 into law, suspending California net operating loss utilization and imposing a $5.0&#160;million cap on the amount of business incentive tax credits companies can utilize, effective for tax years 2020 through 2022. As a result of the legislation, we are utilizing $2.4 million of California research and development credits for the tax year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of net operating losses and credit carryforwards is subject to an annual limitation due to ownership change limitations provided by Section&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state provisions. An ownership change limitation occurred as a result of the stock offering completed in February 2009. The limitation will result in approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1.9 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of U.S. research and development tax credits that will expire unused. The related deferred tax assets have been removed from the components of our deferred tax assets as summarized in the table below. The tax benefits related to the remaining federal and state net operating losses and tax credit carryforwards may be further limited or lost if future cumulative changes in ownership exceed 50% within any three-year period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets and liabilities as of December 31, 2020 and 2019 are shown below. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our U.S. operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years of cumulative income. We analyzed both positive and negative evidence, and as a result, we released our valuation allowance on our deferred tax assets, with the exception of our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Share-based compensation</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.6&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.3)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92.2)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We released $287.2 million of valuation allowance related to our deferred tax assets, of which $285.5 million was recorded to income tax benefit and $1.7 million was recorded to additional paid-in capital. We maintain a valuation allowance of $55.5 million against our California research and development tax credits and certain foreign intangible assets.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:</span></div><div style="margin-bottom:9pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory tax rate</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent items</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock and officers compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in statutory tax rates</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of adoption of ASU 2016-16</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Tax Cuts and Jobs Act of 2017</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275.0)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes at effective rates</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2020, the Supreme Court effectively resolved the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altera Corp. v. Commissioner</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case when it denied its petition to hear the case. Altera Corp. argued that the Treasury Department&#8217;s regulation requiring related companies to share the cost of stock-based employee compensation is arbitrary, and thus invalid. The denial to hear the case supports that related companies should share in the cost of stock-based employee compensation. Pursuant to an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> clause in our cost-sharing agreement, we recalculated and retroactively billed stock-based compensation for years 2016-2020, resulting in an additional $32.0&#160;million cost-share payment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Tax Cuts and Jobs Act included provisions for tax on Global Intangible Low-taxed Income (&#8220;GILTI&#8221;) effective for tax years of foreign corporations beginning after December 31, 2017. We have elected to account for GILTI in the period the tax is incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to our gross unrecognized tax benefits:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January&#160;1, 2018</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to Tax Cuts and Jobs Act of 2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the total unrecognized tax benefits at December 31, 2020, 2019, and 2018, $23.5&#160;million, $0, and $0, respectively, would reduce our annual effective tax rate if recognized. Interest and penalties are classified as a component of income tax expense and were not material for any period presented. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business globally and consequently file income tax returns and are subject to routine compliance audits in numerous jurisdictions including those material jurisdictions listed in the following table. We are currently under a routine examination by the Federal Central Office in Germany for fiscal years 2016-2018. We do not expect any material adjustments as a result of this audit. The U.S. net operating losses generated since 1999 and utilized in recent years are open for examination. The years remaining subject to audit, by major jurisdiction, are as follows:</span></div><div style="margin-bottom:6pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Fiscal Year</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States (Federal and state)</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;1999 - 2020 </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;2016 - 2020 </span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;2017 - 2020 </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;2015 - 2020 </span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate under a tax holiday in the Philippines, which is effective through December 31, 2023, and may be extended for another three years if certain additional requirements are satisfied. The tax holiday is conditional upon remaining in good standing, committing no violation of PEZA Rules and Regulations, pertinent circulars and directives. The impact of this tax holiday decreased foreign taxes by $0.1 million in 2020. We have been granted an investment tax allowance incentive by the Malaysian Investment Development Authority (MIDA) in Malaysia, which is effective through December 31, 2025. The tax incentive had no effect on foreign taxes during 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have approximately $1.4&#160;million of undistributed earnings attributable to operations in our controlled foreign corporations as of December 31, 2020. We assert that any foreign earnings will be indefinitely reinvested. Accordingly, we have not recorded a liability for taxes associated with any future distributions of these undistributed earnings as any distribution would be immaterial.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775287984904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Benefit Plans and Stockholders' Equity</a></td>
<td class="text"><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9. Employee Benefit Plans and Stockholders&#8217; Equity</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a defined contribution 401(k) retirement plan (the 401(k) Plan) covering substantially all employees in the United States that meet certain age requirements. Employees who participate in the 401(k) Plan may contribute up to 75% of their compensation each year, subject to Internal Revenue Service limitations and the terms and conditions of the plan. Under the terms of the 401(k) Plan, we may elect to match a discretionary percentage of contributions. We match 50% of contributions up to 5% of annual compensation. Total matching contributions were $6.7 million and $4.8 million for the twelve months ended December&#160;31, 2020, and 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan, or ESPP</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2015 Employee Stock Purchase Plan (the 2015 ESPP), amended in December 2019, eligible employees can purchase shares of our common stock at semi-annual intervals through periodic payroll deductions during defined Offering </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periods. A total of up to 1.5 million shares may be issued under the 2015 ESPP and it expires upon the earliest to occur of (a) termination of the 2015 ESPP by our board of directors, (b) issuance of all of the shares of common stock reserved for issuance under the plan, or (c) May 28, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payroll deductions may not exceed 10% of the participant&#8217;s cash compensation subject to certain limitations, and the purchase price will not be less than 85% of the lower of the fair market value of the common stock at either the beginning of the applicable Offering Period or the Purchase Date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued 89,194 and 150,408 and 189,904 shares of common stock under the 2015 ESPP during the twelve months ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Incentive Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2015, we adopted the Amended and Restated 2015 Equity Incentive Plan (the 2015 Plan), which replaced our 2005 Equity Incentive Plan and provides for the grant of incentive and nonstatutory stock options, restricted stock, stock bonuses, stock appreciation rights, and restricted stock units to employees, directors or consultants of the Company. On May 30, 2019 our stockholders approved an increase to the maximum number of shares that may be issued under the 2015 Plan. We are permitted to issue up to&#160;9.8 million&#160;shares under the 2015 Plan. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. When we reissue treasury stock, if the proceeds from the sale are more than the average price we paid to acquire the shares we record an increase in additional paid-in capital. Conversely, if the proceeds from the sale are less than the average price we paid to acquire the shares, we record a decrease in additional paid-in capital to the extent of increases previously recorded for similar transactions and a decrease in retained earnings for any remaining amount. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue new shares of common stock to satisfy RSU vesting under our employee equity incentive plans. We have not yet determined the ultimate disposition of the 0.8 million shares that we repurchased in 2018, and consequently we continue to hold them as treasury shares rather than retiring them. No shares of our common stock were repurchased during 2019 or 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not granted any stock options since 2010. As of December&#160;31, 2020, we have no stock options outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised as of the date of exercise was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of options exercised</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units (RSUs)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU awards typically vest annually over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xNTcvZnJhZzo2ZDg1MDIwYmFlZDQ0MGNkOTA1MDZkNzg3NmRmOWQwOS90ZXh0cmVnaW9uOjZkODUwMjBiYWVkNDQwY2Q5MDUwNmQ3ODc2ZGY5ZDA5XzM3NDA_edbeb2b1-17ac-466a-946c-e20c5a225c47">three</span> or four years and vesting is subject to continued services. A summary of our RSU activity for the twelve months ended December&#160;31, 2020, 2019 and 2018 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions except weighted average grant date fair value)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;<br/>Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2017</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.68&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.44&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2018</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.19&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.45&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.63&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.07&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.51&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vest-date fair value of RSUs vested was $331.8 million, $207.2 million and $120.9 million for the twelve months ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock Reserved for Future Issuance</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of common stock reserved for future issuance were as follows as of the dated indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards under our plans:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserved for future grant</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-based Compensation </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the twelve months ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. </span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13 - 0.95</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72 - 2.55</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;- 2.25</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of Dexcom common stock</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.51 - 0.63</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40 - 0.51</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;- 0.67</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr></table>At December&#160;31, 2020, unrecognized estimated compensation costs related to unvested restricted stock units and ESPP shares totaled $147.6 million and are expected to be recognized through 2024.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775287766264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographic Information</a></td>
<td class="text"><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10. Business Segment and Geographic Information</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reportable Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently consider our operations to be, and manage our business globally within, one reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom is domiciled in the United States. We sell our CGM systems through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the United States, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand. We disaggregate our revenue from contracts by geography and by major sales channel as we believe they best depict how the nature, amount and timing of revenues and cash flows are affected by economic factors. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues by geographic region</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2020, 2019 and 2018, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The table below sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product. The majority of our long-lived assets are located in the United States.</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:39.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926.7&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues by customer sales channel</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth revenues by major sales channel for the twelve months ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:39.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926.7&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775287897032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="margin-bottom:15pt;margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SCHEDULE II</span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8211; </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VALUATION AND QUALIFYING ACCOUNTS</span></div></td></tr><tr><td colspan="15" style="background-color:#58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In millions)</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2017</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs and adjustments</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs and adjustments</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs and adjustments</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295367512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div>The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income (loss) and in accumulated other comprehensive income in the equity section of our consolidated balance sheets. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in interest and other income, net in our consolidated statements of operations<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income (loss) and in accumulated other comprehensive income in the equity section of our consolidated balance sheets. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in interest and other income, net in our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#8220;Fair Value Measurements.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#8217; equity in our consolidated balance sheets and included in comprehensive income (loss). Realized gains and losses on marketable debt securities are included in interest and other income, net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. </span></div>We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivables and Allowance for Doubtful Accounts</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Accounts Receivable and Allowance for Doubtful Accounts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are generally recorded at the invoiced amount for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Significant Customers</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk and Significant Customers</span></td></tr></table>Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inventory</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.</span></div>Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property and Equipment</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally three years for computer software and hardware, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE3MDQyNDMwMjk0NDM5_2fca5438-1d1d-4e75-bbcb-835f55e20811">four</span> to fifteen years for machinery and equipment, and five years for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or forty years. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets and Other Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Goodwill</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#8217;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#8217;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#8217;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#8217;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#8217;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#8217;s market capitalization as a part of our analysis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#8217;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded no goodwill impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in goodwill for the twelve months ended December&#160;31, 2020 and December 31, 2019 consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the twelve months ended December 31, 2018 consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Intangible Assets and Other Long-Lived Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are included in other assets in our consolidated balance sheets. We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzE0MDk5_34699fb7-9374-4f8a-8afb-b91db71681d7">two</span> to seven years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. We recorded no intangible asset impairment charges for the twelve months ended December&#160;31, 2020, 2019 or 2018.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our US operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years cumulative income and expect to continue that profitability in future years. We analyzed both positive and negative evidence, and as a result released our valuation allowance on our deferred tax assets. We maintain the valuation allowance on our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></div>We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty Accrual</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Warranty Accrual</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Loss Contingencies</span></td></tr></table>If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.190%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Comprehensive Income (Loss)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two elements, net income (loss) and other comprehensive income. We report all components of comprehensive income (loss), including net income (loss), in our financial statements in the period in which they are recognized. Total comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income (loss) and the components of other comprehensive income, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income (loss).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revenue Recognition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate our revenue from the sale of our reusable transmitter and receiver, collectively referred to as Reusable Hardware, and disposable sensors. We refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining how revenue should be recognized, a five-step process is used which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Policy Elections and Practical Expedients Taken</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our Dexcom Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes but is not limited to rebates, chargebacks, consideration payable to customers such as specialty distributor and wholesaler fees, product returns provision, prompt payment discounts, and various other promotional or incentive arrangements. We classify our provisions related to variable consideration </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a reduction of accounts receivable when we are not required to make a payment or as a liability when we are required to make a payment. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rebates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate provisions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate provisions for chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consideration Payable to the Customer</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pay administrative and service fees to certain of our distributors based on a fixed percentage of the product price. These fees are not in exchange for a distinct good or service and therefore are recognized as a reduction of the transaction price. We accrue for these fees based on actual net sales and contractual fee rates negotiated with the customer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#8220;30-day money back guarantee&#8221; program whereby first-time end-user customers may return Reusable Hardware. We estimate our product returns provision principally based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prompt Payment Discounts</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customers with prompt payment discounts which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discount accruals based on actual net sales and contractual discount rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Various Other Promotional or Incentive Arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other promotional or incentive arrangements are periodically offered to customers, including but not limited to co-payment assistance we provide to patients with commercial insurance, promotional programs related to the launch of products or other targeted promotions. We record a provision for the incentive earned based on the number of estimated claims and our estimate of the cost per claim related to product sales that we have recognized as revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain sales transactions, control transfers at delivery of the product to the customer. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related Reusable Hardware component. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales of Components include an assurance-type warranty.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of December&#160;31, 2020 included unbilled accounts receivable of $10.4 million. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within 12 months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after 12 months was $8.2 million as of December 31, 2020 and $2.1 million as of December 31, 2019. These balances are included in other long-term liabilities in our consolidated balance sheets. Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Cost of Sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Compensation Costs</span></div>We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg4OWIwOTMyNTE5ODRiZmI4ODFhMDk0ZWY1OWM1NGJkL3NlYzo4ODliMDkzMjUxOTg0YmZiODgxYTA5NGVmNTljNTRiZF8xMTUvZnJhZzoxMTRlZjY3MTRjYTI0NjUwOTcwMDU2NmYyYzNkMGE3MS90ZXh0cmVnaW9uOjExNGVmNjcxNGNhMjQ2NTA5NzAwNTY2ZjJjM2QwYTcxXzI0MTYy_26f15051-f810-463e-bb6f-d6109b4adecc">one</span> year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ProductShipmentCostsPolicyTextBlock', window );">Product Shipment Costs</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Product Shipment Costs</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Research and Development</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.</span></div>Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Advertising Costs</span></td></tr></table>We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Leases</span></td></tr></table></div><div style="margin-bottom:11pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Share-Based Compensation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value time-based Restricted Stock Units or RSUs at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div>We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text"><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Net Income (Loss) Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from stock options, restricted stock units, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of stock options and restricted stock units and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Guidance</a></td>
<td class="text"><div style="margin-bottom:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. Our adoption of ASU 2016-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. In addition, the outbreak of the novel strain of coronavirus, SARS-CoV-2 (&#8220;COVID-19&#8221;), has not had a significant impact on our expected credit losses or our consolidated financial statements during 2020. We are continuing to monitor the impact of COVID-19 on expected credit losses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU No. 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-04)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Our adoption of ASU 2017-04 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;Our adoption of ASU 2018-13 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (ASU 2018-15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This new guidance requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We adopted the new standard on January 1, 2020 on a prospective basis. Our adoption of ASU 2018-15 at the beginning of the first quarter of 2020 did not have a significant impact on our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently evaluating the impact that this guidance will have on our consolidated financial statements.</span></div><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This new guidance is intended to reduce the complexity of accounting for convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation and requires enhanced disclosures about the terms of convertible instruments. Entities may adopt ASU 2020-06 using either a partial retrospective or fully retrospective method of transition. This </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU is effective for public business entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently evaluating the impact that this guidance will have on our consolidated financial statements.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ProductShipmentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Shipment Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ProductShipmentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775294737560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedules of Percentage of Total Revenues and Accounts Receivable by Customer</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Accounts Receivable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor A</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor C</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Less than 10%</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Income (Loss) Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per share for the periods shown.</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.6&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127.1)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.06&#160;</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.44)</span></td><td style="background-color:#ddedd0;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and employee stock purchase plan</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share</a></td>
<td class="text">Outstanding anti-dilutive securities not included in the diluted net income (loss) per share attributable to common stockholders calculations were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289191240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Fair Value Hierarchy for Financial Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2020, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494.9&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,040.1&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2019, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock', window );">Schedule of Fair Value of Senior Convertible Notes</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"/><td style="width:69.795%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,936.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Not applicable as no notes were outstanding at this date.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the carrying values of our senior convertible notes, see Note 5, &#8220;Debt.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about fair value of asset and liability not measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2E<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=SL7498357-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775389967400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Short-term Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:46.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></div></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890.1&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available for sale:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available for sale</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086.7&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087.1&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of Reconciliation of Net Gain (Loss) Recognized on Equity Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the net gain recognized on marketable equity securities during the twelve months ended December&#160;31, 2020, 2019 and 2018 to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:59.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended&#160;<br/>&#160;December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains and losses recognized during the period on equity securities</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net gains and losses recognized during the period on equity securities sold during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.3&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154.2)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105.0)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents our finance lease right-of-use assets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable trade</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Accrued Warranty</a></td>
<td class="text">Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2020 and 2019 were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.649%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.0)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock', window );">Schedule of Other Long-Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:72.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295893176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,057.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177.2)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of liability component</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity component</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 years</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding at this date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of Converted Value of Notes</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal is as follows as of the dates indicated:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total by which the notes&#8217; if-converted value exceeds their principal amount</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding at this date.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense recognized on senior notes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rates:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest on the 2022 Notes began accruing upon issuance and was payable semi-annually on May 15 and November 15 of each year. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The effective interest rate presented represents the rate applicable for the period outstanding. The Senior Convertible Notes due 2022 were fully redeemed by July 31, 2020, as described below.</span></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding at this date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Availability and Outstanding Borrowings on Credit Agreement</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Credit Agreement is as follows as of the date indicated: </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available principal amount </span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available balance</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289356232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:  Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease cost excludes $16.3 million of legally binding minimum lease payments for leases signed but not yet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">commenced</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Finance Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:  Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease cost excludes $16.3 million of legally binding minimum lease payments for leases signed but not yet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">commenced</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Components of Lease Expense and Other Information</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the twelve months ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. </span></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease costs are primarily related to common area maintenance charges and property taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 years</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 years</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775290303080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) before Income Taxes Subject to Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.5)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the provision for income taxes are as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current income taxes</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198.8)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268.6)</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock', window );">Schedule of Tax Credit Carryforwards</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant loss and tax credit carryforwards and years of expiration are as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Expiration</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Operating Loss:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Credits:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of Operating Loss Carryforwards</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant loss and tax credit carryforwards and years of expiration are as follows:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Expiration</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Operating Loss:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Credits:</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">Significant components of our deferred tax assets and liabilities as of December 31, 2020 and 2019 are shown below. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. Prior to 2020, due to our U.S. operating losses and earnings volatility in previous years, which did not allow sustainable profitability, we had established and maintained a full valuation allowance on our deferred tax assets. In 2020, we achieved three years of cumulative income. We analyzed both positive and negative evidence, and as a result, we released our valuation allowance on our deferred tax assets, with the exception of our California research and development tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Share-based compensation</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.1&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.6&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.3)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92.2)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation between Effective Tax Rate and Statutory Rate</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:</span></div><div style="margin-bottom:9pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory tax rate</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent items</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock and officers compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in statutory tax rates</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of adoption of ASU 2016-16</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Tax Cuts and Jobs Act of 2017</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275.0)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes at effective rates</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to our gross unrecognized tax benefits:</span></div><div style="margin-bottom:11pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January&#160;1, 2018</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to Tax Cuts and Jobs Act of 2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296916968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock', window );">Schedule of Intrinsic Value of Options Exercised and Fair Value of Options Vested</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised as of the date of exercise was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of options exercised</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text">A summary of our RSU activity for the twelve months ended December&#160;31, 2020, 2019 and 2018 is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions except weighted average grant date fair value)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;<br/>Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2017</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.68&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.44&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2018</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.19&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.45&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="2" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.63&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.07&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.51&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock', window );">Schedule of Stock Options Reserved for Future Issuance</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of common stock reserved for future issuance were as follows as of the dated indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards under our plans:</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserved for future grant</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expenses</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the twelve months ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.2&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions for Employee Stock Purchase Plan</a></td>
<td class="text">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13 - 0.95</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72 - 2.55</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;- 2.25</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of Dexcom common stock</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.51 - 0.63</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40 - 0.51</span></div></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;- 0.67</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of intrinsic value of options exercised and fair value of options vested table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Shares Reserved For Future Issuance [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775287648328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue from External Customers by Geographic Areas</a></td>
<td class="text">The table below sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product. The majority of our long-lived assets are located in the United States.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:39.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161.5&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818.4&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926.7&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth revenues by major sales channel for the twelve months ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:11pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:39.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011.6&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652.9&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ddedd0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ddedd0;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926.7&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.0&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031.6&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ddedd0;padding:0 1pt"/><td colspan="2" style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ddedd0;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775298188168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents', window );">Maturity threshold of investments classified to cash equivalents</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod', window );">Sales return period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled accounts receivable</a></td>
<td class="nump">$ 10,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue that will be satisfied after 12 months</a></td>
<td class="nump">8,200,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">$ 76,500,000<span></span>
</td>
<td class="nump">$ 33,100,000<span></span>
</td>
<td class="nump">$ 24,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Customer contract payment terms</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Customer contract payment terms</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_AmortizationPeriodForIncentiveCompensationCosts', window );">Amortization period for incentive compensation costs</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AmortizationPeriodForIncentiveCompensationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Period For Incentive Compensation Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AmortizationPeriodForIncentiveCompensationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ContractPaymentTermsNumberofDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract Payment Terms, Number of Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ContractPaymentTermsNumberofDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maturity Threshold Of Investments Classified To Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization And Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition, Sales Returns, Coverage Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RevenueRecognitionSalesReturnsCoveragePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118261985&amp;loc=d3e55302-109406<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775294634856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Distributor A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Distributor B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Distributor C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Distributor D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Gross Accounts Receivable | Distributor A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Gross Accounts Receivable | Distributor B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Gross Accounts Receivable | Distributor C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295691800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 493.6<span></span>
</td>
<td class="nump">$ 101.1<span></span>
</td>
<td class="num">$ (127.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 5.23<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 5.06<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (shares)</a></td>
<td class="nump">94.4<span></span>
</td>
<td class="nump">91.1<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (shares)</a></td>
<td class="nump">97.5<span></span>
</td>
<td class="nump">92.3<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options and employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296140088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Anti-dilutive Securities (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775389975672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Verily Life Sciences | Collaborative Arrangement, Initial Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeArrangementUpfrontFee', window );">Initial payment on collaborative agreement</a></td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with acquisition, shares (in shares)</a></td>
<td class="nump">1,840,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118.28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Verily Life Sciences | Collaborative Arrangement, Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments', window );">Additional milestones and incentive payments</a></td>
<td class="nump">$ 275.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones', window );">Milestone payments due upon achievement of future development</a></td>
<td class="nump">$ 275.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues', window );">Potential future common stock issuable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,025,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated', window );">Consecutive days used to calculate volume weighted average trading price</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Development &amp; Regulatory Milestones</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeArrangementUpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Upfront Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeArrangementUpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeResearchAndDevelopmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Research and Development Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeResearchAndDevelopmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DevelopmentAgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Development Agreements [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DevelopmentAgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Future Common Stock Issuable, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PotentialFutureCommonStockIssuableSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Share Price, Consecutive Days Evaluated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289975816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 641.5<span></span>
</td>
<td class="nump">$ 255.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,890.1<span></span>
</td>
<td class="nump">1,087.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">2,535.0<span></span>
</td>
<td class="nump">1,342.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">491.5<span></span>
</td>
<td class="nump">110.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">494.9<span></span>
</td>
<td class="nump">110.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">150.0<span></span>
</td>
<td class="nump">144.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,890.1<span></span>
</td>
<td class="nump">1,087.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">2,040.1<span></span>
</td>
<td class="nump">1,232.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,570.4<span></span>
</td>
<td class="nump">676.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,570.4<span></span>
</td>
<td class="nump">676.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">258.8<span></span>
</td>
<td class="nump">248.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">258.8<span></span>
</td>
<td class="nump">248.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">60.9<span></span>
</td>
<td class="nump">162.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">60.9<span></span>
</td>
<td class="nump">162.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775391194072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount', window );">Transfers between Level 1 and Level 2 securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FairValueAssetsLevel3TransfersAmount', window );">Transfers in or out of Level 3 securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of outstanding hedge to currency risk</a></td>
<td class="nump">$ 48,000,000.0<span></span>
</td>
<td class="nump">$ 8,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FairValueAssetsLevel3TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets, Level 3 Transfers, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FairValueAssetsLevel3TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296796040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Senior Convertible Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of outstanding senior convertible notes</a></td>
<td class="nump">$ 3,155.6<span></span>
</td>
<td class="nump">$ 2,150.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Convertible Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of outstanding senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">890.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of outstanding senior convertible notes</a></td>
<td class="nump">1,936.4<span></span>
</td>
<td class="nump">$ 1,260.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of outstanding senior convertible notes</a></td>
<td class="nump">$ 1,219.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296946744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FinancialStatementDetailsLineItems', window );"><strong>Financial Statement Details [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 1,890.0<span></span>
</td>
<td class="nump">$ 1,086.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">1,890.1<span></span>
</td>
<td class="nump">1,087.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FinancialStatementDetailsLineItems', window );"><strong>Financial Statement Details [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,570.4<span></span>
</td>
<td class="nump">675.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">1,570.4<span></span>
</td>
<td class="nump">676.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FinancialStatementDetailsLineItems', window );"><strong>Financial Statement Details [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">258.7<span></span>
</td>
<td class="nump">248.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">258.8<span></span>
</td>
<td class="nump">248.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FinancialStatementDetailsLineItems', window );"><strong>Financial Statement Details [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">60.9<span></span>
</td>
<td class="nump">163.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">$ 60.9<span></span>
</td>
<td class="nump">$ 162.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FinancialStatementDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial Statement Details [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FinancialStatementDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775298279864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Maximum contractual maturities of debt securities held</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 64.0<span></span>
</td>
<td class="nump">$ 46.9<span></span>
</td>
<td class="nump">$ 28.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain (loss) on disposal of machinery and equipment</a></td>
<td class="num">(13.6)<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dxcm_ReceiverProductComponentMember', window );">Receiver Product Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 24.4<span></span>
</td>
<td class="nump">$ 14.1<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dxcm_ReceiverProductComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dxcm_ReceiverProductComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775397130936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract', window );"><strong>Net gain recognized on equity securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Net gains and losses recognized during the period on equity securities</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (4.2)<span></span>
</td>
<td class="nump">$ 80.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss', window );">Less: Net gains and losses recognized during the period on equity securities sold during the period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="num">(44.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 36.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289331416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable</a></td>
<td class="nump">$ 435.7<span></span>
</td>
<td class="nump">$ 292.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less allowance for doubtful accounts</a></td>
<td class="num">(7.2)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 428.5<span></span>
</td>
<td class="nump">$ 286.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296564440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 69.9<span></span>
</td>
<td class="nump">$ 64.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">11.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">150.6<span></span>
</td>
<td class="nump">43.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 234.7<span></span>
</td>
<td class="nump">$ 119.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295406984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Property and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">$ 669.5<span></span>
</td>
<td class="nump">$ 426.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(154.2)<span></span>
</td>
<td class="num">(105.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">515.3<span></span>
</td>
<td class="nump">321.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">49.2<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">35.7<span></span>
</td>
<td class="nump">32.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">198.9<span></span>
</td>
<td class="nump">130.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">135.8<span></span>
</td>
<td class="nump">102.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">$ 219.0<span></span>
</td>
<td class="nump">$ 132.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296108664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable trade</a></td>
<td class="nump">$ 163.3<span></span>
</td>
<td class="nump">$ 102.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_AccruedTaxAuditAndLegalFees', window );">Accrued tax, audit, and legal fees</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PharmacyRebates', window );">Accrued rebates</a></td>
<td class="nump">247.0<span></span>
</td>
<td class="nump">93.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Accrued warranty</a></td>
<td class="nump">11.7<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">43.8<span></span>
</td>
<td class="nump">39.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 481.1<span></span>
</td>
<td class="nump">$ 256.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AccruedTaxAuditAndLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AccruedTaxAuditAndLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PharmacyRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PharmacyRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295838408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Accrued Warranty (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Beginning balance</a></td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses', window );">Charges to costs and expenses</a></td>
<td class="nump">41.3<span></span>
</td>
<td class="nump">32.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Costs incurred</a></td>
<td class="num">(37.0)<span></span>
</td>
<td class="num">(32.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Ending balance</a></td>
<td class="nump">$ 11.7<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Standard Product Warranty Accrual Charges To Costs And Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296125848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Other Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FinancingLeaseObligation', window );">Finance lease obligations</a></td>
<td class="nump">$ 54.0<span></span>
</td>
<td class="nump">$ 14.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Contractual Obligation</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other liabilities</a></td>
<td class="nump">$ 80.9<span></span>
</td>
<td class="nump">$ 20.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FinancingLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FinancingLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775290930728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Senior Convertible Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Jun. 12, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Carrying amount of liability component</a></td>
<td class="nump">$ 1,667,200,000<span></span>
</td>
<td class="nump">$ 1,059,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">2,057,500,000<span></span>
</td>
<td class="nump">1,250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="num">(371,100,000)<span></span>
</td>
<td class="num">(177,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="num">(19,200,000)<span></span>
</td>
<td class="num">(13,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Carrying amount of liability component</a></td>
<td class="nump">1,667,200,000<span></span>
</td>
<td class="nump">1,059,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying value of equity component</a></td>
<td class="nump">461,000,000.0<span></span>
</td>
<td class="nump">242,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Convertible Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
<td class="nump">$ 260,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component:</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">$ 1,207,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,210,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component:</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296648120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Conversion Value of Convertible Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 1,077.5<span></span>
</td>
<td class="nump">$ 858.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Convertible Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 1,077.5<span></span>
</td>
<td class="nump">$ 372.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775290860184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CashInterestExpenseAbstract', window );"><strong>Cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual coupon interest</a></td>
<td class="nump">$ 9.3<span></span>
</td>
<td class="nump">$ 9.3<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of debt discount</a></td>
<td class="num">(68.6)<span></span>
</td>
<td class="num">(45.8)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense recognized on senior notes</a></td>
<td class="nump">$ 81.9<span></span>
</td>
<td class="nump">$ 58.8<span></span>
</td>
<td class="nump">$ 21.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member', window );">Convertible Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CashInterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Interest Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CashInterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NonCashInterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Interest Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NonCashInterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775278747336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 29, 2020</div></th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>d</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>trading_day </div>
<div>d </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 19, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 12, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,188,800,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 836,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PaymentsForRepurchaseOfConvertibleNotes', window );">Repurchase of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of 2022 notes (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,953,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="num">(5,900,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,057,500,000<span></span>
</td>
<td class="nump">1,250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="nump">850,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 836,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0060869000<span></span>
</td>
<td class="nump">0.0100918000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Stock counterparties to acquire with warrants purchased (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants or rights (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Convertible Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 260,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">400,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 389,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised', window );">Debt Instrument Convertible Principal Amount Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,210,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,207,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,190,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600.42<span></span>
</td>
<td class="nump">0.0016655000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity', window );">Recognized additional paid-in capital from cash conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 289,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of revolving credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount', window );">Option to increase revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold', window );">Value of unrestricted cash on hand threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 289,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital | Senior Notes | Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity', window );">Recognized additional paid-in capital from cash conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 171,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital | Senior Notes | Convertible Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity', window );">Recognized additional paid-in capital from cash conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of 2022 notes (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common&#160;Stock | Senior Notes | Convertible Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of 2022 notes (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,412,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Convertible Notes due 2023 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Convertible Notes due 2023 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Convertible Notes due 2022 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Convertible Notes due 2022 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Convertible Notes due 2025 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Convertible Notes due 2025 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Convertible Notes due 2023 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Convertible Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Convertible Notes due 2022 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Convertible Notes due 2025 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Senior Notes | Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares', window );">Stock issued upon conversion of senior notes (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) | Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) | Line of Credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Convertible Principal Amount Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertiblePrincipalAmountExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Repurchase Price, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentCovenantRepurchasePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsForRepurchaseOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Repurchase of Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsForRepurchaseOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the liability for the conversion option reclassified to stockholders' equity when the embedded option no longer required separation from the host instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35708913&amp;loc=d3e50896-113970<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775298118440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 19, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Total available balance</a></td>
<td class="nump">$ 193.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit available</a></td>
<td class="nump">200.0<span></span>
</td>
<td class="nump">$ 200.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding borrowings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit available</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Outstanding letters of credit</a></td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775386527480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity</a></td>
<td class="nump">$ 1,826.5<span></span>
</td>
<td class="nump">$ 882.6<span></span>
</td>
<td class="nump">$ 663.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 419.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">93.3<span></span>
</td>
<td class="nump">71.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">118.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liability</a></td>
<td class="nump">62.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Asset retirement obligations</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LesseeOperatingLeasesLeaseCostAmortization', window );">Amortization of operating lease right-of-use asset</a></td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear', window );">Purchase obligations</a></td>
<td class="nump">$ 335.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm', window );">Term of purchase obligations</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease terms</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease terms</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity</a></td>
<td class="num">$ (202.1)<span></span>
</td>
<td class="num">$ (695.7)<span></span>
</td>
<td class="num">(798.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (671.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Accounting Standards Update 2016-02 | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LesseeOperatingLeasesLeaseCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Leases, Lease Cost, Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LesseeOperatingLeasesLeaseCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded Unconditional Purchase Obligation Due Within One Year, Maximum Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775294887400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments - Maturity of Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 21.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">22.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">22.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">20.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">32.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease cost</a></td>
<td class="nump">138.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(20.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future payments</a></td>
<td class="nump">118.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current portion</a></td>
<td class="num">(16.5)<span></span>
</td>
<td class="num">$ (13.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">101.8<span></span>
</td>
<td class="nump">$ 72.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2020</a></td>
<td class="nump">10.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">68.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future lease cost</a></td>
<td class="nump">97.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(34.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of future payments</a></td>
<td class="nump">62.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less: Current portion</a></td>
<td class="num">(8.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">54.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced', window );">Minimum lease payments for leases not yet commenced</a></td>
<td class="nump">$ 16.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Future Lease Cost, Lease Not yet Commenced</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296372568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments - Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">18.4<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 27.8<span></span>
</td>
<td class="nump">$ 21.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295827960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments - Other Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 18.3<span></span>
</td>
<td class="nump">$ 14.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">80.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease liabilities</a></td>
<td class="nump">$ 41.7<span></span>
</td>
<td class="nump">$ 15.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term of operating leases</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term of finance leases</a></td>
<td class="text">23 years 3 months 18 days<span></span>
</td>
<td class="text">13 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate of operating leases (as a percent)</a></td>
<td class="nump">500.00%<span></span>
</td>
<td class="nump">500.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate of finance leases (as a percent)</a></td>
<td class="nump">520.00%<span></span>
</td>
<td class="nump">500.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775287693688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="nump">$ 270.7<span></span>
</td>
<td class="nump">$ 119.1<span></span>
</td>
<td class="num">$ (28.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Outside of the United States</a></td>
<td class="num">(45.7)<span></span>
</td>
<td class="num">(14.9)<span></span>
</td>
<td class="num">(98.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total</a></td>
<td class="nump">$ 225.0<span></span>
</td>
<td class="nump">$ 104.2<span></span>
</td>
<td class="num">$ (126.5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295413160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Provision (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income taxes</a></td>
<td class="nump">8.7<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(198.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(51.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(27.1)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income taxes</a></td>
<td class="num">(277.3)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes at effective rates</a></td>
<td class="num">$ (268.6)<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775297054456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Significant Loss and Tax Credit Carryforwards and Years of Expiration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net Operating Loss</a></td>
<td class="nump">$ 169.1<span></span>
</td>
<td class="nump">$ 438.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credits</a></td>
<td class="nump">73.1<span></span>
</td>
<td class="nump">54.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net Operating Loss</a></td>
<td class="nump">236.3<span></span>
</td>
<td class="nump">235.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credits</a></td>
<td class="nump">66.2<span></span>
</td>
<td class="nump">52.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Other States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net Operating Loss</a></td>
<td class="nump">36.1<span></span>
</td>
<td class="nump">88.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net Operating Loss</a></td>
<td class="nump">$ 113.2<span></span>
</td>
<td class="nump">$ 124.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=dxcm_OtherStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=dxcm_OtherStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295123608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ResearchAndDevelopmentTaxCreditsUtilized', window );">Research and development tax credits utilized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_UnusedExpiredFederalIncomeTaxCredits', window );">Tax credit carryforwards subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Release of valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="nump">$ 332.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ShareBasedCompensationIntercompanyCrossCharge', window );">Additional stock-based compensation expense</a></td>
<td class="nump">$ 32.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PossibleExtensionPeriodofTaxHoliday', window );">Possible extension period of tax holiday</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed foreign earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=dxcm_CALIFORNIAAndNonUSMember', window );">California and Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Release of valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dxcm_IncomeTaxExpenseBenefitMember', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Release of valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount', window );">Decrease in foreign taxes from tax holiday</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PossibleExtensionPeriodofTaxHoliday">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Possible Extension Period of Tax Holiday</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PossibleExtensionPeriodofTaxHoliday</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ResearchAndDevelopmentTaxCreditsUtilized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Tax Credits Utilized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ResearchAndDevelopmentTaxCreditsUtilized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ShareBasedCompensationIntercompanyCrossCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation - Intercompany Cross-Charge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ShareBasedCompensationIntercompanyCrossCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_UnusedExpiredFederalIncomeTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal income tax credits likely to expire unused as a result of limitations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_UnusedExpiredFederalIncomeTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayAggregateDollarAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=dxcm_CALIFORNIAAndNonUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=dxcm_CALIFORNIAAndNonUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dxcm_IncomeTaxExpenseBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dxcm_IncomeTaxExpenseBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775295424952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 69.2<span></span>
</td>
<td class="nump">$ 127.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Capitalized research and development expenses</a></td>
<td class="nump">53.6<span></span>
</td>
<td class="nump">57.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">101.1<span></span>
</td>
<td class="nump">78.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">13.0<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Fixed and intangible assets</a></td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities and reserves</a></td>
<td class="nump">110.3<span></span>
</td>
<td class="nump">62.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DeferredTaxAssetsConvertibleDebt', window );">Convertible debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">364.1<span></span>
</td>
<td class="nump">351.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(55.5)<span></span>
</td>
<td class="num">(332.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total net deferred tax assets</a></td>
<td class="nump">308.6<span></span>
</td>
<td class="nump">19.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesClassificationAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Fixed assets and acquired intangibles assets</a></td>
<td class="num">(36.3)<span></span>
</td>
<td class="num">(19.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount', window );">Convertible debt discount</a></td>
<td class="num">(55.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(92.2)<span></span>
</td>
<td class="num">(19.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets (liabilities)</a></td>
<td class="nump">$ 216.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax assets (liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredTaxAssetsConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredTaxAssetsConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Convertible Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesClassificationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesClassificationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296457816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory tax rate</a></td>
<td class="nump">$ 47.3<span></span>
</td>
<td class="nump">$ 21.9<span></span>
</td>
<td class="num">$ (26.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal benefit</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxReconciliationPermanentItems', window );">Permanent items</a></td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="num">(24.4)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="num">(11.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock and officers compensation</a></td>
<td class="num">(28.7)<span></span>
</td>
<td class="num">(14.7)<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Change in statutory tax rates</a></td>
<td class="num">(4.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616', window );">Impact of adoption of ASU 2016-16</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(13.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA', window );">Impact of Tax Cuts and Jobs Act of 2017</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(275.0)<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">56.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes at effective rates</a></td>
<td class="num">$ (268.6)<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Impact of TCJA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxReconciliationPermanentItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Permanent Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxReconciliationPermanentItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296335624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of period</a></td>
<td class="nump">$ 29.5<span></span>
</td>
<td class="nump">$ 25.9<span></span>
</td>
<td class="nump">$ 22.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior year tax positions</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017', window );">Decrease related to Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of period</a></td>
<td class="nump">$ 36.6<span></span>
</td>
<td class="nump">$ 29.5<span></span>
</td>
<td class="nump">$ 25.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775278687560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>May 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized', window );">Stock authorized in ESPP (shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum payroll deductions (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EmployeePurchasePriceFloorPercentage', window );">Employee purchase price floor (as a percent)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock reserved for issuance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OptionsInMoneyNumber', window );">Options in-the-money (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs related to unvested restricted stock units</a></td>
<td class="nump">$ 147.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_A401kPlanMember', window );">401(k) Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum employee contribution (as a percent)</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employee contribution (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total matching contributions</a></td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlan2015Member', window );">Employee Stock Purchase Plan 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (shares)</a></td>
<td class="nump">89,194<span></span>
</td>
<td class="nump">150,408<span></span>
</td>
<td class="nump">189,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of RSUs vested</a></td>
<td class="nump">$ 331.8<span></span>
</td>
<td class="nump">$ 207.2<span></span>
</td>
<td class="nump">$ 120.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EmployeePurchasePriceFloorPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee purchase price floor, percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EmployeePurchasePriceFloorPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan (ESPP), Number of Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OptionsInMoneyNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options that were in-the-money at the balance sheet date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OptionsInMoneyNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_A401kPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_A401kPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289370728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775294891144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares)</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares)</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares)</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares)</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares)</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160; Average Grant&#160;Date Fair&#160;Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (USD per share)</a></td>
<td class="nump">$ 96.63<span></span>
</td>
<td class="nump">$ 69.19<span></span>
</td>
<td class="nump">$ 70.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share)</a></td>
<td class="nump">300.36<span></span>
</td>
<td class="nump">144.37<span></span>
</td>
<td class="nump">66.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (USD per share)</a></td>
<td class="nump">92.07<span></span>
</td>
<td class="nump">69.45<span></span>
</td>
<td class="nump">68.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share)</a></td>
<td class="nump">137.44<span></span>
</td>
<td class="nump">83.45<span></span>
</td>
<td class="nump">68.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (USD per share)</a></td>
<td class="nump">$ 183.51<span></span>
</td>
<td class="nump">$ 96.63<span></span>
</td>
<td class="nump">$ 69.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Aggregate Intrinsic&#160;Value</a></td>
<td class="nump">$ 430.6<span></span>
</td>
<td class="nump">$ 392.0<span></span>
</td>
<td class="nump">$ 319.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296241688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock units (shares)</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_StockOptionsReservedForFutureGrant', window );">Reserved for future grant (shares)</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp', window );">Employee Stock Purchase Plan (shares)</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (shares)</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan ESPP Shares In ESPP</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EmployeeStockPurchasePlanEsppSharesInEspp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockOptionsReservedForFutureGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock options and awards reserved for future grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockOptionsReservedForFutureGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775297140472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense included in operating expenses</a></td>
<td class="nump">$ 119.4<span></span>
</td>
<td class="nump">$ 102.7<span></span>
</td>
<td class="nump">$ 101.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense included in operating expenses</a></td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense included in operating expenses</a></td>
<td class="nump">37.8<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense included in operating expenses</a></td>
<td class="nump">$ 67.0<span></span>
</td>
<td class="nump">$ 60.2<span></span>
</td>
<td class="nump">$ 59.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775297980664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details) - Employee Stock Purchase Plan<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">172.00%<span></span>
</td>
<td class="nump">155.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility of common stock (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">255.00%<span></span>
</td>
<td class="nump">225.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility of common stock (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289169256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296516872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="nump">$ 1,926.7<span></span>
</td>
<td class="nump">$ 1,476.0<span></span>
</td>
<td class="nump">$ 1,031.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of&#160;Total</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="nump">$ 1,437.6<span></span>
</td>
<td class="nump">$ 1,011.6<span></span>
</td>
<td class="nump">$ 652.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of&#160;Total</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="nump">$ 489.1<span></span>
</td>
<td class="nump">$ 464.4<span></span>
</td>
<td class="nump">$ 378.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of&#160;Total</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="nump">$ 1,509.5<span></span>
</td>
<td class="nump">$ 1,161.5<span></span>
</td>
<td class="nump">$ 818.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of&#160;Total</a></td>
<td class="nump">78.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Outside of the United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="nump">$ 417.2<span></span>
</td>
<td class="nump">$ 314.5<span></span>
</td>
<td class="nump">$ 213.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of&#160;Total</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775296372568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Provision for doubtful accounts</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments', window );">Write-offs and adjustments</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesRecoveries', window );">Recoveries</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the write-offs and adjustments in a given period to allowances and reserves for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139775289140136">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>94
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M@1:.2&, ]S="Z,/$- E54SC_"U!+ P04    " !!BDM24XRJDV,%  !>%0
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MP*P9*?#X3/%<D[B4"W2SAL8%DY>^!JK#P!UQ?;6J:P:0?DB7&I Y-/WB9K#
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MXM(@=IDII+@\S*FAT[&2.Z(L&MGLP"736:-\)FS9'XW"KPSMS'0FA9:<I=1
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MGU_SU011_ 8!A="V99J9@GHF*:"/%U'HU?_.IH\6COZ>H___<#R"VF4SP>R
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M]%CJK_+Y'Z(EE!A[F2QK^S]Y;K'1%<F.M9;[=C \P;ZHFK_IC]819P/H?&
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MQ!$L!L^X!F0'7@'>3%FYI>\!U.6QV .<>#.+8N4ZOP'>[^#ON.4*D $G<@U
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MW"PN=EY\[ZJN^ ><Q1<_P8)P&WQ+2*5NZ+=P:-0&P%"; 6X5!4:$#H$IUKC
M+2VPK8 6N]563"30W>AK  N)3+K#([*$0>L)$??+4&[(\!GP03XZ@<:\GM:&
M9^>E]CDH:F4#-FE.@#VA^SM0N__BC09F4KAPWQ$9P'WL!]D,Q-+DR:&9/GL
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M/%KZ(^9%E*HH&CLT4JT?&L-Z&=0<VD'+./1^KZ3-_#!["L" 5!TD<>U&AXI
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M*B)YM!=F0T@TXQE-W6A\S%2Z1K\G18T28_ MIIJ*A5$8+H4ZQU#$OK083M0
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MZ[;M]1^XP:'M/A-XK_X74$L#!!0    ( $&*2U(9*=ZL5P@  &D5   8
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MDOA $MEG='04(\_!1+!.IBR,'NS:#QZUUBR,Y<.+;;][+)(FD@P%5R.;P&:
M9+X-\*UA3:]L01ZF!4GQRR"')W76Q."#Z()'[X N8LNXWP$V.A=R8"/]''!'
MB_>#9B^DD\B!I=^93I /EB;7 (C,$5/JJWG+E22@_[?8ZO(.N8HA5,@2C8)%
M(/Q*O$R.EH(5#E2YK]#_IJ!LTX(,R9*#> -W=9)D-^E1DK1MDEQPDI2L JJ0
M*A8 45.)^B+-016Q 3(<H\!'QJ)OM%_?SZ=KK:RTZ7K[\FA"_\CY\MEMB0*?
MYY0,GK?YM[%>>$[$K\9#JVOIUD)]KC5X,(D3,3T;#V9XCF>CP0C/O_]MGHR3
M5_CK=$J_W*B%WPL5>2=USH9CW(+02_%Q\&$@5N9.V9(-#FO#C#!H0VW<G[T8
M#:8'[]>F*)1EBU>R@K6:#<EL/IC?>[LVMN)H0JA!J.;'T]'@;/\E*)L]+7E'
MGOG9:# ^>/^%\T $P[/Q<S'I*-$\:2VPC!O_"%K( U/(?"*2_FA*/+L^2/JS
MR0Q^(=:WG#J5:[CLBM4:"5%4M74U95UOP 8-IK(D H4W>F$N%J)"J 3E5:F-
MC8%!+FMJ7PH4:4<A@]YB2T N:E]#M65=9O_+ !J?_9\&T'@<G#:>!C=VG#<C
MU_TU 73ZXA2T]M^.!\]T/DCNO1T)GO%ITHF>\/9GPF<T?[$7/N']('Q&@Q<'
MX4-KWQ ^9/\Y/?O))+F7PL;]R33!KW]U^%!]45\@"K59[@_$#KAM%+>7U+64
MCON-A?(;I<H6>MRA1_AU2EY6MU5ZJR3.*1J8#@L-GZ> .<Y1E]"2]? D9H/Q
M;V.&QF1M8,E46>[!0P^U*\.[9) 9[J^CG[_"S2'OI-+:+:WM&@6P<&J/1].\
M=_M0DG&C8N_)75,A6@$C'.B]MNQ#$[JKK&TM>$R&$+>8";"SJ&CL ^DF%FI'
MJ'ED,CH4\T$P9]@-0N%\ZH.]PED:%-@QW'XNO>(F'#.  M(8P*1DK@OM.3N&
M:Q<"+274)G+9284IM3>6V70W,K>% N*5ZP8[CPFZ"*+1DSB%&8UI?)5;-"^2
MLVGVX[F'\SB0Q^: Y3'@K,+XDFJ;U@7UP]3+LEQKB7E&[GLU0[HDTZ!KIZ'H
M8.K;&X4AU8=0]*X-Y+)>DW(_TXP0BEI[KK^;<VBR(,UB5_TL1NCS?M.DQCJ:
M=DB63))C3KI8*YN:1@+R/ ,M,V@!7SU5G9JDL%^E#N/PH%P>5Y=@AC.)^ [_
M3@1U.O,G=T\XG9Y-3M'L(-6>4K?XU)D9[41J($XAP]^_,/#DY"Q,!4<L>2(F
M_3$JZ2FW0]2FSL5W8"-D5>4Q"&'=TG0MWZ7,,431!7,#$M3V&+L/_8B=!Y#\
MF)-I3 T:BUF?JTXR>D7E?L!_CU\1,P7$BFN$.0KZED/G1G'@TH#^IFV7;G<C
MOWAS$'$;2@ K- 44'6N5K3@W4SJ7:;@%P$Z4JSKEA,0\TX:GU>Y3T[GMCUDA
M3+-6GI!=6O0_-%EV[T@::#:S/2G'"-\IV+G)X"/(>.C90O\6!/1- B8+QY6\
M<SWU=%YNZBZ=;!O!DFX7FMS;$8/0@%9)FXPJVJ#K#!Y'0QHUSD5CQ)K! J-J
M ELNU).FNE&Z[(M2^0<E!0A]#&<"$SB'6YN!>/WPE!@1<M#Z G#A>D86IH[D
M3M#8C9JDP =/.@MT0>(JQ3=!^;9_&!> #$%)M07[0>0$X(!4G7LZA>HG0[8]
M4';7_'?4YO+14FRPRQ=4P<$;#M[]@KV,Y0E]47['%8LNB(^T(#'=Q49D/A"_
M0+ #7=27*E[<WM%EQ *=#_DW7$[HG.Y! *G2A]N:>(5X1=T0.OYWL'G6YZ4?
M:FMV4+_& )5I=(4WR//2'M37U+AXY<HPC+9;'@E245?1KCM3!LMS :FD]4U.
MHOV=\8UN/U96%BQ ;*_JO=A^^,HSM/) 29W'3&AW1:_&Q$!Q8-B<79^9W97D
M/4&Z E@:E&SL%V);%M<R0E^5!_B1Z1!95!Z"V=PQ:6,C%^ESNL;:%OP1_I:B
MD#&*=>HE8M-I$!%>KYK.+ 5W[2.V_\2=^,^F_/[>O?A#'P"&G6\KF-)6_ 6)
M<A6B-WQF:5?;CU2OP[>9W?;PA>NMM"M*3;E:XBC&I5D/XO-7H_#B3<5?:A;&
M>U/PGVLEX7O:@-^7!HD\OA"#]M/=Y7\ 4$L#!!0    ( $&*2U)/54)/H@D
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M/8?V$FSS#X':93"<7EY_2"=!?5 C(;R\"$8'=1* L))/D4\S;^4G.J[J:(%
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M_L3"C?[+ LUP_?<9?F1'2D UQU1Z&O=(%]OMERI?\=\9 (8C>.:/"QD!1V@
MKL]SX)'Y0ANX/SSQ_/\ 4$L#!!0    ( $&*2U+ /"0B6 H  ,(Q   9
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MTXP-4-&NAB14]J>.?%U:B[T>BU<J4Y:%_-M?ILD@>7+P$Q]27$ ; QPD@7:
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ML:=]*!+ZH#+/*K&J?O,/2X8BN;2NI+8IC"HJ!::Y1+_,#2"PB]@]H@UX;+1
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M14$Y;(HW?.V'EZ<!'-8QEP"!&/O@YB55??#8:M1ZH-K2<]$(U0MC4S3DS!B
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MMEWF=?G/7%!4%]E-N:S+13G/ZSZ[FL^;H>[+>IF]:ZIR7KHN>VQ_/?GA:4\
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M&3MQP[&=4>S9%@D4D<E S W96%.@00V%C*9L)3C@"9L,(DB\BO3M+G6ZG?F
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MB3>;18EJNW5#1[%E&>K%:FEYEL#!42OGQ.0GUW%L\9S/Q@!O4Y6@@QI7>)V
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M!IKBHPZ#JERXD ,6V =RU)#&AI1""V-98F>W*C>2XTXZ0YVO0\53X2"D$%8
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M;(@HGKRUG[2VN>L:A+#QB^B*ZKA@S70_-X_SP,WEE8CV-#JJ?&5O+D05F+^
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M5DVV-V->DV)VVKLEY"60I;3,O0YLH@V-JR8)-*;(*H\:'8#+1K5(9F)^:1_
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M 3>U'G"!XNPM(3SD\R"#FSNP#[Z7LPFM5V4U +A32RT[:W]=1!S[H O=@R
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MZO[&C8F0Q+6@5\_/OGG^2-+"[ ,=6PR)QM^DYO*?*]+(7(L'Z/=%T_3V 1/
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MSWA6:)G3"9!QF=62!X*M@:QLLQ?8\_]?H<\)^Y(2,?+J%2YN55*DWVC+Q8T
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MQ]T]\/'Q\(XGFK@4,'9\S1J^0@WT!XV9TI)-5EI(=.%A;I;,3<<<US"/!$^
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M^^YV;0YP(&V >;X49MF5 _N"ZD@X_0=02P,$%     @ 08I+4EF!;L0(!
M\0T  !D   !X;"]W;W)K<VAE971S+W-H965T,S(N>&ULO5=-;]LX$/TKA-%#
M F0M4;9LIW ,I':"#=!V@P;I'HH]T-+8)D*)*DG9#= ?WR%%RPHJJ\XA>TA,
M4O-F'N>+Y'0GU9/> !CR(Q.YONIMC"G>!X%.-I QW9<%Y/AE)57&#$[5.M"%
M I8Z4":"* Q'0<9XWIM-W=J]FDUE:03/X5X176894\\?0,C=58_V]@M?^'IC
M[$(PFQ9L#0]@'HM[A;.@UI+R#'+-94X4K*YZU_3]+1U9@)/XRF&G&V-BM[*4
M\LE.[M*K7F@9@8#$6!4,?[8P!R&L)N3QW2OMU38ML#G>:[]UF\?-+)F&N13_
M\M1LKGJ3'DEAQ4IAOLC=W^ W%%M]B13:_2<[+QOV2%)J(S,/1@89SZM?]L,[
MH@&@PR. R .B4P$##QB<"AAZP/!40.P!\:F D0>X8 :5LYRG%\RPV53)'5%6
M&K79@0N70Z.#>6XSZ\$H_,H19V8+V&)V%9@KAK \)?^8#2ARO58 =DV3O\AG
MIA2S\2=G"S","WV.JX\/"W+V[IR\(P'1&Z9 $YZ3QYP;?8&+./[$A<#DT=/
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MV6#4RDOLZ@,F/XV9Q:.J2X(-)X\'4C?+UD0+-[&K)1@N)CD[?_T%^]YO!.
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M',C\SIL/M-AEU\:%T' )S1ZWC*Z8- !XOQ9"/PW,3;3\YV'Z/U!+ P04
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M;^L5N;QX1RX($^2.<8ZET]/ 8""6+DAJIXO*:73&:1B1.RE,ILE'D4+ZFB!
M!8V,:"]C$74RKB#Q23^\(E$OZK4$M'PS/)RTP%=OAX\[U/2;HO0=7_\,WU)B
M6H2&E-PP@>5AE).UH0:PWXR^(DM:V*;1Y.<71));?*%_=?B-&[^Q\QN?\7M'
M7UA>YB3!XBCLR!+]8FN5BAD&FL@-=M2C(1J2_58&/&VK?[<?K'_NZM\1\Z")
M>=#)M0*\[C!#[A:!E\+FK2VBBF7L6.Q=^#P?QM/@^?",5":# Y-XZ$]>&ZU.
MC:*Q/VR,7FD8-AJ&G1H^X?5,+KG4V&2H(F6ZD!ISCPG/:9*AM?I#J$@)/)6L
ML(>@36'E8W00V778/PBM$MEFU?,'1RI;K 9^W*YRU*@<=:I\@ 3P0E'D7LFT
M3 Q9RKR0XD3-*_)Q0S[^KRTS:?Q..D7=BF=T(+$^.VP)N$[E3K059W)Z;&+_
M^ ">&H6Q'QZ5YM1HY/>/*A,<#(0<U-8-5HU]70I37:K-;C.[/[B1=;2_P)E>
MC>!_--4'P1U56X;YY+!!RIX_PHA4-62KA9&%&SN/TN 0<X\9?I> L@;X?B.E
MV2^L@^9+9_X74$L#!!0    ( $&*2U)X?.;"V (  $$(   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,X+GAM;*U6VT[C,!#]%2OB :2E2=,T%-16HH2]2+!"
M5.P^FV2:6#AVL5T*^_4[=M)L>J4/VX?&XYPSES.6)\.E5"^Z ##DO>1"C[S"
MF/F5[^NT@)+JCIR#P#<SJ4IJT%2YK^<*:.9()??#((C]DC+AC8=N[T&-AW)A
M.!/PH(A>E"55'Q/@<CGRNMYJXY'EA;$;_G@XISE,P3S-'Q1:?N,E8R4(S:0@
M"F8C[[I[E<06[P"_&"QU:TUL)<]2OECC1S;R IL0<$B-]4#Q\08WP+EUA&F\
MUCZ])J0EMM<K[U]=[5C+,]5P(_EOEIEBY T\DL&,+KAYE,OO4-?3M_Y2R;7[
M)\L:&W@D76@CRYJ,&91,5$_Z7NO0(G3C/82P)H2;A&@/H5<3>L<2HIH0.66J
M4IP."35T/%1R291%HS>[<&(Z-I;/A&W[U"A\RY!GQA/*J4B!3-T92\!0QC4Y
M)S_1^H:GAIS>2:W/R".D,A?L#V0$NW7[NF#F@TPA72AF&&AR6E//D/LT3<CI
MR1DY(<B_9YQC@_70-YBN#>JG=6J3*K5P3VK=D-Q+80I-;D4&V;H#'^MLB@U7
MQ4["@QX32#NDU_U"PB ,=B1T<S2]>[F#GAQ/'QRHIM>TKN?\]?;XLRW*;8O4
M6F^@ZHUN>G,@5-2$BERHZ)-0FE"1$8XG EO>"IMA*)$34P"9@V+RF$2JAE5Q
M!RZNO:+>QMB8MW9/*D2_A3B/.N$Z*-D&#8).<-G^-8PU!?J- OV#"MR!UE?D
M_^A M.0[L+ODJ9**#\A3(2Y:B&UUMC'G4=3I[E8D;A2)#RKR)'#,<%=V)<EN
M'13,I3+6.JB(P6N"%("Z4+/!RZB!7=K$GQZ=3Q')-J(7;\CBMR[7$E3NAI0F
MJ5P(4UT]S6XS!Z_=];^Q/\'Y6(VS?VZJX7I/56X5Y#!#ET'G ANFJH%5&4;.
MW17^+ T.!+<L<,:#L@!\/Y/2K P;H/EJ&/\%4$L#!!0    ( $&*2U)H^^;_
M<0(  /(%   9    >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;(U474_C,!#\
M*U;$ TB0M$Y#"THCE5;HD X)T>/NX70/;K)M+1R[9SLM_/M;.R$7H*UXB;]V
M9F<G7J<[I9_-&L"2EU)(,P[6UFZNH\CD:RB9"=4&))XLE2Z9Q:5>16:C@14>
M5(J(]GJ74<FX#++4[SWH+%65%5S"@R:F*DNF7V] J-TXZ =O&X]\M;9N(\K2
M#5O!'.S3YD'C*FI9"EZ"-%Q)HF$Y#B;]ZVGBXGW 3PX[TYD35\E"J6>WN"O&
M0<\) @&Y=0P,ARU,00A'A#+^-IQ!F](!N_,W]EM?.]:R8 :F2OSBA5V/@U%
M"EBR2MA'M?L&33U>8*Z$\5^RJV.'&)Q7QJJR :."DLMZ9"^-#QU ?W  0!L
M_2H@;@"Q+[16YLN:,<NR5*L=T2X:V=S$>^/16 V7[B_.K<93CCB;W3#!9 YD
M[J_,#"SCPI +,LES54EKR"/DP+=L(8"<-L=G>/XTGY'3DS-R0K@D]UP(_"<F
MC2Q*<L11WJ2_J=/3 ^EGD(<D[I\3VJ.]/?#IE^']J_?P"(UHW:"M&]3SQ0?X
MIDH6>$.A(+=<HB^<"7(GZUYQEV[&32Z4J320WY.%L1IOX9\C>>,V;^SS#@[D
M;=W6K=O[O*Q)$D_BVG.;#>(D'*;1MFO9YRAZ1<-^&_5.X:!5.#BJ\#L80YC
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M M'TLL90O++M8,F5;BYVN-'M'X1QT.LKSM6G83I,]T/)/@!02P,$%     @
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M=FR3^+>MS0=M@U;;X**V:4'5&C0QDF12&TTP.P1><3AI.-E*-5W:T= /_?A
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MOCM"O&PG7FMHL;)#8RXTCB"[K/ C =(XX/E""/UFF#G4?W;R_U!+ P04
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MFR\%E#; [,^%R6(]L0<TWQ[#/U!+ P04    " !!BDM2+O U=; #  #Z#0
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MSH32/)4-Q.?WB0CQ\A?YS5[;+^\[_1]02P,$%     @ 08I+4H@MZR"H @
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M G6&5 _W4W)Z<D9.""O)#>,<NZ427Z-9(^EGM;'+REC4:BSKD#C\0*(@"O;
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M@LX X;*ZDZI BY4]UF="XR5AATN\QT&:!3@_%T+O G-3N'\&Z1]02P,$%
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M=*>TPTQ??B@,0+^?<Z[6$[-!<YV._P%02P,$%     @ 08I+4G'EX#M5 P
MYPL  !D   !X;"]W;W)K<VAE971S+W-H965T-34N>&ULG5;;3N,P%/P5*^(!
MI"77-DE16PF:1<L#$N*R^VR:DS8BL;NV2]F_7]L)(1<W(/K0QL[,>,:WGOF!
MLA>^!1#HK2P(7UA;(787CL/76R@QM^D.B'R3459B(9MLX_ = YQJ4EDXONN&
M3HES8BWGNN^.+>=T+XJ<P!U#?%^6F/V[@H(>%I9GO7?<YYNM4!W.<K[#&W@
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M[GFFQ49B6ZZW.J5L1;0 */"R!?OKYGAKIV\W6,3@SU\T)'A0))-_.0@%-:'
M$@J.$3);#.!")5S0O_77].:9+>9S<"$-!7G9MH-*R(&%-#JXGL"^;W[&WKJ%
M2[_FTG=R><1O-"LRD..MX&FJU28NK)A)<(%U18"<B$A'HI63&QKZ7=__P1&O
M0<UQX 2JJS4O1)3H_(!<T(B 9<JY.(.F&SWLGZ YK&D.STBKSA\1:YU4W<X
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MVE2Z&Y:F>:.T +-?"*&W$WM _W>0_ -02P,$%     @ 08I+4FOX^0A/!
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M<TSP4I.X6Z[VNT</3!6P;P.:VVT["8+$[8V\;5O%(R@_= >'J-DQ5. F#>J
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M//MP$X$*(QX,(WL_5H4T=DC]LK5_!53.P9[74IJ3X1),_YG\#U!+ P04
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M0ZK@\BV,;17(N@P$C00"$;AEF8P%^#F+2-05,%16=6KHG-H:32J&9*L#"_X
MD(G,@8"N7TR'P0 ]?#G=G\C&JB_**O2L$;WS_=R3 ^.29OO.U?S]6<'!C22I
M^&=B,[O>S"XVLT<VNTK9,9-#EUCRG(*7UY2G%0R0JWL+XZE]M"7,;\-LS^V"
MP@$MTX)Z ^O$[M2Q.Y.QOP=L]_UWT#5_^H-)G PE,2T 35,WS?=#CKF4&%Y
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MVC@4_2M741]:J4-(PE<K0 K)=(LT,YT=2JO5:A],<@/>.C:U#73__=I.)LM
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M8.'N1(9C^'3^_E<CU.T[8,>S#V=G_J7_='&[ZSEWK@OH[06^V@;N@?X6&![
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M1AHVZV8]F(UPLWKYFUE>$+8)^_^GY ]02P,$%     @ 08I+4I>*NQS
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MD;B;1JWMN1./=%8]OWOV%"?;KNWCO%BEY,\8B]6*.AM+YZG/*TL7.IORU_#
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M.'Y\EIUM^K=\-OY9<?$"4$L! A0#%     @ 08I+4@=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !!
MBDM2(8?ZH.X    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " !!BDM2F5R<(Q &  "<)P  $P
M@ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $&*2U+; .@!
MQP8  (4:   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " !!BDM2G8)](GX&  "<&@  &
M@($*#P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 08I+
M4H6R\>;H @  ( H  !@              ("!OA4  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( $&*2U)3C*J38P4  %X5   8
M      " @=P8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M" !!BDM2F7 T1BL#  ","0  &               @(%U'@  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 08I+4O(SW/_T!P  YB@  !@
M             ("!UB$  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( $&*2U(M#R&SJ0D  "4L   8              " @0 J  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !!BDM2@;<;G-@I  "'
MA0  &               @('?,P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ 08I+4ADIWJQ7"   :14  !@              ("![5T
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( $&*2U(MH:D]
MC0D  ,8;   9              " @7IF  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ 08I+4D]50D^B"0  !1H  !D
M ("!/G   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !!
MBDM2G>^RE1(6  "$8@  &0              @($7>@  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( $&*2U+ /"0B6 H  ,(Q   9
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M970Q-RYX;6Q02P$"% ,4    " !!BDM2P,SAOMX"   V!P  &0
M    @(&^O@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M $&*2U*=K;C9#2T  ,6=   9              " @=/!  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ 08I+4C1H(#VW!   +@P  !D
M             ("!%^\  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    " !!BDM2S_($,=\$  #S#0  &0              @($%]   >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( $&*2U(PYIZD)@<
M -$4   9              " @1OY  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ 08I+4A) ,+T1!@  #1(  !D              ("!
M>  ! 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !!BDM2
M>U_>C)8%  #B#P  &0              @(' !@$ >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( $&*2U*'_^H3,PD  -P:   9
M      " @8T, 0!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ 08I+4A@0IVK?!0  +P\  !D              ("!]Q4! 'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " !!BDM2:8LI,IX#  "U"
M&0              @($-' $ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( $&*2U(-0JV@VP0  -L5   9              " @>(? 0!X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ 08I+4L \LU]0
M P  PP\  !D              ("!]"0! 'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    " !!BDM2I MN$3\$   L$0  &0
M@(%[* $ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( $&*
M2U);YX,A8P,  !X.   9              " @?$L 0!X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ 08I+4EF!;L0(!   \0T  !D
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M=#,V+GAM;%!+ 0(4 Q0    ( $&*2U)D80 !,0,  /4(   9
M  " @5=% 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
M08I+4GA\YL+8 @  00@  !D              ("!OT@! 'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    " !!BDM2:/OF_W$"  #R!0  &0
M            @('.2P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    ( $&*2U))E.QE;P(  %P&   9              " @79. 0!X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ 08I+4L,>W@C. P
ME@\  !D              ("!'%$! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    " !!BDM2,--(!NL"  "'"   &0              @($A
M50$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( $&*2U)3
M)%YDO0(  !8'   9              " @4-8 0!X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ 08I+4OY;W6B% @  @@8  !D
M     ("!-UL! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $&*2U*(+>L@J (  "4(   9              "
M@7-U 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ 08I+
M4NO=]T4%!0  +18  !D              ("!4G@! 'AL+W=O<FMS:&5E=',O
M<VAE970U,"YX;6Q02P$"% ,4    " !!BDM2?BF42D$$  "]$   &0
M        @(&.?0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0
M   ( $&*2U+>Z))LY@(  $$(   9              " @0:" 0!X;"]W;W)K
M<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ 08I+4N/W -Y\ P  7PP
M !D              ("!(X4! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q0
M2P$"% ,4    " !!BDM2"/L=$KD"  !:!P  &0              @('6B $
M>&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( $&*2U)QY> [
M50,  .<+   9              " @<:+ 0!X;"]W;W)K<VAE971S+W-H965T
M-34N>&UL4$L! A0#%     @ 08I+4L<W^O4* P  : H  !D
M ("!4H\! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !!
MBDM27ZVB^BX$   +#P  &0              @(&3D@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( $&*2U(;&9D,  0  !H.   9
M          " @?B6 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#
M%     @ 08I+4F(6<5!4!   X0X  !D              ("!+YL! 'AL+W=O
M<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " !!BDM2$TJDK#$#   J
M"0  &0              @(&ZGP$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM
M;%!+ 0(4 Q0    ( $&*2U*APRD5\00  $04   9              " @2*C
M 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ 08I+4N61
M_;Z/ @  &@8  !D              ("!2J@! 'AL+W=O<FMS:&5E=',O<VAE
M970V,BYX;6Q02P$"% ,4    " !!BDM2:_CY"$\$  #+$   &0
M    @($0JP$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    (
M $&*2U+'8*SSH (  ,4&   9              " @9:O 0!X;"]W;W)K<VAE
M971S+W-H965T-C0N>&UL4$L! A0#%     @ 08I+4NDB101F P  ) P  !D
M             ("!;;(! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"
M% ,4    " !!BDM2"RAQFI8#  !I#@  &0              @($*M@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( $&*2U+AMQ*U'0(
M ',$   9              " @=>Y 0!X;"]W;W)K<VAE971S+W-H965T-C<N
M>&UL4$L! A0#%     @ 08I+4M.RW8;. P  O!   !D              ("!
M*[P! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " !!BDM2
MSC$&SBX#   '"0  &0              @($PP $ >&PO=V]R:W-H965T<R]S
M:&5E=#8Y+GAM;%!+ 0(4 Q0    ( $&*2U)/35;MYP$  &<%   9
M      " @97# 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%
M  @ 08I+4O=NV:9@ @  3 T   T              ( !L\4! 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " !!BDM2EXJ[',     3 @  "P
M@ $^R $ 7W)E;',O+G)E;'-02P$"% ,4    " !!BDM2#16OEV$%  "?+@
M#P              @ $GR0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M08I+4MMVL'$Q @  B2D  !H              ( !M<X! 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 08I+4J3(PW?Z 0  M"@  !,
M             ( !'M$! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $X
,3@!9%0  2=,!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>263</ContextCount>
  <ElementCount>499</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2108102 - Disclosure - Development and Other Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentandOtherAgreements</Role>
      <ShortName>Development and Other Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2115104 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2126105 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2133106 - Disclosure - Leases And Other Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitments</Role>
      <ShortName>Leases And Other Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2139107 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2140108 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2149109 - Disclosure - Employee Benefit Plans and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2157110 - Disclosure - Business Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformation</Role>
      <ShortName>Business Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2161111 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Organization and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Organization and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables</Role>
      <ShortName>Organization and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/FairValueMeasurements</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BalanceSheetDetails</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2327304 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/Debt</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2334305 - Disclosure - Leases And Other Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables</Role>
      <ShortName>Leases And Other Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/LeasesAndOtherCommitments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2341306 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/IncomeTaxes</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2350307 - Disclosure - Employee Benefit Plans and Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2358308 - Disclosure - Business Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables</Role>
      <ShortName>Business Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BusinessSegmentandGeographicInformation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Anti-dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Development and Other Agreements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails</Role>
      <ShortName>Development and Other Agreements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails</Role>
      <ShortName>Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Balance Sheet Details - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails</Role>
      <ShortName>Balance Sheet Details - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails</Role>
      <ShortName>Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Balance Sheet Details - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails</Role>
      <ShortName>Balance Sheet Details - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - Balance Sheet Details - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails</Role>
      <ShortName>Balance Sheet Details - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2422414 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails</Role>
      <ShortName>Balance Sheet Details - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2423415 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2424416 - Disclosure - Balance Sheet Details - Accrued Warranty (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails</Role>
      <ShortName>Balance Sheet Details - Accrued Warranty (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2425417 - Disclosure - Balance Sheet Details - Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details - Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2428418 - Disclosure - Debt - Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2429419 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails</Role>
      <ShortName>Debt - Conversion Value of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2430420 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2431421 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2432422 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails</Role>
      <ShortName>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2435423 - Disclosure - Leases And Other Commitments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails</Role>
      <ShortName>Leases And Other Commitments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2436424 - Disclosure - Leases And Other Commitments - Maturity of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases And Other Commitments - Maturity of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2437425 - Disclosure - Leases And Other Commitments - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails</Role>
      <ShortName>Leases And Other Commitments - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2438426 - Disclosure - Leases And Other Commitments - Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails</Role>
      <ShortName>Leases And Other Commitments - Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2442427 - Disclosure - Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2443428 - Disclosure - Income Taxes - Components of Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails</Role>
      <ShortName>Income Taxes - Components of Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2444429 - Disclosure - Income Taxes - Significant Loss and Tax Credit Carryforwards and Years of Expiration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails</Role>
      <ShortName>Income Taxes - Significant Loss and Tax Credit Carryforwards and Years of Expiration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2445430 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2446431 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2447432 - Disclosure - Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2448433 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2451434 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2452435 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2453436 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2454437 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2455438 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2456439 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2459440 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails</Role>
      <ShortName>Business Segment and Geographic Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2460441 - Disclosure - Business Segment and Geographic Information - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails</Role>
      <ShortName>Business Segment and Geographic Information - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2462442 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="dxcm-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - dxcm-20201231.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - dxcm-20201231.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="dxcm-20201231.htm">dxcm-20201231.htm</File>
    <File>dxcm-20201231.xsd</File>
    <File>dxcm-20201231_cal.xml</File>
    <File>dxcm-20201231_def.xml</File>
    <File>dxcm-20201231_lab.xml</File>
    <File>dxcm-20201231_pre.xml</File>
    <File>dxcm12312020ex1043doindemn.htm</File>
    <File>dxcm12312020ex10442015espp.htm</File>
    <File>dxcm12312020ex10452015espp.htm</File>
    <File>dxcm12312020ex1047doubleda.htm</File>
    <File>dxcm12312020ex404securitie.htm</File>
    <File>dxcm12312020exhibit1046moy.htm</File>
    <File>dxcm12312020exhibit2101.htm</File>
    <File>dxcm12312020exhibit2301.htm</File>
    <File>dxcm12312020exhibit3101.htm</File>
    <File>dxcm12312020exhibit3102.htm</File>
    <File>dxcm12312020exhibit3201.htm</File>
    <File>dxcm12312020exhibit3202.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dxcm-20201231_g1.jpg</File>
    <File>dxcm-20201231_g2.jpg</File>
    <File>dxcm-20201231_g3.jpg</File>
    <File>dxcm-20201231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/stpr/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>100
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dxcm-20201231.htm": {
   "axisCustom": 2,
   "axisStandard": 26,
   "contextCount": 263,
   "dts": {
    "calculationLink": {
     "local": [
      "dxcm-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dxcm-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "dxcm-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dxcm-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dxcm-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "dxcm-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 643,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 8,
    "http://www.dexcom.com/20201231": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 14
   },
   "keyCustom": 51,
   "keyStandard": 448,
   "memberCustom": 20,
   "memberStandard": 48,
   "nsprefix": "dxcm",
   "nsuri": "http://www.dexcom.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.dexcom.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Fair Value Measurements",
     "role": "http://www.dexcom.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115104 - Disclosure - Balance Sheet Details",
     "role": "http://www.dexcom.com/role/BalanceSheetDetails",
     "shortName": "Balance Sheet Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126105 - Disclosure - Debt",
     "role": "http://www.dexcom.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133106 - Disclosure - Leases And Other Commitments",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitments",
     "shortName": "Leases And Other Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139107 - Disclosure - Contingencies",
     "role": "http://www.dexcom.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140108 - Disclosure - Income Taxes",
     "role": "http://www.dexcom.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149109 - Disclosure - Employee Benefit Plans and Stockholders' Equity",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity",
     "shortName": "Employee Benefit Plans and Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157110 - Disclosure - Business Segment and Geographic Information",
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformation",
     "shortName": "Business Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2161111 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Organization and Significant Accounting Policies (Policies)",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies",
     "shortName": "Organization and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Balance Sheets",
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Organization and Significant Accounting Policies (Tables)",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables",
     "shortName": "Organization and Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Balance Sheet Details (Tables)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsTables",
     "shortName": "Balance Sheet Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327304 - Disclosure - Debt (Tables)",
     "role": "http://www.dexcom.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334305 - Disclosure - Leases And Other Commitments (Tables)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables",
     "shortName": "Leases And Other Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341306 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.dexcom.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350307 - Disclosure - Employee Benefit Plans and Stockholders' Equity (Tables)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables",
     "shortName": "Employee Benefit Plans and Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358308 - Disclosure - Business Segment and Geographic Information (Tables)",
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables",
     "shortName": "Business Segment and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Organization and Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "ic9cff1bc2dac48ea90553b980fd2c925_D20200101-20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails",
     "shortName": "Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "ic9cff1bc2dac48ea90553b980fd2c925_D20200101-20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share (Details)",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails",
     "shortName": "Organization and Significant Accounting Policies - Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i623dc723c3654d6f84c0203133743a3c_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Securities (Details)",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails",
     "shortName": "Organization and Significant Accounting Policies - Anti-dilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:CollaborativeResearchAndDevelopmentFee",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Development and Other Agreements - Narrative (Details)",
     "role": "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails",
     "shortName": "Development and Other Agreements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "dxcm:DevelopmentAndOtherAgreementsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i615df7321c9348c998d7e063f8bd67aa_I20181120",
      "decimals": "-5",
      "lang": "en-US",
      "name": "dxcm:CollaborativeArrangementUpfrontFee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails",
     "shortName": "Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i6352fa03b74e459290adcf2b8f29d7e9_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails",
     "shortName": "Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i6352fa03b74e459290adcf2b8f29d7e9_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails",
     "shortName": "Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Balance Sheet Details - Narrative (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails",
     "shortName": "Balance Sheet Details - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndEquitySecuritiesGainLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails",
     "shortName": "Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Balance Sheet Details - Accounts Receivable (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails",
     "shortName": "Balance Sheet Details - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Operations",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - Balance Sheet Details - Inventory (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails",
     "shortName": "Balance Sheet Details - Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422414 - Disclosure - Balance Sheet Details - Property and Equipment (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
     "shortName": "Balance Sheet Details - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423415 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i09e2f6d29705425da4375d800e0c8257_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424416 - Disclosure - Balance Sheet Details - Accrued Warranty (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails",
     "shortName": "Balance Sheet Details - Accrued Warranty (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:FinancingLeaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425417 - Disclosure - Balance Sheet Details - Other Liabilities (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails",
     "shortName": "Balance Sheet Details - Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:FinancingLeaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleLongTermNotesPayable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428418 - Disclosure - Debt - Senior Convertible Notes (Details)",
     "role": "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
     "shortName": "Debt - Senior Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i6352fa03b74e459290adcf2b8f29d7e9_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "ifb9d3f521d5d48a9a1710727f9c1ed43_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429419 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)",
     "role": "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
     "shortName": "Debt - Conversion Value of Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "ifb9d3f521d5d48a9a1710727f9c1ed43_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430420 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "role": "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
     "shortName": "Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431421 - Disclosure - Debt - Narrative (Details)",
     "role": "http://www.dexcom.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "ib331a0829e1642b19cf7b81d2e144de8_D20200501-20200531",
      "decimals": "-5",
      "lang": "en-US",
      "name": "dxcm:PaymentsForRepurchaseOfConvertibleNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432422 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "role": "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
     "shortName": "Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435423 - Disclosure - Leases And Other Commitments - Narrative (Details)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
     "shortName": "Leases And Other Commitments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "iacc146a3fcd448f9843cfc23757a5620_I20190101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436424 - Disclosure - Leases And Other Commitments - Maturity of Lease Liabilities (Details)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails",
     "shortName": "Leases And Other Commitments - Maturity of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437425 - Disclosure - Leases And Other Commitments - Lease Cost (Details)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails",
     "shortName": "Leases And Other Commitments - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438426 - Disclosure - Leases And Other Commitments - Other Information (Details)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails",
     "shortName": "Leases And Other Commitments - Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442427 - Disclosure - Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails",
     "shortName": "Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443428 - Disclosure - Income Taxes - Components of Provision (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails",
     "shortName": "Income Taxes - Components of Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i8faa2bf597984c30b119197a6a7e086d_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444429 - Disclosure - Income Taxes - Significant Loss and Tax Credit Carryforwards and Years of Expiration (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails",
     "shortName": "Income Taxes - Significant Loss and Tax Credit Carryforwards and Years of Expiration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i8faa2bf597984c30b119197a6a7e086d_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:ResearchAndDevelopmentTaxCreditsUtilized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445430 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:ResearchAndDevelopmentTaxCreditsUtilized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446431 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447432 - Disclosure - Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails",
     "shortName": "Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i62ab2abda0de42659a37b9c9f8196c4a_I20171231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i62ab2abda0de42659a37b9c9f8196c4a_I20171231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i09e2f6d29705425da4375d800e0c8257_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448433 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "ic82615128e2c4fc99ac6cee2560ef199_I20171231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451434 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Narrative (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452435 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i09e2f6d29705425da4375d800e0c8257_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453436 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i9504f38e9d964a7e8248536f0d74412a_I20171231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454437 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i1697460f2cd94010a9df70dc435b1690_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "dxcm:StockOptionsReservedForFutureGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455438 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i55cba84e376a4aecb83de5d1d311be56_D20191001-20191231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456439 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i55cba84e376a4aecb83de5d1d311be56_D20191001-20191231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459440 - Disclosure - Business Segment and Geographic Information - Narrative (Details)",
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails",
     "shortName": "Business Segment and Geographic Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460441 - Disclosure - Business Segment and Geographic Information - Summary (Details)",
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
     "shortName": "Business Segment and Geographic Information - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "dxcm:RevenuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i09e2f6d29705425da4375d800e0c8257_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462442 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "ic82615128e2c4fc99ac6cee2560ef199_I20171231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and Significant Accounting Policies",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies",
     "shortName": "Organization and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:DevelopmentAndOtherAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108102 - Disclosure - Development and Other Agreements",
     "role": "http://www.dexcom.com/role/DevelopmentandOtherAgreements",
     "shortName": "Development and Other Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "i07693cde315d4ec3b3fad5a726d99948_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:DevelopmentAndOtherAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "idd074ca304794ce49a646d4278e77cdd_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - dxcm-20201231.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - dxcm-20201231.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20201231.htm",
      "contextRef": "idd074ca304794ce49a646d4278e77cdd_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 70,
   "tag": {
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "UK"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents incorporated by reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dxcm_A401kPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "401(k) Plan [Member]",
        "label": "401(k) Plan [Member]",
        "terseLabel": "401(k) Plan"
       }
      }
     },
     "localname": "A401kPlanMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_AccruedTaxAuditAndLegalFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.",
        "label": "Accrued Tax Audit And Legal Fees",
        "terseLabel": "Accrued tax, audit, and legal fees"
       }
      }
     },
     "localname": "AccruedTaxAuditAndLegalFees",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt",
        "label": "Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt",
        "negatedTerseLabel": "Tax benefit from Notes"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_AmortizationPeriodForIncentiveCompensationCosts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Period For Incentive Compensation Costs",
        "label": "Amortization Period For Incentive Compensation Costs",
        "terseLabel": "Amortization period for incentive compensation costs"
       }
      }
     },
     "localname": "AmortizationPeriodForIncentiveCompensationCosts",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_CALIFORNIAAndNonUSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CALIFORNIA and Non-US",
        "label": "CALIFORNIA and Non-US [Member]",
        "terseLabel": "California and Foreign"
       }
      }
     },
     "localname": "CALIFORNIAAndNonUSMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CashInterestExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Interest Expense",
        "label": "Cash Interest Expense [Abstract]",
        "terseLabel": "Cash interest expense:"
       }
      }
     },
     "localname": "CashInterestExpenseAbstract",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Development &amp; Regulatory Milestones",
        "label": "Collaborative Arrangement, Development &amp; Regulatory Milestones",
        "terseLabel": "Milestone payments due upon achievement of future development"
       }
      }
     },
     "localname": "CollaborativeArrangementDevelopmentRegulatoryMilestones",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments",
        "label": "Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments",
        "terseLabel": "Additional milestones and incentive payments"
       }
      }
     },
     "localname": "CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_CollaborativeArrangementInitialPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Initial Payment [Member]",
        "label": "Collaborative Arrangement, Initial Payment [Member]",
        "terseLabel": "Collaborative Arrangement, Initial Payment"
       }
      }
     },
     "localname": "CollaborativeArrangementInitialPaymentMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CollaborativeArrangementMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Milestone Payments [Member]",
        "label": "Collaborative Arrangement, Milestone Payments [Member]",
        "terseLabel": "Collaborative Arrangement, Milestone Payments"
       }
      }
     },
     "localname": "CollaborativeArrangementMilestonePaymentsMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CollaborativeArrangementUpfrontFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Upfront Fee",
        "label": "Collaborative Arrangement, Upfront Fee",
        "terseLabel": "Initial payment on collaborative agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementUpfrontFee",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_CollaborativeResearchAndDevelopmentFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Research and Development Fee",
        "label": "Collaborative Research And Development Fee",
        "terseLabel": "Collaborative research and development fee"
       }
      }
     },
     "localname": "CollaborativeResearchAndDevelopmentFee",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_ContractPaymentTermsNumberofDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Payment Terms, Number of Days",
        "label": "Contract Payment Terms, Number of Days",
        "terseLabel": "Customer contract payment terms"
       }
      }
     },
     "localname": "ContractPaymentTermsNumberofDays",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_ConvertibleNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes Due 2022 [Member]",
        "label": "Convertible Notes Due 2022 [Member]",
        "terseLabel": "Convertible Notes due 2022"
       }
      }
     },
     "localname": "ConvertibleNotesDue2022Member",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_ConvertibleNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes Due 2023 [Member]",
        "label": "Convertible Notes Due 2023 [Member]",
        "terseLabel": "Convertible Notes due 2023"
       }
      }
     },
     "localname": "ConvertibleNotesDue2023Member",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_ConvertibleNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes Due 2025",
        "label": "Convertible Notes Due 2025 [Member]",
        "terseLabel": "Convertible Notes due 2025"
       }
      }
     },
     "localname": "ConvertibleNotesDue2025Member",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CustomerAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer A [Member]",
        "label": "Customer A [Member]",
        "terseLabel": "Distributor A"
       }
      }
     },
     "localname": "CustomerAMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CustomerBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer B [Member]",
        "label": "Customer B [Member]",
        "terseLabel": "Distributor B"
       }
      }
     },
     "localname": "CustomerBMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CustomerCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer C [Member]",
        "label": "Customer C [Member]",
        "terseLabel": "Distributor C"
       }
      }
     },
     "localname": "CustomerCMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CustomerDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer D",
        "label": "Customer D [Member]",
        "terseLabel": "Distributor D"
       }
      }
     },
     "localname": "CustomerDMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConversionTermAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Conversion Term [Axis]",
        "label": "Debt Instrument Conversion Term [Axis]",
        "terseLabel": "Debt Instrument Conversion Term [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermAxis",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_DebtInstrumentConversionTermDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Debt Instrument Conversion Term [Axis]",
        "label": "Debt Instrument Conversion Term [Domain]",
        "terseLabel": "Debt Instrument Conversion Term [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermDomain",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConversionTermOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Conversion Term One [Member]",
        "label": "Debt Instrument Conversion Term One [Member]",
        "terseLabel": "Debt Instrument Conversion Term One"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermOneMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConversionTermTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Conversion Term Two [Member]",
        "label": "Debt Instrument Conversion Term Two [Member]",
        "terseLabel": "Debt Instrument Conversion Term Two"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermTwoMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1",
        "label": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares",
        "terseLabel": "Stock issued upon conversion of senior notes (shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_DebtInstrumentConvertiblePrincipalAmountExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Convertible Principal Amount Exercised",
        "label": "Debt Instrument Convertible Principal Amount Exercised",
        "terseLabel": "Debt Instrument Convertible Principal Amount Exercised"
       }
      }
     },
     "localname": "DebtInstrumentConvertiblePrincipalAmountExercised",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DebtInstrumentCovenantRepurchasePricePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Repurchase Price, Percentage",
        "label": "Debt Instrument, Covenant Repurchase Price, Percentage",
        "terseLabel": "Holder's repurchase price percentage in event of fundamental change (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantRepurchasePricePercentage",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock",
        "label": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock",
        "terseLabel": "Proportion of conversion price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities",
        "label": "Debt Securities, Available-For-Sale And Equity Securities",
        "terseLabel": "Short-term marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecurities",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DeferredTaxAssetsConvertibleDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Convertible Debt",
        "label": "Deferred Tax Assets, Convertible Debt",
        "terseLabel": "Convertible debt"
       }
      }
     },
     "localname": "DeferredTaxAssetsConvertibleDebt",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Convertible Debt Discount",
        "label": "Deferred Tax Liabilities, Convertible Debt Discount",
        "negatedTerseLabel": "Convertible debt discount"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesConvertibleDebtDiscount",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DevelopmentAgreementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Agreements [Line Items]",
        "label": "Development Agreements [Line Items]",
        "terseLabel": "Development Agreements [Line Items]"
       }
      }
     },
     "localname": "DevelopmentAgreementsLineItems",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_DevelopmentAgreementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Agreements [Table]",
        "label": "Development Agreements [Table]",
        "terseLabel": "Development Agreements [Table]"
       }
      }
     },
     "localname": "DevelopmentAgreementsTable",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_DevelopmentAndOtherAgreementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development And Other Agreements [Text Block]",
        "label": "Development And Other Agreements [Text Block]",
        "terseLabel": "Development and Other Agreements"
       }
      }
     },
     "localname": "DevelopmentAndOtherAgreementsTextBlock",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16",
        "label": "Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16",
        "terseLabel": "Impact of adoption of ASU 2016-16"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Impact of TCJA",
        "label": "Effective Income Tax Reconciliation, Impact of TCJA",
        "terseLabel": "Impact of Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationImpactofTCJA",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_EffectiveIncomeTaxReconciliationPermanentItems": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Permanent Items",
        "label": "Effective Income Tax Reconciliation, Permanent Items",
        "terseLabel": "Permanent items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationPermanentItems",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_EmployeePurchasePriceFloorPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee purchase price floor, percentage",
        "label": "Employee Purchase Price Floor Percentage",
        "terseLabel": "Employee purchase price floor (as a percent)"
       }
      }
     },
     "localname": "EmployeePurchasePriceFloorPercentage",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_EmployeeStockPurchasePlan2015Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan 2015",
        "label": "Employee Stock Purchase Plan 2015 [Member]",
        "terseLabel": "Employee Stock Purchase Plan 2015"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlan2015Member",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan (ESPP), Number of Shares Authorized",
        "label": "Employee Stock Purchase Plan (ESPP), Number of Shares Authorized",
        "terseLabel": "Stock authorized in ESPP (shares)"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_EmployeeStockPurchasePlanEsppSharesInEspp": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan ESPP Shares In ESPP",
        "label": "Employee Stock Purchase Plan Espp Shares In Espp",
        "terseLabel": "Employee Stock Purchase Plan (shares)"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanEsppSharesInEspp",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_FairValueAssetsLevel3TransfersAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Assets, Level 3 Transfers, Amount",
        "label": "Fair Value, Assets, Level 3 Transfers, Amount",
        "terseLabel": "Transfers in or out of Level 3 securities"
       }
      }
     },
     "localname": "FairValueAssetsLevel3TransfersAmount",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_FinancialStatementDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Statement Details [Line Items]",
        "label": "Financial Statement Details [Line Items]",
        "terseLabel": "Financial Statement Details [Line Items]"
       }
      }
     },
     "localname": "FinancialStatementDetailsLineItems",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_FinancialStatementDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Statement Details [Table]",
        "label": "Financial Statement Details [Table]",
        "terseLabel": "Financial Statement Details [Table]"
       }
      }
     },
     "localname": "FinancialStatementDetailsTable",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_FinancingLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Lease Obligation",
        "label": "Financing Lease Obligation",
        "terseLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinancingLeaseObligation",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_IncomeTaxExpenseBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit)",
        "label": "Income Tax Expense (Benefit) [Member]",
        "terseLabel": "Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net",
        "label": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net",
        "negatedLabel": "Operating lease right-of-use assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Future Lease Cost, Lease Not yet Commenced",
        "label": "Lessee, Future Lease Cost, Lease Not yet Commenced",
        "terseLabel": "Minimum lease payments for leases not yet commenced"
       }
      }
     },
     "localname": "LesseeFutureLeaseCostLeaseNotyetCommenced",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LesseeOperatingLeasesLeaseCostAmortization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Leases, Lease Cost, Amortization",
        "label": "Lessee, Operating Leases, Lease Cost, Amortization",
        "terseLabel": "Amortization of operating lease right-of-use asset"
       }
      }
     },
     "localname": "LesseeOperatingLeasesLeaseCostAmortization",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount",
        "terseLabel": "Option to increase revolving line of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold",
        "label": "Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold",
        "terseLabel": "Value of unrestricted cash on hand threshold"
       }
      }
     },
     "localname": "LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity Threshold Of Investments Classified To Cash Equivalents",
        "label": "Maturity Threshold Of Investments Classified To Cash Equivalents",
        "terseLabel": "Maturity threshold of investments classified to cash equivalents"
       }
      }
     },
     "localname": "MaturityThresholdOfInvestmentsClassifiedToCashEquivalents",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_NonCashInterestExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Cash Interest Expense",
        "label": "Non-Cash Interest Expense [Abstract]",
        "terseLabel": "Non-cash interest expense:"
       }
      }
     },
     "localname": "NonCashInterestExpenseAbstract",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_OptionsInMoneyNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options that were in-the-money at the balance sheet date",
        "label": "Options In Money Number",
        "terseLabel": "Options in-the-money (shares)"
       }
      }
     },
     "localname": "OptionsInMoneyNumber",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "label": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization And Summary Of Significant Accounting Policies [Table]",
        "label": "Organization And Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_OtherStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other States",
        "label": "Other States [Member]",
        "terseLabel": "Other States"
       }
      }
     },
     "localname": "OtherStatesMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_PaymentsForRepurchaseOfConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Repurchase of Convertible Notes",
        "label": "Payments for Repurchase of Convertible Notes",
        "negatedTerseLabel": "Repurchase of convertible notes",
        "terseLabel": "Repurchase of convertible notes"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfConvertibleNotes",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_PaymentsUnderCollaborationAgreementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments Under Collaboration Agreements [Axis]",
        "label": "Payments Under Collaboration Agreements [Axis]",
        "terseLabel": "Payments Under Collaboration Agreements [Axis]"
       }
      }
     },
     "localname": "PaymentsUnderCollaborationAgreementsAxis",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_PaymentsUnderCollaborationAgreementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Payments Under Collaboration Agreements [Axis]",
        "label": "Payments Under Collaboration Agreements [Domain]",
        "terseLabel": "Payments Under Collaboration Agreements [Domain]"
       }
      }
     },
     "localname": "PaymentsUnderCollaborationAgreementsDomain",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_PharmacyRebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Rebates",
        "label": "Pharmacy Rebates",
        "terseLabel": "Accrued rebates"
       }
      }
     },
     "localname": "PharmacyRebates",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_PossibleExtensionPeriodofTaxHoliday": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Possible Extension Period of Tax Holiday",
        "label": "Possible Extension Period of Tax Holiday",
        "terseLabel": "Possible extension period of tax holiday"
       }
      }
     },
     "localname": "PossibleExtensionPeriodofTaxHoliday",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_PotentialFutureCommonStockIssuableSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Future Common Stock Issuable, Shares, New Issues",
        "label": "Potential Future Common Stock Issuable, Shares, New Issues",
        "terseLabel": "Potential future common stock issuable (shares)"
       }
      }
     },
     "localname": "PotentialFutureCommonStockIssuableSharesNewIssues",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_ProductShipmentCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Shipment Costs [Policy Text Block]",
        "label": "Product Shipment Costs [Policy Text Block]",
        "terseLabel": "Product Shipment Costs"
       }
      }
     },
     "localname": "ProductShipmentCostsPolicyTextBlock",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_PurchaseofConvertibleNoteHedge": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of Convertible Note Hedge",
        "label": "Purchase of Convertible Note Hedge",
        "negatedTerseLabel": "Purchase of convertible note hedge"
       }
      }
     },
     "localname": "PurchaseofConvertibleNoteHedge",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_RDexpensethroughissuanceofcommonstock": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash R&amp;D expense through issuance of common stock",
        "label": "R&amp;D expense through issuance of common stock",
        "terseLabel": "Non-cash collaborative research and development fee through issuance of common stock"
       }
      }
     },
     "localname": "RDexpensethroughissuanceofcommonstock",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_ReceiverProductComponentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receiver Product Component [Member]",
        "label": "Receiver Product Component [Member]",
        "terseLabel": "Receiver Product Component"
       }
      }
     },
     "localname": "ReceiverProductComponentMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recorded Unconditional Purchase Obligation Due Within One Year, Maximum Term",
        "label": "Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term",
        "terseLabel": "Term of purchase obligations"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_ResearchAndDevelopmentTaxCreditsUtilized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Tax Credits Utilized",
        "label": "Research and Development Tax Credits Utilized",
        "terseLabel": "Research and development tax credits utilized"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditsUtilized",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_RevenuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Percentage",
        "label": "Revenue, Percentage",
        "terseLabel": "% of\u00a0Total"
       }
      }
     },
     "localname": "RevenuePercentage",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_RevenueRecognitionSalesReturnsCoveragePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Recognition, Sales Returns, Coverage Period",
        "label": "Revenue Recognition, Sales Returns, Coverage Period",
        "terseLabel": "Sales return period"
       }
      }
     },
     "localname": "RevenueRecognitionSalesReturnsCoveragePeriod",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the write-offs and adjustments in a given period to allowances and reserves for doubtful accounts",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction, Write-offs and Adjustments",
        "negatedTerseLabel": "Write-offs and adjustments"
       }
      }
     },
     "localname": "SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of intrinsic value of options exercised and fair value of options vested table.",
        "label": "Schedule Of Intrinsic Value Of Options Exercised Table [Table Text Block]",
        "terseLabel": "Schedule of Intrinsic Value of Options Exercised and Fair Value of Options Vested"
       }
      }
     },
     "localname": "ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Shares Reserved For Future Issuance [Table Text Block]",
        "label": "Schedule Of Shares Reserved For Future Issuance Table [Table Text Block]",
        "terseLabel": "Schedule of Stock Options Reserved for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_SellingGeneralAndAdministrativeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The allocation of expenses to selling, general and administrative",
        "label": "Selling General And Administrative [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_ShareBasedCompensationIntercompanyCrossCharge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation - Intercompany Cross-Charge",
        "label": "Share-Based Compensation - Intercompany Cross-Charge",
        "terseLabel": "Additional stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensationIntercompanyCrossCharge",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standard Product Warranty Accrual Charges To Costs And Expenses",
        "label": "Standard Product Warranty Accrual Charges To Costs And Expenses",
        "terseLabel": "Charges to costs and expenses"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualChargesToCostsAndExpenses",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_StockOptionsReservedForFutureGrant": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock options and awards reserved for future grant",
        "label": "Stock Options Reserved For Future Grant",
        "terseLabel": "Reserved for future grant (shares)"
       }
      }
     },
     "localname": "StockOptionsReservedForFutureGrant",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017",
        "negatedTerseLabel": "Decrease related to Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_UnusedExpiredFederalIncomeTaxCredits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal income tax credits likely to expire unused as a result of limitations",
        "label": "Unused Expired Federal Income Tax Credits",
        "terseLabel": "Tax credit carryforwards subject to expiration"
       }
      }
     },
     "localname": "UnusedExpiredFederalIncomeTaxCredits",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_VerilyLifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Verily Life Sciences [Member]",
        "label": "Verily Life Sciences [Member]",
        "terseLabel": "Verily Life Sciences"
       }
      }
     },
     "localname": "VerilyLifeSciencesMember",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Share Price, Consecutive Days Evaluated",
        "label": "Weighted Average Share Price, Consecutive Days Evaluated",
        "terseLabel": "Consecutive days used to calculate volume weighted average trading price"
       }
      }
     },
     "localname": "WeightedAverageSharePriceConsecutiveDaysEvaluated",
     "nsuri": "http://www.dexcom.com/20201231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information Disclosure [Abstract]",
        "terseLabel": "Condensed Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "terseLabel": "Condensed Financial Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r59",
      "r120",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r133",
      "r140",
      "r226",
      "r348",
      "r349",
      "r350",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r133",
      "r140",
      "r226",
      "r348",
      "r349",
      "r350",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r133",
      "r140",
      "r226",
      "r348",
      "r349",
      "r350",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r204",
      "r297",
      "r301",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r316",
      "r317",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r510",
      "r556",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r316",
      "r317",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r510",
      "r556",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r204",
      "r297",
      "r301",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r199",
      "r297",
      "r299",
      "r512",
      "r555",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r199",
      "r297",
      "r299",
      "r512",
      "r555",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r306",
      "r316",
      "r317",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r510",
      "r556",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r306",
      "r316",
      "r317",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r510",
      "r556",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "auth_ref": [
      "r124",
      "r410",
      "r603",
      "r606",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.",
        "label": "Condensed Financial Statements [Table]",
        "terseLabel": "Condensed Financial Statements [Table]"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r129",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r200",
      "r201",
      "r297",
      "r300",
      "r558",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r200",
      "r201",
      "r297",
      "r300",
      "r558",
      "r576",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r601",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r395",
      "r396",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities",
        "totalLabel": "Total accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r8",
      "r40"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGross": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Gross Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r22",
      "r541"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r22",
      "r206",
      "r207"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r38",
      "r253"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r25",
      "r62",
      "r63",
      "r64",
      "r545",
      "r568",
      "r572"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r61",
      "r64",
      "r65",
      "r130",
      "r131",
      "r132",
      "r419",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing transactions:"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Balance Sheet Details"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r348",
      "r349",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r393",
      "r394",
      "r395",
      "r396",
      "r513",
      "r514",
      "r515",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": {
     "auth_ref": [
      "r277",
      "r283",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.",
        "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature",
        "terseLabel": "Convertible note hedge"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Equity component of convertible note issuance, net of issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r319",
      "r321",
      "r354",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r266",
      "r277",
      "r283"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Sale of warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r321",
      "r341",
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "verboseLabel": "Share-based compensation expense included in operating expenses"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r209",
      "r229",
      "r231",
      "r232"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "negatedTerseLabel": "Less allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r86",
      "r107",
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "verboseLabel": "Accretion of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r79",
      "r107",
      "r456"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetRetirementObligation": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.",
        "label": "Asset Retirement Obligation",
        "terseLabel": "Asset retirement obligations"
       }
      }
     },
     "localname": "AssetRetirementObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r118",
      "r183",
      "r188",
      "r195",
      "r222",
      "r415",
      "r420",
      "r445",
      "r519",
      "r542"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r58",
      "r118",
      "r222",
      "r415",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r215",
      "r237"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r213",
      "r216",
      "r237",
      "r525"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated Market Value",
        "verboseLabel": "Debt securities, available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r322",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r427",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r35",
      "r109"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r110",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r102",
      "r109",
      "r115"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash, end of period:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r102",
      "r446"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants or rights (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r49",
      "r258",
      "r526",
      "r549"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r261",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "totalLabel": "Total (shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r130",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r21",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common stock, $0.001 par value, 200.0 million shares authorized; 96.9 million and 96.1 million shares issued and outstanding, respectively, at December\u00a031, 2020; and 92.4 million and 91.6 million shares issued and outstanding, respectively, at December\u00a031, 2019"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r304",
      "r305",
      "r318",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Employee Benefit Plans and Stockholders' Equity"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r68",
      "r70",
      "r71",
      "r76",
      "r529",
      "r551"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer software and hardware"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r168",
      "r169",
      "r204",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r168",
      "r169",
      "r204",
      "r442",
      "r443",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r164",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and Significant Customers"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r168",
      "r169",
      "r204",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (as a percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r170",
      "r442",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r286",
      "r287",
      "r298"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r286",
      "r287",
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue that will be satisfied after 12 months"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r297",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r297",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "terseLabel": "Contractual Obligation"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Total fair value of outstanding senior convertible notes"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Senior convertible notes"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Schedule of Converted Value of Notes"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Noncurrent",
        "terseLabel": "Long-term senior convertible notes",
        "totalLabel": "Carrying amount of liability component"
       }
      }
     },
     "localname": "ConvertibleLongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r307",
      "r314",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r84",
      "r512"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r389",
      "r399"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r389"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r389",
      "r399",
      "r401"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r389",
      "r399"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesGainLoss": {
     "auth_ref": [
      "r78",
      "r80"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Gain (Loss)",
        "terseLabel": "Income (loss) from equity investments",
        "totalLabel": "Net gains and losses recognized during the period on equity securities"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesRealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Realized Gain (Loss)",
        "negatedTerseLabel": "Less: Net gains and losses recognized during the period on equity securities sold during the period"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gains recognized during the reporting period on equity securities still held at the reporting date"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r112",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Common stock issued for repurchase and conversions of senior convertible notes"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r112",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Stock counterparties to acquire with warrants purchased (shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r520",
      "r523",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Carrying value of equity component"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price of convertible notes (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r46",
      "r278",
      "r279",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": {
     "auth_ref": [
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.",
        "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal",
        "terseLabel": "Total by which the notes\u2019 if-converted value exceeds their principal amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Convertible, Remaining Discount Amortization Period",
        "terseLabel": "Remaining\u00a0amortization\u00a0period\u00a0of\u00a0debt discount\u00a0on\u00a0the\u00a0liability\u00a0component:"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Number of trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Proportion of applicable conversion price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r455",
      "r457"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ConvertibleLongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Total principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r45",
      "r272",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on convertible notes (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r47",
      "r121",
      "r278",
      "r280",
      "r281",
      "r282",
      "r454",
      "r455",
      "r457",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r454",
      "r457"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ConvertibleLongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Gain (Loss) [Abstract]",
        "terseLabel": "Net gain recognized on equity securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedonEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Short-term Marketable Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTerm": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Debt Securities, Available-for-sale, Term",
        "terseLabel": "Maximum contractual maturities of debt securities held"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r390",
      "r399"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r390",
      "r399"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r365",
      "r366"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r119",
      "r390",
      "r399",
      "r400",
      "r401"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes (including benefit from valuation allowance release)",
        "totalLabel": "Total deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r18",
      "r19",
      "r379",
      "r521",
      "r539"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r390",
      "r399"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Fixed and intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net, Classification [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r385",
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "terseLabel": "Capitalized research and development expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities and reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance",
        "terseLabel": "Valuation allowance amount"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r366",
      "r382"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesClassificationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net, Classification [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesClassificationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Fixed assets and acquired intangibles assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total matching contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employee contribution (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer matching contribution (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Maximum employee contribution (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r107",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r107",
      "r181"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r428",
      "r429",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of outstanding hedge to currency risk"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r77",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r146",
      "r148",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r530",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r77",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r148",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r530",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r446"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the liability for the conversion option reclassified to stockholders' equity when the embedded option no longer required separation from the host instrument.",
        "label": "Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity",
        "terseLabel": "Recognized additional paid-in capital from cash conversion option"
       }
      }
     },
     "localname": "EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r342"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs related to unvested restricted stock units"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options and employee stock purchase plan",
        "verboseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r135",
      "r143",
      "r145",
      "r161",
      "r226",
      "r277",
      "r283",
      "r348",
      "r349",
      "r350",
      "r395",
      "r396",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r81",
      "r82",
      "r107"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedTerseLabel": "Realized (gain) loss on equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.",
        "label": "Fair Value, Assets, Level 1 to Level 2 Transfers, Amount",
        "terseLabel": "Transfers between Level 1 and Level 2 securities"
       }
      }
     },
     "localname": "FairValueAssetsLevel1ToLevel2TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Hierarchy for Financial Assets"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r436",
      "r483",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about fair value of asset and liability not measured at fair value.",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Senior Convertible Notes"
       }
      }
     },
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r307",
      "r308",
      "r313",
      "r314",
      "r436",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r307",
      "r308",
      "r313",
      "r314",
      "r436",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r436",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r483",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r461",
      "r468",
      "r478"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r463",
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r460",
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance lease liability",
        "totalLabel": "Present value of future payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "negatedTerseLabel": "Less: Current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Finance Lease Liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total future lease cost"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r462",
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r461",
      "r468",
      "r478"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r475",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate of finance leases (as a percent)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r474",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term of finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r219",
      "r220",
      "r230",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r239",
      "r240",
      "r241",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful life of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority",
        "verboseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Net Gain (Loss) Recognized on Equity Securities"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "terseLabel": "Gain (loss) on disposal of machinery and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r107",
      "r274",
      "r275"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt",
        "terseLabel": "Loss on extinguishment of debt",
        "verboseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r247",
      "r248",
      "r518"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and intangible asset impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r249",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets and Other Long-Lived Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r83",
      "r118",
      "r183",
      "r187",
      "r191",
      "r194",
      "r197",
      "r222",
      "r445"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r426",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r122",
      "r402"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r74",
      "r183",
      "r187",
      "r191",
      "r194",
      "r197",
      "r516",
      "r527",
      "r532",
      "r553"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r122",
      "r402"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Outside of the United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r122",
      "r183",
      "r187",
      "r191",
      "r194",
      "r197"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjecttoIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]",
        "verboseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r369",
      "r377",
      "r384",
      "r397",
      "r403",
      "r405",
      "r406",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r144",
      "r145",
      "r182",
      "r367",
      "r398",
      "r404",
      "r554"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)",
        "totalLabel": "Income taxes at effective rates"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/IncomeTaxesComponentsofProvisionDetails",
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxHolidayAggregateDollarAmount": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.",
        "label": "Income Tax Holiday, Aggregate Dollar Amount",
        "terseLabel": "Decrease in foreign taxes from tax holiday"
       }
      }
     },
     "localname": "IncomeTaxHolidayAggregateDollarAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r72",
      "r116",
      "r363",
      "r364",
      "r377",
      "r378",
      "r383",
      "r391",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r362",
      "r368"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Change in statutory tax rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "U.S. federal statutory tax rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "terseLabel": "Stock and officers compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income tax, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedTerseLabel": "Research and development credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r104",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid during the year for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued payroll and related expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherDeferredLiability": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred obligations classified as other.",
        "label": "Increase (Decrease) in Other Deferred Liability",
        "terseLabel": "Deferred revenue and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherDeferredLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive potential common stock outstanding (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r73",
      "r180",
      "r453",
      "r456",
      "r531"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r86",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total interest expense recognized on senior notes"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual coupon interest"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r101",
      "r103",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the year for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r27",
      "r245"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r56"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r57",
      "r116",
      "r160",
      "r242",
      "r244",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r29",
      "r245"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r28",
      "r245"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r476",
      "r478"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Components of Lease Expense and Other Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases And Other Commitments"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future lease cost"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases And Other Commitments"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Outstanding letters of credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r42",
      "r118",
      "r189",
      "r222",
      "r416",
      "r420",
      "r421",
      "r445"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r118",
      "r222",
      "r445",
      "r524",
      "r547"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r118",
      "r222",
      "r416",
      "r420",
      "r421",
      "r445"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r16",
      "r523",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Outstanding borrowings"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit available",
        "verboseLabel": "Maximum borrowing capacity of revolving credit agreement"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Total available balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r41",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Unused capacity fee (as a percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r47",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r102",
      "r105",
      "r108"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r66",
      "r69",
      "r75",
      "r108",
      "r118",
      "r134",
      "r138",
      "r139",
      "r140",
      "r141",
      "r144",
      "r145",
      "r152",
      "r183",
      "r187",
      "r191",
      "r194",
      "r197",
      "r222",
      "r445",
      "r528",
      "r550"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Guidance"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Outside of the United States"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r112",
      "r113",
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "terseLabel": "Acquisition of property and equipment included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r183",
      "r187",
      "r191",
      "r194",
      "r197"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r469",
      "r478"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liability",
        "totalLabel": "Present value of future payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: Current portion",
        "terseLabel": "Short-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities",
        "verboseLabel": "Long-term portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r464",
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r459"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r475",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate of operating leases (as a percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r474",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term of operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net Operating Loss"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r1",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r43"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other assets.",
        "label": "Other Assets, Fair Value Disclosure",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r413",
      "r414",
      "r418"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "verboseLabel": "Foreign currency translation gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r67",
      "r70",
      "r413",
      "r414",
      "r418"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income, net of tax",
        "totalLabel": "Total other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r60",
      "r62"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized gain (loss) on marketable debt securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash income and expenses"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r17",
      "r522",
      "r543"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaidInKindInterest": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Paid-in-Kind Interest",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "PaidInKindInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r91",
      "r95",
      "r124"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r89",
      "r92",
      "r214"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r322",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.",
        "label": "Preferred Stock, Value, Outstanding",
        "terseLabel": "Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December\u00a031, 2020 and December\u00a031, 2019"
       }
      }
     },
     "localname": "PreferredStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r33",
      "r34"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible notes, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from sale of warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r98",
      "r100",
      "r124"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r89",
      "r90",
      "r214"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sale and maturity of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Costs incurred"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r38",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r37",
      "r252"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r254",
      "r548"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r36",
      "r116",
      "r254",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r12",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r12",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r208",
      "r210",
      "r211",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivables and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Purchase obligations"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r359",
      "r591"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r116",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r115",
      "r517",
      "r544"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units",
        "verboseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r283",
      "r351",
      "r546",
      "r567",
      "r572"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r135",
      "r143",
      "r145",
      "r226",
      "r348",
      "r349",
      "r350",
      "r395",
      "r396",
      "r563",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r178",
      "r179",
      "r186",
      "r192",
      "r193",
      "r199",
      "r200",
      "r204",
      "r296",
      "r297",
      "r512"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Amount"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r473",
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r473",
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Direct"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Distributor"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r168",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesRevenuesandGrossAccountsReceivablebyCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "verboseLabel": "Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation between Effective Tax Rate and Statutory Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r321",
      "r340",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquitySharebasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r321",
      "r340",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Share-Based Compensation Expenses"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income (Loss) before Income Taxes Subject to Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r10",
      "r30",
      "r31",
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r41",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Availability and Outstanding Borrowings on Credit Agreement"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, classified as other.",
        "label": "Schedule of Other Assets and Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Long-Term Liabilities"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Schedule of Accrued Warranty"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r38",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r183",
      "r184",
      "r190",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r322",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Valuation Assumptions for Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r170",
      "r442",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedules of Percentage of Total Revenues and Accounts Receivable by Customer"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r174",
      "r176",
      "r177",
      "r183",
      "r185",
      "r191",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r203",
      "r204",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes [Abstract]",
        "terseLabel": "Senior Convertible Notes"
       }
      }
     },
     "localname": "SeniorLongtermNotesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r329"
     ],
     "calculation": {
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (shares)",
        "periodStartLabel": "Nonvested at beginning of period (shares)",
        "terseLabel": "Unvested restricted stock units (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityStockOptionsReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0 Average Grant\u00a0Date Fair\u00a0Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of RSUs vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility of common stock (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum payroll deductions (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Stock reserved for issuance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityIntrinsicValueofOptionsExercisedandFairValueofOptionsVestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r320",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r116",
      "r322",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Closing stock price (USD per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "terseLabel": "Aggregate Intrinsic\u00a0Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r335",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityValuationAssumptionsforEachOptionGrantandEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r470",
      "r478"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accrued warranty"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r116",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Warranty Accrual"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r53",
      "r130",
      "r131",
      "r132",
      "r135",
      "r143",
      "r145",
      "r161",
      "r226",
      "r277",
      "r283",
      "r348",
      "r349",
      "r350",
      "r395",
      "r396",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r161",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r52",
      "r277",
      "r278",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Repurchase and conversions of 2022 notes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Shares, Employee Benefit Plan",
        "verboseLabel": "Issuance of common stock under equity incentive plans (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r20",
      "r21",
      "r277",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock for Employee Stock Purchase Plan (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r20",
      "r21",
      "r277",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock in connection with acquisition, shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.",
        "label": "Stock Issued During Period, Shares, Purchase of Assets",
        "terseLabel": "Issuance of common stock for collaborative research and development fee (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments",
        "terseLabel": "Repurchase and conversions of 2022 Notes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Value, Employee Benefit Plan",
        "terseLabel": "Issuance of common stock under equity incentive plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r20",
      "r21",
      "r277",
      "r283"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock for Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.",
        "label": "Stock Issued During Period, Value, Purchase of Assets",
        "terseLabel": "Issuance of common stock for collaborative research and development fee"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r118",
      "r130",
      "r131",
      "r132",
      "r135",
      "r143",
      "r222",
      "r226",
      "r283",
      "r348",
      "r349",
      "r350",
      "r395",
      "r396",
      "r411",
      "r412",
      "r422",
      "r445",
      "r447",
      "r448",
      "r452",
      "r564",
      "r565"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Stockholders' equity",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r370",
      "r376",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Summary of Operating Loss Carryforwards [Table Text Block]",
        "terseLabel": "Schedule of Operating Loss Carryforwards"
       }
      }
     },
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Summary of Tax Credit Carryforwards [Table Text Block]",
        "terseLabel": "Schedule of Tax Credit Carryforwards"
       }
      }
     },
     "localname": "SummaryOfTaxCreditCarryforwardsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax Credits"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesSignificantLossandTaxCreditCarryforwardsandYearsofExpirationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r219",
      "r220",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r51",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r51",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, at cost (shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r21",
      "r277",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock (shares)",
        "terseLabel": "Purchases of treasury stock (shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r51",
      "r284",
      "r285"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost; 0.8 million shares at December\u00a031, 2020 and December\u00a031, 2019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r277",
      "r283",
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r393",
      "r394",
      "r395",
      "r396",
      "r513",
      "r514",
      "r515",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "U.S. government agencies"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShorttermMarketableSecuritiesAvailableforSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ConvertibleLongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTerseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r54",
      "r511"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled accounts receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r360",
      "r407",
      "r537",
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed foreign earnings"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "negatedTerseLabel": "Unrealized gain on equity investment"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r361",
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Decreases related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r162",
      "r163",
      "r165",
      "r166",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedTerseLabel": "Release of valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r125",
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesRecoveries": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery",
        "terseLabel": "Recoveries"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r471",
      "r478"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r147",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used to compute diluted net income (loss) per share (shares)",
        "verboseLabel": "Diluted weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r146",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used to compute basic net income (loss) per share (shares)",
        "verboseLabel": "Basic weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25383-109308"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4724-112606"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28200-109314"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32059-109318"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e34017-109320"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5283-111683"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "15",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=35708913&loc=d3e50896-113970"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498357-110258"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=118261985&loc=d3e55302-109406"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(c)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r592": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r593": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r594": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r595": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r596": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r597": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r598": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r599": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r601": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r602": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r603": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04"
  },
  "r604": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r605": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r606": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "5",
   "Subparagraph": "Schedule I",
   "Subsection": "04"
  },
  "r607": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "7",
   "Subparagraph": "Schedule II",
   "Subsection": "05"
  },
  "r608": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "9",
   "Subsection": "06"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>101
<FILENAME>0001093557-21-000024-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001093557-21-000024-xbrl.zip
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M%(,6O,QB7)_(ZY_/1S_^^7QT:]^-YR__C,676G]PWH)_/HM%_Z3ESE]TNAW
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MG75&\[JTH.I"&Z@[%G6=<D, /3GCDCY[F?M_9M"^P_MWXQ+<.X%+KRDN0((
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MQZ!R:I]6H&Q:/' ?-SR?#:K&4 D)"8SP5$2@5F*$'G*7XX])T,5#=>;A^6R
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MN)3S.9>B<T_1<6>+*CJ2<L5MWI\"J BYEE;BW$5.R7BYVH**SNMAKU,,ACW
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M"1+.$BDA3^I2$0,QN;"8#8%)5#4.%5B*-$_ 3#,?@E((/$4FF!,D)$^UU-(
MQF-Y9[YRM'P^$Y/G$A@SO:'Q*+PS )K&'"%S T(S!$19Z0*7%=@V9?8!QL.D
MICBF(?J\3H,(@< $:T)0HMP0D7&[<*:L*DO1N9$BS\RJLH1,=#G#V.(+>!VU
M"^,*ZXMDRAX6F.F9LD2Y A.T#LC*E%:H.X)X$H1* 82K0![K[&/=A\D/\E*
MQ[ G2/0QR,H\$ R!K!>$2S&N!:X)$NIY!6;>1ST>EFWH.E$H#-.PG4PC06="
MAZR;P5@%(BAO /\X9D>V4\^SBCYU29C:=GV*D#PAPP,+* +!ZIQ B-)!&774
MCH9"T":,AD+P R=+D9@;D;@V!%.:A[L-P92G<C*-(1CPAENGT5IH =QZGKSC
M/B(E\TXR&,O/>"AMKDW*S@#[(%^3DWH&YY=K6_O7!6DUQB)G].0*P$7<[*RY
MDV+@6M,2JJ44WWD@44]M(-$*?+&H.>$N"290I+T$9IP.N19^8!-FM#1^<R0V
M-YG15WOV<_YPV"E&8A OP6V#ZP][\'(XZ+U8GUPV^7'R/5]W^R";B):KX U5
M!GUJM)(Z&ZPT*H)&Y&_8Q*58X0-+T;DN4R-!RH=WL057).SO3MOJP'V;DDL@
M;.?J-*-'YJ^-HE.TA^W%T9U?-[G3(@Y D@C)DNBC%(DK3S$&,80I%[72WBR5
MI')*XLZ62C)=)<&0G 4:F5"2"!^#]1BU0Z2*TX Z$9=*\G!*LGO:78KR]$29
ML  J.4:=" (-O.6,,HU!HA>466>7HCS7HKRT]X^A)%2(!$0"VO>\-E1X+5GR
M+B4,)HQ@R\AA*3]_G]C&.77$, M4">:I#0FI-!((H'GS-C-.4)3C!$4B'WXT
M[B?[+2<$RCLG!.*ITTGLE#$$D0R+G@@"Q"3"+7/4<Z&XAO'2[,?HKJ6Z_=H<
MZ35)N,\B?6J44,2JQ)+@E'LCE5*"*U $\-"-%%\$<FF!YT<D?CVUF-CI6& 9
MT%X0;HR1$>4HN+SBP!@%B1J>PLT4\:7\_/P$3-Z"L=O9&73#YZ7D3D]RJ:;9
MP%&BE!7&)@])&$G1'G(50<Y"<BO1;TY@#U'G+.JX\#$:Z7C"KL0_$<#3<;\I
M9NN3#TN-GUN]4W5F[R@_5T^]SQB?E(HC;P_XCT#B[ID# 5HZQ;2+EH_S&.G2
M4<QMXB3]Y;G'&UE9@@6NG'*1"B00CE'A O<01-26BE'Y<'I9/GPI$O,D$C<*
MEM.?*%A.I^.)C.=.44F2L4PDRHPV3(: KCHHKZFN0/GY92[.?$GQ#,KN*TMB
M0-Y)A5="..N2)P3E.?K(+ _T"2ZRG97\_/"Y<SXA?:>LC4<-UJ:V;PPSS%-B
M0)@HP'F7UUH8I)&6D0"2+95DJ233G,6KI)((%9)R3@0?B' D#^];ISQ)P*R+
MPBR59/&4Y,=3W94499H<N)!LX)R*!-)297WT #)XX\ N1?DIBO+2WE]?WQBU
M#M)S;[03 ,D:%A*5TNJDP:6X'$F;N6Y,GCN_.W5.<3B/>!&"\3JD()1@AJ1@
MA2(&192YM!S.6\KE_(\I2A2E*$+BE"D1C?)!QNB,<LEIX@);9L;<5W8?NGK
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M-H$C"[@4XCL(\<;7M59,.(ITKZZ4H'4!3-1]S@B,G-NHB'>68"RU_J^UQE)
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M,XE[YY^TELG1Y.I.8W\BR5%U#WG:Q'F/],<&3Y'DO+U=3VXWD[-,OKP10,U
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M1<_E:49.5\ $;;_,;I6!QJ:RA$(#3'5?88D<69HH%P-Y9+BI7W^PUJX7V5I
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M=EG5,)C"4KW=_02)RY7TT6VD)5JMB,+,K4@=<#)-###9MQF8P[;!.IMD1>/
MGMQ9K^MF5N0*X)S ".J3IA:8-$-CQ#]AJ<ZS?HXHHK4)S6/]@/C0>-!VYM'Y
M+\% B/H1-%P7SKY4"G2.=H].KJ@>F+;^R:-CE\ZG^AW]ERN$1;%N\ %F+I/E
MA_7)UK3))KZ7-ZQ8VY>.;_'RE2??'9_ZU>95H-GLNJ:8]1*,P-%J$[%D:&:Y
MM>U.!V)W"8IO#B@MG8H=C^G1$V%+$AE1MK$JS/:9+IEMHS.T7T;/%/H?!FXR
M$%:0*S^X6=/#VI6MH^QVK!C&BV1V\4BR?&$*8P\?WT])F_I!M0EK!0S7(KJ5
MS(!K_2'*CP&EF'_*Z:-[H\=(:]?RBNS1?R*VY,$!6_+)Q"_C+<V[17PCXV_1
M?L]&;I8C6DBGV"6Z'6\XREM)\I-S$%.FG.SJ1ZD/>0L+O&?1(TM.LQ8PV?A/
M8*F"?R+$:_OTQN0AM:N*_GC_]%$R$UV4"MO50A H1UG^*SFSK W4S(<9B\CT
M>[Z9=-+IPS^A:=R<61E/CY-7$K"-'\I^+6?*2QEY:Z[?F305T(%(XGSP]#^>
MW@^/X:'K#.BDC X@_^ES9A"=M$ %SO">L]P&SQE,M2S$'Y_<&[[83SY?I/H5
MI0@X=Q=J67F;#,NIX")[^'#1UO6N/(S.>7GOZ?']I&.IQCEDY1NC9#P"+L$\
MF#Z*^.CX.,GA%T<+PX#*/SYZ&*;$SB29APG3\2-?!.N0+/Q+SJP\_N[!S@O,
M!OU&K/W?" U0I^86!29W9&_'U([,Y'W6T<GQPV3DR6!/;DG,5^/=HE-XI=8[
MWKU*$-U]5Q=HO\%VJ\;>&&/3LD5ACBV9U-*J9+XJRGP%2U"Y%-%]G PGFJM_
M2T@33YVUYC#X@-4(59 [3VIA*2X/X., &+\,\43[LP7V$-L8,?_BV\3[BSZ0
MHY",+F<64?'^HS#.KV[N(Y ^Z*C!4#%O+7ZY)Z;P533W_GA1_/O3UZ0#EQP9
M5QWZ4 Q)5:-\>GNI"@BG:$Z]O;K'_Z-)>S#VX>S*XS?'_(JX#2#[=^.7L+Y[
M<&^ &TP!R]HQ18+[7]&8:*5/'O,'R381'I9+;D%[]5>Q(;/WLVZQXCV]38IW
M!RS(F:&UHT.W+M'^RA2<Q!LL:,W!>Q^&+X#NL%-Z(A0O)65Q+!Y.I$ ? DJ8
MGEUP]ZSCY*DSQBT%0' T5OG2)Q"$0;7%I-9YH10A54^&!&O- #Q%? ) (+CL
M=;#FM+RSF=)YL:J;UFZ_!/MGRBY]>'QO&&_33_'<Q:Q^!6[FLR@R9 V=WB9>
M]@G)J^=&@ZN(3Q\YUK-HSN$,4E7>#$YCSB=U-XHJCL"QNZXMN*K!1?6,1 Y\
M^3"K:>;YG&[<9)P1@4-O@SQ,1RM[\OCX 9=(VB,D8$1^G6OG1DN=)Z=')QII
MX3#*R?WC1U[SVYWI%1X8!NR.DW-O3]@7,,&V#W;D=3\KM8XH'L^_^BQO^HW^
M*1Y=805J- OW[VDPZ%/ ,5]'ZOZ%4@J+6:4YV>2EA_?=@EWTUZG<E_8@R3BG
M*18F)X4 A:R;$>@:513-K%YM\\:,N 52SW75*=YL[;*RC14FNE@C6DJB:ZFL
M8FTJ6W^9:DI8>_!)H<9%UO@V?:Q<-;,WHU-FXW.19!Y7RV"42VIV<'P4X?0Y
M3IX7%\[::H2/5 7,]TZJZ]3;JC$%*K0)Y[+BK"&W\BMPGM'I-THA>BN9F>8K
MI2OAT]"])W4F_ "2+.93#VE)??CT*?+S9.IN-ZO*IQ3-4S=80$\J;G"*G/MD
M!G/]2@O=OC_^^GU#LB^'MT#',VE,CG2P "''V/-!J5'G86J0H0@A::FY0LYL
M(*?H*[$DA*%NE) )K/F+F+D]TY7X8,J3IH(V#L89P9<GUX _^#CY0=($'SU=
MXS0SYQ_88JCZM7#1,%MPE#]0[ NRQ[[Z@O_ATT!NZQ,CJ:4-[)^:SO#_)@G(
MB_HB:TE"L\9G9AA3:EA5^O[!G/\V-IRO6,TST-\S<R3/WB.)1P*SJ_#1_X'Q
MW+= \[^A[RG=T8;1U#&;9FBA*\719!FTG;>(0C-:1 -W(>\FBW:56=-=QC5F
MF1$J<1L7X[:+7Y\"SCV7:_.FW@0,$9=4=U!8=( 4&XU.,X>B;6_^/>?R0^-3
M[LXKZGR+<H.6,W'X^$0^'AN09G:GJ6^&I)L ?7^!)BH!HI8'=8-OE#2T!%FL
M/*L,0A6=EQ_+7CLA.%\-=]3T)OHJN:.LA.=%X 6X6;:H9S UBL7T62.BK?(C
M1Q<'?^B\2N6G2";1!H6.+W$.3)Z'$JP=?[L]\GZUY<.L!E=9/SO6"</ )E%3
M>BRS>Q;GD5L^D0 #'&PW&68;QOF+)ALX]1R@FCDV]AIMGB]73DFFX.5.C)>[
MOQ12$+F@HXQC PV9F*4B#"H.'81TF-BR78"O[G\NFYN>SRI$$SR^-!IR#"E5
MS_R#4<])FXHYIQAC1D\J1<S)[I!BACU(LSG*DCL1,[ILW;KR(IA';>G<)@VA
M&<:E 9\0$^?AK<$(872 ^,/Y)X04IC3;#1*ZD /2^V9ERR;;K%2LVQ48W:1\
M2/1*S#>BV%?VECA!V\8';"3>?L;]MH2)+8C1#+7JOB*H_< 1G0Y8T\58[[+!
M2*3:QG=<L>9(;Z6XQG[-MRDCFN;24K;O1(+X<X:$V_ (*B>J:8I;9%J0.>?"
MRH*KCDD,7.=51/+XWM')=XK6DOKD#1?FS+%]Z*<[2A6S7OXY+Y4EYJZ6\="5
M1<VD3R?WCQ_0QNZOBD#\)T(S'GZMT(SKGZ!I"T8,XN1IMDVB'D6@F/E,JDWL
M,_\[KC>U7WXM4I+(_[,O+M9T,#3S__.'_/U\?82LZLGI_9/_;WEZ_.MF^8>$
M7-!]?QKNM--'#S?OOQ].UP1%&,^"_%DEZN&]>YOW$+]//58>'C]Y?"!;_9#!
M_**B4X'T/I?+WZRI_)81?DQUJ4'$5H[-O3;2!\]+B6P*7#".I9 1VO02/[12
M^@P%]FB3>R&HTWJ/S:[V8H'2$)J%8F^T2\[W#X^0<S@MR3!98G087XA5NY5,
M<2T$*[&'P$<D3F%M*; HP78,ZC'ZN4=Y.Y[.I"M-9G3&B$N)0;(GAOB6K.LZ
M:>L]EB0/4HX&[L.WY4):;E36HP,"V1[OBBZ4*5M(BBR>3<,B!]Z/G%MVE)Q!
M2TJ$V;LTIO<-KCZZ=)2.I$ER.YLP\>+=>[N=Q#1;N-)8@HW[2'C1=&RM5MN8
M<''MEA?[3@UR@Y7V%:>0^$(4Z4L!<H'H))<6?"ZS]Z"?/JYU@T;1.97[S_:F
M=52=U#-VW+)!1.N#VWS/O@J4&K)MF8IO80J&G].!*ZHFB2=O.A-8.\IKN#^W
MRYJUA=1D/[&EO]6=\:_>.2UA)&V2Q=GV4 ZHGR%MSK5_&X_%=U_E>%Z.*$86
M9^DOR Q>NQ"M*Z2T3N;'R69=% U\3W;JWXY?*:CN*M'NKASMF]0&"GF,^LUJ
MQ&\<P"/-H'N]R\B9U;26S\1,MS2WXC(:,?2_THP'3LF+ C MU%613Q]SFRBI
MP1#W&=5OW 95\0W%_GXFL;OACBZE-D\7T?>[EW-*W-/8 CX+;J6 9(NX[HA>
M\\XH.DXB>243;Y@T& 8,!\Z!<8;JJ#=]&17WT9"D@R@\5I2<<BI(LJUV%H;>
M,- ;'(E OJF?:04?@E4%/S8"#ZIB0R0NF!9J=\C^WO"HA:-/N\W85MD O!P*
MLA%[E'TM3VV%/]!'6LA6H4M$<9&M4[,ZD*F4X*+2QZCBX&IDSXG6 MK T7DA
MCN=[]]AI4',\G1K4YT_P03']9-&(O#J<VFV[OID!1"T6JL!\FLA^W-W[7TOR
MZVU$88Q QNV@"8OR-5&8:X*@::75:H&1!U%:0:,Q(F8Z4E\;IX[NDY;W9X<1
M)#Y!:D7PTE&UJ+BF/O(U)&8'6!9[&^!'O!W(+%$C.8WO77+RY,G]J.XNJJT\
M'QR4;QN:?/8$GIZ?OR4_P*T1E&]"D8901.YZ@#;-0A\]B%U')<*V=D>&YQJ>
MTV!,8J:E!_?^)+J+]G2^-<TZ'LL.)6$$;57)\&(!)4=VW:(([*W&1!@36?Z-
MAG_!KDP,'D,6!B$2)&]Z[C$OZ*NOBX<9\X6'/R.S%TO[][IO$,"F)>!65G3#
MC9[$-&$_U1>.FY">WCOY3D!REW7B"Z!)98,:H& 0"1CH3N[_B1N[""YOV@MV
M7<2<N>R+G/GM-3,N(CI4!:GV O%EA??^Q/70P@9;<T)]>,=MT ?_DS72LX/^
MQ$5)V%K6BX7FKSR2RG!WH07>XTTG[HGM(6%"N$*G%SZGJ9O+PWY/AH$;14(=
MB4^#6W'540P.5IJ1D&6!H- S6RYS4(@QAUZB 8Q93XY!)<; 9V.&0&46H^?]
MG'30?RWPOYEM<]8T( OL6R0*4=TWKCWS?72]W!B![FT0G->0#89F2#=JV3T
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M9]FT9[ZU"GO3>%OR/^R&ILG;QE4#<#ROJ?BW-YPZZW:2WOM!S0GVN%YOA\O
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ML7>W*>;U4;;>N,;3^.W<X8G$.%5?9IX@;%B%/4GJ3Z[')J+K-I)$SJ1%,&)
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MWO*58]](-J:4RI%9WUE)".KZE(16IZ?50W1<$:?P>[BQVU AJ)S:7+G,Y(2
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M*5VH<FXR/Z6K3)_ [@.C-AE@9)U5B?9$2H4B8A",UYJCJ4S'K0B<A^F,J"9
M32WJDUXTXA1!0F$@B^F@5K:-Z\MXN3\N.BGMJ"5^01IPC4B('TVU%#*/)*(J
M:GNV:/?4CRM<UP!Z.SV"K($4*O?K2\]CI 6YJ&(CX<>Q1SYA&\ISN:SL-BB8
M7[0@5^ #;ME74F>'FD&)5VJUNU4Z]UT+7:P@4T\IL.8ZHS(00<P[:^''1;]D
MWJTWG:>OD"K]R#H89JN5B'2GV)>QH5S6[GG1)>91E@BK:@7BB,.6/!Y&;[[!
M)^FA$CYHJ$M#?%['%ADV+"-(6?AW'B'U7FD^1$I&<A?5A=\*Q3!%%H:4$PRJ
M<K"$TO>OM>2I&F4:43KD'*XU:HAP;AIJ<YC-B6XX,OK8F*J#]H3MOD/,_WHS
M0YR!70R5'ZW9LM#S3=BZHC#K88&N>8&T;6S%_:V=DNL<MLR-K4A(3[$[F$9'
MMA%&>LB,,O\<ENAZETCQ'S[9S1:=YC3GX!?D4V>V'64LQQC'0TKZIA<RY RC
MQ@"6/S0&I,:M%+CDL]0[Q#PAFQ=#*X>IZL/:7J^!N'%PXA=1;+6J+P(TD:DQ
M?:/"P^)<Z^(TY(AKHT'/!_5;L!>'9?@LRS!DY@+ 4ZCA3 \BFHI0]6T(!/V
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MR+^%H,4CY%T; L/3BE4T$/-&M. GNPWQLJ"*/#'_CH(A!_B=QCQ9,V<LRFW
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MW2D'-Z)&EQ8Z=^9W!?+3MB1NWE()U ;<^RW8,5F9[CC-PYVF*34![&C0WZ.
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MXN#'AS93\->C?25W7K53AKLN[!MFX_;>#]I4+]0C@D%T>B_)LRUJ'W"Z232
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MV-P:8/ CMP8[_3;$.H#2DYEQ ]C6KH$@]L&N2<FURN1M91=U(P2E9KFRO:J
M3 Z0L;]F"T".:<==1#RNGNO/];=BA?:M$,XHTKL=4#GNM(FV ,C:=8/&$JV;
MP^66R%9L!6&@#!#Z!9D*]ORM17#T\-"79-&7BT*@;[4&)J)(A0\,GLD4<+63
M6NWZ^8,8CGZK3]%@3B-H:2A'X.6P8$&$55<*<1NGI%[ET5;SRA:@2G*<OK&N
M5\.AQ DY;U)\HEQ )>Z3C1VS5!<$S[09XYSU6#Z&R5:.]/ALI^9\PU;50W:0
M!4Y#73O:8OD7^\'HD<R&M*:[T$0:L<XU">.*]89TY+ID4BX\(7I3( S@VF'8
M!8.XC1 'AZ"S+B=+XUL=C!TWBDI%7(/#<J!P-^ T!]A<M02AG>3QP@:Q$&*
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M3PQ$>TBLF:;@8PW)G7(W%**B&^PGR.Y\3L9\B%./3501)N^SF?>@ )\]RF+
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MXW$\T_=AM6YTM08']&#WM8>5N8F5T=/KJ-]86/.P;;Z:Q6D%]55PU3K3&[;
M2>0&OCWLF9O29H4S_-ZNQ<#&-\H0)699(,J)DH'(F([(:V.>T<-R7NMR7AG@
ML$:W1Z WVH9%'KBCO*;LADAW^%^M2>WP;#NLZS4[!A]<M]S-N3H442'?G,-)
M-S"U[ANS690C*_Q%^F^C&%AN Q)]Y?*>G6]QE-%7L MQB#T>1YHL$7CQ?[7V
M>VWP:01O%V$M#J)TG:+TE/M\2 (E"%7=+#,CN6G'8L(9%[3-D'!.&@>^.*]
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M">92,%AHZ+/HI3$!.FMU2FR.(B'^D12P:S1H+27(XF>N^TK/'[(*D  5DB<
M1/5?3/K-"!LM69/R<GI<XZGR<3D]LE<B8BG-;"#T-@[INBI#:9C0O5I:AP]A
M%PMF3QJ5>6VR+=M;JL_766Z]X3,_;[O2[5M&3$LVS_IDQ64\(59WZ3OUS)HZ
MR\NML"IL&N>[J2C3?+5E-A0\#I:0B[>8T.!PO)\>MRP6.&A!DH.8<)N.IHR)
MYL7HX",SLB#G9,>CNH]GT%/>9\6%]8[8ZN]"VULQ#G5P&7 SW%,BDUJM1598
M)8@,^SAY7@@U)*DKM(3N%#Y3M%X8V50\KZLEH_LP0QPV'W9 DGXT'OZ"JYAX
M'9<I[_76L!FO7CP/P7=NU['*FEFPPD0YNDR@/"(;P=NP>EC^WC8T)4N!%I,V
M887ONT6?BTX>M'[;5#IA,>C=B39UOG%0-,6^2%(;BBD]ICFI*'1CF>P^M)M%
M]!:*<F'AYX+KP(TS>&N=++@Q GF&K5/KI9 FM5Q#W;AXDCGAX&?.]_\BM9&@
M&J=D,_![,.:N4-_-DQF_;G@^9K"P.TO)-_-^K:=08(;KXL9?ERL7J0<26'39
M +*\@8DK)8$=#9=\#V$G:+B^,PT]E>E%9L,-Y%MF7^GK5,OQFF[U&X(IYV=C
M-!F)TT9( G0SC _M3S#H,S-B0^X0&:)T0(<<SQ $%'&U"^\5/A NB##9X=9-
M4UQP;V?Z[;_)M52Y,)D@H6R[TLW*^I)^6\:GSZTZ97_0[SUGZ^:'K"3Y.R>O
M<LW5\5_/B3L]ONC(#:>L8D'M! -J7<U"5@3\1]9_"W[:'$^SLU"?PH0>M.?E
M"K;,UN;Q6^N-4"!N)Y^O)[9!!_'TK1-9H75;P5/KAN2SB3TG\>",C6#TL>RD
M<MWXAN'Y7-/,$\XZD-Q4[LZUSL ,U=)U4M6J/EH82YILR#*-P. C& \^W)IL
M__'D)#UY?,([_H^GI^G]A_>3.UG^*SW=^48FHO3O\C]YF[< ;&)S13-\G+SI
M^1 KRH$2WEE2[>(W:WRW/<0 @MV2<,'Y*BL7AN&+M  ;TL)C9]>WR1VL*O=D
M\[8#XQ+;P-*1BHJ&\5-7:*T4+AYH KOE+JLG\A0:H7A%?\8U&PBT.(6?=%UL
M/::B<<)I9Q@5VU)=)SK/RC$'KSR2+G*8[XFY8O:6:.1J[VG9A_\(4O))EZWM
M@S-K*+/GB;Y;)+<^L=?K1['G,L3D_KUO.Z,1D( -EKJL@=GDR\](-3:5V[9:
MP9^\XC!#RQP=UH,R#6P9'0>G>$^06')_(_;1UG7N(#^,E1KLM1W5E?Q#OMG3
MGO'3HG-D4&!?5&R#5YUUDC>U0783@AEJ+/'FB*S8T +2MC"?M M7C15,IJ5^
MS.6MA D8/QER9/=U'I J5Q?#-J3,Z11UX(DD*2>+(U?J%39Q:;!@!+"X+J:-
M-MZQXJ9'HQ:V:3R!Y66I/ DEG5\N$LPV! >'F^W/8OY'&X2?<U$7N0)Y6]F4
ME5L*"=VFG[';PP6,]5PDBY\>SF>22UW5P:F./K$<M()D"JWFBMZ91XMJ])7X
M^@WMSG4V=[V0U?J/-A&TK';4S4KK$<Q!63CFI.!Q+#-OPT=T4/B(0JRM27^]
M<<5ZUC=M"$7/ZR.H;VLA%.+'XZZD ^Y=)FJH-5IA+Y(Y$!M);.8!S\-NW"]:
MT-'&PUJ=+1;H'@;C[!P3$+/CV"XC:;*^9RPSQDAR0'[&R,]'WP;R\V/#HE]\
MPB*=PB=/VX+&2OH3JT)D4\- >+9I5/8YQP#;:Z),Z.J(32!):;VZ!@,C8H8]
MT^>$MV_Z!G5*[?C)\VG+.3F?2) RLP.T%SVI]?T>@^FZSM[YR(\9L8.! 6G0
M<3!T:IAJ9TR8G[?:=_EY13XNG215\L:5BZ/7%O'Z,;L\_M*\*1\,;W_$(%/+
M_0XL-ZPDR6GS3BX)GDY&)YL]ZX[V>5VCT%@L;GQ'LG9VC$17WZ6CNN;@3A:1
M4(LFIHVP*C::=/%>"N\J&1<73QD'(@M:UOG+X&89]R!G5?E4U],T'''A7,Q[
MX2FU^F@?-O/Q0*X!>_[2Z),:->TETI9^D55]]'%NZ4U*%)D.EIRP@*GO/8ME
M\T&53";JRSCPW\!$O8UWC^I<OX-$QH92'BG<*X,& TWK@]86S68H,9Z^?QN8
M\93C1&G[+'"TR?"XNZ<HAS@T;)2QML]"/X@!>WQF&=JY'$76)Q8):;;DXAX1
MTA?B.'D6(I/Z86'J-&8^S24>A31C'3"M7 8*@ Z<%3A&R6. WA'+> WPK^)#
MHJBBA&*C(4&!">PN =']_\_>VW:W;27IHG^%J^?,K'@M2)&<I#M.SGQ0;"?M
MZ7;L8[L[Y]XO=X$D*"$& 38 2F'_^KOKJ9==&P EQ7%L2^&LU1/;)/&R=^UZ
M?>JID@$J;-/ARVK"4MX&X!$_;EW,/XW,6',A7H*LY P9I26XDK+A3S59,U%2
M= \;-T &9S,NH]^VDO@Q&4*)'VD1C: V#3TWK6-\S7'Z>A3#@Q63+L#> V<_
MFA!V2?83?=7T +.2S#H/M29?04L2" YP"P$W/#QY> *N-*3 2Z&*H%*^/;WE
M@WFD *-6=.YN)*Z<4U+>?F2E*WKD)\^?RN(D6 Y^FF6#VDR#IT#<HT-3Z2D(
MU8_"0%P=VX$DTAG)-Q!,NR3A0"(!P4.2(.BFO'46EYA-CZRHYJHL#@H#>7.;
M6RXSGO8RXTD189T;@XO1]2@BC+/$N0-Y)Y/)!U3MR8EB>VT/U_DIPFDHRTS&
M]],/Y-SP\R"38+IX:8G,L+\?TP:QWKKNZ9"@?OS\Y=^S2/C&K@]X?JSFZ=@]
M)=X(RKC830!YHE43!^T\ET$!KO*F=@;4N5PF<9IY-)38 8O&^BV\P&1LE5DN
M?4CNN3?,R@1JI%E%5L9D?99)W5KI ZR&*-1)XO .B[ML7DWG-*V=RG#"ZH(&
M3]/&F'507F5Q>>G TJMPY'D!F!/]G4R $.,@[[8*MZ(TD+^F47R))PX0R!8*
M18[D#07TL%_!9^<Q8/1KI,,'Y?29]T"RF FVK#>]U'?NJ9X!)(![!=FCJ>(.
M6U *PW&2I"<19>[+74(]/H[(5]C7@O<W_"]6L">JUR@M<OI:A+,8>2)I\3^!
M0:QTVQDH!^U;%#(HQUR0'POB;WW94OZTYQSD8[C-Q-_+J;^PSV<\M3S<%+FO
M^!S'L]<*^<$-QV<!BZ/0@G@Z<=K= 07#9S*/(WZXW;#OMG3G\"8 T35"<%?T
M_+7:\QJG2O*5TVJGOT'GVF2%ZUPH*D(A:  U-/ 5.=714>*ZY<9<"^JZ(SOT
M*RWQ:[SN65CMYAS;IMF/*83CQS7-STF7H3;E?;_>9A^@W.0YYVDZ#@$NU-(.
M@(5:;^&]ON'=5JMW>K>'GW[<G>(XX<E2I4L 6?#%@93D.J-#7QI?HL-SF]N.
M\@UC3^;%KH']!U/V)2CP4^A&13Y_//).:3.[OMX1)#+@PL8YYGHLX8^M7***
M_WX>5B%2>E8KC^C+$*!JF(FCN@#F3?_IC EY3A\]^O/LL[\^>WEV]N#CIU=_
MPTN@R*\%+JEMGZW#HY!@O"H@7'R-5P47X^ RR14>GIP\RI22D^/%$<N:YF@N
MR4G$B@$5R+F:JP8] 59&:&EIOIF&+H]P*!P%CL#.ZQQ\.1QXC*[4C7"J^Z"I
MQ2\H6"!]0)-HUUK7EB?:^8NSP]M'#S3Z, JRXH#W>'8V+- 0D"UF5,BSK9IZ
M9Q%PQ'_A=&8 J95=P[6BL2UVA:1N$[:@(>U@)E<0?8.EO/VJT$_+U4XI?A=A
M"31=2/<%;FCCNQ\(EL<,FV\%V6F?R>4(0;NOIF//R#TL=2VAA)7BET550D:I
M_:2-,*2FG=@>]+@,O/6[,LWGURHV.FFN?P)6_B6)XF(7>RM>N3Z2CZK&1#'D
MU/($B&L" ^!LSMBGW/#['&FVC$R:%)*L5PYP(#&E)#!;:6>3D9\";(VA->%@
M)".(E).$%F7-$X6 %!ABJ<0MBGEN_VW#&R&MI_1=;+21IBC3LI#R05::RUH3
M?F0RE87DKJG>06B524Y,5BP\X 43R!'0]'R;"WY/73HD=HF=5G X@B"S]SB>
M/1[#EB4HL=]QJIZ%S,]A1/(8A01#S"KPI9M]IJO #@T:^8K9=6N:PM^&B_D@
M&X!SXZTP+R:"ACGUZA++27 ;6V/B&P\@(WEZ\YWF+=P])OIG7$!,<BX*'MF1
M\4,[OTT.B>"?)KZ*X&Q;ZWBH'&,V.(_$0"3_K&%#!PO'>7IA/2541K!ZV.-M
MC1UF.[)_5RA\1X];DJOB!&VS[3&4-P^&"^<*%$62&'?3?O ("KM#^D=R(!.(
M._%[_BM?;[Z=_76[1EU9ZZP,KL..<B3\BM0-=P6^>/R*[ISYE&!7]EN#&5TV
M%3B3& .F2V&U%!2:CV?_]#U9K@^+3WJ4?D,2IIRE>._=]))%'6>(+XFMD,)A
M8<%T,GXX]\S[55ERFLD/H'40=%DG2'AW9NDL\_3UI$4VV.9R@)T"J9!#J05'
M,EPZTS=0W*,.)N)6[SC<@Z05GH/ M233U!4%7 9IY(E4!^@@%XPO,(OP<XI!
MEE9RF7 U:\F5LF8B[88G"[_$ G7'.B$:#MC@3'-D%0UJN.4!ZN6A7E\?H%Z_
M+C^@Y6O?IY(E@.-)2X#$OI)SI:H<82 D=-+\HL8F-MI_(),4U,57"KA"_ I,
M1/=PRH;FM(<#"'K[6*GUW<IL,3$6E%R,.Y(VN"G&EA2]313B73!M7]'<FBI7
M8OA9,LD<T'%,/Y/BRD3[+@_($OYYBQH7NW3K$'"U-?>,BT59PWA%?T,O3B'.
M7B=9<(44+3?HX!<"'V3_\E1;)O+";7-.(RI<'U>]5))]9L57Z8H)+/-\CF??
M(W+-R7D58F]Y\#<M6?W'S5H+9A@#0C$I(15I ]0+ 4;"M^8I3'^"#7ED*6CX
MWGFQ3!::QY?J:D=;$IYVVW(;VA0ZGWK&&ADZ84A]E0B=:,?G"]8(.0_<:W*7
M(THA193$8(&Q.T.*\,>Z/!KFH5^&_)_'+XT">I&C19L,-M,1_$]>;VG;3C,@
M'%@7Y)UT E#\+]DAX.]_"<?/I8K<W?6F[&8A0_39XY>OSAZ$F+S#XM2S'X/6
M0DSW!=],BL/A\7!U^OHTQF;?NHV62M1B!/<GX"'ZO8DU/R>*7?82YA"D!-T%
M?QOP@PT1)\(!BY.&-9+4@*ALQ[X6OR6=6<U^Y98:XJN3>G?9#<[)8%"%^#H)
MQ##Z?D4G>!_JZ%.T#-HYT!& C%S9O>U&S0:)!QD<NE[4"?4!8MYAD)F\1\"1
MU]0/% ^RG]C8L6P/_'7:S DQT7.QY2KT!=60>[N ZU5V39?L]T)<8\'1"PW'
M=<Y0F4&3XG3J>,LT7T*2B#2!IH;5+A,%.00*3WSA7X8E9>:6B$2 292S4=2=
MI,]A$#-7[ X/<8X^97!_Y-Q:%]E42#O%5;H/1G,"< 0;0:=E"X60SYM+&01+
MS2"%&",R1?6Y)?\X]RNV00^OUZZB7DJ:<_R0N_2X/I)IW3^VQBQV0?L<A8 D
M7X3SL&1.&XC3BW\^>W)T^F@&_;8N%ZS9&P0\Y\AZ; F('^Q'7_%IK:]1X1*K
M(3",<*2?PX?=LM2^LY^H E2CYYFZY(/"O(*C05K*O^ :]PNQ9B>6LEL$P;$<
MC?NJT1E$T%RPP3D[!IYTAA_*I.^.R-NOA<:KBN ,*$KEW[7E7"L:^(?'C9%)
M@E[CHQ=SF Q'^'OEZ8R_K#.;_CUL>LS7XV>+IMTTK7/ZV1:UA8!WQ0U%F4!!
M([C(&E/2(@!+4OJ2LU=(I&)KQ^S"S)A4$C#)EQ_Z?+42&'ZX34/-;92 9#P1
M9>OMG\)!6)8808Q.4LH9%.M-[QJ,41+%GZ(0HZ+*YM7.!%Q)VGDF8U),"BR+
MNH),%R>6- 4F6+L;5#)PD4:$G&DJPG./*$F89^<JE@G\\WCV8FO=+*S/F*S*
MWL1(.R8CL32AJ$Q 3<SKXY*R*9P#;[<5.S^?IZ04]_.DQ[Z2EU+_>;TE<&A=
M<!O2QSS3+QW G63SI31-OG0Q#"FCB<9#&SM.K@TW=C;H/BS=_.:3;$^_DX4B
MN.L-*W36H687.>7H*+$JXHGC)X^^C0QS0D]HG9W:CK&?XJ:#G1^DWU'ZK C*
M-!@RRLX6YBX)(KWF=*;DI@W&J8HIVEA%YG41^@@'XRU.$KW149 I<M26'C/<
MR$GJR15&%:;I-B1_$FM/<5,.'B8"^;4!-YQK&A=&;GF*3I808;IAB5.K/)E;
MO"8( 0.J]=8RM$Q'4W'20<><D1H<KP,5>TP,M&>70IV:FG/%]06L77'9O*3K
M<GF$!$7Z%<),QKEJ"1]E17*81)GLG3WD)D*_:Q//Z:*(0?; W?ZHWVTX_4M>
MW_'L\?/7T**I]Q/36 FS T,-_]?I\>E7X>VJ"FYD>%-J>]\#<+S^ !%OY889
MHV8-^WZ#Y%[<(!(\6P'KXAX]-Y&^1YZ7VP#?_90G _%;C!:!K--MH'S.4N0\
M3G"5N$6?MMVX;40B ;.SN\I\T+?4M8"*L 8-XW1=-*B>Q.IZ+60=3RE:)74Y
M$$=*FN=X]EH:+P8MK="8@SQ4%*1\V6Q(QI)IZ9\W\DS!]2IJ"J H% O25%R*
M:;(QJBG++\'4C,$J5Q ;JC'L<L6RL'\2YE61WOBI2[NJM2LM190*N^QR23G"
MPTF_$]=U;VV1?%)XWZ\PA>3,-V!Y)9B KF^_A>2:TN -KGV7U5+2"C9GL&WF
M5/$<+P*?[F5);OI@F<RMFU2_*KBJ"ZG)FJO;TDP^HN[@LK6T<B5T7:+\4IK8
MV'!N#"Y<*]3<[MUG)'U&%KS.Q>Y$E,R]T(+^U6CD"Y14.J1YA)28"/DF9JE"
MC-#S$3-DE?26<A2UX^P8_LBG@]HP$[=*XCT=<\+-FGI_O8K@+*2ACIM26J;#
MR27A;M<D@^X'I\3FF>3<@ 8&QTV;,E ,9H/0-U< S!"=2J,LVK1N VIPJWM)
M&ION\G1+G'+AL?Y10ZF$_Y""!DX\+-WCO,Z7.9XI#>T$01S6$%5R"T/O2 QW
M8Z;#%<E60>$55TW[5@2,E,M0(A$KM.>4SM5=D$2V9-N&Z\PR:>SI@%&)0EOG
M/S=NPA')&/]Z]EDP2Y2=K9O>4;O\XV]@(UJM#,D:NSG1DB3731^!\H]$#)54
M6$X?J'5S>05M^'\=7N??15L!G,)L:#*\FN(#->V3(!-N_2G;%CF)IBOV/-.0
M+7ZPS'PH![\!78+<W$J@G 3ANB9[1B+Y^E0B_I,L^:-IID8%SSU"PIA]R8I&
M[1R=Y/'S<GMZE2^XR#3QSNP59"9* !G!(3YO@/= L4;XF((I-Z*B.04$R \_
MQ44RH&L6^G(B'>*('$ A'A3RZ  *^76@$!9"Z_D+8BC!8&*EY%#[$<.4ZN-C
MNR["R4?TPG(LHQ54N,F\%-U$J%J%K^N5A1$LDQ[8=BVU1(*7%8R.6L_+V@P@
M>K?=L9&27^*5,ZT7NK^/./F;_B!7(.V/C73B?]<L=\>*G'U#>:+I7WO/@^ !
M9:==LX"I17T?GT:HS[JAZ882DZDFLYYHQR23LN_WME(@-"*YC3Z'H6/ 0Y"N
M!M<'@Q9=L'MDJ>+";X FEJG8/&7=N#L3"$:I)C[&-CX;&<[/V!Q0_K^L5"L3
M45TG0\G15%IV;\DR;7NJ@$_;CLR;;///*+SI-$W-?)5D^M15.YKOCM1KX_[!
M9&VD(LLML7Y^A,9.5T-E_EQ>[PEKW>B<SSY[_N35@]D5=PNPT[HH.$5T^A=Z
M>#(2N@"@]J6_/"EMDG+"0<WDHF!"U#'P0OM@3!T<CZD,6C+!,G5!M"F:<BDL
MNAR_67A6+7LO*,KF]@IWKB>]&EK:YT'6'_Z9G8F,9L\S-WD7MA)I"IAV.\_V
MGE/NUL@5&>00$DE*AYF?D_++4JHB$L (Y7V%&L3*>LUURSKF/P2IHVB+OY*O
M_#?Z?U,(7\Z#ZLS[15F U_G,D#_ABZ_#&^8;QC+YW,SP+,0LF%SNI0X40A:/
M-E8^8+?<#CN=#U:4\07=.*"@'W-,YHF3>R*,)<CR4\+H^N"%$W2T35>U A#2
M7 7K^['+,^/\-=?KDI FOKHC@)'+,:$OG36"U4X=Y.[Z8WO'HX[3KX*-5>T&
ME]Y'892(01<D;$=?!I\DUHGQ#XM8)Y8N$VU5J9<Z]X(;/H_,B)B?OFB6A4S!
MJMED6$.$PLG=_B:=H^.ZY435-<TZX2_[\E/'W/SC!Q6%X$;+XM;7=WKB,&]0
M0_]0/K6!KBC6FZ#X$(OE1A2[:A9;R-/^(23\E$Q'NQ3V(?TY57]KCQRQ)1%]
M84H1N6QNK&; _S$IFS=%.&W\G>SZ%19$%"?[*'-9TB JHH;@#,'CAHWAT^!^
MT 6^TXKMRP@4V@.L"T^?1'ZG?Z&."Q=QGG5E+OJ64;^P \B[Y6R0W 2 B&<<
MBJA)V3"R(ZVR;2/K*KB$=F0P*&]':W;'S[1F]:<\E0A^(_Y]@Q0IWLN77@T1
M"'LE/4B7>U#13+GK & "L!%76CC3E1D7M\L7;=-UKC$^[0\/^TZB8\D%KN[N
M4 &4:/P?LQ^D<^()7="5CE\YE1\LQ0]/7K[*E/?.WWB8F*CC6+EIQ&7NS1"7
M[=J&$!G4M;+ 2R801-00 )_EI&&G(D<-.1WLC!M(X/INAL,:$E)J22_3[>NF
M/HH^%R\,O2Z^XA)(0IW.);Z')U;?*\(*</</?_3E[#]C7Q2RX&;K^Z:G2GK5
MS"E!L6WK1L:5L'M>+#"6+-RX6XA+)TJ /#"*!BZ"?$H:D9_1UXX[AT[UR$.,
MRP%[?5C%I"6Q8URJ9-PGMG, P0_R,D(U.YF'G&<)E[;6 8)#$L*Y2/HFH\RL
MD9 Q+(L]SNGQ[,>F=G4*1H''_N5^Q.DD'<U6.L#^(#A@5R5H&]IXO6;OV)J.
M9T^V!C8-!ZGA6'<,$$_=83XA<0=<CAM#B[9!7(-BXH(_D;?W0M]D!Y['TS'N
MT_AY,/Y2U7-=T*:"^@;CC2(,.4@.8,*H*\%=KWQAIR 02,^0 X*3$@F+Z)ZE
M(DT'&%XM)7&HG\[X@^@I9[9@CNY!<>9I?5FVW/Y^WXHS+U#C[PJ >W!VG63!
MD]2\:0P9)#7#]B6/,SH]%)P2YB' G,W+\"+GN( VX7>^Z?HB_W?>+AM,QI"/
M#?\R[C&Q!C_J@,&<@\G,=$SIBX7,_+!.GHRJ+=E!.?"8KO@DR,-./C?9YT(P
MV8:^]JP0TT,OIQX2XS=3U$?AQ<QH\6&@\E71B^/5+,+= 6YB;3<O&/13<<OE
M*K8J9@,B+&FF I\7X8"J.)&"6VKLE9#1!].:]BDO_*!);R]MQ$!T2RBI$LE(
M*0(IN2M!YDYJW?=V[RMJ7 ",@_[E"_3@%E2#<'-DXP IG:8)2#U%Q<E)9D(:
M6<7H"T?G#6:8ZH69F!$WFB(Q.PK)'W= ^#KU2)?ZAI^QT/OS1$G5BJ (4K"P
M)(R/J\,S+[D"9#C7+$5@)TL>7J79;L*M']/%V*-"E3]%/6QH7DX_+ONSA\8Z
M(7/'IVFG3H^=.^K!4*7!0'.%2H2=W-;$0D#0PT4.--S,<<#@V=A"8EJ%;/+
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M /&A="H= W&J:;N<Q(R*_L/O-Y3P-O9!K=NHE;\/@O-F:I6N?$=$>],RQ'3
M[;9F]IF#<QIVGNY*55,EW"41#''' V,Q[9+3S11AXL#ME;=L#S&EGW0QH O.
M$F35(.6A&FPWS-:^23,&SEM+5C=%:FG/FQX*Y:-0(E=$7,CLHEE5P38I&-9S
M<\;.&RMGXM#3;\(FT@=N@08;#4\ZW]:+"P4]Q1[:KO=3WGA2X9H0D)NJ,*4!
M6OB"W-#-Q2UA7C<_<#;YM!)'NDO9DR/XGYQ7)P>_N,E*L''H?'^@90F_STO%
M_0A:0&X\0J)Q\HF>AV,CL"(V5,,J9!N494$@!]=.ON(9#@;VT*+8?=1  S2C
M;BRM-C(*8ZX0!G+DW.05_DIYP'IT.&1DN!WW\!N 7)(I-G3HDX1]SL1S%"XR
MKZ51T;HNH%@(I[D8P9/<A=,K%";=XB*$GQ :X)O$&[+N5<>I>)[S =<2/4L@
M.5MEO[7"#Y7[9_,F!,FLG6UTAX:%\B+ATG-*(C,]K_ERLKYF9"^+:4UEAC>+
MS7A%2Q4!'7L[I#'A^;E$CQ(,>XE2E*=E%?TU &LI'[M5VX;L[9/:WR (_,[%
M>E,UNP+^*&@HES9=C!]](HCV>G2_^1C,']01Y'DG.0,97Z3//)"DL& =><?5
M\>PIP<QT/.Q0VI-7-G, _48 >WJ1[Y^<F4YCJU3X%X3B\LB-A*>$MZ\7WL[Q
M+2DG2:DEN;+1*0VZ7*\&%!=&Y\M'%(+?B2ZSNPOI#*R!/+B5_,)+9>E;>+4-
MT&;<2C8SFXI(A</O-Q>[CO*/=<*:DD#;[H-VE(0<2E,YV(?(Z5!ACJ4X2M'%
M*<+I^4[&"'M^]Z%%I6KA*!B(91%H5"H5NX'$3ZMR]O<2+?+/ZB 813@T/S:7
M3?A_X9&)^?4-V&9F3[1R13<BG?__;"B67,Y^(* 5NK/)5SN'A=8^*:=M\5Z,
MF**,787.#$*/AD6Q^IFQAZXY^6=/RP_[S[ 'U<XO :7@P\DYX%<\?N7/!_S*
MKUHP0#J&L:6/>+CB??-1$?DD*=;3,<BD,+ Y*,A=H:D3UI!Y J'G^\+4*I";
MNG@>V6F4"L\2=B5ARB#/5] )75#<37N4;\_I".$^DP=/\O??=%6YGOW?A__U
M'U]_^?7#;_DEP[=?;M<;/G^/.>U_].S_Z'?&S/ZF!+J83K(6/\ ;&")+I%PX
M)7BN5.=9SJD#:*,:P.>LX"C1:5AR@*"YBMN:.XI_LJ* U@M[\C(UQGVSVQ2S
MA[$LSUA?\)D4][H3*:5#8=>-E6)8X8MRD\[JC8-JQ%N'OD<ND2N/F;5JQ/(5
M<_*U?2W@W^$D(#=KYWJ[ -\HMI?%4WDVA!N \8-@2<G-I>5M*IH@\'>W:8F2
M!J#M.-TE/(^9I>AI^C'NRG=!N2K+K9!/!JTJ2*5)N2,OE@)6O9V*7V8$ELX)
M#=^NBG-R3A<Z_C.V_>B2;>B,)DD?1[4]B1)I(R@<+SP"Q>R[39<,&K=;IOT[
MTT/%WWGLT:=\E!S84!@)8I=PX;2:.+=@$P CH1NF@MW0L93^ P(.D5!3T]<2
M\:BV:!?#1'WJ*%HI&'*&W#J\P%G:XNWH4>) OJ ^F[Y(X8H:K]FLEULDQF(B
M1\#B"PJY*M8;_M<)#9#\!L-')I%Z0VJG@>&X56'"W&:V)9I;&"/8(F_5O(AK
MOQ1(5?1$.3#;>1Q7"+4+OT.-4!))7BGA)T$2H>/)48"_JH-KXT\U;-"F@[&Q
MY"E.(2Y$T]1,N/4JSIGQSZY=!9FT$\WV%$O2 D0\B1X,OD\X[CF:533O.\#C
M73FF2X':=4G'E)RAR=I350WV,AJ2X0OEUU6<&#AHHRM<.L))^B"?>*."^M3J
MA"^&>4PD'$2^A34WME/>>C['IZR ?TK1+0DSYQ3R%!(5UH 8$QC5DO25H0LN
M+0$H\%E-.>5:NH(;M62\/=(CI+TNBIK$71QT^.?6*Q=S>^:2.->=PU^P,4P4
M&:CQE9YI*DXQ1R4"?4#09DE*O/*ZE."\MKYH(]X08Z'T<<31!P#Z1@CO+$W.
MY24ZXYMP-8K1R= K"\A@9F(VN]#VR:1F:6]?NZ&Q8D*#VU'DJNJ2,L8X*\_V
M1,>,,R5O1=^271?:/ 7[C*1BJ."\#W-[4O%]=+KWECKNQZ8G&T%GQLI8; ^=
M22L5Y:8IRZ[@_K>!9=$&A/G>*I.PK*00<\<W.5GHGF'.\+ZC=--)HDW./=L"
M8S8]>P/A6WUH\,U=GG1TI^9=8:Y1DE:@75]OV'4B]ZIEU"#GFKGCG3(AP1;.
M*M (6C\,^=P7LV5NZ0L61FWVX>0WZ7$I9[?=MX=]_I#[[ +TD?<RPE7>KJS
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MV=9<R2M4I8X=O&;;PQ],+#BF" D=BH#UTE^)A9;D8=^6Y^?B2,"?D1YQ:T)
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M2ZKC*F1Y1L CY9EK>]8+(2'FP#>B&;4W/8\TZAP3 ;MV3T+!-XT$)CU&F(D
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M@AU_0=$.D89QR] T3@HZB(CK/YEL.IV5JXQQF9HW;"R)TF&7"<#"_%F# MQ
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M)9_H=YK3V<UL:(+CN&FNZG.4#A4_V-&WX'<LBWDTE?R\Z8?D&-8%'@3^BBF
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M]INN+5>ZT,;ZE.>@-SI4P0^SRT@XPCAA@M66H3+NM'&: QU90:ZKP1F@# @
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MYV8'@V=#<.PA=7R*=-R(L3#>O>2YNJ4R#1ZRB7.LE8I.\*7L^&"#.(':<;K
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M;[P3>\H3,,)2V/<FILAZ"FW8>N+O]]A97/HD]F)<LVIFU?WXH2U7@9(:$@.
M(N'E#\\+=>D\7_5HZUG <HGM *O;-N7*PKL]?IX",5VRCBH,WDIGI#K9[0[9
M^<?V59Q SZ(KHD^"1!<#:PM\%D^G>\0I\9WPA*-GDPL 0=97Q(JB/^,=TO63
M9?FHN@R7!?Q]^74;J#>(N#CTQ[:%X4"7(*GH'I_"(KJ*#K[$$ZH]-+A0N#R8
M0LJA7 4,JO0?QT&B.A7GA'+-^45%LLPL!%*211LZ#GR70R[P#GT5(]D4: 5-
M*BQ%XFZ27$7'AQ)2E$;R)%+K(27\U(+E(?-(Z&JD;Z7?/8E44*9A?S SPPH2
M*AO#>U74N*T?&:0G?'R,33H'QP.=V9<+6F!TX,\L&J:A.28P-9;+T:[PJCZ0
M4AJ,7&4B;1,?A=@-J_@LHU7 LB:4B70/.,Y8TK.:C'1<+>HM2%L4.0R\KH\)
MQ2"C>+7IFF*<' WU7=4V$KP?3!3X43?B&MQ;;19>(3T"SV3WL_70_VH8$E[!
MTD!8B56P-E5H57.>D^[$U#1'A1"]HH8U06STO9N.(Y,-&0S#4,=US<6&@-8.
M)E(WAJ#$-R3"-^P*F:?GP@^=)"4_I6NLVO(^VARS57RLGLK1H@25F1!*<XTT
M67(@U'<O$M42EK'OA%\\4E\G%;4,8$Q'2-_IW6#<?(-OX;MRZ)\D>B:,4/H0
MCW^9"NM3FH /&*S%IROP_N[_O:=R9;Y4*1JNZ@%M%;"9 I&KFA4TZ5"=P3J6
M9*AZH]I9:'OK.OXBC%C/$/JXJZA%SL3DDM)1P?N7^D+BGJQ7UFAUH%. :HY=
M?V$AH04# )-E:T'8B&4]K2%=%!]35A(7U^*KF9NA%'POV E^DVX9?_K=BS=%
M=AZE2);K?=(Z*T<4#QG& RTJ9-)YE)Q=P8C!$,%A6K%(EM05>>G38522-8)H
M'Q(<5?VWH=VS*9N_Z$8%UKAX69#)8_MCG\0G9K*RECIPXC?B.\"J(7&^%P\N
M>YZCCW,*1BV>.W.Y FB549& %/9*PI&B1!X/B](70$H-GJSJ0RON=HB/Q?&]
M\XQE[)+LJC9]>E4HR-K%P>;#)_K$]7+/>XQZI>+]EHBN,[8#AH^Y)!7XIW@_
MT0Y<Z9E(7#/\(50<C31P%6B]RL*@[Y2VKNZ:S5#W94L<14)&5,EUQ;F.\4 \
M3.DYO7,7#]DEZ=AAV(Q$C]]XI#&)B +G+>N?B;9;D:3CG/B;M67:CZSHQ-UD
MR'+$=^@F/8%\@$O0@='U[+%Y%.+"B/J 3&[2N"WF! *+><&R4]@R/W)<IM4Q
M&;SDLX%$E-:5)X3R#EL_LL$',[*8W?_S]DTQ/8D</@;TY6SK0G0PI&-PU2P'
ME+-=K"LKC/0%.SE7G(<A"6,2W]TXP'*>\_">*7X0ES%6J[:BEIW(EZ?%2M7A
MY;OR!O_9Q:]#/&]Z!%)2I]KM]#!DR,,,UXR=8MC"OBX?Q\K8W:F &PU_'/Y'
M^J==M$!M9BL>@SNS3M]UGL IK-4Q4]U[8@4J>S-Y*\!@A20LJCLI@,1'NR![
M/6R! U-IZ.@R#4QNRK6^XS',:#=TW& W@T];D:A3W!)M*E$#]D&_#BC#9$"-
M8\Y:4H&%LT*( %6"!32'SB"<]80(NJ:5IWD@-IL6*<>MN&UH26JAO[Y):N.,
M=-MLFGNL85Y&9UW#!X5RWI<ME, V@:F,L;_[JB=0F_Y-,@SLRY*6."=O9<;.
M#?,/W"4#@0?D?Q#@:/31AO70E1LIBQ%--TNB/O_F.]5I/4_5@U/RB*5EN"LY
M 1.TZWE2'KA5,TOHX<2./CC%"^>9>-B9()?462V.62E.8'^3Z5\%"N_ 9)W'
MD/R$C$H6N2&+0UKU%&U(S7>@#,69S>^!)[@;.OC#+/CMTMV$!\I2O9JJ<]E$
MB]0G_NEY%A^ZVP?)'<L(Q5"S^D<TF&=[^= :Y!SAM8!T(@E9'V_]_)>$A3[]
M;<!"SYOB9R)1C+/GQ-=\B@XM!<1O:>=0P8DX2M?T8='=#OV*P/;9[\YF[=/.
M(""* Y"=T@>'M'['17)R]4BL+:7[+75V]@L>=-ZR:H4!&\Z[YZ'Y$X?6: BH
M-M>&LX?\"0)9%$H[(<@NJY:0 +M-284=2<X)?H4 R&38!%1ZGJH'/FS^)O"&
MLQ[KI[!6EOY,W;@G@:S] 0VO)O4GM7^%3 .@Q.7"3+61BH?4U$K-[\ %_7V@
MY.1Z#]*(5";K@FFD*RBG6>:@G-NRW8Z0!IQY9I2. _]0;JQ3&-2ZZ@VBTD17
MBAILT263<,+WU&(=':P[>P\'=YTTP##&"4 .^384.@G4'6_PW8LW$U(-DSWB
M/EJ^ -<P1^SG4%44)HI:OK[9"U:,<9GV5&@UVE!'."$U;NJJ)\Q9?/(X_L/-
M3?184IFT'K;7U%_4+OK]+@ +$A\T.IS@=D"Y]G+QDAD2J)VX..:%HLI.S= B
M)<K-M=1^H']G;%T0O@>BKQB5G1T"^$#E^12*[5]+RX!'7&L>$)U/EB!<.XA1
MU2UNXI_C[!7:;SSSDSFJDVW5:RMT+0*K*^29L; Z!U)U2%Z]$@-%$_Z.H"P9
M% #-6O%HC],-]*%KZ6+T"!)G0WL7JLT&STBZ9ZP/RR$/]\>0Q*UOC]&(R"")
M?R$H%=@3&F6[V!%(LQDZ;"%N'S\&5$ZXJZY9]_=,(D!U^;PTDJ$K/;#<_K(>
M_:(CVH"*7V+=,DIM/\9OZ9.-408>Y' (;Z']-P)>*<2>>!"FL'JG*<BOD./X
M<T1VG8$_.]ZS!Q"I>3([@WZ/L-R%H>+V<L4,89=(;GRV?'97)'5;S<!B,LVA
MX0U1;35GA_#Y<.&QR/_L#^3,_D.1UR-2@'1K:2<S.H6U;]."5[!?IYIE52N'
MS@B9I!ALMHOEZC;H4C IR$):@?+.#+^9&5G9RHO3#JWEGNF)F,CB%!H?%/PV
M.O"BX5LE1":6KO;;;0(X=I);0'RTT5DH5'-D,VV!FL<PIK8<@2=B/JVM9!;8
M*#Y(=[M8;YK[DSBW= KB200#3.LN>CSLX R=:3<NARZ^"GD$KB])(=$\]C@N
M<D2O92+5-LZ(04))FE@X6*K=W$[]9?0EQ*<3+*UMD?H6_"G:I:4 1]=F/>J+
MF&&ON5R\K92D9EVU7>]U!S=EM$:W$S1MO-^S)T\^+ZRMYK9T_031=XR+4&&[
MOJUC(M/A.GX3QU,ZT/@L8+(3J+4;/%C^F;#!UVWS+IBH.ZWI92"TKX? DX6*
M%R9'K(R^Y%:>@;:4NU))7OD&K>?T3 *F=@KQ]MW+Q0_'L:VCGEP[VD8M2F17
MPT\EI;'3D+*WZD; N9'Y"%,36G\+C*=S[O4Z!/?C?4M+)O[+>G1V;06B.D&[
MQDU%_9;QEG%^!(9*'/]A(ZRDQ$66W=AHZ'"C3-L]3?^H@_"U?"Z)^S'$.S^A
MZX9DW$'@7&-I"$@\X;^-H"GZ?-(@8=#&$7LWW_A"ER/OI21,9Q]X*NDQ>]G(
M\X*KL!\'<2/0)*'(AYKLM[.C>%)JHXB_*PSX'Y^S(.>8V4B!].W">PZ'PC!\
MTH=&_&GD7N!B#4/CD^/MSQ$O#%O,'.7C%YD:).7/JED68JCZT^BLO1)WB?5Y
MG3\X)S"Y'2@%2',OLL[Q0GP0$*)<^00IFJFSSE"*&*HZ;JY_!.',TTB>M]*>
M-MN%ESJZ@*<$XC(*6FA;@C3PQU"^J^'*RC2!65@Y6LA-C1%J#Y]J$, P6O;4
ML4,C*C(+)059'1U_.('B,4 H^IO *4X)9!P6G3LWR;+ YY,N5XC^4$Q%;F9]
M0R^K"/E$S,*-F?8B&%I;ZF7<GA*8IWZO:-8VS<Y:--(YI5V%XABFM '0E11;
M2KMBGENQ$UB/Y%E'Z!2<G%>9E/@VA!XI%T\ *GM;YXG6P*I4!:;\X!8V%PW'
M$=X<<E1'.:PT,^ A6SD>E0U)59N7=?B7-'W*T8FOQ/!U4*Z9F?G3WI] "^F?
MH+7]U00-K\U#)$Z8"^I=DYR3$+JGTJHDK1";XP#.PF$V,PY1+-1W?J-I. >)
M][M02@HMVYB$NFRK(%F0& ^?!'GP?Y02?M*[IE<LYL8:2=GQL>":8S_6>]TT
MJQOXQ/@WME7TVQ95VTJ@G#AM$6BC2675$HLS._D<G-"O*?Q?;\KM5ML#R<'C
MN*\C/Q>9EFB X9&LPS+UK_$?HW$(3-G0NZM2JQ!!.RG+4O4AM7TQ3:3U_7$"
MM':4B.8<SXS9Y>+;YIZR3O"M\FQ46NM=M0H7',MVZIU8EF9N)FRIWVR&)5D9
M2=0A9R8K/Q$$C'9 SO24I2#5"[)>]E6S\QZ"7IN3CDNJ$X"^$J=X6,5S>\:]
M_.9S_=WH^!/NHT22*I=!+!K_N:(^ J%FB\<]A:5Q,.+T(\MJ\V(L66HLD['0
M.W7]L-*FHCYY"&(&),]**TX66MZ1S80 Q.%T&ZCK>+%!BI,"G/AG=6Z)5Y1&
M!-[+F0DQ@[P]^VU WGXU3(A"5XOFR[#8-X/V..THE;DJG.U(?=D@N+70YD"N
M?"UQIN=6!3<2ACRSAQT'7G%;__8]#.D/K\D4:R;%\7HXKH^,U".KV9A%_NOE
MV\L1H43.-TU][A6W!TB.O[3PRWLG:,@LT6BO-@@',#6YL=57=X?N)/X.ER/Q
M>-FEY&,KF>RB/:&XGP,3U&I]/F/&-;K\A6OQ'SEGIQ!VOZH7WY5M#-2>/7GZ
MIV)Q5Y5809]JH.<?<D6Q[EWS*2E>-,1/?)VN:D]_BDZ$T(=K+$^&Z^]#%?<O
M \N8+@\'>"44JM42!7/ET!/^/,)SWK0PB\ZS..Q)*<M>8_Q]5=QX^N?'3(NL
MO))$HES63 D9+3:W9\=M2"34SG^;>THR4$,?';!_<#2JW*UE?QO/09?5KLVW
M$TMF/*]FK)1R<V6M\9UF^+_Y_!1B&6)OHL6 PD2?O:DZJW')."!(S@(GW&?$
MRG2HKOTH2V*7&?U?XCB3_&U6B@V/"U:0*!7\0B64OF+AV?C%O]&Y8I>H/,T^
MLKX@/-*&9BZB""D5L]..9YMSSYS:Y!_Q]\YF9FQFO/Q /!07K[^[2O03,GB=
M,$9[:E^<Y.\"[]J<6R]&"FR.8M [)+I>+N0+-]6>*_?$3--IT7%*2%QF][2P
M,KL=$I1&"2P_[S[\]\7H 0]0&5.1&]0\SC-2@61T6>$7V'1AI=4@:LS?9)68
M^2:Z.(0:4ETNC+&><F55NQRV9.!1&_%/BE!<8]5R\K!^<[HZ/#<X)]2%0@M.
MP0+&=9!GP B^MZI6:$S5_/4JA&U&MV'94H2Y;86$N1"+V=9(J9C\#&)(#-5V
MFOOZ8L2^G'YT-CL'O!M;B?>H!=Q;Y!8XZ0$D8O!F*?Z'_=C,DY35B4+!([,F
MS,7CK$WB=3/;T,6YZ]9<,!79$2NV,'>,4<8 W /.;DY5$\$.*).*]&29WA1E
M%=MP*X0S';%JH7.:V:A *I;E61S:1L(TC65U[0)8Q[R_WG#;VYP7WGCAS3.D
M6T;.;5IU1>MR^TOMX*<?C@M_\@EQX=SQ]1$10O')A^OI)QTNN$8=0;T)!AL8
MM*I.P3I5:N0P20>-"MP!(BUXDVB!1HO6K(NR78WAR+9\G4Q&8FM3-22G@ ,!
MG(G^C66]QY(;*DB0':1F=.)F$H;"6<T/"E0T-<-[#F'%AZ5]7*['TOH^-DC@
MXO58W&B>)WH*G>?( SY4".\6H8*G-(TGX\/186183P84"VF>$E_#@(^#3JXV
M50PRGJ2GV&N6A">OGAZ)=E1,N'02'Y^\PX,W48)8X17Z)Q*6OQ[W3H,2.H9!
M0H)2)$[ N,SF(L#R?/Y-+!- WAT3/!](\@I8:4/N+0I0_.]ZG^VN4E?_)M&2
M<D\%,VSR#>J]\*MZT-^7YQZN!^WA@@EG4^N*?+.1$-<_YS.*RE,FH>SX8.L.
M1DGG#N-//M\<UDS/ZD.Y/H]>/4_?PT\?RNPLG=R&B]FR_1@U('U/54T]@:!L
M[KE#< ?&K=G,TWEJ'WYJ9SN4N+5J26 3J'42+DGW+F/YO"/K]^:Y)?JA)]&)
MVJ#FK4[1KME42Q'+]C@A*CR,570L7DEE<-KR)X&LUC91#3X,-)![&YPY#50L
M\J&90 6*:77?TG>_%&  J<$)6B '"Z0?S.'(G'NE;VS65L0#7!]KW@U7!S($
MTG1(5;26&T%8XD($NJ:(:*/ZI_M*40PMTG:YN<;$#,CA<1E<=_" T5G]0@CY
M] 33TT@[^YRC?,00X)3.&T<5;H((@6'D8R49W5-K40P:L?SO6E80&03;IC.*
MOAL&"RLXI?-8=HHA+4VK^H0'>C=]HF9F$8Z>R)#2#I)+>N4U+@KB2TMX$THM
M=$N@::,Q:6^2W(KO[CND3)"Z^@ZU[_V,L@2_&L 2:<L>:#YF@>R,I:!>64]J
MWD[L^F%R076:5U7L ,E!HTH#VK:&7:;S+"4'T]=VZC8FXS71D7C_S)U6X^6/
M82SH>WRJ6+XHFRW^H@B*@CU;^JT+:0?P4QAW;/&>28R3$ TYF&9IIY9QGEC5
M@6JH>2]?5E*58B^^I\P1#,6] W]_!5N9+1?BPI4<JW^F^!(W;;F-9T0-:96R
MK;0_W0.%V1[,7!:"C=>4EI'6K#6*T-DXD.W3UGBZF9B^60V^]Z][/J+ [X:&
MV5SGE3*1\;A:MM4UU;FNP6,^FO9PUVR(]QS)U39:[][-O@A<X,FIH2]^BG/M
MJD//E!I<E^26MRH<[(=P!8';1;AS7==4Y\&,U@]%:W =6IJ;+OX&G9LR(+?5
M3IKCKBM@Y^/MJ!X([5$GCM ]9AL23P&N.D)KF_R]IKZ8R<AWP<$CQ?,I;(5@
MP.GLQ"0QF\P(1&G*J?>EB$Q(ZX&J56F-^SA!R=PBP$AJNTU#X2/Z<U85=1U2
M>P+F*5ZRV8<PKY5GO 2)/=T1%]B"&;7"QE-Q,V!'<["+'CF"Z,(@CC>;UO7C
M[<YP<@\G__<SG/RC!BRSO6;#8W"2&VQOKS.K1Q4:VFFN/X.%YEK>1OR/:B75
MK@]U6YSFT,Q1>,AQ 7K@N 4_HG3ZK^R??#_N>=S%H^ 636&[EE3^=LB!7^]=
M<Y-VM\!E;S3K%J(1J#1<HQ0<AS)86=);RQ0G)A5/YNZN9&Z)_K9J5Q=D_/;Q
M\GMN(!/FG.P,T+6X>/3KJFR%RYM?&BM_]/Z%;;_"]EZQ^.'-J^=7;[XN],R=
M'+6R:]@:]!3RU]87'SUX#L#I.$>#@P[^8P+^5'=T@333[K<L,[<2;X_^SMZ7
M]I*I/V-L(P[-ZNHK$]<VY]70O?TPP_Z>AH1/,><2X(]W#H$I"<8'3_XZ<,\[
M(3&DFY#]ZA2]VRSHWC?40YP']G[#'L;A7MQ!BOL(?G[%ZI$48.?4"F/O-YEX
M^L^RQ1%B>G+"*Z.I,2RU%X%>R2;^6UZG_Q:=IJ\6WP(H]G:&2^7Y=V\S;A.W
MB'F]LY*D+&=KRA%],#-?T]/%O<![HP5>ZV8^^7UTZ\'WA+M:28/M>)VSRJ-U
MU7)X@5_$T;VMKN-,/JH>"Y7-1M(WZ^C1(V\4K]I2\L.'1GKO.&><I&.^-2$E
MTT_98WV)"SWG'U\MXY<?5?%N0QT?G+)O\1@8EHX_CILL)9"(#V)T _I2&'Q.
M%,J=-OL+8I8-J[F@L#OP=%=U7UW\9[5\=UTNWR''%MU2MC;Q >,3^FO)3'"T
M#(Y;C@=#>,<IH1F[$K\(()%DQGP,:V0E.._NP1A);\P.4YDH'_'Y+:T[S:\I
M-R/'$<R((O^='(PL\$KXI?%;'!B9UW;WMV&SOGBCDQ$G3*GC8\BVV:>'IE?J
M?D%8[F\&U!>74?MN\9?R_A<ZNG\[<+WOT)# F6WD$[KHUV_*UMDK2W_DV^=:
M?F=>QVP+I.[XM,N3E2YR@MD"ZW.S,3_0<3_2 H]_-@]TA%U[OSE+R$$V7,I5
MQ3:^'UA9,&Y8R%LSP(]>0DQGE]JK8%&.9+=X(\<W^_R)=:WK19>)ZU;8<^5/
MFM)SSQA^HF('5W*<4/,JFOX;9:.@-'O75S?HKR!0RC6DI!+%4SIT$_.:?ZTD
M]$F \+BRV%P0_S?;G&P,9EY]9,+5=9\-"0N!N*?6#1S3-1;7@6DS'@*:\11;
MT,\0OU*I@-I!KEO&@JM[*E3":R4 PZD(%Z8-&$8PM,3S^R::ZV[21@) 8SET
M?%$^9'$)00HQ?UE"_>B@O(F'5.A#_"OQ4H G;R7@4LA&++YO;^*3_T.B7IRS
M\5;16_\^>E49+Q/G9?U#-6L%L#SYXBNKK&E8E9V[[XOG[R?IZ?F3Y;5._=N!
M3JDZ\".S)SEJ0BCK>D#0*-+Q>A;:\DGV 7QS:VAXKF,H& >*R=;>81V2WW01
M7:10(QQ-O,IQI.!3]=2415,37:0=16H2?O!\$!$554:5G;3G]"]:+ @<BO6B
M;1;7X8:.ZS;.6S(':ASLR<GOM3$A0#)@8O&N-9E#R9)"H5XYG_D]M]7J8D-5
MTOPKI.0]1Y;'SW?3<!NIE+Y 1_CL&;LK?BAG!G%;KI2]L<LJ[/[V%^R<\'6?
MGD(R8\PT\@'^X_.FOFF5'8N^__VK;_@ C 8U;J&JNZ6=RZS<1KJ]7K"D,14V
MJ:JY2ZE\5T<%&]YMV5XW+<K!<:NUA)M@7C0Z4M=H-HU'0(N268W=DZZH3%-R
M$8KKJNUVJ(/BHHS^UIF@V1<]B=D-M-0K/C:IYD#V/67D<PK0N'GCM+(X^ETP
M^NS9P=&YKZ@PO:%35& )H0T85][*T6Y0/VYYU[1S<N^NOI!/O+']P,61U(=;
M"L2$5+T+#!56\4=RV2U8+2FHHGIX]B-0+UD,>?SMM"[B\KRE?TQ&W*/'*EYH
M0QMBU2P$?@^5%L>TBRH/;*9/(;LX<^:HH:? 64:>0>'82>C5L?;OB&$I.8R+
M;MG&I5WOA;W25CHQGF,@^AGJZ+B^1-D]#3LQ&W$K04-* 4F^7H$G:5#Y+_+F
MMB^%2>[POH2Y%M#+NAFX=>*N:C9')X8838DHVFJ0_ O]U^$)-6>G;ZL;T@I(
M)$U33^0Y_*GOHL$'F_=K%*3V%/,P'N@]P3\V ;*_1)G=61E:+M/U[0"O1',!
M\>?I-4[!ZKQ@D"*_-''_TH$I1(M!PGI*D%?@P$PY6-KD1R-\CL;A7N2*$6R)
MHJ&/UZ(%Q*\55R&=/2*F89U,,X;(@EK:Y;1VV:'Q!LI6,O5:P_@<7&V%K]U,
M=T):<.FVRKD%;@);#;JF[7L%DPQ5:XX6TA?C,=>'Y2U#>^-%ZI)9=?][LC_2
M/870W84I1W?%@2B#ZSNCW=51)A)P?X.ZI O.;B_Z"B45%O\98R<:_>G.=D\>
M#9#MKZ"%XZU>,<?7L-T4FSG1,:$+OY-;>E:#]2AVB5M5OD;K2LB2Y1N(Y96Y
M%5UT9I(+'1+Z_L>/[N7BN40"Z>7=P$S&?508/W*X1&,?/?&FQ8(Y,M9H'XNG
MK+(7>U63FPH" =Q2E5YNE;9_)^8W7M5S^;-5. 53Q_RI[SVW:/FX(66&V_M@
MF6>QA@9<3+@C9-:Q K)T AK(P8V2DB5,/9;G2PQ$B2B36@+9COY".1$C_CYT
MJK_O[)2^28E&%T0<31R80QQQ+74X?X=8*/<N<Q%'LC,#6_[;_WKZ^2^>*_W(
MDF<\@A9]N?W$S7P(M@K'Q!0/YZ[?A.M-= #;0IF::/0/;])_2<C,'TX+,O,)
M$+G?^3IWW\;PT-"<<1$0[PJS 6&O^QPQ5=&B[[S_(+2SX+DUOW"B[-VOQ>[-
MU+-=(LT/>.-SJ"GGO"/N['*Y-U #_ZB%B$ Z\$DR0K/" /_3EX1LS4G1<;\_
MZM/$3.#GE9&0AQ\)E<#DV'%+PDT3#QK.*I)]@E;)X2ND-]\='!Z2FSCT658,
M3X<-%U4DH*,65V11Z,3>#AL.YU722-Z]PXG%KB+GJ99QZ0I<E?ZC8\QE73.Y
M,I_-2F[5$2AVZ.T&PAFMG%MKRJEHJX=\ 3JD8*#TI0D!B;BV":U6F" &819$
MNNSH=2>-%>,>#;D7EM7<[RE_9S>0NQ83G)G@X&4/'Y^K4:$+T)I@J%/0Q:^)
M!)FR/O8.-F,8\66CX4]?"; F.D3Q-<>+FX#;FICWH!HV12BE$/UR6U8=\VM<
MN!*8!)_PRT<@;L:OTC-ML* @%!%89\ZUH1S;[73S(<];;^-2A="*;G+DN2^N
M%:A&8_][!0X*0@7^*-,A57)_4<'#^*B^UGL?A>VUVRV<<HHW\>/)FU@")T@_
MZ*/R<#&*NB( _9A.-GT!60:!&A!V'DI%\'C)W"S@T60C&4>?<-3D+))L#P(Y
M-$HQ;&%F[,=":?7BO^(@(:W][$E!I8 GA27"H_O#MJM<O 2R^<U D&5QM-ZP
M!@LMI;>4#?N6LV&OV^A.LQ&@^7\3KE%5?E4K OYU"ZP\)Q!>L[4. ^!*O :?
M4S OBY1.%W]UNJ3&D:^;BKM6WI9Q"[X)HET"4_2:H$OT>N^_FUY-SXW_D'.#
M3W?%&2U>AF"\GUKXNJNZ\ $X%6LV?R'6,GNE:$C^\&SQ_.6;1?26GEY^\=FS
M1[>/N6&*,C85Y9<0#*\"@^WM)7?\DI36Y*3NBDAL?+%0:E8'3L3%H]?_\5WW
M&,/PFAH-7C!:+_$:NS3G_T-<7FM0&VI2X7=J_2]_A_42'YB**<R1%,U+O7!$
M[/$L*5E9I<62B#<IM^&^B8$DL9C&<;N+[D(W?7P]0F/8C76,,J=HP1(P1B53
M6UEIDNNG"0B4=996.:"6LY2UUGRL2OU:&E,8+11?FX^[. JT< 78A6;6N _B
M>8KR62K1_3D^.9T13PLNU5%./<O8R&$0!UW'P!P"KCA4W6(?RO9R\>-MM0GB
M,LCM5G0[-#?P589H#4'_6H'[OB[;MKDGA$:T%XWD!K$>HI-XJ_'U3&-/!T5>
M4[@R!5KMX.+1I&=6K_4RV@PJCNV+Q:UFV='3:C;"VC%9Y:O9D.G"A!$TK5R1
M)%"\$A/L=WW8V62T,&A<W8A/&$1+<7E;;C:!FH[1[2D)?<J R>Z]OPWREMES
M"#42>0O8,'1Z8UZJ-;TUC6DA YB+!Y!G0.^<E0<D&P )3LY[GT3B!^"? ^&)
M("R\<Y(A[;1SV*MM%N/U93@\KJ2Q8X-_J:*&BYC8=Z-*%-EHKHN">DWE4F5-
M02 'BRC<$(/@AKM].L!2CP1<>J/0L<I)X(*X\B>209GK &O2-:Q')ZV)I'L!
M\BR2I !S8AX)8C7Z($32UK+C K>&X4R!-W>#C]MIV% DU=\],J=]*YUIN*Q^
M7Q"\;(V97DVT4?00 4=1KI5HZ&_(UG7B."11Z1-8\+) &--.KI[V?OO5L5BS
M>K86?V&-=$8TRL!YA_H75^0/._> CH[G?]62 <2ZL?X(Q;;I?#JO+Z[G>*AR
M2=O2D_.24I(R *-PD/-S+,HYV^1R0"EUU/LBG< HJ/[V.ZN3P-M0J[Q;8AS8
ML!W<!,G[SO+1-%,1F\0_X$AH7%#S^KLK$GL$(UK!"=ZFY?\5]BC'+=;EY&)9
M=CH]M.=&"&.FB%G9']=S3P=^U?[3#?:_T)2>O"[$#XZIR#%VE(DL<KQV>)44
MOTZ.OT_:&?.^C=,W-^PN)JGY:*P9M@>ER_G=/[?S"PHJEK<7?>C80V$/QP&:
M)X:!NY7I+%C%$+IF'R:%2AK;5TQ.EI,X)W'9;!\G[^Q#V;(*NGZ)XEN1&)US
M&F?C9L([=1XG"F:3&$"F&]-"394T^=S)2"M5Z_/O__O5BXNG7RS 6K.MEAQ_
M:N:M9-7&C@0Y+Q<O^0S>(B8P6C!3WTIQZKR:%]C +#7HS;#G<:PS$D>-"CTA
M/O%%NMV7:X$A2<B7Q2%.Y[%?@&IE^6)*8.WIZ><NS5-BP#;EDM'%820M&BLJ
M$8!4&W9EU]LX)1KM3*A8/B]8NT[+I<+%Q(%B^"EL=U9\??7BZT*R6'K8U'"#
MQBM\FEO->*)XT./5LH%W2:Q!$]#<[,Y;*T7 I*>2]@M=6CTKXN-ITT*Y0>@+
M:B3\$8]G+(]S)'$3@L]?J7G]I%77QMB #[*?)G2/C;MEP4S9Y"!+??QX1\D]
M;B0DE'<X#=&QY\*<)C;1H84W<12Z92FB/XX^1Z$HJ21Q2)K,T37MIH?$40_M
M%UW(I^NSO7 BLB;@XU45#G&\J97)%8CEN,W3+6#KX2P8OD,<>WN]E16<*(G"
M)P3PLDP.)KAD,VA9BRY3Z/1"RL;\,?' S12.$O\,7>K9TWBF/(\7)DGWYZC'
M$&HN'C4=F]AG3YY^[C#UH8YK& JO=\B-([>W%?_'HFO.G8Z8AUR_+=Z?O!IY
M_:Z_2"I]]"<:9BN)I3/<"_S&%[@98EB/=&G-4.N2@F)X-3T='N*>S'24X?K&
M F=TE6L9,RW<)(LH9(C.=S)5%2ZQT1_K9D!7$&L%,4H]KUI9&)"_O*0JW&JR
M9>.[QZ1!I.N:9079 KBZ5;WFLNMNV.Y\??F6W%5*-XRR01D)$1+47#C+AB8?
M"$,Q8 V.>^P@%92>6-DB-I4\$Q.&)"DLWZ9ZQNT0;N>ST\+M_.(#AA96F+C$
M,R-*?'=<H_*J5(BY1WLXY.0SGN'0D6J.^!#1QD:5%<KNK2IR-LGU5[:#C3_1
M#U,_4ODG0RAPFIHRLDKKQ=9.\^\A"2ODK(]PB*4"SN8:Z,RDO.$/'7QYU9;W
M]8QTL@:0CNOS_<[T6*S:Q3P'U"\NI3!GAX*VB79]LWRGA4 $/:)[/Y;THY%5
M.0JO(T;5HM;WCW))@76*%.=. =A24;Z5XD7M<#]*G>DEV<SM%98):4KM)J&<
MQ,P,J>5 )T.P, ?K>@Q:H4E, [)XI/&K+ ZM$0L6MZZ88@GU%29WB>'58UFS
M,HXY [ZJ:Z>TP&US+\T>*>!7W^>P]WIS9*73&J/#9,)VF@6L)Q  T$Z4P#F8
MV\CY)2VKIUD^0'".=<+$NK=4$EAAR7Q0KH.3&A8^N"S%KR)]^^N8HW'"$'9X
MV(:6F*JF8A[%#!F:<!&@\$UZ'V=^\E_J$0Z1S$OPQ=[MO/*1=OI)#ST1$60;
MCJQ0M*S-AJ5T\@^QYQA/,/E=0R9RLSIK"SSLM%OE5.8UU&W<@/ "1H9404ED
M*>^#'/7GZ?I$TT7VMA]6T;&KK/&E#AN4S&4J?9/C@4UZ5FGY-/,GI]S%L$L)
M^F:Y'-KS+OL5S5*'X6\KM,=IA@;J!9QY/^^>3W9854';3*<^!HHHT6$9;FX7
M2I]:]K<^]$9F@N-6'SF=Y_-AYY/HHZI^D)2&R+Q?-Y;;]Y@PF^54=:5V@U3E
M1;8JJ6G,'WCG&7[HJ.*],ZCY$Q"D*I%[8"8$"0U:8U8)+95#TB><D*.L"_]L
MM>B6MV%%,&;.V1#?%%@HE>K!WWQ1WK1!(]8#*Z8 LC5]FFC]+5*2L.GP:CX+
MXWW")7B/I> 78MXO.%I:DO+=;+@?I_ ZU<@GEIM]5PE3AS32T=_)>Z-U&]^@
MIA[%^=5W)%@>HTG@X9, (Y,2H\GDO'9^=>9+F#\3,"FA/R%;$CJEX6=_8^@6
M0@',\5L&R2%U5='5$H(9_I+"BX<Z7JFBY#92*;RT#SR8LCY0OQ'PSFBNLV<Z
M+Z6'74HNG18/BEU89KI@XV0+RR [Q4<G\Y@P<6R%/",6")3HUIUHRCA)%Z83
M2U(T9!/C%PN3%60$&1#/Z/1>-FW+ "-M^D:6-SY\C41Z3^"S&AQ"TU<XKZ]/
MIB^9B3]D>CVYV&3645;*@G245Q(=G5-&GSPQ#ZO-+%3KBKU+ZS>9<2ND_;IA
MP@#63!SJ5!AE):A,Q3G^>KD_Z\)^NKJ+ZG)UOO^7)]G0!#*[+"K'_R#)SYM:
M9MQ7,CU,_B!F5):/];F? +Q0T.]<3)S@YAFJD@!>W6V@_K#XY!=<EVI::!\L
MI069!/.06""DR+0\+T"T4!CN6L28T*PV<RJ22 = _H(_(6)KX;N9<P/X,=QA
M+RT":P__P.J9A0B,@ ]H \X[MG;$\K7DY4:]PM39(>2"<BMU5I?-SE1;%:NP
M3@/<S+\ 5C*1$\8IMMO+  DR2.(K_EX7 VC74L#]_ 0&VH;^EAI,@1W9-A1H
M65Q6Z)_L[H2N[+HQ=;;R\\<WBQN@W=M%H<G90AR1'RWQ?8P,*VT=>&&GT,/\
M@[,QT,F;[]$S[<$MOA9 4V*B>M9G@"A:^_<J?(77ED"]1D,I-RX$Q%M-F@'M
MT;;TR"ESNPO8N>@@N>ZHT:3NI]LL)X3WO2EQUR'MD_J8<GE)7>1(!)CIG6]C
M&HU",=\T!&=^#\]\[K1F$YZ9D+3CO4GGBGMV;"=;GOI5<G=^-[3=P+'D"-T[
M4A'/&QL5:LRYU6.@:."V)JV@>9?6\2-H#%Z:,R0)'F[8L(Z2(^M2TC0"3\NZ
MC$I'^UH8B7W6_2E@PCF<>9*WGD-7C92K)PAH/ #Q*',JR4$"!04Y728'EIFS
M8'/@IJ-H0M]"E-I+Z$YYNTBTA*=@T4347.D1L)TFPSFS.A7[K,BR4H*BR5+U
MK<$JY=13?[MNJE557H=>!*V(64#5C,QF\"YC5BK=J@X[*%D<4]%2Z+A.=4=
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M;YR[,![,;-@,'0O\NO1%8KG2(NW"YHY;M"K $N/JQ1U2K8C$$(J$! : @KJ
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M]X'Z*Q (%&B21V3X#[J8T&64O?6&V26;H=/LM/.?L?NR$JN&>X8RAC.'NXV
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ME:\<RJ.+[U@OZB[$SG.);]1+MJX?B]GC;G:;8PG$^HK-IK"YNOI3I7I6>Z
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M^&?D ?"55C(H-:(P+09$+D%"A$J,D-0SPVU<EY- H0<UFE:K^'K '06*2#*
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M5Y'(,O6_8!&$[S2B(ZHUA4(:A\8F=0U!,1R$%)UC@I5VDLXXP,:)94A^)[.
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M72Q\I.)(J8)1-\QNBVIHNICKP+AW2@$F<2>=$/<.>E=#Q)ZQX_J8L7E-EI
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MHY(M@4.1LZTT!]5+IX3."P6',!ZE/<?Y>)6T4W#R. [H5@[M=]]P?[^":_?
MW91>>+W8T\7%L!SX O[OX'#MZ8_<)W"W4HORB4&SK/-7^,EED6!R 65!/I1K
M;E[6TF[=- U=JR\PY-EB>(VTV );GM.QQAD[78M^$4:9P0BN65[E\H&#N2KA
M/0-7]A:(QLNR\F-E&JF2!HN52Z_8MO-R N=H89#%X,)>4YN; >E@*.@,G@V?
M8-L3_H.T8\57=+]QS'^P!K&8R_>8*5H;X7LF#:?73$+[G/\SEJ;IV&2U$TP-
M#"Z_V3>.YL4'7D"DT5MD/!-LCR[@(7[+^/!^^I]_#LS%6L=S&(AP3O%Y7%0;
M1G\K8?1ML.V><Q-RW"Q2,M3]ULNO3+$%JBDN*:I=DG12P!X.3(E+8 \.V#R5
MH1,( I7(^=-@>P'654[YPTS\B0H<F:NL I\TNCA]=[%W5OYK[R#Z00Z.+K5(
M^8^2L*!GT@5I-P6?;C=&\R!V*)H=<@==TRUX3>"]X>F&SK 3BN2#C0=N%Z+B
MEMBM5^YJO$+@SYQ/0V.V1FLPIZ<NV8JJDQGF94$$T!Z0[_B>1F46)=BTJQ$?
MF;.R)I>'DC:IYHS D\:04Y[]03UG*U(F^,ID594YZBUR^C"8+TLC%@IH@_=H
MIU7@X%0MV:RT<;-DFN5TFO=48](SMN%&.*T]U=\3#DU^.3>4\I 2\$)#5P-\
MR562Y62^:Z@/-K![/;,V9%/#"_6Y]26+'?1CW6!\KVAPO!&Y%Y7D"Z4)L ST
M-IF6!*&56#F):_?MFRP<.%Y?./"0:@ VO>_N?<$&01/L>*=F2=9U8:,MGM-3
M=^$Q:2O!9/*2EI37U'[L(L&Q%7%I4]_6L!;H+:NOR^&BZ6J:HT5M%F#OKXR1
MSL@8F%DY& !>0@1=UL==82P,PUL4/9N)>8-GTJ:WV?Y+"FD@+MZQ]GCO:0H;
MRDQ2\*M #? +:XD#PAVXD*0W/.D*QDZQ"8E 3.5:X;3V-?@"P9QC4M1YAM,G
MN$56I7OH2:X<!$ =2[ID,:9O/R$/W]U73J5-S&5;2 0!)(+B*3)"N+!Q(3 D
M6%?MDD>7=90*1R,X2&>?D$K,8.4_%:\<NL\->\7HEN#\<*'1FM29@M2 4*6^
MO BT(2_KFHT!6%TXDGHGJ_L2^T@$'VK NX&=TD6>/-Q$?(/E3^\!X1@6>O0'
M.*J%<RQ37@K!4,#+X.K'7 MO%>T-*_EA6 <\LYTE?.^BXU 6-J>N4V$S@J*E
M' F2Z&2I^2*X:BKZP(9[:_RE35W9C_%G&.9J*S#7T <D4()[#YU)_3(EFXH6
MM@8M(R>%<#7E*6@X1G.!TUA.T!7I'8IY4EMY\*,D)#1)80]+>-C=>F@,*HC[
M4KQ,+LX1.DE60OFZXA#5FOO<298B7NJYR6'R8)7L+?-DBBH$TV\VHCRZ&'G7
MMXTBQR)L>)SQ,:J!_-,:!T'?V#U&5C:9HL&(@PFG[!D&9(=1R@]#AFBM$1+.
M$WU%8'F2(TD?D@]?N,)H,SK%YD."L7@OW.Z=9,+"R7D%84&M;A=;#V;CMA\.
M$\84=2O4R+0)R[YX*+[/'R(YI&!*@Y'@I1TIALDCAX&#XH!%C)T8KAWEK1)!
M(LJ#9?B6YD3K.:QU<JDQGG62[*D5%LK5T*+;\.VI1;*!'TWZS4<->0YWXVP^
M>![?3W;P. COQ4.AB;):H]S@@\LV2UF-U>Z^$S-3KLDU]C#?]G(E,GJK,C.!
M%<G]<%>="N<JRWMJ]<*8FP!A-J0A$8WQZ3#*B-3GC.7&CP3)1,%ZK3-*'0P;
MUG;^'>3=II[0>!P:<>/!%K;W5]IY_/3PCN"EPV<']X';V3WV #X<;_;8'7@)
ME_$, XL8H#R=TB6,VO-MF6=3&VT4B'.]E? FU,[KX)YR:0[= PS,'-3(H&81
M_I):'^LVE*<- XNM *8/![G16X)-J5+Q")LYFTT_GYZ^Y7N%OVI15&QTW@XK
MM>B5MN9K]0^XHG2;Q;.IVX68?YR,X1N,@SNH^M$E6:# T + ]XW8UGEFS4B;
MZL<5!E]#+!&^Z"F/O.YW30?[N\FLO,!>,$RR)"5YB'9841O$=E?J-_,7\5_V
M>GR#.PP;>%GBGV$[,X9.H(O9TJ P+1RLV.]M>BE ]-]8 CI?0C2)JQ#QW+B$
M77P-E+)!/.,+6;+P)I+Z Q(O\.3KDG/R#.VF]<FJ:;N Y2C(C>DD8%C"%"[-
M,Z++>\$Q5CMZ,+?*EE=_FE35"C_$29L;=CDHAL&P Z(!DR4*<=&PH<J3JF%%
MV%X+X>QH> F>7<W:VI=(GB5_0Z3&2F=9>0'P;0BA_C;/<I8=Q$]F,Q 7G++3
MSDNKG=<!_D%QO"Y!2L=JG]]^>#;%E<>^,-+&A]#YP7'BP7.'A49=-]%4;QZ,
MTM(<>*-1AE-U4>7$B8)C0UC.M9N'A?6_,HL)A7/XJ[4I,I)QS0&R@A5];T0W
M=?"I->'Y0XVJ(UTW._A:5OE:3FLH0FO9IO=.P5=N.'T'AH-US_Y>8FT+_.,Y
M8;?@_'^$0#^8&KYWHF_?F6EY6=#!W(9C:1P\A\609^GAG]4CQQBJ;ND[T]:D
MJ?\!6WN=2 H(/8V2_PXR6I<"2^87L/M':_=O8]]S/3<%W9Q5F:.'28$+T(<2
MCPBCN11GE?M9"_C(GZREJJPAE8" :%N?8XT0+I?#/TT()Y@UN4FW0K/BW!"Q
M#4?:UZUZ^?$:7Z-*X%HZPYA>7.F$50+L]M3XX2Z\M6D?P_5,TM]A,[0PK?L
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M3B(W'.\2IYO>XF?=.+O(98%UL-_7EZTX%'V)JG!=2&JT#(L^"]'#\"_!2E%
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M!'[Y]/,+X.'HX.G=R.-O_NSDV=%]#'9__&S3Q]I#<FC/B&Y641;F3M_\V@L
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MI7Q6..G) (=F%IE73X%_ $0LSFUI@)&!P\1".))'5N7$D"UWR+0LC"J1]]H
MFZ1CRV&&2\3YPVT.9B\B4P5*FK(X%&NCZ8S@E@? CXNKZ\)8FRR^6$8;S(0%
MX/WD/EVFX!K"6/#V.*#96D DX;2FMR<1,<E*Y$6<@FF>\I_O#V/](2(OK$B$
M!Q')L=^S@Q 6KMP4E)FR ! TNZO1'5S&,PGO!\8NP.T>R!F[9&DVF1=3:T2\
M\XE0834$6[WUX6#*R^!;,0S\X,$/?@B&%OL6**==V)GE%S;'B&SB!QM0?"A
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M.BI@R1 -'G)#.09&6>*O:9(T:;FF,PYS/JD(  S'>SKE&<-91JF,,PD_K>J
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M\W0O"Q_N\QF0JF7A&:C59[CX66>@-=O]_'EG8&_DZ9<TLNHPY>E3460KRU2
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M\/XNW'"DC5-:/FY 4[$;)_QQ %8AM<6-/_B3H_$NK7>L-")0"NLZ9*<AETR
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M)\<K->\O=JF6V?<)]?)*?:1SKR[-O@M$E5H_5:Z6:J[FUXEF9_S8-K& [CT
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M4<R/239\L@K1O(O,V@67YJ33%:#<4"G<A!:O1TQ:I]A^H_'.?)]Z]:4M2R8
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M#8"PGUU%(Z C1D#"F$K1&Y7VT5(!U,ZVBC%H '3P2FY= &2<5JM&2VJY6@:
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MRNI?5W63L\-AE>UQBA#]N42S3L!MN)_,ACN3:=YHYF.=S;'OW>4BG4OD[;K
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MR"T4KC8G,X2=I8E8Y"__& 0?9B7&[!8!F>Y@0$EP6H[\"+CQ8X-VFK8WVYH
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M#H@ C#$-.I)DL@0>K674!"17U@1FM>5F-";7OT:?PQ*K=5V4HZCUXFH]E>B
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M7K8B,\JU&@H%2S^IMW*4W)T;W7%LX?@97].T,KY_DM3Q2FB+ 6'CUO,?3[A
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M.^N' A.%8G 0%-/ G!/)=@L6J&;!NV2:6R%+_MASU.(2B7T68FJJIZP [8)
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M!B5X%(TNP%O$5,34T/.Q=G]&.1\?^WR<\H ():B1D4"D0@"S)(!&5*1=IF-
M5F-,1=,.R!>6A"%G:N3OIE,UK#>CUF9PH6O#H$7QJU;6J:=.R[#]@0\#&/6/
M7V<9#ON=MF]=KLE+0K^9'>NI%B0XZ@S+YD#@)CKED/:18L4IT]7XVKMT'JPN
MOGLR&HY,+R]90;+YD.QTN@4]TL$Q;#5P3",PA!DH'#P@:6R,./U@?&5-U]!4
M<%XE>$:1F*51[!EF?UU:7892/PT4O+^" JF14U98T!A98-(CT#Y$T%8RR805
M%./,:>J*Z10D>%%(8)&2'#D>9#I1HM(&4Z004U1Y2S7FMR-![ ^Z9I0N<3IZ
MW3OI^O[HXO4"$@T!B:D9"LX2YI  Z;D'IK@"BPD#PWF(">^Y-+D)\2LA^:HN
M0%& XF>@X$A@31"*D@CFB-?&I5VC8]HY1!BA"F5H.!I,X@3>(N8UU2"(D, ,
M\J T,Z \DM(AZ;"E*VNDML%]!0F:CP3_G ,*-(Y14>&9<XBE%4HTP0H4++6(
M2&%_ 04W6NT53'AB3)C*LU4B,,^P!V1Y @7N!&@7) CA!5>"R&CERIK0?$9]
M^'\51%AN1. T$&VM"%(XYI&QC@1-.$N(()U OB#"LT&$L\GD$N*(0AX#0BX
MT\E\,#)9#IB%@(1%W%5& T*KJ"#",B#"/'%3'4@4GFB)."/<&T8E]PJA@)PB
M7!9KH>DX,(F:(B^%=-Q"1$H 2U /ABD/6$K"DMV06R.NK"E%GD^T82F2RF\=
M YZ>*PQ:H5*GG&8>>J.<<'Z<)T.7'/,'#JB&1(ID5$*PZ%F0T6"G12"64,(Y
M929GE!!TD5&20+*>$> 7C<K+.+?YP?#:[&^7CRW%%"3C%P.+A(,.25282"*D
M]\3E#)(:*FA*4EC)W2MB6HB#:JT]1]('Q05C@6MOC"-&I/]I)3BK"VFO3<\L
M0+L(T$XB5HXKXSD/X%$R.9G3-!F?B70J%P6CBCJCJHE6"_NHBP87H"UB*F(J
M8BIB:@1M05)HZGR@F"<#T5%+8SH)3;(O?&(T3!7:TCC:,CWN.SK!33(0)24F
M\1;'<SH>!2H,M=YJ@9AO&F]Y824&<WK#8G_0NE2#5J4KK7<G W=DAJ&5]>&I
MZP^>(=J5OCY%3$5,R^+RJ-YS"9F%0<S/(*Z-I,*4N1"4!>24!N95!(U,!&^9
MDTY3Z0U;6<-\1M"]*'*S%;G@;1%3$5,1TU*)J>F>C\)>%F<OT\E"4B01(0+$
M4PP,<0=&!00"1T\])<K%V#CZLA3I0./TN:K)9#6A/CM"DAKQUDY_E+ZF?>$?
MN6HX>?F'](GAJ.0%%==\$5,1T[/@$;5[0>XRV7(,KQN7Z+H;-_J]:OUL)VP&
M6W*0YZ05?.(4^?1C^\<A(XQ$BQ.QD%8#"S& 0D;E^94,X4B"B69EC2B]RAH4
M6BFZ72"XB*F(J8BIB*E!CI%":!Z?T- I/\G9[N8Z.^1(""^3T)#W&)CV#+16
M'()1UA%*M B\>91F*;)%]LQIRXYSHEJ#T#&CX%NC?NMCZ+7[@]:4)HR])R5'
MI+COBYB*F)Y%LX;:W"/^U'7O1"42FEXDF/XQZ'<+L:B76+")I^0;V3[?/]3$
M)K$I ]Y9DWB%D& 3403O#7)&2&>"7ED39)4OWK>AJ'A!XB*F(J8BIB*F)^8U
MM7E)"J]I"J^Y<IB<IO?BG1^'3EFM0^3 HB7 +-5@4.(W3DLN!4?42=0D:K,4
MF24?PO%EP8SIY>?,VWZ8UGQXD6-"%O"2%"=Q4WO+;%S)^1K4?0PNO774#F5<
M\WR M_UCTFFF"GDG8RT*[QCPW-6?&25 &XW <<0]]IH;0U;6:*.\PT6M2XCN
MQ8BIJ957?XN\U22Y*09;D'AN)+Z6?.04BC9:#I$:#XS& %H8#BB9& XC)[%*
M2*QDHR;'%1TO4%S$5,14Q%3$U*#<HT)L&N)3.]O=?(,.:40J<*M !:. !6K!
M*N^ AX"9\(9+1AM';?[&K>;;P^...<LW&WX-#.6=Y9WSOW,I4N J)Q]8,PR^
M*AH,O:&I#HMPFG\/)>>M!!V+F(J8G@.)?9**P I *_S<F(+/#WGNPK ]2J1V
M\+WMPIC]?@BN_Z577:4BPH77SN>P.YLX[+;.=S;?'_(H.;4X0OI7HK4:"[!.
M$<!8L#SM.@B9:"W&->36%\4O^%S$5,14Q%3$U BV\R3E@H7M/"K;F7CQMM.]
M'6HJ;62)[A#)&#"".&CM-%CI+29>(.5C\^C.4F3'[811'K+6[][/8[+<@8H2
M3RIB*F(J8BIB*F)JFICF8.34*<F#9H9(QY1V1GGK!(Z!21&$CG,S\D0JMBI.
M\5=_6(+@]^C$\>.J8ZE4DHHH8Y[3$H!%K\$$XP%I1BA"3B)K5]:8IHN/-RXJ
M6I"TB*E9OHV"I#7U-/IQ:+S5DCL!2!D+3#D#"GL"TG O#>76,-<\)%V*9([=
MT5$85&D<@W 4>L,\[WWLE+CJ]SPRIR6EHWC/BYB*F(J8BIAJXFM*81ZB\(Q9
MS'S FI/$WY"F//TQ,CPW7ZM.LHWI@VQ"WZKL\#US^JX_R/>U/AH-VO9D9&PG
M[/7?F4'HE28,\R>,?[F:36:1CLX(#-I%#(E^:]!!4="&&Z4551:Y/-Q4-RC&
M5#2Z &\14Q%30\_'VOT9Y7Q\LH*J'X=<I".0. ;"&@1,$P.6. +8H:!L]%20
MV+0#\H4E8<B9&OF[Z52SK,RHM1E<Z-HP:%'\*C<G0D^=EF'[ Q\&,%Z@US2)
MT?=/<FOIO"Z7KX[ZQZ^SA(?]3MN/7WE)P#BSG9&/6.G@+=4!L\"9IC($C"RW
M@3'O\>'6'2M.JXOOGHR&(]/+2U9 [MZ-B=8/M4182,/!!!* "<=!,RE!>,Z0
M4"%8A5?6M%C%-3EYZ]"/)X[?/!D$/!X2WQ$!_O$4TI]#ZHU"Q9_I8FV0F(OP
MC_J=M'C#<=_*Q!([)WG%9I+#G7XOW\>@WTFW_V4KW5%"U$(6Y\?1]U<X&JW+
M@HJ E57 ;#1@6$!@K"/:.>09J9PI!48+C!88K1=&24+);&=+)RCC-&B++4/,
M8&Y%4,3?#J.Q/^B:4;K$Z>AU[Z3K^Z.+UPO"-@1A]Z\0EF@=5.1)%2C"P+QQ
M8!578$/4%!OB(Y$K:^05)GR5%I0M*%M0MMZL5\JQ1=Y+Y BSB%FGE='"6,L8
MHY(7LMIP*)U$_H(5.DIO0#G*@5'.0"71 B:.ZMPJ2JFJ%3$I,%I@M,!HO8,M
M/ K!"4>=BXYA&VS T5B!L[D8'4:WX^@P/6?ZK0!J0P!UJNS *JIT)!%R(QI@
M*GC05A- !E&:K!)J6)YGCL@,!\#=1UD4."UP6N#T!BUEB:WP8)SQFME$2BW&
M.&BIJ3+V_V?OW9O:2+)]T:^B\+WGQLP)DEU9F5F5V;W#$;3MGN,Y@]T/]_1V
M_T/D$\H6$E,E&>-/?]?*>@H$!B.P@)K8VPU"E96OM=9OO86[ I:.['3+V.E9
MQTXSK3C7J2(L "SE1BMB&&7$>T&E<<K)X)\]A\NRFXSL=&2G(SO=E))/,Y7S
M+ FI!6Z:T$0K%_+$6= 1#?SM"G ZFE*WGK\F [BJ,B4 KGJE/.$Y,T2!+D)"
M9A*?9TS#_X"_[L@T6]-[[>$9 6)4U'_%"P7_=<6GY_\-_[13/M;E83%K9Y8!
M336?Q-FDJQS/>KR!]T_)::SBZ_U$6TS\TK,SV)3);*43V_F%-<\R7-+)O(HE
MFGXH_50OBD_^Q]/"+8Y:%C%XJMF'I']$&SB/Y>+R1[9E?WXF<G4SAO_B?".K
MD%*91+%44"6Y"49*JA/%?1#*"F[< 4W4L_:IH[)=Q(D^],247G\D.L :?]#3
M4WU6/?NOU<L$]V:X[^>WK-Z8Y_]M2GANS5POO9=Q"P874UQR+^,M[\\RDA7L
M_U2?5/Z']H<?VT+8Q2SN8GSH/ W!6YKI*[4K,HHK:$(+F^&;Q>W&Q9UC!,W?
MY"YGE_\YV:67/SH.>_6P:;*;R^L-NS8LE(HK$*>0.J/RF^-"NYM^C@4TH:Z;
M8 'K8T-?^L\OYL<[$P 5N^?HZ[MLQ/?8@Q?S612@>N'=Y/<%_"=6^\.\X!>Z
M.IK\/)V?KO;OO(F I/2<A*0/@A-EV2[G^<:)4.V"(/FF4:_^FV#\#N::L/3!
MS)6E\MMY6Z],?S6H>TC]*QAU%8BNP:(7;_W]Z'WR6ES@W:F??O*3??CB435Y
M-0,8'E'',&3^(A/X^D9NB1D@CO@#%BLM['5LBJ]G$WC1%!L97S 1K;/!7*:0
M/+A[<-VLB.LL^%(B>IP;1]6X<=^V<?(FG&6[LY*N";K>GO@2%&M0RM%,\BDV
M.+M-,M+&KM4W9SL]W4D^Z"I"U[0*]Y6,)W^;SJN+0O'6J;Q;M^3K.P?6+?'1
M&/F?3-6UCZUEGK__\"IY_^X5_>O/WZ9OTE^3OU[^=?SV'8SS[E>Z#^][_^7G
MXOV75^SM[ZUE_N3HS;N]L_UW>Z?OC_]Y_/[X-<SGCR]O7[KCOUY:_M<_?DW>
MP/O_.MYG^[^?L\P?OX(Q7\/[?RIP?N_14O]NG[])__KXYLO1Q[]>_DIAK<?O
MO]C/__-EOXG*>[78WSL0WJO49)RHA$O"M11$AT003^%_B>4)8^F&:JYM7QF!
MD=\\5GX3LH1;FV?2YMS*S#A%G?(BD<)G(DV0WU#5\!NJ1GYSQ_SFK.,WCHI<
M4LF)2:DAW+J4F,P8.(8D9YDV61)RC+.@M\];&_G-R&_N*R8L#4ZX%% .IX[#
M338N48D,N0FYRS5WD>'(EN'(&P2'C9SG-ISG38]T@-U[FZ>!4)$ YTE90K1@
MBK"$29^*+'68S473_%8!LV-AE1O1V* SU&0QGY0>J,H64Q^+RJ[HBOAGBZZD
MDW+^J8"53LS99+[& O+#G=9C&<?8F*VB%G#I;BJV_)*^]"=P,8NZ>[6>N8D^
MQK"Q+_&#2V_;6)ILTTK_\!S@YZF/H7LSMS<XCE%"WDA"_C&T!0!L20SW@01N
M N8[YS5*E])ZKS*K<V^?/<_6"<@'#\U'LKTSW7DDV[L@VUZEYD8H[3VV30@*
MBP928IP$E5J)/-':A,1AVP2YFX]D^WC)=@,:Z$BV=TZV WTT&*:LA^-@2+&<
M991(+PQ)3"ZHYUG*0_+L>:JV2MIN2"=],- _EGXDL2UQ['[2]B7^)M0_-ECZ
M%M0?C^"G\XVA1\YS(\[S?HCS92J\4L$0%SO6*9X1 T=&E,TXTQGSE,D--7L>
M6Z%M,:5N&NB/E+H92NVA/<N#!RP7B F6$1X\8(0TTT2E.:"\W(9$*?26I;?'
M]B.E;B^E;AS;CY2Z$4H=H'GIJ/""YT0R#THXYZ"$<VU(3G.FE$N#R++:KWWK
MVOW;U[OPP<!Y]*%.@-9@BC#]95$=H>L)LY2<-XO1E'^'H/X2]_8_=#&K\%A\
M]7;V:N58WH:7<"@C4[H14[(=T'_S\A5_<WJ@$TI9D)PDF9< ]A-')* &XA//
M%.>I$;EY]EQL54N1T3BX?5!_6&WCBR_G3E='(S'?.3&?K1"SLU)PDQC %D83
MGJ"I/]&,:"%D;I1*1&:[+E\C03]>@MZ 1C 2]/<@Z#>]=!;[OQY(#B?(G"14
M*Y#.TEAB*!.$.J_RS 7M<[^-!/W4_ !OYC,2H\^*IAH4J!"H-_O1$7!OCH!?
M=.%>S_YO,7-;6)+K87"?@1/ JH2%/&=$>DH)UTX1"8H!R67J$V$IHS1[]CSG
M:^H=CI;%QT.DF_8!C$2Z,<R/5D7+F&7:$YG1E'!N-9%".**!@>8A#9H+AMEY
MMT_.&XET>XETX^;_D4@WAN.!2+7.=4BD)WF><,+3U!*=A80(PVB>:."N/'WV
MG.:CY7\; +S%*F!F7L:*E!.X^UZ7]BB&]3O_R4_G)]$E$+R?+(Y@!PX!\U?5
M,G;_G0<, CJ>X^SG]N/H+[A#['^5><)]ML<__/:R4<&:8VI/:1[J,XI'-/*U
M&_&UPZ&&D 05$E &",]51KBE'G"'\00T!Y?[S!H=1F/CDZ#FN_4>C-1\=]3<
MJQ+6T2!4KHF!^P"JA#3$9#(A2=#42=#WC5<C-3\!:MZ8-C'2[9W1[4"[R+56
M+/$I80X$,-<V$.6I)#H8&E2>.JO<L^<IJ!?;E-[SU/P#?\Q*#]/XXMWD4!>S
M&&,4.TU,BMDG7V>XCZZ"[Z0NM&:/_I#0KXENS;>SU]WQC,4U;L:E/@YU!9\P
M8R3'5!DE" \V W3!) %TF#) C$JFR<;0Q6BKW&)2OI](HY&4-TS*9X,J (QR
MEP+M2@0<>1Z(=)(1QER0AGDEM1A)^:&2\CT7M1JI]BZI=IA_H)7RB7:$)BIM
MLHDSRX@*7@3KX8,4J)9EFVA?./H?;DYWO[7JP=]0/_C[9-IF(FQ$2W@2AHM[
MTA+J#H'[?G$T=SUS^NT"XWI95"?S"KL-CESK!ERK:V$-G&OO(*-"I)X&DDII
MT<>0$( 8H#SPW&-^@K+6C%;)IT#<M]<;+LDP&NGYSNEYOZ/G5*8I'"(G20"]
M@<M<$\U#3E2*-<0 FB@!],QWTY&6'Q@M?U?%8:3A.Z?A/SH:%C;C6AM'C,@,
MX<I[HJFR)..<>R: Q%D&-,P?69W<!Z-*O/3!ER6H$DU]W(7^#(/_K6A[6D^,
MG_E0+":AG!]//NGILJE<.IW.3V,<4^FG7E?^\J9DH^WC[C*>V^.KJWJ_TY]?
MU0[4G^I3&UG7S5C76:].O(=G]@\"R!SF<TFD2@3AVN=$\DP1G6F;:*IS+_RS
MYVF>[[+M,(6,ALOMTR5&DKU;DMWO2?;=ZX.$Y=@.G9,@;$ZX%99HP0W)=&*I
M2801+'GV/+F]UC!2[1:+W+OKH3'2[Z;I]X^!R/UX(%*3:Y$ZDE/,)>2,$\5<
M2E)+E:" FKQ6('+7T._H>[@'(GR[./+E9-:G,$>U 3,>FMB]R[N&/DY;QE;H
M ?%4WLQG>"8U8VJXTLB.;L:./@\="L8$GH8T(TX[1GB6!2(E5R0S)M'""T,9
M5DQD6Q4M.5H@MT\#&*GVSJFV=QMHD^;28D- ;PWF.7LB@5(QAA!OJW6I8D"U
M8Y&RQTRT=X?_1Z+='-'V?H( !"OR3!#E<TMX4 DQ'N2M4,PG@5-FL.1IME5$
M^]1\!2^.].P0AL.4A+Y77E7Y1145@&FA33$=^^8]N+YYJ=C-M_WR[5D+JX&;
M5GKKBT_:3/T.-G9\8MKF/;N=5D4?B+L2?7TO??W?U[/V5'[K#F64@C>3@E^&
M"J?/N,FIMD0DCA*>>$^43#51<%&YS%0N/$)7GM[*W33BUFTFVDW[FT:BO1.B
M[?5-EU(G+!,D<^APRA-%C,H582%1083&2I0EMXJ6'VEVBVEVXR%J(\W>"<WV
MZJ;*O0^)5]CF,L,"%I)([1VA7$C#-&BCEC][KMBMO$Q;JFH^!+2/<9FSQ;P\
M&Z/*OB>\;X\!-/J1W=R,W21#7.],QK3(<R)4T-@D3Q/)C2#&.94I:WR646R2
MQW?%=GBUQX"4!XCK1VJ]#;7V@!Z FP4$EQ%',Z!6G7.BC-)$:,DM]YI3SF.A
MW-O$K(_$NL7$>@^ ?B36VQ#KP'$D>,H#]03P#SJ.-,>B=/"K\I2*Q*<\D<^>
M ^;=$LGZU.SVOY3^1!<N.HCF,7:L]AB-=OOO">R;4VEC61L/]M[,1>_V7CRA
MD2W=C"W1(>*GVJ3&P EEC ;"N5%$T\P0ZO*49DEBJ148Q7JQ*?9H$WP<1'SW
M>'\DXCLAXEX1R(T+J0\IT4$SPHWV1'L** -T@F ,9S(/SY[GVV(D'(GX >H!
M(Q'?"1'W"@+@)J&5=L0!>B*<81TKZP3QW#F;9GG0:?[L.=L6[]Q3L_2_[2+)
M8AKY)&X1F0>RA%_6!Y=]>]S/T[!>;$Q_B$6YS[.L8M8=V;_P]YI%P1']JS^A
M-W[,@[LASTJ'VD/.6>9IDI,T!_0!,-(0I8%[2<<R )8J891C#JO<#IO&:(#<
M6NUA).%[)>%>=TA<:@TSFBC#L8:FI02.4!(O$Z&9@S,+Z6T- ",)/^H$E*_V
MN1GI^K[HNE<GC!08(H0%K0R*9B:(3A@G:6:L<\$ WMK*BM9/S>_0Y0N<Z#,,
MEXM*A+:V7/H59>*)^2&VRPW1'M(O]1GMS=Q>?4(#AC5RJYMQ*S94)(3GGHL0
MB,[2G'"$(@!*/*&"YB)DC'F-@4=J7>#1F W[>$CY_I(*1E+>*"GW"H400622
M980+S)#-G2: ,32QB1=6)EEP(0-23M0:2^9(RH^&E.\QUV DY8V2<J]#@$SV
MBAJL:>5 *@<..@1P7Z(R)51J4VN$?/9<9%M5V?JI.2::.X_Z0SF?3J/^4/JI
M7OA;EKIZ$N:/>U >7AV?3.=GWO]6'\K(G+Z9.?&ARI DFF9*940E6>S4G1*5
MY@GQ0N8F9UK9P)X]3[,UT<]C <W'0[]WKS&,]+M!^NWU!*\S;XW-B# 4Z#>E
M"9$"DQRIU=2F1O 4P 5=U[QKI-]'0[_WH":,]+M!^NV5 X]5ZAAUA,(98B6L
M0)2RGB1,\\1:JD+LT<W6./]'[\)]46+7-J/TG_QLZ0?I#:-O83O4@Q@_V9Y3
MRYS.1M9T,]8DAJJ!<CJE5.2$,IX H."6*!HT\0S8DDMD8@VP)BIWLRVR6XP6
MR"T,3KJDMN9(Q7=&Q8.V>B;35LM J'1 Q6G.B>:8WJR"#8Y3QIA9WR!CS&K8
M6OK=+M5@I-H-4>T@S]EE)K4&BQ6EBG#O$Z)X:HBS'&1OQC)-]?J0X,?A,G@(
M!7+?^,4D=L4X*>>?"EC+Q)P-2^7">7SZ=L6@V1PS+YTOR6)^\@/N336?%FZ"
M:WOD;&OC*@.<U@LXK%^:L_KI[(\*N_IT(91[W7&-C.M&C.OU2E=N;;S.51I(
M3C5P+Y=QHIQ41'E'399:+;+DV7.>B]MK#3>BD =DJGRR)+]I)\1(\G=(\@,-
M0WCMM=/$.)$2'M*$R, 2DDG*=)H#!\?T);:VW-E(\D^:Y#>NG(PD?X<DWZLG
M.9P$"S(GN1><\#RW(. U_$1S;QV3UJK\V7/XTL;Z;MXMR6_(H;$EZDI^:9'5
MZKJ:R376_O43^:8N&-<U[#S%&6Y(P]Z2:WI)!;%E:8^P-, \3(YU^=$O8CY/
MY>VRO+4V_0"EZ3V7 AAF(<Z6QVZ^:/Y^7M+^HL^._6Q1O9OOV?\LB]+O?=+%
M%,_JYWGY.TC6W[L3>^G-F(5X0W%[ME)>S#";Y]033Q-%..>.&*T922F6&O,Z
M4:D!A+V3"+DMC7+'$)\M],.-Q+TUQ#UH**(-<W"8)+>9)=R80"13DL#_.Y6E
M64I9]NQYNI.P9"P?\%B)>^.*\$C!=TW!O39L128SX,R$64R[E4"\*AA););8
MW'F5ZP3$,Q?I(ZM*O-UZ1#FWWKMJ$LKY\:3234T D']X[<\VJUX\B4B">]4N
MFM/[&0X/N=7>S.TW)_<V7,[*1C9V,S:VTHX0I([RTN6$9GE*>"*!C:72$.:9
MX%8E(>$>@4@JDK%^P*,F]/O4-$9"OR="[S6.C$F1<LE)EJ6><*$HD3DH((E-
MTSRQTJJ@GCVG.U1E:S2.D= ?#:%O7NL8J?F>J+G7/J2CEG'K22ZM)MPY222<
M)S$F899GCKN QD&5WCZ%=_N"!;=;!6E<&14J&R<EA@:"XH%:B >5_ 3U\]&9
M<7\1@!=,(K\T1_++5,\6P*I>M:<R\J.;\:.57BB9#9E-/05^!,H#5S8E6F02
M)0APJB SZ;%RD5I7N6BT9CX.TMUT)-](NG=(NON#/LG2>DT38A(L)F 4(TIP
M"?]HZFQ@RFF#&7^W:VX^DNX6D^[=.R)&TMT<Z0X2AD+J6<@MR>$ "4\#(YKQ
M0+P3TB=YHIA,GSW/\FWI8OH47!#QPE<%;G+=Q03U@)@QI&M2<*.SX9Z<#><+
MJE_*G7Y:5C#MJHJET]\&#"9N_N)&_G0S_K32X\1RP1C3@ACA).&.!F*\SDBJ
MLDPR.%-MDHT54A]MCEM,V)MU+HR$_5T(>]#YQ'JF?:X(Z B@[IM$$9-EV"%!
M\9#Y-'>)'@G[H1+V=JD.(PUODH8'1<B,I]2G@5 5+.%44R)!1!.6N. IRY6P
M6$20[K+M*!+R%)P'L:C&I+A)TLYHO;@SG\'/\W+HVXR'TR54C4F%W\J%!J6(
M?SU[\V7_@$GM)$M3HEPF$4UP(DT6@!W)/ LLM4'P6W.BT0"YS21\5[Z#D83O
MBH3W!R3\_L!*+H#?>D*]%0 FI"(R8Y:XE%JOF6 9Q29$8Z+28Z7@.],#1@J^
M*PK^HZ/@MR_W#U(/@,GF.;$N15\"S; ?L2.IDD'9%# 5%A^CV^($W&0UX@=5
M=VQ9>0<:PN:4A&MGI3]2SK4!]:$K=7KM".A+2I:,C.W6C&VE-Z)QJ0Y& Q<S
MG (L,928G"8D,&K2-&5,11O'#DBD6S&V&]'0 S)>/EVFL,'ZQR-3V :F,,R]
MSCE3F2<B%QK-#8)HK1*BO9+:4L9,K&,$3$%LHD#RR!0>"U/8@(YS25'TD?+O
MD/('+@\X$9=81VA RI<) Z(/EJ1,:P$'2JVQ0/E,K2FQO&5T_[B\(>N+E_U<
MS/3,;J!XV;7+R7U36:_K&HF>X@R?0L0?JN8G*X4'BJI:PLV-Y<SL_/AXCG.:
MVX]CY-_]^? &-L/7S7&\#2_B8?R.9S$*TIL)TI4N0<&FH!-I0X3"J@$T4 +7
MDQ%L/0C8.O%"H;E?K/'8C<$_CX=H-^ZU&XEVXT3;Z[TT6$JQH*#,L%=H*E(B
M=2J)-E+H "=(I8UN=C42[>,EVCM-_Q^)=C-$VZNLJ;,LJ$03(%Q+>!(2HO+$
M$:>,-(DW5B@LV_$HFP)M->I?R?-?8%.L97EV"YC_<,,$MC?!Y^=Y^9L_:0YJ
MY$G?SI/V5]O]L$1G+L$  8KHWWAB0I(2+5-#,R:-P+3##47_CU$_6TS.]YO6
M,Y+S!LFYUPMT8J7.N0!M +.(<R>)R:@D2IF0:I4SY^1(S@^5G+<EB&^DW$U1
M;J\<N*"5R5)##,<4'L\ED9;E)$\9EA^VQDJ&RL'6E.YX"NZ 7ZYP!<SB1+'V
M\&R^\'U]@.Y;=EXMQFK$6U>-^$5_<F/A])LSK<]#[2%-I<J5BI72*>'!IT1*
M08D5&<B>D-K >"Q$*N56&35&2^0#U1Y&.MX@'0]J .3",4P=S@0#\*$]: Q&
M49)9ID42M$]S-M8 > )T?*<>A9%B;TNQO;J02*]%EEGB0-82GB8&D_0T,59;
M"6(W\1HDKV39[=MTC\Z$&U%;KQROU1.>F$/ANR3_N\_V^')[17<@;_ \1BYT
M,RXTZ#CR&M;T\0#$@-%*6Y)JFV+Y<DH,-9S(D'E/ R!"GC][GLIT#2<:$X:W
MEG"W!_R/U'RGU+R_0LT>*X\R'XBTJ2&<:TVT<@Y^U<8! (1SS$<'PA,@Z@UH
M B-1?S>B;A6%UV?[+_</-,UL#IH!R;3)4+U71(<DD%RRQ&B?".DWI]Z/+H;;
MMCD$M>%4EZ6>C>Z#[Q]^M#8B\L_F>$;.=#/.M-(4/>/>&1$"28VUA <MB?'4
M$T<#"!BF$V\V!S5&H^,6D_+].P]&4MX *??^ R9SX562D%32!%L&&0*<6)(T
M",O3U 5IZ$C*3X"4[RDC823:;R;:03J"U#[('+2"6*I3&D,,Y@%ZE0D5E$X2
M+[!9$-LJU_U3<"'\<H4#87+DW:%_8EZ$[=$+:KM%<S[S\Z:*_X-G,S*E;_8H
M[!TH@P)#:6(I,B7L.ZA#9DA&K<L,,"G%-H<D1OOC%M/Q?3@51CJ^&U_"WH&7
MJ67<*] (4D>X8Q;H&,"%2VGF7,:\XF*DXX=*Q]\E$6$DV;OT%.P=&.ELRA)'
M4FQ!SHU.B&2>DD %S5400NOP['E*Y9JB F,&PIUV$0DWJ9[U.(T0WZL,\.7F
MB('W,IY25^)LK/#WK?QHI>,@9XXYD>8DF* (SS5 "&-RHGU"F9*<Y9EY]ESM
M\NWH:33:$K>Y<.](QO=+QKTF($%U-S35Q)@L(3PH0;20FNA$29UIG9DTOVT[
MD9&,MYB,[Z[4[DC&=TW&?PRDL64A]PG)#%/88E 2H[0G3!GO-,ML*M%;<"O=
M8/O<! ^OI\A)4W=Z8LXVIS9\K6#L^4K(#X2+?<^BII>4"1_9UJW9UDK7D#3G
M/&B;$P?<BG M 'UPQDAB$L[3)-<J3T") !*G&[)"7IM('I")\E&U"?B>55%'
MJK]#JM\?U#36N1'*8654T#E2FQ C4T685QK3DI(\\;'28G[71#]2_,.B^(T'
M,(T4?X<4/V@'DELG1!I($"HGW#I+#',I80G+\Z"-23+Z['D.)'_17+B-)/\4
M?!NO0O VUDSRG^V1GAWZ2:D7?E+_7$V 4E&EV:D5&_^?9?$)Z -T_(F>N4GI
MJT59V 6H.OCW.^F7^/CYW<;UFOI0WX97S9'^!B?Z=H8L$/__57^(OW7GAW_8
MF[G5#P;?'!GCS1@C'RI 5LC$*I41.%4,Q$ASHO(43E,*P+,I S2+7MW;JS\W
MI:4'9*!]5&!H.SPP(YO8!C;1:TPB28(2&JTCF/?M)2=2JT!2RBG-L1%,JIX]
M7Z<P;5DSM9$]/%Q=:60*V\ 4>J7*2BF<R'/"6 Y,(0L4L(,TA-F4.2&5TAJ[
MS&PL/V3+5*H'F#GR>F:Q?86?_ WH+/[T=VPP?\=JU.@>VK@:=2NF]PNL=^[:
MN_"RN0GP^W2)9S!DKS7+';GDS;CD2@,]GJ4)RP4C/.6:<#AD8B03Q+O4:)H8
M)]$SSO(-\,FGZ&)ZH,QC.]2LD8UL.1OI-; \(!UP!2J7SPD/DA$I%&;G:FY3
MZ13'C)E,W4X'&SG(@^$@WU,3&_G&EO.-7DEC:3 .R^@PA1FSU NB+?/$PD\4
MU+3 .$.^(6Y?"?B^F,=3<'Z]N+9*MC,Q_K"8S3".;QXF)Y&ZGECVSTW E/)I
MR%RJ\D3P5(#T!'#N9)+XQ,I4Y >OKQ>J,YJ=[H^C_;K2D] &&SPSG.09IX1;
MFA-#,_A)<2]$[AD<ZK/GG&>W]^6/B0/;2\@@:D ;TBSAN>+6<Z4SGCF>YM+G
MN74N$O)7"X]>V1=HI/'[I?']@6DYHTHDGBB9<\(UMCL3B080D\+GN149%O^C
M.Y3E&W--CU2^A50.,CFC@J;2IY8'JY2VF?4^%5GB U4J4GD^BNMM(^5!'3$N
M?)+P0'R"I3Z2C!&M*4AOI9U SU'0*8IKNBNVB) ?ES<HO[6.X>'#2[6+NS6]
M;)UN]O_>W?H?#=^FF<IYEH34.H4^#ZU<R!-G.1, UE6"?/O.'5TCW[X9WUYI
MWABRU/,,8WQXDA/.3$9,9C1Q5EN6*P?J<O+LN:1R36KVEAJ.-F1U'MG=R.Y&
MJ]*C8'<#_YIV&2!23 >C@G#XD:C(_83+I4Q\JFRV(:O2R.Y&=O>PV=UH>WMT
MG' 0UAGR-'4Y)]IR4-@S)8GV)A!N6*JDXEZKS=G>[MEGV$ZDO?AIY'2;MMI=
M8XS!@ADLR<V76,'[_(IO\X9QEE?,\BF8=W[SP+-M,2UT9.=8+/Y;#3X_7.I/
MWD3PSCC&TXEIB)?M_ V\C8'WL8'*=4M\-+AQDU9!P'_G4-_>XH4NRS/8MG_K
MZ7*L]GQ#$)@,K7].A333W)+$!TMX(G*B,\.)$#3GVG&FLX#6OWRK&LAO"'R,
M_.>1\I]-FNE&_K-Y_C,H"XLU(S/+B*'*$,ZL(]KD@0!;,KD+S#EF:W/<K;T/
M(_\9^<_CLIN-K&GSK*FWCTEF9)9)1BP<(>'4&B(Y%R01S%#/F*))UMK'DBUB
M3H_+YK&>%G_;7+KRXXZKVY0FMFJ"'_G*S?@*':I<D@=C1)"$6:Q19Z0BQE).
M,BU#DE/'<I5AC95-Y>ELD8MQI,M-:R@C7=Z2+GM5)-$)B\6.C'.6<!<4 0A@
M"1.*.6&5TXE$NMQ4&-1(EUM(E]^.W$>ZW"A=#C);K71:)#G)6:! ERXG)N.,
M.&I,)GFN ]-(EYOR48^IJ]>CJG?SA9[>HJ;0-=V]]1K/>WQO4VUMZW;RQE:3
MC6S-H^'98PSZ V3Q*SW^G),,^X"17 F$7CH0Z3)*LBQ8HZAUN9(;BD'?( 5M
MN?5XY)\C_QR#VA\Q_^Q55R:"2[5A1%FEL-N))T:GCJ26!J^5S1(LV[O)4@DC
M_QSYY\@_QRCY1\I:>^N#RT0P.@G$<9D0+HS&"A6"F,R;/&3*2I5NND+%]V2N
MT7+Q7PL-KX/_NN+3\_^&?\[%T[,,:.AD7A6XR!]*/]6+XI/_\;1PBZ.6?@9/
M-0M)^D>T@6DO%Y<_,IBTA3OLR_MG RG.Z6>BNM.+FS'\]ZC+,SC1AR!R2Z\_
M$AU@MC_HZ:D^JY[]U\JBCHL9&>[@^<772WS^WZ:$Y]:\=3B4+@]AM&9G*4J8
MYJ-X+\Y)G&X+X[GVQQ(O$FSE5)]4_H?VAQ]=49U,]=D/Q2QN2'SH_*V!US3S
M5VI79!27T!B\FN&;U>W&U9V[^O7?,L C/+_TS\DNO?1O5PVK=EDJOFG4J_\F
M&+^#N28L?3!S9:F\UJA?,7]^U0U!Q87OKL%1]:V^']0@KY6*\>[43S_YR3Y\
M\:B:O)HY[R(QO_36'QM?3AC=61$&EZ0K\1NE*VTP9^'R%)NM2:MXA%-\7-Z"
M]:3Q^_+D9.JQ-[N>3D# V.F\6I8><X\ ,)'H0"AFGP##QD;5,S=H6[THX<4U
MHJJ^+45I@UEHCWZ,K]S&%AS J?FK7_N0OSENPA.))'PQ/SZ>XUOG]N.DJ*JE
M=ZB63TI_LBSM$391B:EL<^!-984<"%E6Y6<%?*G^=%$@>Y_-%_[Z&6[7#:;8
MNOVZ<=F$QVGSV4"GEVL;?UYZLWC1W;_ZIP5V#ZX6Y1(EZMXQ[/N"CG:>&]EY
M_CCK79 6UK=WX+01E')',IYDA >.=4E90IAD<-*IX()JM/4PD>RJ+8HVN:<"
M,".SVJ:UW6]CF2&S^N++N8M1;2.?NB<^M3_@4Z\.C,RMAF,BP5I!.%>.*$X%
M\8)9GFF5>16> 3^2*4U_'/G4R*<>")_:0/^:D4]]5S[UQX!/[1\H1,8* !2W
M(27<I9Y(J3U)J'4N"..HY=O(IQZ7/6X]6>[9_RR+VAL7Z_^4\Q.8W5E4=C&0
M]P0)85+$;DV@$A>SB;86R:*:G.BSZ$;"K\*'):K,TT*;8@K#W4 ''K.<'S:[
MWGBWTS?S&=J!WY:_Z'+1_#*XIS\7G[W;JRJ_J.*GI7<CC[XACUXI_9SG.6@"
M@1*OL&6ISB31J?-$:Y\D7N4)$^FSYTSLLBU*;QYK+XQ<Z8Z5W9$KW3]7ZH-9
MJ0HZ4U0"5TH4X7"(Q,"_Q :>*"4X<Q(CKOA8$6;D2@^&*VV\->O(E>Z#*_5Q
MH#3D60+ B!CF0)?5B2/2)9($);2WF=#&,.!*R>V[N]]?*9CM\SB/KOS1E;^9
M$*,84!2F\]-),:N-@AAW/-8W'NL;;Z:^\8DNW,0MRQB?=N0G9UZ7,7"DP*!4
M7RU&,]@3@78;-X.];F[0+W#%WOC%"-MN!MN^#$U<*C?6,*-(JEA&N*(YT3G7
MQ.=*!V:#IB*+L&TL;SQRG ?#<39MXAHYSFTY3F^^4AS4_"P8 NH^-M/)$R*5
M3(FPBF:46^!!.G*<1]BU?N0XCY3C;-Q\-7*<VW*<WC2569<#E)&$T\P2GO*,
MF$0I8C2GRJ3<"YH_>\ZV"N(\+GO$M^F)=G[L)PO]>4P;>#(1;G>@*^(M>H>7
M"%GIR$=OQD=7>N&8Q%-G5$X4-\!'3>:)%O"/#=3J7"2",K41/CJ&U(X,Y^&J
MBB/#N1W#&32_\4%)J001G">$YQAZQ3TC/O6,L2S7+@?@QF_O4AP9SLAP'JZF
M.#*<VS&<7E,$_AY$[C1)<Y\#PU&:F$QP(JGQ:28S'ZQY]CR]?;SGYH/QSY=(
M$5>42+F!=_/!?_7J>EVK9:*RU2I1V25%HNZ9P\0Z6[]['Q,,CN'=V+[J7#K]
M6(>,T.3R0F0XX<@, 4V81+%44"6Y"49*JA/%?1#*"F[< :7IL^>W+U_&T]U<
M;+2"F5B]FPUYWTVY,D[%MY0KHW)7)9?_^5O+:HW#WFS8M:;#0<6PB])(2)U1
M^<VVP^Y>GR/ZQAQZ=P%-+_WG%_/CG0E H-USU/1=-N)[[,$;E .3Q7SR8CZ+
MI2XU]I/XN:X-I:>3WQ?PP?&%[N)/8F^&9>4F:"^\N 47D<%UY83HY$0-!=\L
MCV&6=@/VS%5\_[8\U+/B2XS/Z\\8?MF;N5]*7V$X'_[Z-G2'WI_YRZZ0V#N8
MTT_3N?WXO=6"=W^T:@'\#-#\ [S]W6\?WK][G;SY\ >\UY[NO_PC?7/\_NS]
MES<?]__Q*D+\O_[G*+''_Y[I/]7R[8=7G^.X'RS\]\W1_H=?TS?XKB][IV_>
MO4__^O#/#_OIKZ?OWR'$A^^^^S5Y^]*".K'_Y<V7]Z<'0B49ES0A-#>*\$Q9
M(KWEQ#&G3*[3U*6AUMN*V=*[/4R8SJ@6,F2IY49PD0IIK-6*:^H]Y=Z!NN5!
M\SI!3%0N_;,;5B,=A?DX[$:%^6J-Y$$AY,T'E-XY'Z>[DR$7C(G5O\.LB@ S
MG"TF>W7F-:I%O\ B[?DDZYOH@"-QCL-NC#@OT*"#'P&>W0&8:D:\%1'&$7\H
M%O V>PVRO$"3/RTK^%+U[<1WF0&FF#E ,S^DZ6ZM]WX/"\-0V9@4U41/CKW#
MPYDX_ZFP?M(89R:+([W S_QT?E(W>H,E??2+J@44\V4U.9PN[;SRD^/YK%C,
M,?IA9S(O)R_^L;\SJ<XJ@&]5C(+ D B8NCZ,> XK4;A"&X^8WYQ-3F#O$>9A
M@[G2'Q98LF6GKL<("P!&".N=Z"@>XDBG\W+J=B=_S*9P2O&3!JU.2A^3X*K)
M'#XM3XO*[\2_+WP),\$2)&GRXZG?B3_1']M/EM7Y3^;+LOL(!V@^;C:G^Q,L
MK?D+["O\L?V\] 'P.J@S*]N-*RI@ ZNEJ0K8@!(X_#F-[VY!^ KPCC+F[.D"
MZGVZ_V&/'G"9!@T;2P 9!P*23!"CG2(Z2YU/K/8V91= \=T>TT^Z*JJWH<<#
M]5&-![;_[C4_,"JXS(6$:(%=D$)&B4PS14#+=5D&NYSCCJYJ/2*7*K>:>9T:
M;A+0BYU*&4^8TCKEN;F=UO, >C  '.#L3E#&.&R:[.9RA%K7@%J1L:'T'UI\
MHEC\!;"#+4ZF/OYY14X]2ACV[@@V )E4;^P,G;&SZ@Q?;66NB$&ZRERP0Q=P
M!0"6R>D1L)6SR?QT!L.M@(S)WA2&'>B:,7VQA7I&3^'-OD9YPRK\DR/]R4^,
M][.)GQ;',,%%723,#@]H=_*GK[]9>CO5504OP6; <!4U%A0[;NJ)E0 P 33"
M#$M_,B^;H7#B:Y<.Z E>@TF]^&-$><NR1/AX,K@]YRWF*Y+Y@5X.A!>-_*HI
M) KZK\HPO%23L)S%L\/<Z+A=:$; &X/['$]]IIN_#V\(P&L_.?0S7VJ\0KC;
M@#%6!HG''&_'%,XH?F7MN37O@H.#-<U6WP(3F$_^V/U]%_@:2,"RFJ"N=3@Y
M@8V:.^*Q*MUG>Z1GAW"9-*H'J#WH6. BWLY! ;JZ,!TP/- JUCWEM3UJ!FY*
MO7_R  A R9A7S6C^\XF?5<W2.E)KE@B;1**O&>ZI=A^6U:(ER:@CE?X(G@5=
MI0WQ_MMT7E5_KT%^+*.W/%[63T=E9/U#\$W<2%1;%F>3RMNV4A]NX0I[:(AT
M4AUYV(S=R3^ MIH]@??"FH$HEM-H/0KE_+@COQ5*7R%N74U./? %^._*YZ?%
MX@C.O0(R 44LO@)VSLW+JE8*\:H D<R'_&!PU>)BX8OURB[>QS-<7CP<V$Y<
M-2I\DQ)T-:3S]MIT!WH8UPGGURPS3N$T\AH0EI-VA;Y:U'PPOK[>W9W)S"]:
M'K.RF>>N*]R2>-Y5Y!]#TGO^%?YRMXK 'Y5_&UY5B^(8;_53!/PO[>E!SF66
M"Y:1U'M-8"L#,=)9XE*K&/?>98R/;HMQV-$RNF&X#NP'V6/'@!XK$D= >:)K
M$8 +O@XL;[$I"K H,".JZ1$4R']_$J%#[]4YZ92<:"7]Q][>+SN]R7(9(>^Q
M_N@[V>W;G:^Q3E4MCT]J&5T+XA  ,-2Z00.RSR/KKR]%-T;5OEE7!9-P'32Y
M&*X'VD3I==7,'#\>:A;]G%M =7*DRV-M$?8;_,/.$&[@IMA&4G<*#LAV7WS"
MJ[6#0 "MO+!?<XSB\PL?&XC-T-SL^^E_TM-E=X#M%\YV^NK%>EK#0@2/A_4W
M:T%_V,+;E[XZ*6#X%BG/XI?@3&!),)>B.HJH#A'FN9-95HA'= 4P)U9,[@\*
M)F 7\.X&G>'6GL%6!S0/1YB&+^L&^ZY@XV==E/^&7?3[L!*X!G@]1L-CAT/2
M Q,,DUY*8EAF"+>I(5I2393R&9?*:^7R$8>,PXXX9,,X!#G3)+*FR8 W/5XX
MHI>+(Y!NBQCF/CE<@OA&S;\30RAU)@$WY5/<E*,"0$=ICQJG;5%-C*[0[M 8
M%SZC+*M-!>C/10GY8>D.HRMVB5^L95R40;72WH\-WUUO?MF=O)ZU>*=VLEXR
M[0L YW-Q#!L2'UG6"!,DNR^CO ?!>[)L7G9<S"Y\<SF[^-W3(S^;',>+$:T?
MW>0!J,SJV4?[03/WL]B)(O^QFEA8[R',N/'](XQK0,_:S>WV=7G2[.QT?HIV
MAVY7XX2Z0QBBHL:">=Q?W_A]F/UPNGCXBZ/2^WK(JA_3>0!O: 4ZNVJKT3*C
M$>9,86:#'JH/EQS^A?M09R71IH/('[/:&@>[\9_E'/\3(>3 .*4_Z6+:W!#$
M7[A';?!"K,F ZXHQ#\W5'MR.BR[YA[YO:;-OKVMJ&=CG5K=OV 1DN.W]OO:D
M!["\B.,XH&R[0*<#8N;V-^0'Y7QY> 32JJSS=1KZ:LYA @J)CO>]Z@VOYZ>S
M[N@JX A37:X_N!_/#;%ZUE][&M_8OJI;,B@\S31^;"R[<1.!G'N%XWCN(JV6
MS=[BVY$1'7L@4@<'?EBTM]/-XX@-2USA$!U'-MYJY'9(Y\WK(I-N6%-\V\ZD
M6MHCI/7.^%EVVLBG.6XX<CH,J)G!@/$8YH 2:DLR:F+:%7AJ/3,='$R]TTL#
M\@;VKG,(A.5T&B-ID"U%+O0$J(=U7.>BX.EN2;4\:=1NV%O8A@5\!W9E-F]W
M-5ZAHNF[TS]V44 XCQM<S#I5=B@>XK0F[#)_2.\KQ)"LT_AO_WC5V.WK\5&*
M58U-HKZL\1+O1#, *N'HP.MJZZ[<Y)TA)?54L/#V:%;\9]E<PK57>][INA<]
M=P_RHOSI,62M/(MJ?'W6M?[F+8"1VDNU6#G#E2=J?M&;98JN-UG54W@\AA@,
MAS\@YX"AZJ^L-9A$8U;1.[<&;I'6@5I?H)UK]WK:P56@VVP'KE6!TSHY*>>?
M&PL(WMO643:\;V[IVVM= 5I9D,@[X)EV:VHV$B5 M^[=R<]P2X[GI1]6=(8-
M]1/,$9JPG3;B[A*M8+>)P;O:E'*_IA4L$;4W<_B?5_WYC685>&=Z8%R>I'!B
M1#@:"!<I5E(T@GC8Z^ 2H[45Y^.Y;,(]SYSA/%7<\-0DBBM!X3R,9(9>= ==
M$1=P+M?UJ>09T\OSC+]#QO#:B(>OYRJMW@J=A<Q@#0H7*!<L-=;DTJ>.<1TT
M=>RRR(JOWJ;1C#<..YKQ;FO&>]$"F?C#0! ^2D/>GW5X'^B?Y>0(/I^B9@!K
M=M$[U08319U8MZ HAL9L'(L,FN7"8NP/;EDZ?=9B%/?9'O^PW[S_W1'HDD?S
MJ7L;7O>S?-$%];V;G\,P3PZT_/H9QCU@6&<^"3DQ)@',$BS\1&U&!,TRE8&4
MLEB+527G<0>HUV>UPHP^35W[;D$ABK;-DV5ICW0=!H4Z^SFXO\8YN!*I=,<8
M=K_3;G[OE)L:P3ZY.X"9(Z^_' 3-\PPQ*W.)@$O -9&:IB2G.K-*:6F$/P]1
M.*,\\S(WAF4\R:7T)G4F<,MR;Q.E1O_A..P(/#8,/'K6->EYUV,%'3$0?Q"&
M?[EE*F*/TA_K8A8M@"T& ;'4B2(02]$6T\3SHFOJ&&9Q5%N5+CS<QIK/F@K8
MG:2K5DU :Z;39Q'H:34?KN FLV\F< @JZZ)U<W2SN<8LAAX^W+G&9=C8_J,?
M%:0SFN<QG#J:RZ;3VI 5\V#7C@E/5""CJ] $UD<8B*/.O'==P'QKG.NCD7<G
MC\5$.K4Q%![]#E-XUEV(ZFZV>_W^U9;J:$<\\1:MRHU;!^W+M0LF&JC/65<'
M@SEO%I<:9>NKM)R=F]Q*:'UCWM?H>:_J8,$Z51HN5^W+K19S^Q&ALR^KQL/<
MAO6OB\5;#>=O[E?O@+LBPV!W\MNE$YW/KEQUZ5=>LL' ^<NWOD]MN&+SNZV/
MT737.8DX_;@KL.9NGWO%ZF:3?S))1%_%G\__],T^XA9^TB6F;$T69R<U8SUW
MI7::^X3T>?ZVP>.'<P &,]QQ4IW@291P"C'K(SYKY^5)]$E>'#9&T[XKHUU_
M]?*@(V1^#"<3/28G@)7+>/D:UVH?@1O9=8QMJ3#+I?4T]%>D3L?'2 U\,(JY
M:?'11V\GG!=^V":;G!8P@NEB659&71G3>$Q@B<DIL/2SQL4!EUW#^(MXI]&/
M$L5,U7I3,"84!H=7M3)X]Z)Z-_G]VBZ0M@H!+C ^P;LG?FK8SN_(=B8O@4:+
M:5T8@<(#+1G<T7V]%+9=4BPTRNIW**NO1'#?@[K:+0[KG%47A=D%3CR[ ,PN
M\,E[K0SQ6^= '-U2=/_=KU\.5,9\(@PGW":>< 7_Z,SE1'F5B2P)#-3[45L?
MAQVU]0UKZWMM4$+/DR*_W,.@QBB\D.F^G"_-(BRG;=6TQZG/[UT,\#B7J5VG
MP2)R7K1@9%Y8_#UF!,6] OZQ* NS7,R;=%[X+@+\&F;'06LL7G\98_CZ_-\6
MI !,NA \U&?!8-;45!?'F!A<8*H-ON8(WCLO8_!=Z8MCLRRK.O050U/*PN-9
M(OR?+W$NA[J,N$H?XM!-;.[9[N2R/4!\UFDP!O1[>"PB05\')=41=!;06K$X
M!21Q%(MZ155M$)O4YSEW,=.#:2] (W?5SKED=Q"^KEA)U.XWJTXKCVGVTS;Z
M*VB+6Q\GUY_<N5C R.T7^+<^,:@;-SZ*IHZZHL(,K0X#8G M,70!/?CIR3SF
M,.&$XR8T.A06SL*7P2G7>]D^@YMZ"M@#GH*%!3@(U+Z:_++N?3$.H X .BF+
M6@V.@^%^^  O7JS4C?A\I.M@7=R9&*I=8V[GX2ZTP7#=2MO9X#>6PVGNUN%X
M_VBW;V=X';H"%NOM/B<:5H'12'4$7'SOZN#?J/]=(M7OO(@7QH[4NNMO1?7Q
M13Q=_.DI8K67[]F!8PGHL-( . L V)301$NE21(2G6EA4Q7L>4\,Y18VF@>?
M!\5]XDR>26&\,2Y+F%J343YBM7'8$:N="^D8\J)8N:F6-,B,+M2W?=%*LRN@
MVODPS8<+W=;;W[[*=9[_O"X:N,%@G40'^% MS0<$:LNV4E)_$#4<JT^BQ).(
M@2@5%DX"N%;&P/\0XPMVU@05?\U%TN54GT=E$:1@F:A%G=7\^22FD\?I#2:#
M!3^G.@:=1XS31@5="(O!J)GVR?\L=?3#K,9*%XME;WWN?4=]HIR+N5$>3Z=J
M(&8T5<82H[W[H"N/M&H<K"UW \_2H/P-8LC:#MC!LB:]'].*8K74)L^M<_?$
M66(1++A@M35R,+FZ4!%2^K3V*QW#;[7#J*Y_A74!M/L$A(3UCM"N&+$IFEG/
M"C]U5>>C.I<.4M?1Z2SBO=D[_K7?T#:*=9WM\3Y-4;];.+?EU%=OPPI[>1N0
MJ_QTAO_^'!'UT[91[0'NH50DUGB2RTP2[E-.)# 4HKEVE&OO%;M!0?]MYJ:Q
MM%E,:XRNP(8EU8H.L I44>!>XV71ATUFP7P1]<Y8] L]C8?E'#W1:[1)5)9Z
M/3 2>>F;(G,3FORO26OD;?*>X"\GOLY-:^MNM$6.:S*.?N;3V743,.7JQLN[
M- U*P;X%;O)LE[%\XTA+[N:)^J91K_Z;8.DXUXW/E>Y2^N3O .7?KAC<H!_@
ME3I$TP.CX;I7J!!UDLG]-!F5UVJ"\5O-D,^WF/R6+5*/<X?^$>74&BOXUSM?
MW>I^10/6P]ZZ=Z=^"D)YOXY0>P6XQ<6,HV$'K3NY>8]@[_::NL*#7F,;O7#L
M$>[9A69LMUCP$]LXJL:-^[:-DYO@8(]S;T9JW PU?H777[<1^&V,V7=I4:B[
M:O9.\<G>I=<F_?JBKWT/DLF:?;FZ-?KWV)C_7NT)/UG.BMJX-ULB,GBV:O"S
MRH9 C4V=MEQZK1(AF%$R"5B>.15K#7[.V^)83ZNXOU_Q;O[2F77@P0KV"+Y,
MT@=J\7O_YS^KO][-^5]__G;\_L/KSV_^_&OZ_OB/Y/V[??'V'_M?WKQ[??;7
MGS\7^U]^93"'L_=%\\S__//('+OIVP]'T[_^\5>Q_^$5_>OXW\5?[WX[VO_R
MD;^/.6G_G+[_\_67-R\MK/>?Q?]\V5_L_YY\_M>[5XO]O0.:"BX,"\1DU!'.
MO"12>4>D5$)QG^O$I< *6.N#:<__>>UX/T\A&Z,*_&NDCNVFBO]U'<GR-;YX
MJ509V<Q7V(S*G F":<WA_R2G2F2IH8XIX6F0@B.;H:IA,U2-;.9^V<Q9QV8R
M:846W!(FJ"(\5XZ8U'!"G14^<^B6L,^>TWQD,R.;V3XV8[5W"JZP3I#):"N9
MU J8C.$.]H=%]R65+9N1(YNY5S;SID<SJ8KEH23AFL(_2<:(251*<L">B7<B
M R@*;$:,;&9D,]O'9K2S*I&9]L%PSHU75BC&5)[E,A6F1C.CTO3=V$R/9GA(
M$\ZE)EJSC,2?#-6".%!Y%:7:90;1C!K9S.;9S.WL=",/^@H/H@E/;7 I]P9^
MDIETN;!4&\6E4VD^:E3?E0>][:&.5L9KZE(BJ0&H(Z@AA@E!,N%Y#@>2"(N&
M&SKRH&OPH!M;MD/\WX.U;/_T39;M-8M^E#PP]8QE C@;]89[D1N0Y\')/,T-
M%UF>CCCL^_' 7X?&:RZ8DXD'SB<-!1X(/\DL!UA&N7(J#X*[''#8K7G@>FI_
M>&SN&[G;-Z&II\(LE**)RZT+,G7<<:H#]RX8HW/*X#*Z$3!]5V;1*VVYR)PR
M(B<Z,0GADE(B&:<D!.T2$4"3RQ)@%NG(+$9F<5?,P@CF-=,F3]'$P[A,I-'>
M,&><8[G(1T/R]V06 T.RTPD7:; D&*4)S]$CGGI %D%1I=/$IGQD%B.SN%MF
MD1GK<ID%DX : OJ^#$H)ZI0-*DVM&M60[\HL>F01,@/'I!5Q60!D03TC,@\4
MU!"9,0&<WG &S"(9F<7=,(O;&6JV;[?^]Y..NGQQFZC+1R\4!+6)SY(TY124
MER15L&HKI+!)'M*,)Z-0^'Y"X8^A;2KC>::<#D0SD1$NG"<&_B5P5E2DREHE
MT4<H-V2??S)"88/1!H^>6:1>>L%3FC-CX3]:>IT':S15G">6Y:-MZKLRBQY!
M,LD5S60@4J66\)1E1*44L"1+53!:4DK#)A#DR"QNCB"_#J>V;[?^]\A:[YBU
M.N=,[FV6*^XY3U.56)EG*9/,IB&A8ZS6=V6M ^5<ZMQJ'@SHY8(1'C))3.(8
M4=9387,)!\<V8<D;6>M39*U/+7#DY1@X<A7>-LSIE'(MC./6*>58 D)" H3C
M2<K'P)'O*!3>]\HY[L&O!T:EQOH\(T[2E'"O--&)U80F#O1VZ0(/>@P>&:VV
M=XNYQ]T:=VO<K>\(T=I2B<#A_=6;,W[S[K\Y'M8#^N9-VJFP<RT1TGLI(ZNN
M547V?T_^A2U 8G<(FO2H9VW7AXL-MF]0.;=9W_-8?NZ;NWA>,<K=UF#&YN\S
M4 //QF9@^R_WSPZ,SG2BE2*)9(%PF5FB\R"(XE;P- M2RPNMOD/P\(S4EB>6
MYVG0*F,IW,N0,)YG:7JA,/,5;4>:6\S3W1R(Y\>V5/</I9]JK$/<U/=M5-G!
M@\W52OI'M*GFT^7B\D<NE*JZ?^$>B?5G@K:Z%0H=_'M4]K7.#CTQI=<?2>Q-
M\X.>GNJSZME_K9(:4-6Y73R_ 9<36T=R%POZZRQD)N0FN$"Y8*!IFESZU#&N
M@Z:.G;\5J0]!)\SJX#E/#."P),E]KHRPH@Y,7O^>K]^F<^U-O+;>IL)[I[B7
MP 0HMOJD'I3@7.?JV=BL;AQV \,^\08HG:!\E.WGNM5A.Z[8(J[K,S>=G_HR
MMA'!=K;S<GU#.>!>>G*BRP4Q9P3_BUW6BK:1!O80^]PTD M%&5L.[S0_S9>+
MIE\&]K>;:/=AV;;F6,QCIXYZ8BN-SJ9G$__9 L3;F<Q1S/E%K/Q?V1+>A<U
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MZGB9NS6C_F,^=Z?%= H"X/4,[M5A 9=B+^[+:$C=?W?(#I0728;ZB N6H0
M+"-20X)TG*9IDB>XJ^=B5*CPSF:!*P7 DW'IC ^6.R:IYOPFS</'F(%QV#%F
MX%J&UY:5/4I3:^^R/VR6&:'"&L&XXN.;+$IX*0B:LL9>&K2/"@8':02"W "T
M;$!D+=[6B]D"EU^$(O*<!JUJ&UV!M?M]6M1H =WRT>N-EM;V.&KO-HP#.*>3
M,"N@]TA_0H3L/$#=8N$O6DP1MG2*U@XL(:('=+CC_([A#;-E-*B> U-%LS^
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M+/T)TA*<(69CPB%\\E, L$>%/9I$SEY-3@L@F)? %N;'_]__(U.:_U@-'JL
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MP8SQ8O;L,D;QME33Z\AM<&\[ZDX]8G3\M^C+Q=X5.'P]I:\J%%W/ PPBAKD
M 7I/YH'4E66Z[O8[L&4&TZF:G-X>NR]/7(P';GLLU#T3)K_#\_Y.6%F&U^P:
MO.Q"$"A>6L+BT^?-6W 3< #DP33G/TZ^'P_&0N<QX.-X#HKA/'IBJC/0P8_K
MX@153$N:(C>$.4_K=/6BJ7P0?4C?>H!X?_HHGB[6O(GUL5TSEI/ILJK;RQS6
M.=ZQO<PCX)7O!EK\+[BGCX OOKM@F6@%X8"QW-HZ-KGX&K31G9T@C4W/5FMR
MM2P0/JGK:<1F>7C-VC0,%-XQL WVK\#^+5$YZ1,O2E\<FV59-4V4^NP+T[#D
MG57[5-?\+O:9;^H4#+,NL"!L&7'(ZM!EEP<:AYT<%Y]OD16^-1?]WZU=Z\7P
MG!_!;1\T8C]WGRXQY;4*2--,H@FDN\2D-\@E@B^AZ7UGU2[=/#H4V8T8OR"\
M=R?_OFQ&C4D5&SDV_6_Z/HYP/PW>R9VF\IO1%HMJK@X!=[7V \P'-O&VD&=U
M@NW?I^CF[X%-TQ]S#I0(JP(9XO$5;191FVX<(4(5 3^J@2>+#K6W#:>:+HVK
MZ='XW7G3!ZLN(81\ [WD90RW/.X< $#T556$L[974_VVE93C2\YQ;(]ST]P1
ML?VY(U_-!3GG>I<J@^\JH3QS/-%<F?^?O3=MBN/8UH7_2H7>\\&^0;)SK,J4
M[ZL(+,D^. RR)619^D+D""WUP.Y!"/WZNS*KJKMZ !K4B!;4OO?(0'=EY;#6
MLX9<0V&YH:%PBFGM_&4QV-=?V2_DJ'!.A,%:T,"X],%@$Y^DN<2RD!Y?=:F_
M->UTJLHOD<$KU*O<@J/JOC!QV7D5)%UWE&T6;.KI3SYU/BLQ(#5BG8L4;SY\
M^8,/0:"^+E'Y/JV&!U*L9J%V127NLDH(5\6Y3H:Z5QG993--%XNU1C/_1/>K
MPE6C6>WJ,Q"5/6TOI@59RH>BX3Y_*9'"SV;6_:P]X-30ATG YG7*-JBI8LCN
MF_D4XH;8"BEZOUS +'6WTGYC[=>F -R9;P8Z[50($L4M[\A.]JD_..\WJN^.
M0<%U52#>J>[W?3<UJNRG3HA@X.D'8* ]G^D\#X3<(Z$!69^596D:2MV4S)LT
MERA^1K*E_=69]<F-Q+A3E64L#:"::1+_5!1E?"R(UO<GH)25"3N=:-673H3.
MJ/8$):B>S2^.,GU?2EM?7;ZXZ?OMS#7K*+T'=8PGS %FV9A%FL"5O-10>1N;
M,N6LAH'8, E3O?EI;8"R7VC<V#)/?=87?>K6KC9B5MQRQ:%<Q68/0)S-F879
M7S-S(EDWE4GQ4!CP(M,N!FG$G@33<GG5I58RA)(=595.JWQL<S[AF:<L"YTO
MD9++TEZZD4E6T5]%XT>IE$(:NU:LRJ[:921V6?>R=N66=ZBSB[::@X8^ACPO
M1(!GRVK=2F.V]/O&PB%3AU ]H]ER2B$5_4%ED^3RUF8FON#KE8>DP<9+=W8/
M0.Y4):"RUY4A_ !(?W^YZE]95&_8&\V"W*=TG@+VIA<C.^7]R1P75#=QJ=[N
M,+YH-*MX CPSCH!2LT_MSZ@KG)2>[;GA9K[#-**>^4"B^R4 ")=UTP8QZBR;
ME/=Y_8NLUQF-4L55IWM1,=Q)Y1Y3R&/DH9B0 "0<KT*:+;X7P@_KNQ"=I2M9
M_,O&H_%7=,EP^J*.TG=?;*\.T6^$N+Z)7%C1X/-!V<?[KW3A^N@"]/?/#S_N
MG1\KSD2@N4;,X0)QK&+##*&1QD[YX((M-%C]#"]ZA!!L=KQ@\5%] +E^,M&1
M$+U/YTU^F2H)YQ%GS04 ^W T1HGV0,U&DY%OQIO&EA45I2^%P\YK-(TFY,MN
MM0C-_:AL=:]7:TQJ;]XMFVC,^\;3/-*E7]T]ME?:]8W P]D]3W5/V#0PTK2:
M[>N[%_/7E:5?+WD2 [!# 'DP:+@89X./3GTWI$Y"98V_6E&J,YB;\%*K4[5J
M=5))WOHR-T'3PQ FT77Z5^4V>5&[3A^ 4'GGI] Y8XXD6R[S%U=F2LE J0IQ
M9SY;:UK0*D7T5H54@9 &\+N;WF75+-6("M^9^?9'=0'E\NVETM6++:KBW%)#
MYSHEKHQ?6;)"5LV]5)_B[=3Z&M/TV:0V/0!B_J?R])=]V?Z:]_3O3SW]>PU'
MQP.@\U?KWVO447% 594^,TB6LIN[G6DF,L9[GX5+'SM -?7%"Y(RQ3(B<LUM
MR5(?=V9!*PW75:<_F@QUJOC=G/'4E&U<KI2EC"?],JIDZC 8U(@_CH9P::M7
M XT:W8I*.[L2935GSG8E%F]OQA6DN^9):@ :>S9,94:Z^:U23"?#N4N\\O8X
M.BNB^$TWQ(W9UR!0LE[5&+122.<,I$H(/@#VNRH/ZL=EKZ-K<R4ZHWDZ&@'Q
MCX*>VKR71CN]F9C(/;$T"K!BHSG"I3DG"W4F4P'[V?UN<E>GEW?*:I.Q]DJG
MG\18U!;K0(29.3.P=@)2,;9H..V4Q>XKJVAFC!S55ICK#'WEMFK>UI;A;&7D
M6FVT7''WX#TM*/\>=P_W<I<Y3+]%4OAU $IW]M-OKW[]>1;87IY'Q*/DJZ_V
M#G[]+39B>!XSM@%-?OKM^=[*AU(U[++&3L+Y^'09SU?[A"J\:>3'[TPC F;W
M_SIV*XD=]887BUZAI=" !\##^_TJO#)94-\>F.:BZ\&M&=6XL[K6:]5B-,5O
M1*4/ADBFVGS_T68EJ\IP:=;;7\YWG(4+/X2#>P4G55(T++R!=(VXFEBI-6D4
M"&!M5J?V <C3.EHZ^[5LG'O7-[KKIST_F#O>Z197O8DC@]9=.FM'1?5[U>3X
MZJ;&992![R0%M=;WFMG!RXDJ"WB;5:KJ7#K3F>ZXY3#(R=R]4+62VI]OEU8V
MY9D5D15E@F@UQUHCG7H%2C]L[!X1/3W3D1._)?]__"&&2=9SCG]LY$\W6B1?
MX;JD0BC%E124.XZ#TM;D@II@M";4"WQ;UV5]QM5JDCISF%3]07@1XX<>G;OR
MXO#C'CVV#F,GJ4?$Z5@F62BD<%X@ZP37N9>%MV25N_)[-6INSW&-<WQY<:P+
M;04)!&F9.\2ET<A@;U'.G-'>8U_@\.296CY'V.#1@] 2]E8A6E(95G<;GG5?
MG/1!V>M&8VG%$/#\_U2$_MNP,N<F8/,E,I^,W)-YNB>Y*GB. [5.<2!OK5PH
ML+.<"0.?X>/]&;D[;T&KZX[^_R=(+%9#>EO-:9HL]7HZI2?9".PV^&[^*(G]
MT\5QKHQ1>>X1%[Z ?PJ/C 8D487$H)5;^!]^\HS@75Z3>WUTSS*@O"[\L)N]
MO>K4F^79%JS]KY63MZ&(UC*^LJ:B0E!YS"Y20;'*-=QTKY7^W&GF0O6=RCN;
M4MJ3*^!*TJQ<Q7,-MA=9>46]XC;R>"GR.-_^R.-K(XD7(H*]%0;4*),74G*G
M/8A=Q:R@"OY@14$NBSR^-I)XX3T,>##/#:=.*] 8X%%K,'%6R4(I8>G-(H^W
M1YS,?,B+*O$TB#CQ?*+<9!;$FD4+B>)Z7ANV>G0Z?^53U4%*P32QV^A9W8!T
M58IR-!@6O(I--\!JS\-#*!,4'0!75>"961DSQV<%CH16P%CO5B?Z:U,9Q.J@
MRH[&1\UNM/5!-^S!F4O_DGF4SOVZ3>3,_YH*4\QF<0XJR7WH$ZM**OY9A\4?
M#OI5S.$CUBU>TL,7GT"_L/CPA<4P/W:<$ZL$Y@4*CBK$ U-(8ZX0"P"2VGK
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MJZLEUA^..F,_7Q%Q\13J32PGV7#@@ D/6]:8XWHT52\CS2.5(XB'XWQ<TS2
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MP7M?  G KPTP3<'H(-5*AU%4?Z)G*L:!ZD\^%0PH,;T1^;(\^9\J-Y/.NI4
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M4*%9U#T"!;7#@@(B"I\K0V2.]6--.&]!X(Y+Y[21A?>.! UO@O5<Y#1'6/F
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MB&U$I+F.F$9H#-("(^QHK !CP10PHD#8@T& \\(9OSDCOBW"N[VL[+UQPM%
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M(+,#Z,7_'39[XQS8<:KQ^+V0A>BT-9*B/'7 5/*QQFC:^M>-=IR</+Y_99'
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M!C*B$]-4FW"[4EM7S=99^V]&)XR=@C/5MAYB%"XRPNN9\QLMOD47*/3,OWG
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M7'1'*/P:B_L5F"HP=6-YYY]@D??#=H[&CZ$RAZ:64+8K?XTY<V#/_B@ =5>
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MNVCQQA:G^FFZ.CY)_%@)PBU N:Y ^7@.LP*4]P#**<?U,5E,.$868X*XMA&
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M^.(M6%\Y3<ZJJ)F0WA(>J+-"AP!6* V)!H5UH0;/(Z<SV8")49VS18QT G'
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M#L8I[!F&A]6<*Z$#,R#%07)07<+I&VA$\7\^I?R>S\DOAK7 S!ID>:1 +H)
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MUG/$30K(1/@3LR")=A:63VUL<4G6*CFVY.079'KZX^*"3(^+3/4Y9")!.Q4
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M<B:P)"@)(G!MC26*8$55,AX4!2^,\&7JC\^SC! K#[J?882K7#&<)-+>Y5*
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ML;T![[ST%UL0NT+,NJ^Q5=YIAP)S!'$L+7*26N259@Q36,>=NHGJ9U)\>*&
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ML2[3!_M_Q][XK>'7;&--*#JB+XX5-,X;1X=<*UC<$T?2>8JX9@2Y@#7RT>!
M/ ^<V+4-=3.\\+]'=+/9F^T\%BT8O-D]]6HZ_*&,)\H>I4]@.@.[*#['WK<<
M#-)JM@$F1O2[,^I.%'OM_CA.)C2GR6VI*NL@[=EE>O7=T<$IB2T9=I;:LC-2
M?@2@M_!D-M-?GW6OV[&],OXHRT%6#[C(M)[V2]I?G;6BDCX2YEXC/R0 Q<SQ
MZL5V4WGP)<OY%YQSSFW0#JP)I&C,<JZ!_'+/D$K<6$.D5%ZL;8B;,77_?4,N
M5AO][B 3+UH8Z,[183).4:$24EP:Q'$J.RE@Y)GV1@7!J<K",%\61C&4LWTO
M]\KX_?9HS*_)2QG]N)!3^G["<C,F]Q99>=OMPQW'49\KY*YZ;*G8O]@Y/P3R
MAH6-$@DG4RY+H9!63" O%%&*:9:$7MN0Z^IVQ_.B,=<,;.K<\%Y@S[@U8*$;
MG @G#JP9!5;W'<HMW=EO6<O 3V3@<F?S4$A&E#$$12X"XLI@9%+@*&CO5:34
M:Q-RL:2;?58F,E Z[C(S.8\M, +:,-['_:+:@!V[%BN7YE4BSRB%Q\P&<-\C
M%GIE3+N)C5M:M+D_L#_.];PKC@9#]>[SWW\_ YOOBI&6H0L_>NW*TJN^!B__
M+YC^=B4>8'A-G,^5.,16LVHQ>F7P>;C"V?AZ96O6DO]6_NTVB%M1=@7.*6/]
MV&ZBT7K5S S\&\#&9 .J"KUO^MS9-7O% 5ARR'JY9(TVEL;VZVY*E25ZTS5\
M2PK>"VT3JJX-T JV"?VY2W?6!9R_XDV*P#\XURF >4A8D"0Z[['4=+$FE;]I
M:JH@$S#I-D>IEGD;Z<<TOE*MI>PO3K'W,@9FC XE.(RQH23O@ <[I?FPF\KN
MU_W1]O++7II/<>/\D!(;E'8$:<TU+,V,(<,]04XRC)U3C@F2-Q!OTO;)TCQ"
MRU%85+/?!QD?A5_-0'*Y'C?+Q)-F/J$,@\G?B+;7:N:TJ+R]Z#U +LC1'_9?
MI1MBG/TR<D9<7<U=E.CLNK87\M$JRJ7;Z[\J_G#_*I^C##[(QD6K-3[_"MIG
M8#TG2O6^C8*Y)J=>O<39>&']P_^K:,";4CT*+W@&J^S?-U>J/)E5DI"/,"J+
M6>7W5N=)Z^.YK>HW>SW;.2H=KF\NKK[R=]5)??,<Y&'DK)P@PM#U?:]YEL^>
M28M\@:;ZNXO&Y9=#3Q6.EB6$G1>("^T1V,(2L9"T9)+#'Q'4_A;'3:D18]=V
M9S#:2LDDJG\\Z[><<E:.?>93OLE7$^?DA'J=];+_LMSUS_('@-+*>7Z#X[R)
ML9 4WK/(TFVKRV1AR0_ZOM4MZ[Z-G)TO6JXN=_8^'C)FP;RC'$5+8#FA5"#'
MI +#+\8H'/6$I;4-?;OCNVAUSV-O_$>RS1Y@4>\T#@I@V<,X/G"=D\=F&7Z;
M#[D((%L&5HZ^:\_.P*HJM\0GC+MB+L7(J)P8$EL #L\E5W:T$"_&Q%BTEJ;$
MO.:<"RR,CUHEP(?DDT[2W$5I[NP[*8G:=OF86Z5E5,U*1=%N97-7 6#XY2D9
M7&__D.  V$T44C)*Q)/TR+H0D% &8ZXTHR2 DIE7Q-R,^RHA=S&AD"F0J(/
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MKL2,_FI)Z3^V.V-_1O].)907:'2TVF(PKY/<K[XPSJ^[]F(&[@<]V>N!^^'
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MMRAX+7FB&"3 YNJR[!Y,:X4MU>>I^\^::8W4?P@85M.LI2/#%,T2%N>^P\@
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M==AK)1*9I?I*</NEX/:F!3=5@ML<B4EQ'N$OX+&IVVIUS_OY5S@_PT FOZ&
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MUO6*]^".+ZA&<LQXIFZ^GOI B%9KZX,._'OU5?_*L[*V7JV"V-4?$AJ-3@@
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M!$V21B:ZKU $']F,#XE;;=[;EC#U<'D.WF YO!N:$-] ^5JJ0"80\XN6Z-
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M%'^7 G<I,N\W_#IJ?"Y4>3G5!TG<>2.+"P)]6+!/R>>?_@]02P,$%     @
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MGBYFPW&IQ[/:/%BZ1JO?I $''91- 4TO\T1&BS:Y7*YP$7TUFSP/O,F9W7U
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M KZ46Q&EK'UI<463PM^$I$/#VW";$.W9D_&G,#%UU%.-+5<WYJ[<_ZO08#:
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M/>9AA=O3K71<8><L=J:6\XQL!$@E0(BXK">.9L8HGB6N_(W*;?=B ^Z^3&$
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M V8M9Z8TUA"E9FK.F5AN*4F2&RE9U!::'#DX G.?LC-]?1-N>WU=4:1:3'
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MJ6+@!HF91%0JTK*EU09&;X0ZR!1TE(IWL_17F$R?;I(_CH%KJ_^&;NCVI-3
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MAS-(^$<O_7!Z\[?_@!D&WEUHJ *\#G5:6YB=L> ]8I@.2S9E^;M/8UR93DI
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MFA7L,!M/TW)"_8)&^/0;P,\P0>4MWJ+G/$I:AV0")RE;360T@5AM-/$Q6ZI
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M>E=5A<#HRR)]>(UFQ";&6Y2G5&MA4HD 2"!214Z\SIG@NBEE0&>045F#3FW
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M+<R:5K,#A;CWO7;0,':KL6^$JK/WJ%3-%',<=S\10$MJHE!6F8Q>\$&AZGT
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M!LG*=9XDRG0UR9%0PDS!9AL]%]:P*B>-IZ'; YG*WRW;#M%BC;/)R\\7TV\
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MVA[@00>9#\>(4A!-> -$^:B)##Z0(, 1%GF0U"1NU2#+R G/0X8BPB&BKD"
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M%.:+$1JQ$IR,A.L2 8]2$.?QNZ2ME0JW;@Y5DI7Z@7]6O#N!1BL<(6W,F]+
M^TW^?0Z-I$89'.1H-<HG<"(ISR1X;HE)(6:'RRV# ;;Y#51GQ:+^Y%\A0^'E
M>.(G$79"2\Y[(2,08:Q"ASH&XF-.) KON7(<H$Z7XGLPG14Q^I)]A4*H=T?]
M>KQ*;6XB:DDE26)2LN1G /$\4-0D=4P8H7#L]5>+:SQG18<^9%ZAYMEMEMZ
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M?=;O[_=[_7^OW_MA[CW/><YY[CGG.<^YSWGNO90VRB>V)7U_C"L F)H">P
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M0RA=H&)LE$H($I22$4(KZPK2@Y[#P,C$S,+*Q@[Y<R-H(?J-QLT A %"3\=
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M>M;%$JAU+AJO%<:?2J&#(5%Y?O2))AQT\D);Z]M9@RA^0!=P G  'OR) ::
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M*!)T0P6JH__D9,"?O!'0^>&U-#$LOSLE330F(A:#0A,/80]0IQ7DE^LPTMI
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M'.T$RJ2FBI935G55E4-0_1<!<W:%(9P5G5U1X#A]XW?YG</_!_SX_][AOW5
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MG):XPF]YQUE B?6AY/,&7<*DX*<SRCNCK;:@]+[>?20%WVJMHN\BS48\&V-
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MG8-OD/1#YI7JCO<Q%$#SH-]J6&/Q67((3; 6D*,<Y"BG,12!#(T@ PED4*
MHN.S%.!=EL9::?4BN;>G_"2N9X;T%*2)H@#:/A,]'0.K(C@*,*"<-"/H0 &2
M$ZM6)L9&*, = [\E<M.)^8F>;>6KPO+D 1FP&X>@^?%Y"F"8D+OX1AJ\HET0
M\M%02N3=I ?S3;PO/MNEGO4=^!R_FV_XL$2T^NR5K4:ESQE$@QQ&_ T.F;;W
MJ:F)VS*O:39?)_=8ASH,CW+W2T67?QV/C8N*$950E"2S3"1^OAWU:NK)9M]#
M7Y<-;_1N5GYL4>8PY!KS\K8'2=).])E8#2>AO\-Q%''/V^+(NZ,F^Z_L?^_
MFO;FU<DB!V8$T><Q/;/2./V7WAK;<S#VS63HT+N!)Q0@;J#6-/G5P[DOASXF
MFWC>[2HF8\<98VOKEV^PE:B]E<LK&,RTCZ!_9L\J&]PY3_?RM%__-62H=>3^
MU6PKQU&GE3 =3U$_Q-SKTQJME[:LP*JWT:]U&)';>OH&O\P63,=TD_",TC@?
MJ9[Z]Q\D$J /"->6<462YKI-*MO4EL]$E]UI(F38ZL5?J@I+ZPQ[O/I)=4M-
MZNI#_3V?<^F5L5J!HI4<(=J7@\\*<^5'D2<V)P?-56V/Z)^$ZH!-=M*MLWRV
M86F'R(U)&B'*\]E/VKH>E^_H*+Y[OU'--V0U5#,K*?;PX4-[ J73,]*?]WND
MH)SX&;VL;Q+N1=2N/!WWDYI6DE0)B@N=S3!*HY.6?B5G;(B4]$7*IQX\-K_M
M:D!<\B&-^.I \KM4D>W7M'323)*BE4C>I:^$.8OFRWW&2R>Z@G*#YH^-=*^V
M_AX1'50=/%I7\L(:9SI?E+]6_ZQQF.=+@<B1""X]%^Z2NXF[L_I/NV5=0:GO
M,+4T\K>1CG)7W52/;_>*GR:5A7<W^S^YF"XSR"J>O BQ/)G5J-'UH@);$%3Z
M<FJ7W/4(#0;']DJVE<+$+/P3<H);M<,MR9EMS(+%RR@)CG,"6<)Z*CEMQ*W'
M/_;[T1E>1_7EQT8(*LL7[!A+L]8N79ZHL0_PGTN7+HL+2)^\2P$"8\JCXBY&
MJ4]FFY0L?ZK1"%*V)Y@%[Y+>5211/=-W3_2*]7%]4W_K:#S7@&C75NE;*D@[
MGY:FE"OUYQXW;SOKUX?Y+#EDDYEZO_TJ3YV\II=Q\JG@[9V&@A3 7][YZH,.
M%7LCGL(6EVNGEG7UDE>SS*X%1N:NKO6@FU2ZHENX*0"'V]7W7Y(K9:93M(X=
M9ZFA ,KX&UMY^J/(7BN<*6R"_ ]\3[[A;JES0%[Z3)2URV#Q$7 0VW9L5)=W
MN7F<+V]RW@Y4P83!L*[\DNCHLE; (/S$A)E6?;IA,(->U',VH>#XBM4;U35/
MAY 4@--AVC-JX2URK*@W@[Q,OY;8",8CP4(*,-- _E":N^H^)+@T$72! IAR
MK9KG4X#[FEJ?R?'2M=F>!IX:[/1)[,'&U]NVR3-&CV?#;PILXZC8OV00K28U
MKZ+5U+'\?IQ#<JNJ70K]PL<_R-7<6O6RI/R>[LC@LV87"G7AR,@M52$]'-)3
MH!2!BD$*BZ_FYA"?HLBSMH[CF>BOR=%C1:/C=:_VWV25C-Z_=*E'S\VI_FZB
M<OG<OCF9CI#)H!7)3>]1>;?V*&W;*[<8"PM?#6?6"2[O&1L6O^?3-I9ZY.NE
M1 FSN>Y=N:.B\E&MYJ 5ZR]VQ6C**_@<ZB^*4C6WW)S0F+C;MS,/!I,/#VX-
M"ZQ1/^+39)PD(:*^D\U8(J)&@[GT9D()3#M8,E90*JF#[:59C5XZ_9(ERTLD
M-NEAT-O7Q162JE:EEUXK)S]CD/XB'GW[9(_A@OI#["%[_L27%OV* 7M]W7BO
MI.W/#K$2/&QZY67K>R.NR+O1^9'&&9D9?06<%ZV78S\FLJ>C"O-O2)ZNLKEV
M5H;+7%LL*DXZX\C6NX47I,[8^-M9PR[7&*9+,)RL/GBL>ZCNETF50P&N)-6:
M.:U@1H?7'G0'H]L"]BQA#XFJ1KUU/MA]U  O>#V%1PZG.C$UTQPB=/0B7!EW
M#$X!=B5?YC)BJ%SI&*]K?;U<6RS?^]BAY#1_<VO%N^'>\.;3MX^_\F FQ#O?
MTB_Y,)[SOF9;Q>AR['O?J?/-S>\,;*Z%\3>+J1VO\6"R7K2\[;BR-\F8 M1G
MCB$7%3#DV84@#@KPG/E-T@RJE )D.LZ(:I?/KGY)6E+J"7E5/N)VC *$71U"
M+LXZI%& G5[0M?E;\Q,+8HO$M8O7RV=-ULZ.](RLOD'.N)6M7B&W=(-]<$DW
MDJ>'B\W63-H=5T-61$,HP!FNZ\C!ZF *8%T^J)6W5M[YF (8!$U\$%S%#@4U
M)[VU3PTR>>CKYF UZK!<(..7$W+6JW<:4=!!?C$$.VRL+P7W6'L/M;#D>51F
M]-&!I5+YS)S@P]37$V3YB:"RGB=2'WPXKL.RG7HJ&K<^R+L7$Z._;&:0H%"Z
M]VGI>$?(>^%S39:=1A*V)[:8OSW'%,W;V62QCV!X*&K<8QCU^]C'68QZ-$<!
MS'SRIT97&_=L8WPTZ1.0V1YH!KF?XZY3K7_QSO*-XVGPQ:-_/+2R"O/15<[R
MI;]L538A<+/\"4[C[6Q(?+MX'YOUTIZFTQEQYXY<WJ,?*-/MY^D0Y=&I&E&S
M"B\Y,,JX!_/\4/*F ^Y9EHQF0CYVHI-3P=(40"L+O*'UE:;@5WN"SE& CV>_
MU"]!NRE L\(25SIQE?S4;>WB?,\CA:4/K>6?OJB;K07;8D1GD\!Q7.XI_X4Z
MEYP[+PNN-Q*7Y_0I@+WZ_,K>M!_C;K]:_G7B^\ $?1N8TE\&9J1G<NK6ADC5
MK4_ &-,R7T[^Q55 YW </TP![FG.CT:LY9."0Z K%RM/)K;Y=%TH4,$-M-N'
M<*P>ZKFM<>>A\\G*MB4/XZR17;Q;[8^$GHD_<H<I7\*ZX=6]&5%"F-0T:?M
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M.VJWS]>4/#JL:MH-)2'?Q<SN7&GPL!WSDAAHQOJ*3M^HJH#K*UC/O/4Z><R
M[RD840IW5"N)GY%?]L2_[S,;YTT7_9RY3T BZ0"R./B3D^7KAX01V.+>*48P
M])P(!7VVO*!&HBMD4B"]2L7A=-^1^+UUO&N*IT>.(=OII^K8(OO6O$1E'EL:
MM<6.7$KB9>*N/O-AJJ7$Z7[*K?F#CMZ+.RUFU76BS9+9 :82ZF0PGM2*["3K
MB).'1UXGS5J]N:W?6G9R"(&GTU 3?'/@@-&R27'3VKZ319Q2:ZZ.\)1K?0=[
MPV]L&;;;,9*3!:V4Y;P*UY"ZZXS\6%>]$AQ34!+2*R!)!.C?:7N9U3R(65F2
M(OMK5KBZ.BSLTM)A#^1Z])!WV>PPAGPC]^U^C)!Q,2'VZ7[^R>;9GL.2[I59
M 7SO1H<1>:>2[1[:\U:-ZL=TFYVPCNY8P'HKVK\?&SLO.G#POF!)R,>7?65S
M.;N?WRZXO3CW,FWQRDJ1H&_YM/^B4EBP1AA]\_*+N$<W3(_UU#K+O,AZ#+-J
M=E)EW,D1V/"D:PB=?]DK^$A4=NG2@(ROJ(TG6MVV3M5@)5S-8C'+N_J6GD#(
M"M%%SN2-S.[>Z5$2_E7V5='X)(5;!Y%'*(#:^,-:34U1S&SHR <K(QX$;-E^
MAW[)5W;XRXQAC(=SQXW /3JW$W2%2>'8?"=?'H'Z^=,?W&1$YA_58ZN_&KR!
MM3:=D4"+'B?.?1T,>A(T_^CHU:B =K=\8M7E"Y=/UG$_6^9_I?:J_A"J"<RH
MWSOT[O-<>OQ097S\ZXN89I3[<'P,,NK2B\N+F@71^_?.P5F]Z4T/A-MM9A5K
M1[4MIEU_&JL@Z-)UI_!VAKG[2(7<-HO6L3U*QU)68V[XBCB'57_P,\KA XRL
M#$$]>(34*4"^Q;OJ4>V&B6/SXZ6MI<NY/A,A(UU!/47S&PB2*+Z[:>18SIVC
M42C\V+U'F)V7^D[/RP<)7XB];YZI>#LE*R,\:X?48R]%F=*%AUHU!9K3KA_$
M><:7DP5>&>PUM)%>W24IL Q(W^UZX]>>[_]'1\X7QI)CC]130M[JV4[EVLQ_
MH !ODWI=W\*5$X02?.?*#HJ_YBO$HL9*"QMOJ\=B7_;OWQL7]7J(1SLRXU+V
M86-[7GZ\UM)42%>.9AXU_[F[<**UO]&B''[I=(KA->>Q@>[Q@QVSJ3V]W;5[
MD*:DG899KY,;RSRR]U89!.8DUJUY40#Q D*]X0/H-F3FB2F!R:9W#>0@/UGW
MYV&1!W(^7W@0E6+TV##\0@5[)[T3#UYKA>BU5CB7+C?JM)<M-V*GEI>T6[\X
M4]G)W7QXD26B_J3[7)9]T*[SS],BQ"@ ]J/TJF5OXMG$I#77'NFB-PK*R]>)
M^AUV;.UIZ3G/)I*Y++BCS23?GJWO[4U][=29T7BEH--"KSPU<65Y=YOFEP'3
M^$^)XY..[0^S)#O]!W3O;S6[/;X/R:QO+UARL_=)77TPH6 NV\/2'")2)+Q/
M9FYS#1-=9*Y2KV%=]^5%V=T/"K%7BU4?]*4=W@..K,];,R:#3.M]'J'MKS..
MAO2G7LK9%U9]^+.5Y-4&N;'HDEOC?G+$J# \'E'0-12W4PRJ%;+M).QT(E\@
MW?Y=(Y((P\[(HP.,=EZNBKBKM3SFR'KM!1?1H:",6)O!X>4K1:(S5[J#)M ^
M+0+!5>5^Q[K;MZA[MT\%12GHGT]V-7H3)QY;Y'].WRI=71S,C;%\/(9/MD4.
M%7BIO TH<M3%>Y2'&UB+'I?5-[N]51H@12Y[/^B0:Q\Y41+.CO[<J*B_FGS:
M\3IOLY=OTC1VX>MCD;MAN2>V/<XG*#X6;WYG)9R2+]Q88[50%I*T4$S7D_*I
MZ@TO8.3,4H(L"YJH20!3XSCI\CC;/7MW48#N3L^52KV LR,\^&,+A,3.(W+Y
MB(E4_AHN3O6HH=(MK:\R%27JKF9P@LO&.O8^)J_^,#2VK*BMR6N7/SK]WIOQ
MDDZ+4Z07GB./MHPJG\X=EMZ^Y;*L[664\)N>;H^GLL6^71@O;K7T@*,G,P^#
M*5L=\D,3IG!YOK: X5*!YY."J*4C7_ =UHX+U:.#Q6@*$#=?.UH9/C6OZ<#A
M7MN@?;Y=@UU0R,/&<NN02HD/;V[J1Q.)MAA/>KS3[M6N><Y/IW'.:/I3=K<=
M)_585UXODGB3NNJ]I;T<RY\HW*UBH5_+:%KJ2_KP7G5%3:&6O+B6$-DSE]Y.
M7HWJ25A&K?H$/Z< J?&.\W'E(XX'R#FYA:(S#:_!^/4)3(N#%10=:^?[#XD8
MM3]^^'5;I.0[1A4_I]&42]< (9&3(ERL#E*W$:C=!&/5\L<R^$#-B@*GS[BO
MM?=>?PJ-6[PK$9R:-UC7VGTL)!]^G1A^8G"R$KGGY<.D@6.7N!S)"(=5?;BR
M<$I3D)6WY1(J_17V9*H5MO7E[<T>!AIPJ8'D[+C[>>)O]Y_+=;[[;%-^4HG4
MT+8]$T$</-7/GL@V)!68+)Q*BDT1N?KIW1N/>0K@;:#7G;\KV5'EW V6Q3_(
MFWG7NHA#%5D'!D5O(D7*](Q-+K1O>[P@,)VQS]9I8M?GYSCCI'V^40)"@1</
M!K]CVKEK3R;:6J<NO&0Y?M&^,\>JO]I(5F%%KBILCG<3CVAT7W)8)'?<J3W[
MM@Z[?XGR7K2/K]$M<!PLEUC>&B3YR1*0S'I?7^%ZNX[98+YM^4ZU-M+=+]=L
MII3K*V?#J&GN8XO/2E8-:!@TWZ-HIXIOU=@2U.I6S>!*N ?&:"WQ54&.:QO"
M5T$PJ.MC 5_Z(=P<_0**_PH%:,\83/#OEXLZ'O&RV\_(JS&.\YD2.47[$/ZA
MMN:A7-!/U$(2GQEKBMK.CH^/[C]?\C#5"FYC\G#2\L%.Y_04F)4;,>:95WIV
MD_5%0Y$8PHZQ@9[5T*8G0?+O3_B^**W3VQ6"XNP+>'=75-:'&R^R,C5VQW\N
MN.CSN/;S^,MWEEG!A#<?/A@Y@>S_,D7TUC#,^QKL\P#C SWW,"$P2R.F$8_.
MR.J\(1NK;EE0VA@ITS'TMO1E1UCY]B^^1H_"&YME+D&OXVM?U:9-:3<1"X/&
MWA;(ZE]*27D28FW@M_(F/VGAV2#'*PH =;SQ5/VT!=(/??QX*%1 PW/T@(-Z
M:IJ/"$=(2^J%S@"6EN?)8H#=*5FAZUVYWOU>IK61FW9W;&=#.E<R#U2'!FXR
M&:\OA.4_KI4MWQD.,/>)K[FFM899#(&3R+$VT[@W(ZJ$F"MK>I_1@![=LJ\R
MF.%)<Y"K!R9Z8*9($4S"O=**13[>DXE$1]]KWB$QM^45,FXX:[R\<,_S,&BI
M]G0D'=(I8D63;9OG8M;)LN?&O%]4!6J[/6+E.+^TM<7;I39:7Y'!3N=)04X5
MW(DYXX5RYAPMG1CH<$X->A-T>6_R.<:0'O87R <S1+<)O*:]U<O$EL])$Z_V
MY79\VD(!KJFKE;JM?'%W34^[.RYR.SZ4Z;ATIZ;?=?Z[<GIR+ULZ';%KRF6I
M3M?\'CS0";FWFC#!N@U65;L-8CT=S7P?V=]T]=GL5\\I3>J6Z?U;C9K+SNZM
MJXOTGJL/RZ*9$R514\,M18Y]>-.3IZM>QPS?_QK>&6WY?/OB@1W3O7[R_"Z[
MDL9M\7UW4VO>OY F;TGGALM&RFV/1"A=ER?ZR4];,WE%$2.=;PL<R+ZP%J]R
M#W+4(S4Z1$#3-(A+>73[6TCA!U7)!*,L>9O&\I<7Z3DFE>],29+4@GA(.T8H
M[WC&UD1/(7N.O%Q;3&A549]_O^(UT[L:HK8]: [36C1X8K9WQ7\I&-DB BZH
MQSM[5@R7JVAKBMGRUGX*<% K<;:U:+BU?&'-"UQZYX!I]1(1S+U+@WJ.C?0<
M4Z, G,Q+/69O2Y='1[I\ZI>W)9!S%"@ -W69'H(GU\]^7-,JHR[5ERA (DC-
M-5N>"Z[:LXF?6Z?%QM9"TU^.E8Y9.;8[V&_3-9$75#C2.!Y<JB<;ZI"6F.EV
M];ZDB_N=;+<4'^WM7J9DL>L(Z:XQ<*BZMVE6M2^[\ EM;S&J7ME==Z(O<K_S
MJ10?'_DIQ^+B"7EEE:![\+FZ7<H/5ZU%)POVNB/I/[[;\^C$B(O6O7&1T@GA
M:Y$]79Z%NQ\ODW>X]T'76G1YK]@Y)V9M2KCM67_I30-K6*S@"JQ(T, 06]+F
MMYIU(W^PP#1Q#)V'%94RN)VI_M66GY^Y3U^;X4OBZS*ODQ4%%4_'!$WD[BU&
M[O&_YE1E%W VZ=79=TFC(_="_N&&]7#Z&HJLM.E^XRSB6.%0W,.@B<<8H<#M
M+P/=^(-4T2WW&STPII*O.B*\&S6;A^Y=V3WD*N3F2XI.ZMPVSE7BN[=4<AFI
MP%#4;7W-#Q'*VP]=30[W3]]AW025Y!L6&)CPPP:<Z&_/WVER?\ACZX5L"U'%
M)@G[2$8(Y.#V,VRW@HM5"Y95G_IQ)"0]GD_U"W#EBGDN?R0[;R>#Y5.WE(K/
M'S<[3S;IGUOANUS!OYCW>CZ\N&ZUA+BIH;2[8"M.?F_$S5U:1G?#S_;=YKIN
MEU=*9)JM596:".AT2<3+&>:%@$WWP":EQ+,AAI][DN:K5\EH35Z?B;?E+>6M
M@\CJH5GJ,K5<5)<"\-:WK%"-TS,A:D(!RE:"6H^-O.B9\'VZEO9U(C@HE^PX
M7[&*KW_?4Q8<E%.>L=)&/([L6 T>&1OIVM)]:M&F"[F-Z.T2..)C?7&;M>R'
M2U'Q 5,:"AHBM]^SU6J8"37:' !$_0QFFL/5>,[)LA1?>]H3]U3KBVN[@MG[
MF$/GAAN0.<DY7#/OLJ(^I[*47POHC0O0^>32H6#WH>4^>W0#,M<KR'AMYYX>
M=6N?1_.5$S>"O:;2<*_:W-;&?#F%;DAW:9(O9QXF\)V(OJ+ER&J3NO/M6&OZ
M5;%;-BZGSQ_^?/Z)ZX&J/D?ON1"_)\B#)X7;X=D/H%F0T_>Y>B-3KP'\DLSL
M-CF.!#.ML>TCKO7N)^5JX$Q&6^859JZN*4M#0@V9@"M68>/[!GV^+_%M#*?M
M%J:"%-(P&GZX=S?FR69;AV%99MP>-Z\[]B4J]%H\V">$*I!A.,P@2WIN.O\'
M8>6%R (A;2+2T72M4;UG;%9.._9T&71Z\NUV6\A),Z4FA0G;/6M+7V:Z[SOG
M?'(ZI/SY7=Y>[;5WI\5R&;D.%!QIH@"G*4#PS%JYQ027>B5GT0JYQ'XE8$45
M=.-B"N"X6E@^ PYE4^:>]A(O+RD340NYG2'JF8E%X3E,,G YM.1K"S,+^E-L
MIAP-H98(2\B\?Y]_LO%=PJ/=#-QG6. ,)Y^GJ!.VNA3$[OY(>"S!9*D6RG0[
M*DZ\%&?V-:9HEP8%2/85=+-\?=!SVLX=4Z IR^AUL6OAX=RVZ'.];)<X/*//
M]9WB=[!N-)A[++?$]?IFE:CR5$MKJ8%AA.1Q(^9/UX)<'*][2P9F6#V;35I)
M*:^H72G-FX!>R;%[^0#)$=$AONA]''/:0O=99%B]<^0?MWY.H&CFMI2>#IF(
M2_>VU^VM8RJ]Y.OKKEJW%IYX3+RBMS]^4]KYS(8=AFL2UR(]!D+W"2$?I<8,
M#@?WDLM+WHGG=RSN;W%LOGPA+6URM[@D<BA.Z3)!><?'9[-1(LO3L HW5$U^
MXUIVI:FBB%':#&CF5&_')G>K?O7;/<\+ENF0;13 [.M\1*DS!3A6+@A:&A3-
M(5AA3=1Q<B6B?84+%$XN<. X[F!33Y!5SMPEL9S.H'*X\1]5SX.Y)?/P&(_,
ME#YM?>V#]S7UPLY_NM VR?58^)Y'2?>\AG#J"TU;/QX&BR]6E4GZ%H=0?1 M
MAZVCRS;=BT5V8RJLF>.?]T4,RE1%S5C;Q"W1M_0'F[0D!*6IMZ)G0YLORO.B
M/V8H-DT-VJ7D9EQ4_K"WRMJC+L(AH<94TT'_@DA =XO($O^#T9:2TL=>'7*7
M*8! P7DQY3NHJIM1MLX.Y<G5.:>PQ:8Y57EV7@(F)I[^9[BL#LJ2D_NS>V"!
MW*4),YA?LEF]@2_(M\?2%@HB/+"SNN.1%?>3X6KR)176.C"B[*G5O)# ^Y4/
MQCJ57JG%VP2D  L[XK(P44\[.KTBHH]/CB=4=WWPN+QC7.M<G9Y[L)'DP/Y\
M=X8!I+>*UH$"I%V_P]O8##KN["4E$9:D1@2B,5M?O56U3_HM;FE1V-;6M%CU
M0)OP=>6+F*)YS!NK"^U?M8F]!ZYBE Z-"T4$QN]?=(.\ALKNU^$P[J\_\30I
M(5&_O!3J5?F9Y8+1J;7+]UV0JK(R1QBWC/ N9G6&N/571VL45W"V'Q0+S[PZ
M0Z[:,2MOE&-C&Z8OLWIBK;1\+[E@CF&0N35JQ7.U]#XM..:NS1BV+O&2T\"9
M5M2[%!*P1*XD1U&GW<#J+)@?Z9<E@K>3D56GV14*4-*S>D&+>O.F *VK0<'^
M%,")>J=NN,'V2$E&ALG6*N7:U3,I1Y:NG0U&JLZ/MM[/XM]Q];)V>MHA]J\=
MBY?]YO7+D.PW:Y">LZN[PZ4[-%X4N=6:6Z2<CL"-]T?F[HZ$OKSC')[BZ?Y9
M&WTZY*[U%Z3?T[38 X?FE8)#6@HG^YWMN(R^O%&XS2$,?+R787MUM:L_Q %J
M?ZP&G_]P82<R_5[#SC=<EX,]F !A[,ZO[[_XF9^\]>QU]$AV1_6M:JLJE<\?
M$"GA$3Y>TU)7IYH:9!]5.5Q24L\\U%@R4UO+]^@UZ6C.%Q'_-D1=<UH[#D,Z
MM77'21/ADS4M%_,^#N]?M%9UKSEF,V :<5/NP+)I_4BZT&>LL3#Y M&B;ZO)
M;K7[VD#-\A:2["]WW]M)3S6R<M2WN1["E[WM-#^N>'7\>'+XRWLR-U]OB3=2
M;)-UT1V'!:C?X>6W>620Z7*M]YQ#4T0<(LKM2W"1:7U L=W]4.!S7=,+\8N/
M1;5/[:FUT19+".Z92[3OZ.LLB,@+_^"]]T/\-;:(JKCW0'#J*1YXXR)BI58C
MH6@8ID',&<Y:BKG?A\%$A[$>>3<A.[MC6K^O<UOLY6I-/I^K$R-W[KBD02X2
MC"T!XH6C Q."BL1M)FY/BMNP?5?T/ [T(MN-=NV3"-_!OF""%'EH<C/X<\_\
M?/Q[-[>'[?Z^22TG7N2*+7BH99ISG*E3OQ_K>OGQ0U?7G;=NQLI6=D7PX.QB
M7B.3O->(QS3U.*HNN$I&>R864H!<\OR+M=7FP/F!)<>110H0T/N5ND8A'R3W
ML)/#2D&CK74LD8\IK$V#M^2<ITOV2\$AI^Q.D$,T@W+J9RC A8)E_ C(D794
MQ ^13V@ZW%405W-<*>YU2Y;P]0K;9N<I$IQU23HY]VXL6R;&>I6M4(4"T(\M
M>R8D(#X_?7+K\U-=&Y)S=EH3[++V8N35(UV=;9V&/FBBI*J11_9%F].+F[5%
M"[(N+V2LM$PO;/U:+-U7F$0XOO5S2LKH"EKD_NLP Q'^&%+OKEZ;3CYN[R.I
ML<JOQ$-=]Z>)<9SNPY_$W1<1+KB9!<\!GEHL7:  < OR$XOP1Y=04M%"/I?W
MQDSX5,H)]-315YYZQWY-> 0D,#^INV1$'YBU?3:XF.S]L0#'N_6IRDN4<.(S
MUPSQ5\Y*=H$U)T-5)?35FOE-A1TT3!@:C.3EN1BX9YF[+8YT=3C:ZP:@U4T\
MQ<_D),,>:!V_R#T7$NR2E_>V='1S5_O!:'NC.U>:0@]9/3NCJ#TTT1YY]9?M
MNT;1!W,''"X\GK;7<:@N40G[&FY%A].\4)CE6S9493*[_R;NR+D\@V&S#&&7
MT'U&+EIO_+SR_+S*/C_K[K1?.),HR?/_,?;>04UP7?=H%!1$D"*H(!"4(ET!
MZ272F_0. M([H4@O$5!4>I'>>^^0T(OT+KTE(+V#U  )X1>>]_N]]S[SS=RY
M?S 3YI ).6>?M=?:>^WDV;IQ<N7))570!K$T*NTS?,^177_#$S=4R:DA0OJR
M) +OF.XR:+H*Q-5*Y 'L'8ISORP?,,=F$1<*A=ZJ*=L=[MG^5['=2O*MUCNL
M;*Q5=9SOI$O)!J4%S6GEUDT G4 GO]J-1QK)ACWRR4AKRQN "[>>?/OCN_(:
M:U1YS^\6#^>:'-:++9S@L8]R;C-V): TJ$=L#45QVV-D,[U_OOJA+G'Z#O3K
M%K6N03,KJW"#2:V9UH25&\ 1Z$CR-NP>01;\/#&W\#8JKZ4EJ:%D**DA2F-!
M_7=J;&I<X?1,LT[SF+WVC'RBJY_A<<=+MIPBPE).8@"J6KAKF]U16YHND B?
MGBZ0&U\0+U(G0OYEC*!I5&EQ>["&!'X?75C@(W%J@8@R#5+T'*J-:'QV."+1
M7DRCMI!PMF??=X'JDJ&]%U<^LJQP89XL@;XI.K0TSHV,E^>[VGI!NCS#2S ,
M.9/$<>E.5.>P&NNM7S$%\OB((\\U'OZ:JH:&Z7-U#8\;O^1A_ T [[4D+%33
M[\@V?_V80-7&C!9'OHM,.?4^:U<4&Z2R"50E;"S,M+&7ME[/G^ZBPIF\=R[C
MW2%/'L9@:^_ QC^W4BAY)Y_ >B7 _FTFDN1@87J_U9!WX[!>T=G%%Q&JZLW\
M)V=,$R#R>><E M:RY-? G]*SS-'=8VU8_*19HIQ"MO\=D#,JE?@<9W<4#8ZT
M\*,XF[DXP0!5+F8F,WQV$1Z8MG%LKCBZ^ ^S,+JZ!BW> -8@*M[H*Z2A_VOG
MWDGLA>^Y/JQP.P 5 &,@G=@\=2L/AY74U!35[EDPG&AH:2A12/-*BY3=DQ:5
MXJR6%'DL-<C W?DR6$?]V9L_@:)SAJMNGTQIY.B")/#_B&-S5NC.UN'SW"I!
M/?) _+?8@\">QE\1N['-$HS9#8"=56B&=/H4=>G<UFF3'E'@-_8[\O1'0N^/
M!WEY%? I'LVWW.-TFA2:E1,Z X6$-7W=@_(J!TA1OF%P3?EN)EU6DNQ%9R3=
M.)G->R(%BF'AQ,EIQ5C$@;M?-DT1/X6,N*2 \8S)A[MK4?C/)HO+;=2[)F/D
MXX<L3N8(2GL\6**'+8X?BYQ=OB]S4):DUQ..,O(NGI^S*BQ*BIQ*ZP?-P)U%
M3A!*C-U#APQ[MD-=-5QG[+;RE^DYH:$IH0WI*P<>\>Z\5N[L7>A!,GGTE>,-
MP QR#CILJX!ZFY6W@7:-KV%7JUM^V,U<>8U9P##< "JO@-@;[VFP?0VJ&$?[
MO?Z/KBY +4UDC$XL8@\$2[HQG1EGI=@G?<J9%^[]M,?1'89(X7&R@/:L=VH2
ME%K:/=3AO>?'7KR86=T^6/X@=H)=J9@E.D2HFHR@Z2$*47[P<+]Q>[DYO+C\
M2S#>_NDQW9\P$O%MQZ7Z)0>=J*7]&1=)+\KB:BI2C)-O1R$]+JD1E!L;#2<;
M;8VM7!Z.EGE5%RI1-*\G%E;=M5YJB#/QBSD9Z+S2^[I8OV<>^H<$0IGW@_NM
MM_ZS5^9UV87ACSDN=1""7I&Q@C$>YJ')T/U6&^7[26^ENIFT!/(S<7](%'>I
MA^S<UW-I:Z@8^I RI&,EY3L,FQVF)W!OD)N+T3)>9@>XH9F"@EX;WXR1W0"6
MG*\AKZXWEWB$-GJ-T LI?N!>M,;BU>V^>+5=8%YCH^F?6L3W-A3.Z"2D:Q$)
MPZ;V\%<]H!^BT<=-]$U5?A[)<P(VYQ9/F)J841/TZ;V2:D\LO7=LM3+M:1?@
M8+:<57@? ZG-/7O=E#L53"ZTAZ,\QIVU'Q9DIG=*%WF$ JDKJ3[),JK8E+WK
M?12<FM;7U"8L7R]=]\% 9KKCH6?IKJ'%YXEL038EIKJ"!""]SPV </<8BX5'
MZ%.558RI8SNF^08P_.8*!82TWP!&C$]=%T";V(,_'_U]>&TBV(F), "CUS(P
M<U=?HS"J0&;K[61OO^'Q2QOR*.8J5(E'MP9C![_,@#VUQ;.[TT)Y1BK0O/.'
M:?02VSXP86_VF!D,[]W(S2F&\^>I6O(&B(;1S)C;%A< XT>>OGX!/A;.JCI,
MWA.#]HT[Y$7)+!3@:47"Z_'%'5B8)&KN:7VXD$JJ5VE34._ZS"E'VY[:N8_D
M=^E2<FUR> 3].-$EHT?B.Q<%_>Q;][7B7<3'<V2*ER53 X(O_XH.4A?V@\1W
MMH@1;WC*=<P4"]K[HU<W ,6,CR,!ACX9'6VHW9/#I3^[B$^0BJ=M6&;@]4^@
M>V^LHB&]1YC.73NLUM\:0>M>RK:V<IP3\6TO:)&M\?4HZRL8GE1O)@7SNYID
MQ>]I/=O*&5G-B5L,+B52[>LV^,"M^#RLX54:OY@"(N9J.%2OX:[UC_UH4-^N
MNAHZ@DBS.KJ X:1\O=\G&Z%?Y?, _['TA:&?;)1;OS8Z7)QWP:!,^+F-^T;/
M@F%X5;5=_#RJ@(96D5(=*I_3X&E;R/9'&U+7OVI''Y.>?U<^V#-)A7[1?0_5
M$GP-G3M F?]29)E0SP!)E(HDR;%V]@?06#V9:-0]-'#(WX6]9ZA.XF6Y >#3
M]_^<TO,LN2O2:(CBV>K]7^6>8E>,!4C [JJ'(#UHYWV3VN%>"X$8!J&[/3!E
MCZ:52*U]#GG*3:39E,&CR#K,*%'=0D1?%#&A7"T>N7CD$\<Y4C'01-03/B)]
M[:6)E KCHLI@H291U"[\.0%OSR4^V*P?M_\.KZN"VR!RC:>CJ'^%O2F6?4!M
MV:Q&)$WYL[QI+5[H![O2(!<_$Y+_U8D/JFOG+(0AQM9[M1T-,48N9?BCO&<,
M(WM!AQ]N )&;NQ#LB7E@S\[@>@,;T&W>NW[/%S,N&(\]&K=87 UTRMFXGMO6
MF<4GN!XJ%/L5?2\I2*P(*0$^D<LW?BW[DNR7K8+^]^]X4SYWQ=9O /:7HXFK
MBJ$T>3DU)FH,75)?:.^Y>0A=D:MS_4:9G/>F-@2_K:^=#].V9V5(O+"5C08@
M*T7$->FNIM.>*QBOK1_?EWOI/=*[O6.;H&X>2!U\4ASQTF \VWUNLD<R>[[T
M\_UZW,\/: H0J.0D\M9#6/ I$1?&'W_+&5@ITJ=*Z9%"$76$TTWG;\E;L7=I
ME=E;!8HS'AB.E.63?1@^ATA0)'=18A!^[JS 7=7^M:*$HK&JR3*[.#<[:"67
M5]GQ[@X_;;\'V-QKTR$\#Q:\>,P5\R*V,6/;0K<?Q##I*F[T V9LWC ##E^O
M,_#I/OW1YPW)BS:CN&0QVS8J@?%\'7(8*O-_Z&1:+2"RR)FOSYY._UI:(Z)_
MM7B9+SD>&ES-;&M33 \NE@OXBDE?\0FU"Y5?KVL,P%)A&1WUTEPO[F02V:S1
M"C7IX;KAG\?SB(5F':YD[C>L W[X="3^8YL38!0867'6MNA7-4'C#8= T1G8
MH\3F=O9&5"6_A_8A^Z/KV8;BTOM;"W%C,V;<;V,H6'<4AA6UGEXV-OOY/OH]
MV4%G7?!U[AF%J6BB@T_>>7^]_D&*1:>TST-;;> 0:7L1!6$!86X@LXJ,@?(^
MI.J ;R%_SFG,2&H*%\)KLE'ZIOU/D#)T^2+G6!*,SMQYKXWIEKW/[Z3^YM=A
M&HPZK!=\D&Q-'U/,+!)QTDK_,I8@A$6WRIH!OW>0.LNU-[KAUT2:^S-^.8!B
MG1!3&##PW;UWF""3J,NB+*$ ',%+MA0.P5XS&,*AW2!@CAURV "@^E:D82CG
M.QGYYAV/48_HPW^N5K;VF+KYUL[1'($UFS5;43%S2>%.MGQ1\39KMB>K3?&+
M*/)XRC_1T9.!E+J!['[C<N.Z:\&:1(\#\05Q227P3W"IW&2EXF@%R<D_BN-J
MDCB) [EZRV3\[="V%1?#"+VT&B4EU86'+G4RJ[NI/]/ER1S:- 2/ERV+S!\R
MJ3AH]I_7G)3E_!V2N)ST:5]R;A!35MH0#F50=V^P8VRBVN#VO^L[SS/ONYT7
MV274D7&[KKI!N9\MB2IW,?]\ WB7F@<)X?Z4.J,<_W9J3!)X:+P[>P,P$OW<
M"#@[1,[< 'P%_RF2XEP]A(2WK1EAT01:L:YXK"[6N->(B4!0K! 5S9_]/''X
M4<S$IA2RI^ IS<O!74)*1;3\[H><TB"OA>C+.SNFKXS-&CK<_5:,#%ICXOGW
M",U3.=K;@2>?U$052S\2G@FAZ(=7[1%YZRES-E;>4]]COZ82V-P 4HKO'EU,
M 7"K=LU!7C[3>O\6*#BU/D![MT?M"+_89KLGH6 ':E%M_8;R4%&#KKMCJ\R2
MU:5S[&7V/Y24*+#BP$O+L^4Z#FS0'=]19^R(^M+H0!=6=2864M=A:4HAFT(B
M<L6!0!J(QMJW(& /)/3%*2W%:O_D3"6.:7K%X.F#/5[9.HKM[>VOSC\O5Y\K
M6TI,H?N+9_.BYW=7]-C*F\FP<W!-YXI-5EX(^N?WQZXN7F=#SQ&;7(?"$4A?
M.V?G%Z8B/YTT@0SO"L7>Z93B;G"<[R8BTSJ]6D!E(E\FOFN1XP>M%=^-K&ZV
M^VV&93]&2XI 9$#_%01ZKC+VVA #*D#UMK@=<K9@^88OZ,D5:NE""&F <P-@
M.0SE@/ZE,&9 YK_M34&\C7L64953\NU]_7[YWN\-?CEYG0]NSR,T4=ZR5/B9
M$;+W<DH,+&2K4F/L]XU3^9\5N0K]A.%:F(&HV^PS"*C=[PN2X4QK^-#W!_<,
M7]8X!R?H$&C#2>-"C^0S!!\]O;J;.7;T:?&8K33@WSGEXG+UQ(#F"&(C"3W_
M^5-0>0,QJ=Z*Z-7$+<J?KT_@UFC].SR>IL@J*_3V$WFUGFTQ:5*0)&'(F$K#
MXJIDO_O=D?:<$XI?&43*4HK1*_4G?;FV3D-$ML6=A9WP"J?,M<%[T!I6%'K'
M]ZT@:04Q16^F@#3HN4Z_09FA!],&7'@0%(\0KN"-@1N$"NHQNAOP)I8F-S%&
M%<>T#VMHJ(ZR1153B/-)J1;?_7R?8M'(T/&IAM'2!Q&8"S3?@S'IQPD#9C1J
M>9K2:,G(D5]CR1C>/!-3Q8[EUO[F5TXXG^\& 1XE5F WW3@"M&!P#;&YDI]I
MS<$2C4JF\QN S^IM,?0&T!)YUH -QVE;;_WD@>\VS'_2RXOSK?_DY^>'R.^\
M2M=^0/ZF@\3&(EZ6CK60(8;] =)<QT-W57VDY_,==94H(+=O8Z,L0WFT5-AX
M%0#P@"&#[KX\B#-L8^I"[;C)2T-:[\M61+N"S1A#H/T!"U^,$GE8*TNV<'D.
MH1$+3F Y9VF!*J/7.4_U^6ZZ!SF9@4OW8E![XX76)2;K/375WWP9(<HY'^=1
M_J-2*+K.A?SO$2#T)+?TV]X9Y7)Z0MW28-!&NABI&DA>N^]KEWO6(L(F-I7G
MKJ--5=- >8YL+J+6YGY[NO30^GDH7"Y!PV5!O2W8SAU49?DJY^EY+%R@W7)]
MNF# SA7]I0OCAT=Y&&S,>@YWE8_=XAR*$5"LK38Y'[9<T]3DVG59<'/)S/XA
M/LD))01;F!(XMK1L^HC*.&JWT#F/4<9^R]C>N0'PLOI&2GL8(4ZZ8VJ4!OFE
M9?^^"MW&H%[O8H!TWJ\I[?F,<0SY> 1#^TVJ/VTJR0AS2&I$E ?\H'\_61?5
M+2)%:D=Q%6G"LK]9%_>G(6 U"<N#2L5^6\MN_E9?F5X9T0X^F)<KH-::+"'N
M_RS*#X'> &A5KN# L^NZ<?_@UJ2+0WC:=2*&>*H)R%$_S1+#'FS?Q<PW#=1*
MA!H[32<Z:RI7I=D]B)J4NW/4LQEIRFFT+O9Q(R42QWS!/#XX#$N\;3#IDM+/
MAMD*([\\_IV0X"6;Z)4/P;-<2->\'_YB_P=D0G ?;^1SO)B"=ROH!W"0_N'8
M0JSC^3=3<'/Y\MX'(BFM"[CV<'F_ Z+@6\FXI+B.,67NR$&CUYT)!I?K..JC
M&DG1MV-5>*^\'L^%^ALTU2S"_,8V$"L."I4ULF1 B5DOV6@\">Z8TK""TJ0U
ML-6^E^7!@B<<QL*$6.TCY9$ERY"0IA7?>:[PAH&;M&?F>L1/2?3_(NGOUTN&
MZ]5B(FZMKM6P*<400ML\OM>/%<8@Y/"D@:^N$>TK9O$#9W$17VJ 4B3T0^=2
M9GNBP]3#T./T4=?F _"5_%>U([DU]VST,+<G\[T(/"F1_B%A#[9]?H.>C<T.
M\7?9R;EF?[.#NA,Q[[3" :_*E,2DT#_V@#&(((-6Y+JUW.]!>2ATF+H:^MC&
MY'V^G+-NH=%\GAW;Y&3]B9;2K@_@>R+;</-"DVO$/M-VH_P[+NJ/YU+I"CD8
M$;CNVN6=(/3<<$J!@&.,HT'L.)<:^;MSJ8Q?K;E_FJ)U! 4(,N]=0<H@R+:S
MUOCSIUL<,\;**D#CBR74(P%D:\N,Q^;U65O%Q6S0/W5&8V3&16BD]PT SVC[
M!D!1QR_CSI3P 'HR]UWC;#BDTYR;E&,N88J11J18U%9V9@?_:FF^GAWL&&!G
M)VBNME$\C %X&SA #W3LRJ=_V6A,D2;Z_R;.4*MN@H@&?0KE_S*XC-C/%BGG
MKJ'==RZT4:@WM6P\%K@! #^E3^],!2(,FAVV!C1O &^$\H;C]M.C/6S8I?Y.
MA[4=_1&R05_[MV7TH6<A7UNJQHV:08O$*.("%'C[T-"GPAA#=PU:!,W<IFGC
M24A+QD7D;;6^%.?/X?!^_U'HIXG]LF$-PY1MI<XH\7JG]Q.:PW6VMN::L>X.
MW_UD6),A4WIR0=*^+Z=/\-,L5!S\^IK7!M=JFMUC$RS D^]C24%;59$O!1K#
M!(!==\@*H)A5A(O?BNZ2L/Q@3)OW6N*/&X!4&(1?_"@"1XNMMH>8_P=\UEY[
MN7W-AOM"9$,HDN/[@-FF?@AU!,\+%1HM"C<:*:OWM6=O3]A*B O%3DSG5Q:/
M%Q\VZ6DKVJAR5R<':U-HXPV1V(HMUO ]_.Z8%;PQK^7C1?Z?%5Q:7!);8N7%
MI>U_NV\=!U:JDN"6D@^3>\<MN"CU%5+=-9Y&YP>7!]&+ZSWLT)+74Q22OZ?$
M\9X[[I/%BP ZE*VG24.P@5UBO!R#>FGI'6UU9JV #MR/08%"MM:FZ2P?TWD]
M:12J*PL_.HG?SPP4B*CSPYBT/3*[F&LM\HCH*T@\>VIBSJ;\)'4G 956_RT&
M6F$M+]@D)ECDIA+F]2"N:"6&B7-RG[W>X* -UAD+>POGFP+5<\YN4?M2BM&3
MBMF][U%6"%:7EQC^)K;K0G <OTJ[#BU 93>ZYD):<P>?M8U':T<T9'ZTRWW\
M(2/C'.\JU$\L8P(N/RD[@]WL#ZYF&"0&=MMG.;Q>O49>_%,9;WY] Z#')JK%
M*Z2A,^;IYF[OQ6UY!X4T0GE_ZOQX(ASY2O;+PJQOO@=/5$*'^/=?JSO524)S
MW]GI<GM_=ZMI:;'@G&;'.CKL[_KXA#;D0&L#UNM=I375AU0R51^ HD1!#G:N
M/D(&>@LB,*+/W_,2+Y<UR2 OQA;F0(-FZ^?GN8'-;C$.0E1QDN1-"TXF[M?J
MWR9<Q4AW=O@I*,/U]QASPNOI[DJW]*' ->CK^IZ8\)3V[W]YA&1<=^*XB8?Q
M,M3%$'LW -$#YFJ^2>A1^GT;"I6-S)K(-$V_M-<N2P.0=:A0^([UT;5?>II*
M ?#'8I6D'D=T9-9)(II/Y$-YAN;N(''WG@VHJAE):+$:/*T#_&H)R*ALS,9,
MGZ+$4Q=[79O5$E1RXKXMZ\F]NMZG@-@1_SU]!YO^M>AGT7!LP /9+X5.()Y]
MDZKXM<$2SJ&IR$Q\3XII@ZJ1M;#/T^IK^H.<%]%)<F(KB%$[N+O=''1_>OA/
M2QB2/@0832M%&M4>)2.>[QT*4RIQF0,S+< ,^ ./!$H(-P/P@EB.Z:)\?] P
M0#IW1U' BK,K)[_,K38LU/1>+1W37_NA*MQFGK:A55;0P(J)6SYQ!.Y%RZ)6
M(?X51KM+QSPW %+,&3;6\_)[=\-O ',-7]K=-H;A33-<%AZ]^ZF\_D;>GL9:
M!24H 0L%(;6L'_&FT64-?'ASP0NU!RE#-P#%VOV)#W (H?6([-!O*N*DS%6-
ML?29&L>FR7_63CZH;-"K3U:DD##G4.L'Y31 V^)@0X1H4LT9!Z*JVGCS1U4'
M#KM!/%\L"%OU'5KX_L3C6<"R?C6F4[/<'U=*J/:] 7PJ'G?XVZ%F/)G$AJ+G
M)CVG(FT/F RWVH.)(EXV3T//SXYCM"KV(KL*9E46E*L.0>L^QYO6IL4NM0LJ
M8#!S$9UW<HA22L,V-Z4:N<E<-Q\/VQ,J&*,JA4!PW*ND@[OT7+#& ]I!U_4O
MQ$*ZTD[%K%+<]VU]XVIY@#&!RLS$^G#1A,V49[2>^Q_KQUFU65B78NJ59-?J
M7O4]GO*;&IM:W=FQ9MNVRBK/*DR/@894/V IWMK9MK"VM;&UR===+R@LB",0
MXOXF@TN"3P_7W&;@/%((JRZB"\2_K18+XE(%XO>J:4;+$\9(O[6/I2<9: _,
MI2(1[Z,[HA9?G<3JW@J<(TS;1"A&=*;8[7 ;LW -F]@^O;HUCRR)8X 9PP=B
M!=N7V$3S^^OT O+%3$/8N4*@GC9'YPPBMM)%<V=_M:07C A/GZ\@W"D5^:&B
M]3,D3WS9,N#YT=Z,-8)QWI'3\D<51UX7H:BVIQ'[U6?=-Y>%8H;4]DVY*4K=
M\*JJ![QIV#6IW\T?@5&6VBA-VK:;<3+LQ=<U1JOP;R[Q.-_:K$ZI;P#=_CDG
MF%O(.*L'I7-@CFX SV_3A0YPUQC#<B%RZP+:!\4@GS>UMA4@74TA*I=S!RK;
MUWYK'HBEZ]&-R,L<8K2W<C7/P25F_40%/1&$YCZ#&!W'EJ;\ \#A6HI*QHIJ
MTGHJ]PP9/SQ6GQK7ZJ21YE#BE7*@D.95$LG*3G^P[%(>1E"=0B+;*,3P_:@O
M( <K=N_B"] %=0&Y+FF+!ZK9Z N9I;&;3DL7^<9[)O0RS)>@Q^T]A>'V^$6L
M],S)5/%A69)4Q&D3:W5CULO\D3]13VS]RJ)*4Z4Y7C^(2/LMB5%>$;)71H+G
M+]SIT,.#\5?N,4ME),L/S-YM;S]^+-%,;_KVG(J)'56U__.YB(OKZ]?B!8X5
MNQ(YI&3.+XF9^]]:/).0B2(98UFZ1FX@0<9Y^P=W=@"[39#6AEL8W>W= 0%<
M,4<8V&T?$HSLC*S8@,^BEHQVEFX /P_[Y<_!)E-H?WC#_><:57E% _;+PLRA
M%&U%+#BC,M6":D1B6UV_?TY M!S>$H066S'YGO.D+#DBUM8-^B%=G#MC.H'*
M]^1H Z7(;P#*Q8 2VH)1L\N&4IB@H/:QQJF'5#,OFN>.MG%4M,[>=.8='5%[
MPT..QH'6?V5!0*N21_#KU39%L-'O/@*O76=RD!64R^W1NV%'>-XV'^9ML4!<
M47+#ERDA47E9PA&\G%GCU(;X1^KKB$&?GSCL=G*3&$$#THHYHXU\B?MBAO<;
MFA(SUXV,X1Y%GSG(U,@Q@L_Q6VO992JD<?_2V$S4(Y^ /39/# I<UHIKGG]S
MMF"K$2S-LT_7+PU6H5=C-#3\< PLC1EE87B$]_LA0/3D_.!@Y6IGY?S8,F9'
MAW,/KI<X]0.E[-WNLS!8UG.P<75NQ@@?T9M-C3=3AV00<^+0<$.,B$]AJ\>@
MIW^6YOUCSI:P<5UV!MJ-1.;<EMS;EAX>]4YL.XIB$=2[;=#@3_E#CB]=OF$'
M(@R4/_N:IMS\AP;'\Y3?JOW:8$:VN@(UP^+&)T>?4W\@J_CZ0DW'ZK7RF'E;
MS>*< 1:%AN&=]@S$*=8?M*R)1*PTCLC$_W:0%^QX/)%H>+U/#)T>=0 /IUS7
M1R\U+C)1J+9J"$7'>/;@9^J+R1ORUQPR7?4_^J^7K@&4:-5EV+)$8YB^A/(@
M55*$TT"^E@RMN'RJ_+[KH?WP,8ZV^7F\4K;!&JT"<UI5Z7(Z5655"8.KHF<D
M(D*B;L,O?M.MYC,19II[IUUU(.2!=7+&$U:S<LF/)*4(:?]M%XZ*M_8PX:^E
M /!T57SX-TH*ES'^,NE/.LO>JI^'#0U45K'JM JXB_H545E37@%&9E2@#K-N
MF2[D2.0(@H3?.G9T=8ZG#ANN[-:4'SNNV2;Q@<%*DE6NE2)?Q)52BHK9:GB$
MQ/&9<H8UKW.$28H4C7EHW]66[2'?PCA/'.IR*Y3:G-AP(NG6,*'762,QRG>;
M:/,@5I>I>R(S]\)&E5HQ497'9#JG*==;6Z<Y,9Z/H#G(E#3+;_\="-%L-?&U
M^87.W$:G#Z=.K"*#Z4;3=O=.^\'+/O$$'EHYQ3\YJX)'>L2FR^<#Z=F7#?^$
M^>"<W "8%D[R.\06YW6<(BIP,CKIJ!]@\"Z,PUFIOA1N48Y^R'$8,2!$??K"
MN./QZP;00?>LXO2#>UO?#B5.F0R,<V'$_KHC>7XAA5+K&US8XY7>MZ&5W1QK
MVT)N@:MO!25Y:<1C*_'<G +TT1U/VW<'%5,>EH0^[Z,2KD\M*?E8@B-!/.O=
M8;# EM9XO/'K_$G$P5/F'1E)',D;P),WTL2/DD#3L+4;0,OB4F1%[=3EIX3R
MMD*&A2OXT<4_N"'*JZ1$\9[B4^RHHHZ\"*]FG>9X_STL-HH$ZK*R;/Z(L;8,
MUB*\;=#7UP4@S3W"8^3@I2&V^!VX3G27I%U SO(8>?(?_^DG/\ EC1*GQ*7%
M"W<1FM_]8S5( (HUU,"EG&_T;#(VF5 S]5@4VR9/<B,P[3D4$@ 7%?&,M?NO
ML19/S/Q090[[92!P7;&9>#EH)MW@Q#^H2F82TA8SA)<ST?C9QD\B0&&&OP6Z
MZ=G0:RXI'-!B *BIJ/@[@/>W[YY*3&O>GSNO8/"4R?#_VJ+LK- C8L;2"RE=
MG[X9K]]3^7"&T5N')^FS#*H?TAS*,.;%F<3S<4W]<6\M"+X+B,@NRTN9H=(8
M/"01W=A<7T+B#/J\GYKGH+X(:V9*_/C[,E=/Z]B*_5?FBUVRZ]7-CA9CB+9[
M0TG=@JC%1V?V3O(> MEV+Y[)\9"R*14_4"^&^77OS-$!X0[A;L7Y;<,^X)KS
M?ZR^M[9@#!NF[12HXKV+H!D- CT^-F865L=WF:Q3/3,:*LP><'^D13BYJX<C
M-ZZZ+T10>%J]AL1Y-S 41IL>;?Z3Y->;8Q T-91?"&Q=DT,4 0].JV85R=;H
MU?R9SUU,6:):%^-7N^;EU>MU?QU_CN.[34IPA5S F;=Y6+'F)%G= C%-1&;G
MZI:S0+&0O3\/I;Q29*_95F9$>D1@8 AN?FY.;L%7;6:6HJ(532E5"DV 0"4R
M]6\G.:DT+E>Q1 B%)@$@$P#  6!_/B]/.\A2._5$2P28J@( JH W -IWA "1
M>C?AA1;!_Y[#?9K!^05PKG>OYWG\7LRL7\[WY.;QTFRJL'(9&05[F4?A"$-M
M&&]<.I7NCWM:Z_=*LR*KC4R6. 3!EG#^IE7,:S!ML1,[G!3O-.V[V@FO  TY
MN&DXX[7#4]0P2GU^D;O+B=V3E>"RB21G0U;?^;S-ZF!Q?4]T8LYGOG[&D6,N
M-N&%MKBKBJ1RUL=>4ZZ^O>%'/,21(:SZYI.?.LD"Y1M$T$O\*0<F"# L;4!)
MQ[4U9POOGM:JM/0=32]FBMT[L/T=5**''6+5.59K<D2E7_:>]*FF/O,E0>KD
M*>TU!#3=&X3IW=XKR8YHA%UM8MCL:/W;5&XKP-=MP.7NALI_S!G/_<5.^<XN
MG\\E&M7.D61K:2_">).*9'P=9Q<F8R0:V#%R.2^L;;0M=)<):;.SY584>8+V
M9 >:JQI<W4\<:AR*<<,37/_V/J/7@/5ASZ.&).=5UBM6E];5X86NYS*+S,J&
M??OA=ZA2_Y:Q!:CJ?7]6YCT/7DWH>I1T,?HU)\C28?Y]^A%Y-ON,Z<8V73&B
MP?;'RS&=\SH7+U#316.$III:XO+OI_WK?NI\#BZ1=,>'KPQDFORR6Y?S(YW^
M4.JF\CZH""ZX( OMU,X_$,P;2 VO=/E:+0N=9S/:SAGY0_EA0G0I0.4OQ]/)
MQ^I*_%45DK3_-]%LB>YQ%NT:+70J?MY+BX8B\UG&HE^,K&R7,.5R%B"/XM:E
M_5G+)--X-!0)^WU*B"NJRQ9,YY +KG;-#I7P=[)XJG*7);X*_K;BIZ)/''W$
MIEH,ZO+W8=W.CKYIDAH;#P8R)'))UZ?\[9?6A8]Z'0[W6O=&M!S#UZ'F?2'#
M=3,-"C7R7WZU=Q@65C=0L>CP-BP7%+<%]7,(7;#'W<VK4QC31NQ9,>L[PI[.
M<"LY6QI5M?=\#QJ;)3D&V.7GR:0*N*J;$;7-<:I6PS=;4Y6<;;%_L']E+?HL
M8IO9TY;.IO,;+], %(-H=Q"1?K(T?_%>&]&^^I+$K'*6W8WI]5/QNR<KN9E9
M(0369$@^S:?\((T#T]K:NBI8R/C O(!##KFF-$&QF$+FG4LW#@,# [U.FKK<
M!Q35!*S97[5H Z0!P(__=COI(L89K*+C2"G2$+.L+YG9#PZZ<*7NKJ4#D!^8
M&9+O8"K.(&*U<H 8Y^F"&X 81EW;-_I Z.)-735,Y^Q,6?).E?6XA,VQ8TRI
M8-HR:XE-O%^WQGM"W,_J@0)/.M!?*^T0M.[^3AL/GBQJH.*GDN@ RS6R"1OF
M]+"QNP0XQ?4J!Y%"\L,IZ*@%!8BK/@^#1+UKQWHOC;G[%3;)B9*"L5S='@3<
M$^U)DQ%UN[SR@Y2U=68,C]Z2>23:[GKK^A]OYI='9;M$F_"4$[!;3T=WJYGK
M@<(H-*> :"4_/YAY/KN),:9HO%\ZM&=<YF1207R,ZOG=>7'>.3Z'WD0/8:4<
MN\_]/CRJCP!>\69KQ:RZEP#_D7"H4JSS!LW(C/7\\M%K1EMB1H!%4F1,8;^@
MV+LGF<*"OHX8P^O'8P+V#HX^CJ9-H&HI4L6?B"88\)$.4#:*(.)HW[#%J,;L
MS61M3='?R;?@*$=%Y3OX#0G]F(GC7O:%#D9$JD=3]QT;"]6!Y_>C9:8T 7]M
MGXHY2)!;\C.C# 8_5.%R*UHG^-3C:(X7?GR.>1)<_)GJ]^\6@:HM-!86<YVE
MJ:0)Y:JZR6W)!%;%\^C#G_1]_X[%3H"3Z  !.;,6@)E:I.AX1P' #""X,\E>
M3D^1EEG8;<7EB>[A+"-T\X274?#)!.;SG"F$*-1OY"<1GUK0(UX%/BQ,?YBH
M+J>K6@(8\/\MCG>R$]-)?E2K(55!NO+L+O$\D?A.H9C1#8#=OVUIEKT'N47-
M!#(YYR7GI<2;NVCG0K%Y6C/I6=MPY4\*ZW"Q?RSCRB-1%9YC#.=-_A(DB)H+
M+_E45P]OT)YS\'"[UTRQ'PS6>OBW:\WDTW98\GTU]16*S0HK:-K\O ]&'ZIH
MN"PN1G7>_?KT$YJK"LUHG;O\E4BF(6Z2-[%Q?LA=)B;[&WU$<1%6VI8&*^@W
MLN[H)1,4*S1ZQ3$%YJ=[SM$\8V,+)*9?9%"DCNK[._R<84#.@N[6\!04)=Z!
M1T]?JA#/\C%>ERFLM*];3RZ+D B?[B]V7828-OL:LMA+[2]XOG3A#2YO*Y@Y
MN@8!=Y=N*TLW@-9;&SZRO&5J'<+2]K/N@8'&4:3WVJ*^?N+N29J2A@X/C_KD
MNQIS?J:A[] 2C<GVZK6BI^-5S6X2:_UD8?'GK]/@"NBD^B$%DE%;^3_2^G+?
M^D+Z@C[GA.T S NJJ7>&C&-AE"7!/J8J^>9?_+6B_831M1$5D8O*9S%^_\L6
M3PY*0T B]U1^M$Q%5A2$R$,71_O!:$/)K]QCYN[42HUB*TGP(,(Z<H&Y[<2B
MAN"LB33M\[M(8;M0]S4CTQ#I>UDPF\G+DG<B"I$2$M490ERT?G>N^Q9>( 3I
M$U>2[G 9O!WP[900>2>;)Q'E)TY?)MFV"IFY!GM23..[[?J!EOQ!H!6.6S@F
M1L)O +!_QD=*;@"5-P#B4?H=R((/LL)H:\)7[:*H!:,%7H9"L306=[X>#"U9
M1$WG9QPPGQ_P>=&8A"0G#N(=B1S(=FW+*]"XD8SL1=/74QWSTQ]\.&STHRCZ
MNV>6E:S.2J_1?B=<>5)(DU2?3*&0@>@2&(VD=8>W)L\U<[2R4N:]S+KS!]!3
M8$O#MA[CG X-W0*'BTH?M3ERXI6ZMX@2?3@]$D]!:.U2..[#(RD?60YMS).G
MZ[Y'NN5_D91]\*J;X,1W<MU?>590YK?^WK2X.1U>7*%%3+KCZ?VX/]G?6Q6$
MAEH-UD5#?^YUYP^;DT3A]+DR?)M:C!/L4Y,V_H4G>5BE(F'T3S=0 >.2!@Y+
ML'9[[3BAIM&9D V?0GC%];_LB>,]I2Q5\E_M&-=,DY#/[E&"[28#Y?%MT]=L
M :N1BX^MOLSN&5SUX.YRP2S)2]C8Y#Y?1N4QT$^HG=&8C;8M:+Z&[J7,]]P;
M4/[(L:$UEJOJ]REQ/CTYLD*3^ P=C:6#X%U_OY4EW9:9UHS#MNFKD]Z9Q4:D
MH?%5.C$UAIAI:2+R'[\A5AX=MO4NMAKZE#!?L/T%LASK9_D00U2B%EIX0OM:
M7K;0H>RGK_O48EB/ZBG7PV,BB21Y<\KZ;'SJ;3U?<P\RBG3L9]3-4*]TNB$H
ML]9G%^.>><TZ:XK)/:)5T<_VL&5YXV.W_Z49+G/8Q"-=2?_[SK?4"@J-"U5J
MX;#IPI;VZKW8F1:K2N\2AW$'SOIY7=$L&,N]U5X3Z_$TJ_@.)2T_-1LV;K>3
M>[0*R4E,Z0:&B1E> ;5["T;=UO'/I;^XGX=>J*H73*:S]PXGQHN9G\4O6$Y!
M]\ZC9_>UU3JLFRD ./MBYAE\#+%=R:?-YU9CD;?79;H2-.Q:P=7T:IU^D^OM
MF+KXG##]O>9CTO8?Y,:]XVT\T.IJ=F;90ZW>SX'Y.JPB-9,\SZO,#A]>'\U_
M7/":A2]D/O2RCZEC4?).Y^LM^MOY>$,W-?D,J^?VU71=0Q =S[2:H/+/-^DL
MP\/%3$ABW\?N&I5(8G@O0,MV$"CRT76+9(L;!G2$"ZG:/!J]G1L '95[W0#
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MY-1=>;7?6:AP&1C^2!G'SRBNJCM;72)G3WQW\RK#,POY%0!.;?7%1+?M+-\
MK"[/0B&>)"#OX^U\_W25BXN=E'N7+;?((7Y(>]4[TM)[88QYN7E].TG5B/;C
M!&-0U]]HL2P;B7=M@N$#[1]>W@;8S239#0"K]YK_"F+:5L&^P[LIHCYH\/6]
MR#:-,K=#9.>66 (,#WW;'IX!3B_]4;E8G&ZIOYT=;%)9:P8W-1W> (B&O_NW
MG;G ,P[;"IHC4,V0!C0V8;TUN0%$RD_+^"V!X.76-X!D)TBP4<7NHKI;[+]K
M4.7\)U]GV0(/B8+:MK?#R*\#JH! '<X469V4.4'^_.)$^8]4FK\VG0L[4:PA
M$+&CYTO7%=M>"78(+>L$[4;Y,T_]+]A_7\0TX\7N-+//)?2A_\=Y#VGRIWS=
MQ,-9CB#')'+?0J'")@CV3;9B8)MPHDGBF5(L-)#V7F! ,[>R;NO6Q$K<AX[<
MO576S8)K-P H)O4&H'9HZ%.6 OH)O8YU\S4IG*_3(N;0,0 /=P3DAT@6K?RR
MS,E!:#+*6X(?KKE2%.:$>I8*T)ZPS:;]7CPVFVV:VCM( V""QM5N %0>.'N[
M7"W1\&$D8RB_J='XAMP)FD->Y[BD$F@AX&9MM)&>_]^6Q*[R4E+361/;.M#]
M($-84_T&X%_MXT/)D4B_P@>.M%[)^ZJ+0ZWQ>YE,%9_0+>:=J6PK!/6MT?]B
MT\B\A;A(K"A'8R=:G9%^/.L.^B2]D@>N-'2 WAW2T?\A[C)6<:5K0U+0MS5U
M.1WW*KO7E!AX5.)S__3A;JOL3,8V^"^F>>'V9/X SX%'H C!3>POVKSH$NB0
MUV'"@A4]@ZEXS7GP.;RH0H-5GI-NWW-MG'1&G6^],7Z<?#:H$&#19E[:/0/2
M&Y#V3U^T 7&G Z_-L=M8H+Y9[6[C.JI]PCVSO9\7Y9>+W[;[ LL9>PWD4</^
M-:__E:%SIK0TQL1%#3_\G5 ?[^#54E)Z7W1/5%0$WSS=:S.JU*F3\&,-SW/
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M1Q#P"( J4#I#M"U!RC# F<4KI()#2@T,]/$@]<G 7*)M2V>C!Y,$M=%S8HF
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M];"72_IDY>?7/XE?7K5\^*-5;19R%O)+D&$4F48T#-UX%(46H6L!1> 7'FR
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MW!./QKCC0VH\*]S0+C=SHV+-5F'BQ@<W[#EY3G %ZX'WP@210VH\OD!W[YU
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MF@()FI5;8 .7OVCL0_DA"P]0'/1HJ0OT7:A%P"EHD'&;WYE@C66AH:46RJ]
MC%_GN7F<ZT[E9[Q0P"H6:A7-YN\=?Z >X<@@SH6P<>A'-S6P8RVMGN.QJ32&
MN=?69IW,IY*!:/$!^3+=/QA&R@-5Q8TL6)5%6@IG\^&QM)38 /2[1Q(Y3I6Q
M1_],/H+XKSK<*/1ZP0QUS]PPLK.&Z3A2(SZ_,R=(,4(RF-:698+(,&3ZWN%J
M<E(9VYP_O]>AST6*RTOF3J+NT88]XG^T[]1(WY+6DYR9TSPVNU/WVJ$/Z->$
M,5/U]U7  C?@Z*N %'^;\:;;F(6'6M_>]IY E<K =;+EPP;4!V,]74;ZS'\>
MVV#(=GD 6Y&Z1#Q*P_Q,6FW_C8#?/1A7\'BOK)"=EK!9S+#O%J8]+M[,]$OQ
ML.W>O+:#KB[];I_\9_1"7R8-,]M34]J#"W::Q+E''S?X9!"4Y;7R6^5Z1'3,
M^;!O^N85WW[<J/NQM)]N7WSV7:02YYH:R_5>J>2CXK<3&I)UKUBB_[-;Z_8:
MJON(&]$NI6J.ERO%[Y?/B7XZGI=8<[GK;;+_Q.)H:>6B9'"]\>'<]CW*!A2I
M;0_VV#Z]Q*[SL-N(]ZZBJ!GOB=QRD'15>E-!T_O:^/6FP4^G"_P)JIU17E7#
MF*#XR+:-Q@&X9[EC'02C=;(]13J:X_ZT?NZ\R6"-1LY-M-W]X"]!9B^'"BP9
MZ]^Y"5^]_GG)(6X7YY)[)UVY*2^7YI]Q9#?<?T,'CFU*JG-TF$MQ_#5?IG+M
M1']Z=NJ^JS_#\[,>Y7V0N DH+VA>(M<[$._;.?[V^#E2BJ-_V;C+6D)XJ%9(
M5^1/T*%I31RVA>L%K54>3(?O8]DM[*9*#JJKCN6[4*S&M.,\7Z7U!UR.;B*P
M \/NT.\L%"A7U@^W];U:8OXX\6H&['&Q[+J67Z-W\0($;N%?6@UO:6:6GH-+
M:<=/U5L,YB3='R[:2PRHO"??<[#@V<5#D)]SB=DD7:&WM..;>XQ#.]5:SL/L
M:!]P+Y'=.W^QZK9EC.CQG;+LPZ?/:=[@7#AUY;$4(]'>1?&_[Q1[3<<?&#SD
MUP4>, 'AR[1F #VW><&/DWNC"S*A1.KRRA:&&&CAZ0JY#X@9RUY_CN<B<5P&
MC?%4XJ:7/5 B3N0$\%M!1?"3S%C<@'$N<I6Z%OYN1;)'F6I\3YL*'#?\&#7I
M(Q.;H6UF0]ETO._E1K?$<J]>98@Y6N\PKT'1$Q ]PYUSQNNZ9$[#4HZ?8R8W
MN['7(1("WX=$G:@E'Y,]VGQ%Q_6&/@>&PO?_K*<J%7[_WVNV_W'A\U40.\J$
M?"=3@,5>2W&K#\6.@BQ&U5I$9YQ+B3;!HO]*[39@$;G *K]%W6NOQHW"RRGC
MHX\MA# 5A_.<=N^->W#UA*),X/M66(BAJCC*:4%7R@=S0M2;_5V$58D=G;XU
MSQ1(JW+(1HV70@:^>CB,J*O1]:\MX)XIQL@HZOFYR< TD&6&1_MA]X?[VK!_
M@J2FRH3DJ(<@_B&,9'WF[O*!<PKP\_XAXD2:6_5O+(H.65:X8_ <.5T["$E7
M97F#6CQ8+7N-50CR8$5_8=LO6$*$%E#'3SZ!#*<\G"V?G@ Y4<@=UB>% M#
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MCX/+0V&_K/7_)N?UM6B\ORT%::-'3:@]SCR(9&LZ#3@,&0C+]G@>Y>F\\VI
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M5N!S'UEPU]+64LA6I$);#C@M@#.O;>RG-A7(6E!K"$A9$EES'Z]!GG,:[,I
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M, U&P9/._*E 7*!YA*-PQ\-1=WY;;6Z3@=A&N!43_[*H5@,=!8YFR>>::<S
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MJU_%,O/A=/[,?(QVJOFW1N]!2F< 6+_!O?SKSC>A?.P2GQEX\V)FV'Y@Q@V
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MI+?22 6AEF'ZDA]\^[3=Y5QRWYMD76,&"24KNJOB##T<S4148%L$E1U/"F6
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M_F/.G@&ZRDL%YA]A:3-8YM= S>'IOVJQU*\<?S95G#V92I& CC<R$8*C'F6
M-D:_&D%G?L% H 'K275>D:!W[@80LV&08>R:.C9#G1\8)EX.<:1ID?6'R+$S
M-)E7F3*OI_NLC\GM9OKN?B&Y(%*-%Y#@?OB',52!@$SW;M&TVT8!PG!J(W2[
MMQ;(ADK#\FIN%(#_9:Q?3 K]Q  YV-^&KZ"!C\",^GX&*#J# >I5' TK7*1
MUE*I#C*5%&N>4'58CX=O2%S0$.W1(G;(\ ,Y*ER&*)34K"HSE".N:__RJL$3
MU3DZ,IACIW4QU/K:D*% $O@ ;'#*,')N<_D5Q1A.<N^?DS0I+6> Q#YWSJ5_
M,XG"U(EZK^I?I)_2O%%/-.@;IW.I,@&%J9OC9V7+A0E9O,L*!2TV*JV8W_+P
M[C6'Z,U3>EPHO+YE*+FE9",LRV7,W<133#7&A;=U\P>>#U6)<M:\X35-]L_
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M.51A_<LN]OB'PL;3U_KBPI2%4 117C"SS^$D"F13)J^7/@-AX?H0%J[/MF6
MV!B@WUUQGS7@B1LE#%"RTR!RX4]TN/4W=,B<)7;>T]BE,[1(LCD13V5?!GZP
M^AW[W]A!)YW.8A!=J&'H7P S>(C^S_\%RACY_P!02P,$%     @ 08I+4E\&
M7$-*<0$ "T," !0   !D>&-M+3(P,C Q,C,Q7V<R+FIP9^R[!U137[LF?I J
M'021&@04$!#IG8A(%Q"47J(B(""]UR J(%6I2N\=([WW#M*D2>BA]P0$ @G)
MG]]W9^:NVV;-_->:N=_,?#MY3O8Z9;_OL_?9SWG?O4[PO_'+ *VFJH8J0$!
M +RX^@#X%<!4Q<?.!@"TM8%[  "0 <2$! #Q58W@"IJ$A'_[_0N 'NT_U?_:
MZ-$!1/^TGXE.C_Z?ZW^=!Q"$9@% 12Q^#E &KA$0_/7]+X60F/"O0D)$1$A,
M2D)*^A?(KE-<)R,C)R,E):<B)Z>@O"JDUZEIJ"BI_ZK_U<A?E_]UU=67DHR4
MC/)_NN#; 3HR0DO2MX0$7, U.@)".@)\-P"Z\I28X&\%^"^%X!HA$3')E4OD
M%%<GU-!>N4](>.W*66*B*XH$@5?' 2(Z8OK;(DHD-_1>DG*Y,HB^^Y)-QOVH
MHH-1?QS)(_;*+>0Z^4VF6\PL=^[R\O'?$Y>0E)*6D55^K**JIJZA^>RY@:&1
ML8FIU6MK&]LW=O;N'IY>WCZ^?N\_? P-"_\4$1>?D)B4_/5;2DYN7GY!85%Q
M2655=4UM77U#8V=7=T]O7__ X*^)R:GIF=^S\!7$ZMKZQN;6]@[JZ/C/R>D9
M^OSB+UX$ "'!?RW_+B^Z*U[7KL: B/0O7@37O/\Z@8Z(^+8(";V2'NE+UQM<
MHN_(&!Y]R:[HN,XMIH]D?.4V3GZ31WSE#NHO:G]C]C]&+.3_%[/_1NR?><$!
MRJL;\QH=(1T !BZQ.1%\P#_P#_P#_\ _\'>.!MUHZ*T_T. E:N=FK>_RF595
M!(9\H=M./%8?HDF]>)&$/$BJ@.UE,%J .A+FT]G;9XZLON!(#GP0;"^RP[7_
M@C?X-82?1(89/OPN0[H'"'14\87NW\8H+P70MB"_9^:BK9M-RGTJ3_;V]D*S
M:DWN9<6W?$E&)[@'BZ7-2"%S3RM0NC'@-S>0>, <[0X*/:%P()F$O8;0=02]
M70&(!"NRB*KDK9SVVZ7?6J4 9YH"&VUP"APY.#^ !?TN<&5!N.L0H15]YX-4
ME626$+=&^$"$R'K_+]$UDG8"C0Z);3Q0I;8OD!,TD4$4:*6A(7A0?@>C</)A
MA,5!1N1+FJ<AR/,'00<;(R?@)\2@]Y#X_P@8,D6V\J%M5[#('IA/Y*-QGGK6
M'"T,NCQ%;R?[MRTRBPHND%B-WE\.5*IP7A4F_ZFKQ%'NM#2PFU<QR3FYG^1@
MEUW_$;?W1=K3.9OM*=&DG@K \ _\AW!K8PFBWL(#'(H<ECX.YB8?HU=4CU_\
MYGV7^(Z*5?:'8:^1],CTR\56ELNV.ZBECQY?L=1P\M]8$>1/9/G'A:2D7:+,
MIFYMGOW/OU9^2[9'F/]8.X98XGYG,*.\PUO)+#66 Y7U*U$<\?*F'YN]1*O=
M((*O#X,3.7_<TY@;042(# ?$HX9.MU"V^V+(GVA"7:25W<5TT;A2D<J-EN&>
M(0$!A@CV=SG$D_3F<:1 _/ UV^R@Z0OH)W$MT$=%661?A,?YG,8OJQ]C7>U.
MSC4.<T4AG[@^3O9Z]_U(LCHZZ;BMM*9X[6XQ1@C:\;#\SR&3/6BN<33&HR;D
M"!7TC&IX(J]>?B4X25B8FY"2C)#5H1B5O.>(>M;9RHJV_8Y6,XS8[;:D^G6S
MUU'4[M471YM7Z^O!\T[OO6;H,I@N]6EUG7A78!U+X9FWP$YD,WVR\W":R&:Y
M?+7R'I?3)&^G\1YQ.Q;&#^&J 9WNQW2QEL$QD;CK^2L&*.@^.PK<?9'@NF#/
MXMBAXMN[S9VTX?LMW?N:\BMZBM=L(FQK,TK(]Q808CS0\1P;F+.]!ZXZP6@?
M]^8Y'N-&B;M$>DF6-_1&=$=F-^]68J$(=BO<]56,"KJIVS"#/="_$TS;WO@I
M;GE.Q=:SY6M>](^2E8PGE(%]YFRAC"#LC<T.V<,>7;AR#XBQIDAWUHDK\46Z
MU>M0_T_?W'X< I5JM (9,B\'-H*/%']?"2@?7TX$\'<'F-#E=SQ@]P9J/?H1
M/)=I9:'UM+G!3(#5)C#\B/:G2?_:O9**U>+V51D.9\P=:(>*8RL8O0@BWTVY
M->8Y5#2[_SK"\?1,Q<C7_ %E>1T/S5=:&NZHX$ )%8:G!'\#(P): ]EO6XF=
M3>G5XAHJ\RE1/U,J>(0'=JK&"YW/;5I09[$O8QX2MCE"X(NCIQ DZ05_72/*
ML"1??$Y-ADR6>8TP/?*W:T,]#@52Q-+@@9 @AZ7JA;(,:70%@LJ--=V5J/;'
MXWYA=IH%[_ME%06*>_;-UQ0/-6LP?$$_%^]<%BH*M/7$1CSM/]7ES-2MJ(\J
M6:3#P>@RFYS>'[P_&Z'AOM.*R#++Y%F$=G#*T^X$C2*<&547HD(7===99A+1
M32O0*.CR-Q"C^-*--W5&BSQ(Q^6CPZ!G1*+QGU]^I>HPR^4^D_?BQ'TT4D#9
MMGOA 09%9H=%CL88F=O3@M:U73&,WW1Z+TH=7_C34A&\HGD/8A*'Q612>8PR
MO!GF_5W#PSL4S_&:.J^T=YF>4.": IH[1* (%HT'EC\'B7_!<E^)\KR88*/%
MGM%X]^;&-0.1>L+9''-,74O@EX>=$7Q9U_Z!_T,AT ]V6((OJ5TF!S UZOX9
MI;=WE?ZU]Q L1TDH&);3FQ?37*<T'TR3 G:*C2C'F&.]D(>=;21ER9'Y.Z)*
MGJ[KZ>7N9Z]?9CQQR>G7<J'YJ?J0:/YJ;D0'/(A?YHT.X@AXC(2?B]K94,D:
M;3>:65,YF;%[J\847GYM_UZ*NQZ-D;4TO9N-TNK^,7!9#OO&I$U?T$O79&,6
M4G]+5(K\(8B/QP714G4ZAI9R14V<>LS\D;L5L&] Y_SV1E3S^(,7N?+6,VZ4
M>" H1%<):12Q'^"]?"E@5N$X[=>29_0Y;7/M"R%-'TGU[NH2FE=X/["P,$P<
M#WQ<Y#T6;X%J)6E9R!PPY"Q0K86SRI>5:/'I YP$9_7@ET^?ZJDP$!P?8AFD
M3G,GH;:@4*^;%]>-:_# #0W!FS.4A($Q?)W?>)[ZW)?*8EYVXJVE 6$XKX1=
MX<483UAO)GW";@9_LZLW>^+0^?ALQ7G=3YV V:J!$0/=LUCNSU>=DQ*+UH#:
MP3XVL@:,]W,/>HZF>Q7YG,U"7,;N9U]IU8,KC29<R9P]F,$Q9F(9Y7H:A>)]
M)?VR6Y;HH_A-Z)Q"5F>#^W[L_VK=@(6-8C7:EBLA"S&[)PNY> #UJ'4Y2_U*
M3TG^LV.0OU>X@V_A^$RP3&BK,I\<'/-WH>IP^0E*<)"-(!VMGY.-7L;LL \T
M'/QF- I"W<HTAU5&T80V4R\RO*3J&?EFI]"Y4YMT5%E2X77WKO,W-P!WN[VC
M[]?4L?/^!%*M-T,<F0&#F:++/6FHWA0U1K729\SLG<X\[8PX*AUE%8RC?UIO
MN'PC6*DCBWIBM6U?V',YFJ+C!UI-,]9R!G=;LV)K?+XA=/9ICIP6/]NR0#'\
M@2^O_(OCB\Q]0A1HV3E&7LH1):R)_#@:%J#GE_+:M# L926HPPT/N%J;?!*D
MIEGH S)^*T8C"Q$'D0AHL)]P%-E[Y7&>"?J-QXDA*J_"ZZU'">T3.3F6J65Z
M?,J83,/V=U'^RI..CDX>5Y."@VQ2<8ZQ>SD7'7HJ=B0J3*2:M<K[F;G/L#/8
M.Y-14<'G^_'J:RB-(MMV(]5&@^TK"2%3C(FO2D;Z#5HZR5[EJMIU>8XH,%S
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MS@9T1HH'W#+CT/EXX,'2*1[ _6;04X'J@.+^\:+#_WIP^&(,H0.$,VW[2WA
MDPL67;J7":_"J7.T7&7L>.!"CS' $=*7J2Y\SE>$!V;"\<#V8-@!!S,>Z/]>
M>!D O7ARK3$VI)6G#AG;8T'SM-DQZ8?Y.^Y- L9W^GV_G09.&8?&(9'6Z-EE
MU/,*C]9[;E&)I\VF#BBUI5<_4#!5#][J>-WQ4HXEE/.I%4HWHI5OR9[EN>09
MW DFW:!5Y1;Q(TP^E.B@\^1<V=HU*H.X+:H57(>V1LFUU];6@>Q3.TZ+B=?>
M;PB6E<047N;>XL61*.SV><#"@SC'/$ZJ*V8D(N6,CVMO";^.D1@8Z"PFC-/
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M<79]U871Z#30=04TE[FJ&NLRM.G@:@>OJ>!U_L;2V_%#;J4 R#P-1$M\EC?
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M9,MC?N?7</-+MVBHA]I)*:)@/6%-0KZDX)O#LG_N6Z['*ZZ_(&_H^Y7V\60
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M*[-]?*X<OF6](/.J;JF-PJ76#VE>6-WGS*/R9F,V4+A"A5B@4S&9>;S;1>1
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MS3/F/U,^T0,,@H'Q<)P[AAT?ULYF\+LR:W9V=H9JP$^"^I6&CL ID40 V/M
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M,K1XN[D6*[:A?>>;L9:B0Y)*6M=VM4+.[Y]NDCG)!;!D@,@IUESWY.1XC=:
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M)O#]V<>V ]I6W$O7C^B/-^:TXONE!!E,L\OT-%#V.J=/<2/<>K]*7XN_%O>
M9OU/HMY%14&HJMRX8"-D@+G!P\TC3S0)K6*^ZKJ0J'V>3>[G=]X )Y8"X&N_
MJ4=&U?K;![0IL*',BH/#CE[$N8U9@=&LGU#;>4)*[=#V<NR/D+9@D1C#<6=
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MCFW!1I_^(@P26Y-NU1'T8PHH?^8=_WG(C_4=96$B8(P$ ^E"Q%\&U)Z=P]1
MQ?[4'XR$8ZR9*5A-^Z\%8-):^7]T9OY?L]6>@?R'.],2;_/+$,E ZC2B#H5V
MQ1N0(A#G*!&J$T2ZC/AKN2'#';))HL+7R, G'?B\$3,^0@ER1 9D:D$^\-89
M3.8)TY\K_BUQ8.)CT%_/!'+VS].$_UM%("RC.VJ/!/%47Z>8>CT:?,S[IV!
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MC[/B=SSS:^L3;O9\$@IY7:PKK/0P!/'._="*)6VGZY!7,)V_YGI0[9;4R.Y
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MMT?0@6O;B&NPCPTU_/Z$YTV8.UK4;">_<]W<&OCG(IH2LTYU U9QZ^>:_/9
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MGM@#-4C#'Z]%8_T)>Z"H.G%=CRER/^.H'TVBI@+MPT/I$^.E?8MVXHG-^IU
M-*1F/(8[\(_@&B?8?I/SI/$4Y<=]J,Z<)B^)>+7^=K2PLXN@YV&C PS"1:
MH3]/(<Q[=YGPVUDD'+$&1;*=HLKP/FQI+KGOUC<Q+;(0R>P(FWFI<^.IOYV!
M_U.'.":HVE:)=Y[1B=1A]W:+\MW?=5$% 5*%/3Y9A[,DQZ-VJ;X:3S]F#J+$
M@_F-*FJJ4E0#K>YA7;+?E'^Z^2'I82#H@#(2 32+7ARQEYA-&BDFV1L09D9<
MN!W2MLM3"I-Q&52!#)%G&VJ97Q3?5_#./F7B(>3;BUXO=-8C]U?K7?IM5NUK
M*>13\+7ZBWZ9O1!3M4;XQSH;TOH>B/%R*<EEW9'<0.,@N&?.Q!CHCE9%M?A"
MLI[U&=R,*A>UZ!#IY %=]I_$Y(9T\J-R(^"NO<R]P5F%Y99ASTQKO[Q_KG:N
M%)48<3SBT.%)@B>C4T37DZWY*7US5RIOF:\OQ&)D,2L@ 7S2R',NBK('RMU0
M-XH4*1YX\+]@K[5_Z2H.G.YM/@H/TSR&6CME#;G\JUQF#**YT9=H-+A;:A>2
M4\6] Z:QM*Q;U\@2O P(,>7S5>L.XXO7]T"]1UB4.;=DY.[M@;Q_,"D""5Q$
M\O"?[O9JF6!'-;K[L-Z96RG*@=>LK@A5)O#-MGZ(T^4@AOGO@5;0A.PZEJ #
MA+8(H1C[FM+24S:,>R#$*^9XXPR2[WG^J^(__M?]?W__&&R(?M!#F=/*0G&0
MS7IM<7;.F,OM:XR15C*CG1<K[02C;[)$7XG@I;IMLIW]&N3NU-3?."E:E; 0
M]76\?2G8[]#,9SM9>:O30IP;*-\@]%\YC-)\(^+?'3[7._+_'@/Y%\[=_(>'
MUL7TV;3_HU/6_NX,O;\[>/+_Q!W-AR :.,<.#<).\K+-R+\X"FM2G/R4K=K7
M-OX#8,N?L?*O#G[&%GP[6)OZ/^G(N_]1]\Q/3I%3C/!54,S?1D+_M?,9#UF-
M.6\?NV"6R GWNUCH['M'6S#A5K:ET=.M+?G5B?_K$W__COMW_-?N&"B\HDE?
M]7:;ONH-L:O"_7<U',"TLD!67D8<"8+ZY+F:6]XE@!\2.\K[O_=PMI\[J'4Q
MVHX-KD\^?F"2[T*#Q_'3')&-1I>C!R#9CPHIO6ROE!(DD$EF63IE#J*Z-ZHR
M^FR@,VR Q9Y*CI//DV<U:4B1V"Y56!2*E65^O8M.NGME6PWSR=AVI&U*.)4$
M)VH";/?J1E(=(V'$1YE5/67T1'!-]] O%?=DMRP+H=KTFC/EZ]&"MUL%M'</
M?,O[]0\W]#G.-K.P,C%EB]5MNK)8=ZDT7@<U.IS\1#/9XU%W3,NY-SU]K[\]
M?]9VL.X$%5'OFJY+/++N%%,C\'G1!!;*Z:,I9$<&CPQS7?33$S)!U>U"E-I4
MS1&V_56;TJ\0)7N@IHG(JMC2/%<;GB\0-TN4FXL/*+?[NHEK1Y;JC:AGX:VP
M5H^KL>@II^9:Z1FF)JIT<XK$N"\BOU$(O*83(*.8)7[P4\!S:\:@:P#2#) R
M%1LU(S7$20;3XM^G4E1'C#*^7F'!&%^)=?Z!6,LO.#!AMV087/_?O@'KGP.1
M-)GK)"F/2+S9+O##0=K2X4'&T.(F'Q\?OIQ=__@NJU'QMOGS@O.Z+_"_?!=0
M0721N$#VA_?=K]T#-?8 KNL5LF8/!(W#3N.(PM04GS@>/<>4I,QS;?;9(]60
MV/G5^R^.ZZJR'_9EB/]\]7P:IA->@L9?6&^:;J.<1LY,-&ORV[B>P2N$Y2UE
MG!S*NE=D<<SW[ %:3\G4FXOQ(ATE/"4/F2_$@/PC_LO;,\_ 0^$N2.QS;1(O
M?VNU[:L,L<$:X0^D#/53L.*M]^X,]PL]>@Y]N2+VXVN5J+"R9+0?$KL'&BF=
M@<3A^0EG&T.4!V8V(!3#7&V874]([P7.)(GMD?,^O<%E!W!]VNP'FFE]<*99
MTC;!S8(0;=G=^A3[+<QR]Y"TH'-"FX#(@>0+0RS\[YXL(+76H0W@4!7HRB+@
M"S0);2^\4Z-2"]156D:[-1@,!!;1Q_!A()'V25^0IY$>]0@R86L/])PF@@:L
M6;YSB)0*WT<:5^57!VM]I>BD]<2!^>A77%YSZ2OL3+B*-]&8Y%=-0E'9+U\$
MS^.%J4-<98AD63)^UG,HE_SS;N0P$=K13Y&BD7F0% YA8DH\V1A%TOPPH64O
M]>EA0K-Y:9=D9NC9ALBQ[(<<IAN\/],804Y)' MP@F&M5Q/\R![(K9?CYS@L
MZRJM.[)QX>; UMFZ2%5K_6L^KB>NSY57!A=VY.L)*/6(+_7& @X2&C%1)ARW
M&J17S.K*J[^K-%-)%NHO]'HW>+'$7+<!RQ%RG^TMSZ/X$#?2.: F?CD#P[.=
M^%4G\(.BFTW2U=Y$\3+<>9K_:4[JX9F=]+NY[^RE6G0PY[S"6OSAQJT#;377
M72J]O!/CP6-1Y:\$<9NI"=@VZ9(B;EK_XCAU]W&M)#+U\6+]9***,'&AM3[*
M1K#&-^%N[*\F@3J#RLJJBOCK1O#:@POG$1X]09LTYMS"]BDDKJ#%TA2YNN*>
M._2XZRHE_Y7TNRR"B/J.9AQT'3J9W(+XN3F3_*K&CI![T_:$2XC4YL_F)&G8
ML*%<AOV%5\<IGQ REQDO7WW@SY$)_$-EU'@U4\)""[8MIL8^U\8EV?RR>FV9
MXILRQ=-ZX@5ZHEKAMP^&G7O:[JO$67Q?ZNRID@H5U]1HYX'XMV6E59%? ]'>
MXV.GEZ(7[WPNN!,GKG_2+UC!8%,7]]98._C-"L\>*+9.$F8^Y3<"G[JTKAA!
M427B]T".M(%!NU*R3G<UT3]:$3):V>I1$1"I=G3=K;&>/61H#W2D]U6-YK3T
MEQ4RF.B8Q;HPLKTZ4M]IC_8=;O5(S_V!09"6[Q.0+?S8',P4XE7-T:D]T,G@
MB,:XZ4"(@0DZ?'.%O'9F9/+FIY?X,=2]"H_T#Y!)[M]L!RF7",C&-12\478*
MP4;RP^,T!JCO<[6<B#&IY="-07=<94G:C,>6_.R/EH?B#QU61JU%T&?7O:PE
MS2$TLTUEE\$\E;BDT3Q<T=J.NQ,IEQA.8'J&6HZ1MEKO??X[^ X&FNX47(BS
M&M6JU)*:]3LF4U@HHWR(+[R*[2@,K;_>\QR:[YR2@2AT\;.J2>T\]Z("G>K&
M 2E^D=<D+MHP&:H2N4 Q(:N1&-I4MEKSBDCG&G9;\WS0/35U?47%4I>PF>9>
M56>43$VYU$!,UZR9PFJ$LF'GKJ'[?QO*@OM^5UN/&Z;'?+7"-55&*0Q>97=X
M_V[24T_=T/OV[EIY<OD<,0"+F9\PF#!$HTWT0W#IF[CD;"3\?1L@&184\3W0
MQ_<$^M:6+.*:-&7KB,@@*_K@%4/RM> _@]?YS&TUT@</+5[P! :_^VCC)J^A
MQQZ(T(Y@ 53_/060[4;?7H#/,7;3"&87&^4?[G*UT%L#6S%2R_3 /$X^LPEY
MT%G)PZ'D8,;%<X+-V *8MC)E8?R.<M$J+@6#F:XW+-^\A$"7+J!V+8&&W4NR
MHH<XUF<Y6/H&$.*MF#O+?@E.]H6X^_<-408*@[H23_*[GBB!,D++U'SHR7.T
MCK[YM"*0/%,3:"A9D9B1Q8K *D F2KOLJMWG>F1CF@;-X&'U3@@0[)P->D@.
MS #3U!V2]/-73%*11]4VJ[XM@'A?;1+KRF5Z??.7FU:;+7.-^+KN2CTA >;4
M1+M(!BBD%.ZR^&,\&!$R1E9K4?6#W)_APJHSGJ#]V*VIK%3/_HU6E"R;*-JF
M'-28&*G&I>80]T :4Y.V438<I"PBDJ039/BW='7"PDOE.:$:O?6^W30KWNKR
M<MEHO$9X*9 $6C"&;]BMUN0BTD+#KD:>&[JGM&X84K1Z830SV5,UG,L,"& H
MFY8E'R/)<,HV;,)U#_3"J4F#G["&*P_.)<L:A??BSRD^GIC[/(;VLE=NG5ER
MTVS1+.U]JN:%O.^:,O&LAK_0-=DJ:+D3SXV=GH;D<_BI9MJ'F1HG? -YLX/)
M6DOK<[/$Y&'*:#G&'8U;9PZ$.Q:YNU?C*#W/&\<E^VN\/N"64B[EYBYS6P^O
M7=IHG9*2G,>V6+EEBCWIZ'@".Q_[L6(/1'+3#(/_-J%OI3.E[;0':A/_0D"_
M*$,R."OLVKS*<=G52':K;B\M*3<(A/E=<<2^/!A=*LMS7$\XKUB3QB4[94L]
MK1D!#&,$6.?UJBO\6)[71)ZTX6UDM]LB 9=#WF$$0QW:W;8 A6?XL@Z.\@9&
M5N3.0><MTD>F%TX%?>3+IJ.KUZ-+Q:(S]!CRBN&-$V6*]#A8+08(QP;]B4--
MJBJOXY\X6)1_5+8/,[-_]NW0;XX?L-Q&2_-8[W- A0_(4>T-JG +%A-60BTU
MN'LRJ[J,1ERFX;J'& ;--:>@(PO?^ YCBK8,3W\;9^O;,@"J<2XV!@+U.#XG
MAK,^<;FC5+1A]I0*=W\])K@L.$ZZM'^[7F$7BX6@=A--<%[%!IY;M6L;<G\]
MC8W_>D;%\09=HG=+^D&TAO3.%[6B2NNFYN9J^1.#R7XKF^Q F_2*=G+^S0X[
M.Z48%G(VN(!V$G&,!&^J=Q\A(E:Z5<YIECT>*X4G9?F.=4<OG(O+RZ*BES6=
M1H)VRLEHBEK3]OA KG3/'FBN$C&-P)ZCQZ(8J/XVC3^QJ/-))Y;^B<6QZC>C
MESN^?OD^>R* ^Y>:Y/28>)L*:UW>1]> D)+L,?<-J(3[J>EQ2*%I>=6IW&.%
MN4RA1Y;$$>O@E<U)-IYE##"[DU"F9>[LX0F5#;).>45%JFN8=<^O>U.F=Q\1
M0+R,WGQG"$F)DY##$P9]<MV:NOUX/W\%7X5V*/3XO 3.&&2<Y&C_K%UP2^[O
MV^+M7'SEA'IE@.7V3AJ<(H]HK-\51; !'>YC*>!6$G_"<ENJS)^5G8LQL1K\
M3>4W0.$6;&SO"]76J+X36_6[H&.1J ,6?#:( =+]V'L"DO8*T;0'H@@_!C)X
MS)=/%/A9,^F'9PR&?W=KWNM?+=\9]AMN]X J# ,Q:3 )-[5[TP#:XLC@)VO%
MATPDI(SC*XN"0\1_XZ R+N1 C4#;;"0I;0\45N\,!<$6;("V#^8A:=X;DD(#
M_Y]*-ZJE&7>W%'+#LXVEL(WA*?,O<:!WG:D1)U3_Z5VI331>LN^?WK5T>82:
MY0CTKM9SY:OW9Y1&U;6=@$;K_T?+@DUN$!3_:)E?@K]]EA5=R_3+,3< +>MX
MXG\H-AQHM(14NDK_R=#P(+I*K]$S-)VNTG@@0TW0OD,]5]*S?ABSX=D*.@'>
ML37P\L09[D[ OPG@J:FUE550Z.8JT+I04[:1FG]:5_,X__K9G[[TUF5,5^]M
MH'65X*K=[)5Z!G[16Q>]9%F1]UT")H"2S5I*J@Y:5L4[8L>G>3NX_ 0J[!(=
M[-Y\/_];/G/2]L4X!\GZ3U7( E5QG%I-KPJY7X]I?:5 55C&X/P49-/<-7)*
M_[K8W@!T2@/)9P-V"89V=T)\EX/K3R2CB:[#\\NU]5U_.8WC  M<2C('S ']
ME]'8S> 4SVJ #0ST"0K/H=F_4AP168N^U4 W.O<(C8[P.@/Y_%2D4_;*M]GX
M@)09H(DF:'#L@?ID27 @9GC$'NA<UDEJ9CN;77LW-( R7(=@K8+6O[Y+)-Y/
MJK>:(*BRL9/0]*$]\MT",OX,#33\Y1?TH1FM>V9%.F4^M\^^5DE9H$C2%0>(
M1%WR1]C"GTC0^_(PA!Z)[%17@20E4T<E'A 8P([((  [%JY5]&_5RH*'Y:J+
M@.+>^GK?JAOU7&KVR=VIQ'N/GEQ5U_:BG:%F!!V8A 1,W.U38YVD\M]%C<V.
MW_LU/+Q]8O5.$:J/X5B!3!K?-8',(G&J'T[WYP9973IP$UI4E(.SS3-51ZO,
MHJ6MQO=  O]$(O_UI')>QS1"62C&9&F*X#@7@#XOZYKJ5R:P =Z*"*<)=$CO
M%:,QG+E2JV_<-=UG(:?I"(NMG^(B]/Y!6(0+K6L@DTZP.,4=5X!@?_9X5.RF
M:.)"2HG!R;VIT&IX4Y=F,%[%D[)&LWI/$Z5FUM!C 50_Q>M/+.A*XJ9 C\7M
MSDK>IF,%XL=BKS%E%O]5>:W< ['3>C5 ZSVUP/2&'":$E.1;0S:1TF5N;E&O
MRC\#FA<6RV&J P8=^&%^;0H* -GA'Y#?M:=O#?P.EL+0,>IQ$I&P^K ;=8*1
MRQ&8W7BPB39;,=DET-W6J:@H!/C;W[A 'Y9]5-Q'Q7U4W$?%?53<1\5]5-Q'
MQ7U4W$?%?PT5;85I8S87!RA@<C#LK-ZP]$K9&)N6U9G:C V?\".)N2[9CKX7
M[G(V'@??%E]F(SWJ!8#@%HT.!*H $+0NS_&SP^P-2?25K1ZI!L-E9%XKO6C&
ME/X-Q@RN%P'W'G!Q<MC-/]A0-8-!D1O@99YD='5GM]MR[2X$_9Z=6HLH^QLI
M;FW_S^Z+'D1:]_CHF")Z9YOM(,62+M;T!]K3T#]:37^@_;F)KM7ET(V?@%:7
MI#FY_);_)Y3V!T&:GNU29'.*@ 8]VR-"QDKQFB,IW@IPYY%JQSV0I Z^.I6K
M1Y'?Q +(5J!R9](#9NX.4X#*M;];15<ZYV',V=.0VP658T=YQ/*C,T ,'S["
ML?SF<=+"977H^;GR:I^ZB9<&.+*\FY?/^,0\H,3K[G3) QJ O#I=\M  92LR
MTR4/0")FDW SD^<-AWPX_A,+\A<?A?]#"]+WDO9C-N++[#RZ-L3-%AP^ICCQ
M72PP4,K MFB-Q/M7W0V]AP%U"T0"@ DUKS^1&)L=^;FL0(_$G6[4R4X>L5*>
MXR#A#\7/6S1.T>MVU"5@_/V?NIU0Z=D=H==M0[*G$E"WA3)*Y_GH=7LT!*A;
M@D(M--\Y ZC;N'S+54 OO-W< E_ZB9IA?ST+-WUOQ';^S8_A1%HU/FO%/S@C
MN78'/3P\ $$.YF?@TCVMDHO6X&\R9Y!T K0FVI+T:@S_IG7PD?JR+4ZZUKE3
M,^Q9<7Y2'FGN?!_C_FI2R<&6Z0 H0DVFG8(" -AL:S=!A.+55<[UEJ[AZIW>
MY;KC"]+L574_9'VK9Z:7$=Z6$$UR^E-&O65[($>7'_0RPJ=24$ 9/792&@TV
MY,?76Y U.A>ZT6/U4_/\=<1TY1 _(.6ZZ#WLQS@]%A[9RR'*?V*!WRQ<0Z72
M8R'B,!H[%6Z:&*Y[_OD/#-##SBP"IA("(+;)'U-)K\0G=%/YL CU(U')P4%)
M[82N\?T]4"2<[N\6;(#YK0?\'= +RG<PR5CY/[T 0+7K;2SY6<)/0;_$/_Q%
M/_(Q J#V6K1TZ? P0.TVNY#:JC!-2,\.OK,?4]]%E^9"&EV:;]&E.8P#D&:>
MXJ86#:"3LWX8=4T9S\W]M6M=#"#K[I0D?FJTP=RKDD6F*U_&7_!X#MTH_5U?
M!.P,\,-X?BERVZ"!']::[$.W@.4&4?[E7X"PL*3)%!R+/<+TN1"H&"Q/ I$"
MV"((T!C7;7-P_@E@W,@FEBH);_XGE-V23X6NG6$3#H!VI@+:"7A)-#65##:F
M>TF%M9'YRV-HSP6NUJDE<<W&";J79$5:+:4( UZ2#F0UJ9V\W'^ #&">\W:)
MCB;/OPMZRP-)2@>RK#])*OLWFT)/TM^_Z#8%2-*'Z=7EQ1[1>+[0EW#G8)O[
MHQG]NU:I25CH,)EV@!^Z,H;O'@B$(YX0I%N0=+VF=[!+?]/K/QTLFJ[7?SI8
M[!C.BJO5%Z%E\=?UMNBOOS\$VBW=Y"ECBN4-H8#)&Y8W -AGCA@#\?!0&&*I
M3O]1TIC_N7T2I,(B3,W<@FUL!!HLA[A;N:&M\*07M?6E9FA%:SS-Z2\G\C_T
M(%: (P4\2+#T#<"1 AZ$WH]P?SP(('('="S>QS())OQC#\(9AS]^,_"XD5L@
M9A[UFP09"*:$YJ*_SJ)V <IZ]I?M#6!VZ;*CC"D": *0'7H<@-8<6_HG#H#'
MXBEI++CR;?)@ ,LO-9,I23H9MR87+:;0R1@"5'=1/)V, 6P/S3V6WR00>@ P
M> 0TW> QN WOYKP"#-ZOW>QB@'O:=,K1%1&>B9#BEYP.%F\G-YAY65ULE^NP
M&FW)(XN!$ZG!$(@"EJJ?AZ_$"%4&C&_O</_U+!;Y)S)*-[8.0,#I./H+;SH"
M:A-Y_[SP'LBL(6M0JXG^D;ZKV,I6V;( %K6C= XX6O?GA3?  8"#?TQ_X9U.
M=_#N(_6=QM7N\ZU>,6V#?33<%J)TI2X(%XRC\=F1UUP&DA?@&Z.]ZV \*ST8
M&*#X9Q!_@@&("=GB3S#"K;^O L&X]\CSB#KK7];87E(NG61B?9:!Z05(AOXH
M#9KN'YQE17^4=KUXP5OB27Z^# QT/+3JKSH2D6 _G '.DZP.<=N$9J_EX'"?
M38BC:QFCM9*!E!Y-&G?OE"V5O9?^!,?88@^TWK&B9@(8I6]85L!P+06$Q&5C
M\0"P%I\:'^?MXO!3?9TET9$E'']UR8UNE&[1C=*-7KI1.ET.I[A7 V[&@/Z^
M'9"* ,<_[]L!#[C\B/Z^_;#U]\F\)K$OWR>?!D3VL@&>2!,*>"+?T>&Z>@XZ
M*LH!J*B.[,=0C/Z)QS__A+Z6 GT6\)+?L%N !X2=^_/,KKJ]IJ2OB/[,+MO*
M[>-A+C.@K$-UM>A]UI#N4?YD:),&W:/XT3/4B.Y1B$"&BN*J71<X>_I^B400
M(X;FNMOQTMF5E9 <*K1^\N0^*.Z#XCXH[H/B/BCN@^(^*.Z#XCXH[H/B/BCN
M@^(^*.Z#XCXH[H/B/BCN@^(^*.Z#XCXH[H/B/BCN@^(^*.Z#XCXH[H/B/BC^
MGP9%\(L]T&26BE,3VYD&Z R2 =;9:&XC85 QO(O3'RZ:3UF_[*'RR=VJZWI!
M?%:B(*(Z9==J,@[_9A+!$72:T(.:EN8DV6H/(HM>*'HL<7\Z4^C^T?0TZ.ME
M=?UR58FH)?'/4413DOUCP0T-7M*EH?G(F]P&D%-8KH,WPWB8;ARK-'OP1/<0
MIEDEMZ'W**U] EV<FNFVJY$XS79H.9.Q)J VS2_JT-E#'\L%S0Y\?.]1S262
M2VZ-A-L23RW,$I/[1T?+!T+0$]"+]O@=7GSW)GH'$0([.XVARS5]J<!I&%VN
M_RP5T*'+-7VI0)L[OBAZ1A6<6?A/:.UPQ%_^V+;WKR\*.$U?F^/OKYZ]5:\H
MB<(5$2GZ^Y]O[W^^O?_Y]OY*O_V5?OLK_?97^NVO]-M?Z;>_TN__)RO]-O=
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MQ"+YK9W5*A!1D6V$Y<'NBXJ7Q&*U?$2\XM^19I46+7DH'&6S!FL;Q:O^!X-
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M\E?&>?S&6#V:E+*:#+-'5HT*BVU<[!RK\\!V=GW+V)F=PD\A=[1 SD"*,!U
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M*):1SO&&#E9T[95EK":IVP-E^Q3>^8^,#0_WCUIIL\FWLUW^?;)@Y#$ X!E
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MXDAR.W_MXNC2YY?P%!C>&TSICR/'PM;5D+*K.QRT4[IT0*H\'>"%IK:;ST]
MN=K FRI%=( '';!\!O03G@6FI$77T69AR_N96ISF/X U_ZLVI (:PIIX0?.B
ML)/(=3$ZX&M!%W4!T00G"3-3LA'8*BI#QF[_# +7_R3SA",W9>&D*5HB!V5J
M_Q&LTS&,#BBQ@"UC#C;8G0!V_:-#N_XWO8X9Q-2?S*)HXR?:XA NE;7%:;[R
MH@TMP?VE?7$WU5Y=OK%L'=>\,0K";C3!3],!;H$^*'^B6DKR8ZL/LI=J$D0T
M3H>9NW\0@%1/QP\TG(T$S#9*T] T=M+BR7Q2P:VJG^=:$CWE/H@HW,K(=(A)
M^JXBX"1@B@B%'8/(X0UN)>KC&^,\LS$]8FGB=UQ$/I1&U]7(ME-GO/X;>^\=
MU537]8MN104$1)&.$)6J"$A'@0140$1$$*2#2A<# @(! J$(2&\""@)*$>DB
MO49J0$2D0Z@)O2<@(9AVXG>_<<9[QCWO<^X]WWG']XU[GS_F'QE)]IYSS;7F
M_/W67GM.:_7_O1VW[W 7H@^2NY6#&--Q=[ ;/?JR=K#W_+>N"P^6&FB -R&G
MO96'J(4W6*C;],:\;>9RQ2V[[KO6U8<O#[NY7_T!7$[6( EZ-GP56:Q3BPV*
M'-0 L14,;+G@/][TXM?%6)IU_WJ5SP\3+[\Z^6:%4BYI0(!3*H(NPN4HN1^(
MOOCH]4DM[*O<AFP5D_>IXR_$^R.9>@ZG4I)Y8Y,BN AQ\'YZR%*FY"C0@%<Y
MQZ7)UFRU:IJ8VV-:;U5<RGP3Y)3W3_+6_^KP?Q<*?IO;[$XX242*=]M.9MYH
M;GR[K2@EHI3JOSWU=C'RB%EV?K6CDLBNKKI_COW_&+ALV;GY(\G<QKPTP/_S
M.UF;J#KMMH'!^M_CU4'#"-Q]"!/UAT5^QO4.97JFY/U>J_2%:6A<^+S>I6.7
MU.#O91F23VC#3:G,E#S7.1ZZLVVYR/=&?UG.7._>1?N5Y2>+[]ZJNATBK/.(
M8>N5BDC BY[W.M,O#+48_O3#A-#!W_PB\C /='".!DQ[!UF/KXN3SZ73  4[
MZD(.*;ZBKY$L&8M<]+"DSM" H8N($H@V\E"9SY?230.&]V]$2U2\@7C]8XM-
M<"\-"+U-_8%@!:N8DRW&P!(PQX5.M&G("Y4:V(=0 A9M;'*VN4FMZ GK]\I@
MAEKY:4_78?(9$B3H&P)GR,Y"+&FGCSA<?H$]$L&AH*ZX'R=/LEAWN3CJ<S1"
M;,;C1;99$I8M+CENO;?EH58IDIY,0K=;16#NA!#<5FP:WF9CEBOA7IW?1*FN
M2)\W?_IEYI,LK(G,*+NA%GF"#B6J C*?:(&,ILK"K?#I8?UEY>'@S'R7#/V1
M9/T2JP9S>($\BMO^(E <+: Z^3;)3A6I^>WY4YB::BIOH]$*(=G#5%>Y0FFM
MH)*,0)%UKT XG#A7ETW6%ES4(*,2-\KNZ7XSGI\.C&X6*1#?L;;HKQW;6$80
M1<4W"^=MXZ^/=X)XX2;5/+:G6@57<YZV:C=D3[W8Y;97Q=A[U:HXBM[T-%>Y
M5CHWY4I0'40XT@"B1';.?*:D5"LS7I2:%5@PE?E61*Q]V21N88]Y+CS)46,J
MYK'F3+;KNDQX1D4[9$*5RAP^3P/8X<X_X9H5,MV].=8M0]4N?-)BL;SY+YO\
M<'(7.VN;7D/F?'@?UX_NH',/VB"UJ,TYG!-VIR, :C%^CVB+);&?LK9\^F6[
MM;HZ(,;9Q-%=SF@3M%E@GN\HJ2HK&O6)VMM! YRZ(YNV<O,,*^H<MX>'';BS
M284?QD&GJWR[N:ITML:L+;R??W:GS-R1-2PT8KM#'?+&&$GM%O1)%(B-)JC3
MYT<E'?E(DR^1U!).$@<PY;%C0F=(SRQT7KW !ZJ/3XHFM45 AZH:2R(D)I\?
MV?TLMS@6V0TBBNR$-O\!$!=2O@;Q1;LSP)5Q=(8!)=^L,. :J9/3_JA[NM33
M2B'3/H7A^)?B3UO5"ZX!==T5:-N[N HR)\F&J+K@:$X%P<UP6W$Q.I)0/:E;
MD68.#\69FX\(:?S '^F9-*%>#QK,YB;*T._R",\8"?<HFEJE?T[ $>9NYAB^
M;:[?7)'K7ZKJ@<7+E5U.<V.0X[@1ZCK6Z=!@5V)4>,4X,/_)6$QJ.51F2.[
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M3KM923:S5^_DR3+XWE=1[#(53[4"\YSA1S0M'2PF6WBIUI+R Z49._U5SJV
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M*=-AP$'M@' W!_A*S=</UJAFN1%4'_$*](.[^=S4/KUFO?2NP6P\-['XWO%
MJ;O<Y@,/Y1ZZ&"X/2G1=N[$MI?IQV-?'L@I_!7368ZC#8=3%^$'LTIL 2>.B
MZS5.]](N#<>9Z7K>D7UGU]-0@$-I0=7FNF=!E-#6D_ [*9B@&LP._U-T[9N5
M.R-PB_1Q*7<73Q;AYDSI,WK='<N[6V^/\'8\#K^)TZ$R6])S#7WE:\--<./=
M]!G>#IW?FX\BFV .;=9=S6.AWJR&"F4,'U<,YBY<]@$S;%EM62.B:0#NEN1
M@JW@OBV(3HY]PQR(EMB^M?U>18-KA0VU\>9"YK<T.=LNEW PO$V)773PVX'S
MD5[ %?$Y9*YE%DOV,^8HC "(07=>4O"AN<FS'7>M;S_N/A#B$W!_'7]OW%Y
MF=%HJH-1_V$,:K!0/^#V)W/1?IZ .5L_BQ\[)7,/^LHZ844.^W;M?MF2/)!B
MXVSQ;!.1U9$$X; 8CWNIVI1\:Q7%[9*I&7TRG1<?"Z)DDGE(1M31<1M^_'(,
MI2E7Y[W5;%D=>J6FL_?*R;)&'NUY58]W7L,%_BN;93AY@C?.@'S6UX#8@@_
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M/Y;0%+TG,WF \<G$V1$.FG%CK\L(^O*87?$W<T&^RL_E>^:VY#E0&QI"9?@
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MY6*]4Y7>W(=N1RFYFWG;QF8CB5'UDCR.J]=80IVY?O11F>-(RBY@"=S,>.<
MAR:ELLS65E\PJNFHR:M+ BMM&Y*WK=S4E18]]0,_6)ENKN$^D<\0A3$#+-5)
M_4HIKK6^L8\MG.Q$7@:X^[3M6)?]]^GQ+WAP\*\4<"Y]1*\BOMVA"B"F#6B
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MG!E_(M.[[*G0Q1%I-5YWF1K)'R)-;[>W#I2F$XL!0/H>P" 6#(XC%N%SVFG
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M-S 8>Y&YN"=5\<S-"#N+\=1>3&)^R'?,_NQ0M23V+0UPMV8D_"E(^0BN3$S
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M^M% X+2I>67Z2A+_H[!H" \$$7IU+)>I?IE>_$LW%98BJ3$7)]AW0DJ?:!S
M\NB@//8,\@Z W1=:FU?M&$:*^"[6"$$'PF4Q/%CU#ZYNAI7FEZSM<QGW[KY/
M6+Y'"^&8A+ <@I92 3"S,Q^RIZ"Z I%!&%*;RO=59I&*29V20<N#Q86?-($4
M[36OH+=NW<=+K#U21%TR1$R0()N[5F9_5+K;1=?P*!XCW0I/XM(\=.]V50-]
MDW>Y+^?<QSXE:0%+LU-Q)J$':4BV4N:H 2ZCXPPP9%=+YVM$U<S^C$*ZT-1[
M#.Q>=DQ8DZW8G#(?WM%\,)4_J(%&"<:RKRXTXI+"AY(ZU S8JSZ8F3R/*7%#
M1/P:'>MA*PB[VOO:FHKX)CIK-M>YN%1<@U_@,5&([>_0IRO0--#KR/!%R,E
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M91R".!GF7G0\E2/CS=@.X+=/#I]_SK:%D5BX_]ZC(E_JB[C#M2N/B&Z@]^!
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M&BFFXUW9ZMGE6=+7UM*GQ\7]9P4X%;--%5F=JTX>6X'PXKPQZ$,0EY$3O#K
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M\DY_]5!%W!'.O[[,_'LA\YP5^FNFH)SL@O+[HH.K+!W-=QH[8M%7\**X<-"
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MZ=R2S_=*1G@VSXU9KH_^K3R*.N@$ST,L'%IGV@!K' V<G8T[^UXI+^>@E7;
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M^6?3*=%]&:_K/^3>KWFI0?^S5ZG,$6O=C^*'%1%L(J,&DN[C"LTR"[IOD_A
M6_8-G![3JC'FIK3LG=-WYRN5VE+*LL<.C%Y-=;GB/GG^YOM+A\>CF&NL3%"
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M?OO>2C#:L:G8\6UB*9+5?B?AT1ZW]\J!WK0;@H+\=+L!#5UB?^@*S">0*/!
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M'14)*20 I8Q0*F&B;5X!3 +&CX[7,K7E;5EC&?SCJYG%XLZ;+V?WOG^WV(_
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MWYM_; ZL>&64V, QAQ'-1:I;O\ON[8A*6:;=N_#UX&L"\7U&U5%9D.0X5ZB
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M@(]W\&8A@EM*4H6!X23L<3%&-B+9\C#0RUH'+6J67,_Q-0^;$E,*+VX:[S_
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MR&L[@O/^W.!Q898VPTEH=7QF]<)H$F6Q._A8KW*?U*G9<@Q@2TXF RZ8%+*
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MS#(_'\/6]B1.YT\.PCR)0B4"+EEQVTS:I]J9*]3/Y@&7AN>1W>2T-?%<\RR
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M(_=S;T=RDTQTUA'P=UK)S [&M9*O/M-4E5KN>/-'W0?5?=L%*9<[K<5CT P
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M^P(;#S8.7^RUU,M^="3*Q>QQH?3:8^./7JTY*[9 FY/DYK-5YR0160>!&<U
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MXH65 G4V6B7:EW'\S= B>OVO-6.<B0,E7S\DKGL;$5R4QMBF@T[]MMZ,1LB
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MS%YNVI@A4)\6X:L["+Y"!/#$:_@S %ZRJ/Y+ YT(R;61E;DY/B=;.C>(_WT
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MI]*M#5[,[+W:JG[!PEOMM_:5O0&Z$J[?3P-HA''.QS"E*$6#-LH"!3 CX6*
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M@C=$_"X)D>M.Y#C/J<WL0LO$S&Q-T,@']FFNW>X>H';6SN*/AT"A:[)#H+3
MR^+^;=-@CO$[,&O+D&^C<9HH+,(LL!I2@ W*(YVWWA6^NUAAL4=E:(M92Y=Z
MPJ&S%47%<K@'3#"4(%#=UV#T<AH+.A/&^MNQ7,.&_$YH#R?LZ"2\3]^//.OD
MD[%,U<T_[_KA6XNIEK+K4 :D%R6X!810^(BC4 :F;1[;JI%!#U$K6,(L8M6K
M;T,A 25$QVIRF\T^KJR"$QN36.?6UW8Y.B4R/S_9\1P^5./[PN$J,__->SS&
M)\FOBQ':T< $C\_?WHN;\^&B)YD,PF@'O6E;K3.B)!#V('0F8N[$@BO1W-+2
MY.;5TK79:R,,,G_2&][^E19("NM)AE Q+!TE*@P88G'ADLL6N7=(N[T@LX,Q
M[YD_K^\-#2GVWA]SL^<K:JY:ME.'ZJZ+<.FQP(?%P75A36F%(VWXD)!5!_!A
M!#5'=MJI[<]>LD^A4.)/E,3^T?BA\!@./-T#Z6:TE'M,TMKF$\CK5E A*ZB$
MZS[OPAQ:"Q0KWX+I]4_-B*7[YI[@1[;4R)Y2WX2J\'RTF34\P@1="6D%NX1%
M*ZAS)O&T:OW6$B/O5AM+*.393-ZXI]WW_1<KRI[E^21GU43M:>Y9U>C0UJ0$
M,C.L#4H@C78OO:;GA3-[B4-[*QY'J457E+](*\S1/_DW^]Y#Q]]2%7C>14B9
M[3H:SR.!'K.3+.?QKL>*S06JE9^O)B])*1=GC@VM3C#3V8IJ&E#?)%LP(-8+
M-76U>64D$ R):([,/@/W' 5#"\T#+OCW9[.PU]B>YTW7T;;>(]5 XH@H#R!<
M/!?+*B.#2 089W D9W%;R*!5VS965[UV& 4M%AKYXK=,O0S^YQU[X2N^IM^[
M@V?5TCXXLE+@6P;_5B%W%]*^(PJR<07UVW,%->#G] 0]88($LMO(OV(!/T*L
M![-ZD!(/!&'2?#=\-F?.N2I&A[? &L/F81<U]&S_=%W4HQ5LRS&7_;@#A\IV
M:#>H0!SK7E&5[0HJ@ 89/+\]%==@]?1KM"(G,LV/U^C=O+?MSQGU.;KT\"X/
MZ9?&S]P#Y.ZG'S0TS7?TXS$3SB5,T9=O-K8ZZUX)J31,FKG;W"ZV6NL9+>V&
MB68HHOQDR#BPG"+0?A>VMX>-G4.7A S=I6\9S'5(=,L;\@[L )T#?;=@OH9/
MQ&"+D,]VS.7R(__KD$ .S_LLS+<. 8=64/:?E\)V=?]MT=H!6GQ;>/ [P!FP
M,-DT<%[B5G?YZY8U0]A='C_^^<%K.Q$)GQ4-]!*5@@K,)N<5()UV6A4UMK\Y
M:OEF3:L7A>$3"'[-+WK,V);AX5)/C%L7_IC1US@%KVM>0=W7(R*(LC*>05N.
MK*5\=(4L;L#2E_E* -T21L&?25N$Y4T6GM"5FP>.]QI7&\D9?7L[8)&Q68;%
M'3^P(7/NW>29S)<R:1\+=5&D6_ P4(L5;$3S)8EG(>]KW' &LVHXK4DI>IAS
M,9%],ZJ-) V^H$A,9/%F?I9WD&7_3KV?T+QU)=[P'*_T[!L#H>B]\DGNE$ )
MSQJ>'2XC7D5^5:0=RR?*!\QY; 27LG"JT2=^+]\,'=W1=S,=?V-DUY%[B>>D
MTCZ^'7ON'7Q1'Y9RX:19PM+._\F"\V@C9(R=&9Z>G%?#D[87?+C1'EF3AU''
MA:H<+UR2(>BJ_(JYI*)\#(7R&+LJ)E@&Z,98UD_<^%_>C)!JK<'?+@CCXN@F
MB1MP=Z;RNCM:I1"@=KS.%/?O2%@YZJ:GLE<(*LTSW=+TY>K7E"$"9(B>V\8_
M +<CLB0DTT)-1ID<3.QBHVN+>VR_'9=VV[A&EZL\T,^0JTFK]_;U;C"KK]^,
M>C-_;?TY6R-<'!F\BA,HJ!X3O;T.^8F]B!GM.)A_%,)S=;SQR?V'3RI N%;B
M1Z[VD6O'N]VF$M7&NDQ13W5Z?@*"]5&\VF$:Z^U8>B*W@_>>^R/MY0RNZG;-
M[=K;X%A_I$G-<&PNK&CU+4#*\.-3-C7M2DY?^<<8 R?Y8^@Z@/5(533+ ;$L
MHEYODP% /U0#)"QK556$D$. 1%\9,.Q[8WLJ#G^(:EGU2]'@B*J-O_/:M1V$
M!^-.%%&!G2CI?045. _INB>'L/(;)0017 _O2K[['9:S#'O5V'CF!VI4_QRA
MJL7S]/;;(;K;;<4.[!6.EX;F>&EEAY>'GKP6.10YOZ_U0?> O6&'^,@&V(KF
M[ZHQ0P/=72&3W%@;'0'I:PFE%4C;-59;7NR[([K],<%D3-&5/MGI['V5*B-L
M$R]'D99('<FBE$#2N.^J2N%3V!3N)4LA%,Y(HW57R0TV<]4H43<,..;M(?8,
M7UW7F#I>]?0DM=O8;,%!D5@H#DN+WK^)@&H#0-]AK5\8'30Y-2L$QSO&HM*(
M]@%/HOTFR3%!]?US5_,?OG ;+PG^NY]5-K<^NW#;Y6]56Z<V=>!*!NFD?J *
M8&#'QEDY52":L_1H(?AZO[>3F==>0]"%<%GSH^+![HI2W? #&B7;#WD\?;*6
M%DH>RT<"JS>(:<54Y\ZI3T:;HZ6@B_W=M,;[*M?.W*VDR_K]R G9^$H7WV4F
M]@N_@.?)B/I;(&9^%,NBDE6LW5Z2&+ TB&WNB;-9U^AM-8^!IFSS6[T&A?W&
MT!R+ZIQ_X]RVU++,+:?WZV:8.KT[0,Q&Q/26U&^S(Y^32*>,_&*XY<FM&6;\
MM=DY>&'RBL*?7R'?WM1&:4HE&_V.6[[Y7'@(NQ]@#0()=?HQ6%8R3F:IW'C,
MO(X;6$*9V5M]+V.I:@6%]_$JQ)S85!,+L';/V6ZD")02>6/(.IL ^D:B?#$\
MH&5#@_!\>Z)FQBEJ%3=CE(BYC/B" V:['8L4#D2$7_Q<?P^3=U[7^MXVU_S+
M?#0L):H$U1#F ZQB6E6YJ,.2);Y_7TG^;!XOMF3[<SB1J&3F]>59IOBY>(.2
MK;\.;+..S14-WH. 9T31O 5WN%=+87C.+T<1)+1:WDWVV$Y5J57TL44T7?UI
M6E,IKB=1H#[%=XYFL%T%RCMAE.>O+$UQ3G%\A(R/P]$OQ!<-KV_/E__>*5Q,
M-WA)A^<8_+/BBUA8)N!_=NQJ%F6>PML]?V+7X5C,5JS,)]8MKE;QJS."W0,7
M?IL_H%7[]2=E>WA$7#7[XKW]O?3"[A,-%PDWD5"%.'E6E>].Y!EUQ%7<;&:'
MBS[CND<K>164L+LFS(JA4F6'MWD8KHYWOI\>\OR2<T>XAMPW<84"RUCO%51M
MU.PX"SLN TO[E<!=*RA%;;EGT!3/@+LK*VIKJIFW>9-.WZVHM6A!=8I+9G'A
MH1<T<1HK"5.=F$YC9>! KW'"+;+F#_A]_SS1(0H<YYQ1<#RX0]WXX$X??]:%
ME#\&UXA?@)*%G0R$9UGQ?> ^+07A72 0NQ'NM[%,?M$O4&77/W8<;;^L-_OS
M;5P?UG/+@P[I=?.;4P1H2!W1JH, /8!D0AIO4A8F6LPGTL2M+3B8]427:M"W
M,#R"]>EH1%_%=YKW-I_LB.,_KAT]G2UK&=:LLX<R#(Q?T>:[D\:9$BNHLW>.
M3T$W&,,&7#QGP.?XK'E7K%:RWR:L@5%W:?('^84MV?H7AA?\0''8_33X5UAP
M?07UZUBP^/(\1'A./-1+W":7V(;;$$+:-.0VTE/R<UE\^N[>K#^QXE_.*&^Z
MY/H@?,Y[X+BM4H,SGB/#1.,\H9.G:_N7]H3YN]C ?UJ_M!%VGE!PN.6DGGW@
M[/UU^3'M["&:!,"JP("7R0+E1%CJ)O\*E,\[D(")TS*NZC.<)51_C1"(E8PY
M6:NZ3YN6W9/S;*E3\=]]7B.8D!O9RY_'=>8*-!$3V5;(310FBS(B^I2>H*=5
M63<IHKP*S.SSY]$];;1J-$,#FZ2E!_[(+QEUQH,O_O)-#N=Y1^9X7]L4YO?I
MG4_?P3@[W8/7CD9JLD]R=3H ,+)#5,#A)J34D&. &@P=%W^])C>&>"W\*<3I
M:?':]73UW\MC/M6J6+^W.?\&3\^&:S3X!VGDOJ3\/,!#^%ZF) O@*R[V"/72
M:1JT4 #:#"0@JOF*^<:D ] D&O;-SC;MBE;E/8&R].,C] W6#Y4GU!@TW;NL
M/>GW^)-,9>L)JIN3WGO)F:EFPI@.FSIWAV_YDUEM,LO@2G<=^RPX]]1B.*'F
MG9%LY^JRLB>NJ*MAW,/2SE)7S_;6*13Y$Y^#V$G$\JK:,>!)UR2@<@75:G*'
MO+J_F8RVWODL.A7*<(9P)<:%96._KGS1W?5,?T@V\HUX0'2Y<8!XUWX=FW-2
MD&A )Q>QPX &4>?0A\(7->A1 QXEZW@_22F:W"H7P'F,=4]Q_ 'Z5I=_L^ F
M)_P<4)(_TQ$S?APG\6QD!45C5L&%Q;]$E1V4C+K:K)MR@^7#S92$!>\SXQ^T
M]OCAF8K*$>?N?K!;+4]?$[,/ TN+,APEA/E85AZYJNDIWY'4[[L]L\>9>M\[
MQ,LMQ3!W>7#&P#PR\I[*<=TRY63=5YM+K=Z\RL1: >=-H*W# E4,+'.N+!2G
M@O7'K2-:"!\W24Z//<J))!ES?6^;)$6X'/;G<YO3N6U73AHTQMEM4#CEI+--
M?,$;7O='6$$,X-)@Z8<W^+M[2HXVJ4-6;+XF]DC_7\PV"J7\+*VNKN/O:!#U
M%MG9K>,*4(B!].;I&#E2-P >)<<!DM;;_#:JC#DP7#9]N788E?<;?ZK@EU\&
M)Y/CZ6_S.UA\:@6505:AL6JPX%'F[0W%"(*1'Q.8"\NL]=CCZB9$^^+H&XPH
M+6GNOL:Z;2'Z"18%\-"OW0,JP8,J)R0_:-S=QX2E_/@GHYF\,6&LS49XD"9_
M=<;;"->Q(6*H,-SO/#8B-(''WGS[J-C9>Z^V<$S'H[2<*$_4W08*7VY*7>^P
MVD.>OYO4 ZRC!1#BO1R:";=RLL:A\/V9/Z=WY:Y+#2LL^.5-UHO<'KO!O&V]
MG[:RG:'=>;$OQ^V54/^W7QYT#.B63TY?0=50YE3!'EB*R3><MI$?I%S5N..:
M0E.^T!!>\M5K6F'Z^LT_QMDOONXK,W-LF3EV$IM=]<-GQ[?;6YIFN$I:F]Z!
MPB7JK24K*R-WYST>1QH'+OC^FIA@/97O--QFZ&)J<+8:KQL0LVFOXENB*U\3
M,2HD0%W$C@*\#JB0?Q;J@:4-V*X8)M'O75]/VM4T#]957JE$$WG*J+SIL>%U
M[J[DC69="HF>";NJ2E_KQA 9HC$0PMLT5BF9.CRK438F. \=Y^^["(7V1S.<
MWX(F*37C:>>:NL),QHS*)]_U]^TY\CI'RS/BR[3ZQE<I_P[ LK3_#.!I4>3>
M:6>"1X&-,S?,5U#J+; ^:'C2J>573N]VW^;X>N?0>UWI,:=ID92?)SDV#[D:
MI\&B9:"%IO33:U?EEM66$[K@[%CYLXIU![P94:$]!7L/-RX/<V@M:,BLB@,T
MFXRI'A06_R=SPOT<^#>E80_GX-"B)X*N8L^=K7D<L+#ZO$[YW7.;[N]\5*J]
M_8K4$W0O 3+6%SRC<8:%\8M,X=[1X0* WL%\;2FPI H4%MJO.R1<Q=5 7>PQ
MLEJTU8<,TTZCHHL7PW(W4A\']S][PN]+RK"RC\*!Q[$CEKP.(0T;$ ($1-/"
MF&NCUW2<J:["J<]<5Z6/E_RF_(C[?A';2_QZ26:W9V'B3O)>UWN)^8G;;6(@
M2;;KF&2+UNIX6V$AO#,:W^'U97V'_##1BA5R5?F==*R7T]D;_#;3/1K):86V
M3F*H9A2FNT>P80^+F8ZK9K:-]\3!NDTA35+$S=PT2NO,IWV?9[/: H?PFKM,
MP_]>;IHGN)H=N5WZ&L$J+-JW)B)"O2NQ7DC8*@T5BOIZ7!(=U<&BM"53@?PD
M19PHDU1#32=M_N6[M2ZJYG1:D<<ZB=J"![H/PIZZ)9M>LV)*GTGY)PE+,Q%W
M#0JNB>9F$CU!9BLE%?&\QRAR4.!XRU[KNLCXPF@"ZU:;O%[NQQQ/_WR?P,Q#
MVI(:I[8;JUK=05VG"C3F6$(=CJI@_4G65 S1MFQHPU1<39K-OV/L5+-0#VX3
MNF+(0O!7U!S(&L-A0GH9@HWJ().-FT-+\MR0;R496B;4>)=F_^$$4PIS6@R:
MO8L4'*(V_A):4^7Z:"],D#MF];A3HI9K%A"!=X0+S.UC4Y)(\F!:X\!>61Y3
M]D=OC9YGA2_+L H(_=*VN;1KJ]KMTR5G:D_E<)#(6<8$]P,C?%BZMW@4*N38
M#5ACN*H.5?Q=B5Q%QN6G=:?M#%_['%Q!&7V1_NAYZOY5W=E[XCO.HFM*12.>
MXS_8; NA*=-8+VVD(!V6_TW7DV &PUG#:'_?!S-=QK'&AK=OG<_>R>P^>\-#
M>HWKHQT&/&]V<3,!,G&@,V]'TB3*@ O *+\#_\)3+R>?J]H^@1K2&9K0\[EC
MU*KR]X74#VG)[J.G4]_[ZV:UP\U,D"!)IXQ2>8]HPB8L?C[-J[B#EIY74+%,
M%>B1M/L*W_0OCD_MX=O79%;%;K]46;_G=)Q^]D9[#Y36.R34OA?>;3C EP+H
M6M9H_@ZH^^NYX4631(]A7YV8'02=XXV6JG^/Y6!N=.5]Y_3LUU&;5!Y =D4+
MA04/HT??RJ^@S+$,S/(%:L4\KQ%RX1\2$* #KX@[D'"(A:+8GX;JBR9"EG.3
M+,BH3Y0S=ANY2:TYK_+2\@YL%]>6V_30:7MD6I&EJ)'I*()-0] C>-X-L&.V
M@^O'>P'.M_;(029V/OH,RUJ:7&"OQ=;RR>U&DP6$.>>7SQV?R:G)2.\\KFYX
MN!9$TU=0T!XFO#8HBJ\L.$R&I17YVM!Y9UR"C=Y@#D[YY_+!  _Z<D-&=MX.
M\J^RJ;MQ#_Z=>_#O[*N&[=@C-%8_^0Y-GF0MRJRP/LZ-YS!3](<$SA1B\-#%
MB'+?>:VP;RNH\_W9S^_&F,Y1#;]VZO[!+\9S7!F F. <!)0)MD-/V<Y&48R"
MS?V!_4N-F..WG"2^5[\\X?C8]=BI>S-?S@[W .!A$VC+<"*-E8-;1?3D6T*8
M]BMXWPTT*+<$2FSYXZ.MNBM2]=BX8605U4DWJ:7KQ[J-$A>VZ=E*+HB:XAE!
M$I,9D%Z0:)"P^["U'YO_LCK-@+-$S6C0OJJC'2&GY7($U]QKR;W/L&V]FBFI
M6<J7 /\F745K1)_O:".I#&UNZENZL;9B<6Y_MT_O%^\/L9/9:A'N[K)K9^VC
M301*X;!4&'\3(H 3)(4VD,HK LVK>HK-,Z,);5[67832X,RW8A,35\IVU:I>
M/6'0RC_U1N&50S?M#4:@V /+(%JP>@HTHL[R^7O@KS1I>"O1O$^)P0XSF<3&
M+JE%:*X;UGU>9KGW9J_IH7?-"@%NMFLK7TJCL'L UO>,<0>> #%H/_A+P09$
M@;;!$RLHY:OSLM'Y[)H7C<;9KV:FH\.,\Y9YHZU7.M7OMG>%:81=:36ST5B]
M'6X!Z!NJ<4EU5('B/)O0 :1B,-9XKG@;( ]C0K0V#5M@5/%:UP]8#+Y]^Z><
M8W_JMFKW:/,7NE+E>3/<1G@4 UXTF1,5^)T7%E4#8PZPM"L_$#KI?%.1\?EG
M9($:9,#:,U>HXG39G"73>/AWH +A;9;QY[=[,-MC4X0VPH(F2<B$%PBA6<S1
M879K+H6]@A)'Y&W7BSOQR/G24.UK77GU,]L3KKPTW1]S])+D8=0L_G]Y]DF9
MJ6_EP?KUGXW+&]1+1TZ'9J@8$BQ<+.:-.,"\]<Y/,HY[0=T#\[@T,A40;,!Q
MD87*\SVA#E[+?ZK'3?LN--A/6I5>,S&LQL82E)\W1/)>C]DIA2[/U*K(1-_/
M.7\ZSM4+)4SMM3"R.@3JO:"4,@_@0_!%'1:#GUJ?ZB18))E9[62?0CGIQT@
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MIOC0Z;%K(X9X\$!N1[1=<\#N".E&M+C!U%)R+Z^;^^4+&1:>: YQ)6$JL;>
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MOZY3&."NX4%-PKI'^?1L@+QT%;6/:6+T$BBF2C\:MC=LG7KX:5=OF)Q9<,G
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M]VLH3C>TA8UA$:EXUOQKG1YO<!;)05._7N'2;HT[W0A).^%74-QQHT M?%?
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M5;8IA:TZT*Z,T%"'$_E</<[T7T.IMUG.L?>*P<_=1]1=Q?]<L8_#]AAB.3]
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MERS+4#1$^;U;>&9B.UM-W(*L2@UVN1A()*_L!G[NJO3Z@X1ST;0UU%U7XF
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M_R> 61Y0:Y8<Q<KR67H/-;"R3&7W%/6J%?MO=>N4-]>\2OI[D5K0]P8^*;Z
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M?9F]:FZC.*^\8JHTWG#_PM:%<\W4),?R_$O1H$1PV";U5.'5[<AP=\-3EP-
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M-PDUTZJ639/GX$0L\RYV^9#-=F#L ^'$&FKXK0?E'0!9E/VWK2HM[_")QJS
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M,,OT9:'@7?8@:B'D$]"I$28?%^&= HP"35'7W4&!=&E9>!.6=RTV*(<*E.E
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M2&4!+7<+D0?B1-Q'GV<B-M+ZDMG(E(>Y&=&/Y-W8*^/:R/"W]KDZV,X"4ED
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MV@&EDO2GQ=?":<_.'X7<@U5%D&#X)U!\(JJ^LH1<2TB\B8!$^X(Q)? U.W"
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M2F%X@R<:0(W'3I6GM*M3CUH0V7'Q/.4E-84$:3, 4-UI!D?RB]U3W5YD] :
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MV,.&PI=$K  %V0#@Y1BS?G^&E'G8I3Z56^@*=/BMRLJJ%_(^%]\?R\K#6P$
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MBC^S!'K>M*'ZF'!/4"Y6[J7N_B\YA,<&]Z@SM$LP/FHN&8L;!P'A1]QKRW]
M1W+J'4S$MR]]%[[NR\49);+10S]B(,X"O!\ ;0U";8DZN*E]]R!2<.[*YWBS
M4U^ZI]_N^3C4<7KKB5<;1P7?^M=0#D8Z._;WO !OS5_E!%.OP-AEI6$>>+4
MC-<@81E[W[, C05SE$ D"V!PG 68RC3^[?BL,#M9_)_;?JWUPK:"-B3#F#N%
MR)%1!)W*SC/P<- ?AP#+W^[)9@J!^!#?[P-IBR4(-W<68'T:R-@1_NUPE\4?
MM\3_)EO-'T)?^[^27YHM3KWI^Q\+K\X'%1A)2>7?4)9MK]9BFQ1W? 1X7HN+
ML6FM)^;JII8D9^HN!*J\?*(WK&-QF/F-C<SF.D"TC:.[D;\U.(CTANK"#+N*
MF++VHYVQ8 &0XHC5[]E_'+[G0?R?6ZP0+2[X^)W]ABQ J'7/,A',A+$-$W,N
M_H_#QTHLP!\W7?M-*EMP>04+L$V.9#)X?CL$Y/YVC_%ODCG^)O(_I?_[I;>!
M_"4[^?Z'K8HDX.J4=?SS)1TNO6&474M^(:M]E1/S/\V?_BG_WY:_AVK:5KL_
M[JV\]J.<:Z6U24]+EQW"[)%_F*YE<Z"-[\+UDY4)&K0[V:KB>E[%B/^>'O5/
MZ?^6]*ZCT!1#"]&)R<;\ \^)+E:)>H+<GTO"_I"^*.:,LN;TF1^Q.0Y&[^ZH
M)Q_G-P,X_,]RIO]&\C<:LQ%Q&*+YRDGD,U%;\#Z#7?=)D]2R.QJ+NFTWH!4W
MH<=J\'.4^71SBVY'%H N#&;RF.5 Q2$P7L8[E.>'(>8]K1ZAT7"E7,H]SQ^A
M"W427 (;$K#7['J$74G2A=*<&%GHHP::,,_*6C3I]A?7JJJDMVI:(YJ)88,W
MOP69#-;P3J2LE2@0OL#=XX+%@"&#&8EYE4^7W'I+RA8JO%4;(1I?/0@>#%/U
M(>]@?Z=-^I19<JX^C9_9]BB7:$2HI&:3D?;59:1HYY/#0;9"VJ/HSJV97G'Z
MF,FW[=JY0[XC2CM)^!A4Q"0OB8$,USORX"11V^+)K;+2BA?R#SNR=UF?)51L
M(/FH?H;]JAM.0F?+*\HKPF^CT9655G%'!VY96_$!N  \I7]HTW:0A.+&G7;@
MZC2=+%2/\PX&]REG;=>5#W2MU4JXRMY84JQ;90$ <T0]T_>Y,5ZK$*NH"Y32
M I,,[CT_;7)_\S.K\K)R \V&J%&C"KN.<]LN@)]#F-]L &+U*/P_L]W\%;NW
MY25736\UJX]L760.4A.*1YLU,SW,U"857JTL,3YC3_=(I?&<27!\LPSG56GI
M%HK)E_2?+GR=:@(;Z0UON5WZ(^I[:_,WWQ$C)\PKW=7?/D&V&%5F\HB1/'#O
MA.XU2M9"A*CAOMD6GU(.C%4Q3J7M40/7UJ6].%#S%99-,V1.L@"B<'WGJC #
M:7<+_(3DK,4191D5K\:&SB8[^6MUR.W9-]*XE))RBA?;^"'4L8Z/4^T06;6/
M).:;'_Z][^6(_7'5OKZ?..9]&8;6>L-XN]SHMULBTPI)) .)@>0^E-8]XZ]*
M]^K?;3[ZL!=>^A@GG1M)ZL62K0,X:[/%@DT[T87KUWH#7NEE=R"%,.[J8VY8
MC844W_'[-Q(#2A)<:6F\G'I>!]/SQX/C3&7?ZO'LA%#8;?P4#I.@^E$0HK#[
M9,[XYP$YK1]3:W1#RT,* 6YR@X\A%/-=J ]P6;H\U9.4VYH M<2S &$/_,>.
M/F:,'W_:=TJC87PFQYOR)G'5 ?.'BD,<E7%,R)-V%N"^#Z=M;(>IS5S0/HP\
M4]G?M]?]7@<VI4U6;EH#BLB[L\$LC+!7D%+2FAUNA1?H;B4>;2=@N,?:/AD6
M.F0=#K]@OOO)]UUQG&?^HIF(X#"5(+KP&<IU1HS_B"I3COITOW';7=6A#(%>
M01W4S\_;5V)>?CK$I(?[:E9HB*/&CY_FN^L2%0?B-?OF[2J"H+K.E8$5L;/B
M*N7[5<S5LIZ)KIAW,WF7JT*!GMX25#OANJ67@+TFJGV-IQGL/(>K0I2CEE=%
MAL/@W!7@ _4.LC\/=X36.L5L,#:;6 ![=J),]G$[?;!6DK[#R,?\FN".'B9N
M$7Q(N4VZJD,QF??+@T5E]Y+\3YCZP($7,BY<4^B5*P"4DM/?2J#@C.<(W.-)
M>;+8B,%!YJA]6ZI9PIB\\[[>%:N)R[I/_![6W#!<25B!@3 2XJB!3^\$7CT<
MW#=].J.L<?&%T]A:X.#VVJART3+<Y,7T."W:1[")]&'O4%^QUIWZOD?J:AZ=
M&^$]R3"S:=18.9.GD.RNLKH2 !+\*ER7^:F*!;C8NW'IQW0@M\ YC0[*$>..
M$W,B.UPT 42S./@N\@G2A;Q*5"#(G,%.*L4_>/Y1SXTFV\[88[ZK5H[6]SB2
M&?Q4$^(-TZ!JD+)QF#!B_2Y2(7XE\?T\)6SKE&Y :M9<76F'TS>=0(7G/Q.=
MN'X+'<[FH80C9Z3.+]HYBDKQ5US6-4&=JL3<HX_I9\B2>M2;;AM@TLP(I>JV
M2DO"],2&T57U5T:\"&'JN;X]:/2@:E:T/+>T3VQ!]%X @!TQ[R/^5="AO)[>
MTU_YIY6.4^YS?V&RY\328L*^C"$M$\WF@^^BYW\#-I__+&9^_Q]>Z10:R=PQ
M/'S*.L)0IMWHC]=:-0&.[P7,<_Y-'A%8(@O &<+( ^,R,)QPK@7(7@3N/9AW
MM?&P^Y20]]TRTERK$[#EU9)D<I56;<ZK3D\^URN>@%>GUL.R#P6,CD6ANM3W
M0M.8^[QI(DNID40(J9"Y+Y;F[ A%M4C"1I'ABM2WN/WG0J4NU85+X)(M_?)T
MC:6]A+?+5&(/."VM']7ZE_', /(<%O$4(8UQ \5-E0.7-?-A=\E#B838D"M]
M*19D1\E[%96U_1=2DJ\'DVJ3JBO1R=:O]>XJ^<]7)]V!IG5AW+VIQ\3HHMHF
MC'28=_XBF.0]5)P[BGJ&YO#)NP^6JM"WF>R3\SRR_;$L>O?6M:R95(#FP>OO
MO+X"X.]^477/357D+E>1C"G5I/VH5D3<I&C-0 41;%\Y=#*_@G%_U:RN'RWE
MV\';[5&H<SN#.UNEW4E:(-'9E&3*Y'8AJ>,CVSW8#7Z@WIH0'S6*KHI3(&N'
M1<;2SP>'<$6N9'1-#IA_,CUS7G^Q2+5RYQ)]QG8T_&$[,RWKL8$9XR,&%XDD
M78D? TVK9=/.,ON0@(!X86B=5<11+[1#_'.F_&,5C1?&?%>;\W*N7JBY+1<K
MLNONZ6[!1Q8C;DQN.19@SP8C!J8UC=H'_P8JK]>5B6PK5CHY)=4>0G"RM/2\
M_E4N0^M)#J;F[;19E=#NTB0NN/FEZP9Q[&_?8;P%XQ+ I6[+Z;(I'^E:W^EN
M>?>8L@.B6RV-HF3V:]SL>OTE>JNPJAGI0;Z4A,OQZ_*3UY*D9FVY4BDL0"P+
MP $78O:!>='>82 INI [ ;3?XVK1HXBW@7:&QYJG$V1XZD]D%]2:2BEWS)>\
M*'H?5Q8-6,.$@4JQS=Y/G<$-U(:<(Q@"4&)J02FG>QHH24U=M1O(ZK]&;R^-
M\,B7;M[+ J2_.IYEO.OGY'3 HP__#U\-UY_3_OP%<J"_3'7SM[C='_S;&;;_
ME,K]3XB!K/X^[IU_E$!_E=S]7V,FLD:GNYF05A+]4!ZCZ0U)2>_V:TU,#&2=
MQL=>M!M)VW660S[5+*^PX=GHY>52^>>")\NJK:_^FIRE;P9_A&@^#\:Q0\UH
M82A)FW*7O$LTUU]R-:;H9_,;_WNJ-_R=,S^"0K)\UK6EV [^:W K>0DLK:;&
MY(/M::@I(R7X[<TLN"BAIE7RT-K8ZC$+$+1ZFO:#R_,1D"XTS>2&5F9AIR.)
MVN\C4F:0YTGAX\'<$W?K+ >V#F0@L3V?P8>_4=,T">/^9<XR\-E!97_3 HNJ
MU"$'8S-(EXN?BKF'$VZ-T3BPX]!)H4/,^-E^.L-VE>Y::O*#QM/,[SMZ+Z%!
M,T@CTC*N*#4W(/76X,T5L3!%9R&VK";%GIX//%U*2ROCQ&^]D#_>]L1:F(\3
M\! @#3AV%B#. ?#?'4W[)HE_5Q=Q7!D889M(S=E*7%^N4TTI'MLZL5P%3/Y.
M\1]J@-@R_'_-U^Z5??+7F)JT2O\W'X:UIXM=+UW_HT7QTDXQ.C:]PG5%;67N
M!N&YL<W=V[OC_2R5+@KX)I8YE':<>/?Z=LG(W5*ZWS2[56$G21N3Q\A;SY<W
MT@UVK8]/?CD@-&(5<%<_R5#Q$RJ%!;C'CHMN83#5.:H'[LCK5.+:C)1#PT73
MT_%7LAZN"RRMH<[Q\FPC#4D61%N:'_3[DJ!!9LD)DS(GVZN(8RU-LI?S 8?Y
M:7*<\4X?,1($B(1O_1%EFG;D@EZ@ZOQK-1SR7=)X,:8N-UAN8SR^]0I<#K@Y
M3LAJP0\5=W69/0)'L "3PQ5V1'"%-UT$;#.HQP+PPK_5NMQH\HTGF%T^<->G
M_WB+[X%'FC]QC$&]X22Z*",.? \YBK$W.$/>_W4P.2WTX*NY=ME#;D$U7-0L
MFS-STYF?S36J_5&%"#<P]<AJB\4SB!L9U*8!BM&:)^%+\.U)Y2Q _VGSH)>(
MY^O?#Q1XS ]:&^V+!G  =C6)X'$P#4*<5KNQQC3,<L8>"S0;U5CS=)?M25[S
M>)2B[V@K<T=//3(9&)ZGYIGN7E@UFSBXY3@4'7(.F\SL091N-2-'OGU5TU/*
M"JVRTR!6#V\J 'U'I)]-"R@Q%W<EO$CN\!B8_S4]X1Q)O66*9X(Z33".V2#R
M&I>:;3U*+@Q\>5Z<F'Q[K\59W<2F/<,K(^86C[L>?FIV'; ^K2I\LY:.]MST
M(C;T=/JI](C$%^LYZQ:^KO)-7%BDF*Y<;'^(J. B:I'4*8XD/^C<-++-8__>
MSQ&BO=]F2M3& RX=NM*IZ8\W[/!]J(/J80'&C)G\N_O]UX-PX!_EK87!QR>D
MJ-/.Z,,*^MKVHY\X&>>_/DGX\D ']0J^C]G! E0AZ,);V#78E4$O+;-SWU8\
MJYCZY/ O,>Z23WU?ON).\3YHQ)/DO.N'#FIH#<'OP8 LC<Q81[RO/54SE921
M@#&=A$R 0=_J+5H9;HO28!,"&6B:,RZ6/E1F6EP,6I7MIKG_&M<UT( Y:,/W
M,)+\Q^(YY@5%8]';796E@9$O,AT_O <OB[Z\*7!X33F>$8_!Q2+0ZD3/?&.R
MYK3UX.K3>BV$^JB7EO>!"VOW4S.FJ^NOZ@#7W0P>?# <E[B0KKQA25%E1Y>+
M\"^@L@-HLM/0*SVWZ=.!&+I\[6994N7+('35S,&Y;,$U?CA,VG90:R1V>KQ<
MKK5>C.^JU;!]F>UK-B#'**J_OM;^F+1ZBL!WQ8=N&Q6@4/M![!ZV$YVU?G6J
MZ.U/2!EJ69MVBMDQ*</$4I5QXC<;DP5D,PG*=(N\*<2P2=0>M8NP"I[':\*V
M);U&<*?H=D+IX Q$0%NG82S(>Q7LT(PCO87+GCP^,'!(YO5U$]C+:T8BW_S_
MX1NLV,8AF@WKG<@>39!2XS:,)&Q/J0=&:@$N4EU#BDVM4Q\-4&BN>D;T/QT<
M>$@JY5#4YR5GK%FR>.Z+=KW+BX\*2PS? [\(,\H0N 7?:+8@3PWHLBH 1:8:
M.FH.1!$Z35]ZSO@(]D11==5_0:V@_$40R104D2%5&=8B&3-!C3E/3?3P"_EP
M3C7GA--8NVR.O4F64]_AO-MV>T7BNQ!.^>7G1=K,]I"5L_-MC1TCN)[NTS<"
MZ/XUUK)_+M?Z1RW7JM^BO&3D&HC NS,X$5*P*T/G3CY)N=)7_-FC^-Q5@Y^7
M+ P[;N!MY11?\HL7V4AQ1B8]6K_VS'KLD?R+Q<'<BVGIQG>J'BS Y6&72=HM
MZGN=Z6>IL80SH<HF_=-3?D$/QT../>FNT>.\:J((L)V))R;1@F#7&17U3F*M
MP(A1FTQ7O)VZC:IRZU"T\Y)-2J# ''?ZLCE/VXD"GZTW7D7 %R!IA#N8>G2U
MPP',.[^CVMY53V0\P9MI=59]BL],OGB:\S%8KR?>LS <]![T:94N-->$+(N(
M!T7##"FAWEBQXX3U&R-OBL* J5(W6X\UO'BV%PZ?/^-!7G9V?4=-B$[F56U0
MX7/*O5:HLXUX#?>KC-H^5OW.[<"@_\/A6)'Z.A; J9&)Y?Y_I^"XNH/WM",[
M0/&BIW8B8TAE"[6&ATU#Q3?Y+ [;8;<BK($3G;N6ENV/H@;*'!/5/A_7:,'A
MNT7JEA0G+0H1))'DR'X<Z0:,D_-R=!D=DL9S-*O!)>]HUON!3>7]4F;50UH.
M%57HBB>S-1DV+5C)IU_:*(#=")[KKV^)*9V1/_DN/7DVX#=\  '_"M!HSQ2B
MTK2Z6-'0@H=^>*_G";Y;.?TQ"4*?5J:S71[;A7I,!$P@SI$:DT[5$9SN]UN4
M53GU3T(<5:Y=U+=[\Q@LN78"1CO64Y8W>T,WVLH5$>(=7K$:6M0_ON&GD@MZ
M/2O8?/OFH)&G]L21XLDMU0'=B,Q;.2.F^?=3OH\YG V?JZY^??AB=J&F+&!+
M:VT5RT84MBV_J)I&0<W%2O77\DIL:><\O_]HFSC!O6NV>3G3*BX>HKPT:< H
M!GOV",L(RA5Z=,GSU9J_%8ANZ4<FO=LM9^'V<HY10!]^#G/#?RG #)3EU7LI
MS&>;WIBJTC5GOKR^#?)^!75-GQ5N1+_1"G^/]LW/*6:*#F*(<Z"WFP@L"T!5
MVFK!1$["GY">]L)L"_*4*=]G3E(=AA&3:;+/P^6RA[LD,=&_9B2/)79P7#',
M7YJ1YSQ)DU_SI['1!E_4],;DG,]"(N0<?1=;X9;NNL&1;> *]2BCY?<1LJ#>
M6==G(:;:?).+:3YQTM$[TRT&?*24QR>/PC1Q2'X[=WL8QY9-\JDE28YQ'+_)
MBH5B ZP>JMV&$)0O(!LH+KZQ+<BT,-%BS 2F%(V/(F[);E2G/*T^HI9A9+PD
M'LX"J+N5P2V,UZ*C/8B:,\B1.2:W*Q[()ZYG2EZW,?/=?KB4=>.,PCNW/F/\
MK$'K_<T]QU&%&TY"%TFS27LC\<0CHQU=H\>3AY(?JOA<R"XK> S8L2XP]H\U
MK>.TEI!_!U"F.$OB^67PTNJ?NN:/0H*]=1#1%K8+9?,)VQ^#VX)[!&PIU3LE
M-B.>XCM&]QJ"0AU$"Q=W&A/?NP=)3M85.(S8V5_HFW!V^E;:SG?_A--$%,][
M7Y/3(N0Y8A);Y46,-YB[*#3U/#Z]#W:>_.#,RY'YJK/NE%?\8$3@KNN&BPE<
M.GLTS-';Z60(Y1VC$8S+PP@(-04N%"[U=FN_=<4A><;T[ .RYI[+GWUX#KGM
M>4:F!GQ<VG:YABLRN,/38NGTQT\;HB5^O6.U,9497MWE;M/OC EW31*M=TH$
M],P/S6?NMZ;I*"_-B"CVYH0R:*Z(YN#&?70Y,3@O(V7C<WTP8=_6Q8!\NT1C
M-/PMW_$MJ'[VZ#-?>7WE]?4@NK 4DP=+MO *P(AW>X/-52L\!1R8VT^!*<S1
MTY#I^S1EBB8+$ ;?,%-<SM!A5.A=J8UM4CY,53Q;Z_HDA%A3ZW@R(_SPZ"[I
M2TT$C#&=D[3>A.354_; (2(F@?W^JK+MIT87:JU3#?E<:G@>\V7D;"J^,D%E
M(05)D7L-^S[G%6Q2 MP*G.,O,N2ZD(&PKP8BT^8ZJ<5M6AD@8&WV?BEG#ZL&
MUZ\*]#PJ@O)K9Y8#='ZJ)L5"BMFO_1U*:_,A)O@_D7"2[67H5;8Z)2P=W.?W
M!7:W<>W3IT]]1;?Z3]8=]2PN)MP@$HG3^Q(.OSA6$"<,. [ 60W8S@8WAJ3.
M_8CWC"N8W5&+Z53(VH;U#)YP!G520_8O'Q>V$K,=W.ZRL%U_Y,\.5O6)(__H
MM5Q_\:]^CI+/R(<+,;'@O2BX-MVEH4'2$SU3'!Z'_& ?FD6SQM2^/8@N13\3
MF.U1*8DJ?+G75/-8X7%23P2(9 EZKBT+KB?UL"/!C]8. Z'>$@.5,:K8%;)L
M6IY[[3M))\8744\/_KS*K0<D"?FZ&W2JS0V.VD,/+ZGLVOPJLLY%_-7EI3"
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M&+R0V07$ ]^A8C+(>VU;J[6C.KYU9]EW65380CH#[DUC74@CH2!WN[&R18;
M,J8211<6PU<MIW_HQ#><Z1R&N>OIE'_/2OF)_KSM6G-K2RQSGT'0M#C70_H&
M"=R*&8UA\IB1*Z?M&S!I5]_4QEHZ-G"J^,?XFMP8X!?F#VQ#:DHC5[4"P*4]
M=*%5 I883N @&Q,"/^0M9 A7U[JC L:&U(,+:QY4/^Y\-:*S7]/5\)OVR[,,
M(ZH3J1#/K@$1G/8P ZH;/BU4^7*9HY&W5WVY;,ER<)#^R'/%(8Q&JVO-5A3U
M#6%=N;<I%VKIT,,N92L1%,)@^>P"GCQ^_IIUF[.P3>\B"U#" @3YO60DLP!W
MD.&@,L33R(AZCMS@G? NI2&MI1R0.\9G$?%D%ZTTCJM.$#MP- L#8==?-7#)
MT["3PH=$[B1W[RQNA90O'>W]<"XUU\Q.+8JMDX63/,<^UJ#FG27Z%8;J38KM
MW2D/7WP-"GE8>B%LH/P )Y2K'4-50BV325M?/Y'"VZ=BU/L/'DG.</KD?3'#
M\*E^KZ-M>#I9&TB: 7F\)=PR\;_^"',)]0@BWV.K_+G\Q4KND;W/"L *69LA
MZFG&O=9K4W01#LKC^"8$[VVJ#IYA9&M#-J8CBKS7FV_FSG[3D76YQ57PG!.V
M3@YB:X5V$7;UA+NS4'UD2[+@'17=@T=F4ACY8[-<D\>3UIG9^?=UVS=J,XH1
M6H-?5IP]8MZ:=LH]*M>01_I!OCD?HBZDW TV@J'D<K6)EC&%Z@%',3')NIT3
M3DYKZ) ?C,(PV-$.G)_D#?J0CV/\6TMG2J&76UGY4'<J97P!S@=S(_<T>4L;
MDSGPF\O7(%A/U3K5MA#"*QVQ/2=^>@&(MYA]2G/B)7W85@QZCEA.V 5?**8F
MB%XW&/%GFB/OA1 5'VB\0_#$8K\/O[2=CZ0+TJ9;H"P 7GZ*6ZOP?8 %]TO5
M\Z!4#S'YS*T?8R]W.$#%<#O\1P?3F/)[#U=NQ>:;[E=S+_"!+\^^JAU<^TA(
M,^MPL+,K7ZV>EK*,]-UV.ZVG<LPF-FM.H>CVJMO'8J</'L4T.2Z<&UTPL462
M]WPQ'4K6&"K9*SX_:EE_JB!4UEG^):)6CNZQV,--U6Z!<_0>)DT]K==V_7#C
M'#C(_=:#TH,&U5=/6/@&ZR]=CF8.XAOY\"6"F<MK7_1N3JY-^FXFUB,_+-?*
M(XZ[P<PR?$2<8:%N"GUGC!X9N:]/U?'H!J"2$1YLA*J,74ZC*8;FMOI 8YA"
M%B*M-0B\#.EKRZ6#+Q'[OV(UFGLXX<%<6\KK7!2V&3]-AX\AJE*BN%K5^3H1
M']PE<R*DP!Q428E4T^^(IW>O?/6_M%A_J.,<#R,RDF[04_ZYH"^^-!NCM]%?
M&[<Z;#0+/]\&EW^X"NS\_JRA(;3F4$G#!]64CV7,A1TWVDU$\VW,G=41"-%
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ML5-. &K3D2L4=5QD5F^Z6M][)5(C(#1A?ZRBV;V2[,[/JS/QSXSQ<M,7('R
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MH I/W4@&H(=Q'E7B^VRE-*4SWJ-NV8 O@3+$]:D&C5KH:+HRZE@OXZ+GL-E
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M%2"S6,4)>2HS'N.@=Z("T*?4#I>^-BQ"8N^<6#'QB3HL[1U6I)YW66#;LFP
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MLX8Y_3HRC<(&'>I=?_SX+CJ%8&,Y.PQY!M&I%2XV0D9$+ID997=U84]@2'H
M:K )GXDY9"NG/'MY/?(FP]S.:4U#F-;'S,8\@(XL-&/YE#'#O22_7-*8V#<X
M(4E]T2HFQ,7Q0 M!J^67E!M".:76S7_L*_2H4GS4YU9.J2C#U*FS^-#?7J$T
MX2$2"M3SGUGRK %6+^+@F/5W23ITB($_=77W8Q]:Z-C7,J^O+1> @1C8]ED2
MPS$1#$F:01QX\L&P]X,VJ6)+<TL][B%M?46VBPVZ9W4VV'>JBD0"9SZ UJM_
M[>!SBC^MHUXRJ;Z1*!F?LNEM1LY8E''DL5Z"!;3./89^E0]AOF=!.)C&=T(D
ML_BY+^UM2LH-OML[UK+)-54)5EL/(BA(V*QILI>QP-VUT:IP#^L#MY1BZ1(Q
M(TUL4"E**7I2>D AHY?<_9'/NEE#-;+U+.-BX.TP-1BMQIP6QP8] #+DKVLF
MWV &E+-!S\-A#_;$"\.+RZ-,SFYFG+_ALWX./&-QCW.&P[$=$E_SQCY)4S=C
MG32PWB-)4=T%2_5+@E NP8<4G6DZK//!,RLM9"G.[$H$1^2J,L26Z/O:1:)5
MB&&'XG_V-@IM05(+(5GH]J5J*<SJ?!&=DUPD24&A43_9H*022"MF]51]&>>;
M7L#N^\DL8?=H27(N'*K3"X>ESC;!BSEGGN+OTE/3_!OP87[T6"W_4'<C8D%[
M,U/)P(<34%1TH\^3$\!SZGEQW[,+B=RPS?[PS\)8BF?V8C"=54?%D*_=H:?Y
MLM* ;7*GS[8)@F>&#8(E$3G\QI*:!EDC,8D4OF?M+-Z?O_UF*UNP]R9YW<M@
M0:2P+FY<JY+W-K6G=!$S\15/,9*OJ<5$EN:ZQV-A]:;O@OSD+9/'V:"Z"GCQ
MN[>L+H ^>;O63F/V]*^Z#;+*Y,A&7NX*<)Y.<GB*+\:XL$$'KWF=WV))/+L!
M0>E59,RG'39C@]Y$_-R"L2Z'#FHX9;-!9_JDU^",0HDE>S:(BX.ZGSF,/7$"
M)@8RH\@8KOE0":)TKL7X;XV)![^E$^:=A(@E+Z*J7[%>I<.U1V MGO)3UIQO
M;+GQ,OXC>BB^4>D;]IN;C,1;X?:M 04VB"&&F%1K85QG@]P4%.V?QI8@K^A5
MK/1,?6*U4-*R&]Z8VW&2V2JV#U;&L,^B3I7 ,Y/8($4F^*OR"H=,,_B[S5J&
M\:Y@+L5%^R75^Q+XC9\ZL"S/.6(Y]Z+\YR4A3*E3/:/L?%[MV2_1X9I[)"[Y
M+,'?$6(98K'4U6.8(HPS@KM[$$$X[9G>G3UFF7=4EW5@B%GXOMT%(\@2'=WQ
M;J^OYI7S6F\@]O?B-QC.;)"%AEH.0Z,?9\X&$3ZP0?GH4[=8)TV$9]F@MAM,
M\UZ\"W38^G8+S;BE.W30NG9EN-KT_M8,I.'XBG4RIA$:K/ZE*VDR]L!H%']*
MD-$8<#10!:WV6T2?#5HB.6*+X4BA-9&68<;54]U,1KE5 YXSHD(<5+O8I<""
M.*NBGJ9@! @Q8V@_>!9DWIBKCR7APS6?P0:U'F.#X&KS2=1S%_"ZT)[]S,:R
M4.WJV,[BB %S;JX,\WO8&Q'Q_U8F<74C6$ 2S!# ZV%*1M#=VFW[PQ50\"P'
MIZ@=M/?$EY_8(!(!3S&''4 E8KFJ[^TA)@EI23Y]P7UO:E1"\Q0;%!;0T,N2
M\-7FH&T(HP1./0S$09J^NT%_O^J9(+F9\I?%&5>'!1PA@'S7$]41)._D;K4M
M#L38,/AXX2@;Y"\[LY'!$B0RA.RO[9$/@M BPL!8H?B%&TH+JV=G8O,AU/V4
M.):$BS:3R(@' Q%#WS'\IPIJV: !'N;T7QM>4)SH;BQ>@TP,KH+Y,6--/2A+
MXY)/K.'$-BV#)2S,$((9,1MK3P",%]!JF9)^?8AM*[8K%@A)R*+8S^+?8!KM
M,B"QBGFU!JP=],X_&.Y,#3+$4Q (SHSML__^E!]&>35S_REVBVO;LL6?2+D)
M!F2%W@8H8G/0/^$'EY://XR_K-GQB?IE/B_K(<^ZRC1&%*W"" "F/A. E,GR
MV W. AS]ACL0W57AQ8%=4Z=?+9-TQZ04+QQ+*UVF8'99M'Y-?*%P?[;OYG2U
MO4QGGO11P=+^W'&"[7KAZCLGLA^\45P5#LUZD;/7..F.57NB=V(9VF+KG;F
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MG8?O7,GB]UD=FOUK9;CIX8TMU=!JZ5>E<FJ.LKA26-!V[BPV7=O-0UBWN-S
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M&_1E\#F._PXU]KEO[%%7EQXVJ#GY5SED:P]4\;!FQ$'Y640HA\>!&2>*6=V
M.0774"L6ZMDK$9)>YWSD\=;U"H9;5CK^?NZ;R=R;T7O[T%UR;:HE]ZMTY,<,
M6J5B.[YL65B'Y,OU?6HR,EJVL.G<?(VM)J9XA B8V#B]_X>_%S\GTFN9D1B7
M6 (;Q!*,92B5-\ !/0Q)@D5@#;%!X9T)V<,,3C<#X-0UY<>; >>8HY,(M>_=
M=3#*%!Z0Q3#%X"P[=54VZ*3EBJ/@-I\NV2C@I>,CRI' 1Z/''U^05<U[E[JD
M7!Y4!CO?S5 @L20[YQ^H)9>:S5O-GWL66R4HZ%97$[=0 8C]EJ-QY7"'.->;
M;Q?Q3D=G"VYB 8-U[^]JDBEM*2QQ#KGF@K)!&6YL4'N+#F>1MS'[_K3A"V?-
MD@3S8[J38<!^#C&^-XEI/$R";S'A;-!.3MUKJX\XA6L##SW[6]E$^7J8V\H(
M?8(# [#9^AEC-HI5Y-838RZD*MGFV=5S$J2M@]E7OY\>)NFUBM^)<7S:YA77
M2)X_==F3^*NR?%CA3HSDH:N\^GVY\E*!@XV8\+2=@#9)#'<4I4\U_!B;=:?@
M055UO'.WHTG_*,V<*WQB%SP%5J;+$#0E"S=7**+%43NMB7Q(5XLS[>A0SXR<
MG$D1^ 8/YFNV]U'KW5D!+RK(&$+O;PG>D-.2SV9N5^@H(+*MGO.E9%QJX8K1
MOYU4Z"=-!#G&< 4QZ:*<S*'"$D1W>(\@VYN>@?F1G6:JM$P.[,H84LTJ\?@1
MD^:&FA%WWYV/-K96(\,/NAD<>)T=6C?>\WG]=546@GD2RKBE/[3E0EX3W_9,
M$WRL;NNPB1ET7'/JP!3B&(<MFXB'6*U4?MIK@WSN*R@##U+?1>B*Y:<U8VL'
M+>P"3_?>!DL.JN+>#W#78?970RFJ=1@P0\DIT\5"GZQ25E@8? +*>+9JI+4F
MD16CKQ%GB,8-)K)Z\(6(Q6XZ9[KNLT$-UQ@J;%!P*.O02@FGM'  XS2M=Y&%
M29AF@UI*?JZ,_6K:+([F\ M8$=(VT6LS]$+_?@>7BH=K/JU2,_+U)O,]UY><
MD^UP:",I$GA)0@B7.!%@;O4N;7T%X><=7Z5?FNZGCT"8;M6EXQ_#?N_"- 3_
M8Q.F+Y9U(V\$#DA:,O@]C07&7'!TM>DC2Z]^PDC0 36I=^^8Q2I,3L@="GV!
MF>E$,/9 &%\8UJQC28*8[GD((&C,LD ?'MPX#E?@7$,B!Z\G0]8],%O(!1CC
M+?R6Y33KN'?,G2:LQ7:F#,2I&^TK2'UH-? :GS!.FT5GD7"[IZN/;N *N@[3
MJA-_/?2;FJG9RH!,6Y1N<Y8L/ 7R*>2?J(A'_O9]=^M_WBKF3T94?WR#_L>?
M2^J_X/B/0@A!"H<7TFD]S(\P!S!@ :-T$0_C21*_HX;N1K=G20U88IQ7M>JF
M,"T=Y]Q'9@PVO5-'9W9!]EAQEL>#WZH_F^5GAPGHGYU215_U,N![9AN+^9]P
M;T/R@UB&I"[?U*F#'3GF6:(/I]'KF<DFG@I5E[.*'R^BO=.0V%<.(AVK;>NN
M;9D7+"N.E(RF9^8'?%R/L_9$S_X)CEB284T80!;+$"B?6$I+W,8L274B'B-8
MG,B@A#DO"JWD/>%W^C$C.1LD'\E!(SV8.@X"FIV"K7;]Q&_Q??VJ^XPJ[O/R
M5E>1NZWHU\#JT:+IY(%SWG%NP[.]D8S.K[F--[CW."4\C"+NM4L-1%7_G,JF
MI6<FHWNM/^(E-XLX"2\:=OE_^<!6/I7*W40,9O'O1YE380V5=TW6CEZU>B8>
MY/^U0*P17HY?U">9V^>Q!N!@\Y<D<CG5(W,5VG_"#]%3.3MQ=BB6=.MUS0GB
MKQCUK1CX"Y:*<\N /MI]HY+Q^U;H:S9HFG-5HRULT-?*[?)&(N5V-R #"8G4
M]J'KCMA=KY'L53YZ9<;_9]QH]G3_UF_/LGAFA187:W00P[>$<6I5R;^$O#W/
M!A%NC;N =Y83T$U3B[N7$<!F_(5=XKZ=Z-!O(B>]DZA&$)&(AJ[44VOCII%1
MYG.M"@YQ8YEH%[(.)NZ!N&1X'<G[3(Z%36*PM(@^(5.L1Z'FL#MPOXSA,G$4
M\RWZ;N6B&*SD]*WIT^!*L!ELB>^<9M,C-F@7ZY ;^B2U,X]U[(?B^U[W;H*B
MQ/3P*VDYG:&Z>\\3FW7?JRQ!CK)$.ZDR=2\&#9[";Q7'=Q:.UOE+1+W5 .G.
MIW]EZ&Q?YV3<70#NM1<AU^BV:_EVOYU#/]1E^>=F?$F 0\4\T=5#Z?L$.*/K
M<;/=D>GJ*W-&:LE^VZ47E>=7'_<'C=BN::_VEJT90N1^YY/.+BQ=EF%:W4+
M%'LH#797RT VZTL#NR.KI>D&*/@8&\1;1<NE6E2(8]$]*Q:5%9$23QU?R\7>
M_5I@+*!QGV*JC/0W#7/.,DAC=2D5$%45\G)T#!8W7 +26D+0(DC\JSSCDY>M
MC,JE:S(_7%:T>SS6[\+,*G)GI@,9=$=6&XPK.)P*HX528EYI7$HJ3+$)6?ZZ
M$'8HV1100(U0G5B\<W0P<,BAG+(3B6TNESQQOJ?DN9NG,=W8S]Y+<^ \KNL
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M !O!\Z.N<?VBQG^<]4/&K:['+NN^"NGF&@HYJA2W@]'&_(!Q(Q)T:0"U']]
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M:OX];>>XM:5I7 >KUZ)P^M[JNP=.YO>59++U%--J\%J+4^@#C$/ /0IOW4L
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MFX><'^* Z./H1KK>?,\#S3EDE^=]@XVRBYLO8#//">6&:E*6[JW)CQE:7L]
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M*FY?<CVC2\7GX-1TA#<;I'@:]M%_GQZ]1"5O=&HZB\ UB]W%Z8UO@Z37KL-
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MNE]UYWAM";O.1XYQE HUW%-AFQ[_3>LNAMXE);+YQ)$^]OF'+4\$GG'1#UT
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MY;C(XP1@$D(5^VB!$O/]C'F!*19]U(N;0#=:(; $2B^$8IT)WH@U1% U0>2
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MPRIP=.T:R@"PIZNP)G"5Z4\QKLP["YC;Q087^C=/O>W;-[RM3HASB3(/--M
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M=/UVNB7J,"6M_NV\'E1^(*#6 'Y@O%V0+&T1]3@W^=1D2\A+<X%/S_1G?H+
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MYU ^0(!^'MU5L_*8C(C6W_.V^M'NQ6TGZN!MO?1TS;RB-%O_-\>Q4BS*FWU
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MW+.@/?I[.)T'>IL9@Y.>#7F#;3*+S-.\_;/"&QGG*.-X=<S0;5%G&A;T3F0
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M*QJA<([C=09A](!\1\]X]CN?UP= HCE'_@P+>:Y(R@D44'#22%L]1O_+MP0
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MC7N_C?>6??K]T_6!DZ[+UX4N^;]%!7%@Q3RQ/]L@.\4L+.-!P38HBX 4[GW
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MO!0Q,J6;453QDR0 ?=P0I^W0Q/=B3_6C+(]$I0E'7>/5XWIB($+PG >-0Y7
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M^"N+KQ9&]AM/_6%B?E;F]=D/.=V,=I-:5FR*-6\T^U%4GL7/<JS,*R_TPK#
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MG<^U/MK4WW6,OP-2@$=?=H8$HG^2D,=M9=-7Y/QQE[M<./3Y0;-M WIV<N&
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MM5CJ;I$I*1($70D%1'^_5(.':5)"X\<I8JE#0% &)L9<07LM"]+#1'<"S>J
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MCZ%O_L0RUXX 0)]2[078H 7H$/^M?$ [P%I *$@]2+@*@2_8OZ:"M1ZZ$C]
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M W#\MPH@W=P!B,5ZCO>,@H$\!1(778!0D9QD8RLR*F"%%W!P,4J2S=^D94P
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MOI;GBJO)1WY_3G _N&\IEZGLP[O;0B3H9?2JH4<WS$UF_6EJ)<UW8"Y<XP%
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MN]/F<AN0G6>KV-2J<XMDP@D [(""L9,R+2Z-%880:,'.*675_B:_[&*)?D$
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M2R^? !YAS:P9$4@P,+B@Y2GZ:+#=9_W0!_$W#<&52[&X1U82#><;O7E^*%C
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M0Y%.>>(4T[(.CYF1F&KLEL*4@*P!SCGI^^5>#MLL:Q.N.FU.2^*.G5(?0Y2
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M5[&D9@1ANY\3A.ZF 567:$ 3*_5J$Q@/7H<154SK0X8DQ&(\G7( 3BCUX%M
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MEP+=V^D'Q0U)EC/2D8(SJ/S";/NLF5[JFXNH0O>&O;_L;^YMV&_G@+PZWUN
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M'+L+#=CYA08,)T"/OGG D6=E"5+^=S,$VD,0YXPNJ2/3"0H.AZ_HU6#E9^X
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M]XHN567S[CZM:I/Q7=J=.U3FJ;G"+$-O0LNW&/L!H*Y%YXG[HKI!C"+ZJ)D
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MUGC<Y5N-,*2HF=8]MBVU=*?W";SB)N)!"G\9_$6;\F-51?_O4M"L_"D%C1K
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M8>Q*'!"WZGLN9V"[G82>&<]1^8:'\.>?U=354-[XD:+RK/$C1;^*#9$W727
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M4AWI[@%:-+N!'PB,S_IUKJ]=]7Y26TC2($"8,2/.6&$'W+E(@/,@!]'[=Z<
ME+@.YB\ SR&4APXA/XZT8P)I[BY3,W.X?4CHA3!+%^!8UMYOM8#6*AM+S+6+
M;8A9?X6'>I/;R':M%NC%(:A<YE77MS./8N/EO85@RG<M*U_*:$7O0MQ8CKN
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MJ<TB=@\LR(PNKL@.7) 8JRAW\M'&YCL+6P=[#^Q^&MS3.\<Q<MW"CN+9 <Q
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M@+'%/WU!!V#N%^W^14MHNICZB+ XX%<&,@,:=7J-W=M'KX+RX7XME@6J258
M9HV^#LQ4*4#NBC]_0P#:F W40Z8M7Z4\ &9' W+3N@TNUL5>0X-$-6!4BS8
M@'+!3H";=CH$ $,B*HY''T#O%N6,MH_0L+4H /%G*46,0<,..F*4 X2GX\<O
MND8(/XT7Y1<SU2)SN K%@"D(6",,BN<FQ0H/$PP! T8-QK.C$&<LA ^LNACH
M >KRTQ?D+@'N5\V6I/, MJ[.\P._G*H-8086Z*I>81'#=W3V?+C_H0"W[1&C
MG?J)/BK'OHW)0A+P6X:P/%@+X'L1/WU!^PC_GHP)<.?,BJ$!;@XV209SP'^-
M=48'>$"6YI!GP$46+")799" SG(&M_M<3O4T5GW->RT6?MQABZ(8S_/]\<U0
M>Q)Y^)?3\%-_"/?\[#:8R[C;#YA>'[F\L';8VV$D\?9K)9?YIPU/EQYJRAXT
MA\-,=5C8_,)RJ?!4AZ7GG\8MNG6SNV&[M<UI? #!HP;NV%\-LWV]!;CR^;Q-
M,4 2EPLE\1D16T$HH/^.>#CV$3A+2*#C*Q$8G0!HB(ZY+C:W-A#NT)@.YK-6
M@/NLQ71L.D[E*F414-5FF//2O/8.,':OA2/;VPQPE6,?#05@I1O\=CV'24 U
M'X#E]P[_B[?_> ;?Q4@+"UR*1U0A; MYDG^RL#36=:&$?P32-^N.8NZ*BV6F
MUK?;)&/XF41*%5E[I/DG><QS?#Z6JO^Y%Z695FX^ZPDREZ6DSR-.\HAN?@^%
M]&Q<:OFF^>;F\NSM(^I[@:62$RN#!V5"P0T+X?ZW ES8<2:5.Z4$9AX7X$:M
MD,[AFUI8B+=0.$\PT*.4K$YH4.\ '3%Y#'IPF=?U2['\1>]_&%09)&[35$ *
MSEM@8@!47:+^>V;/[A_[(_]]?QYT*H>$>:7N^%#5<E-^B\E9=V)/JMN9F;)P
MO6.?^V_-HGVD1OF;)26L]O7;YN^P2CY0EW\M!^4;%ONK(;H2YX(/[%FJ&&'C
M>KSG>)\ 9TYY041<"6)P1Q)0*6I40#QU=8/H@UO "I*QY= :J+^U)%,1(C9W
M( CZWR)I,0P4AX7K8J ,9D!L92!,:(@ %_R9[8N%NX(Q#.C$].&B?D18UE57
M&/4\"#0N_^1O&00*$O=&\G]/U66Q_WG1_W4O"LM!>MB'5JPQ+'FMB!_"J*T.
M8N6,0,;@UD$B*DW@T.I_#V^D#A;(L"1S A\]W;5$[\:M+^TGG^2<2!3FQNA-
MOSD$F;04+'AE5+PLTD1E9IGG0H5 #Z?E6-V=OM2N?DBS'/#2P%;,4P@- BHQ
M_=O#9Y %C!;R!>$E(0W^+>7\#J_GUN^(@=5;:,M=J*R+34X3'0Y %D)?4@!V
M4L[FOOM-?23RDE)QA+<*E>OC0.O!6+]+PF?A"Y?6MD0*VY-*>/![8&+SXFWD
MC90F168<'#[6&K_V,)(+LV=-R:E@?O+Y0<?PTXU[PP2X;*;*Y1L7#Q,T@@A/
MH=_JZ2N.H?B^#_:K;R[:V2X_N:G-XU!:6JO&FU=''YB[3RE+]6SJ)+[3^S>:
M^=16^O>H)=[V_R^PY?B/,(9'^VVK)O;$'8,=@  E",]@\K=4PO'P*0&NS?;?
MBHUO?P>-M\/WG8@#57T$- P!XSL5'TSO( +#>80(2';MXKQ5K#"=I NF+HG1
MU0]%>?L9]_!]#;T-OV?,FF,1Y^)15S<+E0UICL9;S]<<#;X>L<4Q2RZ[_K%7
M7>7TPJNN<\YV;CB6%;/IC9D]_1(J_H.AMO@.&O&'?H]S@ '_/KD/>;< )]M9
M" U./P<&5QB'$\/6[C&VY4LV 3[30T<^X[_#"]HC#;^'S']((;3XAIP MVHF
M!94&+5L 32CX <O9?0\7Z/[P[\[8SSF2?NS//)./:O8?"N96EQN-9E\_@GZ*
M^ZZ#Y%*L"!(".>)T5.V=;MX:MG61X4#R!1^_:"^&5-/++N4/TU(DUEMN-A*]
M1?/\3[;A_[4Q;6>6GR<IL: 9.SW-U3EW(X@2[TW!V#2QS;?G3EN2;KL27CC(
M^ Z"$6B_IY#[1\(_J,;Z%9?6M"SZ<BS9=?/960>>E"D$/JHY<D^[BY9/U(1M
M_>Q+GO1-,=I@:A*SWF#^^F/7?&(N]1GZ/E U:K8Q:Q[-[%?!%.,*&=P%IW0Q
ML60$H&^)2F8??T8^& O16M1KJ/UW!AQM_A']=>(YJG[/,-)F, Z><'_MO^<]
M4 O!2.\//K+M?U[Q;WE%PU8FL8G G'<AJ=([!76L=COQ9)%BSZXV;[MF\Q#Z
MME];LI^=)7=8ME/]C@4-^'TQ,L[>IW_#>\6JLIKJ3N4C<-C !]L6RK0CKMOZ
M49>%=D$>GZ9?\W4FKM!]CK[$9_MVMS-:A-ZK #S?TX[GB+T)PKRDA9!,#-4>
MK/V=WO+7HDWE7P[P'\#N &+.U">B4R#6!L@+W_CB.%)Z&V:N$N#$^4M_2_&?
MR1B]!7E!C<7T,J$O;((,L@6 ""?R:P%N<'L6@8?!171K^N^-R:U%E-?3>4[8
MZ];D,IWQASFNX)P>CD6D6J@AW/2 !##<[L^>!CO,+*A7/"*=G+I+6N2KUY#%
M[W3Z2QG+HY7ML^2=BMT]147O'LW:Q]RN]R^S9]8G+3S:9$6CK_EW8K$!/!+T
M04^ @U)AYF9ANIPW?V?RJW_\HJ&7_KL."#46=90/0,^$4&'FA2%K'>PD'^"X
M*$@<^L%]^./U;[H3*=_W9/?_>/7^"_ 8WEZ/KO!)'IWFE[-N_\#E#'[F(2.1
M?,('!\?_%.I*RC/AX$W9M6</HR:7:Y.-9^S\X&*O95BU8IOOD1L:>=<<PFL:
MGM4AIB//>^5:)%_Z=:\[]?5H=MT^&QU9ZU,V@[T_NZAN?X]@N+_998+W#WZ;
MVO)_<MS\]SFB=$_>+@MN+FDR%QOQ2=T#JP\F=EFJ3V_Q5J&Z'!IS[_7H]B3P
M3+ JKEAW1JN_^VI$B=FE7>D__=.GK[7%"E$5<H=<[6.7;..%]Y!5A)6?,X,9
MQ?D3OG8-D]EK'U4F-N5%6[&LE[N[B4=;+6V+/OW//CCK_[=]</G"FAO3,;4.
M;'I&S1!>[4!&E?@+3=L>RTUZV@_;EJI.H355_9[>[*?,?!*ATNHK7OM"[WW9
MY9GV%_9V:"D-K-<+M*GST:CTC.R*';%VJ>5#18<D7Z*S6G9<_6*]HB[5>,N=
M=^Y*%K%;SE[?,/WN*&V2^VLO@DW:&!QP9\'\&3J@J9-!OSC;X*)&A"# K9,0
MBOPE&+4G5_ZNC+^B_HB,@6%HT3]BBX[>!H"V2ICD[0*>_9@,[JA>#29A'UZ
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M^-]\_?J_PF G.*!@<"("S-3BBJ-]["Z,&-2(-*\'GX):R?2=GPY3T#'5J)B
M9@GWWS*P3I6_B@M]**.^)_-X+J859X;ZA!% ^[DM"A%H6$(X^] 7J%:-<7T
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MJU4.AQ4JF@+JLW^!F:?TZ%L<4"D7!_/Z\SF@#Q-HPA@'%+2]JXOY>\</S<Q
MP*X@<M&UBG9<[36)I][A@/ZJ+J.;=_3^LF!, 0ZH@/&& 04J/+A$'<(3.=MG
MP@'Y3_S.XEO-)SZ=?O+F.URG)L2:<9GW>M.!!) P%537T\$!T2]R0+F._TJ:
M>3$LN1I8-F!4:Y>A\[S*>\);/9PL/;M>"G,AF&A#%1:&?@IJE+;;Q::2\7Z8
M1&5M8)IQ"ACBIM]'R.@8<J!;G[+2^[&-#MORA<'@L')#VK/A"8F!G0'#FVFO
M1#.K GYNLX5.,DZMHAL64_%>: 'F7N [K=T&2^,J,(67D6[]X]=1H^8Z[_.=
MQ[X_E?;U\FLY\G/HVW*I^-N1C]= (+[U3:F=[1[$5]737"5S^2LR#+"B15-@
M=,D%X8E0N!B@U[<H9;0HYGS]NNU]3Z.67\?]\YWVRBU)C_>[R(7D[_,\G-*P
M! 8TIS>,2 H#'%!\^U*ARZK8.OXKUEP_&.RO0ZZ..6^S;%3VGCA;;*KI>-G3
M*_JA0[<E8:\&ST)E?0Z:])J;#1T0B1 JO&@D05D8'_N3X0&\HID0WA^NGOTQ
M;>+8ZFKWN5P0L6"CIG'FGJ_N^6,O_;QR_:YY6PW4 KGT'ZQG4$TRGA_(<@0>
M/=A<FFY#[/<-5Y::V/I=[+E!SB"<*>^^\Z>N@5='E3^\]/&GTS>L^6J_>+A3
MT4M<-3[/"$5J36WCA)!V1>Y?7D[4A>J)91S=8EA/-%?_2#[@>@G?UO&V[6+Z
M*_YO>Q[]"/@&!XREU]@[; %/'_,W50N(ZY 4G):$A[],,'1'O.J"B8U:?%,K
MGW9O[MPHWP]O*>IWIJ(]"T^& 6HC?>@,!)BM$EG?@].F9N9[WB>ST#WFVKBQ
M+1WW%ML3BT4NEZUK%4S%R(FR2WS[D+/<Q"T,^-6P/T"H%B/@_RB+YP.?/;#$
M]\A<(S*@1UEZ:HQQ#1BJ6S=%I^AN#1?:^855K&'SC<=3H'^5'#P57*RH^Z_N
MV5VWB$)L/*4-].*E.*!;]4F0YJ2!4_KC/41L,DK>S^,0+:SE"\-0_OJ.L\6]
M^^W#*@1Y@Y-FGZ]8?8HT2B#A 4V^#>^ED;3WD*Y:R-*^/)0ZS;TFWQS<1.-+
M##MU%"+1D_:N;%PW.+ T[JH=_EB WV%>U,WL85!TAM027@@=C)\Q6X(/#-^G
M7P<":.8Q5A2^1%4_J TY@CI5'GR_[ 4HZ=U.[9<;CL+M<A^3%MHC@N16.U09
M%Y%RM)$^C"033/V>H@?I71#$9J(EO\Y'HG:)I\Q/PB;-YNP$>\X_-+!J&7F6
MO%7T5/:AZ,]4:HP66]"'(<85,1(=1M37L(RA@#>1Q-7:#G%T563$U<8QI)W&
MP.#KM0CI5<_*XQ^(.BNY42JZ(4<1_VK87,3?0.QAVM"<>L"2[$D<&$M3CS6T
MG$2ZEQ]YM8)[NG>.$-#H*>OM0HQ./N1VY^_63PWGKZ-\[[YXJ%+OLP5-&++L
M4<R>ED4B@I3?'TJ#Q74<CS'"I.C]RN"[G+=D6R@F?ZVM29H+'4FWWH;KB>TQ
M#PG?N>J.[CZ/]@Q S-P>H!,A\C?:@"N5VAE\F=K- >MI:M;?HR-R["6%1RV/
M9"SMJ FV/Y0;$GX8[2#5 V31\P 9LEZ\*6P@!DTQ>J(L31/I?()3GG \J1;C
MM)E<'Z!4P_\Z(.6U(^_!#'G+SWMSG3%-BYM8QG'41(D&3?TA2AAYT01UF!K:
M,$#!"P28'M[*JO$[<N89<0D^<3!V1>WF'_=7@O,I+\ .I?_5WJ.T:+;R(-<W
M]W!!E<$%U;JG7%!M1A-F8*07L%\(],_),?Q?:5QH*?X+Y+=Z'.R'6Q+WZ1IR
M4?4 <^[??C>S[,1G64R(/0>48Y[& 24UHKM/HW_@.*#EZG+T3QW4<^Z_GS+7
M9IX&EAF0R'.4_#X=-,/>8Q+6;#X?0W=^L8/L/+LB^??@>8O>>Z745R<&!]6F
MN2EAE'O:$>Y%( L@#JBMGET<K$7#*+9%)/W,E'CIQA-??B&HP_Z)9H](O8\#
MD69#7#4+#&V'M )"O<\MGM]+>'""Z>TZ>DUMPN?J?1O&A0NK-BW1QO6=15LQ
M,A:23C]?LN[\Q]L7IY6!#4_:_3X$]3J&R$?!]J,/(,_11/,9ADQ=6AE.!(@A
M90D&_#%U!<:O8L_G;3M.ZNHHG]S2H0_M29R.C*]Y]<G2*Y"]RCC';:W)P<9Q
MY/$ER-?J 90.@*Z+]!E8@$S]AHG\8!OC[!3ZY,-*J@/N1=R,\#$<WN\5J[GW
M8U6.M&#ZBG&H"L3EBX<1+9@M*,<01_(#G<%4,.7[YDFR#KC?2=YAX?6"\ON)
M[G>M3:W-.5M^6WOWZKP2.[\E?^M15\^6&H\;>9LI&4=7!6H9IEQMWI)$&"$*
M79A$\E6O\UF/&45'NV4;OWPC('RK7\@R^?IPZ*<R;8$#UDM/'15'^;!7N,AI
M0/_,*H+Y+LK]6^W*EF):^"$=R-X93 L2*^)\YY??7)R'30[K)+X4EM$\X!7X
M9*"A\=C H;>XP]Q.6\(\M^/U T( #H@2\[NNF%QKUSR,[@U? $_6_8HQ9[E<
MJ5F>J-WT&-;=E][P3!AW(SM/_^4'5Q!]36L$I8.:P/#B!(&2\2ZVT=3O@(SP
M/Y=R+Z>=I0[$_]8)^:N=W1L8H8,K"H:^[>[8.&!=E=#X,F6?8WW72.:B -HO
M.($8T8]YA#/$TL )OZ-T[>VF=&YEJ[8%1*<$OB:J.03G^7I=S([#JJK$GC8E
M:OWD@-BB(>]I: (\%L/#/HP\"C0MX?D#E ]QY>8ILGO(]VZV^:3AR^BR>5=_
ML%%[>7EOP)!;[[F'2G?O$HZ\0P-:D%1S'72W(@[*_KRHA/?,RD*(AXD<X";)
M S>H21DHT<@EBFXU)4 DA'@C'N[_OK;OTU13Y=QKZ^LB/\\\57WP8<_N%PLD
MC6;/%N0&W#XRH$5!R )F%*M--(FA8T]F/S;2DW-QF^\<7[U<\.JA&L;'BO4W
MY]J5H'?/OCU^MB^S"CV+IU]&)"D+ !7E3-<LIS&VFA^%T>6XH#2F%W;*"M'Z
ML[=6IP[C)YQ__ZBJYN,:JX\?=HQ'^>J^>'A2?>B#K$*8+QP$Q%'@W8NIX<0%
M#%ES2X7FT.SH=-Q?7J=7<%BG<SZ^H7:RN?L:YHAUWKE,R>F5[9ZL3$C#(E,*
M3^]CO3'?AYJ!!$S_XH>>>P7 21U.RK(3XDR3H%9]PVEZ2&>#O,/Z7$-!G=?/
M;P</6>I(^K_@^=V3"MBR!;)?H;N/P[SJ19G^4WAO/'&I%R,5I@=N?;PHST14
M WD[O5B]L$ _->D-98V9(P4YFF=L;VQ87QL8DA?=9@NX<^'I"G"3>]0!(BHC
M"83P!XGYE;C..O."4@]?F;O-KD9UI5-Y8T-F5M_DYH4OT=32/X[I+_%;@W8_
M_E?\%?P93Q2B;["J.L"TH;X%42J^#]:X^MXG.6BS)A#_=@/Q,>6PM\,<5?H.
MZ*0:Y@&74I I^%8KEC2$B?VUS;:J@]-KN4SP&6V;E9&_N'NR>F2=^7.D;3J]
M\ONSJM =[;.I;PQS:J^H/2G.N4Y40WLM0_4(1OHUT.^/2F?C%8*>* 3V^;/&
M9V'_Y57KW_[[QA:C@-- A@/VM9'YE/I_A<V" Z%GIZ9V6*G\QN=5$N@4R=.H
MVYXY!B.NS-'Z43B@EL1\/"*._OJ5 ]JUY44ED+"2]XP#!D+? G-A_LUS1\U=
M)I^_"E-2*C_2_ ,9D3(C:I5/+;[P];J.Z?VKB0WQMWX_6,OQF7QRQ0+MC?E$
M_H_I5=3=-42S4^\B<-2**15'@6R(D" I;!5J4M?(S+9-2W!JOH?PU)'Q%KA<
MP!]U\=7$W?F\:%N-GDN-_,HGU:*CKC4X72UI87AS<4$O=/X^W8F&38+=!"L#
M!#*BUZ;C>!@DJ9YIM!1SUBSPTKT#@<V=B2Y$3<<[49:D>HPTB_:A3*P+<NO*
M=2Y%)5IQ"7-7M)T43BNRQ%;D7*^]H3Q?TH;A;(;MM<DCYW<.9T[U?SP9%%1H
M^!?S,8.N]^FKXB1\YCN]B56"]J\6N;U-LNIM#[R-%EE3A]-TLXV>TTWSTL)&
MMO3N!"VEKHR=BST[+"^QI_^N+\\7WWJ))+:@)D,%3K$[0+C'A'<.I'380I*8
MQVM-XHT<QHQJ[5:.U=;FO0Y$]86O6-QCO'F.VOQ\-]TJ<X3KD4\!832IXD']
MAFA]U2PQTJU;PGV=. [87WYR??WJFO1;-^+LLY>W;F8:W/5ZGG6X>-)A1\&+
M9V-7HUX0*.">KL5*-1=#K%$C.:"EDRUOJ5MU[YU2.NP"R)T7ML^-;J<=+0K8
M=%R8V;A3[NCM:+-B>?:CK.:AAZ>F4O]R24HW(]P/TE#!/+ ]@%=B\E(FE-7>
M4Y5?W:.N7VD<OXUOS0.(*PM+GQ)/'N)_;?U-1--Y$>05&]"'OP'[NDW79977
MF/.R9V'\T)N433"E@C BY)=!$^J35^I<R8=EUNDV3YJ(!^2X=RDX.16%XOQ\
M;H3L>Z8*@KQ\XO0]B2GSBOX^E^Y#T]M8YHY46HD9S20.Q0/\H3A,)O6/R  7
MUE:FUK2< _?E.8+#_,]3W>8N?AY_=N'C*/%CU5=M<+3)QBGJ;K \4X[U&D\J
M651@V@:2*I&!/FC*B&AD ,5BI8*,D?(=$?Z W2L7Y)WT*?5VXA7MPQ%5;?<.
MBC\!,2ZD_AQ)1[?F;RQ15?OQU%IH])+=6;1$7?SNY$ 25(_L#G>?T GM"TFD
M1P?J+U#<HF-(E7D6UV[OVVM]J*.(3@$JJ&[T=_\^<T2Z >M45<H<\7MB$!L<
MF>M"'4B%RE "VG5VB*O3W@K#+3DF9D?2J[O5%1Z7)=]U?&A>4XK[-]-Z$6E-
M=>K9!E3YNN I:,D.3\_2'^]]NFLEEJY-&06TI,I>F[4T,6M8<W[(YW@;Y/58
M:Q(GAEK@@!HK!B#I)OBFQ5ASU7DB\)-PP?T28C]0WT,LB:NRO>7FVYXX:]^*
MS:$(TU9ZZ^)42RQ T2)2%-0)[CU34!\0HF%*9\?[%@_4OV@>"UO<L+/M%8L\
MY]CVI?8W_,3I.V[VB9,U?1\*XH] S#Y)8+0KT7F=C?_+UU[]_QF4JZZ;_D-=
M%_Q3UR[_-FROIF[AH\QU(@^PI;-Z\ >0!NQ)!IBIY@'I'&//?HO"^S#.@V4*
MFD*V9_%F$<)+<DH!Y$7@'H+EKLYV@;!F$9E 0<^[/V*>;W_K[T+7COLQ1C.*
MM^EE63D4:)-25NVE:P<_Y41,ZN("(9AFIQ\RS!/U[+I<#D@[B[WYBJWHQ $Y
MV7"IL!4'%#Z]@J:)1,ZR'Z%_/D S"W;0:ROW.2!S_$]?#JB +K-1\&\R@SK"
M'J1G<$!EQZ9?.,&H^5T8:C5."O A8^CULWBR$I65ET]?5/W(L)HA67<,%Q7=
MWBR8;5LZ,;CNSHN^0M*\E+G_Z<GJ$_V:NV6YL(LOY<[&>^J,(?YM%S;E+_4W
MC@/B4^* !J^R$F$;5*@1!_1JJ7Y\C8HGXMD"6 :$/;MPA#J=AO>KWQ.PH-))
M#:HLQ"1DU/?:15Q,L^VT2]!]F=A/EQWSUBBSP=[M[O[V;2\"T$1UTA ]B]1+
M'%"FN1H@.QU 84 2Y)ELY5PXW^;Q>9WX/F7%$._K01?OM^GN647HH0;D85W!
MF5QM?R<_":FGTUH<13;#SV1N#;GS^>0K_6XMUO?X +?(,_OZ.A?MD&URUS+@
MEX+EEYI?.H=$)#[:%JA@LX8L<9UY*XZ0S2$#@P\Q,RE_ZHM"N5E,;\.*'( 0
MC[3M,1>G&6>1T-)K(?[FAP'W\LCO]E@J[N4]U?U/<(6YR8Z:_'MM0X7V51EW
MW"E[ V)^[G@/M' '8U\A-S(N>S"#\V@MKQBN3-C/Y0F!'=$B>N<YQHF<N:6-
MO=-!Z"2I/Q6;,!H/^78+%W;O )Y4+FP3BH\PZ,DM@$7U6BON!,VR/(*5348(
MVB);QZWOO,@[_F9N,.R Y>/]\94N<J]/2T+0K!K\S<69?#H1,/&D*M 3@ A6
M.7E8U:EI,O2$X;#EDEW1!5R+<.L?Z297:,CI'W5K@L?^NN>_[+L+D\*3'F/>
M6O5#Q"-Y^CV. /"JF0"TB.%J* <D%+"@1&NM?>VOY:/5D7OF7D1 2.Y\3:.-
MP8=QL_:.'8/C^A^<>;[_>PW%+G[S ]*RO3GR,C*N[^VZ:SP,LCG,+A=Y'CYX
M/X08TESW]N4A*&X[7]MRP259C<@!Q2&X"DJ*CJ%?@W+CJL*E^L=(+)YJ&_PU
MF!X*U"_!,A#[S(7 P@%L,VRF4E",C#NN-57*^KQ9#3G3VU9&XY@75OQ#R**Q
M@-0X^P/D[?3&,&-_Y/YU<O!&/:D83L I=TQXXXML.FB)U56]6'W%P:,B9]?N
MB]\?NC/;]C,DZ@6XA,MKONG]/>LT,,*0^<4!L<Q<G/I@K>"-8=A&$G6'_N]S
M\++(7 )*%?A"U>I>X*<R(;+FXL Z D\[C$F2H'S> TEI'G(_&Y6C>3/"P>NR
M^%E+R4/03$P-NJ5^PY-AQIY;%-)%\;/'V1*3T'-DLY6,%I']XWV[K_.#HY8_
MYO0?D98Y]K?;*T.1;XY'1<7+L8* F4DC87H6'XFS/Y7(4VN'IQ]Y<J5F@Q-A
M06TZ..S9Y^)O0NB&_(DCA99)@WMAV@WN'9Z%(. /6VB1]OW2%(R4_GYZ8"3.
M7#TFN&NW_PWYE)73)-.D$=T*^ =Z#'[WQ6JIEF5+63I=+5?S#COJ[&3'.,<>
MQ#3Z;,91%\EZFQ:T"CJ9]B<=>9P,E_==. HXU/F9/!!Y/[<V-J(8OI>O8:PT
MS].P7O&6V**!&#]OR*DT>C3W&?FP^Q8;OW</>](C@)/4^LMQ7?*;"<.9Y:08
M=#^Q'UMVJK,?"8R-7&TOD76\V+JMXQ2^,K)P<@<_H\?F=^-&R!=6"NX8@39
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MNT3%O\8KE.7Y'-D_QE_M_??:S+;EG#Y%_Z^%Z_=+J2QI#BB)AP.:Y"J^9:Y
MG)] $QYQ0&L;Z)^]'-#6&GN- TH>).-9?.CEHXO,&O9^[F\M2C +A%YVA3'?
M,E?KB1! ;9'YBM$%^2/% 8W7+B-7.2!1/@ZHNH$#&CK  ;57;T)F3$A@IOZ?
M#0Z(.]X<4'P3XSX#O(F@&3+X9CHX(-.M@*S?'EY%]U8V&0-F]_OOPM1I:5F
M;6K;[<P#6KV,"]FU<BV#5\W7$L[/?Y>M_=;<^7OV_N]%7B9T252"4OCUT[3(
MQNK']!>84R>C/X<2'>._T=,B6IH7/;_XEJ:R V$5_]'?#UQ/,0K9N<QZ"C6A
M+;$%3&B=,K9 ,;6"4KSPEAC8$P5_X_O'D?[6*GIOB7=\9UON)SD%W<T16OIO
M#/5^1/RX%1#,.,4\1TU*A9XASP?TPIH'$CM4Z_S-Y6E2"YC#].RH8.2.VX7
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MW>WYYI&4B<\NSUEY?"YY]LEA8WO+$>_RQ\VZ?"^^B674;#$#D?I8, R8CV,
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MN(ZW4S- PR4=]8F;E'T,[#XD&Y-7!I:]V2][\7Y5EHN419P)%  N:: X):6
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MTV0_@Q29-A_0-5@=I0RZJK'!]=A;U_3WJ_SNJR@>/NAX("6N.DZ*<:S8+PR
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M\.I"#%_)C\]" YLMLTK/[9^;I,I- :C;]5NAVB9+/>MNU)!XVKVOB'X!8Q9
MGU* (R%U(O8 4,Q\(*5:22/B\]CNV-2I=G-;<__ZER]_\62ML5>V*GMK\L,K
ME+IVTYC;?C2;JYZM=\9>VTLI6)6OJ*D,HU2LTX;L&ZH3^38V>5NC#M^IBJYO
M7!X]C@*[RPG%K8*3SAJC8'LX-8PCY,I*6=6U6WO;MDAP'"9(^("$201@*A'
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M5P$+5O@,#H.<+E3!RA[CX$<'@0S54O3]+DN^SNU=>S O.$:0<NTM2/4"$+(
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MZ!I=718;,<'$;:V17HD3EQHQL?ZXTHC16\,#K%]G)5NN='+:W76Y+W"*L9"
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M1]4;KU'684XY(U"<9I'KESAMWC@CZX\RQ9F]-? R*LOUPJV*+%_@)!%!X".
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M\/6F2[1H;KIDB?8V[J5*'/#Z\'1$C2?'^FGG>M]F_UC@""("DT@?+F  &>>
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M8^,S*YN1QQ80-;;I>$@G==VMVT;._V=.U;/8_"*)XL+B9,1J'@P.HD*A&Y@
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M1#B'14FB@B)!DM0J3=";96.+7OHOZ(WU]4*A;W^KEV*Y#/,WG98AT9"3-&
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MAB%EHH1(O5 @CM6"G0F1)@4KHR)*;!;L9\8:VPNC,Q601M)\"18;6^T"VG,
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MQKW]+?5O3_/%JDD+^ITL_BE6]:[OUC-[6C6>$G,:#0'T$+2YM?L&;"R'<KZ
M2V5[6#TG!]A\LZ+Q^(.SH"TRQUC/^AZN+">KF3Z"G*T6%5WK(TC=)_'#\\MT
M_BH6OY,5>U++SIW?"_4EGJTFBO (IK*$,8U2B K%>313/V4Q*0LITBPGPH[S
M7$T9&P.V)@O >K:"W\@2$/#2F&PI=WW%-)GRX!#@!V?%V@G0M[+NXGH#.D=
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M2;N[#KLKZ>3QP;ZDVUV<A>CXFJW^3G1"Q.KUEK'%FDR[UI032ACG)),PH;&
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MJ,@'<4@B7'#,:1)S*VV1Z\P9&U-=2*QUEB&Y<M+,"&ZXJ0@==ET_"_;UK%[
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M.5]H=?8)S7B9)AF&"2K5@A07*2QQ$L.8B#S+\H(F46J5SV5KP=A>"T<D2&[
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M.M\Z&^"P"=&V9Q1?U0/]I SYNJB8^#B=SQ=M2B-Y%),R21DI\@RR)(\AHJR
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M)>=.3$:-5)Q!F1 )B4PPY-)N2I5K38<IE1GR;_AP3=K8"&L_AUQ9_8+R]:\
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M82Y_I_Q>()&^*3V_$^HOR9?J2_+/ZINQIVK,V2]7\8@[\N6RN($GO5RU^W3
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M[4:>#@*Z\OENWE?%-[KL7=ET2WFNBVI6;S:ZBB5OEA.:*U9@7L#,I-2Z6L1
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M5570^OBTJ9IA?C1O^=(-5U]]TLLOW_C2JC'7[]?Z<35)!.4%E@74)A>0%-A
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ML_\LO;*&.\@>&]-OM0-3IUX _P1B[D'J_2'9,[UO%=]G]$/=[\ .Z??](AW
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M:TK^P6)^=-K-'Y9:^Y_\^,+NL1V/"V;OE+0/VIZV=Z#6%UB%XV(8L-&.B^5
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M;&^_1M>ZR*X\F/BNE^NRT=5\L;ZQSBY@3?Q\[GZ0[OGM=3(:=HMZ55!7J3[
M>%@?O/J;$-LJ_06'Q/J@TCXGUNL./9RZOBX?UE4YTN+U[L'=-7>?Y"A1A*<"
M9HQS2"ASV7LHAS3G!&O$4DV#SC%N4V=L[/=9/S5I_<X'D5O]5\X)L5_JM.'
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M.+<R1T[.,+5U6],(YDNX?E#PT5#JZ,(ZC6;W0O:"T<!KN8'G>@E* D%%X;G
M.$34G O02-$TV\+,34/O]0-?@^\J5[OOEOZE_@$(OBB#NHH'I=8@Y6M?6=!=
M>'5&W!S]X'C1-EUT[T3:=#[8UW)9\_E2GQAYOM3&;E&'DL2"4Y:D%&:8AA"S
M,(,T53',.,H2BE L(Z<Z6<>GF9I&O)1ZP3Q7S;;T47HNYXZUR$Z@2:7,8B$%
M1)2:K04+R%-%8,S#P)0V1H1)M\)PY^,Y3@FXAD[0$.H%3ULK\5R,!K<6]\#Q
M&/]D!X)? _+H3",;DEW<'AJ4G4_W,"R/%4LOM,J^4_GC^]6CGFV6A%D<8I+
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MU=K7QIA VX6.JK:VGSFE9=N"^*2_^\=?FM_H+Z;9TS_^\A]02P,$%     @
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MN_[+JV^?\=_^LIR>?3Z]_-ZG!99_^TO^FLYH4<&XV"SY7Z_^\J]7JW]>X)(
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MXST>P [21H_ VI[ZKD3CG2S@<JWGQ=H8T1KZ,NH2>70ZJ29U_ _0,W9&]MB
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M^[V?E#O "<6F\_/:-N#C^_H8)"SR\H_/]?KS1;W17$Y)0J^GR]7$F<R],YQ
M7Q]SU\ZJL?;'((>4%:.4($>R4=)@%_HZ28OO"8.[^8+!==(!U&Z7^+R:W;W-
M?#<_/7TY7_Q)/$\*A:^Q-K%S6/O0Z[7%10&E*/(F1-"LS22X)]+9B9L_#/1:
MZJ@#"-XSJK,(+U(6H$7M0,!Y!-HU%H3."3UB<6W&G.SY"K$5C)KJ_?:A>9 2
M]D;1Y[6'1_MEL1K(P[HM(!+B9BS+O36%#[7925:H$#BY'P04I8NOYMR#DKZ^
M+I>1G),V7MD0Y(\^&.5XJ#V^NON"^F:(X_52\,U&?G'V^73^#2_:_KP]#;-)
M-B9F&P7DXLBG3C:",]9 2,4QC5IC;G+M_51"1Q_6<ESXME)A%\]A'N!P/2CY
M/@9)FEXRI\"QI#;>L]>:0PG9&LM-B;Y1%>63Z!Q]+LS8$!U$@3WXGKOLP,V8
M[_-%^D3"KEPN)URKDD.*8*00H%A!<%(&D"F7Z()%'HZ)T^_1.WJ#];'Q.JA"
M^\7MC6UYA\N)EJ((2ZQEK1.H[!@$63O=($6EIF1F0CNW]JG4CM[H?6S,#JC,
M?A&[V9@7C+TI=7CF:ED3^[4/DP-E QTCM"E)L*;4EH1!.T-^4&J29GH2E:,W
MCQ\;H0,HKU]DKK??'=X$NE)<<. +MQ0@&O+ A6? LTHRVN!"F]KAIQ Y>N/Y
ML7%YN.HZ@.759>?RP_R!JMAG\QE%:ZMZ^5![\Z_'$:^_M:3??8EA=;[ 24G$
M-"\"(JLULU;41)[*D ,F90TK*3?Q58=B8/2.]T>#\R@J_T&@?JO\[DVY)8A)
M]EG2]E; 62W3#5)"T,$"VI($C[3)8Y/&AD,0/WX7_*XP/JBNQYXKN@O#'\+7
M;1*EC@SX+OOUV98IRA 49:;MG3-$K>J$C)B=4,SJ<JMHY($9I,/3-GXK_>9(
M[D&KA\[]^G"<N.[J9+K![E4OFTFI]8DV>6#,U;GVD4ZJB 5B,(H)A\&I)E;[
M,++'GP$PMHO=0K\=>"*/!13?97;=/N2:89BP.KL(T==[1=K1)DEP-CEPSECD
MS"?6YI'RH%R,/[Q@;*P?0?L=0/_&:Y3-]CY))%ZB9&)\QAPQ@#2)0F=D$KP7
M'HR5PK%D;<0F?;8>H6G\00='@^50FNG':;C!T7I[73#T;+Y<_1U7G^9Y(F24
MSB<$'W6N!4@&H@B"W/V<$QK-%6_R8G$7XL:?AS .^H;053\PW,6)_T=8+,)L
MM3D5)L9A,H8I(+JK.\,CD%P=1&_0(9<\\R;IWR=3.O[\A*XR"OMKL8.3>1<&
MU\=")$FO^^7A;+G6]3LD22^G*W)3%E^F"3?^S#M,\X^S]:>L]_,$C<G%: 8&
M)1TBW-#NY=*#SRZC--$GT<32MF9LMTWP4]S0=861#O;,S6$$CMOBI"E@F&-$
MO*8 5-2Y9%S$I(NF?=^DH'R/21 _Q;W<_M+O #J'-JC520FKD$,QLL[M,0A.
M9PU>19E<5#;^N$V)^4]QSW9,#7< Z+MO.T2)6*SW=1I+?:2&#)PI"5PIB6?#
MBF1M$E-[/; 1/\7%UV%:./#9P8M9[NE]36*J6*LYH%<.%/D/$%E6]"<7BT:E
MI&WSP.N([VM^Z#NN$?4]*-*/,\XN+#^]/)W_.>P N\L/;3FR[G[*AV^<?;G0
MU0@!([(1B;8HG9B@2BU?Y;1CDV-U5' VFK?NEWV'J &"COJ9;Q?S+U,2WV_?
M_J!8Z]7L#2$SU)?C)VDU_;*9X7$I!N4P&F,IK*JUDBI)B$KK^@C-&9U2%*J)
M&)Y.:B>O^0_%TCVA2DN==>#^W0S&ZL@$C"E0")80E!"ZCDQPY,!R%,*SE.3/
M/A2QM<H?#8:?(O\.P',CKU230K,T/<4;+'V8/U6:G.GL+-:!7H97)Z V0^ *
M4C+>*8G)MK']+9@9]['UD:$\.AHZV!'/D59.T[6*Z<^GN)UQ=W)6'>+_O?[^
M)')G,L8(B1E&)Q(YWD%I XJG'((3RK(F;9UV(6Y<XSL^A.:-]=D!1M>YAM]N
M9_HGT3HG51UFE"6%811V@1-&@]#,F9 BB[E-L[%[R1G7<G:'PP%TU@'RZL#"
M914>+M_,7GRM<CJ?+C]M//=UF:M#G= %A&A3(4$E :Y$K#W[HLN&Z21C"Q!^
ME[)Q^TYTA\=A-=E/T<?F2O0_IK-\F9Z2%BT6%B"IO,Z0.0CT#Q3#HXZ"I=@F
M"+]+RKB-);K#X(&Z&OOIQ[OG^+5:<EQ]6LS//WZ:+I?G899P7M)Z4LJR9E<G
M21?KDL\01+U-JGV(?,G$(%/!!1.R=[N]YMAIN7%;072#L$;ZZ> $OIHA?#4\
M^-7L"UZ4):,(R3G/(0LA05EDM(%2)*L=L_8L)N::#)+^#EWCMGOH!I<MM-C/
MV;NY0MK4C%YQ\^X.I\^GR\_S93B=9*4E0QW!^7IW)5R$8%P YIUE/)8L]"[C
M YX,UJ<2.FXKB.[0VU3/_<#Y^7;UC9@_A*\O-L?)]M7?Q#!))[3*H$VNPSP4
M$G_<@%7:QL PL#9=HKY#U[C](;H#ZY!:[.#\7Q<WU7MX$N&&I2T_$R>%*)Y'
MX))I4*H.3?=!0LU?J<BL=FF7F0;[%:;=1]&XG1VZ ^(PFNO'/-XM5+F4W+8B
M^5)L*%RNLR' J%HBBBH!.3$%2J%-9X(LKLVMY.XDCIL=.O(]3R/-=6 =[W*V
M;>R_) N TR_KZ1,Z<%]JP;*H$]M4UA*\*82?P*613-&F:](G;Q?B>FM)/@PP
MOHN_ [5TJ%%LA+WJ&\_H+]67\E+1=M7%@)#)@"()0;2EMOK5UC*9E;)-XO)'
MJ>JME?B1T+:O7CJ%V=L%?@[3?.'H;KV*D]EF\NFV/1HKJ7A%^+#U99SR$L&C
M=1"88R1!QX1N<CFX'[F]-0D_$C 'U^2HB%TG86\S.;V2Y>OZ]8:I,,NOIR%.
M3R]Z+4R,,#XDP8%5HZ]"(4_;: L616#%9)5NMPI_(&V^)P&]]0 ?%(%'TTRG
M%O/"W7@;OE5?HY:#I+0XQ^NL3K3CF+VUD'/)=;JO@XA%0=8LH_>6TQ?'=1,?
M([>W'N!'=AP'TV270<Q%F^AWN)YH?ITW$EU2T@FP%B5%?Q@@<*W 6.M4S58$
MU22%_A0B>^OU?21L#J2U+A&Y=D@N_)0+SKY-;.WZY6O_75]'[;!:^5Q%R:T5
MQ+.T)1\IM+Z?P-YZ>A\)B0-HJP,4[IXEFR3,,1@O@>7@:AE)@6 HR&,J9*EK
M3Z70I)'+[B3VUL6["1(;:6Q_+,Z)LY98W-R&WI^QK3/','$&UC/R0F)M&)>9
M *>%L1')H^9-_,FGD]K)>,TCO04;2F<=6$CR@B]ZQ&R:>)U\"=/3ZAB_G"_>
MA^O]#-<EGCRX%)+.$(JJ3]0E25,GVGX\6*ZB4YDW20H]D<XNWY,-!IL[19'M
M=-A%.$Z"3(AY6;LF5WXH9OM[[6M/'LF;\C"S$Y%3D5X%$%%[8H_^%%%&*)G'
M$HJ6.3:YW]Z3WBY?CC4#[1%TVJ-]);[)EUE]JR.;5L1TK8SZ7']E$H/U7E-(
MQ[2/E;,,OD@$@5':3')M] !^=Q*[O/(^FE4=1G-]&-3;O/UVOIS.L#[M6+<[
MJG*^["B+RJ3(Z]CZM,[>DI_M7'& R6:;>-0L-8G0GT+DN+GWL9$YE/:ZPB:9
M_NMGQ#HA<8]$)\C)@5&J[CN.H*P5X+.Q(#)W6:A@$VLR&>Z)=(Z;;1\)H2UT
MV$\YV^Y"G:3L%$-EZ[UK[7(4,L3B29@*L_=99*];-=G8D<1Q,^Y'QF<CS?6;
M97HYG859NE^0SDL;:_R'* ,HJ12$5*NH0D[1*F4<'C/+] BIX_J?Q\XR#:6S
M'J*@:X? J^V;NCHUH[ZI6W>4F_#"92$[#T3YNB%<!!=-HGU-^\M'K8ML$_Q\
MC[(N,TF#0>.1H/QP/?4 O"M'Y!U^OAP >ITC$HXO2D0PK,XG,)4C1$,,)B>#
MX\:R)MUYOT]:E_F@9M ;5E/]>(G7]]3M"6\&#?<YU,(H1J>&\AF\JR]$1"Y)
MRN#1-VE]\0A-7>9XCF'O#M'-V'T%'MP\ERS]/E^1,ZL8$4^1/P0C*,YRH=0Q
MF0Z2""'+9),4NY5([KA@EVF9H<'43 -]VK KOV [0V4Y"27ID*(AY]?4AVZ"
MV%-9U?>1P5IMO-5-(HC'R>HRXW)<SVTO#8UNS+:[9WY[]_P[YH\XP2)BJ%/;
MA:[],H-T%)!C!FXXD\QI9\5W>RSOL$Z7^9 VIFLX>?=IL:[9YG4&\AXI3J+V
M(<><06M.OJ6DX"9PQ4'YJ# K'7RCNH:GT3EN->*(-FUH'780F^XNS4D4117:
M+*#Y^L$N)B!OP8"3G+Y@#-$>LSAQ7V V*TX\,C ;::Z#]/&+0L[IZDUY\96.
MA-E'?$=6^<VL,EO_7V^\OX137#^[)3E.$]GL]6WC+-_\QK7?G&1+SJV3!7C$
MFBARM4[3<="Q6&>=R]BFZ4D#7L:-9YHEH,?6>@?&^"!F-Q/R[E9(;P>C7!?K
M1M03(S%S1<$?]]: (BL /F4.R QB5-**JRF$0^Z)X[(Y;@36;+MTC)4.CI##
MS :S)C$7:YK-2HHV",5.)4_1JN<4<23%2I-!4.V/A6:Q8I\X?Y(F#QSQ1!)8
MK#H K^6%9<=(Q$G6KDS&0HRBE@[PZ#@S2; FE7+MP=LLI.P4O$_19">3^ YB
M^%+D3#DNA:;#1BO:M<@*."2WK41?E \&I6^2!QF$^G&#T#ZAO)=F.W'(B:_;
MW%#@O5A\(T=I,X1:VZ*TE!F2CN0;Q1 @,-JQ06&415N#JLD+CYVH&[=T9 34
MW(/;856X-RZ_X"+.!T+F3:%-F##2LZ2A6.:)?A,@6A& "!?,6"E,&PC>)&/<
M6I'QL7: 4CHQ=OL[*\H(%*+4-LF*F*7@D.0F:\6_3U)E0=$C=G=FCUMG,CY@
MCZ?R#G(")SE/JVK#Z85G].)T,W*6N'Q__OGSYJNK'[^:E?GB; .'"VD+G\GW
MSAZ*U.1"8>$07-;@DB[)<Y8P-4D-#$'\N(V-FWFF1]=K![:Z%H=M+LJ7Q,7V
MRKQ>_Q [YY7;D[/:7XI/N/*22S1@-3&GC%84/BKR<W@,,2N6O6AR:;<K@6./
M_3LV=.YT>6^@QP[PN>T7_F;Q-BQ6VR_6KP&7:WF_G'[%O&G4=_%&D%B4='@$
ML@&6U_(@)FV=*6>!.6X#,UZ5V*0EV!ZTCCTD<&34MM9N!P#>58S%1^]5-B"4
M(T?(6 ].1P3'1-1,.\MDDX>?0Q[YG/UP9WX+]72 NHMY<G7"7.U9:ETN(CD+
M&6N?"<8<!,O=>I9AB?03H74+=-VB8]Q#NHFN[_2>VU_P7>!F.R0&EY6#B;9<
M6$OQ&'I12\\2@G=%@(OD/:"T'E.K[IK7Z1BY(==1<+._X ?#S;_^>D>^K^D;
MZQ^M?U+_UCLLO]3__O'NU8W/S_B56/@K_7_SX6\6'\-L.V ZD#LQ_3B;EFFJ
MW48V/6NGLX]OYZ?35.OM;G"RG)Z1O+]7]?RDS__UBH?;W&V7N8.8X?C!KRN<
M9<Q_.7#RT34"R,%?TEHY;*=YO[W&U)NR+=T+IY?'YM5AZ54R22/MN.(3*&L<
M.&,5..M*0DX8:_,^>A#J#QX>=0@1SZ?+=#I?GB_P VGTM]/ZB$\9Q3DK"E@D
M02I'6SY8VJM%12&E3BG;)N?JT(R,>S ?']EW9E.-"8P?WWX?RXZ/9<]_ +O.
M,"M)P3;(&&N%:C)UC%]]E"<E1V=MR$UJ,+NPZ[^%Y73YIMQ2W+?-OZ\V)9,1
MM4P%I*NUAR(6H,\B&?F,,;%@7&Y2N[T;>3^##7X*"F_;X 9*[""BNB'+V[S(
M*) 938"I,E.\\F*5!RM31B^3"Z*)^_ 84>/&6N/#<#"%=0"^/^JK[1?+U90B
M55Q.@C9U9">#*)$"U!1(+"Q%X'08Y^ <:M$DQWB3C''ORL<'V %*Z0!2+\-T
ML2YU^CN&ZO)6N=QOJ)VR4KJUC+P A?0O7X('Y,B2CCQ(V:1^>&<*QWW_-#X0
MVZBR XS>7ZIWFRE%\O&<HC./A9A26H(+)$2/*<1(C@5MO>-56^Z#S6:/C<;'
MYO J[ "7?P^+?^*J=@*_:@&^86F2572VH 2M:@E4+#5Y(0)(K;A!GD1*38[F
MATD:]QG0^ @<2%D=P.YJJ/"=#>1,2@J+ 8N)!"0] Q^))Y%"*3*7A&VJ>AXF
M:=P'/./#;B!E=0 [DE\BL2S6 GLW7?[S&=$P7=4_393!D 4G?Q==E5!&VD%)
M@DE!*=H^&-LTR'R$IG&?VXP/O*'4U0'R+N9;W_%CO>4Z%;+43BEBAGR$VOXX
M SJ>716/%4V*;A\B:-Q"VO$Q-XBB.@#<@\,T;O.5.0_$0@)DY#2H3'8\6!,@
MT?>+-!ZE:S-]8D<"1R[S&A^13339 4+_-I_G/Z>GI\32*Q+B[&-MB[8IK;P3
M5&6M%7,()6E+055 \"1$,%BSGR[9E)IT]]^=Q-U0^A-?E3329@<XO:R#NLV'
M(.>WH"#4R"JNDC+XA!JTT3K7*6^)-7F8^!!!NV'P)[XG&413'2".Q#++84%2
MF^?SM-HV&=UZ)!.!IF0E!-07F.3^F@3>:P.T=3!PA@%MDT#E4:IVP]Y/?(4R
MG,XZ &!M"C]=73R[(('6NV^<7=:=7-M:@?S?DHR"D..ZS9\#[WCUDKF00@?.
M39L& 3N3N!LT?^)+E4;:[ .GM/0GG"VG7W!C_>^_+<HL(R\*P?AUKWE>>R49
M#B)GJR3]3+5)*NY*X&X8_9DO5UIHL@.$OL,O.#O'[?R#M9S^,5U]>G:^7!&+
MBSM)!EW(&Z'3P6I3@)QD3B+T",DX<E%$D98UR08]C<S=T/H37\0TU.KHS>$W
M_LO[3YL<P[/Y\FX %TQQV17RGRU/M2T#0O0Q RO1."V",'BKA]5#'>*_O]AN
M6/L);U^::*,+B[A$(J!>I3^G;70Z7W/VXNMGLOU;FS\A#\3YG!W$0'M%D<&'
M*$T$[:6V";DMK$F(LP-MN^'Q)[Z4&5I_'4#R)*^G,BS)+;YWA[F"3#NA0)1:
M8LD"16_)>\BI)*D*F7+1Y('2=^C:#8H_\5W-D'KK (:OZX1I?%W;%=]AQ3+K
M=<H&,D=+8JH3T)G-H ()2#'&S55R>4@(/D+3;E79/_'%S%#ZZ@!Z[S^1S'\C
M1G(-Q,B2;T3W>2O/5^M[>(K,ZAW41<E1U,48VF+ 0TWC)R? .2Q0C!2!I^S3
M;2]PH#SDTVG=#:H_\>U,:_UV .$783&C@Z#V?U]S>R<(RUYC+!:"1E;G)3@(
M3AGZ%X_)ZF1T;I*H_ Y=NT'S)[ZT&5)O'<#P=_SSVG.QQ7Q&?TP;<=V?T*IO
MA',T"JQUBB3F)3BT" (Y%^2I<(9-QN,^E=#=@/H3W_ TU>R/_^#ZP[I ]"8_
MPS^WWJYRY,?6]_'6U5/K;-&J$C4PXSQ!+2H(M>V9RQX=8Y9,9Y-:_2Z>6K]/
MGS"?DX+6XV"O*D;?E%HI^MNW^N^7M,Y\<;4WC1+1Z^*A\%HOSY4E0T "2UG:
M)(MF%!XV<5Z?3NO/\ C[*?B\X[LV5F\'3L,%BV_*;6^HOD!/-=4V/3VO\SNK
M(;H698I8#(^YEM\'4(P.%_+,+2 /GGPC67B;*5=[TOLSO.,> LDMU=P5FD_H
M%,V5)0HMKYXLO?A:9W%AWER?G7T^OY#[;:E<22 &JWU6";3V&E1@)'5)4:FP
M12:9BW"Y2=.WX5GY&9Z:#[,'1@''@ ,N1O.T?Z^U955JSW$5IJ?-?>X[ZQW9
M^WZ<WZ[\<)YBB$5:R%()4 +)[W!%0DJ9^9@T5[))_<:H?OCZIOHZ!>M6S6=G
M8?'M3?E^7#5Q&0VOQ9&TD3DH[0WX@ (DX37$R FUZGMX/I"&G\''?@KV;A09
M'$EU(WHFR\5J\JY._3SY.EU.K.:FV*#H^+*UR-$)""%:,$(E$UEB+.W298$^
M]-H&I:]N;\X;JXZ#L*/J=WZHL'M R-_Q+.)BDJ.WEJ4,RM2'S5PB^$0NMW+&
MFLP,EK)+9+4[1C;KCH.2 S1V6^=[B&]DK?]].IN>G9]M"2\\"!&4@LQSO6TP
M"5SP HHCHKTWZDYIV_YZO['RR)K?1V_S(80XMO;#UVN$,RR!LRR!J]KXRCD-
MT94,AGM;D'C2?#CM7U]YG,S(8-K?6X@=9"L>?%[[V[</]!%KDYB##D6C!ENB
M!,4R0E1D(5V*5O(L5"A-TNL[T#8.<L;P*UHIK&<,5H:>S\_"=#81'+GCD:QH
MJ&,\32:1^:) &-0JV**";)+KW8&V<:.GP?&P*][V5$X'>-LDUG!QR<K6=)-E
M%M(8#5G(6K5F,H3DZO0DEVS@QEC1!&,/T-,IKO;5^SU/G@Y50@=8^GL@.<YP
M\>VZB+:LQ&2<RZ;.&S&"0HF<Z4_>@U)1E)(D!M<D'?8(3>/>0;7&U%#*Z !7
M+\\7L^GJ?('$RLOIU_JGY9832XYEDA1:I")KPI]GB")(T*P(D3%*%YNT WF8
MI'%O=5JC:B!5= "JW\Y)D.2-;JE'G8*.M2P[1PI4 P6JZZ=37"656#1*ZM@"
M2#?)&+?I;VOP'"#RL=]"[A7@O";[^VJ%9\N)\#'P@@YR810(*^O!HW>0E$H\
M)&&=N%79.>2]QB4=X]BF,2+$8RMM;'S^/:SJK?FW#X2>Y:?Y:7Y3:ONZY:;7
MP[/3L%P2QY@_S&^/-X^JH*J3B+2F#:A,4K2AK0"+2@8?"DHA=H+FWB3\:/<A
M>R)D?G1U=7#*/GBD_+'$<G[Z>EIP8KP-QG(/$>E\5+9H\%'2=N?)\L!][>%Y
MU'3&%6T_6DKM,&BV4EH'.'RX)]VKL\]ANJC<33*+F6F90:A:/90U!V=* BVT
M]D6D'-L$$[L0]Z,=W<,@<7"U=0#%EU.*H/#U] O>YNG:]F+,&&G)N;9,(?D\
M24 PI0#9=PK2BV><-7EGO@MQXP0I8T-Q<+6-[3)N.]>\PS0GX56)OB<?8_D.
MR369+9_-O^ B?,2WN)C.\T345@TL"!"Z1%"2A\U-'F;O4$ICZ9^=O,2GK#K.
MF)%1'<-F2AD;;1?-D=Z&;^N, B[.EK^?USS O#P/WY:3["3JJ#5H)W)]IQ$A
MR"HR:YED+MCHY4X(^]Y*XXP.&155@PJ_@R/TCUDDIP#S!5_+J[D4$VXTUR5H
M"%'5RH48P8EB"2BYH$TQV=(DD?<(3>-,#1G[P!Q*21W@[;[.;J^G@?BC&/[W
M^2R=+Q9K3]2BT"XS<%Y*.OX#@G.2(O0@:\_A6#AK$D#L2-\X0T3&QF$+Y8U]
MFIZ<S1>KK3@WSL#+^>*R=<?UQA[K;D@3+87WCD7PIA:$([FDS@5R%YBV'"EL
M<K>;23YPN#YQX7%&B(QZUK9430>F\%JCK6VCMXE%S5VI@^1U[<,J8JH#QPPP
M5WC(0<;HFY3$W25EI $A8UNX W7RXS><V$9-2_J]ORWFR^7V-ZYY'/';A>D_
MTDNY?4@Z\F.Z@Z76U7L[28=UD HA6FW(CJ(&IVT!ZYP-A?Q-(YJ\"^ZB[\6=
M\6B;FU,;/.;Z^DL&%4@FUH&/1@!9FF)22"::1KW.[R/G9WA9]Q24?7>&W=.5
MU($#<(>+W[[]AK/TB4Z[?ZX+;%.=H9*+)(=&UI(RQR%J+H$Q9X5(P3O7)'7]
M/<+&A=\0RO\>G@[11)?(NN!F6WL4+2O9!?*,M%6@6-(0O5804XF!(C3+59N9
MV-\AK#-D'02#[V+L )UT@+%M-GWM^/R.%_6P+(>DI70@+$-0LA 3*@O(QEC,
M,7&AVO04N8^:WM!TB,)O=_PX6/H=0.BNF[SE(W!,IF@.RF&H!;"UOEI1]&6Q
M!!^X#KQ)YODA@L:M;V\*I$%T,/I[T_\Y7US$5\O-VR2')G)3GUE& <H73SM!
M6[#"B1*BM([MXJ_O^.CT]O*=X65_!VD Z8Z,C=_#&;XI-WC8[AJM--E+4>J3
MVMK(7E$ PNEL5\Y;89Q76NQB9':"R(-4C/="_5"USH>6\=@W 1>DGVP-H#,N
M2!\B),QZ:U5#"6"4T,ESEZ3;K9SWU@>/I_*!]#0?2&B]*/RW+>U"271":$@J
MYMJ;/8,S,H*Q+D5M<D#)GZ3PW\;N0]!0X?L(K1>%/[MHS< H>N-(M*,FL"JO
MP'F1@+QE%WBV6=^>@/T=A3\;\^%:8X7O([1>%/[\ JS::YE00@BBCBR.$J(E
ML.9LM";R8^3F20I_/N9CL\8*WT=H'025=[S?JYO!E+SVG N0QA$G+$;BA!RU
M***1S%N=8I.I  ^3-.X3UV-D4O>3?H\X>HN+^HWP$?D$4=52/@=!*D-&$!W$
MLI93L(Y+I9$U27,]1E1GV:X]%?\]/.VKA1__:OYVK]XC7;\_M.R1K]AWXKZK
M:W1K IW % 4)<HA!9<[I!#4&4 @3I&91W7X.^A-=HU]UI+Y_2M;)8E%[I*W7
M_.W;U>]LZZI/_@R+O'VS'%-"%Q"B<R1&C 8\%QSJ^"(LD0?-F]1$#<;!SW!9
M_Q0L/]R<_)A0Z,"#.+ 7^V_?[O^ =:H.G8Q,4;"M0XW",!MP+ O@V2?+N>2D
ME28W).UX&G>?C(32V[<QG4"FV]U3X]V+6Z^"BE>?+\LJ9YL]Q!JA1E=<"D(Z
MR_%X6^"*L'%QW V"=D+VGNKL )XOR,^>?T-\OYJG?VYF?EZTFDO1Q&P*^(*B
M/J+.$.IS:JF#+3*;Q%63R^L'*>H1D/LJ_O:<RT&TT &<WB%Y6M.TPKQFY8_9
M=+5\]_Z/+3.>QRB+<L"$=J D$ELA6T"& B,*EFR3ZM-'J1KWDKLIK(;3QH"C
M<?8'US_JK)?+EH5>%>:"#V"UKR_K%8,8#3GT4NH4I"HI-YG2=X.*<1.?3<&S
MO[0[L$,4(JY?P) C^QSCZDHX%V95!YZT8:"***!,$.!1%< D"C+#G0]-!CY_
MAZYQN_TUA=.0&ND 8-^-KAX*KJ[RR39G.LY+@!)";=RE#415#.24C8N1UMQI
MC,C3,T('DS[ND=E'B'MD '0 ^=]Q]6J6YF?X>KY<3@0CKU0E"ZYX TJPVC7=
M&4"-4G'CF6XS)/<&%2/G6HX,@3LSQ_?51P=@NG?(Z4382 $-R^ EN1JJ6!)'
MT &RT#;;'.E\:9(+N9>:D:W<N. Z7#\=@FP[07>BA;,*E0")MKY_,;17HI>@
MDX_)&849F]S%/$#/N$%$9T#;1T<=0.T?./WXB>@^V?3CVO12VGHHRS?GJ^4J
MS&JGZ\T^\B%QP<@Z^SK!03G'P!?O(1FOD2(I4523\.-)5(X;C(P,RW;Z["*5
M0H[#8BW%<$KB/9O/-HR=K%:+:3Q?K4>,S^_*]YIG/6%.QH#$I"^JOJYAM:&$
M]"!0Y2(H8$MMYLL?3OHX700[ ?:1-=^O:=X>-'=V](2XD*(4!:S4YR.E-E%4
M,D,HF95B)&>RR7/U)](Y3M?"3E#<4J<_PQCX^U-Y1RJU>WSQ(Q?</4$2797=
M2654%,&!=.AJ6W\)D6)YJ#7O(G%C#,LMK% 797?WJ/&RA(OGZ#73$'.=0VK0
M4EP@U@^UZCCB8B,VR3L]3-+/4!CW%+0]\/3Z4&5UX"E<998/+#_9/D!P'+6/
M'F2JCU%#K@-K?(*B/,]9*F_:I!F&96/DLHN!P/5@,>?1-=T!SEL65SFFDRL^
M@$\.0:E0NU>2DIPI5B:=@G!M[///7]%Y?*@>L:SS*;CI=@M=NRLW@J&S%!K+
MM77RNH!G)'9MBHA):RMRD_3(_W_+.I^$H*>6=3Y%G1W \^&"PL0#%X[5\AT6
M:J-UDE+P$01R73B++O FL[5^U++.)RE^Y[+.IVBABX3QXZ6$ 4O,4J\G?I&0
M K'CR2NK<T>LT<Q2;-'$V/W(A9V' &LX;71@JVX6&DJ7E78L R93Q\CI2'LD
M9PBZ..8C":5-T/0CE74> IW]I=T!5+Y71*A2SCYJ!]QZ58>7K^\H!*#-FAF3
MK(C_IZQS4#@-J9$. ':@?WIUN2$SEU+5_OI86ZSZ),!I+P$IXD+:<:+<;M'2
M11C\NK<2SQ\]YMT/$3_^3C@YJVF[26'9(2,OQ,EZQY>U F>YJ#.[N5<Z!,0F
MMQB#4-]C9-(:>,.B?P\4]-G@Y#E^P=/Y>N1QF.4WJT^X./FXP&T]R1[WJ8]_
MX !WI$^@>*![SUI.,MW,*S^9K8>\$11P5G/VSZ?+=#I?GA,B+K+WR7BI:Z\]
M88PA5!(^0[ )A [1,!/0NB9^_I.H/*AKVS4-G-S1P <2^F_TJ_^<<.]B=MH"
M"[5+L<\&O.(,-!<)673DA,?OH>D)ZXW=7JD51F[T?FL@^A_0+OU>0[UJN0^H
M^WC: JWMUN,<C6+'%"NF7D2"%[* JF5Q(14&1;+L=4;AVG@XX]BQJTVT=JP3
M[</$0@$I+))C34>\YUP1K1X#+S;$VPWN=[!=-]?XD>S54[#PH+TZ0,0=A T?
MZ/<H:KNJ ]P,',E&28D,7$1R08L.$$VQQ$G402?O,S;)#]]+S3B(&E3/\Z&%
MW@%RKI<8TU[[?3X+5]_Y0']:TA8C)5UDEEBRB1O'P<KZ:M@39\X)7ST$)T(M
MO&^#J2?2.:[]&@ 9MR/"AFKJ (7/YJ?TW?G&R[C&ZY8;"E>-#,J#%D&#DK9.
MIO$9 @O6*E<P\R;5+8^3-7*BHB4B[J2;!U//R ,]GM7,""Y(Q*MO-1>_WI@J
MY8)>,C#"T<84/("WBN2C63(QLICE+N/"=YKE<1\!XV1]6QR-@XAX9(B\P\_G
MB_0I+/%2(K=9VM[@E)RT4\9"B$J"8HC@941 @CT3-8S=J5A\)]SL3-5X T(.
M5_R\M1;&'BGPG[B8GGY[/2WXGH*96;J\L$/F$P4N&9BF+:8P,@@J!W"2HA=4
M6L>RVV#XAU88#Q:--#D?6JQC8V/[7&OYQXQT<>W$)0U=6N;UEC)HB_:U"4"B
MXUPE.LEC*AQ(.L7F)%!;NQ-6=EUQG+J,%N=3.T'_".C9;C.AT)ND-"3.+<4A
M2E$<8AD([ZR-SFCC=DL?[;[FB,%_&VT_%4][B'YL1#WD]+^:35?3<+KE^F*N
MC\PA2:=!ADR&-D7R_HTMP,G*(N>F,*]VPM135NT<5?OH?'X,!?2*K+]/3W&Y
MFL_P0KI;WHQBRG FR,B[2#YD<1"Y1"C>)JDS'0)8#@+7 PN/&)>-B:\AU# V
MQ.[U&UY?%F?PHHC:$$%F9'5&K0-7$QA,RH 8965S_QN4UT\JYQJ\ K&9XS2@
M4,?&QT/8_^,SR7&V>HDX*5R$I&QM4%[WE0H4.\@<H<2$Z*(7/.6#K,[56KW=
MC>RITUV,RYX"[B!'O:[Y?[5<GF-^?KZH3V,IZIQONU[\CG^N?[2<H-?D,#(%
MF%@=I^T$1%W3.:KX1$RBD$URU;N1UUNJ\3"D-53-J,]_[NZ@=Z0H(N;3R2Q?
MDV/=1=R98#7)33M+IW(("([GFN>(23MGE1/ZZ6;JP?5ZRP4,;:J&$70/YJJ"
M_^UBFG 24C9<:0.>U><F+A/ETBL(W$HO2Q96-*F*OR*A-T=H(+.SGXA[]7VN
M2>H=?CP_K9_Q[3(86'Z8K\+IU0_"++]:3U>D#[D(%"96:UM*2! B*Z!J6SY'
M\@4=?0E*8F;IL#3 X32.TX9N%%_KR K]07$]82$FYY,!"F-K_5@(4!^H0-*!
M&2F]]NZP],)W"!BGI5R/B'R2*L:&V]OYJFZ6</KR?'6^P&U;QPM/M$;:M_U/
MG;,(UE&XS5@59Q80?*;CPD2.45B&8K=+OB<OO1/$[ \%L;;B'QM<MSHM7GD:
MM=D8IO7+H.?AV_+%EW!Z'FKG9J8XE]K7L2 FT=9!LM1K<VT*Q=$Z232[Q0%/
M7GHG<+D?"EQMQ=_GHX:78;KX3V('_XZAUE??\V1IM\<+]W_0 (\4=J!PH,<(
MERM=E9M?=4 K2G.=4X$HG #%B@./T4.,6@K.O':)WY31,.'48T0=&BW>)]I7
ML\_GJVL%]U<O>)R/(4I!N\G+>E7J'416YQ.PZ+GQ$7EJ,E'N252.6YXY&()N
M!YWM-/4#F:7U1<9PQFG[<:U,U'W4'L-0H5="RJ+J]#@+2DL&7M6RAJ"5L3;[
M$IO,D#^*H3I9+K%>3:[%G-_,WM5WTHOM;(!KKPTSU\8R&=9<UXMQ#<2W <RY
M6)3!HF\KA!T)[=A</05'#YJK%OKJ(,UZC^#>E#6O)[/\>AKB]'2Z^O;[?'7!
M^<GJ\J^L[<(5YS(+GQGWD+*E4T'6=[<J"2"C;8+ H@H>RZ_8DX5QVY>TQ_!Q
M=?P#G<>7W_SW*05,B_3IV_RJ\?5FYQ_P&OK0)5N=Z_MR?8RS/PJ!AEL#N3[R
M4<9(<C$3!RN"EX99"HN;7$,?\>R_MOG6G:_NG"R;9U&+FP?-N@0F%X=** <A
MAP+*60K47;* #IF+T0FFFTQ9'XR#CKV%IR#O.]["D33<@QMQ839>S4B,YY=O
M1C.3R2$6*)B0(D5IP =3H X(\-9CV>V)T=.!>C\]G<#NN.BXC=$!5-4!XM9/
M1&GE*L;WN/@R322B:^,JKKA;UN?,R_M_M*U!M<HKEJ4$KE,=]%/'2(L4P.OD
M=<"2F&[3:6! )D;&]A"HNMV@8"P5=P#O/][_;?X%%[/-<[/%YVWU=!7%R;:5
MR)VNF9()VOR6@T_9U[:L'KS$#$;*Z&,4.G'= L5[T#IR?X/1@#4_KI8[ '*]
MV,1%6C_X^(R++1,>LRJ:%XB^2(HCLZ5P5BJ(W):<-8_)-FJY>P\UXX;]W8#Q
M<$UU ;?-+KJ_KW#0RANM&2B>'"@OB1G#)4@4M)F*X,4W:L3Q"%7CM@WO"'Y#
M::X#&%ZZ^K]]NYME>5UO_=?>471,:8X*DJU/" )&XLI9,)GV52@RJMM%#P/'
M\8^2UTDZ=-QH:7A%]@3/Q].!%[LZLZ*5$>"P<-K5CG9UJFQZ9H66A9AGQ[HN
M?Y#*3D+[ 6&RP\7Y,#KK"9";4H"UQ/C6]%N;;/:^]ENEDT7564TQUNU;!#H7
MA/"I;2KX+DV=@&UX)#R$N0/5TBG"Q$4#,*$5HC2@=+"U^(U$E(L $57DQ(_/
MH4V6\F&:.CE[1T'8/FKI%&'RHKV!B]P;DDZPD?A)J:;!M*4H2M4^05JPT&0Z
M_",TC1MVC(NP?=32$\(.<(E?7U87!V6%9\&#BX5"*JQM#YDQ=3 N[35-,M!M
M,3D$%YV@N(\8Y>BPZ&!// O+3R_^U_GT2SBM)N1D]2PL%M^(K;5$)CKS["/S
MD+6N4ZJRAL!LM2'6,X7"%=DFT?@H69WXC\?'R^V<SW#*ZP"*)U_"]+3NYI?S
MQ7OBZ"J)=3.E-2&1H(R9079:DW<3%42L+SR"R\8*AUQB"U#N2F GSN?H\&RB
MT"X&LVXF9*SE>T\QS"3K8%CMR<1U'30K))U+3&I@V42>I?:,-0'HXV3]^&?]
M,+ <4'D]6,T'&3'!2!43!^\<>>="1?+.A05?:$_%%.@\:#,&[B  -IO(V0\
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M_"YU!]XO+A>KJNF,LR7F:WV6RWQQMB;V37F[!NZS^=GG,/OV9G;Z[0H!E_=
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M<)(Q,'2F@N#.8YOU=<]2->U+C([@-Y;FIGZ.MM=Y?WO;\<^X8J:DS<Z$NN*
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MQGA0/F>ZFVO>JJZ,"VA8,.H$=,@>]KR<"QW'R+1/=.@M)\$1M2(I8/&ZRT&
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M,YC("RA6ZHL\YB!J9-FD$I$-2<4, L40@J;M=F[J-HRNC\[QM4UEL215=$I
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M5Z<;:K+IWA-7&K5A,A@Z?N>+CZ<M_$Z)M8/TT*NANZDJ*BN+=,H#D\:"LD)
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M>JV,M9;IES83^9&D[XGY-[R\>[JFBT6.%D01Y&Z&K"&P* &=E%&CLK)-^_%
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M<?N&]+WX7/.JUW\U4SP*+66!(&HR2UH%=3\GU&&I!7G2@3?I5CB$R&EK>I/
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MC1O/5O1X(Y-(.2_-P$I&0=!B+A_Q"X\^&N*3IUV.DQW/:0X2MYM[/=<=N1.
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M;Q<,-+!6<)_^*^!(N7,<F$VH0E7*0J]RZ:?JLXF></__C']5D/ DX]\N9FD
M4U4XOD),PB:C((ER0HE9"59D DQB(N@4S50-L\Q[XHQ_.V'K&(Q_NQBZ ; _
ME.I]^/AY<TU;,J:(+"0Q.L=2 R2P1=D^I*AX8ICL'H/Y[_ZH&K^:61TT3S,
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MO5.P"WKK->+9!0,#)D[SV6+TH8BT6DK4+'H?DL::B.*@O6?@/ U -::D3.B
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MW1S4-$QJQX( Z@UZ$L>IPK%H@3B)^7%VSFWW**NS#OS0X)JY"7B47*]W<S4
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M"(Y151C:.8D'\\T#PQWDXX,92#(M<]H'>SJA2QGMVZHH:E'KNQZZF1YR2W!
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M&N2U*N@SIV\8OA+::<D-98::=CA@:HJ V)[6?M)%9Y)U6UR;7;<:M+(/ EQ
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M_;$;A FDH'V&QW@G16O"'8VR,(7%P:UHR9E$!-[X)H'=FO$I#/59T9?5O)D
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M,$ 8%3L88N<7T\UH)3F9@=NELCN4CHAY]G]^TITR7!^1#!^PYI)E4PQ,QH&
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MBFY#/W.T,E[(8A'I@WM4AZ2NH\LM 0*?>5SJ^OI0ZRN3NBES[PT]]+",Z5C
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M&A[W?G?;L&= G+/^6\-A#VG*/&UX?3.5V=\>G#YP-TQE' .KGY],;\0Q+%#
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M;VCNH I$"M0468X4#8?#%<=_,!T@YP0S_*B7;:QH7-U([D<+.P_[)V'FLVW
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MLZ$BEC\:M')6GA^<'0T?KDW(O\I+U=!%FV2@?RVO^!VD6:-O_L'/_\XKX%#
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MM?CH[PNA*&,-=7 CR3GTL@ @CSYD^3Q1\;5J9S:B%O=&!Q@ H6DR XV:E;*
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M[[K4(@_['?@6G4VGQ0KD\E5A^5119S'N;D_6<E%QEVG_9!=1YR+2)=]([J_
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MBQ0/KM>N[NV93B-G8IC":V'"!*=)@)*?4;W.C,UKD]>R_&W["7I5A)R2HUE
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M5E):[9_)S#A:Y'7Y')S)N>PKS>:28FL*UO.ZN) 5\1IQ$R5PCQ+;07FW652
MEO9 EDHEMMUY)A1"+M)VI+0B". 7FHV$/6%L2JGVO6&4\ &!I.X&<9D#<<I(
MAE1LL-4-KC8ADG#/R 1A%< )]B!<9>WX!Q.T(LYPWECJU/,TYC"N_B(S\28:
M,UE'1#V44B3G"#6BJTY@9570KM9Y8:R>*<9Y"UG)6-TVWD]_ 5K+<QN-IW.
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MM]&+%0NH]8.7;^:;[6W]?M^Y'!<*DST^>Z<[WBF8?^/90_9>A"N\Q&MX**:
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M(<"ZU!+F+F)QC/^FQ9K;PW^']1>**^!JM..Y!Z%I../(N'JJ3H5^+4$R, *
M&GFIYW8#HU]#/5;QJ+[4,CD@"Y/_-"TS#)MM1TQAPX[23U-"K5N[_&EH_#A/
M_W*5ZG9OLH,DA&N*#)S#FQ5^346YBU?K8D<=.9[,.=SHFR/G4H>GJBM41,%2
M$GHBY4Q,L^+?!XE96,Q6*K^V$)LH.SI!HW5N=/9S8D4F@.+N!*&.&A5#IHB^
MX:- [4W2L&HZ@ %LC5"E-?C=QE"X[QCJ$F14#!K%]G;WY(_;+54C.Z'Q14,;
M>\I$N<5<U%_@/B0D/G[] ZP\.GO >'BABA(DNQQ>")9P6L(4+)PO68Q^U4>(
MU!MH1#RT6&R:2ZR&]"B;B$"JF"G"?1WD[)>4:=5-D5HC" U/B&KHUE5[BVR$
MICC8+$UQ*5&Y];-OU6! '-$Y.7N;Y [W@&S&?DB: I8,+%TA4S/V;\W]^1/N
M3 VZ]"&^"[W",*:S*Q/Y!?U7Y6;)=:RXF$F,D682*5P5L!'.4'M(JJK:FC>2
MK\%PX+-+<CL8$YY3Z.BG^F8HD';)4QLY *F8SE1<S)Z.8&=\%V^1[/ZI1NJH
MW +^H?++82'1R_(>UPF!8^-#^95ZW7,DGPP*C'70&0)UD63[)0=2].6_>$R=
M283<9Y4%_P8HQK&U1A;=,-H\1TX8F9U;"%FEHWWG^?0]@KCY-M.'_"=\)P1"
M)0ZS!SQY.BKXA*0Z*YF KDC#G+'C[5%&\^P"HSK4JH<=+E(I=1JRH2H# 6BS
M+1=Z9>"T9 $BSU+ 8?0UC+8-Q\('2X^%C\[/WO6/>V>#?O>$O^F?O3N_/.7Z
M*L]#]!IQW_)%[GXKQ0ZP^"C"-4>[IU^=)+9  $E2EXUQ<!Q.@)D>1T\$$]DY
M_*R=_-F:(:>;3K//K#G ]#WP551"QA^B)T<V8T+X5 XF)\U3QP"(-YU(=UD,
M"])'N@(6ZWK&9X>Y5EG G43E3+%*EXMR>SPL_.6Z2+;1F"N*T2"D?K4K'C+"
MBAWBBD5/F&P;T1#^&2<'E[C7D'EL*ZT8)U1ZA?$*+2!S]ET7DE25,B,["4(O
MO>7^&HVMM$M#'4(PZ2J7_A<CQ_SWPA3C1K8O9Y)Z(X6GJ/48BSE.-9O/+4<S
ML'^NR</E1)\LY%P<G5OX48P?9Y&$D6!2TO^DBO8N.^^GK"T4HTN7 BO':&Q<
M3+H$3Y03AL''YT2%20>Z156"&.(HGLDY<!-,T8D)])2N=K:^7NU"N?8\=I6*
MP!Z;G%;+(-6K&2QQ.BJHD645^6+7_7:<2D<33#M2'KX-Z!JF9F1"YF!SE<3&
M8'TH%0+HBQ?.X0BFCIS6@:>>.!.K[8K"DQ>54W:>"?K=V!* I<O/J+6U-E<V
MU.M&YTRHT^XLA4&I14<@260V_EE3KS(7T\_>SD*"K??0QIU N&"PQ+1:)@+"
M45*!<C<]OM (BA*X[=]\CL/G4C;:6R:25/MO-&>:="T,M'!ZL$)O4Y0SPBQ\
M-$8.=@6XW?1"G!I,DJ@VK7G)$KA)> H]?+0U./61>P>1<R&M#D:<UT<VSA]E
M%N4A4X=T3)$</57K]KQM5LOSI5;+I^[E9??L[B*)OUTBPJL?B0C?C1 W+)&0
M2E:+B%M3X#2[J$*H*<N:XSK''.1^R DBR#J_JI7C!I?RE^W*YB"&D'$JX2#V
M<@,U50%E7=_9?%5158U)!_8-&( R"=K<(18S]:X5=^!IY#ESX(=@!VR=GLE=
M-DF%E7DL[Q-46^7 U\^F<DJ!OC%9I':$H<;YU]JAV(2%+0B;/M^TI)^+3#\U
M,7=)M;;U NOF-H>5+$^(\TF9^"8NV7#$$K3UJK=R"B!RVX2IX#/@Q]:3I8*S
M/"\GNM[SAY:*3<Q:+45S*#E-NTW+..3J53(RXXBKS^;Z//C6!^);QA%WNUU@
MG]7K:-%'=J?Q54$?M_G))C'7AIU>7V&C</$2>)[I2&"!6@#,@6Z#EA:B(X/P
M4IT9F#R5J@-X,]VF"M4LRX8+[].7Q,V8<:&0SJ,4VY9[F,/]N//$FTE]-MA[
M:.PMU*T$]AI(QU.KMR0TNV#.ME[&A$UD0%-=,\=^V&34=(+GQJ?T*/O5R#E1
M@5?(^?23RH^VH D1$<J+I9[,H'=Y2A4Y^*%_=@^L57LERXM-,Y&QR=*ZSSCK
MC,R'3Q@3(T7%9YAUW$/.?RL3.H+G FDZ&P$VQR@M6<,!O&U(NFY)-R3'U)92
M4 HXPO\Y,8W"+_18>%(1Q9)Z:BSG4PK[[C-<Y-XVY'2]V#23<R [C_$@%*=O
M*0BT9FKNN>UY,=!JZ;.IL2+6E:ES/8>Q2*?,[(G'G1I/13'G\V!HCPX*)12&
M5(_Q<YV "MQ]XH5JAJHICJG!MXW/FGZ/J!SA$12'PUGAX2Z/Q,G1V0I*:"-H
M?,,LOR:-@V%QHQ/"R%N[V-8V4(S40T?S=Y [B6&*-4@ (/$Z!T26IH>;"F]8
M8#=H,YWC$T;LP1^JY?EFY-G9?;4V^GRLGBRCSX]3T87ZRS3*;'H<G? [1#(O
M)T9R%9]GS!N_4^#Y*<9@0AU'D@7JEJ_>75?QF4ZG\ B5\N&21GY>;I-(8>3<
M?H%Y&?2'")[MV+SAM]^\QW)Z=_=5]DS%10YPSED,,A:H^"<5L,TB<#S\GGHI
MJ@DF1.950DI8"K:EFBE3@FI+726V,(^X8!D5W]T:<:' <-978^N8.7@H/7PC
M1D;!Z8"-W'\HN3!<1#@CIE&Y2="U<:XYJ8&/( -DZ7-J6>@+CQ"EUD9,[3DC
MONF#(TB*)!U_.]B*M5HG&Y8K>U4"_]^HN VFB-,_=F0$7N[M[>SYWK[O'?C>
M\QWX]P7_!_Y\253VBJDYIQ?1#V7);3A>?KDT*//7[.J2$HJ/B,FR3KKRUOGZ
M)_W3_H"B8'5,Q)-^]VW_I#_X?5WMO'EIO/Z9=W;N]7[KG0V\3_V3$\*C[Y[]
M[IU?>M*FI0L_O>UY...3GO<.?L#?KRYZ1_WNB0\C'%'")7Z^^'C6'_1_ZYF[
M>__O(Z=B>L?=T^[[WI5W_H[N_N\^@?;@16>](UP>>/K@@S?XT+^J>L+X-#&O
M_V[)K#YTKV!F> 7E>/9HR.[Q;]VSHQX^:?"AYUV<7UWU>:GQJZN/1Q_,9+:!
MZ5\M9?KWO;/>9??D1T*)32@Y_)%0\MVH<,.BY6<ISZX7LWU1/XN[!)L@7']N
M28\]1D7F-'KE8*37<)*;X6\V>J1"P/$@:^=8SE%81,7A_*Z+BW(L'H;D.,(T
MJ "/@CET\$S!G+L'06^'"]FQI+W@8CT*[B,LZ0,/Q3:)*38L#-^E"I)U=_8"
MPC_3S=B[E#^C&5]515<TS!4P5+V*V *%=G^]+S>"DJYNQXBAPE2)CZW2>ALA
M2]?%I4@91T9,J!//CSG#OHM1-_@.G&MMZK>%3<TK5!.FI&'S1'*^92#?LN!-
M&H4P[%4=+ )D@;Y.*0]Y">LB!C*5STZE/XS4:> Y@PSB'%T73C!XBAY3@;.'
M&6'>=%JO8_^6A]EKY=,-.TKHH=1$8=HJ;64R1^9@G3D'0M (2RK*D3YS?$,S
M^L5U"EP[PT4-BZ-0+N1V+1)* ]0J#PU&R8*#-T=0.)$'A'%(_BB3@#G38";6
M4Z\, )\V^X% @)$>59P,,Q$82;"6"RZ^"*L;*0,LU)DI&JBZ%5">I<44LNJU
M5B)CX1@X6^:K,^<WA4LW+*36-<#,HC%XKNMN!(--,=C^D^(8A-:OUYP:5KDC
MSX)2J\IACDS+Y4X(*0$FGCUCMNJG#KM<(1LU5H? K1=A8<]QA<VM8F:KJN](
M;<[-0TJDS#2VAAN>;Q8WO,<JZ,2F%)^HV[6'FA=:2]<T3S[^,OF 15;JA<<8
MR ;@S.3&<+HJY#CL"(@&V"B)E,^8?(R$2Y ):4@*!YV@.B9XE1U,O^9B0S)8
MEG KI^0'6O/);0;JRB*C++/_J.ZRJ $7&D )'5(;"X%2T5RVE7MQ&E :EERV
M\+5,%SPW<Z !?B0FK+$RK1U0J__"<6YT4FH+Y+8M'/IBLSCT"HM\!6MNK;RY
MKMK[)2'R]NTB3$ITN+58%QPR1\B3V)@BN8%7#1D!2;0[J6"4<*90<UEYIB^(
MA!,14_7#.?RM(7"<Y,L2_FQF8#IRPTY=T2\ZM!*KDKDY53$Q=(D[=9$H$_4E
MFI03@YU!_BHCNTI#BZV1)2_;1X5WAU>+%M0R=+D@@!Q1Z8!$;%#%->Y4G$X?
M  :%H/0(-@VH7)S29$8J(, R;=!C*-/"YXN DSC,P]8/JF$99F9*$ZCL!R\&
M6P!<3!@1&"CV3>8$^728'B%6!T\MQ*F&!(V0<&"'.II,B\9;F^M=-0S&=$:M
M!)Q8,K79$R@+IWVP7(H\*&:T.,*\"+4H72VY;Z&M!(LLI_E;PY:O-HLM>^ $
M98[(;I<)3F(_*LI"YP+)@" *11/9FMX'^2&TZ)+524,]@-E$J!2WU2UBDG1I
M[IN-%JI&4 M%>5&1 0TT3\OKCW/Z.YCP+[)ZAO!8*S]:K'P"\LS\.3A&!0\*
MS;O=I_*MSVWS\]($K?U14Y8)4I2T_*XG_VX-<QYN%G-^(@I8<SH()F Q*1IZ
MJ\***U$?YH57C(SX,;71,&B$$-28X>K$*X$WU$17W<N,C;EB3O&F4&1G=[-(
M\@@SAW6&\F'=MEQ#5YBHGL$IHN+J:K*^9VB+0X,-NXG0:B*@')34B)P@:'K2
MES*]%J'.!6R6F+$*U;@O1*^<MOH=@^R+,TA6&_H[I=JLEO;V\T^'G3=7_?=G
MW<''RYYWT7V/F6,G)^>?KN"G_7OQ<+_'<OWM\ITZNYN9\/1--S\*__$HTGJX
MOW^X>] )]O8/1D.M]&'G\&!W_U70>3[:VQW]3V?_T;WS>;%P.G^],MG?Q[8<
ME#!YUKNZ\CY]Z%WVSM_Y=5NN!N/63,A))*Q#YJFIXW =0L*#)Q#'%3GUSL5Y
MB!A;.A"?L%JN1+2QIP@9K*:Y?FT^O!%<U]=10FM&-[VY0=\Z4+&,6:33BH!W
M=IF("YAA$9KQY><=^NE9$<[_=K"_\_)E9^G/NSO+?[MKV,.=SO,7WWQ4FNS^
M2L,^HX7@Q8!5S:<J^<>C_4>5M C1$WJ]-_WB=>I;%>M1L6"I_WH-1,+OLG_T
MH7MY[!V??WQ[TCON_F[I3U;@CI?;Q5=[M-*EK5^'X]Z_CLY/*4U[I[8$F[?1
MB[5<_O-/!R_?>)=@NJDL]([3$E@^5+.MW^\[E^-"(?[F9^]TQSLML^EX]I"]
M%^E*.993!E0)/9SZFZ]8L14NO?]YK5_V/[7>WV=5-V;M>K]=^-[1&),Y3NBP
M^YP;.RU:PH8QWWE.J[".9:U=NBW"M+-'X@,#%?#/WN[>[M]4C-ZS$']:@+9^
M 1">Y]ON_38N"M'!,_(R5O%XEWH]AU_O/OWYV]85*:(E710I&IR;*K_^V?NJ
M''!QY.A'Z&>1^.HL#_T\PQ0T^&=<3.)?_S]02P,$%     @ 08I+4H0DXXA0
M%   1'<  !X   !D>&-M,3(S,3(P,C!E>#0P-'-E8W5R:71I92YH=&WM7>M3
M&\>6_[Y_15^RN3>W2A(28&(#<14!8E/KV"Z0-]E/6STS+:GCF>G)] Q"^]?O
M>73/0])@L'' 1+=R,6BF7Z?/^9UGMX[^<?KN9/P_[\_$K$AB\?[#SV_.3\16
M?WO[M]V3[>W3\:EX/?[UC=@;#$=BG,O4ZD*;5,;;VV=OM\36K"BR@^WM^7P^
MF.\.3#[='E]L8U=[V[$Q5@VB(MIZ>82?P$\EHY?_<?2/?E^<FK!,5%J(,%>R
M4)$HK4ZGXK=(V8^BWW=OG9ALD>OIK! [PYV1^,WD'_65Y.>%+F+UTO=SM,U_
M'VW3($>!B18OCR)])73TTY;>'>T]WQ].GK]0N^'>[FCR7(;A<'\O"%^$P=Y(
MJ?\=P22WX75N8XM%K'[:2G3:GRD<_V#O658<SG54S Y&P^'W6ZWW"G5=]&6L
MI^D!S1:>3@RLS3T.36SR@^^&]+]#?-*?R$3'BX-_C76BK'BKYN+")#+]5\\"
MA?M6Y7K"+UK]?^I@M .#TY]SGLV/T$^L4^5G-]H9?G](LXA4:'*)6W10II'*
M\:VMEV>_OS[_^7R,N[AWM(T]^=6NKEGF4UAV8(K") ?[,'!C=2%06N7WOKS1
M+9:W]?+T[/+DXOS]^/S=6_'N%S%^?28NSEZ=7XXOCM^.__G=\YW1CX>7XO+L
MY,/%^?C\[-(O]'[G.ER:Z][:N8JC('_Y=29P.V(Q9<XNSDY!IB\N/P")Q/@=
M4H?H-]KQ)-S0BR9P]OO)Z^.WK\[$\<D823-ZL;LD*8]%1JC' UW :.$M*'ML
MA9F(4Q6J)%"YV!WU$$N'/?CH^L0D/7&>A@/Q0S%3 F5H9W@(GV8R7?3HS]&A
M_WBN_ <F]Y^9,G<?_EO,9"1,JD082TMC6A66.6@+6%VNIMH"51#G$97$I0H1
MHY /X4T<_+)^^^PZG,ETJL1Q6.!CW(M_?O?L.8Q<YB(T20(M;6'"CP/QJ3TJ
M3'8P>M[>H3]*6^C)XJ%@3-DPUQDM'Q9W(C/<2W&)Z[G5:G8>9C7KV6L,6S<Q
M<6SFJ+YMF<!,%WY/8<<38@7:-[=0VCBAK0BD17[(D [P/%>V($L@5#DL2(?P
M![;5*6BTS"FUGI!62%#XD8K@]S1J-PT6L9S;@<!9^;G 2*DID&VR6!6*6\&'
M?Y9 OXFF5M##!+@S#6'.YBZSP54NO4&S(],&NEKSO-5#UQ)Z8C[3X4S(',BK
M8_@<UJVN9SK0A>6.80G':0J+$!<*N@-)2<4O)D_$:-C_+^H7&]>C+2]T!O_J
M="!^4P+^ACE(D+B%*;%WL,FBOY(,O74TH#5@2YEE@'4RB)7(<G.E+;2PGL=.
M%;R+*WVE4I4#-4X:U'TCYSV$J]-7)V]ZP*>YD%'D#%B8 7R0T(N#QRQXZV'$
M+_<QSWP]9 ##S>05;&M9S$P.#:,E; AA>T%=(*# )N\,A[TA_U_8&>PT;7U3
M"_3$?PX'0_!/,IF+*QF7P">@8^AE%O=G:WI 162!&L1Q&<D%ZJ=/]GA+G?.H
MF.6$J44ZYDNFSQ]IH%Q:'.R"X?, 9DZ'5M57&F85"7+ [*T6N??0:[Q13"[+
MX ^PDA ^LPJU ?MGLA")7! J+O IV&H-ME[B9 #6 E UC5":H"6I99@F8_;,
MQ&"-U2JZ(52D/8 $Z%5'K!-"I4%L(T=IBUUCRTF)?\1J*F.8D+R2.B:LUMQI
M8&0>X7N1ABX*DX-RTZE /19I,(44*X!(H;4 5"#UIJTMFT,Y50"60HICU.O@
M1] ?*8K$E&GA:+1^;")=-=87R?+C%8;_-@2>3T847M^!3=$%N3*%(FVO)-A0
M)!M@[L3HGPA@4N"!HL#^;!DDNBBXH>1FZ+A@QTXTGBB'O"5040FX(2#20"FK
M85Q0=D^&9]XM,XKS YJ\TB !K[MR#O!-6P,P6"17P P$5 "MU C=%J1;^A%E
M#4&P89T^4;:YH%AL0QG$^L]21VQL YH7N0[*@LSS;Y^#/GC/M+'('J[2FKCT
M^P]N+ZK6?IFQ1I76JF*=-D0X:E+(.YI-L!%S4P)*!:I^D]J"-P/_+E"_ :M]
M4G&CZP<V =BNA0YU)DD9?-(NP!]D&-BFX:&1QZ$'.Y&A#UD@A#:;1RHH:-18
MRT#'',3QSINW70H-]KU#%^S#/Y8+<A+AHR8O-2R>'AH2&(\B](9U-8?NM'NZ
M/;IF0#\SG,XXR,&+1!SH#/&[6-^P;B(#XH/N)E\_)GB[V.JHDQ0=>8N7S6!L
M,TW /V>Y;Y_)J>H'N9(?^W(""SR0\5PN[-:=DBB?&/,^D&--Y]^"U_:^8NG;
M.VZ/&U+?K;?)0>'6P8 6 ,5@EA22-0I(.$9. PYD4>R'PCJ5NS#)34(81B$G
M_+?,\-=UWO\R'.J4+$= N\2 M8CK0^B!UAB4"F)M9VOZQTFD)076T6[DWN%A
M0(&WN(P4^29LAE*7#'Q&3/0UM?8Q"-(MF9DK=(^:_IZL?5H7\:H7L=POH2.]
MI',?WPR9>KT6*0T'VW(=NH=^DJ&T"G0:[ 7X=I,RAZYR9Q?GPFF 8+&BN ;B
MAIV-+1C7J,9PHU+,]UKJ+E+N][54)!VQ\*M;W;&> .U(=EJ@8C/O[(04F^N%
M/<A:??2JI>)0][!<="YA[_UJ*Z:FV2&32HR\KF$_G <.3#&OO&%O^KVG981D
M'L@(GRFT!R83DI.9\FV)@[ '0TMI,\X-1@.'S&^8(06D?0"65.\D5M>:U/T"
MV0>FG+JD#BT&]*352 <9@EIGG<E<RE.KPM(B*^$WB])&Z^LY,X=?*V8P%CRB
MB"$N0O&:D>R@LQ>TBQ%-U=$.)GZ%Y@;:-<(EDGA^16[BQN(QR4432LBJ74M6
M0-:/JD [B*FRUMAJT+]>WQU([P.B*3@:98ZVDLABF=; =F.$YUN,1YY= SA:
M="!^,7F9/ W%YM)2C-A+J0P6&^7,;&"($V #XN*3&4I<G3.[+%R"I$IL:,N,
M7]%L@C3C;$:*P:Q<7Y'QZA&+A,"$2I&<!KDID;^=,Q.HF8PG/6KJWD>?)7<"
M@]8<Z $,Z^FH##5FT**R6'0V"&.I$R&G4J>V$"6(>*ZIE ?$&M&DRO^PLKY#
M4@E1[&:RMB9%V@6,4!"/HL?1T1YX^T"FT*D;%_1C>04VBA"Z8-S[GI3;F-L0
MB_@!-GAJ 'S2VK*AE6"2"K!(:@".R(2@KC%B.<;,7Q5I<"XCZL$J(&Q+#*[Z
M?4<3QE%!TE;B_+RGMJCJK]S [=P[+\0!-LT=N8Y3D_CVA\'E0$Q41)DHS"'"
MN 1E-;/^40(_1&QHL-Z\24Z\#EZ1%S\(.\9AX4=S4O,AU079R= 9?7B<@%B$
M$G01.*N!ZI0@F(")KQBZ%YPDALUI;YHL+:<TW88Z!N=*AJ7:!2#;-YA,/ 9]
MV1_+CPK94+RODZS?/C*/9VNSQG<%HUN4'3CS[/:6"J8_*._.[,=BEH&9 $Q&
MO@:93O3V>NN%K#;;7%^S;H +("B_2B9RC\S3==-KSJ/P7!#HB"LI%M0;F?'L
MK2 -0$8POL0>4E4^P).W8&\KBHJB#4QK4,T5E.0CI6H*-A-2>P( 5[#5N#YI
M0R82K$&KJP8D!"I5$\T8X/T*BL$6J@I587\9?,#A)X]YK=%I7+"VRG0"3D(:
MQ02090JXH$-"%;<$1/Z">(T]-VW!9 0%!PNW*V24.!$P:V'4!A%@Y8%B//$3
M<!,M_$92&\]+P&%E7""Q88(ZP7U6/ES&7AZ5V#S1:'-E ;V1\R> 1,##+)95
M=*-8P29?%[<SW&U"%1;0E3$'<FO'R8LJ[/]Y*J9<$-+C!LV.8 A7. 1<609
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M?_:0=)C:Y*P>686UQ]&V7YURJ[SOCJE@>*>T6/,38>=BA&:*RQ#C-C>1S1U
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MR_G1!/J"T;%<;++F6-;L-3\AEIU5J_X+4$L#!!0    ( $&*2U)M!S+ Y ,
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M$#8[\$FM*.%G9Q?_[ZHN9L5+(N1 X%Q5H4^C*R$K!?_Y9RNN)7OD>D+9?-/
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M_XL)T4^P":"7NEZ_$T12,_=@+XV4D,6#6>DG96'O_/=3QGIX*3FV\1S[^$[
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M#U!+ 0(4 Q0    ( $&*2U*^&J*?*9\$ &'D*P 1              "  0
M  !D>&-M+3(P,C Q,C,Q+FAT;5!+ 0(4 Q0    ( $&*2U*@X:OU:A4  &C>
M   1              "  5B?! !D>&-M+3(P,C Q,C,Q+GAS9%!+ 0(4 Q0
M   ( $&*2U++YQ'UJS(  'D6 @ 5              "  ?&T! !D>&-M+3(P
M,C Q,C,Q7V-A;"YX;6Q02P$"% ,4    " !!BDM273$UG<EK  #.D 0 %0
M            @ '/YP0 9'AC;2TR,#(P,3(S,5]D968N>&UL4$L! A0#%
M  @ 08I+4C<85J12"@$ O$8! !0              ( !RU,% &1X8VTM,C R
M,#$R,S%?9S$N:G!G4$L! A0#%     @ 08I+4E\&7$-*<0$ "T," !0
M         ( !3UX& &1X8VTM,C R,#$R,S%?9S(N:G!G4$L! A0#%     @
M08I+4E,HJH;G< ( ]@D# !0              ( !R\\' &1X8VTM,C R,#$R
M,S%?9S,N:G!G4$L! A0#%     @ 08I+4F(^"GWC(0$ 'W4! !0
M     ( !Y$ * &1X8VTM,C R,#$R,S%?9S0N:G!G4$L! A0#%     @ 08I+
M4HDMWH^],P$ 97P, !4              ( !^6(+ &1X8VTM,C R,#$R,S%?
M;&%B+GAM;%!+ 0(4 Q0    ( $&*2U+P>UF#];4  #M("  5
M  "  >F6# !D>&-M+3(P,C Q,C,Q7W!R92YX;6Q02P$"% ,4    " !!BDM2
M+52]=LPO   X+P$ '@              @ $130T 9'AC;3$R,S$R,#(P97@Q
M,#0S9&]I;F1E;6XN:'1M4$L! A0#%     @ 08I+4D7.9XO8.   BVH! !X
M             ( !&7T- &1X8VTQ,C,Q,C R,&5X,3 T-#(P,35E<W!P+FAT
M;5!+ 0(4 Q0    ( $&*2U+.T=V'R!\  "/-   >              "  2VV
M#0!D>&-M,3(S,3(P,C!E>#$P-#4R,#$U97-P<"YH=&U02P$"% ,4    " !!
MBDM2+I_@@,$T  !N< $ '@              @ $QU@T 9'AC;3$R,S$R,#(P
M97@Q,#0W9&]U8FQE9&$N:'1M4$L! A0#%     @ 08I+4H0DXXA0%   1'<
M !X              ( !+@L. &1X8VTQ,C,Q,C R,&5X-# T<V5C=7)I=&EE
M+FAT;5!+ 0(4 Q0    ( $&*2U*X6!Y6=!P  )"W   >              "
M ;H?#@!D>&-M,3(S,3(P,C!E>&AI8FET,3 T-FUO>2YH=&U02P$"% ,4
M" !!BDM2D%N<Q=H$   &-P  &P              @ %J/ X 9'AC;3$R,S$R
M,#(P97AH:6)I=#(Q,#$N:'1M4$L! A0#%     @ 08I+4FT',L#D P  Q X
M !L              ( !?4$. &1X8VTQ,C,Q,C R,&5X:&EB:70R,S Q+FAT
M;5!+ 0(4 Q0    ( $&*2U*F8%VF&0@  -PF   ;              "  9I%
M#@!D>&-M,3(S,3(P,C!E>&AI8FET,S$P,2YH=&U02P$"% ,4    " !!BDM2
M]C?ZK/L'  !D)0  &P              @ 'L30X 9'AC;3$R,S$R,#(P97AH
M:6)I=#,Q,#(N:'1M4$L! A0#%     @ 08I+4JC+9\EG!   Z1   !L
M         ( !(%8. &1X8VTQ,C,Q,C R,&5X:&EB:70S,C Q+FAT;5!+ 0(4
M Q0    ( $&*2U+MX,%M3P0  /\/   ;              "  <!:#@!D>&-M
M,3(S,3(P,C!E>&AI8FET,S(P,BYH=&U02P4&     !8 %@ 0!@  2%\.

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
